PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dhar, N; Rana, S; Razdan, S; Bhat, WW; Hussain, A; Dhar, RS; Vaishnavi, S; Hamid, A; Vishwakarma, R; Lattoo, SK				Dhar, Niha; Rana, Satiander; Razdan, Sumeer; Bhat, Wajid Waheed; Hussain, Aashiq; Dhar, Rekha S.; Vaishnavi, Samantha; Hamid, Abid; Vishwakarma, Ram; Lattoo, Surrinder K.			Cloning and Functional Characterization of Three Branch Point Oxidosqualene Cyclases from Withania somnifera (L.) Dunal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; GENE-EXPRESSION; TRITERPENE SYNTHASES; PROMOTER ANALYSIS; METHYL JASMONATE; MESSENGER-RNA; WITHAFERIN-A; PLANT; SQUALENE; PROTEIN	Oxidosqualene cyclases (OSCs) positioned at a key metabolic subdividing junction execute indispensable enzymatic cyclization of 2,3-oxidosqualene for varied triterpenoid biosynthesis. Such branch points present favorable gene targets for redirecting metabolic flux toward specific secondary metabolites. However, detailed information regarding the candidate OSCs covering different branches and their regulation is necessary for the desired genetic manipulation. The aim of the present study, therefore, was to characterize members of OSC superfamily from Withania somnifera (Ws), a medicinal plant of immense repute known to synthesize a large array of biologically active steroidal lactone triterpenoids called withanolides. Three full-length OSC cDNAs, beta-amyrin synthase (WsOSC/BS), lupeol synthase (WsOSC/LS), and cycloartenol synthase (WsOSC/CS), having open reading frames of 2289, 2268, and 2277 bp, were isolated. Heterologous expression in Schizosaccharomyces pombe, LC-MS analyses, and kinetic studies confirmed their monofunctionality. The three WsOSCs were found to be spatially regulated at transcriptional level with WsOSC/CS being maximally expressed in leaf tissue. Promoter analysis of three WsOSCs genes resulted in identification of distinct cis-regulatory elements. Further, transcript profiling under methyl jasmonate, gibberellic acid, and yeast extract elicitations displayed differential transcriptional regulation of each of the OSCs. Changes were also observed in mRNA levels under elicitations and further substantiated with protein expression levels by Western blotting. Negative regulation by yeast extract resulted in significant increase in withanolide content. Empirical evidence suggests that repression of competitive branch OSCs like WsOSC/BS and WsOSC/LS possibly leads to diversion of substrate pool toward WsOSC/CS for increased withanolide production.	[Dhar, Niha; Rana, Satiander; Razdan, Sumeer; Bhat, Wajid Waheed; Dhar, Rekha S.; Lattoo, Surrinder K.] CSIR Indian Inst Integrat Med, Plant Biotechnol Div, Jammu 180001, India; [Hussain, Aashiq; Hamid, Abid] CSIR Indian Inst Integrat Med, Div Canc Pharmacol, Jammu 180001, India; [Vishwakarma, Ram] CSIR Indian Inst Integrat Med, Div Med Chem, Jammu 180001, India; [Vaishnavi, Samantha] Shri Mata Vaishno Devi Univ, Sch Biotechnol, Katra 182320, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Shri Mata Vaishno Devi University	Lattoo, SK (corresponding author), CSIR Indian Inst Integrat Med, Plant Biotechnol Div, Canal Rd, Jammu 180001, India.	sklattoo@iiim.ac.in	Rana, Satiander/G-3696-2012; Bhat, Wajid Waheed/E-6645-2012	Rana, Satiander/0000-0001-9197-8378; Bhat, Wajid Waheed/0000-0002-7049-8671; DHAR, NIHA/0000-0002-3295-8016	Council of Scientific and Industrial Research, Government of India, New Delhi [BSC-0108]; Council of Scientific and Industrial Research, Government of India, New Delhi	Council of Scientific and Industrial Research, Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Council of Scientific and Industrial Research, Government of India, New Delhi, under Network Project BSC-0108 and by a Senior Research Fellowship from the Council of Scientific and Industrial Research, Government of India, New Delhi (to N. D., S. R., S. R., A. H., and W. W. B.).	ABE I, 1993, CHEM REV, V93, P2189, DOI 10.1021/cr00022a009; Aoyagi H, 2001, APPL MICROBIOL BIOT, V57, P482, DOI 10.1007/s002530100819; Bais HP, 2001, IN VITRO CELL DEV-PL, V37, P293, DOI 10.1007/s11627-001-0052-8; Bhat WW, 2012, GENE, V499, P25, DOI 10.1016/j.gene.2012.03.004; Brendolise C, 2011, FEBS J, V278, P2485, DOI 10.1111/j.1742-4658.2011.08175.x; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Byun S. Y., 1989, THESIS STATE U NEW J; Cheong JJ, 2003, TRENDS GENET, V19, P409, DOI 10.1016/S0168-9525(03)00138-0; Dhar RS, 2006, PHYTOCHEMISTRY, V67, P2269, DOI 10.1016/j.phytochem.2006.07.014; ELSAKKA M, 1990, Revista Medico-Chirurgicala Societatii di Medici si Naturalisti din Iasi, V94, P385; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Fu N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000216; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hayashi H, 2004, BIOL PHARM BULL, V27, P1086, DOI 10.1248/bpb.27.1086; Hayashi H, 2003, PLANT CELL PHYSIOL, V44, P404, DOI 10.1093/pcp/pcg054; Husselstein-Muller T, 2001, PLANT MOL BIOL, V45, P75, DOI 10.1023/A:1006476123930; Iturbe-Ormaetxe I, 2003, PLANT MOL BIOL, V51, P731, DOI 10.1023/A:1022519709298; Jacobs DI, 2000, PHYTOCHEM ANALYSIS, V11, P277, DOI 10.1002/1099-1565(200009/10)11:5&lt;277::AID-PCA535&gt;3.0.CO;2-S; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kawano N, 2002, BIOL PHARM BULL, V25, P477, DOI 10.1248/bpb.25.477; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Kolkman A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100069; Kushiro T, 2000, J AM CHEM SOC, V122, P6816, DOI 10.1021/ja0010709; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lattoo SK, 2007, CURR SCI INDIA, V92, P1390; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu LS, 1999, EUR J BIOCHEM, V262, P247, DOI 10.1046/j.1432-1327.1999.00349.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu MB, 2001, PLANT CELL REP, V20, P674; MAHATO SB, 1992, PHYTOCHEMISTRY, V31, P2199, DOI 10.1016/0031-9422(92)83257-Y; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; McCloud TG, 2010, MOLECULES, V15, P4526, DOI 10.3390/molecules15074526; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Morita M, 2000, EUR J BIOCHEM, V267, P3453, DOI 10.1046/j.1432-1327.2000.01357.x; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Pal S, 2011, J HORTIC SCI BIOTECH, V86, P391, DOI 10.1080/14620316.2011.11512779; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; PRENTICE HL, 1992, NUCLEIC ACIDS RES, V20, P621, DOI 10.1093/nar/20.3.621; Radman R, 2003, BIOTECHNOL APPL BIOC, V37, P91, DOI 10.1042/BA20020118; Rana S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057068; Rana S, 2012, IN VITRO CELL DEV-PL, V48, P546, DOI 10.1007/s11627-012-9458-8; Razdan S, 2013, MOL BIOL REP, V40, P905, DOI 10.1007/s11033-012-2131-9; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sharaf-Eldin MA, 2007, SCI HORTIC-AMSTERDAM, V111, P326, DOI 10.1016/j.scienta.2006.12.002; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Walther D, 2007, PLOS GENET, V3, P216, DOI 10.1371/journal.pgen.0030011; Wang ZH, 2010, J BIOL CHEM, V285, P29703, DOI 10.1074/jbc.M109.098871; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Xu R, 2004, PHYTOCHEMISTRY, V65, P261, DOI 10.1016/j.phytochem.2003.11.014; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zuckerkandl E, 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	56	50	54	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17249	17267		10.1074/jbc.M114.571919	http://dx.doi.org/10.1074/jbc.M114.571919			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24770414	Green Published, hybrid			2022-12-25	WOS:000338016200057
J	Meyer, MB; Benkusky, NA; Pike, JW				Meyer, Mark B.; Benkusky, Nancy A.; Pike, J. Wesley			The RUNX2 Cistrome in Osteoblasts CHARACTERIZATION, DOWN-REGULATION FOLLOWING DIFFERENTIATION, AND RELATIONSHIP TO GENE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING SITES; TRANSCRIPTION-FACTOR; BONE-FORMATION; DISTAL ENHANCERS; CLEIDOCRANIAL DYSPLASIA; RECEPTOR ACTIVATOR; EPIGENETIC CONTROL; CANCER CELLS; GENOME; CBFA1	RUNX2 is a transcription factor that is first expressed in early osteoblast-lineage cells and represents a primary determinant of osteoblastogenesis. While numerous target genes are regulated by RUNX2, little is known of sites on the genome occupied by RUNX2 or of the gene networks that are controlled by these sites. To explore this, we conducted a genome-wide analysis of the RUNX2 cistrome in both pre-osteoblastic MC3T3-E1 cells (POB) and their mature osteoblast progeny (OB), characterized the two cistromes and assessed their relationship to changes in gene expression. We found that although RUNX2 was widely bound to the genome in POB cells, this binding profile was reduced upon differentiation to OBs. Numerous sites were lost upon differentiation, new sites were also gained; many sites remained common to both cell states. Additional features were identified as well including location relative to potential target genes, abundance with respect to single genes, the frequent presence of a consensus TGTGGT RUNX2 binding motif, co-occupancy by C/EBP beta and the presence of a typical epigenetic histone enhancer signature. This signature was changed quantitatively following differentiation. While RUNX2 binding sites were associated extensively with adjacent genes, the distal nature of the majority of these sites prevented assessment of whether they represented direct targets of RUNX2 action. Changes in gene expression, however, revealed an abundance of genes that contained RUNX2 binding sites and were regulated in concert. These studies establish a basis for further analysis of the role of RUNX2 activity and its function during osteoblast lineage maturation.	[Meyer, Mark B.; Benkusky, Nancy A.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, Hector F Deluca Biochem Labs, Room 543D,433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health [DK-072281]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-072281 (to J. W. P.).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Blyth K, 2010, BLOOD CELL MOL DIS, V45, P117, DOI 10.1016/j.bcmd.2010.05.007; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931; Cameron ER, 2003, BLOOD CELL MOL DIS, V30, P194, DOI 10.1016/S1079-9796(03)00031-7; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Delgado-Calle J, 2012, CURR GENOMICS, V13, P252, DOI 10.2174/138920212800543129; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gordon JAR, 2011, CELLS TISSUES ORGANS, V194, P146, DOI 10.1159/000324790; Hassan MQ, 2009, CELLS TISSUES ORGANS, V189, P122, DOI 10.1159/000151453; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Ivkosic A, 2006, COLLEGIUM ANTROPOL, V30, P401; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jonason JH, 2009, J DENT RES, V88, P693, DOI 10.1177/0022034509341629; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kilbey A, 2008, CELL CYCLE, V7, P2333; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lian JB, 2013, J BONE MINER RES, V28, P2060, DOI 10.1002/jbmr.2076; Little GH, 2012, NUCLEIC ACIDS RES, V40, P3538, DOI 10.1093/nar/gkr1219; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Martowicz ML, 2011, J CELL BIOCHEM, V112, P2030, DOI 10.1002/jcb.23123; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Reinhold MI, 2007, J BIOL CHEM, V282, P3653, DOI 10.1074/jbc.M608995200; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saltman LH, 2005, J CELL PHYSIOL, V204, P871, DOI 10.1002/jcp.20329; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Stein GS, 2010, ADV ENZYME REGUL, V50, P160, DOI 10.1016/j.advenzreg.2009.10.026; Stein GS, 2009, BIOCHEM CELL BIOL, V87, P1, DOI 10.1139/O08-094; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Taher L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r117; Takarada T, 2013, J BONE MINER RES, V28, P2064, DOI 10.1002/jbmr.1945; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; van der Deen M, 2012, J BIOL CHEM, V287, P4503, DOI 10.1074/jbc.M111.287771; Vierstra J, 2014, NAT METHODS, V11, P66, DOI [10.1038/NMETH.2713, 10.1038/nmeth.2713]; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; Wamstad JA, 2014, TRENDS CELL BIOL, V24, P294, DOI 10.1016/j.tcb.2013.10.008; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Wuelling M, 2011, ENDOCR DEV, V21, P1, DOI 10.1159/000328081; Zaidi SK, 2006, J CELL PHYSIOL, V209, P935, DOI 10.1002/jcp.20791; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zanotti S, 2009, J ENDOCRINOL, V201, P263, DOI 10.1677/JOE-08-0514; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	76	85	88	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16016	16031		10.1074/jbc.M114.552216	http://dx.doi.org/10.1074/jbc.M114.552216			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764292	hybrid, Green Published			2022-12-25	WOS:000337965700012
J	Exil, V; Ping, L; Yu, Y; Chakraborty, S; Caito, SW; Wells, KS; Karki, P; Lee, E; Aschner, M				Exil, Vernat; Ping, Li; Yu, Yingchun; Chakraborty, Sudipta; Caito, Samuel W.; Wells, K. Sam; Karki, Pratap; Lee, Eunsook; Aschner, Michael			Activation of MAPK and FoxO by Manganese (Mn) in Rat Neonatal Primary Astrocyte Cultures	PLOS ONE			English	Article							PARKINSONS-DISEASE; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; ENERGY-METABOLISM; MAGNETIC-RESONANCE; GLUCOSE-METABOLISM; CELL-CYCLE; NEUROTOXICITY; BRAIN; EPIDEMIOLOGY	Environmental exposure to manganese (Mn) leads to a neurodegenerative disease that has shared clinical characteristics with Parkinson's disease (PD). Mn-induced neurotoxicity is time-and dose-dependent, due in part to oxidative stress. We ascertained the molecular targets involved in Mn-induced neurodegeneration using astrocyte culture as: (1) Astrocytes are vital for information processing within the brain, (2) their redox potential is essential in mitigating reactive oxygen species (ROS) levels, and (3) they are targeted early in the course of Mn toxicity. We first tested protein levels of Mn superoxide dismutase -2 (SOD-2) and glutathione peroxidase (GPx-1) as surrogates of astrocytic oxidative stress response. We assessed levels of the forkhead winged-helix transcription factor O (FoxO) in response to Mn exposure. FoxO is highly regulated by the insulin-signaling pathway. FoxO mediates cellular responses to toxic stress and modulates adaptive responses. We hypothesized that FoxO is fundamental in mediating oxidative stress response upon Mn treatment, and may be a biomarker of Mn-induced neurodegeneration. Our results indicate that 100 or 500 mu M of MnCl2 led to increased levels of FoxO (dephosphorylated and phosphorylated) compared with control cells (P<0.01). p-FoxO disappeared from the cytosol upon Mn exposure. Pre-treatment of cultured cells with (R)-(2)-2-oxothiazolidine-4-carboxylic acid (OTC), a cysteine analog rescued the cytosolic FoxO. At these concentrations, MAPK phosphorylation, in particular p38 and ERK, and PPAR gamma coactivator-1 (PGC-1) levels were increased, while AKT phosphorylation remained unchanged. FoxO phosphorylation level was markedly reduced with the use of SB203580 (a p38 MAPK inhibitor) and PD98059 (an ERK inhibitor). We conclude that FoxO phosphorylation after Mn exposure occurs in parallel with, and independent of the insulin-signaling pathway. FoxO levels and its translocation into the nucleus are part of early events compensating for Mn-induced neurotoxicity and may serve as valuable targets for neuroprotection in the setting of Mn-induced neurodegeneration.	[Exil, Vernat] Vanderbilt Univ, Monroe Carrell Jr Childrens Hosp, Sch Med, Dept Pediat,Thomas P Graham Div Pediat Cardiol, Nashville, TN 37235 USA; [Ping, Li; Yu, Yingchun; Chakraborty, Sudipta; Caito, Samuel W.; Aschner, Michael] Vanderbilt Univ, Monroe Carrell Jr Childrens Hosp, Sch Med, Dept Pediat,Div Pediat Toxicol, Nashville, TN 37235 USA; [Wells, K. Sam] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Karki, Pratap; Lee, Eunsook] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Meharry Medical College	Exil, V (corresponding author), Vanderbilt Univ, Monroe Carrell Jr Childrens Hosp, Sch Med, Dept Pediat,Thomas P Graham Div Pediat Cardiol, 221 Kirkland Hall, Nashville, TN 37235 USA.	vernat.exil@vanderbilt.edu	Exil, Vernat/GYD-7777-2022	Exil, Vernat/0000-0001-5935-4039	NIH HHS/United States [RO1 ES010563-08/ES/NIEHS]; Toxicology Pilot Grant (Vanderbilt University Medical Center)/United States [404-228-1704/NIH P30 ES000267]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563] Funding Source: NIH RePORTER	NIH HHS/United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Toxicology Pilot Grant (Vanderbilt University Medical Center)/United States; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Michael Aschner: RO1 ES010563-08/ES/NIEHS NIH HHS/United States. Vernat Exil: Toxicology Pilot Grant (Vanderbilt University Medical Center)/United States 404-228-1704/NIH P30 ES000267/ (https://my.vanderbilt.edu/toxicology). There were no individuals employed or contracted by the funders (other than the named authors) that played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mubarak B, 2009, CHANNELS, V3, P233; Alhosin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057883; Aschner M, 2002, BRAIN PATHOL, V12, P475; Aschner M, 2000, NEUROCHEM INT, V37, P199, DOI 10.1016/S0197-0186(00)00023-1; Au C, 2007, BIOL TRACE ELEM RES, V120, P248, DOI 10.1007/s12011-007-0067-z; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Bosco D, 2011, J CELL MOL MED, V15, P1807, DOI 10.1111/j.1582-4934.2011.01318.x; Brenneman KA, 1999, NEUROTOXICOLOGY, V20, P477; BROUILLET EP, 1993, EXP NEUROL, V120, P89, DOI 10.1006/exnr.1993.1042; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; CALNE DB, 1983, LANCET, V2, P1457, DOI 10.1016/S0140-6736(83)90802-4; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Chen CJ, 2002, EXP NEUROL, V175, P216, DOI 10.1006/exnr.2002.7894; Dapper JD, 2013, NEUROBIOLOGY DIS; de Lau LML, 2006, ARCH NEUROL-CHICAGO, V63, P362, DOI 10.1001/archneur.63.3.noc50312; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Desole MS, 1997, NEUROCHEM INT, V31, P169, DOI 10.1016/S0197-0186(96)00146-5; Dorman DC, 2006, TOXICOL SCI, V92, P201, DOI 10.1093/toxsci/kfj206; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Erikson KM, 2004, SCI TOTAL ENVIRON, V334, P409, DOI 10.1016/j.scitotenv.2004.04.044; Exil VJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014228; Exil VJ, 2006, AM J PHYSIOL-HEART C, V290, pH1289, DOI 10.1152/ajpheart.00811.2005; Exil VJ, 2003, CIRC RES, V93, P448, DOI 10.1161/01.RES.0000088786.19197.E4; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Gavin CE, 1999, NEUROTOXICOLOGY, V20, P445; GAVIN CE, 1992, TOXICOL APPL PHARM, V115, P1, DOI 10.1016/0041-008X(92)90360-5; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Gorell JM, 2004, J NEUROL SCI, V217, P169, DOI 10.1016/j.jns.2003.09.014; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gunter TE, 2006, NEUROTOXICOLOGY, V27, P765, DOI 10.1016/j.neuro.2006.05.002; HaMai D, 2004, ANN NY ACAD SCI, V1012, P129, DOI 10.1196/annals.1306.010; Hofman A, 2006, LANCET NEUROL, V5, P545, DOI 10.1016/S1474-4422(06)70473-2; HSIE AW, 1986, P NATL ACAD SCI USA, V83, P9616, DOI 10.1073/pnas.83.24.9616; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kim JH, 2012, CELL MOL BIOL, V58, P1780, DOI 10.1170/209; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; KRIEGER D, 1995, LANCET, V346, P270, DOI 10.1016/S0140-6736(95)92164-8; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; NEWLAND MC, 1989, EXP NEUROL, V106, P251, DOI 10.1016/0014-4886(89)90157-X; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Racette BA, 2001, NEUROLOGY, V56, P8, DOI 10.1212/WNL.56.1.8; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Shanker G, 2005, MOL BRAIN RES, V137, P11, DOI 10.1016/j.molbrainres.2005.02.006; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Taylor DM, 2013, J NEUROSCI, V33, P2313, DOI 10.1523/JNEUROSCI.4965-11.2013; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Wirdefeldt K, 2005, ANN NEUROL, V57, P27, DOI 10.1002/ana.20307; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; YAMADA M, 1986, ACTA NEUROPATHOL, V70, P273, DOI 10.1007/BF00686083; Yin ZB, 2008, BRAIN RES, V1203, P1, DOI 10.1016/j.brainres.2008.01.079; Zwingmann C, 2004, NEUROTOXICOLOGY, V25, P573, DOI 10.1016/j.neuro.2003.08.002; Zwingmann C, 2003, J CEREBR BLOOD F MET, V23, P756, DOI 10.1097/01.WCB.0000056062.25434.4D	65	39	40	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94753	10.1371/journal.pone.0094753	http://dx.doi.org/10.1371/journal.pone.0094753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787138	Green Submitted, Green Published, gold			2022-12-25	WOS:000336655700016
J	Kalmady, SV; Venkatasubramanian, G; Shivakumar, V; Gautham, S; Subramaniam, A; Jose, DA; Maitra, A; Ravi, V; Gangadhar, BN				Kalmady, Sunil Vasu; Venkatasubramanian, Ganesan; Shivakumar, Venkataram; Gautham, S.; Subramaniam, Aditi; Jose, Dania Alphonse; Maitra, Arindam; Ravi, Vasanthapuram; Gangadhar, Bangalore N.			Relationship between Interleukin-6 Gene Polymorphism and Hippocampal Volume in Antipsychotic-Naive Schizophrenia: Evidence for Differential Susceptibility?	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MAGNETIC-RESONANCE IMAGES; PLASMA IL-6 LEVELS; LOW-BIRTH-WEIGHT; GRAY-MATTER; PROMOTER POLYMORPHISM; PRENATAL INFECTION; BRAIN-DEVELOPMENT; IL6 GENE; NEUROTROPHIC FACTOR	Background: Various lines of evidence including epidemiological, genetic and foetal pathogenetic models suggest a compelling role for Interleukin-6 (IL-6) in the pathogenesis of schizophrenia. IL-6 mediated inflammatory response triggered by maternal infection or stress induces disruption of prenatal hippocampal development which might contribute towards psychopathology during adulthood. There is a substantial lack of knowledge on how genetic predisposition to elevated IL-6 expression effects hippocampal structure in schizophrenia patients. In this first-time study, we evaluated the relationship between functional polymorphism rs1800795 of IL-6 and hippocampal gray matter volume in antipsychotic-naive schizophrenia patients in comparison with healthy controls. Methodology: We examined antipsychotic-naive schizophrenia patients [N = 28] in comparison with healthy controls [N = 37] group matched on age, sex and handedness. Using 3 Tesla - MRI, bilateral hippocampi were manually segmented by blinded raters with good inter-rater reliability using a valid method. Additionally, Voxel-based Morphometry (VBM) analysis was performed using hippocampal mask. The IL-6 level was measured in blood plasma using ELISA technique. SNP rs1800795 was genotyped using PCR and DNA sequencing. Psychotic symptoms were assessed using Scale for Assessment of Positive Symptoms and Scale for Assessment of Negative Symptoms. Results: Schizophrenia patients had significantly deficient left and right hippocampal volumes after controlling for the potential confounding effects of age, sex and total brain volume. Plasma IL-6 levels were significantly higher in patients than controls. There was a significant diagnosis by rs1800795 genotype interaction involving both right and left hippocampal volumes. Interestingly, this effect was significant only in men but not in women. Conclusion: Our first time observations suggest a significant relationship between IL-6 rs1800795 and reduced hippocampal volume in antipsychotic-naive schizophrenia. Moreover, this relationship was antithetical in healthy controls and this effect was observed in men but not in women. Together, these observations support a "differential susceptibility" effect of rs1800795 in schizophrenia pathogenesis mediated through hippocampal volume deficit that is of possible neurodevelopmental origin.	[Kalmady, Sunil Vasu; Venkatasubramanian, Ganesan; Shivakumar, Venkataram; Subramaniam, Aditi; Jose, Dania Alphonse; Gangadhar, Bangalore N.] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Schizophrenia Clin, Bangalore, Karnataka, India; [Kalmady, Sunil Vasu; Venkatasubramanian, Ganesan; Shivakumar, Venkataram; Gautham, S.; Subramaniam, Aditi; Jose, Dania Alphonse] Natl Inst Mental Hlth & Neurosci, Neurobiol Res Ctr, Cognit Neurobiol Div, Translat Psychiat Lab, Bangalore, Karnataka, India; [Maitra, Arindam] Natl Inst Biomed Genom, Kalyani, W Bengal, India; [Ravi, Vasanthapuram] Natl Inst Mental Hlth & Neurosci, Dept Neurovirol, Bangalore, Karnataka, India	National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); National Institute of Mental Health & Neurosciences - India	Venkatasubramanian, G (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Schizophrenia Clin, Bangalore, Karnataka, India.	venkat.nimhans@yahoo.com	V, Shivakumar/AAR-6917-2020; Venkatasubramanian, Ganesan/AAD-9117-2019; Vasanthapuram, Ravi/AAD-5555-2019	V, Shivakumar/0000-0003-0353-8597; Venkatasubramanian, Ganesan/0000-0002-0949-898X; Kalmady, Sunil/0000-0002-4876-9121; Gangadhar, Bangalore/0000-0002-9887-6515	Innovative Young Biotechnologist Award by the Department of Biotechnology (Government of India) [BT/04/IYBA/2011]; Wellcome Trust/DBT India Alliance Senior Fellowship [500236/Z/11/Z]; Wellcome Trust/DBT India Alliance; Indian Council of Medical Research; Department of Science & Technology (Government of India)	Innovative Young Biotechnologist Award by the Department of Biotechnology (Government of India); Wellcome Trust/DBT India Alliance Senior Fellowship(Wellcome Trust DBT India Alliance); Wellcome Trust/DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Science & Technology (Government of India)(Department of Science & Technology (India))	This study is supported by the Innovative Young Biotechnologist Award by the Department of Biotechnology (Government of India) to GV (BT/04/IYBA/2011) as well as by the Wellcome Trust/DBT India Alliance Senior Fellowship research grant to GV (500236/Z/11/Z). SVK is supported by the Wellcome Trust/DBT India Alliance. VS is supported by the Indian Council of Medical Research. AS & DAJ are supported by the Department of Science & Technology (Government of India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baier PC, 2009, BEHAV BRAIN RES, V200, P192, DOI 10.1016/j.bbr.2009.01.013; Baune BT, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-125; Beauchamp MH, 2008, BRAIN, V131, P2986, DOI 10.1093/brain/awn227; Behrens MM, 2008, J NEUROSCI, V28, P13957, DOI 10.1523/JNEUROSCI.4457-08.2008; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Bonafe M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.0.CO;2-X; Brown Alan S, 2011, Front Psychiatry, V2, P63, DOI 10.3389/fpsyt.2011.00063; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brune M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-38; Chua SE, 2007, SCHIZOPHR RES, V89, P12, DOI 10.1016/j.schres.2006.09.009; Cole SW, 2010, P NATL ACAD SCI USA, V107, P5681, DOI 10.1073/pnas.0911515107; Csernansky JG, 2002, AM J PSYCHIAT, V159, P2000, DOI 10.1176/appi.ajp.159.12.2000; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; Ebdrup BH, 2010, J PSYCHIATR NEUROSCI, V35, P95, DOI 10.1503/jpn.090049; Ebner F, 2008, SCHIZOPHR RES, V104, P71, DOI 10.1016/j.schres.2008.06.007; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Freedman R, 2010, PROG NEUROBIOL, V90, P263, DOI 10.1016/j.pneurobio.2009.10.008; Giannitrapani L, 2011, OMICS, V15, P183, DOI 10.1089/omi.2010.0093; Gilmore JH, 2004, NEUROPSYCHOPHARMACOL, V29, P1221, DOI 10.1038/sj.npp.1300446; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Heckers S, 2001, HIPPOCAMPUS, V11, P520, DOI 10.1002/hipo.1068; Heckers S, 2004, AM J PSYCHIAT, V161, P2138, DOI 10.1176/appi.ajp.161.11.2138-a; Hu MR, 2013, SCHIZOPHR RES, V144, P37, DOI 10.1016/j.schres.2012.12.018; Huang MY, 2013, DNA CELL BIOL, V32, P654, DOI 10.1089/dna.2013.2148; Hulkkonen J, 2001, RHEUMATOLOGY, V40, P656, DOI 10.1093/rheumatology/40.6.656; Jayakumar PN, 2005, PROG NEURO-PSYCHOPH, V29, P587, DOI 10.1016/j.pnpbp.2005.01.020; Job DE, 2002, NEUROIMAGE, V17, P880, DOI 10.1006/nimg.2002.1180; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Keller SS, 2002, NEUROIMAGE, V16, P23, DOI 10.1006/nimg.2001.1072; Keshavan MS, 2002, SCHIZOPHR RES, V58, P173, DOI 10.1016/S0920-9964(01)00404-2; Kilpinen S, 2001, EUR CYTOKINE NETW, V12, P62; Konrad C, 2009, NEUROIMAGE, V47, P1185, DOI 10.1016/j.neuroimage.2009.05.019; Kovacs EJ, 2004, J LEUKOCYTE BIOL, V76, P36, DOI 10.1189/jlb.1103538; Kubicki M, 2002, NEUROIMAGE, V17, P1711, DOI 10.1006/nimg.2002.1296; Lindberg O, 2012, AM J NEURORADIOL, V33, P1957, DOI 10.3174/ajnr.A3093; Lodge DJ, 2010, INT J DEV NEUROSCI; Lowe GC, 2008, AM J PHYSIOL-REG I, V295, pR1563, DOI 10.1152/ajpregu.90350.2008; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maitra A, 2008, THROMB HAEMOSTASIS, V99, P944, DOI 10.1160/TH07-11-0686; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; Marx CE, 2001, BIOL PSYCHIAT, V50, P743, DOI 10.1016/S0006-3223(01)01209-4; McDonald C, 2006, AM J PSYCHIAT, V163, P478, DOI 10.1176/appi.ajp.163.3.478; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Mehler MF, 1999, ADV PROTEIN CHEM, V52, P223; Meyer U, 2009, SCHIZOPHRENIA BULL, V35, P959, DOI 10.1093/schbul/sbn022; Mondelli V, 2011, J CLIN PSYCHIAT, V72, P1677, DOI 10.4088/JCP.10m06745; Muller N, 1997, EUR ARCH PSY CLIN N, V247, P308, DOI 10.1007/BF02922260; Narr KL, 2004, NEUROIMAGE, V21, P1563, DOI 10.1016/j.neuroimage.2003.11.011; Neumeister A, 2005, BIOL PSYCHIAT, V57, P935, DOI 10.1016/j.biopsych.2005.01.016; Nicodemus KK, 2008, MOL PSYCHIATR, V13, P873, DOI 10.1038/sj.mp.4002153; Nosarti C, 2012, ARCH GEN PSYCHIAT, V69, P610, DOI 10.1001/archgenpsychiatry.2011.1374; Paul-Samojedny M, 2013, J NEUROPSYCH CLIN N, V25, P72, DOI 10.1176/appi.neuropsych.12020021; Pereira DS, 2011, BRAZ J MED BIOL RES, V44, P123, DOI 10.1590/S0100-879X2011000200006; Phillips LJ, 2006, AUST NZ J PSYCHIAT, V40, P725, DOI 10.1080/j.1440-1614.2006.01877.x; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Qi HP, 2012, PLOS ONE, V7; Rajarethinam R, 2001, PSYCHIAT RES-NEUROIM, V108, P79, DOI 10.1016/S0925-4927(01)00120-2; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Rivera-Chavez FA, 2003, SHOCK, V20, P218, DOI 10.1097/00024382-200309000-00004; Rizos EN, 2011, SCHIZOPHR RES, V129, P201, DOI 10.1016/j.schres.2011.03.011; Salgado-Pineda P, 2003, NEUROIMAGE, V19, P365, DOI 10.1016/S1053-8119(03)00094-6; Samuelsson AM, 2006, AM J PHYSIOL-REG I, V290, pR1345, DOI 10.1152/ajpregu.00268.2005; Sanderson SC, 2009, ATHEROSCLEROSIS, V204, P459, DOI 10.1016/j.atherosclerosis.2008.09.019; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith GN, 2001, SCHIZOPHR RES, V47, P177, DOI 10.1016/S0920-9964(00)00004-9; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Tamminga CA, 2010, AM J PSYCHIAT, V167, P1178, DOI 10.1176/appi.ajp.2010.09081187; Tepest R, 2003, BIOL PSYCHIAT, V54, P1234, DOI 10.1016/S0006-3223(03)00702-9; Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200; Testa C, 2004, J MAGN RESON IMAGING, V19, P274, DOI 10.1002/jmri.20001; Uchida RR, 2008, AN ACAD BRAS CIENC, V80, P149, DOI 10.1590/S0001-37652008000100010; Vignozzi L, 2012, J ENDOCRINOL, V214, P31, DOI 10.1530/JOE-12-0142; Yang XL, 2005, OBES RES, V13, P813, DOI 10.1038/oby.2005.92; Zakharyan R, 2012, TISSUE ANTIGENS, V80, P136, DOI 10.1111/j.1399-0039.2012.01886.x; ZALCMAN S, 1994, BRAIN RES, V643, P40, DOI 10.1016/0006-8993(94)90006-X; Zaretsky MV, 2004, OBSTET GYNECOL, V103, P546, DOI 10.1097/01.AOG.0000114980.40445.83	88	51	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96021	10.1371/journal.pone.0096021	http://dx.doi.org/10.1371/journal.pone.0096021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787542	Green Submitted, gold, Green Published			2022-12-25	WOS:000336655700049
J	Koster, WM; Dawson, DR; O'Mahony, DJ; Moloney, PD; Crook, DA				Koster, Wayne M.; Dawson, David R.; O'Mahony, Damien J.; Moloney, Paul D.; Crook, David A.			Timing, Frequency and Environmental Conditions Associated with Mainstem-Tributary Movement by a Lowland River Fish, Golden Perch (Macquaria ambigua)	PLOS ONE			English	Article							AUSTRALIAN FRESHWATER FISHES; ALTERED FLOW REGIMES; SPAWNING MIGRATION; FLOODPLAIN CONNECTIVITY; REARING EXPERIMENTS; MURRAY RIVER; DIVERSITY; HABITAT; TROUT; WATER	Tributary and mainstem connections represent important links for the movement of fish and other biota throughout river networks. We investigated the timing, frequency and environmental conditions associated with movements by adult golden perch (Macquaria ambigua) between the mainstem of the mid-Murray River and a tributary, the Goulburn River, in south-eastern Australia, using acoustic telemetry over four years (2007-2011). Fish were tagged and released in autumn 2007-2009 in the mid-Murray (n = 42) and lower Goulburn (n = 37) rivers within 3-6 km of the mid-Murray-lower Goulburn junction. 38% of tagged fish undertook mainstem-tributary movements, characterised mostly by temporary occupation followed by return of fish to the original capture river. Approximately 10% of tagged fish exhibited longer-term shifts between the mainstem and tributary. Movement of fish from the tributary into the mainstem occurred primarily during the spawning season and in some years coincided with the presence of golden perch eggs/larvae in drift samples in the mainstem. Many of the tributary-to-mainstem movements occurred during or soon after changes in flow. The movements of fish from the mainstem into the tributary were irregular and did not appear to be associated with spawning. The findings show that golden perch moved freely across the mainstem-tributary interface. This demonstrates the need to consider the spatial, behavioural and demographic interdependencies of aquatic fauna across geographic management units such as rivers.	[Koster, Wayne M.; Dawson, David R.; O'Mahony, Damien J.; Moloney, Paul D.; Crook, David A.] Arthur Rylah Inst Environm Res, Dept Environm & Primary Ind, Heidelberg, Vic, Australia; [Koster, Wayne M.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia	Arthur Rylah Institute for Environmental Research (ARI); Deakin University	Koster, WM (corresponding author), Arthur Rylah Inst Environm Res, Dept Environm & Primary Ind, Heidelberg, Vic, Australia.	Wayne.Koster@depi.vic.gov.au		Crook, David/0000-0003-4035-050X; Moloney, Paul/0000-0002-5010-214X	Goulburn Broken Catchment Management Authority (GBCMA)	Goulburn Broken Catchment Management Authority (GBCMA)	The Goulburn Broken Catchment Management Authority (GBCMA) funded this study (www.gbcma.vic.gov.au). The funders had no role in study design, data collection and analysis. Permission was sought from GBCMA to publish. GBCMA provided comments on an ealier version of this manuscript.	Alldredge P, 2011, ECOL FRESHW FISH, V20, P513, DOI 10.1111/j.1600-0633.2011.00499.x; Allen G.R., 2002, FIELD GUIDE FRESHWAT; Argent DG, 2009, NORTHEAST NAT, V16, P607, DOI 10.1656/045.016.n410; Baran E., 2006, FISH MIGRATION TRIGG; Barton K., 2012, MUMIN MULTIMODEL INF; BERNARD D R, 1982, Northwest Science, V56, P148; Bramblett RG, 2002, T AM FISH SOC, V131, P498, DOI 10.1577/1548-8659(2002)131<0498:SUOSTA>2.0.CO;2; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Burgess OT, 2013, RIVER RES APPL, V29, P718, DOI 10.1002/rra.2567; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Copp G. H., 2003, Journal of Fish Biology, V63, P248, DOI 10.1111/j.1095-8649.2003.216ax.x; Cottingham P, 2003, 012003 COOP RES CTR; Crook DA, 2004, J ANIM ECOL, V73, P353, DOI 10.1111/j.0021-8790.2004.00802.x; Crook DA, 2004, CAN J FISH AQUAT SCI, V61, P2183, DOI 10.1139/F04-151; DAMES HR, 1989, T AM FISH SOC, V118, P670, DOI 10.1577/1548-8659(1989)118<0670:MOCAFC>2.3.CO;2; DoW Resources, 1989, WAT VICT RES HDB; Ecological Associates and SKM, 2011, ENV WAT DEL YARR TOC; Faulks LK, 2010, MOL ECOL, V19, P4723, DOI 10.1111/j.1365-294X.2010.04848.x; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Fullerton AH, 2010, FRESHWATER BIOL, V55, P2215, DOI 10.1111/j.1365-2427.2010.02448.x; Gehrke PC, 1995, REGUL RIVER, V11, P363, DOI 10.1002/rrr.3450110310; Gido KB, 2013, CAN J FISH AQUAT SCI, V70, P554, DOI 10.1139/cjfas-2012-0441; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Henderson Richard, 2000, North American Journal of Fisheries Management, V20, P584, DOI 10.1577/1548-8675(2000)020&lt;0584:TALOSB&gt;2.3.CO;2; Johnson GE, 2004, FISH RES, V69, P349, DOI 10.1016/j.fishres.2004.06.007; Kiffney PM, 2006, CAN J FISH AQUAT SCI, V63, P2518, DOI 10.1139/F06-138; King AJ, 2012, MAR FRESHWATER RES, V63, P576, DOI 10.1071/MF11275; King AJ, 2009, RIVER RES APPL, V25, P1205, DOI 10.1002/rra.1209; King Alison J., 2005, Ecological Management & Restoration, V6, P136, DOI 10.1111/j.1442-8903.2005.230-3.x; Koehn J, 1998, MURRAY DARLING BASIN, P1; Koster WM, 2008, ECOL FRESHW FISH, V17, P146, DOI 10.1111/j.1600-0633.2007.00269.x; Koster WM, 2013, MAR FRESHWATER RES, V64, P31, DOI 10.1071/MF12196; LAKE JS, 1967, AUST J MAR FRESH RES, V18, P155; LAKE JS, 1967, AUST J MAR FRESH RES, V18, P137, DOI 10.1071/MF9670137; Li RY, 2005, ECOL FRESHW FISH, V14, P319, DOI 10.1111/j.1600-0633.2005.00106.x; Magee JP, 1996, T AM FISH SOC, V125, P768, DOI 10.1577/1548-8659(1996)125<0768:SVISHO>2.3.CO;2; MAHESHWARI BL, 1995, REGUL RIVER, V10, P15, DOI 10.1002/rrr.3450100103; Mallen-Cooper M., 1999, INNOVATIONS FISH PAS, P173; Mallen-Cooper M, 1996, 1995 RIV ENV RES FOR, P33; Nunn AD, 2010, ECOL FRESHW FISH, V19, P153, DOI 10.1111/j.1600-0633.2009.00399.x; O'Connor JP, 2005, J FISH BIOL, V66, P392, DOI 10.1111/j.0022-1112.2005.00604.x; Ovidio M, 1998, HYDROBIOLOGIA, V372, P263, DOI 10.1023/A:1017068115183; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Pracheil BM, 2009, ECOL FRESHW FISH, V18, P603, DOI 10.1111/j.1600-0633.2009.00376.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rakowitz G, 2008, ECOL FRESHW FISH, V17, P502, DOI 10.1111/j.1600-0633.2008.00302.x; Rice SP, 2006, CAN J FISH AQUAT SCI, V63, P2553, DOI 10.1139/F06-145; ROWLAND SJ, 1983, AQUACULTURE, V35, P221, DOI 10.1016/0044-8486(83)90093-5; Serafini LG, 2004, PRELIMINARY GUIDE ID; Sullivan SMP, 2009, J FISH BIOL, V74, P1394, DOI 10.1111/j.1095-8649.2009.02205.x; Svendsen JC, 2004, J FISH BIOL, V64, P528, DOI 10.1111/j.0022-1112.2004.00319.x; Winter HV, 2001, FISHERIES MANAG ECOL, V8, P513, DOI 10.1046/j.1365-2400.2001.00271.x; Winter JD, 1996, FISHERIES TECHNIQUES, P550; [No title captured]	54	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96044	10.1371/journal.pone.0096044	http://dx.doi.org/10.1371/journal.pone.0096044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788137	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700051
J	Forrest, GF; Hutchinson, K; Lorenz, DJ; Buehner, JJ; VanHiel, LR; Sisto, SA; Basso, DM				Forrest, Gail F.; Hutchinson, Karen; Lorenz, Douglas J.; Buehner, Jeffrey J.; VanHiel, Leslie R.; Sisto, Sue Ann; Basso, D. Michele			Are the 10 Meter and 6 Minute Walk Tests Redundant in Patients with Spinal Cord Injury?	PLOS ONE			English	Article							OUTCOME MEASURES; AMBULATION; CAPACITY; VALIDITY; DISTANCE; ABILITY; SPEED; GAIT	Objective: To evaluate the relationship and redundancy between gait speeds measured by the 10 Meter Walk Test (10MWT) and 6 Minute Walk Test (6MWT) after motor incomplete spinal cord injury (iSCI). To identify gait speed thresholds supporting functional ambulation as measured with the Spinal Cord Injury Functional Ambulation Inventory (SCI-FAI). Design: Prospective observational cohort. Setting: Seven outpatient rehabilitation centers from the Christopher and Dana Reeve Foundation NeuroRecovery Network (NRN). Participants: 249 NRN patients with American Spinal Injury Association Impairment Scale (AIS) level C (n = 20), D (n = 179) and (n = 50) iSCI not AIS evaluated, from February 2008 through April 2011. Interventions: Locomotor training using body weight support and walking on a treadmill, overground and home/community practice. Main Outcome Measure(s): 10MWT and 6MWT collected at enrollment, approximately every 20 sessions, and upon discharge. Results: The 10MWT and 6MWT speeds were highly correlated and the 10MWT speeds were generally faster. However, the predicted 6MWT gait speed from the 10MWT, revealed increasing error with increased gait speed. Regression lines remained significantly different from lines of agreement, when the group was divided into fast (>= 0.44 m/s) and slow walkers (< 0.44 m/s). Significant differences between 6MWT and 10MWT gait speeds were observed across SCI-FAI walking mobility categories (Wilcoxon sign rank test p<.001), and mean speed thresholds for limited community ambulation differed for each measure. The smallest real difference for the 6MWT and 10MWT, as well as the minimally clinically important difference (MCID) values, were also distinct for the two tests. Conclusions: While the speeds were correlated between the 6MWT and 10MWT, redundancy in the tests using predictive modeling was not observed. Different speed thresholds and separate MCIDs were defined for community ambulation for each test.	[Forrest, Gail F.] Kessler Fdn Res Ctr, Human Performance & Engn Lab, W Orange, NJ 07052 USA; [Forrest, Gail F.] Rutgers State Univ, Dept Phys Med & Rehabil, Newark, NJ 07102 USA; [Hutchinson, Karen] Boston Univ, Dept Phys Therapy & Athlet Training, Boston, MA 02215 USA; [Lorenz, Douglas J.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Lorenz, Douglas J.] Univ Louisville, Kentucky Spinal Cord Res Ctr, Louisville, KY 40292 USA; [Buehner, Jeffrey J.] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [VanHiel, Leslie R.] Shepherd Ctr, Hulse Spinal Cord Injury Lab, Atlanta, GA USA; [VanHiel, Leslie R.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA; [Sisto, Sue Ann] SUNY Stony Brook, Sch Hlth Technol & Management, Rehabil Res & Movement Performance Lab, Stony Brook, NY 11794 USA; [Basso, D. Michele] Ohio State Univ, Sch Allied Med Profess, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA	Kessler Institute for Rehabilitation; Rutgers State University Newark; Rutgers State University New Brunswick; Boston University; University of Louisville; University of Louisville; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Ohio; Ohio State University	Forrest, GF (corresponding author), Kessler Fdn Res Ctr, Human Performance & Engn Lab, W Orange, NJ 07052 USA.	gforrest@kesslerfoundation.org			Christopher and Dana Reeve Foundation [NRN-2008]	Christopher and Dana Reeve Foundation	Funding for this work is from the Christopher and Dana Reeve Foundation; NRN-2008. THESE FUNDERS AIDED IN PAYMENT OF TREATMENT SESSIONS/STAFF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbeau H, 2007, NEUROREHAB NEURAL RE, V21, P302, DOI 10.1177/1545968306298937; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; Behrman AL, 2005, PHYS THER, V85, P1356, DOI 10.1093/ptj/85.12.1356; Brooks D, 2003, AM J RESP CRIT CARE, V167, P1287, DOI 10.1164/ajrccm.167.9.950; Buehner JJ, 2012, ARCH PHYS MED REHAB, V93, P1530, DOI 10.1016/j.apmr.2012.02.035; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Ditunno JF, 2005, J REHABIL RES DEV, V42, P35, DOI 10.1682/JRRD.2004.08.0098; DIXON R E, 1969, Journal of Physiology (Cambridge), V202, p68P; Dobkin BH, 2006, NEUROLOGY, V66, P584, DOI 10.1212/01.wnl.0000198502.88147.dd; Field-Fote EC, 2001, J REHABIL MED, V33, P177, DOI 10.1080/165019701750300645; Forrest GF, 2012, ARCH PHYS MED REHAB, V93, P1553, DOI 10.1016/j.apmr.2011.08.051; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1508, DOI 10.1016/j.apmr.2011.01.024; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Jackson AB, 2008, J SPINAL CORD MED, V31, P487, DOI 10.1080/10790268.2008.11753644; Kim CM, 2004, SPINAL CORD, V42, P156, DOI 10.1038/sj.sc.3101569; Lam T, 2008, SPINAL CORD, V46, P246, DOI 10.1038/sj.sc.3102134; Lemay JF, 2010, SPINAL CORD, V48, P245, DOI 10.1038/sc.2009.119; Lorenz DJ, 2011, STAT MED, V30, P3181, DOI 10.1002/sim.4368; Musselman KE, 2007, PHYS THER REV, V12, P287, DOI 10.1179/108331907X223128; Musselman KE, 2007, J REHABIL MED, V39, P567, DOI 10.2340/16501977-0090; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Development Core Team, 2011, LANG ENV STAT COMP V; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Tilson JK, 2010, PHYS THER, V90, P196, DOI 10.2522/ptj.20090079; Tyson S, 2009, CLIN REHABIL, V23, P1018, DOI 10.1177/0269215509339004; van Hedel HJ, 2005, ARCH PHYS MED REHAB, V86, P190, DOI 10.1016/j.apmr.2004.02.010; van Hedel HJ, 2009, NEUROREHAB NEURAL RE; van Hedel HJA, 2005, SPINAL CORD, V43, P593, DOI 10.1038/sj.sc.3101768; van Hedel HJA, 2007, NEUROREHAB NEURAL RE, V21, P295, DOI 10.1177/1545968306297861; van Hedel HJA, 2009, NEUROREHAB NEURAL RE, V23, P117, DOI 10.1177/1545968308320640; Wirz M, 2010, SPINAL CORD, V48, P407, DOI 10.1038/sc.2009.149; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	33	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94108	10.1371/journal.pone.0094108	http://dx.doi.org/10.1371/journal.pone.0094108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788068	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600010
J	Missirlis, D				Missirlis, Dimitris			The Effect of Substrate Elasticity and Actomyosin Contractility on Different Forms of Endocytosis	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; NONVIRAL GENE DELIVERY; MYOSIN-II; FOCAL ADHESIONS; VIRUS-INFECTION; CELLULAR UPTAKE; CHOLERA-TOXIN; CELLS; STIFFNESS; MECHANISMS	Substrate mechanical properties have emerged as potent determinants of cell functions and fate. We here tested the hypothesis that different forms of endocytosis are regulated by the elasticity of the synthetic hydrogels cells are cultured on. Towards this objective, we quantified cell-associated fluorescence of the established endocytosis markers transferrin (Tf) and cholera toxin subunit B (CTb) using a flow-cytometry based protocol, and imaged marker internalization using microscopy techniques. Our results demonstrated that clathrin-mediated endocytosis of Tf following a 10-minute incubation with a fibroblast cell line was lower on the softer substrates studied (5 kPa) compared to those with elasticities of 40 and 85 kPa. This effect was cancelled after 1-hour incubation revealing that intracellular accumulation of Tf at this time point did not depend on substrate elasticity. Lipid-raft mediated endocytosis of CTb, on the other hand, was not affected by substrate elasticity in the studied range of time and substrate elasticity. The use of pharmacologic contractility inhibitors revealed inhibition of endocytosis for both Tf and CTb after a 10-minute incubation and a dissimilar effect after 1 hour depending on the inhibitor type. Further, the internalization of fluorescent NPs, used as model drug delivery systems, showed a dependence on substrate elasticity, while transfection efficiency was unaffected by it. Finally, an independence on substrate elasticity of Tf and CTb association with HeLa cells indicated that there are cell-type differences in this respect. Overall, our results suggest that clathrin-mediated but not lipid-raft mediated endocytosis is potentially influenced by substrate mechanics at the cellular level, while intracellular trafficking and accumulation show a more complex dependence. Our findings are discussed in the context of previous work on how substrate mechanics affect the fundamental process of endocytosis and highlight important considerations for future studies.	[Missirlis, Dimitris] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Missirlis, Dimitris] Heidelberg Univ, Dept Biophys Chem, Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Missirlis, D (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany.	missirlis@uni-heidelberg.de	Missirlis, Dimitris/S-3798-2019	Missirlis, Dimitris/0000-0003-1874-676X	Marie Curie IIF fellowship; CellNetworks Postdoctoral fellowship; Max Planck Society	Marie Curie IIF fellowship(European Commission); CellNetworks Postdoctoral fellowship; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded through a Marie Curie IIF fellowship to DM, a CellNetworks Postdoctoral fellowship to DM and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AF, 2010, NANO TODAY, V5, P553, DOI 10.1016/j.nantod.2010.10.007; Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pF179, DOI 10.1152/ajprenal.2002.282.2.F179; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Byfield FJ, 2009, BIOPHYS J, V96, P5095, DOI 10.1016/j.bpj.2009.03.046; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Canton I, 2012, CHEM SOC REV, V41, P2718, DOI 10.1039/c2cs15309b; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chopra A, 2012, J BIOMECH, V45, P824, DOI 10.1016/j.jbiomech.2011.11.023; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Dhaliwal A, 2012, SOFT MATTER, V8, P1451, DOI 10.1039/c1sm06591b; Dhaliwal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035046; Dhaliwal A, 2010, ACTA BIOMATER, V6, P3436, DOI 10.1016/j.actbio.2010.03.038; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Doiron AL, 2011, BIOTECHNOL BIOENG, V108, P2988, DOI 10.1002/bit.23253; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Holt JP, 2007, CELL MOTIL CYTOSKEL, V64, P756, DOI 10.1002/cm.20220; HOPKINS CR, 1985, J CELL SCI, P173; Huang CJ, 2013, NANO LETT, V13, P1611, DOI 10.1021/nl400033h; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; KILAR F, 1985, BIOPHYS J, V48, P799, DOI 10.1016/S0006-3495(85)83838-8; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mih JD, 2012, J CELL SCI, V125, P5974, DOI 10.1242/jcs.108886; Missirlis D, 2014, BIOMACROMOLECULES, V15, P195, DOI 10.1021/bm4014827; Missirlis D, 2010, J BIOMED MATER RES A, V93A, P1557, DOI 10.1002/jbm.a.32648; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Samaniego R, 2007, J CELL SCI, V120, P3534, DOI 10.1242/jcs.006296; Santos dos T, 2011, SMALL, V7, P3341, DOI [10.1002/smll.201101076, DOI 10.1002/SMLL.201101076]; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tekle C, 2008, NANO LETT, V8, P1858, DOI 10.1021/nl0803848; Thiel L, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-163; Torgersen ML, 2001, J CELL SCI, V114, P3737; Trappmann B., 2012, NAT MATER, V11, P1; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345	57	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96548	10.1371/journal.pone.0096548	http://dx.doi.org/10.1371/journal.pone.0096548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788199	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600106
J	Tempest, GD; Eston, RG; Parfitt, G				Tempest, Gavin D.; Eston, Roger G.; Parfitt, Gaynor			Prefrontal Cortex Haemodynamics and Affective Responses during Exercise: A Multi-Channel Near Infrared Spectroscopy Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TRANSIENT HYPOFRONTALITY; CEREBRAL OXYGENATION; BRAIN ACTIVATION; AEROBIC EXERCISE; EEG ASYMMETRY; INTENSITY; EMOTION; PERSPECTIVES; DISPLEASURE	The dose-response effects of the intensity of exercise upon the potential regulation (through top-down processes) of affective (pleasure-displeasure) responses in the prefrontal cortex during an incremental exercise protocol have not been explored. This study examined the functional capacity of the prefrontal cortex (reflected by haemodynamics using near infrared spectroscopy) and affective responses during exercise at different intensities. Participants completed an incremental cycling exercise test to exhaustion. Changes (Delta) in oxygenation (O(2)Hb), deoxygenation (HHb), blood volume (tHb) and haemoglobin difference (HbDiff) were measured from bilateral dorsal and ventral prefrontal areas. Affective responses were measured every minute during exercise. Data were extracted at intensities standardised to: below ventilatory threshold, at ventilatory threshold, respiratory compensation point and the end of exercise. During exercise at intensities from ventilatory threshold to respiratory compensation point, Delta O(2)Hb, Delta HbDiff and Delta tHb were greater in mostly ventral than dorsal regions. From the respiratory compensation point to the end of exercise, Delta O(2)Hb remained stable and Delta HbDiff declined in dorsal regions. As the intensity increased above the ventilatory threshold, inverse associations between affective responses and oxygenation in (a) all regions of the left hemisphere and (b) lateral (dorsal and ventral) regions followed by the midline (ventral) region in the right hemisphere were observed. Differential activation patterns occur within the prefrontal cortex and are associated with affective responses during cycling exercise.	[Tempest, Gavin D.; Eston, Roger G.; Parfitt, Gaynor] Univ S Australia, Sansom Inst Hlth Res, Sch Hlth Sci, Adelaide, SA 5001, Australia; [Eston, Roger G.] Univ Exeter, Exeter EX4 4QJ, Devon, England	University of South Australia; University of Exeter	Tempest, GD (corresponding author), Univ S Australia, Sansom Inst Hlth Res, Sch Hlth Sci, Adelaide, SA 5001, Australia.	gavin.tempest@unisa.edu.au	Parfitt, Gaynor/G-7640-2012; Eston, Roger G/C-7666-2011	Parfitt, Gaynor/0000-0002-5547-5797; Eston, Roger G/0000-0002-2680-7473; Tempest, Gavin/0000-0002-8550-523X				American College of Sports Medicine, 2017, ACSMS GUIDELINES EXE, V10th ed.; [Anonymous], 2011, EXERCISE SPORTS SCI; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bhambhani Y, 2007, RESP PHYSIOL NEUROBI, V156, P196, DOI 10.1016/j.resp.2006.08.009; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DAVIDSON RJ, 1993, COGNITION EMOTION, V7, P115, DOI 10.1080/02699939308409180; DAVIDSON RJ, 1985, PSYCHOPHYSIOLOGY, V22, P353, DOI 10.1111/j.1469-8986.1985.tb01615.x; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Davidson RJ, 2004, BIOL PSYCHOL, V67, P219, DOI 10.1016/j.biopsycho.2004.03.008; Dietrich A, 2003, CONSCIOUS COGN, V12, P231, DOI 10.1016/S1053-8100(02)00046-6; Dietrich A, 2006, PSYCHIAT RES, V145, P79, DOI 10.1016/j.psychres.2005.07.033; DUNCAN A, 1995, PHYS MED BIOL, V40, P295, DOI 10.1088/0031-9155/40/2/007; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ekkekakis P, 2005, J SPORT SCI, V23, P477, DOI 10.1080/02640410400021492; Ekkekakis P, 2004, PREV MED, V38, P149, DOI 10.1016/j.ypmed.2003.09.038; Ekkekakis P, 2003, COGNITION EMOTION, V17, P213, DOI 10.1080/02699930302292; Ekkekakis P, 2000, J BEHAV MED, V23, P245, DOI 10.1023/A:1005558025163; Ekkekakis P, 1999, SPORTS MED, V28, P337, DOI 10.2165/00007256-199928050-00005; Ekkekakis P., 2006, PSYCHOBIOLOGY PHYS A, P91; Ekkekakis P, 2008, ANN BEHAV MED, V35, P136, DOI 10.1007/s12160-008-9025-z; Ekkekakis P, 2013, PSYCHOL SPORT EXERC, V14, P751, DOI 10.1016/j.psychsport.2013.04.007; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Ekkekakis P, 2009, J SPORT EXERCISE PSY, V31, P505, DOI 10.1123/jsep.31.4.505; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Gaesser GA, 1996, EXERCISE SPORT SCI R, V24, P25; Gaskill SE, 2001, MED SCI SPORT EXER, V33, P1841, DOI 10.1097/00005768-200111000-00007; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Harmon-Jones E, 2004, COGNITION EMOTION, V18, P337, DOI 10.1080/02699930341000059; Ide K, 2000, PROG NEUROBIOL, V61, P397, DOI 10.1016/S0301-0082(99)00057-X; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Lazarus R.S., 1991, EMOTION ADAPTATION; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Oussaidene K, 2013, EUR J APPL PHYSIOL, V113, P2047, DOI 10.1007/s00421-013-2637-4; Parfitt G, 2006, BRIT J HEALTH PSYCH, V11, P39, DOI 10.1348/135910705X43606; Perrey S., 2012, FUNCTIONAL NEUROIMAG, P335, DOI DOI 10.1007/978-1-4614-3293-7_14; Petruzzello SJ, 1997, PSYCHOPHYSIOLOGY, V34, P527, DOI 10.1111/j.1469-8986.1997.tb01739.x; Petruzzello SJ, 2001, PSYCHOPHYSIOLOGY, V38, P99, DOI 10.1111/1469-8986.3810099; Petruzzello SJ, 2006, PSYCHOBIOLOGY PHYS A, P91; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Rooks CR, 2010, PROG NEUROBIOL, V92, P134, DOI 10.1016/j.pneurobio.2010.06.002; Rose EA, 2007, J SPORT EXERCISE PSY, V29, P281, DOI 10.1123/jsep.29.3.281; Rupp T, 2008, EUR J APPL PHYSIOL, V102, P153, DOI 10.1007/s00421-007-0568-7; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schaefer SM, 2002, J COGNITIVE NEUROSCI, V14, P913, DOI 10.1162/089892902760191135; Schneider M, 2009, J SPORT EXERCISE PSY, V31, P706, DOI 10.1123/jsep.31.6.706; Shibuya K, 2004, J SPORT MED PHYS FIT, V44, P215; Subudhi AW, 2007, J APPL PHYSIOL, V103, P177, DOI 10.1152/japplphysiol.01460.2006; Subudhi AW, 2009, J APPL PHYSIOL, V106, P1153, DOI 10.1152/japplphysiol.91475.2008; Tempest G, 2013, J SPORT EXERCISE PSY, V35, P503, DOI 10.1123/jsep.35.5.503; Tuscan LA, 2013, BRAIN IMAGING BEHAV, V7, P140, DOI 10.1007/s11682-012-9206-z; Williams DM, 2008, PSYCHOL SPORT EXERC, V9, P231, DOI 10.1016/j.psychsport.2007.04.002; Williams DM, 2012, ANN BEHAV MED, V44, P43, DOI 10.1007/s12160-012-9362-9	58	52	53	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95924	10.1371/journal.pone.0095924	http://dx.doi.org/10.1371/journal.pone.0095924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG6EE	24788166	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600055
J	Li, SM; Joseph, C; Becourt, C; Klibi, J; Luce, S; Dubois-Laforgue, D; Larger, E; Boitard, C; Benlagha, K				Li, Shamin; Joseph, Claudine; Becourt, Chantal; Klibi, Jihene; Luce, Sandrine; Dubois-Laforgue, Daniele; Larger, Etienne; Boitard, Christian; Benlagha, Kamel			Potential Role of IL-17-Producing iNKT Cells in Type 1 Diabetes	PLOS ONE			English	Article							KILLER T-CELLS; INVARIANT NKT CELLS; NOD MICE; TH17 CELLS; IFN-GAMMA; MOUSE MODEL; BETA-CELLS; ACTIVATION; IL-17; IDENTIFICATION	We explored in this study the status and potential role of IL-17-producing iNKT cells (iNKT17) in type 1 diabetes (T1D) by analyzing these cells in patients with T1D, and in NOD mice, a mouse model for T1D. Our analysis in mice showed an increase of iNKT17 cells in NOD vs control C57BL/6 mice, partly due to a better survival of these cells in the periphery. We also found a higher frequency of these cells in autoimmune-targeted organs with the occurrence of diabetes, suggesting their implication in the disease development. In humans, though absent in fresh PMBCs, iNKT17 cells are detected in vitro with a higher frequency in T1D patients compared to control subjects in the presence of the proinflammatory cytokine IL-1 beta, known to contribute to diabetes occurrence. These IL-1 beta-stimulated iNKT cells from T1D patients keep their potential to produce IFN-gamma, a cytokine that drives islet beta-cell destruction, but not IL-4, with a reverse picture observed in healthy volunteers. On the whole, our results argue in favour of a potential role of IL-17-producing iNKT cells in T1D and suggest that inflammation in T1D patients could induce a Th1/Th17 cytokine secretion profile in iNKT cells promoting disease development.	[Li, Shamin; Joseph, Claudine; Benlagha, Kamel] Univ Paris Diderot, Sorbonne Paris Cite, Inst Univ Hematol Paris, Paris, France; [Li, Shamin; Joseph, Claudine; Benlagha, Kamel] INSERM, UMR1160, Paris, France; [Becourt, Chantal; Luce, Sandrine; Dubois-Laforgue, Daniele; Larger, Etienne; Boitard, Christian] Univ Paris 05, Sorbonne Paris Cite, Inst Cochin, Paris, France; [Becourt, Chantal; Luce, Sandrine; Dubois-Laforgue, Daniele; Larger, Etienne; Boitard, Christian] INSERM, U1016, Paris, France; [Klibi, Jihene] Inst Pasteur, Dept Bacteriol, Paris, France; [Dubois-Laforgue, Daniele; Larger, Etienne; Boitard, Christian] GH Cochin Hotel Dieu Broca, Hotel Dieu, Serv Diabetol, AP HP, Paris, France; [Dubois-Laforgue, Daniele; Larger, Etienne; Boitard, Christian] Univ Paris 05, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Benlagha, K (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Inst Univ Hematol Paris, Paris, France.	kamel.benlagha@inserm.fr	Benlagha, Kamel/I-5035-2016; Benlagha, Kamel/GLQ-8342-2022	BOITARD, Christian/0000-0003-3985-9405; benlagha, kamel/0000-0002-3251-9195; LUCE, Sandrine/0000-0002-9519-333X; Dubois-Laforgue, Daniele/0000-0003-3287-6309	Inserm Avenir [R04193KS]; FRM [INE20051105133]; ANR [R07119KS]; AP-HP "contrat d' interface"; Institut Universitaire d' Hematologie (IUH), Hopital St-Louis, Paris France	Inserm Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); FRM(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); AP-HP "contrat d' interface"; Institut Universitaire d' Hematologie (IUH), Hopital St-Louis, Paris France	This work was supported by "Inserm Avenir" Grant R04193KS, FRM Grant INE20051105133, ANR Grant R07119KS, and AP-HP "contrat d' interface" Grant awarded to KB. SL and CJ was supported by the Institut Universitaire d' Hematologie (IUH), Hopital St-Louis, Paris France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arif S, 2011, DIABETES, V60, P2112, DOI 10.2337/db10-1643; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Bertin-Maghit S, 2011, DIABETES, V60, P248, DOI 10.2337/db10-0104; Bradshaw EM, 2009, J IMMUNOL, V183, P4432, DOI 10.4049/jimmunol.0900576; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Chen HJ, 1997, J IMMUNOL, V159, P2240; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Fujii S, 2003, J IMMUNOL METHODS, V272, P147, DOI 10.1016/S0022-1759(02)00497-0; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Han GC, 2010, IMMUNOLOGY, V129, P197, DOI 10.1111/j.1365-2567.2009.03166.x; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Jain R, 2008, J EXP MED, V205, P207, DOI 10.1084/jem.20071878; Kis J, 2007, J LEUKOCYTE BIOL, V81, P654, DOI 10.1189/jlb.1106654; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Kuriya G, 2013, DIABETOLOGIA, V56, P1773, DOI 10.1007/s00125-013-2935-8; LARGER E, 1995, J EXP MED, V181, P1635, DOI 10.1084/jem.181.5.1635; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Lin H, 2004, EUR J IMMUNOL, V34, P2664, DOI 10.1002/eji.200324834; Markle JGM, 2013, J IMMUNOL, V190, P5392, DOI 10.4049/jimmunol.1203502; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Marwaha AK, 2010, J IMMUNOL, V185, P3814, DOI 10.4049/jimmunol.1001860; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Miljkovic D, 2005, CELL MOL LIFE SCI, V62, P2658, DOI 10.1007/s00018-005-5259-0; Moreira-Teixeira L, 2011, J IMMUNOL, V186, P5758, DOI 10.4049/jimmunol.1003043; Oikawa Y, 2002, DIABETES CARE, V25, P1818, DOI 10.2337/diacare.25.10.1818; Rogers PR, 2004, J IMMUNOL METHODS, V285, P197, DOI 10.1016/j.jim.2003.12.003; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Simoni Y, 2011, EUR J IMMUNOL, V41, P3574, DOI 10.1002/eji.201141751; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419	36	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96151	10.1371/journal.pone.0096151	http://dx.doi.org/10.1371/journal.pone.0096151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788601	gold, Green Submitted, Green Published			2022-12-25	WOS:000338917300029
J	Tuoresmaki, P; Vaisanen, S; Neme, A; Heikkinen, S; Carlberg, C				Tuoresmaki, Pauli; Vaisanen, Sami; Neme, Antonio; Heikkinen, Sami; Carlberg, Carsten			Patterns of Genome-Wide VDR Locations	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; RESPONSE ELEMENTS; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; LEUKEMIA-CELLS; EXPRESSION; TARGET; GENE; DIFFERENTIATION; ASSOCIATION	The genome-wide analysis of the binding sites of the transcription factor vitamin D receptor (VDR) is essential for a global appreciation the physiological impact of the nuclear hormone 1 alpha, 25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3). Genome-wide analysis of lipopolysaccharide (LPS)-polarized THP-1 human monocytic leukemia cells via chromatin immunoprecipitation sequencing (ChIP-seq) resulted in 1,318 high-confidence VDR binding sites, of which 789 and 364 occurred uniquely with and without 1,25(OH)(2)D-3 stimulation, while only 165 were common. We re-analyzed five public VDR ChIP-seq datasets with identical peak calling settings (MACS, version 2) and found, using a novel consensus summit identification strategy, in total 23,409 non-overlapping VDR binding sites, 75% of which are unique within the six analyzed cellular models. LPS-differentiated THP-1 cells have 22% more genomic VDR locations than undifferentiated cells and both cell types display more overlap in their VDR locations than the other investigated cell types. In general, the intersection of VDR binding profiles of ligand-stimulated cells is higher than those of unstimulated cells. De novo binding site searches and HOMER screening for binding motifs formed by direct repeats spaced by three nucleotides (DR3) suggest for all six VDR ChIP-seq datasets that these sequences are found preferentially at highly ligand responsive VDR loci. Importantly, all VDR ChIP-seq datasets display the same relationship between the VDR occupancy and the percentage of DR3-type sequences below the peak summits. The comparative analysis of six VDR ChIP-seq datasets demonstrated that the mechanistic basis for the action of the VDR is independent of the cell type. Only the minority of genome-wide VDR binding sites contains a DR3-type sequence. Moreover, the total number of identified VDR binding sites in each ligand-stimulated cell line inversely correlates with the percentage of peak summits with DR3 sites.	[Tuoresmaki, Pauli; Vaisanen, Sami; Neme, Antonio; Heikkinen, Sami; Carlberg, Carsten] Univ Eastern Finland, Dept Biosci, Kuopio, Finland	University of Eastern Finland	Carlberg, C (corresponding author), Univ Eastern Finland, Dept Biosci, Kuopio, Finland.	carsten.carlberg@uef.fi	Carlberg, Carsten/C-9075-2011; Heikkinen, Sami P/L-1460-2013; Neme, Antonio/A-8999-2018	Carlberg, Carsten/0000-0003-2633-0684; Heikkinen, Sami P/0000-0002-6083-2402; Neme, Antonio/0000-0002-9952-1943	Academy of Finland; Juselius Foundation	Academy of Finland(Academy of Finland); Juselius Foundation	This work was supported by the Academy of Finland and the Juselius Foundation. Kind thanks to Gene Core team of the EMBL for massive parallel sequencing service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; Carlberg C, 2013, STEROIDS, V78, P127, DOI 10.1016/j.steroids.2012.10.019; Carlberg C, 2012, CURR TOP MED CHEM, V12, P528, DOI 10.2174/156802612799436623; Carlberg C, 2012, ANTICANCER RES, V32, P271; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gynther P, 2011, BBA-MOL CELL RES, V1813, P810, DOI 10.1016/j.bbamcr.2011.01.037; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malinen M, 2008, NUCLEIC ACIDS RES, V36, P121, DOI 10.1093/nar/gkm913; Matilainen JM, 2010, BBA-MOL CELL RES, V1803, P1276, DOI 10.1016/j.bbamcr.2010.07.009; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Orlov I, 2012, EMBO J, V31, P291, DOI 10.1038/emboj.2011.445; Palmer HG, 2003, CANCER RES, V63, P7799; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Polly P, 2000, FASEB J, V14, P1455, DOI 10.1096/fj.14.10.1455; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; PREHN JL, 1992, BLOOD, V80, P2811; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanchez-Martinez R, 2008, MOL CELL BIOL, V28, P3817, DOI 10.1128/MCB.01909-07; SCHRADER M, 1995, MOL CELL BIOL, V15, P1154; Seuter S, 2013, J STEROID BIOCH MOL; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Suzuki T, 2006, BIOMED RES-TOKYO, V27, P99, DOI 10.2220/biomedres.27.99; Toell A, 2000, BIOCHEM J, V352, P301, DOI 10.1042/0264-6021:3520301; TSUCHIYA S, 1982, CANCER RES, V42, P1530; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; White SL, 2005, LEUKEMIA RES, V29, P1141, DOI 10.1016/j.leukres.2005.02.012; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	90	90	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96105	10.1371/journal.pone.0096105	http://dx.doi.org/10.1371/journal.pone.0096105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24787735	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917300026
J	Iwaki, H; Sasaki, S; Matsushita, A; Ohba, K; Matsunaga, H; Misawa, H; Oki, Y; Ishizuka, K; Nakamura, H; Suda, T				Iwaki, Hiroyuki; Sasaki, Shigekazu; Matsushita, Akio; Ohba, Kenji; Matsunaga, Hideyuki; Misawa, Hiroko; Oki, Yutaka; Ishizuka, Keiko; Nakamura, Hirotoshi; Suda, Takafumi			Essential Role of TEA Domain Transcription Factors in the Negative Regulation of the MYH 7 Gene by Thyroid Hormone and Its Receptors	PLOS ONE			English	Article							HEAVY-CHAIN GENES; THYROTROPIN-BETA GENE; IN-VIVO REGULATION; GLUCOCORTICOID-RECEPTOR; ALPHA(1)-ADRENERGIC AGONIST; CARDIAC-HYPERTROPHY; SIGNALING PATHWAYS; MOLECULAR ASPECTS; HEART-FAILURE; ALPHA-MYOSIN	MYH7 (also referred to as cardiac myosin heavy chain beta) gene expression is known to be repressed by thyroid hormone (T3). However, the molecular mechanism by which T3 inhibits the transcription of its target genes (negative regulation) remains to be clarified, whereas those of transcriptional activation by T3 (positive regulation) have been elucidated in detail. Two MCAT (muscle C, A, and T) sites and an A/T-rich region in the MYH7 gene have been shown to play a critical role in the expression of this gene and are known to be recognized by the TEAD/TEF family of transcription factors (TEADs). Using a reconstitution system with CV-1 cells, which has been utilized in the analysis of positive as well as negative regulation, we demonstrate that both T3 receptor (TR) beta 1 and alpha 1 inhibit TEAD-dependent activation of the MYH7 promoter in a T3 dose-dependent manner. TR beta 1 bound with GC-1, a TR beta-selective T3 analog, also repressed TEAD-induced activity. Although T3-dependent inhibition required the DNA-binding domain (DBD) of TR beta 1, it remained after the putative negative T3-responsive elements were mutated. A co-immunoprecipitation study demonstrated the in vivo association of TRb1 with TEAD-1, and the interaction surfaces were mapped to the DBD of the TR beta 1 and TEA domains of TEAD-1, both of which are highly conserved among TRs and TEADs, respectively. The importance of TEADs in MYH7 expression was also validated with RNA interference using rat embryonic cardiomyocyte H9c2 cells. These results indicate that T3-bound TRs interfere with transactivation by TEADs via protein-protein interactions, resulting in the negative regulation of MYH7 promoter activity.	[Iwaki, Hiroyuki; Sasaki, Shigekazu; Matsushita, Akio; Ohba, Kenji; Matsunaga, Hideyuki; Misawa, Hiroko; Oki, Yutaka; Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan; [Ishizuka, Keiko] Hamamatsu Univ Sch Med, Dept Lab Med, Hamamatsu, Shizuoka 4313192, Japan; [Nakamura, Hirotoshi] Kuma Hosp, Dept Internal Med, Kobe, Hyogo, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Kuma Hospital	Sasaki, S (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan.	sasakis@hama-med.ac.jp	Ohba, Kenji/AAU-5180-2021	Ohba, Kenji/0000-0001-8538-8742	Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in part, by a Health Sciences Research Grant to SS and HN and a Grant-in Aid for Scientific Research to SS, AM and HN from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson C, 2004, J PHARMACOL EXP THER, V311, P164, DOI 10.1124/jpet.104.069153; Baxter JD, 2004, TRENDS ENDOCRIN MET, V15, P154, DOI 10.1016/j.tem.2004.03.008; Belke DD, 2007, ENDOCRINOLOGY, V148, P2870, DOI 10.1210/en.2007-0009; Chen W, 2011, SEMIN CELL DEV BIOL, V22, P749, DOI 10.1016/j.semcdb.2011.07.026; Chen W, 2010, P NATL ACAD SCI USA, V107, P10196, DOI 10.1073/pnas.1005626107; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Cohen R. N., 2013, WERNER INGBARS THYRO, P149; Danzi S, 2005, AM J PHYSIOL-HEART C, V288, pH455, DOI 10.1152/ajpheart.00896.2004; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De K, 2004, J ENDOCRINOL, V182, P303, DOI 10.1677/joe.0.1820303; Dillmann W, 2010, HEART FAIL REV, V15, P125, DOI 10.1007/s10741-008-9125-7; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; EDWARDS JG, 1994, BIOCHEM BIOPH RES CO, V199, P1482, DOI 10.1006/bbrc.1994.1398; EVERETT AW, 1984, BIOCHEMISTRY-US, V23, P1596, DOI 10.1021/bi00303a002; Fukuyama K, 2003, HYPERTENSION, V41, P598, DOI 10.1161/01.HYP.0000056524.35294.80; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gordon DF, 2010, THYROID STIMULATING, V2, P1362; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Haddad F, 1998, AM J PHYSIOL-ENDOC M, V274, pE1018, DOI 10.1152/ajpendo.1998.274.6.E1018; Haddad F, 2010, AM J PHYSIOL-HEART C, V299, pH1968, DOI 10.1152/ajpheart.00644.2010; Haddad F, 2008, AM J PHYSIOL-HEART C, V294, pH29, DOI 10.1152/ajpheart.01125.2007; Herron TJ, 2002, CIRC RES, V90, P1150, DOI 10.1161/01.RES.0000022879.57270.11; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Karasseva N, 2003, MOL CELL BIOL, V23, P5143, DOI 10.1128/MCB.23.15.5143-5164.2003; KARIYA K, 1994, J BIOL CHEM, V269, P3775; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; KAWANA M, 1994, ADAPTED HEART, P393; Khoury SF, 1996, CIRC RES, V79, P727, DOI 10.1161/01.RES.79.4.727; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; Kinugawa K, 2001, CIRC RES, V89, P591, DOI 10.1161/hh1901.096706; Kinugawa K, 2001, CIRCULATION, V103, P1089, DOI 10.1161/01.CIR.103.8.1089; KNOTTS S, 1994, J BIOL CHEM, V269, P31275; LADENSON PW, 1992, P NATL ACAD SCI USA, V89, P5251, DOI 10.1073/pnas.89.12.5251; LEE Y, 1993, J BIOL CHEM, V268, P2021; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Maeda T, 2002, J BIOL CHEM, V277, P24346, DOI 10.1074/jbc.M201171200; Maeda T, 2002, BIOCHEM BIOPH RES CO, V294, P791, DOI 10.1016/S0006-291X(02)00556-9; MAGNER JA, 1988, WESTERN J MED, V149, P86; Makino A, 2009, ENDOCRINOLOGY, V150, P2008, DOI 10.1210/en.2008-0634; Mansen A, 2001, MOL ENDOCRINOL, V15, P2106, DOI 10.1210/me.15.12.2106; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; Meischl C, 2008, AM J PHYSIOL-CELL PH, V294, pC1227, DOI 10.1152/ajpcell.00328.2007; Misawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028916; MORKIN E, 1993, CIRCULATION, V87, P1451, DOI 10.1161/01.CIR.87.5.1451; Nakano K, 2004, BIOCHEM J, V378, P549, DOI 10.1042/BJ20031592; Nishi H, 2011, MOL CELL BIOL, V31, P744, DOI 10.1128/MCB.00581-10; Ohba K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018667; Ojamaa K, 1996, ENDOCRINOLOGY, V137, P802, DOI 10.1210/en.137.3.802; Ojamaa K, 2000, AM J PHYSIOL-ENDOC M, V279, pE1319, DOI 10.1152/ajpendo.2000.279.6.E1319; Pandya K, 2006, P NATL ACAD SCI USA, V103, P16864, DOI 10.1073/pnas.0607700103; Pandya K, 2011, GENE EXPRESSION, V15, P51, DOI 10.3727/105221611X12973615737505; Pei LM, 2011, NAT MED, V17, P1466, DOI 10.1038/nm.2450; RINDT H, 1995, P NATL ACAD SCI USA, V92, P1540, DOI 10.1073/pnas.92.5.1540; Sadow PM, 2003, MOL CELL ENDOCRINOL, V203, P65, DOI 10.1016/S0303-7207(03)00122-9; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Sasaki S, 2011, CONT ASPECTS ENDOCRI, P101; SHIMIZU N, 1992, MOL CELL BIOL, V12, P619, DOI 10.1128/MCB.12.2.619; THOMPSON WR, 1991, J BIOL CHEM, V266, P22678; Tinnikov A, 2002, EMBO J, V21, P5079, DOI 10.1093/emboj/cdf523; Trivieri MG, 2006, P NATL ACAD SCI USA, V103, P6043, DOI 10.1073/pnas.0601072103; Trost SU, 2000, ENDOCRINOLOGY, V141, P3057, DOI 10.1210/en.141.9.3057; Tsika RW, 2010, J BIOL CHEM, V285, P13721, DOI 10.1074/jbc.M109.063057; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Venditti P, 2009, J EXP BIOL, V212, P986, DOI 10.1242/jeb.021808; Vyas DR, 1999, J BIOL CHEM, V274, P30832, DOI 10.1074/jbc.274.43.30832; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; Wright CE, 1999, AM J PHYSIOL-CELL PH, V276, pC883, DOI 10.1152/ajpcell.1999.276.4.C883; Yasunami M, 1996, BIOCHEM BIOPH RES CO, V228, P365, DOI 10.1006/bbrc.1996.1667; Yoshida T, 2008, ARTERIOSCL THROM VAS, V28, P8, DOI 10.1161/ATVBAHA.107.155788	71	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e88610	10.1371/journal.pone.0088610	http://dx.doi.org/10.1371/journal.pone.0088610			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781449	Green Submitted, Green Published, gold			2022-12-25	WOS:000335504900001
J	Rahman, MH; Shovan, LR; Hjeljord, LG; Aam, BB; Eijsink, VGH; Sorlie, M; Tronsmo, A				Rahman, Md Hafizur; Shovan, Latifur Rahman; Hjeljord, Linda Gordon; Aam, Berit Bjugan; Eijsink, Vincent G. H.; Sorlie, Morten; Tronsmo, Arne			Inhibition of Fungal Plant Pathogens by Synergistic Action of Chito-Oligosaccharides and Commercially Available Fungicides	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR A3(2); CELL-WALL COMPOSITION; SERRATIA-MARCESCENS; ANTIFUNGAL ACTIVITY; MUCOR-PIRIFORMIS; IN-VITRO; CHITINASE; DEGRADATION; INSIGHT	Chitosan is a linear heteropolymer consisting of beta 1,4-linked N-acetyl-D-glucosamine (GlcNAc) and D-glucosamine (GlcN). We have compared the antifungal activity of chitosan with DPn (average degree of polymerization) 206 and F-A (fraction of acetylation) 0.15 and of enzymatically produced chito-oligosaccharides (CHOS) of different DPn alone and in combination with commercially available synthetic fungicides, against Botrytis cinerea, the causative agent of gray mold in numerous fruit and vegetable crops. CHOS with DPn in the range of 15-40 had the greatest anti-fungal activity. The combination of CHOS and low dosages of synthetic fungicides showed synergistic effects on antifungal activity in both in vitro and in vivo assays. Our study shows that CHOS enhance the activity of commercially available fungicides. Thus, addition of CHOS, available as a nontoxic byproduct of the shellfish industry, may reduce the amounts of fungicides that are needed to control plant diseases.	[Rahman, Md Hafizur; Shovan, Latifur Rahman; Hjeljord, Linda Gordon; Aam, Berit Bjugan; Eijsink, Vincent G. H.; Sorlie, Morten; Tronsmo, Arne] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway	Norwegian University of Life Sciences	Tronsmo, A (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	arne.tronsmo@nmbu.no			Norwegian University of Life Sciences (UMB), Norway	Norwegian University of Life Sciences (UMB), Norway	The work is funded by Norwegian University of Life Sciences (UMB), P.O. 5003, N-1432 As, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; Aarstad PA, 2008, 200952 STAT SENT; ALLAN CR, 1979, EXP MYCOL, V3, P285, DOI 10.1016/S0147-5975(79)80054-7; Badawy EIM, 2011, INT J CARBOHYD CHEM, V2011; Bardin M, 2008, BIOL CONTROL, V46, P476, DOI 10.1016/j.biocontrol.2008.05.012; Brent K.J., 2007, FRAC MONOGRAPH, V2; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Choi BK, 2001, INT J ANTIMICROB AG, V18, P553, DOI 10.1016/S0924-8579(01)00434-4; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Einbu A, 2008, BIOMACROMOLECULES, V9, P1870, DOI 10.1021/bm8001123; ELGHAOUTH A, 1992, PHYTOPATHOLOGY, V82, P398, DOI 10.1094/Phyto-82-398; Fishel F.M., 2012, FUNGICIDE RESISTANCE; Gerasimenko DV, 2004, APPL BIOCHEM MICRO+, V40, P253, DOI 10.1023/B:ABIM.0000025947.84650.b4; Gust AA, 2012, TRENDS PLANT SCI, V17, P495, DOI 10.1016/j.tplants.2012.04.003; HADWIGER LA, 1980, PLANT PHYSIOL, V66, P205, DOI 10.1104/pp.66.2.205; Hamel LP, 2010, PLANTA, V232, P787, DOI 10.1007/s00425-010-1215-9; Haware M. P., 1998, P473; Heggset EB, 2010, BIOMACROMOLECULES, V11, P2487, DOI 10.1021/bm1006745; Heggset EB, 2009, BIOMACROMOLECULES, V10, P892, DOI 10.1021/bm801418p; Hjeljord LG, 2000, BIOL CONTROL, V19, P149, DOI 10.1006/bcon.2000.0859; Hu XW, 2007, CARBOHYD POLYM, V70, P451, DOI 10.1016/j.carbpol.2007.05.002; Levy, 1986, EPPO B, V16, P651; Muto M., 2005, Plant Pathology Bulletin, V14, P25; Palma-Guerrero J, 2008, J APPL MICROBIOL, V104, P541, DOI 10.1111/j.1365-2672.2007.03567.x; Palma-Guerrero J, 2009, FUNGAL GENET BIOL, V46, P585, DOI 10.1016/j.fgb.2009.02.010; Palma-Guerrero J, 2010, ENZYME MICROB TECH, V46, P568, DOI 10.1016/j.enzmictec.2010.02.009; Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001; Raafat D, 2008, APPL ENVIRON MICROB, V74, P3764, DOI 10.1128/AEM.00453-08; Rahman MH, 2013, THESIS NORWEGIAN U, V12, P1; Rhoades J, 2000, APPL ENVIRON MICROB, V66, P80, DOI 10.1128/AEM.66.1.80-86.2000; SHOLBERG PL, 1990, CAN J PLANT PATHOL, V12, P219, DOI 10.1080/07060669009501032; Sorbotten A, 2005, FEBS J, V272, P538, DOI 10.1111/j.1742-4658.2004.04495.x; SUDARSHAN NR, 1992, FOOD BIOTECHNOL, V6, P257, DOI 10.1080/08905439209549838; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Vesentini D, 2007, MYCOL RES, V111, P875, DOI 10.1016/j.mycres.2007.05.015; Xu JG, 2007, PESTIC BIOCHEM PHYS, V87, P220, DOI 10.1016/j.pestbp.2006.07.013	37	48	52	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e93192	10.1371/journal.pone.0093192	http://dx.doi.org/10.1371/journal.pone.0093192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24770723	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736600002
J	Moreau, DTR; Gamperl, AK; Fletcher, GL; Fleming, IA				Moreau, Darek T. R.; Gamperl, A. Kurt; Fletcher, Garth L.; Fleming, Ian A.			Delayed Phenotypic Expression of Growth Hormone Transgenesis during Early Ontogeny in Atlantic Salmon (Salmo salar)?	PLOS ONE			English	Article							LIFE-HISTORY STRATEGIES; COHO SALMON; METABOLIC-RATE; PRIOR RESIDENCE; EGG-SIZE; RESPIRATORY METABOLISM; TERRITORIAL CONTESTS; SWIMMING PERFORMANCE; COMPETITIVE ABILITY; DISSOLVED-OXYGEN	Should growth hormone (GH) transgenic Atlantic salmon escape, there may be the potential for ecological and genetic impacts on wild populations. This study compared the developmental rate and respiratory metabolism of GH transgenic and non-transgenic full sibling Atlantic salmon during early ontogeny; a life history period of intense selection that may provide critical insight into the fitness consequences of escaped transgenics. Transgenesis did not affect the routine oxygen consumption of eyed embryos, newly hatched larvae or first-feeding juveniles. Moreover, the timing of early life history events was similar, with transgenic fish hatching less than one day earlier, on average, than their non-transgenic siblings. As the start of exogenous feeding neared, however, transgenic fish were somewhat developmentally behind, having more unused yolk and being slightly smaller than their non-transgenic siblings. Although such differences were found between transgenic and non-transgenic siblings, family differences were more important in explaining phenotypic variation. These findings suggest that biologically significant differences in fitness-related traits between GH transgenic and non-transgenic Atlantic salmon were less than family differences during the earliest life stages. The implications of these results are discussed in light of the ecological risk assessment of genetically modified animals.	[Moreau, Darek T. R.; Gamperl, A. Kurt; Fletcher, Garth L.; Fleming, Ian A.] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada; [Moreau, Darek T. R.; Fleming, Ian A.] Mem Univ Newfoundland, Cognit & Behav Ecol Programme, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Moreau, DTR (corresponding author), Govt Newfoundland & Labrador, Dept Fisheries & Aquaculture, St John, NF, Canada.	dmoreau@mun.ca	Fleming, Ian/I-7217-2012		USDA Biotechnology Risk Assessment Research Grants Program; NSERC Discovery grants	USDA Biotechnology Risk Assessment Research Grants Program; NSERC Discovery grants(Natural Sciences and Engineering Research Council of Canada (NSERC))	Principal funding for this project was held by IAF and was part of a collaborative grant led by Dr. Eric M. Hallerman and funded by the USDA Biotechnology Risk Assessment Research Grants Program. Supplementary funding came from NSERC Discovery grants awarded to IAF, AKG and GLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MV, 1999, ANIM BEHAV, V58, P933, DOI 10.1006/anbe.1999.1229; ALDERDICE DF, 1958, J FISH RES BOARD CAN, V15, P229, DOI 10.1139/f58-013; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; BRANNAS E, 1995, EVOL ECOL, V9, P411, DOI 10.1007/BF01237763; Brannon E.L., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P120; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; CHANDLER GL, 1988, T AM FISH SOC, V117, P432, DOI 10.1577/1548-8659(1988)117<0432:AGAIOJ>2.3.CO;2; CHAPMAN DW, 1988, T AM FISH SOC, V117, P1, DOI 10.1577/1548-8659(1988)117<0001:CROVUT>2.3.CO;2; Cook JT, 2000, AQUACULTURE, V188, P33, DOI 10.1016/S0044-8486(00)00332-X; Cutts CJ, 1998, J FISH BIOL, V52, P1026, DOI 10.1111/j.1095-8649.1998.tb00601.x; Cutts CJ, 2002, FUNCT ECOL, V16, P73, DOI 10.1046/j.0269-8463.2001.00603.x; Cutts CJ, 2001, CAN J FISH AQUAT SCI, V58, P961, DOI 10.1139/cjfas-58-5-961; Cutts CJ, 1999, J FISH BIOL, V55, P784, DOI 10.1111/j.1095-8649.1999.tb00717.x; De Leaniz CG, 2000, FISHERIES MANAG ECOL, V7, P489, DOI 10.1046/j.1365-2400.2000.00223.x; Deitch EJ, 2006, J EXP BIOL, V209, P1310, DOI 10.1242/jeb.02105; Devlin RH, 2006, TRENDS BIOTECHNOL, V24, P89, DOI 10.1016/j.tibtech.2005.12.008; Devlin RH, 2004, P NATL ACAD SCI USA, V101, P9303, DOI 10.1073/pnas.0400023101; Devlin RH, 2004, AQUACULTURE, V236, P607, DOI 10.1016/j.aquaculture.2004.02.026; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; DU SJ, 1992, BIO-TECHNOL, V10, P176, DOI 10.1038/nbt0292-176; Einum S, 2002, P ROY SOC B-BIOL SCI, V269, P2325, DOI 10.1098/rspb.2002.2150; Einum S, 2005, OECOLOGIA, V143, P203, DOI 10.1007/s00442-004-1793-y; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Einum S, 2008, J ANIM ECOL, V77, P167, DOI 10.1111/j.1365-2656.2007.01326.x; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; Ferguson A., 2007, ATLANTIC SALMON GENE; Fleming IA, 1996, REV FISH BIOL FISHER, V6, P379, DOI 10.1007/BF00164323; HEGGBERGET TG, 1988, CAN J FISH AQUAT SCI, V45, P845, DOI 10.1139/f88-102; Jensen AJ, 1999, FUNCT ECOL, V13, P778, DOI 10.1046/j.1365-2435.1999.00358.x; Jobling M, 1994, FISH BIOENERGETICS, P61; Johnsson JI, 1999, FUNCT ECOL, V13, P514, DOI 10.1046/j.1365-2435.1999.00341.x; JOHNSSON JI, 1993, ANIM BEHAV, V45, P1219, DOI 10.1006/anbe.1993.1143; Johnsson JI, 2002, BEHAV ECOL SOCIOBIOL, V51, P282, DOI 10.1007/S00265-001-0430-6; KAPUSCINSKI AR, 1991, CAN J FISH AQUAT SCI, V48, P99, DOI 10.1139/f91-308; Killen SS, 2007, MAR BIOL, V152, P1249, DOI 10.1007/s00227-007-0772-3; LACROIX GL, 1985, CAN J FISH AQUAT SCI, V42, P292, DOI 10.1139/f85-037; Lahti K, 2002, FUNCT ECOL, V16, P167, DOI 10.1046/j.1365-2435.2002.00618.x; Leggatt RA, 2003, J FISH BIOL, V62, P1053, DOI 10.1046/j.1095-8649.2003.00096.x; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Lohmus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009980; McCarthy ID, 2001, J FISH BIOL, V59, P1002, DOI 10.1006/jfbi.2001.1714; Metcalfe NB, 2003, J APPL ECOL, V40, P535, DOI 10.1046/j.1365-2664.2003.00815.x; METCALFE NB, 1995, ANIM BEHAV, V49, P431, DOI 10.1006/anbe.1995.0056; Moreau DTR, 2011, J FISH BIOL, V78, P726, DOI 10.1111/j.1095-8649.2010.02888.x; Moreau DTR, 2014, ANNU REV ANIM BIOSCI, V2, P515, DOI 10.1146/annurev-animal-022513-114231; Morris MRJ, 2008, CAN J FISH AQUAT SCI, V65, P2807, DOI 10.1139/F08-181; Muir WM, 2002, TRANSGENIC RES, V11, P101, DOI 10.1023/A:1015203812200; Nam YK, 2007, ENV RISK ASSESS GENE, V3, P61, DOI 10.1079/9781845932961.0061; Nislow KH, 2000, T AM FISH SOC, V129, P1067, DOI 10.1577/1548-8659(2000)129<1067:SEBAOH>2.0.CO;2; Nislow KH, 2004, J FISH BIOL, V65, P188, DOI 10.1111/j.0022-1112.2004.00561.x; O'Connor KI, 2000, BEHAV ECOL, V11, P13, DOI 10.1093/beheco/11.1.13; OCONNOR M, 2003, CHI TRIB        1218, P1; Pakkasmaa S, 2006, J COMP PHYSIOL B, V176, P387, DOI 10.1007/s00360-005-0057-4; Peterson NP, 1996, J FISH BIOL, V48, P131, DOI 10.1006/jfbi.1996.0011; Rhodes JS, 1998, J FISH BIOL, V53, P1220, DOI 10.1111/j.1095-8649.1998.tb00243.x; Rollinson N, 2011, CAN J FISH AQUAT SCI, V68, P1307, DOI [10.1139/F2011-069, 10.1139/f2011-069]; Rollinson N, 2010, EVOL ECOL RES, V12, P949; Rubin JF, 1996, J FISH BIOL, V48, P585, DOI 10.1006/jfbi.1996.0059; SHEARS MA, 1992, TRANSGENIC FISH, P44; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Skoglund H, 2006, J FISH BIOL, V68, P507, DOI 10.1111/j.0022-1112.2006.00938.x; Skoglund H, 2011, J ANIM ECOL, V80, P365, DOI 10.1111/j.1365-2656.2010.01783.x; Stevens ED, 1998, CAN J FISH AQUAT SCI, V55, P2028, DOI 10.1139/cjfas-55-9-2028; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; Sundstrom LF, 2003, ETHOLOGY, V109, P701, DOI 10.1046/j.1439-0310.2003.00908.x; Sundstrom LF, 2005, EVOLUTION, V59, P1560, DOI 10.1111/j.0014-3820.2005.tb01805.x; Sundt-Hansen L, 2007, BIOL LETTERS, V3, P165, DOI 10.1098/rsbl.2006.0598; Symonds MRE, 1999, J ZOOL, V249, P315; Thorstad E.B., 2008, 36 NINA; Tymchuk WEV, 2005, T AM FISH SOC, V134, P381, DOI 10.1577/T04-084.1; Yamamoto T, 1998, J FISH BIOL, V52, P281, DOI 10.1006/jfbi.1997.0580; Yaskowiak ES, 2006, TRANSGENIC RES, V15, P465, DOI 10.1007/s11248-006-0020-5	75	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95853	10.1371/journal.pone.0095853	http://dx.doi.org/10.1371/journal.pone.0095853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763675	Green Published, Green Accepted, gold			2022-12-25	WOS:000335505000039
J	Cha, JH; Wee, HJ; Seo, JH; Ahn, BJ; Park, JH; Yang, JM; Lee, SW; Kim, EH; Lee, OH; Heo, JH; Lee, HJ; Gelman, IH; Arai, K; Lo, EH; Kim, KW				Cha, Jong-Ho; Wee, Hee-Jun; Seo, Ji Hae; Ahn, Bum Ju; Park, Ji-Hyeon; Yang, Jun-Mo; Lee, Sae-Won; Kim, Eun Hee; Lee, Ok-Hee; Heo, Ji Hoe; Lee, Hyo-Jong; Gelman, Irwin H.; Arai, Ken; Lo, Eng H.; Kim, Kyu-Won			AKAP12 Mediates Barrier Functions of Fibrotic Scars during CNS Repair	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; REGENERATION; RATS; HOMEOSTASIS; JUNCTIONS; MENINGEAL; PATHWAY; DISEASE	The repair process after CNS injury shows a well-organized cascade of three distinct stages: inflammation, new tissue formation, and remodeling. In the new tissue formation stage, various cells migrate and form the fibrotic scar surrounding the lesion site. The fibrotic scar is known as an obstacle for axonal regeneration in the remodeling stage. However, the role of the fibrotic scar in the new tissue formation stage remains largely unknown. We found that the number of A-kinase anchoring protein 12 (AKAP12)-positive cells in the fibrotic scar was increased over time, and the cells formed a structure which traps various immune cells. Furthermore, the AKAP12-positive cells strongly express junction proteins which enable the structure to function as a physical barrier. In in vivo validation, AKAP12 knock-out (KO) mice showed leakage from a lesion, resulting from an impaired structure with the loss of the junction complex. Consistently, focal brain injury in the AKAP12 KO mice led to extended inflammation and more severe tissue damage compared to the wild type (WT) mice. Accordingly, our results suggest that AKAP12-positive cells in the fibrotic scar may restrict excessive inflammation, demonstrating certain mechanisms that could underlie the beneficial actions of the fibrotic scar in the new tissue formation stage during the CNS repair process.	[Cha, Jong-Ho; Wee, Hee-Jun; Seo, Ji Hae; Ahn, Bum Ju; Park, Ji-Hyeon; Yang, Jun-Mo; Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVasc Protect Res Ctr, Seoul, South Korea; [Cha, Jong-Ho; Wee, Hee-Jun; Seo, Ji Hae; Ahn, Bum Ju; Park, Ji-Hyeon; Yang, Jun-Mo; Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Lee, Sae-Won] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Lee, Sae-Won] Seoul Natl Univ Hosp, Innovat Res Inst Cell Therapy, Seoul 110744, South Korea; [Kim, Eun Hee; Heo, Ji Hoe] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Kim, Eun Hee; Heo, Ji Hoe] Yonsei Univ, Coll Med, Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul, South Korea; [Kim, Eun Hee; Heo, Ji Hoe] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Lee, Hyo-Jong] Inje Univ, Coll Pharm, Gimhae, South Korea; [Gelman, Irwin H.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Seo, Ji Hae; Arai, Ken; Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Boston, MA 02114 USA; [Seo, Ji Hae; Arai, Ken; Lo, Eng H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Seo, Ji Hae; Arai, Ken; Lo, Eng H.] Harvard Univ, Sch Med, Boston, MA USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Inje University; Roswell Park Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kim, KW (corresponding author), Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVasc Protect Res Ctr, Seoul, South Korea.	qwonkim@snu.ac.kr	Kim, Kyu Won/AAJ-7213-2020	Lee, Hyo-Jong/0000-0003-4826-7954; Heo, Ji Hoe/0000-0001-9898-3321	Global Research Laboratory Program [2011-0021874]; Brain Korea 21 Program; Global Core Research Center (GCRC) Program [2011-0030001]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning or Ministry of Education [2013R1A1A2058956]; NIH [R37-NS37074, R01-76694, P01-NS55104]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055104, R37NS037074] Funding Source: NIH RePORTER	Global Research Laboratory Program; Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Global Core Research Center (GCRC) Program; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning or Ministry of Education; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Global Research Laboratory Program (2011-0021874), Brain Korea 21 Program, the Global Core Research Center (GCRC) Program (2011-0030001), and Basic Science Research Program (2013R1A1A2058956 to J.H. Seo) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning or Ministry of Education. E.H. Lo is the recipient of NIH grants (R37-NS37074, R01-76694 and P01-NS55104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura S, 2008, CANCER RES, V68, P5096, DOI 10.1158/0008-5472.CAN-07-5619; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Chew DJ, 2012, PROG BRAIN RES, V201, P253, DOI 10.1016/B978-0-444-59544-7.00013-5; Choi SA, 2007, CURR NEUROVASC RES, V4, P89, DOI 10.2174/156720207780637252; Choi YK, 2007, J NEUROSCI, V27, P4472, DOI 10.1523/JNEUROSCI.5368-06.2007; Dragunow M, 2013, BRAIN RES, V1501, P32, DOI 10.1016/j.brainres.2013.01.013; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Ikeshima-Kataoka H, 2008, IN VIVO, V22, P409; Jeong CH, 2007, J BIOL CHEM, V282, P13672, DOI 10.1074/jbc.M700534200; Kawano H, 2012, CELL TISSUE RES; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; Kuroiwa T, 2009, STROKE, V40, P248, DOI 10.1161/STROKEAHA.108.527853; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; O'Neill CA, 2011, EXP DERMATOL, V20, P88, DOI 10.1111/j.1600-0625.2010.01206.x; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sirisinha S, 2011, ASIAN PAC J ALLERGY, V29, P1; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; WANG LJC, 1995, STROKE, V26, P2087, DOI 10.1161/01.STR.26.11.2087; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Weiser DC, 2007, GENE DEV, V21, P1559, DOI 10.1101/gad.1535007; Xia W, 2001, CANCER RES, V61, P5644	31	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94695	10.1371/journal.pone.0094695	http://dx.doi.org/10.1371/journal.pone.0094695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760034	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200023
J	Ciglia, E; Vergin, J; Reimann, S; Smits, SHJ; Schmitt, L; Groth, G; Gohlke, H				Ciglia, Emanuele; Vergin, Janina; Reimann, Sven; Smits, Sander H. J.; Schmitt, Lutz; Groth, Georg; Gohlke, Holger			Resolving Hot Spots in the C-Terminal Dimerization Domain that Determine the Stability of the Molecular Chaperone Hsp90	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; IN-VIVO FUNCTION; THERMODYNAMIC STABILITY; ATP-BINDING; FREE-ENERGY; INTERACTION INHIBITORS; CONFORMATIONAL-CHANGES; DYNAMICS; SITE; HEAT-SHOCK-PROTEIN-90	Human heat shock protein of 90 kDa (hHsp90) is a homodimer that has an essential role in facilitating malignant transformation at the molecular level. Inhibiting hHsp90 function is a validated approach for treating different types of tumors. Inhibiting the dimerization of hHsp90 via its C-terminal domain (CTD) should provide a novel way to therapeutically interfere with hHsp90 function. Here, we predicted hot spot residues that cluster in the CTD dimerization interface by a structural decomposition of the effective energy of binding computed by the MM-GBSA approach and confirmed these predictions using in silico alanine scanning with DrugScore(PPI). Mutation of these residues to alanine caused a significant decrease in the melting temperature according to differential scanning fluorimetry experiments, indicating a reduced stability of the mutant hHsp90 complexes. Size exclusion chromatography and multi-angle light scattering studies demonstrate that the reduced stability of the mutant hHsp90 correlates with a lower complex stoichiometry due to the disruption of the dimerization interface. These results suggest that the identified hot spot residues can be used as a pharmacophoric template for identifying and designing small-molecule inhibitors of hHsp90 dimerization.	[Ciglia, Emanuele; Gohlke, Holger] Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany; [Vergin, Janina; Groth, Georg] Univ Dusseldorf, Inst Biochem Plant Physiol, Dusseldorf, Germany; [Reimann, Sven; Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Gohlke, H (corresponding author), Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany.	gohlke@uni-duesseldorf.de			Strategischer Forschungsfonds of the Heinrich-Heine-University, Dusseldorf	Strategischer Forschungsfonds of the Heinrich-Heine-University, Dusseldorf	This work was supported by funds from the Strategischer Forschungsfonds of the Heinrich-Heine-University, Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archontis G, 2001, J MOL BIOL, V306, P307, DOI 10.1006/jmbi.2000.4285; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Bjork A, 2003, FEBS LETT, V553, P423, DOI 10.1016/S0014-5793(03)01076-7; Blazer LL, 2009, NEUROPSYCHOPHARMACOL, V34, P126, DOI 10.1038/npp.2008.151; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Case D.A., 2022, AMBER 2020; Chene P, 2006, CHEMMEDCHEM, V1, P400, DOI 10.1002/cmdc.200600004; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cummings CG, 2010, CURR OPIN CHEM BIOL, V14, P341, DOI 10.1016/j.cbpa.2010.04.001; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis JM, 2007, CHEM SOC REV, V36, P326, DOI 10.1039/b608043j; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fischer PM, 2005, DRUG DES REV ONLINE, V2, P179; Froese DS, 2010, MOL GENET METAB, V100, P29, DOI 10.1016/j.ymgme.2010.02.005; Garnier C, 2002, J BIOL CHEM, V277, P12208, DOI 10.1074/jbc.M111874200; Gerrard JA, 2007, MINI-REV MED CHEM, V7, P151, DOI 10.2174/138955707779802561; Gohlke H, 2002, ANGEW CHEM INT EDIT, V41, P2645; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Golden MS, 2013, J AM CHEM SOC, V135, P6242, DOI 10.1021/ja400914z; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kervinen J, 2006, ARCH BIOCHEM BIOPHYS, V449, P47, DOI 10.1016/j.abb.2006.03.018; Kruger DM, 2011, NACHR CHEM, V59, P44, DOI 10.1002/nadc.201177770; Kruger DM, 2010, NUCLEIC ACIDS RES, V38, pW480, DOI 10.1093/nar/gkq471; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Lee CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019961; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; Mandelman D, 1998, PROTEIN SCI, V7, P2089, DOI 10.1002/pro.5560071005; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Mateu MG, 1998, EMBO J, V17, P2748, DOI 10.1093/emboj/17.10.2748; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mayer MP, 2009, NAT STRUCT MOL BIOL, V16, P2, DOI 10.1038/nsmb0109-2; Metz A, 2013, J CHEM INF MODEL, V53, P2197, DOI 10.1021/ci400332e; Metz A, 2012, CURR PHARM DESIGN, V18, P4630, DOI 10.2174/138161212802651553; Metz A, 2012, J CHEM INF MODEL, V52, P120, DOI 10.1021/ci200322s; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Morelli X, 2011, CURR OPIN CHEM BIOL, V15, P475, DOI 10.1016/j.cbpa.2011.05.024; Moullintraffort L, 2010, J BIOL CHEM, V285, P15100, DOI 10.1074/jbc.M109.094698; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Nemoto T, 1998, BIOCHEM J, V330, P989, DOI 10.1042/bj3300989; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Ratzke C, 2010, P NATL ACAD SCI USA, V107, P16101, DOI 10.1073/pnas.1000916107; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Ryan DP, 2005, CURR OPIN STRUC BIOL, V15, P441, DOI 10.1016/j.sbi.2005.06.001; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sgobba M, 2008, CHEM BIOL DRUG DES, V71, P420, DOI 10.1111/j.1747-0285.2008.00650.x; Sharma SV, 1998, ONCOGENE, V16, P2639, DOI 10.1038/sj.onc.1201790; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Spanier L, 2014, J ORG CHEM, V79, P1582, DOI 10.1021/jo402353z; Thanos CD, 2006, P NATL ACAD SCI USA, V103, P15422, DOI 10.1073/pnas.0607058103; Thorn KS, 2001, BIOINFORMATICS, V17, P284, DOI 10.1093/bioinformatics/17.3.284; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Whitley D, 1999, J VASC SURG, V29, P748, DOI 10.1016/S0741-5214(99)70329-0; Wichmann C, 2010, BLOOD, V116, P603, DOI 10.1182/blood-2009-10-248047; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Yun BG, 2004, BIOCHEMISTRY-US, V43, P8217, DOI 10.1021/bi0497998; Zerbe BS, 2012, J CHEM INF MODEL, V52, P2236, DOI [10.1021/ci300175u, 10.1021/cI300175u]; Zinzalla G, 2009, FUTURE MED CHEM, V1, P65, DOI [10.4155/fmc.09.12, 10.4155/FMC.09.12]	86	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96031	10.1371/journal.pone.0096031	http://dx.doi.org/10.1371/journal.pone.0096031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760083	gold, Green Submitted, Green Published			2022-12-25	WOS:000335298200127
J	Clemens, B; Jung, S; Mingoia, G; Weyer, D; Domahs, F; Willmes, K				Clemens, Benjamin; Jung, Stefanie; Mingoia, Gianluca; Weyer, David; Domahs, Frank; Willmes, Klaus			Influence of Anodal Transcranial Direct Current Stimulation (tDCS) over the Right Angular Gyrus on Brain Activity during Rest	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; HUMAN MOTOR CORTEX; INDEPENDENT COMPONENT ANALYSIS; STATE FUNCTIONAL CONNECTIVITY; DORSOLATERAL PREFRONTAL CORTEX; MAGNETIC STIMULATION; DC-STIMULATION; STRUCTURAL CONNECTIVITY; HEALTHY-INDIVIDUALS; PARKINSONS-DISEASE	Although numerous studies examined resting-state networks (RSN) in the human brain, so far little is known about how activity within RSN might be modulated by non-invasive brain stimulation applied over parietal cortex. Investigating changes in RSN in response to parietal cortex stimulation might tell us more about how non-invasive techniques such as transcranial direct current stimulation (tDCS) modulate intrinsic brain activity, and further elaborate our understanding of how the resting brain responds to external stimulation. Here we examined how activity within the canonical RSN changed in response to anodal tDCS applied over the right angular gyrus (AG). We hypothesized that changes in resting-state activity can be induced by a single tDCS session and detected with functional magnetic resonance imaging (fMRI). Significant differences between two fMRI sessions (pre-tDCS and post-tDCS) were found in several RSN, including the cerebellar, medial visual, sensorimotor, right frontoparietal, and executive control RSN as well as the default mode and the task positive network. The present results revealed decreased and increased RSN activity following tDCS. Decreased RSN activity following tDCS was found in bilateral primary and secondary visual areas, and in the right putamen. Increased RSN activity following tDCS was widely distributed across the brain, covering thalamic, frontal, parietal and occipital regions. From these exploratory results we conclude that a single session of anodal tDCS over the right AG is sufficient to induce large-scale changes in resting-state activity. These changes were localized in sensory and cognitive areas, covering regions close to and distant from the stimulation site.	[Clemens, Benjamin] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Clemens, Benjamin; Mingoia, Gianluca; Weyer, David; Willmes, Klaus] Rhein Westfal TH Aachen, Sch Med, Interdisciplinary Ctr Clin Res, Brain Imaging Facil, Aachen, Germany; [Clemens, Benjamin; Willmes, Klaus] Rhein Westfal TH Aachen, Sch Med, Sect Neuropsychol, Neurol Clin, Aachen, Germany; [Jung, Stefanie] Univ Tubingen, Dept Psychol, Tubingen, Germany; [Jung, Stefanie] IWM KMRC, Knowledge Media Res Ctr, Tubingen, Germany; [Domahs, Frank] Univ Marburg, Dept German Linguist, Marburg, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Leibniz Institut fur Wissensmedien; Philipps University Marburg	Clemens, B (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	bclemens@ukaachen.de	Clemens, Benjamin/AAW-7273-2021; Willmes, Klaus F/A-1268-2014	Willmes, Klaus F/0000-0002-9012-0553	START program of the Faculty of Medicine, RWTH Aachen University, Aachen, Germany	START program of the Faculty of Medicine, RWTH Aachen University, Aachen, Germany	This research was supported by the START program of the Faculty of Medicine, RWTH Aachen University, Aachen, Germany (http://www.medizin.rwth-aachen.de/go/id/tfy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero N, 2007, EXP BRAIN RES, V178, P261, DOI 10.1007/s00221-006-0733-y; Amadi U, 2014, NEUROIMAGE, V88, P155, DOI 10.1016/j.neuroimage.2013.11.037; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Antal A, 2007, EUR J NEUROSCI, V26, P2687, DOI 10.1111/j.1460-9568.2007.05896.x; Antal A, 2012, RESTOR NEUROL NEUROS, V30, P255, DOI 10.3233/RNN-2012-110208; Antal A, 2011, NEUROIMAGE, V55, P590, DOI 10.1016/j.neuroimage.2010.11.085; Arrington CM, 2000, J COGNITIVE NEUROSCI, V12, P106, DOI 10.1162/089892900563975; Banich MT, 2000, COGNITIVE BRAIN RES, V10, P1, DOI 10.1016/S0926-6410(00)00015-X; Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Benninger DH, 2010, J NEUROL NEUROSUR PS, V81, P1105, DOI 10.1136/jnnp.2009.202556; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Birn RM, 2012, NEUROIMAGE, V62, P864, DOI 10.1016/j.neuroimage.2012.01.016; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brunelin J, 2012, AM J PSYCHIAT, V169, P719, DOI 10.1176/appi.ajp.2012.11071091; Brunoni AR, 2013, JAMA PSYCHIAT, V70, P383, DOI 10.1001/2013.jamapsychiatry.32; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cattaneo Z, 2011, NEUROSCIENCE, V183, P64, DOI 10.1016/j.neuroscience.2011.03.058; Cecere R, 2013, J NEUROSCI, V33, P6469, DOI 10.1523/JNEUROSCI.3431-12.2013; Chambers CD, 2004, NAT NEUROSCI, V7, P217, DOI 10.1038/nn1203; Clemens B, 2015, CEREB CORTEX, V25, P1771, DOI 10.1093/cercor/bht366; Clemens B, 2013, NEUROPSYCHOLOGIA, V51, P1279, DOI 10.1016/j.neuropsychologia.2013.03.023; Clemens B, 2013, RESTOR NEUROL NEUROS, V31, P311, DOI 10.3233/RNN-120266; Clemens B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025453; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; Dehaene S, 2004, CURR OPIN NEUROBIOL, V14, P218, DOI 10.1016/j.conb.2004.03.008; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Filippi M, 2013, HUM BRAIN MAPP, V34, P1330, DOI 10.1002/hbm.21514; Fiori V, 2011, J COGNITIVE NEUROSCI, V23, P2309, DOI 10.1162/jocn.2010.21579; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox MD, 2012, NEUROIMAGE, V62, P2232, DOI 10.1016/j.neuroimage.2012.03.035; Fregni F, 2006, BIPOLAR DISORD, V8, P203, DOI 10.1111/j.1399-5618.2006.00291.x; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Garavan H, 2006, BRAIN RES, V1105, P130, DOI 10.1016/j.brainres.2006.03.029; Gerardin E, 2004, NEUROREPORT, V15, P2327, DOI 10.1097/00001756-200410250-00005; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021; Homan P, 2011, AM J PSYCHIAT, V168, P853, DOI 10.1176/appi.ajp.2011.11030496; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jamadar S, 2013, BRAIN IMAGING BEHAV, V7, P15, DOI 10.1007/s11682-012-9168-1; Kasahara K, 2013, NEUROSCI LETT, V545, P86, DOI 10.1016/j.neulet.2013.04.022; Keeser D, 2011, J NEUROSCI, V31, P15284, DOI 10.1523/JNEUROSCI.0542-11.2011; KEMP JM, 1971, PHILOS T R SOC B, V262, P441, DOI 10.1098/rstb.1971.0106; Kiviniemi V, 2004, MAGN RESON IMAGING, V22, P197, DOI 10.1016/j.mri.2003.09.007; Koyama MS, 2010, CEREB CORTEX, V20, P2549, DOI 10.1093/cercor/bhq005; Kuo MF, 2008, NEUROPSYCHOLOGIA, V46, P2122, DOI 10.1016/j.neuropsychologia.2008.02.023; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Lindenberg R, 2013, J NEUROSCI, V33, P9176, DOI 10.1523/JNEUROSCI.0055-13.2013; Loo CK, 2012, BRIT J PSYCHIAT, V200, P52, DOI 10.1192/bjp.bp.111.097634; Maeoka H, 2012, NEUROSCI LETT, V512, P12, DOI 10.1016/j.neulet.2012.01.037; Makris N, 2009, CEREB CORTEX, V19, P777, DOI 10.1093/cercor/bhn124; Marangolo P, 2011, BEHAV BRAIN RES, V225, P498, DOI 10.1016/j.bbr.2011.08.008; McKeown MJ, 1998, P NATL ACAD SCI USA, V95, P803, DOI 10.1073/pnas.95.3.803; Meinzer M, 2012, J NEUROSCI, V32, P1859, DOI 10.1523/JNEUROSCI.4812-11.2012; Merzagora AC, 2010, NEUROIMAGE, V49, P2304, DOI 10.1016/j.neuroimage.2009.10.044; Mingoia G, 2013, PSYCHIAT RES-NEUROIM, V214, P80, DOI 10.1016/j.pscychresns.2013.05.013; Mingoia G, 2012, SCHIZOPHR RES, V138, P143, DOI 10.1016/j.schres.2012.01.036; Miniussi C, 2008, BRAIN STIMUL, V1, P326, DOI 10.1016/j.brs.2008.07.002; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Miranda PC, 2009, CLIN NEUROPHYSIOL, V120, P1183, DOI 10.1016/j.clinph.2009.03.023; Moliadze V, 2010, CLIN NEUROPHYSIOL, V121, P2165, DOI 10.1016/j.clinph.2010.04.033; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2004, NEUROPSYCHOPHARMACOL, V29, P1573, DOI 10.1038/sj.npp.1300517; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostendorp TF, 2008, IEEE ENG MED BIO, P4226, DOI 10.1109/IEMBS.2008.4650142; Park CH, 2013, NEUROSCI LETT, V539, P7, DOI 10.1016/j.neulet.2013.01.047; Pena-Gomez C, 2012, BRAIN STIMUL, V5, P252, DOI 10.1016/j.brs.2011.08.006; Polania R, 2012, HUM BRAIN MAPP, V33, P2499, DOI 10.1002/hbm.21380; Polania R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030971; Polania R, 2011, HUM BRAIN MAPP, V32, P1236, DOI 10.1002/hbm.21104; Polania R, 2011, NEUROIMAGE, V54, P2287, DOI 10.1016/j.neuroimage.2010.09.085; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Sadleir RJ, 2010, NEUROIMAGE, V51, P1310, DOI 10.1016/j.neuroimage.2010.03.052; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schlaug G, 2008, EXPERT REV MED DEVIC, V5, P759, DOI 10.1586/17434440.5.6.759; Schutter DJLG, 2004, SYNTHESE, V141, P155, DOI 10.1023/B:SYNT.0000042951.25087.16; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Sehm B, 2012, J NEUROPHYSIOL, V108, P3253, DOI 10.1152/jn.00606.2012; Shafi MM, 2012, EUR J NEUROSCI, V35, P805, DOI 10.1111/j.1460-9568.2012.08035.x; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Shulman GL, 2009, J NEUROSCI, V29, P4392, DOI 10.1523/JNEUROSCI.5609-08.2009; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Stevens WD, 2010, CEREB CORTEX, V20, P1997, DOI 10.1093/cercor/bhp270; Sturm W, 2004, NEUROPSYCHOLOGIA, V42, P563, DOI 10.1016/j.neuropsychologia.2003.11.004; Suh HS, 2010, IEEE ENG MED BIO, P2053, DOI 10.1109/IEMBS.2010.5626502; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Teo Florence, 2011, Front Psychiatry, V2, P45, DOI 10.3389/fpsyt.2011.00045; Uddin LQ, 2010, CEREB CORTEX, V20, P2636, DOI 10.1093/cercor/bhq011; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vanderhasselt MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062219; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; Wong D L, 1988, Pediatr Nurs, V14, P9; Zheng X, 2011, NEUROIMAGE, V58, P26, DOI 10.1016/j.neuroimage.2011.06.018	132	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95984	10.1371/journal.pone.0095984	http://dx.doi.org/10.1371/journal.pone.0095984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760013	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200122
J	Li, BZ; Liu, N; Li, YQ; Jing, WX; Fan, JH; Li, D; Zhang, LY; Zhang, XF; Zhang, ZM; Wang, L				Li, Baozhen; Liu, Na; Li, Yongquan; Jing, Weixin; Fan, Jinhua; Li, Dan; Zhang, Longyan; Zhang, Xiaofeng; Zhang, Zhaoming; Wang, Lan			Reduction of Selenite to Red Elemental Selenium by Rhodopseudomonas palustris Strain N	PLOS ONE			English	Article							PHOTOSYNTHETIC BACTERIA; SERUM SELENIUM; RESISTANCE; MORTALITY; HEALTH; GROWTH; PROTEOBACTERIA; IDENTIFICATION; NANOPARTICLES; TELLURITE	The trace metal selenium is in demand for health supplements to human and animal nutrition. We studied the reduction of selenite (SeO3-2) to red elemental selenium by Rhodopseudomonas palustris strain N. This strain was cultured in a medium containing SeO3-2 and the particles obtained from cultures were analyzed using transmission electron microscopy (TEM), energy dispersive microanalysis (EDX) and X ray diffraction analysis (XRD). Our results showed the strain N could reduce SeO3-2 to red elemental selenium. The diameters of particles were 80-200 nm. The bacteria exhibited significant tolerance to SeO3-2 up to 8.0 m mol/L concentration with an EC50 value of 2.4 m mol/L. After 9 d of cultivation, the presence of SeO3-2 up to 1.0 m mol/L resulted in 99.9% reduction of selenite, whereas 82.0% (p<0.05), 31.7% (p<0.05) and 2.4% (p<0.05) reduction of SeO3-2 was observed at 2.0, 4.0 and 8.0 m mol/L SeO3-2 concentrations, respectively. This study indicated that red elemental selenium was synthesized by green technology using Rhodopseudomonas palustris strain N. This strain also indicated a high tolerance to SeO3-2 . The finding of this work will contribute to the application of selenium to human health.	[Li, Baozhen; Liu, Na; Li, Yongquan; Jing, Weixin; Fan, Jinhua; Li, Dan; Zhang, Longyan; Zhang, Zhaoming; Wang, Lan] Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China; [Zhang, Xiaofeng] Shanxi Coal Geol Bur, Taiyuan, Peoples R China	Shanxi University	Wang, L (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China.	Lanwang@sxu.edu.cn	li, bz/GVR-7133-2022; li, bing/GWQ-9617-2022		Shanxi Provincial Key Technologies Research and Development Program [20130321033-03, 20100311050]; Postgraduate Innovation Project of Shanxi Province [011352901019]	Shanxi Provincial Key Technologies Research and Development Program; Postgraduate Innovation Project of Shanxi Province	This work was supported by the Shanxi Provincial Key Technologies Research and Development Program (20130321033-03 and 20100311050) and Postgraduate Innovation Project of Shanxi Province (011352901019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkar E, 2003, FEMS MICROBIOL LETT, V226, P107, DOI 10.1016/S0378-1097(03)00609-8; Akbaraly NT, 2005, CLIN CHEM, V51, P2117, DOI 10.1373/clinchem.2005.055301; Avazeri C, 1997, MICROBIOL-SGM, V143, P1181, DOI 10.1099/00221287-143-4-1181; Bansal V, 2012, ADV COLLOID INTERFAC, V179, P150, DOI 10.1016/j.cis.2012.06.013; Bansal V, 2011, AUST J CHEM, V64, P279, DOI 10.1071/CH10343; Bebien M, 2001, APPL ENVIRON MICROB, V67, P4440, DOI 10.1128/AEM.67.10.4440-4447.2001; Bledsoe TL, 1999, APPL MICROBIOL BIOT, V51, P682, DOI 10.1007/s002530051452; Bleys J, 2008, ARCH INTERN MED, V168, P404, DOI 10.1001/archinternmed.2007.74; Broome CS, 2004, AM J CLIN NUTR, V80, P154; Domokos-Szabolcsy E, 2012, PLANT GROWTH REGUL, V68, P525, DOI 10.1007/s10725-012-9735-x; Dwivedi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057404; Euzeby J, 2008, INT J SYST EVOL MICR, V58, P1057; Fordyce F., 2005, ESSENTIALS MED GEOLO; Garbisu C, 1999, BIOFACTORS, V10, P311, DOI 10.1002/biof.5520100401; Getha K, 1998, WORLD J MICROB BIOT, V14, P505, DOI 10.1023/A:1008855125634; Giotta L, 2006, CHEMOSPHERE, V62, P1490, DOI 10.1016/j.chemosphere.2005.06.014; Hawkes WC, 2001, BIOL TRACE ELEM RES, V81, P189, DOI 10.1385/BTER:81:3:189; HESS WM, 1966, STAIN TECHNOL, V41, P27, DOI 10.3109/10520296609116276; Hoffmann FW, 2010, J NUTR, V140, P1155, DOI 10.3945/jn.109.120725; Hunter WJ, 2007, CURR MICROBIOL, V55, P455, DOI 10.1007/s00284-007-9020-9; Hunter WJ, 2008, CURR MICROBIOL, V57, P83, DOI 10.1007/s00284-008-9160-6; Hunter WJ, 2007, CURR MICROBIOL, V55, P344, DOI 10.1007/s00284-007-0202-2; Hunter WJ, 2007, CURR MICROBIOL, V54, P376, DOI 10.1007/s00284-006-0474-y; Hunter WJ, 2009, CURR MICROBIOL, V58, P493, DOI 10.1007/s00284-009-9358-2; Johnson CC, 2010, P NUTR SOC, V69, P119, DOI 10.1017/S0029665109991807; Kessi J, 2006, MICROBIOL-SGM, V152, P731, DOI 10.1099/mic.0.28240-0; Kessi J, 1999, APPL ENVIRON MICROB, V65, P4734; KINKLE BK, 1994, APPL ENVIRON MICROB, V60, P1674, DOI 10.1128/AEM.60.5.1674-1677.1994; Kiremidjian-Schumacher L, 2000, BIOL TRACE ELEM RES, V73, P97, DOI 10.1385/BTER:73:2:97; KOBAYASHI M, 1978, PROCESS BIOCHEM, V13, P27; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; LOWRY OH, 1951, J BIOL CHEM, V193, P265; [吕常江 Lu Changjiang], 2012, [环境科学学报, Acta Scientiae Circumstantiae], V32, P2375; Mishra RR, 2011, CHEMOSPHERE, V84, P1231, DOI 10.1016/j.chemosphere.2011.05.025; MOORE MD, 1992, J BACTERIOL, V174, P1505, DOI 10.1128/jb.174.5.1505-1514.1992; Narasingarao P, 2007, APPL ENVIRON MICROB, V73, P3519, DOI 10.1128/AEM.02737-06; OREMLAND RS, 1989, APPL ENVIRON MICROB, V55, P2333, DOI 10.1128/AEM.55.9.2333-2343.1989; OREMLAND RS, 1990, ENVIRON SCI TECHNOL, V24, P1157, DOI 10.1021/es00078a001; ORMEROD JG, 1961, ARCH BIOCHEM BIOPHYS, V94, P449, DOI 10.1016/0003-9861(61)90073-X; Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978; Ramanathan R, 2013, NANOSCALE, V5, P2300, DOI 10.1039/c2nr32887a; Ramanathan R, 2011, LANGMUIR, V27, P714, DOI 10.1021/la1036162; Ray AL, 2006, J NUTR, V136, P172, DOI 10.1093/jn/136.1.172; Rayman MP, 2008, BRIT J NUTR, V100, P254, DOI 10.1017/S0007114508939830; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Reilly C., 2006, SELENIUM FOOD HLTH, V2nd; Rider CV, 2005, TOXICOL SCI, V87, P520, DOI 10.1093/toxsci/kfi247; SCHMIDT MG, 1986, CAN J MICROBIOL, V32, P825, DOI 10.1139/m86-152; Wang HL, 2007, FREE RADICAL BIO MED, V42, P1524, DOI 10.1016/j.freeradbiomed.2007.02.013; Wood, 2000, Integr Med, V2, P85, DOI 10.1016/S1096-2190(00)00009-3; YANKE LJ, 1995, ANAEROBE, V1, P61, DOI 10.1016/S1075-9964(95)80457-9; Zhang J, 2004, CHINESE CHEM LETT, V15, P1345; Zhang JS, 2008, TOXICOL SCI, V101, P22, DOI 10.1093/toxsci/kfm221; Zhang YQ, 1999, SCI TOTAL ENVIRON, V229, P183, DOI 10.1016/S0048-9697(99)00061-3; Zhang Z, 1992, J SHANXI U NAT SCI, V15, P379	56	49	52	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95955	10.1371/journal.pone.0095955	http://dx.doi.org/10.1371/journal.pone.0095955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759917	gold, Green Submitted, Green Published			2022-12-25	WOS:000335298200116
J	Zhu, P; Wei, GY				Zhu, Ping; Wei, Guiyi			Stochastic Heterogeneous Interaction Promotes Cooperation in Spatial Prisoner's Dilemma Game	PLOS ONE			English	Article							EVOLUTIONARY GAMES; NETWORKS; EMERGENCE; MECHANISM; STRATEGY	Previous studies mostly investigate player's cooperative behavior as affected by game time-scale or individual diversity. In this paper, by involving both time-scale and diversity simultaneously, we explore the effect of stochastic heterogeneous interaction. In our model, the occurrence of game interaction between each pair of linked player obeys a random probability, which is further described by certain distributions. Simulations on a 4-neighbor square lattice show that the cooperation level is remarkably promoted when stochastic heterogeneous interaction is considered. The results are then explained by investigating the mean payoffs, the mean boundary payoffs and the transition probabilities between cooperators and defectors. We also show some typical snapshots and evolution time series of the system. Finally, the 8-neighbor square lattice and BA scale-free network results indicate that the stochastic heterogeneous interaction can be robust against different network topologies. Our work may sharpen the understanding of the joint effect of game time-scale and individual diversity on spatial games.	[Zhu, Ping; Wei, Guiyi] Zhejiang Gongshang Univ, Sch Comp Sci & Informat Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang Gongshang University	Zhu, P (corresponding author), Zhejiang Gongshang Univ, Sch Comp Sci & Informat Engn, Hangzhou, Zhejiang, Peoples R China.	zhuping.ustc@gmail.com			National Natural Science Foundation of China [61305148/F030707]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by National Natural Science Foundation of China, grant number: 61305148/F030707. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Cao L, 2011, J THEOR BIOL, V272, P8, DOI 10.1016/j.jtbi.2010.12.008; Cao XB, 2010, PHYSICA A, V389, P1273, DOI 10.1016/j.physa.2009.11.044; Chen XJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.017103; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036260; Chen XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046109; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Chen Z, 2011, PHYSICA A, V390, P1615, DOI 10.1016/j.physa.2011.01.004; Doebeli M, 1998, P NATL ACAD SCI USA, V95, P8676, DOI 10.1073/pnas.95.15.8676; Du WB, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/1/010204; Du WB, 2009, PHYSICA A, V388, P5005, DOI 10.1016/j.physa.2009.08.026; Du WB, 2009, PHYSICA A, V388, P4509, DOI 10.1016/j.physa.2009.07.012; Du WB, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/5/058701; Du WB, 2009, PHYSICA A, V388, P2215, DOI 10.1016/j.physa.2009.02.012; Fang SX, 2012, CHINESE PHYS B, V21; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Guan JY, 2006, EUROPHYS LETT, V76, P1214, DOI 10.1209/epl/i2006-10381-4; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; Hammerstein P., 2003, GENETIC CULTURAL EVO; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Jiang LL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036108; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Lin YT, 2011, PHYSICA A, V390, P77, DOI 10.1016/j.physa.2010.07.034; Liu YK, 2009, CHINESE PHYS B, V18, P2623, DOI 10.1088/1674-1056/18/7/001; Maynard Smith J., 1982, pi; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Rapoport A, 1965, PRISONERS DILEMMA; Ren J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045101; Roca CP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.158701; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Rong ZH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.027101; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026101; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2012, J THEOR BIOL, V299, P88, DOI 10.1016/j.jtbi.2011.09.003; Shigaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076942; Sicardi EA, 2009, J THEOR BIOL, V256, P240, DOI 10.1016/j.jtbi.2008.09.022; Sigmund K., 1993, GAMES LIFE; Sirakoulis GC, 2012, IEEE T SYST MAN CY A, V42, P596, DOI 10.1109/TSMCA.2011.2172417; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2009, EUR PHYS J B, V67, P337, DOI 10.1140/epjb/e2008-00470-8; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056104; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021901; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tanimoto J, 2007, BIOSYSTEMS, V90, P105, DOI 10.1016/j.biosystems.2006.07.005; Tanimoto J, 2012, PHYSICA A, V391, P680, DOI 10.1016/j.physa.2011.08.039; Tanimoto J, 2011, SOCIOBIOLOGY, V58, P315; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Traulsen A, 2007, J THEOR BIOL, V244, P349, DOI 10.1016/j.jtbi.2006.08.008; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Wang Z, 2011, J THEOR BIOL, V277, P19, DOI 10.1016/j.jtbi.2011.02.016; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wu ZX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021107; Wu ZX, 2007, PHYSICA A, V379, P672, DOI 10.1016/j.physa.2007.02.085; Wu ZX, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036106; Wu ZX, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.037103; Yang HX, 2008, CHINESE PHYS B, V17, P2759, DOI 10.1088/1674-1056/17/8/002; Yang HX, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056107; Zhang HF, 2010, PHYSICA A, V389, P1099, DOI 10.1016/j.physa.2009.11.029; Zhang J, 2011, PHYSICA A, V390, P2251, DOI 10.1016/j.physa.2011.02.036; Zhang M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011121; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	79	14	14	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95169	10.1371/journal.pone.0095169	http://dx.doi.org/10.1371/journal.pone.0095169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759921	gold, Green Submitted, Green Published			2022-12-25	WOS:000335298200037
J	Liu, SL; Premont, RT; Rockey, DC				Liu, Songling; Premont, Richard T.; Rockey, Don C.			Endothelial Nitric-oxide Synthase (eNOS) Is Activated through G-protein-coupled Receptor Kinase-interacting Protein 1 (GIT1) Tyrosine Phosphorylation and Src Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAVEOLIN BINDING; ANGIOTENSIN-II; RAT-LIVER; EXPRESSION; COMPLEX; CELLS; TRANSACTIVATION; IDENTIFICATION; CLONING; DOMAIN	Nitric oxide (NO) is a critical regulator of vascular tone and plays an especially prominent role in liver by controlling portal blood flow and pressure within liver sinusoids. Synthesis of NO in sinusoidal endothelial cells by endothelial nitric-oxide synthase (eNOS) is regulated in response to activation of endothelial cells by vasoactive signals such as endothelins. The endothelin B (ETB) receptor is a G-protein-coupled receptor, but the mechanisms by which it regulates eNOS activity in sinusoidal endothelial cells are not well understood. In this study, we built on two previous strands of work, the first showing that G-protein beta gamma subunits mediated activation of phosphatidylinositol 3-kinase and Akt to regulate eNOS and the second showing that eNOS directly bound to the G-protein-coupled receptor kinase-interacting protein 1 (GIT1) scaffold protein, and this association stimulated NO production. Here we investigated the mechanisms by which the GIT1-eNOS complex is formed and regulated. GIT1 was phosphorylated on tyrosine by Src, and Y293F and Y554F mutations reduced GIT1 phosphorylation as well as the ability of GIT1 to bind to and activate eNOS. Akt phosphorylation activated eNOS (at Ser(1177)), and Akt also regulated the ability of Src to phosphorylate GIT1 as well as GIT1-eNOS association. These pathways were activated by endothelin-1 through the ETB receptor; inhibiting receptor-activated G-protein beta gamma subunits blocked activation of Akt, GIT1 tyrosine phosphorylation, and ET-1-stimulated GIT1-eNOS association but did not affect Src activation. These data suggest a model in which Src and Akt cooperate to regulate association of eNOS with the GIT1 scaffold to facilitate NO production.	[Liu, Songling; Rockey, Don C.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Premont, Richard T.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Medical University of South Carolina; Duke University	Rockey, DC (corresponding author), Med Univ S Carolina, Dept Med, 96 Jonathan Lucas St,Suite 803,MSC 623, Charleston, SC 29425 USA.	rockey@musc.edu		Premont, Richard/0000-0002-8053-5026	National Institutes of Health [R01 DK 57830]; Burroughs Wellcome Fund Translational Scientist Award; American Liver Fund Liver Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Translational Scientist Award(Burroughs Wellcome Fund); American Liver Fund Liver Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK 57830 (to D. C. R.). This work was also supported by a Burroughs Wellcome Fund Translational Scientist Award (to D. C. R.) and an American Liver Fund Liver Scholar Award (to S. L.).	Albert PR, 2002, CELL SIGNAL, V14, P407, DOI 10.1016/S0898-6568(01)00259-5; Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Banquet S, 2011, CELL SIGNAL, V23, P1136, DOI 10.1016/j.cellsig.2011.02.008; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Ciccarelli M, 2007, CELL SIGNAL, V19, P1949, DOI 10.1016/j.cellsig.2007.05.007; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Fulton D, 2005, J BIOL CHEM, V280, P35943, DOI 10.1074/jbc.M504606200; Fulton D, 2008, CIRC RES, V102, P497, DOI 10.1161/CIRCRESAHA.107.162933; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; HOUSSET C, 1993, P NATL ACAD SCI USA, V90, P9266, DOI 10.1073/pnas.90.20.9266; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-152; Imamura T, 2001, J BIOL CHEM, V276, P43663, DOI 10.1074/jbc.M105364200; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Liu SL, 2003, J BIOL CHEM, V278, P49929, DOI 10.1074/jbc.M306930200; Liu SL, 2012, J BIOL CHEM, V287, P12309, DOI 10.1074/jbc.M111.320465; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Manabe R, 2002, J CELL SCI, V115, P1497; McGarrigle Deirdre, 2007, Sci STKE, V2007, ppe35, DOI 10.1126/stke.3922007pe35; Menon P, 2010, J CELL PHYSIOL, V225, P777, DOI 10.1002/jcp.22282; Natarajan Kanchana, 2006, V332, P51; Pang JJ, 2009, CIRCULATION, V119, P1524, DOI 10.1161/CIRCULATIONAHA.108.823997; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Ribas C, 2002, J BIOL CHEM, V277, P50223, DOI 10.1074/jbc.C200567200; Rockey DC, 1998, GASTROENTEROLOGY, V114, P344, DOI 10.1016/S0016-5085(98)70487-1; Ruan L, 2013, VASC PHARMACOL, V59, P27, DOI 10.1016/j.vph.2013.05.004; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Schmalzigaug R, 2007, J HISTOCHEM CYTOCHEM, V55, P1039, DOI 10.1369/jhc.7A7207.2007; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Shah V, 1999, GASTROENTEROLOGY, V117, P1222, DOI 10.1016/S0016-5085(99)70408-7; Shikata Y, 2003, FASEB J, V17, P2240, DOI 10.1096/fj.03-0198com; Spinella F, 2013, J MOL MED, V91, P395, DOI 10.1007/s00109-012-0956-2; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Su KH, 2009, CARDIOVASC RES, V82, P468, DOI 10.1093/cvr/cvp091; Tang LP, 2007, AM J PHYSIOL-LUNG C, V292, pL1467, DOI 10.1152/ajplung.00446.2006; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Yu Q, 2002, AM J PHYSIOL-GASTR L, V282, pG565, DOI 10.1152/ajpgi.00512.2000; Zhan SX, 2009, GASTROENTEROLOGY, V136, P2345, DOI 10.1053/j.gastro.2009.01.062; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002	53	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18163	18174		10.1074/jbc.M113.521203	http://dx.doi.org/10.1074/jbc.M113.521203			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24764294	Green Published, hybrid			2022-12-25	WOS:000338042000019
J	Ross, LS; Gamo, FJ; Lafuente-Monasterio, MJ; Singh, OMP; Rowland, P; Wiegand, RC; Wirth, DF				Ross, Leila S.; Gamo, Francisco Javier; Lafuente-Monasterio, Maria Jose; Singh, Onkar M. P.; Rowland, Paul; Wiegand, Roger C.; Wirth, Dyann F.			In Vitro Resistance Selections for Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors Give Mutants with Multiple Point Mutations in the Drug-binding Site and Altered Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTEMETHER-LUMEFANTRINE; ANTIMALARIAL ACTIVITY; VIVO SELECTION; MALARIA; DISCOVERY; ATOVAQUONE; EVOLUTION; FITNESS	Malaria is a preventable and treatable disease; yet half of the world's population lives at risk of infection, and an estimated 660,000 people die of malaria-related causes every year. Rising drug resistance threatens to make malaria untreatable, necessitating both the discovery of new antimalarial agents and the development of strategies to identify and suppress the emergence and spread of drug resistance. We focused on in-development dihydroorotate dehydrogenase (DHODH) inhibitors. Characterizing resistance pathways for antimalarial agents not yet in clinical use will increase our understanding of the potential for resistance. We identified resistance mechanisms of Plasmodium falciparum (Pf) DHODH inhibitors via in vitro resistance selections. We found 11 point mutations in the PfDHODH target. Target gene amplification and unknown mechanisms also contributed to resistance, albeit to a lesser extent. These mutant parasites were often hypersensitive to other PfDHODH inhibitors, which immediately suggested a novel combination therapy approach to preventing resistance. Indeed, a combination of wild-type and mutant-type selective inhibitors led to resistance far less often than either drug alone. The effects of point mutations in PfDHODH were corroborated with purified recombinant wild-type and mutant-type PfDHODH proteins, which showed the same trends in drug response as the cognate cell lines. Comparative growth assays demonstrated that two mutant parasites grew less robustly than their wild-type parent, and the purified protein of those mutants showed a decrease in catalytic efficiency, thereby suggesting a reason for the diminished growth rate. Co-crystallography of PfDHODH with three inhibitors suggested that hydrophobic interactions are important for drug binding and selectivity.	[Ross, Leila S.; Wirth, Dyann F.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Gamo, Francisco Javier; Lafuente-Monasterio, Maria Jose] GlaxoSmithKline, Madrid 28760, Spain; [Singh, Onkar M. P.; Rowland, Paul] GlaxoSmithKline, Computat & Struct Chem, Stevenage SG1 2NY, Herts, England; [Wiegand, Roger C.; Wirth, Dyann F.] Broad Inst, Infect Dis Initiat, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; GlaxoSmithKline; GlaxoSmithKline; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Wirth, DF (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave,SPH1 Rm 705, Boston, MA 02115 USA.	dfwirth@hsph.harvard.edu		Ross, Leila/0000-0003-4360-5213	National Institutes of Health [R01 AI093716-01A1]; Medicines for Malaria Venture; Bill and Melinda Gates Foundation; Broad Institute SPARC program; Genzyme Humanitarian Assistance for Neglected Diseases Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medicines for Malaria Venture; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Broad Institute SPARC program; Genzyme Humanitarian Assistance for Neglected Diseases Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI093716-01A1 (to R. C. W.). This work was also supported by Medicines for Malaria Venture, the Bill and Melinda Gates Foundation, the Broad Institute SPARC program, and the Genzyme Humanitarian Assistance for Neglected Diseases Program.	Anderson T, 2011, PHARMACOGENOMICS, V12, P59, DOI [10.2217/pgs.10.165, 10.2217/PGS.10.165]; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bedingfield PTP, 2012, J MED CHEM, V55, P5841, DOI 10.1021/jm300157n; Booker ML, 2010, J BIOL CHEM, V285, P33054, DOI 10.1074/jbc.M110.162081; Brown KM, 2010, MOL BIOL EVOL, V27, P2682, DOI 10.1093/molbev/msq160; Costanzo MS, 2011, J GENET, V90, P187, DOI 10.1007/s12041-011-0072-z; Deng XY, 2009, J BIOL CHEM, V284, P26999, DOI 10.1074/jbc.M109.028589; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duraisingh MT, 2000, MOL MICROBIOL, V36, P955, DOI 10.1046/j.1365-2958.2000.01914.x; Ekland EH, 2008, INT J PARASITOL, V38, P743, DOI 10.1016/j.ijpara.2008.03.004; Ekland EH, 2007, CURR OPIN MICROBIOL, V10, P363, DOI 10.1016/j.mib.2007.07.007; Fisher N, 2012, J BIOL CHEM, V287, P9731, DOI 10.1074/jbc.M111.324319; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Flannery EL, 2013, NAT REV MICROBIOL, V11, P849, DOI 10.1038/nrmicro3138; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; Guler JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003375; Hurt DE, 2006, ACTA CRYSTALLOGR D, V62, P312, DOI 10.1107/S0907444905042642; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lukens AK, 2014, P NATL ACAD SCI USA, V111, P799, DOI 10.1073/pnas.1320886110; Malmquist NA, 2008, BIOCHEMISTRY-US, V47, P2466, DOI 10.1021/bi702218c; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Nzila A, 2010, J ANTIMICROB CHEMOTH, V65, P390, DOI 10.1093/jac/dkp449; Peixoto L, 2004, PARASITOLOGY, V128, P245, DOI 10.1017/S0031182003004517; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Witkowski B, 2009, DRUG RESIST UPDATE, V12, P42, DOI 10.1016/j.drup.2009.01.001; Yuthavong Y, 2012, P NATL ACAD SCI USA, V109, P16823, DOI 10.1073/pnas.1204556109	36	45	46	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					17980	17995		10.1074/jbc.M114.558353	http://dx.doi.org/10.1074/jbc.M114.558353			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24782313	Green Published, hybrid			2022-12-25	WOS:000338042000003
J	Zhang, SY; Shen, GZ; Li, ZK; Golbeck, JH; Bryant, DA				Zhang, Shuyi; Shen, Gaozhong; Li, Zhongkui; Golbeck, John H.; Bryant, Donald A.			Vipp1 Is Essential for the Biogenesis of Photosystem I but Not Thylakoid Membranes in Synechococcus sp PCC 7002	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGE-SHOCK; PLASMA-MEMBRANE; SP PCC-7002; SYNECHOCYSTIS; PROTEIN; GENE; INACTIVATION; MUTANT; PHOSPHATIDYLGLYCEROL; IDENTIFICATION	The biogenesis of thylakoid membranes in cyanobacteria is presently not well understood, but the vipp1 gene product has been suggested to play an important role in this process. Previous studies in Synechocystis sp. PCC 6803 reported that vipp1 (sll0617) was essential. By constructing a fully segregated null mutant in vipp1 (SynPCC7002_A0294) in Synechococcus sp. PCC 7002, we show that Vipp1 is not essential. Spectroscopic studies revealed that Photosystem I (PS I) was below detection limits in the vipp1 mutant, but Photosystem II (PS II) was still assembled and was active. Thylakoid membranes were still observed in vipp1 mutant cells and resembled those in a psaAB mutant that completely lacks PS I. When the vipp1 mutation was complemented with the orthologous vipp1 gene from Synechocystis sp. PCC 6803 that was expressed from the strong P-cpcBA promoter, PS I content and activities were restored to normal levels, and cells again produced thylakoids that were indistinguishable from those of wild type. Transcription profiling showed that psaAB transcripts were lower in abundance in the vipp1 mutant. However, when the yfp gene was expressed from the P-psaAB promoter in the presence and the absence of Vipp1, no difference in YFP expression was observed, which shows that Vipp1 is not a transcription factor for the psaAB genes. This study shows that thylakoids are still produced in the absence of Vipp1 and that normal thylakoid biogenesis in Synechococcus sp. PCC 7002 requires expression and biogenesis of PS I, which in turn requires Vipp1.	[Zhang, Shuyi; Shen, Gaozhong; Li, Zhongkui; Golbeck, John H.; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Golbeck, John H.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA.	dab14@psu.edu		Zhang, Shuyi/0000-0001-8500-5836	National Science Foundation [MCB-1021725]; Air Force Office of Scientific Research [FA9550-11-1-0148]; Direct For Biological Sciences [1021725] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB-1021725 (to D. A. B. and J. H. G.) and by Air Force Office of Scientific Research Grant FA9550-11-1-0148 (to D. A. B.).	Aseeva E, 2004, J BIOL CHEM, V279, P35535, DOI 10.1074/jbc.M401750200; CHITNIS VP, 1993, FEBS LETT, V336, P330, DOI 10.1016/0014-5793(93)80831-E; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; DeLisa MP, 2004, J BACTERIOL, V186, P366, DOI 10.1128/JB.186.2.366-373.2004; Des Marais DJ, 2000, SCIENCE, V289, P1703; Domonkos I, 2004, PLANT PHYSIOL, V134, P1471, DOI 10.1104/pp.103.037754; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; Frigaard NU, 2004, METH MOL B, V274, P325; Fuhrmann E, 2009, MOL BIOL CELL, V20, P4620, DOI 10.1091/mbc.E09-04-0319; Fuhrmann E, 2009, PLANT PHYSIOL, V149, P735, DOI 10.1104/pp.108.132373; Gao H, 2009, FEMS MICROBIOL LETT, V292, P63, DOI 10.1111/j.1574-6968.2008.01470.x; Gohre V, 2006, PLANT CELL, V18, P1454, DOI 10.1105/tpc.105.038695; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hagio M, 2002, PLANT CELL PHYSIOL, V43, P1456, DOI 10.1093/pcp/pcf185; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Huang F, 2002, MOL CELL PROTEOMICS, V1, P956, DOI 10.1074/mcp.M200043-MCP200; Im CS, 2002, PLANT J, V30, P301, DOI 10.1046/j.1365-313X.2001.01287.x; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI HM, 1994, PLANT MOL BIOL, V25, P619, DOI 10.1007/BF00029601; Lo SM, 2012, PLANT J, V71, P656, DOI 10.1111/j.1365-313X.2012.05020.x; Ludwig M, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00145, 10.3389/fmicb.2012.00354]; Ludwig M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00041; NILSSON F, 1992, ARCH BIOCHEM BIOPHYS, V295, P340, DOI 10.1016/0003-9861(92)90526-3; Nomura CT, 2006, PHOTOSYNTH RES, V87, P215, DOI 10.1007/s11120-005-8533-y; Nordhues A, 2012, PLANT CELL, V24, P637, DOI 10.1105/tpc.111.092692; Reinbothe S, 1996, PLANT CELL, V8, P763, DOI 10.1105/tpc.8.5.763; Sakamoto T, 1998, ARCH MICROBIOL, V169, P10; SHEN GZ, 1995, PHOTOSYNTH RES, V44, P41, DOI 10.1007/BF00018295; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Spence E, 2004, J BIOL CHEM, V279, P55792, DOI 10.1074/jbc.M411041200; Srivastava R, 2006, ARCH MICROBIOL, V185, P238, DOI 10.1007/s00203-006-0086-8; Stanley DN, 2013, PLANT PHYSIOL, V161, P824, DOI 10.1104/pp.112.210542; SUZUKI JY, 1992, PLANT CELL, V4, P929, DOI 10.1105/tpc.4.8.929; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; van de Meene AMT, 2012, BBA-BIOMEMBRANES, V1818, P1427, DOI 10.1016/j.bbamem.2012.01.019; Vothknecht UC, 2001, BBA-MOL CELL RES, V1541, P91, DOI 10.1016/S0167-4889(01)00153-7; Vothknecht UC, 2012, J EXP BOT, V63, P1699, DOI 10.1093/jxb/err357; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Xu Y, 2011, METHODS MOL BIOL, V684, P273, DOI [10.1007/978.1.60761.925.3_21, 10.1007/978-1-60761-925-3_21]	43	42	43	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15904	15914		10.1074/jbc.M114.555631	http://dx.doi.org/10.1074/jbc.M114.555631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764304	Green Published, hybrid			2022-12-25	WOS:000337965700002
J	Angelis, D; Karasmanis, EP; Bai, XB; Spiliotis, ET				Angelis, Dimitrios; Karasmanis, Eva Pauline; Bai, Xiaobo; Spiliotis, Elias T.			In Silico Docking of Forchlorfenuron (FCF) to Septins Suggests that FCF Interferes with GTP Binding	PLOS ONE			English	Article							FILAMENT FORMATION; SACCHAROMYCES-CEREVISIAE; CYTOKININ; PROTEIN; ORGANIZATION; CYTOSKELETON; DYNAMICS; GTPASES	Septins are GTP-binding proteins that form cytoskeleton-like filaments, which are essential for many functions in eukaryotic organisms. Small molecule compounds that disrupt septin filament assembly are valuable tools for dissecting septin functions with high temporal control. To date, forchlorfenuron (FCF) is the only compound known to affect septin assembly and functions. FCF dampens the dynamics of septin assembly inducing the formation of enlarged stable polymers, but the underlying mechanism of action is unknown. To investigate how FCF binds and affects septins, we performed in silico simulations of FCF docking to all available crystal structures of septins. Docking of FCF with SEPT2 and SEPT3 indicated that FCF interacts preferentially with the nucleotide-binding pockets of septins. Strikingly, FCF is predicted to form hydrogen bonds with residues involved in GDP-binding, mimicking nucleotide binding. FCF docking with the structure of SEPT2-GppNHp, a nonhydrolyzable GTP analog, and SEPT7 showed that FCF may assume two alternative non-overlapping conformations deeply into and on the outer side of the nucleotide-binding pocket. Surprisingly, FCF was predicted to interact with the P-loop Walker A motif GxxxxGKS/T, which binds the phosphates of GTP, and the GTP specificity motif AKAD, which interacts with the guanine base of GTP, and highly conserved amino acids including a threonine, which is critical for GTP hydrolysis. Thus, in silico FCF exhibits a conserved mechanism of binding, interacting with septin signature motifs and residues involved in GTP binding and hydrolysis. Taken together, our results suggest that FCF stabilizes septins by locking them into a conformation that mimics a nucleotide-bound state, preventing further GTP binding and hydrolysis. Overall, this study provides the first insight into how FCF may bind and stabilize septins, and offers a blueprint for the rational design of FCF derivatives that could target septins with higher affinity and specificity.	[Angelis, Dimitrios; Karasmanis, Eva Pauline; Bai, Xiaobo; Spiliotis, Elias T.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA	Drexel University	Spiliotis, ET (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	ets33@drexel.edu		Karasmanis, Eva/0000-0002-0139-0210	National Institute of General Medical Sciences [GM097664]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097664] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences grant GM097664 to ET Spiliotis. The funders had no role in study design, collection and analysis, decision to publish, or preparation of the manuscript.	Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Demay BS, 2010, CYTOSKELETON, V67, P383, DOI 10.1002/cm.20452; DeSantis Kara, 2012, Nucl Recept Signal, V10, pe002, DOI 10.1621/nrs.10002; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Ghossoub R, 2013, J CELL SCI, V126, P2583, DOI 10.1242/jcs.111377; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Huang YW, 2006, FEBS J, V273, P3248, DOI 10.1111/j.1742-4658.2006.05333.x; Iwase M, 2004, GENES GENET SYST, V79, P199, DOI 10.1266/ggs.79.199; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kovacs A, 2006, CHEMPHYSCHEM, V7, P455, DOI 10.1002/cphc.200500324; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Macedo JNA, 2013, BIOCHEM J, V450, P95, DOI 10.1042/BJ20120851; Mendoza M, 2002, CURR BIOL, V12, P1858, DOI 10.1016/S0960-9822(02)01258-7; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; NAGATA R, 1993, BIOCHEM BIOPH RES CO, V191, P543, DOI 10.1006/bbrc.1993.1252; Panigrahi SK, 2007, PROTEINS, V67, P128, DOI 10.1002/prot.21253; Ricci A, 2009, PLANT BIOLOGY, V11, P262, DOI 10.1111/j.1438-8677.2008.00165.x; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sirajuddin M, 2009, P NATL ACAD SCI USA, V106, P16592, DOI 10.1073/pnas.0902858106; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; Sotriffer CA, 1996, J COMPUT AID MOL DES, V10, P305, DOI 10.1007/BF00124500; Uniewicz KA, 2010, ANAL CHEM, V82, P3796, DOI 10.1021/ac100188x; Vardi-Oknin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073179; Vrabioiu AM, 2004, J BIOL CHEM, V279, P3111, DOI 10.1074/jbc.M310941200; Wasik AA, 2012, MOL BIOL CELL, V23, P3370, DOI 10.1091/mbc.E11-12-1010; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Zent E, 2014, BIOL CHEM, V395, P169, DOI 10.1515/hsz-2013-0268; Zent E, 2011, BIOL CHEM, V392, P791, DOI 10.1515/BC.2011.082	34	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96390	10.1371/journal.pone.0096390	http://dx.doi.org/10.1371/journal.pone.0096390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787956	Green Submitted, gold, Green Published			2022-12-25	WOS:000336655700084
J	Chandramathi, S; Suresh, K; Sivanandam, S; Kuppusamy, UR				Chandramathi, Samudi; Suresh, Kumar; Sivanandam, Sinnadurai; Kuppusamy, Umah Rani			Stress Exacerbates Infectivity and Pathogenicity of Blastocystis hominis: In Vitro and In Vivo Evidences	PLOS ONE			English	Article							OXIDATIVE STRESS; IMMOBILIZATION STRESS; LIPID-PEROXIDATION; HUMAN-DISEASE; WEIGHT-GAIN; CORTICOSTERONE; RATS; INFLAMMATION; EXERCISE; DEFENSE	Background: Stress alters the oxidant-antioxidant state and immune cell responses which disrupts its function to combat infection. Blastocystis hominis, a common intestinal protozoan has been reported to be opportunistic in immunocompromised patients namely cancer. B. hominis infectivity in other altered immune system conditions especially stress is unknown. We aimed to demonstrate the stress effects towards the susceptibility and pathogenicity of B. hominis infection. Methods/Findings: Three-week-old Wistar rats were divided into four groups: (a) control; (b) stress-induced; (c) B. hominis infected; (d) stress-induced with B. hominis infection; (n = 20 respectively). Stress was induced for an hour daily (30 days) using a Belly Dancer Shaker. Weight gain was monitored, stool samples were collected for B. hominis screening and blood for the determination of differential count, levels of immunoglobulin, oxidative damage, and peripheral blood mononuclear cell (PBMC) proliferation upon induction with solubilized antigen of B. hominis (Blasto-Ag). Group (b) exhibited the highest level of weight gain. Group (d) had higher levels of parasite cyst count in stools, serum IgE, oxidized protein and lipid compared to the group (c). Levels of monocyte and antioxidant in group (d) were decreased and their PBMCs showed highest inhibition of proliferation level when exposed to Blasto-Ag. Monocyte level in Group (b) showed insignificant difference compared to group (a) but was significantly lower compared to group (c). Antioxidant levels in group (c) were generally lower compared to group (a) and (b). Inhibition level exhibited by Blasto-Ag treated PBMCs of group (c) was higher compared to group (a) and (b). Conclusion: The pathogenicity and augmentation of B. hominis infection is enhanced when stress is present. Lifestyles today are becoming increasingly stressed and the present findings suggest that the parasite which has been reported to be one of the most common organisms seen in stool surveys, namely in developing countries, may tend to be more pathogenic in stressful situations.	[Chandramathi, Samudi; Suresh, Kumar; Sivanandam, Sinnadurai] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Kuppusamy, Umah Rani] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Suresh, K (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	suresh@um.edu.my	samudi@raju, Chandramathi/AAR-1595-2021; KUPPUSAMY, UMAH RANI/B-9981-2010; Samudi, Chandramathi/G-5937-2012		The University Malaya High Impact Grant, Malaysia [UM.C/625/1/HIR]	The University Malaya High Impact Grant, Malaysia	This research project was funded by The University Malaya High Impact Grant UM.C/625/1/HIR, Malaysia. The funding source did not play any role in study design, data collection, analysis, interpretation of data, or writing of the report. The corresponding author had the final decision to submit this paper for publication.	Ahmed N, 2006, EUR NEUROPSYCHOPHARM, V16, P260, DOI 10.1016/j.euroneuro.2005.08.001; Angelov I, 2008, J IMAB, V14, P55; Badiani A, 1996, BRAIN RES, V710, P35, DOI 10.1016/0006-8993(95)01295-8; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BOYUM A, 1974, TISSUE ANTIGENS, V4, P269; Chandramathi S, 2010, PARASITOL RES, V106, P1459, DOI 10.1007/s00436-010-1825-y; Chandramathi S, 2010, PARASITOLOGY, V137, P605, DOI 10.1017/S0031182009991351; Chandramathi S, 2012, T ROY SOC TROP MED H, V106, P267, DOI 10.1016/j.trstmh.2011.12.008; Chandramathi S, 2010, PARASITOL RES, V106, P941, DOI 10.1007/s00436-010-1764-7; Cohen S, 2012, J APPL SOC PSYCHOL, V42, P1320, DOI 10.1111/j.1559-1816.2012.00900.x; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Cole SW, 2008, BRAIN BEHAV IMMUN, V22, P1049, DOI 10.1016/j.bbi.2008.02.006; Cooper PJ, 2004, J INFECT DIS, V190, P1338, DOI 10.1086/423944; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Ehiaghe A, 2013, OPEN J IMMUNOL, V3, P123; Ertan Kara P, 2004, EGE TIP DERGISI, V43, P91; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Frick LR, 2009, STRESS, V12, P134, DOI 10.1080/10253890802137437; Geiger SM, 2002, PARASITE IMMUNOL, V24, P499, DOI 10.1046/j.1365-3024.2002.00600.x; Gharavi M.J., 2003, IRAN J PUBL HLTH, V32, P19; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Govind SK, 2002, TRENDS PARASITOL, V18, P528, DOI 10.1016/S1471-4922(02)02402-9; Gunasekaran R., 2001, Indian Journal of Physiology and Pharmacology, V45, P487; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Herrmann M, 2000, RHEUM DIS CLIN N AM, V26, P737, DOI 10.1016/S0889-857X(05)70167-8; KHALIFE J, 1989, J IMMUNOL, V142, P4422; Kivimaki M, 2006, INT J OBESITY, V30, P982, DOI 10.1038/sj.ijo.0803229; KNUUTILA S, 1987, CANCER GENET CYTOGEN, V29, P151, DOI 10.1016/0165-4608(87)90042-2; Liu JK, 1996, FASEB J, V10, P1532, DOI 10.1096/fasebj.10.13.8940299; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; Marsland AL, 2002, PHYSIOL BEHAV, V77, P711, DOI 10.1016/S0031-9384(02)00923-X; McBerry C, EUR J IMMUNOL; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Peake J, 2004, EXERC IMMUNOL REV, V10, P129; Peake JM, 2002, EXERC IMMUNOL REV, V8, P49; Rezaiian M., 2004, IRAN J PUBLIC HEALTH, V33, P18; Roberts HC, 1999, PARASITOLOGY, V118, P117, DOI 10.1017/S0031182098003503; Roitt I., 2001, IMMUNOLOGY, V6th; Roman CW, 2012, BEHAV BRAIN RES, V227, P300, DOI 10.1016/j.bbr.2011.11.010; Sage D, 2001, AM J PHYSIOL-ENDOC M, V280, pE260, DOI 10.1152/ajpendo.2001.280.2.E260; Sahin E, 2007, COMP BIOCHEM PHYS C, V144, P342, DOI 10.1016/j.cbpc.2006.10.009; Santos HJ, 2009, PARASITOL RES, V105, P1303, DOI 10.1007/s00436-009-1556-0; SHEEHAN DJ, 1986, J CLIN MICROBIOL, V24, P548, DOI 10.1128/JCM.24.4.548-550.1986; SIVANANDAM S, 1974, J MED HLTH LAB TECHN, V1, P9; Suresh K, 2004, EUR J CLIN MICROBIOL, V23, P509, DOI 10.1007/s10096-004-1123-7; Suzuki K, 1996, J APPL PHYSIOL, V81, P1213, DOI 10.1152/jappl.1996.81.3.1213; Takeda K, 2003, VET PARASITOL, V113, P327, DOI 10.1016/S0304-4017(03)00080-3; Tan TC, 2008, PARASITOL RES, V104, P85, DOI 10.1007/s00436-008-1163-5; Tekwani BL, 1999, MICROBES INFECT, V1, P385, DOI 10.1016/S1286-4579(99)80055-0; Vennila GD, 1999, PARASITOL RES, V85, P162, DOI 10.1007/s004360050528; VOGEL WH, 1988, NEUROSCI LETT, V87, P183, DOI 10.1016/0304-3940(88)90167-X; Von Borell E., 2001, ANIM SCI J, V79, pE260, DOI [10.2527/jas2001.79E-SupplE260x, DOI 10.2527/JAS2001.79E-SUPPLE260X, DOI 10.2527/jas2001.79E-SupplE260x]; Witko-Sarsat V, 1998, J IMMUNOL, V161, P2524; Wong KHS, 2008, PARASITOL RES, V102, P663, DOI 10.1007/s00436-007-0808-0; Yakoob J, 2004, AM J TROP MED HYG, V70, P383, DOI 10.4269/ajtmh.2004.70.383; Zaman V., 1994, JPMA (Journal of the Pakistan Medical Association), V44, P220; Zhang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051148	57	23	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94567	10.1371/journal.pone.0094567	http://dx.doi.org/10.1371/journal.pone.0094567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788756	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700013
J	Polychronopoulos, D; Sellis, D; Almirantis, Y				Polychronopoulos, Dimitris; Sellis, Diamantis; Almirantis, Yannis			Conserved Noncoding Elements Follow Power-Law-Like Distributions in Several Genomes as a Result of Genome Dynamics	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; SEGMENTAL DUPLICATIONS; IN-VIVO; VERTEBRATE GENOMES; SEQUENCES; EVOLUTION; ENHANCER; DNA; REGIONS; EXPRESSION	Conserved, ultraconserved and other classes of constrained elements (collectively referred as CNEs here), identified by comparative genomics in a wide variety of genomes, are non-randomly distributed across chromosomes. These elements are defined using various degrees of conservation between organisms and several thresholds of minimal length. We here investigate the chromosomal distribution of CNEs by studying the statistical properties of distances between consecutive CNEs. We find widespread power-law-like distributions, i.e. linearity in double logarithmic scale, in the inter-CNE distances, a feature which is connected with fractality and self-similarity. Given that CNEs are often found to be spatially associated with genes, especially with those that regulate developmental processes, we verify by appropriate gene masking that a power-law-like pattern emerges irrespectively of whether elements found close or inside genes are excluded or not. An evolutionary model is put forward for the understanding of these findings that includes segmental or whole genome duplication events and eliminations (loss) of most of the duplicated CNEs. Simulations reproduce the main features of the observed size distributions. Power-law-like patterns in the genomic distributions of CNEs are in accordance with current knowledge about their evolutionary history in several genomes.	[Polychronopoulos, Dimitris; Almirantis, Yannis] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece; [Polychronopoulos, Dimitris] Univ Athens, Dept Biochem & Mol Biol, Fac Biol, Athens 11528, Greece; [Sellis, Diamantis] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	National Centre of Scientific Research "Demokritos"; National & Kapodistrian University of Athens; Stanford University	Almirantis, Y (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece.	yalmir@bio.demokritos.gr	Sellis, Diamantis/M-7855-2016; Polychronopoulos, Dimitris/G-8214-2014	Sellis, Diamantis/0000-0003-4059-5507; Polychronopoulos, Dimitris/0000-0001-9427-3082	General Secretariat for Research and Technology (GSRT)	General Secretariat for Research and Technology (GSRT)(Greek Ministry of Development-GSRT)	Publication fees for this work were covered in the framework of "Target Identification for Disease Diagnosis and Treatment (DIAS)" project within General Secretariat for Research and Technology (GSRT) Development Proposals of Research Organisations-KRIPIS action, funded by Greece and the European Regional Development Fund of the European Union under the O.P. Competitiveness and Entrepreneurship, National Strategic Reference Framework (NSRF) 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L.A., 2002, GLOTTOMETRICS, V3, P143; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Athanasopoulou L, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051917; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Baira E, 2008, RNA BIOL, V5, P132, DOI 10.4161/rna.5.3.6673; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Clark AG, 2001, GENOME RES, V11, P1319, DOI 10.1101/gr.201601; Clarke SL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002852; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; De Grassi A, 2008, GENE, V421, P1, DOI 10.1016/j.gene.2008.05.011; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Dimitrieva S, 2012, BIOINFORMATICS, V28, pI395, DOI 10.1093/bioinformatics/bts400; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Elgar G, 2008, TRENDS GENET, V24, P344, DOI 10.1016/j.tig.2008.04.005; Gibson TJ, 2000, BIOCHEM SOC T, V28, P259, DOI 10.1042/bst0280259; Glazko GV, 2003, TRENDS GENET, V19, P119, DOI 10.1016/S0168-9525(03)00016-7; Glazov EA, 2005, GENOME RES, V15, P800, DOI 10.1101/gr.3545105; Harmston N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0021; Hickey DA, 2008, GENOME, V51, P396, DOI 10.1139/G08-011; Hufton AL, 2009, GENOME RES, V19, P2036, DOI 10.1101/gr.093237.109; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kehrer-Sawatzki H, 2008, CHROMOSOME RES, V16, P41, DOI 10.1007/s10577-007-1207-1; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kim SY, 2007, PLOS GENET, V3, P1572, DOI 10.1371/journal.pgen.0030147; Kirsch S, 2008, GENOME RES, V18, P1030, DOI 10.1101/gr.076711.108; Klimopoulos A, 2012, GENE, V499, P88, DOI 10.1016/j.gene.2012.02.005; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lee AP, 2011, MOL BIOL EVOL, V28, P1205, DOI 10.1093/molbev/msq304; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li W., 2002, GLOTTOMETRICS, V5, P14; LI WT, 1992, NATURE, V360, P635, DOI 10.1038/360635b0; LI WT, 1991, PHYS REV A, V43, P5240, DOI 10.1103/PhysRevA.43.5240; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lockton S, 2005, TRENDS GENET, V21, P60, DOI 10.1016/j.tig.2004.11.013; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Martignetti L, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021902; Martinez-Mekler G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004791; Matsunami M, 2013, GENOME BIOL EVOL, V5, P140, DOI 10.1093/gbe/evs128; Matsunami M, 2010, J MOL EVOL, V71, P427, DOI 10.1007/s00239-010-9396-1; McEwen GK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000762; McLysaght A, 2000, YEAST, V17, P22, DOI 10.1002/(SICI)1097-0061(200004)17:1<22::AID-YEA5>3.0.CO;2-S; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Nelson AC, 2013, DEVELOPMENT, V140, P1385, DOI 10.1242/dev.084459; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Paparidis Z, 2007, DEV GROWTH DIFFER, V49, P543, DOI 10.1111/j.1440-169x.2007.00954.x; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Retelska D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-398; Ritter DI, 2010, MOL BIOL EVOL, V27, P2322, DOI 10.1093/molbev/msq128; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sakuraba Y, 2008, MAMM GENOME, V19, P703, DOI 10.1007/s00335-008-9152-7; Salerno W, 2006, P NATL ACAD SCI USA, V103, P13121, DOI 10.1073/pnas.0605735103; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Sanges R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r56; Sanges R, 2013, NUCLEIC ACIDS RES, V41, P3600, DOI 10.1093/nar/gkt030; Sato S, 2012, DEV BIOL, V368, P95, DOI 10.1016/j.ydbio.2012.05.023; Sellis D, 2007, MOL BIOL EVOL, V24, P2385, DOI 10.1093/molbev/msm181; Sellis D, 2009, GENE, V447, P18, DOI 10.1016/j.gene.2009.04.028; Semon M, 2007, TRENDS GENET, V23, P108, DOI 10.1016/j.tig.2007.01.003; Shin JT, 2005, NUCLEIC ACIDS RES, V33, P5437, DOI 10.1093/nar/gki853; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stephen S, 2008, MOL BIOL EVOL, V25, P402, DOI 10.1093/molbev/msm268; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Sun H, 2006, HUM MOL GENET, V15, P2911, DOI 10.1093/hmg/ddl232; TAKAYASU H, 1991, J STAT PHYS, V65, P725, DOI 10.1007/BF01053751; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Vavouri T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r15; Venkatesh B, 2006, SCIENCE, V314, P1892, DOI 10.1126/science.1130708; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Viturawong T, 2013, CELL REP, V5, P531, DOI 10.1016/j.celrep.2013.09.022; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; Wang JL, 2009, MOL BIOL EVOL, V26, P487, DOI 10.1093/molbev/msn278; Woolfe A, 2008, ADV GENET, V61, P307, DOI 10.1016/S0065-2660(07)00012-0; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Xie XH, 2006, P NATL ACAD SCI USA, V103, P11659, DOI 10.1073/pnas.0604768103	83	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95437	10.1371/journal.pone.0095437	http://dx.doi.org/10.1371/journal.pone.0095437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787386	gold, Green Published, Green Submitted			2022-12-25	WOS:000336655700029
J	Zhang, LJ; Wang, L; Liu, XL; Zheng, DM; Liu, SS; Liu, CX				Zhang, Lijuan; Wang, Lin; Liu, Xiaoliang; Zheng, Dongming; Liu, Sishi; Liu, Caixia			ALDH Expression Characterizes G1-Phase Proliferating Beta Cells during Pregnancy	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; ADULT-MOUSE PANCREAS; PROGENITOR CELLS; PRIMARY MECHANISM; GENE-EXPRESSION; STEM-CELL; TURNOVER; MICE; MASS; REGENERATION	High levels of aldehyde dehydrogenase (ALDH) activity have been detected in various progenitor and stem cells. Thus, Aldefluor fluorescence, which represents precisely the ALDH activity, has been widely used for the identification, evaluation, and isolation of stem and progenitor cells. Recently, ALDH activity was detected in embryonic and adult mouse pancreas, specifically in adult centroacinar and terminal duct cells supposed to harbor endocrine and exocrine progenitor cells in the adult pancreas. Nevertheless, ALDH activity and aldeflour fluorescence have not been examined in beta cells. Here, we report a dynamic increase in the number of aldeflour+ beta cells during pregnancy. Interestingly, nearly all these aldeflour+ beta cells are positive for Ki-67, suggesting that they are in an active cell cycle (G1, S and M phases). To determine precisely at which phase beta cells activate ALDH activity and thus become aldeflour+, we co-stained insulin with additional proliferation markers, phosphohistone3 (PHH3, a marker for M-phase proliferating cells) and Bromodeoxyuridine (BrdU, a marker for S-phase proliferating cells). Our data show little aldeflour+ beta cells that were positive for either PHH3, or BrdU, suggesting that beta cells activate ALDH and become Aldefluor+ when they enter G1-phase of active cell cycle, but may downregulate ALDH when they leave G1-phase and enter S phase. Our data thus reveal a potential change in ALDH activity of proliferating beta cells during pregnancy, which provides a novel method for isolation and analysis of proliferating beta cells. Moreover, our data also suggest that caution needs to be taken on interpretation of Aldefluor lineage-tracing data in pancreas.	[Zhang, Lijuan; Wang, Lin; Liu, Xiaoliang; Zheng, Dongming; Liu, Sishi; Liu, Caixia] China Med Univ, Shengjing Hosp, Dept Gynecol & Obstet, Shenyang, Peoples R China	China Medical University	Liu, CX (corresponding author), China Med Univ, Shengjing Hosp, Dept Gynecol & Obstet, Shenyang, Peoples R China.	caixia_liu14@163.com	Zhang, Li/GWM-7501-2022		Shengjing hospital	Shengjing hospital	This work was financially supported by the internal funding of Shengjing hospital affiliated to China Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Cheah J S, 1980, Ann Acad Med Singap, V9, P98; Chintinne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043959; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Fujita K, 2009, HUM PATHOL, V40, P924, DOI 10.1016/j.humpath.2009.01.004; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Hasegawa Y, 2007, ENDOCRINOLOGY, V148, P2006, DOI 10.1210/en.2006-1351; HELLERSTROM C, 1991, DIABETES, V40, P89, DOI 10.2337/diab.40.2.S89; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Hess DA, 2008, STEM CELLS, V26, P611, DOI 10.1634/stemcells.2007-0429; Hija A, 2014, DIABETES, V63, P578, DOI 10.2337/db12-1035; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Magni M, 1996, BLOOD, V87, P1097, DOI 10.1182/blood.V87.3.1097.bloodjournal8731097; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Misfeldt AA, 2008, DIABETES, V57, P3069, DOI 10.2337/db08-0878; Moreb JS, 2007, CYTOM PART B-CLIN CY, V72B, P281, DOI 10.1002/cyto.b.20161; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Rankin MM, 2010, ISLETS, V2, P345, DOI 10.4161/isl.2.6.13376; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Schraenen A, 2010, DIABETOLOGIA, V53, P2579, DOI 10.1007/s00125-010-1912-8; SWENNE I, 1992, DIABETOLOGIA, V35, P193, DOI 10.1007/BF00400917; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Xiao XW, 2013, J BIOL CHEM, V288, P25297, DOI 10.1074/jbc.M113.484022; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Xue Y, 2010, ENDOCRINE, V37, P83, DOI 10.1007/s12020-009-9273-0	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96204	10.1371/journal.pone.0096204	http://dx.doi.org/10.1371/journal.pone.0096204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787690	Green Submitted, gold, Green Published			2022-12-25	WOS:000336655700061
J	Andriyanov, AV; Koren, E; Barenholz, Y; Goldberg, SN				Andriyanov, Alexander V.; Koren, Erez; Barenholz, Yechezkel; Goldberg, S. Nahum			Therapeutic Efficacy of Combining PEGylated Liposomal Doxorubicin and Radiofrequency (RF) Ablation: Comparison between Slow-Drug-Releasing, Non-Thermosensitive and Fast-Drug-Releasing, Thermosensitive Nano-Liposomes	PLOS ONE			English	Article							TEMPERATURE-SENSITIVE LIPOSOMES; STERICALLY STABILIZED LIPOSOMES; BREAST-TUMOR MODEL; MILD HYPERTHERMIA; THERMAL ABLATION; PHASE-TRANSITION; LIVER-CANCER; SOLID TUMORS; NUDE-MICE; IN-VITRO	Aims: To determine how the accumulation of drug in mice bearing an extra-hepatic tumor and its therapeutic efficacy are affected by the type of PEGylated liposomal doxorubicin used, treatment modality, and rate of drug release from the liposomes, when combined with radiofrequency (RF) ablation. Materials and Methods: Two nano-drugs, both long-circulating PEGylated doxorubicin liposomes, were formulated: (1) PEGylated doxorubicin in thermosensitive liposomes (PLDTS), having a burst-type fast drug release above the liposomes' solid ordered to liquid disordered phase transition (at 42 degrees C), and (2) non-thermosensitive PEGylated doxorubicin liposomes (PLDs), having a slow and continuous drug release. Both were administered intravenously at 8 mg/kg doxorubicin dose to tumor-bearing mice. Animals were divided into 6 groups: no treatment, PLD, RF, RF+PLD, PLDTS, and PLDTS+RF, for intra-tumor doxorubicin deposition at 1, 24, and 72 h post-injection (in total 41, mice), and 31 mice were used for randomized survival studies. Results: Non-thermosensitive PLD combined with RF had the least tumor growth and the best end-point survival, better than PLDTS+RF (p<0.005) or all individual therapies (p<0.001). Although at 1 h post-treatment the greatest amount of intra-tumoral doxorubicin was seen following PLDTS+RF (p<0.05), by 24 and 72 h the greatest doxorubicin amount was seen for PLD+RF (p<0.05); in this group the tumor also has the longest exposure to doxorubicin. Conclusion: Optimizing therapeutic efficacy of PLD requires a better understanding of the relationship between the effect of RF on tumor microenvironment and liposome drug release profile. If drug release is too fast, the benefit of changing the microenvironment by RF on tumor drug localization and therapeutic efficacy may be much smaller than for PLDs having slow and temperature-independent drug release. Thus the much longer circulation time of doxorubicin from PLD than from PLDTS may be beneficial in many therapeutic instances, especially in extra-hepatic tumors.	[Andriyanov, Alexander V.; Koren, Erez; Barenholz, Yechezkel] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lab Membrane & Liposome Res,Dept Biochem, IL-91010 Jerusalem, Israel; [Goldberg, S. Nahum] Hadassah Hebrew Univ, Med Ctr, Dept Radiol, Jerusalem, Israel; [Goldberg, S. Nahum] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Barenholz, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lab Membrane & Liposome Res,Dept Biochem, IL-91010 Jerusalem, Israel.	chezyb@gmail.com	Goldberg, S. Nahum/AAV-4526-2020		NCI [5U54CA151881-04]; Barenholz Fund; Israel Ministry of Health; Israel Science Foundation; NATIONAL CANCER INSTITUTE [U54CA151881] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Barenholz Fund; Israel Ministry of Health; Israel Science Foundation(Israel Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grant 5U54CA151881-04 to SNG, the Barenholz Fund, the Israel Ministry of Health, and the Israel Science Foundation. The Barenholz Fund is originated from royalties Hebrew University received from YB's commercialized projects, and this money is used to support YB's research activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid AH, 2013, EXPERT OPIN DRUG DEL, V10, P775, DOI 10.1517/17425247.2013.776538; Ahmed M, 2005, RADIOLOGY, V235, P469, DOI 10.1148/radiol.2352031856; Ahmed M, 2003, CANCER RES, V63, P6327; Al-Jamal WT, 2012, BIOMATERIALS, V33, P4608, DOI 10.1016/j.biomaterials.2012.03.018; AMSELEM S, 1990, J PHARM SCI, V79, P1045, DOI 10.1002/jps.2600791202; Avnir Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025721; Bandak S, 1999, ANTI-CANCER DRUG, V10, P911, DOI 10.1097/00001813-199911000-00007; Banno B, 2010, J PHARM SCI-US, V99, P2295, DOI 10.1002/jps.21988; Barenholz Y, 2004, SUB CELL BIOCHEM, V37, P167; Barenholz Y, 2000, PHYSICAL CHEMISTRY OF BIOLOGICAL INTERFACES, P171; Barenholz Y., 1993, LIPOSOME TECHNOLOGY, P527; Barenholz Y, 2013, UNPUB; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BILTONEN RL, 1993, CHEM PHYS LIPIDS, V64, P129, DOI 10.1016/0009-3084(93)90062-8; Celsion, 2012, PHAS 3 STUD THERMODO; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Dupuy DE, 2001, J VASC INTERV RADIOL, V12, P1135, DOI 10.1016/S1051-0443(07)61670-4; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Ferrandina G, 2010, THER CLIN RISK MANAG, V6, P463, DOI 10.2147/TCRM.S3348; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon A, 1997, DRUGS, V54, P15, DOI 10.2165/00003495-199700544-00005; Garbuzenko O, 2005, CHEM PHYS LIPIDS, V135, P117, DOI 10.1016/j.chemphyslip.2005.02.003; Garbuzenko O, 2005, LANGMUIR, V21, P2560, DOI 10.1021/la0479105; Gasselhuber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047453; Gasselhuber A, 2010, INT J HYPERTHER, V26, P499, DOI 10.3109/02656731003623590; Gazelle GS, 2000, RADIOLOGY, V217, P633, DOI 10.1148/radiology.217.3.r00dc26633; Goldberg SN, 2002, AM J ROENTGENOL, V179, P93, DOI 10.2214/ajr.179.1.1790093; Goldberg SN, 2000, RADIOLOGY, V217, P827, DOI 10.1148/radiology.217.3.r00dc27827; GREGORIADIS G, 1981, LANCET, V2, P241; Hacker S, 2011, ONCOGENE, V30, P2275, DOI 10.1038/onc.2010.599; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; JACOBSEN PF, 1985, J NEUROPATH EXP NEUR, V44, P472, DOI 10.1097/00005072-198509000-00003; Kale AA, 2010, METHODS MOL BIOL, V605, P213, DOI 10.1007/978-1-60327-360-2_15; Koren E, 2012, J CONTROL RELEASE, V160, P264, DOI 10.1016/j.jconrel.2011.12.002; Ku Y, 1993, Eur J Surg Oncol, V19, P387; Landon C.D., 2011, OPEN NANOMEDICINE J, V3, P38, DOI [DOI 10.2174/1875933501103010038, 10.2174/1875933501103010038]; LASIC DD, 1992, FEBS LETT, V312, P255, DOI 10.1016/0014-5793(92)80947-F; Lasic DD, 1999, CURR OPIN MOL THER, V1, P177; Leung SJ, 2012, THERANOSTICS, V2, P1020, DOI 10.7150/thno.4847; Lewandowski RJ, 2011, RADIOLOGY, V259, P641, DOI 10.1148/radiol.11081489; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; MAHONEY DH, 1986, MED PEDIATR ONCOL, V14, P329, DOI 10.1002/mpo.2950140611; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MAYER LD, 1990, BIOCHIM BIOPHYS ACTA, V1025, P143, DOI 10.1016/0005-2736(90)90091-2; Mills JK, 2005, BBA-BIOMEMBRANES, V1716, P77, DOI 10.1016/j.bbamem.2005.08.007; Monsky WL, 2002, RADIOLOGY, V224, P823, DOI 10.1148/radiol.2243011421; MOURITSEN OG, 1994, CHEM PHYS LIPIDS, V73, P3, DOI 10.1016/0009-3084(94)90171-6; Mouritsen OG, 1998, PHARM RES-DORDR, V15, P1507, DOI 10.1023/A:1011986613392; Moussa M, 2013, J VASC INTERV RADIOL, V24, P1021, DOI 10.1016/j.jvir.2013.03.006; Needham D, 2000, CANCER RES, V60, P1197; Needham D, 2001, ADV DRUG DELIVER REV, V53, P285, DOI 10.1016/S0169-409X(01)00233-2; Needham D, 2013, FARADAY DISCUSS, V161, P515, DOI 10.1039/c2fd20111a; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Poon RTP, 2011, FUTURE ONCOL, V7, P937, DOI [10.2217/fon.11.73, 10.2217/FON.11.73]; Poon RTP, 2009, EXPERT OPIN PHARMACO, V10, P333, DOI [10.1517/14656560802677874 , 10.1517/14656560802677874]; Schroeder A, 2008, J DRUG TARGET, V16, P591, DOI 10.1080/10611860802228939; Schroeder A, 2007, LANGMUIR, V23, P4019, DOI 10.1021/la0631668; Skeel R, 2011, HDB CANC CHEMOTHERAP; Solazzo SA, 2010, RADIOLOGY, V255, P62, DOI 10.1148/radiol.09091196; STORM G, 1985, BIOCHIM BIOPHYS ACTA, V818, P343, DOI 10.1016/0005-2736(85)90008-2; Swenson CE, 2001, BREAST, V10, P1, DOI 10.1016/S0960-9776(01)80001-1; Tagami T, 2011, J CONTROL RELEASE, V154, P290, DOI 10.1016/j.jconrel.2011.05.020; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Torchilin VP, 2012, DRUG DELIV TRANSL RE, V2, P415, DOI 10.1007/s13346-012-0102-2; Torchilin Vladimir P, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-00477-3_1; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Volodkin DV, 2009, ANGEW CHEM INT EDIT, V48, P1807, DOI 10.1002/anie.200805572; Yang W, 2011, INT J HYPERTHER, V27, P527, DOI 10.3109/02656736.2011.582474; Zhang X, 2013, J LIPOSOME RES, V23, P167, DOI 10.3109/08982104.2013.779702; Zucker D, 2012, J CONTROL RELEASE, V160, P281, DOI 10.1016/j.jconrel.2011.10.003; Zucker D, 2010, J CONTROL RELEASE, V146, P326, DOI 10.1016/j.jconrel.2010.05.024	72	49	49	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e92555	10.1371/journal.pone.0092555	http://dx.doi.org/10.1371/journal.pone.0092555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24786533	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600007
J	Larson, KW; Liedvogel, M; Addison, B; Kleven, O; Laskemoen, T; Lifjeld, JT; Lundberg, M; Akesson, S; Bensch, S				Larson, Keith W.; Liedvogel, Miriam; Addison, BriAnne; Kleven, Oddmund; Laskemoen, Terje; Lifjeld, Jan T.; Lundberg, Max; Akesson, Susanne; Bensch, Staffan			Allelic Variation in a Willow Warbler Genomic Region Is Associated with Climate Clines	PLOS ONE			English	Article							GENE-FLOW; REPRODUCTIVE ISOLATION; MIGRATORY DIVIDE; COEREBA-FLAVEOLA; PLANT DIVERSITY; HIGH-ALTITUDE; PEA APHIDS; BIRDS; TROCHILUS; SELECTION	Local adaptation is an important process contributing to population differentiation which can occur in continuous or isolated populations connected by various amounts of gene flow. The willow warbler (Phylloscopus trochilus) is one of the most common songbirds in Fennoscandia. It has a continuous breeding distribution where it is found in all forested habitats from sea level to the tree line and therefore constitutes an ideal species for the study of locally adapted genes associated with environmental gradients. Previous studies in this species identified a genetic marker (AFLP-WW1) that showed a steep north-south cline in central Sweden with one allele associated with coastal lowland habitats and the other with mountainous habitats. It was further demonstrated that this marker is embedded in a highly differentiated chromosome region that spans several megabases. In the present study, we sampled 2,355 individuals at 128 sites across all of Fennoscandia to study the geographic and climatic variables associated with the allele frequency distributions of WW1. Our results demonstrate that 1) allele frequency patterns significantly differ between mountain and lowland populations, 2) these allele differences coincide with extreme temperature conditions and the short growing season in the mountains, and milder conditions in coastal areas, and 3) the northern-allele or "altitude variant" of WW1 occurs in willow warblers that occupy mountainous habitat regardless of subspecies. Finally these results suggest that climate may exert selection on the genomic region associated with these alleles and would allow us to develop testable predictions for the distribution of the genetic marker based on climate change scenarios.	[Larson, Keith W.; Liedvogel, Miriam; Lundberg, Max; Akesson, Susanne; Bensch, Staffan] Lund Univ, Dept Biol, Ctr Anim Movement Res, Lund, Sweden; [Addison, BriAnne] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia; [Kleven, Oddmund; Laskemoen, Terje; Lifjeld, Jan T.] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Kleven, Oddmund] Norweigen Inst Nat Res, Oslo, Norway	Lund University; Western Sydney University; University of Oslo; Norwegian Institute Nature Research	Larson, KW (corresponding author), Lund Univ, Dept Biol, Ctr Anim Movement Res, Ecol Bldg, Lund, Sweden.	Keith.W.Larson@gmail.com	Lifjeld, Jan T/B-1978-2008; Liedvogel, Miriam/HDM-7933-2022; Larson, Keith/G-5585-2010; Liedvogel, Miriam/S-8341-2019; Akesson, Susanne/F-3175-2015; Kleven, Oddmund/A-6116-2009; Liedvogel, Miriam/D-5418-2015	Lifjeld, Jan T/0000-0002-9172-9985; Larson, Keith/0000-0001-7089-524X; Akesson, Susanne/0000-0001-9039-2180; Kleven, Oddmund/0000-0003-0267-6795; Liedvogel, Miriam/0000-0002-8372-8560	Swedish Research Council [621-2007-5930, 621-2010-5584, 349-2007-8690]; Centre for Animal Movement Research (CAnMove); Lund University; Feodor Lynen fellowship, Alexander von Humboldt-Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Animal Movement Research (CAnMove); Lund University; Feodor Lynen fellowship, Alexander von Humboldt-Foundation	This work was supported by project grants from the Swedish Research Council (SB, SA: 621-2007-5930, 621-2010-5584; www.vr.se) and the Centre for Animal Movement Research (CAnMove) financed by a Linnaeus grant (349-2007-8690; www.vr.se) from the Swedish Research Council and Lund University and a Feodor Lynen fellowship, Alexander von Humboldt-Foundation (www.humboldt-foundation.de) to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, WORLDCLIM GLOBAL CLI; Bensch S, 2006, MOL ECOL, V15, P161, DOI 10.1111/j.1365-294X.2005.02766.x; Bensch S, 2006, J AVIAN BIOL, V37, P323, DOI 10.1111/j.2006.0908-8857.03628.x; Bensch S, 1999, J BIOGEOGR, V26, P1225, DOI 10.1046/j.1365-2699.1999.00360.x; Bensch S, 2002, MOL ECOL, V11, P2359, DOI 10.1046/j.1365-294X.2002.01629.x; Bensch S, 2009, MOL ECOL, V18, P3087, DOI 10.1111/j.1365-294X.2009.04210.x; BLACK CP, 1980, RESP PHYSIOL, V39, P217, DOI 10.1016/0034-5687(80)90046-8; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Chamberlain CP, 2000, P ROY SOC B-BIOL SCI, V267, P43, DOI 10.1098/rspb.2000.0964; Coyne JA, 2004, SPECIATION, V37; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; Enemar Anders, 2004, Ornis Svecica, V14, P63; ESRI, 2010, ARCGIS; FARACI FM, 1991, ANNU REV PHYSIOL, V53, P59, DOI 10.1146/annurev.ph.53.030191.000423; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Ivits E, 2012, GLOBAL PLANET CHANGE, V88-89, P85, DOI 10.1016/j.gloplacha.2012.03.010; Lundberg M, 2011, J EVOLUTION BIOL, V24, P1241, DOI 10.1111/j.1420-9101.2011.02259.x; Martin K, 2004, INTEGR COMP BIOL, V44, P177, DOI 10.1093/icb/44.2.177; Nichols R, 2001, TRENDS ECOL EVOL, V16, P358, DOI 10.1016/S0169-5347(01)02203-0; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033; Pereyra ME, 2003, GEN COMP ENDOCR, V130, P222, DOI 10.1016/S0016-6480(02)00568-3; Price T, 2008, SPECIATION BIRDS; R Development Core Team, 2012, R LANG ENV STAT COMP; RIECHERT SE, 1993, BEHAV ECOL SOCIOBIOL, V32, P355; Selas V, 2001, OECOLOGIA, V129, P213, DOI 10.1007/s004420100711; SILVERIN B, 1995, AM ZOOL, V35, P191; Sjors H, 1965, ACTA PHYTOGEOGRAPHIC, P1; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trabucco A, 2009, CGIAR CONSORT SPATIA; Trabucco A, 2008, AGR ECOSYST ENVIRON, V126, P81, DOI 10.1016/j.agee.2008.01.015; Vedin H, 1995, SVERIGES NATIONALATL; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; WINGFIELD JC, 1995, AM ZOOL, V35, P285; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; WUNDERLE JM, 1981, EVOLUTION, V35, P333, DOI 10.1111/j.1558-5646.1981.tb04891.x	41	5	5	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95252	10.1371/journal.pone.0095252	http://dx.doi.org/10.1371/journal.pone.0095252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788148	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600028
J	Cohen, EB; Jun, SJ; Bears, Z; Barrera, FN; Alonso, M; Engelman, DM; DiMaio, D				Cohen, Emily B.; Jun, Susan J.; Bears, Zachary; Barrera, Francisco N.; Alonso, Miriam; Engelman, Donald M.; DiMaio, Daniel			Mapping the Homodimer Interface of an Optimized, Artificial, Transmembrane Protein Activator of the Human Erythropoietin Receptor	PLOS ONE			English	Article							PAPILLOMAVIRUS E5 PROTEIN; FACTOR-BETA RECEPTOR; MEMBRANE-PROTEINS; ALPHA-HELICES; AMINO-ACIDS; IN-VITRO; BRANCHED RESIDUES; GXXXG MOTIF; PROLINE; SEQUENCE	Transmembrane proteins constitute a large fraction of cellular proteins, and specific interactions involving membrane-spanning protein segments play an important role in protein oligomerization, folding, and function. We previously isolated an artificial, dimeric, 44-amino acid transmembrane protein that activates the human erythropoietin receptor (hEPOR) in trans. This artificial protein supports limited erythroid differentiation of primary human hematopoietic progenitor cells in vitro, even though it does not resemble erythropoietin, the natural ligand of this receptor. Here, we used a directed-evolution approach to explore the structural basis for the ability of transmembrane proteins to activate the hEPOR. A library that expresses thousands of mutants of the transmembrane activator was screened for variants that were more active than the original isolate at inducing growth factor independence in mouse cells expressing the hEPOR. The most active mutant, EBC5-16, supports erythroid differentiation in human cells with activity approaching that of EPO, as assessed by cell-surface expression of glycophorin A, a late-stage marker of erythroid differentiation. EBC5-16 contains a single isoleucine to serine substitution at position 25, which increases its ability to form dimers. Genetic studies confirmed the importance of dimerization for activity and identified the residues constituting the homodimer interface of EBC5-16. The interface requires a GxxxG dimer packing motif and a small amino acid at position 25 for maximal activity, implying that tight packing of the EBC5-16 dimer is a crucial determinant of activity. These experiments identified an artificial protein that causes robust activation of its target in a natural host cell, demonstrated the importance of dimerization of this protein for engagement of the hEPOR, and provided the framework for future structure-function studies of this novel mechanism of receptor activation.	[Cohen, Emily B.; Jun, Susan J.; Bears, Zachary; DiMaio, Daniel] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Alonso, Miriam; Engelman, Donald M.; DiMaio, Daniel] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Engelman, Donald M.; DiMaio, Daniel] Yale Canc Ctr, New Haven, CT USA; [DiMaio, Daniel] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Barrera, Francisco N.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA	Yale University; Yale University; Yale University; Yale University; University of Tennessee System; University of Tennessee Knoxville	DiMaio, D (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	daniel.dimaio@yale.edu		Barrera, Francisco N./0000-0002-5200-7891; Cohen, Emily/0000-0002-0017-441X	National Institutes of Health [DK007356, AI055403]; National Research Service Award from the National Cancer Institute [CA0168012]; National Cancer Institute [CA037157]; NATIONAL CANCER INSTITUTE [R37CA037157, R01CA037157, F31CA168012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award from the National Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	EBC was supported by training grants from the National Institutes of Health (DK007356 and AI055403) and an individual National Research Service Award from the National Cancer Institute (CA0168012). This work was supported by a grant to DD from the National Cancer Institute (CA037157) and a generous gift from Ms. Laurel Schwartz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; Andreev OA, 2007, P NATL ACAD SCI USA, V104, P7893, DOI 10.1073/pnas.0702439104; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Bennasroune A, 2005, CELL MOL LIFE SCI, V62, P2124, DOI 10.1007/s00018-005-5226-9; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; Brosig B, 1998, PROTEIN SCI, V7, P1052; Cammett TJ, 2010, P NATL ACAD SCI USA, V107, P3447, DOI 10.1073/pnas.0915057107; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Cunningham F, 2011, BIOPOLYMERS, V96, P340, DOI 10.1002/bip.21565; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Fleming KG, 2001, P NATL ACAD SCI USA, V98, P14340, DOI 10.1073/pnas.251367498; Freeman-Cook LL, 2005, J MOL BIOL, V345, P907, DOI 10.1016/j.jmb.2004.10.072; Freeman-Cook LL, 2004, J MOL BIOL, V338, P907, DOI 10.1016/j.jmb.2004.03.044; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; HORWITZ BH, 1988, MOL CELL BIOL, V8, P4071, DOI 10.1128/MCB.8.10.4071; King G, 2011, BBA-BIOMEMBRANES, V1808, P1493, DOI 10.1016/j.bbamem.2010.11.004; Langosch D, 1998, PROTEINS, V31, P150, DOI 10.1002/(SICI)1097-0134(19980501)31:2<150::AID-PROT5>3.0.CO;2-Q; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; Lehnert U, 2004, Q REV BIOPHYS, V37, P121, DOI 10.1017/S003358350400397X; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Leyland-Jones B, 2003, LANCET ONCOL, V4, P459, DOI 10.1016/S1470-2045(03)01163-X; LI SC, 1992, FEBS LETT, V311, P217, DOI 10.1016/0014-5793(92)81106-V; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; LOFTS FJ, 1993, ONCOGENE, V8, P2813; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Mahajan MC, 2009, EXP HEMATOL, V37, P1143, DOI 10.1016/j.exphem.2009.07.001; Mattoon D, 2001, ONCOGENE, V20, P3824, DOI 10.1038/sj.onc.1204523; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Oates J, 2008, BIOCHEMISTRY-US, V47, P8985, DOI 10.1021/bi8006252; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Oster HS, 2012, LEUKEMIA RES, V36, P939, DOI 10.1016/j.leukres.2012.04.017; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Ptacek JB, 2007, P NATL ACAD SCI USA, V104, P11945, DOI 10.1073/pnas.0704348104; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Reiersen H, 2001, TRENDS BIOCHEM SCI, V26, P679, DOI 10.1016/S0968-0004(01)01957-0; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Reshetnyak YK, 2006, P NATL ACAD SCI USA, V103, P6460, DOI 10.1073/pnas.0601463103; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Scheideman EH, 2012, J VIROL, V86, P10281, DOI 10.1128/JVI.00910-12; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Surti T, 1998, PROTEINS, V33, P601; Swaminathan K, 1997, NAT STRUCT BIOL, V4, P751, DOI 10.1038/nsb0997-751; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Talbert-Slagle K, 2009, VIROLOGY, V384, P345, DOI 10.1016/j.virol.2008.09.033; Talbert-Slagle K, 2009, J VIROL, V83, P9773, DOI 10.1128/JVI.00946-09; Tarasova NI, 1999, J BIOL CHEM, V274, P34911, DOI 10.1074/jbc.274.49.34911; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Tonelli Marcello, 2009, CMAJ, V180, pE62, DOI 10.1503/cmaj.090470; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; Walters KJ, 1997, NAT STRUCT BIOL, V4, P744, DOI 10.1038/nsb0997-744; Weerakkody D, 2013, P NATL ACAD SCI USA, V110, P5834, DOI 10.1073/pnas.1303708110; WILLIAMS KA, 1991, BIOCHEMISTRY-US, V30, P8919, DOI 10.1021/bi00101a001; Yohannan S, 2004, J MOL BIOL, V341, P1, DOI 10.1016/j.jmb.2004.06.025; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	68	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95593	10.1371/journal.pone.0095593	http://dx.doi.org/10.1371/journal.pone.0095593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788775	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917300015
J	Cai, J; Li, T; Huang, BX; Cheng, HH; Ding, H; Dong, WH; Xiao, M; Liu, L; Wang, ZH				Cai, Jing; Li, Tao; Huang, Bangxing; Cheng, Henghui; Ding, Hui; Dong, Weihong; Xiao, Man; Liu, Ling; Wang, Zehua			The Use of Laser Microdissection in the Identification of Suitable Reference Genes for Normalization of Quantitative Real-Time PCR in Human FFPE Epithelial Ovarian Tissue Samples	PLOS ONE			English	Article							CAPTURE MICRODISSECTION; RT-PCR; EXPRESSION; MICROARRAY; CELLS; RNA	Quantitative real-time PCR (qPCR) is a powerful and reproducible method of gene expression analysis in which expression levels are quantified by normalization against reference genes. Therefore, to investigate the potential biomarkers and therapeutic targets for epithelial ovarian cancer by qPCR, it is critical to identify stable reference genes. In this study, twelve housekeeping genes (ACTB, GAPDH, 18S rRNA, GUSB, PPIA, PBGD, PUM1, TBP, HRPT1, RPLP0, RPL13A, and B2M) were analyzed in 50 ovarian samples from normal, benign, borderline, and malignant tissues. For reliable results, laser microdissection (LMD), an effective technique used to prepare homogeneous starting material, was utilized to precisely excise target tissues or cells. One-way analysis of variance (ANOVA) and nonparametric (Kruskal-Wallis) tests were used to compare the expression differences. NormFinder and geNorm software were employed to further validate the suitability and stability of the candidate genes. Results showed that epithelial cells occupied a small percentage of the normal ovary indeed. The expression of ACTB, PPIA, RPL13A, RPLP0, and TBP were stable independent of the disease progression. In addition, NormFinder and geNorm identified the most stable combination (ACTB, PPIA, RPLP0, and TBP) and the relatively unstable reference gene GAPDH from the twelve commonly used housekeeping genes. Our results highlight the use of homogeneous ovarian tissues and multiple-reference normalization strategy, e.g. the combination of ACTB, PPIA, RPLP0, and TBP, for qPCR in epithelial ovarian tissues, whereas GAPDH, the most commonly used reference gene, is not recommended, especially as a single reference gene.	[Cai, Jing; Li, Tao; Huang, Bangxing; Ding, Hui; Dong, Weihong; Xiao, Man; Liu, Ling; Wang, Zehua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China; [Huang, Bangxing] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pathol, Wuhan 430074, Peoples R China; [Cheng, Henghui] Huazhong Univ Sci & Technol, Tongji Hosp, Union Hosp, Dept Pathol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China.	zehuawang@163.net			China Postdoctoral Science Foundation [2012T50650]; Natural Science Foundation of Hubei Province of China [2013CFB128]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province)	This work was supported by China Postdoctoral Science Foundation (Grant No. 2012T50650) and the Natural Science Foundation of Hubei Province of China (Grant No. 2013CFB128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Clement-Ziza M, 2008, RNA, V14, P2698, DOI 10.1261/rna.1261708; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Fu J, 2010, ACTA BIOCH BIOPH SIN, V42, P568, DOI 10.1093/abbs/gmq062; Golubeva Yelena, 2013, Methods Mol Biol, V931, P213, DOI 10.1007/978-1-62703-056-4_12; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kreth S, 2010, NEURO-ONCOLOGY, V12, P570, DOI 10.1093/neuonc/nop072; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ono K, 2000, CANCER RES, V60, P5007; Peters IR, 2004, J IMMUNOL METHODS, V286, P203, DOI 10.1016/j.jim.2004.01.003; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Suarez-Quian CA, 1999, BIOTECHNIQUES, V26, P328, DOI 10.2144/99262rr03; Szaniszlo P, 2004, CYTOM PART A, V59A, P191, DOI 10.1002/cyto.a.20055; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhou J, 2013, ONCOL REP, V30, P2229, DOI 10.3892/or.2013.2672	24	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95974	10.1371/journal.pone.0095974	http://dx.doi.org/10.1371/journal.pone.0095974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776823	gold, Green Published, Green Submitted			2022-12-25	WOS:000346241800021
J	Piegari, E; Lopez, L; Ipina, EP; Dawson, SP				Piegari, Estefania; Lopez, Lucia; Perez Ipina, Emiliano; Ponce Dawson, Silvina			Fluorescence Fluctuations and Equivalence Classes of Ca2+ Imaging Experiments	PLOS ONE			English	Article							INTACT MAMMALIAN-CELLS; XENOPUS-OOCYTES; CALCIUM INDICATORS; CYTOSOLIC CALCIUM; ELEMENTARY; RECEPTOR; SIGNALS; SPARKS; FLUX; CHANNELS	Ca2+ release into the cytosol through inositol 1,4,5-trisphosphate receptors (IP3Rs) plays a relevant role in numerous physiological processes. IP3R-mediated Ca2+ signals involve Ca2+-induced Ca2+-release (CICR) whereby Ca2+ release through one open IP3R induces the opening of other channels. IP3Rs are apparently organized in clusters. The signals can remain localized (i.e., Ca2+ puffs) if CICR is limited to one cluster or become waves that propagate between clusters. Ca2+ puffs are the building blocks of Ca2+ waves. Thus, there is great interest in determining puff properties, especially in view of the current controversy on the spatial distribution of activatable IP3Rs. Ca2+ puffs have been observed in intact cells with optical techniques proving that they are intrinsically stochastic. Obtaining a correct picture of their dynamics then entails being able to detect the whole range of puff sizes. Ca2+ puffs are observed using visible single-wavelength Ca2+ dyes, slow exogenous buffers (e.g., EGTA) to disrupt inter-cluster CICR and UV-photolyzable caged IP3. Single-wavelength dyes increase their fluorescence upon calcium binding producing images that are strongly dependent on their kinetic, transport and photophysical properties. Determining the artifacts that the imaging setting introduces is particularly relevant when trying to analyze the smallest Ca2+ signals. In this paper we introduce a method to estimate the expected signal-to-noise ratio of Ca2+ imaging experiments that use single-wavelength dyes. The method is based on the Number and Brightness technique. It involves the performance of a series of experiments and their subsequent analysis in terms of a fluorescence fluctuation model with which the model parameters are quantified. Using the model, the expected signal-to-noise ratio is then computed. Equivalence classes between different experimental conditions that produce images with similar signal-to-noise ratios can then be established. The method may also be used to estimate the smallest signals that can reliably be observed with each setting.	[Piegari, Estefania] FCEyN UBA, CONICET, Buenos Aires, DF, Argentina; FCEyN UBA, IFIBA, CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Piegari, E (corresponding author), FCEyN UBA, CONICET, Ciudad Univ,Pabellon 1, Buenos Aires, DF, Argentina.	estefipiegari@df.uba.ar		Perez Ipina, Emiliano/0000-0002-1664-0411; Lopez, Lucia Fernanda/0000-0002-2596-2113	Universidad de Buenos Aires (UBACyT) [20020100100064]; Agencia Nacional para la Promocion Cientifica y Tecnologica of Argentina [PICT 2010-1481, PICT 2010-2767]	Universidad de Buenos Aires (UBACyT)(University of Buenos Aires); Agencia Nacional para la Promocion Cientifica y Tecnologica of Argentina	This research has been supported by Universidad de Buenos Aires (UBACyT grant number 20020100100064) and Agencia Nacional para la Promocion Cientifica y Tecnologica of Argentina (Grants: PICT 2010-1481 and PICT 2010-2767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bridge JHB, 1999, J PHYSIOL-LONDON, V518, P469, DOI 10.1111/j.1469-7793.1999.0469p.x; Brochet DXP, 2005, P NATL ACAD SCI USA, V102, P3099, DOI 10.1073/pnas.0500059102; Bruno L, 2010, CELL CALCIUM, V47, P273, DOI 10.1016/j.ceca.2009.12.012; Callamaras N, 1998, J PHYSIOL-LONDON, V509, P81, DOI 10.1111/j.1469-7793.1998.081bo.x; Choe Chi-Un, 2006, Sci STKE, V2006, pre15; Dalal RB, 2008, MICROSC RES TECHNIQ, V71, P69, DOI 10.1002/jemt.20526; Demuro A, 2005, J GEN PHYSIOL, V126, P179, DOI 10.1085/jgp.200509331; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Diambra L, 2009, CHAOS INTERDISCIPLIN, V19; Diambra L, 2011, BIOPHYS J, V100, P822, DOI 10.1016/j.bpj.2011.01.003; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Escobar AL, 1997, PFLUG ARCH EUR J PHY, V434, P615, DOI 10.1007/s004240050444; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fraiman D, 2006, BIOPHYS J, V90, P3897, DOI 10.1529/biophysj.105.075911; Helmchen F, 2011, COLD SPRING HARBOR P, V2011; Izu LT, 2001, BIOPHYS J, V80, P88, DOI 10.1016/S0006-3495(01)75997-8; Lopez L, 2014, BIOPHYS J, V106, p531A, DOI 10.1016/j.bpj.2013.11.2967; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; MINTA A, 1989, J BIOL CHEM, V264, P8171; Pantazaka E, 2011, J BIOL CHEM, V286, P23378, DOI 10.1074/jbc.M111.236372; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Piegari E, 2012, BIOPHYS J, V102, p310A, DOI 10.1016/j.bpj.2011.11.1707; Rios E, 1999, J GEN PHYSIOL, V114, P31, DOI 10.1085/jgp.114.1.31; Shuai JW, 2006, BIOPHYS J, V91, P4033, DOI 10.1529/biophysj.106.088880; Sigaut L, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3592497; Smith GD, 1998, BIOPHYS J, V75, P15, DOI 10.1016/S0006-3495(98)77491-0; Smith I, 2013, BIOPHYS J, V104, p121A, DOI 10.1016/j.bpj.2012.11.699; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Soeller C, 2002, BIOPHYS J, V82, P2396, DOI 10.1016/S0006-3495(02)75584-7; Solovey G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008997; Sun XP, 1998, J PHYSIOL-LONDON, V509, P67, DOI 10.1111/j.1469-7793.1998.067bo.x; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Ventura AC, 2005, BIOPHYS J, V88, P2403, DOI 10.1529/biophysj.104.045260; Wilms CD, 2006, CELL CALCIUM, V40, P73, DOI 10.1016/j.ceca.2006.03.006; Wiltgen SM, 2010, BIOPHYS J, V99, P437, DOI 10.1016/j.bpj.2010.04.037	39	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95860	10.1371/journal.pone.0095860	http://dx.doi.org/10.1371/journal.pone.0095860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776736	gold, Green Published, Green Submitted			2022-12-25	WOS:000346241800017
J	Behr, M; Kaufmann, JK; Ketzer, P; Engelhardt, S; Muck-Hausl, M; Okun, PM; Petersen, G; Neipel, F; Hassel, JC; Ehrhardt, A; Enk, AH; Nettelbeck, DM				Behr, Michael; Kaufmann, Johanna K.; Ketzer, Patrick; Engelhardt, Sarah; Mueck-Hauesl, Martin; Okun, Pamela M.; Petersen, Gabriele; Neipel, Frank; Hassel, Jessica C.; Ehrhardt, Anja; Enk, Alexander H.; Nettelbeck, Dirk M.			Adenoviruses Using the Cancer Marker EphA2 as a Receptor In Vitro and In Vivo by Genetic Ligand Insertion into Different Capsid Scaffolds	PLOS ONE			English	Article							IMPROVES ANTITUMOR EFFICACY; PANCREATIC-CANCER; SHORT-FIBER; SEROTYPE 5; TRANSGENE EXPRESSION; VECTOR TRANSDUCTION; TARGETING PEPTIDES; MALIGNANT-MELANOMA; VIRAL PARTICLES; BINDING SITE	Adenoviral gene therapy and oncolysis would critically benefit from targeted cell entry by genetically modified capsids. This requires both the ablation of native adenovirus tropism and the identification of ligands that remain functional in virus context. Here, we establish cell type-specific entry of HAdV-5-based vectors by genetic ligand insertion into a chimeric fiber with shaft and knob domains of the short HAdV-41 fiber (Ad5T/41sSK). This fiber format was reported to ablate transduction in vitro and biodistribution to the liver in vivo. We show that the YSA peptide, binding to the pan-cancer marker EphA2, can be inserted into three positions of the chimeric fiber, resulting in strong transduction of EphA2-positive but not EphA2-negative cells of human melanoma biopsies and of tumor xenografts after intratumoral injection. Transduction was blocked by soluble YSA peptide and restored for EphA2-negative cells after recombinant EphA2 expression. The YSA peptide could also be inserted into three positions of a CAR binding-ablated HAdV-5 fiber enabling specific transduction; however, the Ad5T/41sSK format was superior in vivo. In conclusion, we establish an adenovirus capsid facilitating functional insertion of targeting peptides and a novel adenovirus using the tumor marker EphA2 as receptor with high potential for cancer gene therapy and viral oncolysis.	[Behr, Michael; Kaufmann, Johanna K.; Ketzer, Patrick; Engelhardt, Sarah; Nettelbeck, Dirk M.] German Canc Res Ctr, Oncolyt Adenovirus Grp, Heidelberg, Germany; [Mueck-Hauesl, Martin; Ehrhardt, Anja] Univ Munich, Dept Virol, Max Von Pettenkofer Inst, Munich, Germany; [Okun, Pamela M.] Univ Heidelberg Hosp, Div Inherited Metab Dis, Dept Gen Pediat, Heidelberg, Germany; [Petersen, Gabriele] Heidelberg Univ, CellNetworks Deep Sequencing Core Facil, COS, Heidelberg, Germany; [Neipel, Frank] Erlangen Univ Hosp, Inst Clin & Mol Virol, Erlangen, Germany; [Hassel, Jessica C.; Enk, Alexander H.] Univ Heidelberg Hosp, Dept Dermatol, Heidelberg, Germany; [Ehrhardt, Anja] Univ Witten Herdecke, Fac Hlth, Dept Human Med, Ctr Biomed Educ & Res,Inst Virol & Microbiol, Witten, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; Witten Herdecke University	Nettelbeck, DM (corresponding author), German Canc Res Ctr, Oncolyt Adenovirus Grp, Heidelberg, Germany.	d.nettelbeck@dkfz.de		Nettelbeck, Dirk M./0000-0002-1225-2593	Helmholtz-University [VH NG 212]; Deutsche Krebshilfe (German Cancer Aid) [10-7946]	Helmholtz-University; Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe)	This work was supported by the Helmholtz-University Young Investigator Group grant VH NG 212 and the Deutsche Krebshilfe (German Cancer Aid) grant 10-7946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Beyer I, 2011, CANCER RES, V71, P7080, DOI 10.1158/0008-5472.CAN-11-2009; Binda E, 2012, CANCER CELL, V22, P765, DOI 10.1016/j.ccr.2012.11.005; Carson SD, 1999, J VIROL, V73, P7077, DOI 10.1128/JVI.73.8.7077-7079.1999; Chow KKH, 2013, MOL THER, V21, P629, DOI 10.1038/mt.2012.210; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Dorer DE, 2009, ADV DRUG DELIVER REV, V61, P554, DOI 10.1016/j.addr.2009.03.013; Duffy MR, 2011, J VIROL, V85, P10914, DOI 10.1128/JVI.05382-11; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; Hahn AS, 2012, NAT MED, V18, P961, DOI 10.1038/nm.2805; HENDRIX MJC, 1987, CANCER LETT, V38, P137, DOI 10.1016/0304-3835(87)90209-6; Hesse A, 2007, J VIROL, V81, P2688, DOI 10.1128/JVI.02722-06; Jakubczak JL, 2001, J VIROL, V75, P2972, DOI 10.1128/JVI.75.6.2972-2981.2001; Kanerva A, 2002, MOL THER, V5, P695, DOI 10.1006/mthe.2002.0599; Kashentseva EA, 2009, J MOL BIOL, V388, P443, DOI 10.1016/j.jmb.2009.03.016; Kaufmann JK, 2013, J INVEST DERMATOL, V133, P1034, DOI 10.1038/jid.2012.459; Ketzer P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks734; Kim J, 2012, BIOMATERIALS, V33, P1838, DOI 10.1016/j.biomaterials.2011.11.020; Kim M, 2006, CANCER BIOL THER, V5, P1647, DOI 10.4161/cbt.5.12.3374; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Kritz AB, 2007, MOL THER, V15, P741, DOI 10.1038/sj.mt.6300094; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Li ZY, 2004, MOL THER, V9, P650, DOI 10.1016/j.ymthe.2004.01.021; MacLeod SH, 2012, CANCER GENE THER, V19, P888, DOI 10.1038/cgt.2012.79; Miura Y, 2013, MOL THER, V21, P139, DOI 10.1038/mt.2012.205; Mizuguchi H, 2002, CANCER GENE THER, V9, P236, DOI 10.1038/sj.cgt.7700440; Nakamura T, 2003, J VIROL, V77, P2512, DOI 10.1128/JVI.77.4.2512-2521.2003; Nicklin SA, 2005, MOL THER, V12, P384, DOI 10.1016/j.ymthe.2005.05.008; Nicol CG, 2004, MOL THER, V10, P344, DOI 10.1016/j.ymthe.2004.05.020; Nishimoto T, 2009, GENE THER, V16, P669, DOI 10.1038/gt.2009.1; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Reynolds PN, 1999, GENE THER, V6, P1336, DOI 10.1038/sj.gt.3300941; Rittner K, 2007, CANCER GENE THER, V14, P509, DOI 10.1038/sj.cgt.7701036; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Ruzsics Z, 2006, J VIROL, V80, P8100, DOI 10.1128/JVI.00687-06; Sakurai F, 2011, FRONT BIOSCI-LANDMRK, V16, P2389, DOI 10.2741/3861; Schoggins JW, 2009, VIROLOGY, V395, P10, DOI 10.1016/j.virol.2009.08.041; Schoggins JW, 2005, J VIROL, V79, P11627, DOI 10.1128/JVI.79.18.11627-11637.2005; Schoggins JW, 2003, J VIROL, V77, P1039, DOI 10.1128/JVI.77.2.1039-1048.2003; Seki T, 2011, J CONTROL RELEASE, V156, P381, DOI 10.1016/j.jconrel.2011.08.022; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Shayakhmetov DM, 2005, J VIROL, V79, P1053, DOI 10.1128/JVI.79.2.1053-1061.2005; Shayakhmetov DM, 2002, CANCER RES, V62, P1063; Short JJ, 2010, MOL CANCER THER, V9, P2536, DOI 10.1158/1535-7163.MCT-10-0332; Smith TAG, 2003, HUM GENE THER, V14, P1595, DOI 10.1089/104303403322542248; Smith TAG, 2003, HUM GENE THER, V14, P777, DOI 10.1089/104303403765255165; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Toyoda E, 2008, INT J ONCOL, V33, P1141, DOI 10.3892/ijo_00000103; Van Geer MA, 2010, INT J ONCOL, V36, P233, DOI 10.3892/ijo_00000494; van Geer MA, 2009, WORLD J GASTROENTERO, V15, P2754, DOI 10.3748/wjg.15.2754; Von Seggern DJ, 2000, J VIROL, V74, P354, DOI 10.1128/JVI.74.1.354-362.2000; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WEBER J, 1994, CANCER RES, V54, P1766; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Willmon C, 2009, MOL THER, V17, P1667, DOI 10.1038/mt.2009.194; Wodrich H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000808; Wu E, 2003, J VIROL, V77, P7225, DOI 10.1128/JVI.77.13.7225-7235.2003; Wu P, 2010, CANCER RES, V70, P9549, DOI 10.1158/0008-5472.CAN-10-1760; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Xu ZL, 2013, NAT MED, V19, P452, DOI 10.1038/nm.3107; Yamamoto M, 2010, MOL THER, V18, P243, DOI 10.1038/mt.2009.266	64	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95723	10.1371/journal.pone.0095723	http://dx.doi.org/10.1371/journal.pone.0095723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760010	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200082
J	Feldman, AB; Murchie, EH; Leung, H; Baraoidan, M; Coe, R; Yu, SM; Lo, SF; Quick, WP				Feldman, Aryo B.; Murchie, Erik H.; Leung, Hei; Baraoidan, Marietta; Coe, Robert; Yu, Su-May; Lo, Shuen-Fang; Quick, William P.			Increasing Leaf Vein Density by Mutagenesis: Laying the Foundations for C-4 Rice	PLOS ONE			English	Article							MUTANT RESOURCES; VENATION; ANATOMY; PHOTOSYNTHESIS; ARCHITECTURE; EVOLUTION; PATTERN; BIOMASS; LEAVES; IR64	A high leaf vein density is both an essential feature of C-4 photosynthesis and a foundation trait to C-4 evolution, ensuring the optimal proportion and proximity of mesophyll and bundle sheath cells for permitting the rapid exchange of photosynthates. Two rice mutant populations, a deletion mutant library with a cv. IR64 background (12,470 lines) and a T-DNA insertion mutant library with a cv. Tainung 67 background (10,830 lines), were screened for increases in vein density. A high throughput method with handheld microscopes was developed and its accuracy was supported by more rigorous microscopy analysis. Eight lines with significantly increased leaf vein densities were identified to be used as genetic stock for the global C-4 Rice Consortium. The candidate population was shown to include both shared and independent mutations and so more than one gene controlled the high vein density phenotype. The high vein density trait was found to be linked to a narrow leaf width trait but the linkage was incomplete. The more genetically robust narrow leaf width trait was proposed to be used as a reliable phenotypic marker for finding high vein density variants in rice in future screens.	[Feldman, Aryo B.] Univ Nottingham, Sch Biosci, Semenyih, Selangor Darul, Malaysia; [Murchie, Erik H.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Leung, Hei; Baraoidan, Marietta] Int Rice Res Inst, Los Banos, Philippines; [Coe, Robert; Quick, William P.] Int Rice Res Inst, Rice Ctr C4, Los Banos, Philippines; [Yu, Su-May; Lo, Shuen-Fang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	University of Nottingham Malaysia; University of Nottingham; CGIAR; International Rice Research Institute (IRRI); CGIAR; International Rice Research Institute (IRRI); Academia Sinica - Taiwan	Murchie, EH (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	erik.murchie@nottingham.ac.uk	Yu, Su-May/ABB-6950-2021; Murchie, Erik/AGU-8921-2022; Murchie, Erik h/G-4074-2013	Yu, Su-May/0000-0001-8744-9246; Murchie, Erik/0000-0002-7465-845X; Murchie, Erik h/0000-0002-7465-845X; Feldman, Aryo/0000-0001-9112-1198; Lo, Shuen-Fang/0000-0003-2278-6262	Beachell Borlaug Scholarship; C<INF>4</INF> rice lab of the International Rice Research institute	Beachell Borlaug Scholarship; C<INF>4</INF> rice lab of the International Rice Research institute	This work received funding from the Beachell Borlaug Scholarship awarded to Aryo Feldman and funding form the C<INF>4</INF> rice lab of the International Rice Research institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat R. S., 2007, Rice functional genomics: challenges, progress and prospects, P149; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Cairns JE, 2009, FIELD CROP RES, V114, P159, DOI 10.1016/j.fcr.2009.07.019; Chen CX, 1994, J BIOL SCI, V3, P4; Chern CG, 2007, PLANT MOL BIOL, V65, P427, DOI 10.1007/s11103-007-9218-z; Dengler N, 2001, CURR OPIN PLANT BIOL, V4, P50, DOI 10.1016/S1369-5266(00)00135-7; Evans JR, 2000, STUD PLAN S, V7, P53; GIVNISH TJ, 1987, NEW PHYTOL, V106, P131, DOI 10.1111/j.1469-8137.1987.tb04687.x; Gowik U, 2011, PLANT PHYSIOL, V155, P56, DOI 10.1104/pp.110.165308; Hirochika H, 2004, PLANT MOL BIOL, V54, P325, DOI 10.1023/B:PLAN.0000036368.74758.66; Hsing YI, 2007, PLANT MOL BIOL, V63, P351, DOI 10.1007/s11103-006-9093-z; Jahn CE, 2011, PLANT PHYSIOL, V155, P157, DOI 10.1104/pp.110.165654; Kajala K, 2011, J EXP BOT, V62, P3001, DOI 10.1093/jxb/err022; Keeley JE, 2003, INT J PLANT SCI, V164, pS55, DOI 10.1086/374192; Klich MG, 2000, ENVIRON EXP BOT, V44, P171, DOI 10.1016/S0098-8472(00)00056-3; Krishnan A, 2009, PLANT PHYSIOL, V149, P165, DOI 10.1104/pp.108.128918; Kuromori T, 2009, PLANT CELL PHYSIOL, V50, P1215, DOI 10.1093/pcp/pcp078; McKown AD, 2007, AM J BOT, V94, P382, DOI 10.3732/ajb.94.3.382; McKown AD, 2009, ANN BOT-LONDON, V104, P1085, DOI 10.1093/aob/mcp210; Mitchell PL, 2007, CHARTING NEW PATHWAY, P27; Murchie E., 2007, CHARTING PATHWAYS C4; Murchie EH, 2005, J EXP BOT, V56, P449, DOI 10.1093/jxb/eri100; Nakhoda B, 2012, FIELD CROP RES, V127, P191, DOI 10.1016/j.fcr.2011.11.004; Neeraja CN, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue3-fulltext-11; Nelson T, 1997, PLANT CELL, V9, P1121, DOI 10.1105/tpc.9.7.1121; Noblin X, 2008, P NATL ACAD SCI USA, V105, P9140, DOI 10.1073/pnas.0709194105; OGURO H, 1985, ANN BOT-LONDON, V55, P859, DOI 10.1093/oxfordjournals.aob.a086967; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; Runions A, 2005, ACM T GRAPHIC, V24, P702, DOI 10.1145/1073204.1073251; Rutger J. N., 2009, Induced plant mutations in the genomics era. Proceedings of an International Joint FAO/IAEA Symposium, 2008, P44; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Sage TL, 2009, PLANT CELL PHYSIOL, V50, P756, DOI 10.1093/pcp/pcp033; Sheehy J.E., 2007, CHARTING NEW PATHWAY, P3, DOI 10.1142/9789812709523_0001; Shi YF, 2009, SCI CHINA SER C, V52, P885, DOI 10.1007/s11427-009-0109-1; Smillie IRA, 2012, J EXP BOT, V63, P4563, DOI 10.1093/jxb/ers142; Madamba MRS, 2009, RICE, V2, P104, DOI 10.1007/s12284-009-9027-x; Uhl D, 1999, PALAEOGEOGR PALAEOCL, V149, P15, DOI 10.1016/S0031-0182(98)00189-8; Wan SY, 2009, PLANT MOL BIOL, V69, P69, DOI 10.1007/s11103-008-9406-5; Wu CJ, 2008, MOL GENET GENOMICS, V279, P605, DOI 10.1007/s00438-008-0337-2; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0	40	27	28	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94947	10.1371/journal.pone.0094947	http://dx.doi.org/10.1371/journal.pone.0094947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760084	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200027
J	Pereira, RO; Wende, AR; Crum, A; Hunter, D; Olsen, CD; Rawlings, T; Riehle, C; Ward, WF; Abel, ED				Pereira, Renata O.; Wende, Adam R.; Crum, Ashley; Hunter, Douglas; Olsen, Curtis D.; Rawlings, Tenley; Riehle, Christian; Ward, Walter F.; Abel, E. Dale			Maintaining PGC-1 alpha expression following pressure overload-induced cardiac hypertrophy preserves angiogenesis but not contractile or mitochondrial function	FASEB JOURNAL			English	Article						mitochondria; heart failure	TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; PROLIFERATOR-ACTIVATED-RECEPTOR; FATTY-ACID OXIDATION; HEART-FAILURE; ENERGY-METABOLISM; SYSTOLIC OVERLOAD; SKELETAL-MUSCLE; BIOGENESIS; ENERGETICS; PROTEINS	During pathological hypertrophy, peroxisome proliferator-activated receptor coactivator 1 alpha (PGC-1 alpha) is repressed in concert with reduced mitochondrial oxidative capacity and fatty acid oxidation (FAO). We therefore sought to determine if maintaining or increasing PGC-1 alpha levels in the context of pressure overload hypertrophy (POH) would preserve mitochondrial function and prevent contractile dysfunction. Pathological cardiac hypertrophy was induced using 4 wk of transverse aortic constriction (TAC) in mice overexpressing the human PGC-1 alpha genomic locus via a bacterial artificial chromosome (TG) and non-transgenic controls (Cont). PGC-1 alpha levels were increased by 40% in TG mice and were sustained following TAC. Although TAC-induced repression of FAO genes and oxidative phosphorylation (oxphos) genes was prevented in TG mice, mitochondrial function and ATP synthesis were equivalently impaired in Cont and TG mice after TAC. Contractile function was also equally impaired in Cont and TG mice following TAC, as demonstrated by decreased +dP/dt and ejection fraction and increased left ventricular developed pressure and end diastolic pressure. Conversely, capillary density was preserved, in concert with increased VEGF expression, while apoptosis and fibrosis were reduced in TG relative to Cont mice after TAC. Hence, sustaining physiological levels of PGC-1 alpha expression following POH, while preserving myocardial vascularity, does not prevent mitochondrial and contractile dysfunction.-Pereira, R. O., Wende, A. R., Crum, A., Hunter, D., Olsen, C. D., Rawlings, T., Riehle, C., Ward, W. F., Abel, E. D. Maintaining PGC-1 alpha expression following pressure overload-induced cardiac hypertrophy preserves angiogenesis but not contractile or mitochondrial function.	[Pereira, Renata O.; Riehle, Christian; Abel, E. Dale] Univ Iowa, Roy J & Lucille A Carver Coll Med, Div Endocrinol & Metab, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Pereira, Renata O.; Wende, Adam R.; Crum, Ashley; Hunter, Douglas; Olsen, Curtis D.; Rawlings, Tenley; Riehle, Christian; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA; [Pereira, Renata O.; Wende, Adam R.; Crum, Ashley; Hunter, Douglas; Olsen, Curtis D.; Rawlings, Tenley; Riehle, Christian; Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Ward, Walter F.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Iowa; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Health San Antonio	Abel, ED (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Div Endocrinol & Metab, Fraternal Order Eagles Diabet Res Ctr, 108 CMAB,451 Newton Rd, Iowa City, IA 52242 USA.	drcadmin@uiowa.edu	Wende, Adam/AFG-8878-2022	Wende, Adam/0000-0002-5536-4675; Abel, E. Dale/0000-0001-5290-0738; Klc, Tenley/0000-0003-0680-992X	U.S. National Institutes of Health (NIH) [RO1-DK-092065, U01-HL-087947]; AHA Western Affiliates; NIH [5T32-HL-007576]; Juvenile Diabetes Research Foundation; German Research Foundation (DFG);  [PO1-HD-038129]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087947, T32HL007576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092065] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Western Affiliates; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Jeffrey Lei, Sylvia Hu, and Li Wang for important technical help during the course of these studies. These studies were supported by U.S. National Institutes of Health (NIH) grants RO1-DK-092065 and U01-HL-087947 to E. D. A., who is an established investigator of the American Heart Association (AHA), and by grant PO1-HD-038129. R. O. P. was supported by a postdoctoral fellowship from the AHA Western Affiliates and NIH grant 5T32-HL-007576. A. R. W. was supported by an advanced postdoctoral fellowship from the Juvenile Diabetes Research Foundation and a postdoctoral fellowship from the AHA Western Affiliates. C. R. was supported by a postdoctoral fellowship from the German Research Foundation (DFG).	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; GUNDERSEN HJG, 1977, DIABETOLOGIA, V13, P43, DOI 10.1007/BF00996326; Hu XL, 2008, CIRC RES, V103, P1009, DOI 10.1161/CIRCRESAHA.107.170795; Hu XL, 2011, HYPERTENSION, V58, P696, DOI 10.1161/HYPERTENSIONAHA.111.174128; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lehman JJ, 2008, AM J PHYSIOL-HEART C, V295, pH185, DOI 10.1152/ajpheart.00081.2008; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Liang H, 2009, AM J PHYSIOL-ENDOC M, V296, pE945, DOI 10.1152/ajpendo.90292.2008; Lu ZB, 2010, ANTIOXID REDOX SIGN, V13, P1011, DOI 10.1089/ars.2009.2940; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; Mettauer B, 2006, PFLUG ARCH EUR J PHY, V452, P653, DOI 10.1007/s00424-006-0072-7; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Patten IS, 2012, TRENDS ENDOCRIN MET, V23, P90, DOI 10.1016/j.tem.2011.09.007; Pereira RO, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000301; Riehle C, 2013, J CLIN INVEST, V123, P5319, DOI 10.1172/JCI71171; Riehle C, 2012, TRENDS CARDIOVAS MED, V22, P98, DOI 10.1016/j.tcm.2012.07.003; Riehle C, 2011, CIRC RES, V109, P783, DOI 10.1161/CIRCRESAHA.111.243964; Rimbaud S, 2009, PHARMACOL REP, V61, P131, DOI 10.1016/S1734-1140(09)70015-5; Sena S, 2007, ENDOCRINOLOGY, V148, P6047, DOI 10.1210/en.2006-1559	28	37	40	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3691	3702		10.1096/fj.14-253823	http://dx.doi.org/10.1096/fj.14-253823			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24776744	Green Published			2022-12-25	WOS:000340265400036
J	Tang, QY; Zhang, Z; Meng, XY; Cui, M; Logothetis, DE				Tang, Qiong-Yao; Zhang, Zhe; Meng, Xuan-Yu; Cui, Meng; Logothetis, Diomedes E.			Structural Determinants of Phosphatidylinositol 4,5-Bisphosphate (PIP2) Regulation of BK Channel Activity through the RCK1 Ca2+ Coordination Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; RECTIFYING K+ CHANNELS; DIASTOLIC HYPERTENSION; SENSITIVITY; VOLTAGE; DOMAIN; SUBUNIT; POLYMORPHISM; EPILEPSY; MUTATION	Big or high conductance potassium (BK) channels are activated by voltage and intracellular calcium (Ca2+). Phosphatidylinositol 4,5-bisphosphate (PIP2), a ubiquitous modulator of ion channel activity, has been reported to enhance Ca2+-driven gating of BK channels, but a molecular understanding of this interplay or even of the PIP2 regulation of this channel's activity remains elusive. Here, we identify structural determinants in the KDRDD loop (which follows the alpha A helix in the RCK1 domain) to be responsible for the coupling between Ca2+ and PIP2 in regulating BK channel activity. In the absence of Ca2+, RCK1 structural elements limit channel activation through a decrease in the channel's PIP2 apparent affinity. This inhibitory influence of BK channel activation can be relieved by mutation of residues that (a) connect either the RCK1 Ca2+ coordination site (Asp(367) or its flanking basic residues in the KDRDD loop) to the PIP2-interacting residues (Lys(392) and Arg(393)) found in the alpha B helix or (b) are involved in hydrophobic interactions between the alpha A and alpha B helix of the RCK1 domain. In the presence of Ca2+, the RCK1-inhibitory influence of channel-PIP2 interactions and channel activity is relieved by Ca2+ engaging Asp367. Our results demonstrate that, along with Ca2+ and voltage, PIP2 is a third factor critical to the integral control of BK channel activity.	[Tang, Qiong-Yao; Zhang, Zhe; Meng, Xuan-Yu; Cui, Meng; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA; [Tang, Qiong-Yao; Zhang, Zhe] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Peoples R China; [Tang, Qiong-Yao; Zhang, Zhe] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesia & Analgesia Appli, Xuzhou 221004, Peoples R China	Virginia Commonwealth University; Xuzhou Medical University; Xuzhou Medical University	Tang, QY (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	qtang@vcu.edu; delogothetis@vcu.edu			National Institutes of Health (NIH) Grants [R01-HL059949, R01-HL090882]; NIH, NCRR [S10RR027411]; American Heart Association Grant [09SDG2290002]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949, R01HL090882] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association Grant(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants R01-HL059949 and R01-HL090882 (to D. E. L.) and by NIH, NCRR, Grant S10RR027411 (to M. C.). This work was also supported by American Heart Association Grant 09SDG2290002 (to Z. Z.).	Abderemane-Ali F, 2012, J BIOL CHEM, V287, P36158, DOI 10.1074/jbc.M112.382085; Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hou PP, 2013, SCI REP-UK, V3, DOI 10.1038/srep01666; Kelley-Hedgepeth A, 2009, J HYPERTENS, V27, P55, DOI 10.1097/HJH.0b013e328317c8ae; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Kohler R, 2000, CIRC RES, V87, P496; Kruse M, 2013, CHANNELS, V7, P530, DOI 10.4161/chan.25816; Kruse M, 2012, J GEN PHYSIOL, V140, P189, DOI 10.1085/jgp.201210806; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Lingle CJ, 2002, J GEN PHYSIOL, V120, P261, DOI 10.1085/jgp.20028689; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; Logothetis DE, 2010, PFLUG ARCH EUR J PHY, V460, P321, DOI 10.1007/s00424-010-0828-y; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lorenz S, 2007, AM J MED GENET B, V144B, P10, DOI 10.1002/ajmg.b.30369; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nielsen T, 2008, J HYPERTENS, V26, P2142, DOI 10.1097/HJH.0b013e32830b894a; Riazi MA, 1999, GENOMICS, V62, P90, DOI 10.1006/geno.1999.5975; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Seibold MA, 2008, HUM MOL GENET, V17, P2681, DOI 10.1093/hmg/ddn168; Senti M, 2005, CIRC RES, V97, P1360, DOI 10.1161/01.RES.0000196557.93717.95; Shelley C, 2010, J GEN PHYSIOL, V135, P461, DOI 10.1085/jgp.200910331; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tang QY, 2010, J BIOL CHEM, V285, P19259, DOI 10.1074/jbc.M109.100156; Tang QY, 2010, CHANNELS, V4, P22, DOI 10.4161/chan.4.1.10481; Tang QY, 2009, J GEN PHYSIOL, V134, P409, DOI 10.1085/jgp.200910251; THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19; Tomas M, 2008, J HYPERTENS, V26, P2147, DOI 10.1097/HJH.0b013e32831103d8; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2004, J NEUROSCI, V24, P5585, DOI 10.1523/JNEUROSCI.1296-04.2004; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239; Zhang GH, 2010, P NATL ACAD SCI USA, V107, P18700, DOI 10.1073/pnas.1010124107; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607; Zhang Z, 2006, J NEUROSCI, V26, P11833, DOI 10.1523/JNEUROSCI.3812-06.2006; Zhang Z, 2013, CHANNELS, V7, P194, DOI 10.4161/chan.24492; Zhang Z, 2010, J NEUROSCI, V30, P7554, DOI 10.1523/JNEUROSCI.0525-10.2010; Zhou Y, 2010, J GEN PHYSIOL, V135, P481, DOI 10.1085/jgp.201010403	56	25	26	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18860	18872		10.1074/jbc.M113.538033	http://dx.doi.org/10.1074/jbc.M113.538033			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24778177	Green Published, hybrid			2022-12-25	WOS:000339062900020
J	Park, Y; Vennekate, W; Yavuz, H; Preobraschenski, J; Hernandez, JM; Riedel, D; Walla, PJ; Jahn, R				Park, Yongsoo; Vennekate, Wensi; Yavuz, Halenur; Preobraschenski, Julia; Hernandez, Javier M.; Riedel, Dietmar; Walla, Peter Jomo; Jahn, Reinhard			alpha-SNAP Interferes with the Zippering of the SNARE Protein Membrane Fusion Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; COMPLEX; DOCKING; YEAST; NSF; PARTICLES; VACUOLES; SYNTAXIN	Neuronal exocytosis is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins. Before fusion, SNARE proteins form complexes bridging the membrane followed by assembly toward the C-terminal membrane anchors, thus initiating membrane fusion. After fusion, the SNARE complex is disassembled by the AAA-ATPase N-ethylmaleimide-sensitive factor that requires the cofactor alpha-SNAP to first bind to the assembled SNARE complex. Using chromaffin granules and liposomes we now show that alpha-SNAP on its own interferes with the zippering of membrane-anchored SNARE complexes midway through the zippering reaction, arresting SNAREs in a partially assembled trans-complex and preventing fusion. Intriguingly, the interference does not result in an inhibitory effect on synaptic vesicles, suggesting that membrane properties also influence the final outcome of alpha-SNAP interference with SNARE zippering. We suggest that binding of alpha-SNAP to the SNARE complex affects the ability of the SNARE complex to harness energy or transmit force to the membrane.	[Park, Yongsoo; Vennekate, Wensi; Yavuz, Halenur; Preobraschenski, Julia; Hernandez, Javier M.; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Vennekate, Wensi; Walla, Peter Jomo] Max Planck Inst Biophys Chem, AG Biomol Spect & Single Mol Detect, D-37077 Gottingen, Germany; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Facil Electron Microscopy, D-37077 Gottingen, Germany; [Walla, Peter Jomo] Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, Dept Biophys Chem, D-38106 Braunschweig, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Braunschweig University of Technology	Jahn, R (corresponding author), Fassberg 11, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Park, Yongsoo/G-9285-2014	Park, Yongsoo/0000-0001-8336-8051; Jahn, Reinhard/0000-0003-1542-3498	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM072694] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Burgalossi A, 2010, NEURON, V68, P473, DOI 10.1016/j.neuron.2010.09.019; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; CLARY DO, 1990, J BIOL CHEM, V265, P10109; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Cypionka A, 2009, P NATL ACAD SCI USA, V106, P18575, DOI 10.1073/pnas.0906677106; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Min D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2692; Muller CB, 2008, J PHYS CHEM B, V112, P8236, DOI 10.1021/jp802280u; Park Y, 2012, NAT STRUCT MOL BIOL, V19, P991, DOI 10.1038/nsmb.2375; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Rodriguez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021925; Siddiqui TJ, 2007, MOL BIOL CELL, V18, P2037, DOI 10.1091/mbc.E07-01-0049; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Wang L, 2000, J BIOL CHEM, V275, P22862, DOI 10.1074/jbc.M001447200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wimmer C, 2001, J BIOL CHEM, V276, P29091, DOI 10.1074/jbc.M011292200; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286	33	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16326	16335		10.1074/jbc.M114.556803	http://dx.doi.org/10.1074/jbc.M114.556803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778182	Green Published, hybrid			2022-12-25	WOS:000337965700036
J	Knoll, N; Jarick, I; Volckmar, AL; Klingenspor, M; Illig, T; Grallert, H; Gieger, C; Wichmann, HE; Peters, A; Wiegand, S; Biebermann, H; Fischer-Posovszky, P; Wabitsch, M; Volzke, H; Nauck, M; Teumer, A; Rosskopf, D; Rimmbach, C; Schreiber, S; Jacobs, G; Lieb, W; Franke, A; Hebebrand, J; Hinney, A				Knoll, Nadja; Jarick, Ivonne; Volckmar, Anna-Lena; Klingenspor, Martin; Illig, Thomas; Grallert, Harald; Gieger, Christian; Wichmann, Heinz-Erich; Peters, Annette; Wiegand, Susanna; Biebermann, Heike; Fischer-Posovszky, Pamela; Wabitsch, Martin; Voelzke, Henry; Nauck, Matthias; Teumer, Alexander; Rosskopf, Dieter; Rimmbach, Christian; Schreiber, Stefan; Jacobs, Gunnar; Lieb, Wolfgang; Franke, Andre; Hebebrand, Johannes; Hinney, Anke			Mitochondrial DNA Variants in Obesity	PLOS ONE			English	Article							HEAVY-STRAND PROMOTER; BODY-MASS INDEX; HUMAN MTDNA; TRANSCRIPTION FACTOR; GENETIC-ASPECTS; CONTROL REGION; IDENTIFICATION; HETEROPLASMY; ASSOCIATION; GENOME	Heritability estimates for body mass index (BMI) variation are high. For mothers and their offspring higher BMI correlations have been described than for fathers. Variation(s) in the exclusively maternally inherited mitochondrial DNA (mtDNA) might contribute to this parental effect. Thirty-two to 40 mtDNA single nucleotide polymorphisms (SNPs) were available from genome-wide association study SNP arrays (Affymetrix 6.0). For discovery, we analyzed association in a case-control (CC) sample of 1,158 extremely obese children and adolescents and 435 lean adult controls. For independent confirmation, 7,014 population-based adults were analyzed as CC sample of n = 1,697 obese cases (BMI >= 30 kg/m(2)) and n = 2,373 normal weight and lean controls (BMI<25 kg/m(2)). SNPs were analyzed as single SNPs and haplogroups determined by HaploGrep. Fisher's two-sided exact test was used for association testing. Moreover, the D-loop was re-sequenced (Sanger) in 192 extremely obese children and adolescents and 192 lean adult controls. Association testing of detected variants was performed using Fisher's two-sided exact test. For discovery, nominal association with obesity was found for the frequent allele G of m. 8994G/A (rs28358887, p = 0.002) located in ATP6. Haplogroup W was nominally overrepresented in the controls (p = 0.039). These findings could not be confirmed independently. For two of the 252 identified D-loop variants nominal association was detected (m.16292C/T, p = 0.007, m.16189T/C, p = 0.048). Only eight controls carried the m.16292T allele, five of whom belonged to haplogroup W that was initially enriched among these controls. m. 16189T/C might create an uninterrupted poly-C tract located near a regulatory element involved in replication of mtDNA. Though follow-up of some D-loop variants still is conceivable, our hypothesis of a contribution of variation in the exclusively maternally inherited mtDNA to the observed larger correlations for BMI between mothers and their offspring could not be substantiated by the findings of the present study.	[Knoll, Nadja; Volckmar, Anna-Lena; Hebebrand, Johannes; Hinney, Anke] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Jarick, Ivonne] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany; [Illig, Thomas; Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Res Unit Mol Epidemiol, Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Grallert, Harald; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol 2, Neuherberg, Germany; [Grallert, Harald] German Ctr Diabet Res, Neuherberg, Germany; [Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Genet Epidemiol, Neuherberg, Germany; [Wichmann, Heinz-Erich] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol 1, Neuherberg, Germany; [Wichmann, Heinz-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, Munich, Germany; [Wichmann, Heinz-Erich] Munich Univ Hosp, Munich, Germany; [Wiegand, Susanna; Biebermann, Heike] Charite, Inst Expt Pediat Endocrinol, Berlin, Germany; [Fischer-Posovszky, Pamela; Wabitsch, Martin] Univ Ulm, Univ Med Ctr, Dept Children & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany; [Voelzke, Henry; Teumer, Alexander] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Rosskopf, Dieter; Rimmbach, Christian] Univ Med Greifswald, Inst Pharmacol, Greifswald, Germany; [Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Jacobs, Gunnar; Lieb, Wolfgang] Univ Kiel, Inst Epidemiol & Biobank Popgen, Kiel, Germany	University of Duisburg Essen; Philipps University Marburg; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ulm University; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; University of Kiel; University of Kiel	Hinney, A (corresponding author), Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany.	Anke.Hinney@uni-due.de	Klingenspor, Martin/K-5033-2019; Wichmann, Heinz Erich/AAA-5695-2022; Grallert, Harald/B-3424-2013; Hinney, Anke/D-6953-2011; Franke, Andre/B-2151-2010; Lieb, Wolfgang/AAC-7650-2022; Klingenspor, Martin/D-6930-2011; Peters, Annette/A-6117-2011; Volckmar, Anna-Lena/ABE-3676-2021; Teumer, Alexander/S-7438-2019	Hinney, Anke/0000-0001-5659-0706; Franke, Andre/0000-0003-1530-5811; Klingenspor, Martin/0000-0002-4502-6664; Peters, Annette/0000-0001-6645-0985; Teumer, Alexander/0000-0002-8309-094X; Wiegand, Susanna/0000-0001-8341-9533; Gieger, Christian/0000-0001-6986-9554; Biebermann, Heike/0000-0002-2024-7778; Fischer-Posovszky, Pamela/0000-0003-3402-9840	German Research Foundation [HI865/2-1]; German Federal Ministry of Education and Research [01KU0903, 01GS0830, 01GS0820, 01ZZ9603, 01ZZ0103, 01ZZ0701, D352300006, 03ZIK012, 01EY1103]; European Community [245009]; University of Duisburg-Essen; Helmholtz Zentrum Munchen - German Research Center for Environmental Health; State of Bavaria; Siemens Healthcare	German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Community(European Commission); University of Duisburg-Essen; Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); State of Bavaria; Siemens Healthcare(Siemens AG)	This work was supported by grants of the German Research Foundation (HI865/2-1), the German Federal Ministry of Education and Research (01KU0903, 01GS0830, 01GS0820), the European Community's Seventh Framework Program (FP7/2007-2013, grant number 245009) and the IFORES program of the University of Duisburg-Essen. The KORA research platform (KORA), Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. Data of the Study of Health of Pomerania (SHIP) were provided by the research alliance "Community Medicine'' of the medical faculty of the Ernst-Moritz-Arndt University of Greifswald and supported by grants of the German Federal Ministry of Education and Research (01ZZ9603, 01ZZ0103, 01ZZ0701, D352300006 and 03ZIK012). Genotyping in SHIP was partly funded by Siemens Healthcare. The popgen 2.0 network is supported by a grant from the German Federal Ministry of Education and Research (01EY1103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andreasson H, 2006, INT J LEGAL MED, V120, P383, DOI 10.1007/s00414-005-0072-8; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2012, INT J LEGAL MED, V126, P901, DOI 10.1007/s00414-012-0762-y; BENDALL KE, 1995, AM J HUM GENET, V57, P248; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; BOUCHARD C, 1993, ANN NY ACAD SCI, V699, P26, DOI 10.1111/j.1749-6632.1993.tb18834.x; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Budowle B, 2002, FORENSIC SCI INT, V126, P30, DOI 10.1016/S0379-0738(02)00019-1; Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844; Cardoso S, 2012, FORENSIC SCI INT-GEN, V6, pE106, DOI 10.1016/j.fsigen.2011.12.007; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; Grant SFA, 2012, INT J OBESITY, V36, P80, DOI 10.1038/ijo.2011.206; Hebebrand J, 1994, AKTUELLE ERNAHRUNGSM, V19, P259; Hebebrand J, 2013, DTSCH ARZTEBL INT, V110, P338, DOI 10.3238/arztebl.2013.0338; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Ingman M, 2001, J HERED, V92, P454, DOI 10.1093/jhered/92.6.454; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552; Lodeiro MF, 2012, P NATL ACAD SCI USA, V109, P6513, DOI 10.1073/pnas.1118710109; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; Magnusson PKE, 2002, INT J OBESITY, V26, P1225, DOI 10.1038/sj.ijo.0802041; Meyer S, 1999, GENETICS, V152, P1103; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; Nothlings U, 2012, BUNDESGESUNDHEITSBLA, V55, P831, DOI 10.1007/s00103-012-1487-2; OHNO K, 1991, BIOCHEM INT, V24, P263; Parker E, 2005, AM J PHYSIOL-ENDOC M, V289, pE1110, DOI 10.1152/ajpendo.00600.2004; Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200; Pliss L, 2006, ANN HUM GENET, V70, P439, DOI 10.1111/j.1469-1809.2005.00238.x; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; PRICE RA, 1991, BEHAV GENET, V21, P1, DOI 10.1007/BF01067662; Putter C, 2011, HUM HERED, V72, P173, DOI 10.1159/000332824; Roberti M, 1998, BIOCHEM BIOPH RES CO, V243, P36, DOI 10.1006/bbrc.1997.8052; Ruckert IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022932; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Sorensen TIA, 1998, INT J OBESITY, V22, P73, DOI 10.1038/sj.ijo.0800548; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; SUZUKI H, 1991, J BIOL CHEM, V266, P2333; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; WILSON MR, 1993, CRIME LAB DIGEST, V20, P68; Yang TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021595; YOZA BK, 1984, J BIOL CHEM, V259, P3909; Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109; ZONTA LA, 1987, HUM HERED, V37, P129, DOI 10.1159/000153690	54	17	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94882	10.1371/journal.pone.0094882	http://dx.doi.org/10.1371/journal.pone.0094882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788344	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700019
J	Carrion, K; Dyo, J; Patel, V; Sasik, R; Mohamed, SA; Hardiman, G; Nigam, V				Carrion, Katrina; Dyo, Jeffrey; Patel, Vishal; Sasik, Roman; Mohamed, Salah A.; Hardiman, Gary; Nigam, Vishal			The Long Non-Coding HOTAIR Is Modulated by Cyclic Stretch and WNT/beta-CATENIN in Human Aortic Valve Cells and Is a Novel Repressor of Calcification Genes	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE EXPRESSION; EXTRACELLULAR-MATRIX; ALKALINE-PHOSPHATASE; INTERSTITIAL-CELLS; STENOSIS; RNA; ATORVASTATIN; PROGRESSION; DISEASE; OSTEOBLASTS	Aortic valve calcification is a significant and serious clinical problem for which there are no effective medical treatments. Individuals born with bicuspid aortic valves, 1-2% of the population, are at the highest risk of developing aortic valve calcification. Aortic valve calcification involves increased expression of calcification and inflammatory genes. Bicuspid aortic valve leaflets experience increased biomechanical strain as compared to normal tricuspid aortic valves. The molecular pathogenesis involved in the calcification of BAVs are not well understood, especially the molecular response to mechanical stretch. HOTAIR is a long non-coding RNA (lncRNA) that has been implicated with cancer but has not been studied in cardiac disease. We have found that HOTAIR levels are decreased in BAVs and in human aortic interstitial cells (AVICs) exposed to cyclic stretch. Reducing HOTAIR levels via siRNA in AVICs results in increased expression of calcification genes. Our data suggest that beta-CATENIN is a stretch responsive signaling pathway that represses HOTAIR. This is the first report demonstrating that HOTAIR is mechanoresponsive and repressed by WNT beta-CATENIN signaling. These findings provide novel evidence that HOTAIR is involved in aortic valve calcification.	[Carrion, Katrina; Dyo, Jeffrey; Patel, Vishal; Nigam, Vishal] Univ Calif San Diego, Dept Pediat Oncol, La Jolla, CA 92093 USA; [Sasik, Roman] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mohamed, Salah A.] Univ Clin Schleswig Holstein, Dept Cardiac Surg, Lubeck, Germany; [Hardiman, Gary] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Hardiman, Gary] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Hardiman, Gary] San Diego State Univ, Biomed Informat Res Ctr, San Diego, CA 92182 USA; [Nigam, Vishal] Rady Childrens Hosp San Diego, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Kiel; Schleswig Holstein University Hospital; Medical University of South Carolina; California State University System; San Diego State University; California State University System; San Diego State University; Rady Childrens Hospital San Diego	Nigam, V (corresponding author), Univ Calif San Diego, Dept Pediat Oncol, La Jolla, CA 92093 USA.	vnigam@ucsd.edu	Mohamed, Salah A./O-2955-2018	Nigam, Vishal/0000-0002-9652-8146; Hardiman, Gary/0000-0003-4558-0400	NIH [K08 HL086775]; UCSD Department of Pediatrics and Rady's Children's Heart Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL086775] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Department of Pediatrics and Rady's Children's Heart Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	V.N. was partially funded by NIH K08 HL086775. Additionally, funding was provided by the UCSD Department of Pediatrics and Rady's Children's Heart Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AH, 2003, HEART DIS STROK STAT; BEPPU S, 1993, AM J CARDIOL, V71, P322, DOI 10.1016/0002-9149(93)90799-I; Caira FC, 2006, J AM COLL CARDIOL, V47, P1707, DOI 10.1016/j.jacc.2006.02.040; Cheng SL, 2010, CIRC RES, V107, P271, DOI 10.1161/CIRCRESAHA.110.219899; Clark-Greuel JN, 2007, ANN THORAC SURG, V83, P946, DOI 10.1016/j.athoracsur.2006.10.026; Davies MJ, 1996, HEART, V75, P174, DOI 10.1136/hrt.75.2.174; Edep ME, 2000, CARDIOVASC PATHOL, V9, P281, DOI 10.1016/S1054-8807(00)00043-0; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Ferdous Z, 2011, BIOMATERIALS, V32, P2885, DOI 10.1016/j.biomaterials.2011.01.030; Fondard O, 2005, EUR HEART J, V26, P1333, DOI 10.1093/eurheartj/ehi248; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Jian B, 2001, AM J PATHOL, V159, P321, DOI 10.1016/S0002-9440(10)61698-7; Kaden JJ, 2005, CARDIOVASC PATHOL, V14, P80, DOI 10.1016/j.carpath.2005.01.002; Kaden JJ, 2004, J HEART VALVE DIS, V13, P560; Kaden JJ, 2003, ATHEROSCLEROSIS, V170, P205, DOI 10.1016/S0021-9150(03)00284-3; Kim K, 2012, ONCOGENE; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Lehmann S, 2009, ANN THORAC SURG, V88, P1476, DOI 10.1016/j.athoracsur.2009.07.025; Liu J, 2005, ANGEW CHEM INT EDIT, V44, P1987, DOI 10.1002/anie.200462552; Mathieu P, 2005, J HEART VALVE DIS, V14, P353; Mohler ER, 1999, J HEART VALVE DIS, V8, P254; Naito Y, 2010, INT J CARDIOL, V144, P260, DOI 10.1016/j.ijcard.2009.01.022; Nigam V, 2010, J HEART VALVE DIS; Nigam V, 2009, J MOL CELL CARDIOL; Nigam V, 2010, J HEART VALVE DIS, V19, P459; Osman L, 2006, CIRCULATION, V114, pI547, DOI 10.1161/CIRCULATIONAHA.105.001115; Rajamannan NM, 2012, J CELL BIOCHEM, V113, P1623, DOI 10.1002/jcb.24031; Rajamannan NM, 2005, CIRCULATION, V112, pI229, DOI 10.1161/01.CIRCULATIONAHA.104.524306; Rajamannan NM, 2005, HEART, V91, P806, DOI 10.1136/hrt.2003.029785; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robicsek F, 2004, ANN THORAC SURG, V77, P177, DOI 10.1016/S0003-4975(03)01249-9; Satta J, 2003, ANN THORAC SURG, V76, P681, DOI 10.1016/S0003-4975(03)00529-0; Schiavo G, 2011, J CELL BIOCHEM, V112, P3206, DOI 10.1002/jcb.23248; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Soini Y, 2001, J PATHOL, V194, P225, DOI 10.1002/path.850; Szeto K, 2013, WORLD J PEDIATR CONG, V4, P362, DOI 10.1177/2150135113501901; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Xie Y, 2009, BIOINFORMATICS, V25, P751, DOI 10.1093/bioinformatics/btp040; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y	47	81	90	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96577	10.1371/journal.pone.0096577	http://dx.doi.org/10.1371/journal.pone.0096577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788418	Green Submitted, gold, Green Published			2022-12-25	WOS:000335510600108
J	Hamada, S; Futamura, N; Ikuta, K; Urakawa, H; Kozawa, E; Ishiguro, N; Nishida, Y				Hamada, Shunsuke; Futamura, Naohisa; Ikuta, Kunihiro; Urakawa, Hiroshi; Kozawa, Eiji; Ishiguro, Naoki; Nishida, Yoshihiro			CTNNB1 S45F Mutation Predicts Poor Efficacy of Meloxicam Treatment for Desmoid Tumors: A Pilot Study	PLOS ONE			English	Article							BETA-CATENIN MUTATIONS; AGGRESSIVE FIBROMATOSIS; PROGNOSTIC-FACTORS; RADIATION-THERAPY; SURGERY; RECURRENCE; EXPRESSION; DIAGNOSIS; LESIONS; SERIES	We hypothesized that patterns of CTNNB1 (beta-catenin) mutations would affect the outcome of conservative therapy in patients with desmoid tumors. This study aimed to determine the significance of CTNNB1 (b-catenin) mutations in predicting the treatment outcome in patients with desmoid tumors treated with meloxicam, a cyclooxygenase-2 (COX-2) selective inhibitor. Between 2003 and 2012, consecutive thirty-three patients with extra-peritoneal sporadic desmoid tumors were prospectively treated with meloxicam as the initial systemic medical therapy. The efficacy of meloxicam was evaluated according to Response Evaluation Criteria in Solid Tumors (RECIST). DNA was isolated from frozen tissue or formalin-fixed materials. CTNNB1 mutation analysis was performed by direct sequencing. Positivity of nuclear beta-catenin staining by immunohistochemistry was compared with the status of CTNNB1 mutations. The correlation between the efficacy of meloxicam treatment and status of CTNNB1 mutations was analyzed. Of the 33 patients with meloxicam treatment, one showed complete remission (CR), 7 partial remission (PR), 12 stable disease (SD), and 13 progressive disease (PD). The following 3 point mutations were identified in 21 of the 33 cases (64%): T41A (16 cases), S45F (4 cases) and S45P (one case). The nuclear expression of beta-catenin correlated significantly with CTNNB1 mutation status (p = 0.035); all four cases with S45F mutation exhibited strong nuclear expression of beta-catenin. S45F mutation was significantly associated with a poor response (all cases; PD) (p = 0.017), whereas the other mutations had no impact on efficacy. The CTNNB1 mutation status was of significant prognostic value for meloxicam treatment in patients with sporadic desmoid tumors.	[Nishida, Yoshihiro] Nagoya Univ, Dept Orthopaed Surg, Grad Sch, Nagoya, Aichi 4648601, Japan; Nagoya City Univ, Sch Med, Nagoya, Aichi 467, Japan	Nagoya University; Nagoya City University	Nishida, Y (corresponding author), Nagoya Univ, Dept Orthopaed Surg, Grad Sch, Nagoya, Aichi 4648601, Japan.	ynishida@med.nagoya-u.ac.jp	Urakawa, Hiroshi/C-3599-2016; Nishida, Yoshihiro/I-7354-2014; Kozawa, Eiji/B-9464-2016; Ishiguro, Naoki/I-1563-2012	Urakawa, Hiroshi/0000-0003-2961-1238; Kozawa, Eiji/0000-0001-8335-803X; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [20591751]; Suzuken Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Suzuken Memorial Foundation	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid 20591751 for Scientific Research (C)], and by the Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony T, 1996, J AM COLL SURGEONS, V182, P369; Ballo MT, 1999, J CLIN ONCOL, V17, P158, DOI 10.1200/JCO.1999.17.1.158; Barbier O, 2010, ORTHOP TRAUMATOL-SUR, V96, P884, DOI 10.1016/j.otsr.2010.07.007; Bhattacharya B, 2005, AM J SURG PATHOL, V29, P653, DOI 10.1097/01.pas.0000157938.95785.da; Bonvalot S, 2012, ANN ONCOL, V23, P158, DOI 10.1093/annonc/mds298; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; Carlson JW, 2007, HISTOPATHOLOGY, V51, P509, DOI 10.1111/j.1365-2559.2007.02794.x; Colombo C, 2013, CANCER-AM CANCER SOC, V119, P3696, DOI 10.1002/cncr.28271; Colombo C, 2011, HISTOPATHOLOGY, V59, P336, DOI 10.1111/j.1365-2559.2011.03932.x; Domont J, 2010, BRIT J CANCER, V102, P1032, DOI 10.1038/sj.bjc.6605557; Escobar C, 2012, ANN ONCOL, V23, P562, DOI 10.1093/annonc/mdr386; Farrugia A, 2010, FORENSIC SCI INT, V194, pE25, DOI 10.1016/j.forsciint.2009.09.004; Fernanda M, 2007, AM J SURG PATHOL, V31, P1299, DOI 10.1097/PAS.0b013e31802f581a; Fiore M, 2009, ANN SURG ONCOL, V16, P2587, DOI 10.1245/s10434-009-0586-2; Gebert C, 2007, HISTOPATHOLOGY, V50, P491, DOI 10.1111/j.1365-2559.2007.02619.x; Gronchi A, 2014, ANN ONCOL, V25, P578, DOI 10.1093/annonc/mdt485; Gronchi A, 2003, J CLIN ONCOL, V21, P1390, DOI 10.1200/JCO.2003.05.150; Hamada S, 2014, TUMOR BIOL, V35, P4561, DOI 10.1007/s13277-013-1600-7; Huss S, 2013, HISTOPATHOLOGY, V62, P294, DOI 10.1111/j.1365-2559.2012.04355.x; Janinis J, 2003, ANN ONCOL, V14, P181, DOI 10.1093/annonc/mdg064; Kikuchi A, 2003, CANCER SCI, V94, P225, DOI 10.1111/j.1349-7006.2003.tb01424.x; Lazar AJF, 2008, AM J PATHOL, V173, P1518, DOI 10.2353/ajpath.2008.080475; Le Guellec S, 2012, MODERN PATHOL, V25, P1551, DOI 10.1038/modpathol.2012.115; Lev D, 2007, J CLIN ONCOL, V25, P1785, DOI 10.1200/JCO.2006.10.5015; Mullen JT, 2013, ONCOLOGIST, V18, P1043, DOI 10.1634/theoncologist.2012-0449; Ng TL, 2005, MODERN PATHOL, V18, P68, DOI 10.1038/modpathol.3800272; Nishida Yoshihiro, 2012, Cancers (Basel), V4, P88, DOI 10.3390/cancers4010088; Nishida Y, 2012, J CLIN ONCOL, V30, P1390, DOI 10.1200/JCO.2011.39.8636; Nishida Y, 2010, J CLIN ONCOL, V28, pE107, DOI 10.1200/JCO.2009.25.5950; Nuyttens JJ, 2000, CANCER, V88, P1517, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1517::AID-CNCR3>3.0.CO;2-9; Oikonomou E, 2005, J NEURO-ONCOL, V73, P205, DOI 10.1007/s11060-004-5232-z; Salas S, 2010, GENE CHROMOSOME CANC, V49, P560, DOI 10.1002/gcc.20766; Shido Y, 2009, ARCH ORTHOP TRAUM SU, V129, P929, DOI 10.1007/s00402-008-0750-3; Tajima S, 2006, RESPIRATION, V73, P558, DOI 10.1159/000088006; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Urakawa H, 2009, CLIN ORTHOP RELAT R, V467, P2932, DOI 10.1007/s11999-009-0814-x	36	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96391	10.1371/journal.pone.0096391	http://dx.doi.org/10.1371/journal.pone.0096391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788118	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600097
J	Fukushima, A; Yagi, R; Kawai, N; Honda, M; Nishina, E; Oohashi, T				Fukushima, Ariko; Yagi, Reiko; Kawai, Norie; Honda, Manabu; Nishina, Emi; Oohashi, Tsutomu			Frequencies of Inaudible High-Frequency Sounds Differentially Affect Brain Activity: Positive and Negative Hypersonic Effects	PLOS ONE			English	Article							50-KHZ ULTRASONIC VOCALIZATIONS; ALPHA-RHYTHM; NUCLEUS-ACCUMBENS; RATS; CALLS; PLAYBACK; EEG; COMMUNICATION; 22-KHZ; STATES	The hypersonic effect is a phenomenon in which sounds containing significant quantities of non-stationary high-frequency components (HFCs) above the human audible range (max. 20 kHz) activate the midbrain and diencephalon and evoke various physiological, psychological and behavioral responses. Yet important issues remain unverified, especially the relationship existing between the frequency of HFCs and the emergence of the hypersonic effect. In this study, to investigate the relationship between the hypersonic effect and HFC frequencies, we divided an HFC (above 16 kHz) of recorded gamelan music into 12 band components and applied them to subjects along with an audible component (below 16 kHz) to observe changes in the alpha2 frequency component (10-13 Hz) of spontaneous EEGs measured from centroparieto-occipital regions (Alpha-2 EEG), which we previously reported as an index of the hypersonic effect. Our results showed reciprocal directional changes in Alpha-2 EEGs depending on the frequency of the HFCs presented with audible low-frequency component (LFC). When an HFC above approximately 32 kHz was applied, Alpha-2 EEG increased significantly compared to when only audible sound was applied (positive hypersonic effect), while, when an HFC below approximately 32 kHz was applied, the Alpha-2 EEG decreased (negative hypersonic effect). These findings suggest that the emergence of the hypersonic effect depends on the frequencies of inaudible HFC.	[Fukushima, Ariko; Nishina, Emi] Open Univ Japan, Dept Liberal Arts, Chiba, Japan; [Yagi, Reiko] Tokyo Seitoku Coll, Dept Early Childhood Educ, Tokyo, Japan; [Kawai, Norie; Oohashi, Tsutomu] Fdn Adv Int Sci, Dept Res & Dev, Tsukuba, Ibaraki, Japan; [Kawai, Norie] Waseda Univ, Res Council, Tokyo, Japan; [Honda, Manabu] Natl Ctr Neurol & Psychiat, Dept Funct Brain Res, Kodaira, Tokyo, Japan; [Nishina, Emi] Grad Univ Adv Studies SOKENDAI, Sch Cultural & Social Studies, Dept Cyber Soc & Culture, Kanagawa, Japan	Waseda University; National Center for Neurology & Psychiatry - Japan; Graduate University for Advanced Studies - Japan	Nishina, E (corresponding author), Open Univ Japan, Dept Liberal Arts, Chiba, Japan.	nishina@ouj.ac.jp	HONDA, Manabu/AAO-1202-2020		JSPS KAKENHI [22240049]; MEXT KAKENHI [22135008]; JSPS through the "Funding Program for Next Generation World-Leading Researchers"; Council for Science and Technology Policy	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS through the "Funding Program for Next Generation World-Leading Researchers"; Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP))	This work was partly supported by JSPS KAKENHI Grant Number 22240049 and by MEXT KAKENHI Grant Number 22135008 for MH. This work was partly supported by JSPS through the "Funding Program for Next Generation World-Leading Researchers" for EN, initiated by the Council for Science and Technology Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2010, CAN J COMMUN, V35, P455; BRUDZYNSKI SM, 1995, PHYSIOL BEHAV, V57, P1039, DOI 10.1016/0031-9384(95)00003-2; Brudzynski SM, 2001, NEUROSCI BIOBEHAV R, V25, P611, DOI 10.1016/S0149-7634(01)00058-6; Brudzynski SM, 2007, BEHAV BRAIN RES, V182, P261, DOI 10.1016/j.bbr.2007.03.004; Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014; Burgdorf J, 2001, BEHAV NEUROSCI, V115, P940, DOI 10.1037/0735-7044.115.4.940; Burgdorf J, 2007, BEHAV BRAIN RES, V182, P274, DOI 10.1016/j.bbr.2007.03.010; Denda M, 2010, BRIT J DERMATOL, V162, P503, DOI 10.1111/j.1365-2133.2009.09509.x; DiFrancesco MW, 2008, J CLIN NEUROPHYSIOL, V25, P255, DOI 10.1097/WNP.0b013e3181879d56; DUFFY FH, 1979, ANN NEUROL, V5, P309, DOI 10.1002/ana.410050402; Feige B, 2005, J NEUROPHYSIOL, V93, P2864, DOI 10.1152/jn.00721.2004; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Honda M, 2013, ASIAGRAPH, V8, P41; Kim EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015077; Litvin Y, 2007, BEHAV BRAIN RES, V182, P166, DOI 10.1016/j.bbr.2006.11.038; Martinez-Montes E, 2004, NEUROIMAGE, V22, P1023, DOI 10.1016/j.neuroimage.2004.03.038; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Nishiguchi T, 2009, APPL ACOUST, V70, P921, DOI 10.1016/j.apacoust.2009.01.002; Omata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066869; Oohashi T, 2006, BRAIN RES, V1073, P339, DOI 10.1016/j.brainres.2005.12.096; Oohashi T, 2000, J NEUROPHYSIOL, V83, P3548, DOI 10.1152/jn.2000.83.6.3548; Oohashi T., 2002, INTERAREAL COUPLING, P27; Parsana AJ, 2012, BEHAV BRAIN RES, V232, P395, DOI 10.1016/j.bbr.2012.03.031; Sadananda M, 2008, NEUROSCI LETT, V435, P17, DOI 10.1016/j.neulet.2008.02.002; Sadato N, 1998, NEUROREPORT, V9, P893, DOI 10.1097/00001756-199803300-00024; Salek-Haddadi A, 2003, BRAIN RES REV, V43, P110, DOI 10.1016/S0165-0173(03)00193-0; Thompson B, 2006, BEHAV BRAIN RES, V168, P64, DOI 10.1016/j.bbr.2005.10.012; Ueno S, 1976, Iyodenshi To Seitai Kogaku, V14, P118; Walsh C, 2008, YOUTH JUSTICE, V8, P122, DOI 10.1177/1473225408091373; Wohr M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001365; Yagi R., 2003, Acoustical Science and Technology, V24, P197, DOI 10.1250/ast.24.197; Yagi R, 2003, NEUROSCI LETT, V351, P191, DOI 10.1016/j.neulet.2003.07.020; Yamasaki Y, 1994, US Patent, Patent No. 5351048; Yamazaki K, 2008, J ACOUSTICAL SOC JAP, V64, P545	34	13	20	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95464	10.1371/journal.pone.0095464	http://dx.doi.org/10.1371/journal.pone.0095464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788141	Green Published, gold			2022-12-25	WOS:000338917300014
J	Pereira, FV; Ferreira-Guimaraes, CA; Paschoalin, T; Scutti, JAB; Melo, FM; Silva, LS; Melo, ACL; Silva, P; Tiago, M; Matsuo, AL; Juliano, L; Juliano, MA; Carmona, AK; Travassos, LR; Rodrigues, EG				Pereira, Felipe V.; Ferreira-Guimaraes, Carla A.; Paschoalin, Thaysa; Scutti, Jorge A. B.; Melo, Filipe M.; Silva, Luis S.; Melo, Amanda C. L.; Silva, Priscila; Tiago, Manoela; Matsuo, Alisson L.; Juliano, Luiz; Juliano, Maria A.; Carmona, Adriana K.; Travassos, Luiz R.; Rodrigues, Elaine G.			A Natural Bacterial-Derived Product, the Metalloprotease Arazyme, Inhibits Metastatic Murine Melanoma by Inducing MMP-8 Cross-Reactive Antibodies	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; MATRIX METALLOPROTEINASES; CANCER PROGRESSION; CELL INVASION; IN-VITRO; EXPRESSION; GROWTH; ROLES; PROTEASES; SURVIVAL	The increased incidence, high rates of mortality and few effective means of treatment of malignant melanoma, stimulate the search for new anti-tumor agents and therapeutic targets to control this deadly metastatic disease. In the present work the antitumor effect of arazyme, a natural bacterial-derived metalloprotease secreted by Serratia proteomaculans, was investigated. Arazyme significantly reduced the number of pulmonary metastatic nodules after intravenous inoculation of B16F10 melanoma cells in syngeneic mice. In vitro, the enzyme showed a dose-dependent cytostatic effect in human and murine tumor cells, and this effect was associated to the proteolytic activity of arazyme, reducing the CD44 expression at the cell surface, and also reducing in vitro adhesion and in vitro/in vivo invasion of these cells. Arazyme treatment or immunization induced the production of protease-specific IgG that cross-reacted with melanoma MMP-8. In vitro, this antibody was cytotoxic to tumor cells, an effect increased by complement. In vivo, arazyme-specific IgG inhibited melanoma lung metastasis. We suggest that the antitumor activity of arazyme in a preclinical model may be due to a direct cytostatic activity of the protease in combination with the elicited anti-protease antibody, which cross-reacts with MMP-8 produced by tumor cells. Our results show that the bacterial metalloprotease arazyme is a promising novel antitumor chemotherapeutic agent.	[Pereira, Felipe V.; Ferreira-Guimaraes, Carla A.; Scutti, Jorge A. B.; Melo, Filipe M.; Silva, Luis S.; Melo, Amanda C. L.; Silva, Priscila; Matsuo, Alisson L.; Travassos, Luiz R.; Rodrigues, Elaine G.] Univ Fed Sao Paulo UNIFESP, EPM, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Paschoalin, Thaysa; Juliano, Luiz; Juliano, Maria A.; Carmona, Adriana K.] EPM UNIFESP, Dept Biophys, Sao Paulo, Brazil; [Tiago, Manoela] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Rodrigues, EG (corresponding author), Univ Fed Sao Paulo UNIFESP, EPM, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.	rodrigues.elaine@unifesp.br	Melo, Filipe/L-8170-2019; Carmona, Adriana K/D-2240-2012; Rodrigues, Elaine G/H-3688-2014; Travassos, Luiz/V-2467-2019; Rodrigues, Elaine Guadelupe/ABB-6632-2021; de Melo, Filipe Menegatti/J-9918-2014	Carmona, Adriana K/0000-0003-3311-5456; Rodrigues, Elaine Guadelupe/0000-0002-3248-3081; de Melo, Filipe Menegatti/0000-0002-3672-3636	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [10/51423-0, 12/50191-4]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Brazilian National Research Council (CNPq); CNPq	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) grants 10/51423-0 and 12/50191-4, CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and Brazilian National Research Council (CNPq). EGR, AKC, LRT, LJN and MAJ are recipients of fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Artacho-Cordon F, 2012, SURG ONCOL, V21, pE143, DOI 10.1016/j.suronc.2012.06.001; Atkins MB, 2000, CANCER J SCI AM, V6, pS11; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bersanetti PA, 2005, ENZYME MICROB TECH, V37, P574, DOI 10.1016/j.enzmictec.2005.01.041; Berzaghi R, 2009, CLIN VACCINE IMMUNOL, V16, P1538, DOI 10.1128/CVI.00176-09; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Blackburn JS, 2009, PIGM CELL MELANOMA R, V22, P248, DOI 10.1111/j.1755-148X.2009.00573.x; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen YH, 2012, J DERMATOL, V39, P339, DOI 10.1111/j.1346-8138.2011.01441.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; Decock J, 2008, CLIN GENET, V73, P197, DOI 10.1111/j.1399-0004.2007.00946.x; Dejonckheere E, 2011, CYTOKINE GROWTH F R, V22, P73, DOI 10.1016/j.cytogfr.2011.02.002; Dobroff AS, 2002, HYBRIDOMA HYBRIDOM, V21, P321, DOI 10.1089/153685902761022661; Frohlich E, 2001, CANCER-AM CANCER SOC, V91, P972; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Grabowska E, 1997, INT J ONCOL, V11, P243; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Greyner HJ, 2010, MATRIX BIOL, V29, P503, DOI 10.1016/j.matbio.2010.06.004; Guimaraes-Ferreira CA, 2007, NEOPLASIA, V9, P723, DOI 10.1593/neo.07427; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Hedayat M, 2012, MED RES REV, V32, P294, DOI 10.1002/med.20214; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; Kaimal R, 2013, CANCER RES, V73, P2457, DOI 10.1158/0008-5472.CAN-12-1426; Kenessey I, 2009, THROMB HAEMOSTASIS, V102, P1265, DOI 10.1160/TH09-01-0059; Kim IS, 2013, MOL MED REP, V8, P551, DOI 10.3892/mmr.2013.1520; Krishnamachary B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044078; Kwak J, 2007, J MICROBIOL BIOTECHN, V17, P761; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956; Marhaba R, 2004, J MOL HISTOL, V35, P211; Melnikova VO, 2008, CANCER BIOL THER, V7, P997, DOI 10.4161/cbt.7.7.6535; Middleton MR, 2000, BRIT J CANCER, V82, P1158; Moilanen M, 2002, J PATHOL, V197, P72, DOI 10.1002/path.1078; Mondal S, 2012, ANTI-CANCER AGENT ME, V12, P49, DOI 10.2174/187152012798764697; Mouawad R, 2010, CRIT REV ONCOL HEMAT, V74, P27, DOI 10.1016/j.critrevonc.2009.08.005; Mummert ME, 2003, MOL CANCER THER, V2, P295; Negi LM, 2012, J DRUG TARGET, V20, P561, DOI 10.3109/1061186X.2012.702767; Oba-Shinjo SM, 2006, NEOPLASIA, V8, P231, DOI 10.1593/neo.05781; Orimoto AM, 2008, J CUTAN PATHOL, V35, P285, DOI 10.1111/j.1600-0560.2007.00810.x; Orlikova B, 2012, CURR MED CHEM, V19, P2061, DOI 10.2174/092986712800228998; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Park JK, 2008, TOXICOLOGY, V246, P132, DOI 10.1016/j.tox.2008.01.006; Park SY, 2013, INT J ONCOL, V42, P287, DOI 10.3892/ijo.2012.1695; Rambaruth NDS, 2011, ACTA HISTOCHEM, V113, P591, DOI 10.1016/j.acthis.2011.03.001; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; STOCKER W, 1993, EUR J BIOCHEM, V214, P215, DOI 10.1111/j.1432-1033.1993.tb17915.x; STOCKER W, 1995, PROTEIN SCI, V4, P823; Wald M, 2001, CANCER CHEMOTH PHARM, V47, pS16, DOI 10.1007/s002800170004; Wald M, 2008, INTEGR CANCER THER, V7, P295, DOI 10.1177/1534735408327036; Wiranowska M, 2010, INT J CANCER, V127, P532, DOI 10.1002/ijc.25085; Yarani R, 2013, PHARM BIOL, V51, P361, DOI 10.3109/13880209.2012.729147; Zhang YC, 2011, INVEST NEW DRUG, V29, P666, DOI 10.1007/s10637-010-9616-y	57	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96141	10.1371/journal.pone.0096141	http://dx.doi.org/10.1371/journal.pone.0096141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788523	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917300028
J	Cheah, HL; Lim, V; Sandai, D				Cheah, Hong-Leong; Lim, Vuanghao; Sandai, Doblin			Inhibitors of the Glyoxylate Cycle Enzyme ICL1 in Candida albicans for Potential Use as Antifungal Agents	PLOS ONE			English	Article							ISOCITRATE LYASE; ROSMARINIC ACID; FUNGAL-INFECTIONS; CAFFEIC ACID; MACROPHAGE; VIRULENCE; EPIDEMIOLOGY; METABOLISM; EXPRESSION; MANAGEMENT	Candida albicans is an opportunistic pathogen that causes candidiasis in humans. In recent years, metabolic pathways in C. albicans have been explored as potential antifungal targets to treat candidiasis. The glyoxylate cycle, which enables C. albicans to survive in nutrient-limited host niches and its. Key enzymes (e.g., isocitrate lyase (ICL1), are particularly attractive antifungal targets for C. albicans. In this study, we used a new screening approach that better reflects the physiological environment that C. albicans cells experience during infection to identify potential inhibitors of ICL. Three compounds (caffeic acid (CAFF), rosmarinic acid (ROS), and apigenin (API)) were found to have antifungal activity against C. albicans when tested under glucose-depleted conditions. We further confirmed the inhibitory potential of these compounds against ICL using the ICL enzyme assay. Lastly, we assessed the bioavailability and toxicity of these compounds using Lipinski's rule-of-five and ADMET analysis.	[Cheah, Hong-Leong; Lim, Vuanghao; Sandai, Doblin] Univ Sains Malaysia, Adv Med & Dent Inst, George Town, Malaysia	Universiti Sains Malaysia	Sandai, D (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, George Town, Malaysia.	doblin@amdi.usm.edu.my	Lim, Vuanghao/S-1783-2018; Lim, Vuanghao/E-1988-2012	Lim, Vuanghao/0000-0001-5081-0982; Lim, Vuanghao/0000-0003-2762-2697; Cheah, Hong Leong/0000-0001-9172-2487	Malaysian Fundamental Research Grant Scheme [203/CIPPT/11242]	Malaysian Fundamental Research Grant Scheme	Funding came from a Malaysian Fundamental Research Grant Scheme 203/CIPPT/11242. http://jpt.mohe.gov.my. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askun T, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-365; Brock M, 2009, CURR OPIN MICROBIOL, V12, P371, DOI 10.1016/j.mib.2009.05.004; Chandrasekar P, 2011, J ANTIMICROB CHEMOTH, V66, P457, DOI 10.1093/jac/dkq479; CHELL RM, 1978, BIOCHEM J, V173, P165, DOI 10.1042/bj1730165; Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a; Chuang CM, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-49; CLSI, 2008, M27S3 CLSI, V3rd; Cruz AHD, 2011, FEBS J, V278, P2318, DOI 10.1111/j.1742-4658.2011.08150.x; De Oliveira NCD, 2012, FOOD CHEM TOXICOL, V50, P1208, DOI 10.1016/j.fct.2012.01.028; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Ebel F, 2006, FUNGAL GENET BIOL, V43, P476, DOI 10.1016/j.fgb.2006.01.015; Ene IV, 2013, INFECT IMMUN, V81, P238, DOI 10.1128/IAI.01092-12; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Fernandez-Arenas E, 2007, MOL CELL PROTEOMICS, V6, P460, DOI 10.1074/mcp.M600210-MCP200; Fleck CB, 2011, INT J MED MICROBIOL, V301, P400, DOI 10.1016/j.ijmm.2011.04.007; Fradin C, 2003, MOL MICROBIOL, V47, P1523, DOI 10.1046/j.1365-2958.2003.03396.x; Gautam Manish K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS1660; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Gulcin I, 2006, TOXICOLOGY, V217, P213, DOI 10.1016/j.tox.2005.09.011; Hirose M, 1998, CARCINOGENESIS, V19, P207, DOI 10.1093/carcin/19.1.207; Karthik D, 2011, J CARDIOVASC PHARM, V58, P514, DOI 10.1097/FJC.0b013e31822c265d; Kitamura A, 2009, ANTIMICROB AGENTS CH, V53, P670, DOI 10.1128/AAC.00844-08; Klancnik A, 2010, J MICROBIOL METH, V81, P121, DOI 10.1016/j.mimet.2010.02.004; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Kratky M, 2012, CURR MED CHEM, V19, P6126; Krysan DJ, 2008, J BIOMOL SCREEN, V13, P657, DOI 10.1177/1087057108320713; Levin G.M., 2012, CURR PSYCHIAT, V11, P38; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Lynch T, 2007, AM FAM PHYSICIAN, V76, P391; Marcil A, 2008, INFECT IMMUN, V76, P4345, DOI 10.1128/IAI.00588-07; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Merlot C, 2010, DRUG DISCOV TODAY, V15, P16, DOI 10.1016/j.drudis.2009.09.010; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Petersen M, 2003, PHYTOCHEMISTRY, V62, P121, DOI 10.1016/S0031-9422(02)00513-7; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Prigneau O, 2003, YEAST, V20, P723, DOI 10.1002/yea.998; Singh P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031964; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST), 2008, CLIN MICROBIOL INFEC, V14, P398, DOI [10.1111/j.1469-0691.2007.01935.x, DOI 10.1111/J.1469-0691.2007.01935.X]; Van Acker H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058943; van Schaik EJ, 2009, INFECT IMMUN, V77, P4275, DOI 10.1128/IAI.00609-09; Vasanthanathan P, 2009, DRUG METAB DISPOS, V37, P658, DOI 10.1124/dmd.108.023507; Zbidah M, 2012, J AGR FOOD CHEM, V60, P533, DOI 10.1021/jf204107f	47	61	64	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e95951	10.1371/journal.pone.0095951	http://dx.doi.org/10.1371/journal.pone.0095951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781056	gold, Green Published, Green Submitted			2022-12-25	WOS:000335504900014
J	Chen, N; Wang, JQ; Hu, YJ; Cui, B; Li, WJ; Xu, GX; Liu, L; Liu, SR				Chen, Na; Wang, Jiaqi; Hu, Yijun; Cui, Bei; Li, Wenjie; Xu, Guixia; Liu, Lin; Liu, Shanrong			MicroRNA-410 Reduces the Expression of Vascular Endothelial Growth Factor and Inhibits Oxygen-Induced Retinal Neovascularization	PLOS ONE			English	Article							HUMAN GLIOBLASTOMA CELLS; INDUCED RETINOPATHY; VEGF EXPRESSION; TUMOR-SUPPRESSOR; MOUSE MODEL; IN-VIVO; ANGIOGENESIS; QUANTIFICATION; ACTIVATION; ARGONAUTE	Retinal neovascularization (RNV) is an eye disease that can cause retinal detachment and even lead to blindness. RNV mainly occurs in the elderly population. The pathogenesis of RNV has been previously reported to be highly related to the expression of vascular endothelial growth factor A (VEGFA), basic fibroblast growth factor (bFGF) and other angiogenic factors. It has also been reported that VEGFA and other factors associated with RNV could be regulated by certain microRNAs (miRNA), a group of small non-coding RNAs which are able to regulate the expression of many genes in vivo. Here, we demonstrate that the miRNA miR-410 is highly expressed in mice within two weeks after birth. miR-410 could suppress VEGFA expression through interaction with the 3'UTR of the VEGFA messenger RNA. Overexpressing a miR-410 mimic effectively suppresses VEGFA expression in various cell lines. Further experiments on oxygen-induced retinopathy (OIR) in mice revealed that eye drops containing large amounts of miR-410 efficiently downregulate VEGFA expression, prevent retinal angiogenesis and effectively treat RNV. These results not only show the underlying mechanism of how miR-410 targets VEGFA but also provide a potential treatment strategy for RNV that might be used in the near future.	[Chen, Na; Liu, Lin] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Chen, Na] Second Mil Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Shanghai, Peoples R China; [Wang, Jiaqi; Hu, Yijun; Xu, Guixia; Liu, Shanrong] Second Mil Med Univ, Changhai Hosp, Clin Res Ctr, Shanghai, Peoples R China; [Cui, Bei] Navy Gen Hosp, Dept Sea Air Examinat Ctr, Beijing, Peoples R China; [Li, Wenjie] Second Mil Med Univ, Dept Lab Diag, Affiliated Hosp 1, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University; Naval Medical University; Sixth Medical Center of Chinese PLA General Hospital; Naval Medical University	Liu, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China.	linliu@sh163.net; liushanrong@hotmail.com			Stem Cell and Medicine Research Center's Innovation Research Program (Stem Cell and Medicine Research Center, SMMU); Program for New Century Excellent Talents in University	Stem Cell and Medicine Research Center's Innovation Research Program (Stem Cell and Medicine Research Center, SMMU); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	Financial support was provided by Stem Cell and Medicine Research Center's Innovation Research Program (Stem Cell and Medicine Research Center, SMMU), Program for New Century Excellent Talents in University and specially-appointed Professor of Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MICRORNA TRANSCRIPTO; Avunduk AM, 1997, ACTA OPHTHALMOL SCAN, V75, P441; Bai YY, 2011, EXP MOL PATHOL, V91, P471, DOI 10.1016/j.yexmp.2011.04.016; Bai YY, 2009, J PATHOL, V219, P446, DOI 10.1002/path.2611; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Ben-Ami R, 2013, J INFECT DIS, V207, P1066, DOI 10.1093/infdis/jis940; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; Chen P, 2012, MOL VIS, V18, P864; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Coveney D, 2008, 4 DIMENSIONAL ANAL V; Dejean E, 2011, LEUKEMIA, V25, P1882, DOI 10.1038/leu.2011.168; Donahue ML, 1996, RETINAL VASCULAR END; Dvorak HF, 1995, VASCULAR PERMEABILIT; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hayreh SS, 2012, RETINA-J RET VIT DIS, V32, P1553, DOI 10.1097/IAE.0b013e318246912c; Hewing NJ, 2013, INVEST OPHTH VIS SCI, V54, P864, DOI 10.1167/iovs.12-10954; Ildefonso CJ, 2010, MOL THER, V18, P1885, DOI 10.1038/mt.2010.139; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Ishida S, 2003, INVEST OPHTH VIS SCI, V44, P2155, DOI 10.1167/iovs.02-0807; Jeziorska M, 1999, HUM PATHOL, V30, P919, DOI 10.1016/S0046-8177(99)90245-9; KANDEL J, 1991, CELL, V66, P1095, DOI 10.1016/0092-8674(91)90033-U; Karali M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022166; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kong YC, 2013, CHINESE MED J-PEKING, V126, P1440, DOI 10.3760/cma.j.issn.0366-6999.20130199; Kusari J, 2010, INVEST OPHTH VIS SCI, V51, P1044, DOI 10.1167/iovs.08-3293; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lamoke F, 2011, EXP EYE RES, V93, P350, DOI 10.1016/j.exer.2011.02.007; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Leske DA, 2004, MOL VIS, V10, P43; Leske DA, 2004, ROLE VEGF IGF 1 HYPE; Lin HT, 2011, MOL VIS, V17, P3450; Lin M, 2011, DIABETOLOGIA, V54, P1554, DOI 10.1007/s00125-011-2081-0; Liu F, 2012, KIDNEY BLOOD PRESS R, V35, P182, DOI 10.1159/000331054; Lofqvist C, 2009, INVEST OPHTH VIS SCI, V50, P1831, DOI 10.1167/iovs.08-2903; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Moravski CJ, 2000, HYPERTENSION, V36, P1099, DOI 10.1161/01.HYP.36.6.1099; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Poulaki V, 2004, AM J PATHOL, V165, P457, DOI 10.1016/S0002-9440(10)63311-1; Rahman ISA, 2011, CURR EYE RES, V36, P654, DOI 10.3109/02713683.2010.551172; Saint-Geniez M, 2013, AM J PATHOL, V182, P255, DOI 10.1016/j.ajpath.2012.09.003; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Sundermeier TR, 2012, CELL MOL LIFE SCI; Takagi H, 2003, INTERNAL MED, V42, P299, DOI 10.2169/internalmedicine.42.299; Tong YC, 2010, J CONTROL RELEASE, V147, P76, DOI 10.1016/j.jconrel.2010.06.006; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Vanhaesebrouck S, 2009, PEDIATR RES, V65, P307, DOI 10.1203/PDR.0b013e3181973dc8; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Xia XB, 2008, CURR EYE RES, V33, P892, DOI 10.1080/02713680802416670; Yue X, 2012, ONCOL REP, V27, P1200, DOI 10.3892/or.2011.1588; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang QQ, 2012, NEURO-ONCOLOGY, V14, P278, DOI 10.1093/neuonc/nor216; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	63	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95665	10.1371/journal.pone.0095665	http://dx.doi.org/10.1371/journal.pone.0095665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24777200	gold, Green Published, Green Submitted			2022-12-25	WOS:000346241800012
J	Cote, O; Clark, ME; Viel, L; Labbe, G; Seah, SYK; Khan, MA; Douda, DN; Palaniyar, N; Bienzle, D				Cote, Olivier; Clark, Mary Ellen; Viel, Laurent; Labbe, Genevieve; Seah, Stephen Y. K.; Khan, Meraj A.; Douda, David N.; Palaniyar, Nades; Bienzle, Dorothee			Secretoglobin 1A1 and 1A1A Differentially Regulate Neutrophil Reactive Oxygen Species Production, Phagocytosis and Extracellular Trap Formation	PLOS ONE			English	Article							RECURRENT AIRWAY-OBSTRUCTION; CELL SECRETORY PROTEIN; IN-VITRO; PREMATURE-INFANTS; BINDING PROTEIN; UTEROGLOBIN; INFLAMMATION; HORSES; INHIBITION; EXPRESSION	Secretoglobin family 1A member 1 (SCGB 1A1) is a small protein mainly secreted by mucosal epithelial cells of the lungs and uterus. SCGB 1A1, also known as club (Clara) cell secretory protein, represents a major constituent of airway surface fluid. The protein has anti-inflammatory properties, and its concentration is reduced in equine recurrent airway obstruction (RAO) and human asthma. RAO is characterized by reversible airway obstruction, bronchoconstriction and neutrophilic inflammation. Direct effects of SCGB 1A1 on neutrophil functions are unknown. We have recently identified that the SCGB1A1 gene is triplicated in equids and gives rise to two distinct proteins. In this study we produced the endogenously expressed forms of SCGBs (SCGB 1A1 and 1A1A) as recombinant proteins, and analyzed their effects on reactive oxygen species production, phagocytosis, chemotaxis and neutrophil extracellular trap (NET) formation ex vivo. We further evaluated whether NETs are present in vivo in control and inflamed lungs. Our data show that SCGB 1A1A but not SCGB 1A1 increase neutrophil oxidative burst and phagocytosis; and that both proteins markedly reduce neutrophil chemotaxis. SCGB 1A1A reduced chemotaxis significantly more than SCGB 1A1. NET formation was significantly reduced in a time-and concentration-dependent manner by SCGB 1A1 and 1A1A. SCGB mRNA in bronchial biopsies, and protein concentration in bronchoalveolar lavage fluid, was lower in horses with RAO. NETs were present in bronchoalveolar lavage fluid from horses with exacerbated RAO, but not in fluid from horses with RAO in remission or in challenged healthy horses. These findings indicate that SCGB 1A1 and 1A1A have overlapping and diverging functions. Considering disparities in the relative abundance of SCGB 1A1 and 1A1A in airway secretions of animals with RAO suggests that these functional differences may contribute to the pathogenesis of RAO and other neutrophilic inflammatory lung diseases.	[Cote, Olivier; Clark, Mary Ellen; Labbe, Genevieve; Bienzle, Dorothee] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Viel, Laurent] Univ Guelph, Dept Clin Studies, Guelph, ON N1G 2W1, Canada; [Seah, Stephen Y. K.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Douda, David N.; Palaniyar, Nades] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Palaniyar, Nades] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Khan, Meraj A.; Douda, David N.; Palaniyar, Nades] Hosp Sick Children, Program Physiol & Expt Med, Lung Innate Immun Res Lab, Toronto, ON M5G 1X8, Canada	University of Guelph; University of Guelph; University of Guelph; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bienzle, D (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	dbienzle@uoguelph.ca	Labbé, Geneviève/N-4531-2017; Khan, Meraj/AAG-9398-2019; Bienzle, Dorothee/AAY-5009-2020	Labbé, Geneviève/0000-0001-9720-7574; Bienzle, Dorothee/0000-0002-2301-2931; Palaniyar, Nades/0000-0002-2170-8548	Equine Guelph; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs program; University of Guelph; CIHR [MOP111012]; Dr. Goran Enhorning Award in Pulmonary Research; Peterborough K.M. Hunter Graduate Studentship	Equine Guelph; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs); University of Guelph; CIHR(Canadian Institutes of Health Research (CIHR)); Dr. Goran Enhorning Award in Pulmonary Research; Peterborough K.M. Hunter Graduate Studentship	Operating funds from Equine Guelph, the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Research Chairs program supported this work. The University of Guelph and the Ontario Ministry of Agriculture and Rural Affairs supported animal resources. OC is the recipient of a graduate award from the University of Guelph. MAK was supported by a postdoctoral fellowship from CIHR operating grant MOP111012 to NP. DND was supported by Dr. Goran Enhorning Award in Pulmonary Research, and a Peterborough K.M. Hunter Graduate Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth DM, 2006, AM J VET RES, V67, P669, DOI 10.2460/ajvr.67.4.669; Alghamdi AS, 2005, BIOL REPROD, V73, P1174, DOI 10.1095/biolreprod.105.045666; ANDERSSON O, 1994, J BIOL CHEM, V269, P19081; BEATO M, 1976, J STEROID BIOCHEM, V7, P327, DOI 10.1016/0022-4731(76)90091-1; Beeler-Marfisi J, 2010, AM J VET RES, V71, P682, DOI 10.2460/ajvr.71.6.682; Bin LH, 2003, J IMMUNOL, V171, P924, DOI 10.4049/jimmunol.171.2.924; Bohdanowicz M, 2013, PHYSIOL REV, V93, P69, DOI 10.1152/physrev.00002.2012; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Burmeister R, 2001, J BIOL CHEM, V276, P13295, DOI 10.1074/jbc.M010679200; Callebaut I, 2000, ANN NY ACAD SCI, V923, P90; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Cote O, 2013, MOL PHYLOGENET EVOL, V69, P430, DOI 10.1016/j.ympev.2013.08.012; Cote O, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-712; DEHARO MSL, 1994, FEBS LETT, V349, P249, DOI 10.1016/0014-5793(94)00678-4; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Dworski R, 2011, J ALLERGY CLIN IMMUN, V127, P1260, DOI 10.1016/j.jaci.2010.12.1103; Geerts L, 2001, CRIT CARE MED, V29, P1920, DOI 10.1097/00003246-200110000-00012; Hall JA, 2006, J VET DIAGN INVEST, V18, P257, DOI 10.1177/104063870601800304; Hurst JK, 2012, FREE RADICAL BIO MED, V53, P508, DOI 10.1016/j.freeradbiomed.2012.05.008; Johansson S, 2009, INFLAMMATION, V32, P65, DOI 10.1007/s10753-008-9103-1; Johnston CJ, 1997, AM J RESP CELL MOL, V17, P147, DOI 10.1165/ajrcmb.17.2.2676; Katavolos P, 2011, VET IMMUNOL IMMUNOP, V139, P1, DOI 10.1016/j.vetimm.2010.07.021; Katavolos P, 2009, VET PATHOL, V46, P604, DOI 10.1354/vp.08-VP-0255-B-FL; Klug J, 2000, ANN NY ACAD SCI, V923, P348; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lee DS, 2004, KIDNEY INT, V66, P1061, DOI 10.1111/j.1523-1755.2004.00855.x; Leguillette R, 2003, VET CLIN N AM-EQUINE, V19, P63, DOI 10.1016/S0749-0739(02)00067-6; Lensmar C, 2000, CELL MOL LIFE SCI, V57, P976, DOI 10.1007/PL00000738; LESUR O, 1995, AM J RESP CRIT CARE, V152, P290, DOI 10.1164/ajrccm.152.1.7541278; LEVIN SW, 1986, LIFE SCI, V38, P1813, DOI 10.1016/0024-3205(86)90135-9; Levine CR, 2005, PEDIATR RES, V58, P15, DOI 10.1203/01.PDR.0000156371.89952.35; LEYTON J, 1994, CANCER RES, V54, P3696; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Moreno JJ, 1997, GEN PHARMACOL-VASC S, V28, P23, DOI 10.1016/S0306-3623(96)00151-6; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Peroni JF, 2001, EQUINE VET J, V33, P231, DOI 10.2746/042516401776249688; Pilon AL, 2000, ANN NY ACAD SCI, V923, P280; Ray R, 2006, FEBS LETT, V580, P6022, DOI 10.1016/j.febslet.2006.09.059; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Shijubo N, 1999, AM J RESP CRIT CARE, V160, P930, DOI 10.1164/ajrccm.160.3.9803113; Stripp BR, 1996, AM J PHYSIOL-LUNG C, V271, pL656, DOI 10.1152/ajplung.1996.271.4.L656; UMLAND TC, 1994, NAT STRUCT BIOL, V1, P538, DOI 10.1038/nsb0894-538; VASANTHAKUMAR G, 1988, BIOCHEM PHARMACOL, V37, P389, DOI 10.1016/0006-2952(88)90204-3; Wei Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/690937; Welty SE, 2005, PEDIATR RES, V58, P7, DOI 10.1203/01.PDR.0000163373.65809.F5; Zeilhofer HU, 2000, CURR OPIN HEMATOL, V7, P178, DOI 10.1097/00062752-200005000-00009; Zheng F, 1999, NAT MED, V5, P1018, DOI 10.1038/12458	48	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e96217	10.1371/journal.pone.0096217	http://dx.doi.org/10.1371/journal.pone.0096217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24777050	Green Published, gold, Green Submitted			2022-12-25	WOS:000346241800030
J	Mejia-Falla, PA; Cortes, E; Navia, AF; Zapata, FA				Mejia-Falla, Paola A.; Cortes, Enric; Navia, Andres F.; Zapata, Fernando A.			Age and Growth of the Round Stingray Urotrygon rogersi, a Particularly Fast-Growing and Short-Lived Elasmobranch	PLOS ONE			English	Article							MODELING FISH GROWTH; GULF-OF-MEXICO; REPRODUCTIVE-BIOLOGY; LIFE-HISTORY; UROLOPHUS-PAUCIMACULATUS; MULTIMODEL INFERENCE; UROBATIS-HALLERI; SEAL-BEACH; SHARK; VALIDATION	We examined the age and growth of Urotrygon rogersi on the Colombian coast of the Eastern Tropical Pacific Ocean by directly estimating age using vertebral centra. We verified annual deposition of growth increments with marginal increment analysis. Eight growth curves were fitted to four data sets defined on the basis of the reproductive cycle (unadjusted or adjusted for age at first band) and size variables (disc width or total length). Model performance was evaluated using Akaike's Information Criterion (AIC), AIC weights and multi-model inference criteria. A two-phase growth function with adjusted age provided the best description of growth for females (based on five parameters, DW infinity = 20.1 cm, k = 0.22 yr(-1)) and males (based on four and five parameters, DW infinity = 15.5 cm, k = 0.65 yr(-1)). Median maturity of female and male U. rogersi is reached very fast (mean +/- SE = 1.0 +/- 0.1 year). This is the first age and growth study for a species of the genus Urotrygon and results indicate that U. rogersi attains a smaller maximum size and has a shorter lifespan and lower median age at maturity than species of closely related genera. These life history traits are in contrast with those typically reported for other elasmobranchs.	[Mejia-Falla, Paola A.; Navia, Andres F.] SQUALUS, Fdn Colombiana Invest & Conservac Tiburones & Ray, Cali, Colombia; [Mejia-Falla, Paola A.; Zapata, Fernando A.] Univ Valle, Dept Biol, Grp Invest Ecol Arrecifes Coralinos, Cali 25360, Colombia; [Cortes, Enric] NOAA Natl Marine Fisheries Serv, Panama City, FL USA	Universidad del Valle; National Oceanic Atmospheric Admin (NOAA) - USA	Mejia-Falla, PA (corresponding author), SQUALUS, Fdn Colombiana Invest & Conservac Tiburones & Ray, Carrera 60A 11-39, Cali, Colombia.	pmejia@squalus.org	Cortes, Enric/H-2700-2013; Navia, Andrés Felipe/ABD-7561-2021	Cortes, Enric/0000-0001-6001-2482; Mejia-Falla, Paola Andrea/0000-0003-2220-6969; Navia, Andres Felipe/0000-0002-6758-7729	PADI Foundation; Initiative of Endangered Species (IEA-Scolarships); Colciencias-Universidad del Valle-SQUALUS project [1106-452-21080, RC-258-2008]; Colciencias	PADI Foundation; Initiative of Endangered Species (IEA-Scolarships); Colciencias-Universidad del Valle-SQUALUS project; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was partially supported by the PADI Foundation (www.padifoundation.org), the Initiative of Endangered Species (IEA-Scolarships, http://www.omacha.org/2012-04-12-18-55-26/iniciativa-de-especies-amenazadas) and the Colciencias-Universidad del Valle-SQUALUS project (Code: 1106-452-21080, Contract: RC-258-2008). P.A.M. was funded by a scholarship from Colciencias (www.colciencias.gov.co) for PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PB, 1980, FISH B-NOAA, V78, P1; Ainsley SM, 2011, ICES J MAR SCI, V68, P1426, DOI 10.1093/icesjms/fsr072; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Araya M, 2006, ENVIRON BIOL FISH, V77, P293, DOI 10.1007/s10641-006-9110-8; Babel J.S., 1967, FISH B, V137, P1; Barnett LAK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065000; Barreto RR, 2011, FISH RES, V110, P170, DOI 10.1016/j.fishres.2011.04.003; BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; BEUKEMA JJ, 1989, NETH J ZOOL, V39, P79, DOI 10.1163/156854289X00048; Brett JR., 1979, FISH PHYSIOL, P677, DOI [10.1016/S1546-5098(08)60034-5, DOI 10.1016/S1546-5098(08)60034-5]; Brothers EB, 1983, NOAA TECHNICAL REPOR, V8, P35; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cailliet G.M., 1986, P345; Cailliet G.M., 1983, NOAA TECHN REP NMFS, V8, P157; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 2001, J FISH BIOL, V59, P197, DOI 10.1006/jfbi.2001.1668; CAMPANA SE, 1995, T AM FISH SOC, V124, P131, DOI 10.1577/1548-8659(1995)124<0131:GASMFD>2.3.CO;2; Carlson JK, 2005, FISH B-NOAA, V103, P280; Chin A, 2013, MAR FRESHWATER RES, V64; Conrath CL, 2002, FISH B-NOAA, V100, P674; Cortes E, 2002, STOCK ASSESSMENT SMA; Dale JJ, 2012, MAR FRESHWATER RES, V63, P475, DOI 10.1071/MF11231; Ebert DA, 2009, 715  N PAC RES BOARD; EDWARDS RRC, 1980, AUST J MAR FRESH RES, V31, P459; Geraghty PT, 2014, ICES J MAR SCI, V71, P559, DOI 10.1093/icesjms/fst164; Gervelis BJ, 2013, T AM FISH SOC, V142, P1535, DOI 10.1080/00028487.2013.815658; Goldman K.J, 2002, THESIS VIRGINIA I MA; Goodwin NB, 2002, PHILOS T R SOC B, V357, P259, DOI 10.1098/rstb.2001.0958; Haddon M., 2011, MODELLING QUANTITATI; Hale LF, 2008, J FISH BIOL, V73, P510, DOI 10.1111/j.1095-8649.2008.01940.x; Hale LF, 2006, ENVIRON BIOL FISH, V77, P317, DOI 10.1007/s10641-006-9124-2; Harry AV, 2013, MAR FRESHWATER RES, V64, P277, DOI 10.1071/MF12142; Harry AV, 2010, FISH RES, V106, P393, DOI 10.1016/j.fishres.2010.09.010; HOENIG JM, 1995, CAN J FISH AQUAT SCI, V52, P364, DOI 10.1139/f95-038; Holden M.J., 1974, SEA FISHERIES RES, P187; JENSEN AL, 1985, CAN J FISH AQUAT SCI, V42, P164, DOI 10.1139/f85-020; Katsanevakis S, 2008, FISH FISH, V9, P178, DOI 10.1111/j.1467-2979.2008.00279.x; Katsanevakis S, 2006, FISH RES, V81, P229, DOI 10.1016/j.fishres.2006.07.002; KIMURA DK, 1980, FISH B-NOAA, V77, P765; Mejia-Falla PA, 2012, J FISH BIOL, V80, P1246, DOI 10.1111/j.1095-8649.2012.03237.x; Mejia-Falla P A, 2012, THESIS U VALLE; Mollet HF, 2000, FISH B-NOAA, V98, P299; Moreau J., 1987, P81; Motulsky H, 2003, PRACTICAL GUIDE CURV; NATANSON LJ, 1995, FISH B-NOAA, V93, P116; NATANSON LJ, 1990, COPEIA, P1133, DOI 10.2307/1446499; Navia AF, 2011, J FISH BIOL, V78, P1213, DOI 10.1111/j.1095-8649.2011.02931.x; Navia AF, 2009, AVANCES CONOCIMIENTO, P133; Neer JA, 2005, ENVIRON BIOL FISH, V73, P321, DOI 10.1007/s10641-005-2136-5; Neer JA, 2001, COPEIA, P842, DOI 10.1643/0045-8511(2001)001[0842:AOTLHO]2.0.CO;2; PERRIN N, 1989, FUNCT ECOL, V3, P279, DOI 10.2307/2389366; Robertson D. R., 2008, SHOREFISHES TROPICAL; SIBLY R, 1985, J THEOR BIOL, V112, P553, DOI 10.1016/S0022-5193(85)80022-9; SIMPFENDORFER CA, 1993, ENVIRON BIOL FISH, V36, P233, DOI 10.1007/BF00001718; SORIANO M, 1992, T AM FISH SOC, V121, P486, DOI 10.1577/1548-8659(1992)121<0486:NFFTAO>2.3.CO;2; Stearns S.C., 1992, pi; Thorson JT, 2009, FISH RES, V98, P75, DOI 10.1016/j.fishres.2009.03.016; Trinnie FI, 2009, MAR FRESHWATER RES, V60, P845, DOI 10.1071/MF08165; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Wang YG, 2000, FISH B-NOAA, V98, P874; White WT, 2005, MAR FRESHWATER RES, V56, P101, DOI 10.1071/MF04225; White WT, 2002, MAR BIOL, V140, P699, DOI 10.1007/s00227-001-0756-7; White WT, 2001, MAR BIOL, V138, P135, DOI 10.1007/s002270000436; WOURMS JP, 1977, AM ZOOL, V17, P379	65	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e96077	10.1371/journal.pone.0096077	http://dx.doi.org/10.1371/journal.pone.0096077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776963	Green Submitted, gold, Green Published			2022-12-25	WOS:000346241800027
J	Balaguer-Ballester, E; Tabas-Diaz, A; Budka, M				Balaguer-Ballester, Emili; Tabas-Diaz, Alejandro; Budka, Marcin			Can We Identify Non-Stationary Dynamics of Trial-to-Trial Variability?	PLOS ONE			English	Article							DUFFING EQUATION; NEURAL VARIABILITY; TRANSIENT DYNAMICS; TIME-SERIES; NOISE; INFORMATION; NETWORKS; MODEL; STATE	Identifying sources of the apparent variability in non-stationary scenarios is a fundamental problem in many biological data analysis settings. For instance, neurophysiological responses to the same task often vary from each repetition of the same experiment (trial) to the next. The origin and functional role of this observed variability is one of the fundamental questions in neuroscience. The nature of such trial-to-trial dynamics however remains largely elusive to current data analysis approaches. A range of strategies have been proposed in modalities such as electro-encephalography but gaining a fundamental insight into latent sources of trial-to-trial variability in neural recordings is still a major challenge. In this paper, we present a proof-of-concept study to the analysis of trial-to-trial variability dynamics founded on non-autonomous dynamical systems. At this initial stage, we evaluate the capacity of a simple statistic based on the behaviour of trajectories in classification settings, the trajectory coherence, in order to identify trial-to-trial dynamics. First, we derive the conditions leading to observable changes in datasets generated by a compact dynamical system (the Duffing equation). This canonical system plays the role of a ubiquitous model of non-stationary supervised classification problems. Second, we estimate the coherence of class-trajectories in empirically reconstructed space of system states. We show how this analysis can discern variations attributable to non-autonomous deterministic processes from stochastic fluctuations. The analyses are benchmarked using simulated and two different real datasets which have been shown to exhibit attractor dynamics. As an illustrative example, we focused on the analysis of the rat's frontal cortex ensemble dynamics during a decision-making task. Results suggest that, in line with recent hypotheses, rather than internal noise, it is the deterministic trend which most likely underlies the observed trial-to-trial variability. Thus, the empirical tool developed within this study potentially allows us to infer the source of variability in in-vivo neural recordings.	[Balaguer-Ballester, Emili; Tabas-Diaz, Alejandro; Budka, Marcin] Bournemouth Univ, Fac Sci & Technol, Poole BH12 5BB, Dorset, England; [Balaguer-Ballester, Emili] Med Fac Mannheim, Bernstein Ctr Computat Neurosci, Mannheim, Germany; [Balaguer-Ballester, Emili] Heidelberg Univ, Mannheim, Germany	Bournemouth University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Balaguer-Ballester, E (corresponding author), Bournemouth Univ, Fac Sci & Technol, Poole BH12 5BB, Dorset, England.	eb-ballester@bournemouth.ac.uk	Budka, Marcin/AAE-6979-2020	Budka, Marcin/0000-0003-0158-6309; Balaguer-Ballester, Emili/0000-0002-0695-7191	Graduate School PhD studentship scheme, Bournemouth University; BU Open Access Publication Fund; European Union [251617]	Graduate School PhD studentship scheme, Bournemouth University; BU Open Access Publication Fund; European Union(European Commission)	The author ATD has been funded by The Graduate School PhD studentship scheme, Bournemouth University. This paper has been funded by the BU Open Access Publication Fund. The research leading to these results has received partial funding from the European Union 7th Framework Programme (FP7/2007-2013) under grant agreement 251617. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, LEARNING KERNELS; Balaguer E, 2008, EXPERT SYST APPL, V34, P665, DOI 10.1016/j.eswa.2006.10.003; Balaguer-Ballester E, 2007, BIOL CYBERN, V97, P479, DOI 10.1007/s00422-007-0187-8; Balaguer-Ballester E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002057; Balaguer-Ballester E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000301; Ballester EB, 2002, ECOL MODEL, V156, P27; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Beck JM, 2012, NEURON, V74, P30, DOI 10.1016/j.neuron.2012.03.016; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bernal-Casas D, 2013, NEUROIMAGE, V82, P555, DOI 10.1016/j.neuroimage.2013.05.120; Bishop C. M., 2006, J ELECT IMAG, V16, P140; Blythe DAJ, 2012, IEEE T NEUR NET LEAR, V23, P631, DOI 10.1109/TNNLS.2012.2185811; Bouchachia A, 2011, NEUROCOMPUTING, V74, P1785, DOI 10.1016/j.neucom.2010.12.017; Braun J, 2010, NEUROIMAGE, V52, P740, DOI 10.1016/j.neuroimage.2009.12.126; Brazdil P., 2009, COGNITIVE TECHNOLOGI; Budka M, 2011, NAT COMPUT, V10, P921, DOI 10.1007/s11047-010-9182-4; Chen J, 2014, COMPUTATION IN PRESS; Churchland MM, 2012, NAT NEUROSCI, V15, P1472, DOI 10.1038/nn.3247; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Csorgo H, 2009, NONPARAMETRIC METHOD, V7, P403; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Du JA, 2010, INT J COMPUT MATH, V87, P2088, DOI 10.1080/00207160802610843; Duong T, 2005, SCAND J STAT, V32, P485, DOI 10.1111/j.1467-9469.2005.00445.x; Durstewitz D, 2010, NEUROFORUM, V1, P89; Durstewitz D, 2010, NEURON, V66, P438, DOI 10.1016/j.neuron.2010.03.029; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Feng ZS, 2006, DISCRETE CONT DYN-B, V6, P1097; Freyer F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002634; Gama J, 2013, MACH LEARN, V90, P317, DOI 10.1007/s10994-012-5320-9; Gomez-Sanchis J, 2006, ATMOS ENVIRON, V40, P6173, DOI 10.1016/j.atmosenv.2006.04.067; Ha JH, 2004, J MATH ANAL APPL, V289, P77, DOI 10.1016/j.jmaa.2003.08.024; Hara S, 2012, NEURAL NETWORKS, V33, P7, DOI 10.1016/j.neunet.2012.04.001; Hastie T., 2009, UNSUPERVISED LEARNIN; HOLMES P, 1983, PHYSICA D, V7, P111, DOI 10.1016/0167-2789(83)90121-5; Honeine P, 2012, IEEE T PATTERN ANAL, V34, P1814, DOI 10.1109/TPAMI.2011.270; Hyman JM, 2012, P NATL ACAD SCI USA, V109, P5086, DOI 10.1073/pnas.1114415109; Jiang ZP, 2002, IEEE T CIRCUITS-I, V49, P244, DOI 10.1109/81.983872; Kantz H., 2004, NONLINEAR TIME SERIE; Kobayashi R, 2011, NEURAL COMPUT, V23, P3070, DOI 10.1162/NECO_a_00205; Kuncheva LI, 2013, IEEE T KNOWL DATA EN, V25, P1175, DOI 10.1109/TKDE.2011.226; LAPISH CL, 2008, P NATL ACAD SCI USA, V105, P12010; Ledberg A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043166; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Mann ME, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019569; Masquelier T, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00007; Mazel DS., 2013, INTRO APPL NONLINEAR; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Milad L, 2013, FRONT COMPUT NEUROSC, V7, P00109; Moreno-Bote R, 2011, P NATL ACAD SCI USA, V108, P12491, DOI 10.1073/pnas.1101430108; Nason G, 2013, J R STAT SOC B, V75, P879, DOI 10.1111/rssb.12015; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Omi T, 2011, NEURAL COMPUT, V23, P3125, DOI 10.1162/NECO_a_00213; Paninski L, 2012, J COMPUT NEUROSCI, V33, P1, DOI 10.1007/s10827-011-0371-7; Priestley M, 1969, J R STAT SOC B, V31; PROVENZALE A, 1992, PHYSICA D, V58, P31, DOI 10.1016/0167-2789(92)90100-2; Quiroga Lombard C, 2013, J NEUROPHYSIOL, V110, P562; Rabinovich MI, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00024; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Robinson JW, 2010, J MACH LEARN RES, V11, P3647; Saadi K, 2007, NEURAL NETWORKS, V20, P832, DOI 10.1016/j.neunet.2007.05.005; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; Sayed-Mouchaweh M., 2012, LEARNING NONSTATIONA; Scaglione A, 2011, P NATL ACAD SCI USA, V108, P14956, DOI 10.1073/pnas.1103168108; Schapire RE, 1998, ANN STAT, V26, P1651; Smola AJ, 2001, ADV NEUR IN, V13, P308; Staude B, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00016; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Stiefel KM, 2013, P NATL ACAD SCI USA, V110, P7886, DOI 10.1073/pnas.1305219110; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Toups JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002615; Vapnik V., 1998, STAT LEARNING THEORY; Volpi M, 2012, IEEE GEOSCI REMOTE S, V9, P1026, DOI 10.1109/LGRS.2012.2189092; von Bunau P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.214101; WERNER G, 1963, J NEUROPHYSIOL, V26, P958, DOI 10.1152/jn.1963.26.6.958; WHITSEL BL, 1977, J NEUROPHYSIOL, V40, P589, DOI 10.1152/jn.1977.40.3.589; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Zliobaite I, 2013, IEEE T NEUR IN PRESS; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	82	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e95648	10.1371/journal.pone.0095648	http://dx.doi.org/10.1371/journal.pone.0095648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769735	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000336736600008
J	de Pina-Araujo, IIM; Guimaraes, ML; Bello, G; Vicente, ACP; Morgado, MG				de Pina-Araujo, Isabel Ines M.; Guimaraes, Monick L.; Bello, Gonzalo; Vicente, Ana Carolina P.; Morgado, Mariza G.			Profile of the HIV Epidemic in Cape Verde: Molecular Epidemiology and Drug Resistance Mutations among HIV-1 and HIV-2 Infected Patients from Distinct Islands of the Archipelago	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-2; SUB-SAHARAN AFRICA; GENETIC DIVERSITY; ANTIRETROVIRAL THERAPY; NAIVE INDIVIDUALS; GUINEA-BISSAU; DISEASE PROGRESSION; SUBTYPE-A; RECOMBINANT; TRANSMISSION	HIV-1 and HIV-2 have been detected in Cape Verde since 1987, but little is known regarding the genetic diversity of these viruses in this archipelago, located near the West African coast. In this study, we characterized the molecular epidemiology of HIV-1 and HIV-2 and described the occurrence of drug resistance mutations (DRM) among antiretroviral therapy naive (ARTn) patients and patients under treatment (ARTexp) from different Cape Verde islands. Blood samples, socio-demographic and clinical-laboratory data were obtained from 221 HIV-positive individuals during 2010-2011. Phylogenetic and bootscan analyses of the pol region (1300 bp) were performed for viral subtyping. HIV-1 and HIV-2 DRM were evaluated for ARTn and ARTexp patients using the Stanford HIV Database and HIV-GRADE e.V. Algorithm Homepage, respectively. Among the 221 patients (169 [76.5%] HIV-1, 43 [19.5%] HIV-2 and 9 [4.1%] HIV-1/HIV-2 co-infections), 67% were female. The median ages were 34 (IQR = 1-75) and 47 (IQR = 12-84) for HIV-1 and HIV-2, respectively. HIV-1 infections were due to subtypes G (36.6%), CRF02_AG (30.6%), F1 (9.7%), URFs (10.4%), B (5.2%), CRF05_DF (3.0%), C (2.2%), CRF06_cpx (0.7%), CRF25_cpx (0.7%) and CRF49_cpx (0.7%), whereas all HIV-2 infections belonged to group A. Transmitted DRM (TDRM) was observed in 3.4% (2/58) of ARTn HIV-1-infected patients (1.7% NRTI, 1.7% NNRTI), but not among those with HIV-2. Among ARTexp patients, DRM was observed in 47.8% (33/69) of HIV-1 (37.7% NRTI, 37.7% NNRTI, 7.4% PI, 33.3% for two classes) and 17.6% (3/17) of HIV-2-infections (17.6% NRTI, 11.8% PI, 11.8% both). This study indicates that Cape Verde has a complex and unique HIV-1 molecular epidemiological scenario dominated by HIV-1 subtypes G, CRF02_AG and F1 and HIV-2 subtype A. The occurrence of TDRM and the relatively high level of DRM among treated patients are of concern. Continuous monitoring of patients on ART, including genotyping, are public policies to be implemented.	[de Pina-Araujo, Isabel Ines M.; Guimaraes, Monick L.; Bello, Gonzalo; Morgado, Mariza G.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil; [Vicente, Ana Carolina P.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genet Mol Microorganismos, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	de Pina-Araujo, IIM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.	iniza.araujo@adm.unicv.edu.cv; mmorgado@ioc.fiocruz.br	Bentancor, Gonzalo Jose Bello/N-7377-2019; Bello, Gonzalo/E-6842-2013	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Monteiro de Pina Araujo, Isabel Ines/0000-0001-7766-1059	PROAFRICA/CNPq [490468/2008-0]; Oswaldo Cruz Institute/Fiocruz; Cape Verde University; Cape Verde Ministry of Health; CAPES PEC-PG Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106701] Funding Source: NIH RePORTER	PROAFRICA/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Institute/Fiocruz; Cape Verde University; Cape Verde Ministry of Health; CAPES PEC-PG Program(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the PROAFRICA/CNPq grant number 490468/2008-0. Oswaldo Cruz Institute/Fiocruz, Cape Verde University and Cape Verde Ministry of Health also supported the conduction of this project. IIMPA is supported by a fellowship from the CAPES PEC-PG Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; ADJORLOLOJOHNSON G, 1994, JAMA-J AM MED ASSOC, V272, P462, DOI 10.1001/jama.272.6.462; Afonso JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042996; Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; Andersson S, 1999, VIROLOGY, V262, P312, DOI 10.1006/viro.1999.9867; ANDREASSON PA, 1993, AIDS, V7, P989, DOI 10.1097/00002030-199307000-00013; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Ayouba A, 2013, AIDS, V27, P2488, DOI 10.1097/01.aids.0000432443.22684.50; Ayouba A, 2009, AIDS RES HUM RETROV, V25, P1193, DOI 10.1089/aid.2009.0142; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Charpentier C, 2011, ANTIVIR THER, V16, P429, DOI 10.3851/IMP1754; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; Cohen MS, 2012, CURR OPIN HIV AIDS, V7, P99, DOI 10.1097/COH.0b013e32834f5cf2; Cuevas MT, 2002, AIDS, V16, P1643, DOI 10.1097/00002030-200208160-00010; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; de Silva TI, 2013, AIDS, V27, P125, DOI 10.1097/QAD.0b013e32835ab12c; Derache A, 2008, J ANTIMICROB CHEMOTH, V62, P456, DOI 10.1093/jac/dkn234; Direccao Geral de Saude PdLcaSSdE Ministerio da Saude de Cabo Verde, 2007, SIT EP VIH SIDA CAB; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568; Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0; Foley B, 2013, LAUR1326007; Freimanis GL, 2012, J CLIN VIROL, V53, P350, DOI 10.1016/j.jcv.2011.12.026; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamel DJ, 2007, AIDS RES HUM RETROV, V23, P1189, DOI 10.1089/aid.2007.0037; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Ibe S, 2010, JAIDS-J ACQ IMM DEF, V54, P241, DOI 10.1097/QAI.0b013e3181dc98c1; Imamichi H, 2009, AIDS RES HUM RETROV, V25, P45, DOI 10.1089/aid.2008.0111; Instituto Nacional de Estatistica de Cabo Verde MdSdCVeMI, 2008, SEG INQ DEM SAUD REP; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kaleebu P, 2001, AIDS, V15, P293, DOI 10.1097/00002030-200102160-00001; Lihana RW, 2012, AIDS REV, V14, P83; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Maueia C, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-408; Meloni ST, 2004, J VIROL, V78, P12438, DOI 10.1128/JVI.78.22.12438-12445.2004; Menendez-Arias L, 2014, ANTIVIR RES, V102, P70, DOI 10.1016/j.antiviral.2013.12.001; Morgado MG, 2002, MEM I OSWALDO CRUZ, V97, P143, DOI 10.1590/S0074-02762002000200001; Oliveira V, 2012, AIDS RES HUM RETROV, V28, P510, DOI [10.1089/aid.2011.0174, 10.1089/AID.2011.0174]; Organization WH, 2013, CONS GUID US ANT DRU, P272; Palm AA, 2013, J INFECT DIS; Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009; Parreira R, 2000, AIDS RES HUM RETROV, V16, P1307, DOI 10.1089/08892220050117069; Peeters M, 1998, AIDS RES HUM RETROV, V14, P51, DOI 10.1089/aid.1998.14.51; Poulsen AG, 2000, SCAND J INFECT DIS, V32, P169, DOI 10.1080/003655400750045286; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Ray S, 2003, SIMPLOT V3 5 1; Rodes B, 2000, J CLIN MICROBIOL, V38, P1370; Sacktor N, 2009, CLIN INFECT DIS, V49, P780, DOI 10.1086/605284; Ssemwanga D, 2012, AIDS RES HUM RETROV, V28, P1784, DOI [10.1089/aid.2012.0090, 10.1089/AID.2012.0090]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000; Thiam M, 2013, J CLIN MICROBIOL, V51, P578, DOI 10.1128/JCM.02452-12; Toure-Kane C, 2000, AIDS RES HUM RETROV, V16, P603, DOI 10.1089/088922200309025; UNAIDS, 2013, UNAIDS REP MOR THAN; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; van der Loeff MFS, 2006, INT J EPIDEMIOL, V35, P1322, DOI 10.1093/ije/dyl037; Vercauteren J, 2013, J ANTIMICROB CHEMOTH, V68, P911, DOI 10.1093/jac/dks470; Verde INdEdC, 2010, 4 REC GER POP HAB CE; Verde MdSdC, 2004, DIR GER SAUD PDLCA; WILKINS A, 1991, AIDS, V5, P1529, DOI 10.1097/00002030-199112000-00018; WILKINS A, 1993, AIDS, V7, P1119, DOI 10.1097/00002030-199308000-00015	66	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96201	10.1371/journal.pone.0096201	http://dx.doi.org/10.1371/journal.pone.0096201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763617	Green Published, gold			2022-12-25	WOS:000335505000072
J	Uchiyama, K; Takagi, T; Iwamoto, Y; Kondo, N; Okayama, T; Yoshida, N; Kamada, K; Katada, K; Handa, O; Ishikawa, T; Yasuda, H; Sakagami, J; Konishi, H; Yagi, N; Naito, Y; Itoh, Y				Uchiyama, Kazuhiko; Takagi, Tomohisa; Iwamoto, Yasunori; Kondo, Norihiko; Okayama, Tetsuya; Yoshida, Naohisa; Kamada, Kazuhiro; Katada, Kazuhiro; Handa, Osamu; Ishikawa, Takeshi; Yasuda, Hiroaki; Sakagami, Junichi; Konishi, Hideyuki; Yagi, Nobuaki; Naito, Yuji; Itoh, Yoshito			New Genetic Biomarkers Predicting Azathioprine Blood Concentrations in Combination Therapy with 5-Aminosalicylic Acid	PLOS ONE			English	Article							THIOPURINE S-METHYLTRANSFERASE; INFLAMMATORY-BOWEL-DISEASE; 6-THIOGUANINE NUCLEOTIDE LEVELS; TISSUE EXPRESSION PATTERN; ADVERSE DRUG-REACTIONS; TRANSPORT SYSTEM; JAPANESE PATIENTS; CROHNS-DISEASE; 6-MERCAPTOPURINE; SUBTYPE	Background and Aims: Azathioprine (AZA) is widely used for the treatment of inflammatory bowel disease (IBD) patients. AZA is catabolized by thiopurine S-methyltransferase (TPMT), which exhibits genetic polymorphisms. It has also been reported that 5-aminosalicylic acid (5-ASA) inhibits TPMT activity, and that increased 6-thioguanine nucleotide (6-TGN, a metabolite of AZA) blood concentrations result in an increased number of ADRs. In this study, single nucleotide polymorphisms (SNPs) related to differential gene expression affecting AZA drug metabolism in combination therapy with 5-ASA were examined. Methods: To identify genetic biomarkers for the prediction of 6-TGN blood concentration, ExpressGenotyping analysis was used. ExpressGenotyping analysis is able to detect critical pharmacogenetic SNPs by analyzing drug-induced expression allelic imbalance (EAI) of premature RNA in HapMap lymphocytes. We collected blood samples on 38 patients with inflammatory bowel disease treated with AZA and corroboration of the obtained SNPs was attempted in clinical samples. Results: A large number of SNPs with AZA/5-ASA-induced EAI within the investigated HapMap lymphocytes was identified by ExpressGenotyping analysis. The respective SNPs were analyzed in IBD patients' blood samples. Among these SNPs, several that have not yet been described to be induced by AZA/5-ASA were found. SNPs within SLC38A9 showed a particular correlation with patients' 6-TGN blood concentrations. Conclusions: Based on these results, ExpressGenotyping analysis and genotyping of patients appears to be a useful way to identify inter-individual differences in drug responses and ADRs to AZA/5-ASA. This study provides helpful information on genetic biomarkers for optimized AZA/5-ASA treatment of IBD patients.	[Uchiyama, Kazuhiko; Takagi, Tomohisa; Iwamoto, Yasunori; Kondo, Norihiko; Okayama, Tetsuya; Yoshida, Naohisa; Kamada, Kazuhiro; Katada, Kazuhiro; Handa, Osamu; Ishikawa, Takeshi; Yasuda, Hiroaki; Sakagami, Junichi; Konishi, Hideyuki; Yagi, Nobuaki; Naito, Yuji; Itoh, Yoshito] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto, Japan	Kyoto Prefectural University of Medicine	Uchiyama, K (corresponding author), Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.	k-uchi@koto.kpu-m.ac.jp	Yasuda, Hiroaki/ABA-8525-2021; Handa, Osamu/AEW-4869-2022; 半田, 修/GQA-9627-2022	Yasuda, Hiroaki/0000-0002-8346-9853; Uchiyama, Kazuhiko/0000-0001-5210-167X; Handa, Osamu/0000-0003-2228-0405	Japan Society for the Promotion of Science [24590665]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency;  [08101559]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); 	This work was supported by a Grant-in-Aid for Challenging Exploratory Research to Yuji Naito (No. 08101559); a Grant-in-Aid for Scientific Research (C) to Kazuhiko Uchiyama (No. 24590665) from the Japan Society for the Promotion of Science; the City Area Program to Yuji Naito from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and the Adaptable and Seamless Technology Transfer Program through target-driven R&D to Yuji Naito from the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban H, 2008, INTERNAL MED, V47, P1645, DOI 10.2169/internalmedicine.47.1268; CANDY S, 1995, GUT, V37, P674, DOI 10.1136/gut.37.5.674; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Cubelos B, 2005, GLIA, V49, P230, DOI 10.1002/glia.20106; Cuffari C, 1996, GUT, V39, P401, DOI 10.1136/gut.39.3.401; Cuffari C, 2004, CLIN GASTROENTEROL H, V2, P410, DOI 10.1016/S1542-3565(04)00127-2; de Jong DJ, 2003, SCAND J GASTROENTERO, V38, P69, DOI 10.1080/00855920310002726; Derijks LJJ, 2006, THER DRUG MONIT, V28, P45, DOI 10.1097/01.ftd.0000179839.71138.6d; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Fraser AG, 2002, GUT, V50, P485, DOI 10.1136/gut.50.4.485; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Gonzalez-Gonzalez IM, 2005, NEUROSCIENCE, V130, P61, DOI 10.1016/j.neuroscience.2004.09.023; Gu SM, 2000, P NATL ACAD SCI USA, V97, P3230, DOI 10.1073/pnas.050318197; Haglund S, 2008, BRIT J CLIN PHARMACO, V65, P69, DOI 10.1111/j.1365-2125.2007.02985.x; Hatanaka T, 2001, BBA-BIOMEMBRANES, V1510, P10, DOI 10.1016/S0005-2736(00)00390-4; He Lei, 2009, Human Genomics, V3, P195; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hiratsuka M, 2000, MUTAT RES-FUND MOL M, V448, P91, DOI 10.1016/S0027-5107(00)00004-X; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Ishikawa S, 2005, BIOCHEM BIOPH RES CO, V333, P1309, DOI 10.1016/j.bbrc.2005.06.040; Jharap B, 2010, INFLAMM BOWEL DIS, V16, P1541, DOI 10.1002/ibd.21221; Knight JC, 2004, NAT GENET, V36, P394, DOI 10.1038/ng1331; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; KRYNETSKI EY, 1995, P NATL ACAD SCI USA, V92, P949, DOI 10.1073/pnas.92.4.949; Kubota T, 2004, THER DRUG MONIT, V26, P319, DOI 10.1097/00007691-200406000-00017; Kumagai K, 2001, PHARMACOGENETICS, V11, P275, DOI 10.1097/00008571-200104000-00012; Kusuhara H, 2009, DRUG METAB PHARMACOK, V24, P37, DOI 10.2133/dmpk.24.37; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Melone M, 2004, CEREB CORTEX, V14, P562, DOI 10.1093/cercor/bhh018; Midorikawa Y, 2006, ONCOGENE, V25, P5581, DOI 10.1038/sj.onc.1209537; Morales A, 2007, INFLAMM BOWEL DIS, V13, P380, DOI 10.1002/ibd.20028; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; Nakanishi T, 2001, AM J PHYSIOL-CELL PH, V281, pC1757, DOI 10.1152/ajpcell.2001.281.6.C1757; Osterman MT, 2006, GASTROENTEROLOGY, V130, P1047, DOI 10.1053/j.gastro.2006.01.046; Otterness DM, 1998, J CLIN INVEST, V101, P1036, DOI 10.1172/JCI1004; PEARSON DC, 1995, ANN INTERN MED, V123, P132, DOI 10.7326/0003-4819-123-2-199507150-00009; Pike MG, 2001, J CHROMATOGR B, V757, P1, DOI 10.1016/S0378-4347(00)00513-2; PRESENT DH, 1980, NEW ENGL J MED, V302, P981, DOI 10.1056/NEJM198005013021801; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Salavaggione OE, 2005, PHARMACOGENET GENOM, V15, P801, DOI 10.1097/01.fpc.0000174788.69991.6b; Schwab M, 2002, PHARMACOGENETICS, V12, P429, DOI 10.1097/00008571-200208000-00003; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Szumlanski C, 1996, DNA CELL BIOL, V15, P17, DOI 10.1089/dna.1996.15.17; Tai HL, 1999, PHARMACOGENETICS, V9, P641, DOI 10.1097/01213011-199910000-00011; Tai HL, 1997, P NATL ACAD SCI USA, V94, P6444, DOI 10.1073/pnas.94.12.6444; Takatsu N, 2009, J GASTROEN HEPATOL, V24, P1258, DOI 10.1111/j.1440-1746.2009.05917.x; Timmer A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub2; Uchiyama K, 2009, J GASTROENTEROL, V44, P197, DOI 10.1007/s00535-008-2307-1; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Wright S, 2004, GUT, V53, P1123, DOI 10.1136/gut.2003.032896; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200	58	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95080	10.1371/journal.pone.0095080	http://dx.doi.org/10.1371/journal.pone.0095080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24762746	gold, Green Submitted, Green Published			2022-12-25	WOS:000335505000013
J	Xu, X; Yonkers, KA; Ruger, JP				Xu, Xiao; Yonkers, Kimberly A.; Ruger, Jennifer P.			Costs of a Motivational Enhancement Therapy Coupled with Cognitive Behavioral Therapy versus Brief Advice for Pregnant Substance Users	PLOS ONE			English	Article							ABUSE TREATMENT; HIV PREVENTION; BIRTH-WEIGHT; WOMEN; ALCOHOL; ADDICTION; DRINKING; DRUGS; ERA	Objectives: To determine and compare costs of a nurse-administered behavioral intervention for pregnant substance users that integrated motivational enhancement therapy with cognitive behavioral therapy (MET-CBT) to brief advice (BA) administered by an obstetrical provider. Both interventions were provided concurrent with prenatal care. Methods: We conducted a micro-costing study that prospectively collected detailed resource utilization and unit cost data for each of the two intervention arms (MET-CBT and BA) within the context of a randomized controlled trial. A three-step approach for identifying, measuring and valuing resource utilization was used. All cost estimates were inflation adjusted to 2011 U.S. dollars. Results: A total of 82 participants received the MET-CBT intervention and 86 participants received BA. From the societal perspective, the total cost (including participants' time cost) of the MET-CBT intervention was $120,483 or $1,469 per participant. In contrast, the total cost of the BA intervention was $27,199 or $316 per participant. Personnel costs (nurse therapists and obstetric providers) for delivering the intervention sessions and supervising the program composed the largest share of the MET-CBT intervention costs. Program set up costs, especially intervention material design and training costs, also contributed substantially to the overall cost. Conclusions: Implementation of an MET-CBT program to promote drug abstinence in pregnant women is associated with modest costs. Future cost effectiveness and cost benefit analyses integrating costs with outcomes and benefits data will enable a more comprehensive understanding of the intervention in improving the care of substance abusing pregnant women.	[Xu, Xiao; Yonkers, Kimberly A.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Yonkers, Kimberly A.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Ruger, Jennifer P.] Yale Univ, Dept Hlth Policy & Management, New Haven, CT USA; [Ruger, Jennifer P.] Yale Univ, Sch Med, Dept Publ Hlth, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Xu, X (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.	xiao.xu@yale.edu			National Institutes of Health (National Institute on Drug Abuse) [R01DA025555, R01DA019135]; Patrick and Catherine Weldon Donaghue Medical Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019135, R01DA025555, R01DA027194, R21DA029914] Funding Source: NIH RePORTER	National Institutes of Health (National Institute on Drug Abuse)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Patrick and Catherine Weldon Donaghue Medical Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institutes of Health (National Institute on Drug Abuse grants R01DA025555 and R01DA019135). JPR was also supported by the Patrick and Catherine Weldon Donaghue Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NSDUH SER H; Barnett PG, 2009, MED CARE, V47, pS82, DOI 10.1097/MLR.0b013e31819e1f3f; Behnke M, 2013, PEDIATRICS, V131, pE1009, DOI 10.1542/peds.2012-3931; Burstyn I, 2010, CAN J PUBLIC HEALTH, V101, P149, DOI 10.1007/BF03404362; Chang G, 1999, J STUD ALCOHOL, V60, P306, DOI 10.15288/jsa.1999.60.306; Cowell AJ, 2012, J STUD ALCOHOL DRUGS, V73, P226, DOI 10.15288/jsad.2012.73.226; Daley M, 2005, SUBST USE MISUSE, V40, P375, DOI 10.1081/JA-200030798; Daley M, 2000, J SUBST ABUSE TREAT, V19, P445, DOI 10.1016/S0740-5472(00)00138-0; Daley M, 2001, J PSYCHOACTIVE DRUGS, V33, P57, DOI 10.1080/02791072.2001.10400469; DeAntonio DA, 2010, MON LABOR REV, V133, P41; Dunlap LJ, 2010, MED CARE, V48, P306, DOI 10.1097/MLR.0b013e3181ca3d40; French Michael T, 2002, Subst Abus, V23, P31, DOI 10.1023/A:1013630710518; Frick KD, 2009, MED CARE, V47, pS76, DOI 10.1097/MLR.0b013e31819bc064; Gold MR, 1996, COST EFFECTIVENESS H; Gorsky RD, 1996, PUBLIC HEALTH REP, V111, P115; Grivell R, 2009, BEST PRACT RES CL OB, V23, P795, DOI 10.1016/j.bpobgyn.2009.06.004; Heerey Adrienne, 2002, Expert Rev Pharmacoecon Outcomes Res, V2, P29, DOI 10.1586/14737167.2.1.29; Internal Review Service, 2006, IRS ANN 2007 STAND M; Internal Review Service, 2008, IRS ANN 2009 STAND M; Internal Review Service, 2007, IRS ANN 2008 STAND M; Internal Review Service, 2009, IRS ANN 2010 STAND M; Internal Review Service IRS, INT REV SERV IRS ANN; Jansson LM, 1996, J SUBST ABUSE TREAT, V13, P321, DOI 10.1016/S0740-5472(96)00070-0; Kilmer B, 2011, J STUD ALCOHOL DRUGS, V72, P823, DOI 10.15288/jsad.2011.72.823; Neighbors CJ, 2010, J STUD ALCOHOL DRUGS, V71, P384, DOI 10.15288/jsad.2010.71.384; Office of National Drug Control Policy, 2004, EC COSTS DRUG AB US; PHIBBS CS, 1991, JAMA-J AM MED ASSOC, V266, P1521, DOI 10.1001/jama.266.11.1521; Rayburn WF, 2007, CLIN PERINATOL, V34, P559, DOI 10.1016/j.clp.2007.09.001; Rodriguez EM, 1996, AIDS, V10, P273, DOI 10.1097/00002030-199603000-00006; Ruger JP, 2012, HEALTH SERV RES, V47, P865, DOI 10.1111/j.1475-6773.2011.01335.x; Ruger JP, 2012, ADDICT BEHAV, V37, P1, DOI 10.1016/j.addbeh.2011.07.042; Ruger JP, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-46; Ruger JP, 2010, PUBLIC HEALTH REP, V125, P83, DOI 10.1177/00333549101250S111; Russell M, 1996, AM J PUBLIC HEALTH, V86, P1435, DOI 10.2105/AJPH.86.10.1435; Schulte J, 2007, PEDIATRICS, V119, pE900, DOI 10.1542/peds.2006-1123; Svikis DS, 1997, DRUG ALCOHOL DEPEN, V45, P105, DOI 10.1016/S0376-8716(97)01352-5; Taillac Cosette, 2007, Perm J, V11, P5; Tan SS, 2009, EUR J HEALTH ECON, V10, P39, DOI 10.1007/s10198-008-0101-x; U.S. Bureau of Labor Statistics, OV BLS WAG DAT AR OC; U. S. Bureau of Labor Statistics, 2012, CONS PRIC IND; U.S. Census Bureau Center for Economic Studies, 2006, Q WORKF IND 2006 201; Van Dyke RB, 2011, LIFE SCI, V88, P922, DOI 10.1016/j.lfs.2011.03.006; Yonkers KA, 2012, GEN HOSP PSYCHIAT, V34, P439, DOI 10.1016/j.genhosppsych.2012.06.002; Yonkers KA, 2010, OBSTET GYNECOL, V116, P827, DOI 10.1097/AOG.0b013e3181ed8290; Yonkers KA, 2009, ARCH WOMEN MENT HLTH, V12, P221, DOI 10.1007/s00737-009-0069-2	45	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95264	10.1371/journal.pone.0095264	http://dx.doi.org/10.1371/journal.pone.0095264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG3EI	24760017	Green Published, gold			2022-12-25	WOS:000335298200043
J	Lo, D; Zhang, Y; Dai, MS; Sun, XX; Zeng, SX; Lu, H				Lo, D.; Zhang, Y.; Dai, M-S; Sun, X-X; Zeng, S. X.; Lu, H.			Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF	ONCOGENE			English	Article							CELL-CYCLE ARREST; P53-DEPENDENT APOPTOSIS; RIBOSOME BIOGENESIS; TUMOR SUPPRESSION; ACTIVATES P53; P19(ARF); PROTEIN; MDM2; PROLIFERATION; DEGRADATION	Upregulated expression of nucleolar GTPase nucleostemin (NS) has been associated with increased cellular proliferation potential and tumor malignancy during cancer development. Recent reports attribute the growth regulatory effects of NS protein to its role in facilitating ribosome production. However, the oncogenic potential of NS remains unclear, as imbalanced levels of NS have been reported to exert growth inhibitory effect by modulating p53 tumor-suppressor activity. It also remains in questions if aberrant NS levels might have a p53-independent role in regulation of cell proliferation and growth. In this study, we performed affinity purification and mass spectrometry analysis to explore protein-protein interactions influencing NS growth regulatory properties independently of p53 tumor suppressor. We identified the alternative reading frame (ARF) protein as a key protein associating with NS and further verified the interaction through in vitro and in vivo assays. We demonstrated that NS is able to regulate cell cycle progression by regulating the stability of the ARF tumor suppressor. Furthermore, overexpression of NS suppressed ARF polyubiquitination by its E3 ligase Ubiquitin Ligase for ARF and elongated its half-life, whereas knockdown of NS led to the decrease of ARF levels. Also, we found that NS can enhance NPM stabilization of ARF. Thus, we propose that in the absence of p53, ARF can be stabilized by NS and nucleophosmin to serve as an alternative tumor-suppressor surveillance, preventing potential cellular transformation resulting from the growth-inducing effects of NS overexpression.	[Lo, D.; Zhang, Y.; Zeng, S. X.; Lu, H.] Tulane Univ, Tulane Canc Ctr, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Dai, M-S; Sun, X-X] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA	Tulane University; Oregon Health & Science University	Lu, H (corresponding author), Tulane Univ, Tulane Canc Ctr, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	hlu2@tulane.edu			NIH-NCI grant [CA095441, CA079721, CA129828, CA172468]; NATIONAL CANCER INSTITUTE [R01CA129828, R01CA172468, R01CA095441, R01CA079721, R01CA160474] Funding Source: NIH RePORTER	NIH-NCI grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L David at Oregon Health and Science University for conducting the mass spectrometry analysis in the affinity purification, W Gu at Columbia University for supplying the ULF reagents, and Y Dong at Tulane University School of Medicine for offering the lentivirus vector. This work was supported in part by NIH-NCI grants CA095441, CA079721, CA129828 and CA172468 to HL.	Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Lessard F, 2010, MOL CELL, V38, P539, DOI 10.1016/j.molcel.2010.03.015; Lin T, 2010, CANCER RES, V70, P9444, DOI 10.1158/0008-5472.CAN-10-2159; Lindstrom MS, 2006, CELL BIOCHEM BIOPHYS, V46, P79, DOI 10.1385/CBB:46:1:79; Lo D, 2012, J BIOL CHEM, V287, P10013, DOI 10.1074/jbc.M111.335141; Lo D, 2010, CELL CYCLE, V9, P3227, DOI 10.4161/cc.9.16.12605; Ma HH, 2008, MOL BIOL CELL, V19, P2870, DOI 10.1091/mbc.E08-02-0128; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Nakajima TE, 2012, CANCER SCI, V103, P233, DOI 10.1111/j.1349-7006.2011.02142.x; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; QUELLE DE, 1995, CELL, V83, P993; Radfar A, 1998, P NATL ACAD SCI USA, V95, P13194, DOI 10.1073/pnas.95.22.13194; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sijin L, 2004, J EXP CLIN CANC RES, V23, P529; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; Tamase A, 2009, P NATL ACAD SCI USA, V106, P17163, DOI 10.1073/pnas.0905016106; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Ye F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-108; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhou Xiang, 2012, Genes Cancer, V3, P298, DOI 10.1177/1947601912455200; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zwolinska AK, 2012, ONCOGENE, V31, P3311, DOI 10.1038/onc.2011.507	44	9	9	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 26	2015	34	13					1688	1697		10.1038/onc.2014.103	http://dx.doi.org/10.1038/onc.2014.103			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE5CS	24769896	Green Accepted			2022-12-25	WOS:000351848400009
J	Neumann, S; Hasenauer, J; Pollak, N; Scheurich, P				Neumann, Simon; Hasenauer, Jan; Pollak, Nadine; Scheurich, Peter			Dominant Negative Effects of Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL) Receptor 4 on TRAIL Receptor 1 Signaling by Formation of Heteromeric Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEATH RECEPTOR; DECOY RECEPTOR; COLON-CANCER; CELL-DEATH; DOMAIN; APO2L/TRAIL; INHIBITION; ACTIVATION; PATHWAYS	The cytokine TNF-related apoptosis-inducing ligand (TRAIL) and its cell membrane receptors constitute an elaborate signaling system fulfilling important functions in immune regulation and tumor surveillance. Activation of the death receptors TRAILR1 and TRAILR2 can lead to apoptosis, whereas TRAILR3 and TRAILR4 are generally referred to as decoy receptors, which have been shown to inhibit TRAIL-induced apoptosis. The underlying molecular mechanisms, however, remain unclear. Alike other members of the TNF receptor superfamily, TRAIL receptors contain a pre-ligand binding assembly domain (PLAD) mediating receptor oligomerization. Still, the stoichiometry of TRAIL receptor oligomers as well as the issue of whether the PLAD mediates only homotypic or also heterotypic interactions remained inconclusive until now. Performing acceptor-photobleaching FRET studies with receptors 1, 2, and 4, we demonstrate interactions in all possible combinations. Formation of dimers was shown by chemical cross-linking experiments for interactions of TRAILR2 and heterophilic interactions between the two death receptors or between either of the death receptors and TRAILR4. Implications of the demonstrated receptor-receptor interactions on signaling were investigated in suitable cellular models. Both apoptosis induction and activation of the transcription factor NF kappa B were significantly reduced in the presence of TRAILR4. Our experimental data combined with mathematical modeling show that the inhibitory capacity of TRAILR4 is attributable to signaling-independent mechanisms, strongly suggesting a reduction of signaling competent death receptors through formation heteromeric receptor complexes. In summary, we propose a model of TRAIL receptor interference driven by PLAD-mediated formation of receptor heterodimers on the cell membrane.	[Neumann, Simon; Pollak, Nadine; Scheurich, Peter] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; [Hasenauer, Jan] Helmholtz Zentrum Munchen, Inst Computat Biol, D-85764 Neuherberg, Germany; [Hasenauer, Jan] Tech Univ Munich, Dept Math, D-85748 Garching, Germany	University of Stuttgart; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Scheurich, P (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.	peter.scheurich@izi.uni-stuttgart.de	Hasenauer, Jan/B-8853-2013	Hasenauer, Jan/0000-0002-4935-3312	German Research Foundation (DFG) within the Cluster of Excellence in Simulation Technology at the University of Stuttgart [EXC 310/1]; German Federal Ministry of Education and Research (BMBF) [PREDICT 0316186A]; BMBF [0315766, 0316042G]	German Research Foundation (DFG) within the Cluster of Excellence in Simulation Technology at the University of Stuttgart(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the German Research Foundation (DFG) within the Cluster of Excellence in Simulation Technology (EXC 310/1) at the University of Stuttgart, German Federal Ministry of Education and Research (BMBF) Grant PREDICT 0316186A (to S. N. and P. S.), and by the BMBF within Virtual Liver Project Grant 0315766 and LungSys II Grant 0316042G (to J. H.).	Azijli K, 2013, CELL DEATH DIFFER, V20, P858, DOI 10.1038/cdd.2013.28; Boschert V, 2010, CELL SIGNAL, V22, P1088, DOI 10.1016/j.cellsig.2010.02.011; Branschadel M, 2010, CELL SIGNAL, V22, P404, DOI 10.1016/j.cellsig.2009.10.011; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; De Toni EN, 2008, CLIN CANCER RES, V14, P4713, DOI 10.1158/1078-0432.CCR-07-5019; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Gerken M, 2010, BBA-BIOMEMBRANES, V1798, P1081, DOI 10.1016/j.bbamem.2010.02.021; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Harper N, 2001, J BIOL CHEM, V276, P34743, DOI 10.1074/jbc.M105693200; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Krippner-Heidenreich A, 2002, J BIOL CHEM, V277, P44155, DOI 10.1074/jbc.M207399200; Lalaoui N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019679; Lee HW, 2005, BIOCHEM BIOPH RES CO, V330, P1205, DOI 10.1016/j.bbrc.2005.03.101; Lewis AK, 2012, BIOCHEMISTRY-US, V51, P6545, DOI 10.1021/bi3006626; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Meng RD, 2000, MOL THER, V1, P130, DOI 10.1006/mthe.2000.0025; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Papoff G, 1999, J BIOL CHEM, V274, P38241, DOI 10.1074/jbc.274.53.38241; Richter C, 2012, MOL CELL BIOL, V32, P2515, DOI 10.1128/MCB.06458-11; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Stepensky D, 2007, BIOCHEM BIOPH RES CO, V359, P752, DOI 10.1016/j.bbrc.2007.05.180; Truneh A, 2000, J BIOL CHEM, V275, P23319, DOI 10.1074/jbc.M910438199; Tur V, 2008, J BIOL CHEM, V283, P20560, DOI 10.1074/jbc.M800457200; Valley CC, 2012, J BIOL CHEM, V287, P21265, DOI 10.1074/jbc.M111.306480; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Winkel C, 2012, MATH BIOSCI ENG, V9, P663, DOI 10.3934/mbe.2012.9.663; Zinonos I, 2011, J BONE MINER RES, V26, P630, DOI 10.1002/jbmr.244	36	38	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16576	16587		10.1074/jbc.M114.559468	http://dx.doi.org/10.1074/jbc.M114.559468			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764293	Green Published, hybrid			2022-12-25	WOS:000337965700058
J	Hermans, T; Jeurissen, L; Hackert, V; Hoebe, C				Hermans, Tia; Jeurissen, Leonne; Hackert, Volker; Hoebe, Christian			Land-Applied Goat Manure as a Source of Human Q-Fever in the Netherlands, 2006-2010	PLOS ONE			English	Article							COXIELLA-BURNETII; INFECTION; EPIDEMIC; OUTBREAK	Studies have shown a link between Q-fever positive farms (QFPFs) and community cases of human Q-fever. Our study is the first to investigate the potential role of contaminated land-applied manure in human Q-fever, based on a large set of nationwide notification and farm management data. Time between manure application and disease onset in geographically linked notified human cases coincided with the incubation period of Q-fever. Proximity of contaminated land parcels predicted human cases better than proximity of QFPFs (80% vs. 58%, 0-5 km in 2009). Incidence around QFPFs and contaminated land parcels decreased with distance, but not around non-contaminated land parcels. Incidence was higher around contaminated land parcels than non-contaminated land parcels (RR = [10], 95%CI = [7,1-14,2]). Our findings deliver evidence that, apart from QFPFs, land-applied contaminated manure may be another source of human Q-fever.	[Hermans, Tia; Jeurissen, Leonne] Wageningen UR, Alterra, Wageningen, Netherlands; [Hackert, Volker; Hoebe, Christian] Dept Sexual Hlth Infect Dis & Environm Hlth, South Limburg Publ Hlth Serv, Geleen, Netherlands; [Hackert, Volker; Hoebe, Christian] Maastricht Univ, Med Ctr, Sch Publ Hlth & Primary Care, Dept Med Microbiol, Maastricht, Netherlands	Wageningen University & Research; Maastricht University	Hermans, T (corresponding author), Wageningen UR, Alterra, Wageningen, Netherlands.	tia.hermans@wur.nl		Hackert, Volker/0000-0003-1025-4381; Hoebe, Christian/0000-0003-1815-0974	R&D means of Alterra	R&D means of Alterra	This study was funded by the R&D means of Alterra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinanti FR, 1958, AM J HYG, V58, P385; Bouvery NA, 2003, VET RES, V34, P423, DOI 10.1051/vetres:2003017; Brandsen-Schreijer AJM, 2010, INFECT B, V21, P334; BRP, 2010, DUTCH LAND PARC REG; Casey JA, 2013, JAMA INTERN MED, V173, P1980, DOI 10.1001/jamainternmed.2013.10408; CFSPH, 2006, Q FEV FAST FACTS; Commandeur M, 2014, INT J ENVIRON HEAL R, V24, P137, DOI 10.1080/09603123.2013.800963; de Bruin A, 2011, APPL ENVIRON MICROB, V77, P6516, DOI 10.1128/AEM.05097-11; De Bruin A, 2011, 330291005 RIVM; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; EFSA (European Food Safety Authority), 2009, EFSA J, V7, P358, DOI [10.2903/j.efsa.2009.1438, DOI 10.2903/J.EFSA.2009.1438, 10.2903/j.efsa.2010.1496]; Hackert VH, 2012, CLIN INFECT DIS, V55, P1591, DOI 10.1093/cid/cis734; Hawker J I, 1998, Commun Dis Public Health, V1, P180; Hunink JE, 2010, Q FEVER TRANSMISSION; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Oyston PCF, 2011, J MED MICROBIOL, V60, P9, DOI 10.1099/jmm.0.024778-0; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Roest HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048949; Roest HJ, 2013, COXIELLA BURNETII PR; Roest HJ, 2011, 11CVI0212; Schimmer B, 2010, BMC INFECT DIS, V10; TIGERTT WD, 1956, T ASSOC AM PHYSICIAN, V69, P98; Tissut-Dupont H, 2004, EMERG INFECT DIS; van der Hoek W, 2011, INT J ENVIRON HEAL R, V21, P441, DOI 10.1080/09603123.2011.574270; Van Vliet JA, 2009, TIJDSCHRIFT INFECTIE, V2, P51	25	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96607	10.1371/journal.pone.0096607	http://dx.doi.org/10.1371/journal.pone.0096607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788538	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700117
J	Petry, FR; Pelletier, J; Bretteville, A; Morin, F; Calon, F; Hebert, SS; Whittington, RA; Planel, E				Petry, Franck R.; Pelletier, Jerome; Bretteville, Alexis; Morin, Francoise; Calon, Frederic; Hebert, Sebastien S.; Whittington, Robert A.; Planel, Emmanuel			Specificity of Anti-Tau Antibodies when Analyzing Mice Models of Alzheimer's Disease: Problems and Solutions	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; NEURODEGENERATIVE DISORDERS; ELECTROPHORETIC TRANSFER; POLYACRYLAMIDE GELS; PROTEIN-TAU; A-BETA; PHOSPHORYLATION; HYPERPHOSPHORYLATION; MICROTUBULES; INHIBITION	Aggregates of hyperphosphorylated tau protein are found in a group of diseases called tauopathies, which includes Alzheimer's disease. The causes and consequences of tau hyperphosphorylation are routinely investigated in laboratory animals. Mice are the models of choice as they are easily amenable to transgenic technology; consequently, their tau phosphorylation levels are frequently monitored by Western blotting using a panel of monoclonal/polyclonal anti-tau antibodies. Given that mouse secondary antibodies can recognize endogenous mouse immunoglobulins (Igs) and the possible lack of specificity with some polyclonal antibodies, non-specific signals are commonly observed. Here, we characterized the profiles of commonly used anti-tau antibodies in four different mouse models: non-transgenic mice, tau knock-out (TKO) mice, 3xTg-AD mice, and hypothermic mice, the latter a positive control for tau hyperphosphorylation. We identified 3 tau monoclonal antibody categories: type 1, characterized by high non-specificity (AT8, AT180, MC1, MC6, TG-3), type 2, demonstrating low non-specificity (AT270, CP13, CP27, Tau12, TG5), and type 3, with no non-specific signal (DA9, PHF-1, Tau1, Tau46). For polyclonal anti-tau antibodies, some displayed non-specificity (pS262, pS409) while others did not (pS199, pT205, pS396, pS404, pS422, A0024). With monoclonal antibodies, most of the interfering signal was due to endogenous Igs and could be eliminated by different techniques: i) using secondary antibodies designed to bind only non-denatured Igs, ii) preparation of a heat-stable fraction, iii) clearing Igs from the homogenates, and iv) using secondary antibodies that only bind the light chain of Igs. All of these techniques removed the non-specific signal; however, the first and the last methods were easier and more reliable. Overall, our study demonstrates a high risk of artefactual signal when performing Western blotting with routinely used anti-tau antibodies, and proposes several solutions to avoid non-specific results. We strongly recommend the use of negative (i. e., TKO) and positive (i. e., hypothermic) controls in all experiments.	[Petry, Franck R.; Pelletier, Jerome; Bretteville, Alexis; Hebert, Sebastien S.; Planel, Emmanuel] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ G1K 7P4, Canada; [Calon, Frederic] Univ Laval, Fac Pharm, Quebec City, PQ G1K 7P4, Canada; [Petry, Franck R.; Pelletier, Jerome; Bretteville, Alexis; Morin, Francoise; Calon, Frederic; Hebert, Sebastien S.; Planel, Emmanuel] CHUL, Ctr Rech CHU Quebec, Montreal, PQ, Canada; [Whittington, Robert A.] Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY USA	Laval University; Laval University; Laval University; Columbia University	Planel, E (corresponding author), Univ Laval, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ G1K 7P4, Canada.	emmanuel@planel.org	Hébert, Sébastien S./Q-2729-2017; Calon, Frederic/AAF-4390-2020	Calon, Frederic/0000-0002-4203-0887; Planel, Emmanuel/0000-0001-5128-0565; Hebert, Sebastien/0000-0002-0391-9325	National Institute of General Medical Sciences [K08GM00681, 1R01GM101698]; Alzheimer Society of Canada; Canadian Institutes for Health Research [MOP-106423, PCN-102993]; Natural Sciences and Engineering Research Council [354722]; Canada Foundation for Innovation [23905]; Fonds de la Recherche en Sante du Quebec [16205, 20048]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM000681, R01GM101698] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alzheimer Society of Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institute of General Medical Sciences grants K08GM00681 and 1R01GM101698 (to R. A. W.), Biomedial Doctoral Award from the Alzheimer Society of Canada (to F. R. K.), grants from Canadian Institutes for Health Research (MOP-106423, PCN-102993), Natural Sciences and Engineering Research Council (354722), Canada Foundation for Innovation (23905), and a Research Scholar Career Awards (16205, 20048) from the Fonds de la Recherche en Sante du Quebec (to E. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; COUCHIE D, 1985, FEBS LETT, V188, P331, DOI 10.1016/0014-5793(85)80397-5; d'Abramo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062402; Dawson HN, 2001, J CELL SCI, V114, P1179; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Goedert M, 1996, ANN NY ACAD SCI, V777, P121, DOI 10.1111/j.1749-6632.1996.tb34410.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Herskovits AZ, 2006, NEUROBIOL DIS, V23, P398, DOI 10.1016/j.nbd.2006.04.004; Janke C, 1999, MOL BRAIN RES, V68, P119, DOI 10.1016/S0169-328X(99)00079-0; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2008, J NEUROSCI, V28, P12798, DOI 10.1523/JNEUROSCI.4101-08.2008; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; RENART J, 1979, P NATL ACAD SCI USA, V76, P3116, DOI 10.1073/pnas.76.7.3116; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; St-Amour I, 2013, J CEREBRAL BLOOD FLO; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	33	76	86	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94251	10.1371/journal.pone.0094251	http://dx.doi.org/10.1371/journal.pone.0094251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788298	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700011
J	Bruno, G; Barutta, F; Landi, A; Perin, PC; Gruden, G				Bruno, Graziella; Barutta, Federica; Landi, Andrea; Perin, Paolo Cavallo; Gruden, Gabriella			The Effect of Age and NT-proBNP on the Association of Central Obesity with 6-Years Cardiovascular Mortality of Middle-Aged and Elderly Diabetic People: The Population-Based Casale Monferrato Study	PLOS ONE			English	Article							BODY-MASS INDEX; C-REACTIVE PROTEIN; NATRIURETIC PEPTIDE; WAIST CIRCUMFERENCE; PROSPECTIVE COHORT; FOLLOW-UP; ALL-CAUSE; RISK; WEIGHT; DEATH	Background: Among people with type 2 diabetes the relationship between central obesity and cardiovascular mortality has not been definitely assessed. Moreover, NT-proBNP is negatively associated with central obesity, but no study has examined their combined effect on survival. We have examined these issues in a well-characterized population-based cohort. Methods and Findings: Survival data of 2272 diabetic people recruited in 2000 who had no other chronic disease have been updated to 31 December 2006. NT-proBNP was measured in a subgroup of 1690 patients. Cox proportional hazards modeling was employed to estimate the independent associations between cardiovascular and all-cause mortality and waist circumference. Mean age was 67.9 years, 49.3% were men. Both age and NT-proBNP were negatively correlated with waist circumference (r = -0.11, p < 0.001 and r = -0.07, p = 0.002). Out of 2272 subjects, 520 deaths (221 for CV mortality) occurred during a median follow-up of 5.4 years. Central obesity was not associated with CV mortality (hazard ratio, HR, adjusted for age, sex, diabetes duration, 1.14, 95% CI 0.86-1.52). NTproBNP was a negative confounder and age a strong modifier of this relationship (p for interaction <0.001): age <70 years, fully adjusted model HR = 3.52 (1.17-10.57) and age >= 70 years, HR = 0.80 (0.46-1.40). Respective HRs for all-cause mortality were 1.86 (1.03-3.32) and 0.73 (0.51-1.04). Conclusions: In diabetic people aged 70 years and lower, central obesity was independently associated with increased cardiovascular mortality, independently of the negative effect of NT-proBNP. In contrast, no effect on 6-years survival was evident in diabetic people who have yet survived up to 70 years.	[Bruno, Graziella; Barutta, Federica; Landi, Andrea; Perin, Paolo Cavallo; Gruden, Gabriella] Univ Turin, Dept Med Sci, Turin, Italy	University of Turin	Bruno, G (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	graziella.bruno@unito.it		BRUNO, Graziella/0000-0002-3011-8304	Piedmont Region (Ricerca Sanitaria Finalizzata)	Piedmont Region (Ricerca Sanitaria Finalizzata)	The Casale Monferrato Study is supported by grants from the Piedmont Region (Ricerca Sanitaria Finalizzata 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Breeze E, 2006, INT J EPIDEMIOL, V35, P169, DOI 10.1093/ije/dyi212; Bruno G, 2008, NUTR METAB CARDIOVAS, V18, P39, DOI 10.1016/j.numecd.2006.08.007; Bruno G, 2013, DIABETES CARE, V36, P2677, DOI 10.2337/dc13-0353; Bruno G, 2009, DIABETES, V58, P926, DOI 10.2337/db08-0900; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cheng S, 2011, AM J CARDIOL, V108, P979, DOI 10.1016/j.amjcard.2011.05.033; Chrysant SG, 2013, J AM SOC HYPERTENS, V7, P85, DOI 10.1016/j.jash.2012.11.008; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; Eeg-Olofsson K, 2009, DIABETOLOGIA, V52, P65, DOI 10.1007/s00125-008-1190-x; Kalra PR, 2002, INT J CARDIOL, V85, P125, DOI 10.1016/S0167-5273(02)00241-3; Katzmarzyk PT, 2013, DIABETES CARE, V36, P3128, DOI 10.2337/dc13-0219; Kim BH, 2010, J INT MED RES, V38, P1737, DOI 10.1177/147323001003800519; Ko KP, 2012, J EPIDEMIOL, V22, P433, DOI 10.2188/jea.JE20110164; Kyrou I, 2009, DIABETES CARE, V32, pS403, DOI 10.2337/dc09-S348; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Martin J, 2013, CAN J CARDIOL, V29, P969, DOI 10.1016/j.cjca.2012.11.010; Moro C, 2013, AM J PHYSIOL-HEART C, V304, pH358, DOI 10.1152/ajpheart.00704.2012; Nakamura Kazuyo, 2011, Environmental Health and Preventive Medicine, V16, P52, DOI 10.1007/s12199-010-0165-y; Park Seung Jei, 2009, Korean Circ J, V39, P538, DOI 10.4070/kcj.2009.39.12.538; Perotto M, 2013, ACTA DIABETOL, V50, P563, DOI 10.1007/s00592-011-0338-1; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Price GM, 2006, AM J CLIN NUTR, V84, P449; Tarnow L, 2006, DIABETOLOGIA, V49, P2256, DOI 10.1007/s00125-006-0359-4; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Yamada-Goto N, 2013, DIABETES, V62, P1500, DOI 10.2337/db12-0718; Zeller M, 2008, CIRCULATION, V118, P482, DOI 10.1161/CIRCULATIONAHA.107.753483; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96076	10.1371/journal.pone.0096076	http://dx.doi.org/10.1371/journal.pone.0096076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788805	Green Submitted, Green Published, gold			2022-12-25	WOS:000335510600072
J	Cox-Witton, K; Reiss, A; Woods, R; Grillo, V; Baker, RT; Blyde, DJ; Boardman, W; Cutter, S; Lacasse, C; McCracken, H; Pyne, M; Smith, I; Vitali, S; Vogelnest, L; Wedd, D; Phillips, M; Bunn, C; Post, L				Cox-Witton, Keren; Reiss, Andrea; Woods, Rupert; Grillo, Victoria; Baker, Rupert T.; Blyde, David J.; Boardman, Wayne; Cutter, Stephen; Lacasse, ClauDe; McCracken, Helen; Pyne, Michael; Smith, Ian; Vitali, Simone; Vogelnest, Larry; Wedd, Dion; Phillips, Martin; Bunn, Chris; Post, Lyndel			Emerging Infectious Diseases in Free-Ranging Wildlife-Australian Zoo Based Wildlife Hospitals Contribute to National Surveillance	PLOS ONE			English	Article							WEST-NILE-VIRUS; PUBLIC-HEALTH; POPULATION; CHYTRIDIOMYCOSIS; TUBERCULOSIS; CHALLENGES; SENTINELS; ZOONOSES; ECOLOGY	Emerging infectious diseases are increasingly originating from wildlife. Many of these diseases have significant impacts on human health, domestic animal health, and biodiversity. Surveillance is the key to early detection of emerging diseases. A zoo based wildlife disease surveillance program developed in Australia incorporates disease information from free-ranging wildlife into the existing national wildlife health information system. This program uses a collaborative approach and provides a strong model for a disease surveillance program for free-ranging wildlife that enhances the national capacity for early detection of emerging diseases.	[Cox-Witton, Keren; Woods, Rupert; Grillo, Victoria] Australian Wildlife Hlth Network, Mosman, NSW, Australia; [Reiss, Andrea; Phillips, Martin] Zoo & Aquarium Assoc, Mosman, NSW, Australia; [Baker, Rupert T.] Zoos Victoria, Healesville Sanctuary, Healesville, Vic, Australia; [Blyde, David J.] Sea World, Gold Coast, Qld, Australia; [Boardman, Wayne; Smith, Ian] Zoos South Australia, Adelaide Zoo, Adelaide, SA, Australia; [Cutter, Stephen; Wedd, Dion] Terr Wildlife Pk, Berry Springs, NT, Australia; [Lacasse, ClauDe] Australia Zoo Wildlife Hosp, Beerwah, Qld, Australia; [McCracken, Helen] Zoos Victoria, Melbourne Zoo, Parkville, Vic, Australia; [Pyne, Michael] Currumbin Wildlife Sanctuary, Currumbin, Qld, Australia; [Vitali, Simone] Perth Zoo, S Perth, WA, Australia; [Vogelnest, Larry] Taronga Conservat Soc Australia, Taronga Zoo, Mosman, NSW, Australia; [Bunn, Chris; Post, Lyndel] Australian Govt Dept Agr, Canberra, ACT, Australia		Cox-Witton, K (corresponding author), Australian Wildlife Hlth Network, Mosman, NSW, Australia.	kcox-witton@wildlifehealthaustralia.com.au	Boardman, Wayne/ABE-7528-2020; Boardman, Wayne S.J/J-6479-2013; McCracken, Henry Joy/AAA-1489-2019	Boardman, Wayne/0000-0002-1746-0682; McCracken, Henry Joy/0000-0002-9489-7765; Smith, Ian G/0000-0003-3813-2917	Australian Government Department of Agriculture; Australian Centre of Excellence for Risk Analysis	Australian Government Department of Agriculture(Australian Government); Australian Centre of Excellence for Risk Analysis	The zoo based wildlife disease surveillance program described in this paper was funded by the Australian Government Department of Agriculture and the Australian Centre of Excellence for Risk Analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Arthur R, 2011, ANIMAL HLTH SURVEILL, V16, P10; *AUSTR GOV DEP ENV, 2009, EPBC ACT LIST THREAT; Australian Animal Health Council, 2012, ANIMAL HLTH AUSTR 20; Australian Government Department of Agriculture, 2011, AUSTR WORLD ORG AN H; Australian Government Department of the Environment, 2009, LIST KEY THREAT PROC; Australian Government Department of the Environment and Energy, 2013, SPEC PROF THREATS DA; Australian Wildlife Health Network, 2014, AWHN; Australian Wildlife Health Network, 2014, ZOO AN HLTH REF GROU; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Beri V., 2010, International Zoo Yearbook, V44, P192, DOI 10.1111/j.1748-1090.2009.00104.x; Black PF, 2008, REV SCI TECH OIE, V27, P563, DOI 10.20506/rst.27.2.1815; Bunn C, 2005, MICROBIOL AUST, V26, P53; Cameron A, 2011, REV ZOO BASED UNPUB; Cook Robert A., 2008, P55, DOI 10.1016/B978-141604047-7.50009-9; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Field H, 2012, CURR TOP MICROBIOL, V359, P11, DOI 10.1007/82_2012_214; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Funnell O, 2013, J WILDLIFE DIS, V49, P1066, DOI 10.7589/2013-03-066; Grillo T, 2012, ANIMAL HLTH SURVEILL, V17, P6; Halliday J, 2012, PHILOS T R SOC B, V367, P2872, DOI 10.1098/rstb.2011.0362; HERBST LH, 1995, ENVIRON HEALTH PERSP, V103, P27, DOI 10.2307/3432408; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310; Ludwig GV, 2002, AM J TROP MED HYG, V67, P67, DOI 10.4269/ajtmh.2002.67.67; Ma GM, 2013, VET PARASITOL, V192, P158, DOI 10.1016/j.vetpar.2012.11.009; Mathews F, 2009, ADV PARASIT, V68, P185, DOI 10.1016/S0065-308X(08)00608-8; McAloose D, 2009, NAT REV CANCER, V9, P517, DOI 10.1038/nrc2665; McCallum H, 2008, TRENDS ECOL EVOL, V23, P631, DOI 10.1016/j.tree.2008.07.001; McFarlane R, 2012, ECOHEALTH, V9, P24, DOI 10.1007/s10393-012-0763-9; McNamara T., 2007, International Zoo Yearbook, V41, P12, DOI 10.1111/j.1748-1090.2007.00019.x; McNamara T, 2011, ECOHEALTH, V7, pS21; Murray KA, 2012, ENVIRON INT, V48, P56, DOI 10.1016/j.envint.2012.06.015; Newman SJ, 2006, VET PATHOL, V43, P865, DOI 10.1354/vp.43-6-865; NOLAN A, 1994, VET MICROBIOL, V40, P179, DOI 10.1016/0378-1135(94)90054-X; ONeil BD, 1995, NEW ZEAL VET J, V43, P249, DOI 10.1080/00480169./1995.35903; Paskin R, 2011, ANIMAL HLTH SURVEILL, V16, P3; Powling J, 2012, ANIMAL HLTH SURVEILL, V17, P27; Prowse SJ, 2009, VET ITAL, V45, P67; Pultorak E, 2011, PUBLIC HEALTH, V125, P592, DOI 10.1016/j.puhe.2011.03.013; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Sleeman J., 2012, NEW DIRECTIONS CONSE, P539; Spratt DM, 2005, MICROBIOL AUST, V26, P63; Watanabe Myrna, 2003, Bioscience, V53, P792, DOI 10.1641/0006-3568(2003)053[0792:B]2.0.CO;2; World Organisation for Animal Health (OIE), 2012, M OIE WORK GROUP WIL, P12; Zoo Animal Health Network, 2012, FLU ZOO TABL EX	48	18	20	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95127	10.1371/journal.pone.0095127	http://dx.doi.org/10.1371/journal.pone.0095127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787430	Green Published, gold			2022-12-25	WOS:000335510600025
J	de Costa, D; Broodman, I; Calame, W; Stingl, C; Dekker, LJM; Vernhout, RM; de Koning, HJ; Hoogsteden, HC; Smitt, PAES; van Klaveren, RJ; Luider, TM; VanDuijn, MM				de Costa, Dominique; Broodman, Ingrid; Calame, Wim; Stingl, Christoph; Dekker, Lennard J. M.; Vernhout, Rene M.; de Koning, Harry J.; Hoogsteden, Henk C.; Smitt, Peter A. E. Sillevis; van Klaveren, Rob J.; Luider, Theo M.; VanDuijn, Martijn M.			Peptides from the Variable Region of Specific Antibodies Are Shared among Lung Cancer Patients	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; IMMUNOGLOBULIN PEPTIDES; ANTIGEN; REPERTOIRE; SELECTION; SEQUENCE; RECEPTOR; USAGE	Late diagnosis of lung cancer is still the main reason for high mortality rates in lung cancer. Lung cancer is a heterogeneous disease which induces an immune response to different tumor antigens. Several methods for searching autoantibodies have been described that are based on known purified antigen panels. The aim of our study is to find evidence that parts of the antigen-binding-domain of antibodies are shared among lung cancer patients. This was investigated by a novel approach based on sequencing antigen-binding-fragments (Fab) of immunoglobulins using proteomic techniques without the need of previously known antigen panels. From serum of 93 participants of the NELSON trial IgG was isolated and subsequently digested into Fab and Fc. Fab was purified from the digested mixture by SDS-PAGE. The Fab containing gel-bands were excised, tryptic digested and measured on a nano-LC-Orbitrap-Mass-spectrometry system. Multivariate analysis of the mass spectrometry data by linear canonical discriminant analysis combined with stepwise logistic regression resulted in a 12-antibody-peptide model which was able to distinguish lung cancer patients from controls in a high risk population with a sensitivity of 84% and specificity of 90%. With our Fab-purification combined Orbitrap-mass-spectrometry approach, we found peptides from the variable-parts of antibodies which are shared among lung cancer patients.	[de Costa, Dominique; Hoogsteden, Henk C.; van Klaveren, Rob J.] Erasmus MC, Dept Pulmonol, Rotterdam, Netherlands; [Broodman, Ingrid] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands; [Calame, Wim] StatistiCal BV, Wassenaar, Netherlands; [Stingl, Christoph; Dekker, Lennard J. M.; Smitt, Peter A. E. Sillevis; Luider, Theo M.; VanDuijn, Martijn M.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Vernhout, Rene M.] Erasmus MC, Unit Trials & Stat, Rotterdam, Netherlands; [de Koning, Harry J.] Erasmus MC, Unit Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Luider, TM (corresponding author), Erasmus MC, Dept Neurol, Rotterdam, Netherlands.	t.luider@erasmusmc.nl	de+Koning, Harry/AAF-9062-2019	de+Koning, Harry/0000-0003-4682-3646; van Duijn, Martijn/0000-0002-6654-994X	Roche Diagnostics; NWO (The Netherlands Organization for Scientific Research) [93511034]	Roche Diagnostics; NWO (The Netherlands Organization for Scientific Research)(Netherlands Organization for Scientific Research (NWO))	The authors thank Roche Diagnostics for their unrestricted research grant and NWO (The Netherlands Organization for Scientific Research) for their financial support (Zenith grant 93511034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Afifi A., 2003, COMPUTER AIDED MULTI; Andersen PS, 2007, MOL IMMUNOL, V44, P412, DOI 10.1016/j.molimm.2006.02.021; Anderson KS, 2005, J PROTEOME RES, V4, P1123, DOI 10.1021/pr0500814; Arentz G, 2012, J AUTOIMMUN, V39, P466, DOI 10.1016/j.jaut.2012.07.003; Armitage P., 2002, STAT METHODS MED RES; BALDWIN RW, 1955, BRIT J CANCER, V9, P646, DOI 10.1038/bjc.1955.69; Baranzini SE, 1999, J IMMUNOL, V163, P5133; Brichory F, 2001, CANCER RES, V61, P7908; Brichory FM, 2001, P NATL ACAD SCI USA, V98, P9824, DOI 10.1073/pnas.171320598; Caron M, 2007, MOL CELL PROTEOMICS, V6, P1115, DOI 10.1074/mcp.R600016-MCP200; Chapman CJ, 2012, TUMOUR BIOL; de Costa D, 2010, J PROTEOME RES, V9, P2937, DOI 10.1021/pr901114w; Ferlay JSI, 2013, GLOBOCAN 2012 V1 0 C; Foreman AL, 2008, AUTOIMMUNITY, V41, P80, DOI 10.1080/08916930701619656; Gure AO, 1998, CANCER RES, V58, P1034; Hanash S, 2003, NAT BIOTECHNOL, V21, P37, DOI 10.1038/nbt0103-37; Horeweg N, 2013, EUR RESPIR J, V42, P1659, DOI 10.1183/09031936.00197712; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Khattar NH, 2010, CANCER BIOL THER, V10; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Koziol JA, 2003, CLIN CANCER RES, V9, P5120; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Liu L, 2012, J CANC RES CLIN ONCO; Maat P, 2012, J AUTOIMMUN, V38, P354, DOI 10.1016/j.jaut.2012.02.002; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Pass HI, 2010, PRINCIPLES PRACTICE; Pecot CV, 2012, CANCER EPIDEM BIOMAR, V21, P786, DOI 10.1158/1055-9965.EPI-11-0932; Saada R, 2007, IMMUNOL CELL BIOL, V85, P323, DOI 10.1038/sj.icb.7100055; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; SNEDECOR G W, 1980; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; VanDuijn MM, 2010, J BIOL CHEM, V285, P29247, DOI 10.1074/jbc.M110.139071; VILLENEUVE PJ, 1994, CAN J PUBLIC HEALTH, V85, P385; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Zhong L, 2006, J THORAC ONCOL, V1, P513, DOI 10.1097/01243894-200607000-00003	39	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96029	10.1371/journal.pone.0096029	http://dx.doi.org/10.1371/journal.pone.0096029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787687	gold, Green Published			2022-12-25	WOS:000335510600066
J	Farrahi, K; Emonet, R; Cebrian, M				Farrahi, Katayoun; Emonet, Remi; Cebrian, Manuel			Epidemic Contact Tracing via Communication Traces	PLOS ONE			English	Article							MOBILITY; NETWORK	Traditional contact tracing relies on knowledge of the interpersonal network of physical interactions, where contagious outbreaks propagate. However, due to privacy constraints and noisy data assimilation, this network is generally difficult to reconstruct accurately. Communication traces obtained by mobile phones are known to be good proxies for the physical interaction network, and they may provide a valuable tool for contact tracing. Motivated by this assumption, we propose a model for contact tracing, where an infection is spreading in the physical interpersonal network, which can never be fully recovered; and contact tracing is occurring in a communication network which acts as a proxy for the first. We apply this dual model to a dataset covering 72 students over a 9 month period, for which both the physical interactions as well as the mobile communication traces are known. Our results suggest that a wide range of contact tracing strategies may significantly reduce the final size of the epidemic, by mainly affecting its peak of incidence. However, we find that for low overlap between the face-to-face and communication interaction network, contact tracing is only efficient at the beginning of the outbreak, due to rapidly increasing costs as the epidemic evolves. Overall, contact tracing via mobile phone communication traces may be a viable option to arrest contagious outbreaks.	[Farrahi, Katayoun] Univ London, Dept Comp, London, England; [Emonet, Remi] Lab Hubert Curien, Dept Machine Learning, St Etienne, France; [Cebrian, Manuel] MIT, Media Lab, Cambridge, MA 02139 USA; [Cebrian, Manuel] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Cebrian, Manuel] Natl Informat & Commun Technol Australia, Melbourne, Vic, Australia	University of London; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego	Farrahi, K (corresponding author), Univ London, Dept Comp, London, England.	k.farrahi@gold.ac.uk	; Farrahi, Katayoun/E-1355-2013	Emonet, Remi/0000-0002-1870-1329; Farrahi, Katayoun/0000-0001-6775-127X	Australian Government; Australian Research Council through the ICT Centre of Excellence program	Australian Government(Australian GovernmentCGIAR); Australian Research Council through the ICT Centre of Excellence program(Australian Research Council)	Manuel Cebrian is funded by the Australian Government as represented by The Department of Broadband, Communications and the Digital Economy, and The Australian Research Council through the ICT Centre of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DELIBERATIVE DEMOCRA, DOI [10.7551/mitpress/11633.003.0005, DOI 10.7551/MITPRESS/2324.003.0014, DOI 10.7551/MITPRESS/8022.001.0001]; Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002; Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barabasi AL, 2013, POLITICO; Cho E., 2011, P 17 ACM SIGKDD INT, P1082, DOI [DOI 10.1145/2020408.2020579, 10.1145/2020408.2020579]; Christakis N.A., 2009, CONNECTED SURPRISING; Crandall DJ, 2010, P NATL ACAD SCI USA, V107, P22436, DOI 10.1073/pnas.1006155107; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eames KTD, 2003, P ROY SOC B-BIOL SCI, V270, P2565, DOI 10.1098/rspb.2003.2554; Farrahi K, 2012, IEEE INT SYM WRBL CO, P9, DOI 10.1109/ISWC.2012.19; Holme P, 2013, ARXIV13076436; Isella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017144; Jones JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052168; Madan A, 2012, IEEE PERVAS COMPUT, V11, P36, DOI 10.1109/MPRV.2011.79; Madan A, 2011, LECT NOTES COMPUT SC, V6696, P214, DOI 10.1007/978-3-642-21726-5_14; Madan A, 2010, UBICOMP 2010: PROCEEDINGS OF THE 2010 ACM CONFERENCE ON UBIQUITOUS COMPUTING, P291; Margolin D., 2013, 7 INT AAAI C WEBL SO; Salathe M, 2013, NEW ENGL J MED, V369, P401, DOI 10.1056/NEJMp1307752; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Stehle J, 2012, THESIS AIX MARSEILLE; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; Tsimring LS, 2003, PHYSICA A, V325, P33, DOI 10.1016/S0378-4371(03)00180-8; Wang D., 2011, P 17 ACM SIGKDD INT, P1100, DOI DOI 10.1145/2020408.2020581; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467	27	54	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95133	10.1371/journal.pone.0095133	http://dx.doi.org/10.1371/journal.pone.0095133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787614	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600026
J	Pan, XQ; Malykhina, AP				Pan, Xiao-Qing; Malykhina, Anna P.			Estrous Cycle Dependent Fluctuations of Regulatory Neuropeptides in the Lower Urinary Tract of Female Rats upon Colon-Bladder Cross-Sensitization	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; GENE-RELATED PEPTIDE; ROOT GANGLION NEURONS; CHRONIC PELVIC PAIN; NEUROTROPHIC FACTOR; INTERSTITIAL CYSTITIS; RECEPTOR-BETA; UP-REGULATION; INFLAMMATORY PAIN; MESSENGER-RNA	Co-morbidity of bladder, bowel, and non-specific pelvic pain symptoms is highly prevalent in women. Little evidence is present on modulation of pelvic pain syndromes by sex hormones, therefore, the objective of this study was to clarify the effects of hormonal fluctuations within the estrous cycle on regulatory neuropeptides in female rats using a model of neurogenic bladder dysfunction. The estrous cycle in female rats (Sprague-Dawley, 230-250 g) was assessed by vaginal smears and weight of uterine horns. Neurogenic bladder dysfunction was induced by a single inflammatory insult to the distal colon. Protein expression of calcitonin gene related peptide (CGRP), substance P (SP), nerve growth factor (NGF), and brain derived neurotrophic factor (BDNF) in the pelvic organs, sensory ganglia and lumbosacral spinal cord was compared in rats in proestrus (high estrogen) vs diestrus (low estrogen). Under normal physiological conditions, concentration of SP and CGRP was similar in the distal colon and urinary bladder during all phases of the estrous cycle, however, acute colitis induced a significant up-regulation of CGRP content in the colon (by 63%) and urinary bladder (by 54%, p <= 0.05 to control) of rats in proestrus. These changes were accompanied by a significant diminution of CGRP content in L6-S2 DRG after colonic treatment, likely associated with its release in the periphery. In rats with high estrogen at the time of testing (proestrus), experimental colitis caused a significant up-regulation of BDNF colonic content from 26.1 +/- 8.5 pg/ml to 83.46 +/- 32.5 pg/ml (N = 7, p <= 0.05 to control) and also induced similar effects on BDNF in the urinary bladder which was also up-regulated by 5-fold in rats in proestrus (p <= 0.05 to respective control). Our results demonstrate estrous cycle dependent fluctuations of regulatory neuropeptides in the lower urinary tract upon colon-bladder cross-sensitization, which may contribute to pain fluctuations in female patients with neurogenic bladder pain.	[Pan, Xiao-Qing; Malykhina, Anna P.] Univ Penn, Div Urol, Dept Surg, Glenolden, PA USA	University of Pennsylvania	Malykhina, AP (corresponding author), Univ Penn, Div Urol, Dept Surg, Glenolden, PA USA.	Anna.Malykhina@uphs.upenn.edu			NIH/NIDDK [DK077699, DK 077699-S2]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077699] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH/NIDDK DK077699 grant DK 077699-S2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron LA, 2001, ANN INTERN MED, V134, P868, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00011; Alagiri M, 1997, UROLOGY, V49, P52, DOI 10.1016/S0090-4295(99)80332-X; Ball CL, 2010, J UROLOGY, V184, P1529, DOI 10.1016/j.juro.2010.05.090; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Bi RF, 2001, P NATL ACAD SCI USA, V98, P13391, DOI 10.1073/pnas.241507698; Bradshaw HB, 2000, J NEUROSCI, V20, P7722; Bueno L, 2002, GUT, V51, pI19, DOI 10.1136/gut.51.suppl_1.i19; Butrick CW, 2003, CLIN OBSTET GYNECOL, V46, P811, DOI 10.1097/00003081-200312000-00011; Candenas L, 2005, LIFE SCI, V76, P835, DOI 10.1016/j.lfs.2004.10.004; Craft RM, 2007, PAIN, V132, pS3, DOI 10.1016/j.pain.2007.09.028; Delafoy L, 2006, GUT, V55, P940, DOI 10.1136/gut.2005.064063; di Mola FF, 2000, GUT, V46, P670, DOI 10.1136/gut.46.5.670; Frias B, 2013, NEUROSCIENCE, V234, P88, DOI 10.1016/j.neuroscience.2012.12.044; Gangula PRR, 2000, BIOL REPROD, V62, P1033, DOI 10.1095/biolreprod62.4.1033; Hextall A, 2001, INT UROGYNECOL J, V12, P258, DOI 10.1007/s001920170049; Imamov O, 2007, P NATL ACAD SCI USA, V104, P9806, DOI 10.1073/pnas.0703410104; Jezierski MK, 2000, MOL BRAIN RES, V85, P77, DOI 10.1016/S0169-328X(00)00244-8; Ji Y, 2008, NEUROSCIENCE, V154, P1562, DOI 10.1016/j.neuroscience.2008.04.070; Johnson OL, 2002, AM J PHYSIOL-REG I, V282, pR289, DOI 10.1152/ajpregu.2002.282.1.R289; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Lanlua P, 2001, BIOL REPROD, V64, P331, DOI 10.1095/biolreprod64.1.331; Lei Q, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-3; Li F, 2010, NEUROSCI LETT, V478, P184, DOI 10.1016/j.neulet.2010.05.013; Li WP, 1999, NEUROSCI LETT, V260, P49, DOI 10.1016/S0304-3940(98)00958-6; Lin ADY, 2006, UROLOGY, V68, P1139, DOI 10.1016/j.urology.2006.08.1094; Lin YT, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-126; Liuzzi FJ, 2001, EXP NEUROL, V170, P101, DOI 10.1006/exnr.2001.7697; Lowe EM, 1997, BRIT J UROL, V79, P572, DOI 10.1046/j.1464-410X.1997.00097.x; LUNDBERG JM, 1992, ANN NY ACAD SCI, V657, P187, DOI 10.1111/j.1749-6632.1992.tb22767.x; MacGregor EA, 2006, NEUROLOGY, V67, P2154, DOI 10.1212/01.wnl.0000233888.18228.19; Malykhina AP, 2006, NEUROGASTROENT MOTIL, V18, P936, DOI 10.1111/j.1365-2982.2006.00807.x; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Michael GJ, 1997, J NEUROSCI, V17, P8476; Okragly AJ, 1999, J UROLOGY, V161, P438, DOI 10.1016/S0022-5347(01)61915-3; Pan XQ, 2010, EXP NEUROL, V225, P262, DOI 10.1016/j.expneurol.2010.05.012; Papka RE, 2001, CELL TISSUE RES, V304, P193, DOI 10.1007/s004410100363; Parsons CL, 2001, UROLOGY, V57, P428, DOI 10.1016/S0090-4295(00)01110-9; Patrone C, 1999, P NATL ACAD SCI USA, V96, P10905, DOI 10.1073/pnas.96.19.10905; Purves-Tyson TD, 2004, NEUROSCIENCE, V129, P629, DOI 10.1016/j.neuroscience.2004.08.019; Qiao LY, 2008, NEUROGASTROENT MOTIL, V20, P928, DOI 10.1111/j.1365-2982.2008.01119.x; Qiao LY, 2007, EXP NEUROL, V204, P667, DOI 10.1016/j.expneurol.2006.12.024; Qiao LY, 2010, PAIN, V151, P117, DOI 10.1016/j.pain.2010.06.029; Rudick CN, 2012, J UROLOGY, V187, P715, DOI 10.1016/j.juro.2011.10.048; Saunders PTK, 1997, J ENDOCRINOL, V154, pR13, DOI 10.1677/joe.0.154R013; Shaffer AD, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-18; Sutcliffe S, 2015, NEUROUROL URODYNAM, V34, P188, DOI 10.1002/nau.22534; Taleghany N, 1999, J NEUROSCI RES, V57, P603, DOI 10.1002/(SICI)1097-4547(19990901)57:5<603::AID-JNR3>3.3.CO;2-I; Taylor AH, 2000, J MOL ENDOCRINOL, V24, P145, DOI 10.1677/jme.0.0240145; Terado M, 2005, ENDOCRINE, V26, P55, DOI 10.1385/ENDO:26:1:055; ToranAllerand CD, 1996, J STEROID BIOCHEM, V56, P169, DOI 10.1016/0960-0760(95)00234-0; Wesselmann U, 2001, WORLD J UROL, V19, P180, DOI 10.1007/s003450100201; Williams SJ, 1997, LIFE SCI, V61, P2551, DOI 10.1016/S0024-3205(97)01009-6; Winnard KP, 2006, AM J PHYSIOL-REG I, V291, pR1592, DOI 10.1152/ajpregu.00455.2006; Xia CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-30; Zhou XF, 1996, NEUROSCIENCE, V74, P945, DOI 10.1016/S0306-4522(96)00237-0; Zondervan KT, 1999, BRIT J OBSTET GYNAEC, V106, P1149, DOI 10.1111/j.1471-0528.1999.tb08140.x	56	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94872	10.1371/journal.pone.0094872	http://dx.doi.org/10.1371/journal.pone.0094872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788240	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600020
J	Ramey, AM; Poulson, RL; Gonzalez-Reiche, AS; Perez, DR; Stallknecht, DE; Brown, JD				Ramey, Andrew M.; Poulson, Rebecca L.; Gonzalez-Reiche, Ana S.; Perez, Daniel R.; Stallknecht, David E.; Brown, Justin D.			Genomic Characterization of H14 Subtype Influenza A Viruses in New World Waterfowl and Experimental Infectivity in Mallards (Anas platyrhynchos)	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; HEMAGGLUTININ SUBTYPE; RT-PCR; REPLICATION; SEQUENCES; DISEASE; ALASKA; SET	Recent repeated isolation of H14 hemagglutinin subtype influenza A viruses (IAVs) in the New World waterfowl provides evidence to suggest that host and/or geographic ranges for viruses of this subtype may be expanding. In this study, we used genomic analyses to gain inference on the origin and evolution of H14 viruses in New World waterfowl and conducted an experimental challenge study in mallards (Anas platyrhynchos) to evaluate pathogenicity, viral replication, and transmissibility of a representative viral strain in a natural host species. Genomic characterization of H14 subtype IAVs isolated from New World waterfowl, including three isolates sequenced specifically for this study, revealed high nucleotide identity among individual gene segments (e. g. >= 95% shared identity among H14 HA gene segments). In contrast, lower shared identity was observed among internal gene segments. Furthermore, multiple neuraminidase subtypes were observed for H14 IAVs isolated in the New World. Gene segments of H14 viruses isolated after 2010 shared ancestral genetic lineages with IAVs isolated from wild birds throughout North America. Thus, genomic characterization provided evidence for viral evolution in New World waterfowl through genetic drift and genetic shift since purported introduction from Eurasia. In the challenge study, no clinical disease or lesions were observed among mallards experimentally inoculated with A/blue-winged teal/Texas/AI13-1028/2013(H14N5) or exposed via contact with infected birds. Titers of viral shedding for mallards challenged with the H14N5 IAV were highest at two days post-inoculation (DPI); however shedding was detected up to nine DPI using cloacal swabs. The distribution of viral antigen among mallards infected with H14N5 IAV was largely restricted to enterocytes lining the villi in the lower intestinal tract and in the epithelium of the bursa of Fabricius. Characterization of the infectivity of A/blue-winged teal/Texas/AI13-1028/2013(H14N5) in mallards provides support for similarities in viral replication and shedding as compared to previously described waterfowl-adapted, low pathogenic IAV strains in ducks.	[Ramey, Andrew M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99504 USA; [Ramey, Andrew M.; Poulson, Rebecca L.; Stallknecht, David E.; Brown, Justin D.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA USA; [Gonzalez-Reiche, Ana S.; Perez, Daniel R.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, Dept Vet Med, College Pk, MD 20742 USA; [Gonzalez-Reiche, Ana S.] Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala	United States Department of the Interior; United States Geological Survey; University System of Georgia; University of Georgia; University System of Maryland; University of Maryland College Park; Universidad del Valle de Guatemala	Ramey, AM (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99504 USA.	aramey@usgs.gov	Poulson, Rebecca/AAD-2231-2021; Poulson, Rebecca/K-4014-2019; Perez, Daniel R./D-5044-2016; Gonzalez-Reiche, Ana/ABH-2585-2020	Poulson, Rebecca/0000-0002-8087-3295; Perez, Daniel R./0000-0002-6569-5689; Gonzalez-Reiche, Ana/0000-0003-3583-4497; Ramey, Andrew/0000-0002-3601-8400	U.S. Geological Survey through the Wildlife Program of the Ecosystem Mission Area; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); Department of Health and Human Services [HHSN266200700007C]	U.S. Geological Survey through the Wildlife Program of the Ecosystem Mission Area; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Health and Human Services	Funding for this work was provided by the U.S. Geological Survey through the Wildlife Program of the Ecosystem Mission Area and by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), and the Department of Health and Human Services under contract HHSN266200700007C. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript. The opinions expressed herein are those of the authors and do not necessarily reflect the views of any of the funding agencies.	Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Bellrose F, 1980, DUCKS GEESE SWANS N; Boyce WM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00543-13; Bragstad K, 2005, VIRUS RES, V109, P181, DOI 10.1016/j.virusres.2004.12.004; Brown J, 2012, AVIAN DIS, V56, P969, DOI 10.1637/10158-040912-Reg.1; Brown JD, 2012, J WILDLIFE DIS, V48, P991, DOI 10.7589/2011-09-280; Daoust PY, 2011, J WILDLIFE DIS, V47, P401, DOI 10.7589/0090-3558-47.2.401; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Driskell EA, 2010, VIROLOGY, V399, P280, DOI 10.1016/j.virol.2010.01.005; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Franca M, 2012, AVIAN DIS, V56, P976, DOI 10.1637/10153-040812-ResNote.1; Fries AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059216; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Hoper D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019075; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; KAWAOKA Y, 1990, VIROLOGY, V179, P759, DOI 10.1016/0042-6822(90)90143-F; KIDA H, 1980, INFECT IMMUN, V30, P547; Kimble JB, 2014, J VIROL, V88, P66, DOI 10.1128/JVI.02677-13; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003443; Li OTW, 2007, J VIROL METHODS, V142, P218, DOI 10.1016/j.jviromet.2007.01.015; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005022; Mundt E, 2009, ARCH VIROL, V154, P1241, DOI 10.1007/s00705-009-0437-2; Nolting J, 2012, PLOS CURRENTS INFLUE, DOI [10.1371/cur-rents.RRN1290, DOI 10.1371/CUR-RENTS.RRN1290]; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pearce JM, 2011, MOL ECOL, V20, P1015, DOI 10.1111/j.1365-294X.2010.04908.x; Pearce JM, 2009, EVOL APPL, V2, P457, DOI 10.1111/j.1752-4571.2009.00071.x; Phipps LP, 2004, J VIROL METHODS, V122, P119, DOI 10.1016/j.jviromet.2004.08.008; Ramey AM, 2013, J WILDL DIS IN PRESS; Ramey AM, 2010, VIROLOGY, V401, P179, DOI 10.1016/j.virol.2010.02.006; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Stallknecht D, 1997, AVIAN DIS, V47, P61; Swayne D. E., 2008, LAB MANUAL ISOLATION, P128; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Zou SM, 1997, J CLIN MICROBIOL, V35, P2623, DOI 10.1128/JCM.35.10.2623-2627.1997	39	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95620	10.1371/journal.pone.0095620	http://dx.doi.org/10.1371/journal.pone.0095620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788792	Green Submitted, gold, Green Published			2022-12-25	WOS:000335510600043
J	Wu, Y; Gan, Y; Gao, FM; Zhao, ZM; Jin, Y; Zhu, Y; Sun, ZH; Wu, H; Chen, TY; Wang, JB; Sun, Y; Fan, CS; Xiang, YB; Qian, GS; Groopman, JD; Gu, JR; Tu, H				Wu, Yan; Gan, Yu; Gao, Fumin; Zhao, Zhimei; Jin, Yan; Zhu, Yu; Sun, Zhihan; Wu, Hao; Chen, Taoyang; Wang, Jinbing; Sun, Yan; Fan, Chunsun; Xiang, Yongbing; Qian, Gengsun; Groopman, John D.; Gu, Jianren; Tu, Hong			Novel Natural Mutations in the Hepatitis B Virus Reverse Transcriptase Domain Associated with Hepatocellular Carcinoma	PLOS ONE			English	Article							BASAL CORE PROMOTER; PRE-S DELETION; HIGH PREVALENCE; DNA LEVEL; HIGH-RISK; HBV; CARRIERS; ENHANCER; QIDONG; GENE	Background/Aim: Hepatitis B Virus (HBV) mutations play a role in the development of hepatocellular carcinoma (HCC). However, the association between HBV polymerase gene mutations and HCC has not been reported. In this study, we conducted a multi-stage study to identify HCC-related mutations in the reverse transcriptase (RT) domain of the HBV polymerase gene. Methods: A total of 231 HCCs and 237 non-HCC controls from Qidong, China, were included in this study. The entire sequence of HBV RT was first compared between 29 HCC and 35 non-HCC cases, and candidate mutations were then evaluated in two independent validation sets. Results: There were 15 candidate mutations identified from the discovery set, with A799G and T1055A being consistently associated with HCC across all studies. A pooled analysis of samples revealed that A799G, A987G, and T1055A were independent risk factors for HCC, with adjusted odds ratios of 5.53 [95% confidence interval (CI), 1.69-18.10], 4.20 (95% CI, 1.15-15.35), and 3.78 (95% CI, 1.45-9.86), respectively. A longitudinal study showed that these mutations were detectable 45 years prior to HCC diagnosis. Conclusions: Our study provides evidence the first that HBV RT contains naturally occurring mutations that can be used as predictive markers for HCC.	[Wu, Yan; Gan, Yu; Gao, Fumin; Zhao, Zhimei; Jin, Yan; Zhu, Yu; Xiang, Yongbing; Qian, Gengsun; Gu, Jianren; Tu, Hong] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Renji Hosp, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200030, Peoples R China; [Gao, Fumin] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Sun, Zhihan; Wu, Hao] Fudan Univ, Sch Basic Med Sci, Shanghai 200433, Peoples R China; [Chen, Taoyang; Wang, Jinbing; Sun, Yan; Fan, Chunsun] Qidong Peoples Hosp, Qidong Liver Canc Inst, Dept Etiol, Qidong, Jiangsu, Peoples R China; [Groopman, John D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Shanghai Jiao Tong University; Fudan University; Fudan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tu, H (corresponding author), Shanghai Jiao Tong Univ, Shanghai Canc Inst, Renji Hosp, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200030, Peoples R China.	tuhong@shsci.org	/X-4205-2019	/0000-0003-4690-2133; Gan, Yu/0000-0002-5769-6809; Tu, Hong/0000-0002-8298-5207	Chinese state key project specialized for infectious diseases [2012ZX10002-008-002]; NIEHS [ES06052]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES006052] Funding Source: NIH RePORTER	Chinese state key project specialized for infectious diseases; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Chinese state key project specialized for infectious diseases (2012ZX10002-008-002) to H. T. and NIEHS grant PO I (ES06052) to J.D.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu M, 2006, J GASTROEN HEPATOL, V21, P1783, DOI 10.1111/j.1440-1746.2006.04567.x; [Anonymous], 2009, WKLY EPIDEMIOL REC, V84, P405; Arbuthnot P, 2001, INT J EXP PATHOL, V82, P77, DOI 10.1111/j.1365-2613.2001.iep178.x; Bai X, 2011, CARCINOGENESIS, V32, P63, DOI 10.1093/carcin/bgq195; Cao ZG, 2008, ARCH VIROL, V153, P1807, DOI 10.1007/s00705-008-0176-9; Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen CH, 2008, J INFECT DIS, V198, P1634, DOI 10.1086/592990; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen JG, 2011, SEMIN CANCER BIOL, V21, P59, DOI 10.1016/j.semcancer.2010.11.002; Chen Jian-guo, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P721; Fang ZL, 2008, AM J GASTROENTEROL, V103, P2254, DOI 10.1111/j.1572-0241.2008.01974.x; Fukai K, 1997, VIROLOGY, V236, P279, DOI 10.1006/viro.1997.8750; Ghany M, 2007, GASTROENTEROLOGY, V132, P1574, DOI 10.1053/j.gastro.2007.02.039; GUO WT, 1991, J VIROL, V65, P6686, DOI 10.1128/JVI.65.12.6686-6692.1991; Guo X, 2008, J HEPATOL, V49, P718, DOI 10.1016/j.jhep.2008.06.026; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Jang ES, 2013, LIVER INT, V33, P1092, DOI 10.1111/liv.12186; Jin Yan, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P511, DOI 10.3760/cma.j.issn.1007-3418.2010.07.010; Keeffe EB, 2008, CLIN GASTROENTEROL H, V6, P268, DOI 10.1016/j.cgh.2007.12.043; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kuang SY, 2004, P NATL ACAD SCI USA, V101, P3575, DOI 10.1073/pnas.0308232100; LIAW YF, 1986, LIVER, V6, P133; Liaw YF, 2013, LIVER INT, V33, P111, DOI 10.1111/liv.12057; Lin X, 2005, J GEN VIROL, V86, P85, DOI 10.1099/vir.0.80581-0; Lin X, 2001, J VIROL, V75, P11827, DOI 10.1128/JVI.75.23.11827-11833.2001; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Liu TT, 2008, WORLD J GASTROENTERO, V14, P3059, DOI 10.3748/wjg.14.3059; Locarnini S, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-828672; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Motavaf M, 2013, ACTA VIROL, V57, P389, DOI 10.4149/av_2013_04_389; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Qu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059583; Amitis RA, 2008, INT J INFECT DIS, V12, P252, DOI 10.1016/j.ijid.2007.08.003; Sun Yan, 2012, Zhonghua Yi Xue Za Zhi, V92, P1874; Sun Yan, 2011, Tumor, V31, P841; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan Y, 2012, PLOS ONE, V7, P1; Tauseef I, 2012, PAK J PHARM SCI, V25, P349; Tong MJ, 2007, LIVER INT, V27, P1356, DOI 10.1111/j.1478-3231.2007.01585.x; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Wang YX, 2007, J MED VIROL, V79, P676, DOI 10.1002/jmv.20835; Wang YX, 2007, FEBS LETT, V581, P558, DOI 10.1016/j.febslet.2007.01.024; Xu J, 2009, J DIGEST DIS, V10, P138, DOI 10.1111/j.1751-2980.2009.00376.x; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043; Yuan JM, 2009, CANCER EPIDEM BIOMAR, V18, P590, DOI 10.1158/1055-9965.EPI-08-0966; Yuen MF, 2008, GUT, V57, P98, DOI 10.1136/gut.2007.119859; Zhou JY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-16; Zhu Y, 2010, CANCER EPIDEM BIOMAR, V19, P2623, DOI 10.1158/1055-9965.EPI-10-0469; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	54	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94864	10.1371/journal.pone.0094864	http://dx.doi.org/10.1371/journal.pone.0094864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788140	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600019
J	Prathapan, A; Vineetha, VP; Raghu, KG				Prathapan, Ayyappan; Vineetha, Vadavanath Prabhakaran; Raghu, Kozhiparambil Gopalan			Protective Effect of Boerhaavia diffusa L. against Mitochondrial Dysfunction in Angiotensin II Induced Hypertrophy in H9c2 Cardiomyoblast Cells	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; RESPIRATORY-CHAIN COMPLEXES; CARDIAC-HYPERTROPHY; HEART-FAILURE; OXIDATIVE STRESS; ARSENIC TRIOXIDE; THERAPEUTIC TARGET; BOERHAVIA-DIFFUSA; GROWTH-FACTOR; RAT	Mitochondrial dysfunction plays a critical role in the development of cardiac hypertrophy and heart failure. So mitochondria are emerging as one of the important druggable targets in the management of cardiac hypertrophy and other associated complications. In the present study, effects of ethanolic extract of Boerhaavia diffusa (BDE), a green leafy vegetable against mitochondrial dysfunction in angiotensin II (Ang II) induced hypertrophy in H9c2 cardiomyoblasts was evaluated. H9c2 cells challenged with Ang II exhibited pathological hypertrophic responses and mitochondrial dysfunction which was evident from increment in cell volume (49.09 +/- 1.13%), protein content (55.17 +/- 1.19%), LDH leakage (58.74 +/- 1.87%), increased intracellular ROS production (26.25 +/- 0.91%), mitochondrial superoxide generation (65.06 +/- 2.27%), alteration in mitochondrial transmembrane potential (Delta Psi m), opening of mitochondrial permeability transition pore (mPTP) and mitochondrial swelling. In addition, activities of mitochondrial respiratory chain complexes (I-IV), aconitase, NADPH oxidase, thioredoxin reductase, oxygen consumption rate and calcium homeostasis were evaluated. Treatment with BDE significantly prevented the generation of intracellular ROS and mitochondrial superoxide radicals and protected the mitochondria by preventing dissipation of DYm, opening of mPTP, mitochondrial swelling and enhanced the activities of respiratory chain complexes and oxygen consumption rate in H9c2 cells. Activities of aconitase and thioredoxin reductase which was lowered (33.77 +/- 0.68% & 45.81 +/- 0.71% respectively) due to hypertrophy, were increased in BDE treated cells (P <= 0.05). Moreover, BDE also reduced the intracellular calcium overload in Ang II treated cells. Overall results revealed the protective effects of B. diffusa against mitochondrial dysfunction in hypertrophy in H9c2 cells and the present findings may shed new light on the therapeutic potential of B. diffusa in addition to its nutraceutical potentials.	[Prathapan, Ayyappan; Vineetha, Vadavanath Prabhakaran; Raghu, Kozhiparambil Gopalan] CSIR Natl Inst Interdisciplinary Sci & Technol NI, Agroproc & Nat Prod Div, Thiruvananthapuram, Kerala, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Raghu, KG (corresponding author), CSIR Natl Inst Interdisciplinary Sci & Technol NI, Agroproc & Nat Prod Div, Thiruvananthapuram, Kerala, India.	raghukgopal2009@gmail.com	Raghu, K G/AAT-8042-2021	Ayappan, Prathapan/0000-0002-5508-2360	Council of Scientific and Industrial Research (CSIR)	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	First author thank Council of Scientific and Industrial Research (CSIR) for Senior Research Fellowship.	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; Agrawal M, 2010, INT J PHARM SCI RES, V1, P1, DOI 10.13040/IJPSR.0975-8232.1(5).1-21; Ahsan MK, 2009, ANTIOXID REDOX SIGN, V11, P2741, DOI [10.1089/ars.2009.2683, 10.1089/ARS.2009.2683]; Aviello G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019628; Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021; Bayeva M, 2010, CURR HYPERTENS REP, V12, P426, DOI 10.1007/s11906-010-0149-8; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Cassis L, 2002, AM J PHYSIOL-REG I, V282, pR445, DOI 10.1152/ajpregu.00261.2001; Chaminda T, 2001, PHYTOTHER RES, V15, P519, DOI 10.1002/ptr.994; Chan SHH, 2009, HYPERTENSION, V53, P217, DOI 10.1161/HYPERTENSIONAHA.108.116905; Correa F, 2013, FREE RADICAL BIO MED, V61, P119, DOI 10.1016/j.freeradbiomed.2013.03.017; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Ferreres F, 2005, PHYTOCHEM ANALYSIS, V16, P451, DOI 10.1002/pca.869; Hajjar RJ, 2006, CIRC RES, V98, P169, DOI 10.1161/01.RES.0000204557.09610.01; Javadov S, 2007, CELL PHYSIOL BIOCHEM, V20, P1, DOI 10.1159/000103747; Javadov S, 2006, J PHARMACOL EXP THER, V317, P1036, DOI 10.1124/jpet.105.100107; Javadov S, 2009, J PHARMACOL EXP THER, V330, P670, DOI 10.1124/jpet.109.153213; Ji KQ, 2008, ANN THORAC CARDIOVAS, V14, P210; Kaur M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep192; Kim HS, 2010, YONSEI MED J, V51, P187, DOI 10.3349/ymj.2010.51.2.187; Kristal BS, 1996, J BIOL CHEM, V271, P6033, DOI 10.1074/jbc.271.11.6033; LAMI N, 1991, CHEM PHARM BULL, V39, P1551, DOI 10.1248/cpb.39.1551; Larson AJ, 2012, ADV NUTR, V3, P39, DOI 10.3945/an.111.001271; Lin CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038706; Lin CS, 2003, RES VET SCI, V74, P219, DOI 10.1016/S0034-5288(02)00189-3; Liobikas J, 2011, J NAT PROD, V74, P1640, DOI 10.1021/np200060p; Liu CJ, 2008, MOL CELL BIOCHEM, V313, P167, DOI 10.1007/s11010-008-9754-0; Manu KA, 2009, IMMUNOPHARM IMMUNOT, V31, P377, DOI 10.1080/08923970802702036; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; Osterholt M, 2013, HEART FAIL REV, V18, P645, DOI 10.1007/s10741-012-9346-7; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Pandey R, 2005, INT IMMUNOPHARMACOL, V5, P541, DOI 10.1016/j.intimp.2004.11.001; Pari L, 2004, J MED FOOD, V7, P472, DOI 10.1089/jmf.2004.7.472; Paul MK, 2008, TOXICOL APPL PHARM, V226, P140, DOI 10.1016/j.taap.2007.09.020; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Prathapan A, 2013, BRIT J NUTR, V110, P1201, DOI 10.1017/S0007114513000561; Prathapan A, 2011, J FOOD BIOCHEM, V35, P1548, DOI 10.1111/j.1745-4514.2010.00477.x; Qin FZ, 2006, FREE RADICAL BIO MED, V40, P236, DOI 10.1016/j.freeradbiomed.2005.08.010; Rafieian-kopaei M, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/680856; Raghu KG, 2009, J TRACE ELEM MED BIO, V23, P61, DOI 10.1016/j.jtemb.2008.10.001; Rimbaud S, 2009, PHARMACOL REP, V61, P131, DOI 10.1016/S1734-1140(09)70015-5; Ritchie RH, 2006, CLIN EXP PHARMACOL P, V33, P159, DOI 10.1111/j.1440-1681.2006.04342.x; Riya MP, 2014, J SCI FOOD AGR, V94, P943, DOI 10.1002/jsfa.6340; Rocha M, 2014, MED RES REV, V34, P160, DOI 10.1002/med.21285; Rooban BN, 2010, BIOL TRACE ELEM RES, V138, P282, DOI 10.1007/s12011-010-8633-1; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Shukla SK, 2010, NAT PROD RES, V24, P873, DOI 10.1080/14786410903417378; Sreeja S, 2009, J ETHNOPHARMACOL, V126, P221, DOI 10.1016/j.jep.2009.08.041; Sudheesh NP, 2013, INT J CARDIOL, V165, P117, DOI 10.1016/j.ijcard.2011.07.103; Sudheesh NP, 2009, BIOGERONTOLOGY, V10, P627, DOI 10.1007/s10522-008-9208-9; Takemoto M, 2001, J CLIN INVEST, V108, P1429, DOI 10.1172/JCI200113350; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Vineetha VP, 2013, CARDIOVASC TOXICOL, V13, P123, DOI 10.1007/s12012-012-9191-x; Vineetha VP, 2014, FOOD FUNCT, V5, P502, DOI 10.1039/c3fo60470e; Wallace TC, 2011, ADV NUTR, V2, P1, DOI 10.3945/an.110.000042; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Will Y, 2006, NAT PROTOC, V1, P1; Yan LM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070658, 10.1371/journal.pone.0072548]	64	61	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96220	10.1371/journal.pone.0096220	http://dx.doi.org/10.1371/journal.pone.0096220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788441	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917300033
J	Casanova, F; Carney, PR; Sarntinoranont, M				Casanova, Fernando; Carney, Paul R.; Sarntinoranont, Malisa			Effect of Needle Insertion Speed on Tissue Injury, Stress, and Backflow Distribution for Convection-Enhanced Delivery in the Rat Brain	PLOS ONE			English	Article							MALIGNANT GLIOMAS; IN-VIVO; INFUSION; CANNULA; MODEL; MACROMOLECULES; MOLECULES; DIFFUSION; THERAPY; ALBUMIN	Flow back along a needle track (backflow) can be a problem during direct infusion, e.g. convection-enhanced delivery (CED), of drugs into soft tissues such as brain. In this study, the effect of needle insertion speed on local tissue injury and backflow was evaluated in vivo in the rat brain. Needles were introduced at three insertion speeds (0.2, 2, and 10 mm/s) followed by CED of Evans blue albumin (EBA) tracer. Holes left in tissue slices were used to reconstruct penetration damage. These measurements were also input into a hyperelastic model to estimate radial stress at the needle-tissue interface (pre-stress) before infusion. Fast insertion speeds were found to produce more tissue bleeding and disruption; average hole area at 10 mm/s was 1.87-fold the area at 0.2 mm/s. Hole measurements also differed at two fixation time points after needle retraction, 10 and 25 min, indicating that pre-stresses are influenced by time-dependent tissue swelling. Calculated pre-stresses were compressive (0 to 485 Pa) and varied along the length of the needle with smaller average values within white matter (116 Pa) than gray matter (301 Pa) regions. Average pre-stress at 0.2 mm/s (351.7 Pa) was calculated to be 1.46-fold the value at 10 mm/s. For CED backflow experiments (0.5, 1, and 2 mu L/min), measured EBA backflow increased as much as 2.46-fold between 10 and 0.2 mm/s insertion speeds. Thus, insertion rate-dependent damage and changes in pre-stress were found to directly contribute to the extent of backflow, with slower insertion resulting in less damage and improved targeting.	[Casanova, Fernando; Sarntinoranont, Malisa] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Carney, Paul R.] Wilder Ctr Excellence Epilepsy Res, Dept Pediat, Gainesville, FL USA; [Carney, Paul R.] Wilder Ctr Excellence Epilepsy Res, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL USA; [Casanova, Fernando] Univ Valle, Escuela Ingn Mecan, Cali, Colombia	State University System of Florida; University of Florida; Universidad del Valle	Sarntinoranont, M (corresponding author), Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA.	msarnt@ufl.edu		Casanova, Fernando/0000-0002-3146-2027	National Institute of Neurological Disorders and Stroke [R01NS063360]; Universidad del Valle, Cali, Colombia; Fulbright-COLCIENCIAS-DNP grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063360] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Universidad del Valle, Cali, Colombia; Fulbright-COLCIENCIAS-DNP grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by award number R01NS063360 from the National Institute of Neurological Disorders and Stroke; the Universidad del Valle, Cali, Colombia; and by the Fulbright-COLCIENCIAS-DNP grant. The funders had no role in study design, data collection and analysis, decison to publish, or preparation of the manuscript.	Abbott NJ, 1996, MOL MED TODAY, V2, P106, DOI 10.1016/1357-4310(96)88720-X; Andrei A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/1/016005; Astary GW, 2010, J NEUROSCI METH, V187, P129, DOI 10.1016/j.jneumeth.2010.01.002; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Byard RW, 2012, J FORENSIC SCI, V57, P973, DOI 10.1111/j.1556-4029.2012.02109.x; Casanova F, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006404; Chen MY, 1999, J NEUROSURG, V90, P315, DOI 10.3171/jns.1999.90.2.0315; Dubowitz DJ, 2009, J APPL PHYSIOL, V107, P244, DOI 10.1152/japplphysiol.90349.2008; Elkin BS, 2011, J NEUROTRAUM, V28, P2235, DOI 10.1089/neu.2010.1604; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Garcia JJ, 2013, J COMPUT NONLIN DYN, V8, DOI 10.1115/1.4007311; Haar PJ, 2010, PHYSIOL MEAS, V31, P1075, DOI 10.1088/0967-3334/31/9/001; Juratli TA, 2013, PHARMACOL THERAPEUT, V139, P341, DOI 10.1016/j.pharmthera.2013.05.003; Kim JH, 2012, J NEUROSCI METH, V209, P62, DOI 10.1016/j.jneumeth.2012.05.024; Krauze MT, 2005, J NEUROSURG, V103, P923, DOI 10.3171/jns.2005.103.5.0923; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; Lee SJ, 2011, J BIOMED MATER RES B, V97B, P84, DOI 10.1002/jbm.b.31789; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; LIEBERMAN DM, 1995, J NEUROSURG, V82, P1021, DOI 10.3171/jns.1995.82.6.1021; Lonser RR, 2002, J NEUROSURG, V97, P905, DOI 10.3171/jns.2002.97.4.0905; Maikala RV, 2010, INT J IND ERGONOM, V40, P125, DOI 10.1016/j.ergon.2009.02.011; Mase G.E., 1999, CONTINUUM MECH ENG; METZ H, 1970, J BIOMECH, V3, P453, DOI 10.1016/0021-9290(70)90017-5; Morrison PF, 1999, AM J PHYSIOL-REG I, V277, pR1218, DOI 10.1152/ajpregu.1999.277.4.R1218; Neeves KB, 2006, J CONTROL RELEASE, V111, P252, DOI 10.1016/j.jconrel.2005.11.018; Neeves KB, 2007, BRAIN RES, V1180, P121, DOI 10.1016/j.brainres.2007.08.050; Nicholson C, 2001, REP PROG PHYS, V64, P815, DOI 10.1088/0034-4885/64/7/202; Oh S, 2007, J NEUROSURG, V107, P568, DOI 10.3171/JNS-07/09/0568; Paxinos G, 1989, RAT BRAIN STEROTAXIC; Prabhu SS, 1998, SURG NEUROL, V50, P367, DOI 10.1016/S0090-3019(97)00361-3; Qiao M, 2004, PEDIATR RES, V55, P101, DOI 10.1203/01.PDR.0000100477.59081.FE; Quester R, 1997, J NEUROSCI METH, V75, P81, DOI 10.1016/S0165-0270(97)00050-2; Raghavan R, 2010, PHYS MED BIOL, V55, P281, DOI 10.1088/0031-9155/55/1/017; Rosenbluth KH, 2011, J NEUROSCI METH, V196, P118, DOI 10.1016/j.jneumeth.2010.12.022; ROUSCHE PJ, 1992, ANN BIOMED ENG, V20, P413, DOI 10.1007/BF02368133; Sampson JH, 2008, NEURO-ONCOLOGY, V10, P320, DOI 10.1215/15228517-2008-012; Sampson JH, 2010, J NEUROSURG, V113, P301, DOI 10.3171/2009.11.JNS091052; Sarntinoranont M, 2003, ANN BIOMED ENG, V31, P448, DOI 10.1114/1.1558032; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Szerlip NJ, 2007, J NEUROSURG, V107, P560, DOI 10.3171/JNS-07/09/0560; Tsoga A, 1999, BIOPOLYMERS, V49, P267, DOI 10.1002/(SICI)1097-0282(19990405)49:4<267::AID-BIP1>3.0.CO;2-1; Varenika V, 2008, J NEUROSURG, V109, P874, DOI 10.3171/JNS/2008/109/11/0874; Vazquez LC, 2012, J MATER SCI-MATER M, V23, P2037, DOI 10.1007/s10856-012-4652-0; Vogelbaum MA, 2007, NEUROSURGERY, V61, P1031, DOI 10.1227/01.neu.0000303199.77370.9e; Welkenhuysen M, 2011, IEEE T BIO-MED ENG, V58, P3250, DOI 10.1109/TBME.2011.2166963; Welsh JP, 1998, METHODS NEURAL ENSEM; White E, 2011, J NEUROSCI METH, V199, P87, DOI 10.1016/j.jneumeth.2011.04.027; Xu G, 2010, J BIOMECHANICAL ENG, V132; Xu G, 2009, BIOMECH MODEL MECHAN, V8, P253, DOI 10.1007/s10237-008-0131-4; YAMANE K, 1994, SURG NEUROL, V41, P477, DOI 10.1016/0090-3019(94)90011-6; Yin DL, 2011, NEUROIMAGE, V54, pS196, DOI 10.1016/j.neuroimage.2009.08.069; Yin D, 2010, J NEUROSCI METH, V187, P46, DOI 10.1016/j.jneumeth.2009.12.008	54	44	45	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e94919	10.1371/journal.pone.0094919	http://dx.doi.org/10.1371/journal.pone.0094919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776986	Green Published, Green Submitted, gold			2022-12-25	WOS:000346241800005
J	Grotegut, CA; Chisholm, CA; Johnson, LNC; Brown, HL; Heine, RP; James, AH				Grotegut, Chad A.; Chisholm, Christian A.; Johnson, Lauren N. C.; Brown, Haywood L.; Heine, R. Phillips; James, Andra H.			Medical and Obstetric Complications among Pregnant Women Aged 45 and Older	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; ADVANCED MATERNAL AGE; UNITED-STATES; OOCYTE DONATION; OUTCOMES; MORBIDITY; HOSPITALIZATIONS; DELIVERY; RISK	Objective: The number of women aged 45 and older who become pregnant is increasing. The objective of this study was to estimate the risk of medical and obstetric complications among women aged 45 and older. Methods: The Nationwide Inpatient Sample was used to identify pregnant woman during admission for delivery. Deliveries were identified using International Classification of Diseases, Ninth Revision (ICD-9-CM) codes. Using ICD-9-CM codes, preexisting medical conditions and medical and obstetric complications were identified in women at the time of delivery and were compared for women aged 45 years and older to women under age 35. Outcomes among women aged 35-44 were also compared to women under age 35 to determine if women in this group demonstrated intermediate risk between the older and younger groups. Logistic regression analyses were used to calculate odds ratios with 95% confidence intervals for pre-existing medical conditions and medical and obstetric complications for both older groups relative to women under 35. Multivariable logistic regression analyses were also developed for outcomes at delivery among older women, while controlling for pre-existing medical conditions, multiple gestation, and insurance status, to determine the effect of age on the studied outcomes. Results: Women aged 45 and older had higher adjusted odds for death, transfusion, myocardial infarction/ischemia, cardiac arrest, acute heart failure, pulmonary embolism, deep vein thrombosis, acute renal failure, cesarean delivery, gestational diabetes, fetal demise, fetal chromosomal anomaly, and placenta previa compared to women under 35. Conclusion: Pregnant women aged 45 and older experience significantly more medical and obstetric complications and are more likely to die at the time of a delivery than women under age 35, though the absolute risks are low and these events are rare. Further research is needed to determine what associated factors among pregnant women aged 45 and older may contribute to these findings.	[Grotegut, Chad A.; Brown, Haywood L.; Heine, R. Phillips] Duke Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Durham, NC 27708 USA; [Chisholm, Christian A.; James, Andra H.] Univ Virginia, Div Maternal Fetal Med, Dept Obstet & Gynecol, Charlottesville, VA USA; [Johnson, Lauren N. C.] Univ Penn, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Philadelphia, PA 19104 USA	Duke University; University of Virginia; University of Pennsylvania	Grotegut, CA (corresponding author), Duke Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Durham, NC 27708 USA.	chad.grotegut@duke.edu	Heine, R. Phillips/AAR-1189-2020	James, Andra/0000-0003-4570-6595				ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Amer Coll Obstetricians, 2008, FERTIL STERIL, V90, pS154, DOI 10.1016/j.fertnstert.2008.08.130; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; [Anonymous], 2012, FERTILITY STERILITY; Berg CJ, 2003, OBSTET GYNECOL, V101, P289, DOI 10.1016/S0029-7844(02)02587-5; Bianco A, 1996, OBSTET GYNECOL, V87, P917, DOI 10.1016/0029-7844(96)00045-2; Centers for Disease Control and Prevention, NAT CTR HLTH STAT VI; Cheng YW, 2009, OBSTET GYNECOL, V114, P326, DOI 10.1097/AOG.0b013e3181ae8d85; CLARK SL, 1989, AM J OBSTET GYNECOL, V161, P1439, DOI 10.1016/0002-9378(89)90900-9; Dulitzki M, 1998, OBSTET GYNECOL, V92, P935, DOI 10.1016/S0029-7844(98)00335-4; Ethics Comm Amer Soc Reprod Med, 2004, FERTIL STERIL, V82, pS254, DOI 10.1016/j.fertnstert.2004.05.027; Healthcare Cost and Utilization Project  Agency for Healthcare Research and Quality, OV NAT INP SAMPL NIS; Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087; Hoffman MC, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.862; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; Hoyert Donna L, 2007, Vital Health Stat 3, P1; James AH, 2006, CIRCULATION, V113, P1564, DOI 10.1161/CIRCULATIONAHA.105.576751; James AH, 2005, OBSTET GYNECOL, V106, P509, DOI 10.1097/01.AOG.0000172428.78411.b0; Kuklina EV, 2011, BJOG-INT J OBSTET GY, V118, P345, DOI 10.1111/j.1471-0528.2010.02743.x; Kuklina EV, 2008, MATERN CHILD HLTH J, V12, P469, DOI 10.1007/s10995-007-0256-6; Kuklina EV, 2010, OBSTET GYNECOL, V115, P93, DOI 10.1097/AOG.0b013e3181c4ee8c; Kuklina EV, 2009, OBSTET GYNECOL, V113, P293, DOI 10.1097/AOG.0b013e3181954e5b; Laskov I, 2012, J MATERNAL FETAL NEN; LUND CJ, 1967, AM J OBSTET GYNECOL, V98, P393, DOI 10.1016/0002-9378(67)90160-3; Martin Joyce A, 2012, Natl Vital Stat Rep, V61, P1; MENKEN J, 1986, SCIENCE, V233, P1389, DOI 10.1126/science.3755843; Naylor CD, 1997, NEW ENGL J MED, V337, P1591, DOI 10.1056/NEJM199711273372204; Paulson RJ, 2002, JAMA-J AM MED ASSOC, V288, P2320, DOI 10.1001/jama.288.18.2320; PRITCHAR.JA, 1965, ANESTHESIOLOGY, V26, P393, DOI 10.1097/00000542-196507000-00004; Rudick B, 2010, FERTIL STERIL, V94, P2642, DOI 10.1016/j.fertnstert.2010.04.079; Salihu HM, 2003, OBSTET GYNECOL, V102, P1006, DOI 10.1016/S0029-7844(03)00739-7; SAUER MV, 1995, FERTIL STERIL, V64, P111, DOI 10.1016/S0015-0282(16)57665-1; SAUER MV, 1990, NEW ENGL J MED, V323, P1157, DOI 10.1056/NEJM199010253231702; Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2; Universtiy of Ottawa. Society the Individual and Medicine, ATTR RISK POP ATTR R	35	40	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e96237	10.1371/journal.pone.0096237	http://dx.doi.org/10.1371/journal.pone.0096237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769856	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736600032
J	Rivest, EB; Hofmann, GE				Rivest, Emily B.; Hofmann, Gretchen E.			Responses of the Metabolism of the Larvae of Pocillopora damicornis to Ocean Acidification and Warming	PLOS ONE			English	Article							LIFE-HISTORY STAGES; CORAL-REEF; ELEVATED-TEMPERATURE; CLIMATE-CHANGE; EMBRYONIC-DEVELOPMENT; SCLERACTINIAN CORALS; OXYGEN-CONSUMPTION; THERMAL TOLERANCE; ENERGY-METABOLISM; MARINE ECOSYSTEMS	Ocean acidification and warming are expected to threaten the persistence of tropical coral reef ecosystems. As coral reefs face multiple stressors, the distribution and abundance of corals will depend on the successful dispersal and settlement of coral larvae under changing environmental conditions. To explore this scenario, we used metabolic rate, at holobiont and molecular levels, as an index for assessing the physiological plasticity of Pocillopora damicornis larvae from this site to conditions of ocean acidity and warming. Larvae were incubated for 6 hours in seawater containing combinations of CO2 concentration (450 and 950 mu atm) and temperature (28 and 30 degrees C). Rates of larval oxygen consumption were higher at elevated temperatures. In contrast, high CO2 levels elicited depressed metabolic rates, especially for larvae released later in the spawning period. Rates of citrate synthase, a rate-limiting enzyme in aerobic metabolism, suggested a biochemical limit for increasing oxidative capacity in coral larvae in a warming, acidifying ocean. Biological responses were also compared between larvae released from adult colonies on the same day (cohorts). The metabolic physiology of Pocillopora damicornis larvae varied significantly by day of release. Additionally, we used environmental data collected on a reef in Moorea, French Polynesia to provide information about what adult corals and larvae may currently experience in the field. An autonomous pH sensor provided a continuous time series of pH on the natal fringing reef. In February/March, 2011, pH values averaged 8.075 +/- 0.023. Our results suggest that without adaptation or acclimatization, only a portion of naive Pocillopora damicornis larvae may have suitable metabolic phenotypes for maintaining function and fitness in an end-of-the century ocean.	[Rivest, Emily B.; Hofmann, Gretchen E.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Rivest, EB (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	emily.rivest@lifesci.ucsb.edu			Moorea Coral Reef Long Term Ecological Research mini-grant; National Science Foundation; University of California; Division Of Ocean Sciences [1236905] Funding Source: National Science Foundation	Moorea Coral Reef Long Term Ecological Research mini-grant; National Science Foundation(National Science Foundation (NSF)); University of California(University of California System); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by the Moorea Coral Reef Long Term Ecological Research mini-grant awarded to E. B. R. and G. E. H. E. B. R. was supported by the National Science Foundation Graduate Research Fellowship Program. Portions of this project were supported by funds from the University of California in support of a multi-campus research program, Ocean Acidification: A Training and Research Consortium (http://oceanacidification.msi.ucsb.edu/) to G. E. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2014, MAR BIOL, V161, P531, DOI 10.1007/s00227-013-2355-9; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; [Anonymous], 2007, AR4 CLIM CHANG 2007; [Anonymous], 2007, N PACIFIC MARINE SCI; [Anonymous], CLIMATE CHANGE 2007; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Bibby R, 2007, BIOLOGY LETT, V3, P699, DOI 10.1098/rsbl.2007.0457; Boatta F, 2013, MAR POLLUT BULL, V73, P485, DOI 10.1016/j.marpolbul.2013.01.029; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckley LB, 2012, ANNU REV ECOL EVOL S, V43, P205, DOI 10.1146/annurev-ecolsys-110411-160516; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Chierici M, 2009, BIOGEOSCIENCES, V6, P2421, DOI 10.5194/bg-6-2421-2009; CHILDRESS JJ, 1990, AM ZOOL, V30, P161; CHU KH, 1994, J EXP MAR BIOL ECOL, V183, P11, DOI 10.1016/0022-0981(94)90153-8; Chua CM, 2013, MAR ECOL PROG SER, V486, P143, DOI 10.3354/meps10318; Cohen AA, 2012, TRENDS ECOL EVOL, V27, P428, DOI 10.1016/j.tree.2012.04.008; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Crawley MJ, 2013, R BOOK, P557; Cumbo VR, 2013, J EXP MAR BIOL ECOL, V439, P100, DOI 10.1016/j.jembe.2012.10.019; Cumbo VR, 2012, MAR BIOL, V159, P2853, DOI 10.1007/s00227-012-2046-y; Cumbo VR, 2013, MAR BIOL, V160, P2903, DOI 10.1007/s00227-013-2280-y; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Edmunds PJ, 2013, J EXP MAR BIOL ECOL, V443, P33, DOI 10.1016/j.jembe.2013.02.032; Edmunds PJ, 2012, GLOBAL CHANGE BIOL, V18, P2173, DOI 10.1111/j.1365-2486.2012.02695.x; Edmunds PJ, 2005, MAR BIOL, V146, P655, DOI 10.1007/s00227-004-1485-5; Edmunds PJ, 2001, MAR BIOL, V139, P981; Evans TG, 2012, PHILOS T R SOC B, V367, P1733, DOI 10.1098/rstb.2012.0019; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fan TY, 2006, MAR ECOL PROG SER, V321, P133, DOI 10.3354/meps321133; Fan TY, 2002, ZOOL STUD, V41, P288; Fangue NA, 2010, LIMNOL OCEANOGR-METH, V8, P441, DOI 10.4319/lom.2010.8.441; Feely RA, 2008, B AM METEOROLOGICAL, pS1; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Forsman ZH, 2013, OCEANOGRAPHY, V26, P153, DOI 10.5670/oceanog.2013.58; Frieder CA, 2012, BIOGEOSCIENCES, V9, P3917, DOI 10.5194/bg-9-3917-2012; Gagliano M, 2010, MAR BIOL, V157, P1849, DOI 10.1007/s00227-010-1456-y; Gaither MR, 2010, J EXP MAR BIOL ECOL, V386, P45, DOI 10.1016/j.jembe.2010.02.003; GATTUSO JP, 1993, MAR ECOL PROG SER, V92, P267, DOI 10.3354/meps092267; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Guadayol O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085213; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hand S.C., 1991, Advances in Comparative and Environmental Physiology, V8, P1; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Harii S, 2010, MAR BIOL, V157, P1215, DOI 10.1007/s00227-010-1401-0; Harriott V.J., 1983, Coral Reefs, V2, P151, DOI 10.1007/BF00336721; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Hauri C, 2009, OCEANOGRAPHY, V22, P60, DOI 10.5670/oceanog.2009.97; HAZEL JR, 1974, PHYSIOL REV, V54, P620, DOI 10.1152/physrev.1974.54.3.620; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hofmann GE, 2013, OCEANOGRAPHY, V26, P140, DOI 10.5670/oceanog.2013.56; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; JAECKLE WB, 1989, BIOL BULL, V177, P237, DOI 10.2307/1541939; Jan S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004887; Jimenez IM, 2008, LIMNOL OCEANOGR, V53, P1548, DOI 10.4319/lo.2008.53.4.1548; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Karnauskas KB, 2012, NAT CLIM CHANGE, V2, P530, DOI 10.1038/NCLIMATE1499; Kelly MW, 2013, FUNCT ECOL, V27, P980, DOI 10.1111/j.1365-2435.2012.02061.x; Kelly SA, 2012, COMPR PHYSIOL, V2, P1417, DOI 10.1002/cphy.c110008; KIESSLING A, 1991, AQUACULTURE, V93, P357, DOI 10.1016/0044-8486(91)90226-W; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Lemos D, 2003, COMP BIOCHEM PHYS B, V135, P707, DOI 10.1016/S1096-4959(03)00166-0; LESSER MP, 1994, J EXP MAR BIOL ECOL, V178, P153, DOI 10.1016/0022-0981(94)90034-5; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; Marsh AG, 1999, J EXP BIOL, V202, P2041; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2009, AQUAT TOXICOL, V92, P30, DOI 10.1016/j.aquatox.2008.12.011; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Moran AL, 2004, J EXP MAR BIOL ECOL, V306, P17, DOI 10.1016/j.jembe.2003.12.021; Moyes CD, 2003, J EXP BIOL, V206, P4385, DOI 10.1242/jeb.00699; Munday PL, 2009, MAR ECOL PROG SER, V388, P235, DOI 10.3354/meps08137; Nakamura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014521; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; O'Donnell M, 2009, MAR BIOL, V156, P439, DOI 10.1007/s00227-008-1097-6; Ohde S, 1999, B MAR SCI, V65, P559; Okubo N, 2008, MAR ECOL PROG SER, V366, P305, DOI 10.3354/meps07562; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 1998, J EXP BIOL, V201, P43; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; Putnam HM, 2010, INVERTEBR BIOL, V129, P199, DOI 10.1111/j.1744-7410.2010.00199.x; Reipschloger A., 1996, OCEAN STORAGE CARBON, P57; Richmond R., 1982, Proceedings of the International Coral Reef Symposium, P153; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; RICHMOND RH, 1984, B MAR SCI, V34, P280; Robbins L. L., 2010, USGS NUMBERED SERIES; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Sheppard Brennand H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011372; Sokolova IM, 2013, INTEGR COMP BIOL, V53, P597, DOI 10.1093/icb/ict028; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; THUESEN EV, 1994, BIOL BULL-US, V187, P84, DOI 10.2307/1542168; Torda G, 2013, MOL ECOL, V22, P5821, DOI 10.1111/mec.12539; Veron J.E.N., 2000, CORALS WORLD, V1-3; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Walther K, 2009, BIOGEOSCIENCES, V6, P2207, DOI 10.5194/bg-6-2207-2009; Walther K, 2010, MAR ECOL PROG SER, V417, P159, DOI 10.3354/meps08807; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; Weiss M, 2012, J EXP MAR BIOL ECOL, V413, P100, DOI 10.1016/j.jembe.2011.11.023; Wootton JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053396; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yates KK, 2007, MAR CHEM, V104, P110, DOI 10.1016/j.marchem.2006.12.008; Yates KK, 2006, ESTUARIES COASTS, V29, P24, DOI 10.1007/BF02784696; Yu PC, 2011, J EXP MAR BIOL ECOL, V400, P288, DOI 10.1016/j.jembe.2011.02.016; Zuur Alain F., 2009, P1	126	55	57	2	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e96172	10.1371/journal.pone.0096172	http://dx.doi.org/10.1371/journal.pone.0096172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769774	gold, Green Submitted, Green Published			2022-12-25	WOS:000336736600028
J	Michalkova, V; Benoit, JB; Attardo, GM; Medlock, J; Aksoy, S				Michalkova, Veronika; Benoit, Joshua B.; Attardo, Geoffrey M.; Medlock, Jan; Aksoy, Serap			Amelioration of Reproduction-Associated Oxidative Stress in a Viviparous Insect Is Critical to Prevent Reproductive Senescence	PLOS ONE			English	Article							FLY GLOSSINA-MORSITANS; TSETSE-FLY; FAT-BODY; DROSOPHILA-MELANOGASTER; SUPEROXIDE-DISMUTASE; GENE-EXPRESSION; UTERINE GLAND; TRADE-OFFS; MILK GLAND; FRUIT-FLY	Impact of reproductive processes upon female health has yielded conflicting results; particularly in relation to the role of reproduction-associated stress. We used the viviparous tsetse fly to determine if lactation, birth and involution lead to damage from oxidative stress (OS) that impairs subsequent reproductive cycles. Tsetse females carry an intrauterine larva to full term at each pregnancy cycle, and lactate to nourish them with milk secretions produced by the accessory gland (= milk gland) organ. Unlike most K-strategists, tsetse females lack an apparent period of reproductive senescence allowing the production of 8-10 progeny over their entire life span. In a lactating female, over 47% of the maternal transcriptome is associated with the generation of milk proteins. The resulting single larval offspring weighs as much as the mother at birth. In studying this process we noted an increase in specific antioxidant enzyme (AOE) transcripts and enzymatic activity at critical times during lactation, birth and involution in the milk gland/fat body organ and the uterus. Suppression of superoxide dismutase (sod) decreased fecundity in subsequent reproductive cycles in young mothers and nearly abolished fecundity in geriatric females. Loss of fecundity was in part due to the inability of the mother to produce adequate milk to support larval growth. Longevity was also impaired after sod knockdown. Generation of OS in virgin females through exogenous treatment with hydrogen peroxide at times corresponding to pregnancy intervals reduced survival, which was exacerbated by sod knockdown. AOE expression may prevent oxidative damage associated with the generation of nutrients by the milk gland, parturition and milk gland breakdown. Our results indicate that prevention of OS is essential for females to meet the growing nutritional demands of juveniles during pregnancy and to repair the damage that occurs at birth. This process is particularly important for females to remain fecund during the latter portion of their lifetime.	[Michalkova, Veronika; Benoit, Joshua B.; Attardo, Geoffrey M.; Aksoy, Serap] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Michalkova, Veronika] Slovak Acad Sci, Inst Zool, Sect Mol & Appl Zool, Bratislava, Slovakia; [Medlock, Jan] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA	Yale University; Slovak Academy of Sciences; Oregon State University	Benoit, JB (corresponding author), Univ Cincinnati, McMicken Coll Arts & Sci, Dept Biol Sci, Cincinnati, OH 45221 USA.	joshua.benoit@uc.edu	Aksoy, Serap/K-2244-2019; Attardo, Geoffrey Michael/I-3320-2019	Aksoy, Serap/0000-0001-9941-143X; Attardo, Geoffrey Michael/0000-0001-6265-2969	National Institutes of Health [AI081774]; Ambrose Monell Foundation; NIH [F32AI093023]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081774, R21AI109263, F32AI093023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ambrose Monell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study received support from the National Institutes of Health grant AI081774 and Ambrose Monell Foundation awarded to SA and from NIH F32AI093023 to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOMED ONLINE, V11, P641, DOI 10.1016/S1472-6483(10)61174-1; Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Alonso-Alvarez C, 2010, PHYSIOL BIOCHEM ZOOL, V83, P110, DOI 10.1086/605395; Attardo GM, 2008, J INSECT PHYSIOL, V54, P1236, DOI 10.1016/j.jinsphys.2008.06.008; Attardo GM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002645; Attardo GM, 2012, INSECT BIOCHEM MOLEC, V42, P360, DOI 10.1016/j.ibmb.2012.01.007; Attardo GM, 2006, J INSECT PHYSIOL, V52, P1128, DOI 10.1016/j.jinsphys.2006.07.007; Back P, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/608478; Baumann AA, 2013, MOL CELL ENDOCRINOL, V372, P30, DOI 10.1016/j.mce.2013.02.019; Benoit JB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003874; Benoit JB, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100008; Benoit JB, 2011, J INSECT PHYSIOL, V57, P1553, DOI 10.1016/j.jinsphys.2011.08.009; Blagosklonny MV, 2007, CELL CYCLE, V6, P2997, DOI 10.4161/cc.6.24.5124; Blagosklonny MV, 2006, CELL CYCLE, V5, P2087, DOI 10.4161/cc.5.18.3288; Blagosklonny MV, 2012, AGING-US, V4, P861, DOI 10.18632/aging.100525; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; BURSELL E, 1977, INSECT BIOCHEM, V7, P427, DOI 10.1016/S0020-1790(77)90068-3; Cabreiro F, 2011, FREE RADICAL BIO MED, V51, P1575, DOI 10.1016/j.freeradbiomed.2011.07.020; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; Carey JR, 1998, J GERONTOL A-BIOL, V53, pB245, DOI 10.1093/gerona/53A.4.B245; Castillo C, 2006, RES VET SCI, V80, P133, DOI 10.1016/j.rvsc.2005.06.003; Castillo C, 2005, VET J, V169, P286, DOI 10.1016/j.tvjl.2004.02.001; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; CMELIK SHW, 1969, COMP BIOCHEM PHYSIOL, V29, P447, DOI 10.1016/0010-406X(69)91764-2; Dao A, 2010, J MED ENTOMOL, V47, P769, DOI 10.1603/ME10052; De Loof A, 2011, J INSECT PHYSIOL, V57, P1, DOI 10.1016/j.jinsphys.2010.08.018; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; DENLINGER DL, 1974, J INSECT PHYSIOL, V20, P1015, DOI 10.1016/0022-1910(74)90143-7; Diaz-Albiter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017486; Duan RD, 2007, EUR J LIPID SCI TECH, V109, P987, DOI 10.1002/ejlt.200700074; Duan RD, 2011, J DIGEST DIS, V12, P60, DOI 10.1111/j.1751-2980.2011.00481.x; Fedorka KM, 2004, EVOLUTION, V58, P2478; Garratt M, 2011, P ROY SOC B-BIOL SCI, V278, P1098, DOI 10.1098/rspb.2010.1818; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Gillespie MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-452; Ginger MR, 1999, COMP BIOCHEM PHYS B, V124, P133, DOI 10.1016/S0305-0491(99)00110-8; Guz N, 2007, J INSECT PHYSIOL, V53, P715, DOI 10.1016/j.jinsphys.2007.03.013; Halliwell B., 2007, FREE RADICALS BIOL M; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; HECKER H, 1983, J INSECT PHYSIOL, V29, P651, DOI 10.1016/0022-1910(83)90018-5; Heiss RS, 2012, PHYSIOL BIOCHEM ZOOL, V85, P499, DOI 10.1086/666840; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Hettinga K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019433; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Jarry M, 1996, ENTOMOL EXP APPL, V78, P51, DOI 10.1007/BF00304456; Jasienska G, 2009, AM J HUM BIOL, V21, P524, DOI 10.1002/ajhb.20931; Khazaeli AA, 2013, J GERONTOL A-BIOL, V68, P546, DOI 10.1093/gerona/gls226; Kontopidis G, 2004, J DAIRY SCI, V87, P785, DOI 10.3168/jds.S0022-0302(04)73222-1; LANGLEY PA, 1981, INSECT BIOCHEM, V11, P225, DOI 10.1016/0020-1790(81)90100-1; Langley PA, 1998, FUNCT ECOL, V12, P866, DOI 10.1046/j.1365-2435.1998.00262.x; LANGLEY PA, 1980, INSECT BIOCHEM, V10, P11, DOI 10.1016/0020-1790(80)90033-5; Le Bourg E, 2001, FEBS LETT, V498, P183, DOI 10.1016/S0014-5793(01)02457-7; Lefevre CM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-417; Lemay DG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r43; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Lewis KN, 2013, ANTIOXID REDOX SIGN, V19, P1388, DOI 10.1089/ars.2012.4911; Lopez-Martinez G, 2008, INSECT BIOCHEM MOLEC, V38, P796, DOI 10.1016/j.ibmb.2008.05.006; Lopez-Martinez G, 2012, J EXP BIOL, V215, P2150, DOI 10.1242/jeb.065631; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004; MA WC, 1975, TISSUE CELL, V7, P319, DOI 10.1016/0040-8166(75)90008-7; MADUBUNYI LC, 1989, INSECT SCI APPL, V10, P75, DOI 10.1017/S1742758400003374; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Metcalfe NB, 2013, TRENDS ECOL EVOL, V28, P347, DOI 10.1016/j.tree.2013.01.015; MOLOO SK, 1971, PARASITOLOGY, V63, P507, DOI 10.1017/S0031182000080021; Munks RJL, 2005, INSECT MOL BIOL, V14, P483, DOI 10.1111/j.1365-2583.2005.00579.x; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Neville MC, 1997, ANNU REV NUTR, V17, P159, DOI 10.1146/annurev.nutr.17.1.159; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Novoseltsev VN, 2003, J GERONTOL A-BIOL, V58, P484; Nyberg L, 1998, J PEDIATR GASTR NUTR, V27, P560, DOI 10.1097/00005176-199811000-00013; O'Donnell R, 2004, INT DAIRY J, V14, P1013, DOI 10.1016/j.idairyj.2004.04.004; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oldakowski L, 2012, J EXP BIOL, V215, P1799, DOI 10.1242/jeb.068452; Owens IPF, 1999, TRENDS ECOL EVOL, V14, P170, DOI 10.1016/S0169-5347(98)01580-8; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; Pais R, 2008, APPL ENVIRON MICROB, V74, P5965, DOI 10.1128/AEM.00741-08; Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011; Piccione G, 2012, REPROD DOMEST ANIM, V47, P591, DOI 10.1111/j.1439-0531.2011.01925.x; Piccione G, 2007, ACTA AGR SCAND A-AN, V19, P1; PIMLEY RW, 1981, J INSECT PHYSIOL, V27, P839, DOI 10.1016/0022-1910(81)90085-8; PIMLEY RW, 1982, J INSECT PHYSIOL, V28, P781, DOI 10.1016/0022-1910(82)90139-1; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rijnkels M, 2002, J MAMMARY GLAND BIOL, V7, P327, DOI 10.1023/A:1022808918013; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Salmon AB, 2001, EVOLUTION, V55, P1600, DOI 10.1111/j.0014-3820.2001.tb00679.x; Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015; Sharma N, 2011, ASIAN AUSTRAL J ANIM, V24, P479, DOI 10.5713/ajas.2011.10220; Singh K, 2008, J DAIRY SCI, V91, P2236, DOI 10.3168/jds.2007-0900; Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132; Strickler-Dinglasan PM, 2006, INSECT BIOCHEM MOLEC, V36, P921, DOI 10.1016/j.ibmb.2006.09.003; TOBE SS, 1978, EXPERIENTIA, V34, P1462, DOI 10.1007/BF01932354; TOBE SS, 1978, ANNU REV ENTOMOL, V23, P283, DOI 10.1146/annurev.en.23.010178.001435; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Wang Y, 2001, EXP GERONTOL, V36, P1349, DOI 10.1016/S0531-5565(01)00095-X; Weiss BL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000619; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; Wit J, 2013, EXP GERONTOL, V48, P349, DOI 10.1016/j.exger.2013.01.008; Yang G, 2010, INSECT MOL BIOL, V19, P253, DOI 10.1111/j.1365-2583.2009.00987.x	105	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e87554	10.1371/journal.pone.0087554	http://dx.doi.org/10.1371/journal.pone.0087554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763119	Green Submitted, Green Published, gold			2022-12-25	WOS:000335505000002
J	Zhang, X; Ge, XL; Shi, W; Huang, P; Min, QJ; Li, MH; Yu, XP; Wu, YM; Zhao, GY; Tong, Y; Jin, ZB; Qu, J; Gu, F				Zhang, Xiao; Ge, Xianglian; Shi, Wei; Huang, Ping; Min, Qingjie; Li, Minghan; Yu, Xinping; Wu, Yaming; Zhao, Guangyu; Tong, Yi; Jin, Zi-Bing; Qu, Jia; Gu, Feng			Molecular Diagnosis of Putative Stargardt Disease by Capture Next Generation Sequencing	PLOS ONE			English	Article							CONE-ROD DYSTROPHY; ABCA4 ABCR GENE; MACULAR DEGENERATION; RETINITIS-PIGMENTOSA; FRAMESHIFT MUTATION; PROM1 GENE; SPECTRUM; CHROMOSOME-4; EXOME; MAPS	Stargardt Disease (STGD) is the commonest genetic form of juvenile or early adult onset macular degeneration, which is a genetically heterogeneous disease. Molecular diagnosis of STGD remains a challenge in a significant proportion of cases. To address this, seven patients from five putative STGD families were recruited. We performed capture next generation sequencing (CNGS) of the probands and searched for potentially disease-causing genetic variants in previously identified retinal or macular dystrophy genes. Seven disease-causing mutations in ABCA4 and two in PROM1 were identified by CNGS, which provides a confident genetic diagnosis in these five families. We also provided a genetic basis to explain the differences among putative STGD due to various mutations in different genes. Meanwhile, we show for the first time that compound heterozygous mutations in PROM1 gene could cause cone-rod dystrophy. Our findings support the enormous potential of CNGS in putative STGD molecular diagnosis.	[Zhang, Xiao; Ge, Xianglian; Li, Minghan; Yu, Xinping; Jin, Zi-Bing; Qu, Jia; Gu, Feng] Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xiao; Ge, Xianglian; Li, Minghan; Yu, Xinping; Jin, Zi-Bing; Qu, Jia; Gu, Feng] Minist Hlth, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xiao; Ge, Xianglian; Li, Minghan; Yu, Xinping; Jin, Zi-Bing; Qu, Jia; Gu, Feng] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Shi, Wei] Capital Med Univ, Beijing Childrens Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Huang, Ping] Wenzhou Med Univ, Dept Dev & Planning, Wenzhou, Zhejiang, Peoples R China; [Min, Qingjie] Wenzhou Med Univ, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China; [Wu, Yaming] Wenzhou Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Wenzhou, Zhejiang, Peoples R China; [Zhao, Guangyu; Tong, Yi] Fuzhou Southeastern Eye Hosp, Fuzhou, Peoples R China	Wenzhou Medical University; Capital Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Gu, F (corresponding author), Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China.	gufenguw@gmail.com	Jin, Zi-Bing/J-6810-2014; Jin, Zi-Bing/AAE-4106-2019	Jin, Zi-Bing/0000-0003-0515-698X; Jin, Zi-Bing/0000-0003-0515-698X; Zhang, Xiao/0000-0002-8599-3181; Gu, Feng/0000-0002-9600-8407	Chinese National Program on Key Basic Research Project (973 Program) [2013CB967502]; Natural Science Foundation of China [81201181/H1818]; Zhejiang provincial & Ministry of Health research fund for medical sciences [WKJ2013-2-023]; Wenzhou Medical College [QTJ12011]	Chinese National Program on Key Basic Research Project (973 Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang provincial & Ministry of Health research fund for medical sciences; Wenzhou Medical College	This work was supported by grants from the Chinese National Program on Key Basic Research Project (973 Program, 2013CB967502, F.G.), the Natural Science Foundation of China (81201181/H1818, F.G.), Zhejiang provincial & Ministry of Health research fund for medical sciences (WKJ2013-2-023, F.G.), Wenzhou Medical College PI starting grant (QTJ12011, F.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 1997, NAT GENET, V17, P122, DOI 10.1038/ng0997-122b; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Baum L, 2003, OPHTHALMOLOGICA, V217, P111, DOI 10.1159/000068553; Chacon-Camacho OF, 2013, EXP EYE RES, V109, P77, DOI 10.1016/j.exer.2013.02.006; Coffey AJ, 2011, EUR J HUM GENET, V19, P827, DOI 10.1038/ejhg.2011.28; Duno M, 2012, OPHTHALMIC GENET, V33, P225, DOI 10.3109/13816810.2011.643441; Fujinami K, 2013, INVEST OPHTH VIS SCI, V54, P6662, DOI 10.1167/iovs.13-12570; Glockle N, 2014, EUR J HUM GENET, V22, P99, DOI 10.1038/ejhg.2013.72; Huang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063832; Jaakson K, 2003, HUM MUTAT, V22, P395, DOI 10.1002/humu.10263; Klevering BJ, 2004, EUR J HUM GENET, V12, P1024, DOI 10.1038/sj.ejhg.5201258; Kniazeva M, 1999, AM J HUM GENET, V64, P1394, DOI 10.1086/302377; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Michaelides M, 2007, BRIT J OPHTHALMOL, V91, P1650, DOI 10.1136/bjo.2007.118356; Michaelides M, 2003, INVEST OPHTH VIS SCI, V44, P1657, DOI 10.1167/iovs.02-0941; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Permanyer J, 2010, INVEST OPHTH VIS SCI, V51, P2656, DOI 10.1167/iovs.09-4857; Pras E, 2009, MOL VIS, V15, P1709; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Scholl HPN, 2001, INVEST OPHTH VIS SCI, V42, P1380; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; September AV, 2004, INVEST OPHTH VIS SCI, V45, P1705, DOI 10.1167/iovs.03-1167; Strom SP, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-67; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Zernant J, 2011, INVEST OPHTH VIS SCI, V52, P8479, DOI 10.1167/iovs.11-8182; Zhang QJ, 2007, HUM GENET, V122, P293, DOI 10.1007/s00439-007-0395-2	29	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95528	10.1371/journal.pone.0095528	http://dx.doi.org/10.1371/journal.pone.0095528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763286	gold, Green Submitted, Green Published			2022-12-25	WOS:000335505000023
J	Devanathan, S; Erban, A; Perez-Torres, R; Kopka, J; Makaroff, CA				Devanathan, Sriram; Erban, Alexander; Perez-Torres, Rodolfo, Jr.; Kopka, Joachim; Makaroff, Christopher A.			Arabidopsis thaliana Glyoxalase 2-1 Is Required during Abiotic Stress but Is Not Essential under Normal Plant Growth	PLOS ONE			English	Article							GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; TRIOSEPHOSPHATE ISOMERASE; HETEROLOGOUS EXPRESSION; MOLECULAR-CLONING; PURIFICATION; LIVER; RAT; INVOLVEMENT; TOLERANCE	The glyoxalase pathway, which consists of the two enzymes, GLYOXALASE 1 (GLX 1) (E. C.: 4.4.1.5) and 2 (E. C. 3.1.2.6), has a vital role in chemical detoxification. In Arabidopsis thaliana there are at least four different isoforms of glyoxalase 2, two of which, GLX2-1 and GLX2-4 have not been characterized in detail. Here, the functional role of Arabidopsis thaliana GLX2-1 is investigated. Glx2-1 loss-of-function mutants and plants that constitutively over-express GLX2-1 resemble wild-type plants under normal growth conditions. Insilico analysis of publicly available microarray datasets with ATTEDII, Mapman and Genevestigator indicate potential role(s) in stress response and acclimation. Results presented here demonstrate that GLX21 gene expression is up-regulated in wild type Arabidopsis thaliana by salt and anoxia stress, and by excess L-Threonine. Additionally, a mutation in GLX2-1 inhibits growth and survival during abiotic stresses. Metabolic profiling studies show alterations in the levels of sugars and amino acids during threonine stress in the plants. Elevated levels of polyamines, which are known stress markers, are also observed. Overall our results suggest that Arabidopsis thaliana GLX2-1 is not essential during normal plant life, but is required during specific stress conditions.	[Devanathan, Sriram; Perez-Torres, Rodolfo, Jr.; Makaroff, Christopher A.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA; [Erban, Alexander; Kopka, Joachim] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	University System of Ohio; Miami University; Max Planck Society	Devanathan, S (corresponding author), Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA.	devanas@miamioh.edu	devanathan, sriram/H-6519-2014	Makaroff, Christopher/0000-0001-6237-1868; Kopka, Joachim/0000-0001-9675-4883	Miami University	Miami University	The work was supported in part from funds from Miami University. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; Allwood JW, 2009, METABOLOMICS, V5, P479, DOI 10.1007/s11306-009-0169-z; [Anonymous], FEBS J, V276, P7177; BALL JC, 1979, ABSTR PAP AM CHEM S, P44; Bito A, 1999, PROTEIN EXPRES PURIF, V17, P456, DOI 10.1006/prep.1999.1151; CASAZZA JP, 1984, J BIOL CHEM, V259, P231; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crowder MW, 1997, FEBS LETT, V418, P351, DOI 10.1016/S0014-5793(97)01416-6; Daub CO, 2003, BIOINFORMATICS, V19, P2332, DOI 10.1093/bioinformatics/btg321; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Ellis MH, 1999, PLANT PHYSIOL, V119, P57, DOI 10.1104/pp.119.1.57; Erban Alexander, 2007, V358, P19, DOI 10.1007/978-1-59745-244-1_2; Fiehn O, 2000, ANAL CHEM, V72, P3573, DOI 10.1021/ac991142i; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; HAN LPB, 1975, FED PROC, V34, P496; Holdorf MM, 2008, J INORG BIOCHEM, V102, P1825, DOI 10.1016/j.jinorgbio.2008.06.003; Holdorf MM, 2012, PLANT PHYSIOL, V160, P226, DOI 10.1104/pp.112.201855; Huang J, 2000, PLANT PHYSIOL, V122, P747, DOI 10.1104/pp.122.3.747; Irsch T, 2004, J BIOL CHEM, V279, P22209, DOI 10.1074/jbc.M401240200; Jones R., 2000, BIOCH MOL BIOL PLANT, P1158, DOI DOI 10.12691/WJAR-2-2-2; KURASAWA S, 1976, AGR BIOL CHEM TOKYO, V40, P559, DOI 10.1080/00021369.1976.10862080; Limphong P, 2009, BIOCHEM J, V417, P323, DOI 10.1042/BJ20081151; Limphong P, 2010, BIOCHEMISTRY-US, V49, P8228, DOI 10.1021/bi1010865; Limphong P, 2009, BIOCHEMISTRY-US, V48, P8491, DOI 10.1021/bi9010539; Liu J, 2008, J PLANT BIOL, V51, P11, DOI 10.1007/BF03030735; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Maiti MK, 1997, PLANT MOL BIOL, V35, P471, DOI 10.1023/A:1005891123344; MANNERVIK B, 1982, METHOD ENZYMOL, V90, P535; Marasinghe GPK, 2005, J BIOL CHEM, V280, P40668, DOI 10.1074/jbc.M509748200; MILLER PH, 1995, J CLIN MICROBIOL, V33, P2388, DOI 10.1128/JCM.33.9.2388-2391.1995; Mohanty B, 2005, ANN BOT-LONDON, V96, P669, DOI 10.1093/aob/mci219; Nelson DE, 1998, PLANT CELL, V10, P753; NORTON SJ, 1990, BIOCHEM INT, V22, P411; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Ohmori S, 1989, Prog Clin Biol Res, V290, P397; Oray B, 1982, METHOD ENZYMOL, P547; POMPLIANO DL, 1990, BIOCHEMISTRY-US, V29, P3186, DOI 10.1021/bi00465a005; RAY M, 1987, J BIOL CHEM, V262, P5974; RHEE H, 1986, BIOCHEM BIOPH RES CO, V141, P993, DOI 10.1016/S0006-291X(86)80142-5; RICHARD JP, 1991, BIOCHEMISTRY-US, V30, P4581, DOI 10.1021/bi00232a031; RICHARD JP, 1984, J AM CHEM SOC, V106, P4926, DOI 10.1021/ja00329a050; Ridderstrom M, 1997, BIOCHEM J, V322, P449, DOI 10.1042/bj3220449; Ridderstrom M, 1996, J BIOL CHEM, V271, P319, DOI 10.1074/jbc.271.1.319; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Strehmel N, 2008, J CHROMATOGR B, V871, P182, DOI 10.1016/j.jchromb.2008.04.042; Tapia G, 2005, PLANT PHYSIOL, V138, P2075, DOI 10.1104/pp.105.059766; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; UOTILA L, 1973, BIOCHEMISTRY-US, V12, P3944, DOI 10.1021/bi00744a025; Zang TM, 2001, J BIOL CHEM, V276, P4788, DOI 10.1074/jbc.M005090200; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	55	29	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95971	10.1371/journal.pone.0095971	http://dx.doi.org/10.1371/journal.pone.0095971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760003	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200120
J	Gil-Ortega, M; Condezo-Hoyos, L; Garcia-Prieto, CF; Arribas, SM; Gonzalez, MC; Aranguez, I; Ruiz-Gayo, M; Somoza, B; Fernandez-Alfonso, MS				Gil-Ortega, Marta; Condezo-Hoyos, Luis; Garcia-Prieto, Concha F.; Arribas, Silvia M.; Carmen Gonzalez, M.; Aranguez, Isabel; Ruiz-Gayo, Mariano; Somoza, Beatriz; Fernandez-Alfonso, Maria S.			Imbalance between Pro and Anti-Oxidant Mechanisms in Perivascular Adipose Tissue Aggravates Long-Term High-Fat Diet-Derived Endothelial Dysfunction	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; SPONTANEOUSLY HYPERTENSIVE-RATS; NITRIC-OXIDE BIOAVAILABILITY; HYDROGEN-PEROXIDE; VASCULAR FUNCTION; OXIDATIVE STRESS; INDUCED OBESITY; MICE; EXPRESSION; VASOCONSTRICTION	Background: The hypothesis of this study is that long-term high-fat diets (HFD) induce perivascular adipose tissue (PVAT) dysfunction characterized by a redox imbalance, which might contribute to aggravate endothelial dysfunction in obesity. Methods and Results: C57BL/6J mice were fed either control or HFD (45% kcal from fat) for 32 weeks. Body weight, lumbar and mesenteric adipose tissue weights were significantly higher in HFD animals compared to controls. The anticontractile effect of PVAT in mesenteric arteries (MA) was lost after 32 week HFD and mesenteric endothelial-dependent relaxation was significantly impaired in presence of PVAT in HFD mice (E-max = 71.0 +/- 5.1 vs E-max = 58.5 +/- 4.2, p<0.001). The inhibitory effect of L-NAME on Ach-induced relaxation was less intense in the HFD group compared with controls suggesting a reduction of endothelial NO availability. Expression of eNOS and NO bioavailability were reduced in MA and almost undetectable in mesenteric PVAT of the HFD group. Superoxide levels and NOX activity were higher in PVAT of HFD mice. Apocynin only reduced contractile responses to NA in HFD animals. Expression of ec-SOD and total SOD activity were significantly reduced in PVAT of HFD mice. No changes were observed in Mn-SOD, Cu/Zn-SOD or catalase. The ratio [GSSG]/([IGSH]+[GSSG]) was 2-fold higher in the mesenteric PVAT from HFD animals compared to controls. Conclusions: We suggest that the imbalance between pro-oxidant (NOX, superoxide anions, hydrogen peroxide) and antioxidant (eNOS, NO, ecSOD, GSSG) mechanisms in PVAT after long-term HFD might contribute to the aggravation of endothelial dysfunction.	[Gil-Ortega, Marta; Garcia-Prieto, Concha F.; Ruiz-Gayo, Mariano; Somoza, Beatriz] Univ CEU San Pablo, Fac Farm, Dept Ciencias Farmaceut & Salud, Madrid, Spain; [Condezo-Hoyos, Luis; Arribas, Silvia M.; Carmen Gonzalez, M.] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Fernandez-Alfonso, Maria S.] Univ Complutense, Fac Farm, Inst Pluridisciplinar, E-28040 Madrid, Spain; [Fernandez-Alfonso, Maria S.] Univ Complutense, Fac Farm, Dept Farmacol, E-28040 Madrid, Spain; [Aranguez, Isabel] Univ Complutense, Fac Farm, Dept Bioquim, E-28040 Madrid, Spain	San Pablo CEU University; Autonomous University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid	Somoza, B (corresponding author), Univ CEU San Pablo, Fac Farm, Dept Ciencias Farmaceut & Salud, Madrid, Spain.	bsomsza@ceu.es	Gonzalez-Garcia, M Carmen/AAE-9533-2019; Somoza, Beatriz/M-1260-2017; Gil-Ortega, Marta/M-8742-2015; Ruiz-Gayo, Mariano/H-3720-2015; Fernández-Alfonso, María S./F-5066-2016	Gonzalez-Garcia, M Carmen/0000-0002-5522-0786; Gil-Ortega, Marta/0000-0002-6366-8214; Ruiz-Gayo, Mariano/0000-0002-2805-5076; Fernández-Alfonso, María S./0000-0002-9110-8070; Condezo-Hoyos, Luis/0000-0001-8470-0976; Somoza, Beatriz/0000-0003-1232-7791; Aranguez, Isabel/0000-0003-1869-009X; Arribas, Silvia M/0000-0001-7103-6105	Ministerio de Ciencia e Investigacion [BFU2011-25303]; Ministerio de Economia y Competitividad [SAF2009-09714, SAF2011-25303, BFU2012-35353]; Grupos Universidad Complutense de Madrid (UCM) [GR-921641]; Fundacion Universitaria San Pablo-CEU; Fundacion Mutua Madrilena; Sociedad para el Estudio de la Salud Cardiometabolica (SESCAMET); Ministerio de Educacion y Ciencia	Ministerio de Ciencia e Investigacion; Ministerio de Economia y Competitividad(Spanish Government); Grupos Universidad Complutense de Madrid (UCM); Fundacion Universitaria San Pablo-CEU; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Sociedad para el Estudio de la Salud Cardiometabolica (SESCAMET); Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by grants from Ministerio de Ciencia e Investigacion (BFU2011-25303), Ministerio de Economia y Competitividad (SAF2009-09714, SAF2011-25303, BFU2012-35353), Grupos Universidad Complutense de Madrid (UCM; GR-921641), Fundacion Universitaria San Pablo-CEU, Fundacion Mutua Madrilena and Sociedad para el Estudio de la Salud Cardiometabolica (SESCAMET). MGO and CFG-P are supported by Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2009, REDOX REP, V14, P34, DOI 10.1179/135100009X392467; Ardanaz N, 2006, EXP BIOL MED, V231, P237; Cascino T, 2011, ANTIOXID REDOX SIGN, V15, P1507, DOI 10.1089/ars.2010.3631; Dong F, 2006, HYPERTENSION, V47, P222, DOI 10.1161/01.HYP.0000198555.51645.f1; Dubrovska G, 2004, AM J PHYSIOL-HEART C, V286, pH1107, DOI 10.1152/ajpheart.00656.2003; Fernandez-Alfonso MS, 2010, ROLE PERIVASCULAR AD, P75; Fesus G, 2007, CARDIOVASC RES, V75, P719, DOI 10.1016/j.cardiores.2007.05.025; Fukai T, 1998, J CLIN INVEST, V101, P2101, DOI 10.1172/JCI2105; Galvez B, 2006, ARTERIOSCL THROM VAS, V26, P1297, DOI 10.1161/01.ATV.0000220381.40739.dd; Galvez-Prieto B, 2008, HYPERTENS RES, V31, P1415, DOI 10.1291/hypres.31.1415; Galvez-Prieto B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00103; Gao YJ, 2007, BRIT J PHARMACOL, V151, P323, DOI 10.1038/sj.bjp.0707228; Gao YJ, 2005, OBES RES, V13, P687, DOI 10.1038/oby.2005.77; Gao YJ, 2006, CARDIOVASC RES, V71, P363, DOI 10.1016/j.cardiores.2006.03.013; Gil-Ortega M, 2010, ENDOCRINOLOGY, V151, P3299, DOI 10.1210/en.2009-1464; Gollasch M, 2004, TRENDS PHARMACOL SCI, V25, P647, DOI 10.1016/j.tips.2004.10.005; Gonzalez JM, 2008, CLIN SCI, V114, P651, DOI 10.1042/CS20070361; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Jung O, 2003, CIRC RES, V93, P622, DOI 10.1161/01.RES.0000092140.81594.A8; Ketonen J, 2010, CIRC J, V74, P1479, DOI 10.1253/circj.CJ-09-0661; Kondo M, 2009, J BIOL CHEM, V284, P1718, DOI 10.1074/jbc.M805301200; Liu JQ, 2004, AM J PHYSIOL-LUNG C, V287, pL111, DOI 10.1152/ajplung.00006.2004; Lohn M, 2002, FASEB J, V16, P1057, DOI 10.1096/fj.02-0024com; Lu C, 2010, EUR J PHARMACOL, V634, P107, DOI 10.1016/j.ejphar.2010.02.006; Marchesi C, 2009, HYPERTENSION, V54, P1384, DOI 10.1161/HYPERTENSIONAHA.109.138305; MARKLUND SL, 1984, BIOCHIM BIOPHYS ACTA, V798, P302, DOI 10.1016/0304-4165(84)90102-8; Mian KB, 1997, BRIT J PHARMACOL, V121, P813, DOI 10.1038/sj.bjp.0701187; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Oury TD, 1996, LAB INVEST, V75, P617; Roberts CK, 2006, METABOLISM, V55, P928, DOI 10.1016/j.metabol.2006.02.022; Shimabukuro M, 2003, J CLIN ENDOCR METAB, V88, P3236, DOI 10.1210/jc.2002-021883; Somoza B, 2007, ENDOCRINOLOGY, V148, P924, DOI 10.1210/en.2006-0914; Stucchi P, 2011, BIOCHIMIE; SUTTORP N, 1986, AM J PHYSIOL, V251, pC671, DOI 10.1152/ajpcell.1986.251.5.C671; Takemori K, 2007, HYPERTENSION, V49, P365, DOI 10.1161/01.HYP.0000255576.16089.b9; Zhou JY, 2006, J PHARMACEUT BIOMED, V40, P1143, DOI 10.1016/j.jpba.2005.09.022	37	68	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95312	10.1371/journal.pone.0095312	http://dx.doi.org/10.1371/journal.pone.0095312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760053	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200046
J	Ha, GH; Kim, JL; Petersson, A; Oh, S; Denning, MF; Patel, T; Breuer, EK				Ha, G-H; Kim, J-L; Petersson, A.; Oh, S.; Denning, M. F.; Patel, T.; Breuer, E-K			TACC3 deregulates the DNA damage response and confers sensitivity to radiation and PARP inhibition	ONCOGENE			English	Article							DOUBLE-STRAND BREAKS; ACIDIC COILED-COIL; HOMOLOGOUS RECOMBINATION REPAIR; GENE-EXPRESSION PROFILES; HISTONE H2AX; S-PHASE; IONIZING-RADIATION; HUMAN-CELLS; CHROMOSOMAL-ABERRATIONS; GENOME INSTABILITY	Deregulation of the transforming acidic coiled-coil protein 3 (TACC3), an important factor in the centrosome-microtubule system, has been linked to a variety of human cancer types. We have recently reported on the oncogenic potential of TACC3; however, the molecular mechanisms by which TACC3 mediates oncogenic function remain to be elucidated. In this study, we show that high levels of TACC3 lead to the accumulation of DNA double-strand breaks (DSBs) and disrupt the normal cellular response to DNA damage, at least in part, by negatively regulating the expression of ataxia telangiectasia mutated (ATM) and the subsequent DNA damage response (DDR) signaling cascade. Cells expressing high levels of TACC3 display defective checkpoints and DSB-mediated homologous recombination (HR) and non-homologous end joining (NHEJ) repair systems, leading to genomic instability. Importantly, high levels of TACC3 confer cellular sensitization to radiation and poly(ADP-ribose) polymerase (PARP) inhibition. Overall, our findings provide critical information regarding the mechanisms by which TACC3 contributes to genomic instability, potentially leading to cancer development, and suggest a novel prognostic, diagnostic and therapeutic strategy for the treatment of cancer types expressing high levels of TACC3.	[Ha, G-H; Kim, J-L; Petersson, A.; Denning, M. F.; Breuer, E-K] Loyola Univ, Stritch Sch Med, Cardinal Bernardin Canc Ctr, Inst Oncol, Maywood, IL 60153 USA; [Ha, G-H; Kim, J-L; Petersson, A.; Oh, S.; Breuer, E-K] Loyola Univ, Stritch Sch Med, Dept Radiat Oncol, Maywood, IL 60153 USA; [Denning, M. F.] Loyola Univ, Stritch Sch Med, Dept Pathol, Maywood, IL 60153 USA; [Patel, T.] Loyola Univ, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Breuer, EK (corresponding author), Loyola Univ, Stritch Sch Med, Dept Radiat Oncol, 2160 South First Ave, Maywood, IL 60153 USA.	eubreuer@luc.edu		Denning, Mitchell/0000-0001-6165-6925; Ha, Geun-Hyoung/0000-0002-9125-1934	Program Development Startup from Loyola University Chicago	Program Development Startup from Loyola University Chicago	This study was supported by the Program Development Startup from Loyola University Chicago.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Albee AJ, 2008, MOL BIOL CELL, V19, P3347, DOI 10.1091/mbc.E07-11-1204; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bargo S, 2010, BIOCHEM BIOPH RES CO, V400, P606, DOI 10.1016/j.bbrc.2010.08.111; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Beck H, 2010, J CELL BIOL, V188, P629, DOI 10.1083/jcb.200905059; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bignold LP, 2006, EXP SUPPL, V96, P1; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Bugler B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-29; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Craig AL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-195; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Dell H, 1999, J BIOL CHEM, V274, P9013, DOI 10.1074/jbc.274.13.9013; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Dodson GE, 2004, J BIOL CHEM, V279, P34010, DOI 10.1074/jbc.C400242200; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3; Fernet M, 2010, DNA REPAIR, V9, P48, DOI 10.1016/j.dnarep.2009.10.006; FRANKENBERG D, 1981, RADIAT RES, V88, P524, DOI 10.2307/3575641; Gangisetty O, 2004, ONCOGENE, V23, P2559, DOI 10.1038/sj.onc.1207424; Garriga-Canut M, 2004, J BIOL CHEM, V279, P23597, DOI 10.1074/jbc.M313987200; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Ha GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070353; Ha GH, 2013, CANCER LETT, V336, P24, DOI 10.1016/j.canlet.2013.04.022; Ha GH, 2013, CANCER LETT, V332, P63, DOI 10.1016/j.canlet.2013.01.013; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Hu N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-576; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Jung CK, 2006, PATHOL INT, V56, P503, DOI 10.1111/j.1440-1827.2006.01998.x; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kobayashi J, 2009, BIOCHEM BIOPH RES CO, V380, P752, DOI 10.1016/j.bbrc.2009.01.109; Kocher S, 2012, NUCLEIC ACIDS RES, V40, P8336, DOI 10.1093/nar/gks604; Lauffart B, 2003, GENOMICS, V81, P192, DOI 10.1016/S0888-7543(02)00039-3; Lauffart B, 2002, BIOCHEM J, V363, P195, DOI 10.1042/0264-6021:3630195; Lauffart B., 2007, CANC THERAPY, V5, P409; Lauffart Brenda, 2005, BMC Womens Health, V5, P8, DOI 10.1186/1472-6874-5-8; Lauffart B, 2007, J CELL COMMUN SIGNAL, V1, P5, DOI 10.1007/s12079-007-0001-3; Li WR, 2011, CANCER RES, V71, P4130, DOI 10.1158/0008-5472.CAN-10-2540; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lio YC, 2004, J BIOL CHEM, V279, P42313, DOI 10.1074/jbc.M405212200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; Ma WJ, 2012, P NATL ACAD SCI USA, V109, P6590, DOI 10.1073/pnas.1118078109; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; McKeveney PJ, 2001, BRIT J HAEMATOL, V112, P1016, DOI 10.1046/j.1365-2141.2001.02644.x; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Mistrik M, 2009, CELL CYCLE, V8, P2592, DOI 10.4161/cc.8.16.9331; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakada S, 2006, J CLIN INVEST, V116, P80, DOI 10.1172/JCI25716; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; OBE G, 1992, MUTAGENESIS, V7, P3, DOI 10.1093/mutage/7.1.3; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Piekorz RP, 2002, EMBO J, V21, P653, DOI 10.1093/emboj/21.4.653; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sadek CM, 2000, MECH DEVELOP, V97, P13, DOI 10.1016/S0925-4773(00)00415-9; Sadek CM, 2003, GENE EXPR PATTERNS, V3, P203, DOI 10.1016/S1567-133X(02)00066-2; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Schneider L, 2007, J BIOL CHEM, V282, P29273, DOI 10.1074/jbc.M704151200; Schuendeln MM, 2004, MOL CELL BIOL, V24, P6403, DOI 10.1128/MCB.24.14.6403-6409.2004; Shanware NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012173; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sourisseau T, 2010, EMBO MOL MED, V2, P130, DOI 10.1002/emmm.201000068; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stewart JP, 2004, BRIT J HAEMATOL, V126, P72, DOI 10.1111/j.1365-2141.2004.04996.x; Still IH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-16; Stroup D, 2000, J LIPID RES, V41, P1; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Ulisse S, 2007, ENDOCR-RELAT CANCER, V14, P827, DOI 10.1677/ERC-07-0053; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; Vettaikkorumakankauv A., 2008, CANC THERAPY, V6, P805; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Wu J, 2012, MOL CELL, V46, P351, DOI 10.1016/j.molcel.2012.02.018; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yim EK, 2009, ONCOL REP, V21, P549, DOI 10.3892/or_00000256; Yochum GS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-102; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	114	17	17	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 26	2015	34	13					1667	1678		10.1038/onc.2014.105	http://dx.doi.org/10.1038/onc.2014.105			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE5CS	24769898				2022-12-25	WOS:000351848400007
J	Liu, XY; Li, L; Wang, YQ; Yan, H; Ma, XF; Wang, PG; Zhang, LW				Liu, Xiaoyan; Li, Ling; Wang, Yuqiu; Yan, Hui; Ma, Xiaofeng; Wang, Peng George; Zhang, Lianwen			A peptide panel investigation reveals the acceptor specificity of O-GlcNAc transferase	FASEB JOURNAL			English	Article						OGT; amino acid preference	LINKED N-ACETYLGLUCOSAMINE; MODIFIED PROTEINS; POSTTRANSLATIONAL MODIFICATIONS; NUCLEOCYTOPLASMIC PROTEIN; TETRATRICOPEPTIDE REPEATS; FUNCTIONAL CONSEQUENCES; DIRECT IDENTIFICATION; TRANSCRIPTION FACTOR; INSULIN-SECRETION; MASS-SPECTROMETRY	O-linked beta-N-acetylglucosaminylation (O-GlcNAcylation) is widely distributed on nucleocytoplasmic proteins and participates in various physiological processes. But O-GlcNAc status on numerous proteins remains unknown. To better understand this modification, computational analysis combined with experimental study was performed in this work. Structural analysis of many O-GlcNAcylation sites indicated that the modification occurred predominantly in a random coil region. Frequency analysis on many O-GlcNAcylated peptides revealed a signature sequence, PPVS/TSATT, around the modification site (underlined, position 0). Based on the sequence, a peptide panel was designed to investigate key positions affecting O-GlcNAcylation of peptides and their amino acid preference. It was indicated that 3 positions (-2, -1, and -2) had an important role for this modification, where the presence of uncharged amino acids with small side chains could confer high reactivity. The amino acid preference at key positions was further investigated on bovine crystalline alpha via site-directed mutagenesis. The preferred amino acids were Pro > Ala > Gly at position -2, Ala > Thr > Val > Lys > Pro at position -1, and Ala > Gly > Arg > Glu at position -2. Altogether, these findings suggested that a substrate (peptide or protein) with Pro, Ala at position -2, and/or Val, Ala, Thr, Ser at position -1, and/or Ala, Ser, Pro, Thr, Gly at position + 2 would have more chances for O-GlcNAcylation. To test the rule, 2 O-GlcNAcylation sites on sOGT (S52 and T449) were predicted and confirmed by Western blot. The present work systematically investigated the sequence signature for O-GlcNAcylation. The result will contribute to predict-ing the O-GlcNAc status of a protein and further functional studies.	Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, LW (corresponding author), Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Weijin Rd, Tianjin 300071, Peoples R China.	lianwen@nankai.edu.cn	WANG, Peng/GSN-5263-2022		National Basic Research Program of China (973 Program) [2012CB910300]; National Natural Science Foundation of China [30970644]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (973 Program, grant 2012CB910300) and the National Natural Science Foundation of China (grant 30970644).	Ahmad I, 2006, NUCLEIC ACIDS RES, V34, P175, DOI 10.1093/nar/gkj401; Ahmad IU, 2008, J MANAGE ENG, V24, P1, DOI 10.1061/(ASCE)0742-597X(2008)24:1(1); Akimoto Y, 2007, GLYCOBIOLOGY, V17, P127, DOI 10.1093/glycob/cwl067; Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; BHATNAGAR D, 1988, BIOCHEMISTRY-US, V27, P1988, DOI 10.1021/bi00406a027; Boeggeman E, 2007, BIOCONJUGATE CHEM, V18, P806, DOI 10.1021/bc060341n; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Gay LM, 2011, NAT CHEM BIOL, V7, P134, DOI 10.1038/nchembio.529; Goodwin OY, 2013, J BIOTECHNOL, V168, P315, DOI 10.1016/j.jbiotec.2013.10.008; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; GRIFFITH LS, 1995, BIOCHEM BIOPH RES CO, V213, P424, DOI 10.1006/bbrc.1995.2149; Gurcel C, 2008, ANAL BIOANAL CHEM, V390, P2089, DOI 10.1007/s00216-008-1950-y; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Ho CC, 2009, PROTEINS, V76, P213, DOI 10.1002/prot.22341; Kastrup IB, 2000, TISSUE ANTIGENS, V56, P129, DOI 10.1034/j.1399-0039.2000.560203.x; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Khwaja TA, 2008, J CELL BIOCHEM, V103, P479, DOI 10.1002/jcb.21412; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Leavy TM, 2007, BIOORG MED CHEM LETT, V17, P3851, DOI 10.1016/j.bmcl.2007.05.008; Lefebvre T, 2002, J CELL BIOCHEM, V85, P208, DOI 10.1002/jcb.10119; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Ma XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063452; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Rexach JE, 2008, NAT CHEM BIOL, V4, P97, DOI 10.1038/nchembio.68; Riu IH, 2008, BIOCHEM BIOPH RES CO, V372, P203, DOI 10.1016/j.bbrc.2008.05.034; Sprung R, 2005, J PROTEOME RES, V4, P950, DOI 10.1021/pr050033j; Tai HC, 2004, J AM CHEM SOC, V126, P10500, DOI 10.1021/ja047872b; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Vosseller K, 2005, PROTEOMICS, V5, P388, DOI 10.1002/pmic.200401066; Wang JL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-91; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Wang Z, 2009, DIABETES, V58, P309, DOI 10.2337/db08-0994; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Zachara Natasha E., 2009, V534, P251, DOI 10.1007/978-1-59745-022-5_19; Zhou F, 2013, BIOCHEM BIOPH RES CO, V438, P427, DOI 10.1016/j.bbrc.2013.07.091; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008	46	22	24	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3362	3372		10.1096/fj.13-246850	http://dx.doi.org/10.1096/fj.13-246850			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24760753				2022-12-25	WOS:000340265400008
J	Bielopolski, N; Lam, AD; Bar-On, D; Sauer, M; Stuenkel, EL; Ashery, U				Bielopolski, Noa; Lam, Alice D.; Bar-On, Dana; Sauer, Markus; Stuenkel, Edward L.; Ashery, Uri			Differential Interaction of Tomosyn with Syntaxin and SNAP25 Depends on Domains in the WD40 beta-Propeller Core and Determines Its Inhibitory Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE COMPLEX-FORMATION; NEUROTRANSMITTER RELEASE; PLASMA-MEMBRANE; FLUORESCENT-PROBES; CHROMAFFIN CELLS; IMAGING REVEALS; LIVING CELLS; LIVE CELLS; PROTEIN; EXOCYTOSIS	Neuronal exocytosis depends on efficient formation of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complexes and is regulated by tomosyn, a SNARE-binding protein. To gain new information about tomosyn's activity, we characterized its mobility and organization on the plasma membrane (PM) in relation to other SNARE proteins and inhibition of exocytosis. By using direct stochastic optical reconstruction microscopy (dSTORM), we found tomosyn to be organized in small clusters adjacent to syntaxin clusters. In addition, we show that tomosyn is present in both syntaxin-tomosyn complexes and syntaxin-SNAP25-tomosyn complexes. Tomosyn mutants that lack residues 537-578 or 897-917 from its beta-propeller core diffused faster on the PM and exhibited reduced binding to SNAP25, suggesting that these mutants shift the equilibrium between tomosyn-syntaxin-SNAP25 complexes on the PM to tomosyn-syntaxin complexes. As these deletion mutants impose less inhibition on exocytosis, we suggest that tomosyn inhibition is mediated via tomosyn-syntaxin-SNAP25 complexes and not tomosyn-syntaxin complexes. These findings characterize, for the first time, tomosyn's dynamics at the PM and its relation to its inhibition of exocytosis.	[Bielopolski, Noa; Bar-On, Dana; Ashery, Uri] Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Bar-On, Dana; Ashery, Uri] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Lam, Alice D.; Stuenkel, Edward L.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Sauer, Markus] Univ Wurzburg, Dept Biotechnol & Biophys, D-97074 Wurzburg, Germany	Tel Aviv University; Tel Aviv University; University of Michigan System; University of Michigan; University of Wurzburg	Ashery, U (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	uria@post.tau.ac.il	Sauer, Markus/C-4378-2017	Sauer, Markus/0000-0002-1692-3219; Ashery, Uri/0000-0001-6338-7888; Stuenkel, Edward/0000-0001-8225-5725	National Institutes of Health [RO1 NS053978]; Israel Science Foundation [730/11]; United States-Israel Binational Science Foundation [2009279]; German-Israeli Foundation [1125-145.1/2010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS053978 (to E. S. and U. A.). This work was also supported by Israel Science Foundation Grant 730/11 (to U. A.), United States-Israel Binational Science Foundation Grant 2009279 (to U. A.), and German-Israeli Foundation Grant 1125-145.1/2010 (to U. A. and M. S.).	Aikawa Y, 2006, MOL BIOL CELL, V17, P2113, DOI 10.1091/mbc.E06-01-0074; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; Bar-On D, 2008, FEBS LETT, V582, P3563, DOI 10.1016/j.febslet.2008.08.040; Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Bar-On D, 2009, J NEUROSCI, V29, P12292, DOI 10.1523/JNEUROSCI.0710-09.2009; Berkovich R, 2011, TRAFFIC, V12, P1648, DOI 10.1111/j.1600-0854.2011.01264.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burdina AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026185; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; Foran P, 1996, BIOCHEMISTRY-US, V35, P2630, DOI 10.1021/bi9519009; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gladycheva SE, 2004, J PHYSIOL-LONDON, V558, P857, DOI 10.1113/jphysiol.2004.067249; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Halemani ND, 2010, TRAFFIC, V11, P394, DOI 10.1111/j.1600-0854.2009.01020.x; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Knowles MK, 2010, P NATL ACAD SCI USA, V107, P20810, DOI 10.1073/pnas.1014840107; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Li YL, 2007, BIOPHYS J, V93, P2178, DOI 10.1529/biophysj.106.101220; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Liu J, 2004, J BIOL CHEM, V279, P55924, DOI 10.1074/jbc.M410024200; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; Neer EJ, 2000, P NATL ACAD SCI USA, V97, P960, DOI 10.1073/pnas.97.3.960; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pertsinidis A, 2013, P NATL ACAD SCI USA, V110, pE2812, DOI 10.1073/pnas.1310654110; Ribrault C, 2011, J NEUROSCI, V31, P17590, DOI 10.1523/JNEUROSCI.4065-11.2011; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; SCHIAVO G, 1995, J BIOL CHEM, V270, P10566, DOI 10.1074/jbc.270.18.10566; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Smyth AM, 2013, J BIOL CHEM, V288, P5102, DOI 10.1074/jbc.M112.407585; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; XIA ZX, 1992, J BIOL CHEM, V267, P22289; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330; Zilly FE, 2011, EMBO J, V30, P1209, DOI 10.1038/emboj.2011.53	52	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17087	17099		10.1074/jbc.M113.515296	http://dx.doi.org/10.1074/jbc.M113.515296			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24782308	Green Published, hybrid			2022-12-25	WOS:000338016200042
J	Halpert, G; Eitan, T; Voronov, E; Apte, RN; Rath-Wolfson, L; Albeck, M; Kalechman, Y; Sredni, B				Halpert, Gilad; Eitan, Tom; Voronov, Elena; Apte, Ron N.; Rath-Wolfson, Lea; Albeck, Michael; Kalechman, Yona; Sredni, Benjamin			Multifunctional Activity of a Small Tellurium Redox Immunomodulator Compound, AS101, on Dextran Sodium Sulfate-induced Murine Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPRIA MONONUCLEAR-CELLS; GROWTH-FACTOR-BETA; ULCERATIVE-COLITIS; CROHNS-DISEASE; INTESTINAL INFLAMMATION; ADHESION MOLECULE-1; EPITHELIAL-CELLS; UP-REGULATION; T-CELLS; INDUCTION	Inflammatory bowel diseases (IBDs) are a group of idiopathic, chronic immune-mediated diseases characterized by an aberrant immune response, including imbalances of inflammatory cytokine production and activated innate and adaptive immunity. Selective blockade of leukocyte migration into the gut is a promising strategy for the treatment of IBD. This study explored the effect of the immunomodulating tellurium compound ammonium trichloro (dioxoethylene-o,o') tellurate (AS101) on dextran sodium sulfate (DSS)-induced murine colitis. Both oral and intraperitoneal administration of AS101 significantly reduced clinical manifestations of IBD. Colonic inflammatory cytokine levels (IL-17 and IL-1 beta) were significantly down-regulated by AS101 treatment, whereas IFN-gamma was not affected. Neutrophil and alpha 4 beta 7(+) macrophage migration into the tissue was inhibited by AS101 treatment. Adhesion of mesenteric lymph node cells to mucosal addressin cell adhesion molecule (MAdCAM-1), the ligand for alpha 4 beta 7 integrin, was blocked by AS101 treatment both in vitro and in vivo. DSS-induced destruction of colonic epithelial barrier/integrity was prevented by AS101, via up-regulation of colonic glial-derived neurotrophic factor, which was found previously to regulate the intestinal epithelial barrier through activation of the PI3K/AKT pathway. Indeed, the up-regulation of glial-derived neurotrophic factor by AS101 was associated with increased levels of colonic pAKT and BCL-2 and decreased levels of BAX. Furthermore, AS101 treatment reduced colonic permeability to Evans blue and decreased colonic TUNEL+ cells. Our data revealed multifunctional activities of AS101 in the DSS-induced colitis model via anti-inflammatory and anti-apoptotic properties. We suggest that treatment with the small, nontoxic molecule AS101 may be an effective early therapeutic approach for controlling human IBD.	[Halpert, Gilad; Eitan, Tom; Kalechman, Yona; Sredni, Benjamin] Bar Ilan Univ, CAIR Inst, Mina & Everard Goodman Fac Life Sci, Safdie AIDS & Immunol Res Ctr, IL-52900 Ramat Gan, Israel; [Voronov, Elena; Apte, Ron N.] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Voronov, Elena; Apte, Ron N.] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Voronov, Elena; Apte, Ron N.] Ben Gurion Univ Negev, Canc Res Ctr, IL-84105 Beer Sheva, Israel; [Rath-Wolfson, Lea] Rabin Med Ctr, Dept Pathol, IL-49372 Petah Tiqwa, Israel; [Rath-Wolfson, Lea] Tel Aviv Univ, Sackler Sch Med, IL-6997801 Tel Aviv, Israel; [Albeck, Michael] Bar Ilan Univ, Dept Chem, Fac Exact Sci, IL-52900 Ramat Gan, Israel	Bar Ilan University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University	Sredni, B (corresponding author), Bar Ilan Univ, CAIR Inst, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	srednib@gmail.com			Dr. Tovi Comet-Walerstein Cancer Research Chair; Dave and Florence Muskovitz Chair in Cancer Research; Jaime Lusinchi Research Institute in Applied Sciences	Dr. Tovi Comet-Walerstein Cancer Research Chair; Dave and Florence Muskovitz Chair in Cancer Research; Jaime Lusinchi Research Institute in Applied Sciences	This work was supported in part by the Dr. Tovi Comet-Walerstein Cancer Research Chair, by the Dave and Florence Muskovitz Chair in Cancer Research, and the Jaime Lusinchi Research Institute in Applied Sciences.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Albeck A, 1998, INORG CHEM, V37, P1704, DOI 10.1021/ic971456t; Ando Tomoaki, 2007, BMC Physiology, V7, P10, DOI 10.1186/1472-6793-7-10; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Briskin M, 1997, AM J PATHOL, V151, P97; Brodsky M, 2007, J INTERF CYTOK RES, V27, P453, DOI 10.1089/jir.2007.0168; Brodsky M, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-3; Brodsky M, 2009, J HEPATOL, V51, P491, DOI 10.1016/j.jhep.2009.04.024; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Connor EM, 1999, J LEUKOCYTE BIOL, V65, P349, DOI 10.1002/jlb.65.3.349; Cornet A, 2001, P NATL ACAD SCI USA, V98, P13306, DOI 10.1073/pnas.231474098; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; D'Haens GR, 2010, NAT REV GASTRO HEPAT, V7, P86, DOI 10.1038/nrgastro.2009.222; Da Silva APB, 2006, J CELL PHYSIOL, V208, P629, DOI 10.1002/jcp.20701; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Feagan BG, 2005, NEW ENGL J MED, V352, P2499, DOI 10.1056/NEJMoa042982; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Grimm MC, 2009, J GASTROEN HEPATOL, V24, pS69, DOI 10.1111/j.1440-1746.2009.06074.x; Hall LJ, 2011, DIGEST DIS SCI, V56, P79, DOI 10.1007/s10620-010-1240-3; Holtta V, 2008, INFLAMM BOWEL DIS, V14, P1175, DOI 10.1002/ibd.20475; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwamoto M, 1996, J PATHOL, V180, P152; Kanai T, 2012, MUCOSAL IMMUNOL, V5, P240, DOI 10.1038/mi.2012.6; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Koenders MI, 2005, AM J PATHOL, V167, P141, DOI 10.1016/S0002-9440(10)62961-6; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; NYSKA A, 1989, ARCH TOXICOL, V63, P386, DOI 10.1007/BF00303128; O'Sullivan BJ, 2006, J IMMUNOL, V176, P7278, DOI 10.4049/jimmunol.176.12.7278; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Okun E, 2006, DEV COMP IMMUNOL, V30, P441, DOI 10.1016/j.dci.2005.07.002; Peyrin-Biroulet L, 2008, LANCET, V372, P67, DOI 10.1016/S0140-6736(08)60995-2; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; SATSANGI J, 1987, CLIN EXP IMMUNOL, V67, P594; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Sredni B, 2003, FASEB J, V17, P400, DOI 10.1096/fj.03-0552fje; SREDNI B, 1987, NATURE, V330, P173, DOI 10.1038/330173a0; SREDNI B, 1995, J CLIN ONCOL, V13, P2342, DOI 10.1200/JCO.1995.13.9.2342; Sredni B, 1996, INT J CANCER, V65, P97, DOI 10.1002/(SICI)1097-0215(19960103)65:1<97::AID-IJC17>3.0.CO;2-F; Sredni B, 2007, FASEB J, V21, P1870, DOI 10.1096/fj.06-7500com; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sund M, 2005, IMMUNOLOGY, V114, P554, DOI 10.1111/j.1365-2567.2005.02123.x; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Vetuschi A, 2002, DIGEST DIS SCI, V47, P1447, DOI 10.1023/A:1015931128583; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang Y, 1996, IMMUNOL CELL BIOL, V74, P383, DOI 10.1038/icb.1996.67; Zhang DK, 2010, J PATHOL, V222, P213, DOI 10.1002/path.2749	71	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17215	17227		10.1074/jbc.M113.536664	http://dx.doi.org/10.1074/jbc.M113.536664			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24764299	Green Published, hybrid			2022-12-25	WOS:000338016200054
J	Patananan, AN; Capri, J; Whitelegge, JP; Clarke, SG				Patananan, Alexander N.; Capri, Joseph; Whitelegge, Julian P.; Clarke, Steven G.			Non-repair Pathways for Minimizing Protein Isoaspartyl Damage in the Yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-METHYLTRANSFERASE; LIFE-SPAN; OXIDATIVE-STRESS; PHYLOGENETIC DISTRIBUTION; OXIDIZED PROTEINS; ASPARTYL RESIDUES; ALTERED PROTEINS; AB-INITIO; DEGRADATION; PROTEASOME	The spontaneous degradation of asparaginyl and aspartyl residues to isoaspartyl residues is a common type of protein damage in aging organisms. Although the protein-L-isoaspartyl (D-aspartyl) O-methyltransferase (EC 2.1.1.77) can initiate the repair of L-isoaspartyl residues to L-aspartyl residues in most organisms, no gene homolog or enzymatic activity is present in the budding yeast Saccharomyces cerevisiae. Therefore, we used biochemical approaches to elucidate how proteins containing isoaspartyl residues are metabolized in this organism. Surprisingly, the level of isoaspartyl residues in yeast proteins (50-300 pmol of isoaspartyl residues/mg of protein extract) is comparable with organisms with protein-L-isoaspartyl (D-aspartyl) O-methyltransferase, suggesting a novel regulatory pathway. Interfering with common protein quality control mechanisms by mutating and inhibiting the proteasomal and autophagic pathways in vivo did not increase isoaspartyl residue levels compared with wild type or uninhibited cells. However, the inhibition of metalloproteases in in vitro aging experiments by EDTA resulted in an similar to 3-fold increase in the level of isoaspartyl-containing peptides. Characterization by mass spectrometry of these peptides identified several proteins involved in metabolism as targets of isoaspartyl damage. Further analysis of these peptides revealed that many have an N-terminal isoaspartyl site and originate from proteins with short half-lives. These results suggest that one or more metalloproteases participate in limiting isoaspartyl formation by robust proteolysis.	[Patananan, Alexander N.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Patananan, Alexander N.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Capri, Joseph; Whitelegge, Julian P.] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, Neuropsychiat Inst, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.	clarke@chem.ucla.edu			National Institutes of Health [AG032303, GM026020, GM007185]; Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center; Ellison Medical Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, T32GM007185, R01GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG032303 and GM026020 (to S. G. C.) and GM007185, a Ruth L. Kirschstein National Research Service Award (to A. N. P.). This work was also supported by the Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center (to S. G. C.) and a Senior Scholar in Aging Award from the Ellison Medical Foundation (to S. G. C.).	Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; BALZI E, 1994, J BIOL CHEM, V269, P2206; Banfield KL, 2008, J GERONTOL A-BIOL, V63, P798, DOI 10.1093/gerona/63.8.798; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bonangelino CJ, 1997, MOL CELL BIOL, V17, P6847, DOI 10.1128/MCB.17.12.6847; Borek D, 2004, EUR J BIOCHEM, V271, P3215, DOI 10.1111/j.1432-1033.2004.04254.x; Cacia J, 1996, BIOCHEMISTRY-US, V35, P1897, DOI 10.1021/bi951526c; Cantor JR, 2009, BIOCHEMISTRY-US, V48, P11026, DOI 10.1021/bi901397h; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Chen QH, 2006, FREE RADICAL BIO MED, V40, P120, DOI 10.1016/j.freeradbiomed.2005.08.048; Chondrogianni N, 2014, MOL ASPECTS MED, V35, P1, DOI 10.1016/j.mam.2012.09.001; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Cloos PAC, 2002, MATRIX BIOL, V21, P39, DOI 10.1016/S0945-053X(01)00188-3; Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Costa V, 2007, IUBMB LIFE, V59, P293, DOI 10.1080/15216540701225958; Dai SJ, 2013, ANAL CHEM, V85, P2423, DOI 10.1021/ac303428h; DeLuna A, 2005, BIOCHEM BIOPH RES CO, V328, P1083, DOI 10.1016/j.bbrc.2005.01.057; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; Doyle HA, 2003, J IMMUNOL, V171, P2840, DOI 10.4049/jimmunol.171.6.2840; Doyle HA, 2007, AUTOIMMUNITY, V40, P131, DOI 10.1080/08916930601165180; Doyle HA, 2006, J BIOL CHEM, V281, P32676, DOI 10.1074/jbc.M604847200; Farrar C, 2002, J BIOL CHEM, V277, P27856, DOI 10.1074/jbc.M203911200; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Fuertes G, 2003, INT J BIOCHEM CELL B, V35, P651, DOI 10.1016/S1357-2725(02)00382-5; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; GEIGER T, 1987, J BIOL CHEM, V262, P785; Gomez TA, 2007, DEV BIOL, V303, P493, DOI 10.1016/j.ydbio.2006.11.023; Hecht KA, 2013, FEMS YEAST RES, V13, P471, DOI 10.1111/1567-1364.12050; Hejazi M, 2002, BIOCHEM J, V364, P129, DOI 10.1042/bj3640129; Hipkiss AR, 2006, EXP GERONTOL, V41, P464, DOI 10.1016/j.exger.2006.03.004; Hooi MYS, 2013, EXP EYE RES, V106, P34, DOI 10.1016/j.exer.2012.10.013; Hooi MYS, 2012, INVEST OPHTH VIS SCI, V53, P3554, DOI 10.1167/iovs.11-9085; Ichikawa JK, 1998, ARCH BIOCHEM BIOPHYS, V358, P222, DOI 10.1006/abbi.1998.0830; JOHNSON BA, 1991, BIOCHEM INT, V24, P841; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; Ju DH, 2004, BIOCHEM BIOPH RES CO, V321, P51, DOI 10.1016/j.bbrc.2004.06.105; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kagan RM, 1997, ARCH BIOCHEM BIOPHYS, V348, P320, DOI 10.1006/abbi.1997.0362; Khare S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020850; Khare S, 2009, MECH AGEING DEV, V130, P670, DOI 10.1016/j.mad.2009.08.002; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kim E, 1999, J BIOL CHEM, V274, P20671, DOI 10.1074/jbc.274.29.20671; Kindrachuk J, 2003, J BIOL CHEM, V278, P50880, DOI 10.1074/jbc.M308423200; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KODAMA T, 1995, BBA-GEN SUBJECTS, V1245, P269, DOI 10.1016/0304-4165(95)00092-P; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Lanthier J, 2006, BIOCHEM CELL BIOL, V84, P684, DOI 10.1139/O06-055; Larsen RA, 2001, J BACTERIOL, V183, P3089, DOI 10.1128/JB.183.10.3089-3097.2001; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Lee JC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1933; LI C, 1992, J BACTERIOL, V174, P355, DOI 10.1128/jb.174.2.355-361.1992; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; LOWENSON JD, 1991, J BIOL CHEM, V266, P19396; LOWENSON JD, 1992, J BIOL CHEM, V267, P5985; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; Marques M, 2006, MICROBIOL-SGM, V152, P3595, DOI 10.1099/mic.0.29040-0; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; Meiling-Wesse K, 2002, FEBS LETT, V530, P174, DOI 10.1016/S0014-5793(02)03456-7; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mudgett MB, 1997, PLANT PHYSIOL, V115, P1481, DOI 10.1104/pp.115.4.1481; Nayak NR, 2013, PLANT CELL, V25, P2573, DOI 10.1105/tpc.113.113456; Niewmierzycka A, 1999, ARCH BIOCHEM BIOPHYS, V364, P209, DOI 10.1006/abbi.1999.1114; Noguchi S, 2010, BIOPOLYMERS, V93, P1003, DOI 10.1002/bip.21514; OConnor MB, 1997, INSECT BIOCHEM MOLEC, V27, P49, DOI 10.1016/S0965-1748(96)00071-9; Oge L, 2008, PLANT CELL, V20, P3022, DOI 10.1105/tpc.108.058479; Patananan AN, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1654, DOI 10.1016/B978-0-12-382219-2.00374-4; Qin ZX, 2014, INVEST OPHTH VIS SCI, V55, P1572, DOI 10.1167/iovs.13-13668; Radkiewicz JL, 2001, J AM CHEM SOC, V123, P3499, DOI 10.1021/ja0026814; Radkiewicz JL, 1996, J AM CHEM SOC, V118, P9148, DOI 10.1021/ja953505b; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shimizu T, 2000, ARCH BIOCHEM BIOPHYS, V381, P225, DOI 10.1006/abbi.2000.1955; Sitte N, 1998, FEBS LETT, V440, P399, DOI 10.1016/S0014-5793(98)01495-1; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Villa ST, 2006, PHYSIOL PLANTARUM, V128, P581, DOI 10.1111/j.1399-3054.2006.00772.x; Visick JE, 1998, J BACTERIOL, V180, P2623, DOI 10.1128/JB.180.10.2623-2629.1998; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Yang HQ, 2011, J ALZHEIMERS DIS, V27, P113, DOI 10.3233/JAD-2011-110626; Yang ML, 2006, J IMMUNOL, V177, P4541, DOI 10.4049/jimmunol.177.7.4541	89	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16936	16953		10.1074/jbc.M114.564385	http://dx.doi.org/10.1074/jbc.M114.564385			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24764295	hybrid, Green Published			2022-12-25	WOS:000338016200029
J	Ridley, C; Kouvatsos, N; Raynal, BD; Howard, M; Collins, RF; Desseyn, JL; Jowitt, TA; Baldock, C; Davis, CW; Hardingham, TE; Thornton, DJ				Ridley, Caroline; Kouvatsos, Nikos; Raynal, Bertrand D.; Howard, Marj; Collins, Richard F.; Desseyn, Jean-Luc; Jowitt, Thomas A.; Baldock, Clair; Davis, C. William; Hardingham, Timothy E.; Thornton, David J.			Assembly of the Respiratory Mucin MUC5B A NEW MODEL FOR A GEL-FORMING MUCIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; CYSTIC-FIBROSIS; HYDRODYNAMIC PROPERTIES; MOLECULAR-MECHANISM; ELECTRON-MICROSCOPY; TERMINAL DOMAINS; INTESTINAL MUCIN; MUCUS; SECRETION; CALCIUM	Mucins are essential components in mucus gels that form protective barriers at all epithelial surfaces, but much remains unknown about their assembly, intragranular organization, and post-secretion unfurling to form mucus. MUC5B is a major polymeric mucin expressed by respiratory epithelia, and we investigated the molecular mechanisms involved during its assembly. Studies of intact polymeric MUC5B revealed a single high affinity calcium-binding site, distinct from multiple low affinity sites on each MUC5B monomer. Self-diffusion studies with intact MUC5B showed that calcium binding at the protein site catalyzed reversible cross-links between MUC5B chains to form networks. The site of cross-linking was identified in the MUC5B D3-domain as it was specifically blocked by D3 peptide antibodies. Biophysical analysis and single particle EM of recombinant MUC5B N terminus (D1D2D'D3; NT5B) and subdomains (D1, D1-D2, D2-D'-D3, and D3) generated structural models of monomers and disulfide-linked dimers and suggested that MUC5B multimerizes by disulfide linkage between D3-domains to form linear polymer chains. Moreover, these analyses revealed reversible homotypic interactions of NT5B at low pH and in high calcium, between disulfide-linked NT5B dimers, but not monomers. These results enable a model of MUC5B to be derived, which predicts mechanisms of mucin intracellular assembly and storage, which may be common to the other major gel-forming polymeric mucins.	[Ridley, Caroline; Kouvatsos, Nikos; Raynal, Bertrand D.; Howard, Marj; Jowitt, Thomas A.; Baldock, Clair; Hardingham, Timothy E.; Thornton, David J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Ridley, Caroline; Kouvatsos, Nikos; Raynal, Bertrand D.; Howard, Marj; Collins, Richard F.; Jowitt, Thomas A.; Baldock, Clair; Hardingham, Timothy E.; Thornton, David J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Desseyn, Jean-Luc] Univ Lille, INSERM, U995, F-59045 Lille, France; [Davis, C. William] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27517 USA	University of Manchester; University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; University of North Carolina; University of North Carolina Chapel Hill	Thornton, DJ (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	dave.thornton@manchester.ac.uk	Desseyn, Jean-Luc/M-5070-2018	Desseyn, Jean-Luc/0000-0001-6876-8049; Baldock, Clair/0000-0003-3497-1959; Hardingham, Timothy/0000-0001-8271-6763; Jowitt, Thomas/0000-0002-4045-0933; raynal, Bertrand/0000-0001-5634-0408; Ridley, Caroline/0000-0002-5483-0320; Thornton, David/0000-0001-7148-1970; Kouvatsos, Nikolaos/0000-0003-0425-1141	Cystic Fibrosis Foundation Therapeutics [THORNT07XXX0]; Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust [088785/Z/09/Z]; Biotechnology and Biological Sciences Research Council [BB/D522389/1] Funding Source: researchfish; BBSRC [BB/D522389/1] Funding Source: UKRI	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from Cystic Fibrosis Foundation Therapeutics (THORNT07XXX0) and Biotechnology and Biological Sciences Research Council (BBSRC). The Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, is supported by core funding from the Wellcome Trust (088785/Z/09/Z).	Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Asker N, 1998, BIOCHEM J, V335, P381, DOI 10.1042/bj3350381; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Collins RF, 2013, BIOCHEM J, V450, P417, DOI 10.1042/BJ20121599; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; de la Torre JG, 2001, EUR BIOPHYS J BIOPHY, V30, P457, DOI 10.1007/s002490100176; Desseyn JL, 1998, J BIOL CHEM, V273, P30157, DOI 10.1074/jbc.273.46.30157; FORSTNER JF, 1976, PEDIATR RES, V10, P609, DOI 10.1203/00006450-197606000-00009; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; GUM JR, 1994, J BIOL CHEM, V269, P2440; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; Kuver R, 2004, BIOCHEM BIOPH RES CO, V314, P330, DOI 10.1016/j.bbrc.2003.12.088; Kuver R, 2000, GLYCOBIOLOGY, V10, P149, DOI 10.1093/glycob/10.2.149; Perez-Vilar J, 2006, J BIOL CHEM, V281, P4844, DOI 10.1074/jbc.M510520200; Perez-Vilar J, 1998, J BIOL CHEM, V273, P14442, DOI 10.1074/jbc.273.23.14442; PerezVilar J, 1996, J BIOL CHEM, V271, P9845, DOI 10.1074/jbc.271.16.9845; Quinton PM, 2010, AM J PHYSIOL-LUNG C, V298, pL13, DOI 10.1152/ajplung.00358.2009; Raynal BDE, 2003, J BIOL CHEM, V278, P28703, DOI 10.1074/jbc.M304632200; Raynal BDE, 2002, BIOCHEM J, V362, P289, DOI 10.1042/0264-6021:3620289; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Rogers DF, 2004, CURR OPIN PHARMACOL, V4, P241, DOI 10.1016/j.coph.2004.01.011; Round AN, 2004, J STRUCT BIOL, V145, P246, DOI 10.1016/j.jsb.2003.10.029; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheehan JK, 2004, J BIOL CHEM, V279, P15698, DOI 10.1074/jbc.M313241200; SHEEHAN JK, 1995, AM J RESP CELL MOL, V13, P748, DOI 10.1165/ajrcmb.13.6.7576713; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Thornton DJ, 1997, J BIOL CHEM, V272, P9561; Thornton DJ, 2000, AM J PHYSIOL-LUNG C, V278, pL1118, DOI 10.1152/ajplung.2000.278.6.L1118; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; VERDUGO P, 1987, BIORHEOLOGY, V24, P625; VERDUGO P, 1987, J DENT RES, V66, P506, DOI 10.1177/00220345870660022001; Verdugo P, 2012, P NATL ACAD SCI USA, V109, pE2956, DOI 10.1073/pnas.1211117109; VISCHER UM, 1994, BLOOD, V83, P3536; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268	45	65	66	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16409	16420		10.1074/jbc.M114.566679	http://dx.doi.org/10.1074/jbc.M114.566679			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778189	Green Published, hybrid			2022-12-25	WOS:000337965700043
J	Adams, TS; Eissenstat, DM				Adams, Thomas S.; Eissenstat, David M.			The Continuous Incorporation of Carbon into Existing Sassafras albidum Fine Roots and Its Implications for Estimating Root Turnover	PLOS ONE			English	Article							FOREST; RADIOCARBON; ALLOCATION; AGE; DYNAMICS; STARCH; SEASON; SUGAR; TREES	Although understanding the timing of the deposition of recent photosynthate into fine roots is critical for determining root lifespan and turnover using isotopic techniques, few studies have directly examined the deposition and subsequent age of root carbon. To gain a better understanding of the timing of the deposition of root carbon, we labeled four individual Sassafras albidum trees with 99% C-13 CO2. We then tracked whether the label appeared in roots that were at least two weeks old and no longer elongating, at the time of labeling. We found that not only were the non-structural carbon pools (soluble sugars and starch) of existing first-order tree roots incorporating carbon from current photosynthate, but so were the structural components of the roots, even in roots that were more than one year old at the time of labeling. Our findings imply that carbon used in root structural and nonstructural pools is not derived solely from photosynthate at root initiation and have implications regarding the determination of root age and turnover using isotopic techniques.	[Adams, Thomas S.; Eissenstat, David M.] Penn State Univ, Grad Program Ecol, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Eissenstat, DM (corresponding author), Penn State Univ, Grad Program Ecol, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA.	dme9@psu.edu	Eissenstat, David/AAE-2793-2020		National Science Foundation [IOS-0824704, IOS-1120482]; Direct For Biological Sciences [1120482] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (IOS-0824704, IOS-1120482) to DM Eissenstat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carbone MS, 2007, GLOBAL CHANGE BIOL, V13, P466, DOI 10.1111/j.1365-2486.2006.01300.x; Comas LH, 2005, NEW PHYTOL, V167, P829, DOI 10.1111/j.1469-8137.2005.01456.x; Eissenstat DM, 1999, NEW PHYTOL, V141, P309, DOI 10.1046/j.1469-8137.1999.00342.x; Fahey TJ, 2012, CAN J FOREST RES, V42, P1792, DOI 10.1139/X2012-128; FAYLE DFC, 1968, 9 U TOR FAC FOR; Gaudinski JB, 2009, GLOBAL CHANGE BIOL, V15, P992, DOI 10.1111/j.1365-2486.2008.01736.x; Gaudinski JB, 2001, OECOLOGIA, V129, P420, DOI 10.1007/s004420100746; Gaul D, 2009, FUNCT PLANT BIOL, V36, P11, DOI 10.1071/FP08195; Keel SG, 2012, NEW PHYTOL, V194, P972, DOI 10.1111/j.1469-8137.2012.04120.x; Kosola KR, 2002, TREE PHYSIOL, V22, P741, DOI 10.1093/treephys/22.10.741; MARSHALL JD, 1985, CAN J FOREST RES, V15, P791, DOI 10.1139/x85-129; McCormack ML, 2012, NEW PHYTOL, V195, P823, DOI 10.1111/j.1469-8137.2012.04198.x; NGUYEN PV, 1990, TREE PHYSIOL, V7, P95, DOI 10.1093/treephys/7.1-2-3-4.95; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Riley WJ, 2009, NEW PHYTOL, V184, P387, DOI 10.1111/j.1469-8137.2009.02980.x; Sah SP, 2011, BIOGEOCHEMISTRY, V104, P91, DOI 10.1007/s10533-010-9485-7; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P217, DOI 10.1111/j.1365-2486.2005.001063.x; Vargas R, 2009, NEW PHYTOL, V182, P710, DOI 10.1111/j.1469-8137.2009.02789.x; Wells CE, 2001, ECOLOGY, V82, P882, DOI 10.1890/0012-9658(2001)082[0882:MDISAA]2.0.CO;2; Zadworny M, 2011, NEW PHYTOL, V190, P213, DOI 10.1111/j.1469-8137.2010.03598.x	20	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95321	10.1371/journal.pone.0095321	http://dx.doi.org/10.1371/journal.pone.0095321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788762	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700027
J	Jacobsen, HB; Bjorngaard, JH; Hara, KW; Borchgrevink, PC; Woodhouse, A; Landro, NI; Harris, A; Stiles, TC				Jacobsen, Henrik B.; Bjorngaard, Johan Hakon; Hara, Karen W.; Borchgrevink, Petter C.; Woodhouse, Astrid; Landro, Nils Inge; Harris, Anette; Stiles, Tore C.			The Role of Stress in Absenteeism: Cortisol Responsiveness among Patients on Long-Term Sick Leave	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; ACUTE PSYCHOSOCIAL STRESS; INSOMNIA SEVERITY INDEX; MAJOR DEPRESSION; RESPONSES; PAIN; FIBROMYALGIA; POPULATION; PREVALENCE; VALIDATION	Objective: This study aimed to (1) See whether increased or decreased variation relate to subjective reports of common somatic and psychological symptoms for a population on long-term sick leave; and (2) See if this pattern in variation is correlated with autonomic activation and psychological appraisal. Methods: Our participants (n = 87) were referred to a 3.5-week return-to-work rehabilitation program, and had been on paid sick leave >8 weeks due to musculoskeletal pain, fatigue and/or common mental disorders. An extensive survey was completed, addressing socio-demographics, somatic and psychological complaints. In addition, a physician and a psychologist examined the participants, determining baseline heart rate, medication use and SCID-I diagnoses. During the 3.5-week program, the participants completed the Trier Social Stress Test for Groups. Participants wore heart rate monitors and filled out Visual Analogue Scales during the TSST-G. Results: Our participants presented a low cortisol variation, with mixed model analyses showing a maximal increase in free saliva cortisol of 26% (95% CI, 0.21-0.32). Simultaneously, the increase in heart rate and Visual Analogue Scales was substantial, indicating autonomic and psychological activation consistent with intense stress from the Trier Social Stress Test for Groups. Conclusions: The current findings are the first description of a blunted cortisol response in a heterogeneous group of patients on long-term sick leave. The results suggest lack of cortisol reactivity as a possible biological link involved in the pathway between stress, sustained activation and long-term sick leave.	[Jacobsen, Henrik B.; Hara, Karen W.; Borchgrevink, Petter C.] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Jacobsen, Henrik B.; Hara, Karen W.; Borchgrevink, Petter C.; Woodhouse, Astrid; Stiles, Tore C.] St Olavs Univ Hosp, Hysnes Rehabil Ctr, Trondheim, Norway; [Jacobsen, Henrik B.; Hara, Karen W.; Borchgrevink, Petter C.; Woodhouse, Astrid; Landro, Nils Inge; Stiles, Tore C.] St Olavs Univ Hosp, Natl Ctr Complex Disorders, Trondheim, Norway; [Bjorngaard, Johan Hakon; Woodhouse, Astrid] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Bjorngaard, Johan Hakon] St Olavs Univ Hosp, Forens Dept, Trondheim, Norway; [Bjorngaard, Johan Hakon] St Olavs Univ Hosp, Res Ctr Broset, Trondheim, Norway; [Landro, Nils Inge] Univ Oslo, Dept Psychol, Clin Neurosci Res Grp, Oslo, Norway; [Harris, Anette] Univ Bergen, Fac Psychol, Dept Hlth Promot & Dev, Bergen, Norway; [Stiles, Tore C.] Norwegian Univ Sci & Technol, Dept Psychol, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo; University of Bergen; Norwegian University of Science & Technology (NTNU)	Jacobsen, HB (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway.	henrik.b.jacobsen@ntnu.no		Jacobsen, Henrik/0000-0001-5329-0003; Stiles, Tore C./0000-0001-5853-6674	Central Norway Regional Health Authority	Central Norway Regional Health Authority	This study was done using government funding through the regional health. The full name of funder is the Central Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2014, NEUROSCI BIOBEHAV R, V38, P94, DOI 10.1016/j.neubiorev.2013.11.005; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bremmer MA, 2007, BIOL PSYCHIAT, V62, P479, DOI 10.1016/j.biopsych.2006.11.033; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Childs E, 2006, PSYCHOPHYSIOLOGY, V43, P366, DOI 10.1111/j.1469-8986.2006.00414.x; Cleare AJ, 2003, ENDOCR REV, V24, P236, DOI 10.1210/er.2002-0014; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; First MB., 1997, USERS GUIDE STRUCTUR; Foley P, 2010, NEUROSCI BIOBEHAV R, V35, P91, DOI 10.1016/j.neubiorev.2010.01.010; Gaab J, 2002, PSYCHOSOM MED, V64, P951, DOI 10.1097/01.PSY.0000038937.67401.61; Grynderup MB, 2013, PSYCHONEUROENDOCRINO, V10, P242; Hansen AM, 2008, SCAND J CLIN LAB INV, V68, P448, DOI 10.1080/00365510701819127; Haug TT, 2004, PSYCHOSOM MED, V66, P845, DOI 10.1097/01.psy.0000145823.85658.0c; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kirschbaum C, 2007, 10 YEARS RES TRIER S; Knudsen A, 2012, ACTA PSYCHIAT SCAND, P287; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Kristenson M, 2004, SOC SCI MED, V58, P1511, DOI 10.1016/S0277-9536(03)00353-8; Kudielka B M, 2006, G Ital Med Lav Ergon, V28, P34; Kudielka BM, 2006, BIOL PSYCHOL, V72, P147, DOI 10.1016/j.biopsycho.2005.09.001; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; Landmark T, 2012, PAIN, V153, P1368, DOI 10.1016/j.pain.2012.02.004; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; LUTGENDORF SK, 1995, PSYCHOSOM MED, V57, P310, DOI 10.1097/00006842-199507000-00002; Menke A, 2013, GENES BRAIN BEHAV, V12, P289, DOI 10.1111/gbb.12026; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; NAV-statistics, 2013, STAT DAT SHORT REP; Oyeflaten I, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-748; Petrowski K, 2010, PSYCHONEUROENDOCRINO, V35, P414, DOI 10.1016/j.psyneuen.2009.08.003; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Reme SE, 2011, EUR J PAIN, V15, P1075, DOI 10.1016/j.ejpain.2011.04.012; Riva R, 2012, PSYCHONEUROENDOCRINO, V37, P299, DOI 10.1016/j.psyneuen.2011.06.014; Riva R, 2010, INT J BEHAV MED, V17, P223, DOI 10.1007/s12529-010-9097-6; Suarez-Hitz KA, 2012, PSYCHOSOM MED, V74, P221, DOI 10.1097/PSY.0b013e318244fb82; Ursin H, 2004, PSYCHONEUROENDOCRINO, V29, P567, DOI 10.1016/S0306-4530(03)00091-X; Van Houdenhove Boudewijn, 2005, Curr Rheumatol Rep, V7, P365; von Dawans B, 2011, PSYCHONEUROENDOCRINO, V36, P514, DOI 10.1016/j.psyneuen.2010.08.004; Ware J, 2001, MANUAL USERS SF 8 HL, P4; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Witteveen AB, 2010, PSYCHONEUROENDOCRINO, V35, P1113, DOI 10.1016/j.psyneuen.2009.12.013; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	44	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96048	10.1371/journal.pone.0096048	http://dx.doi.org/10.1371/journal.pone.0096048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZS	24788346	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700052
J	Mahadev, V; Starr, R; Wright, SL; Martinez, C; Jensen, MC; Barish, ME; Forman, SJ; Brown, CE				Mahadev, Vaidehi; Starr, Renate; Wright, Sarah L.; Martinez, Catalina; Jensen, Michael C.; Barish, Michael E.; Forman, Stephen J.; Brown, Christine E.			Cytokine Induction of VCAM-1 but Not IL13R alpha 2 on Glioma Cells: A Tale of Two Antibodies	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; ADHESION MOLECULE-1; RECEPTOR ALPHA-2; T-CELLS; EXPRESSION; INTERLEUKIN-13; IL-13; IL-13R-ALPHA-2; IMMUNOTHERAPY; RECOGNITION	The interleukin-13 receptor alpha2 (IL13R alpha 2) is a cell surface receptor that is over-expressed by a subset of high-grade gliomas, but not expressed at significant levels by normal brain tissue. For both malignant and non-malignant cells, IL13R alpha 2 surface expression is reported to be induced by various cytokines such as IL-4 or IL-13 and tumor necrosis factor (TNF). Our group has developed a therapeutic platform to target IL13R alpha 2-positive brain tumors by engineering human cytotoxic T lymphocytes (CTLs) to express the IL13-zetakine chimeric antigen receptor. We therefore sought to investigate the potential of cytokine stimulation to induce IL13R alpha 2 cell surface expression, and thereby increase susceptibility to IL13R alpha 2-specific T cell killing. In the course of these experiments, we unexpectedly found that the commercially available putative IL13R alpha 2-specific monoclonal antibody B-D13 recognizes cytokine-induced VCAM-1 on glioblastoma. We provide evidence that the induced receptor is not IL13R alpha 2, because its expression does not consistently correlate with IL13R alpha 2 mRNA levels, it does not bind IL-13, and it is not recognized by IL13-zetakine CTL. Instead we demonstrate by immunoprecipitation experiments and mass spectrometry that the antigen recognized by the B-D13 antibody following cytokine stimulation is VCAM-1, and that VCAM-1, but not IL13R alpha 2, is induced on glioma cells by TNF alone or in combination with IL-13 or IL-4. Further evaluation of several commercial B-D13 antibodies revealed that B-D13 is bi-specific, recognizing both IL13R alpha 2 and VCAM-1. This binding is non-overlapping based on soluble receptor competition experiments, and mass spectrometry identifies two distinct heavy and light chain species, providing evidence that the B-D13 reagent is di-clonal. PE-conjugation of the B-D13 antibody appears to disrupt IL13R alpha 2 recognition, while maintaining VCAM-1 specificity. While this work calls into question previous studies that have used the B-D13 antibody to assess IL13R alpha 2 expression, it also suggests that TNF may have significant effects on glioma biology by up-regulating VCAM-1.	[Mahadev, Vaidehi; Starr, Renate; Wright, Sarah L.; Martinez, Catalina; Forman, Stephen J.; Brown, Christine E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA; [Mahadev, Vaidehi; Starr, Renate; Wright, Sarah L.; Martinez, Catalina; Forman, Stephen J.; Brown, Christine E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapy & Tumor Immunol, Duarte, CA 91010 USA; [Barish, Michael E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Neurosci, Duarte, CA 91010 USA; [Jensen, Michael C.] Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Seattle Children's Hospital	Brown, CE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA.	cbrown@coh.org		Brown, Christine/0000-0003-4915-8207	NCI [P30 CA33572]; California Institute for Regenerative Medicine [CIRM TR3-05641]; Chubb Charity Golf Tournament; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Chubb Charity Golf Tournament; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NCI (P30 CA33572), California Institute for Regenerative Medicine (CIRM TR3-05641), and generous donations from Joan and Larry Flax and the Chubb Charity Golf Tournament. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no conflicting financial interests.	Brown CE, 2012, CLIN CANCER RES, V18, P2199, DOI 10.1158/1078-0432.CCR-11-1669; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Cooper LJN, 2003, BLOOD, V101, P1637, DOI 10.1182/blood-2002-07-1989; Daines MO, 2002, J BIOL CHEM, V277, P10387, DOI 10.1074/jbc.M108109200; Debinski W, 1999, INT J ONCOL, V15, P481; Di Tomaso T, 2010, CLIN CANCER RES, V16, P800, DOI 10.1158/1078-0432.CCR-09-2730; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Han SJ, 2012, NEUROSURG CLIN N AM, V23, P357, DOI 10.1016/j.nec.2012.05.001; Jarboe JS, 2007, CANCER RES, V67, P7983, DOI 10.1158/0008-5472.CAN-07-1493; Jonnalagadda M, 2013, GENE THER, V20, P853, DOI 10.1038/gt.2012.97; Joshi BH, 2008, NEURO-ONCOLOGY, V10, P265, DOI 10.1215/15228517-2007-066; Kahlon KS, 2004, CANCER RES, V64, P9160, DOI 10.1158/0008-5472.CAN-04-0454; Kawakami M, 2004, CANCER-AM CANCER SOC, V101, P1036, DOI 10.1002/cncr.20470; Kunwar S, 2010, NEURO-ONCOLOGY, V12, P871, DOI 10.1093/neuonc/nop054; Lupardus PJ, 2010, STRUCTURE, V18, P332, DOI 10.1016/j.str.2010.01.003; Meza JE, 2004, ASS BIOM RES FAC ABR; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; RICE GE, 1989, SCIENCE, V246, P1303, DOI 10.1126/science.2588007; ROSENMAN SJ, 1995, J IMMUNOL, V154, P1888; Russell SM, 2011, ORAL ONCOL, V47, P810, DOI 10.1016/j.oraloncology.2011.05.015; Ruzevick J, 2012, NEUROSURG CLIN N AM, V23, P459, DOI 10.1016/j.nec.2012.04.003; Saikali S, 2007, J NEURO-ONCOL, V81, P139, DOI 10.1007/s11060-006-9220-3; Saka M, 2010, J NEUROSURG, V113, P270, DOI 10.3171/2009.9.JNS09708; Strober W, 2009, CURR MOL MED, V9, P740, DOI 10.2174/156652409788970652; Wang YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060834; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278	28	1	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95123	10.1371/journal.pone.0095123	http://dx.doi.org/10.1371/journal.pone.0095123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787244	Green Submitted, Green Published, gold			2022-12-25	WOS:000336655700026
J	Shi, YY; Jia, YD; Hou, SP; Fang, J; Zhou, Y; Kijlstra, A; Yang, PZ				Shi, Yanyun; Jia, Yading; Hou, Shengping; Fang, Jing; Zhou, Yan; Kijlstra, Aize; Yang, Peizeng			Association of a TNIP1 Polymorphism with Vogt-Koyanagi-Harada Syndrome but Not with Ocular Behcet's Disease in Han Chinese	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SUSCEPTIBILITY LOCI; DIAGNOSTIC-CRITERIA; RISK; STAT4; REPLICATION; PROTEIN-1; PSORIASIS; TNFAIP3; IL10	Objectives: The aim of the study was to investigate the association of TNF alpha-induced protein 3 interacting with protein 1 (TNIP1) gene polymorphisms with Vogt-Koyanagi-Harada (VKH) syndrome and Behcet's disease (BD) in a Han Chinese population. Methods: A total of 656 BD patients, 961 VKH syndrome patients and 1534 healthy controls were included in this two-stage case control study. Seven SNPs, including rs17728338, rs7708392, rs10036748, rs3762999, rs999556, rs4958881 and rs3792783, belonging to TNIP1 were genotyped and analyzed by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The data were analyzed by using the chi(2) or Fisher's exact test and corrected for multiple comparisons by the Bonferroni method. Results: A significantly increased frequency of the GG genotype and a decreased frequency of the AG genotype of rs17728338 were found in VKH patients (Pc = 0.038 OR = 1.934, 95% CI = 1.438 similar to 2.601). No significant difference was noted in allele or genotype frequencies of rs7708392, rs10036748, rs3762999, rs999556, rs4958881 and rs3792783, between VKH patients and healthy controls (Pc>0.05). No significant difference was noted in allele or genotype frequencies of the tested 7 SNPs between BD patients and healthy controls. Analysis of extraocular clinical findings, did not reveal an association of the TNIP1 gene polymorphisms with BD or VKH syndrome subgroups. Conclusion: A TNIP1 polymorphism may be a risk factor for VKH syndrome in Han Chinese.	[Shi, Yanyun; Hou, Shengping; Fang, Jing; Zhou, Yan; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; [Jia, Yading] Shanxi Eye Hosp, Taiyuan, Shanxi, Peoples R China; [Hou, Shengping; Yang, Peizeng] Chongqing Eye Inst, Chongqing, Peoples R China; [Hou, Shengping; Yang, Peizeng] Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Eye Clin Maastricht, Maastricht, Limburg, Netherlands	Chongqing Medical University; Shanxi Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China.	peizengycmu@126.com			Natural Science Foundation [81320108009, 31370893]; Key Project of Natural Science Foundation [81130019]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Clinic Key Project of Ministry of Health; Basic Research program of Chongqing [cstc2013jcyjC10001]; Fund for PAR-EU Scholars Program	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Project of Natural Science Foundation; Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Clinic Key Project of Ministry of Health; Basic Research program of Chongqing; Fund for PAR-EU Scholars Program	This work was supported by Natural Science Foundation Major International (Regional) Joint Research (81320108009), Key Project of Natural Science Foundation (81130019), National Natural Science Foundation Project (31370893), Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), Clinic Key Project of Ministry of Health, Basic Research program of Chongqing (cstc2013jcyjC10001), and Fund for PAR-EU Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; Arellanes-Garcia L, 1998, OCUL IMMUNOL INFLAMM, V6, P93, DOI 10.1076/ocii.6.2.93.4049; Baranathan V, 2007, ANN RHEUM DIS, V66, P1531, DOI 10.1136/ard.2007.073866; Bordaberry MF, 2010, CURR OPIN OPHTHALMOL, V21, P430, DOI 10.1097/ICU.0b013e32833eb78c; Bowes J, 2011, ANN RHEUM DIS, V70, P1641, DOI 10.1136/ard.2011.150102; Damico FM, 2009, ARQ BRAS OFTALMOL, V72, P413, DOI 10.1590/S0004-27492009000300028; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Fang W, 2008, CURR EYE RES, V33, P517, DOI 10.1080/02713680802233968; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gurevich I, 2013, GENE, V515, P42, DOI 10.1016/j.gene.2012.11.041; Gurevich I, 2012, BBA-GENE REGUL MECH, V1819, P1, DOI 10.1016/j.bbagrm.2011.09.006; He CF, 2010, LUPUS, V19, P1181, DOI 10.1177/0961203310367918; Horie Y, 2009, MOL VIS, V15, P1115; Hu DN, 2011, INVEST OPHTH VIS SCI, V52, P3767, DOI 10.1167/iovs.10-6908; Jiang ZX, 2010, HUM IMMUNOL, V71, P414, DOI 10.1016/j.humimm.2010.01.026; Kawasaki A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3134; Kim ES, 2012, LIFE SCI, V90, P740, DOI 10.1016/j.lfs.2012.03.017; Kim MH, 2000, AM J OPHTHALMOL, V129, P173, DOI 10.1016/S0002-9394(99)00434-1; Krause I, 2008, CURR OPIN RHEUMATOL, V20, P82, DOI 10.1097/BOR.0b013e3282f154d1; Mignogna MD, 2000, J RHEUMATOL, V27, P2725; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Ramirez VP, 2012, CYTOKINE GROWTH F R, V23, P109, DOI 10.1016/j.cytogfr.2012.04.002; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Sahin N, 2007, TISSUE ANTIGENS, V70, P432, DOI 10.1111/j.1399-0039.2007.00928.x; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Shen L, 2013, GENE, V526, P259, DOI 10.1016/j.gene.2013.05.022; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; WEISZ JM, 1995, OPHTHALMOLOGY, V102, P1012; Yang PZ, 2005, CURR EYE RES, V30, P943, DOI 10.1080/02713680500263606; Yi L, 2013, INT J IMMUNOPATH PH, V26, P473, DOI 10.1177/039463201302600220; Yuan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064572; Zhang J, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/265823; Zhong H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3514	35	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95573	10.1371/journal.pone.0095573	http://dx.doi.org/10.1371/journal.pone.0095573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788730	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700033
J	Xu, TT; Ripp, S; Sayler, GS; Close, DM				Xu, Tingting; Ripp, Steven; Sayler, Gary S.; Close, Dan M.			Expression of a Humanized Viral 2A-Mediated lux Operon Efficiently Generates Autonomous Bioluminescence in Human Cells	PLOS ONE			English	Article							BACTERIAL LUCIFERASE; REPORTER; VECTORS; ASSAY; PCR	Background: Expression of autonomous bioluminescence from human cells was previously reported to be impossible, suggesting that all bioluminescent-based mammalian reporter systems must therefore require application of a potentially influential chemical substrate. While this was disproven when the bacterial luciferase (lux) cassette was demonstrated to function in a human cell, its expression required multiple genetic constructs, was functional in only a single cell type, and generated a significantly reduced signal compared to substrate-requiring systems. Here we investigate the use of a humanized, viral 2A-linked lux genetic architecture for the efficient introduction of an autobioluminescent phenotype across a variety of human cell lines. Methodology/Principal Findings: The lux cassette was codon optimized and assembled into a synthetic human expression operon using viral 2A elements as linker regions. Human kidney, breast cancer, and colorectal cancer cell lines were both transiently and stably transfected with the humanized operon and the resulting autobioluminescent phenotype was evaluated using common imaging instrumentation. Autobioluminescent cells were screened for cytotoxic effects resulting from lux expression and their utility as bioreporters was evaluated through the demonstration of repeated monitoring of single populations over a prolonged period using both a modified E-SCREEN assay for estrogen detection and a classical cytotoxic compound detection assay for the antibiotic Zeocin. Furthermore, the use of self-directed bioluminescent initiation in response to target detection was assessed to determine its amenability towards deployment as fully autonomous sensors. In all cases, bioluminescent measurements were supported with traditional genetic and transcriptomic evaluations. Conclusions/Significance: Our results demonstrate that the viral 2A-linked, humanized lux genetic architecture successfully produced autobioluminescent phenotypes in all cell lines tested without the induction of cytotoxicity. This autobioluminescent phenotype allowed for repeated interrogation of populations and self-directed control of bioluminescent activation with detection limits and EC50 values similar to traditional reporter systems, making the autobioluminescent cells amenable to automated monitoring and significantly reducing the time and cost required to perform bioluminescent workflows.	[Xu, Tingting; Sayler, Gary S.] Oak Ridge Natl Lab, Joint Inst Biol Sci, Oak Ridge, TN USA; [Ripp, Steven; Close, Dan M.] 490 BioTech Inc, Knoxville, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Close, DM (corresponding author), 490 BioTech Inc, Knoxville, TN USA.	dan.close@490BioTech.com	Ripp, Steven/AAU-1225-2021; Ripp, Steven/B-2305-2008; Close, Dan/A-4417-2012	Ripp, Steven/0000-0002-6836-1764; Ripp, Steven/0000-0002-6836-1764; Close, Dan/0000-0003-4790-4448	NIH SBIR program [1R43ES022567-01]; National Institutes of Health, National Cancer Institute, Cancer Imaging Program [CA127745-01]; National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) [CBET-0853780]; Alternative Research & Development Foundation; Army Defense University Research Instrumentation Program; Directorate For Engineering [1159344] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R21CA127745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R43ES022567, R44ES022567] Funding Source: NIH RePORTER	NIH SBIR program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Cancer Institute, Cancer Imaging Program; National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET)(National Science Foundation (NSF)); Alternative Research & Development Foundation; Army Defense University Research Instrumentation Program; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the NIH SBIR program, award number 1R43ES022567-01, the National Institutes of Health, National Cancer Institute, Cancer Imaging Program, award number CA127745-01, the National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET), award number CBET-0853780, the Alternative Research & Development Foundation, and the Army Defense University Research Instrumentation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Close DM, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3564910; Close DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012441; Constance J, 2010, MOL IMAGING MARKETS; Costa S, 1991, EXPRESSION FUSED BAC; DEWET JR, 1986, METHOD ENZYMOL, V133, P3; Freundlieb S, 2007, CLONTECHNIQUES, P14; GOSSEN M, 1993, NUCLEIC ACIDS RES, V21, P4411, DOI 10.1093/nar/21.18.4411; Hollis RP, 2001, FEBS LETT, V506, P140, DOI 10.1016/S0014-5793(01)02905-2; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Legler J, 1999, TOXICOL SCI, V48, P55, DOI 10.1093/toxsci/48.1.55; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; MEIGHEN EA, 1988, ANNU REV MICROBIOL, V42, P151, DOI 10.1146/annurev.mi.42.100188.001055; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; MEIGHEN EA, 1979, BIOCHEM BIOPH RES CO, V87, P1080, DOI 10.1016/S0006-291X(79)80018-2; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Promega, 2009, TECHN MAN PGL4 LUC; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Sambrook J, 2001, MOL CLONING LAB MANU; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Soto AM, 2006, BEST PRACT RES CL EN, V20, P15, DOI 10.1016/j.beem.2005.09.001; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tinikul R, 2012, J BIOTECHNOL, V162, P346, DOI 10.1016/j.jbiotec.2012.08.018; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; VERVOORT J, 1986, BIOCHEMISTRY-US, V25, P8067, DOI 10.1021/bi00372a041; Welham PA, 2009, MOL BIOSYST, V5, P68, DOI 10.1039/b812094c; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu T, 2013, J VISUALIZED EXPT, V18; Yarranton Geoffrey T., 1992, Current Opinion in Biotechnology, V3, P506, DOI 10.1016/0958-1669(92)90078-W	33	30	31	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96347	10.1371/journal.pone.0096347	http://dx.doi.org/10.1371/journal.pone.0096347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788811	Green Submitted, Green Published, gold			2022-12-25	WOS:000336655700078
J	Zhang, H; Zhao, B; Huang, C; Meng, XM; Bian, EB; Li, J				Zhang, Hui; Zhao, Bin; Huang, Cheng; Meng, Xiao-Ming; Bian, Er-Bao; Li, Jun			Melittin Restores PTEN Expression by Down-Regulating HDAC2 in Human Hepatocelluar Carcinoma HepG2 Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; TUMOR-SUPPRESSOR PTEN; ANTICANCER ACTIVITY; CANCER CELLS; APOPTOSIS; INACTIVATION; PANOBINOSTAT; METASTASIS; EFFICACY; THERAPY	Melittin is a water-soluble toxic peptide derived from the venom of the bee. Although many studies show the anti-tumor activity of melittin in human cancer including glioma cells, the underlying mechanisms remain elusive. Here the effect of melittin on human hepatocelluar carcinoma HepG2 cell proliferation in vitro and further mechanisms was investigated. We found melittin could inhibit cell proliferation in vitro using Flow cytometry and MTT method. Besides, we discovered that melittin significantly downregulated the expressions of CyclinD1 and CDK4. Results of western Blot and Real-time PCR analysis indicated that melittin was capable to upregulate the expression of PTEN and attenuate histone deacetylase 2 (HDAC2) expression. Further studies demonstrated that knockdown of HDAC2 completely mimicked the effects of melittin on PTEN gene expression. Conversely, it was that the potential utility of melittin on PTEN expression was reversed in cells treated with a recombinant pEGFP-C2-HDAC2 plasmid. In addition, treatment with melittin caused a downregulation of Akt phosphorylation, while overexpression of HDAC2 promoted Akt phosphorylation. These findings suggested that the inhibitory of cell growth by melittin might be led by HDAC2-mediated PTEN upregulation, Akt inactivation, and inhibition of the PI3K/Akt signaling pathways.	[Zhang, Hui; Zhao, Bin; Huang, Cheng; Meng, Xiao-Ming; Bian, Er-Bao; Li, Jun] Anhui Med Univ, Sch Pharm, Anhui Key Lab Bioact Nat Prod, Hefei, Anhui, Peoples R China; [Zhang, Hui; Zhao, Bin; Huang, Cheng; Meng, Xiao-Ming; Bian, Er-Bao; Li, Jun] Anhui Med Univ, Inst Liver Dis, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Li, J (corresponding author), Anhui Med Univ, Sch Pharm, Anhui Key Lab Bioact Nat Prod, Hefei, Anhui, Peoples R China.	lj@ahmu.edu.cn			National Science Foundation of China [81072686, 81273526]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Science Foundation of China (NO 81072686, 81273526). The funder had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahn S, 2013, GUT LIVER, V7, P206, DOI 10.5009/gnl.2013.7.2.206; Barneda-Zahonero B, 2012, MOL ONCOL, V6, P579, DOI 10.1016/j.molonc.2012.07.003; Bian EB, 2012, TOXICOL APPL PHARM, V264, P13, DOI 10.1016/j.taap.2012.06.022; Correia NC, 2014, EUR J CANCER, V50, P216, DOI 10.1016/j.ejca.2013.08.017; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gan YH, 2009, ORAL ONCOL, V45, pE150, DOI 10.1016/j.oraloncology.2009.05.563; Huang WJ, 2011, J ETHNOPHARMACOL, V136, P156, DOI 10.1016/j.jep.2011.04.034; Icardi L, 2012, CYTOKINE GROWTH F R, V23, P283, DOI 10.1016/j.cytogfr.2012.08.002; Ikenoue T, 2008, CANCER RES, V68, P6908, DOI 10.1158/0008-5472.CAN-08-1107; Jeong JB, 2013, BIOCHEM BIOPH RES CO, V430, P381, DOI 10.1016/j.bbrc.2012.11.018; Kim JK, 2013, MOL CANCER RES, V11, P62, DOI 10.1158/1541-7786.MCR-12-0332; Kwak MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053476; Lachenmayer A, 2012, J HEPATOL, V56, P1343, DOI 10.1016/j.jhep.2012.01.009; Lee WR, 2011, TOXICOL APPL PHARM, V256, P209, DOI 10.1016/j.taap.2011.08.012; Li QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033379; Lin CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051916; Liu SJ, 2008, HEPATOLOGY, V47, P1964, DOI 10.1002/hep.22240; Lu YS, 2007, HEPATOLOGY, V46, P1119, DOI 10.1002/hep.21804; Luo L, 2013, MOL CELL BIOCHEM, V375, P1, DOI 10.1007/s11010-012-1484-7; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Moon DO, 2008, TOXICON, V51, P112, DOI 10.1016/j.toxicon.2007.08.015; Moon SH, 2013, INT J ONCOL, V42, P921, DOI 10.3892/ijo.2013.1765; Morine Y, 2012, SURGERY, V151, P412, DOI 10.1016/j.surg.2011.07.038; Noro R, 2007, INT J ONCOL, V31, P1157; Oiso H, 2011, BIOCHEM BIOPH RES CO, V404, P166, DOI 10.1016/j.bbrc.2010.11.086; Pan LN, 2007, CANCER, V109, P1676, DOI 10.1002/cncr.22585; Peyrou M, 2010, WORLD J GASTROENTERO, V16, P4627, DOI 10.3748/wjg.v16.i37.4627; Regel I, 2012, GASTROENTEROLOGY, V143, P99, DOI 10.1053/j.gastro.2012.03.035; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Sakamoto K, 2009, MOL BIOL CELL, V20, P1606, DOI 10.1091/mbc.E08-07-0762; Song MS, 2012, FUNCTIONS REGULATION; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Wikman H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3150; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang L, 2012, MOL CELL BIOCHEM, V361, P39, DOI 10.1007/s11010-011-1085-x; Zhu XH, 2013, EXP THER MED, V5, P57, DOI 10.3892/etm.2012.749	38	29	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95520	10.1371/journal.pone.0095520	http://dx.doi.org/10.1371/journal.pone.0095520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788349	Green Submitted, Green Published, gold			2022-12-25	WOS:000336655700031
J	Andrade, FA; Restini, CBA; Grando, MD; Ramalho, LNZ; Bendhack, LM				Andrade, Fernanda A.; Restini, Carolina B. A.; Grando, Marcella D.; Ramalho, Leandra N. Z.; Bendhack, Lusiane M.			Vascular Relaxation Induced by C-Type Natriuretic Peptide Involves the Ca2+/NO-Synthase/NO Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CYCLIC-GMP; CLEARANCE RECEPTOR; CYTOPLASMIC DOMAIN; ADENYLYL-CYCLASE; G-PROTEIN; MECHANISMS; SYSTEM; PHOSPHORYLATION; ACTIVATION	Aims: C-type natriuretic peptide (CNP) and nitric oxide (NO) are endothelium-derived factors that play important roles in the regulation of vascular tone and arterial blood pressure. We hypothesized that NO produced by the endothelial NO-synthase (NOS-3) contributes to the relaxation induced by CNP in isolated rat aorta via activation of endothelial NPR-C receptor. Therefore, the aim of this study was to investigate the putative contribution of NO through NPR-C activation in the CNP induced relaxation in isolated conductance artery. Main Methods: Concentration-effect curves for CNP were constructed in aortic rings isolated from rats. Confocal microscopy was used to analyze the cytosolic calcium mobilization induced by CNP. The phosphorylation of the residue Ser(1177) of NOS was analyzed by Western blot and the expression and localization of NPR-C receptors was analyzed by immunohistochemistry. Key Findings: CNP was less potent in inducing relaxation in denuded endothelium aortic rings than in intact ones. L-NAME attenuated the potency of CNP and similar results were obtained in the presence of hydroxocobalamin, an intracellular NO0 scavenger. CNP did not change the phosphorylation of Ser(1177), the activation site of NOS-3, when compared with control. The addition of CNP produced an increase in [Ca2+](c) in endothelial cells and a decrease in [Ca2+](c) in vascular smooth muscle cells. The NPR-C-receptors are expressed in endothelial and adventitial rat aortas. Significance: These results suggest that CNP-induced relaxation in intact aorta isolated from rats involves NO production due to [Ca2+](c) increase in endothelial cells possibly through NPR-C activation expressed in these cells. The present study provides a breakthrough in the understanding of the close relationship between the vascular actions of nitric oxide and CNP.	[Andrade, Fernanda A.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil; [Restini, Carolina B. A.] Univ Ribeirao Preto, Dept Med, Ribeirao Preto, Brazil; [Grando, Marcella D.; Bendhack, Lusiane M.] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Chem & Phys, Sao Paulo, Brazil; [Ramalho, Leandra N. Z.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Cellular & Mol Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Ribeirao Preto; Universidade de Sao Paulo; Universidade de Sao Paulo	Bendhack, LM (corresponding author), Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Chem & Phys, Sao Paulo, Brazil.	bendhack@usp.br	Ramalho, Leandra Náira Zambelli/A-3983-2010; Ramalho, Leandra/AAA-6432-2021; Bendhack, Lusiane/J-6158-2015	Ramalho, Leandra Náira Zambelli/0000-0002-3486-5294; 	FAPESP (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo); CNPq/Brazil (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPESP (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq/Brazil (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by FAPESP (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo), CNPq/Brazil (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay M, 2007, PHARMACOL RES, V55, P385, DOI 10.1016/j.phrs.2007.01.007; Amin J, 1996, HYPERTENSION, V27, P684, DOI 10.1161/01.HYP.27.3.684; AnandSrivastava MB, 1996, J BIOL CHEM, V271, P19324, DOI 10.1074/jbc.271.32.19324; Costa MA, 2007, BIOCHEM BIOPH RES CO, V359, P180, DOI 10.1016/j.bbrc.2007.05.095; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; BLATTER LA, 1995, CIRC RES, V76, P922, DOI 10.1161/01.RES.76.5.922; Bonaventura D, 2007, VASC PHARMACOL, V46, P215, DOI 10.1016/j.vph.2006.10.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunner F, 2001, CARDIOVASC RES, V51, P577, DOI 10.1016/S0008-6363(01)00283-8; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; Caniffi C, 2010, PEPTIDES, V31, P1309, DOI 10.1016/j.peptides.2010.03.030; Chen HH, 1998, J CARDIOVASC PHARM, V32, pS22; Costa MA, 2010, AM J PHYSIOL-HEART C, V298, pH778, DOI 10.1152/ajpheart.00488.2009; Costa MA, 2006, REGUL PEPTIDES, V135, P63, DOI 10.1016/j.regpep.2006.04.002; Elesgaray R, 2008, REGUL PEPTIDES, V151, P130, DOI 10.1016/j.regpep.2008.05.008; Figueroa XF, 2002, J PHYSIOL-LONDON, V544, P883, DOI 10.1113/jphysiol.2002.021972; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; IGNARRO LJ, 1990, HYPERTENSION, V16, P477, DOI 10.1161/01.HYP.16.5.477; Janki A, 1996, HYPERTENSION, V27, P684; LINCOLN TM, 1989, PHARMACOL THERAPEUT, V41, P479, DOI 10.1016/0163-7258(89)90127-7; Madhani M, 2003, BRIT J PHARMACOL, V139, P1289, DOI 10.1038/sj.bjp.0705365; Matsubara M, 2003, J BIOCHEM, V133, P773, DOI 10.1093/jb/mvg099; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; MONCADA S, 1991, PHARMACOL REV, V43, P109; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Murthy KS, 1998, AM J PHYSIOL-CELL PH, V275, pC1409, DOI 10.1152/ajpcell.1998.275.6.C1409; Murthy KS, 2000, AM J PHYSIOL-GASTR L, V278, pG974, DOI 10.1152/ajpgi.2000.278.6.G974; Pagano M, 2001, J BIOL CHEM, V276, P22064, DOI 10.1074/jbc.M101587200; PALMER RMJ, 1987, NATURE, V327, P534; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; RAND MJ, 1992, CLIN EXP PHARMACOL P, V19, P147, DOI 10.1111/j.1440-1681.1992.tb00433.x; Sabrane K, 2005, J CLIN INVEST, V115, P1666, DOI 10.1172/JCI23360; WEI CM, 1994, BIOCHEM BIOPH RES CO, V205, P765, DOI 10.1006/bbrc.1994.2731; WEI CM, 1993, AM J PHYSIOL, V264, pH71, DOI 10.1152/ajpheart.1993.264.1.H71; Wilkins MR, 1997, LANCET, V349, P1307, DOI 10.1016/S0140-6736(96)07424-7; Woodard GE, 2008, INT REV CEL MOL BIO, V268, P59, DOI 10.1016/S1937-6448(08)00803-4; Wright RS, 1996, J AM COLL CARDIOL, V28, P1031, DOI 10.1016/S0735-1097(96)00241-0	41	13	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95446	10.1371/journal.pone.0095446	http://dx.doi.org/10.1371/journal.pone.0095446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787693	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600038
J	Feng, GY; Liu, JH; Zhao, XC; Wei, JL; Ou, WC; Xiao, SY; Hu, ZW; Wei, HQ; Liu, Z				Feng, Guiying; Liu, Jianhua; Zhao, Xiaochen; Wei, Jinglu; Ou, Wencai; Xiao, Shuyi; Hu, Zhiwen; Wei, Hongqin; Liu, Zheng			Hemostatic Effects of Microbubble-Enhanced Low-Intensity Ultrasound in a Liver Avulsion Injury Model	PLOS ONE			English	Article							FOCUSED ULTRASOUND; CONTRAST AGENT; DISRUPTION; KIDNEY; TRAUMA; TUMOR	Objectives: Microbubble-enhanced therapeutic ultrasound (MEUS) can block the blood flow in the organs. The aim of this study was to evaluate the hemostatic effect of microbubble-enhanced pulsed, low-intensity ultrasound in a New Zealand White rabbit model of avulsion trauma of the liver. The therapeutic ultrasound (TUS) transducer was operated with the frequency of 1.2 MHz and an acoustic pressure of 3.4 MPa. Microbubble-(MB) enhanced ultrasound (MEUS) (n = 6) was delivered to the distal part of the liver where the avulsion was created. Livers were treated by TUS only (n = 4) or MB only (n = 4) which served as controls. Bleeding rates were measured and contrast enhanced ultrasound (CEUS) was performed to assess the hemostatic effect, and liver hemoperfusion before and after treatment. Generally, bleeding rates decreased more than 10-fold after the treatment with MEUS compared with those of the control group (P<0.05). CEUS showed significant declines in perfusion. The peak intensity value and the area under the curve also decreased after insonation compared with those of the control group (P<0.05). Histological examination showed cloudy and swollen hepatocytes, dilated hepatic sinusoids, perisinusoidal spaces with erythrocyte accumulation in small blood vessels, obvious hemorrhage around portal areas and scattered necrosis in liver tissues within the insonation area of MEUS Group. In addition, necrosis was found in liver tissue 48 h after insonation. We conclude that MEUS might provide an effective hemostatic therapy for serious organ trauma such as liver avulsion injury.	[Feng, Guiying; Liu, Jianhua; Wei, Jinglu; Ou, Wencai; Xiao, Shuyi; Hu, Zhiwen; Wei, Hongqin] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Med Ultrasound, Guangzhou, Guangdong, Peoples R China; [Zhao, Xiaochen; Liu, Zheng] Third Mil Med Univ, Xinqiao Hosp, Dept Ultrasound, Chongqing, Peoples R China	Guangzhou Medical University; Army Medical University	Liu, JH (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Med Ultrasound, Guangzhou, Guangdong, Peoples R China.	Liujianhua266@163.com			Natural Science Foundation of Guangdong Province, China [S2013010016277]; Science and Technology Planning Project of Guangdong Province, China	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China	Supported by Natural Science Foundation of Guangdong Province, China (Grant No. S2013010016277) and supported by Science and Technology Planning Project of Guangdong Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad SS, 2012, SURG INFECT, V13, P234, DOI 10.1089/sur.2012.131; Gao YJ, 2012, ULTRASOUND MED BIOL, V38, P91, DOI 10.1016/j.ultrasmedbio.2011.09.018; [皋月娟 Gao Yuejuan], 2010, [中华超声影像学杂志, Chinese Journal of Ultrasonography], V19, P614; Geng XP, 2009, J HEPATOBILIARY SURG, V17, P409; Hwang JH, 2005, ULTRASOUND MED BIOL, V31, P553, DOI 10.1016/j.ultrasmedbio.2004.12.014; Jiao ZY, 2011, CHINESE J MED ULTRAS, V08, P1905; Kieran K, 2007, J UROLOGY, V178, P672, DOI 10.1016/j.juro.2007.03.093; Kozar RA, 2011, J TRAUMA, V71, P1, DOI 10.1097/TA.0b013e318220b192; [李秋颖 Li Qiuying], 2008, [中国超声医学杂志, Chinese Journal of Ultrasonic in Medical], V24, P297; Li WX, 2008, SHANXI MED J, V37, P582; Liu JH, 2012, ULTRASOUND MED BIOL, V38, P1930, DOI 10.1016/j.ultrasmedbio.2012.07.012; Liu P, 2011, ULTRASONICS, V51, P210, DOI 10.1016/j.ultras.2010.07.008; [刘青 Liu Qing], 2012, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V28, P1440; Liu Z, 2012, ULTRASOUND MED BIOL, V38, P253, DOI 10.1016/j.ultrasmedbio.2011.11.007; Lv FQ, 2008, CHIN J ULTRASONOGR, V17, P598; Mohr AM, 2003, J TRAUMA, V55, P1077, DOI 10.1097/01.TA.0000100219.02085.AB; [区文财 Ou Wencai], 2012, [中华超声影像学杂志, Chinese Journal of Ultrasonography], V21, P75; Poliachik SL, 2001, ULTRASOUND MED BIOL, V27, P1567, DOI 10.1016/S0301-5629(01)00444-6; Satoi S, 2005, HEPATO-GASTROENTEROL, V52, P1180; Tinkoff G, 2008, J AM COLL SURGEONS, V207, P646, DOI 10.1016/j.jamcollsurg.2008.06.342; Vaezy S, 2005, ULTRASONICS, V43, P265, DOI 10.1016/j.ultras.2004.07.002; Vaezy S, 1997, ULTRASOUND MED BIOL, V23, P1413, DOI 10.1016/S0301-5629(97)00143-9; Vaezy S, 2001, ECHOCARDIOGR-J CARD, V18, P309; Vaezy S, 1999, J VASC SURG, V29, P533, DOI 10.1016/S0741-5214(99)70282-X; Vaezy S, 1999, J TRAUMA, V47, P521, DOI 10.1097/00005373-199909000-00015; Wood AKW, 2007, ULTRASOUND MED BIOL, V33, P1901, DOI 10.1016/j.ultrasmedbio.2007.06.013; [吴盛正 Wu Shengzheng], 2011, [中华超声影像学杂志, Chinese Journal of Ultrasonography], V20, P988; Wu Z, 2008, SURGERY; Xie Xia, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P1260; Zeng LB, 2013, CHINA MODERN DOCTOR, V51, P12; Zhao XC, 2012, EUR RADIOL, V22, P379, DOI 10.1007/s00330-011-2273-5; Zhong Y, 2012, NATL MED J CHINA, V92, P477	32	13	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95589	10.1371/journal.pone.0095589	http://dx.doi.org/10.1371/journal.pone.0095589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788757	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600042
J	Gentile, LF; Nacionales, DC; Lopez, MC; Vanzant, E; Cuenca, A; Szpila, BE; Cuenca, AG; Joseph, A; Moore, FA; Leeuwenburgh, C; Baker, HV; Moldawer, LL; Efron, PA				Gentile, Lori F.; Nacionales, Dina C.; Lopez, M. Cecilia; Vanzant, Erin; Cuenca, Angela; Szpila, Benjamin E.; Cuenca, Alex G.; Joseph, Anna; Moore, Frederick A.; Leeuwenburgh, Christiaan; Baker, Henry V.; Moldawer, Lyle L.; Efron, Philip A.			Host Responses to Sepsis Vary in Different Low-Lethality Murine Models	PLOS ONE			English	Article							LABORATORY MODELS; ANIMAL-MODELS; IMMUNOSUPPRESSION; INFLAMMATION; INTERFERON; MORTALITY; IMMUNITY; MOUSE; SHOCK	Introduction: Animal models for the study of sepsis are being increasingly scrutinized, despite their essential role for early translational research. In particular, recent studies have suggested that at the level of the leukocyte transcriptome, murine models of burns, trauma and endotoxemia markedly differ from their human equivalents, and are only weakly similar amongst themselves. We compared the plasma cytokine and leukocyte transcriptome responses between two different low-lethality murine models of polymicrobial intra-abdominal sepsis. Methods: Six to ten week male C57BL/6j mice underwent either the 'gold standard' cecal ligation and puncture (CLP) model of intra-abdominal sepsis or administration of a cecal slurry (CS), where cecal contents are injected intraperitoneally. Surviving mice were euthanized at two hours, one or three days after sepsis. Results: The murine leukocyte transcriptomic response to the CLP and CS models of sepsis was surprisingly dissimilar at two hours, one, and three days after sepsis. The Pearson correlation coefficient for the maximum change in expression for the entire leukocyte transcriptome that changed significantly over time (n = 19,071) was R = 0.54 (R-2 = 0.297). The CS model resulted in greater magnitude of early inflammatory gene expression changes in response to sepsis with associated increased production of inflammatory chemokines and cytokines. Two hours after sepsis, CLP had more significant expression of genes associated with IL-10 signaling pathways, whereas CS had greater expression of genes related to CD28, apoptosis, IL-1 and T-cell receptor signaling. By three days, the changes in gene expression in both sepsis models were returning to baseline in surviving animals. Conclusion: These analyses reveal that the murine blood leukocyte response to sepsis is highly dependent on which model of intra-abdominal sepsis is employed, despite their similar lethality. It may be difficult to extrapolate findings from one murine model to another, let alone to human sepsis.	[Gentile, Lori F.; Nacionales, Dina C.; Vanzant, Erin; Cuenca, Angela; Szpila, Benjamin E.; Cuenca, Alex G.; Moore, Frederick A.; Moldawer, Lyle L.; Efron, Philip A.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32611 USA; [Lopez, M. Cecilia; Baker, Henry V.] Univ Florida, Coll Med, Gainesville, FL USA; [Joseph, Anna; Leeuwenburgh, Christiaan] Univ Florida, Coll Med, Inst Aging, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Efron, PA (corresponding author), Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32611 USA.	philip.efron@surgery.ufl.edu	Lopez, Maria/HHC-3659-2022	Leeuwenburgh, Christiaan/0000-0003-0826-4257; Moldawer, Lyle/0000-0002-9041-9838; Baker, Henry/0000-0002-8273-5320	National Institute of General Medical Sciences (NIGMS), U.S. [R01 GM-40586-24, R01-GM-GM-081923-06]; NIGMS [T32 GM-008721]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097531, T32GM008721, R01GM081923, R01GM040586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS), U.S.; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was Supported by R01 GM-40586-24, R01-GM-GM-081923-06, awarded by the National Institute of General Medical Sciences (NIGMS), U.S. P. H. S. LFG, AGC and BES were supported by a T32 training grant in trauma burns and sepsis (T32 GM-008721) awarded by NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BARTLETT JG, 1978, ARCH SURG-CHICAGO, V113, P853; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Ciesla DJ, 2005, ARCH SURG-CHICAGO, V140, P432, DOI 10.1001/archsurg.140.5.432; Cuenca AG, 2013, CRIT CARE MED, P5; Cuenca Alex G, 2010, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1913s91; Deitch EA, 2005, SHOCK, V24, P19, DOI 10.1097/01.shk.0000191386.18818.0a; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; FINK MP, 1990, J SURG RES, V49, P186, DOI 10.1016/0022-4804(90)90260-9; GENTILE LF, 2014, CRIT CARE M IN PRESS; GENTILE LF, 2014, J IMMUNOL; Gentile LF, 2013, CRIT CARE MED, V41, P1075, DOI 10.1097/CCM.0b013e318275d1f9; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; KAZARIAN KK, 1994, SHOCK, V1, P201, DOI 10.1097/00024382-199403000-00008; LANG CH, 1983, J SURG RES, V35, P201, DOI 10.1016/S0022-4804(83)80005-5; Marshall JC, 2005, SHOCK, V24, P1, DOI 10.1097/01.shk.0000191383.34066.4b; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; REMICK D, 1995, SHOCK, V4, P89, DOI 10.1097/00024382-199508000-00002; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Schwandt T, 2012, EMBO J, V31, P201, DOI 10.1038/emboj.2011.380; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 2002, CRIT CARE, V6, pS1, DOI 10.1186/cc1860; Warren HS, 2009, MOL MED, V15, P220, DOI 10.2119/molmed.2009.00027; Weighardt H, 2000, SURGERY, V127, P309, DOI 10.1067/msy.2000.104118; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	34	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94404	10.1371/journal.pone.0094404	http://dx.doi.org/10.1371/journal.pone.0094404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788351	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600011
J	Albuquerque-Silva, I; Vecellio, L; Durand, M; Avet, J; Le Pennec, D; de Monte, M; Montharu, J; Diot, P; Cottier, M; Dubois, F; Pourchez, J				Albuquerque-Silva, Iolanda; Vecellio, Laurent; Durand, Marc; Avet, John; Le Pennec, Deborah; de Monte, Michele; Montharu, Jerome; Diot, Patrice; Cottier, Michele; Dubois, Francis; Pourchez, Jeremie			Particle Deposition in a Child Respiratory Tract Model: In Vivo Regional Deposition of Fine and Ultrafine Aerosols in Baboons	PLOS ONE			English	Article							AIRWAY; SIZE; METHACHOLINE; HUMANS; REST	To relate exposure to adverse health effects, it is necessary to know where particles in the submicron range deposit in the respiratory tract. The possibly higher vulnerability of children requires specific inhalation studies. However, radio-aerosol deposition experiments involving children are rare because of ethical restrictions related to radiation exposure. Thus, an in vivo study was conducted using three baboons as a child respiratory tract model to assess regional deposition patterns (thoracic region vs. extrathoracic region) of radioactive polydisperse aerosols ([d16-d84], equal to [0.15 mu m-0.5 mm], [0.25 mu m-1 mu m], or [1 mu m-9 mu m]). Results clearly demonstrated that aerosol deposition within the thoracic region and the extrathoraic region varied substantially according to particle size. High deposition in the extrathoracic region was observed for the [1 mu m-9 mu m] aerosol (72%+/- 17%). The [0.15 mu m-0.5 mu m] aerosol was associated almost exclusively with thoracic region deposition (84%+/- 4%). Airborne particles in the range of [0.25 mu m-1 mu m] showed an intermediate deposition pattern, with 49%+/- 8% in the extrathoracic region and 51%+/- 8% in the thoracic region. Finally, comparison of baboon and human inhalation experiments for the [1 mu m-9 mu m] aerosol showed similar regional deposition, leading to the conclusion that regional deposition is species-independent for this airborne particle sizes.	[Albuquerque-Silva, Iolanda; Durand, Marc; Avet, John; Cottier, Michele; Dubois, Francis; Pourchez, Jeremie] LINA, EA 4624, St Etienne, France; [Albuquerque-Silva, Iolanda; Pourchez, Jeremie] Ecole Natl Super Mines, CIS EMSE, LINA EA 4624, F-42023 St Etienne, France; [Albuquerque-Silva, Iolanda; Durand, Marc; Avet, John; Cottier, Michele; Dubois, Francis; Pourchez, Jeremie] SFR IFRESIS, St Etienne, France; [Vecellio, Laurent; de Monte, Michele; Montharu, Jerome; Diot, Patrice] Univ Tours, Fac Med, CEPR, EA6305, Tours, France; [Vecellio, Laurent; Le Pennec, Deborah] DTF Aerodrug, Fac Med, Tours, France; [Durand, Marc] Ctr Hosp Emile Roux, Le Puy En Velay, France; [Avet, John; Cottier, Michele; Dubois, Francis] Univ St Etienne, Fac Med, St Etienne, France; [Avet, John; Cottier, Michele; Dubois, Francis] CHU St Etienne, St Etienne, France; [Avet, John; Cottier, Michele; Dubois, Francis] Univ Lyon, St Etienne, France; [Diot, Patrice] CHRU Tours, Serv Pneumol, Tours, France	IMT - Institut Mines-Telecom; Mines Saint-Etienne; Universite de Tours; Universite Jean Monnet; CHU de St Etienne; CHU Tours	Pourchez, J (corresponding author), LINA, EA 4624, St Etienne, France.	pourchez@emse.fr	Patrice, DIOT/R-8972-2016; POURCHEZ, Jérémie/AAC-4612-2019; Pourchez, Jeremie/F-4976-2011	POURCHEZ, Jérémie/0000-0002-4573-6711; Pourchez, Jeremie/0000-0002-4573-6711; Le Pennec, Deborah/0000-0002-5655-645X; pourchez, jeremie/0000-0001-9221-4003; DIOT, Patrice/0000-0002-2779-9719	Regional French Association for Aid to Chronic Respiratory Failure Patients (ARAIR - Association Regionale d'Aide aux Insuffisants Respiratoires de la region centre); Saint-Etienne Metropole; Conseil General de la Loire	Regional French Association for Aid to Chronic Respiratory Failure Patients (ARAIR - Association Regionale d'Aide aux Insuffisants Respiratoires de la region centre)(Region Centre-Val de Loire); Saint-Etienne Metropole; Conseil General de la Loire(Region Auvergne-Rhone-AlpesRegion Centre-Val de Loire)	The authors would like to acknowledge the financial support of the Regional French Association for Aid to Chronic Respiratory Failure Patients (ARAIR - Association Regionale d'Aide aux Insuffisants Respiratoires de la region centre), Saint-Etienne Metropole and the Conseil General de la Loire. DTF-Aerodrug provided support in the form of salaries for author LV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgharian B, 2006, TOXICOLOGY LUNG; BRAIN JD, 1983, AM REV RESPIR DIS, V128, pS87; Brouwer D, 2010, TOXICOLOGY, V269, P120, DOI 10.1016/j.tox.2009.11.017; Brown RH, 2000, AM J RESP CRIT CARE, V161, P1256, DOI 10.1164/ajrccm.161.4.9806051; Daigle CC, 2003, INHAL TOXICOL, V15, P539, DOI 10.1080/08958370304468; Durand M, 2012, EUR ANN OTORHINOLARY, V129, P244, DOI 10.1016/j.anorl.2011.09.002; Finlay WH, 1999, J AEROSOL SCI, V30, P105, DOI 10.1016/S0021-8502(98)00024-X; Geiser M, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-2; Ginsberg GL, 2008, J TOXICOL ENV HEAL A, V71, P166, DOI 10.1080/15287390701597889; Golshahi L, 2011, J AEROSOL SCI, V42, P474, DOI 10.1016/j.jaerosci.2011.04.002; HOFMANN W, 1982, RESP PHYSIOL, V49, P115, DOI 10.1016/0034-5687(82)90106-2; ICRP, 1994, HUM RESP TRACT MOD R; International Organization for Standardization, 2008, 27687 ISO TS; Kasper G, 2008, NANOSAFE2009 GREN NO; Kelly JT, 2005, INHAL TOXICOL, V17, P823, DOI 10.1080/08958370500241270; Kuehl PJ, 2012, INHAL TOXICOL, V24, P27, DOI 10.3109/08958378.2011.632787; Laube BL, 1996, J AEROSOL MED, V9, pS77, DOI 10.1089/jam.1996.9.Suppl_1.S-77; Lerondel S, 2001, HUM GENE THER, V12, P1, DOI 10.1089/104303401450915; Londahl J, 2013, J AEROSOL MED, V26, P1; Londahl J, 2008, INHAL TOXICOL, V20, P923, DOI 10.1080/08958370802087124 ; Londahl J, 2007, INHAL TOXICOL, V19, P109, DOI 10.1080/08958370601051677; Londahl J, 2006, J AEROSOL SCI, V37, P1152, DOI 10.1016/j.jaerosci.2005.11.004; Martonen TB, 2001, INHAL TOXICOL, V13, P307, DOI 10.1080/089583701750127412; McMahon T A, 1975, Inhaled Part, V4 Pt 1, P23; Menache MG, 2008, INHAL TOXICOL, V20, P101, DOI [10.1080/08958370701821433, 10.1080/08958370701821433 ]; Newman S, 2011, EXPERT OPIN DRUG DEL, V8, P841, DOI 10.1517/17425247.2011.577063; Olvera HA, 2012, PULM MED, V2012, DOI 10.1155/2012/736290; ORIORDAN TG, 1993, CHEST, V103, P1385, DOI 10.1378/chest.103.5.1385; PATRA AL, 1986, ANAT REC, V215, P42, DOI 10.1002/ar.1092150107; PATRA AL, 1986, J TOXICOL ENV HEALTH, V17, P163, DOI 10.1080/15287398609530813; PHALEN RF, 1985, ANAT RECORD, V212, P368, DOI 10.1002/ar.1092120408; Phalen RF, 2001, RESP PHYSIOL, V128, P119, DOI 10.1016/S0034-5687(01)00270-5; Phalen RF, 2008, J AEROSOL MED PULM D, V21, P113, DOI 10.1089/jamp.2007.0673; RUSCONI F, 1994, PEDIATRICS, V94, P350; Schuepp KG, 2005, J AEROSOL MED, V18, P225, DOI 10.1089/jam.2005.18.225; Seipenbusch M, 2008, ANN OCCUP HYG, V52, P707, DOI 10.1093/annhyg/men067; Snell NJC, 1999, RESP MED, V93, P123, DOI 10.1016/S0954-6111(99)90302-5; Vecellio L, 2011, INT J PHARMACEUT, V407, P87, DOI 10.1016/j.ijpharm.2011.01.024	38	40	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95456	10.1371/journal.pone.0095456	http://dx.doi.org/10.1371/journal.pone.0095456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24787744	gold, Green Submitted, Green Published			2022-12-25	WOS:000338917300012
J	Wang, JW; Wan, XY; Zhu, HT; Lu, C; Yu, WL; Yu, CH; Shen, Z; Li, YM				Wang, Jie-wei; Wan, Xing-yong; Zhu, Hua-tuo; Lu, Chao; Yu, Wei-lai; Yu, Chao-hui; Shen, Zhe; Li, You-ming			Lipotoxic Effect of p21 on Free Fatty Acid-Induced Steatosis in L02 Cells	PLOS ONE			English	Article							LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; PROTEASOME INHIBITOR; OXIDATIVE STRESS; PROGRESSION; MICE; SENESCENCE; REGENERATION; PATHOGENESIS; HEPATOCYTES	Nonalcoholic fatty liver disease (NAFLD) is increasingly regarded as a hepatic manifestation of metabolic syndrome. Though with high prevalence, the mechanism is poorly understood. This study aimed to investigate the effects of p21 on free fatty acid (FFA)-induced steatosis in L02 cells. We therefore analyzed the L02 cells with MG132 and siRNA treatment for different expression of p21 related to lipid accumulation and lipotoxicity. Cellular total lipid was stained by Oil Red O, while triglyceride content, cytotoxicity assays, lipid peroxidation markers and anti-oxidation levels were measured by enzymatic kits. Treatment with 1 mM FFA for 48 hr induced magnificent intracellular lipid accumulation and increased oxidative stress in p21 overload L02 cells compared to that in p21 knockdown L02 cells. By increasing oxidative stress and peroxidation, p21 accelerates FFA-induced lipotoxic effect in L02 cells and might provide information about potentially new targets for drug development and treatments of NAFLD.	[Wang, Jie-wei; Wan, Xing-yong; Zhu, Hua-tuo; Lu, Chao; Yu, Wei-lai; Yu, Chao-hui; Shen, Zhe; Li, You-ming] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Li, YM (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	zlym@zju.edu.cn		Ma, Han/0000-0001-9985-3035	National Natural Science Foundation of China [81270487, 81300303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China Grant number: 81270487, 81300303 (http://www.nsfc.gov.cn/publish/portal0/default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova A, 2008, CELL BIOCHEM FUNCT, V26, P392, DOI 10.1002/cbf.1459; Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904; Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chu JH, 2011, WORLD J GASTROENTERO, V17, P2379, DOI 10.3748/wjg.v17.i19.2379; Cortez-Pinto H, 1999, GASTROENTEROLOGY, V116, P1184, DOI 10.1016/S0016-5085(99)70022-3; Day CP, 2002, BEST PRACT RES CL GA, V16, P663, DOI 10.1053/bega.2002.0333; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Guo N, 2013, ASIA-PAC J CLIN ONCO, V9, P6, DOI 10.1111/j.1743-7563.2012.01535.x; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Letteron P, 1996, J HEPATOL, V24, P200, DOI 10.1016/S0168-8278(96)80030-4; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Masgras I, 2012, J BIOL CHEM, V287, P9845, DOI 10.1074/jbc.M111.250357; Mehta K, 2002, NUTR REV, V60, P289, DOI 10.1301/002966402320387224; Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X; Seki S, 2005, HEPATOL RES, V33, P132, DOI 10.1016/j.hepres.2005.09.020; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tomita K, 2012, J HEPATOL, V57, P837, DOI 10.1016/j.jhep.2012.05.013; Torbenson M, 2002, AM J PATHOL, V161, P155, DOI 10.1016/S0002-9440(10)64167-3; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wu XD, 2008, HEPATOLOGY, V47, P1905, DOI 10.1002/hep.22239; Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082; Zhang X, 2011, AM J PHYSIOL-GASTR L, V302, P558	33	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96124	10.1371/journal.pone.0096124	http://dx.doi.org/10.1371/journal.pone.0096124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788149	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917300027
J	Zhao, CL; Farruggio, AP; Bjornson, CRR; Chavez, CL; Geisinger, JM; Neal, TL; Karow, M; Calos, MP				Zhao, Chunli; Farruggio, Alfonso P.; Bjornson, Christopher R. R.; Chavez, Christopher L.; Geisinger, Jonathan M.; Neal, Tawny L.; Karow, Marisa; Calos, Michele P.			Recombinase-Mediated Reprogramming and Dystrophin Gene Addition in mdx Mouse Induced Pluripotent Stem Cells	PLOS ONE			English	Article							SITE-SPECIFIC INTEGRATION; SKELETAL-MUSCLE; SATELLITE CELLS; MUSCULAR-DYSTROPHY; IN-VIVO; DIFFERENTIATION; GENERATION; EXPRESSION; MYOBLASTS; THERAPY	A cell therapy strategy utilizing genetically-corrected induced pluripotent stem cells (iPSC) may be an attractive approach for genetic disorders such as muscular dystrophies. Methods for genetic engineering of iPSC that emphasize precision and minimize random integration would be beneficial. We demonstrate here an approach in the mdx mouse model of Duchenne muscular dystrophy that focuses on the use of site-specific recombinases to achieve genetic engineering. We employed non-viral, plasmid-mediated methods to reprogram mdx fibroblasts, using phiC31 integrase to insert a single copy of the reprogramming genes at a safe location in the genome. We next used Bxb1 integrase to add the therapeutic full-length dystrophin cDNA to the iPSC in a site-specific manner. Unwanted DNA sequences, including the reprogramming genes, were then precisely deleted with Cre resolvase. Pluripotency of the iPSC was analyzed before and after gene addition, and ability of the genetically corrected iPSC to differentiate into myogenic precursors was evaluated by morphology, immunohistochemistry, qRT-PCR, FACS analysis, and intramuscular engraftment. These data demonstrate a non-viral, reprogramming-plus-gene addition genetic engineering strategy utilizing site-specific recombinases that can be applied easily to mouse cells. This work introduces a significant level of precision in the genetic engineering of iPSC that can be built upon in future studies.	[Zhao, Chunli; Farruggio, Alfonso P.; Bjornson, Christopher R. R.; Chavez, Christopher L.; Geisinger, Jonathan M.; Neal, Tawny L.; Karow, Marisa; Calos, Michele P.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Calos, MP (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	calos@stanford.edu		Karow, Marisa/0000-0003-4935-1365	California Institute for Regenerative Medicine [TR2-01756]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the California Institute for Regenerative Medicine (grant # TR2-01756), the Muscular Dystrophy Association (http://mda.org/research/gaag/dmdbmd-calos), and a gift from Robert and Paulette Files. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Banks GB, 2010, MUSCLE NERVE, V42, P268, DOI 10.1002/mus.21700; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Boldrin L, 2012, STEM CELLS, V30, P1971, DOI 10.1002/stem.1158; Bushby Kate, 2009, Pract Neurol, V9, P314, DOI 10.1136/jnnp.2009.193938; Cazzella V, 2012, MOL THER, V20, P2134, DOI 10.1038/mt.2012.178; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chang H, 2009, FASEB J, V23, P1907, DOI 10.1096/fj.08-123661; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Darabi R, 2011, STEM CELL REV REP, V7, P948, DOI 10.1007/s12015-011-9258-2; Darabi R, 2011, STEM CELLS, V29, P777, DOI 10.1002/stem.625; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Goudenege S, 2012, MOL THER, V20, P2153, DOI 10.1038/mt.2012.188; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Karow M, 2011, STEM CELLS, V29, P1696, DOI 10.1002/stem.730; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Keravala A, 2011, GENE THER, V18, P842, DOI 10.1038/gt.2011.31; Keravala A, 2006, MOL GENET GENOMICS, V276, P135, DOI 10.1007/s00438-006-0129-5; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Merkl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055170; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tedesco FS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003541; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Ye L, 2010, P NATL ACAD SCI USA, V107, P19467, DOI 10.1073/pnas.1012677107; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	46	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96279	10.1371/journal.pone.0096279	http://dx.doi.org/10.1371/journal.pone.0096279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781921	Green Published, gold, Green Submitted			2022-12-25	WOS:000335504900028
J	de Souza, AWS; de Leeuw, K; van Timmeren, MM; Limburg, PC; Stegeman, CA; Bijl, M; Westra, J; Kallenberg, CGM				de Souza, Alexandre W. S.; de Leeuw, Karina; van Timmeren, Mirjan M.; Limburg, Pieter C.; Stegeman, Coen A.; Bijl, Marc; Westra, Johanna; Kallenberg, Cees G. M.			Impact of Serum High Mobility Group Box 1 and Soluble Receptor for Advanced Glycation End-Products on Subclinical Atherosclerosis in Patients with Granulomatosis with Polyangiitis	PLOS ONE			English	Article							WEGENERS-GRANULOMATOSIS; HMGB1 LEVELS; DISEASE; INFLAMMATION; ACTIVATION; STRESS	The objective of this study was to evaluate whether levels of high mobility group box 1 (HMGB1) in granulomatosis with polyangiitis (GPA) patients are associated with carotid atherosclerosis, related to levels of soluble receptor for advanced glycation end-products (sRAGE) and influenced by immunosuppressive or lipid-lowering therapy. Twenty-three GPA patients and 20 controls were evaluated for HMGB1- and sRAGE levels and for carotid atherosclerosis using ultrasound to determine intima-media thickness (IMT). In vitro the effect of atorvastatin on the production of HMGB1 by lipopolysaccharide (LPS)-stimulated human umbilical vein endothelial cells (HUVEC) was assessed. Serum HMGB1 and sRAGE levels did not differ between patients and controls. A negative correlation was found between sRAGE and maximum IMT but HMGB1 and carotid IMT were not related. HMGB1 levels were reduced in GPA patients on statins and prednisolone. In vitro, atorvastatin reduced HMGB1 levels in supernatants of activated HUVEC. In conclusion, carotid IMT is inversely correlated with sRAGE levels but not with HMGB1 levels. Statins and prednisolone are associated with reduced serum HMGB1 levels and atorvastatin decreases HMGB1 release by activated HUVEC in vitro, indicating an additional anti-inflammatory effect of statins.	[de Souza, Alexandre W. S.; de Leeuw, Karina; Westra, Johanna; Kallenberg, Cees G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [van Timmeren, Mirjan M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Limburg, Pieter C.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Stegeman, Coen A.] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands; [Bijl, Marc] Martini Hosp, Groningen, Netherlands; [de Souza, Alexandre W. S.] Univ Fed Sao Paulo, Escola Paulista Med Unifesp EPM, Div Rheumatol, Sao Paulo, Brazil	University of Groningen; University of Groningen; University of Groningen; University of Groningen; Martini Hospital; Universidade Federal de Sao Paulo (UNIFESP)	de Souza, AWS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	alexandre.wagner@unifesp.br	de Souza, Alexandre Wagner Silva/J-4472-2017	de Souza, Alexandre Wagner Silva/0000-0001-7681-6215; Stegeman, Coen/0000-0002-0224-0927	GUIDE Institute; Jan Kornelis de Cock Institute	GUIDE Institute; Jan Kornelis de Cock Institute	This study was sponsored by the GUIDE Institute and by the Jan Kornelis de Cock Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulahad DA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3332; Bao XM, 2009, ACTA PHARMACOL SIN, V30, P1392, DOI 10.1038/aps.2009.135; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Leeuw K, 2005, ANN RHEUM DIS, V64, P753, DOI 10.1136/ard.2004.029033; de Leeuw K, 2010, CLIN EXP RHEUMATOL, V28, pS18; de Leeuw K, 2010, ANN RHEUM DIS, V69, P625, DOI 10.1136/ard.2009.123851; de Souza AWS, 2012, AUTOIMMUN REV, V11, P909, DOI 10.1016/j.autrev.2012.03.007; Dulak J, 2005, ENDOTHELIUM-J ENDOTH, V12, P233, DOI 10.1080/10623320500476559; Faurschou M, 2009, ARTHRITIS RHEUM-US, V60, P1187, DOI 10.1002/art.24386; Haraba R, 2011, CELL TISSUE RES, V346, P361, DOI 10.1007/s00441-011-1277-4; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Henes FO, 2011, ANN RHEUM DIS, V70, P1926, DOI 10.1136/ard.2010.146456; Hol J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040673; Hot A, 2013, ANN RHEUM DIS, V72, P754, DOI 10.1136/annrheumdis-2012-201887; Huang YH, 2011, J SURG RES, V170, pE47, DOI 10.1016/j.jss.2011.05.033; Izidoro-Toledo TC, 2011, N-S ARCH PHARMACOL, V383, P547, DOI 10.1007/s00210-011-0623-0; Jia F, 2012, CARDIOVASC THER, V30, P317, DOI 10.1111/j.1755-5922.2011.00287.x; Jin DQ, 2012, EXP THER MED, V4, P1124, DOI 10.3892/etm.2012.732; Kalea AZ, 2009, CLIN SCI, V116, P621, DOI 10.1042/CS20080494; Pullerits R, 2011, J RHEUMATOL, V38, P1523, DOI 10.3899/jrheum.110091; Schierbeck H, 2010, MOL MED, V16, P343, DOI 10.2119/molmed.2010.00031; de Souza AWS, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4284; Suppiah R, 2011, ARTHRIT CARE RES, V63, P588, DOI 10.1002/acr.20433; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Wibisono D, 2010, ANN RHEUM DIS, V69, P1888, DOI 10.1136/ard.2009.119172	25	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e96067	10.1371/journal.pone.0096067	http://dx.doi.org/10.1371/journal.pone.0096067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776932	Green Published, Green Submitted, gold			2022-12-25	WOS:000346241800026
J	Kneipp, M; Turner, J; Hambauer, S; Krieg, SM; Lehmberg, J; Lindauer, U; Razansky, D				Kneipp, Moritz; Turner, Jake; Hambauer, Sebastian; Krieg, Sandro M.; Lehmberg, Jens; Lindauer, Ute; Razansky, Daniel			Functional Real-Time Optoacoustic Imaging of Middle Cerebral Artery Occlusion in Mice	PLOS ONE			English	Article							ISCHEMIC PENUMBRA; TOMOGRAPHY; RATS	Background and Purpose: Longitudinal functional imaging studies of stroke are key in identifying the disease progression and possible therapeutic interventions. Here we investigate the applicability of real-time functional optoacoustic imaging for monitoring of stroke progression in the whole brain of living animals. Materials and Methods: The middle cerebral artery occlusion (MCAO) was used to model stroke in mice, which were imaged preoperatively and the occlusion was kept in place for 60 minutes, after which optoacoustic scans were taken at several time points. Results: Post ischemia an asymmetry of deoxygenated hemoglobin in the brain was observed as a region of hypoxia in the hemisphere affected by the ischemic event. Furthermore, we were able to visualize the penumbra in-vivo as a localized hemodynamically-compromised area adjacent to the region of stroke-induced perfusion deficit. Conclusion: The intrinsic sensitivity of the new imaging approach to functional blood parameters, in combination with real time operation and high spatial resolution in deep living tissues, may see it become a valuable and unique tool in the development and monitoring of treatments aimed at suspending the spread of an infarct area.	[Kneipp, Moritz; Turner, Jake; Razansky, Daniel] Tech Univ Munich, Fac Med, D-80290 Munich, Germany; [Kneipp, Moritz; Turner, Jake; Razansky, Daniel] Tech Univ Munich, Fac Elect Engn, D-80290 Munich, Germany; [Kneipp, Moritz; Turner, Jake; Razansky, Daniel] Helmholtz Zentrum Munchen, Inst Biol & Med Imaging, Neuherberg, Germany; [Hambauer, Sebastian; Krieg, Sandro M.; Lehmberg, Jens; Lindauer, Ute] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, D-80290 Munich, Germany; [Krieg, Sandro M.; Lindauer, Ute] Tech Univ Munich, TUM Neuroimaging Ctr, D-80290 Munich, Germany; [Lindauer, Ute] Munich Cluster Syst Neurol SyNergy, Munich, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; University of Munich	Razansky, D (corresponding author), Tech Univ Munich, Fac Med, D-80290 Munich, Germany.	dr@tum.de	Krieg, Sandro M./L-8902-2016; Razansky, Daniel/B-8590-2015	Krieg, Sandro M./0000-0003-4050-1531; Razansky, Daniel/0000-0001-8676-0964	European Research Council [ERC-2010-StG-260991]; Deutsche Forschungsgemeinschaft (German Research Foundation) [EXC 1010 SyNergy]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	D.R. acknowledges funding support from the European Research Council under grant agreement ERC-2010-StG-260991; http://erc.europa.eu/. U.L. was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy); http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton NC, 2013, NEUROIMAGE, V65, P522, DOI 10.1016/j.neuroimage.2012.09.053; Dean-Ben XL, 2013, PHOTOACOUSTICS, V1, P68, DOI 10.1016/j.pacs.2013.10.002; Deng Z., 2012, J BIOMED OPT, V17; Dirnagl Ulrich and Group Members of the MCAO-SOP, 2012, STAND OP PROC SOP EX; HEISS WD, 1994, J CEREBR BLOOD F MET, V14, P892, DOI 10.1038/jcbfm.1994.120; Heiss WD, 2012, ANN NY ACAD SCI, V1268, P26, DOI 10.1111/j.1749-6632.2012.06668.x; Liu SM, 2004, J CEREBR BLOOD F MET, V24, P343, DOI 10.1097/01.WCB.0000110047.43905.01; Razansky D, 2012, IEEE J SEL TOP QUANT, V18, P1234, DOI 10.1109/JSTQE.2011.2172192; Razansky D, 2012, CURR PHARM BIOTECHNO, V13, P504, DOI 10.2174/138920112799436258; Razansky D, 2011, NAT PROTOC, V6, P1121, DOI 10.1038/nprot.2011.351; Rosenthal A, 2010, IEEE T MED IMAGING, V29, P1275, DOI 10.1109/TMI.2010.2044584; Sheppard C.J.R., 2013, BIOMEDICAL OPTICAL I; van Dorsten FA, 1999, NMR BIOMED, V12, P525, DOI 10.1002/(SICI)1099-1492(199912)12:8<525::AID-NBM597>3.0.CO;2-F; Yu LF, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505016; Zaharchuk G, 2000, J CEREBR BLOOD F MET, V20, P1341, DOI 10.1097/00004647-200009000-00009	15	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e96118	10.1371/journal.pone.0096118	http://dx.doi.org/10.1371/journal.pone.0096118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776997	Green Published, Green Submitted, gold			2022-12-25	WOS:000346241800028
J	Macedo, GA; Gonin, MLC; Pone, SM; Cruz, OG; Nobre, FF; Brasil, P				Macedo, Gleicy A.; Gonin, Michelle Luiza C.; Pone, Sheila M.; Cruz, Oswaldo G.; Nobre, Flavio F.; Brasil, Patricia			Sensitivity and Specificity of the World Health Organization Dengue Classification Schemes for Severe Dengue Assessment in Children in Rio de Janeiro	PLOS ONE			English	Article							INFECTION; DIAGNOSIS; FEVER; SHOCK	Background: The clinical definition of severe dengue fever remains a challenge for researchers in hyperendemic areas like Brazil. The ability of the traditional (1997) as well as the revised (2009) World Health Organization (WHO) dengue case classification schemes to detect severe dengue cases was evaluated in 267 children admitted to hospital with laboratory-confirmed dengue. Principal Findings: Using the traditional scheme, 28.5% of patients could not be assigned to any category, while the revised scheme categorized all patients. Intensive therapeutic interventions were used as the reference standard to evaluate the ability of both the traditional and revised schemes to detect severe dengue cases. Analyses of the classified cases (n = 183) demonstrated that the revised scheme had better sensitivity (86.8%, P<0.001), while the traditional scheme had better specificity (93.4%, P<0.001) for the detection of severe forms of dengue. Conclusions/Significance: This improved sensitivity of the revised scheme allows for better case capture and increased ICU admission, which may aid pediatricians in avoiding deaths due to severe dengue among children, but, in turn, it may also result in the misclassification of the patients' condition as severe, reflected in the observed lower positive predictive value (61.6%, P<0.001) when compared with the traditional scheme (82.6%, P<0.001). The inclusion of unusual dengue manifestations in the revised scheme has not shifted the emphasis from the most important aspects of dengue disease and the major factors contributing to fatality in this study: shock with consequent organ dysfunction.	[Macedo, Gleicy A.; Nobre, Flavio F.] Univ Fed Rio de Janeiro, COPPE, Programa Engn Biomed, Lab Engn Sistemas Saude, Rio de Janeiro, Brazil; [Gonin, Michelle Luiza C.] SMSDC RJ, Hosp Municipal Jesus HMMJ, Rio De Janeiro, Brazil; [Pone, Sheila M.; Cruz, Oswaldo G.; Brasil, Patricia] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Brasil, P (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.	patricia.brasil@ipec.fiocruz.br	Nobre, Flavio F/K-6179-2012; Brasil, Patricia/P-3536-2014	Nobre, Flavio/0000-0003-4261-8258; Moura Pone, Sheila/0000-0002-6246-8915; Brasil, Patricia/0000-0001-9555-7976	Rede Dengue FIOCRUZ; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [10/2008]	Rede Dengue FIOCRUZ; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Rede Dengue FIOCRUZ and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ, under notice number 10/2008 for supporting research about neglected and reemerging diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106; COHEN SN, 1966, J PEDIATR-US, V68, P448, DOI 10.1016/S0022-3476(66)80249-4; de Souza LJ, 2013, BRAZ J INFECT DIS, V17, P27, DOI 10.1016/j.bjid.2012.08.020; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Gibson G, 2013, CAD SAUDE PUBLICA, V29, P82, DOI 10.1590/S0102-311X2013000100010; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hadinegoro RS, 2012, PAEDIATR INT CHILD H, V32, P33, DOI 10.1179/2046904712Z.00000000052; Hawass NED, 1997, BRIT J RADIOL, V70, P360, DOI 10.1259/bjr.70.832.9166071; Lee LK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001676; Mayxay M, 2011, TROP MED INT HEALTH, V16, P127, DOI 10.1111/j.1365-3156.2010.02641.x; Moskowitz CS, 2006, CLIN TRIALS, V3, P272, DOI 10.1191/1740774506cn147oa; Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397; Phuong CXT, 2004, AM J TROP MED HYG, V70, P172, DOI 10.4269/ajtmh.2004.70.172; Proulx F, 2009, PEDIATR CRIT CARE ME, V10, P12, DOI 10.1097/PCC.0b013e31819370a9; R Core Team, 2022, R LANG ENV STAT COMP; WHO, DENG HAEM FEV DIAGN; World Health Organization, DENG GUID DIAGN TREA	22	28	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e96314	10.1371/journal.pone.0096314	http://dx.doi.org/10.1371/journal.pone.0096314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24777054	Green Submitted, Green Published, gold			2022-12-25	WOS:000346241800031
J	Roforth, MM; Atkinson, EJ; Levin, ER; Khosla, S; Monroe, DG				Roforth, Matthew M.; Atkinson, Elizabeth J.; Levin, Ellis R.; Khosla, Sundeep; Monroe, David G.			Dissection of Estrogen Receptor Alpha Signaling Pathways in Osteoblasts Using RNA-Sequencing	PLOS ONE			English	Article							GENE-EXPRESSION; PLASMA-MEMBRANE; BREAST-CANCER; IN-VITRO; MUTATION; NUCLEAR; BINDING; BONE; DNA; LOCALIZATION	The effects of 17-beta-estradiol in osteoblasts are primarily mediated by the nuclear transcription factors, estrogen receptor (ER)alpha and ER beta. ERs function through three general modes of action: DNA-binding dependent through estrogen response elements (EREs; designated nuclear ERE signaling); nuclear signaling via protein-protein interactions to other transcription factors (nuclear non-ERE signaling); and extra-nuclear signaling (membrane-bound functions of ERs). Identification of the specific transcriptional signatures regulated by each of these modes of action should contribute to an enhanced understanding of estrogen signaling in osteoblasts. To achieve this goal, we utilized specific mutations of ER alpha that eliminate the ability of the receptor to signal through a specific mode of action. The non-classical ER alpha knock-in (NERKI) mutation is incapable of signaling through direct DNA binding to EREs and the nuclear only ER alpha (NOER) mutation eliminates all membrane-localized signaling. Comparison of the gene expression patterns elicited by these mutations with the wild-type ER alpha (WT) pattern provides mode-specific data concerning transcriptional regulation by ER alpha. We expressed these constructs in the ER-negative osteoblastic cell line hFOB (-/+ estrogen) and performed global RNA-sequencing. Using a series of pair-wise comparisons, we generated three lists of genes that were regulated either by the nuclear ERE-dependent, nuclear ERE-independent, or extra-nuclear actions of ER alpha. Pathway and gene ontology analyses revealed that genes regulated through the nuclear ERE and nuclear non-ERE pathways were largely involved in transcriptional regulation, whereas genes regulated through extra-nuclear mechanisms are involved in cytoplasmic signaling transduction pathways. We also intersected our data with genes linked to bone density and fractures from a recent genome-wide association study and found 25 of 72 genes (35%) regulated by estrogen. These data provide a comprehensive list of genes and pathways targeted by these specific modes of ER alpha action and suggest that "mode-specific'' ligands could be developed to modulate specific ER alpha functionality in bone.	[Roforth, Matthew M.; Atkinson, Elizabeth J.; Khosla, Sundeep; Monroe, David G.] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA; [Roforth, Matthew M.; Atkinson, Elizabeth J.; Khosla, Sundeep; Monroe, David G.] Mayo Clin, Kogod Ctr Aging, Rochester, MN USA; [Levin, Ellis R.] VA Long Beach Healthcare Syst, Endocrinol & Metab, Irvine, CA USA; [Levin, Ellis R.] Univ Calif Irvine, Irvine, CA USA	Mayo Clinic; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine	Monroe, DG (corresponding author), Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA.	monroe.david@mayo.edu	Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372; Migliaccio, Antimo/0000-0002-4197-2055	NIH [P01 AG004875]; Mayo Kogod Center on Aging; NATIONAL INSTITUTE ON AGING [P01AG004875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Kogod Center on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by NIH Grant P01 AG004875 and the Mayo Kogod Center on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Adlanmerini M, 2014, P NATL ACAD SCI USA, V111, pE283, DOI 10.1073/pnas.1322057111; Altucci L, 1996, ONCOGENE, V12, P2315; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fujita K, 2014, OSTEOPOROSIS INT, V25, P887, DOI 10.1007/s00198-013-2529-9; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; Khosla S, 2011, J BONE MINER RES, V26, P441, DOI 10.1002/jbmr.262; La Rosa P, 2012, MOL ENDOCRINOL, V26, P762, DOI 10.1210/me.2011-1208; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levin ER, 2011, MOL ENDOCRINOL, V25, P377, DOI 10.1210/me.2010-0284; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Modder UI, 2012, J CELL BIOCHEM, V113, P2248, DOI 10.1002/jcb.24095; Modder UI, 2011, BONE, V49, P202, DOI 10.1016/j.bone.2011.04.015; Pedram A, 2005, J BIOL CHEM, V280, P26339, DOI 10.1074/jbc.M414409200; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pedram A, 2013, MOL BIOL CELL, V24, P3805, DOI 10.1091/mbc.E13-08-0444; Pedram A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004013; Razandi M, 2003, MOL CELL BIOL, V23, P1633, DOI 10.1128/MCB.23.5.1633-1646.2003; Razandi M, 2004, MOL CELL BIOL, V24, P5900, DOI 10.1128/MCB.24.13.5900-5913.2004; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Syed FA, 2005, J BONE MINER RES, V20, P1992, DOI 10.1359/JBMR.050713; Syed FA, 2007, ENDOCRINOLOGY, V148, P1902, DOI 10.1210/en.2006-1165; Syed FA, 2011, BONE, V49, P208, DOI 10.1016/j.bone.2011.03.771; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Zhang DP, 2006, COMP BIOCHEM PHYS A, V144, P306, DOI 10.1016/j.cbpa.2006.01.025	30	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95987	10.1371/journal.pone.0095987	http://dx.doi.org/10.1371/journal.pone.0095987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776842	Green Published, gold, Green Submitted			2022-12-25	WOS:000346241800022
J	Joshi, S; Singh, AR; Zulcic, M; Bao, L; Messer, K; Ideker, T; Dutkowski, J; Durden, DL				Joshi, Shweta; Singh, Alok R.; Zulcic, Muamera; Bao, Lei; Messer, Karen; Ideker, Trey; Dutkowski, Janusz; Durden, Donald L.			Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo	PLOS ONE			English	Article							GTPASE RAC2; RHO FAMILY; CELL; ACTIVATION; INTEGRIN; INFLAMMATION; POLARIZATION; EXPRESSION; PROGRESSION; CSF	Although it is well-established that the macrophage M1 to M2 transition plays a role in tumor progression, the molecular basis for this process remains incompletely understood. Herein, we demonstrate that the small GTPase, Rac2 controls macrophage M1 to M2 differentiation and the metastatic phenotype in vivo. Using a genetic approach, combined with syngeneic and orthotopic tumor models we demonstrate that Rac2-/- mice display a marked defect in tumor growth, angiogenesis and metastasis. Microarray, RT-PCR and metabolomic analysis on bone marrow derived macrophages isolated from the Rac2-/- mice identify an important role for Rac2 in M2 macrophage differentiation. Furthermore, we define a novel molecular mechanism by which signals transmitted from the extracellular matrix via the alpha(4)beta(1) integrin and MCSF receptor lead to the activation of Rac2 and potentially regulate macrophage M2 differentiation. Collectively, our findings demonstrate a macrophage autonomous process by which the Rac2 GTPase is activated downstream of the alpha(4)beta(1) integrin and the MCSF receptor to control tumor growth, metastasis and macrophage differentiation into the M2 phenotype. Finally, using gene expression and metabolomic data from our Rac2-/- model, and information related to M1-M2 macrophage differentiation curated from the literature we executed a systems biologic analysis of hierarchical protein-protein interaction networks in an effort to develop an iterative interactome map which will predict additional mechanisms by which Rac2 may coordinately control macrophage M1 to M2 differentiation and metastasis.	[Joshi, Shweta; Singh, Alok R.; Zulcic, Muamera; Durden, Donald L.] Univ Calif San Diego, Moores Canc Ctr, UCSD Dept Pediat, La Jolla, CA 92093 USA; [Bao, Lei; Messer, Karen] Univ Calif San Diego, Moores Canc Ctr, UCSD Dept Biostat, La Jolla, CA 92093 USA; [Dutkowski, Janusz] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Durden, Donald L.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Durden, Donald L.] Rady Childrens Hosp, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Durden, DL (corresponding author), Univ Calif San Diego, Moores Canc Ctr, UCSD Dept Pediat, La Jolla, CA 92093 USA.	ddurden@ucsd.edu	Joshi, Shweta/D-4711-2015	Ideker, Trey/0000-0002-1708-8454	NIH [HL091385, CA94233-09];  [P30 CA23100-22]; NATIONAL CANCER INSTITUTE [R01CA094233, R56CA094233, P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091385] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research effort was funded by HL091385 and CA94233-09 from NIH to DLD. Work was supported by core facilities funded by P30 CA23100-22 to Moores UCSD Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Buhtoiarov IN, 2011, IMMUNOLOGY, V132, P226, DOI 10.1111/j.1365-2567.2010.03357.x; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Croker BA, 2002, IMMUNOL CELL BIOL, V80, P231, DOI 10.1046/j.1440-1711.2002.01077.x; De P, 2009, EXP CELL RES, V315, P248, DOI 10.1016/j.yexcr.2008.10.003; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; DIEKMANN D, 1995, EMBO J, V14, P5297, DOI 10.1002/j.1460-2075.1995.tb00214.x; Dutkowski J, 2013, NUCL ACIDS RES; Dutkowski J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002180; Elsegood CL, 2006, INT J BIOCHEM CELL B, V38, P1518, DOI 10.1016/j.biocel.2006.02.011; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fattouh R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061629; Feral CC, 2006, J CLIN INVEST, V116, P715, DOI 10.1172/JCI26091; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Jin H, 2006, CANCER RES, V66, P2146, DOI 10.1158/0008-5472.CAN-05-2704; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; LOBB RR, 1994, J CLIN INVEST, V94, P1722, DOI 10.1172/JCI117519; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Norris MD, 2000, MED PEDIATR ONCOL, V35, P585, DOI 10.1002/1096-911X(20001201)35:6<585::AID-MPO20>3.3.CO;2-G; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pradip D, 2003, J BIOL CHEM, V278, P41661, DOI 10.1074/jbc.M306491200; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vanderslice P, 1998, Angiogenesis, V2, P265, DOI 10.1023/A:1009296700991; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Vedham V, 2005, MOL CELL BIOL, V25, P4211, DOI 10.1128/MCB.25.10.4211-4220.2005; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915	66	73	77	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e95893	10.1371/journal.pone.0095893	http://dx.doi.org/10.1371/journal.pone.0095893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24770346	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736600018
J	Cacioppo, JA; Oh, SW; Kim, HY; Cho, J; Lin, PCP; Yanagisawa, M; Ko, C				Cacioppo, Joseph A.; Oh, Sang Wook; Kim, Hey-young; Cho, Jongki; Lin, Po-Ching Patrick; Yanagisawa, Masashi; Ko, CheMyong			Loss of Function of Endothelin-2 Leads to Reduced Ovulation and CL Formation	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; POLYCYSTIC-OVARY-SYNDROME; SMOOTH-MUSCLE-CELLS; HUMAN CORPUS-LUTEUM; GENE-EXPRESSION; GROWTH-FACTOR; RAT OVARY; INTESTINAL CONTRACTOR; ESTROUS-CYCLE; ANGIOGENESIS	Endothelin-2 (EDN2), a potent vasoconstrictive peptide, is transiently produced by periovulatory follicles at the time of ovulation when corpus luteum (CL) formation begins. EDN2 induces contraction of ovarian smooth muscles ex vivo via an endothelin receptor A-mediated pathway. In this study, we aimed to determine if EDN2 is required for normal ovulation and subsequent CL formation in vivo. In the ovaries of a mouse model that globally lacks the Edn2 gene (Edn2 knockout mouse; Edn2KO), histology showed that post-pubertal Edn2KO mice possess follicles of all developmental stages, but no corpora lutea. When exogenous gonadotropins were injected to induce super-ovulation, Edn2KO mice exhibited significantly impaired ovulation and CL formation compared to control littermates. Edn2KO ovaries that did ovulate in response to gonadotropins did not contain histologically and functionally identifiable CL. Intra-ovarian injection of EDN2 peptide results suggest partial induction of ovulation in Edn2KO mice. Endothelin receptor antagonism in wild type mice similarly disrupted ovulation, CL formation, and progesterone secretion. Overall, this study suggests that EDN2 is necessary for normal ovulation and CL formation.	[Cacioppo, Joseph A.; Oh, Sang Wook; Kim, Hey-young; Cho, Jongki; Lin, Po-Ching Patrick; Ko, CheMyong] Univ Illinois, Coll Vet Med, Urbana, IL 61801 USA; [Oh, Sang Wook] Chonbuk Natl Univ, Inst Fus Sci, Dept Biol Educ, Jeonju, South Korea; [Cho, Jongki] Chungnam Natl Univ, Coll Vet Med, Vet Med Res Inst, Taejon, South Korea; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Illinois System; University of Illinois Urbana-Champaign; Jeonbuk National University; Chungnam National University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ko, C (corresponding author), Univ Illinois, Coll Vet Med, Urbana, IL 61801 USA.	jayko@illinois.edu	Cho, Jongki/ABF-8410-2020; Ko, CheMyong Jay/A-7475-2019	Cho, Jongki/0000-0002-8431-0457; Ko, CheMyong Jay/0000-0002-0963-3731; Kim, Heyyoung/0000-0003-0356-5042; Cacioppo, Joseph/0000-0002-9763-9139	NIH [R01HD052694]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by an NIH grant to Dr. CheMyong Ko (R01HD052694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apa R, 1998, HUM REPROD, V13, P2425, DOI 10.1093/humrep/13.9.2425; Bagnato A, 2003, TRENDS ENDOCRIN MET, V14, P44, DOI 10.1016/S1043-2760(02)00010-3; Bazer FW, 2008, REPROD BIOL, V8, P179, DOI 10.1016/S1642-431X(12)60012-6; Bianchi M, 2012, BIOCHEM BIOPH RES CO, V417, P1113, DOI 10.1016/j.bbrc.2011.12.053; Bramall AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058023; Bridges PJ, 2010, REPROD FERT DEVELOP, V22, P780, DOI 10.1071/RD09194; Cazaubon S, 2006, M S-MED SCI, V22, P416, DOI 10.1051/medsci/2006224416; Chang I, 2013, J CLIN INVEST, V123, P2643, DOI 10.1172/JCI66735; Choi DH, 2011, HUM REPROD, V26, P1171, DOI 10.1093/humrep/der066; Conti M, 2012, MOL CELL ENDOCRINOL, V356, P65, DOI 10.1016/j.mce.2011.11.002; Craig J, 2007, FRONT BIOSCI-LANDMRK, V12, P3628, DOI 10.2741/2339; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Fraser HM, 2009, REPROD FERT DEVELOP, V21, P377, DOI 10.1071/RD08272; GIBSON M, 1995, AM J MED, V98, pS67, DOI 10.1016/S0002-9343(99)80061-8; Girsh E, 2002, MOL REPROD DEV, V63, P71, DOI 10.1002/mrd.10159; Girsh E, 1996, ENDOCRINOLOGY, V137, P1306, DOI 10.1210/en.137.4.1306; Grimshaw MJ, 2002, MOL CANCER THER, V1, P1273; Grimshaw MJ, 2002, EUR J IMMUNOL, V32, P2393, DOI 10.1002/1521-4141(200209)32:9<2393::AID-IMMU2393>3.0.CO;2-4; Grimshaw MJ, 2004, CANCER RES, V64, P2461, DOI 10.1158/0008-5472.CAN-03-1069; Guimaraes CL, 1992, HYPERTENSION, V19, pII79; Hinckley ST, 2001, BIOL REPROD, V64, P1619, DOI 10.1095/biolreprod64.6.1619; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Klipper E, 2010, ENDOCRINOLOGY, V151, P1914, DOI 10.1210/en.2009-0767; Ko C, 2006, ENDOCRINOLOGY, V147, P1770, DOI 10.1210/en.2005-1228; Ko C, 2012, LIFE SCI, V91, P501, DOI 10.1016/j.lfs.2012.05.010; Koong AC, 2000, CANCER RES, V60, P883; Lee KJ, 2007, HYPERTENS PREGNANCY, V26, P189, DOI 10.1080/10641950701204604; Ling L, 2013, BRIT J PHARMACOL, V168, P283, DOI 10.1111/j.1476-5381.2011.01786.x; Liu K, 1999, ENDOCRINOLOGY, V140, P5330, DOI 10.1210/en.140.11.5330; Matousek M, 2001, REPRODUCTION, V121, P307, DOI 10.1530/reprod/121.2.307; Meidan R, 2002, DOMEST ANIM ENDOCRIN, V23, P287, DOI 10.1016/S0739-7240(02)00164-9; Milvae RA, 2000, REV REPROD, V5, P1; Miyamoto A, 2001, BIOL ROPROD, V64; Na G, 2008, CAN J PHYSIOL PHARM, V86, P310, DOI 10.1139/Y08-025; Nio-Kobayashi J, 2013, MOL HUM REPROD, V19, P82, DOI 10.1093/molehr/gas052; Nothnick WB, 1996, BIOL REPROD, V54, P616, DOI 10.1095/biolreprod54.3.616; Ohtani M, 1998, BIOL REPROD, V58, P103, DOI 10.1095/biolreprod58.1.103; Okuda Y, 1998, LIFE SCI, V63, P477, DOI 10.1016/S0024-3205(98)00296-3; Oropeza MV, 2000, LIFE SCI, V66, pPL345, DOI 10.1016/S0024-3205(00)80010-7; Palanisamy GS, 2006, MOL ENDOCRINOL, V20, P2784, DOI 10.1210/me.2006-0093; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Rattner A, 2013, P NATL ACAD SCI USA, V110, pE3830, DOI 10.1073/pnas.1315509110; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; SAITO A, 1991, BRIT J PHARMACOL, V103, P1129, DOI 10.1111/j.1476-5381.1991.tb12312.x; Sakata K, 2000, INT J ONCOL, V17, P673; Sills ES, 2000, EUR J OBSTET GYN R B, V91, P135, DOI 10.1016/S0301-2115(99)00287-0; Skipor J, 2010, POL J VET SCI, V13, P597, DOI 10.2478/v10181-010-0009-0; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Takizawa S, 2005, J MOL ENDOCRINOL, V35, P201, DOI 10.1677/jme.1.01787; Uchide T, 1999, J MOL ENDOCRINOL, V22, P161, DOI 10.1677/jme.0.0220161; Weems YS, 2009, PROSTAG OTH LIPID M, V90, P63, DOI 10.1016/j.prostaglandins.2009.08.004; Wright MF, 2001, BIOL REPROD, V65, P1710, DOI 10.1095/biolreprod65.6.1710; Wulff C, 2000, J CLIN ENDOCR METAB, V85, P4302, DOI 10.1210/jc.85.11.4302; Zhang JS, 2012, J REPROD DEVELOP, V58, P678, DOI 10.1262/jrd.2012-089; Zuidervaart W, 2003, BRIT J CANCER, V89, P1914, DOI 10.1038/sj.bjc.6601374	58	23	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96115	10.1371/journal.pone.0096115	http://dx.doi.org/10.1371/journal.pone.0096115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763822	Green Submitted, Green Published, gold			2022-12-25	WOS:000335505000061
J	Doro, MG; Piras, D; Leoni, GG; Casu, G; Vaccargiu, S; Parracciani, D; Naitana, S; Pirastu, M; Novelletto, A				Doro, Maria Grazia; Piras, Daniela; Leoni, Giovanni Giuseppe; Casu, Giuseppina; Vaccargiu, Simona; Parracciani, Debora; Naitana, Salvatore; Pirastu, Mario; Novelletto, Andrea			Phylogeny and Patterns of Diversity of Goat mtDNA Haplogroup A Revealed by Resequencing Complete Mitogenomes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA ANALYSIS; ANIMAL DOMESTICATION; EVOLUTION; ORIGINS; SELECTION; GENOME; CATTLE; HIRCUS	We sequenced to near completion the entire mtDNA of 28 Sardinian goats, selected to represent the widest possible diversity of the most widespread mitochondrial evolutionary lineage, haplogroup (Hg) A. These specimens were reporters of the diversity in the island but also elsewhere, as inferred from their affiliation to each of 11 clades defined by D-loop variation. Two reference sequences completed the dataset. Overall, 206 variations were found in the full set of 30 sequences, of which 23 were protein-coding non-synonymous single nucleotide substitutions. Many polymorphic sites within Hg A were informative for the reconstruction of its internal phylogeny. Bayesian and network clustering revealed a general similarity over the entire molecule of sequences previously assigned to the same D-loop clade, indicating evolutionarily meaningful lineages. Two major sister groupings emerged within Hg A, which parallel distinct geographical distributions of D-loop clades in extant stocks. The pattern of variation in protein-coding genes revealed an overwhelming role of purifying selection, with the quota of surviving variants approaching neutrality. However, a simple model of relaxation of selection for the bulk of variants here reported should be rejected. Non-synonymous diversity of Hg's A, B and C denoted that a proportion of variants not greater than that allowed in the wild was given the opportunity to spread into domesticated stocks. Our results also confirmed that a remarkable proportion of pre-existing Hg A diversity became incorporated into domestic stocks. Our results confirm clade A11 as a well differentiated and ancient lineage peculiar of Sardinia.	[Doro, Maria Grazia; Piras, Daniela; Casu, Giuseppina; Vaccargiu, Simona; Pirastu, Mario] CNR, Inst Populat Genet, Sassari, Italy; [Piras, Daniela] Expt Zooprophylact Inst Sardinia, Sassari, Italy; [Leoni, Giovanni Giuseppe; Naitana, Salvatore] Univ Sassari, Fac Vet Sci, I-07100 Sassari, Italy; [Parracciani, Debora; Pirastu, Mario] Genet Pk Ogliastra, Perdasdefogu, Italy; [Novelletto, Andrea] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); IZS Della Sardegna; University of Sassari; University of Rome Tor Vergata	Novelletto, A (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	novelletto@bio.uniroma2.it	doro, maria grazia/AAX-8971-2020	Novelletto, Andrea/0000-0002-1146-7680	Istituto di Genetica delle Popolazioni; Progetti di ricerca e innovazione al di sotto della soglia de minimis; Programma Operativo Regionale Sardegna Asse 3 Risorse Umane Misura 3.1.3.; Ricerca e sviluppo tecnologico nelle imprese e territorio; Sviluppo di un sistema informatico integrato per l'identificazione, la valorizzazione e la conservazione del patrimonio caprino in Sardegna; Promozione della ricerca scientifica e dell' innovazione tecnologica in Sardegna (Bando); Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale - Ministero dell' Istruzione dell' Universita e della Ricerca [2012JA4BTY_003]	Istituto di Genetica delle Popolazioni; Progetti di ricerca e innovazione al di sotto della soglia de minimis; Programma Operativo Regionale Sardegna Asse 3 Risorse Umane Misura 3.1.3.; Ricerca e sviluppo tecnologico nelle imprese e territorio; Sviluppo di un sistema informatico integrato per l'identificazione, la valorizzazione e la conservazione del patrimonio caprino in Sardegna; Promozione della ricerca scientifica e dell' innovazione tecnologica in Sardegna (Bando); Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale - Ministero dell' Istruzione dell' Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	Work was supported by grants Istituto di Genetica delle Popolazioni - Progetti di ricerca e innovazione al di sotto della soglia de minimis - Programma Operativo Regionale Sardegna 2000/2006 Asse 3 Risorse Umane Misura 3.1.3. - Ricerca e sviluppo tecnologico nelle imprese e territorio - "Sviluppo di un sistema informatico integrato per l'identificazione, la valorizzazione e la conservazione del patrimonio caprino in Sardegna'' to M.P.; L.R. 7 agosto 2007, n. 7 - Promozione della ricerca scientifica e dell' innovazione tecnologica in Sardegna (Bando 2008) - "Diversita genetica, conservazione e diffusione del germoplasma di specie di interesse faunistico presenti in Sardegna'' to G.G.L.; Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale - Ministero dell' Istruzione dell' Universita e della Ricerca 2012JA4BTY_003 to A.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Amills M, 2009, ANIM GENET, V40, P315, DOI 10.1111/j.1365-2052.2008.01837.x; Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bjornerfeldt S, 2006, GENOME RES, V16, P990, DOI 10.1101/gr.5117706; Brandano P, 1978, ANN FAC AGR SASSARI, V26, P232; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fernandez H, 2006, P NATL ACAD SCI USA, V103, P15375, DOI 10.1073/pnas.0602753103; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Hassanin A, 2010, MITOCHONDR DNA, V21, P68, DOI 10.3109/19401736.2010.490583; Hughes AL, 2013, GENE, V515, P28, DOI 10.1016/j.gene.2012.11.064; Hughes S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030272; Kang LL, 2013, MOL BIOL EVOL, V30, P2579, DOI 10.1093/molbev/mst147; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lancioni H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073712; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Nomura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067775; Pereira F, 2009, MOL BIOL EVOL, V26, P2765, DOI 10.1093/molbev/msp200; Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006; Piras D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030785; SAKUTA R, 1993, AM J HUM GENET, V53, P964; Shipman P, 2011, ANIMAL CONNECTION; Soares P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058993; Taberlet P, 2008, MOL ECOL, V17, P275, DOI 10.1111/j.1365-294X.2007.03475.x; Taberlet P, 2011, CR BIOL, V334, P247, DOI 10.1016/j.crvi.2010.12.007; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tudge Colin, 1998, NEANDERTHALS BANDITS; Vacca GM, 2010, J ANIM BREED GENET, V127, P352, DOI 10.1111/j.1439-0388.2010.00863.x; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Zeder MA, 2001, J ARCHAEOL SCI, V28, P61, DOI 10.1006/jasc.1999.0555; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105	37	22	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95969	10.1371/journal.pone.0095969	http://dx.doi.org/10.1371/journal.pone.0095969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763315	Green Submitted, Green Published, gold			2022-12-25	WOS:000335505000047
J	Li, XZ; Lu, J; Zhao, J; Qu, YB				Li, Xuezhi; Lu, Jie; Zhao, Jian; Qu, Yinbo			Characteristics of Corn Stover Pretreated with Liquid Hot Water and Fed-Batch Semi-Simultaneous Saccharification and Fermentation for Bioethanol Production	PLOS ONE			English	Article							DILUTE-ACID PRETREATMENT; ENZYMATIC-HYDROLYSIS; ETHANOL-PRODUCTION; RICE STRAW; SACCHAROMYCES-CEREVISIAE; LIGNOCELLULOSIC BIOMASS; SUGARCANE BAGASSE; WHEAT-STRAW; OPTIMIZATION; DIGESTIBILITY	Corn stover is a promising feedstock for bioethanol production because of its abundant availability in China. To obtain higher ethanol concentration and higher ethanol yield, liquid hot water (LHW) pretreatment and fed-batch semi-simultaneous saccharification and fermentation (S-SSF) were used to enhance the enzymatic digestibility of corn stover and improve bioconversion of cellulose to ethanol. The results show that solid residues from LHW pretreatment of corn stover can be effectively converted into ethanol at severity factors ranging from 3.95 to 4.54, and the highest amount of xylan removed was approximately 89%. The ethanol concentrations of 38.4 g/L and 39.4 g/L as well as ethanol yields of 78.6% and 79.7% at severity factors of 3.95 and 4.54, respectively, were obtained by fed-batch S-SSF in an optimum conditions (initial substrate consistency of 10%, and 6.1% solid residues added into system at the prehydrolysis time of 6 h). The changes in surface morphological structure, specific surface area, pore volume and diameter of corn stover subjected to LHW process were also analyzed for interpreting the possible improvement mechanism.	[Li, Xuezhi; Lu, Jie; Zhao, Jian; Qu, Yinbo] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Lu, Jie] Dalian Polytech Univ, Dalian, Peoples R China	Shandong University; Dalian Polytechnic University	Zhao, J (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhaojian@sdu.edu.cn			National Key Basic Research Development Program [2011CB707401]; National Natural Science Foundation of China [31100440, 21276143, 21376141]; State Key Laboratory of Microbial Technology [M 2013 06]	National Key Basic Research Development Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Microbial Technology	The National Key Basic Research Development Program (2011CB707401) (http://program.most.gov.cn/), the National Natural Science Foundation of China (No. 31100440, 21276143, 21376141) (http://www.nsfc.gov.cn/Portal0/default152.htm), and the State Key Laboratory of Microbial Technology (M 2013 06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ask M, 2012, PROCESS BIOCHEM, V47, P1452, DOI 10.1016/j.procbio.2012.05.016; Avci A, 2013, BIORESOURCE TECHNOL, V142, P312, DOI 10.1016/j.biortech.2013.05.002; Avci A, 2013, BIORESOURCE TECHNOL, V130, P603, DOI 10.1016/j.biortech.2012.12.104; Bafrncova P, 1999, BIOTECHNOL LETT, V21, P337, DOI 10.1023/A:1005436816047; Balat M, 2011, ENERG CONVERS MANAGE, V52, P858, DOI 10.1016/j.enconman.2010.08.013; Buranov AU, 2010, CARBOHYD POLYM, V79, P17, DOI 10.1016/j.carbpol.2009.06.014; Cara C, 2008, BIORESOURCE TECHNOL, V99, P1869, DOI 10.1016/j.biortech.2007.03.037; Chaudhary G, 2012, BIORESOURCE TECHNOL, V124, P111, DOI 10.1016/j.biortech.2012.08.067; Chen WH, 2011, BIORESOURCE TECHNOL, V102, P2916, DOI 10.1016/j.biortech.2010.11.052; Chundawat SPS, 2010, BIORESOURCE TECHNOL, V101, P8429, DOI 10.1016/j.biortech.2010.06.027; Erdei B, 2010, BIOTECHNOL BIOFUELS, V3, DOI [10.1186/1754-6834-3-21, 10.1186/1754-6834-3-16]; Fang X, 2010, BIORESOURCE TECHNOL, V101, P4814, DOI 10.1016/j.biortech.2009.11.050; Santos ALF, 2011, J SUPERCRIT FLUID, V56, P277, DOI 10.1016/j.supflu.2010.10.044; Hahn-Hagerdal B, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-31; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hsu TC, 2010, BIORESOURCE TECHNOL, V101, P4907, DOI 10.1016/j.biortech.2009.10.009; Ibarra D, 2004, ENZYME MICROB TECH, V35, P173, DOI 10.1016/j.enzmictec.2004.04.002; Jimenez-Marti E, 2011, INT J FOOD MICROBIOL, V145, P211, DOI 10.1016/j.ijfoodmicro.2010.12.023; Kim I, 2012, BIOMASS BIOENERG, V46, P210, DOI 10.1016/j.biombioe.2012.08.024; Kou XM, 2013, BIORESOURCES, V8, P4899; Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g; Kumar R, 2009, BIORESOURCE TECHNOL, V100, P3948, DOI 10.1016/j.biortech.2009.01.075; Li BZ, 2010, BIORESOURCE TECHNOL, V101, P1285, DOI 10.1016/j.biortech.2009.09.044; Li CL, 2011, BIORESOURCE TECHNOL, V102, P6928, DOI 10.1016/j.biortech.2011.04.005; Limayem A, 2012, PROG ENERG COMBUST, V38, P449, DOI 10.1016/j.pecs.2012.03.002; Liu L, 2009, BIORESOURCE TECHNOL, V100, P5853, DOI 10.1016/j.biortech.2009.06.040; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Mooney CA, 1998, BIORESOURCE TECHNOL, V64, P113, DOI 10.1016/S0960-8524(97)00181-8; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P1986, DOI 10.1016/j.biortech.2005.01.013; Overend R, 1994, ABSTR PAP AM CHEM 1; Palukurty MA, 2008, AFR J MICROBIOL RES, V2, P87; Peng LC, 2011, BIOMASS BIOENERG, V35, P1600, DOI 10.1016/j.biombioe.2011.01.059; Pereira FB, 2010, BIORESOURCE TECHNOL, V101, P7856, DOI 10.1016/j.biortech.2010.04.082; Rezende CA, 2011, BIOTECHNOL BIOFUELS, V4, P1, DOI 10.1186/1754-6834-4-54; SANCHEZ B, 1988, ENZYME MICROB TECH, V10, P315, DOI 10.1016/0141-0229(88)90135-4; Sathitsuksanoh N, 2012, BIORESOURCE TECHNOL, V117, P228, DOI 10.1016/j.biortech.2012.04.088; Shen JC, 2010, BIOMASS BIOENERG, V34, P1098, DOI 10.1016/j.biombioe.2010.02.014; STONE JE, 1969, ADV CHEM SER, P219; Taherzadeh MJ, 2000, APPL MICROBIOL BIOT, V53, P701, DOI 10.1007/s002530000328; Taherzadeh MJ, 2008, INT J MOL SCI, V9, P1621, DOI 10.3390/ijms9091621; TANAKA M, 1988, BIOTECHNOL BIOENG, V32, P698, DOI 10.1002/bit.260320515; Tengborg C, 2001, ENZYME MICROB TECH, V28, P835, DOI 10.1016/S0141-0229(01)00342-8; Tomas-Pejo E, 2012, BIOMASS BIOENERG, V45, P168, DOI 10.1016/j.biombioe.2012.06.002; Tomas-Pejo E, 2008, BIOTECHNOL BIOENG, V100, P1122, DOI 10.1002/bit.21849; Torija MJ, 2003, INT J FOOD MICROBIOL, V80, P47, DOI 10.1016/S0168-1605(02)00144-7; Wan CX, 2011, BIORESOURCE TECHNOL, V102, P6254, DOI 10.1016/j.biortech.2011.02.075; Wan CX, 2010, BIORESOURCE TECHNOL, V101, P6398, DOI 10.1016/j.biortech.2010.03.070; Wang L, 2012, APPL ENERG, V99, P23, DOI 10.1016/j.apenergy.2012.03.045; Wang W, 2012, BIORESOURCE TECHNOL, V107, P282, DOI 10.1016/j.biortech.2011.12.116; WEIMER PJ, 1985, BIOTECHNOL BIOENG, V27, P1540, DOI 10.1002/bit.260271104; WONG KKY, 1988, BIOTECHNOL BIOENG, V31, P447, DOI 10.1002/bit.260310509; Xue C, 2008, WORLD J MICROB BIOT, V24, P2257, DOI 10.1007/s11274-008-9739-x; Yao Lan, 2012, Chemistry and Industry of Forest Products, V32, P87; YOON HH, 1995, APPL BIOCHEM BIOTECH, V51-2, P5, DOI 10.1007/BF02933407; Yu G, 2010, APPL BIOCHEM BIOTECH, V160, P539, DOI 10.1007/s12010-008-8420-z; Yu Q, 2013, BIORESOURCE TECHNOL, V129, P592, DOI 10.1016/j.biortech.2012.11.099; Yu ZD, 2012, BIORESOURCE TECHNOL, V121, P335, DOI 10.1016/j.biortech.2012.06.055; Zeng MJ, 2007, BIOTECHNOL BIOENG, V97, P265, DOI 10.1002/bit.21298; Zhao J, 2009, FUEL PROCESS TECHNOL, V90, P1193, DOI 10.1016/j.fuproc.2009.05.018	59	37	37	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95455	10.1371/journal.pone.0095455	http://dx.doi.org/10.1371/journal.pone.0095455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763192	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000020
J	Milenkovic, D; Vanden Berghe, W; Boby, C; Leroux, C; Declerck, K; Szic, KSV; Heyninck, K; Laukens, K; Bizet, M; Defrance, M; Dedeurwaerder, S; Calonne, E; Fuks, F; Haegeman, G; Haenen, GRMM; Bast, A; Weseler, AR				Milenkovic, Dragan; Vanden Berghe, Wim; Boby, Celine; Leroux, Christine; Declerck, Ken; Szic, Katarzyna Szarc Vel; Heyninck, Karen; Laukens, Kris; Bizet, Martin; Defrance, Matthieu; Dedeurwaerder, Sarah; Calonne, Emilie; Fuks, Francois; Haegeman, Guy; Haenen, Guido R. M. M.; Bast, Aalt; Weseler, Antje R.			Dietary Flavanols Modulate the Transcription of Genes Associated with Cardiovascular Pathology without Changes in Their DNA Methylation State	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; EXPRESSION PROFILES; LEUKOCYTE ADHESION; SMOKING; POLYPHENOLS; CANCER; SUPPLEMENTATION; EPIGENETICS; EPIGENOME; PATTERNS	Background: In a recent intervention study, the daily supplementation with 200 mg monomeric and oligomeric flavanols (MOF) from grape seeds for 8 weeks revealed a vascular health benefit in male smokers. The objective of the present study was to determine the impact of MOF consumption on the gene expression profile of leukocytes and to assess changes in DNA methylation. Methodology/Principal Findings: Gene expression profiles were determined using whole genome microarrays (Agilent) and DNA methylation was assessed using HumanMethylation450 BeadChips (Illumina). MOF significantly modulated the expression of 864 genes. The majority of the affected genes are involved in chemotaxis, cell adhesion, cell infiltration or cytoskeleton organisation, suggesting lower immune cell adhesion to endothelial cells. This was corroborated by in vitro experiments showing that MOF exposure of monocytes attenuates their adhesion to TNF-alpha-stimulated endothelial cells. Nuclear factor kappa B (NF-kappa B) reporter gene assays confirmed that MOF decrease the activity of NF-kB. Strong inter-individual variability in the leukocytes' DNA methylation was observed. As a consequence, on group level, changes due to MOF supplementation could not be found. Conclusion: Our study revealed that an 8 week daily supplementation with 200 mg MOF modulates the expression of genes associated with cardiovascular disease pathways without major changes of their DNA methylation state. However, strong inter-individual variation in leukocyte DNA methylation may obscure the subtle epigenetic response to dietary flavanols. Despite the lack of significant changes in DNA methylation, the modulation of gene expression appears to contribute to the observed vascular health effect of MOF in humans.	[Milenkovic, Dragan] INRA, UNH, CRNH Auvergne, UMR 1019, Clermont Ferrand, France; [Milenkovic, Dragan] Univ Clermont Ferrand 2, Univ Auvergne, Unite Nutr Humaine, Clermont Ferrand, France; [Vanden Berghe, Wim; Heyninck, Karen; Haegeman, Guy] Univ Ghent, Lab Eukaryot Gene Express & Signal Transduct LEGE, B-9000 Ghent, Belgium; [Vanden Berghe, Wim; Declerck, Ken; Szic, Katarzyna Szarc Vel] Univ Antwerp, Dept Biomed Sci, PPES, Antwerp, Belgium; [Boby, Celine; Leroux, Christine] INRA, Herbivores UMR1213, F-63122 St Genes Champanelle, France; [Laukens, Kris] Univ Antwerp, Dept Math & Comp Sci, B-2020 Antwerp, Belgium; [Laukens, Kris] Univ Antwerp, Univ Antwerp Hosp, Biomed Informat Res Ctr Antwerp Biomina, Edegem, Belgium; [Bizet, Martin; Defrance, Matthieu; Dedeurwaerder, Sarah; Calonne, Emilie; Fuks, Francois] Free Univ Brussels, Lab Canc Epigenet, Brussels, Belgium; [Haenen, Guido R. M. M.; Bast, Aalt; Weseler, Antje R.] Maastricht Univ, Dept Toxicol, Maastricht, Netherlands	INRAE; Universite Clermont Auvergne (UCA); Ghent University; University of Antwerp; INRAE; VetAgro Sup; University of Antwerp; University of Antwerp; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Maastricht University	Weseler, AR (corresponding author), INRA, UNH, CRNH Auvergne, UMR 1019, Clermont Ferrand, France.	a.weseler@maastrichtuniversity.nl	Vanden Berghe, Wim/HGE-4696-2022; Bast, Aalt/I-7809-2013; Berghe, Wim Vanden/S-6425-2018; Laukens, Kris/V-1121-2018	Berghe, Wim Vanden/0000-0003-0161-7355; Laukens, Kris/0000-0002-8217-2564; Bast, Aalt/0000-0002-5383-2789; Defrance, Matthieu/0000-0002-3090-3142; Leroux, Christine/0000-0001-6835-3978; BOBY, Celine/0000-0002-4420-7033; Haenen, Guido/0000-0001-6986-290X; Declerck, Ken/0000-0001-8104-8054; Milenkovic, Dragan/0000-0001-6353-0912	International Nutrition Company (INC) BV, Loosdrecht, The Netherlands; European Union [226588]; University of Antwerp, Belgium	International Nutrition Company (INC) BV, Loosdrecht, The Netherlands(Netherlands Government); European Union(European Commission); University of Antwerp, Belgium	The study was financially supported by International Nutrition Company (INC) BV, Loosdrecht, The Netherlands, the European Union (grant 226588, entitled Flaviola) within the Seventh Framework Programme and by the University of Antwerp, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; Auclair Sylvain, 2009, Atherosclerosis, V204, pe21, DOI 10.1016/j.atherosclerosis.2008.12.007; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-405; Bellavia A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000212; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boomgaarden I, 2010, BRIT J NUTR, V104, P336, DOI 10.1017/S0007114510000711; Boque N, 2013, MOL NUTR FOOD RES, V57, P1473, DOI 10.1002/mnfr.201200686; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Chanet A, 2013, BRIT J NUTR, V110, P587, DOI 10.1017/S0007114512005454; Chanet A, 2012, J NUTR BIOCHEM, V23, P469, DOI 10.1016/j.jnutbio.2011.02.001; Chao CL, 2011, EUR J NUTR, V50, P401, DOI 10.1007/s00394-010-0151-6; Coban D, 2012, MOL NUTR FOOD RES, V56, P1270, DOI 10.1002/mnfr.201100818; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crescenti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065744; de Boer VCJ, 2006, CELL MOL LIFE SCI, V63, P2847, DOI 10.1007/s00018-006-6316-z; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dedeurwaerder S, 2013, BRIEF BIOIN IN PRESS; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Dogan MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-151; Ehrlich S, 2012, CAN J PSYCHIAT, V57, P168, DOI 10.1177/070674371205700306; Elliott HR, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-4; Faulk C, 2011, EPIGENETICS-US, V6, P791, DOI 10.4161/epi.6.7.16209; Feringa HHH, 2011, J AM DIET ASSOC, V111, P1173, DOI 10.1016/j.jada.2011.05.015; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Friso S, 2013, CANCER EPIDEM BIOMAR, V22, P348, DOI 10.1158/1055-9965.EPI-12-0859; Gao Y, 2012, WORLD J GASTRO ONCOL, V4, P193, DOI 10.4251/wjgo.v4.i8.193; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Heiss C, 2010, EUR HEART J, V31, P2583, DOI 10.1093/eurheartj/ehq332; Howard TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026791; Jacoby M, 2012, EPIGENETICS-US, V7, P1421, DOI 10.4161/epi.22845; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kaul D, 2004, PHYTOTHER RES, V18, P177, DOI 10.1002/ptr.1411; Leiro J, 2005, INT IMMUNOPHARMACOL, V5, P393, DOI 10.1016/j.intimp.2004.10.006; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Man SM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003197; Milenkovic D, 2013, FREE RADICAL BIO MED, V64, P40, DOI 10.1016/j.freeradbiomed.2013.05.046; Milenkovic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026669; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Nola S, 2008, HUM MOL GENET, V17, P3552, DOI 10.1093/hmg/ddn248; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Overman A, 2011, INT J OBES LOND, V34, P800; Paur I, 2008, FOOD CHEM TOXICOL, V46, P1288, DOI 10.1016/j.fct.2007.09.103; Price EM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-4; Ray P, 2012, BIOCHEM J, V442, P433, DOI 10.1042/BJ20111341; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Schroeter H, 2010, MOL ASPECTS MED, V31, P546, DOI 10.1016/j.mam.2010.09.008; Scoccianti C, 2011, EPIGENETICS-US, V6, P1114, DOI 10.4161/epi.6.9.16515; Shanmugam MK, 2012, SUBCELL BIOCH, V61, P627; Shenker NS, 2013, HUM MOL GENET, V22, P843, DOI 10.1093/hmg/dds488; Simoons M L, 1998, Ned Tijdschr Geneeskd, V142, P2096; Sulistyoningrum DC, 2012, EPIGENETICS-US, V7, P514, DOI 10.4161/epi.19836; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tome-Carneiro J, 2013, PHARMACOL RES, V72, P69, DOI 10.1016/j.phrs.2013.03.011; Tonna S, 2010, NAT REV NEPHROL, V6, P332, DOI 10.1038/nrneph.2010.55; Udali S, 2013, MOL ASPECTS MED, V34, P883, DOI 10.1016/j.mam.2012.08.001; van den Berg R, 2001, ENVIRON TOXICOL PHAR, V9, P147, DOI 10.1016/S1382-6689(00)00070-3; van der Velpen V, 2013, J NUTR, V143, P774, DOI 10.3945/jn.113.174037; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vanden Berghe W, 2012, PHARMACOL RES, V65, P565, DOI 10.1016/j.phrs.2012.03.007; Vanhees K, 2011, FASEB J, V25, P797, DOI 10.1096/fj.10-172155; Von Hundelshausen P, 2009, MICROCIRCULATION, V16, P84, DOI 10.1080/10739680802564787; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Weber C, 2004, ARTERIOSCL THROM VAS, V24, P1997, DOI 10.1161/01.ATV.0000142812.03840.6f; Weseler AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028460; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	68	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95527	10.1371/journal.pone.0095527	http://dx.doi.org/10.1371/journal.pone.0095527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763279	Green Published, gold			2022-12-25	WOS:000335505000022
J	Pereira, PMR; Silva, S; Cavaleiro, JAS; Ribeiro, CAF; Tome, JPC; Fernandes, R				Pereira, Patricia M. R.; Silva, Sandrina; Cavaleiro, Jose A. S.; Ribeiro, Carlos A. F.; Tome, Joao P. C.; Fernandes, Rosa			Galactodendritic Phthalocyanine Targets Carbohydrate-Binding Proteins Enhancing Photodynamic Therapy	PLOS ONE			English	Article							PHOTOPHYSICAL PROPERTIES; SUPEROXIDE-DISMUTASE; CONJUGATED CHLORINS; CELL RECOGNITION; EXPRESSION; PHOTOSENSITIZERS; DENDRIMERS; EFFICIENCY; PORPHYRIN; DELIVERY	Photosensitizers (PSs) are of crucial importance in the effectiveness of photodynamic therapy (PDT) for cancer. Due to their high reactive oxygen species production and strong absorption in the wavelength range between 650 and 850 nm, where tissue light penetration is rather high, phthalocyanines (Pcs) have been studied as PSs of excellence. In this work, we report the evaluation of a phthalocyanine surrounded by a carbohydrate shell of sixteen galactose units distributed in a dendritic manner (PcGal(16)) as a new and efficient third generation PSs for PDT against two bladder cancer cell lines, HT-1376 and UM-UC-3. Here, we define the role of galacto-dendritic units in promoting the uptake of a Pc through interaction with GLUT1 and galectin-1. The photoactivation of PcGal(16) induces cell death by generating oxidative stress. Although PDT with PcGal(16) induces an increase on the activity of antioxidant enzymes immediately after PDT, bladder cancer cells are unable to recover from the PDT-induced damage effects for at least 72 h after treatment. PcGal(16) co-localization with galectin-1 and GLUT1 and/or generation of oxidative stress after PcGal(16) photoactivation induces changes in the levels of these proteins. Knockdown of galectin-1 and GLUT1, via small interfering RNA (siRNA), in bladder cancer cells decreases intracellular uptake and phototoxicity of PcGal(16). The results reported herein show PcGal(16) as a promising therapeutic agent for the treatment of bladder cancer, which is the fifth most common type of cancer with the highest rate of recurrence of any cancer.	[Pereira, Patricia M. R.; Silva, Sandrina; Cavaleiro, Jose A. S.; Tome, Joao P. C.] Univ Aveiro, QOPNA, P-3800 Aveiro, Portugal; [Pereira, Patricia M. R.; Silva, Sandrina; Cavaleiro, Jose A. S.; Tome, Joao P. C.] Univ Aveiro, Dept Chem, P-3800 Aveiro, Portugal; [Pereira, Patricia M. R.; Ribeiro, Carlos A. F.] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci, Lab Pharmacol & Expt Therapeut, Coimbra, Portugal; [Tome, Joao P. C.] Univ Ghent, Dept Organ Chem, B-9000 Ghent, Belgium; [Fernandes, Rosa] Ctr Invest Environm Genet & Oncobiol, Coimbra, Portugal; [Fernandes, Rosa] Univ Coimbra, Fac Med, IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Coimbra; Ghent University; Universidade de Coimbra; Universidade de Coimbra	Tome, JPC (corresponding author), Univ Aveiro, QOPNA, P-3800 Aveiro, Portugal.	jtome@ua.pt; rcfernandes@fmed.uc.pt	Tome, Joao P. C./K-6782-2014; Fernandes, Rosa/P-1102-2014	Tome, Joao P. C./0000-0001-6057-4936; Fernandes, Rosa/0000-0001-7828-2296; Silva, Sandrina/0000-0001-7728-8485; Cavaleiro, Jose/0000-0001-5495-5126; Pereira, Patricia/0000-0002-4772-9339	FCT- Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/CTM/101538/2008]; FCT; Fundo Europeu de Desenvolvimento Regional (FEDER) [Pest-C/SAU/UI3282/2011, Pest-C/SAU/UI3282/2013, PEst-C/QUI/UI0062/2013]	FCT- Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission)	The synthesis of the photosensitizer was supported by the grant PTDC/CTM/101538/2008 (FCT- Fundacao para a Ciencia e a Tecnologia, Portugal). Thanks are due to FCT and Fundo Europeu de Desenvolvimento Regional (FEDER) for funding IBILI (Pest-C/SAU/UI3282/2011 and Pest-C/SAU/UI3282/2013) and QOPNA (PEst-C/QUI/UI0062/2013) research units. Thanks are due to ACIMAGO (ref. 12/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RR, 2010, PHOTODIAGN PHOTODYN, V7, P61, DOI 10.1016/j.pdpdt.2010.02.001; Almeida RD, 2004, BBA-REV CANCER, V1704, P59, DOI 10.1016/j.bbcan.2004.05.003; [Anonymous], TETRAHEDRON IN PRESS; [Anonymous], CURR ORG SY IN PRESS; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Ballardini R, 2003, EUR J ORG CHEM, V2003, P288; Ballut S, 2009, CHEM COMMUN, P224, DOI 10.1039/b816128c; Bancirova M, 2011, LUMINESCENCE, V26, P685, DOI 10.1002/bio.1296; BARNETT JEG, 1975, BIOCHEM J, V145, P417, DOI 10.1042/bj1450417a; Bogoeva VP, 2010, PROTEOMICS, V10, P1946, DOI 10.1002/pmic.200900581; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Carruthers A, 2009, AM J PHYSIOL-ENDOC M, V297, pE836, DOI 10.1152/ajpendo.00496.2009; Chan JYW, 1999, LIFE SCI, V65, P63, DOI 10.1016/S0024-3205(99)00219-2; CHIARIOTTI L, 1992, ONCOGENE, V7, P2507; Choi CF, 2008, ORG BIOMOL CHEM, V6, P2173, DOI 10.1039/b802212g; Cindolo L, 1999, INT J CANCER, V84, P39, DOI 10.1002/(SICI)1097-0215(19990219)84:1<39::AID-IJC8>3.3.CO;2-5; Daly R, 2012, CHEM-EUR J, V18, P14671, DOI 10.1002/chem.201202064; David A, 2010, ISR J CHEM, V50, P204, DOI 10.1002/ijch.201000021; Ernst B, 2009, NAT REV DRUG DISCOV, V8, P661, DOI 10.1038/nrd2852; Fernandes R, 2004, MOL VIS, V10, P618; Fernandes R, 2011, AM J PHYSIOL-CELL PH, V300, pC927, DOI 10.1152/ajpcell.00140.2010; Fujimoto K, 2000, J AM CHEM SOC, V122, P3558, DOI 10.1021/ja993993d; Gary-Bobo M, 2013, CURR MED CHEM, V20, P1946, DOI 10.2174/0929867311320150002; Gillies ER, 2005, DRUG DISCOV TODAY, V10, P35, DOI 10.1016/S1359-6446(04)03276-3; Hirohara S, 2005, J PHOTOCH PHOTOBIO B, V78, P7, DOI 10.1016/j.jphotobiol.2004.09.003; Iqbal Z, 2009, TETRAHEDRON LETT, V50, P873, DOI 10.1016/j.tetlet.2008.12.015; Klajnert B, 2012, CURR MED CHEM, V19, P4903; Laville I, 2006, J MED CHEM, V49, P2558, DOI 10.1021/jm0580151; Lee PPS, 2005, TETRAHEDRON LETT, V46, P1551, DOI 10.1016/j.tetlet.2004.12.137; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; LOTAN R, 1988, ANN NY ACAD SCI, V551, P385, DOI 10.1111/j.1749-6632.1988.tb22372.x; Lourenco LMO, 2009, RAPID COMMUN MASS SP, V23, P3478, DOI 10.1002/rcm.4262; Noguchi Y, 2000, CANCER LETT, V154, P175, DOI 10.1016/S0304-3835(00)00392-X; Pandey SK, 2007, MOL PHARMACEUT, V4, P448, DOI 10.1021/mp060135x; Park YK, 2008, B KOREAN CHEM SOC, V29, P130; Pereira PMR, 2014, ORG BIOMOL CHEM, V12, P1804, DOI 10.1039/c3ob42082e; Plaetzer K, 2009, LASER MED SCI, V24, P259, DOI 10.1007/s10103-008-0539-1; Ribeiro AO, 2006, TETRAHEDRON LETT, V47, P9177, DOI 10.1016/j.tetlet.2006.10.155; Saczko J, 2007, FOLIA HISTOCHEM CYTO, V45, P93; Sattler UGA, 2009, INT J RADIAT BIOL, V85, P963, DOI 10.3109/09553000903258889; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Silva AMG, 2005, SYNLETT, P857, DOI 10.1055/s-2005-863736; Silva JN, 2008, PHOTOCH PHOTOBIO SCI, V7, P834, DOI 10.1039/b800348c; Silva S, 2012, CHEM COMMUN, V48, P3608, DOI 10.1039/c2cc17561d; Singh S, 2010, BIOCONJUGATE CHEM, V21, P2136, DOI 10.1021/bc100356z; Soares ARM, 2012, CHEM RES TOXICOL, V25, P940, DOI 10.1021/tx300035a; Soares ARM, 2009, CARBOHYD RES, V344, P507, DOI 10.1016/j.carres.2008.12.009; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Vedachalam S, 2011, MEDCHEMCOMM, V2, P371, DOI 10.1039/c0md00175a; Wang ZJ, 2012, J PHOTOCH PHOTOBIO B, V115, P16, DOI 10.1016/j.jphotobiol.2012.06.005; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Wolinsky JB, 2008, ADV DRUG DELIVER REV, V60, P1037, DOI 10.1016/j.addr.2008.02.012; Younes M, 1996, CANCER RES, V56, P1164; Zheng G, 2001, J ORG CHEM, V66, P8709, DOI 10.1021/jo0105080	55	47	47	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95529	10.1371/journal.pone.0095529	http://dx.doi.org/10.1371/journal.pone.0095529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763311	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000024
J	Pulixi, EA; Tobaldini, E; Battezzati, PM; D'Ingianna, P; Borroni, V; Fracanzani, AL; Maggioni, M; Pelusi, S; Bulgheroni, M; Zuin, M; Fargion, S; Montano, N; Valenti, L				Pulixi, Edoardo Alessandro; Tobaldini, Eleonora; Battezzati, Pier Maria; D'Ingianna, Paola; Borroni, Vittorio; Fracanzani, Anna Ludovica; Maggioni, Marco; Pelusi, Serena; Bulgheroni, Mara; Zuin, Massimo; Fargion, Silvia; Montano, Nicola; Valenti, Luca			Risk of Obstructive Sleep Apnea with Daytime Sleepiness Is Associated with Liver Damage in Non-Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							INTERMITTENT HYPOXIA; AMINOTRANSFERASE LEVELS; BERLIN QUESTIONNAIRE; HEPATIC STEATOSIS; SYMPTOMS; SENSITIVITY; PREVALENCE; SEVERITY; ENZYMES	Background: A high prevalence of obstructive sleep apnea syndrome (OSAS) has been reported in severely obese patients with nonalcoholic fatty liver disease (NAFLD), but few studies have evaluated OSAS in non-morbidly obese NAFLD patients. Aims: To determine the prevalence of risk for OSAS with or without daytime sleepiness in non-morbidly obese patients with NAFLD and evaluate the association with the severity of liver damage. Methods: We considered 159 consecutive patients with histological NAFLD and body mass index (BMI) <35 Kg/m(2), and 80 controls without ultrasonographic steatosis matched for age, sex, and BMI. OSAS risk was determined by positivity for Berlin questionnaire (BQ), and daytime sleepiness by the Sleepness Epworth Scale (ESS). Liver damage was evaluated according to the NAFLD activity score. Results: In NAFLD patients, BQ alone was positive in 39 (25%), ESS in 8 (5%), and both in 13 (8%, OSAS with sleepines); p = ns vs. controls without steatosis. In NAFLD patients at risk for OSAS with (but not in those without) sleepiness, we observed a higher prevalence of nonalcoholic steatohepatitis (NASH; 11/13, 85% vs. 72/146, 49%; p = 0.018), and of clinically significant fibrosis (stage >1; 9/13, 69% vs. 39/146, 27%; p = 0.003). At multivariate logistic regression analysis, OSAS with sleepiness was strongly associated with NASH and fibrosis >1 independently of known clinical risk factors such as age, gender, BMI, diabetes, and ALT levels (OR 7.1, 95% c.i. 1.7-51, p = 0.005 and OR 14.0, 95% c.i. 3.5-70, p = 0.0002, respectively). Conclusions: A proportion of NAFLD patients without severe obesity is at risk for OSAS with daytime sleepiness, which is associated with the severity of liver damage independently of body mass and other cofactors.	[Pulixi, Edoardo Alessandro; Borroni, Vittorio; Fracanzani, Anna Ludovica; Pelusi, Serena; Fargion, Silvia; Valenti, Luca] Univ Milan, Dept Pathophysiol & Transplantat, Fdn IRCCS Ca Granda Osped Policlin Milano, Milan, Italy; [Tobaldini, Eleonora; Bulgheroni, Mara; Montano, Nicola] Univ Milan, Dept Biomed & Clin Sci L Sacco, Div Med & Pathophysiol, Osped Luigi Sacco, Milan, Italy; [Battezzati, Pier Maria; D'Ingianna, Paola; Zuin, Massimo] Univ Milan, Dept Hlth Sci, Div Med & Gastroenterol, Milan, Italy; [Battezzati, Pier Maria; D'Ingianna, Paola; Zuin, Massimo] Osped San Paolo, Liver Unit, Milan, Italy; [Maggioni, Marco] Fdn IRCCS Ca Granda Osped Policlin Milano, Milan, Italy; [Montano, Nicola] St Anne Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; Luigi Sacco Hospital; University of Milan; San Paolo-Polo Universitaria Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; St Anne's University Hospital Brno (FNUSA-ICRC)	Valenti, L (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Fdn IRCCS Ca Granda Osped Policlin Milano, Milan, Italy.	luca.valenti@unimi.it	Tobaldini, Eleonora/K-8380-2016; Fracanzani, Anna Ludovica/J-8986-2018; Maggioni, Marco/AAC-4617-2022; pelusi, serena/AAC-2725-2022; Valenti, Luca/B-3695-2009	Tobaldini, Eleonora/0000-0003-3627-8293; Fracanzani, Anna Ludovica/0000-0001-5918-0171; Maggioni, Marco/0000-0001-8603-8998; Valenti, Luca/0000-0001-8909-0345; Battezzati, Pier Maria/0000-0003-1344-3452; Zuin, Massimo/0000-0003-3906-4362; Montano, Nicola/0000-0001-9206-0075	Centro Universitario per lo Studio e la Cura delle Malattie Metaboliche del Fegato; Universita degli Studi di Milano; Associazione Malattie Metaboliche del Fegato ONLUS; European Regional Development Fund - Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]	Centro Universitario per lo Studio e la Cura delle Malattie Metaboliche del Fegato; Universita degli Studi di Milano; Associazione Malattie Metaboliche del Fegato ONLUS; European Regional Development Fund - Project FNUSA-ICRC	The work was supported by the "Centro Universitario per lo Studio e la Cura delle Malattie Metaboliche del Fegato", Universita degli Studi di Milano, and by the "Associazione Malattie Metaboliche del Fegato ONLUS" (academic and non-profit organizations for the study and care of metabolic liver diseases). NM was partially supported by a European Regional Development Fund - Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123). There is no conflict of interest to disclose relevant to this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, Diabetes Care, V23 Suppl 1, pS1; Aron-Wisnewsky J, 2012, J HEPATOL, V56, P225, DOI 10.1016/j.jhep.2011.04.022; Aurora RN, 2013, LANCET RESP MED, V1, P329, DOI 10.1016/S2213-2600(13)70039-0; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Bersagliere A, 2012, HEPATOLOGY, V55, P869, DOI 10.1002/hep.24741; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Chin K, 2003, AM J MED, V114, P370, DOI 10.1016/S0002-9343(02)01570-X; Day CP, 2006, GASTROENTEROLOGY, V130, P207, DOI 10.1053/j.gastro.2005.11.017; Dongiovanni P, 2013, CURR PHARM DES; Drager LF, 2011, OBESITY, V19, P2167, DOI 10.1038/oby.2011.240; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Garvey JF, 2009, EUR RESPIR J, V33, P1195, DOI 10.1183/09031936.00111208; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gus M, 2008, AM J HYPERTENS, V21, P832, DOI 10.1038/ajh.2008.184; Hiestand DM, 2006, CHEST, V130, P780, DOI 10.1378/chest.130.3.780; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Kallivitz ER, 2007, J CLIN GASTROENTEROL, V41, P918, DOI 10.1097/01.mcg.0000225692.62121.55; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohler M, 2009, RESPIRATION, V78, P141, DOI 10.1159/000170785; Li JG, 2005, J APPL PHYSIOL, V99, P1643, DOI 10.1152/japplphysiol.00522.2005; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Mishra P, 2008, LIVER INT, V28, P1080, DOI 10.1111/j.1478-3231.2008.01822.x; Mishra P, 2007, AM J GASTROENTEROL, V102, P2716, DOI 10.1111/j.1572-0241.2007.01520.x; Musso G, 2013, OBES REV, V14, P417, DOI 10.1111/obr.12020; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Newton JL, 2008, GUT, V57, P807, DOI 10.1136/gut.2007.139303; Newton JL, 2010, DIGEST DIS, V28, P214, DOI 10.1159/000282089; Rosselli M, 2013, GUT, V62, P1234, DOI 10.1136/gutjnl-2012-302826; Savransky V, 2007, HEPATOLOGY, V45, P1007, DOI 10.1002/hep.21593; Simon S, 2012, CHEST, V142, P1645, DOI 10.1378/chest.12-2391; Singh H, 2005, DIGEST DIS SCI, V50, P2338, DOI 10.1007/s10620-005-3058-y; Tanne F, 2005, HEPATOLOGY, V41, P1290, DOI 10.1002/hep.20725; Tatsumi K, 2005, HEPATOL RES, V33, P100, DOI 10.1016/j.hepres.2005.09.014; Turkay C, 2012, RESP CARE, V57, P244, DOI 10.4187/respcare.01184; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622	39	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96349	10.1371/journal.pone.0096349	http://dx.doi.org/10.1371/journal.pone.0096349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763757	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000077
J	Shin, JM; Kim, MY; Sohn, KC; Jung, SY; Lee, HE; Lim, JW; Kim, S; Lee, YH; Im, M; Seo, YJ; Kim, CD; Lee, JH; Lee, Y; Yoon, TJ				Shin, Jung-Min; Kim, Mi Yoon; Sohn, Kyung-Cheol; Jung, So-Young; Lee, Hae-Eul; Lim, Jae Woo; Kim, Sooil; Lee, Young-Ho; Im, Myung; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon; Lee, Young; Yoon, Tae-Jin			Nrf2 Negatively Regulates Melanogenesis by Modulating PI3K/Akt Signaling	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEASOMAL DEGRADATION; TRANSCRIPTION FACTOR; MELANOMA-CELLS; ENZYME GENES; PATHWAY; PIGMENTATION; KERATINOCYTES; ACTIVATION; TYROSINASE	Nrf2 plays a role in protection of cells against oxidative stress and xenobiotic damage by regulating cytoprotective genes. In this study, we investigated the effect of Nrf2 on melanogenesis in normal human melanocytes (NHMCs). When NHMCs were transduced with a recombinant adenovirus expressing Nrf2, melanin synthesis was significantly decreased. Consistent with this result, overexpression of Nrf2 decreased the expression of tyrosinase and tyrosinase-related protein 1. The inhibitory effect of Nrf2 was reversed by overexpression of Keap1, an intracellular regulator of Nrf2. Interestingly, Nrf2 overexpression resulted in marked activation of PI3K/Akt signaling. Conversely, inhibition of PI3K activity by treatment with wortmannin reversed the depigmentary effects of Nrf2. Taken together, these results strongly suggest that Nrf2 negatively regulates melanogenesis by modulating the PI3K/Akt signaling pathway.	[Shin, Jung-Min; Kim, Mi Yoon; Sohn, Kyung-Cheol; Jung, So-Young; Lee, Hae-Eul; Lim, Jae Woo; Im, Myung; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon; Lee, Young] Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon, South Korea; [Shin, Jung-Min; Kim, Mi Yoon; Sohn, Kyung-Cheol; Jung, So-Young; Lee, Hae-Eul; Lim, Jae Woo; Im, Myung; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon; Lee, Young] Chungnam Natl Univ, Sch Med, Res Inst Med Sci, Taejon, South Korea; [Kim, Sooil; Lee, Young-Ho] Chungnam Natl Univ, Sch Med, Dept Anat, Taejon, South Korea; [Yoon, Tae-Jin] Gyeongsang Natl Univ, Sch Med, Dept Dermatol, Jinju, South Korea; [Yoon, Tae-Jin] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju, South Korea	Chungnam National University; Chungnam National University; Chungnam National University; Gyeongsang National University; Gyeongsang National University	Lee, Y (corresponding author), Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon, South Korea.	resina20@cnu.ac.kr; yoontj@gnu.ac.kr		Seo, Young-Joon/0000-0002-4955-590X; Lee, Young/0000-0001-9205-1785; Kim, Chang Deok/0000-0001-9341-6491; Lee, Young Ho/0000-0001-8238-2345	Amorepacific research fund	Amorepacific research fund	This work was supported by Amorepacific research fund, 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bellei B, 2010, J BIOL CHEM, V285, P7288, DOI 10.1074/jbc.M109.070573; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Choi TY, 2010, J INVEST DERMATOL, V130, P784, DOI 10.1038/jid.2009.280; D'Orazio J, 2011, CELL CYCLE, V10, P8, DOI 10.4161/cc.10.1.14292; Guan CP, 2008, EXP DERMATOL, V17, P1059, DOI 10.1111/j.1600-0625.2008.00752.x; Hirota A, 2011, EXP DERMATOL, V20, P664, DOI 10.1111/j.1600-0625.2011.01292.x; Ishii T, 2002, METHOD ENZYMOL, V348, P182, DOI 10.1016/S0076-6879(02)48637-5; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Khaled M, 2003, J INVEST DERMATOL, V121, P831, DOI 10.1046/j.1523-1747.2003.12420.x; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lee JH, 2010, INT J MOL MED, V26, P101, DOI 10.3892/ijmm_00000440; Lee JS, 2013, ANN DERMATOL, V25, P36, DOI 10.5021/ad.2013.25.1.36; Li ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077159; Natarajan VT, 2010, J INVEST DERMATOL, V130, P2781, DOI 10.1038/jid.2010.201; Oka M, 2000, J INVEST DERMATOL, V115, P699, DOI 10.1046/j.1523-1747.2000.00095.x; Patrick E, 1999, FOOD CHEM TOXICOL, V37, P169, DOI 10.1016/S0278-6915(98)00127-6; Schiaffino MV, 2010, INT J BIOCHEM CELL B, V42, P1094, DOI 10.1016/j.biocel.2010.03.023; Shirasugi I, 2010, BIOSCI BIOTECH BIOCH, V74, P579, DOI 10.1271/bbb.90778; Yeang HXA, 2012, J BIOL CHEM, V287, P10556, DOI 10.1074/jbc.M111.322420	23	44	45	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96035	10.1371/journal.pone.0096035	http://dx.doi.org/10.1371/journal.pone.0096035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763530	Green Published, Green Submitted, gold			2022-12-25	WOS:000335505000054
J	Szollosi, D; Horvath, T; Han, KH; Dokholyan, NV; Tompa, P; Kalmar, L; Hegedus, T				Szoellosi, Daniel; Horvath, Tamas; Han, Kyou-Hoon; Dokholyan, Nikolay V.; Tompa, Peter; Kalmar, Lajos; Hegedus, Tamas			Discrete Molecular Dynamics Can Predict Helical Prestructured Motifs in Disordered Proteins	PLOS ONE			English	Article							DOMAIN; RECOGNITION; FEATURES; CREB	Intrinsically disordered proteins (IDPs) lack a stable tertiary structure, but their short binding regions termed Pre-Structured Motifs (PreSMo) can form transient secondary structure elements in solution. Although disordered proteins are crucial in many biological processes and designing strategies to modulate their function is highly important, both experimental and computational tools to describe their conformational ensembles and the initial steps of folding are sparse. Here we report that discrete molecular dynamics (DMD) simulations combined with replica exchange (RX) method efficiently samples the conformational space and detects regions populating alpha-helical conformational states in disordered protein regions. While the available computational methods predict secondary structural propensities in IDPs based on the observation of protein-protein interactions, our ab initio method rests on physical principles of protein folding and dynamics. We show that RX-DMD predicts alpha-PreSMos with high confidence confirmed by comparison to experimental NMR data. Moreover, the method also can dissect alpha-PreSMos in close vicinity to each other and indicate helix stability. Importantly, simulations with disordered regions forming helices in X-ray structures of complexes indicate that a preformed helix is frequently the binding element itself, while in other cases it may have a role in initiating the binding process. Our results indicate that RX-DMD provides a breakthrough in the structural and dynamical characterization of disordered proteins by generating the structural ensembles of IDPs even when experimental data are not available.	[Szoellosi, Daniel; Hegedus, Tamas] Hungarian Acad Sci, MTA SE Mol Biophys Res Grp, Budapest, Hungary; [Szoellosi, Daniel; Hegedus, Tamas] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Horvath, Tamas; Tompa, Peter; Kalmar, Lajos] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Han, Kyou-Hoon] Univ Sci & Technol, Dept Bioinformat, Taejon, South Korea; [Han, Kyou-Hoon] Korea Res Inst Biosci & Biotechnol, Biomed Translat Res Ctr, Div Convergent Biomed Res, Taejon, South Korea; [Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Tompa, Peter] Vrije Univ Brussel, VIB, Dept Biol Struct, Brussels, Belgium; [Hegedus, Tamas] Hungarian Acad Sci, Inst Mol Pharmacol, Res Ctr Nat Sci, Budapest, Hungary	Hungarian Academy of Sciences; Semmelweis University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of North Carolina; University of North Carolina Chapel Hill; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Hegedus, T (corresponding author), Hungarian Acad Sci, MTA SE Mol Biophys Res Grp, Budapest, Hungary.	hegedus@hegelab.org	Hegedus, Tamas/P-8625-2015; Dokholyan, Nikolay/D-8081-2018; Szöllösi, Dániel/ABH-9228-2020; Kalmar, Lajos/C-3040-2014	Hegedus, Tamas/0000-0002-5195-749X; Dokholyan, Nikolay/0000-0002-8225-4025; Szöllösi, Dániel/0000-0003-4641-3065; Kalmar, Lajos/0000-0003-3691-8350	KRCF-HAS JL grant;  [KTIA-AIK-12-2012-0025]	KRCF-HAS JL grant; 	This work was supported by grants KTIA-AIK-12-2012-0025 (Hegedus) and KRCF-HAS JL grant (Tompa and Han). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JR, 2009, J AM CHEM SOC, V131, P18314, DOI 10.1021/ja904716h; Barz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034345; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Choy WY, 2001, J MOL BIOL, V308, P1011, DOI 10.1006/jmbi.2001.4750; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Gypas F, 2013, BIOINFORMATICS, V29, P2517, DOI 10.1093/bioinformatics/btt427; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lee SH, 2012, CURR PROTEIN PEPT SC, V13, P34, DOI 10.2174/138920312799277974; Love JJ, 2004, BIOCHEMISTRY-US, V43, P8725, DOI 10.1021/bi049591m; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Meszaros B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035003; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Midic U, 2009, PROTEIN PEPTIDE LETT, V16, P1533, DOI 10.2174/092986609789839377; Ozenne V, 2012, BIOINFORMATICS, V28, P1463, DOI 10.1093/bioinformatics/bts172; R Core Team R, 2022, R LANG ENV STAT COMP; Radhakrishnan I, 1998, FEBS LETT, V430, P317, DOI 10.1016/S0014-5793(98)00680-2; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Samiotakis A, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3404401; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Wang W, 2014, CHEM BIOL DRUG DES; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200	28	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95795	10.1371/journal.pone.0095795	http://dx.doi.org/10.1371/journal.pone.0095795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763499	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000335505000035
J	Varmuzova, K; Matulova, ME; Sebkova, A; Sekelova, Z; Havlickova, H; Sisak, F; Babak, V; Rychlik, I				Varmuzova, Karolina; Matulova, Marta Elsheimer; Sebkova, Alena; Sekelova, Zuzana; Havlickova, Hana; Sisak, Frantisek; Babak, Vladimir; Rychlik, Ivan			The Early Innate Response of Chickens to Salmonella enterica Is Dependent on the Presence of O-Antigen but Not on Serovar Classification	PLOS ONE			English	Article							DYNAMICS FOLLOWING INFECTION; GENE-EXPRESSION; INTERNAL CONTROL; CELLULAR-CHANGES; IMMUNE-RESPONSE; TYPHIMURIUM; ENTERITIDIS; INFANTIS; INVASIVENESS; AVIRULENCE	Salmonella vaccines used in poultry in the EU are based on attenuated strains of either Salmonella serovar Enteritidis or Typhimurium which results in a decrease in S. Enteritidis and S. Typhimurium but may allow other Salmonella serovars to fill an empty ecological niche. In this study we were therefore interested in the early interactions of chicken immune system with S. Infantis compared to S. Enteritidis and S. Typhimurium, and a role of O-antigen in these interactions. To reach this aim, we orally infected newly hatched chickens with 7 wild type strains of Salmonella serovars Enteritidis, Typhimurium and Infantis as well as with their rfaL mutants and characterized the early Salmonella-chicken interactions. Inflammation was characterized in the cecum 4 days post-infection by measuring expression of 43 different genes. All wild type strains stimulated a greater inflammatory response than any of the rfaL mutants. However, there were large differences in chicken responses to different wild type strains not reflecting their serovar classification. The initial interaction between newly-hatched chickens and Salmonella was found to be dependent on the presence of O-antigen but not on its structure, i.e. not on serovar classification. In addition, we observed that the expression of calbindin or aquaporin 8 in the cecum did not change if inflammatory gene expression remained within a 10 fold fluctuation, indicating the buffering capacity of the cecum, preserving normal gut functions even in the presence of minor inflammatory stimuli.	[Varmuzova, Karolina; Matulova, Marta Elsheimer; Sebkova, Alena; Sekelova, Zuzana; Havlickova, Hana; Sisak, Frantisek; Babak, Vladimir; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic	Czech Veterinary Research Institute	Rychlik, I (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	, Ivan/GPS-9674-2022	, Ivan/0000-0001-7995-6483	Czech Ministry of Agriculture [MZE0002716202]; Czech Ministry of Education [CZ.1.05/2.1.00/01.0006 ED0006/01/01]; Czech Science Foundation [P502/12/0303]	Czech Ministry of Agriculture(Ministry of Agriculture, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This work has been supported by projects MZE0002716202 of the Czech Ministry of Agriculture, AdmireVet project CZ.1.05/2.1.00/01.0006 ED0006/01/01 from the Czech Ministry of Education and Czech Science Foundation project P502/12/0303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabo S, 2002, AVIAN PATHOL, V31, P41, DOI 10.1080/03079450120106615; Andrews-Polymenis HL, 2004, J BACTERIOL, V186, P2619, DOI 10.1128/JB.186.9.2619-2628.2004; Berndt A, 2007, INFECT IMMUN, V75, P5993, DOI 10.1128/IAI.00695-07; Coward C, 2013, FEMS MICROBIOL LETT, V343, P169, DOI 10.1111/1574-6968.12143; Crhanova M, 2011, VET MICROBIOL, V152, P131, DOI 10.1016/j.vetmic.2011.04.018; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; GuardPetter J, 1996, EPIDEMIOL INFECT, V117, P219, DOI 10.1017/S0950268800001394; Karasova D, 2009, VACCINE, V27, P5265, DOI 10.1016/j.vaccine.2009.06.060; Kohl KS, 2000, EPIDEMIOL INFECT, V125, P491, DOI 10.1017/S0950268800004829; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; Lahuerta A, 2011, EUROSURVEILLANCE, V16, P5; Li YP, 2005, VET MICROBIOL, V110, P155, DOI 10.1016/j.vetmic.2005.06.014; Matulova M, 2012, VACCINE, V30, P2090, DOI 10.1016/j.vaccine.2012.01.050; Matulova M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-37; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; Najjar Z, 2012, EPIDEMIOL INFECT, V140, P2264, DOI 10.1017/S0950268812000180; Setta AM, 2012, COMP IMMUNOL MICROB, V35, P397, DOI 10.1016/j.cimid.2012.03.004; Setta A, 2012, VET IMMUNOL IMMUNOP, V146, P212, DOI 10.1016/j.vetimm.2012.03.008; Spector MP, 1998, ADV MICROB PHYSIOL, V40, P233, DOI 10.1016/S0065-2911(08)60133-2; Swords WE, 1997, INFECT IMMUN, V65, P2451, DOI 10.1128/IAI.65.6.2451-2453.1997; Trebichavsky I, 1997, INFECT IMMUN, V65, P5244; WilmesRiesenberg MR, 1997, INFECT IMMUN, V65, P203, DOI 10.1128/IAI.65.1.203-210.1997; Zhang SP, 2003, INFECT IMMUN, V71, P4795, DOI 10.1128/IAI.71.8.4795-4803.2003	24	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96116	10.1371/journal.pone.0096116	http://dx.doi.org/10.1371/journal.pone.0096116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763249	gold, Green Submitted, Green Published			2022-12-25	WOS:000335505000062
J	Bochynek, T; Robson, SKA				Bochynek, Thomas; Robson, Simon K. A.			Physical and Biological Determinants of Collective Behavioural Dynamics in Complex Systems: Pulling Chain Formation in the Nest-Weaving Ant Oecophylla smaragdina	PLOS ONE			English	Article							DIVISION-OF-LABOR; DECISION-MAKING; ORGANIZATION; EVOLUTION; HYMENOPTERA; RETRIEVAL; PATTERNS; PROMOTE	The evolution of nest weaving, the inclusion of larval silk in the nest walls, is considered one of the pinnacles of cooperative behaviour in social insects. Within the four ant genera in which this has evolved, Oecophylla are unique in being the only group that precedes the deposition of larval silk by actively manipulating the leaf substrate to form a nest chamber. Here we provide the first descriptions of the manipulation process within a complex-systems framework. Substrate manipulation involves individual ants selecting, grasping and attempting to pull the edge of the substrate. These individuals are then joined by nest mates at the work site, who either select a site beside the first individual or grasp the body of the first or preceding worker to form a chain of pulling ants that together drag and bend the substrate. Site selection by individual workers is not random when confronted with an artificial leaf, with individuals more likely to grasp a substrate at its tip rather than along a more broad edge. The activity of additional individuals is also not random, with their activity being grouped in both space and time. Additional individuals are more likely to join an existing biting individual or pulling group. The positive feedback associated with the early stages of pulling behaviour appears typical for many of the collective actions observed in social insects.	[Bochynek, Thomas; Robson, Simon K. A.] James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia	James Cook University	Bochynek, T (corresponding author), Monash Univ, Fac Informat Technol, NICTA Victoria Res Lab, Melbourne, Vic 3004, Australia.	Thomas.Bochynek@monash.edu	Robson, Simon/D-1168-2011	Robson, Simon/0000-0001-8870-1933	ARC Discovery Grant [DP1093553]	ARC Discovery Grant(Australian Research Council)	This research was supported by ARC Discovery Grant DP1093553 (http://www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2002, INSECT SOC, V49, P99, DOI 10.1007/s00040-002-8286-y; Beekman M, 2001, P NATL ACAD SCI USA, V98, P9703, DOI 10.1073/pnas.161285298; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Bonabeau E, 1998, PHYS REV E, V57, P5904, DOI 10.1103/PhysRevE.57.5904; Britton NF, 2002, P ROY SOC B-BIOL SCI, V269, P1383, DOI 10.1098/rspb.2002.2001; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Crozier RH, 2010, MYRMECOL NEWS, V13, P57; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Franks NR, 2006, ANIM BEHAV, V72, P611, DOI 10.1016/j.anbehav.2005.11.019; Goldsby HJ, 2012, P NATL ACAD SCI USA, V109, P13686, DOI 10.1073/pnas.1202233109; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; HOLLDOBLER B, 1983, AM SCI, V71, P490; HOLLDOBLER BK, 1977, SCI AM, V237, P146; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Karsai I, 2000, J INSECT BEHAV, V13, P111, DOI 10.1023/A:1007771727503; Lioni A, 2004, NATURWISSENSCHAFTEN, V91, P237, DOI 10.1007/s00114-004-0519-7; Lioni A, 2001, J INSECT BEHAV, V14, P679, DOI 10.1023/A:1012283403138; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; Page RE, 2002, NATURWISSENSCHAFTEN, V89, P91, DOI 10.1007/s00114-002-0299-x; Pratt SC, 2005, INSECT SOC, V52, P383, DOI 10.1007/s00040-005-0823-z; Reid CR, 2011, J EXP BIOL, V214, P50, DOI 10.1242/jeb.048173; Robinson EJH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019981; Robson SK, 1998, J INSECT BEHAV, V11, P1, DOI 10.1023/A:1020859531179; ROBSON SK, 1995, NATURWISSENSCHAFTEN, V82, P526, DOI 10.1007/BF01134490; Robson SK, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P239; Robson SKA, 2002, NATURWISSENSCHAFTEN, V89, P128, DOI 10.1007/s00114-002-0300-8; Seeley T.D., 2010, HONEYBEE DEMOCRACY; Sudd JH, 1967, INTRO BEHAV ANTS; Sumpter DJT, 2009, CURR BIOL, V19, pR325, DOI 10.1016/j.cub.2009.02.049; Theraulaz G, 2003, PHILOS T R SOC A, V361, P1263, DOI 10.1098/rsta.2003.1198; TRANIELLO JFA, 1991, BEHAV ECOL SOCIOBIOL, V29, P283, DOI 10.1007/BF00163986	32	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95112	10.1371/journal.pone.0095112	http://dx.doi.org/10.1371/journal.pone.0095112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759886	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000335298200035
J	Cai, X; Sheng, JH; Tang, CN; Nandakumar, V; Ye, H; Ji, H; Tang, HY; Qin, Y; Guan, HW; Lou, F; Zhang, DD; Sun, H; Dong, HC; Zhang, GC; Liu, ZY; Dong, ZS; Guo, BS; Yan, H; Yan, CW; Wang, L; Su, ZY; Li, YY; Jones, L; Huang, XF; Chen, SY; Wu, TH; Lin, HL				Cai, Xin; Sheng, Jianhui; Tang, Chuanning; Nandakumar, Vijayalakshmi; Ye, Hua; Ji, Hong; Tang, Haiying; Qin, Yu; Guan, Hongwei; Lou, Feng; Zhang, Dandan; Sun, Hong; Dong, Haichao; Zhang, Guangchun; Liu, Zhiyuan; Dong, Zhishou; Guo, Baishuai; Yan, He; Yan, Chaowei; Wang, Lu; Su, Ziyi; Li, Yangyang; Jones, Lindsey; Huang, Xue F.; Chen, Si-Yi; Wu, Taihua; Lin, Hongli			Frequent Mutations in EGFR, KRAS and TP53 Genes in Human Lung Cancer Tumors Detected by Ion Torrent DNA Sequencing	PLOS ONE			English	Article							NEVER-SMOKERS; CHEMOTHERAPY; RADIATION; DATABASE; THERAPY; GENOME	Lung cancer is the most common malignancy and the leading cause of cancer deaths worldwide. While smoking is by far the leading cause of lung cancer, other environmental and genetic factors influence the development and progression of the cancer. Since unique mutations patterns have been observed in individual cancer samples, identification and characterization of the distinctive lung cancer molecular profile is essential for developing more effective, tailored therapies. Until recently, personalized DNA sequencing to identify genetic mutations in cancer was impractical and expensive. The recent technological advancements in next-generation DNA sequencing, such as the semiconductor-based Ion Torrent sequencing platform, has made DNA sequencing cost and time effective with more reliable results. Using the Ion Torrent Ampliseq Cancer Panel, we sequenced 737 loci from 45 cancer-related genes to identify genetic mutations in 76 human lung cancer samples. The sequencing analysis revealed missense mutations in KRAS, EGFR, and TP53 genes in the breast cancer samples of various histologic types. Thus, this study demonstrates the necessity of sequencing individual human cancers in order to develop personalized drugs or combination therapies to effectively target individual, breast cancer-specific mutations.	[Cai, Xin; Sheng, Jianhui; Ji, Hong; Tang, Haiying; Qin, Yu; Guan, Hongwei; Wu, Taihua; Lin, Hongli] Dalian Med Univ, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China; [Tang, Chuanning; Ye, Hua; Lou, Feng; Zhang, Dandan; Sun, Hong; Dong, Haichao; Zhang, Guangchun; Liu, Zhiyuan; Dong, Zhishou; Guo, Baishuai; Yan, He; Yan, Chaowei; Wang, Lu; Su, Ziyi; Li, Yangyang] San Valley Biotechnol Inc, Beijing, Peoples R China; [Nandakumar, Vijayalakshmi; Jones, Lindsey; Huang, Xue F.; Chen, Si-Yi] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	Dalian Medical University; University of Southern California	Chen, SY (corresponding author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	siyichen@usc.edu; wutaihua@sina.com; Linhongli@vip.163.com		Tang, Chuanning/0000-0001-5413-6470	National Natural Science Foundation of China; Wu Jieping Foundation; National Institute of Health [R01 CA90427, R01 AI084811]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wu Jieping Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the grants from National Natural Science Foundation of China, the Wu Jieping Foundation, and the National Institute of Health (R01 CA90427 & R01 AI084811 to SY Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2004, CLIN CANCER RES, V10, p4276S, DOI 10.1158/1078-0432.CCR-040010; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Chen Hong, 2008, Reviews on Environmental Health, V23, P243; Clapp Richard W., 2008, Reviews on Environmental Health, V23, P1; Dempke WCM, 2010, LUNG CANCER, V67, P257, DOI 10.1016/j.lungcan.2009.10.012; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hadd AG, 2013, J MOL DIAGN; Hannay DR, 2000, BMJ-BRIT MED J, V321, P576; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Idbaih A, 2009, NEUROPATH APPL NEURO, V35, P208, DOI 10.1111/j.1365-2990.2008.00977.x; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Lyon, 2004, WHO CLASSIFICATION T; Ninomiya T, 2013, MOL CANCER THER, V12, P589, DOI 10.1158/1535-7163.MCT-12-0885; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; ORY K, 1994, EMBO J, V13, P3496, DOI 10.1002/j.1460-2075.1994.tb06656.x; Peart MJ, 2006, CANCER CELL, V10, P173, DOI 10.1016/j.ccr.2006.08.014; Pelosi G, 2011, VIRCHOWS ARCH, V458, P497, DOI 10.1007/s00428-010-1011-8; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Pisters KMW, 2007, J CLIN ONCOL, V25, P5506, DOI 10.1200/JCO.2007.14.1226; Rosell R, 2002, LUNG CANCER, V38, P217, DOI 10.1016/S0169-5002(02)00224-6; Schmid K, 2010, DTSCH ARZTEBL INT, V107, P181, DOI 10.3238/arztebl.2010.0181; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sigal A, 2000, CANCER RES, V60, P6788; Simon GR, 2007, CHEST, V132, p324S, DOI 10.1378/chest.07-1385; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Sun YG, 2013, MOL CANCER THER, V12, P696, DOI 10.1158/1535-7163.MCT-12-0868; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; Travis WD., 2004, TRAVIS WB WHO CLASSI; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623	36	34	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95228	10.1371/journal.pone.0095228	http://dx.doi.org/10.1371/journal.pone.0095228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760004	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200041
J	Chang, YY; Huang, HL; Chen, YC; Hsu, JT; Shieh, TM; Tsai, MT				Chang, Yin-Yu; Huang, Heng-Li; Chen, Ya-Chi; Hsu, Jui-Ting; Shieh, Tzong-Ming; Tsai, Ming-Tzu			Biological Characteristics of the MG-63 Human Osteosarcoma Cells on Composite Tantalum Carbide/Amorphous Carbon Films	PLOS ONE			English	Article							DIAMOND-LIKE CARBON; OSTEOBLAST-LIKE CELLS; POROUS TANTALUM; IN-VITRO; MECHANICAL-PROPERTIES; NITRIDE FILMS; BIOCOMPATIBILITY; COATINGS; TITANIUM; DEPOSITION	Tantalum (Ta) is a promising metal for biomedical implants or implant coating for orthopedic and dental applications because of its excellent corrosion resistance, fracture toughness, and biocompatibility. This study synthesizes biocompatible tantalum carbide (TaC) and TaC/amorphous carbon (a-C) coatings with different carbon contents by using a twin-gun magnetron sputtering system to improve their biological properties and explore potential surgical implant or device applications. The carbon content in the deposited coatings was regulated by controlling the magnetron power ratio of the pure graphite and Ta cathodes. The deposited TaC and TaC/a-C coatings exhibited better cell viability of human osteosarcoma cell line MG-63 than the uncoated Ti and Ta-coated samples. Inverted optical and confocal imaging was used to demonstrate the cell adhesion, distribution, and proliferation of each sample at different time points during the whole culture period. The results show that the TaC/a-C coating, which contained two metastable phases (TaC and a-C), was more biocompatible with MG-63 cells compared to the pure Ta coating. This suggests that the TaC/a-C coatings exhibit a better biocompatible performance for MG-63 cells, and they may improve implant osseointegration in clinics.	[Chang, Yin-Yu] Natl Formosa Univ, Dept Mech & Comp Aided Engn, Yunlin, Taiwan; [Huang, Heng-Li; Hsu, Jui-Ting] China Med Univ, Sch Dent, Taichung, Taiwan; [Chen, Ya-Chi] Mingdao Univ, Dept Mat Sci & Engn, Changhua, Taiwan; [Shieh, Tzong-Ming] China Med Univ, Dept Dent Hyg, Taichung, Taiwan; [Tsai, Ming-Tzu] Hungkuang Univ, Dept Biomed Engn, Taichung, Taiwan	National Formosa University; China Medical University Taiwan; Mingdao University; China Medical University Taiwan; Hungkuang University	Tsai, MT (corresponding author), Hungkuang Univ, Dept Biomed Engn, Taichung, Taiwan.	anniemtt@sunrise.hk.edu.tw	Tsai, Ming-Tzu/GSM-9284-2022; Hsu, Jui-Ting/I-8224-2012		National Science Council of Taiwan [NSC 102-2221-E-150-006, NSC 101-2314-B-039-022-MY3]; Taichung Veterans General Hospital/Hungkuang University Joint Research Program [TCVGH-HK1008008, TCVGH-HK1028002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital/Hungkuang University Joint Research Program	This work was partially funded by the National Science Council of Taiwan (Grant No. NSC 102-2221-E-150-006 and NSC 101-2314-B-039-022-MY3), and Taichung Veterans General Hospital/Hungkuang University Joint Research Program (TCVGH-HK1008008 and TCVGH-HK1028002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F; Amon M, 1996, J MATER SCI-MATER M, V7, P273, DOI 10.1007/BF00058566; Balagna C., 2012, MAT SCI ENG C; Balla VK, 2010, JOM-US, V62, P61, DOI 10.1007/s11837-010-0110-y; Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046; Balla VK, 2010, ACTA BIOMATER, V6, P2329, DOI 10.1016/j.actbio.2009.11.021; Banakh O, 2006, THIN SOLID FILMS, V513, P136, DOI 10.1016/j.tsf.2006.01.060; Bharathy PV, 2010, THIN SOLID FILMS, V519, P1623; Blanco JF, 2011, EUR SPINE J, V20, P353, DOI 10.1007/s00586-011-1901-8; Chen JS, 2001, THIN SOLID FILMS, V398, P110, DOI 10.1016/S0040-6090(01)01455-9; Cheng HC, 2009, J ALLOY COMPD, V477, P931, DOI 10.1016/j.jallcom.2008.11.043; Ciapetti G, 2002, BIOMATERIALS, V23, P617, DOI 10.1016/S0142-9612(01)00149-1; Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4; Fukunaga A, 1998, J MATER RES, V13, P2465, DOI 10.1557/JMR.1998.0345; Gutensohn K, 2000, INFUS THER TRANSFUS, V27, P200; Kiuru M, 2003, J BIOMED MATER RES B, V66B, P425, DOI 10.1002/jbm.b.10029; Kobayashi S, 2005, KEY ENG MAT, V284-286, P783, DOI 10.4028/www.scientific.net/KEM.284-286.783; Leng YX, 2006, NUCL INSTRUM METH B, V242, P30, DOI 10.1016/j.nimb.2005.08.002; Leng YX, 2001, THIN SOLID FILMS, V398, P471, DOI 10.1016/S0040-6090(01)01448-1; Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041; Lin J, 2008, THIN SOLID FILMS, V517, P1131, DOI 10.1016/j.tsf.2008.07.021; Lopez-Santos C, 2013, J BIOMATER APPL, V27, P669, DOI 10.1177/0885328211422832; Moulder J. F., 1995, HDB XRAY PHOTOELECTR; Pei YT, 2005, ACTA MATER, V53, P4505, DOI 10.1016/j.actamat.2005.05.045; Randeniya LK, 2010, DIAM RELAT MATER, V19, P329, DOI 10.1016/j.diamond.2010.01.003; Sagomonyants KB, 2011, J ORTHOP RES, V29, P609, DOI 10.1002/jor.21251; Schulz H, 2005, SURF COAT TECH, V200, P1123, DOI 10.1016/j.surfcoat.2005.02.019; Sollazzo V, 2011, INT J PERIODONT REST, V31, pE17; Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602; Stueber M, 2005, THIN SOLID FILMS, V493, P104, DOI 10.1016/j.tsf.2005.07.290; Teghil R, 2001, APPL SURF SCI, V173, P233, DOI 10.1016/S0169-4332(00)00900-4; Wang N, 2012, ACS APPL MATER INTER, V4, P4516, DOI 10.1021/am300727v; Watson PS, 1998, CATHETER CARDIO DIAG, V43, P168; Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336; Wilks JA, 2007, APPL SURF SCI, V253, P6176, DOI 10.1016/j.apsusc.2007.01.020; Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5	36	24	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95590	10.1371/journal.pone.0095590	http://dx.doi.org/10.1371/journal.pone.0095590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760085	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200066
J	Choudhary, A; He, KHH; Mertins, P; Udeshi, ND; Dancik, V; Fomina-Yadlin, D; Kubicek, S; Clemons, PA; Schreiber, SL; Carr, SA; Wagner, BK				Choudhary, Amit; He, Kaihui Hu; Mertins, Philipp; Udeshi, Namrata D.; Dancik, Vlado; Fomina-Yadlin, Dina; Kubicek, Stefan; Clemons, Paul A.; Schreiber, Stuart L.; Carr, Steven A.; Wagner, Bridget K.			Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; P38 MAP KINASE; INSULIN-SECRETION; ISLET TRANSPLANTATION; TRANSCRIPTION FACTOR; NEUROPEPTIDE-Y; SAD KINASES; GLUCOSE; LKB1; PHOSPHORYLATION	Type-1 diabetes (T1D) is an autoimmune disease in which insulin-secreting pancreatic beta cells are destroyed by the immune system. An emerging strategy to regenerate beta-cell mass is through transdifferentiation of pancreatic alpha cells to beta cells. We previously reported two small molecules, BRD7389 and GW8510, that induce insulin expression in a mouse alpha cell line and provide a glimpse into potential intermediate cell states in beta-cell reprogramming from alpha cells. These small-molecule studies suggested that inhibition of kinases in particular may induce the expression of several beta-cell markers in alpha cells. To identify potential lineage reprogramming protein targets, we compared the transcriptome, proteome, and phosphoproteome of alpha cells, beta cells, and compound-treated alpha cells. Our phosphoproteomic analysis indicated that two kinases, BRSK1 and CAMKK2, exhibit decreased phosphorylation in beta cells compared to alpha cells, and in compound-treated alpha cells compared to DMSO-treated alpha cells. Knock-down of these kinases in alpha cells resulted in expression of key beta-cell markers. These results provide evidence that perturbation of the kinome may be important for lineage reprogramming of alpha cells to beta cells.	[Choudhary, Amit] Harvard Univ, Soc Fellows, Cambridge, MA 02138 USA; [Choudhary, Amit; He, Kaihui Hu; Mertins, Philipp; Udeshi, Namrata D.; Dancik, Vlado; Fomina-Yadlin, Dina; Kubicek, Stefan; Clemons, Paul A.; Schreiber, Stuart L.; Carr, Steven A.; Wagner, Bridget K.] Broad Inst, Ctr Sci Therapeut, Cambridge, MA 02142 USA; [Fomina-Yadlin, Dina] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Schreiber, Stuart L.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Howard Hughes Medical Institute	Wagner, BK (corresponding author), Broad Inst, Ctr Sci Therapeut, Cambridge, MA 02142 USA.	bwagner@broadinstitute.org	Carr, Steven A./AAH-8366-2019; Kubicek, Stefan/C-2089-2017	Kubicek, Stefan/0000-0003-0855-8343	JDRF [17-2008-1030, 17-2011-260]; Harvard Society of Fellows	JDRF(Juvenile Diabetes Research Foundation); Harvard Society of Fellows	This work was supported by JDRF 17-2008-1030 and 17-2011-260 (BKW, SLS) and Harvard Society of Fellows (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bora RS, 2012, MOL MED REP, V6, P9, DOI 10.3892/mmr.2012.871; Borowiak M, 2009, CURR OPIN CELL BIOL, V21, P727, DOI 10.1016/j.ceb.2009.08.006; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bright NJ, 2008, J BIOL CHEM, V283, P14946, DOI 10.1074/jbc.M710381200; Cao WG, 2011, RNA BIOL, V8, P1061, DOI 10.4161/rna.8.6.16691; Cary RL, 2013, J BONE MINER RES, V28, P1599, DOI 10.1002/jbmr.1890; Chatenoud L, 2008, NEW ENGL J MED, V358, P1192, DOI 10.1056/NEJMcibr0708067; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dalgin G, 2011, DEVELOPMENT, V138, P4597, DOI 10.1242/dev.067736; de Kort H, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d217; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Fomina-Yadlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028808; Fomina-Yadlin D, 2010, P NATL ACAD SCI USA, V107, P15099, DOI 10.1073/pnas.1010018107; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Guo SL, 2010, J BIOL CHEM, V285, P12655, DOI 10.1074/jbc.M110.105759; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; HIRSCH IB, 1990, DIABETES CARE, V13, P1265, DOI 10.2337/diacare.13.12.1265; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kubicek S, 2012, P NATL ACAD SCI USA, V109, P5364, DOI 10.1073/pnas.1201079109; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mertins P, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014423; MOLTZ JH, 1985, PEPTIDES, V6, P1155, DOI 10.1016/0196-9781(85)90443-7; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ong Shao-En, 2007, Methods Mol Biol, V359, P37; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Rajab A, 2010, CURR DIABETES REP, V10, P332, DOI 10.1007/s11892-010-0130-6; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sii-Felice K, 2005, FEBS LETT, V579, P3547, DOI 10.1016/j.febslet.2005.04.086; SKOGLUND G, 1993, EUR J PHARMACOL, V236, P69, DOI 10.1016/0014-2999(93)90228-A; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Strowski MZ, 2000, ENDOCRINOLOGY, V141, P111, DOI 10.1210/en.141.1.111; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wagner BK, 2010, NAT CHEM BIOL, V6, P877, DOI 10.1038/nchembio.472; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yechoor V, 2010, MOL ENDOCRINOL, V24, P1501, DOI 10.1210/me.2009-0311; Zhou G, 2013, CURR MOL MED, V13, P377	51	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95194	10.1371/journal.pone.0095194	http://dx.doi.org/10.1371/journal.pone.0095194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759943	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000335298200038
J	Macaulay, EC; Roberts, HE; Cheng, X; Jeffs, AR; Baguley, BC; Morison, IM				Macaulay, Erin C.; Roberts, Hester E.; Cheng, Xi; Jeffs, Aaron R.; Baguley, Bruce C.; Morison, Ian M.			Retrotransposon Hypomethylation in Melanoma and Expression of a Placenta-Specific Gene	PLOS ONE			English	Article							GO POTASSIUM CHANNELS; CANCER/TESTIS ANTIGENS; DNA HYPOMETHYLATION; GENOME BROWSER; ION CHANNELS; CELL-LINES; METHYLATION; CANCER; FAMILY; ETHER	In the human placenta, DNA hypomethylation permits the expression of retrotransposon-derived genes that are normally silenced by methylation in somatic tissues. We previously identified hypomethylation of a retrotransposon-derived transcript of the voltage-gated potassium channel gene KCNH5 that is expressed only in human placenta. However, an RNA sequence from this placental-specific transcript has been reported in melanoma. This study examined the promoter methylation and expression of the retrotransposon-derived KCNH5 transcript in 25 melanoma cell lines to determine whether the acquisition of 'placental' epigenetic marks is a feature of melanoma. Methylation and gene expression analysis revealed hypomethylation of this retrotransposon in melanoma cell lines, particularly in those samples that express the placental KCNH5 transcript. Therefore we propose that hypomethylation of the placental-specific KCNH5 promoter is frequently associated with KCNH5 expression in melanoma cells. Our findings show that melanoma can develop hypomethylation of a retrotransposon-derived gene; a characteristic notably shared with the normal placenta.	[Macaulay, Erin C.; Roberts, Hester E.; Cheng, Xi; Jeffs, Aaron R.; Morison, Ian M.] Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand; [Macaulay, Erin C.; Roberts, Hester E.; Morison, Ian M.] Gravida Natl Ctr Growth & Dev, Auckland, New Zealand; [Baguley, Bruce C.] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand	University of Otago; University of Auckland	Macaulay, EC (corresponding author), Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand.	erin.macaulay@otago.ac.nz	Morison, Ian M/A-1236-2008; Macaulay, Erin/G-3577-2013	Morison, Ian M/0000-0003-3616-0025; Macaulay, Erin/0000-0001-5308-1033	University of Otago and Gravida; National Centre for Growth and Development (New Zealand)	University of Otago and Gravida; National Centre for Growth and Development (New Zealand)	This work was funded by the University of Otago and Gravida: National Centre for Growth and Development (New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rodriguez-Rasgado JA, 2012, SENSORS-BASEL, V12, P5986, DOI 10.3390/s120505986; Baguley BC, 2004, EUR J CANCER, V40, P794, DOI 10.1016/j.ejca.2003.12.019; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bieche I, 2003, BIOL REPROD, V68, P1422, DOI 10.1095/biolreprod.102.010322; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Camacho J, 2006, CANCER LETT, V233, P1, DOI 10.1016/j.canlet.2005.02.016; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Farias LMB, 2004, CANCER RES, V64, P6996, DOI 10.1158/0008-5472.CAN-04-1204; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fisher S J, 1993, Semin Cell Biol, V4, P183, DOI 10.1006/scel.1993.1022; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P3087, DOI 10.1093/nar/11.10.3087; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HELLMANNBLUMBERG U, 1993, MOL CELL BIOL, V13, P4523, DOI 10.1128/MCB.13.8.4523; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Hoshimoto S, 2012, J INVEST DERMATOL, V132, P1689, DOI 10.1038/jid.2012.36; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; KATO N, 1987, J VIROL, V61, P2182, DOI 10.1128/JVI.61.7.2182-2191.1987; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HS, 2006, GENE, V370, P34, DOI 10.1016/j.gene.2005.11.008; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Ludwig J, 2000, MOL CELL NEUROSCI, V16, P59, DOI 10.1006/mcne.2000.0851; Macaulay EC, 2011, MAMM GENOME, V22, P722, DOI 10.1007/s00335-011-9355-1; MARSHALL ES, 1994, EUR J CANCER, V30A, P1370, DOI 10.1016/0959-8049(94)90188-0; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Okahara G, 2004, GENOMICS, V84, P982, DOI 10.1016/j.ygeno.2004.09.004; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Reiss D, 2007, NUCLEIC ACIDS RES, V35, P4743, DOI 10.1093/nar/gkm455; Ross JP, 2010, EPIGENOMICS-UK, V2, P245, DOI 10.2217/EPI.10.2; Schinke C, 2010, MELANOMA RES, V20, P253, DOI 10.1097/CMR.0b013e328338a35a; Shen HM, 2006, J HUM GENET, V51, P440, DOI 10.1007/s10038-006-0382-9; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stones Clare J., 2013, Frontiers in Genetics, V4, P66, DOI 10.3389/fgene.2013.00066; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Szpakowski S, 2009, GENE, V448, P151, DOI 10.1016/j.gene.2009.08.006; Wadhwa S, 2009, INT UROL NEPHROL, V41, P251, DOI 10.1007/s11255-008-9459-z; WILKINSON DA, 1993, J VIROL, V67, P2981, DOI 10.1128/JVI.67.6.2981-2989.1993; Zendman AJW, 2001, MELANOMA RES, V11, P451, DOI 10.1097/00008390-200110000-00003	45	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95840	10.1371/journal.pone.0095840	http://dx.doi.org/10.1371/journal.pone.0095840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759919	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200097
J	Mayoral, JG; Etebari, K; Hussain, M; Khromykh, AA; Asgari, S				Mayoral, Jaime G.; Etebari, Kayvan; Hussain, Mazhar; Khromykh, Alexander A.; Asgari, Sassan			Wolbachia Infection Modifies the Profile, Shuttling and Structure of MicroRNAs in a Mosquito Cell Line	PLOS ONE			English	Article							EXPRESSION ANALYSIS; GENE-EXPRESSION; AEDES-AEGYPTI; SMALL RNAS; IDENTIFICATION; RECOGNITION; MIRANALYZER; SEQUENCE; PATHWAY; TARGETS	MicroRNAs (miRNAs) are small non-coding RNAs that play important roles in many biological processes such as development, cell signaling and immune response. Small RNA deep sequencing technology provided an opportunity for a thorough survey of the miRNA profile of a mosquito cell line from Aedes aegypti. We characterized the miRNA composition of the nucleus and the cytoplasm of uninfected cells and compared it with the one of cells infected with the endosymbiotic bacterium Wolbachia strain wMelPop-CLA. We found an overall increase of small RNAs between 18 and 28 nucleotides in both cellular compartments in Wolbachia-infected cells and identified specific miRNAs induced and/or suppressed by the Wolbachia infection. We discuss the mechanisms that the cell may use to shuttle miRNAs between the cytoplasm and the nucleus. In addition, we identified piRNAs that changed their abundance in response to Wolbachia infection. The miRNAs and piRNAs identified in this study provide promising leads for investigations into the host-endosymbiont interactions and for better understanding of how Wolbachia manipulates the host miRNA machinery in order to facilitate its persistent replication in infected cells.	[Mayoral, Jaime G.; Etebari, Kayvan; Hussain, Mazhar; Asgari, Sassan] Univ Queensland, Sch Biol Sci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Khromykh, Alexander A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Asgari, S (corresponding author), Univ Queensland, Sch Biol Sci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	s.asgari@uq.edu.au	Khromykh, Alexander/X-7200-2018; Etebari, Kayvan/C-6436-2008; Asgari, Sassan/G-2678-2011; G. Mayoral, Jaime/J-5392-2018	Khromykh, Alexander/0000-0001-6206-6935; Etebari, Kayvan/0000-0001-5213-6362; Asgari, Sassan/0000-0001-7885-6544; G. Mayoral, Jaime/0000-0002-8813-6804	National Health and Medical Research Council [APP1062983]; Australian Research Council [DE120101512]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council (http://www.nhmrc.gov.au/) project grant APP1062983 (to S. A. and A. A. K.) and the Australian Research Council (www.arc.gov.au) Discovery Early Career Researcher Award fellowship DE120101512 (to M. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Asgari S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00048; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Cheng XH, 2013, J GEN VIROL, V94, P177, DOI 10.1099/vir.0.045591-0; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Daneshvar K, 2013, BIOL OPEN, V2, P1, DOI 10.1242/bio.20122725; Dedeine F, 2005, HEREDITY, V95, P394, DOI 10.1038/sj.hdy.6800739; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Etebari K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084747; Etebari K, 2013, INSECT BIOCHEM MOLEC, V43, P309, DOI 10.1016/j.ibmb.2013.01.004; Eun SH, 2013, DEVELOPMENT, V140, P23, DOI 10.1242/dev.086397; Gao L, 2013, DEV BIOL, V377, P166, DOI 10.1016/j.ydbio.2013.02.002; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45; Hussain M, 2013, RNA BIOL, V10, P1868, DOI 10.4161/rna.27392; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jeffries CD, 2011, RNA, V17, P675, DOI 10.1261/rna.2006511; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Li P, 2011, MOL BIOL REP, V38, P355, DOI 10.1007/s11033-010-0115-1; Li S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-581; Liu F, 2012, INSECT MOL BIOL, V21, P297, DOI 10.1111/j.1365-2583.2012.01135.x; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Mehrabadi M, 2013, J GEN VIROL, V94, P1385, DOI 10.1099/vir.0.051060-0; Mehta JP, 2007, ANTICANCER RES, V27, P1295; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Osei-Amo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050049; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Sparks ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061190; Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861; Wang GH, 2013, INSECT SCI, V20, P78, DOI 10.1111/j.1744-7917.2012.01555.x; Weng RF, 2013, ELIFE, V2, DOI 10.7554/eLife.00640; Westholm JO, 2012, RNA, V18, P177, DOI 10.1261/rna.030627.111; Winter F, 2007, NUCLEIC ACIDS RES, V35, P6953, DOI 10.1093/nar/gkm686; Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	56	46	49	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96107	10.1371/journal.pone.0096107	http://dx.doi.org/10.1371/journal.pone.0096107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759922	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200135
J	Price, MHH; Connors, BM				Price, Michael H. H.; Connors, Brendan M.			Evaluating Relationships between Wild Skeena River Sockeye Salmon Productivity and the Abundance of Spawning Channel Enhanced Sockeye Smolts	PLOS ONE			English	Article							PACIFIC SALMON; SURVIVAL RATES; ONCORHYNCHUS-KISUTCH; OCEAN CONDITIONS; MARINE SURVIVAL; POPULATIONS; GROWTH; BIODIVERSITY; COMPETITION; HATCHERIES	The enhancement of salmon populations has long been used to increase the abundance of salmon returning to spawn and/or to be captured in fisheries. However, in some instances enhancement can have adverse impacts on adjacent nonenhanced populations. In Canada's Skeena watershed, smolt-to-adult survival of Babine Lake sockeye from 1962-2002 was inversely related to the abundance of sockeye smolts leaving Babine Lake. This relationship has led to the concern that Babine Lake smolt production, which is primarily enhanced by spawning channels, may depress wild Skeena (Babine and non-Babine) sockeye populations as a result of increased competition between wild and enhanced sockeye smolts as they leave their natal lakes and co-migrate to sea. To test this hypothesis we used data on Skeena sockeye populations and oceanographic conditions to statistically examine the relationship between Skeena sockeye productivity (adult salmon produced per spawner) and an index of Babine Lake enhanced smolt abundance while accounting for the potential influence of early marine conditions. While we had relatively high power to detect large effects, we did not find support for the hypothesis that the productivity of wild Skeena sockeye is inversely related to the abundance of enhanced sockeye smolts leaving Babine Lake in a given year. Importantly, life-time productivity of Skeena sockeye is only partially explained by marine survival, and likely is an unreliable measure of the influence of smolt abundance. Limitations to our analyses, which include: (1) the reliance upon adult salmon produced per spawner (rather than per smolt) as an index of marine survival, and (2) incomplete age structure for most of the populations considered, highlight uncertainties that should be addressed if understanding relationships between wild and enhanced sockeye is a priority in the Skeena.	[Price, Michael H. H.] SkeenaWild Conservat Trust, Terrace, BC, Canada; [Connors, Brendan M.] ESSA Technol Ltd, Vancouver, BC, Canada; [Connors, Brendan M.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Price, MHH (corresponding author), SkeenaWild Conservat Trust, Terrace, BC, Canada.	pricem@skeenawild.org			Gordon and betty Moore Foundation	Gordon and betty Moore Foundation(Gordon and Betty Moore Foundation)	Gordon and betty Moore Foundation (http://www.moore.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JH, 2013, EVOL APPL, V6, P165, DOI 10.1111/j.1752-4571.2012.00271.x; [Anonymous], 2012, LANG ENV STAT COMP; [Anonymous], 2006, MIXED EFFECTS MODELS; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Beamish RJ, 2004, T AM FISH SOC, V133, P26, DOI 10.1577/T03-028; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brannon EL, 2004, FISHERIES, V29, P12, DOI 10.1577/1548-8446(2004)29[12:TCASH]2.0.CO;2; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chilcote MW, 2011, CAN J FISH AQUAT SCI, V68, P511, DOI 10.1139/F10-168; Connors BM, 2012, CONSERV LETT, V5, P304, DOI 10.1111/j.1755-263X.2012.00244.x; Connors BM, 2010, J APPL ECOL, V47, P1372, DOI 10.1111/j.1365-2664.2010.01889.x; Cox-Rogers S, 2012, CAN TECH REP FISH AQ, P2956; English K.K., 2012, REV N CENTRAL COAST; English KK., 2012, DATASETS EXTENDED TI; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; Gottesfeld A., 2008, SKEENA RIVER FISH TH; HILBORN R, 1992, FISHERIES, V17, P5, DOI 10.1577/1548-8446(1992)017<0005:HATFOS>2.0.CO;2; HINDAR K, 1991, CAN J FISH AQUAT SCI, V48, P945, DOI 10.1139/f91-111; HOLTBY LB, 1990, CAN J FISH AQUAT SCI, V47, P2181, DOI 10.1139/f90-243; Kostow K, 2009, REV FISH BIOL FISHER, V19, P9, DOI 10.1007/s11160-008-9087-9; Mueter FJ, 2005, T AM FISH SOC, V134, P105, DOI 10.1577/T-04-033.1; Mueter FJ, 2002, CAN J FISH AQUAT SCI, V59, P456, DOI 10.1139/f02-020; Mueter FJ, 2002, FISH OCEANOGR, V11, P205, DOI 10.1046/j.1365-2419.2002.00192.x; Myers RA, 2004, SCIENCE, V303, P1980, DOI 10.1126/science.1095410; Myers RA, 1998, FISH RES, V37, P51; Nickelson T, 2003, CAN J FISH AQUAT SCI, V60, P1050, DOI 10.1139/F03-091; PETERMAN RM, 1983, CAN J FISH AQUAT SCI, V40, P1212, DOI 10.1139/f83-138; PETERMAN RM, 1982, CAN J FISH AQUAT SCI, V39, P904, DOI 10.1139/f82-121; PETERMAN RM, 1984, CAN J FISH AQUAT SCI, V41, P1825, DOI 10.1139/f84-223; PETERMAN RM, 1990, CAN J FISH AQUAT SCI, V47, P2, DOI 10.1139/f90-001; Rand PS, 2012, ENVIRON BIOL FISH, V94, P1, DOI 10.1007/s10641-012-9987-3; RICKER W E, 1975, P382; Ruggerone GT, 2012, ENVIRON BIOL FISH, V94, P149, DOI 10.1007/s10641-011-9856-5; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Tavel Certification, 2010, BRIT COL COMM SOCK S, V1; Traxler GS, 1998, J AQUAT ANIM HEALTH, V10, P143, DOI 10.1577/1548-8667(1998)010&lt;0143:IMIEIS&gt;2.0.CO;2; Walters C.J., 2008, REPORT SKEENA INDEPE; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Wood CC, 1998, CAN TECH REP FISH AQ, P2241; Wood CC, 2008, AM FISH S S, V49, P349; Zabel RW, 2002, OECOLOGIA, V133, P349, DOI 10.1007/s00442-002-1051-0	43	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95718	10.1371/journal.pone.0095718	http://dx.doi.org/10.1371/journal.pone.0095718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760007	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200081
J	Wei, XW; Zhang, EK; Wang, C; Gu, DY; Shen, LL; Wang, ML; Xu, Z; Gong, WD; Tang, CJ; Gao, JL; Chen, JF; Zhang, ZD				Wei, Xiaowei; Zhang, Enke; Wang, Chun; Gu, Dongying; Shen, Lili; Wang, Meilin; Xu, Zhi; Gong, Weida; Tang, Cuiju; Gao, Jinglong; Chen, Jinfei; Zhang, Zhengdong			A MAP3k1 SNP Predicts Survival of Gastric Cancer in a Chinese Population	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; PROGESTERONE-RECEPTORS; SEX-HORMONES; EXPRESSION; SUSCEPTIBILITY; CARCINOMA; GROWTH; RISK; BETA	Objectives: Genome-wide association studies (GWAS) have demonstrated that the single nucleotide polymorphism (SNP) MAP3K1 rs889312 is a genetic susceptibility marker significantly associated with a risk of hormone-related tumors such as breast cancer. Considering steroid hormone-mediated signaling pathways have an important role in the progression of gastric cancer, we hypothesized that MAP3K1 rs889312 may be associated with survival outcomes in gastric cancer. The purpose of this study was to test this hypothesis. Methods: We genotyped MAP3K1 rs889312 using TaqMan in 884 gastric cancer patients who received subtotal or total gastrectomy. Kaplan-Meier survival analysis and Cox proportional hazard regression were used to analyze the association between MAP3K1 rs889312 genotypes and survival outcomes of gastric cancer. Results: Our findings reveal that the rs889312 heterozygous AC genotype was significantly associated with an increased rate of mortality among patients with diffuse-type gastric cancer (log-rank P = 0.028 for AC versus AA/CC, hazard ratio [HR] = 1.32, 95% confidence interval [CI] = 1.03-1.69), compared to those carrying the homozygous variant genotypes (AA/CC). Additionally, univariate and multivariate Cox regression analysis demonstrate that rs889312 polymorphism was an independent risk factor for poor survival in these patients. Conclusions: In conclusion, we demonstrate that MAP3K1 rs889312 is closely correlated with outcome among diffuse-type gastric cancer. This raises the possibility for rs889312 polymorphisms to be used as an independent indicator for predicting the prognosis of diffuse-type gastric cancer within the Chinese population.	[Wei, Xiaowei; Wang, Chun; Gu, Dongying; Shen, Lili; Xu, Zhi; Tang, Cuiju; Chen, Jinfei] Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Dept Environm Genom, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Dept Genet Toxicol,Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Zhang, Enke] Shanxi Peoples Hosp, Cent Lab, Xian, Shanxi Province, Peoples R China; [Gong, Weida] Yixing Tumor Hosp, Dept Gen Surg, Yixing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Shanxi People's Hospital	Chen, JF (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	jinfeichen2013@163.com; drzdzhang@gmail.com	zhang, zheng/HCH-9684-2022					Amedei A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/437348; Camargo MC, 2012, CANCER EPIDEM BIOMAR, V21, P20, DOI 10.1158/1055-9965.EPI-11-0834; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; Chandanos E, 2008, GASTRIC CANCER, V11, P168, DOI 10.1007/s10120-008-0475-6; de Bruin MA, 2012, FAM CANCER, V11, P429, DOI 10.1007/s10689-012-9531-9; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; FURUKAWA H, 1994, J SURG ONCOL, V55, P3, DOI 10.1002/jso.2930550103; Garcia-Closas M, 2008, CLIN CANCER RES, V14, P8000, DOI 10.1158/1078-0432.CCR-08-0975; HARRISON JD, 1989, CANCER, V63, P2148, DOI 10.1002/1097-0142(19890601)63:11<2148::AID-CNCR2820631113>3.0.CO;2-C; Jara L, 2013, BREAST CANCER RES TR, V137, P559, DOI 10.1007/s10549-012-2359-z; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kameda C, 2010, BRIT J CANCER, V102, P738, DOI 10.1038/sj.bjc.6605517; Karat D, 1999, BRIT J CANCER, V80, P1271, DOI 10.1038/sj.bjc.6690497; Klinge CM, 2005, J BIOL CHEM, V280, P7460, DOI 10.1074/jbc.M411565200; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Li YF, 2011, CLIN CANCER RES, V17, P3830, DOI 10.1158/1078-0432.CCR-10-2877; Lu PH, 2011, BREAST CANCER RES TR, V126, P663, DOI 10.1007/s10549-010-1151-1; Martinez-Ramos D, 2011, REV ESP ENFERM DIG, V103, P133, DOI 10.4321/s1130-01082011000300005; MATSUI M, 1992, SURG TODAY, V22, P421, DOI 10.1007/BF00308791; Ming Si-Chun, 1998, Gastric Cancer, V1, P31, DOI 10.1007/s101200050053; Rebbeck TR, 2009, CARCINOGENESIS, V30, P269, DOI 10.1093/carcin/bgn247; Roukos DH, 2007, CANCER BIOL THER, V6, P308, DOI 10.4161/cbt.6.3.3994; Takano N, 2002, CANCER LETT, V176, P129, DOI 10.1016/S0304-3835(01)00739-X; TOKUNAGA A, 1986, CANCER, V57, P1376, DOI 10.1002/1097-0142(19860401)57:7<1376::AID-CNCR2820570722>3.0.CO;2-Z; Vasselli JR, 2003, P NATL ACAD SCI USA, V100, P6958, DOI 10.1073/pnas.1131754100; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; Witowsky JA, 2003, J BIOL CHEM, V278, P1403, DOI 10.1074/jbc.C200616200; Xu SC, 1997, J BIOL CHEM, V272, P32056, DOI 10.1074/jbc.272.51.32056; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141; Zhao XH, 2003, WORLD J GASTROENTERO, V9, P665, DOI 10.3748/wjg.v9.i4.665	30	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96083	10.1371/journal.pone.0096083	http://dx.doi.org/10.1371/journal.pone.0096083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759887	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200133
J	Nelson, DW; Gao, Y; Yen, MI; Yen, CLE				Nelson, David W.; Gao, Yu; Yen, Mei-I; Yen, Chi-Liang Eric			Intestine-specific Deletion of Acyl-CoA: Monoacylglycerol Acyltransferase (MGAT) 2 Protects Mice from Diet-induced Obesity and Glucose Intolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE; ENERGY-BALANCE; FATTY-ACIDS; 1 DGAT1; METABOLISM; SECRETION; TRIGLYCERIDE; DEFICIENCY; ABSORPTION; MECHANISMS	The absorption of dietary fat involves the re-esterification of digested triacylglycerol in the enterocytes, a process catalyzed by acyl-CoA: monoacylglycerol acyltransferase (MGAT) 2. Mice without a functional gene encoding MGAT2 (Mogat2(-/-)) are protected from diet-induced obesity. Surprisingly, these mice absorb normal amounts of dietary fat but increase their energy expenditure. MGAT2 is expressed in tissues besides intestine, including adipose tissue in both mice and humans. To test the hypothesis that intestinal MGAT2 regulates systemic energy balance, we generated and characterized mice deficient in MGAT2 specifically in the small intestine (Mogat2(IKO)). We found that, like Mogat2(-/-) mice, Mogat2(IKO) mice also showed a delay in fat absorption, a decrease in food intake, and a propensity to use fatty acids as fuel when first exposed to a high fat diet. Mogat2(IKO) mice increased energy expenditure although to a lesser degree than Mogat2(-/-) mice and were protected against diet-induced weight gain and associated comorbidities, including hepatic steatosis, hypercholesterolemia, and glucose intolerance. These findings illustrate that intestinal lipid metabolism plays a crucial role in the regulation of systemic energy balance and may be a feasible intervention target. In addition, they suggest that MGAT activity in extraintestinal tissues may also modulate energy metabolism.	[Nelson, David W.; Gao, Yu; Yen, Mei-I; Yen, Chi-Liang Eric] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Yen, CLE (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	yen@nutrisci.wisc.edu	Gao, Yu/AAU-9530-2021	Gao, Yu/0000-0002-4210-7338	National Institutes of Health [R01DK088210, T32DK007665]; United States Department of Agriculture [WIS01442]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088210, T32DK007665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK088210 (to E. Y.) and T32DK007665 (to D. N.). This work was also supported by United States Department of Agriculture Grant WIS01442.	Ables GP, 2012, J LIPID RES, V53, P2364, DOI 10.1194/jlr.M029041; Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chambers AP, 2013, CURR BIOL, V23, pR379, DOI 10.1016/j.cub.2013.03.020; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Cheng D, 2008, J BIOL CHEM, V283, P29802, DOI 10.1074/jbc.M800494200; Chon SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043962; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Denison H, 2014, DIABETES OBES METAB, V16, P334, DOI 10.1111/dom.12221; Doi R, 2010, J BIOL CHEM, V285, P22114, DOI 10.1074/jbc.M110.110361; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao Y, 2013, J LIPID RES, V54, P1644, DOI 10.1194/jlr.M035493; Haas JT, 2012, J CLIN INVEST, V122, P4680, DOI 10.1172/JCI64873; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hiramine Y, 2010, J LIPID RES, V51, P1424, DOI 10.1194/jlr.M002584; KAYDEN HJ, 1967, J CLIN INVEST, V46, P1695, DOI 10.1172/JCI105660; Kindel T, 2010, ATHEROSCLEROSIS SUPP, V11, P11, DOI 10.1016/j.atherosclerosissup.2010.03.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansbach CM, 2010, ANNU REV PHYSIOL, V72, P315, DOI 10.1146/annurev-physiol-021909-135801; Mansbach CM, 2007, AM J PHYSIOL-GASTR L, V293, pG645, DOI 10.1152/ajpgi.00299.2007; Mitra MS, 2013, P NATL ACAD SCI USA, V110, P642, DOI 10.1073/pnas.1213493110; Nelson DW, 2011, J LIPID RES, V52, P1723, DOI 10.1194/jlr.M016840; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Quarta C, 2011, TRENDS MOL MED, V17, P518, DOI 10.1016/j.molmed.2011.05.002; Ryan KK, 2012, CELL METAB, V15, P137, DOI 10.1016/j.cmet.2011.12.013; Storch J, 2008, J LIPID RES, V49, P1762, DOI 10.1194/jlr.M800116-JLR200; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899	43	49	50	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17338	17349		10.1074/jbc.M114.555961	http://dx.doi.org/10.1074/jbc.M114.555961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24784138	hybrid, Green Published			2022-12-25	WOS:000338018100005
J	Kumari, G; Ulrich, T; Krause, M; Finkernagel, F; Gaubatz, S				Kumari, Geeta; Ulrich, Tanja; Krause, Michael; Finkernagel, Florian; Gaubatz, Stefan			Induction of p21CIP1 Protein and Cell Cycle Arrest after Inhibition of Aurora B Kinase Is Attributed to Aneuploidy and Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CHROMOSOMAL PASSENGER COMPLEX; MAMMALIAN-CELLS; DNA-DAMAGE; TETRAPLOIDY CHECKPOINT; P53; PHOSPHORYLATION; MITOSIS; ELONGATION; P21(CIP1)	Cell cycle progression requires a series of highly coordinated events that ultimately lead to faithful segregation of chromosomes. Aurora B is an essential mitotic kinase, which is involved in regulation of microtubule-kinetochore attachments and cytokinesis. Inhibition of Aurora B results in stabilization of p53 and induction of p53-target genes such as p21 to inhibit proliferation. We have previously demonstrated that induction of p21 by p53 after inhibition of Aurora B is dependent on the p38 MAPK, which promotes transcriptional elongation of p21 by RNA Pol II. In this study, we show that a subset of p53-target genes are induced in a p38-dependent manner upon inhibition of Aurora B. We also demonstrate that inhibition of Aurora B results in down-regulation of E2F-mediated transcription and that the cell cycle arrest after Aurora B inhibition depends on p53 and pRB tumor suppressor pathways. In addition, we report that activation of p21 after inhibition of Aurora B is correlated with increased chromosome missegregation and aneuploidy but not with binucleation or tetraploidy. We provide evidence that p21 is activated in aneuploid cells by reactive oxygen species (ROS) and p38 MAPK. Finally, we demonstrate that certain drugs that act on aneuploid cells synergize with inhibitors of Aurora B to inhibit colony formation and oncogenic transformation. These findings provide an important link between aneuploidy and the stress pathways activated by Aurora B inhibition and also support the use of Aurora B inhibitors in combination therapy for treatment of cancer.	[Kumari, Geeta; Ulrich, Tanja; Gaubatz, Stefan] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97080 Wurzburg, Germany; [Kumari, Geeta; Ulrich, Tanja; Gaubatz, Stefan] Comprehens Canc Ctr Mainfranken, D-97080 Wurzburg, Germany; [Krause, Michael; Finkernagel, Florian] Univ Marburg, Inst Mol Biol & Tumor Res IMT, D-35033 Marburg, Germany	University of Wurzburg; University of Wurzburg; Philipps University Marburg	Gaubatz, S (corresponding author), Univ Wurzburg, Theodor Boveri Inst, Dept Physiol Chem, Bioctr, D-97074 Wurzburg, Germany.	stefan.gaubatz@biozentrum.uni-wuerzburg.de		Gaubatz, Stefan/0000-0001-8751-4191	DFG [575/6-1, TR17-B1]; priority research program LOEWE Tumor and Inflammation; German Excellence Initiative	DFG(German Research Foundation (DFG)); priority research program LOEWE Tumor and Inflammation; German Excellence Initiative	This work was supported by grants from the DFG (575/6-1 and TR17-B1) (to S. G.) and the priority research program LOEWE Tumor and Inflammation (to F. F.).; Supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg.	Al-Romaih K, 2003, CANCER GENET CYTOGEN, V144, P91, DOI 10.1016/S0165-4608(02)00929-9; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Bayani J, 2003, GENE CHROMOSOME CANC, V36, P7, DOI 10.1002/gcc.10132; Blagosklonny MV, 2006, CELL CYCLE, V5, P971, DOI 10.4161/cc.5.9.2711; Boss DS, 2009, ONCOLOGIST, V14, P780, DOI 10.1634/theoncologist.2009-0019; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dreier MR, 2009, EXP CELL RES, V315, P1085, DOI 10.1016/j.yexcr.2009.02.008; EARNSHAW WC, 1991, J CELL SCI, V98, P443; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Gizatullin F, 2006, CANCER RES, V66, P7668, DOI 10.1158/0008-5472.CAN-05-3353; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gully CP, 2012, P NATL ACAD SCI USA, V109, pE1513, DOI 10.1073/pnas.1110287109; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Katayama H, 2010, BBA-GENE REGUL MECH, V1799, P829, DOI 10.1016/j.bbagrm.2010.09.004; Kawauchi J, 2013, J BIOL CHEM, V288, P24302, DOI 10.1074/jbc.M113.496703; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; KIERSTEAD TD, 1993, J VIROL, V67, P1817, DOI 10.1128/JVI.67.4.1817-1829.1993; Kumari G, 2013, CELL CYCLE, V12, P2051, DOI 10.4161/cc.25100; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Margolis RL, 2003, J CELL BIOCHEM, V88, P673, DOI 10.1002/jcb.10411; Marxer M, 2014, ONCOGENE, V33, P3550, DOI 10.1038/onc.2013.325; Nair JS, 2009, MOL BIOL CELL, V20, P2218, DOI 10.1091/mbc.E08-08-0885; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Quignon F, 2007, ONCOGENE, V26, P165, DOI 10.1038/sj.onc.1209787; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Trakala M, 2013, CELL CYCLE, V12, P1030, DOI 10.4161/cc.24004; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Valin A, 2013, MOL CELL BIOL, V33, P1582, DOI 10.1128/MCB.00323-12; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; Wu LM, 2011, J BIOL CHEM, V286, P2236, DOI 10.1074/jbc.M110.174755; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; ZALVIDE J, 1995, MOL CELL BIOL, V15, P5800	47	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16072	16084		10.1074/jbc.M114.555060	http://dx.doi.org/10.1074/jbc.M114.555060			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24782314	hybrid, Green Published			2022-12-25	WOS:000337965700016
J	Feng, JJ; Cui, LW; Ma, CY; Fei, HL; Fan, PF				Feng, Jun-Juan; Cui, Liang-Wei; Ma, Chang-Yong; Fei, Han-Lan; Fan, Peng-Fei			Individuality and Stability in Male Songs of Cao Vit Gibbons (Nomascus nasutus) with Potential to Monitor Population Dynamics	PLOS ONE			English	Article							BLACK CRESTED GIBBON; HYLOBATES-AGILIS; CONCOLOR-JINGDONGENSIS; HOOLOCK-LEUCONEDYS; SINGING BEHAVIOR; VOCAL DIVERSITY; FEMALE SONGS; MT. WULIANG; CONSERVATION; CHINA	Vocal individuality and stability has been used to conduct population surveys, monitor population dynamics, and detect dispersal patterns in avian studies. To our knowledge, it has never been used in these kinds of studies among primates. The cao vit gibbon is a critically endangered species with only one small population living in a karst forest along China-Vietnam border. Due to the difficult karst terrain, an international border, long life history, and similarity in male morphology, detailed monitoring of population dynamics and dispersal patterns are not possible using traditional observation methods. In this paper, we test individuality and stability in male songs of cao vit gibbons. We then discuss the possibility of using vocal individuality for population surveys and monitoring population dynamics and dispersal patterns. Significant individuality of vocalization was detected in all 9 males, and the correct rate of individual identification yielded by discriminant function analysis using a subset of variables was satisfactory (>90%). Vocal stability over 2-6 years was also documented in 4 males. Several characters of cao vit gibbons allowed long-term population monitoring using vocal recordings in both China and Vietnam: 1) regular loud calls, 2) strong individuality and stability in male songs, 3) stable territories, and 4) long male tenure. During the course of this research, we also observed one male replacement (confirmed by vocal analysis). This time- and labor-saving method might be the most effective way to detect dispersal patterns in this transboundary population.	[Feng, Jun-Juan; Ma, Chang-Yong; Fei, Han-Lan; Fan, Peng-Fei] Dali Univ, Inst Eastern Himalaya Biodivers Res, Dali, Yunnan, Peoples R China; [Feng, Jun-Juan; Ma, Chang-Yong] Southwest Forestry Univ, Coll Life Sci, Kunming, Yunnan, Peoples R China; [Cui, Liang-Wei] Southwest Forestry Univ, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Yunnan, Peoples R China	Dali University; Southwest Forestry University - China; Southwest Forestry University - China	Fan, PF (corresponding author), Dali Univ, Inst Eastern Himalaya Biodivers Res, Dali, Yunnan, Peoples R China.	fanpf1981@gmail.com	Fei, Hanlan/GOH-3239-2022		National Natural Science Foundation of China [30900169]; Conservation Leadership Programme [060208, F0237110]; Fauna and Flora International; Association of Zoos and Aquariums	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Conservation Leadership Programme; Fauna and Flora International; Association of Zoos and Aquariums	This research was funded by the National Natural Science Foundation of China (# 30900169, www.nsfc.gov.cn), Conservation Leadership Programme (060208, F0237110, http:// www.conservationleadershipprogramme.org/), Fauna and Flora International (http://www.fauna-flora.org), and Association of Zoos and Aquariums (www.aza.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockelman Warren Y., 2009, P435, DOI 10.1007/978-0-387-88604-6_20; Brockelman WY, 1998, BEHAV ECOL SOCIOBIOL, V42, P329, DOI 10.1007/s002650050445; BROCKELMAN WY, 1993, AM J PRIMATOL, V29, P93, DOI 10.1002/ajp.1350290203; Buckley C, 2006, PRIMATES, V47, P327, DOI 10.1007/s10329-006-0195-7; BUTYNSKI TM, 1992, AM J PRIMATOL, V28, P183, DOI 10.1002/ajp.1350280303; COWLISHAW G, 1992, BEHAVIOUR, V121, P131, DOI 10.1163/156853992X00471; Dallmann R, 2001, CONTRIB ZOOL, V70, P41, DOI 10.1163/18759866-07001003; Dallmann R, 2001, BEHAVIOUR, V138, P629, DOI 10.1163/156853901316924511; ELOWSON AM, 1994, ANIM BEHAV, V47, P1267, DOI 10.1006/anbe.1994.1175; Fan PF, 2013, BIOL CONSERV, V161, P39, DOI 10.1016/j.biocon.2013.02.014; Fan PF, 2012, AM J PRIMATOL, V74, P632, DOI 10.1002/ajp.22016; Fan PF, 2011, FOLIA PRIMATOL, V82, P83, DOI 10.1159/000329128; Fan PF, 2011, BIOL CONSERV, V144, P2247, DOI 10.1016/j.biocon.2011.05.016; Fan PF, 2011, ORYX, V45, P129, DOI 10.1017/S003060531000089X; Fan Peng-Fei, 2010, Zoological Research, V31, P293, DOI 10.3724/SP.J.1141.2010.03293; Fan PF, 2009, AM J PRIMATOL, V71, P539, DOI 10.1002/ajp.20686; Fei Hanlan, 2010, Acta Theriologica Sinica, V30, P377; Fei HL, 2012, AM J PRIMATOL, V00, P1; [冯军娟 Feng Junjuan], 2013, [兽类学报, Acta Theriologica Sinica], V33, P203; Fox EJS, 2008, ANIM BEHAV, V75, P1187, DOI 10.1016/j.anbehav.2007.11.003; GALEOTTI P, 1991, ETHOL ECOL EVOL, V3, P113, DOI 10.1080/08927014.1991.9525378; Geissmann T, 2002, BIOL REV, V77, P57, DOI 10.1017/S1464793101005826; Geissmann T, 2000, ANIM BEHAV, V60, P805, DOI 10.1006/anbe.2000.1540; HAIMOFF EH, 1985, FOLIA PRIMATOL, V44, P129, DOI 10.1159/000156207; HAIMOFF EH, 1985, AM J PRIMATOL, V8, P239, DOI 10.1002/ajp.1350080306; IUCN, 2022, IUCN RED LIST THREAT; JANIK VM, 1994, BEHAV ECOL SOCIOBIOL, V35, P243, DOI 10.1007/s002650050094; Jiang XL, 2006, PRIMATES, V47, P264, DOI 10.1007/s10329-005-0175-3; JONES BS, 1993, AM J PRIMATOL, V31, P67, DOI 10.1002/ajp.1350310107; Klenova AV, 2009, J ETHOL, V27, P401, DOI 10.1007/s10164-008-0133-9; Koda H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071432; Konrad R, 2006, INT J PRIMATOL, V27, P713, DOI 10.1007/s10764-006-9042-3; Le T. D., 2008, GLOBAL CAO VIT UNPUB; Leighton D.R., 1987, P135; Lok CBP, 2008, ASIAN PRIMATES J, V1, P17; Long Y.C., 2009, PRIMATES PERIL WORLD, P60; MITANI JC, 1994, ETHOLOGY, V96, P233, DOI 10.1111/j.1439-0310.1994.tb01012.x; Mitani JC, 1996, INT J PRIMATOL, V17, P569, DOI 10.1007/BF02735192; Mootnick AR, 2011, AM J PRIMATOL, V71, P1; Oyakawa C, 2007, AM J PRIMATOL, V69, P777, DOI 10.1002/ajp.20390; Park SR, 2000, AUK, V117, P228, DOI 10.1642/0004-8038(2000)117[0228:STFIII]2.0.CO;2; Phoonjampa R, 2008, ORYX, V42, P600, DOI 10.1017/S0030605308000306; Puglisi L, 2004, AUK, V121, P541, DOI 10.1642/0004-8038(2004)121[0541:DOIVIM]2.0.CO;2; Ruppell JC, 2010, INT J PRIMATOL, V31, P73, DOI 10.1007/s10764-009-9384-8; Sun GZ, 2011, AM J PRIMATOL, V73, P431, DOI 10.1002/ajp.20917; Terry Andrew M.R., 2005, Frontiers in Zoology, V2, P1; Thinh VN, 2010, AM J PRIMATOL, V72, P1047, DOI 10.1002/ajp.20861; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Tripp TM, 2006, CAN J ZOOL, V84, P744, DOI 10.1139/Z06-055; Xia CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042528	50	17	19	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96317	10.1371/journal.pone.0096317	http://dx.doi.org/10.1371/journal.pone.0096317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788306	Green Submitted, gold, Green Published			2022-12-25	WOS:000336655700073
J	Prentice, JC; Marion, G; White, PCL; Davidson, RS; Hutchings, MR				Prentice, Jamie C.; Marion, Glenn; White, Piran C. L.; Davidson, Ross S.; Hutchings, Michael R.			Demographic Processes Drive Increases in Wildlife Disease following Population Reduction	PLOS ONE			English	Article							BADGER MELES-MELES; EMERGING INFECTIOUS-DISEASES; BOVINE TUBERCULOSIS; SPATIAL-ORGANIZATION; MYCOBACTERIUM-BOVIS; CATTLE; PERTURBATION; ECOLOGY; IMPACT; TRANSMISSION	Population reduction is often used as a control strategy when managing infectious diseases in wildlife populations in order to reduce host density below a critical threshold. However, population reduction can disrupt existing social and demographic structures leading to changes in observed host behaviour that may result in enhanced disease transmission. Such effects have been observed in several disease systems, notably badgers and bovine tuberculosis. Here we characterise the fundamental properties of disease systems for which such effects undermine the disease control benefits of population reduction. By quantifying the size of response to population reduction in terms of enhanced transmission within a generic non-spatial model, the properties of disease systems in which such effects reduce or even reverse the disease control benefits of population reduction are identified. If population reduction is not sufficiently severe, then enhanced transmission can lead to the counter intuitive perturbation effect, whereby disease levels increase or persist where they would otherwise die out. Perturbation effects are largest for systems with low levels of disease, e. g. low levels of endemicity or emerging disease. Analysis of a stochastic spatial meta-population model of demography and disease dynamics leads to qualitatively similar conclusions. Moreover, enhanced transmission itself is found to arise as an emergent property of density dependent dispersal in such systems. This spatial analysis also shows that, below some threshold, population reduction can rapidly increase the area affected by disease, potentially expanding risks to sympatric species. Our results suggest that the impact of population reduction on social and demographic structures is likely to undermine disease control in many systems, and in severe cases leads to the perturbation effect. Social and demographic mechanisms that enhance transmission following population reduction should therefore be routinely considered when designing control programmes.	[Prentice, Jamie C.; Davidson, Ross S.; Hutchings, Michael R.] SRUC, Dis Syst Team, Edinburgh, Midlothian, Scotland; [Prentice, Jamie C.; Marion, Glenn] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Prentice, Jamie C.; White, Piran C. L.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	James Hutton Institute; University of York - UK	Marion, G (corresponding author), Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland.	glenn@bioss.ac.uk	Marion, Glenn/J-4738-2013; White, Piran Crawfurd Limond/AAH-6851-2021; Hutchings, Mike/P-6836-2019; Davidson, Ross/I-8210-2014	White, Piran Crawfurd Limond/0000-0002-7496-5775; Prentice, Jamie/0000-0002-5672-2163; Marion, Glenn/0000-0002-0454-9338; Hutchings, Mike/0000-0003-3338-471X; Davidson, Ross/0000-0003-1468-5867	Scottish Government; EU [212414]	Scottish Government; EU(European Commission)	SRUC and Biomathematics and Statistics Scotland (BioSS) receive funding from the Scottish Government. This work was also supported by the EU (project number 212414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Artois M, 2001, VET J, V162, P141, DOI 10.1053/tvjl.2001.0601; Bodin C, 2006, BEHAV PROCESS, V72, P84, DOI 10.1016/j.beproc.2006.01.001; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Carter Stephen P., 2009, P121, DOI 10.1007/978-4-431-77134-0_7; Cunningham AA, 1996, CONSERV BIOL, V10, P349, DOI 10.1046/j.1523-1739.1996.10020349.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Davidson RS, 2008, J THEOR BIOL, V253, P424, DOI 10.1016/j.jtbi.2008.03.021; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Evensen DT, 2008, NATURE, V452, P282, DOI 10.1038/452282a; Frolich K, 2002, ANN NY ACAD SCI, V969, P4, DOI 10.1111/j.1749-6632.2002.tb04343.x; Gallagher J, 2000, RES VET SCI, V69, P203, DOI 10.1053/rvsc.2000.0422; GINZBURG LR, 1992, TRENDS ECOL EVOL, V7, P133, DOI 10.1016/0169-5347(92)90149-6; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; GUBERTI V, 1998, MEASURES CONTROL CLA, P54; Hui C, 2006, ECOL MODEL, V192, P317, DOI 10.1016/j.ecolmodel.2005.07.001; Independent Scientific Group, 2007, BOV TB SCI EV SCI BA; Johst K, 1997, ECOL MODEL, V104, P87, DOI 10.1016/S0304-3800(97)00112-9; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keeling M. J., 2007, MODELLING INFECT DIS; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Lintott RA, 2013, J THEOR BIOL, V323, P57, DOI 10.1016/j.jtbi.2013.01.027; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Macdonald David, 1995, P33; Macdonald DW, 2008, J MAMMAL, V89, P1077, DOI 10.1644/07-MAMM-A-185.1; Smith GC, 2001, J APPL ECOL, V38, P520, DOI 10.1046/j.1365-2664.2001.00610.x; Swinton J, 1997, PHILOS T R SOC B, V352, P619, DOI 10.1098/rstb.1997.0042; Tuyttens FAM, 2000, J ANIM ECOL, V69, P815, DOI 10.1046/j.1365-2656.2000.00437.x; Tuyttens Frank A.M., 2000, Conservation Biology Series (Cambridge), V2, P315; Vial F, 2012, BIOL LETTERS, V8, P50, DOI 10.1098/rsbl.2011.0554; Wobeser G.A., 1994, INVESTIGATION MANAGE; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x	35	15	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e86563	10.1371/journal.pone.0086563	http://dx.doi.org/10.1371/journal.pone.0086563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24784544	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000336655700001
J	Zheng, B; van Bergenhenegouwen, J; Overbeek, S; van de Kant, HJG; Garssen, J; Folkerts, G; Vos, P; Morgan, ME; Kraneveld, AD				Zheng, Bin; van Bergenhenegouwen, Jeroen; Overbeek, Saskia; van de Kant, Hendrik J. G.; Garssen, Johan; Folkerts, Gert; Vos, Paul; Morgan, Mary E.; Kraneveld, Aletta D.			Bifidobacterium breve Attenuates Murine Dextran Sodium Sulfate-Induced Colitis and Increases Regulatory T Cell Responses	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; TRANSCRIPTION FACTOR; INTESTINAL INFLAMMATION; EXPRESSION; MICE; TISSUE; DIFFERENTIATION; LACTOBACILLUS; PATHOGENESIS; TOLERANCE	While some probiotics have shown beneficial effects on preventing or treating colitis development, others have shown no effects. In this study, we have assessed the immunomodulating effects of two probiotic strains, Lactobacillus rhamnosus (L. rhamnosus) and Bifidobacterium breve (B. breve) on T cell polarization in vitro, using human peripheral blood mononuclear cells (PBMC), and in vivo, using murine dextran sodium sulfate (DSS) colitis model. With respect to the latter, the mRNA expression of T cell subset-associated transcription factors and cytokines in the colon was measured and the T helper type (Th) 17 and regulatory T cell (Treg) subsets were determined in the Peyer's patches. Both L. rhamnosus and B. breve incubations in vitro reduced Th17 and increased Th2 cell subsets in human PBMCs. In addition, B. breve incubation was also able to reduce Th1 and increase Treg cell subsets in contrast to L. rhamnosus. In vivo intervention with B. breve, but not L. rhamnosus, significantly attenuated the severity of DSS-induced colitis. In DSS-treated C57BL/6 mice, intervention with B. breve increased the expression of mRNA encoding for Th2- and Treg-associated cytokines in the distal colon. In addition, intervention with B. breve led to increases of Treg and decreases of Th17 cell subsets in Peyer's patches of DSS-treated mice. B. breve modulates T cell polarization towards Th2 and Treg cell-associated responses in vitro and in vivo. In vivo B. breve intervention ameliorates DSS-induced colitis symptoms and this protective effect may mediated by its effects on the T-cell composition.	[Zheng, Bin; van Bergenhenegouwen, Jeroen; Overbeek, Saskia; van de Kant, Hendrik J. G.; Garssen, Johan; Folkerts, Gert; Morgan, Mary E.; Kraneveld, Aletta D.] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands; [van Bergenhenegouwen, Jeroen; Garssen, Johan; Vos, Paul] Nutricia Res, Utrecht, Netherlands	Utrecht University; Danone Nutricia	Kraneveld, AD (corresponding author), Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands.	A.D.Kraneveld@uu.nl	Kraneveld, Aletta D/J-3351-2016; garssen, johan/I-7159-2016	Kraneveld, Aletta D/0000-0001-9819-383X; 	Dutch Top Institute Pharma [D1-101]	Dutch Top Institute Pharma	This study was performed within the framework of Dutch Top Institute Pharma (project D1-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson LG, 1996, INFLAMM RES, V45, P181, DOI 10.1007/BF02285159; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boehm F, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-97; Boirivant M, 2007, CURR OPIN GASTROEN, V23, P679, DOI 10.1097/MOG.0b013e3282f0cffc; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; de Roock S, 2010, CLIN EXP ALLERGY, V40, P103, DOI 10.1111/j.1365-2222.2009.03344.x; de Roock S, 2011, CLIN NUTR, V30, P845, DOI 10.1016/j.clnu.2011.05.005; du Pre MF, 2011, ALLERGY, V66, P478, DOI 10.1111/j.1398-9995.2010.02519.x; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fujii T, 2006, J PEDIATR GASTR NUTR, V43, P83, DOI 10.1097/01.mpg.0000228100.04702.f8; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Geier MS, 2009, DIGEST DIS SCI, V54, P1222, DOI 10.1007/s10620-008-0495-4; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Hauet-Broere F, 2003, EUR J IMMUNOL, V33, P2801, DOI 10.1002/eji.200324115; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hudcovic T, 2001, FOLIA MICROBIOL, V46, P565, DOI 10.1007/BF02818004; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jeon Seong Gyu, 2012, PLoS Pathog, V8, pe1002714, DOI 10.1371/journal.ppat.1002714; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Kidd Parris, 2003, Altern Med Rev, V8, P223; Koboziev I, 2010, ANN NY ACAD SCI, V1207, pE86, DOI 10.1111/j.1749-6632.2010.05711.x; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kumar NSN, 2008, J GASTROEN HEPATOL, V23, P1834, DOI 10.1111/j.1440-1746.2008.05723.x; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P6102, DOI 10.3748/wjg.v12.i38.6102; Leon B, 2013, NAT IMMUNOL, V14, P419, DOI 10.1038/ni.2593; MA M, 2014, PROBIOTICS MARKET PR; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Maynard CL, 2009, IMMUNITY, V31, P389, DOI 10.1016/j.immuni.2009.08.012; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; Monteleone G, 2010, CLIN SCI, V118, P707, DOI 10.1042/CS20100027; Morgan MAJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071974, 10.1371/journal.pone.0056738, 10.1371/journal.pone.0069936]; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Plantinga TS, 2011, CLIN VACCINE IMMUNOL, V18, P621, DOI 10.1128/CVI.00498-10; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Ringel Y, 2012, AM J GASTROENTEROL S, V1, P34, DOI DOI 10.1038/AJGSUP.2012.7; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Roselli M, 2009, INFLAMM BOWEL DIS, V15, P1526, DOI 10.1002/ibd.20961; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shevach EM, 2011, ADV IMMUNOL, V112, P137, DOI 10.1016/B978-0-12-387827-4.00004-8; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Veltkamp C, 2011, GUT, V60, P1345, DOI 10.1136/gut.2010.217117; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wang Y, 2011, J DIGEST DIS, V12, P286, DOI 10.1111/j.1751-2980.2011.00505.x; WARRINGTON LE, 2005, NAT IMMUNOL, V6, P1123; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Yazbeck R, 2011, J CELL PHYSIOL, V226, P3219, DOI 10.1002/jcp.22682; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	57	56	79	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95441	10.1371/journal.pone.0095441	http://dx.doi.org/10.1371/journal.pone.0095441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787575	gold, Green Submitted, Green Published			2022-12-25	WOS:000336655700030
J	Charron, L; Geffard, O; Chaumot, A; Coulaud, R; Jaffal, A; Gaillet, V; Dedourge-Geffard, O; Geffard, A				Charron, Laetitia; Geffard, Olivier; Chaumot, Arnaud; Coulaud, Romain; Jaffal, Ali; Gaillet, Veronique; Dedourge-Geffard, Odile; Geffard, Alain			Influence of Molting and Starvation on Digestive Enzyme Activities and Energy Storage in Gammarus fossarum	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; CRUSTACEA-AMPHIPODA; SPINY LOBSTER; ZEBRA MUSSELS; RESERVES; PULEX; HEPATOPANCREAS; ALLOCATION; DECAPODA; PROTEINASES	Among the many biological responses studied in ecotoxicology, energy-based biomarkers such as digestive enzyme activities and energy reserves appear to be useful predictive tools for detecting physiological disturbances in organisms. However, the use of these biological responses as biomarkers could be limited by the effects of confounding factors (biotic and abiotic) and physiological processes, such as the reproductive cycle. Thus, the optimal use of these biomarkers will be facilitated by understanding the effects of these factors on the energy metabolism of the sentinel species being studied. We considered abiotic factors (temperature and conductivity) in a previous study, whereas the present study investigated the effects of gender, the female reproductive stage, and food availability on the digestive enzyme activities and energy storage of Gammarus fossarum. The results indicated that, during the female reproductive cycle, the activities of digestive enzymes (amylase, cellulase, and trypsin) decreased significantly, whereas the levels of reserves (proteins, lipids, and sugar) increased until the last premolt stage. Restricted food diets only led to decreased amylase activities in both sexes. Food starvation also induced a decrease in the energy outcomes in females, whereas there were no effects in males. In general, the biochemical (digestive enzyme activities) and physiological (energy reserves) responses were more stable in males than in females. These results support the use of males fed ad libitum to limit the effects of confounding factors when using these energy biomarkers in Gammarus fossarum during biomonitoring programs.	[Charron, Laetitia; Jaffal, Ali; Gaillet, Veronique; Dedourge-Geffard, Odile; Geffard, Alain] Univ Reims, Unite Interact Anim Environm, Reims, France; [Geffard, Olivier; Chaumot, Arnaud; Coulaud, Romain] Inst Natl Rech Sci Technol Environm & Agr, Unite Rech Milieux Aquat Ecol & Pollut MAEP, Villeurbanne, France	Universite de Reims Champagne-Ardenne; INRAE	Geffard, A (corresponding author), Univ Reims, Unite Interact Anim Environm, Reims, France.	alain.geffard@univ-reims.fr		Geffard, Alain/0000-0001-9236-2890; Geffard, olivier/0000-0001-7760-4644; Dedourge-Geffard, Odile/0000-0001-6308-2080; chaumot, arnaud/0000-0001-9132-3419	ANR CESA [GAMMA 021 02]; PIREN-Seine Program	ANR CESA(French National Research Agency (ANR)); PIREN-Seine Program	Financial support was provided by the ANR CESA program GAMMA 021 02 "Variability-adaptation-diversity and Ecotoxicology in gammarids" (2012-2015), and the PIREN-Seine Program.	Addinsoft, 2012, MICR EXC XLSTAT PRO; Amiard-Triquet C., 2013, ECOLOGICAL BIOMARKER; Becker J, 2013, FRESHWATER BIOL, V58, P372, DOI 10.1111/fwb.12065; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Boucher J, 1975, ETUDE NUTR REGIME RY, P85; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrillo-Farnes O, 2007, CRUSTACEANA, V80, P257, DOI 10.1163/156854007780162424; Casillas-Hernandez R, 2002, REV INVESTIGACIONES, V23, P35; Charron L., 2013, ENVIRON SCI POLLUT R, P1; Correia AD, 2003, J EXP MAR BIOL ECOL, V289, P83, DOI 10.1016/S0022-0981(03)00040-6; Coulaud R, 2011, WATER RES, V45, P6417, DOI 10.1016/j.watres.2011.09.035; Cuzon G., 1980, STARVATION EFFECT ME, ppp; De Coen W. M., 1997, Journal of Aquatic Ecosystem Stress and Recovery, V6, P43, DOI 10.1023/A:1008228517955; De Coen WM, 2003, ENVIRON TOXICOL CHEM, V22, P1632, DOI [10.1897/1551-5028(2003)22&lt;1632:TMBLRB&gt;2.0.CO;2, 10.1002/etc.5620220727]; Dedourge-Geffard O, 2009, CHEMOSPHERE, V77, P1569, DOI 10.1016/j.chemosphere.2009.09.042; ELWOOD R, 1987, ANIM BEHAV, V35, P1, DOI 10.1016/S0003-3472(87)80203-8; Felten V, 2008, COMP BIOCHEM PHYS C, V147, P189, DOI 10.1016/j.cbpc.2007.09.006; Fernandez I, 1997, COMP BIOCHEM PHYS A, V118, P1267, DOI 10.1016/S0300-9629(97)86802-8; Forrow DM, 2000, ENVIRON TOXICOL CHEM, V19, P2100, DOI 10.1002/etc.5620190820; Garcia-Carreno F, 1996, ENZIMAS SISTEMA DIGE, P1; GARCIACARRENO FL, 1993, J FOOD BIOCHEM, V17, P97, DOI 10.1111/j.1745-4514.1993.tb00864.x; Geffard O, 2010, ENVIRON TOXICOL CHEM, V29, P2249, DOI 10.1002/etc.268; Gimenez AVF, 2002, COMP BIOCHEM PHYS B, V132, P593, DOI 10.1016/S1096-4959(02)00080-5; Gimenez AVF, 2001, COMP BIOCHEM PHYS B, V130, P331, DOI 10.1016/S1096-4959(01)00437-7; Gismondi E, 2012, ENVIRON RES, V118, P47, DOI 10.1016/j.envres.2012.06.004; Gismondi E, 2012, ENVIRON POLLUT, V160, P17, DOI 10.1016/j.envpol.2011.09.021; Handy RD, 2003, ECOTOXICOLOGY, V12, P331, DOI 10.1023/A:1022527432252; HASSETT RP, 1983, MAR BIOL, V75, P47, DOI 10.1007/BF00392629; Hyne RV, 2011, ENVIRON TOXICOL CHEM, V30, P2647, DOI 10.1002/etc.673; Hyne RV, 2003, ECOTOX ENVIRON SAFE, V54, P366, DOI 10.1016/S0147-6513(02)00119-7; Jormalainen V, 2001, MAR ECOL PROG SER, V220, P219, DOI 10.3354/meps220219; KERAMBRUN P, 1993, COMP BIOCHEM PHYS A, V105, P303, DOI 10.1016/0300-9629(93)90212-M; Koop JHE, 2011, AQUAT ECOL, V45, P547, DOI 10.1007/s10452-011-9375-7; Macneil C, 1999, BIOL REV, V74, P375, DOI 10.1017/S0006323199005368; Maltby L., 1994, P98; MALTBY L, 1990, ECOTOX ENVIRON SAFE, V19, P292, DOI 10.1016/0147-6513(90)90031-Y; Marsden ID, 2004, J EXP MAR BIOL ECOL, V300, P373, DOI 10.1016/j.jembe.2003.12.009; MARTIN A. L., 1965, J ZOOL PROC ZOOL SOC LONDON, V147, P185; MAYZAUD O, 1984, J EXP MAR BIOL ECOL, V84, P15, DOI 10.1016/0022-0981(84)90228-4; McGrath CC, 2000, J N AM BENTHOL SOC, V19, P298, DOI 10.2307/1468072; Minguez L, 2012, ENVIRON POLLUT, V162, P234, DOI 10.1016/j.envpol.2011.11.005; Moolman L, 2007, ECOTOX ENVIRON SAFE, V68, P443, DOI 10.1016/j.ecoenv.2006.12.017; Muhlia-Almazan A, 2002, COMP BIOCHEM PHYS B, V133, P383, DOI 10.1016/S1096-4959(02)00163-X; Muhlia-Almazan Adriana, 2003, P77; Palais F, 2012, ECOTOXICOLOGY, V21, P888, DOI 10.1007/s10646-012-0851-1; Palais F, 2010, MOLLUSCAN RES, V30, P29; Perera E, 2008, COMP BIOCHEM PHYS B, V151, P250, DOI 10.1016/j.cbpb.2008.07.005; Plaistow SJ, 2003, ANIM BEHAV, V65, P683, DOI 10.1006/anbe.2003.2116; READ GHL, 1980, COMP BIOCHEM PHYS A, V66, P431, DOI 10.1016/0300-9629(80)90188-7; Sanchez-Paz A, 2006, INSECT BIOCHEM MOLEC, V36, P241, DOI 10.1016/j.ibmb.2006.01.002; Sanchez-Paz A, 2007, J EXP MAR BIOL ECOL, V340, P184, DOI 10.1016/j.jembe.2006.09.006; SCHULTZ TW, 1976, J MORPHOL, V149, P383, DOI 10.1002/jmor.1051490307; Sornom P, 2010, ENVIRON POLLUT, V158, P1288, DOI 10.1016/j.envpol.2010.01.022; Sutcliffe DW, 2010, REPROD GAMMARUS CRUS; TRAVIS DF, 1955, BIOL BULL, V108, P88, DOI 10.2307/1538400; VanWormhoudt A, 1974, THESIS U AIX MARSEIL; Vega-Villasante F, 1999, B MAR SCI, V65, P1; Verslycke T, 2004, J EXP MAR BIOL ECOL, V306, P245, DOI 10.1016/j.jembe.2004.01.014; Watson PJ, 1998, AM NAT, V151, P46, DOI 10.1086/286101; Widdows J, 2002, MAR ENVIRON RES, V53, P327, DOI 10.1016/S0141-1136(01)00120-9; Xuereb B, 2009, AQUAT TOXICOL, V93, P225, DOI 10.1016/j.aquatox.2009.05.006; Zilli L, 2003, J COMP PHYSIOL B, V173, P355, DOI 10.1007/s00360-003-0348-6; Zimmer M, 2003, LIMNOL OCEANOGR, V48, P2208, DOI 10.4319/lo.2003.48.6.2208	63	33	33	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96393	10.1371/journal.pone.0096393	http://dx.doi.org/10.1371/journal.pone.0096393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788197	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917300039
J	Soriano-Tarraga, C; Jimenez-Conde, J; Giralt-Steinhauer, E; Mola, M; Ois, A; Rodriguez-Campello, A; Cuadrado-Godia, E; Fernandez-Cadenas, I; Carrera, C; Montaner, J; Elosua, R; Roquer, J				Soriano-Tarraga, Carolina; Jimenez-Conde, Jordi; Giralt-Steinhauer, Eva; Mola, Marina; Ois, Angel; Rodriguez-Campello, Ana; Cuadrado-Godia, Elisa; Fernandez-Cadenas, Israel; Carrera, Caty; Montaner, Joan; Elosua, Roberto; Roquer, Jaume		GeneStroke Spanish Stroke Genetics	Global DNA Methylation of Ischemic Stroke Subtypes	PLOS ONE			English	Article							CARDIOVASCULAR EPIGENETICS; RISK-FACTORS; BLOOD DNA; CLASSIFICATION; EPIGENOMICS; DISEASE; ASSAY; LUMA	Ischemic stroke (IS), a heterogeneous multifactorial disorder, is among the leading causes of mortality and long-term disability in the western world. Epidemiological data provides evidence for a genetic component to the disease, but its epigenetic involvement is still largely unknown. Epigenetic mechanisms, such as DNA methylation, change over time and may be associated with aging processes and with modulation of the risk of various pathologies, such as cardiovascular disease and stroke. We analyzed 2 independent cohorts of IS patients. Global DNA methylation was measured by luminometric methylation assay (LUMA) of DNA blood samples. Univariate and multivariate regression analyses were used to assess the methylation differences between the 3 most common IS subtypes, large-artery atherosclerosis (LAA), small-artery disease (SAD), and cardio-aortic embolism (CE). A total of 485 IS patients from 2 independent hospital cohorts (n = 281 and n = 204) were included, distributed across 3 IS subtypes: LAA (78/281, 59/204), SAD (97/281, 53/204), and CE (106/281, 89/204). In univariate analyses, no statistical differences in LUMA levels were observed between the 3 etiologies in either cohort. Multivariate analysis, adjusted by age, sex, hyperlipidemia, and smoking habit, confirmed the lack of differences in methylation levels between the analyzed IS subtypes in both cohorts. Despite differences in pathogenesis, our results showed no global methylation differences between LAA, SAD, and CE subtypes of IS. Further work is required to establish whether the epigenetic mechanism of methylation might play a role in this complex disease.	[Soriano-Tarraga, Carolina; Jimenez-Conde, Jordi; Giralt-Steinhauer, Eva; Mola, Marina; Ois, Angel; Rodriguez-Campello, Ana; Cuadrado-Godia, Elisa; Roquer, Jaume] Univ Autonoma Barcelona, DCEXS Univ Pompeu Fabra, Inst Hosp Mar Invest Med, Dept Neurol,Neurovasc Res Grp,IMIM Hosp Mar, E-08193 Barcelona, Spain; [Fernandez-Cadenas, Israel] Fundacio Docencia & Recerca Mutua Terrassa, Lab Neurovasc Pharmacogen & Genet, Terrassa, Barcelona, Spain; [Fernandez-Cadenas, Israel; Carrera, Caty; Montaner, Joan] Univ Autonoma Barcelona, Hosp Vall Hebron, Inst Recerca, Neurovasc Res Lab, E-08193 Barcelona, Spain; [Elosua, Roberto] IMIM, Cardiovasc Epidemiol & Genet Grp, Barcelona, Spain	Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Institut Hospital del Mar d'Investigacions Mediques (IMIM)	Soriano-Tarraga, C (corresponding author), Univ Autonoma Barcelona, DCEXS Univ Pompeu Fabra, Inst Hosp Mar Invest Med, Dept Neurol,Neurovasc Res Grp,IMIM Hosp Mar, E-08193 Barcelona, Spain.	csoriano@imim.es	Ois, A/X-2922-2019; Montaner, Joan/D-3063-2015; Roquer, Jaume/G-8919-2017; JIMENEZ-CONDE, JORDI/C-1941-2012; Ois, A/AAE-7583-2022; TARRAGA, CAROLINA SORIANO/AAG-8777-2019; Campello, Ana Rodriguez/AAP-7757-2021	Ois, A/0000-0002-1375-5950; Montaner, Joan/0000-0003-4845-2279; Roquer, Jaume/0000-0001-5992-2606; Ois, A/0000-0002-1375-5950; Campello, Ana Rodriguez/0000-0001-8621-1420; ELOSUA, ROBERTO/0000-0001-8235-0095; Fernandez-Cadenas, Israel/0000-0003-4821-2363; Soriano Tarraga, Carolina/0000-0002-5635-273X; Cuadrado-Godia, Elisa/0000-0002-9147-875X; Giralt Steinhauer, Eva/0000-0002-7463-0983; Carrera, Caty/0000-0002-0804-0969	Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III); FEDER [RD12/0042/0020]; Carlos III Institute of Health, Spain [CP12/03298];  [PI10/02064];  [PI12/01238]	Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III); FEDER(European Commission); Carlos III Institute of Health, Spain(Instituto de Salud Carlos III); ; 	Supported in part by Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III), FEDER, RD12/0042/0020 and Funding in Research in Health, PI10/02064 and PI12/01238. Neurovascular Research Laboratory takes part into the Spanish stroke research network INVICTUS (RD12/0014/0005). I.F-C. is supported by the Miguel Servet programme (CP12/03298) from the Carlos III Institute of Health, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Anderson CD, 2013, STROKE, V44, P612, DOI 10.1161/STROKEAHA.112.672089; Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Baccarelli A, 2010, CIRC-CARDIOVASC GENE, V3, P567, DOI 10.1161/CIRCGENETICS.110.958744; Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Baccarelli A, 2010, EPIGENETICS-US, V5; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Giralt-Steinhauer E, 2014, NEUROLOGIA, V29, P560, DOI 10.1016/j.nrl.2013.04.005; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Jeffs B, 1997, NAT GENET, V16, P364, DOI 10.1038/ng0897-364; Karimi M, 2006, EPIGENETICS-US, V1, P45; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Markus HS, 2011, HUM MOL GENET, V20, pR124, DOI 10.1093/hmg/ddr345; Ois A, 2007, STROKE, V38, P2085, DOI 10.1161/STROKEAHA.107.482950; Pearce MS, 2012, INT J EPIDEMIOL, V41, P210, DOI 10.1093/ije/dys020; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; Udali S, 2013, MOL ASPECTS MED, V34, P883, DOI 10.1016/j.mam.2012.08.001; WHO, 2011, STROK CER ACC; Wu HC, 2011, EPIGENETICS-US, V6, P76, DOI 10.4161/epi.6.1.13391; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	32	37	38	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96543	10.1371/journal.pone.0096543	http://dx.doi.org/10.1371/journal.pone.0096543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788121	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917300043
J	Niens, LM; Zelle, SG; Gutierrez-Delgado, C; Pena, GR; Balarezo, BRH; Steller, ER; Rutten, FFH				Niens, Laurens M.; Zelle, Sten G.; Gutierrez-Delgado, Cristina; Rivera Pena, Gustavo; Hidalgo Balarezo, Blanca Rosa; Rodriguez Steller, Erick; Rutten, Frans F. H.			Cost-Effectiveness of Breast Cancer Control Strategies in Central America: The Cases of Costa Rica and Mexico	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; RESOURCE COUNTRIES; MORTALITY; CARE; MANAGEMENT; AFRICA	This paper reports the most cost-effective policy options to support and improve breast cancer control in Costa Rica and Mexico. Total costs and effects of breast cancer interventions were estimated using the health care perspective and WHO-CHOICE methodology. Effects were measured in disability-adjusted life years (DALYs) averted. Costs were assessed in 2009 United States Dollars (US$). To the extent available, analyses were based on locally obtained data. In Costa Rica, the current strategy of treating breast cancer in stages I to IV at a 80% coverage level seems to be the most cost-effective with an incremental cost-effectiveness ratio (ICER) of US$ 4,739 per DALY averted. At a coverage level of 95%, biennial clinical breast examination (CBE) screening could improve Costa Rica's population health twofold, and can still be considered very cost-effective (ICER US$5,964/DALY). For Mexico, our results indicate that at 95% coverage a mass-media awareness raising program (MAR) could be the most cost-effective (ICER US$5,021/DALY). If more resources are available in Mexico, biennial mammography screening for women 50-70 yrs (ICER US$12,718/DALY), adding trastuzumab (ICER US$13,994/DALY) or screening women 40-70 yrs biennially plus trastuzumab (ICER US$17,115/DALY) are less cost-effective options. We recommend both Costa Rica and Mexico to engage in MAR, CBE or mammography screening programs, depending on their budget. The results of this study should be interpreted with caution however, as the evidence on the intervention effectiveness is uncertain. Also, these programs require several organizational, budgetary and human resources, and the accessibility of breast cancer diagnostic, referral, treatment and palliative care facilities should be improved simultaneously. A gradual implementation of early detection programs should give the respective Ministries of Health the time to negotiate the required budget, train the required human resources and understand possible socioeconomic barriers.	[Niens, Laurens M.; Rutten, Frans F. H.] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands; [Niens, Laurens M.; Rutten, Frans F. H.] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands; [Zelle, Sten G.] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Gutierrez-Delgado, Cristina] IMSS, Mexico City, DF, Mexico; [Rivera Pena, Gustavo] Unidad Anal Econ, Secretaria Salud, Mexico City, DF, Mexico; [Hidalgo Balarezo, Blanca Rosa] Costarricense Seguro Social, Pharmacoecon Dept, San Jose, Costa Rica; [Rodriguez Steller, Erick] Minist Salud, San Jose, Costa Rica	Erasmus University Rotterdam; Erasmus University Rotterdam; Radboud University Nijmegen; Instituto Mexicano del Seguro Social	Niens, LM (corresponding author), Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands.	niens@bmg.eur.nl			Susan G. Komen for the Cure	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation)	With funding from Susan G. Komen for the Cure, this research and the collaboration with the World Health Organization, Radboud University Nijmegen, could be established. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2009, WORLD J SURG, V33, P2069, DOI 10.1007/s00268-009-0150-z; Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; Anderson BO, 2011, LANCET ONCOL, V12, P387, DOI 10.1016/S1470-2045(11)70031-6; Anderson BO, 2006, BREAST J, V12, pS54, DOI 10.1111/j.1075-122X.2006.00203.x; Anderson BO, 2006, BREAST J, V12, pS3, DOI 10.1111/j.1075-122X.2006.00199.x; [Anonymous], 2010, DEC MAK TOOLS HLTH C; Bland KI, 1998, CANCER-AM CANCER SOC, V83, P1262, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1262::AID-CNCR28>3.0.CO;2-2; BLOOM HJG, 1962, BRIT MED J, P213, DOI 10.1136/bmj.2.5299.213; Bobo JK, 2000, J NATL CANCER I, V92, P971, DOI 10.1093/jnci/92.12.971; Comision Nacional de Proteccion Social en Salud, 2011, CAS REG VAL CANC MAM; Consejo Nacional de Poblacion, 2011, PROYECC POBL 2005 20; Devi BCR, 2007, ANN ONCOL, V18, P1172, DOI 10.1093/annonc/mdm105; Duffy SW, 2005, BRIT J CANCER, V92, P597, DOI 10.1038/sj.bjc.6602345; Edejer T, 2003, WHO GUIDE COST EFFEC; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez I, 2012, MEX MIN HLTH JUN 8; Flores-Luna L, 2008, SALUD PUBLICA MEXICO, V50, P119, DOI 10.1590/S0036-36342008000200005; Franco-Marina F, 2009, SALUD PUBLICA MEXICO, V51, pS157, DOI 10.1590/s0036-36342009000800005; Martinez-Montanez OG, 2009, SALUD PUBLICA MEXICO, V51, pS350, DOI 10.1590/S0036-36342009000800028; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Greene FL, 2006, AJCC CANC STAGING AT, Vix; Groot MT, 2006, BREAST J, V12, pS81, DOI 10.1111/j.1075-122X.2006.00206.x; Hortobagyi GN, 2002, SEMIN ONCOL, V29, P134, DOI 10.1053/sonc.2002.34066; Instituto Mexicano del Seguro Social Unidad Analisis Economico, 2012, MOD EC MICR CANC MAN; International Agency for Research on Cancer, 2012, GLOBOCAN 2008; Khan SA, 2002, SURGERY, V132, P620, DOI 10.1067/msy.2002.127544; Knaul FM, 2005, HEALTH AFFAIR, V24, P1467, DOI 10.1377/hlthaff.24.6.1467; KNAUL FM, 2009, SALUD PUBLICA MEX S2, V51; Kumar SK, 2007, J PAIN SYMPTOM MANAG, V33, P623, DOI 10.1016/j.jpainsymman.2007.02.005; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez-Rios O, 1997, SALUD PUBLICA MEXICO, V39; Gonzalez-Robledo LM, 2010, SALUD PUBLICA MEXICO, V52, P533, DOI 10.1590/S0036-36342010000600009; Knaul FM, 2008, REPROD HEALTH MATTER, V16, P113, DOI 10.1016/S0968-8080(08)32414-8; Miller D, 2008, INTERVENTIONS RELIEV; Ministerio de Salud, 2007, INC MORT CANC COST R; Ministry of Construction, 2000, MIN CONSTR NOT NO 14, P1; Ministry of Medical Services Ministry of Public Health and Sanitation, 2009, NAT GUID INT MAN AC, P22; Norum J, 2005, ANN ONCOL, V16, P909, DOI 10.1093/annonc/mdi188; Oanda, 2013, FOR TRAD EXCH RAT SE; Ortiz Astrid, 2007, THESIS; Palacio-Mejia LS, 2009, SALUD PUBLICA MEXICO, V51, pS208, DOI 10.1590/S0036-36342009000800011; Parkin DM, 2006, BREAST J, V12, pS70, DOI 10.1111/j.1075-122X.2006.00205.x; Pisani P, 2006, INT J CANCER, V118, P149, DOI 10.1002/ijc.21343; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Purmonen TT, 2011, ACTA ONCOL, V50, P344, DOI 10.3109/0284186X.2011.553841; Robles Sylvia C, 2002, Rev Panam Salud Publica, V11, P178, DOI 10.1590/S1020-49892002000300007; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Secretaria de Salud de Mexico - Direccion General de Epidemiologia, 2006, REG HIST GIC NEOPL M; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Walsh D, 2006, SUPPORT CARE CANCER, V14, P831, DOI 10.1007/s00520-005-0899-z; Whyte S, 2011, VALUE HEALTH, V14, P465, DOI 10.1016/j.jval.2010.10.037; World Bank Group, 2013, WORLD DEV IND; World Health Organization, 2012, COST EFF THRESH; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization (WHO), 2012, BREAST CANC PREV CON; Zelle SG, 2012, TROP MED INT HEALTH, V17, P1031, DOI 10.1111/j.1365-3156.2012.03021.x; Zotov Vladimir, 2003, Breast J, V9 Suppl 2, pS75, DOI 10.1046/j.1524-4741.9.s2.7.x	58	18	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e95836	10.1371/journal.pone.0095836	http://dx.doi.org/10.1371/journal.pone.0095836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3CM	24769920	Green Published, gold			2022-12-25	WOS:000336736600016
J	Ghosh, TS; Sen Gupta, S; Bhattacharya, T; Yadav, D; Barik, A; Chowdhury, A; Das, B; Mande, SS; Nair, GB				Ghosh, Tarini Shankar; Sen Gupta, Sourav; Bhattacharya, Tanudeep; Yadav, Deepak; Barik, Anamitra; Chowdhury, Abhijit; Das, Bhabatosh; Mande, Sharmila S.; Nair, G. Balakrish			Gut Microbiomes of Indian Children of Varying Nutritional Status	PLOS ONE			English	Article							DIETARY FIBER; HEALTHY; MUCOSAL	Background: Malnutrition is a global health problem affecting more than 300 million pre-school children worldwide. It is one of the major health concerns in India since around 50% of children below the age of two suffer from various forms of malnutrition. The gut microbiome plays an important role in nutrient pre-processing, assimilation and energy harvest from food. Consequently, dysbiosis of the gut microbiota has been implicated in malnutrition. Methodology/Principal Findings: Metagenomics approach was adopted to investigate the gut microbiome sampled from 20 rural Indian children with varying nutritional status. The changes in the abundances of various taxonomic and functional groups were investigated across these gut microbiomes. A core set of 23 genera were observed across samples, with some showing differential abundances with varying nutritional status. One of the findings of the current study is the positive/negative associations of specific taxonomic and functional groups with the nutritional status of the children. Notable alterations in the architecture of the inter-microbial co-occurrence networks were also observed with changes in nutritional status. A key example is the clustering of potentially pathogenic groups into a distinct hub in severely malnourished gut. Our data does not demonstrate causality with the microbiome patterns that we observed, rather a description of some interesting patterns, whose underlying mechanism remains to be uncovered. Conclusions: The present study envisioned interrelationships between the pattern of gut microbiome and the nutritional status of children. The cause of this pattern needs to be explored. However, insights obtained from the present study form the basis for further metagenomic investigations on larger population of children. Results of such studies will be useful in identifying the key microbial groups that can be utilized for targeted therapeutic interventions for managing severe acute malnutrition.	[Ghosh, Tarini Shankar; Bhattacharya, Tanudeep; Yadav, Deepak; Mande, Sharmila S.] TCS Innovat Labs, Bio Sci R&D, Pune, Maharashtra, India; [Sen Gupta, Sourav; Das, Bhabatosh; Nair, G. Balakrish] Translat Hlth Sci & Technol Inst, Ctr Human Microbial Ecol, Gurgaon, India; [Chowdhury, Abhijit] Inst Post Grad Med Educ & Res, Sch Digest & Liver Dis, Dept Hepatol, Kolkata, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Mande, SS (corresponding author), TCS Innovat Labs, Bio Sci R&D, Pune, Maharashtra, India.	sharmila.mande@tcs.com; nairgb@thsti.res.in	Ghosh, Tarini/AAW-5456-2020	Ghosh, Tarini/0000-0001-9570-0365; SEN GUPTA, SOURAV/0000-0001-5861-0600; Das, Bhabatosh/0000-0002-2447-5380	Department of Biotechnology, Govt. of India [BT/MB/THSTI/HMC-SFC/2011]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was supported by the financial grant from the Department of Biotechnology, Govt. of India, for the establishment of Center for Human Microbial Ecology (Grant No. BT/MB/THSTI/HMC-SFC/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andoh A, 2003, CURR PHARM DESIGN, V9, P347, DOI 10.2174/1381612033391973; [Anonymous], 2012, REP ASS VOL AG RUR D; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Benus RFJ, 2010, BRIT J NUTR, V104, P693, DOI 10.1017/S0007114510001030; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Brown KH, 2003, J NUTR, V133, p328S, DOI 10.1093/jn/133.1.328S; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Ghosh TS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S14; Gordon JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004347; Gragnolati M, 2005, INDIAS UNDERNOURISHE; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hakansson A, 2011, NUTRIENTS, V3, P637, DOI 10.3390/nu3060637; Monira S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00228; Peuhkuri K, 2010, WORLD J GASTROENTERO, V16, P1057, DOI 10.3748/wjg.v16.i9.1057; Picot J, 2012, HEALTH TECHNOL ASSES, V16, pIX, DOI 10.3310/hta16190; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Sen Gupta S, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-7; Shoham J, 2009, FOOD NUTR BULL, V30, pS464, DOI 10.1177/15648265090303S306; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; UN, 2012, EST LEV TRENDS CHILD; Van den Abbeele P, 2011, ENVIRON MICROBIOL, V13, P2667, DOI 10.1111/j.1462-2920.2011.02533.x; World Health Organization, 2009, WHO CHILD GROWTH STA, DOI DOI 10.4067/S0370-41062009000400012; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	33	107	110	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95547	10.1371/journal.pone.0095547	http://dx.doi.org/10.1371/journal.pone.0095547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763225	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000026
J	Baeken, C; Marinazzo, D; Van Schuerbeek, P; Wu, GR; De Mey, J; Luypaert, R; De Raedt, R				Baeken, Chris; Marinazzo, Daniele; Van Schuerbeek, Peter; Wu, Guo-Rong; De Mey, Johan; Luypaert, Robert; De Raedt, Rudi			Left and Right Amygdala - Mediofrontal Cortical Functional Connectivity Is Differentially Modulated by Harm Avoidance	PLOS ONE			English	Article							PREFRONTAL CORTEX AREA-10; VALENCED BABY FACES; EMOTIONAL STIMULI; HEALTHY FEMALES; INDIVIDUAL-DIFFERENCES; MOOD DISORDERS; BRAIN; ANXIETY; ACTIVATION; COGNITION	Background: The left and right amygdalae are key regions distinctly involved in emotion-regulation processes. Individual differences, such as personality features, may affect the implicated neurocircuits. The lateralized amygdala affective processing linked with the temperament dimension Harm Avoidance (HA) remains poorly understood. Resting state functional connectivity imaging (rsFC) may provide more insight into these neuronal processes. Methods: In 56 drug-naive healthy female subjects, we have examined the relationship between the personality dimension HA on lateralized amygdala rsFC. Results: Across all subjects, left and right amygdalae were connected with distinct regions mainly within the ipsilateral hemisphere. Females scoring higher on HA displayed stronger left amygdala rsFC with ventromedial prefrontal cortical (vmPFC) regions involved in affective disturbances. In high HA scorers, we also observed stronger right amygdala rsFC with the dorsomedial prefrontal cortex (dmPFC), which is implicated in negative affect regulation. Conclusions: In healthy females, left and right amygdalae seem implicated in distinct mPFC brain networks related to HA and may represent a vulnerability marker for sensitivity to stress and anxiety (disorders).	[Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, B-9000 Ghent, Belgium; [Baeken, Chris] Univ Hosp UZBrussel, Dept Psychiat, Brussels, Belgium; [Baeken, Chris] Ghent Expt Psychiat GHEP Lab, Ghent, Belgium; [Marinazzo, Daniele; Wu, Guo-Rong] Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium; [Van Schuerbeek, Peter; De Mey, Johan; Luypaert, Robert] Univ Hosp UZBrussel, Dept Radiol & Med Imaging, Brussels, Belgium; [Wu, Guo-Rong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [De Raedt, Rudi] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Ghent University; Ghent University; University of Electronic Science & Technology of China; Ghent University	Baeken, C (corresponding author), Univ Ghent, Dept Psychiat & Med Psychol, B-9000 Ghent, Belgium.	chris.baeken@UGent.be	de Mey, Johan/F-3602-2011; De Raedt, Rudi/AAL-4093-2021; De Raedt, Rudi/A-3269-2012; Baeken, Chris/D-6790-2013; Marinazzo, Daniele/H-4793-2019; de Mey, Johan/AAL-9312-2021; Baeken, Chris/E-2074-2013	De Raedt, Rudi/0000-0001-6781-4808; De Raedt, Rudi/0000-0001-6781-4808; Marinazzo, Daniele/0000-0002-9803-0122; de Mey, Johan/0000-0002-3601-3212; Van Schuerbeek, Peter/0000-0003-3647-4446	Scientific Fund W. Gepts UZBrussel; Ghent University;  [BOF10/GOA/014]	Scientific Fund W. Gepts UZBrussel; Ghent University(Ghent University); 	This research was supported by a grant from the Scientific Fund W. Gepts UZBrussel and supported by the Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control". Preparation of this paper was also supported by Grant BOF10/GOA/014 for a Concerted Research Action of Ghent University (awarded to RDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Amting JM, 2010, J NEUROSCI, V30, P10039, DOI 10.1523/JNEUROSCI.6434-09.2010; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Baeken C, 2010, BEHAV BRAIN RES, V214, P450, DOI 10.1016/j.bbr.2010.06.029; Baeken C, 2012, BRAIN COGNITION, V80, P230, DOI 10.1016/j.bandc.2012.07.005; Baeken C, 2010, NEUROSCI LETT, V478, P97, DOI 10.1016/j.neulet.2010.04.073; Baeken C, 2009, BRAIN RES, V1296, P94, DOI 10.1016/j.brainres.2009.08.010; Beck AT, 1996, PSYCHOL ASSESS; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Bzdok D, 2013, HUM BRAIN MAPP, V34, P3247, DOI 10.1002/hbm.22138; Canli T, 2004, J PERS, V72, P1105, DOI 10.1111/j.1467-6494.2004.00292.x; Cerqueira JJ, 2008, BRAIN BEHAV IMMUN, V22, P630, DOI 10.1016/j.bbi.2008.01.005; Cisler JM, 2013, PSYCHOL MED, V43, P507, DOI 10.1017/S0033291712001390; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Cloninger CR, 2006, J AFFECT DISORDERS, V92, P35, DOI 10.1016/j.jad.2005.12.034; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Courtin J, 2013, NEUROSCIENCE, V240, P219, DOI 10.1016/j.neuroscience.2013.03.001; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Davidson RJ, 2002, BIOL PSYCHIAT, V52, P478, DOI 10.1016/S0006-3223(02)01458-0; Dolcos F, 2011, J COGN PSYCHOL, V23, P669, DOI 10.1080/20445911.2011.594433; Duijsens IJ, 2000, PERS INDIV DIFFER, V28, P487, DOI 10.1016/S0191-8869(99)00114-2; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Ferreira LK, 2013, NEUROSCI BIOBEHAV R, V37, P384, DOI 10.1016/j.neubiorev.2013.01.017; Fossati P, 2012, EUR NEUROPSYCHOPHARM, V22, pS487, DOI 10.1016/j.euroneuro.2012.07.008; Glascher J, 2003, J NEUROSCI, V23, P10274; Goossens L, 2009, HUM BRAIN MAPP, V30, P3332, DOI 10.1002/hbm.20755; Harrison NA, 2010, J NEUROSCI, V30, P12878, DOI 10.1523/JNEUROSCI.1725-10.2010; Hillert L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054781; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Kampman O, 2011, J AFFECT DISORDERS, V135, P20, DOI 10.1016/j.jad.2010.12.021; Kim JM, 2011, CEREB CORTEX, V21, P1667; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035925; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Marchetti I, 2012, NEUROPSYCHOL REV, V22, P229, DOI 10.1007/s11065-012-9199-9; Mather M, 2004, PSYCHOL SCI, V15, P259, DOI 10.1111/j.0956-7976.2004.00662.x; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Pannekoek JN, 2013, EUR NEUROPSYCHOPHARM, V23, P186, DOI 10.1016/j.euroneuro.2012.04.018; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Pujol J, 2009, PSYCHOL MED, V39, P1177, DOI 10.1017/S003329170800500X; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Ray RD, 2012, NEUROSCI BIOBEHAV R, V36, P479, DOI 10.1016/j.neubiorev.2011.08.005; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Shackman AJ, 2009, PSYCHOL SCI, V20, P1500, DOI 10.1111/j.1467-9280.2009.02476.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith R, 2011, BRAIN IMAGING BEHAV, V5, P229, DOI 10.1007/s11682-011-9127-2; Soloff PH, 2010, PSYCHIAT RES-NEUROIM, V181, P77, DOI 10.1016/j.pscychresns.2009.08.007; Spielberger CD, 1988, STAI MANUAL STATE TR; Sturm VE, 2013, SOC COGN AFFECT NEUR, V8, P468, DOI 10.1093/scan/nss023; Sullivan RM, 2002, PSYCHONEUROENDOCRINO, V27, P99, DOI 10.1016/S0306-4530(01)00038-5; Vaidya CJ, 2013, BRAIN CONNECT, V3, P99, DOI 10.1089/brain.2012.0110; Van Schuerbeek P, 2011, BRAIN RES, V1371, P32, DOI 10.1016/j.brainres.2010.11.073; Van Strien JW, 2000, BRAIN COGNITION, V44, P645, DOI 10.1006/brcg.1999.1137; Wager TD, 2005, NEUROREPORT, V16, P85, DOI 10.1097/00001756-200502080-00001; Wang DH, 2013, J NEUROPHYSIOL, V109, P46, DOI 10.1152/jn.00598.2012; Wang L, 2012, J AFFECT DISORDERS, V142, P6, DOI 10.1016/j.jad.2012.04.013; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wendelken C, 2008, J COGNITIVE NEUROSCI, V20, P682, DOI 10.1162/jocn.2008.20055; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	76	41	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95740	10.1371/journal.pone.0095740	http://dx.doi.org/10.1371/journal.pone.0095740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG3EI	24760033	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200084
J	De Filippo, K; Neill, DR; Mathies, M; Bangert, M; McNeill, E; Kadioglu, A; Hogg, N				De Filippo, Katia; Neill, Daniel R.; Mathies, Meg; Bangert, Mathieu; McNeill, Eileen; Kadioglu, Aras; Hogg, Nancy			A new protective role for S100A9 in regulation of neutrophil recruitment during invasive pneumococcal pneumonia	FASEB JOURNAL			English	Article						Streptococcus pneumoniae; leukocytes; G-CSF	COLONY-STIMULATING FACTOR; MYELOID-RELATED PROTEIN-8/14; G-CSF; STREPTOCOCCUS-PNEUMONIAE; LEUKOCYTE RECRUITMENT; IMMUNE-RESPONSE; LUNG INFECTION; HOST RESPONSE; GRANULOCYTE; EXPRESSION	The S100A8/A9 heterodimer is abundantly expressed by myeloid cells, especially neutrophils, but its mechanism of action is only partially determined. In this study we investigated S100A8/A9 involvement in the host response to Streptococcus pneumoniae infection making use of S100a9(-/-) mice that lack heterodimer expression in myeloid cells. S100a9(-/-) mice that were infected intranasally with pneumococci rapidly succumbed, with 80% mortality after 48 h, whereas the majority of wild-type mice recovered. Over this time period, S100a9(-/-) mice displayed an average 6-fold reduction in circulating and lung-recruited neutrophils. Taqman analysis of S100a9(-/-) lungs revealed decreased production of a dominant subset of 5 cytokines and chemokines associated with neutrophil recruitment. The greatest differential was with the cytokine granulocyte colony-stimulating factor (G-CSF) that causes bone marrow release of neutrophils into the circulation (1900-fold difference at 48 h). Treating S100a9(-/-) mice with G-CSF reversed their increased susceptibility to infection by enhancing both circulating neutrophils and neutrophil recruitment into infected lungs, by reducing pneumococcal colony forming units, and by elevation of chemokine CXCL1, cytokine IL-6, and endogenous G-CSF proteins. Thus S100A9, potentially with its partner S100A8, makes a major contribution in the host response to pneumococcal infection by increasing circulating neutrophils principally regulation of G-CSF production.-De Filippo, K., Neill, D. R., Mathies, M., Bangert, M., McNeill, E., Kadioglu, A., Hogg, N. A new protective role for S100A9 in regulation of neutrophil recruitment during invasive pneumococcal pneumonia.	[De Filippo, Katia; Mathies, Meg; McNeill, Eileen; Hogg, Nancy] Canc Res UK London Res Inst, Leukocyte Adhes Lab, London WC2A 3LY, England; [Neill, Daniel R.; Bangert, Mathieu; Kadioglu, Aras] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Neill, Daniel R.; Bangert, Mathieu; Kadioglu, Aras] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England	Cancer Research UK; University of Liverpool; University of Leicester	Hogg, N (corresponding author), Canc Res UK London Res Inst, Leukocyte Adhes Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	nancy.hogg@cancer.org.uk	Neill, Daniel/E-1403-2012; Neill, Daniel/Q-6290-2019; Bangert, Mathieu/K-7233-2019	Neill, Daniel/0000-0002-7911-8153; Neill, Daniel/0000-0002-7911-8153; De Filippo, Katia/0000-0002-2863-8888; McNeill, Eileen/0000-0003-0971-9858; kadioglu, aras/0000-0003-1137-6321; Bangert, Mathieu/0000-0003-1320-8145				Achouiti A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002987; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Balakrishnan I, 2000, J INFECTION, V40, P256, DOI 10.1053/jinf.2000.0653; Bergeron Y, 1998, INFECT IMMUN, V66, P912, DOI 10.1128/IAI.66.3.912-922.1998; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berthier S, 2003, J BIOL CHEM, V278, P25499, DOI 10.1074/jbc.M209755200; Bianchi M, 2011, J ALLERGY CLIN IMMUN, V127, P1243, DOI 10.1016/j.jaci.2011.01.021; Burdon PCE, 2008, BRIT J HAEMATOL, V142, P100, DOI 10.1111/j.1365-2141.2008.07018.x; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; DEMETRI GD, 1991, BLOOD, V78, P2791; DENNY FW, 1986, AM J TROP MED HYG, V35, P1; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Endoh Y, 2009, J IMMUNOL, V182, P2258, DOI 10.4049/jimmunol.0802683; Gingles NA, 2001, INFECT IMMUN, V69, P426, DOI 10.1128/IAI.69.1.426-434.2001; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hierholzer C, 1997, AM J PHYSIOL-LUNG C, V273, pL1058, DOI 10.1152/ajplung.1997.273.5.L1058; HIRSCH S, 1983, IMMUNOGENETICS, V18, P229, DOI 10.1007/BF00952962; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Hoggatt J, 2011, CURR OPIN HEMATOL, V18, P231, DOI 10.1097/MOH.0b013e3283477962; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Kadioglu A, 2004, INFECT IMMUN, V72, P2689, DOI 10.1128/IAI.72.5.2689-2697.2004; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kadioglu A, 2011, J IMMUNOL, V186, P5907, DOI 10.4049/jimmunol.1001533; Kohler A, 2011, BLOOD, V117, P4349, DOI 10.1182/blood-2010-09-308387; Lauw FN, 2002, J IMMUNOL, V168, P372, DOI 10.4049/jimmunol.168.1.372; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Liu FL, 1997, BLOOD, V90, P2583, DOI 10.1182/blood.V90.7.2583.2583_2583_2590; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Markowitz J, 2013, BBA-REV CANCER, V1835, P100, DOI 10.1016/j.bbcan.2012.10.003; McDonald B, 2010, IMMUNITY, V33, P148, DOI 10.1016/j.immuni.2010.08.006; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Passey RJ, 1999, J LEUKOCYTE BIOL, V66, P549, DOI 10.1002/jlb.66.4.549; PATON JC, 1993, ANNU REV MICROBIOL, V47, P89, DOI 10.1146/annurev.mi.47.100193.000513; Quinton LJ, 2002, J INFECT DIS, V185, P1476, DOI 10.1086/340504; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Schnekenburger J, 2008, J CELL PHYSIOL, V216, P558, DOI 10.1002/jcp.21433; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Shimizu K, 2011, CIRCULATION, V124, P2920, DOI 10.1161/CIRCULATIONAHA.110.009910; Srikrishna G, 2012, J INNATE IMMUN, V4, P31, DOI 10.1159/000330095; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Walker F, 2008, BLOOD, V111, P3978, DOI 10.1182/blood-2007-10-119636; Wang Y., 2014, J CLIN INVEST; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	57	32	32	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3600	3608		10.1096/fj.13-247460	http://dx.doi.org/10.1096/fj.13-247460			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24776746				2022-12-25	WOS:000340265400028
J	Canas, C; Suzuki, Y; Marchisone, C; Carrasco, B; Freire-Beneitez, V; Takeyasu, K; Alonso, JC; Ayora, S				Canas, Cristina; Suzuki, Yuki; Marchisone, Chiara; Carrasco, Begona; Freire-Beneitez, Veronica; Takeyasu, Kunio; Alonso, Juan C.; Ayora, Silvia			Interaction of Branch Migration Translocases with the Holliday Junction-resolving Enzyme and Their Implications in Holliday Junction Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; ESCHERICHIA-COLI RUVA; BACILLUS-SUBTILIS; DNA-REPLICATION; HOMOLOGOUS RECOMBINATION; IN-VITRO; MYCOPLASMA-PNEUMONIAE; GENETIC-RECOMBINATION; ATPASE ACTIVITY; RECG HELICASE	Double-strand break repair involves the formation of Holliday junction (HJ) structures that need to be resolved to promote correct replication and chromosomal segregation. The molecular mechanisms of HJ branch migration and/or resolution are poorly characterized in Firmicutes. Genetic evidence suggested that the absence of the RuvAB branch migration translocase and the RecU HJ resolvase is synthetically lethal in Bacillus subtilis, whereas a recU recG mutant was viable. In vitro RecU, which is restricted to bacteria of the Firmicutes phylum, binds HJs with high affinity. In this work we found that RecU does not bind simultaneously with RecG to a HJ. RuvB by interacting with RecU bound to the central region of HJ DNA, loses its nonspecific association with DNA, and re-localizes with RecU to form a ternary complex. RecU cannot stimulate the ATPase or branch migration activity of RuvB. The presence of RuvB.ATP gamma S greatly stimulates RecU-mediated HJ resolution, but the addition of ATP or RuvA abolishes this stimulatory effect. A RecU.HJ.RuvAB complex might be formed. RecU does not increase the RuvAB activities but slightly inhibits them.	[Canas, Cristina; Marchisone, Chiara; Carrasco, Begona; Freire-Beneitez, Veronica; Alonso, Juan C.; Ayora, Silvia] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid 28049, Spain; [Suzuki, Yuki; Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Kyoto University	Alonso, JC (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid 28049, Spain.	jcalonso@cnb.cisc.es; sayora@cnb.cisc.es	Suzuki, Yuki/H-9950-2015; Ayora, Silvia/D-2552-2009; Alonso, Juan Carlos/D-2595-2009	Suzuki, Yuki/0000-0003-1848-0105; Ayora, Silvia/0000-0003-3121-1786; Alonso, Juan Carlos/0000-0002-5178-7179; Carrasco, Begona/0000-0002-5671-1296; Freire Beneitez, Veronica/0000-0003-1485-8596	Ministerio de Economia y Competividad (MINECO) [BFU2012-39879-C02-01, CSD2007-00010, BFU2012-39879-C02-02]; Comunidad de Madrid [S2009MAT-1507]; Japan-Spain Bilateral Joint Project [2010JP0017];  [BFU2006-01062]	Ministerio de Economia y Competividad (MINECO); Comunidad de Madrid(Comunidad de Madrid); Japan-Spain Bilateral Joint Project; 	This work was supported by Ministerio de Economia y Competividad (MINECO) Grants BFU2012-39879-C02-01, CSD2007-00010 (to J. C. A.) and BFU2012-39879-C02-02 (to S. A.), by Comunidad de Madrid Grant S2009MAT-1507 (to J. C. A.), and Japan-Spain Bilateral Joint Project Award 2010JP0017 (to J. C. A. and K. T.).; Recipient of a Fellowship (BFU2006-01062 to J. C. A.).	Abd Wahab S, 2013, J BIOL CHEM, V288, P26397, DOI 10.1074/jbc.M113.500223; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; Ayora S, 2004, P NATL ACAD SCI USA, V101, P452, DOI 10.1073/pnas.2533829100; Ayora S, 2011, FEMS MICROBIOL REV, V35, P1055, DOI 10.1111/j.1574-6976.2011.00272.x; Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; Bradley AS, 2011, J BIOL CHEM, V286, P22372, DOI 10.1074/jbc.M111.233908; Canas C, 2008, NUCLEIC ACIDS RES, V36, P5242, DOI 10.1093/nar/gkn500; Canas C, 2011, J MOL BIOL, V410, P39, DOI 10.1016/j.jmb.2011.05.008; Carrasco B, 2005, NUCLEIC ACIDS RES, V33, P3942, DOI 10.1093/nar/gki713; Carrasco B, 2004, J BACTERIOL, V186, P5557, DOI 10.1128/JB.186.17.5557-5566.2004; Carrasco B, 2009, J MOL BIOL, V390, P1, DOI 10.1016/j.jmb.2009.04.065; Davies AA, 1998, CURR BIOL, V8, P725, DOI 10.1016/S0960-9822(98)70282-9; Dawid A, 2004, P NATL ACAD SCI USA, V101, P11611, DOI 10.1073/pnas.0404369101; Declais AC, 2008, CURR OPIN STRUC BIOL, V18, P86, DOI 10.1016/j.sbi.2007.11.001; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Estevao S, 2011, J BACTERIOL, V193, P6425, DOI 10.1128/JB.06003-11; Fogg JM, 2000, BIOCHEMISTRY-US, V39, P4082, DOI 10.1021/bi992785v; Garcia-Gonzalez A, 2013, GENE, V528, P295, DOI 10.1016/j.gene.2013.05.082; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; HOLLIDAY R, 1964, GENETICS, V50, P323; Kang J, 2008, J BACTERIOL, V190, P4218, DOI 10.1128/JB.01848-07; Khanduja JS, 2012, J BIOL CHEM, V287, P1345, DOI 10.1074/jbc.M111.304741; Kosa JL, 2004, MUTAT RES-FUND MOL M, V554, P149, DOI 10.1016/j.mrfmmm.2004.04.011; Lee YC, 2003, J MOL BIOL, V333, P677, DOI 10.1016/j.jmb.2003.08.047; LLOYD RG, 1991, J BACTERIOL, V173, P5414, DOI 10.1128/jb.173.17.5414-5418.1991; Lo Piano A, 2011, VIRUS RES, V160, P1, DOI 10.1016/j.virusres.2011.06.009; MANDAL TN, 1993, J BACTERIOL, V175, P4325, DOI 10.1128/JB.175.14.4325-4334.1993; Manosas M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3368; MCCULLOCH R, 1994, EMBO J, V13, P1844, DOI 10.1002/j.1460-2075.1994.tb06453.x; McGlynn P, 2002, TRENDS GENET, V18, P413, DOI 10.1016/S0168-9525(02)02720-8; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; McGregor N, 2005, STRUCTURE, V13, P1341, DOI 10.1016/j.str.2005.05.011; MITCHELL AH, 1994, J MOL BIOL, V243, P208, DOI 10.1006/jmbi.1994.1648; Nettikadan S, 1996, BIOCHEM BIOPH RES CO, V226, P645, DOI 10.1006/bbrc.1996.1409; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; Pratto F, 2009, J BIOL CHEM, V284, P30298, DOI 10.1074/jbc.M109.035410; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; Sanchez H, 2005, GENETICS, V171, P873, DOI 10.1534/genetics.105.045906; Sanchez H, 2007, MOL MICROBIOL, V65, P920, DOI 10.1111/j.1365-2958.2007.05835.x; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Sechman EV, 2006, MOL MICROBIOL, V61, P185, DOI 10.1111/j.1365-2958.2006.05213.x; SHARPLES GJ, 1994, EMBO J, V13, P6133, DOI 10.1002/j.1460-2075.1994.tb06960.x; Sluijter M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038301; Sluijter M, 2010, MOL MICROBIOL, V77, P1261, DOI 10.1111/j.1365-2958.2010.07288.x; Suzuki Y., 2014, NUCL ACIDS IN PRESS; Thakur RS, 2013, FEBS J, V280, P1841, DOI 10.1111/febs.12208; Tong J, 1996, J BACTERIOL, V178, P2695, DOI 10.1128/jb.178.9.2695-2700.1996; van Gool AJ, 1998, EMBO J, V17, P1838, DOI 10.1093/emboj/17.6.1838; van Gool AJ, 1999, GENE DEV, V13, P1861, DOI 10.1101/gad.13.14.1861; Wen Q, 2005, DNA REPAIR, V4, P23, DOI 10.1016/j.dnarep.2004.07.008; West SC, 2009, BIOCHEM SOC T, V37, P519, DOI 10.1042/BST0370519; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; White MF, 2011, BIOCHEM SOC T, V39, P15, DOI 10.1042/BST0390015; Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326; Zecchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048440; Zegeye ED, 2012, MICROBIOL-SGM, V158, P1982, DOI 10.1099/mic.0.058693-0; Zerbib D, 1997, J MOL BIOL, V270, P663, DOI 10.1006/jmbi.1997.1157	60	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17634	17646		10.1074/jbc.M114.552794	http://dx.doi.org/10.1074/jbc.M114.552794			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24770420	hybrid, Green Published			2022-12-25	WOS:000338018100028
J	Ludwig, M; Pandelia, ME; Chew, CY; Zhang, B; Golbeck, JH; Krebs, C; Bryant, DA				Ludwig, Marcus; Pandelia, Maria-Eirini; Chew, Chyue Yie; Zhang, Bo; Golbeck, John H.; Krebs, Carsten; Bryant, Donald A.			ChlR Protein of Synechococcus sp PCC 7002 Is a Transcription Activator That Uses an Oxygen-sensitive [4Fe-4S] Cluster to Control Genes involved in Pigment Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPROPORPHYRINOGEN-III OXIDASE; ESCHERICHIA-COLI; CHLOROBIUM-TEPIDUM; CRYSTAL-STRUCTURE; HEME OXYGENASE; SUFBCDS OPERON; 2FE-2S; BIOGENESIS; CLONING; FNR	Synechococcus sp. PCC 7002 and many other cyanobacteria have two genes that encode key enzymes involved in chlorophyll a, biliverdin, and heme biosynthesis: acsF(I)/acsF(II), ho1/ho2, and hemF/hemN. Under atmospheric O-2 levels, AcsF(I) synthesizes 3,8-divinyl protochlorophyllide from Mg-protoporphyrin IX monomethyl ester, Ho1 oxidatively cleaves heme to form biliverdin, and HemF oxidizes coproporphyrinogen III to protoporphyrinogen IX. Under microoxic conditions, another set of genes directs the synthesis of alternative enzymes AcsF(II), Ho2, and HemN. In Synechococcus sp. PCC 7002, open reading frame SynPCC7002_ A1993 encodes a MarR family transcriptional regulator, which is located immediately upstream from the operon comprising acsF(II), ho2, hemN, and desF (the latter encodes a putative fatty acid desaturase). Deletion and complementation analyses showed that this gene, denoted chlR, is a transcriptional activator that is essential for transcription of the acsF(II)-ho2-hemN-desF operon under microoxic conditions. Global transcriptome analyses showed that ChlR controls the expression of only these four genes. Co-expression of chlR with a yfp reporter gene under the control of the acsF(II) promoter from Synechocystis sp. PCC 6803 in Escherichia coli demonstrated that no other cyanobacterium-specific components are required for proper functioning of this regulatory circuit. A combination of analytical methods and Mossbauer and EPR spectroscopies showed that reconstituted, recombinant ChlR forms homodimers that harbor one oxygen-sensitive [4Fe-4S] cluster. We conclude that ChlR is a transcriptional activator that uses a [4Fe-4S] cluster to sense O-2 levels and thereby control the expression of the acsF(II)-ho2-hemN-desF operon.	[Ludwig, Marcus; Chew, Chyue Yie; Golbeck, John H.; Krebs, Carsten; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Pandelia, Maria-Eirini; Zhang, Bo; Golbeck, John H.; Krebs, Carsten] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA.	dab14@psu.edu	Zhang, Bo/O-9996-2014; Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053	Air Force Office of Scientific Research Multidisciplinary University Research Initiative Grant [FA9550-11-1-0148]; National Science Foundation [MCB-1021725]; Direct For Biological Sciences [1021725] Funding Source: National Science Foundation	Air Force Office of Scientific Research Multidisciplinary University Research Initiative Grant; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Air Force Office of Scientific Research Multidisciplinary University Research Initiative Grant FA9550-11-1-0148 (to D. A. B.) and National Science Foundation Grant MCB-1021725 (to D. A. B. and J. H. G.).	Alvey RM, 2011, J BACTERIOL, V193, P1663, DOI 10.1128/JB.01392-10; Aoki R, 2012, J BIOL CHEM, V287, P13500, DOI 10.1074/jbc.M112.346205; Aoki R, 2011, PLANT CELL PHYSIOL, V52, P1744, DOI 10.1093/pcp/pcr108; BEALE SI, 1993, CHEM REV, V93, P785, DOI 10.1021/cr00018a008; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Beinert H, 1978, Methods Enzymol, V54, P435; Bennette NB, 2011, ANAL CHEM, V83, P3808, DOI 10.1021/ac200108a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryant D.A., 1994, MOL BIOL CYANOBACTER; Bryant DA, 2013, ADV BOT RES, V66, P99, DOI 10.1016/B978-0-12-397923-0.00004-7; Cannon WR, 2011, J PROTEOME RES, V10, P2306, DOI 10.1021/pr101130b; Cicchillo RM, 2004, J BIOL CHEM, V279, P32418, DOI 10.1074/jbc.M404381200; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; Flores E, 2005, PHOTOSYNTH RES, V83, P117, DOI 10.1007/s11120-004-5830-9; Frigaard NU, 2004, METH MOL B, V274, P325; Frigaard NU, 2004, J BACTERIOL, V186, P646, DOI 10.1128/JB.186.3.646-653.2004; Goto T, 2010, PLANT CELL PHYSIOL, V51, P650, DOI 10.1093/pcp/pcq023; Grove TL, 2013, BIOCHEMISTRY-US, V52, P2874, DOI 10.1021/bi400136u; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Jervis AJ, 2009, P NATL ACAD SCI USA, V106, P4659, DOI 10.1073/pnas.0804943106; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Layer G, 2004, CURR OPIN CHEM BIOL, V8, P468, DOI 10.1016/j.cbpa.2004.08.001; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ludwig M, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00145, 10.3389/fmicb.2012.00354]; Ludwig M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00041; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Phillips JD, 2004, J BIOL CHEM, V279, P38960, DOI 10.1074/jbc.M406050200; Porra RJ, 1996, EUR J BIOCHEM, V239, P85, DOI 10.1111/j.1432-1033.1996.0085u.x; Roche B, 2013, BBA-BIOENERGETICS, V1827, P923, DOI 10.1016/j.bbabio.2013.05.001; SAKAMOTO T, 1994, J BIOL CHEM, V269, P25576; Sakamoto T, 1997, MOL MICROBIOL, V23, P1281, DOI 10.1046/j.1365-2958.1997.3071676.x; Saunders AH, 2008, BIOCHEMISTRY-US, V47, P10999, DOI 10.1021/bi801268f; Shen G, 2007, J BIOL CHEM, V282, P31909, DOI 10.1074/jbc.M705554200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; STEVENS SE, 1980, P NATL ACAD SCI-BIOL, V77, P6052, DOI 10.1073/pnas.77.10.6052; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; SWEENEY WV, 1980, ANNU REV BIOCHEM, V49, P139, DOI 10.1146/annurev.bi.49.070180.001035; TRAUTWEIN AX, 1991, STRUCT BOND, V78, P1; TROUP B, 1994, J BACTERIOL, V176, P673, DOI 10.1128/jb.176.3.673-680.1994; TROUP B, 1995, J BACTERIOL, V177, P3326, DOI 10.1128/jb.177.11.3326-3331.1995; Wang T, 2004, J BACTERIOL, V186, P956, DOI 10.1128/JB.186.4.956-967.2004; Xu Y., 2010, THESIS PENNSYLVANIA; Xu Y, 2011, METHODS MOL BIOL, V684, P273, DOI [10.1007/978.1.60761.925.3_21, 10.1007/978-1-60761-925-3_21]; Yilmaz M, 2010, PHOTOSYNTH RES, V103, P47, DOI 10.1007/s11120-009-9506-3; Yu JP, 2003, J BACTERIOL, V185, P3878, DOI 10.1128/JB.185.13.3878-3887.2003; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109; Zhang XH, 2005, FEBS J, V272, P1012, DOI 10.1111/j.1742-4658.2004.04535.x	57	18	19	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16624	16639		10.1074/jbc.M114.561233	http://dx.doi.org/10.1074/jbc.M114.561233			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24782315	hybrid, Green Published			2022-12-25	WOS:000338016200002
J	Hoede, C; Arnoux, S; Moisset, M; Chaumier, T; Inizan, O; Jamilloux, V; Quesneville, H				Hoede, Claire; Arnoux, Sandie; Moisset, Mark; Chaumier, Timothee; Inizan, Olivier; Jamilloux, Veronique; Quesneville, Hadi			PASTEC: An Automatic Transposable Element Classification Tool	PLOS ONE			English	Article							SEQUENCES	The classification of transposable elements (TEs) is key step towards deciphering their potential impact on the genome. However, this process is often based on manual sequence inspection by TE experts. With the wealth of genomic sequences now available, this task requires automation, making it accessible to most scientists. We propose a new tool, PASTEC, which classifies TEs by searching for structural features and similarities. This tool outperforms currently available software for TE classification. The main innovation of PASTEC is the search for HMM profiles, which is useful for inferring the classification of unknown TE on the basis of conserved functional domains of the proteins. In addition, PASTEC is the only tool providing an exhaustive spectrum of possible classifications to the order level of the Wicker hierarchical TE classification system. It can also automatically classify other repeated elements, such as SSR (Simple Sequence Repeats), rDNA or potential repeated host genes. Finally, the output of this new tool is designed to facilitate manual curation by providing to biologists with all the evidence accumulated for each TE consensus.	[Hoede, Claire; Arnoux, Sandie; Moisset, Mark; Chaumier, Timothee; Inizan, Olivier; Jamilloux, Veronique; Quesneville, Hadi] INRA, URGI Res Unit Genom Info UR1164, F-78026 Versailles, France; [Hoede, Claire] INRA, Plateforme Bioinformat Genotoul Math & Informat A, UR875, F-31326 Castanet Tolosan, France; [Arnoux, Sandie] INRA, LUNAM Universite, BioEpAR UMR1300, F-44026 Nantes, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE	Quesneville, H (corresponding author), INRA, URGI Res Unit Genom Info UR1164, F-78026 Versailles, France.	Hadi.quesneville@versailles.inra.fr	Quesneville, Hadi/AAG-1048-2020	Quesneville, Hadi/0000-0003-3001-4908; Jamilloux, Veronique/0000-0002-6898-4910; Hoede, Claire/0000-0001-5054-7731	French National Research Agency [ANR-08-KBBE-012-02]	French National Research Agency(French National Research Agency (ANR))	Claire Hoede's work was supported by a grant from the French National Research. Agency (ANR-08-KBBE-012-02) attributed to Hadi Quesneville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusan G, 2009, BIOINFORMATICS, V25, P1329, DOI 10.1093/bioinformatics/btp084; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergman CM, 2007, BRIEF BIOINFORM, V8, P382, DOI 10.1093/bib/bbm048; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Feschotte C, 2009, GENOME BIOL EVOL, V1, P205, DOI 10.1093/gbe/evp023; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Permal Emmanuelle, 2012, Methods Mol Biol, V859, P53, DOI 10.1007/978-1-61779-603-6_3; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165	9	155	155	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e91929	10.1371/journal.pone.0091929	http://dx.doi.org/10.1371/journal.pone.0091929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24786468	gold, Green Submitted, Green Published			2022-12-25	WOS:000336655700003
J	Wachowicz, K; Hermann-Kleiter, N; Meisel, M; Siegmund, K; Thuille, N; Baier, G				Wachowicz, Katarzyna; Hermann-Kleiter, Natascha; Meisel, Marlies; Siegmund, Kerstin; Thuille, Nikolaus; Baier, Gottfried			Protein Kinase C theta Regulates the Phenotype of Murine CD4(+) Th17 Cells	PLOS ONE			English	Article							IFN-GAMMA EXPRESSION; PKC-THETA; T-CELLS; DIFFERENTIAL REGULATION; INTERFERON-GAMMA; TGF-BETA; STAT4; GENE; RESPONSES; MECHANISMS	Protein kinase C theta (PKC theta) is involved in signaling downstream of the T cell antigen receptor (TCR) and is important for shaping effector T cell functions and inflammatory disease development. Acquisition of Th1-like effector features by Th17 cells has been linked to increased pathogenic potential. However, the molecular mechanisms underlying Th17/Th1 phenotypic instability remain largely unknown. In the current study, we address the role of PKC theta in differentiation and function of Th17 cells by using genetic knock-out mice. Implementing in vitro (polarizing T cell cultures) and in vivo (experimental autoimmune encephalomyelitis model, EAE) techniques, we demonstrated that PKC theta-deficient CD4(+) T cells show normal Th17 marker gene expression (interleukin 17A/F, ROR gamma t), accompanied by enhanced production of the Th1-typical markers such as interferon gamma (IFN-gamma) and transcription factor T-bet. Mechanistically, this phenotype was linked to aberrantly elevated Stat4 mRNA levels in PKC theta(-/-) CD4(+) T cells during the priming phase of Th17 differentiation. In contrast, transcription of the Stat4 gene was suppressed in Th17-primed wild-type cells. This change in cellular effector phenotype was reflected in vivo by prolonged neurological impairment of PKC theta-deficient mice during the course of EAE. Taken together, our data provide genetic evidence that PKC theta is critical for stabilizing Th17 cell phenotype by selective suppression of the STAT4/IFN-gamma/T-bet axis at the onset of differentiation.	[Wachowicz, Katarzyna; Hermann-Kleiter, Natascha; Meisel, Marlies; Siegmund, Kerstin; Thuille, Nikolaus; Baier, Gottfried] Med Univ Innsbruck, Dept Pharmacol & Genet, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Baier, G (corresponding author), Med Univ Innsbruck, Dept Pharmacol & Genet, A-6020 Innsbruck, Austria.	Gottfried.Baier@i-med.ac.at	Bellaire-Siegmund, Kerstin/AAA-9702-2021; Kleiter, Natascha/I-5101-2018; Bellaire-Siegmund, Kerstin/D-4774-2018	Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Kleiter, Natascha/0000-0003-4389-9813; Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Baier, Gottfried/0000-0002-2085-8325; Thuille, Nikolaus/0000-0002-2253-3946	Austrian Science Fund (MCBO-DK) [SFB-021, P23537-B13, P25044-B21]; European Community [HEALTH-F4-2008-201106]; Austrian Science Fund (FWF) [P 25044, P 23537] Funding Source: researchfish	Austrian Science Fund (MCBO-DK)(Austrian Science Fund (FWF)); European Community(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the Austrian Science Fund (MCBO-DK, SFB-021, P23537-B13 and P25044-B21), http://www.fwf.ac.at/en/index. asp, and the European Community Program SYBILLA grant agreement HEALTH-F4-2008-201106, http://sybilla-t-cell.de/de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Pham D, 2013, J IMMUNOL, V191, P902, DOI 10.4049/jimmunol.1203229; Ferber IA, 1996, J IMMUNOL, V156, P5; Foletta VC, 1996, IMMUNOL CELL BIOL, V74, P121, DOI 10.1038/icb.1996.17; Gruber T, 2009, MOL IMMUNOL, V46, P2071, DOI 10.1016/j.molimm.2009.02.030; Hermann-Kleiter N, 2008, IMMUNITY, V29, P205, DOI 10.1016/j.immuni.2008.06.008; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Huang Y, 2011, J LEUKOCYTE BIOL, V90, P87, DOI 10.1189/jlb.1210674; Isakov N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00273; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Kurschus FC, 2010, EUR J IMMUNOL, V40, P3336, DOI 10.1002/eji.201040755; Kwon MJ, 2012, J IMMUNOL, V188, P5887, DOI 10.4049/jimmunol.1102941; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Lupov IP, 2011, BLOOD, V118, P6097, DOI 10.1182/blood-2011-03-341867; Marsland BJ, 2005, P NATL ACAD SCI USA, V102, P14374, DOI 10.1073/pnas.0506250102; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; Meisel M, 2013, IMMUNITY, V38, P41, DOI 10.1016/j.immuni.2012.09.021; Mittleman BB, 1996, J CLIN IMMUNOL, V16, P230, DOI 10.1007/BF01541229; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nishanth G, 2010, INFECT IMMUN, V78, P3454, DOI 10.1128/IAI.01407-09; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Salek-Ardakani S, 2005, J IMMUNOL, V175, P7635, DOI 10.4049/jimmunol.175.11.7635; Salek-Ardakani S, 2004, J IMMUNOL, V173, P6440, DOI 10.4049/jimmunol.173.10.6440; Santarlasci V, 2009, EUR J IMMUNOL, V39, P207, DOI 10.1002/eji.200838748; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Shin HJ, 2005, J IMMUNOL, V175, P7143, DOI 10.4049/jimmunol.175.11.7143; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sutcliffe EL, 2011, MOL CELL, V41, P704, DOI 10.1016/j.molcel.2011.02.030; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; van Rietschoten JGI, 2001, J BIOL CHEM, V276, P34509, DOI 10.1074/jbc.M102536200; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang KS, 2001, BLOOD, V97, P3860, DOI 10.1182/blood.V97.12.3860; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Williams CL, 2013, J IMMUNOL, V191, P678, DOI 10.4049/jimmunol.1203360; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang EY, 2013, ADV PHARMACOL, V66, P267, DOI 10.1016/B978-0-12-404717-4.00006-8; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	53	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96401	10.1371/journal.pone.0096401	http://dx.doi.org/10.1371/journal.pone.0096401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788550	Green Submitted, gold, Green Published			2022-12-25	WOS:000336655700087
J	Chen, F; Rao, XH; Yang, JL; Pan, MX; Gao, Y; Li, ZL; Li, Y; Zhu, YF; Wang, Y				Chen, Feng; Rao, Xiao-Hui; Yang, Jin-Lian; Pan, Ming-Xing; Gao, Yi; Li, Zhen-Lin; Li, Yang; Zhu, You-Fu; Wang, Yan			Up-Regulating CYP3A4 Expression in C3A Cells by Transfection with a Novel Chimeric Regulator of hPXR-p53-AD	PLOS ONE			English	Article							PREGNANE-X RECEPTOR; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; CYTOCHROME-P450 ENZYMES; DRUG DISPOSITION; HEPATOMA-CELLS; INDUCTION; METABOLISM; LINE; IDENTIFICATION	Most hepatoma cell lines lack proper expression and induction of CYP3A4 enzyme, which limits their use for predicting drug metabolism and toxicity. Nuclear receptor pregnane X receptor (PXR) has been well recognized for its critical role in regulating expression of CYP3A4 gene. However, its physiological activity of binding to the particular site of promoter is significantly weakened in hepatic cell lines. To address this problem, we created "chimeric PXR" constructs by appending a strong activation domain (AD) from p53 subunit to either N- or C-termini of the human PXR (hPXR), that is, hPXR-p53 and p53-hPXR. C3A, a hepatoma cell line, was used as the cell model to test the regulation effect of chimeric hPXR over wild type (WT) hPXR on CYP3A4 expression at gene, protein, and metabolism levels, respectively. Compared with C3A cells transiently transfected with WT hPXR, the activity of CYP3A4.XREM.luc reporter gene in C3A cells transfected with hPXR-p53 or p53-hPXR increased 5- and 9-fold respectively, and the levels of CYP3A4 mRNA expression increased 3.5- and 2.6-fold, respectively. C3A cells stably transfected with hPXR-p53-AD exhibited an improved expression of CYP3A4 at both gene (2-fold) and protein (1.5-fold) levels compared to WT C3A cells. Testosterone, a CYP3A4-specific substrate, was used for detecting the metabolism activity of CYP3A4. No testosterone metabolite could be detected in microsomes from WT C3A cells and WT C3A cells-based array, while the formation of 6 beta-hydroxytestosterone metabolite in the transfected cells was 714 and 55 pmol/mg protein/min, respectively. In addition, all the above expression levels in the transfected cell models could be further induced with additional treatment of Rifampicin, a specific inducer for CYP3A4. In conclusion, our study established a proof-of-principle example that genetic modification with chimeric hPXR-p53-AD could improve CYP3A4 metabolism ability in hepatic cell line.	[Chen, Feng; Yang, Jin-Lian; Pan, Ming-Xing; Gao, Yi; Li, Yang; Wang, Yan] Southern Med Univ, Zhujiang Hosp, Inst Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Rao, Xiao-Hui] Huizhou Municipal Cent Hosp, Dept Hepatobiliary Surg, Huizhou, Peoples R China; [Pan, Ming-Xing; Gao, Yi; Wang, Yan] Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China; [Li, Zhen-Lin] Southern Med Univ, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China; [Zhu, You-Fu] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Wang, Y (corresponding author), Southern Med Univ, Zhujiang Hosp, Inst Regenerat Med, Guangzhou, Guangdong, Peoples R China.	yanwang@smu.edu.cn		Chen, Feng/0000-0002-6366-5064	National Natural Science Foundation of China [31100701]; Research Grant for the Doctoral Program of Higher Education Institution by the Ministry of Education of China [20114433120001]; Southern Medical University Zhujiang Hospital Young Talent Project [2012003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grant for the Doctoral Program of Higher Education Institution by the Ministry of Education of China; Southern Medical University Zhujiang Hospital Young Talent Project	This work is supported partly by the National Natural Science Foundation of China (31100701), the Research Grant for the Doctoral Program of Higher Education Institution by the Ministry of Education of China (20114433120001), and the Southern Medical University Zhujiang Hospital Young Talent Project (2012003) funding to Prof. Yan Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butura A, 2004, BIOCHEM PHARMACOL, V67, P1249, DOI 10.1016/j.bcp.2003.10.033; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; CHANG J, 1995, J BIOL CHEM, V270, P25014, DOI 10.1074/jbc.270.42.25014; COSGROVE PG, 1993, J LIPID RES, V34, P1983; Donato MT, 2008, CURR DRUG METAB, V9, P1; Elizondo G, 2003, LIFE SCI, V73, P141, DOI 10.1016/S0024-3205(03)00262-5; Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357; Gellner K, 2001, PHARMACOGENETICS, V11, P111, DOI 10.1097/00008571-200103000-00002; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Gomez-Lechon MJ, 2001, EUR J BIOCHEM, V268, P1448, DOI 10.1046/j.1432-1327.2001.02011.x; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; Hariparsad N, 2009, NUCLEIC ACIDS RES, V37, P1160, DOI 10.1093/nar/gkn1047; Hewitt NJ, 2007, XENOBIOTICA, V37, P1196, DOI 10.1080/00498250701534893; Hewitt NJ, 2004, XENOBIOTICA, V34, P243, DOI 10.1080/00498250310001657568; Honkakoski P., 2003, Current Pharmacogenomics, V1, P75, DOI 10.2174/1570160033476296; Honkakoski P, 2001, PHARMACEUT RES, V18, P146, DOI 10.1023/A:1011068015301; Jover R, 1998, FEBS LETT, V431, P227, DOI 10.1016/S0014-5793(98)00746-7; Korjamo T, 2005, EUR J PHARM SCI, V26, P266, DOI 10.1016/j.ejps.2005.06.004; Korjamo T, 2006, PHARM RES-DORDR, V23, P1991, DOI 10.1007/s11095-006-9068-4; Kublbeck J, 2010, EUR J PHARM SCI, V40, P263, DOI 10.1016/j.ejps.2010.03.022; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Makinen JM, 2002, MOL PHARMACOL, V62, P366, DOI 10.1124/mol.62.2.366; Martin P, 2010, ACTA PHARMACOL SIN, V31, P51, DOI 10.1038/aps.2009.187; Nishimura M, 2003, BIOL PHARM BULL, V26, P1052; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Ohno M, 2008, TISSUE ENG PT A, V14, P1861, DOI 10.1089/ten.tea.2007.0160; Pelkonen O, 2008, ARCH TOXICOL, V82, P667, DOI 10.1007/s00204-008-0332-8; PFEIFER AMA, 1993, P NATL ACAD SCI USA, V90, P5123, DOI 10.1073/pnas.90.11.5123; Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Sivertsson L, 2010, DRUG METAB DISPOS, V38, P995, DOI 10.1124/dmd.110.032367; Stanley LA, 2006, DRUG METAB REV, V38, P515, DOI 10.1080/03602530600786232; Sumida A, 2000, BIOCHEM BIOPH RES CO, V267, P756, DOI 10.1006/bbrc.1999.2029; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; WAXMAN DJ, 1988, ARCH BIOCHEM BIOPHYS, V263, P424, DOI 10.1016/0003-9861(88)90655-8; Zelko I, 2000, BIOCHEM BIOPH RES CO, V277, P1, DOI 10.1006/bbrc.2000.3557; Zhu XH, 2007, J BIOMED MATER RES B, V82B, P7, DOI 10.1002/jbm.b.30698	40	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95752	10.1371/journal.pone.0095752	http://dx.doi.org/10.1371/journal.pone.0095752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788541	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600052
J	Gurel, Z; Zaro, BW; Pratt, MR; Sheibani, N				Gurel, Zafer; Zaro, Balyn W.; Pratt, Matthew R.; Sheibani, Nader			Identification of O-GlcNAc Modification Targets in Mouse Retinal Pericytes: Implication of p53 in Pathogenesis of Diabetic Retinopathy	PLOS ONE			English	Article							PROTEIN-KINASE; FLUORESCENT DETECTION; CLICK-CHEMISTRY; APOPTOSIS; EXPRESSION; REGULATOR; SURVIVAL; FAMILY; BCL-2; CARF	Hyperglycemia is the primary cause of the majority of diabetes complications, including diabetic retinopathy (DR). Hyperglycemic conditions have a detrimental effect on many tissues and cell types, especially the retinal vascular cells including early loss of pericytes (PC). However, the mechanisms behind this selective sensitivity of retinal PC to hyperglycemia are undefined. The O-linked b-N-acetylglucosamine (O-GlcNAc) modification is elevated under hyperglycemic condition, and thus, may present an important molecular modification impacting the hyperglycemia-driven complications of diabetes. We have recently demonstrated that the level of O-GlcNAc modification in response to high glucose is variable in various retinal vascular cells. Retinal PC responded with the highest increase in O-GlcNAc modification compared to retinal endothelial cells and astrocytes. Here we show that these differences translated into functional changes, with an increase in apoptosis of retinal PC, not just under high glucose but also under treatment with O-GlcNAc modification inducers, PUGNAc and Thiamet-G. To gain insight into the molecular mechanisms involved, we have used click-It chemistry and LC-MS analysis and identified 431 target proteins of O-GlcNAc modification in retinal PC using an alkynyl-modified GlcNAc analog (GlcNAlk). Among the O-GlcNAc target proteins identified here 115 of them were not previously reported to be target of O-GlcNAc modification. We have identified at least 34 of these proteins with important roles in various aspects of cell death processes. Our results indicated that increased O-GlcNAc modification of p53 was associated with an increase in its protein levels in retinal PC. Together our results suggest that post-translational O-GlcNAc modification of p53 and its increased levels may contribute to selective early loss of PC during diabetes. Thus, modulation of O-GlcNAc modification may provide a novel treatment strategy to prevent the initiation and progression of DR.	[Gurel, Zafer; Sheibani, Nader] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Gurel, Zafer; Sheibani, Nader] Univ Wisconsin, McPherson Eye Res Inst, Sch Med & Publ Hlth, Madison, WI USA; [Zaro, Balyn W.; Pratt, Matthew R.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Zaro, Balyn W.; Pratt, Matthew R.] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Southern California; University of Southern California	Gurel, Z (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA.	zgurel@wisc.edu; matthew.pratt@usc.edu	Gurel, Zafer/AAF-3072-2021; Sheibani, Nader/AAG-2379-2020	Sheibani, Nader/0000-0003-2723-9217; Zaro, Balyn/0000-0002-8938-9889	National Institutes of Health [R01 EY016995, RC4 EY021357, P30 EY016665, P30 CA014520]; Research to Prevent Blindness; American Diabetes Association [1-10-BS-160]; Retina Research Foundation; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [RC4EY021357, P30EY016665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); American Diabetes Association(American Diabetes Association); Retina Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants R01 EY016995, RC4 EY021357, P30 EY016665, and P30 CA014520 UW Paul P. Carbone Cancer Center Support Grant from National Institutes of Health and an unrestricted departmental award from Research to Prevent Blindness. NS is a recipient of Research Award from American Diabetes Association, 1-10-BS-160 and Retina Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 2005, NEW ENGL J MED, V353, P839, DOI 10.1056/NEJMe058142; Ammirante M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.23; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Berger AC, 2000, J IMMUNOTHER, V23, P519, DOI 10.1097/00002371-200009000-00002; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Burastero SE, 2012, CLIN IMMUNOL, V143, P207, DOI 10.1016/j.clim.2012.03.006; Chae HZ, 2012, ANTIOXID REDOX SIGN, V16, P506, DOI 10.1089/ars.2011.4260; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chen WM, 2013, CELL CYCLE, V12, P2321, DOI 10.4161/cc.25404; Cheung CT, 2011, CELL DEATH DIFFER, V18, P589, DOI 10.1038/cdd.2010.129; Cheung CTY, 2009, MECH AGEING DEV, V130, P18, DOI 10.1016/j.mad.2008.05.002; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; COGAN DG, 1961, ARCH OPHTHALMOL-CHIC, V66, P366, DOI 10.1001/archopht.1961.00960010368014; Emami S, 2011, CLIN RES HEPATOL GAS, V35, P98, DOI 10.1016/j.gcb.2010.10.002; Festa M, 2011, AM J PATHOL, V178, P2504, DOI 10.1016/j.ajpath.2011.02.002; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Fuller-Pace FV, 2013, BBA-GENE REGUL MECH, V1829, P756, DOI 10.1016/j.bbagrm.2013.03.004; Gao XY, 2009, MOL BIOL REP, V36, P1977, DOI 10.1007/s11033-008-9407-0; Gardner TW, 2007, NAT MED, V13, P131, DOI 10.1038/nm0207-131; Gurcel C, 2008, ANAL BIOANAL CHEM, V390, P2089, DOI 10.1007/s00216-008-1950-y; Gurel Z, 2013, MOL VIS, V19, P1047; Hahne H, 2013, J PROTEOME RES, V12, P927, DOI 10.1021/pr300967y; Hsu DK, 2006, METHOD ENZYMOL, V417, P256, DOI 10.1016/S0076-6879(06)17018-4; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Jablonski EM, 2004, AM J PHYSIOL-CELL PH, V286, pC975, DOI 10.1152/ajpcell.00180.2003; Joly AL, 2010, J INNATE IMMUN, V2, P238, DOI 10.1159/000296508; Kaul SC, 2006, ANN NY ACAD SCI, V1067, P217, DOI 10.1196/annals.1354.026; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim YH, 2005, DIABETOLOGIA, V48, P1411, DOI 10.1007/s00125-005-1774-7; Kubota S, 2011, INVEST OPHTH VIS SCI, V52, P9142, DOI 10.1167/iovs.11-8041; Li Y, 2013, FEBS J, V280, P775, DOI 10.1111/febs.12079; Li ZL, 2009, CELL CYCLE, V8, P2703, DOI 10.4161/cc.8.17.9418; Mahul-Mellier AL, 2008, J BIOL CHEM, V283, P34954, DOI 10.1074/jbc.M803140200; Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McPherson JP, 1998, CANCER RES, V58, P4519; Meares GP, 2008, CELL SIGNAL, V20, P347, DOI 10.1016/j.cellsig.2007.10.032; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Ngoh GA, 2008, J PHARMACOL EXP THER, V327, P602, DOI 10.1124/jpet.108.143263; Ngoh GA, 2010, CIRC RES, V107, P171, DOI 10.1161/CIRCRESAHA.110.224675; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; Renault TT, 2011, BIOCHIMIE, V93, P1379, DOI 10.1016/j.biochi.2011.05.013; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Rosati A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.24; Ruan HB, 2013, MOL CELL PROTEOMICS, V12, P3489, DOI 10.1074/mcp.R113.029751; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Scheef E, 2005, MOL VIS, V11, P613; Scheef EA, 2009, AM J PHYSIOL-CELL PH, V296, pC724, DOI 10.1152/ajpcell.00409.2008; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Shahzidi S, 2013, CANCER LETT, V339, P25, DOI 10.1016/j.canlet.2013.07.026; Strappazzon F, 2010, BIOCHEM BIOPH RES CO, V397, P64, DOI 10.1016/j.bbrc.2010.05.062; Su XJ, 2003, MOL VIS, V9, P171; Wan QW, 2007, APOPTOSIS, V12, P319, DOI 10.1007/s10495-006-0574-y; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang Z, 2013, CURR NEUROVASC RES, V10, P4, DOI 10.2174/156720213804805909; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zaro BW, 2011, P NATL ACAD SCI USA, V108, P8146, DOI 10.1073/pnas.1102458108; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08	64	38	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95561	10.1371/journal.pone.0095561	http://dx.doi.org/10.1371/journal.pone.0095561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788674	gold, Green Submitted, Green Published			2022-12-25	WOS:000335510600041
J	Wallner, AM; Hamilton, GC; Nielsen, AL; Hahn, N; Green, EJ; Rodriguez-Saona, CR				Wallner, Adam M.; Hamilton, George C.; Nielsen, Anne L.; Hahn, Noel; Green, Edwin J.; Rodriguez-Saona, Cesar R.			Landscape Factors Facilitating the Invasive Dynamics and Distribution of the Brown Marmorated Stink Bug, Halyomorpha halys (Hemiptera: Pentatomidae), after Arrival in the United States	PLOS ONE			English	Article							HETEROPTERA-PENTATOMIDAE; PATTERNS; DISPERSAL; SPREAD; CORN	The brown marmorated stink bug, Halyomorpha halys, a native of Asia, has become a serious invasive pest in the USA. H. halys was first detected in the USA in the mid 1990s, dispersing to over 41 other states. Since 1998, H. halys has spread throughout New Jersey, becoming an important pest of agriculture, and a major nuisance in urban developments. In this study, we used spatial analysis, geostatistics, and Bayesian linear regression to investigate the invasion dynamics and colonization processes of this pest in New Jersey. We present the results of monitoring H. halys from 51 to 71 black light traps that were placed on farms throughout New Jersey from 2004 to 2011 and examined relationships between total yearly densities of H. halys and square hectares of 48 landscape/land use variables derived from urban, wetland, forest, and agriculture metadata, as well as distances to nearest highways. From these analyses we propose the following hypotheses: (1) H. halys density is strongly associated with urban developments and railroads during its initial establishment and dispersal from 2004 to 2006; (2) H. halys overwintering in multiple habitats and feeding on a variety of plants may have reduced the Allee effect, thus facilitating movement into the southernmost regions of the state by railroads from 2005 to 2008; (3) density of H. halys contracted in 2009 possibly from invading wetlands or sampling artifact; (4) subsequent invasion of H. halys from the northwest to the south in 2010 may conform to a stratified-dispersal model marked by rapid long-distance movement, from railroads and wetland rights-of-way; and (5) high densities of H. halys may be associated with agriculture in southern New Jersey in 2011. These landscape features associated with the invasion of H. halys in New Jersey may predict its potential rate of invasion across the USA and worldwide.	[Wallner, Adam M.] USDA, Anim & Plant Hlth Serv, Plant Protect Quarantine Plant Inspect Stn, Miami, FL 33158 USA; [Hamilton, George C.; Nielsen, Anne L.; Hahn, Noel; Rodriguez-Saona, Cesar R.] Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08903 USA; [Green, Edwin J.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA	United States Department of Agriculture (USDA); Rutgers State University New Brunswick; Rutgers State University New Brunswick	Wallner, AM (corresponding author), USDA, Anim & Plant Hlth Serv, Plant Protect Quarantine Plant Inspect Stn, Miami, FL 33158 USA.	adam.m.wallner@aphis.usda.gov			U.S. Hatch Funds; U.S. Department of Agriculture - National Institute of Food and Agriculture - Specialty Crop Research Initiative Award [2011-51181-30937]	U.S. Hatch Funds; U.S. Department of Agriculture - National Institute of Food and Agriculture - Specialty Crop Research Initiative Award	Funding came from U.S. Hatch Funds and the U.S. Department of Agriculture - National Institute of Food and Agriculture - Specialty Crop Research Initiative Award #2011-51181-30937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W.C, 1931, ANIMAL AGGREGATION S; American/Western Fruit Grower, 2011, BROWN MARMORATED STI; Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Capinha C, 2011, DIVERS DISTRIB, V17, P13, DOI 10.1111/j.1472-4642.2010.00727.x; CARLIN BP, 2000, C&H TEXT STAT SCI, P1; Chung B. K., 1995, J AGR SCI, V37, P376; Congdon P., 2001, BAYESIAN STAT MODELI; ESRI, 2011, ARCGIS DESKT REL 10; Fordyce JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026785; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Green P., 2009, GENETICS, V155; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Hasse J, 2010, URBAN GROWTH OPEN SP; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Holmstrom KE, 2001, HORTTECHNOLOGY, V11, P103, DOI 10.21273/HORTTECH.11.1.103; Inkley DB, 2012, J ENTOMOL SCI, V47, P125; Jones VP, 2001, ENVIRON ENTOMOL, V30, P1028, DOI 10.1603/0046-225X-30.6.1028; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kiritani K, 2006, POPUL ECOL, V48, P5, DOI 10.1007/s10144-005-0225-0; Latimer AM, 2006, ECOL APPL, V16, P33, DOI 10.1890/04-0609; Leskey T. C, 2010, BROWN MARM STINK BUG; Leskey TC, 2005, J ECON ENTOMOL, V98, P143, DOI 10.1603/0022-0493-98.1.143; Leskey TC, 2012, OUTLOOKS PEST MANAGE, DOI [10.1564/23aug00, DOI 10.1564/23AUG00]; Leskey Tracy C., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/535062; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Lunn DJ, 2006, GENET EPIDEMIOL, V30, P231, DOI 10.1002/gepi.20140; Lunn DJ, 2008, STAT COMPUTING, DOI 10:1007/S11222-008-9100-0; McPherson J.E., 2000, STINK BUGS EC IMPORT; New Jersey Department of Environmental Protection, 2010, GEOGR INF SYST LAND; New Jersey Division of Fish and Wildlife, 2012, NEW JERS LANDSC PROJ; Nielsen AL, 2013, J ECON ENTOMOL, V106, P1495, DOI 10.1603/EC12472; Nielsen AL, 2011, ENVIRON ENTOMOL, V40, P231, DOI 10.1603/EN10187; Nielsen AL, 2009, ANN ENTOMOL SOC AM, V102, P608, DOI 10.1603/008.102.0405; Nielsen AL, 2009, J ECON ENTOMOL, V102, P1133, DOI 10.1603/029.102.0335; Petit JN, 2008, BIOL INVASIONS, V10, P955, DOI 10.1007/s10530-007-9172-3; Qi GuoJun, 2012, Acta Phytophylacica Sinica, V39, P129; Reay-Jones FPF, 2010, ENVIRON ENTOMOL, V39, P944, DOI 10.1603/EN09274; SHEPHERD RF, 1988, MEM ENTOMOL SOC CAN, P107, DOI 10.4039/entm120146107-1; Silverman B.W., 1986, DENSITY ESTIMATION S; Spieglehalter DJ, 2003, WINBUGS 1 4 MANUAL; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Tillman PG, 2011, ENVIRON ENTOMOL, V40, P1159, DOI 10.1603/EN10243; Tillman PG, 2009, ENVIRON ENTOMOL, V38, P1038, DOI 10.1603/022.038.0411; Toyama M, 2011, APPL ENTOMOL ZOOL, V46, P37, DOI 10.1007/s13355-010-0002-1; USDA, 2007, CENS AGR COUNT DAT; Van Driesche R. G., 1996, BIOL CONTROL; Xu JW, 2014, BIOL INVASIONS, V16, P153, DOI 10.1007/s10530-013-0510-3; Zhang Cuituan, 1993, Forest Research, V6, P271; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	53	45	46	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95691	10.1371/journal.pone.0095691	http://dx.doi.org/10.1371/journal.pone.0095691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787576	Green Published, gold			2022-12-25	WOS:000335510600048
J	Wang, XC; Fan, Y; Zhao, F; Wang, ZM; Ge, JQ; Zhang, K; Gao, ZX; Gao, JH; Yang, YH; Fan, J; Zou, QH; Liu, PN				Wang, Xingchao; Fan, Yang; Zhao, Fu; Wang, Zhenmin; Ge, Jianqiao; Zhang, Kai; Gao, Zhixian; Gao, Jia-Hong; Yang, Yihong; Fan, Jin; Zou, Qihong; Liu, Pinan			Altered Regional and Circuit Resting-State Activity Associated with Unilateral Hearing Loss	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; VISUAL-ATTENTION; INSULAR CORTEX; DEAF-CHILDREN; COCHLEAR IMPLANTS; BRAIN NETWORKS; CORTICAL REORGANIZATION; COGNITIVE FUNCTION; EXECUTIVE FUNCTION; AUDITORY-CORTEX	The deprivation of sensory input after hearing damage results in functional reorganization of the brain including cross-modal plasticity in the sensory cortex and changes in cognitive processing. However, it remains unclear whether partial deprivation from unilateral auditory loss (UHL) would similarly affect the neural circuitry of cognitive processes in addition to the functional organization of sensory cortex. Here, we used resting-state functional magnetic resonance imaging to investigate intrinsic activity in 34 participants with UHL from acoustic neuroma in comparison with 22 matched normal controls. In sensory regions, we found decreased regional homogeneity (ReHo) in the bilateral calcarine cortices in UHL. However, there was an increase of ReHo in the right anterior insular cortex (rAI), the key node of cognitive control network (CCN) and multimodal sensory integration, as well as in the left parahippocampal cortex (lPHC), a key node in the default mode network (DMN). Moreover, seed-based resting-state functional connectivity analysis showed an enhanced relationship between rAI and several key regions of the DMN. Meanwhile, lPHC showed more negative relationship with components in the CCN and greater positive relationship in the DMN. Such reorganizations of functional connectivity within the DMN and between the DMN and CCN were confirmed by a graph theory analysis. These results suggest that unilateral sensory input damage not only alters the activity of the sensory areas but also reshapes the regional and circuit functional organization of the cognitive control network.	[Wang, Xingchao; Wang, Zhenmin; Zhang, Kai; Gao, Zhixian; Liu, Pinan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Fan, Yang; Ge, Jianqiao; Gao, Jia-Hong; Zou, Qihong] Peking Univ, MRI Res Ctr, Beijing 100871, Peoples R China; [Fan, Yang; Ge, Jianqiao; Gao, Jia-Hong; Zou, Qihong] Peking Univ, Beijing City Key Lab Med Phys & Engn, Beijing 100871, Peoples R China; [Zhao, Fu; Liu, Pinan] Capital Med Univ, Dept Neural Reconstruct, Beijing Neurosurg Inst, Beijing, Peoples R China; [Gao, Jia-Hong] Peking Univ, McGovern Inst Brain Res, Beijing 100871, Peoples R China; [Yang, Yihong] NIDA, Neuroimaging Res Branch, NIH, Baltimore, MD USA; [Fan, Jin] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Fan, Jin] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Fan, Jin] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Fan, Jin] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA	Capital Medical University; Peking University; Peking University; Beijing Neurosurgical Institute; Capital Medical University; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); City University of New York (CUNY) System; Queens College NY (CUNY); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Zou, QH (corresponding author), Peking Univ, MRI Res Ctr, Beijing 100871, Peoples R China.	zouqihong@pku.edu.cn; pinanliu@ccmu.edu.cn	Zhao, Fu/AHD-4463-2022; Fan, Jin/A-6716-2009; Fan, Jin/L-2055-2019	Zhao, Fu/0000-0002-5286-5650; Fan, Jin/0000-0001-9630-8330; Fan, Jin/0000-0001-9630-8330	National Science and Technology Support Program of the 12th Five-Year of China [2012BAI12B03]; Natural Science Foundation of Beijing [7112049]; China's National Strategic Basic Research Program (973) [2012CB720700]; Natural Science Foundation of China [81201142, 31200761]	National Science and Technology Support Program of the 12th Five-Year of China; Natural Science Foundation of Beijing(Beijing Natural Science Foundation); China's National Strategic Basic Research Program (973); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science and Technology Support Program of the 12th Five-Year of China (grant number: 2012BAI12B03), Natural Science Foundation of Beijing (grant number: 7112049), China's National Strategic Basic Research Program (973) (grant number: 2012CB720700), and Natural Science Foundation of China (grant numbers: 81201142 and 31200761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Auer ET, 2007, NEUROREPORT, V18, P645, DOI 10.1097/WNR.0b013e3280d943b9; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bengoetxea H, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/305693; Bilecen D, 2000, NEUROLOGY, V54, P765, DOI 10.1212/WNL.54.3.765; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Buckley KA, 2011, EAR HEARING, V32, P2, DOI 10.1097/AUD.0b013e3181fa41bb; Burton H, 2012, BRAIN RES, V1454, P33, DOI 10.1016/j.brainres.2012.02.066; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cauda F, 2012, NEUROIMAGE, V62, P343, DOI 10.1016/j.neuroimage.2012.04.012; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Dieterich M, 2007, BRAIN, V130, P2108, DOI 10.1093/brain/awm130; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; Dye MWG, 2007, NEUROPSYCHOLOGIA, V45, P1801, DOI 10.1016/j.neuropsychologia.2006.12.019; Dye MWG, 2010, RESTOR NEUROL NEUROS, V28, P181, DOI 10.3233/RNN-2010-0501; Eggermont JJ, 2008, EAR HEARING, V29, P819, DOI 10.1097/AUD.0b013e3181853030; Fan J, 2013, J COGNITIVE NEUROSCI, V6; Figueras B, 2008, J DEAF STUD DEAF EDU, V13, P362, DOI 10.1093/deafed/enm067; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Horn DL, 2004, INT CONGR SER, V1273, P332, DOI 10.1016/j.ics.2004.07.048; Humes LE, 2013, ATTEN PERCEPT PSYCHO, V75, P508, DOI 10.3758/s13414-012-0406-9; Husain FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026639; Hutson KA, 2008, HEARING RES, V237, P19, DOI 10.1016/j.heares.2007.12.007; Jancke L, 2002, HEARING RES, V170, P166, DOI 10.1016/S0378-5955(02)00488-4; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; KING AJ, 1991, TRENDS NEUROSCI, V14, P31, DOI 10.1016/0166-2236(91)90181-S; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Kronenberger WG, 2013, J PEDIATR PSYCHOL, V38, P902, DOI 10.1093/jpepsy/jst034; Lazard DS, 2013, HUM BRAIN MAPP, V34, P1208, DOI 10.1002/hbm.21504; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Li YY, 2013, CEREB CORTEX, V23, P1988, DOI 10.1093/cercor/bhs185; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Liu C, 2011, NEUROREPORT, V22, P190, DOI 10.1097/WNR.0b013e3283447c09; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Manoliu A, 2014, SCHIZOPHRENIA BULL, V40, P428, DOI 10.1093/schbul/sbt037; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MORECRAFT RJ, 1993, ARCH NEUROL-CHICAGO, V50, P279, DOI 10.1001/archneur.1993.00540030045013; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; Nagai M, 2007, EUR PSYCHIAT, V22, P387, DOI 10.1016/j.eurpsy.2007.02.006; Oberg E, 2011, CHILD NEUROPSYCHOL, V17, P521, DOI 10.1080/09297049.2011.555760; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P17, DOI 10.1503/jpn.100176; Parasnis I, 2003, J SPEECH LANG HEAR R, V46, P1166, DOI 10.1044/1092-4388(2003/091); Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Proksch J, 2002, J COGNITIVE NEUROSCI, V14, P687, DOI 10.1162/08989290260138591; Quittner AL, 2004, ARCH OTOLARYNGOL, V130, P547, DOI 10.1001/archotol.130.5.547; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Repovs G, 2011, BIOL PSYCHIAT, V69, P967, DOI 10.1016/j.biopsych.2010.11.009; Salvador Karina Krähembühl, 2011, J. Soc. Bras. Fonoaudiol., V23, P381, DOI 10.1590/S2179-64912011000400015; Scheffler K, 1998, CEREB CORTEX, V8, P156, DOI 10.1093/cercor/8.2.156; Schmithorst VJ, 2005, NEUROREPORT, V16, P463, DOI 10.1097/00001756-200504040-00009; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharda M, 2012, NEUROSCIENCE, V214, P49, DOI 10.1016/j.neuroscience.2012.03.053; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shin MS, 2007, EAR HEARING, V28, p22S, DOI 10.1097/AUD.0b013e318031541b; Sladen DP, 2005, J SPEECH LANG HEAR R, V48, P1529, DOI 10.1044/1092-4388(2005/106); Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stephani C, 2011, BRAIN STRUCT FUNCT, V216, P137, DOI 10.1007/s00429-010-0296-3; Sullivan EV, 2013, BIOL PSYCHIAT, V74, P547, DOI 10.1016/j.biopsych.2013.02.026; Suzuki M, 2002, NEUROREPORT, V13, P1829, DOI 10.1097/00001756-200210070-00029; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Daza MT, 2013, RES DEV DISABIL, V34, P2661, DOI 10.1016/j.ridd.2013.05.012; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Tibbetts K, 2011, OTOLARYNG HEAD NECK, V144, P602, DOI 10.1177/0194599810394954; Tu PC, 2012, NEUROIMAGE, V59, P238, DOI 10.1016/j.neuroimage.2011.07.086; VASAMA JP, 1995, HEARING RES, V87, P132, DOI 10.1016/0378-5955(95)00086-J; de Araujo PGV, 2010, BRAZ J OTORHINOLAR, V76, P378, DOI 10.1590/S1808-86942010000300018; Weisberg J, 2012, NEUROIMAGE, V60, P661, DOI 10.1016/j.neuroimage.2011.12.031; Welsh LW, 2004, ANN OTO RHINOL LARYN, V113, P987, DOI 10.1177/000348940411301209; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; Wu CM, 2009, AM J NEURORADIOL, V30, P1773, DOI 10.3174/ajnr.A1681; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	95	43	44	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96126	10.1371/journal.pone.0096126	http://dx.doi.org/10.1371/journal.pone.0096126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788317	Green Published, gold			2022-12-25	WOS:000335510600078
J	Zhang, LM; Bose, P; Warren, RA				Zhang, Liming; Bose, Poulomee; Warren, Richard A.			Dopamine Preferentially Inhibits NMDA Receptor-Mediated EPSCs by Acting on Presynaptic D-1 Receptors in Nucleus Accumbens during Postnatal Development	PLOS ONE			English	Article							EXCITATORY SYNAPTIC-TRANSMISSION; LOCAL-ANESTHETIC INHIBITION; PAIRED-PULSE FACILITATION; VOLTAGE-DEPENDENT BLOCK; RAT HIPPOCAMPAL SLICES; D-ASPARTATE RECEPTORS; MEDIUM SPINY NEURONS; PROTEIN-KINASE-C; IN-VITRO; IDENTIFIED NEURONS	Nucleus accumbens (nAcb), a major site of action of drugs of abuse and dopamine (DA) signalling in MSNs (medium spiny neurons), is critically involved in mediating behavioural responses of drug addiction. Most studies have evaluated the effects of DA on MSN firing properties but thus far, the effects of DA on a cellular circuit involving glutamatergic afferents to the nAcb have remained rather elusive. In this study we attempted to characterize the effects of dopamine (DA) on evoked glutamatergic excitatory postsynaptic currents (EPSCs) in nAcb medium spiny (MS) neurons in 1 to 21 day-old rat pups. The EPSCs evoked by local nAcb stimuli displayed both AMPA/KA and NMDA receptor-mediated components. The addition of DA to the superfusing medium produced a marked decrease of both components of the EPSCs that did not change during the postnatal period studied. Pharmacologically isolated AMPA/KA receptor-mediated response was inhibited on average by 40% whereas the isolated NMDA receptor-mediated EPSC was decreased by 90%. The effect of DA on evoked EPSCs were mimicked by the D-1-like receptor agonist SKF 38393 and antagonized by the D1-like receptor antagonist SCH 23390 whereas D-2-like receptor agonist or antagonist respectively failed to mimic or to block the action of DA. DA did not change the membrane input conductance of MS neurons or the characteristics of EPSCs produced by the local administration of glutamate in the presence of tetrodotoxin. In contrast, DA altered the paired-pulse ratio of evoked EPSCs. The present results show that the activation D1-like dopaminergic receptors modulate glutamatergic neurotransmission by preferentially inhibiting NMDA receptor-mediated EPSC through presynaptic mechanisms.	[Zhang, Liming; Warren, Richard A.] Univ Montreal, Ctr Rech Fernand Seguin, Montreal, PQ, Canada; [Zhang, Liming] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Bose, Poulomee; Warren, Richard A.] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Warren, RA (corresponding author), Univ Montreal, Ctr Rech Fernand Seguin, Montreal, PQ, Canada.	richard.warren@umontreal.ca	Zhang, Li/GWM-7501-2022		Fonds de la Recherche en Sante du Quebec; National Science and Engineering Research Council of Canada [OGP 184095]	Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by the Fonds de la Recherche en Sante du Quebec and by the National Science and Engineering Research Council of Canada (OGP 184095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALREJA M, 1994, BRAIN RES, V639, P320, DOI 10.1016/0006-8993(94)91746-9; ANDRADE R, 1991, EUR J PHARMACOL, V199, P259, DOI 10.1016/0014-2999(91)90467-5; Andre VM, 2010, EUR J NEUROSCI, V31, P14, DOI 10.1111/j.1460-9568.2009.07047.x; Antonopoulos J, 2002, NEUROSCIENCE, V110, P245, DOI 10.1016/S0306-4522(01)00575-9; Araki KY, 2007, BRAIN RES, V1156, P31, DOI 10.1016/j.brainres.2007.04.043; Baldo BA, 2002, BEHAV BRAIN RES, V137, P165, DOI 10.1016/S0166-4328(02)00293-0; Baldwin AE, 2000, BEHAV NEUROSCI, V114, P84, DOI 10.1037/0735-7044.114.1.84; Behr J, 2000, J NEUROPHYSIOL, V84, P112, DOI 10.1152/jn.2000.84.1.112; Belleau ML, 2000, J NEUROPHYSIOL, V84, P2204, DOI 10.1152/jn.2000.84.5.2204; Beurrier C, 2002, J NEUROSCI, V22, P5817; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BOUYER JJ, 1984, J COMP NEUROL, V227, P92, DOI 10.1002/cne.902270110; BOUYER JJ, 1984, REGUL PEPTIDES, V8, P105, DOI 10.1016/0167-0115(84)90165-4; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Cepeda C, 1998, J NEUROPHYSIOL, V79, P82, DOI 10.1152/jn.1998.79.1.82; Chen X, 1999, NEUROSCIENCE, V90, P457, DOI 10.1016/S0306-4522(98)00594-6; Chergui K, 1999, NEUROPHARMACOLOGY, V38, P223, DOI 10.1016/S0028-3908(98)00187-7; Cui CH, 2006, MOL PHARMACOL, V70, P1761, DOI 10.1124/mol.106.028332; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Finch DM, 1996, HIPPOCAMPUS, V6, P495; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Groenewegen HJ, 1996, PROG BRAIN RES, V107, P485; Hahnenkamp K, 2006, BRIT J ANAESTH, V96, P77, DOI 10.1093/bja/aei271; Hara Y, 2005, J COMP NEUROL, V492, P442, DOI 10.1002/cne.20740; Harvey BH, 2003, BRAIN RES, V983, P97, DOI 10.1016/S0006-8993(03)03033-6; Harvey J, 1996, J PHYSIOL-LONDON, V492, P143, DOI 10.1113/jphysiol.1996.sp021296; Harvey J, 1997, J NEUROSCI, V17, P5271; Heimer L, 1997, J NEUROPSYCH CLIN N, V9, P354; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; HIGASHI H, 1989, J PHYSIOL-LONDON, V408, P587, DOI 10.1113/jphysiol.1989.sp017478; Hollmann MW, 2000, ANESTHESIOLOGY, V93, P497, DOI 10.1097/00000542-200008000-00030; Hollmann MW, 2004, ANESTHESIOLOGY, V100, P852, DOI 10.1097/00000542-200404000-00015; Hollmann MW, 2002, ANESTHESIOLOGY, V97, P1451, DOI 10.1097/00000542-200212000-00017; Hollmann MW, 2001, BRIT J PHARMACOL, V133, P207, DOI 10.1038/sj.bjp.0704040; Hollmann MW, 2001, MOL PHARMACOL, V59, P294, DOI 10.1124/mol.59.2.294; Huppe-Gourgues F, 2012, SYNAPSE, V66, P584, DOI 10.1002/syn.21544; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Ishikawa M, 2013, J NEUROSCI, V33, P6759, DOI 10.1523/JNEUROSCI.4694-12.2013; JOHNSON LR, 1994, NEUROSCIENCE, V61, P851, DOI 10.1016/0306-4522(94)90408-1; Jung AB, 1996, DEV BRAIN RES, V94, P133, DOI 10.1016/0165-3806(96)00035-1; Kalivas PW, 1999, CURR OPIN NEUROBIOL, V9, P223, DOI 10.1016/S0959-4388(99)80031-2; Kalivas PW, 1997, BRAIN RES, V761, P173, DOI 10.1016/S0006-8993(97)00464-2; Kalivas PW, 1997, DOPAMINE REGULATION; Kasanetz F, 2009, J NEUROPHYSIOL, V101, P2516, DOI 10.1152/jn.91039.2008; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; Kline DD, 2002, J NEUROPHYSIOL, V88, P2736, DOI 10.1152/jn.00224.2002; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LAMBERT NA, 1993, J NEUROPHYSIOL, V69, P630, DOI 10.1152/jn.1993.69.2.630; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Levine MS, 1996, SYNAPSE, V24, P65, DOI 10.1002/syn.890240102; Levine MS, 1996, J NEUROSCI, V16, P5870; Lin JY, 2003, BRAIN RES, V959, P251, DOI 10.1016/S0006-8993(02)03757-5; Lu XY, 1998, NEUROSCIENCE, V82, P767; Maldve RE, 2002, NAT NEUROSCI, V5, P641, DOI 10.1038/nn877; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MEREDITH GE, 1993, PROG BRAIN RES, V99, P3; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Moyer JT, 2007, J NEUROPHYSIOL, V98, P3731, DOI 10.1152/jn.00335.2007; Nair VD, 1995, DEV BRAIN RES, V90, P180, DOI 10.1016/0165-3806(96)83499-7; NATHAN T, 1990, NEUROSCI LETT, V110, P309, DOI 10.1016/0304-3940(90)90865-7; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nicola SM, 1997, J NEUROSCI, V17, P5697; Nicola SM, 1996, J NEUROSCI, V16, P1591; Nicola SM, 1998, J NEUROPHYSIOL, V79, P1768, DOI 10.1152/jn.1998.79.4.1768; ODONNELL P, 1993, SYNAPSE, V13, P135, DOI 10.1002/syn.890130206; ODONNELL P, 1994, BRAIN RES, V634, P105, DOI 10.1016/0006-8993(94)90263-1; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; Paxinos G, 1986, RAT BRAIN ATLAS STER; PENNARTZ CMA, 1992, J NEUROPHYSIOL, V67, P1325, DOI 10.1152/jn.1992.67.5.1325; PENNARTZ CMA, 1993, EUR J NEUROSCI, V5, P107, DOI 10.1111/j.1460-9568.1993.tb00475.x; Podda MV, 2010, NEUROSCIENCE, V167, P678, DOI 10.1016/j.neuroscience.2010.02.075; Price CJ, 2001, J NEUROPHYSIOL, V86, P1149, DOI 10.1152/jn.2001.86.3.1149; Santschi LA, 2003, BRAIN RES, V962, P78, DOI 10.1016/S0006-8993(02)03846-5; Schramm NL, 2002, SYNAPSE, V45, P213, DOI 10.1002/syn.10104; Schwartz JC, 1998, BRAIN RES REV, V26, P236, DOI 10.1016/S0165-0173(97)00046-5; SESACK SR, 1990, BRAIN RES, V527, P266, DOI 10.1016/0006-8993(90)91146-8; Sharpe NA, 1998, NEUROSCIENCE, V84, P1163, DOI 10.1016/S0306-4522(97)00583-6; Slesinger PA, 2001, BIOPHYS J, V80, P707, DOI 10.1016/S0006-3495(01)76050-X; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; Tarazi FI, 1998, NEUROSCI LETT, V254, P21, DOI 10.1016/S0304-3940(98)00644-2; Tarazi FI, 1999, DEV NEUROSCI-BASEL, V21, P43, DOI 10.1159/000017365; Tarazi FI, 2000, INT J DEV NEUROSCI, V18, P29, DOI 10.1016/S0736-5748(99)00108-2; TEICHER MH, 1991, DEV BRAIN RES, V63, P229, DOI 10.1016/0165-3806(91)90082-T; TEICHER MH, 1995, DEV BRAIN RES, V89, P167, DOI 10.1016/0165-3806(95)00109-Q; Tong H, 2008, J PHYSIOL-LONDON, V586, P4693, DOI 10.1113/jphysiol.2008.158931; TOTTERDELL S, 1989, J CHEM NEUROANAT, V2, P285; UCHIMURA N, 1990, J PHYSIOL-LONDON, V422, P369, DOI 10.1113/jphysiol.1990.sp017989; UCHIMURA N, 1986, BRAIN RES, V375, P368, DOI 10.1016/0006-8993(86)90760-2; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; WILLNER P, 1991, BEHAV PHARMACOL, V2, P1; Xiong ZL, 1999, MOL PHARMACOL, V55, P150, DOI 10.1124/mol.55.1.150; ZAHM DS, 1992, NEUROSCIENCE, V50, P751, DOI 10.1016/0306-4522(92)90202-D; Zhang L, 2008, NEUROSCIENCE, V154, P1440, DOI 10.1016/j.neuroscience.2008.05.002; Zhang L., 1998, Society for Neuroscience Abstracts, V24, P1641; ZHANG L, 1990, DEV BRAIN RES, V56, P127, DOI 10.1016/0165-3806(90)90171-T; Zhang LM, 2002, J NEUROPHYSIOL, V88, P3315, DOI 10.1152/jn.01025.2001; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	101	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e86970	10.1371/journal.pone.0086970	http://dx.doi.org/10.1371/journal.pone.0086970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24784836	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600001
J	Gunaydin, G; Alvarez, B; Lin, Y; Hammarstrom, L; Marcotte, H				Gunaydin, Gokce; Alvarez, Beatriz; Lin, Yin; Hammarstroem, Lennart; Marcotte, Harold			Co-Expression of Anti-Rotavirus Proteins (Llama VHH Antibody Fragments) in Lactobacillus: Development and Functionality of Vectors Containing Two Expression Cassettes in Tandem	PLOS ONE			English	Article							ROTAVIRUS-INDUCED DIARRHEA; SINGLE-CHAIN ANTIBODY; RHAMNOSUS GG; DOUBLE-BLIND; VACCINE; PROTECTION; INFECTION; CHILDREN; INFANTS; DOMAIN	Rotavirus is an important pediatric pathogen, causing severe diarrhea and being associated with a high mortality rate causing approximately 500 000 deaths annually worldwide. Even though some vaccines are currently available, their efficacy is lower in the developing world, as compared to developed countries. Therefore, alternative or complementary treatment options are needed in the developing countries where the disease burden is the largest. The effect of Lactobacillus in promoting health and its use as a vehicle for delivery of protein and antibody fragments was previously shown. In this study, we have developed co-expression vectors enabling Lactobacillus paracasei BL23 to produce two VHH fragments against rotavirus (referred to as anti-rotavirus proteins 1 and 3, ARP1 and ARP3) as secreted and/or surface displayed products. ARP1 and ARP3 fragments were successfully co-expressed as shown by Western blot and flow cytometry. In addition, engineered Lactobacillus produced VHH antibody fragments were shown to bind to a broad range of rotavirus serotypes (including the human rotavirus strains 69M, Va70, F45, DS1, Wa and ST3 and simian rotavirus strains including RRV and SA11), by flow cytometry and ELISA. Hereby, we have demonstrated for the first time that when RRV was captured by one VHH displayed on the surface of co-expressor Lactobacillus, targeting other epitope was possible with another VHH secreted from the same bacterium. Therefore, Lactobacillus producing two VHH antibody fragments may potentially serve as treatment against rotavirus with a reduced risk of development of escape mutants. This co-expression and delivery platform can also be used for delivery of VHH fragments against a variety of mucosal pathogens or production of other therapeutic molecules.	[Gunaydin, Gokce; Alvarez, Beatriz; Lin, Yin; Hammarstroem, Lennart; Marcotte, Harold] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Immunol & Transfus Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Marcotte, H (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Immunol & Transfus Med, Stockholm, Sweden.	harold.marcotte@ki.se	Alvarez, Beatriz/AAL-5969-2020; günaydın, gökçe/GWI-5176-2022; Marcotte, Harold/P-9375-2017; Alvarez, Beatriz/L-1266-2014	Alvarez, Beatriz/0000-0002-9613-5473; Marcotte, Harold/0000-0002-7168-349X; Alvarez, Beatriz/0000-0002-9613-5473	European Union (EU) [202162]; LACTOBODY; China Scholarship Council (CSC)	European Union (EU)(CGIAREuropean Commission); LACTOBODY; China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the European Union (EU) funded project LACTOBODY (202162). The web address of the European Commission for Seventh Framework Programme (FP7) is as follows: http://cordis.europa.eu/fp7/home_en.html. Harold Marcotte, Beatriz Alvarez and Gokce Gunaydin were financially supported by LACTOBODY grant. Yin Lin was financially supported by the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032949; Andersen KK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-126; Ciarlet M, 2000, METH MOLEC MED, V34, P147, DOI 10.1385/1-59259-078-0:147; Martin MC, 2011, APPL ENVIRON MICROB, V77, P2174, DOI 10.1128/AEM.02690-10; de Palma O, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2825; Grandy G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-253; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Gunaydin G, 2014, VACCINE, V32, P470, DOI 10.1016/j.vaccine.2013.11.057; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Ludert JE, 2002, J VIROL, V76, P6643, DOI 10.1128/JVI.76.13.6643-6651.2002; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Marcotte H, 2006, J APPL MICROBIOL, V100, P256, DOI 10.1111/j.1365-2672.2005.02786.x; Pant N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-86; Pant N, 2006, J INFECT DIS, V194, P1580, DOI 10.1086/508747; Pant N, 2011, FUTURE MICROBIOL, V6, P583, DOI [10.2217/fmb.11.32, 10.2217/FMB.11.32]; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Patton JT, 2012, DISCOV MED, V13, P85; Perez-Arellano I, 2001, PLASMID, V46, P106, DOI 10.1006/plas.2001.1531; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; SVENSSON L, 1991, J VIROL, V65, P4190, DOI 10.1128/JVI.65.8.4190-4197.1991; Szajewska H, 2013, ALIMENT PHARM THER; Tokuhara D, 2013, J CLIN INVE IN PRESS; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Ventola H, 2012, WORLD J GASTROENTERO, V18, P5925, DOI 10.3748/wjg.v18.i41.5925; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; World Health Organization, 2017, GUID DRINK WAT QUAL, VFourth, DOI 10.1016/S1462-0758(00)00006-6; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	28	19	21	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96409	10.1371/journal.pone.0096409	http://dx.doi.org/10.1371/journal.pone.0096409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781086	Green Submitted, gold, Green Published			2022-12-25	WOS:000335504900034
J	Stumm, CL; Halcsik, E; Landgraf, RG; Camara, NOS; Sogayar, MC; Jancar, S				Stumm, Camila Leindecker; Halcsik, Erik; Landgraf, Richardt Gama; Saraiva Camara, Niels Olsen; Sogayar, Mari Cleide; Jancar, Sonia			Lung Remodeling in a Mouse Model of Asthma Involves a Balance between TGF-beta 1 and BMP-7	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; GROWTH-FACTOR-BETA; GENE-EXPRESSION; FIBROBLASTS; FIBROSIS; GREMLIN; MYOFIBROBLASTS; DISEASE; MURINE; SMAD7	A key event in chronic allergic asthma is the TGF-beta-induced activation of fibroblasts into alpha-SMA-positive myofibroblasts which synthesize type-I collagen. In the present study we investigated the effect of the anti-fibrotic molecule BMP-7 in asthma. Balb/c mice were immunized i. p. with ovalbumin in alum and challenged every 2 days with ovalbumin aerosol (two or six challenges for acute and chronic protocols, respectively). The lung was evaluated for: alpha-SMA and type-I collagen by immunohistochemistry; BMP-7 and TGF- beta 1 gene expression by qRT-PCR; type-I collagen and Smads 2 and 3 by immunoblotting; mucus by PSA staining. Type-I collagen around bronchi, a-SMA, mucus secretion, TGF- beta 1 and BMP-7 gene expression were all increased in asthma. The TGF- beta 1/BMP-7 ratio was higher in the chronic group and correlated with higher levels of collagen. Fibroblasts isolated from asthmatic and healthy lungs produced type-I collagen upon stimulation with TGF- beta 1 via phosphorylation of Smad-2, Smad-3. Pre-treatment of the fibroblasts with BMP-7 reduced collagen production and Smads phosphorylation. Intranasal treatment of asthmatic mice with recombinant BMP-7 during the immunization protocol reduced lung inflammation and type I collagen deposition. These results suggest a protective role for BMP-7 in lung allergic inflammation, opposing the pro-fibrotic effects of TGF- beta 1.	[Stumm, Camila Leindecker; Saraiva Camara, Niels Olsen; Jancar, Sonia] Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil; [Halcsik, Erik; Sogayar, Mari Cleide] Univ Sao Paulo, Dept Biochem, Sao Paulo, Brazil; [Landgraf, Richardt Gama] Univ Fed Sao Paulo, Dept Biol Sci, Diadema, SP, Brazil; [Saraiva Camara, Niels Olsen] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Jancar, S (corresponding author), Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil.	sojancar@icb.usp.br	Landgraf, Richardt/F-7146-2012; Jancar, Sonia/C-5153-2012; camara, niels olsen saraiva/AAX-3269-2020; Camara, Niels OS/G-8336-2011; Sogayar, Mari C/B-3980-2017	Landgraf, Richardt/0000-0001-7774-7880; Jancar, Sonia/0000-0001-7983-3459; camara, niels olsen saraiva/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248; Sogayar, Mari C/0000-0003-4805-4609	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Pesquisa e Tecnologia (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Tecnologia (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Pesquisa e Tecnologia (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; Bustos-Valenzuela JC, 2010, MOL BIOTECHNOL, V46, P118, DOI 10.1007/s12033-010-9287-0; Camp TM, 2003, J HYPERTENS, V21, P1719, DOI 10.1097/00004872-200309000-00022; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Itoh S, 1998, J BIOL CHEM, V273, P29195, DOI 10.1074/jbc.273.44.29195; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund RJ, 2002, CURR OPIN NEPHROL HY, V11, P31, DOI 10.1097/00041552-200201000-00005; Mauviel A, 2005, METH MOLEC MED, V117, P69; Moore BB, 2005, J IMMUNOL, V174, P5644, DOI 10.4049/jimmunol.174.9.5644; Myllarniemi M, 2008, J PATHOL, V214, P456, DOI 10.1002/path.2300; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; Pegorier S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-85; Piscione TD, 2001, AM J PHYSIOL-RENAL, V280, pF19, DOI 10.1152/ajprenal.2001.280.1.F19; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; Reddi A. Hari, 1997, Cytokine and Growth Factor Reviews, V8, P11, DOI 10.1016/S1359-6101(96)00049-4; Reddi AH, 2000, PEDIATR NEPHROL, V14, P598, DOI 10.1007/s004670000364; Roy SG, 2001, INT J BIOCHEM CELL B, V33, P723, DOI 10.1016/S1357-2725(01)00041-3; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Stumm CL, 2011, AM J PHYSIOL-LUNG C, V301, pL636, DOI 10.1152/ajplung.00158.2011; Sugiura H, 2007, AM J RESP CELL MOL, V37, P424, DOI 10.1165/rcmb.2007-0089OC; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Yang T, 2012, MOL MED REP, V6, P246, DOI 10.3892/mmr.2012.892; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang XL, 2005, J AM SOC NEPHROL, V16, P79, DOI 10.1681/ASN.2004050395	27	33	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e95959	10.1371/journal.pone.0095959	http://dx.doi.org/10.1371/journal.pone.0095959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781156	Green Published, gold, Green Submitted			2022-12-25	WOS:000335504900016
J	Song, NJ; Zhong, XT; Li, QG				Song, Najie; Zhong, Xueting; Li, Qingge			Real-Time Bidirectional Pyrophosphorolysis-Activated Polymerization for Quantitative Detection of Somatic Mutations	PLOS ONE			English	Article							CELL LUNG-CANCER; FRAGMENT-LENGTH-POLYMORPHISM; MELTING CURVE ANALYSIS; PEPTIDE NUCLEIC-ACID; K-RAS MUTATIONS; KRAS MUTATIONS; 1ST-LINE TREATMENT; CHAIN-REACTION; RARE ALLELES; DIGITAL PCR	Detection of somatic mutations for targeted therapy is increasingly used in clinical settings. However, due to the difficulties of detecting rare mutations in excess of wild-type DNA, current methods often lack high sensitivity, require multiple procedural steps, or fail to be quantitative. We developed real-time bidirectional pyrophosphorolysis-activated polymerization (real-time Bi-PAP) that allows quantitative detection of somatic mutations. We applied the method to quantify seven mutations at codons 12 and 13 in KRAS, and 2 mutations (L858R, and T790M) in EGFR in clinical samples. The real-time Bi-PAP could detect 0.01% mutation in the presence of 100 ng template DNA. Of the 34 samples from the colon cancer patients, real-time Bi-PAP detected 14 KRAS mutant samples whereas the traditional real-time allele-specific PCR missed two samples with mutation abundance <1% and DNA sequencing missed nine samples with mutation abundance <10%. The detection results of the two EGFR mutations in 45 non-small cell lung cancer samples further supported the applicability of the real-time Bi-PAP. The real-time Bi-PAP also proved to be more efficient than the real-time allele-specific PCR in the detection of templates prepared from formalin-fixed paraffin-embedded samples. Thus, real-time Bi-PAP can be used for rapid and accurate quantification of somatic mutations. This flexible approach could be widely used for somatic mutation detection in clinical settings.	[Song, Najie; Zhong, Xueting; Li, Qingge] Xiamen Univ, State Key Lab Mol Vaccinol & Mol Diagnost, Engn Res Ctr Mol Diagnost, Sch Life Sci,Minist Educ, Xiamen, Fujian, Peoples R China	Xiamen University	Li, QG (corresponding author), Xiamen Univ, State Key Lab Mol Vaccinol & Mol Diagnost, Engn Res Ctr Mol Diagnost, Sch Life Sci,Minist Educ, Xiamen, Fujian, Peoples R China.	qgli@xmu.edu.cn						Altimari A, 2013, ONCOTARGETS THER, V6, P1057, DOI 10.2147/OTT.S42369; Andersen SN, 1996, BRIT J CANCER, V74, P99, DOI 10.1038/bjc.1996.322; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen CY, 2004, CLIN CHEM, V50, P481, DOI 10.1373/clinchem.2003.024505; Cushman-Vokoun AM, 2013, AM J CLIN PATHOL, V140, P7, DOI 10.1309/AJCPMF26ABEOYCHZ; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dieterle CP, 2004, CLIN CANCER RES, V10, P641, DOI 10.1158/1078-0432.CCR-1355-02; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Harden SV, 2004, CLIN CANCER RES, V10, P2379, DOI 10.1158/1078-0432.CCR-03-0405; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; JACOBSON DR, 1994, ONCOGENE, V9, P553; Leelatian N, 2014, EXP MOL PATHOL, V96, P85, DOI 10.1016/j.yexmp.2013.12.006; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Liu Q, 2004, BIOTECHNIQUES, V36, P156, DOI 10.2144/04361DD03; Liu Q, 2004, HUM MUTAT, V23, P426, DOI 10.1002/humu.20036; Liu Q, 2002, NUCLEIC ACIDS RES, V30, P598, DOI 10.1093/nar/30.2.598; Liu Q, 2000, BIOTECHNIQUES, V29, P1072, DOI 10.2144/00295rr03; Luo JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj008; Madic J, 2012, CLIN CANCER RES, V18, P3934, DOI 10.1158/1078-0432.CCR-12-0309; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Morlan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004584; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; NICKERSON DA, 1990, P NATL ACAD SCI USA, V87, P8923, DOI 10.1073/pnas.87.22.8923; Oh JE, 2010, J MOL DIAGN, V12, P418, DOI 10.2353/jmoldx.2010.090146; Parsons BL, 2010, CANCER INVEST, V28, P364, DOI 10.3109/07357901003630975; Peeters M, 2013, J CLIN ONCOL, V31, P759, DOI 10.1200/JCO.2012.45.1492; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Thiede C, 1996, NUCLEIC ACIDS RES, V24, P983, DOI 10.1093/nar/24.5.983; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	37	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e96420	10.1371/journal.pone.0096420	http://dx.doi.org/10.1371/journal.pone.0096420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769870	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736600034
J	Bian, ZY; Liao, HH; Zhang, Y; Wu, QQ; Zhou, H; Yang, Z; Fu, JR; Wang, T; Yan, L; Shen, DF; Li, HL; Tang, QZ				Bian, Zhouyan; Liao, Haihan; Zhang, Yan; Wu, Qingqing; Zhou, Heng; Yang, Zheng; Fu, Jinrong; Wang, Teng; Yan, Ling; Shen, Difei; Li, Hongliang; Tang, Qizhu			Never in Mitosis Gene A Related Kinase-6 Attenuates Pressure Overload-Induced Activation of the Protein Kinase B Pathway and Cardiac Hypertrophy	PLOS ONE			English	Article							IN-VIVO; NEK6; CELLS; GROWTH; CANCER; OVEREXPRESSION; TRANSFORMATION; PHOSPHORYLATE; EXPRESSION; STRESS	Cardiac hypertrophy appears to be a specialized form of cellular growth that involves the proliferation control and cell cycle regulation. NIMA (never in mitosis, gene A)-related kinase-6 (Nek6) is a cell cycle regulatory gene that could induce centriole duplication, and control cell proliferation and survival. However, the exact effect of Nek6 on cardiac hypertrophy has not yet been reported. In the present study, the loss- and gain-of-function experiments were performed in Nek6 gene-deficient (Nek6(-/-)) mice and Nek6 overexpressing H9c2 cells to clarify whether Nek6 which promotes the cell cycle also mediates cardiac hypertrophy. Cardiac hypertrophy was induced by transthoracic aorta constriction (TAC) and then evaluated by echocardiography, pathological and molecular analyses in vivo. We got novel findings that the absence of Nek6 promoted cardiac hypertrophy, fibrosis and cardiac dysfunction, which were accompanied by a significant activation of the protein kinase B (Akt) signaling in an experimental model of TAC. Consistent with this, the overexpression of Nek6 prevented hypertrophy in H9c2 cells induced by angiotonin II and inhibited Akt signaling in vitro. In conclusion, our results demonstrate that the cell cycle regulatory gene Nek6 is also a critical signaling molecule that helps prevent cardiac hypertrophy and inhibits the Akt signaling pathway.	[Bian, Zhouyan; Liao, Haihan; Zhang, Yan; Wu, Qingqing; Zhou, Heng; Yang, Zheng; Fu, Jinrong; Wang, Teng; Yan, Ling; Shen, Difei; Li, Hongliang; Tang, Qizhu] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Hubei Province, Peoples R China; [Bian, Zhouyan; Liao, Haihan; Zhang, Yan; Wu, Qingqing; Yang, Zheng; Wang, Teng; Li, Hongliang; Tang, Qizhu] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University; Wuhan University	Tang, QZ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Hubei Province, Peoples R China.	qztang@whu.edu.cn			National Natural Science Foundation of China [81000036, 81270303, 81200071]; Fundamental Research Funds for the Central Universities of China [302274021/121097]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by grants from National Natural Science Foundation of China (No. 81000036, 81270303, and 81200071), and the Fundamental Research Funds for the Central Universities of China (302274021/121097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Bian ZY, 2012, J MOL MED, V90, P895, DOI 10.1007/s00109-012-0883-2; Bian ZY, 2010, HYPERTENSION, V55, P257, DOI 10.1161/HYPERTENSIONAHA.109.135665; Busk PK, 2002, CARDIOVASC RES, V56, P64, DOI 10.1016/S0008-6363(02)00510-2; Cao XL, 2012, PATHOL ONCOL RES, V18, P201, DOI 10.1007/s12253-011-9429-0; Chen BL, 2010, ACTA BIOCH BIOPH SIN, V42, P253, DOI 10.1093/abbs/gmq012; Dai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053412; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; Guan HJ, 2013, J NUTR BIOCHEM, V24, P62, DOI 10.1016/j.jnutbio.2012.02.002; Hashimoto Y, 2002, BIOCHEM BIOPH RES CO, V293, P753, DOI 10.1016/S0006-291X(02)00297-8; Hou JL, 2012, PHARMACOL THERAPEUT, V135, P337, DOI 10.1016/j.pharmthera.2012.06.006; Jee HJ, 2010, CELL CYCLE, V9, P4703, DOI 10.4161/cc.9.23.14059; Jeon YJ, 2010, J BIOL CHEM, V285, P28126, DOI 10.1074/jbc.M110.137190; Kang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023872; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Kim S, 2011, J CELL SCI, V124, P3760, DOI 10.1242/jcs.078089; Kitagishi Yasuko, 2012, Depress Res Treat, V2012, P752563, DOI 10.1155/2012/752563; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Liu L, 2012, NEPHROL DIAL TRANSPL, V27, P90, DOI 10.1093/ndt/gfr265; Liu XD, 2013, J NEUROSURG-SPINE, V19, P2; Liu YL, 2012, CELL BIOCHEM BIOPHYS, V62, P229, DOI 10.1007/s12013-011-9287-0; Lizcano JM, 2002, J BIOL CHEM, V277, P27839, DOI 10.1074/jbc.M202042200; Meirelles GV, 2010, J PROTEOME RES, V9, P6298, DOI 10.1021/pr100562w; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nassirpour R, 2010, MOL CANCER RES, V8, P717, DOI 10.1158/1541-7786.MCR-09-0291; Neeland IJ, 2013, J AM COLL CARDIOL, V61, P187, DOI 10.1016/j.jacc.2012.10.012; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Tamamori-Adachi M, 2002, BIOCHEM BIOPH RES CO, V296, P274, DOI 10.1016/S0006-291X(02)00854-9; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252	34	9	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96095	10.1371/journal.pone.0096095	http://dx.doi.org/10.1371/journal.pone.0096095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763737	gold, Green Submitted, Green Published			2022-12-25	WOS:000335505000058
J	Aghemo, A; Grassi, E; Rumi, MG; D'Ambrosio, R; Galmozzi, E; Degasperi, E; Castaldi, D; Soffredini, R; Colombo, M				Aghemo, Alessio; Grassi, Eleonora; Rumi, Maria Grazia; D'Ambrosio, Roberta; Galmozzi, Enrico; Degasperi, Elisabetta; Castaldi, Davide; Soffredini, Roberta; Colombo, Massimo			Limited Utility of ITPA Deficiency to Predict Early Anemia in HCV Patients with Advanced Fibrosis Receiving Telaprevir	PLOS ONE			English	Article							TRIPLE THERAPY; TRANSIENT ELASTOGRAPHY; RIBAVIRIN; MANAGEMENT; VARIANTS; PROTECT	Background: Severe anemia is a common side effect of Pegylated Interferon + Ribavirin (PR) and Telaprevir (TVR) in hepatitis C virus (HCV) genotype 1 patients with advanced fibrosis or cirrhosis (F3-F4). Inosine triphosphatase (ITPA) genetic variants are associated with RBV-induced anemia and dose reduction. Aim: To test the association of ITPA polymorphisms rs1127354 and rs7270101 with hemoglobin (Hb) decline, need for RBV dose reduction (RBV DR), erythropoietin (EPO) support and blood transfusions during the first 12 weeks of TVR triple therapy. Materials and Methods: 69 consecutive HCV-1 patients (mean age 57 years) with F3-F4 who received PR and TVR were genotyped for ITPA polymorphisms rs1127354 and rs7270101. Estimated ITPA deficiency was graded on severity (0-3, no deficiency/mild/moderate/severe). Results: ITPA deficiency was absent in 48 patients (70%), mild in 12 (17%) and moderate in 9 patients (13%). Mean week 4 Hb decline was higher in non ITPA deficient patients (3,85 g/dL) than in mildly or moderately ITPA deficient patients (3,07 g/dL and 1,67 g/dL, p<0.0001). Grade 3-4 anemia developed in 81% non ITPA deficient patients versus 67% mild deficient and 55% moderate deficient patients (p = ns). Grade of ITPA deficiency was not associated with RbvDR (no deficiency: 60%, mild: 58%, moderate: 67%; p = ns), EPO use (no deficiency: 65%, mild: 58%, moderate: 56%; p = ns) or need for blood transfusion (no deficiency: 27%, mild: 17%, moderate: 33%; p = ns). Conclusions: In patients with F3-F4 chronic hepatitis C receiving TVR based therapy, ITPA genotype does not impact on the management of early anemia.	[Aghemo, Alessio; Grassi, Eleonora; D'Ambrosio, Roberta; Galmozzi, Enrico; Degasperi, Elisabetta; Soffredini, Roberta; Colombo, Massimo] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol 1, AM & A Migliavacca Ctr Liver Dis, Milan, Italy; [Rumi, Maria Grazia] Univ Milan, Hepatol Unit, Osped San Giuseppe, IRCCS Multimed, Milan, Italy; [Castaldi, Davide] Univ Milano Bicocca, Dept Informat Systemist & Comunicat DISCo, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Multimedica; University of Milan; University of Milano-Bicocca	Aghemo, A (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol 1, AM & A Migliavacca Ctr Liver Dis, Milan, Italy.	alessio.aghemo@policlinico.mi.it	Aghemo, Alessio/ABE-5976-2021; D'Ambrosio, Roberta/K-3078-2016	Aghemo, Alessio/0000-0003-0941-3226; D'Ambrosio, Roberta/0000-0003-0019-1153; RUMI, MARIAGRAZIA/0000-0002-5876-8528; Galmozzi, Enrico/0000-0001-8831-2401	Massimo Colombo, MD, grant; Merck; Roche; BMS; Gilead Science	Massimo Colombo, MD, grant; Merck(Merck & Company); Roche(Roche Holding); BMS(Bristol-Myers Squibb); Gilead Science(Gilead Sciences)	Massimo Colombo, MD, grant and research support: Merck, Roche, BMS, Gilead Science; Advisory committees: Merck, Roche, Novartis, Bayer, BMS. Alessio Aghemo, MD, grant and research support: Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghemo A, 2013, DIGEST LIVER DIS, V45, P1, DOI 10.1016/j.dld.2012.05.002; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Boglione L, 2014, J VIRAL HEPATITIS, V21, P260, DOI 10.1111/jvh.12170; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Clark PJ, 2013, J VIRAL HEPATITIS, V20, P858, DOI 10.1111/jvh.12113; Colombo M, 2014, GUT, V63, P1150, DOI 10.1136/gutjnl-2013-305667; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Galmozzi E, 2013, J VIROL METHODS, V187, P271, DOI 10.1016/j.jviromet.2012.11.026; Hammond K, 2013, REV ANTIV THER INFEC, V3, P26; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Hitomi Y, 2011, GASTROENTEROLOGY, V140, P1314, DOI 10.1053/j.gastro.2010.12.038; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Ogawa E, 2013, J HEPATOL, V59, P667, DOI 10.1016/j.jhep.2013.05.017; Poordad F, 2013, GASTROENTEROLOGY, V145, P1035, DOI 10.1053/j.gastro.2013.07.051; Romero-Gomez M, 2013, J HEPATOL, V59, P1323, DOI 10.1016/j.jhep.2013.07.014; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sulkowski MS, 2013, HEPATOLOGY, V57, P974, DOI 10.1002/hep.26096; Sulkowski MS, 2011, J HEPATOL, V56, pS459; Suzuki F, 2011, HEPATOLOGY, V53, P415, DOI 10.1002/hep.24058; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P1181, DOI 10.1053/j.gastro.2010.06.016; Werner CR, 2014, J VIRAL HEPATITIS, V21, P333, DOI 10.1111/jvh.12145	22	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95881	10.1371/journal.pone.0095881	http://dx.doi.org/10.1371/journal.pone.0095881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760000	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200100
J	Mazumder, M; Padhan, N; Bhattacharya, A; Gourinath, S				Mazumder, Mohit; Padhan, Narendra; Bhattacharya, Alok; Gourinath, Samudrala			Prediction and Analysis of Canonical EF Hand Loop and Qualitative Estimation of Ca2+ Binding Affinity	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SUPPORT VECTOR MACHINES; METAL-ION-BINDING; CALCIUM-BINDING; SECONDARY STRUCTURE; TROPONIN-C; THEORETICAL ESTIMATION; ENTAMOEBA-HISTOLYTICA; CELL-DEATH; CONSTANTS	The diversity of functions carried out by EF hand-containing calcium-binding proteins is due to various interactions made by these proteins as well as the range of affinity levels for Ca2+ displayed by them. However, accurate methods are not available for prediction of binding affinities. Here, amino acid patterns of canonical EF hand sequences obtained from available crystal structures were used to develop a classifier that distinguishes Ca2+-binding loops and non Ca2+-binding regions with 100% accuracy. To investigate further, we performed a proteome-wide prediction for E. histolytica, and classified known EF-hand proteins. We compared our results with published methods on the E. histolytica proteome scan, and demonstrated our method to be more specific and accurate for predicting potential canonical Ca2+-binding loops. Furthermore, we annotated canonical EF-hand motifs and classified them based on their Ca2+-binding affinities using support vector machines. Using a novel method generated from position-specific scoring metrics and then tested against three different experimentally derived EF-hand-motif datasets, predictions of Ca2+-binding affinities were between 87 and 90% accurate. Our results show that the tool described here is capable of predicting Ca2+-binding affinity constants of EF-hand proteins. The web server is freely available at http://202.41.10.46/calb/index.html.	[Mazumder, Mohit; Padhan, Narendra; Bhattacharya, Alok; Gourinath, Samudrala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Padhan, Narendra] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Uppsala University; Jawaharlal Nehru University, New Delhi	Gourinath, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	samudralag@yahoo.com		mazumder, mohit/0000-0002-2593-725X	Innovative Young Biotechnology Award, Department of Biotechnology, and Govt. of India	Innovative Young Biotechnology Award, Department of Biotechnology, and Govt. of India	This study was supported by Innovative Young Biotechnology Award, Department of Biotechnology, and Govt. of India (http://www.dbtindia.gov.in/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasopoulos A., 2011, P 12 INT WORKSH IM A; BAIROCH A, 1990, FEBS LETT, V269, P454, DOI 10.1016/0014-5793(90)81214-9; Bencina M, 2009, FUNGAL GENET BIOL, V46, pS93, DOI 10.1016/j.fgb.2008.07.019; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bhasin M, 2004, PROTEIN SCI, V13, P596, DOI 10.1110/ps.03373104; Bhattacharya A, 2006, ARCH MED RES, V37, P221, DOI 10.1016/j.arcmed.2005.10.002; Bock JR, 2001, BIOINFORMATICS, V17, P455, DOI 10.1093/bioinformatics/17.5.455; BOGUTA G, 1988, J THEOR BIOL, V135, P63, DOI 10.1016/S0022-5193(88)80174-7; BOGUTA G, 1988, J THEOR BIOL, V135, P41, DOI 10.1016/S0022-5193(88)80173-5; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Chang CL, 2011, GENOME RES, V21, P21, DOI 10.1101/gr.110593.110; Deng H, 2006, PROTEINS, V64, P34, DOI 10.1002/prot.20973; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1035, DOI 10.1038/nbt0804-1035; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; FINN BE, 1995, STRUCTURE, V3, P7, DOI 10.1016/S0969-2126(01)00130-7; Franke S, 2010, ADV APPL BIOINFORM C, V3, P1; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; GODZIK A, 1989, PROTEIN ENG, V2, P589, DOI 10.1093/protein/2.8.589; Gopal B, 1997, BIOCHEMISTRY-US, V36, P10910, DOI 10.1021/bi9702546; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Henikoff JG, 1996, COMPUT APPL BIOSCI, V12, P135; Henikoff S, 1997, SCIENCE, V278, P609, DOI 10.1126/science.278.5338.609; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; KLEIN P, 1984, BIOCHIM BIOPHYS ACTA, V787, P221, DOI 10.1016/0167-4838(84)90312-1; Kuhn LA, 1995, PROTEINS, V23, P536, DOI 10.1002/prot.340230408; Kunal J, 2010, J CELL MOL BIOL, V8, P41; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lin HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S13; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; LINSE S, 1988, NATURE, V335, P651, DOI 10.1038/335651a0; Liu TY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-72; Lo SL, 2005, PROTEOMICS, V5, P876, DOI 10.1002/pmic.200401118; MANN KG, 1990, BLOOD, V76, P1; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; MOESCHLER HJ, 1980, EUR J BIOCHEM, V111, P73; NAKAYAMA S, 1994, ANNU REV BIOPH BIOM, V23, P473, DOI 10.1146/annurev.bb.23.060194.002353; Ramana J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009695; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Rout AK, 2010, BIOCHEMISTRY; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; TATUSOV RL, 1994, P NATL ACAD SCI USA, V91, P12091, DOI 10.1073/pnas.91.25.12091; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Verkhratsky A., 2007, V45, P465; Wang X, 2009, PROTEINS, V75, P787, DOI 10.1002/prot.22285; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xiao X, 2006, AMINO ACIDS, V30, P49, DOI 10.1007/s00726-005-0225-6; Xiao X, 2009, J COMPUT CHEM, V30, P1414, DOI 10.1002/jcc.21163; Zhou Y, 2006, PROTEINS, V65, P643, DOI 10.1002/prot.21139; Zhou YB, 2009, CELL CALCIUM, V46, P1, DOI 10.1016/j.ceca.2009.05.005	59	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96202	10.1371/journal.pone.0096202	http://dx.doi.org/10.1371/journal.pone.0096202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760183	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200146
J	Saute, R; Dabbs, K; Jones, JE; Jackson, DC; Seidenberg, M; Hermann, BP				Saute, Ricardo; Dabbs, Kevin; Jones, Jana E.; Jackson, Daren C.; Seidenberg, Michael; Hermann, Bruce P.			Brain Morphology in Children with Epilepsy and ADHD	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TEMPORAL-LOBE EPILEPSY; DEFICIT-HYPERACTIVITY-DISORDER; QUALITY-OF-LIFE; PEDIATRIC EPILEPSY; CEREBELLAR ATROPHY; HIPPOCAMPAL SCLEROSIS; CORTICAL THICKNESS; CHILDHOOD EPILEPSY; LOCUS-COERULEUS	Background: Attention deficit hyperactivity disorder (ADHD) is a common comorbidity of childhood epilepsy, but the neuroanatomical correlates of ADHD in epilepsy have yet to be comprehensively characterized. Methods: Children with new and recent-onset epilepsy with (n = 18) and without (n = 36) ADHD, and healthy controls (n = 46) underwent high resolution MRI. Measures of cortical morphology (thickness, area, volume, curvature) and subcortical and cerebellar volumes were compared between the groups using the program FreeSurfer 5.1. Results: Compared to the control group, children with epilepsy and ADHD exhibited diffuse bilateral thinning in the frontal, parietal and temporal lobes, with volume reductions in the brainstem and subcortical structures (bilateral caudate, left thalamus, right hippocampus). There were very few group differences across measures of cortical volume, area or curvature. Conclusions: Children with epilepsy and comorbid ADHD exhibited a pattern of bilateral and widespread decreased cortical thickness as well as decreased volume of subcortical structures and brainstem. These anatomic abnormalities were evident early in the course of epilepsy suggesting the presence of antecedent neurodevelopmental changes, the course of which remains to be determined.	[Saute, Ricardo] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Fac Med, Porto Alegre, RS, Brazil; [Dabbs, Kevin; Jones, Jana E.; Jackson, Daren C.; Hermann, Bruce P.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53706 USA; [Seidenberg, Michael] Rosalind Franklin Univ Sci & Med, Dept Psychol, Chicago, IL USA	Pontificia Universidade Catolica Do Rio Grande Do Sul; University of Wisconsin System; University of Wisconsin Madison; Chicago Medical School; Rosalind Franklin University Medical & Science	Hermann, BP (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53706 USA.	hermann@neurology.wisc.edu	Hermann, Bruce/ACM-4355-2022; Lutzky Saute, Ricardo/AAX-8525-2021	Lutzky Saute, Ricardo/0000-0002-5570-9055	National Institute of Neurological Disorders and Stroke (NINDS) [2RO1-44351]; Clinical and Translational Science Award (CTSA) program through National Center for Research Resources (NCRR) [1UL1RR025011]; National Center for Advancing Translational Sciences (NCATS) [9U54TR000021]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044351] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Clinical and Translational Science Award (CTSA) program through National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) 2RO1-44351 and the Clinical and Translational Science Award (CTSA) program, previously through the National Center for Research Resources (NCRR) grant 1UL1RR025011, and now by the National Center for Advancing Translational Sciences (NCATS), grant 9U54TR000021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhusaini S, 2012, EPILEPSY RES, V99, P156, DOI 10.1016/j.eplepsyres.2011.11.005; Almeida LG, 2010, J PSYCHIATR RES, V44, P1214, DOI 10.1016/j.jpsychires.2010.04.026; American Psychiatric Association, 2017, DIAGN STAT MAN MENT, V5th; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; Bansal R, 2010, AM J PSYCHIAT, V167, P397; Berg AT, 2011, EPILEPSY BEHAV, V20, P550, DOI 10.1016/j.yebeh.2010.12.038; Bohland JW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00078; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Caplan R, 2005, EPILEPSIA, V46, P720, DOI 10.1111/j.1528-1167.2005.43604.x; Cohen R, 2012, J CHILD NEUROL; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Dabbs K, 2012, EPILEPSIA, V53, P1033, DOI 10.1111/j.1528-1167.2012.03447.x; Davies S, 2003, DEV MED CHILD NEUROL, V45, P292, DOI 10.1017/S0012162203000550; Duerden EG, 2012, BRAIN RES, V1445, P82, DOI 10.1016/j.brainres.2012.01.034; Dunn DW, 2009, DEV MED CHILD NEUROL, V51, P364, DOI 10.1111/j.1469-8749.2008.03172.x; Dunn DW, 2003, DEV MED CHILD NEUROL, V45, P50, DOI 10.1017/S0012162203000094; Ellison-Wright I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-51; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Hagemann G, 2002, J NEUROL, V249, P1651, DOI 10.1007/s00415-002-0843-9; Hermann BP, 2005, EPILEPSY BEHAV, V7, P279, DOI 10.1016/j.yebeh.2005.05.022; Hermann B, 2007, BRAIN, V130, P3135, DOI 10.1093/brain/awm227; Hoekzema E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048286; Kattimani S, 2011, ANN INDIAN ACAD NEUR, V14, P9, DOI 10.4103/0972-2327.78042; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kim JH, 2013, J NEUROL; Koneski JAS, 2011, EPILEPSY BEHAV, V21, P228, DOI 10.1016/j.yebeh.2011.02.029; Liu RSN, 2002, ANN NEUROL, V52, P573, DOI 10.1002/ana.10338; Luo LQ, 2010, NAT REV NEUROSCI, V11, P718, DOI 10.1038/nrn2912; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Mirsky AF, 2001, ANN NY ACAD SCI, V931, P17; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Narr KL, 2009, J AM ACAD CHILD PSY, V48, P1014, DOI 10.1097/CHI.0b013e3181b395c0; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Ott D, 2003, EPILEPSIA, V44, P591, DOI 10.1046/j.1528-1157.2003.25002.x; Oyegbile TO, 2011, EPILEPSIA, V52, P698, DOI 10.1111/j.1528-1167.2010.02937.x; Pail M, 2010, EPILEPSIA, V51, P511, DOI 10.1111/j.1528-1167.2009.02324.x; Proal E, 2011, ARCH GEN PSYCHIAT, V68, P1122, DOI 10.1001/archgenpsychiatry.2011.117; Qiu MG, 2011, BRAIN TOPOGR, V24, P243, DOI 10.1007/s10548-010-0168-4; Russ SA, 2012, PEDIATRICS, V129, P256, DOI 10.1542/peds.2010-1371; Rutter M, 1970, NEUROPSYCHIATRIC STU; Saini J, 2013, SEIZURE-EUR J EPILEP, V22, P230, DOI 10.1016/j.seizure.2013.01.001; Sandok EK, 2000, EPILEPSIA, V41, P1315, DOI 10.1111/j.1528-1157.2000.tb04611.x; Santos K, 2013, DEV MED CHILD NEUROL, V55, P654, DOI 10.1111/dmcn.12121; Selemon LD, 1998, J COMP NEUROL, V392, P402; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Shaw P, 2012, BIOL PSYCHIAT, V72, P191, DOI 10.1016/j.biopsych.2012.01.031; Shaw P, 2009, CURR PSYCHIAT REP, V11, P393, DOI 10.1007/s11920-009-0059-0; Shaw P, 2010, AM J PSYCHIAT, V167, P363, DOI 10.1176/appi.ajp.2010.10010037; Sherman EMS, 2007, EPILEPSIA, V48, P1083, DOI 10.1111/j.1528-1167.2007.01028.x; Sherman EMS, 2010, EPILEPSY BEHAV, V19, P428, DOI 10.1016/j.yebeh.2010.08.015; Spencer TJ, 2007, AMBUL PEDIATR, V7, P73, DOI 10.1016/j.ambp.2006.07.006; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Wolosin SM, 2009, HUM BRAIN MAPP, V30, P175, DOI 10.1002/hbm.20496; World Medical Association, 1991, J LAW MED ETHICS, V19, P264, DOI [DOI 10.1111/J.1748-720X.1991.TBO1824.X, 10.1111/j.1748-720X.1991.tb01824.x]; Xia SG, 2012, PSYCHIAT RES-NEUROIM, V204, P161, DOI 10.1016/j.pscychresns.2012.04.011; Yoo HK, 2009, EPILEPTIC DISORD, V11, P301, DOI 10.1684/epd.2009.0278	60	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95269	10.1371/journal.pone.0095269	http://dx.doi.org/10.1371/journal.pone.0095269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760032	Green Submitted, gold, Green Published			2022-12-25	WOS:000335298200044
J	Walsh, KP; Minamide, LS; Kane, SJ; Shaw, AE; Brown, DR; Pulford, B; Zabel, MD; Lambeth, JD; Kuhn, TB; Bamburg, JR				Walsh, Keifer P.; Minamide, Laurie S.; Kane, Sarah J.; Shaw, Alisa E.; Brown, David R.; Pulford, Bruce; Zabel, Mark D.; Lambeth, J. David; Kuhn, Thomas B.; Bamburg, James R.			Amyloid-beta and Proinflammatory Cytokines Utilize a Prion Protein-Dependent Pathway to Activate NADPH Oxidase and Induce Cofilin-Actin Rods in Hippocampal Neurons	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; A-BETA; MITOCHONDRIAL DYSFUNCTION; NOX ENZYMES; SYNAPTIC PLASTICITY; CROSS-LINKING; BRAIN-INJURY; TNF-ALPHA; ADF/COFILIN	Neurites of neurons under acute or chronic stress form bundles of filaments (rods) containing 1:1 cofilin: actin, which impair transport and synaptic function. Rods contain disulfide cross-linked cofilin and are induced by treatments resulting in oxidative stress. Rods form rapidly (5-30 min) in >80% of cultured hippocampal or cortical neurons treated with excitotoxic levels of glutamate or energy depleted (hypoxia/ischemia or mitochondrial inhibitors). In contrast, slow rod formation (50% of maximum response in similar to 6 h) occurs in a subpopulation (similar to 20%) of hippocampal neurons upon exposure to soluble human amyloid-beta dimer/trimer (A beta d/t) at subnanomolar concentrations. Here we show that proinflammatory cytokines (TNF alpha, IL-1 beta, IL-6) also induce rods at the same rate and within the same neuronal population as Abd/t. Neurons from prion (PrPC)-null mice form rods in response to glutamate or antimycin A, but not in response to proinflammatory cytokines or A beta d/t. Two pathways inducing rod formation were confirmed by demonstrating that NADPH-oxidase (NOX) activity is required for prion-dependent rod formation, but not for rods induced by glutamate or energy depletion. Surprisingly, overexpression of PrPC is by itself sufficient to induce rods in over 40% of hippocampal neurons through the NOX-dependent pathway. Persistence of PrPC-dependent rods requires the continuous activity of NOX. Removing inducers or inhibiting NOX activity in cells containing PrPC-dependent rods causes rod disappearance with a half-life of about 36 min. Cofilin-actin rods provide a mechanism for synapse loss bridging the amyloid and cytokine hypotheses for Alzheimer disease, and may explain how functionally diverse Ab-binding membrane proteins induce synaptic dysfunction.	[Walsh, Keifer P.; Minamide, Laurie S.; Kane, Sarah J.; Shaw, Alisa E.; Kuhn, Thomas B.; Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Kane, Sarah J.; Zabel, Mark D.; Bamburg, James R.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Pulford, Bruce; Zabel, Mark D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Prion Res Ctr, Ft Collins, CO 80523 USA; [Lambeth, J. David] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Kuhn, Thomas B.] Univ Alaska, Dept Chem & Biochem, Fairbanks, AK 99701 USA	Colorado State University; Colorado State University; University of Bath; Colorado State University; Emory University; University of Alaska System; University of Alaska Fairbanks	Bamburg, JR (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	James.Bamburg@ColoState.edu		Kane, Sarah/0000-0002-6072-5682	National Institutes of Health [NS040371, AG044812, GM103395]; Colorado State University Core Infrastructure Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG044812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado State University Core Infrastructure Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research was supported in part by National Institutes of Health grants NS040371 and AG044812 (JRB), GM103395 (TBK), a Colorado State University Core Infrastructure Grant, and generous donations to the Colorado State University Research Foundation in support of the authors' research. The funders except the named authors played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; Altenhofer S, 2014, ANTIOXID REDOX SIGN; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Ansari MA, 2011, FREE RADICAL BIO MED, V51, P171, DOI 10.1016/j.freeradbiomed.2011.03.025; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Barth BM, 2012, CELL SIGNAL, V24, P1126, DOI 10.1016/j.cellsig.2011.12.020; Barth BM, 2009, MOL CELL NEUROSCI, V41, P274, DOI 10.1016/j.mcn.2009.03.007; Bate C, 2012, J BIOL CHEM, V287, P7935, DOI 10.1074/jbc.M111.275743; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Benilova I, 2013, SCIENCE, V341, P1354, DOI 10.1126/science.1244166; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Bruce-Keller AJ, 2011, NEUROBIOL DIS, V44, P317, DOI 10.1016/j.nbd.2011.07.012; Cacquevel M, 2004, CURR DRUG TARGETS, V5, P529, DOI 10.2174/1389450043345308; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Campos SB, 2009, AM J PHYSIOL-RENAL, V296, pF487, DOI 10.1152/ajprenal.00112.2008; Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Davis RC, 2009, J ALZHEIMERS DIS, V18, DOI 10.3233/JAD-2009-1122; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Griffin W Sue T, 2010, US Neurol, V6, P19; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Haigh CL, 2005, MOL CELL NEUROSCI, V30, P186, DOI 10.1016/j.mcn.2005.07.001; He J, 2013, J NEUROL SCI, V326, P89, DOI 10.1016/j.jns.2013.01.020; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hernandez-Rapp J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00025; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Ironside JW, 2004, CURR TOP MICROBIOL, V284, P133; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Keller JN, 2005, NEUROLOGY, V64, P1152, DOI 10.1212/01.WNL.0000156156.13641.BA; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Liu L, 2014, AGEING RES REV, V15, P6, DOI 10.1016/j.arr.2013.12.007; Malchiodi-Albedi F, 2010, BBA-MOL BASIS DIS, V1802, P406, DOI 10.1016/j.bbadis.2010.01.007; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Maulik M, 2013, MOL NEUROBIOL, V47, P37, DOI 10.1007/s12035-012-8337-y; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; McDonald JM, 2012, BRAIN RES, V1450, P138, DOI 10.1016/j.brainres.2012.02.041; Mi JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083609; Minamide LS, 2010, J BIOL CHEM, V285, P5450, DOI 10.1074/jbc.M109.063768; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Minamide LS, 2003, METHOD CELL BIOL, V71, P387, DOI 10.1016/S0091-679X(03)01019-7; Mo G-L, 2014, NEUROCHEM RES; Moore BD, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt121; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Moya KL, 2000, MICROSC RES TECHNIQ, V50, P58, DOI 10.1002/1097-0029(20000701)50:1<58::AID-JEMT9>3.0.CO;2-5; Mrak RE, 2005, J ALZHEIMERS DIS, V8, P369; Mucke L, 2012, COLD SPRING HARBOR P, V2012, DOI 10.110/cshperspect.a006338; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Orsucci D, 2013, CURR NEUROVASC RES, V10, P76, DOI 10.2174/156720213804805972; Pluta R, 2013, MOL NEUROBIOL, V48, P500, DOI 10.1007/s12035-013-8439-1; Pluta R, 2013, MOL NEUROBIOL, V47, P425, DOI 10.1007/s12035-012-8360-z; Roh SE, 2013, FASEB J, V27, P4776, DOI 10.1096/fj.13-234765; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; Sagy-Bross C, 2013, NEUROCHEM INT, V63, P541, DOI 10.1016/j.neuint.2013.09.007; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Sauer H, 2003, FREE RADICAL BIO MED, V35, P586, DOI 10.1016/S0891-5849(03)00360-5; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Sorce S, 2012, CELL MOL LIFE SCI, V69, P2387, DOI 10.1007/s00018-012-1014-5; Sudduth TL, 2013, NEUROBIOL AGING, V34, P1051, DOI 10.1016/j.neurobiolaging.2012.09.012; Syed I, 2012, CELL PHYSIOL BIOCHEM, V30, P1051, DOI 10.1159/000341481; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Vural P, 2009, ACTA NEUROL SCAND, V120, P396, DOI 10.1111/j.1600-0404.2009.01230.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069; Wilcock DM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-84; Woo JA, 2012, CELL DEATH DIFFER, V19, P1413, DOI 10.1038/cdd.2012.14; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206	95	46	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95995	10.1371/journal.pone.0095995	http://dx.doi.org/10.1371/journal.pone.0095995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760020	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200123
J	Yang, KS; Lim, JH; Kim, TW; Kim, MY; Kim, Y; Chung, SJ; Shin, SJ; Choi, BS; Kim, HW; Kim, YS; Chang, YS; Kim, HW; Park, CW				Yang, Keun Suk; Lim, Ji Hee; Kim, Tae Woo; Kim, Min Young; Kim, Yaeni; Chung, Sungjin; Shin, Seok Joon; Choi, Beom Soon; Kim, Hyung Wook; Kim, Yong-Soo; Chang, Yoon Sik; Kim, Hye Won; Park, Cheol Whee			Vascular Endothelial Growth Factor-Receptor 1 Inhibition Aggravates Diabetic Nephropathy through eNOS Signaling Pathway in db/db Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-TYROSINE KINASES; VEGF-A; FACTOR EXPRESSION; ANGIOGENESIS; APOPTOSIS; FLT-1; PATHOGENESIS; AUTOCRINE; SURVIVAL	The manipulation of vascular endothelial growth factor (VEGF)-receptors (VEGFRs) in diabetic nephropathy is as controversial as issue as ever. It is known to be VEGF-A and VEGFR2 that regulate most of the cellular actions of VEGF in experimental diabetic nephropathy. On the other hand, such factors as VEGF-A, -B and placenta growth factor bind to VEGFR1 with high affinity. Such notion instigated us to investigate on whether selective VEGFR1 inhibition with GNQWFI hexamer aggravates the progression of diabetic nephropathy in db/db mice. While diabetes suppressed VEGFR1, it did increase VEGFR2 expressions in the glomerulus. Db/db mice with VEGFR1 inhibition showed more prominent features with respect to, albuminuria, mesangial matrix expansion, inflammatory cell infiltration and greater numbers of apoptotic cells in the glomerulus, and oxidative stress than that of control db/db mice. All these changes were related to the suppression of diabetes-induced increases in PI3K activity and Akt phosphorylation as well as the aggravation of endothelial dysfunction associated with the inactivation of FoxO3a and eNOS-NOx. In cultured human glomerular endothelial cells (HGECs), high-glucose media with VEGFR1 inhibition induced more apoptotic cells and oxidative stress than did high-glucose media alone, which were associated with the suppression of PI3K-Akt phosphorylation, independently of the activation of AMP-activated protein kinase, and inactivation of FoxO3a and eNOS-NOx pathway. In addition, transfection with VEGFR1 siRNA in HGECs also suppressed PI3K-Akt-eNOS signaling. In conclusion, the specific blockade of VEGFR1 with GNQWFI caused severe renal injury related to profound suppression of the PI3K-Akt, FoxO3a and eNOS-NOx pathway, giving rise to the oxidative stress-induced apoptosis of glomerular cells in type 2 diabetic nephropathy.	[Yang, Keun Suk; Lim, Ji Hee; Kim, Tae Woo; Kim, Min Young; Kim, Yaeni; Chung, Sungjin; Shin, Seok Joon; Choi, Beom Soon; Kim, Hyung Wook; Kim, Yong-Soo; Chang, Yoon Sik; Park, Cheol Whee] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea; [Kim, Hye Won] Catholic Univ Korea, Coll Med, Dept Rehabil Med, Bucheon St Marys Hosp, Bucheon, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Park, CW (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea.	cheolwhee@hanmail.net	Chung, Sungjin/AAJ-8836-2020		Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea 18 [A111055]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A3020151]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea 18; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea 18 (C.W.P; A111055) and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (H.W.K; 2012R1A1A3020151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae DG, 2005, CLIN CANCER RES, V11, P2651, DOI 10.1158/1078-0432.CCR-04-1564; Bridgewater DJ, 2005, KIDNEY INT, V67, P1308, DOI 10.1111/j.1523-1755.2005.00208.x; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Chen S, 2008, CURR DIABETES REP, V8, P470, DOI 10.1007/s11892-008-0081-3; Cheng HF, 2012, KIDNEY INT, V82, P1176, DOI 10.1038/ki.2012.248; Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Elefitheriadis T, 2012, REN FAIL, V35, P592; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Feliers D, 2005, KIDNEY INT, V68, P1648, DOI 10.1111/j.1523-1755.2005.00575.x; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Flyvbjerg A, 2002, DIABETES, V51, P3090, DOI 10.2337/diabetes.51.10.3090; Habib SL, 2013, WORLD J DIABETES, V4, P27, DOI 10.4239/wjd.v4.i2.27; Harper SJ, 2005, NAT REV CANDER, V437, P497; Heeringa P, 2002, KIDNEY INT, V61, P822, DOI 10.1046/j.1523-1755.2002.00227.x; Kang DH, 2001, J AM SOC NEPHROL, V12, P1448, DOI 10.1681/ASN.V1271448; Karalliedde J, 2011, DIABETES CARE, V34, pS291, DOI 10.2337/dc11-s241; Kee NJ, 1997, KIDNEY INT, V52, P309, DOI 10.1038/ki.1997.336; Kim HW, 2011, NEPHROL DIAL TRANSPL, V26, P1173, DOI 10.1093/ndt/gfq610; Kim YG, 2000, KIDNEY INT, V58, P2390, DOI 10.1046/j.1523-1755.2000.00422.x; Kosugi T, 2010, AM J PHYSIOL-RENAL, V298, pF609, DOI 10.1152/ajprenal.00377.2009; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Linehan WM, 2013, CLIN CANCER RES, V19, P3345, DOI 10.1158/1078-0432.CCR-13-0304; Meek RL, 2013, NEPHROL DIAL TRANSPL, V28, P1711, DOI 10.1093/ndt/gfs579; Muller-Deile J, 2009, AM J PHYSIOL-RENAL, V297, pF1656, DOI 10.1152/ajprenal.00275.2009; Nakagawa T, 2009, DIABETES, V58, P1471, DOI 10.2337/db09-0119; Namba T, 2003, CIRCULATION, V108, P2250, DOI 10.1161/01.CIR.0000093190.53478.78; Remuzzi G, 2002, KIDNEY INT, V61, P2594; Sato Y, 2000, ANN NY ACAD SCI, V902, P201; Schrijvers BF, 2004, KIDNEY INT, V65, P2003, DOI 10.1111/j.1523-1755.2004.00621.x; Shen B, 2010, AM J PHYSIOL-HEART C, V299, pH1419, DOI 10.1152/ajpheart.00591.2010; Simmons S, 2008, DIABETES, V57, P2626; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; TAKAHASHI T, 1995, BIOCHEM BIOPH RES CO, V209, P218, DOI 10.1006/bbrc.1995.1492; Velagapudi C, 2011, J AM SOC NEPHROL, V22, P262, DOI 10.1681/ASN.2010040352; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Williams B, 1998, MINER ELECTROL METAB, V24, P400, DOI 10.1159/000057401; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370	41	19	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94540	10.1371/journal.pone.0094540	http://dx.doi.org/10.1371/journal.pone.0094540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759928	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200017
J	Gao, W; Gu, Y; Li, Z; Cai, H; Peng, Q; Tu, M; Kondo, Y; Shinjo, K; Zhu, Y; Zhang, J; Sekido, Y; Han, B; Qian, Z; Miao, Y				Gao, W.; Gu, Y.; Li, Z.; Cai, H.; Peng, Q.; Tu, M.; Kondo, Y.; Shinjo, K.; Zhu, Y.; Zhang, J.; Sekido, Y.; Han, B.; Qian, Z.; Miao, Y.			miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma	ONCOGENE			English	Article							HUMAN CANCER-CELLS; DNA METHYLATION; MICRORNA EXPRESSION; MICROSATELLITE INSTABILITY; GENE POLYMORPHISMS; DISEASE; RISK; PROGNOSIS; IGF2	Pancreatic ductal adenocarcinoma (PDAC) is a highly invasive cancer with a poor prognosis. Although microRNA (miRNA) transcripts have a crucial role in carcinogenesis and development, little information is known regarding the aberrant DNA methylation of miRNAs in PDAC. Using methylated DNA immunoprecipitation-chip analysis, we found that miR-615-5p was hypermethylated in its putative promoter region, which silenced its expression in PDAC cell lines. In addition, the overexpression of miR-615-5p in pancreatic cancer cells suppressed cell proliferation, migration and invasion. Insulin-like growth factor 2 (IGF2) is an imprinted gene, and its abnormal expression contributes to tumor growth. Here, we identified IGF2 as a target of miR-615-5p using a luciferase reporter assay. IGF2 upregulation in PDAC tissues was not correlated with a loss of imprinting but was inversely correlated with miR-615-5p downregulation. In addition, miR-615-5p suppressed pancreatic cancer cell proliferation, migration and invasion by directly targeting IGF2, and this effect could be reversed by co-transfection with IGF2. Furthermore, the stable overexpression of miR-615-5p inhibited tumor growth in vivo and was correlated with IGF2 expression. Using RNA sequencing, we further identified miR-615-5p as potentially targeting other genes, such as the proto-oncogene JUNB, and interfering with the insulin signaling pathway. Taken together, our results demonstrate that miR-615-5p was abnormally downregulated in PDAC cells due to promoter hypermethylation, which limited its inhibition of IGF2 and other target genes, thereby contributing to tumor growth, invasion and migration. These data demonstrate a novel and important role of miR-615-5p as a tumor suppressor in PDAC.	[Gao, W.; Gu, Y.; Li, Z.; Tu, M.; Zhu, Y.; Zhang, J.; Qian, Z.; Miao, Y.] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210029, Jiangsu, Peoples R China; [Cai, H.] First Peoples Hosp Changzhou, Dept Hepatobiliary Surg, Changzhou, Peoples R China; [Peng, Q.] PLA 105 Hosp, Dept Gen Surg, Hefei, Peoples R China; [Kondo, Y.; Shinjo, K.] Aichi Canc Ctr, Res Inst, Div Epigenom, Nagoya, Aichi 464, Japan; [Sekido, Y.] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Nagoya, Aichi 464, Japan; [Han, B.] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Aichi Cancer Center; Aichi Cancer Center; Nanjing Medical University	Gao, W (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, 300 GuangZhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	gao11@hotmail.com; qianzhusilver@163.com; miaoyi@njmu.edu.cn	Sekido, Yoshitaka/P-9756-2015	Sekido, Yoshitaka/0000-0002-2428-3848	National Nature Science Foundation of China [81172267, 30901627]; National Project For Translational Research Of Early Diagnosis And Comprehensive Treatment In Pancreatic Cancer [201202007]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Project For Translational Research Of Early Diagnosis And Comprehensive Treatment In Pancreatic Cancer; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National Nature Science Foundation of China (Nos 81172267 and 30901627), the National Project For Translational Research Of Early Diagnosis And Comprehensive Treatment In Pancreatic Cancer (201202007) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801).	Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Dong XQ, 2012, CANCER EPIDEMIOL, V36, P206, DOI 10.1016/j.canep.2011.05.013; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; El TH, 2012, FEBS LETT, V586, P3309; Fiorucci G, 2012, CURR MED CHEM, V19, P461, DOI 10.2174/092986712798918798; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Han L, 2007, CANCER BIOL THER, V6, P1284; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Jacinto FV, 2008, BIOTECHNIQUES, V44, P35, DOI 10.2144/000112708; Kim M, 2011, LANCET ONCOL, V12, P319, DOI 10.1016/S1470-2045(11)70067-5; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; Kunej T, 2011, MUTAT RES-FUND MOL M, V717, P77, DOI 10.1016/j.mrfmmm.2011.03.008; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Mardin W, 2009, ANN SURG ONCOL, V16, P3183, DOI 10.1245/s10434-009-0623-1; Mou HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077217; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Rachagani S, 2010, CANCER LETT, V292, P8, DOI 10.1016/j.canlet.2009.11.010; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Soares MR, 2010, GROWTH HORM IGF RES, V20, P295, DOI 10.1016/j.ghir.2010.03.006; Suzuki H, 2008, CANCER EPIDEM BIOMAR, V17, P3467, DOI 10.1158/1055-9965.EPI-08-0514; Teschendorff AE, 2012, BIOINFORMATICS, V28, P1487, DOI 10.1093/bioinformatics/bts170; Tricoli James V, 2007, Cancer Res, V67, P4553, DOI 10.1158/0008-5472.CAN-07-0563; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Wang J, 2011, J BIOSCIENCES, V36, P481, DOI 10.1007/s12038-011-9083-4; Weber B, 2007, CELL CYCLE, V6, P1001, DOI 10.4161/cc.6.9.4209; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yang Y, 2012, BIOCHEM GENET, V50, P122, DOI 10.1007/s10528-011-9478-9; Zhou X, 2007, PLOS COMPUT BIOL, V3	36	62	65	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 26	2015	34	13					1629	1640		10.1038/onc.2014.101	http://dx.doi.org/10.1038/onc.2014.101			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE5CS	24769899				2022-12-25	WOS:000351848400003
J	Bhattacharyya, S; Feferman, L; Tobacman, JK				Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.			Increased Expression of Colonic Wnt9A through Sp1-mediated Transcriptional Effects involving Arylsulfatase B, Chondroitin 4-Sulfate, and Galectin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; CANCER CELLS; SULFATASE ACTIVITY; COLORECTAL-CANCER; PROMOTER ACTIVITY; PROSTATE-CANCER; SP-SITES; SP1; CARRAGEENAN; ACTIVATION	In cultured human colonic epithelial cells and mouse colonic tissue, exposure to the common food additive carrageenan leads to inflammation, activation of Wnt signaling, increased Wnt9A expression, and decline in the activity of the enzyme arylsulfatase B (ARSB; N-acetylgalactosamine-4-sulfatase). In this study, the novel transcriptional mechanism by which carrageenan and decline in ARSB increase Wnt9A expression in NCM460 and HT-29 human colonic epithelial cells and in mouse colon is presented. Increased expression of Wnt9A has been associated with multiple malignancies, including colon carcinoma, and with ectodermal and mesoendodermal morphogenesis. When ARSB activity was reduced by siRNA or by exposure to carrageenan (1 mu g/ml for 24 h), degradation of chondroitin 4-sulfate (C4S) was inhibited, leading to accumulation of more highly sulfated C4S, which binds less galectin-3, a beta-galactoside-binding protein. Nuclear galectin-3 increased and mediated increased binding of Sp1 to the Sp1 consensus sequence in the Wnt9A promoter, shown by oligonucleotide-binding assay and by chromatin immunoprecipitation assay. When galectin-3 was silenced, the increases in Sp1 binding to the Wnt9A promoter and in Wnt9A expression, which followed carrageenan or ARSB silencing, were inhibited. Mithramycin A, a specific inhibitor of Sp1 oligonucleotide binding, and Sp1 siRNA blocked the carrageenanand ARSB siRNA-induced increases in Wnt9A expression. These studies reveal how carrageenan exposure can lead to transcriptional events in colonic epithelial cells through decline in arylsulfatase B activity, with subsequent impact on C4S, galectin-3, Sp1, and Wnt9A and can exert significant effects on Wnt-initiated signaling and related vital cell processes.	[Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, CSN 440,M-C 718, Chicago, IL 60612 USA.	jkt@uic.edu						An CH, 2010, PATHOLOGY, V42, P583, DOI 10.3109/00313025.2010.508735; [Anonymous], 1983, IARC Monogr Eval Carcinog Risk Chem Hum, V31, P79; [Anonymous], 2010, ENC BRIT MACR, V13, P236; ARAKAWA S, 1986, J NUTR SCI VITAMINOL, V32, P481, DOI 10.3177/jnsv.32.481; Bhattacharyya S, 2014, ONCOGENE, V33, P5467, DOI 10.1038/onc.2013.483; Bhattacharyya S, 2008, BBA-GEN SUBJECTS, V1780, P973, DOI 10.1016/j.bbagen.2008.03.019; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Bhattacharyya S, 2008, J BIOL CHEM, V283, P9523, DOI 10.1074/jbc.M707967200; Bhattacharyya S, 2007, DIGEST DIS SCI, V52, P2766, DOI 10.1007/s10620-006-9531-4; Bhattacharyya S, 2007, J STEROID BIOCHEM, V103, P20, DOI 10.1016/j.jsbmb.2006.08.002; Bhattacharyya S, 2014, NUTR CANCER, V66, P117, DOI 10.1080/01635581.2014.852228; Bhattacharyya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033250; Bhattacharyya S, 2010, J NUTR BIOCHEM, V21, P906, DOI 10.1016/j.jnutbio.2009.07.002; Bhattacharyya S, 2009, CLIN EXP METASTAS, V26, P535, DOI 10.1007/s10585-009-9253-z; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chang WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-94; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cox AA, 2010, GENE EXPR PATTERNS, V10, P251, DOI 10.1016/j.gep.2010.05.005; Curtain M. M., 2009, JACKSON LAB J; Encarnacao PC, 2013, BIOCHEM J, V452, P519, DOI 10.1042/BJ20121666; Feferman L, 2013, PROSTATE CANCER P D, V16, P277, DOI 10.1038/pcan.2013.18; Funato Y, 2010, FREE RADICAL RES, V44, P379, DOI 10.3109/10715761003610745; Gold L. S., 1997, HDB CARCINOGENIC POT, P116; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Iwaki J, 2008, BIOCHEM BIOPH RES CO, V373, P206, DOI 10.1016/j.bbrc.2008.05.190; Johar K, 2014, EUR J NEUROSCI, V39, P566, DOI 10.1111/ejn.12415; KAWAURA A, 1982, Tokushima Journal of Experimental Medicine, V29, P125; Keith W Nicol, 2004, BMC Blood Disord, V4, P3, DOI 10.1186/1471-2326-4-3; Kirikoshi H, 2001, INT J ONCOL, V19, P1221; Kovarik A, 1996, J BIOL CHEM, V271, P18140, DOI 10.1074/jbc.271.30.18140; Kumawat K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094801; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lin HM, 2002, ONCOGENE, V21, P8001, DOI 10.1038/sj.onc.1205820; MAJELLO B, 1995, ONCOGENE, V10, P1841; Maurer GD, 2007, CLIN CANCER RES, V13, P1123, DOI 10.1158/1078-0432.CCR-06-1668; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Olender T, 2013, ISR J CHEM, V53, P185, DOI 10.1002/ijch.201200094; Onishi T, 2001, BBA-MOL CELL RES, V1538, P218, DOI 10.1016/S0167-4889(01)00068-4; Pagliuca A, 2000, J CELL BIOCHEM, V76, P360, DOI 10.1002/(SICI)1097-4644(20000301)76:3<360::AID-JCB3>3.0.CO;2-1; Prabhu SV, 2011, J HISTOCHEM CYTOCHEM, V59, P328, DOI 10.1369/0022155410395511; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rozen S, 2000, Methods Mol Biol, V132, P365; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; SERAFINI EP, 1981, GUT, V22, P648, DOI 10.1136/gut.22.8.648; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Song SM, 2005, GASTROENTEROLOGY, V129, P1581, DOI 10.1053/j.gastro.2005.09.002; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; Wang F, 2013, J PATHOL, V229, P12, DOI 10.1002/path.4078; WANG L, 1995, BIOCHEM BIOPH RES CO, V217, P292, DOI 10.1006/bbrc.1995.2777; WATANABE K, 1978, CANCER RES, V38, P4427; Yang B, 2012, BIOCHIMIE, V94, P1309, DOI 10.1016/j.biochi.2012.02.031; Yokoyama KD, 2012, GENOME BIOL EVOL, V4, P1102, DOI 10.1093/gbe/evs085; Yoo BC, 2009, CELL MOL LIFE SCI, V66, P350, DOI 10.1007/s00018-009-8562-3; Yu B, 2003, NUCLEIC ACIDS RES, V31, P5368, DOI 10.1093/nar/gkg706; Zhao YY, 2013, ONCOL REP, V30, P1782, DOI 10.3892/or.2013.2627; Zhu GH, 2002, ONCOGENE, V21, P8477, DOI 10.1038/sj.onc.1206030	59	22	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17564	17575		10.1074/jbc.M114.561589	http://dx.doi.org/10.1074/jbc.M114.561589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24778176	Green Published, hybrid			2022-12-25	WOS:000338018100022
J	Wang, DDH; Guo, XE; Modrek, AS; Chen, CF; Chen, PL; Lee, WH				Wang, Dennis Ding-Hwa; Guo, Xuning Emily; Modrek, Aram Sandaldjian; Chen, Chi-Fen; Chen, Phang-Lang; Lee, Wen-Hwa			Helicase SUV3, Polynucleotide Phosphorylase, and Mitochondrial Polyadenylation Polymerase Form a Transient Complex to Modulate Mitochondrial mRNA Polyadenylated Tail Lengths in Response to Energetic Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POLY(A) POLYMERASE; RAT-LIVER; INORGANIC-PHOSPHATE; DEGRADATION; PNPASE; DECAY; TRANSLATION; EXONUCLEASE; TURNOVER	Mammalian mitochondrial mRNA (mt-mRNA) transcripts are polyadenylated at the 3' end with different lengths. The SUV3.PNPase complex and mtPAP have been shown to degrade and polyadenylate mt mRNA, respectively. How these two opposite actions are coordinated to modulate mt-mRNA poly(A) lengths is of interest to pursue. Here, we demonstrated that a fraction of the SUV3.PNPase complex interacts with mitochondrial polyadenylation polymerase (mtPAP) under low mitochondrial matrix inorganic phosphate (P-i) conditions. In vitro binding experiments using purified proteins suggested that SUV3 binds to mtPAP through the N-terminal region around amino acids 100-104, distinctive from the C-terminal region around amino acids 510-514 of SUV3 for PNPase binding. mtPAP does not interact with PNPase directly, and SUV3 served as a bridge capable of simultaneously binding with mtPAP and PNPase. The complex consists of a SUV3 dimer, a mtPAP dimer, and a PNPase trimer, based on the molecular sizing experiments. Mechanistically, SUV3 provides a robust single strand RNA binding domain to enhance the polyadenylation activity of mtPAP. Furthermore, purified SUV3.PNPase.mtPAP complex is capable of lengthening or shortening the RNA poly(A) tail lengths in low or high P-i/ATP ratios, respectively. Consistently, the poly(A) tail lengths of mt-mRNA transcripts can be lengthened or shortened by altering the mitochondrial matrix P-i levels via selective inhibition of the electron transport chain or ATP synthase, respectively. Taken together, these results suggested that SUV3.PNPase.mtPAP form a transient complex to modulate mt-mRNA poly(A) tail lengths in response to cellular energy changes.	[Wang, Dennis Ding-Hwa; Guo, Xuning Emily; Modrek, Aram Sandaldjian; Chen, Chi-Fen; Chen, Phang-Lang; Lee, Wen-Hwa] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA; [Lee, Wen-Hwa] China Med Univ, Grad Inst Clin Med Sci, Taichung 40402, Taiwan	University of California System; University of California Irvine; China Medical University Taiwan	Lee, WH (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA.	whlee@uci.edu		Chen, Phang-Lang/0000-0002-0357-9017; Modrek, Aram/0000-0001-7586-9833; Chen, Chi-Fen/0000-0002-6391-821X	National Institutes of Health [AG027877, T32 CA113265]; NATIONAL CANCER INSTITUTE [T32CA113265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG027877 (to W. H. L.).; Supported by National Institutes of Health training Grant T32 CA113265. Present address: Dept. of Medicine, Baylor College of Medicine, Houston, TX 77030.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bai Y, 2011, MOL CELL, V41, P311, DOI 10.1016/j.molcel.2011.01.013; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bollenbach TJ, 2004, PROG NUCLEIC ACID RE, V78, P305, DOI 10.1016/S0079-6603(04)78008-3; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Borowski LS, 2010, BBA-BIOENERGETICS, V1797, P1066, DOI 10.1016/j.bbabio.2010.01.028; CAO GJ, 1992, P NATL ACAD SCI USA, V89, P10380, DOI 10.1073/pnas.89.21.10380; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Carpousis AJ, 2001, METHOD ENZYMOL, V342, P333, DOI 10.1016/S0076-6879(01)42556-0; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Crosby AH, 2010, AM J HUM GENET, V87, P655, DOI 10.1016/j.ajhg.2010.09.013; Das SK, 2011, ONCOGENE, V30, P1733, DOI 10.1038/onc.2010.572; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; Guo XE, 2011, J BIOL CHEM, V286, P38783, DOI 10.1074/jbc.M111.257956; HAJNSDORF E, 1994, EMBO J, V13, P3368, DOI 10.1002/j.1460-2075.1994.tb06639.x; JACOB ST, 1972, BIOCHEM BIOPH RES CO, V48, P126, DOI 10.1016/0006-291X(72)90353-1; Jedrzejczak R, 2011, ACTA CRYSTALLOGR D, V67, P988, DOI 10.1107/S0907444911040248; Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; MANLEY JL, 1994, GENE DEV, V8, P259, DOI 10.1101/gad.8.3.259; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Nagao A, 2008, METHOD ENZYMOL, V447, P489, DOI 10.1016/S0076-6879(08)02223-4; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Portnoy V, 2008, RNA, V14, P297, DOI 10.1261/rna.698108; Poulsen JB, 2011, NUCLEIC ACIDS RES, V39, P3754, DOI 10.1093/nar/gkq1282; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rorbach J, 2011, NUCLEIC ACIDS RES, V39, P7750, DOI 10.1093/nar/gkr470; Sarkar D, 2006, CELL CYCLE, V5, P1080, DOI 10.4161/cc.5.10.2741; Shu ZY, 2004, BIOCHEMISTRY-US, V43, P4781, DOI 10.1021/bi0356449; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; Slomovic S, 2008, RNA, V14, P310, DOI 10.1261/rna.697308; Smith AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016206; Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036; Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238; THIAUDIERE E, 1993, FEBS LETT, V330, P231, DOI 10.1016/0014-5793(93)80280-8; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Tomita K, 1996, NUCLEIC ACIDS RES, V24, P4987, DOI 10.1093/nar/24.24.4987; Vidal G, 1997, ARCH BIOCHEM BIOPHYS, V337, P317, DOI 10.1006/abbi.1996.9775; Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Wydro M, 2010, NUCLEIC ACIDS RES, V38, P3732, DOI 10.1093/nar/gkq068; XU FF, 1995, NATURE, V374, P180, DOI 10.1038/374180a0; Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001; Yokobori S, 1997, J MOL BIOL, V265, P95, DOI 10.1006/jmbi.1996.0728	52	25	25	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16727	16735		10.1074/jbc.M113.536540	http://dx.doi.org/10.1074/jbc.M113.536540			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24770417	Green Published, hybrid			2022-12-25	WOS:000338016200012
J	De Vos, M; El Ramy, R; Quenet, D; Wolf, P; Spada, F; Magroun, N; Babbio, F; Schreiber, V; Leonhardt, H; Bonapace, IM; Dantzer, F				De Vos, Mike; El Ramy, Rosy; Quenet, Delphine; Wolf, Patricia; Spada, Fabio; Magroun, Najat; Babbio, Federica; Schreiber, Valerie; Leonhardt, Heinrich; Bonapace, Ian Marc; Dantzer, Francoise			Poly(ADP-ribose) Polymerase 1 (PARP1) Associates with E3 Ubiquitin-Protein Ligase UHRF1 and Modulates UHRF1 Biological Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; HEMI-METHYLATED DNA; PERICENTRIC HETEROCHROMATIN; BINDING-PROTEIN; UNMETHYLATED STATE; MAMMALIAN-CELLS; HISTONE-BINDING; DNMT1; NP95; REPLICATION	Poly(ADP-ribose) polymerase 1 (PARP1, also known as ARTD1) is an abundant nuclear enzyme that plays important roles in DNA repair, gene transcription, and differentiation through the modulation of chromatin structure and function. In this work we identify a physical and functional poly(ADP-ribose)-mediated interaction of PARP1 with the E3 ubiquitin ligase UHRF1 (also known as NP95, ICBP90) that influences two UHRF1-regulated cellular processes. On the one hand, we uncovered a cooperative interplay between PARP1 and UHRF1 in the accumulation of the heterochromatin repressive mark H4K20me3. The absence of PARP1 led to reduced accumulation of H4K20me3 onto pericentric heterochromatin that coincided with abnormally enhanced transcription. The loss of H4K20me3 was rescued by the additional depletion of UHRF1. In contrast, although PARP1 also seemed to facilitate the association of UHRF1 with DNMT1, its absence did not impair the loading of DNMT1 onto heterochromatin or the methylation of pericentric regions, possibly owing to a compensating interaction of DNMT1 with PCNA. On the other hand, we showed that PARP1 controls the UHRF1-mediated ubiquitination of DNMT1 to timely regulate its abundance during S and G(2) phase. Together, this report identifies PARP1 as a novel modulator of two UHRF1-regulated heterochromatin-associated events: the accumulation of H4K20me3 and the clearance of DNMT1.	[De Vos, Mike; El Ramy, Rosy; Quenet, Delphine; Magroun, Najat; Schreiber, Valerie; Dantzer, Francoise] Univ Strasbourg, Poly ADP Ribosyl Ation & Genome Integr Grp, Lab Excellence Medalis,Equipe Labellisee Ligue Na, CNRS,Inst Rech,UMR7242,Ecole Biotechnol Strasbour, F-67412 Illkirch Graffenstaden, France; [Wolf, Patricia; Spada, Fabio; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany; [Babbio, Federica; Bonapace, Ian Marc] Univ Insubria, Dept Struct & Funct Biol, I-21052 Busto Arsizio, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Munich; University of Insubria	Dantzer, F (corresponding author), Univ Strasbourg, Poly ADP Ribosyl Ation & Genome Integr Grp, Lab Excellence Medalis,Equipe Labellisee Ligue Na, CNRS,Inst Rech,UMR7242,Ecole Biotechnol Strasbour, Blvd Sebastien Brant,BP10413, F-67412 Illkirch Graffenstaden, France.	francoise.dantzer@unistra.fr	Dantzer, Françoise/O-2126-2016; Leonhardt, Heinrich/B-2791-2014; Spada, Fabio/J-4354-2013; Schreiber, Valérie/M-5007-2016	Spada, Fabio/0000-0002-7148-9013; Schreiber, Valérie/0000-0003-0507-639X; BONAPACE, IAN MARC/0000-0001-6580-8893; Dantzer, Francoise/0000-0003-0945-8483	Association pour le Recherche Contre le Cancer (ARC); CNRS; Universite de Strasbourg; French government via the Agence Nationale de la Recherche under the Programme d'Investissement d'Avenir; Fonds National de la Recherche (Luxembourg); Deutsche Forschungsgemeinschaft (DFG) [SFB 684]	Association pour le Recherche Contre le Cancer (ARC); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; French government via the Agence Nationale de la Recherche under the Programme d'Investissement d'Avenir(French National Research Agency (ANR)); Fonds National de la Recherche (Luxembourg)(Luxembourg National Research Fund); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Association pour le Recherche Contre le Cancer (ARC), the CNRS, and the Universite de Strasbourg. This work has also been published within the LABEX ANR-10-LABX-0034_Medalis and received financial support from the French government via the Agence Nationale de la Recherche under the Programme d'Investissement d'Avenir.; Supported by the Fonds National de la Recherche (Luxembourg).; Supported by Deutsche Forschungsgemeinschaft (DFG) Grant SFB 684.	Achour M, 2009, BIOCHEM BIOPH RES CO, V390, P523, DOI 10.1016/j.bbrc.2009.09.131; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Boehler C, 2011, P NATL ACAD SCI USA, V108, P2783, DOI 10.1073/pnas.1016574108; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Cheng JD, 2013, J BIOL CHEM, V288, P1329, DOI 10.1074/jbc.M112.415398; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; De Capoa A, 1999, FASEB J, V13, P89; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; El Ramy R, 2009, CELL MOL LIFE SCI, V66, P3219, DOI 10.1007/s00018-009-0105-4; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016627; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; Guetg C, 2012, MOL CELL, V45, P790, DOI 10.1016/j.molcel.2012.01.024; Hopfner R, 2000, CANCER RES, V60, P121; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Kalisch T, 2012, TRENDS BIOCHEM SCI, V37, P381, DOI 10.1016/j.tibs.2012.06.001; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kashima L, 2012, J BIOL CHEM, V287, P12975, DOI 10.1074/jbc.M111.321828; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Mistry Helena, 2010, Genome Integr, V1, P7, DOI 10.1186/2041-9414-1-7; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Pageau GJ, 2006, J CELL BIOL, V175, P693, DOI 10.1083/jcb.200602055; Papait R, 2007, MOL BIOL CELL, V18, P1098, DOI 10.1091/mbc.E06-09-0874; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Quenet D, 2008, FASEB J, V22, P3853, DOI 10.1096/fj.08-113464; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Rowbotham SP, 2011, MOL CELL, V42, P285, DOI 10.1016/j.molcel.2011.02.036; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; Saxena A, 2002, HUM MOL GENET, V11, P2319, DOI 10.1093/hmg/11.19.2319; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717; Zardo G, 2002, FASEB J, V16, P1319, DOI 10.1096/fj.01-0827fje; Zardo G, 1998, J BIOL CHEM, V273, P16517, DOI 10.1074/jbc.273.26.16517; Zardo G, 1997, BIOCHEMISTRY-US, V36, P7937, DOI 10.1021/bi970241s; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	58	33	33	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16223	16238		10.1074/jbc.M113.527424	http://dx.doi.org/10.1074/jbc.M113.527424			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24782312	Green Published, hybrid			2022-12-25	WOS:000337965700027
J	Banerjee, S; Banerjee, S; Saraswat, G; Bandyopadhyay, SA; Kabir, SN				Banerjee, Sayani; Banerjee, Sutapa; Saraswat, Ghungroo; Bandyopadhyay, Soma Aditya; Kabir, Syed N.			Female Reproductive Aging Is Master-Planned at the Level of Ovary	PLOS ONE			English	Article							GERM-CELLS; FOLLICULAR DEVELOPMENT; OXIDATIVE STRESS; C-KIT; MOUSE; APOPTOSIS; OOCYTES; FOLLICLES; HORMONE; GROWTH	The ovary receives a finite pool of follicles during fetal life. Atresia remains the major form of follicular expenditure at all stages since development of ovary. The follicular reserve, however, declines at an exponential rate leading to accelerated rate of decay during the years preceding menopause. We examined if diminished follicle reserve that characterizes ovarian aging impacts the attrition rate. Premature ovarian aging was induced in rats by intra-embryonic injection of galactosyltransferase-antibody on embryonic day 10. On post-natal day 35 of the female litters, either a wedge of fat (sham control) or a wild type ovary collected from 25-day old control rats, was transplanted under the ovarian bursa in both sides. Follicular growth and atresia, and ovarian microenvironment were evaluated in the follicle-deficient host ovary and transplanted ovary by real time RT-PCR analysis of growth differentiation factor-9, bone morphogenetic protein 15, and kit ligand, biochemical evaluation of ovarian lipid peroxidation, superoxide dismutase (SOD) and catalase activity, and western blot analysis of ovarian pro-and anti-apoptotic factors including p53, bax, bcl2, and caspase 3. Results demonstrated that the rate of follicular atresia, which was highly preponderant in the follicle-deficient ovary of the sham-operated group, was significantly prevented in the presence of the transplanted ovary. As against the follicle-deficient ovary of the sham-operated group, the follicle-deficient host ovary as well as the transplanted ovary in the ovary-transplanted group exhibited stimulated follicle growth with increased expression of anti-apoptotic factors and down regulation of pro-apoptotic factors. Both the host and transplanted ovaries also had significantly lower rate of lipid peroxidation with increased SOD and catalase activity. We conclude that the declining follicular reserve is perhaps the immediate thrust that increases the rate of follicle depletion during the final phase of ovarian life when the follicle reserve wanes below certain threshold size.	[Banerjee, Sayani; Banerjee, Sutapa; Saraswat, Ghungroo; Bandyopadhyay, Soma Aditya; Kabir, Syed N.] CSIR Indian Inst Chem Biol, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Kabir, SN (corresponding author), CSIR Indian Inst Chem Biol, Kolkata, W Bengal, India.	snkabir@iicb.res.in			Council of Scientific & Industrial Research, New Delhi [BSC 0101, 31/002(0842)/2010-EMR-I]	Council of Scientific & Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The study was funded by Council of Scientific & Industrial Research, New Delhi in the form of a network Project (No. BSC 0101) and a Senior Research Fellowship (31/002(0842)/2010-EMR-I) awarded to Sayani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Amsterdam A, 1997, STEROIDS, V62, P207, DOI 10.1016/S0039-128X(96)00182-1; Anasti JN, 1998, FERTIL STERIL, V70, P1, DOI 10.1016/S0015-0282(98)00099-5; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; BAKKEN AH, 1978, CHROMOSOMA, V67, P21, DOI 10.1007/BF00285645; Bandyopadhyay S, 2004, BIOL REPROD, V71, P1822, DOI 10.1095/biolreprod.104.028555; Banerjee S, 2006, THESIS JADAVPUR U KO; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Billig H, 1996, HUM REPROD UPDATE, V2, P103, DOI 10.1093/humupd/2.2.103; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Carbone MC, 2003, MOL HUM REPROD, V9, P639, DOI 10.1093/molehr/gag090; Combelles CMH, 2004, MOL REPROD DEV, V69, P347, DOI 10.1002/mrd.20128; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; De Miguel MP, 2002, P NATL ACAD SCI USA, V99, P10458, DOI 10.1073/pnas.122249399; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Fortune JE, 2003, ANIM REPROD SCI, V78, P135, DOI 10.1016/S0378-4320(03)00088-5; Foster DL, 1999, BIOL REPROD, V60, P205, DOI 10.1095/biolreprod60.2.205; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; Gosden R, 1997, BRIT MED BULL, V53, P644; Hale GE, 2014, J STEROID BIOCHEM, V142, P121, DOI 10.1016/j.jsbmb.2013.08.015; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; Jin M, 2012, SCI CHINA LIFE SCI, V55, P677, DOI 10.1007/s11427-012-4355-2; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Kim JM, 1998, BIOL REPROD, V58, P1170, DOI 10.1095/biolreprod58.5.1170; Lacham-Kaplan O, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-58; Linnekin D, 1999, INT J BIOCHEM CELL B, V31, P1053, DOI 10.1016/S1357-2725(99)00078-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maruyama T, 2013, ENDOCR J, DOI [10.1507/endocrj.EJ13-003, DOI 10.1507/ENDOCRJ.EJ13-003]; Mazerbourg S, 2003, MOL CELL ENDOCRINOL, V202, P31, DOI 10.1016/S0303-7207(03)00058-3; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Motta PM, 1997, EUR J OBSTET GYN R B, V75, P5, DOI 10.1016/S0301-2115(97)00216-9; Niikura Y, 2009, AGING-US, V1, P971, DOI 10.18632/aging.100105; OJEDA SR, 1976, ENDOCRINOLOGY, V98, P630, DOI 10.1210/endo-98-3-630; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Plowchalk DR., 1993, FEMALE REPROD TOXI B, V3B, P57; Quirk S M, 2004, J Anim Sci, V82 E-Suppl, pE40; Richards JS, 2001, ENDOCRINOLOGY, V142, P2184, DOI 10.1210/en.142.6.2184; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; Saito Hidekazu, 2008, Clin Calcium, V18, P967, DOI CliCa0807967972; Samuel JB, 2011, J MED TOXICOL, V7, P195, DOI 10.1007/s13181-011-0143-9; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Tatone C, 2008, HUM REPROD UPDATE, V14, P131, DOI 10.1093/humupd/dmm048; Thomford P J, 1987, Reprod Toxicol, V1, P41, DOI 10.1016/0890-6238(87)90070-0; Tilly J L, 1996, Rev Reprod, V1, P162, DOI 10.1530/revreprod/1.3.162; Tsai-Turton M, 2006, ENDOCRINOLOGY, V147, P1224, DOI 10.1210/en.2005-1281; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vitt UA, 2002, BIOL REPROD, V67, P473, DOI 10.1095/biolreprod67.2.473; Vujovic S, 2012, SRP ARK CELOK LEK, V140, P806, DOI 10.2298/SARH1212806V; Wu J, 2011, TOXICOL LETT, V202, P168, DOI 10.1016/j.toxlet.2011.01.029; Xu MF, 2001, AM J PHYSIOL-HEART C, V281, pH1295, DOI 10.1152/ajpheart.2001.281.3.H1295	62	30	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96210	10.1371/journal.pone.0096210	http://dx.doi.org/10.1371/journal.pone.0096210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788203	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700063
J	Romano, S; Dittmar, T; Bondarev, V; Weber, RJM; Viant, MR; Schulz-Vogt, HN				Romano, Stefano; Dittmar, Thorsten; Bondarev, Vladimir; Weber, Ralf J. M.; Viant, Mark R.; Schulz-Vogt, Heide N.			Exo-Metabolome of Pseudovibrio sp FO-BEG1 Analyzed by Ultra-High Resolution Mass Spectrometry and the Effect of Phosphate Limitation	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; ESCHERICHIA-COLI; CROSS-TALK; ANTIMICROBIAL ACTIVITIES; PSEUDOMONAS-AERUGINOSA; FUNCTIONAL GENOMICS; GAS-CHROMATOGRAPHY; CYCLIC DIPEPTIDES; MARINE SPONGES; AMINO-ACIDS	Oceanic dissolved organic matter (DOM) is an assemblage of reduced carbon compounds, which results from biotic and abiotic processes. The biotic processes consist in either release or uptake of specific molecules by marine organisms. Heterotrophic bacteria have been mostly considered to influence the DOM composition by preferential uptake of certain compounds. However, they also secrete a variety of molecules depending on physiological state, environmental and growth conditions, but so far the full set of compounds secreted by these bacteria has never been investigated. In this study, we analyzed the exo-metabolome, metabolites secreted into the environment, of the heterotrophic marine bacterium Pseudovibrio sp. FO-BEG1 via ultra-high resolution mass spectrometry, comparing phosphate limited with phosphate surplus growth conditions. Bacteria belonging to the Pseudovibrio genus have been isolated worldwide, mainly from marine invertebrates and were described as metabolically versatile Alphaproteobacteria. We show that the exo-metabolome is unexpectedly large and diverse, consisting of hundreds of compounds that differ by their molecular formulae. It is characterized by a dynamic recycling of molecules, and it is drastically affected by the physiological state of the strain. Moreover, we show that phosphate limitation greatly influences both the amount and the composition of the secreted molecules. By assigning the detected masses to general chemical categories, we observed that under phosphate surplus conditions the secreted molecules were mainly peptides and highly unsaturated compounds. In contrast, under phosphate limitation the composition of the exo-metabolome changed during bacterial growth, showing an increase in highly unsaturated, phenolic, and polyphenolic compounds. Finally, we annotated the detected masses using multiple metabolite databases. These analyses suggested the presence of several masses analogue to masses of known bioactive compounds. However, the annotation was successful only for a minor part of the detected molecules, underlining the current gap in knowledge concerning the biosynthetic ability of marine heterotrophic bacteria.	[Romano, Stefano; Bondarev, Vladimir] Max Planck Inst Marine Microbiol, Bremen, Germany; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Res Grp Marine Geochem, D-26111 Oldenburg, Germany; [Weber, Ralf J. M.; Viant, Mark R.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Schulz-Vogt, Heide N.] Leibniz Inst Baltic Sea Res Warnemuende IOW, Dept Biol Oceanog, Rostock, Germany	Max Planck Society; Carl von Ossietzky Universitat Oldenburg; University of Birmingham; Leibniz Institut fur Ostseeforschung Warnemunde	Romano, S (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	sromano@mpi-bremen.de	Viant, Mark R/B-6339-2009; Dittmar, Thorsten/L-7796-2013; Schulz-Vogt, Heide/I-1397-2012; Romano, Stefano/J-3756-2013	Viant, Mark R/0000-0001-5898-4119; Dittmar, Thorsten/0000-0002-3462-0107; Schulz-Vogt, Heide/0000-0003-1445-0291; Romano, Stefano/0000-0002-7600-1953	European Research Council [203364]; Max Planck Society; NERC [NBAF010004] Funding Source: UKRI; Natural Environment Research Council [NBAF010004] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by the European Research Council, Grant No. 203364 and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni Asaph, 2002, OMICS A Journal of Integrative Biology, V6, P217, DOI 10.1089/15362310260256882; Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Anton J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064701; Barreto MC, 2011, EUR FOOD RES TECHNOL, V232, P575, DOI 10.1007/s00217-011-1426-8; Behrends V, 2009, APPL ENVIRON MICROB, V75, P2453, DOI 10.1128/AEM.01742-08; BENNING C, 1995, ARCH BIOCHEM BIOPHYS, V317, P103, DOI 10.1006/abbi.1995.1141; Boersma MG, 2001, J IND MICROBIOL BIOT, V26, P22, DOI 10.1038/sj.jim.7000027; Bondarev V, 2013, ENVIRON MICROBIOL, V15, P2095, DOI 10.1111/1462-2920.12123; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Brito-Echeverria J, 2011, EXTREMOPHILES, V15, P379, DOI 10.1007/s00792-011-0366-3; Brown SC, 2005, MASS SPECTROM REV, V24, P223, DOI 10.1002/mas.20011; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P7263, DOI 10.1128/AEM.71.11.7263-7270.2005; CARLIER JP, 1990, LETT APPL MICROBIOL, V11, P133, DOI 10.1111/j.1472-765X.1990.tb00142.x; Carlson C., 2002, BIOGEOCHEMISTRY MARI, P91, DOI DOI 10.1016/B978-012323841-2/50006-3; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Cotner JB, 1997, AQUAT MICROB ECOL, V13, P141, DOI 10.3354/ame013141; Coucheney E, 2008, J MICROBIOL METH, V75, P491, DOI 10.1016/j.mimet.2008.07.029; CUNDY KV, 1991, J CLIN MICROBIOL, V29, P260, DOI 10.1128/JCM.29.2.260-263.1991; Degrassi G, 2002, CURR MICROBIOL, V45, P250, DOI 10.1007/s00284-002-3704-y; Dictionary of Natural Products, 2014, DICT NATURAL PRODUCT; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P3724, DOI 10.1128/AEM.72.5.3724-3732.2006; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Flemer B, 2012, J APPL MICROBIOL, V112, P289, DOI 10.1111/j.1365-2672.2011.05211.x; Gerard F, 1999, MICROBIOL-UK, V145, P1547, DOI 10.1099/13500872-145-7-1547; Greer EM, 2008, J ORG CHEM, V73, P280, DOI 10.1021/jo7018416; Gruber DF, 2006, APPL ENVIRON MICROB, V72, P4184, DOI 10.1128/AEM.02882-05; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HERRMANN KM, 1995, PLANT PHYSIOL, V107, P7, DOI 10.1104/pp.107.1.7; Holden MTG, 1999, MOL MICROBIOL, V33, P1254, DOI 10.1046/j.1365-2958.1999.01577.x; Hosoya S, 2007, INT J SYST EVOL MICR, V57, P1952, DOI 10.1099/ijs.0.64922-0; Huang RM, 2010, CHEM BIODIVERS, V7, P2809, DOI 10.1002/cbdv.200900211; Junot C, 2010, ANALYST, V135, P2203, DOI 10.1039/c0an00021c; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawasaki N, 2006, LIMNOL OCEANOGR, V51, P2170, DOI 10.4319/lo.2006.51.5.2170; Kennedy J, 2009, MAR BIOTECHNOL, V11, P384, DOI 10.1007/s10126-008-9154-1; Kind T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-234; KINTAKA K, 1984, J ANTIBIOT, V37, P1294, DOI 10.7164/antibiotics.37.1294; Koch BP, 2006, RAPID COMMUN MASS SP, V20, P926, DOI 10.1002/rcm.2386; KRAMER R, 1994, FEMS MICROBIOL REV, V13, P75, DOI 10.1111/j.1574-6976.1994.tb00036.x; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Kujawinski EB, 2009, GEOCHIM COSMOCHIM AC, V73, P4384, DOI 10.1016/j.gca.2009.04.033; Liang L, 2003, INVESTIGATION SECOND, P136; Mapelli V, 2008, TRENDS BIOTECHNOL, V26, P490, DOI 10.1016/j.tibtech.2008.05.008; Maranon E, 2004, LIMNOL OCEANOGR, V49, P1652, DOI 10.4319/lo.2004.49.5.1652; Marshall AG, 2004, PHYSICA B, V346, P503, DOI 10.1016/j.physb.2004.01.136; Martin JF, 2004, J BACTERIOL, V186, P5197, DOI 10.1128/JB.186.16.5197-5201.2004; Martin JF, 2011, MICROB BIOTECHNOL, V4, P165, DOI 10.1111/j.1751-7915.2010.00235.x; MINNIKIN DE, 1972, FEBS LETT, V27, P16, DOI 10.1016/0014-5793(72)80398-3; Moreau PL, 2004, J BACTERIOL, V186, P7364, DOI 10.1128/JB.186.21.7364-7368.2004; Nagata T, 2000, PRODUCTION MECH DISS, P121; O' Halloran JA, 2011, J APPL MICROBIOL, V110, P1495, DOI 10.1111/j.1365-2672.2011.05008.x; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1; Paczia N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-122; Penesyan A, 2011, MAR DRUGS, V9, P1391, DOI 10.3390/md9081391; PRASAD C, 1995, PEPTIDES, V16, P151, DOI 10.1016/0196-9781(94)00017-Z; RINAS U, 1995, APPL ENVIRON MICROB, V61, P4147, DOI 10.1128/AEM.61.12.4147-4151.1995; ROBERTSON BR, 1979, J BACTERIOL, V138, P884, DOI 10.1128/JB.138.3.884-895.1979; Rossel PE, 2013, ORG GEOCHEM, V60, P62, DOI 10.1016/j.orggeochem.2013.04.013; Rossello-Mora R, 2008, ISME J, V2, P242, DOI 10.1038/ismej.2007.93; Roue M, 2012, NAT PROD REP, V29, P739, DOI 10.1039/c2np20040f; Santl-Temkiv T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053550; Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S; Seyedsayamdost MR, 2011, J AM CHEM SOC, V133, P18343, DOI 10.1021/ja207172s; Shieh WY, 2004, INT J SYST EVOL MICR, V54, P2307, DOI 10.1099/ijs.0.63107-0; Shnayderman M, 2005, ANAL CHEM, V77, P5930, DOI 10.1021/ac050348i; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Takahashi H, 2008, ANAL BIOANAL CHEM, V391, P2769, DOI 10.1007/s00216-008-2195-5; Teira E, 2001, LIMNOL OCEANOGR, V46, P1370, DOI 10.4319/lo.2001.46.6.1370; Thiel V, 2010, ORG BIOMOL CHEM, V8, P234, DOI 10.1039/b909133e; Thingstad TF, 2005, SCIENCE, V309, P1068, DOI 10.1126/science.1112632; Traxler MF, 2012, P NATL ACAD SCI USA, V109, P10128, DOI 10.1073/pnas.1207725109; Want EJ, 2007, J PROTEOME RES, V6, P459, DOI 10.1021/pr060505+; Weber RJM, 2010, CHEMOMETR INTELL LAB, V104, P75, DOI 10.1016/j.chemolab.2010.04.010; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Yamashita Y, 2003, MAR CHEM, V82, P145, DOI 10.1016/S0304-4203(03)00049-5; Yuan ZC, 2005, MOL MICROBIOL, V58, P877, DOI 10.1111/j.1365-2958.2005.04874.x	80	48	48	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96038	10.1371/journal.pone.0096038	http://dx.doi.org/10.1371/journal.pone.0096038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787987	gold, Green Published, Green Submitted			2022-12-25	WOS:000336655700050
J	Zheng, SG; Xu, HX; Guo, LH; Liu, LN; Lu, F				Zheng, Shu-Guang; Xu, Hui-Xiong; Guo, Le-Hang; Liu, Lin-Na; Lu, Feng			The Safety and Treatment Response of Combination Therapy of Radioimmunotherapy and Radiofrequency Ablation for Solid Tumor: A Study In Vivo	PLOS ONE			English	Article							ADVANCED LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; INJECTION; TOSITUMOMAB; DELIVERY; ANTIBODY; IMPROVES	Objection: To investigate the safety and treatment response of radioimmunotherapy (RIT) in combination with radiofrequency ablation (RFA) for the treatment of VX2 tumor on rabbit. Materials and Methods: A total of 36 rabbits bearing VX2 tumor on the thigh were randomly assigned into 3 groups (group I: 1-2 cm; group II: 2-3 cm; group III: 3-4 cm) and 4 subgroups (A: as control, just puncture the tumor using the RFA electrode without power output; B: RFA alone; C: I-131-chTNT intratumoral injection alone; D: RFA+ I-131-chTNT intratumoral injection 3 days later). The variation of blood assay, weight and survival among different groups and subgroups were used to assess the treatment safety. Ultrasound (US) was used to monitor and assess the tumor response after treatment. Results: According to the results of the weight and the blood assay among different groups, subgroups, and at two time points (one day before and the 16th day after treatment), no damages to the liver, kidney function and myelosuppression resulting from the treatment were found. No significant differences in survivals among the four subgroups (p = 0.087) were found. In addition, I-131-chTNT did not show significant inhibition effect on VX2 tumor progression according to US measurements. Conclusion: I-131-chTNT intratumoral injection alone or in combination with RFA is relatively safe for rabbit without significant toxicity and shows no significant effect on the survival. The treatment response is not as satisfactory as anticipated.	[Zheng, Shu-Guang; Xu, Hui-Xiong; Guo, Le-Hang; Liu, Lin-Na; Lu, Feng] Tongji Univ, Peoples Hosp 10, Shanghai Peoples Hosp 10, Dept Med Ultrasound, Shanghai 200092, Peoples R China; [Zheng, Shu-Guang; Xu, Hui-Xiong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Ultrason, Guangzhou 510275, Guangdong, Peoples R China	Tongji University; Sun Yat Sen University	Xu, HX (corresponding author), Tongji Univ, Peoples Hosp 10, Shanghai Peoples Hosp 10, Dept Med Ultrasound, Shanghai 200092, Peoples R China.	xuhuixiong@hotmail.com		Zheng, Shu Guang/0000-0001-5116-066X	National Scientific Foundation Committee of China [30970837, 81371570, 81301229]	National Scientific Foundation Committee of China(National Natural Science Foundation of China (NSFC))	Supported by National Scientific Foundation Committee of China, No. 30970837, 81371570, 81301229. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbet J, 2011, EUR J NUCL MED MOL I, V38, P271, DOI 10.1007/s00259-010-1707-7; Brace CL, 2009, CURR PROBL DIAGN RAD, V38, P135, DOI 10.1067/j.cpradiol.2007.10.001; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chatal JF, 2009, J CANCER RES THER, V5, P36, DOI 10.4103/0973-1482.55139; Chen SL, 2005, J CLIN ONCOL, V23, P1538, DOI 10.1200/JCO.2005.06.108; de Jong G, 2011, EJSO-EUR J SURG ONC, V37, P258, DOI 10.1016/j.ejso.2010.12.009; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Frampas E, 2011, NUCL MED COMMUN, V32, P147, DOI 10.1097/MNM.0b013e328341b268; Goldenberg DM, 2008, J NUCL MED, V49, P158, DOI 10.2967/jnumed.107.046185; Hanaoka H, 2009, ANN NUCL MED, V23, P479, DOI 10.1007/s12149-009-0265-1; Horning SJ, 2005, J CLIN ONCOL, V23, P712, DOI 10.1200/JCO.2005.07.040; Huang CY, 2012, CANCER TREAT REV, V38, P854, DOI 10.1016/j.ctrv.2011.12.005; Lindegren S, 2011, CURR RADIOPHARM, V4, P248, DOI 10.2174/1874471011104030248; Navarro-Teulon I, 2013, IMMUNOTHERAPY-UK, V5, P467, DOI [10.2217/IMT.13.34, 10.2217/imt.13.34]; Pasquetto MV, 2011, J IMMUNOTHER, V34, P611, DOI 10.1097/CJI.0b013e318234ecf5; Pohlman B, 2006, EXPERT REV ANTICANC, V6, P445, DOI 10.1586/14737140.6.3.445; PRESSMAN D, 1953, CANCER, V6, P619, DOI 10.1002/1097-0142(195305)6:3<619::AID-CNCR2820060319>3.0.CO;2-Y; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sharkey RM, 2012, FUTURE ONCOLOGY, V8, P659; Sharkey RM, 2011, MOL CANCER THER, V10, P1072, DOI 10.1158/1535-7163.MCT-11-0115; Song H, 2011, CURR DRUG DELIV, V8, P26, DOI 10.2174/156720111793663651; Srinivasan A, 2011, AM J NEURORADIOL, V32, P637, DOI 10.3174/ajnr.A2593; Tomblyn M, 2012, CANCER CONTROL, V19, P196, DOI 10.1177/107327481201900304; Tracy CR, 2010, CANCER-AM CANCER SOC, V116, P3135, DOI 10.1002/cncr.25002; Wang H, 2008, CANCER IMMUNOL IMMUN, V57, P677, DOI 10.1007/s00262-007-0406-0; Wu L, 2010, CANCER BIOTHER RADIO, V25, P657, DOI 10.1089/cbr.2010.0801; Yu LK, 2006, CANCER BIOTHER RADIO, V21, P5, DOI 10.1089/cbr.2006.21.5; Zheng SG, 2013, CANCER BIOTHER RADIO, V28, P725, DOI 10.1089/cbr.2012.1418	28	3	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96539	10.1371/journal.pone.0096539	http://dx.doi.org/10.1371/journal.pone.0096539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787957	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700111
J	Nakakura, S; Terao, E; Nagatomi, N; Matsuo, N; Shimizu, Y; Tabuchi, H; Kiuchi, Y				Nakakura, Shunsuke; Terao, Etsuko; Nagatomi, Nozomi; Matsuo, Naoko; Shimizu, Yoshie; Tabuchi, Hitoshi; Kiuchi, Yoshiaki			Cross-Sectional Study of the Association between a Deepening of the Upper Eyelid Sulcus-Like Appearance and Wide-Open Eyes	PLOS ONE			English	Article							THERAPY; BIMATOPROST; TRAVOPROST; GLAUCOMA	Background: Deepening of the upper eyelid sulcus (DUES) is a common complication of prostaglandin F2 alpha analog treatment, which causes cosmetic problems. However, identifying this condition using photographs is difficult due to such problems as the camera flash effects, blepharoptosis or wide-open eyes. Purpose: We investigated the association between a DUES-like appearance and wide-open eyes regarding the presence of wide-open eyes as a cause for overestimating the incidence of DUES. Subjects and Methods: One eye and the forehead in 100 subjects (31 younger subjects, 30 older subjects and 39 patients with blepharoptosis) were evaluated in the present study. Digital photographs of the subjects with natural open and wide-open eyes were taken with a flash. Five signs (a puffy eyelid, the presence/absence of the upper eyelid sulcus (UES), wrinkles on the forehead with natural open eyes and an increase in the number of wrinkles on the forehead and a DUES-like appearance with wide-open eyes) were judged to be negative or positive by three independent observers. Univariate and multivariate logistic regression analyses were performed to determine the independent predictor(s) of a DUES-like appearance with wide-open eyes. Results: Fourteen subjects (four young, three old and seven subjects with blepharoptosis) were judged to have a DUES-like appearance with wide-open eyes (14%). The only predictive factor was the presence of UES in the patients with natural open eyes (odds ratio = 17.244, 95% confidence interval: 3.447-86.270, P < 0.001). Among the 12 UES-positive subjects, six (50%) exhibited a DUES-like appearance with wide-open eyes. Conclusions: The presence of wide-open eyes can thus cause a DUES-like appearance. Blepharoptosis itself is not a predictive factor; however, care should be taken not to overestimate the incidence of DUES, especially in patients with UES with natural open eyes, as a DUES-like appearance can be caused by wide-open eyes, even in treatment-naive patients.	[Nakakura, Shunsuke; Terao, Etsuko; Nagatomi, Nozomi; Matsuo, Naoko; Shimizu, Yoshie; Tabuchi, Hitoshi] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Kiuchi, Yoshiaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan	Hiroshima University	Nakakura, S (corresponding author), Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan.	shunsukenakakura@yahoo.co.jp						Aihara M, 2011, JPN J OPHTHALMOL, V55, P600, DOI 10.1007/s10384-011-0075-6; Alward WL, 1998, AM J OPHTHALMOL, V126, P498; GOLDBERG RA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1598, DOI 10.1001/archopht.1992.01080230098030; Inoue K, 2012, J GLAUCOMA; Jayaprakasam A, 2010, ORBIT, V29, P357, DOI 10.3109/01676830.2010.527028; Kakizaki H, 2005, OPHTHAL PLAST RECONS, V21, P379, DOI 10.1097/01.iop.0000173192.84698.d6; Kikkawa DO, 1997, INT OPHTHALMOL CLIN, V37, P193, DOI 10.1097/00004397-199703730-00014; Kitazawa T, 2013, EPLASTY, V19, p[13, e30]; Lee AJ, 2010, CLIN OPHTHALMOL, V4, P741; Maniglia JJ, 2006, ARCH FACIAL PLAST S, V8, P269, DOI 10.1001/archfaci.8.4.269; Maruyama K, 2012, J GLAUCOMA; Nakakura S, 2011, OPTOMETRY VISION SCI, V88, P1140, DOI 10.1097/OPX.0b013e3182231202; Peplinski LS, 2004, OPTOMETRY VISION SCI, V81, P574, DOI 10.1097/01.opx.0000141791.16683.4a; Sakata R, 2013, JPN J OPHTHALMOL, V57, P179, DOI 10.1007/s10384-012-0219-3; Sall K, 2000, SURV OPHTHALMOL, V44, pS155, DOI 10.1016/S0039-6257(99)00107-1; Shah M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061638; Small R G, 1989, Ophthalmic Plast Reconstr Surg, V5, P171; VANBUSKIRK EM, 1980, OPHTHALMOLOGY, V87, P447; VANDENBOSCH WA, 1992, OPHTHALMOLOGY, V99, P1759; Yang HK, 2009, JPN J OPHTHALMOL, V53, P176, DOI 10.1007/s10384-008-0623-x	20	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96249	10.1371/journal.pone.0096249	http://dx.doi.org/10.1371/journal.pone.0096249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781779	Green Published, Green Submitted, gold			2022-12-25	WOS:000335504900025
J	Hong, Y; Shao, AW; Wang, JF; Chen, S; Wu, HJ; McBride, DW; Wu, Q; Sun, XJ; Zhang, JM				Hong, Yuan; Shao, Anwen; Wang, Jianfeng; Chen, Sheng; Wu, HaiJian; McBride, Devin W.; Wu, Qun; Sun, XueJun; Zhang, JianMin			Neuroprotective Effect of Hydrogen-Rich Saline against Neurologic Damage and Apoptosis in Early Brain Injury following Subarachnoid Hemorrhage: Possible Role of the Akt/GSK3 beta Signaling Pathway	PLOS ONE			English	Article							OXIDATIVE STRESS; SPINAL-CORD; ACTIVATION; PROTECTS; SURVIVAL; RATS; SUPEROXIDE; AKT; ANTIOXIDANT; INHIBITION	Backgrounds: Early brain injury (EBI) plays a key role in the pathogenesis of subarachnoid hemorrhage (SAH). Neuronal apoptosis is involved in the pathological process of EBI. Hydrogen can inhibit neuronal apoptosis and attenuate EBI following SAH. However, the molecular mechanism underlying hydrogen-mediated anti-apoptotic effects in SAH has not been elucidated. In the present study, we aimed to evaluate whether hydrogen alleviates EBI after SAH, specifically neuronal apoptosis, partially via the Akt/GSK3 beta signaling pathway. Methods: Sprague-Dawley rats (n = 85) were randomly divided into the following groups: sham group (n = 17), SAH group (n = 17), SAH + saline group (n = 17), SAH + hydrogen-rich saline (HS) group (n = 17) and SAH + HS + Ly294002 (n = 17) group. HS or an equal volume of physiological saline was administered immediately after surgery and repeated 8 hours later. The PI3K inhibitor, Ly294002, was applied to manipulate the proposed pathway. Neurological score and SAH grade were assessed at 24 hours after SAH. Western blot was used for the quantification of Akt, pAkt, GSK3 beta, pGSK3 beta, Bcl-2, Bax and cleaved caspase-3 proteins. Neuronal apoptosis was identified by double staining of terminal deoxynucleotidyl transferase mediated nick end labeling (TUNEL) staining and NeuN, and quantified by apoptosis index. Immunohistochemistry and immunofluorescent double-labeling staining was performed to clarify the relationships between neuronal apoptosis and pAkt or pGSK3 beta. Results: HS significantly reduced neuronal apoptosis and improved neurological function at 24 hours after SAH. The levels of pAkt and pGSK3 beta, mainly expressed in neurons, were markedly up-regulated. Additionally, Bcl-2 was significantly increased while Bax and cleaved caspase-3 was decreased by HS treatment. Double staining of pAkt and TUNEL showed few colocalization of pAkt-positive cells and TUNEL-positive cells. The inhibitor of PI3K, Ly294002, suppressed the beneficial effects of HS. Conclusions: HS could attenuate neuronal apoptosis in EBI and improve the neurofunctional outcome after SAH, partially via the Akt/GSK3 beta pathway.	[Hong, Yuan; Shao, Anwen; Wang, Jianfeng; Chen, Sheng; Wu, HaiJian; Wu, Qun; Zhang, JianMin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Jianfeng] Taizhou Hosp, Taizhou Enze Med Ctr Grp, Dept Neurosurg, Taizhou, Peoples R China; [McBride, Devin W.] Loma Linda Univ, Dept Physiol & Pharmacol, Sch Med, Loma Linda, CA USA; [Sun, XueJun] Second Mil Med Univ, Dept Diving Med, Shanghai, Peoples R China	Zhejiang University; Loma Linda University; Naval Medical University	Zhang, JM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China.	zjm153vip@sina.com	Shao, Anwen/L-4860-2019; sun, xuejun/A-5561-2010; Shao, Anwen/R-9023-2019	Shao, Anwen/0000-0001-5616-0394; sun, xuejun/0000-0003-2387-5531; Shao, Anwen/0000-0001-9986-6290; chen, sheng/0000-0002-8374-136X	National Natural Science Foundation of China [81171096, 81371369]; Doctoral Program of the Ministry of Education [20120101120030]; Health department of Zhejiang province [2013KYA088]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of the Ministry of Education; Health department of Zhejiang province	This project was funded by Grant 81171096 and 81371369 from National Natural Science Foundation of China; Grant 20120101120030 from Doctoral Program of the Ministry of Education; Grant 2013KYA088 from Health department of Zhejiang province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Cai JM, 2009, BRAIN RES, V1256, P129, DOI 10.1016/j.brainres.2008.11.048; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Chen JY, 2014, J PINEAL RES, V56, P12, DOI 10.1111/jpi.12086; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Dong ML, 2013, BBA-MOL BASIS DIS, V1832, P848, DOI 10.1016/j.bbadis.2013.02.023; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Endo H, 2007, J CEREBR BLOOD F MET, V27, P975, DOI 10.1038/sj.jcbfm.9600399; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Ersahin M, 2012, PROSTAG OTH LIPID M, V99, P131, DOI 10.1016/j.prostaglandins.2012.09.002; Ersahin M, 2009, J PINEAL RES, V46, P324, DOI 10.1111/j.1600-079X.2009.00664.x; Friedrich V, 2012, NEUROSCI LETT, V512, P6, DOI 10.1016/j.neulet.2012.01.036; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; Golan E, 2013, J CRIT CARE, V28, P173, DOI 10.1016/j.jcrc.2012.07.001; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; Hong Y, 2010, J INT MED RES, V38, P1893, DOI 10.1177/147323001003800602; Hong Y, 2012, J NEUROSCI RES, V90, P1670, DOI 10.1002/jnr.22739; Jiang Y, 2012, J CLIN NEUROSCI, V19, P866, DOI 10.1016/j.jocn.2011.08.038; KELLOGG EW, 1977, J BIOL CHEM, V252, P6721; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Kuo CP, 2013, J NEUROSURG, V119, P1028, DOI 10.3171/2013.4.JNS121919; Li ZR, 2013, MOL VIS, V19, P1656; Liu GD, 2013, INT J OPHTHALMOL-CHI, V6, P280, DOI 10.3980/j.issn.2222-3959.2013.03.05; Liu Q, 2010, LIVER INT, V30, P958, DOI 10.1111/j.1478-3231.2010.02254.x; Love S, 2003, PROG NEURO-PSYCHOPH, V27, P267, DOI 10.1016/S0278-5846(03)00022-8; Ma JP, 2012, CRIT CARE, V16, DOI 10.1186/cc11686; MISRA HP, 1972, J BIOL CHEM, V247, P6960; Mocco J, 2006, Neurosurg Focus, V21, pE9; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ostrowski RP, 2006, STROKE, V37, P1314, DOI 10.1161/01.STR.0000217310.88450.c3; Pan JJ, 2011, INT J ONCOL, V39, P1285, DOI 10.3892/ijo.2011.1157; Pan JJ, 2010, CHEM RES TOXICOL, V23, P568, DOI 10.1021/tx9003193; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Topkoru BC, 2013, STROKE, V44, P3189, DOI 10.1161/STROKEAHA.113.001574; Velat GJ, 2011, WORLD NEUROSURG, V76, P446, DOI 10.1016/j.wneu.2011.02.030; Wang C, 2011, NEUROSCI LETT, V491, P127, DOI 10.1016/j.neulet.2011.01.022; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; Wang Z, 2012, J PINEAL RES, V53, P129, DOI 10.1111/j.1600-079X.2012.00978.x; Willis S, 2003, J CELL SCI, V116, P4053, DOI 10.1242/jcs.00754; Xiao M, 2013, EUR REV MED PHARMACO, V17, P1033; Yuan P, 2013, NEUROL SCI, V34, P1133, DOI 10.1007/s10072-012-1199-2; Yuksel S, 2012, TURK NEUROSURG, V22, P529, DOI 10.5137/1019-5149.JTN.5731-12.1; Zhan Y, 2012, CRIT CARE MED, V40, P1291, DOI 10.1097/CCM.0b013e31823da96d; Zhang HY, 2013, CNS NEUROSCI THER, V19, P20, DOI 10.1111/cns.12013; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zhua YM, 2013, BRAIN RES, V1494, P1, DOI 10.1016/j.brainres.2012.11.047; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	51	76	84	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96212	10.1371/journal.pone.0096212	http://dx.doi.org/10.1371/journal.pone.0096212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763696	Green Published, Green Submitted, gold			2022-12-25	WOS:000335505000074
J	Lenarcic, R; Morisset, D; Pirc, M; Llop, P; Ravnikar, M; Dreo, T				Lenarcic, Rok; Morisset, Dany; Pirc, Manca; Llop, Pablo; Ravnikar, Maja; Dreo, Tanja			Loop-Mediated Isothermal Amplification of Specific Endoglucanase Gene Sequence for Detection of the Bacterial Wilt Pathogen Ralstonia solanacearum	PLOS ONE			English	Article							REAL-TIME; STRAINS; PHYLOGENY; MULTIPLEX; PICKETTII	The increased globalization of crops production and processing industries also promotes the side-effects of more rapid and efficient spread of plant pathogens. To prevent the associated economic losses, and particularly those related to bacterial diseases where their management relies on removal of the infected material from production, simple, easy-to-perform, rapid and cost-effective tests are needed. Loop-mediated isothermal amplification (LAMP) assays that target 16S rRNA, fliC and egl genes were compared and evaluated as on-site applications. The assay with the best performance was that targeted to the egl gene, which shows high analytical specificity for diverse strains of the betaproteobacterium Ralstonia solanacearum, including its non-European and non-race 3 biovar 2 strains. The additional melting curve analysis provides confirmation of the test results. According to our extensive assessment, the egl LAMP assay requires minimum sample preparation (a few minutes of boiling) for the identification of pure cultures and ooze from symptomatic material, and it can also be used in a high-throughput format in the laboratory. This provides sensitive and reliable detection of R. solanacearum strains of different phylotypes.	[Lenarcic, Rok; Morisset, Dany; Pirc, Manca; Llop, Pablo; Ravnikar, Maja; Dreo, Tanja] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia	National Institute of Biology - Slovenia	Lenarcic, R (corresponding author), Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia.	rok.lenarcic@nib.si	Dreo, Tanja/X-1638-2019; Llop, Pablo/H-3032-2017; Llop, Pablo/ABD-5403-2022	Dreo, Tanja/0000-0002-0850-4874; Llop, Pablo/0000-0003-3075-8376; Pirc, Manca/0000-0003-2519-0026; Morisset, Dany/0000-0001-8967-9424; Ravnikar, Maja/0000-0002-6630-1362	EU [FP7-KBBE-2009-3, 245047]; Slovenian Research Agency [Q-finder L1-3642]	EU(European Commission); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was carried out under the sponsorship of the EU Framework 7 Programme (FP7-KBBE-2009-3) project 245047 (Qdetect - Developing quarantine pest detection methods for use by national plant protection organisations - NPPO and inspection services) and of the Slovenian Research Agency funded project Q-finder L1-3642 (Developing simple, rapid and on-site methods for plant pathogens detection). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B., 2010, CURRENT RES TECHNOLO, P267, DOI DOI 10.1111/MPP.12038; [Anonymous], 2004, Bulletin OEPP, V34, P173, DOI 10.1111/j.1365-2338.2004.00715.x; Bentsink L, 2002, J APPL MICROBIOL, V93, P647, DOI 10.1046/j.1365-2672.2002.01725.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cellier G, 2012, APPL ENVIRON MICROB, V78, P2367, DOI 10.1128/AEM.06123-11; Elphinstone J. G., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P9; Elphinstone J. G., 1998, Bulletin OEPP, V28, P93, DOI 10.1111/j.1365-2338.1998.tb00709.x; EPPO, 2014, PQR EPPO DAT QUAR PE; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; GILLINGS MR, 1994, BACTERIAL WILT, P95; Griep RA, 1998, PHYTOPATHOLOGY, V88, P795, DOI 10.1094/PHYTO.1998.88.8.795; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; JANSE J D, 1988, Bulletin OEPP, V18, P343, DOI 10.1111/j.1365-2338.1988.tb00385.x; Janse JD, 2004, J PLANT PATHOL, V86, P147; Kubota R, 2008, PHYTOPATHOLOGY, V98, P1045, DOI 10.1094/PHYTO-98-9-1045; Kubota R., 2011, BIOL ENG T, V4, P100, DOI DOI 10.13031/2013.38509; Lambert CD, 2002, FED REGISTER, V67, P76907; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Pastrik KH, 2002, EUR J PLANT PATHOL, V108, P831, DOI 10.1023/A:1021218201771; Pirc M, 2009, PLANT PATHOL, V58, P872, DOI 10.1111/j.1365-3059.2009.02083.x; Pradhanang PM, 2002, 1 REPORT SO WILST CA; Prior P, 2005, ACTA HORTIC, P127, DOI 10.17660/ActaHortic.2005.695.14; Remenant B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024356; RobinsonSmith A, 1995, FOOD AGR IMMUNOL, V7, P67, DOI 10.1080/09540109509354866; SEAL SE, 1993, J GEN MICROBIOL, V139, P1587, DOI 10.1099/00221287-139-7-1587; Swanson JK, 2007, PLANT DIS, V91, P828, DOI 10.1094/PDIS-91-7-0828; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Temple TN, 2011, PLANT DIS, V95, P423, DOI 10.1094/PDIS-09-10-0636; Weller SA, 2000, APPL ENVIRON MICROB, V66, P2853, DOI 10.1128/AEM.66.7.2853-2858.2000; Wicker E, 2012, ISME J, V6, P961, DOI 10.1038/ismej.2011.160; Williamson L, 2002, PLANT DIS, V86, P987, DOI 10.1094/PDIS.2002.86.9.987; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x	33	26	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96027	10.1371/journal.pone.0096027	http://dx.doi.org/10.1371/journal.pone.0096027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763488	Green Published, Green Submitted, gold			2022-12-25	WOS:000335505000052
J	Li, XG; Zhao, G; Ma, B; Li, R; Hong, J; Liu, SW; Wang, DW				Li, Xuguang; Zhao, Gang; Ma, Ben; Li, Rui; Hong, Jiang; Liu, Shaowen; Wang, Dao Wen			20-Hydroxyeicosatetraenoic Acid Impairs Endothelial Insulin Signaling by Inducing Phosphorylation of the Insulin Receptor Substrate-1 at Ser(616)	PLOS ONE			English	Article							NITRIC-OXIDE; VASCULAR DYSFUNCTION; PROMOTING PRODUCTION; PROTEIN-KINASE; CELLS; ACTIVATION; RESISTANCE; PATHWAY; RAT; INHIBITION	20-hydroxyeicosatetraenoic acid (20-HETE) induces endothelial dysfunction and is correlated with diabetes. This study was designed to investigate the effects of 20-HETE on endothelial insulin signaling. Human umbilical vein endothelial cells (HUVECs) or C57BL/6J mice were treated with 20-HETE in the presence or absence of insulin, and p-ERK1/2, p-JNK, IRS-1/PI3K/AKT/eNOS pathway, were examined in endothelial cells and aortas by immunoblotting. eNOS activity and nitric oxide production were measured. 20-HETE increased ERK1/2 phosphorylation and IRS-1 phosphorylation at Ser(616); these effects were reversed by ERK1/2 inhibition. We further observed that 20-HETE treatment resulted in impaired insulin-stimulated IRS-1 phosphorylation at Tyr(632) and subsequent PI3-kinase/Akt activation. Furthermore, 20-HETE treatment blocked insulin-stimulated phosphorylation of eNOS at the stimulatory Ser(1177) site, eNOS activation and NO production; these effects were reversed by inhibiting ERK1/2. Treatment of C57BL/6J mice with 20-HETE resulted in ERK1/2 activation and impaired insulin-dependent activation of the IRS-1/PI3K/Akt/eNOS pathway in the aorta. Our data suggest that the 20-HETE activation of IRS-1 phosphorylation at Ser(616) is dependent on ERK1/2 and leads to impaired insulin-stimulated vasodilator effects that are mediated by the IRS-1/PI3K/AKT/eNOS pathway.	[Li, Xuguang; Hong, Jiang; Liu, Shaowen] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China; [Zhao, Gang; Ma, Ben; Li, Rui; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Internal Med, Wuhan 430074, Peoples R China	Shanghai Jiao Tong University; Huazhong University of Science & Technology	Li, XG (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China.	li.xg@163.com	Liu, Shaowen/AAJ-4121-2020	Hong, Jiang/0000-0002-3745-5549	National Natural Science Foundation of China [81300090, 30930039]; Young Physician Training Project of Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Physician Training Project of Shanghai	This work was supported by the National Natural Science Foundation of China (No. 81300090 and No. 30930039, http://www.nsfc.gov.cn/) and the Young Physician Training Project of Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Andreozzi F, 2004, CIRC RES, V94, P1211, DOI 10.1161/01.RES.0000126501.34994.96; Andreozzi F, 2007, MOL CELL BIOL, V27, P2372, DOI 10.1128/MCB.01340-06; Benter IF, 2005, PHARMACOL RES, V52, P252, DOI 10.1016/j.phrs.2005.04.001; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Chen J, 2008, AM J PHYSIOL-HEART C, V294, pH2305, DOI 10.1152/ajpheart.00868.2007; Cheng J, 2008, AM J PHYSIOL-HEART C, V294, pH1018, DOI 10.1152/ajpheart.01172.2007; Cheng J, 2012, ARTERIOSCL THROM VAS, V32, P1917, DOI 10.1161/ATVBAHA.112.248344; Cheng J, 2010, J PHARMACOL EXP THER, V332, P57, DOI 10.1124/jpet.109.159863; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Elshenawy OH, 2013, CURR DRUG METAB, V14, P706, DOI 10.2174/1389200211314060007; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guo AM, 2007, J PHARMACOL EXP THER, V321, P18, DOI 10.1124/jpet.106.115360; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang A, 2012, DIABETES, V61, P3181, DOI 10.2337/db12-0559; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Ishizuka T, 2008, J PHARMACOL EXP THER, V324, P103, DOI 10.1124/jpet.107.130336; Lai GR, 2012, MOL ENDOCRINOL, V26, P1907, DOI 10.1210/me.2012-1139; Li XG, 2011, HYPERTENS RES, V34, P869, DOI 10.1038/hr.2011.44; Lukaszewicz KM, 2013, CLIN SCI, V124, P695, DOI 10.1042/CS20120483; Mather KJ, 2013, J CLIN INVEST, V123, P1003, DOI 10.1172/JCI67166; Medhora M, 2008, AM J PHYSIOL-LUNG C, V294, pL902, DOI 10.1152/ajplung.00278.2007; Miyata N, 2005, J PHARMACOL EXP THER, V314, P77, DOI 10.1124/jpet.105.083964; Miyata Noriyuki, 2005, Journal of Smooth Muscle Research, V41, P175, DOI 10.1540/jsmr.41.175; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Orozco LD, 2013, J PHARM EXP THER; Padilla J, 2013, J PHYSIOL PHARMACOL, V64, P557; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Singh H, 2007, HYPERTENSION, V50, P123, DOI 10.1161/HYPERTENSIONAHA.107.089599; Taguchi K, 2011, AM J PHYSIOL-HEART C, V301, pH571, DOI 10.1152/ajpheart.01189.2010; Wang ZL, 2011, EXP EYE RES, V93, P108, DOI 10.1016/j.exer.2011.05.011; Ward NC, 2004, CIRCULATION, V110, P438, DOI 10.1161/01.CIR.0000136808.72912.D9; Yousif M. H. M., 2009, Autonomic & Autacoid Pharmacology, V29, P1, DOI 10.1111/j.1474-8673.2009.00426.x; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	37	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95841	10.1371/journal.pone.0095841	http://dx.doi.org/10.1371/journal.pone.0095841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763529	Green Published, Green Submitted, gold			2022-12-25	WOS:000335505000037
J	Egyir, B; Guardabassi, L; Esson, J; Nielsen, SS; Newman, MJ; Addo, KK; Larsen, AR				Egyir, Beverly; Guardabassi, Luca; Esson, Joseph; Nielsen, Soren Saxmose; Newman, Mercy Jemima; Addo, Kennedy Kwasi; Larsen, Anders Rhod			Insights into Nasal Carriage of Staphylococcus aureus in an Urban and a Rural Community in Ghana	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; POPULATION-STRUCTURE; PREVALENCE; EPIDEMIOLOGY; SPA; STRAINS; CLONES	The epidemiology of Staphylococcus aureus in the community in Ghana was never investigated prior to this study. The aims of the study were: i) to assess prevalence of nasal S. aureus carriage in Ghanaian people living in an urban and a rural area, and ii) to identify phenotypic and genotypic traits of strains isolated from the two communities. Nasal swabs were collected from healthy individuals living in an urban community situated in the suburb of the capital city, Accra (n = 353) and in a rural community situated in the Dangme-West district (n = 234). The overall prevalence of nasal carriage was 21% with a significantly higher prevalence in the urban (28%) than in the rural community (11%) (p<0.0001). The levels of antimicrobial resistance were generally low (<5%) except for penicillin (91%) and tetracycline (25%). The only two (0.3%) MRSA carriers were individuals living in the urban area and had been exposed to hospitals within the last 12 months prior to sampling. Resistance to tetracycline (p = 0.0009) and presence of Panton-Valentine leukocidin (PVL) gene (p = 0.02) were significantly higher among isolates from the rural community compared to isolates from the urban community. Eleven MLST clonal complexes (CC) were detected based on spa typing of the 124 S. aureus isolates from the two communities: CC8 (n = 36), CC152 (n = 21), CC45 (n = 21), CC15 (n = 18), CC121 (n = 6), CC97 (n = 6), CC30 (n = 5), CC5 (n = 5), CC508 (n = 4), CC9 (n = 1), and CC707 (n = 1). CC8 and CC45 were less frequent in the rural area than in the urban area (p = 0.02). These results reveal remarkable differences regarding carriage prevalence, tetracycline resistance, PVL content and clonal distribution of S. aureus in the two study populations. Future research may be required to establish whether such differences in nasal S. aureus carriage are linked to socio-economic differences between urban and rural communities in this African country.	[Egyir, Beverly; Larsen, Anders Rhod] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Egyir, Beverly; Guardabassi, Luca] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Egyir, Beverly; Addo, Kennedy Kwasi] Noguchi Mem Inst Med Res, Dept Bacteriol, Accra, Ghana; [Esson, Joseph; Newman, Mercy Jemima] Univ Ghana, Sch Med, Dept Microbiol, Accra, Ghana; [Nielsen, Soren Saxmose] Univ Copenhagen, Fac Hlth & Med Sci, Dept Large Anim Sci, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen; University of Ghana; University of Ghana; University of Copenhagen	Egyir, B (corresponding author), Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark.	begyir@sund.ku.dk		Guardabassi, Luca/0000-0002-2389-5084; Nielsen, Soren/0000-0003-2417-0787; Larsen, Anders Rhod/0000-0002-1713-8765; Egyir, Beverly/0000-0002-5032-8739	Antibiotic Drug use, Monitoring and Evaluation of Resistance (ADMER)-Danish International Development Agency (DANIDA)	Antibiotic Drug use, Monitoring and Evaluation of Resistance (ADMER)-Danish International Development Agency (DANIDA)	This study was supported by Antibiotic Drug use, Monitoring and Evaluation of Resistance (ADMER), a project funded by the Danish International Development Agency (DANIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesida SA, 2007, BRAZ J INFECT DIS, V11, P63, DOI 10.1590/S1413-86702007000100016; Alabi AS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-455; [Anonymous], 2012, J VET ADV; Aubry-Damon H, 2004, EMERG INFECT DIS, V10, P873, DOI 10.3201/eid1005.030735; Centers for Disease Control and Prevention, 2019, ACT BACT COR SURV RE; Charlebois ED, 2002, CLIN INFECT DIS, V34, P425, DOI 10.1086/338069; Choi Chong Seng, 2006, Journal of Microbiology Immunology and Infection, V39, P458; David MZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018217; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Deurenberg RH, 2009, CURR MOL MED, V9, P100, DOI 10.2174/156652409787581637; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Donkor ES, 2012, TROP MED INT HEALTH, V17, P462, DOI 10.1111/j.1365-3156.2012.02955.x; Du JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027328; Egyir B, 2013, J GLOB ANTIMICROB RE, V1, P189, DOI 10.1016/j.jgar.2013.05.006; Egyir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089716; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fitzgibbon MM, 2007, J CLIN MICROBIOL, V45, P3263, DOI 10.1128/JCM.00836-07; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kimang' AN, 2012, ETHIOP J HLTH SCI, V22, P2; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Larsen AR, 2008, CLIN MICROBIOL INFEC, V14, P611, DOI 10.1111/j.1469-0691.2008.01995.x; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Munckhof WJ, 2009, CLIN MICROBIOL INFEC, V15, P149, DOI 10.1111/j.1469-0691.2008.02652.x; Nakamura MM, 2002, PEDIATR INFECT DIS J, V21, P917, DOI 10.1097/00006454-200210000-00006; Newman Mercy J, 2011, Infect Drug Resist, V4, P215, DOI 10.2147/IDR.S21769; Ngoa UA, 2012, ACTA TROP, V124, P42, DOI 10.1016/j.actatropica.2012.06.005; Okon KO, 2009, J CLIN MICROBIOL, V47, P3000, DOI 10.1128/JCM.01119-09; Onanuga A, 2011, AFR HEALTH SCI, V11, P176; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Scerri J, 2013, J EPIDEMIOL GLOB HEA, V3, P165, DOI 10.1016/j.jegh.2013.05.003; Schaumburg F, 2011, CLIN MICROBIOL INFEC, V17, P1507, DOI 10.1111/j.1469-0691.2011.03534.x; Schaumburg F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001150; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; Skramm I, 2011, APMIS, V119, P522, DOI 10.1111/j.1600-0463.2011.02758.x; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wannet WJB, 2005, J CLIN MICROBIOL, V43, P3341, DOI 10.1128/JCM.43.7.3341-3345.2005; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Zanelli G, 2002, EPIDEMIOL INFECT, V129, P417, DOI 10.1017/S0950268802007434	48	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96119	10.1371/journal.pone.0096119	http://dx.doi.org/10.1371/journal.pone.0096119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760001	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200138
J	Sahlberg, SH; Spiegelberg, D; Glimelius, B; Stenerlow, B; Nestor, M				Sahlberg, Sara Haggblad; Spiegelberg, Diana; Glimelius, Bengt; Stenerlow, Bo; Nestor, Marika			Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LARGE GENE LISTS; COLORECTAL-CANCER; BREAST-CANCER; SIGNALING PATHWAYS; INITIATING CELLS; SURVIVAL PATHWAY; CARCINOMA CELLS; LYN KINASE; EXPRESSION	The cell surface proteins CD133, CD24 and CD44 are putative markers for cancer stem cell populations in colon cancer, associated with aggressive cancer types and poor prognosis. It is important to understand how these markers may predict treatment outcomes, determined by factors such as radioresistance. The scope of this study was to assess the connection between EGFR, CD133, CD24, and CD44 (including isoforms) expression levels and radiation sensitivity, and furthermore analyze the influence of AKT isoforms on the expression patterns of these markers, to better understand the underlying molecular mechanisms in the cell. Three colon cancer cell-lines were used, HT-29, DLD-1, and HCT116, together with DLD-1 isogenic AKT knock-out cell-lines. All three cell-lines (HT-29, HCT116 and DLD-1) expressed varying amounts of CD133, CD24 and CD44 and the top ten percent of CD133 and CD44 expressing cells (CD133(high)/CD44(high)) were more resistant to gamma radiation than the ten percent with lowest expression (CD133(low)/CD44(low)). The AKT expression was lower in the fraction of cells with low CD133/CD44. Depletion of AKT1 or AKT2 using knock out cells showed for the first time that CD133 expression was associated with AKT1 but not AKT2, whereas the CD44 expression was influenced by the presence of either AKT1 or AKT2. There were several genes in the cell adhesion pathway which had significantly higher expression in the AKT2 KO cell-line compared to the AKT1 KO cell-line; however important genes in the epithelial to mesenchymal transition pathway (CDH1, VIM, TWIST1, SNAI1, SNAI2, ZEB1, ZEB2, FN1, FOXC2 and CDH2) did not differ. Our results demonstrate that CD133(high)/CD44(high) expressing colon cancer cells are associated with AKT and increased radiation resistance, and that different AKT isoforms have varying effects on the expression of cancer stem cell markers, which is an important consideration when targeting AKT in a clinical setting.	[Sahlberg, Sara Haggblad; Spiegelberg, Diana; Stenerlow, Bo; Nestor, Marika] Uppsala Univ, Sect Biomed Radiat Sci, Dept Radiol Oncol & Radiat Sci, Rudbeck Lab, Uppsala, Sweden; [Glimelius, Bengt] Uppsala Univ, Sect Oncol, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden; [Nestor, Marika] Uppsala Univ, Dept Surg Sci, Sect Otolaryngol & Head & Neck Surg, Uppsala, Sweden; [Nestor, Marika] Uppsala Univ, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University	Sahlberg, SH (corresponding author), Uppsala Univ, Sect Biomed Radiat Sci, Dept Radiol Oncol & Radiat Sci, Rudbeck Lab, Uppsala, Sweden.	sara.sahlberg@bms.uu.se	Spiegelberg, Diana/AAC-7174-2020; Nestor, Marika/HEZ-1169-2022	Spiegelberg, Diana/0000-0002-1509-2142; Nestor, Marika/0000-0003-4662-3142	Swedish Cancer Society	Swedish Cancer Society(Swedish Cancer Society)	This work has been funded by grants from the Swedish Cancer Society, www.cancerfonden.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; Al-Assar O, 2009, INT J RADIAT ONCOL, V75, P1216, DOI 10.1016/j.ijrobp.2009.07.001; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Banky B, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-83; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bates RC, 2001, CANCER RES, V61, P5275; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Baumann M, 2010, CLIN CANCER RES, V16, P5091, DOI 10.1158/1078-0432.CCR-10-2244; Baumann M, 2009, INT J RADIAT BIOL, V85, P391, DOI 10.1080/09553000902836404; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Botchkina G, 2013, CANCER LETT, V338, P127, DOI 10.1016/j.canlet.2012.04.006; Butof R, 2013, RADIOTHER ONCOL, V108, P388, DOI 10.1016/j.radonc.2013.06.002; Chen KL, 2011, CLIN EXP METASTAS, V28, P751, DOI 10.1007/s10585-011-9407-7; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056380; Cho SH, 2012, INT J ONCOL, V41, P211, DOI 10.3892/ijo.2012.1453; Choi D, 2009, WORLD J GASTROENTERO, V15, P2258, DOI 10.3748/wjg.15.2258; Chu P, 2009, INT J CANCER, V124, P1312, DOI 10.1002/ijc.24061; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; Dittfeld C, 2009, RADIOTHER ONCOL, V92, P353, DOI 10.1016/j.radonc.2009.06.034; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Du ZY, 2011, DIGEST DIS SCI, V56, P741, DOI 10.1007/s10620-010-1340-0; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Galizia G, 2012, ARCH SURG-CHICAGO, V147, P18, DOI 10.1001/archsurg.2011.795; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Hart LS, 2011, CELL CYCLE, V10, P2331, DOI 10.4161/cc.10.14.16418; Herishanu Y, 2011, LEUKEMIA LYMPHOMA, V52, P1758, DOI 10.3109/10428194.2011.569962; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaler P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045462; Kawamoto A, 2012, EXP THER MED, V3, P403, DOI 10.3892/etm.2011.438; Kawamoto H, 2010, CELL TRANSPLANT, V19, P857, DOI 10.3727/096368910X508988; Ke J, 2012, NEOPLASMA, V59, P282, DOI 10.4149/neo_2012_036; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lakshman M, 2004, EXP MOL PATHOL, V77, P18, DOI 10.1016/j.yexmp.2004.03.002; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; Ma L, 2013, FEBS J, V280, P2027, DOI 10.1111/febs.12226; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marhaba R, 2004, J MOL HISTOL, V35, P211; Muraro MG, 2012, STEM CELL TRANSL MED, V1, P592, DOI 10.5966/sctm.2012-0003; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Peng ZG, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-61; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Sahlberg SH, 2013, TUMOUR BIOL; Saigusa S, 2010, ONCOL REP, V24, P345, DOI 10.3892/or_00000865; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spiegelberg D, 2013, TUMOUR BIOL; Subramaniam V, 2007, EXP MOL PATHOL, V83, P207, DOI 10.1016/j.yexmp.2007.04.008; Tamura K, 2010, J NEUROSURG, V113, P310, DOI 10.3171/2010.2.JNS091607; Wang YK, 2010, CARCINOGENESIS, V31, P1376, DOI 10.1093/carcin/bgq120; Weichert W, 2005, CLIN CANCER RES, V11, P6574, DOI 10.1158/1078-0432.CCR-05-0606; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Wobus M, 2002, APPL IMMUNOHISTO M M, V10, P34, DOI 10.1097/00022744-200203000-00006; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Zhang LS, 2010, CELL PROLIFERAT, V43, P385, DOI 10.1111/j.1365-2184.2010.00689.x	65	150	159	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94621	10.1371/journal.pone.0094621	http://dx.doi.org/10.1371/journal.pone.0094621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760019	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200022
J	Zhang, XJ; Lu, HJ; Ai, H; Peng, R; Yang, YB; Li, AY; Hong, HZ; Peng, JX; Liu, KY				Zhang, Xiaojuan; Lu, Hongjuan; Ai, Hui; Peng, Rong; Yang, Yongbo; Li, Aiying; Hong, Huazhu; Peng, Jianxin; Liu, Kaiyu			Distribution, Cleavage and Lipidation of Atg8 Fusion Proteins in Spodoptera litura Sl-HP Cells	PLOS ONE			English	Article							AUTOPHAGOSOME FORMATION; MAMMALIAN HOMOLOG; LC3; LIGHT-CHAIN-3; DYNAMICS; MARKER	Atg8 proteins fused with tags are commonly used to detect autophagy. The expression patterns of Lepidopteran insect Atg8 are relatively well documented. However, the influence of protein tags on characterization of Atg8 is still not very clear. Our results showed that endogenous Spodoptera litura Atg8 and HA tagged Atg8 driven by the baculovirus ie2 promoter were enriched in cytoplasm. The recombinant plasmid pEGFP-Atg8(EGFP) in which Atg8 contained a stop codon was constructed and expressed. Green fluorescence was accumulated in cytoplasm. However, red fluorescence was located in both cytoplasm and nucleoplasm in most cells transfected with the recombinant plasmid pmCherry-Atg8(EGFP). In contrast to pEGFP-Atg8(EGFP), green fluorescence was also located in both cytoplasm and nucleoplasm in most cells transfected with the recombinant plasmid pie2/EGFP-Atg8 driven by the baculovirus ie2 promoter in which the CMV promoter and EGFP nucleotide sequences were removed, and the high level of the EGFP-Atg8 expression significantly increased its abundance in nucleoplasm. HA-Atg8 expressed at high level through baculovirus under the control of polyherin promoter was also localized in cytoplasm and nucleoplasm. The cleavage of mCherry-Atg8 was different from that of EGFP-Atg8. Both the mutant mCherry-Atg8(F77/79A) resulting in non-cleavage of the Atg8 and the mutant mCherry-Atg8(G) exposing its glycine residue at the end of C-terminus were also localized in cytoplasm and nucleoplasm. The increase of autophagosomes decreased the abundance of mCherry-Atg8 in nucleoplasm. In addition, the ratio of HA-Atg8-PE/HA-Atg8 was less than that of endogenous Atg8-PE/Atg8. These results demonstrated that the Atg8 is located in both nucleus and cytoplasm when expressed at high level and exported to the cytoplasm when autophagy is activated, and the fusion tags of Atg8 might have influence on the processing of Atg8 fusion proteins.	[Zhang, Xiaojuan; Lu, Hongjuan; Ai, Hui; Peng, Rong; Yang, Yongbo; Li, Aiying; Hong, Huazhu; Peng, Jianxin; Liu, Kaiyu] Cent China Normal Univ, Sch Life Sci, Wuhan, Peoples R China	Central China Normal University	Peng, JX (corresponding author), Cent China Normal Univ, Sch Life Sci, Wuhan, Peoples R China.	jxpeng@mail.ccnu.edu.cn; liukaiyu@mail.ccnu.edu.cn			National Natural Science Foundation of China [31372260]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is funded by the National Natural Science Foundation of China (31372260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar N, 2006, EMBO REP, V7, P635, DOI 10.1038/sj.embor.7400698; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Cieehomska IA, 2007, AUTOPHAGY, V3, P586, DOI 10.4161/auto.4843; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Drake KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009806; Fass E, 2007, AUTOPHAGY, V3, P48, DOI 10.4161/auto.3417; Franzetti E, 2012, APOPTOSIS, V17, P305, DOI 10.1007/s10495-011-0675-0; Furuta S, 2002, ONCOGENE, V21, P7060, DOI 10.1038/sj.onc.1205790; Gai ZC, 2013, ARCH INSECT BIOCHEM, V84, P57, DOI 10.1002/arch.21114; Hale AN, 2013, AUTOPHAGY, V9, P951, DOI 10.4161/auto.24273; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Khoa DB, 2012, INSECT MOL BIOL, V21, P473, DOI 10.1111/j.1365-2583.2012.01152.x; Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2011, AUTOPHAGY, V7, P1093, DOI 10.4161/auto.7.10.15492; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mizushima N, 2006, AUTOPHAGY, V2, P302, DOI 10.4161/auto.2945; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nowak J, 2009, MOL BIOL CELL, V20, P870, DOI 10.1091/mbc.E08-07-0671; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Seldenbecher CI, 2004, J MOL BIOL, V336, P957, DOI 10.1016/j.jmb.2003.12.054; Shu CW, 2011, J BIOMOL SCREEN, V16, P174, DOI 10.1177/1087057110392996; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yu ZQ, 2012, AUTOPHAGY, V8, P883, DOI 10.4161/auto.19652	33	5	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96059	10.1371/journal.pone.0096059	http://dx.doi.org/10.1371/journal.pone.0096059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788719	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700054
J	Aunkham, A; Schulte, A; Winterhalter, M; Suginta, W				Aunkham, Anuwat; Schulte, Albert; Winterhalter, Mathias; Suginta, Wipa			Porin Involvement in Cephalosporin and Carbapenem Resistance of Burkholderia pseudomallei	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; ANTIBIOTIC SUSCEPTIBILITY; PULMONARY MELIOIDOSIS; PROVIDENCIA-STUARTII; BROTH MICRODILUTION; NORTHEAST THAILAND; AGAR DILUTION; EFFLUX PUMP; DIFFUSION	Background: Burkholderia pseudomallei (Bps) is a Gram-negative bacterium that causes frequently lethal melioidosis, with a particularly high prevalence in the north and northeast of Thailand. Bps is highly resistant to many antimicrobial agents and this resistance may result from the low drug permeability of outer membrane proteins, known as porins. Principal Findings: Microbiological assays showed that the clinical Bps strain was resistant to most antimicrobial agents and sensitive only to ceftazidime and meropenem. An E. coli strain defective in most porins, but expressing BpsOmp38, exhibited considerably lower antimicrobial susceptibility than the control strain. In addition, mutation of Tyr119, the most prominent pore-lining residue in BpsOmp38, markedly altered membrane permeability, substitution with Ala (mutant BpsOmp38Y119A) enhanced uptake of the antimicrobial agents, while substitution with Phe (mutant BpsOmp38Y119F) inhibited uptake. Channel recordings of BpsOmp38 reconstituted in a planar black lipid membrane (BLM) suggested that the higher permeability of BpsOmp38Y119A was caused by widening of the pore interior through removal of the bulky side chain. In contrast, the lower permeability of BpsOmp38Y119F was caused by introduction of the hydrophobic side chain (Phe), increasing the 'greasiness' of the pore lumen. Significantly, liposome swelling assays showed no permeation through the BpsOmp38 channel by antimicrobial agents to which Bps is resistant (cefoxitin, cefepime, and doripenem). In contrast, high permeability to ceftazidime and meropenem was observed, these being agents to which Bps is sensitive. Conclusion/Significance: Our results, from both in vivo and in vitro studies, demonstrate that membrane permeability associated with BpsOmp38 expression correlates well with the antimicrobial susceptibility of the virulent bacterium B. pseudomallei, especially to carbapenems and cephalosporins. In addition, substitution of the residue Tyr119 affects the permeability of the BpsOmp38 channel to neutral sugars and antimicrobial agents.	[Aunkham, Anuwat; Schulte, Albert; Suginta, Wipa] Suranaree Univ Technol, Biochem Electrochem Res Unit, Sch Chem, Nakhon Ratchasima, Thailand; [Aunkham, Anuwat; Schulte, Albert; Suginta, Wipa] Suranaree Univ Technol, Sch Biochem, Inst Sci, Nakhon Ratchasima, Thailand; [Winterhalter, Mathias] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany	Suranaree University of Technology; Suranaree University of Technology; Jacobs University	Suginta, W (corresponding author), Suranaree Univ Technol, Biochem Electrochem Res Unit, Sch Chem, Nakhon Ratchasima, Thailand.	wipa@sut.ac.th		Winterhalter, Mathias/0000-0002-1604-3318	Thailand Research Fund [RMU5380055]; Suranaree University of Technology [SUT1-102-55-24-12]; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD53K0022]	Thailand Research Fund(Thailand Research Fund (TRF)); Suranaree University of Technology; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	This work was financially supported by the Thailand Research Fund (contract no. RMU5380055) and Suranaree University of Technology (Grant no: SUT1-102-55-24-12). AA received a Ph.D. scholarship under the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant no PHD53K0022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous P, 2005, NATURE, V434, P692, DOI 10.1038/434692a; Amsler K, 2010, J CLIN MICROBIOL, V48, P3353, DOI 10.1128/JCM.00494-10; Bajaj H, 2012, BIOCHEMISTRY-US, V51, P10244, DOI 10.1021/bi301398j; *CDCP, 2010, BIOT AG DIS; Centers for Disease Control and Prevention, 2012, NAT CTR ZOON VECT BO; Cheng AC, 2004, ANTIMICROB AGENTS CH, V48, P1763, DOI 10.1128/AAC.48.5.1763-1765.2004; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chetchotisakd Ploenchan, 2001, American Journal of Tropical Medicine and Hygiene, V64, P24; *CLIN LAB STAND I, 2006, M7A7 CLIN LAB STAND, V26; Danelon C, 2006, BIOPHYS J, V90, P1617, DOI 10.1529/biophysj.105.075192; EVERETT ED, 1975, AM REV RESPIR DIS, V112, P331; Harris P, 2011, INT J ANTIMICROB AG, V37, P547, DOI 10.1016/j.ijantimicag.2011.02.001; IP M, 1995, CHEST, V108, P1420, DOI 10.1378/chest.108.5.1420; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; KANAPHUN P, 1993, J INFECT DIS, V167, P230, DOI 10.1093/infdis/167.1.230; Kern WV, 2006, J ANTIMICROB CHEMOTH, V57, P339, DOI 10.1093/jac/dki445; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Luber P, 2003, J CLIN MICROBIOL, V41, P1062, DOI 10.1128/JCM.41.3.1062-1068.2003; LUCKEY M, 1980, BIOCHEM BIOPH RES CO, V93, P166, DOI 10.1016/S0006-291X(80)80261-0; LUGTENBERG B, 1983, BIOCHIM BIOPHYS ACTA, V737, P51, DOI 10.1016/0304-4157(83)90014-X; MARLEY EF, 1995, J CLIN MICROBIOL, V33, P3191, DOI 10.1128/JCM.33.12.3191-3193.1995; Mima T, 2010, ANTIMICROB AGENTS CH, V54, P3113, DOI 10.1128/AAC.01803-09; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Peacock SJ, 2006, CURR OPIN INFECT DIS, V19, P421, DOI 10.1097/01.qco.0000244046.31135.b3; Prilipov A, 1998, J BACTERIOL, V180, P3388, DOI 10.1128/JB.180.13.3388-3392.1998; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Schulte A, 2009, J MEMBRANE BIOL, V230, P101, DOI 10.1007/s00232-009-9194-0; Shih HI, 2009, INFECTION, V37, P9, DOI 10.1007/s15010-008-7324-8; Simpson AJH, 1999, CLIN INFECT DIS, V29, P381, DOI 10.1086/520219; Siritapetawee J, 2004, BIOCHEM J, V384, P609, DOI 10.1042/BJ20041102; Siritapetawee J, 2004, BIOCHEM J, V377, P579, DOI 10.1042/BJ20031118; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Suginta W, 2011, BBA-BIOMEMBRANES, V1808, P1552, DOI 10.1016/j.bbamem.2010.10.018; SUPUTTAMONGKOL Y, 1994, CLIN INFECT DIS, V19, P846, DOI 10.1093/clinids/19.5.846; Thamlikitkul V, 2010, INT J ANTIMICROB AG, V35, P514, DOI 10.1016/j.ijantimicag.2010.01.002; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Tran QT, 2010, J BIOL CHEM, V285, P32273, DOI 10.1074/jbc.M110.143305; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; WOODS JB, 2005, BIOL WEAPONS DEFENSE, P285; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445; YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84	42	16	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95918	10.1371/journal.pone.0095918	http://dx.doi.org/10.1371/journal.pone.0095918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788109	Green Submitted, Green Published, gold			2022-12-25	WOS:000335510600054
J	Dalpadado, P; Arrigo, KR; Hjollo, SS; Rey, F; Ingvaldsen, RB; Sperfeld, E; van Dijken, GL; Stige, LC; Olsen, A; Ottersen, G				Dalpadado, Padmini; Arrigo, Kevin R.; Hjollo, Solfrid S.; Rey, Francisco; Ingvaldsen, Randi B.; Sperfeld, Erik; van Dijken, Gert L.; Stige, Leif C.; Olsen, Are; Ottersen, Geir			Productivity in the Barents Sea - Response to Recent Climate Variability	PLOS ONE			English	Article							MARGINAL ICE-ZONE; CALANUS-FINMARCHICUS; PHYTOPLANKTON BLOOMS; NORWEGIAN SEA; DYNAMICS; FISH; FLUCTUATIONS; RETENTION; AMPHIPODS; IMPACT	The temporal and spatial dynamics of primary and secondary biomass/production in the Barents Sea since the late 1990s are examined using remote sensing data, observations and a coupled physical-biological model. Field observations of mesozooplankton biomass, and chlorophyll a data from transects (different seasons) and large-scale surveys (autumn) were used for validation of the remote sensing products and modeling results. The validation showed that satellite data are well suited to study temporal and spatial dynamics of chlorophyll a in the Barents Sea and that the model is an essential tool for secondary production estimates. Temperature, open water area, chlorophyll a, and zooplankton biomass show large interannual variations in the Barents Sea. The climatic variability is strongest in the northern and eastern parts. The moderate increase in net primary production evident in this study is likely an ecosystem response to changes in climate during the same period. Increased open water area and duration of open water season, which are related to elevated temperatures, appear to be the key drivers of the changes in annual net primary production that has occurred in the northern and eastern areas of this ecosystem. The temporal and spatial variability in zooplankton biomass appears to be controlled largely by predation pressure. In the southeastern Barents Sea, statistically significant linkages were observed between chlorophyll a and zooplankton biomass, as well as between net primary production and fish biomass, indicating bottom-up trophic interactions in this region.	[Dalpadado, Padmini; Hjollo, Solfrid S.; Ingvaldsen, Randi B.; Sperfeld, Erik] Inst Marine Res, N-5024 Bergen, Norway; [Arrigo, Kevin R.; van Dijken, Gert L.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Rey, Francisco; Ottersen, Geir] Inst Marine Res, Oslo, Norway; [Stige, Leif C.; Ottersen, Geir] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Olsen, Are] Univ Bergen, Inst Geophys, Bergen, Norway; [Olsen, Are] Bjerknes Ctr Climate Res, Bergen, Norway; [Olsen, Are] Uni Res AS, Uni Climate, Bergen, Norway	Institute of Marine Research - Norway; Stanford University; Institute of Marine Research - Norway; University of Oslo; University of Bergen; Bjerknes Centre for Climate Research; University of Bergen	Dalpadado, P (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	padmini.dalpadado@imr.no	Olsen, Are/A-1511-2011; Ottersen, Geir/AAS-3046-2020; Ottersen, Geir/M-9676-2019; Stige, Leif Christian/P-6806-2015	Olsen, Are/0000-0003-1696-9142; Ottersen, Geir/0000-0002-9453-6679; Stige, Leif Christian/0000-0002-6808-1383; Van Dijken, Gert/0000-0002-9587-6317; Sperfeld, Erik/0000-0002-3229-407X; Hjollo, Solfrid Saetre/0000-0003-2897-474X; Arrigo, Kevin/0000-0002-7364-876X	Institute of Marine Research (IMR), Bergen, Norway ("Barents Sea Ecosystem" research program); Norwegian Research Council through ADMAR [200497/130]; Centre of Climate Dynamics (SKD) at the Bjerknes Centre, Norway; NASA [NNX10AF42G]	Institute of Marine Research (IMR), Bergen, Norway ("Barents Sea Ecosystem" research program); Norwegian Research Council through ADMAR; Centre of Climate Dynamics (SKD) at the Bjerknes Centre, Norway; NASA(National Aeronautics & Space Administration (NASA))	The work resulting in this article was financed by the Institute of Marine Research (IMR), Bergen, Norway ("Barents Sea Ecosystem" research program), and by the Norwegian Research Council through ADMAR (Adaptive management of living marine resources by integrating different data sources and key ecological processes), grant 200497/130. ADMAR is a collaborative project between the IMR, Bergen, and CEES, University of Oslo. Are Olsen and Solfrid Saetre Hjollo acknowledge support from the Centre of Climate Dynamics (SKD) at the Bjerknes Centre, Norway. The participation by Kevin Arrigo and Gert van Dijken in this project was supported by NASA (award #NNX10AF42G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLANDSVIK B, 1991, POLAR RES, V10, P45, DOI 10.1111/j.1751-8369.1991.tb00633.x; Aminot A, 2000, TECH MAR ENV SCI, V28; [Anonymous], 2010, IMR PINRO JOINT REPO, V4/2010; Arrigo KR, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007151; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Arthun M, 2012, J CLIMATE, V25, P4736, DOI 10.1175/JCLI-D-11-00466.1; Berge J, 2012, BIOL LETTERS, V8, P1012, DOI 10.1098/rsbl.2012.0517; Boitsov VD, 2012, ICES J MAR SCI, V69, P833, DOI 10.1093/icesjms/fss075; Carlotti F, 1996, LIMNOL OCEANOGR, V41, P522, DOI 10.4319/lo.1996.41.3.0522; Dalpadado P, 1996, MAR ECOL PROG SER, V144, P175, DOI 10.3354/meps144175; Dalpadado P, 2013, COMP ANAL FEEDING EC, DOI [10.1016/j.pocean.2013.05.007, DOI 10.1016/J.POCEAN.2013.05.007]; Dalpadado P, 2012, ICES J MAR SCI, V69, P1303, DOI 10.1093/icesjms/fss063; Dalpadado P, 2008, DEEP-SEA RES PT II, V55, P2266, DOI 10.1016/j.dsr2.2008.05.016; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; De Laender F, 2010, MAR ECOL PROG SER, V398, P93, DOI 10.3354/meps08335; Dickson RR, 2000, J CLIMATE, V13, P2671, DOI 10.1175/1520-0442(2000)013<2671:TAORTT>2.0.CO;2; Dolgov A.V., 2011, BARENTS SEA ECOSYSTE, P438; Dommasnes A., 2001, FISH CENT RES REP, V9, p213?240; Drinkwater KF, 2011, PROG OCEANOGR, V90, P47, DOI 10.1016/j.pocean.2011.02.006; Edvardsen A, 2003, FISH OCEANOGR, V12, P61, DOI 10.1046/j.1365-2419.2003.00219.x; Eiane K, 2009, ECOSYSTEM BARENTS SE; Engel A, 2013, BIOGEOSCIENCES, V10, P1291, DOI 10.5194/bg-10-1291-2013; Eriksen E, 2011, POLAR BIOL, V34, P647, DOI 10.1007/s00300-010-0920-y; Falk-Petersen S, 2000, J MARINE SYST, V27, P131, DOI 10.1016/S0924-7963(00)00064-6; Frank KT, 2013, FISH OCEANOGR, V22, P143, DOI 10.1111/fog.12007; Frey KE, 2011, ARCTIC OCEAN PRIMARY; Friedland KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028945; Gjosaeter H, 2002, ICES J MAR SCI, V59, P959, DOI 10.1006/jmsc.2002.1240; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; Greene CH, 2013, FISH OCEANOGR, V22, P140, DOI 10.1111/fog.12006; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; HARRISON WG, 1991, POLAR RES, V10, P87, DOI 10.1111/j.1751-8369.1991.tb00637.x; Hatun H, 2005, SCIENCE, V309, P1841, DOI 10.1126/science.1114777; Hjollo SS, 2012, MAR BIOL RES, V8, P508, DOI 10.1080/17451000.2011.642805; Holliday NP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032675; Hunt GL, 2013, J MARINE SYST, V109, P43, DOI 10.1016/j.jmarsys.2012.08.003; Huse G., 2005, GLOBEC INT NEWSLETTE, V11, P19; ICES, 2012, 2012ACOM15 ICES CM; ICES, 2011, 2011ACOM05 ICES CM; ICES, 2008, ICES, P10; Ingvaldsen R., 2003, ICES MAR SCI S, V219, P160; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Kahru M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006500; Kiorboe T, 2013, LIMNOL OCEANOGR, V58, P1843, DOI 10.4319/lo.2013.58.5.1843; Kirby RR, 2009, ECOSYSTEMS, V12, P548, DOI 10.1007/s10021-009-9241-9; Lind S, 2012, DEEP-SEA RES PT I, V62, P70, DOI 10.1016/j.dsr.2011.12.007; Loeng H, 2007, DEEP-SEA RES PT II, V54, P2478, DOI 10.1016/j.dsr2.2007.08.013; Moline MA, 2008, ANN NY ACAD SCI, V1134, P267, DOI 10.1196/annals.1439.010; Mueter FJ, 2009, PROG OCEANOGR, V81, P93, DOI 10.1016/j.pocean.2009.04.018; NIXON S W, 1986, Journal of the Limnological Society of Southern Africa, V12, P43; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Orlova E.L., 2011, BARENTS SEA ECOSYSTE, P91; Petrie B, 2009, FISH OCEANOGR, V18, P83, DOI 10.1111/j.1365-2419.2009.00500.x; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Quenouille M. H., 1952, ASS MEASUREMENTS; Rey F, 2012, ICES J MAR SCI, V69, P208, DOI 10.1093/icesjms/fss007; Sakshaug Egil, 2009, P167; Schulz KG, 2013, BIOGEOSCIENCES, V10, P161, DOI 10.5194/bg-10-161-2013; Skagseth O., 2008, ARCTIC SUBARCTIC OCE, P45, DOI DOI 10.1007/978-1-4020-6774-7_3; Skardhamar J, 2011, AQUAT BIOL, V12, P129, DOI 10.3354/ab00321; Skjoldal H.R., 1989, AAAS (American Association for the Advancement of Science) Selected Symposium, V111, P241; Skjoldal Hein Rune, 2004, P447; Steinacher M, 2010, BIOGEOSCIENCES, V7, P979, DOI 10.5194/bg-7-979-2010; Stige LC, 2014, PROG OCEANOGR, V120, P243, DOI 10.1016/j.pocean.2013.09.006; Strass VH, 1996, POLAR BIOL, V16, P409; Tereschenko VV, 1996, 1996C11 ICES CM; Thingstad F, 2008, ECOSYSTEM BARENTS SE, P235; Torgersen T, 2005, ICES J MAR SCI, V62, P1301, DOI 10.1016/j.icesjms.2005.05.016; Utne KR, 2012, MAR BIOL RES, V8, P527, DOI 10.1080/17451000.2011.642804; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wassmann P, 2006, J MARINE SYST, V59, P1, DOI 10.1016/j.jmarsys.2005.05.006	72	90	91	3	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95273	10.1371/journal.pone.0095273	http://dx.doi.org/10.1371/journal.pone.0095273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788513	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600031
J	Deng, N; Weaver, JM; Mosmann, TR				Deng, Nan; Weaver, Jason M.; Mosmann, Tim R.			Cytokine Diversity in the Th1-Dominated Human Anti-Influenza Response Caused by Variable Cytokine Expression by Th1 Cells, and a Minor Population of Uncommitted IL-2+IFN gamma-Thpp Cells	PLOS ONE			English	Article							CD4(+) T-CELLS; INFLUENZA-VIRUS INFECTION; CXC CHEMOKINE RECEPTOR-5; GAMMA-SECRETING CELLS; MEMORY STEM-CELLS; MONOALLELIC EXPRESSION; B-CELLS; EFFECTOR; GENE; IL-4	Within overall Th1-like human memory T cell responses, individual T cells may express only some of the characteristic Th1 cytokines when reactivated. In the Th1-oriented memory response to influenza, we have tested the contributions of two potential mechanisms for this diversity: variable expression of cytokines by a uniform population during activation, or different stable subsets that consistently expressed subsets of the Th1 cytokine pattern. To test for short-term variability, in vitro-stimulated influenza-specific human memory CD4+ T cells were sorted according to IL-2 and IFN gamma expression, cultured briefly in vitro, and cytokine patterns measured after restimulation. Cells that were initially IFN gamma+ and either IL-2+ or IL-2- converged rapidly, containing similar proportions of IL-2-IFN gamma+ and IL-2+IFN gamma+ cells after culture and restimulation. Both phenotypes expressed Tbet, and similar patterns of mRNA. Thus variability of IL-2 expression in IFN gamma+ cells appeared to be regulated more by short-term variability than by stable differentiated subsets. In contrast, heterogeneous expression of IFN gamma in IL-2+ influenza-specific T cells appeared to be due partly to stable T cell subsets. After sorting, culture and restimulation, influenza-specific IL-2+IFN gamma- and IL-2+IFN gamma+ cells maintained significantly biased ratios of IFN gamma+ and IFN gamma- cells. IL-2+IFN gamma-cells included both Tbet(lo) and Tbet(hi) cells, and showed more mRNA expression differences with either of the IFN gamma+ populations. To test whether IL-2+IFN gamma-Tbet(lo) cells were Thpp cells (primed but uncommitted memory cells, predominant in responses to protein vaccines), influenza-specific IL-2+IFN gamma- and IL-2+IFN gamma+ T cells were sorted and cultured in Th1- or Th2-generating conditions. Both cell types yielded IFN gamma-secreting cells in Th1 conditions, but only IL-2+IFN gamma- cells were able to differentiate into IL-4-producing cells. Thus expression of IL-2 in the anti-influenza response may be regulated mainly by short term variability, whereas different T cell subsets, Th1 and Thpp, may contribute to variability in IFN gamma expression.	[Deng, Nan; Weaver, Jason M.; Mosmann, Tim R.] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA	University of Rochester	Mosmann, TR (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA.	Tim_Mosmann@urmc.rochester.edu			Rochester Human Immunology Center from the National Institute for Allergy and Infectious Diseases; New York Influenza Center of Excellence from the National Institute for Allergy and Infectious Diseases [HHSN266200700008C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI054953] Funding Source: NIH RePORTER	Rochester Human Immunology Center from the National Institute for Allergy and Infectious Diseases; New York Influenza Center of Excellence from the National Institute for Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Rochester Human Immunology Center (R24AI054953) from the National Institute for Allergy and Infectious Diseases and New York Influenza Center of Excellence (HHSN266200700008C) from the National Institute for Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; ALLAN W, 1990, J IMMUNOL, V144, P3980; Bakocevic N, 2010, J IMMUNOL, V184, P1317, DOI 10.4049/jimmunol.0902277; Bayley JP, 2003, J IMMUNOL, V171, P2349, DOI 10.4049/jimmunol.171.5.2349; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; BUCY RP, 1994, J EXP MED, V180, P1251, DOI 10.1084/jem.180.4.1251; Caserta S, 2010, J IMMUNOL, V185, P6545, DOI 10.4049/jimmunol.1001867; CROFT M, 1991, J IMMUNOL, V146, P4055; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Herve MGD, 2010, J IMMUNOL, V185, P1028, DOI 10.4049/jimmunol.0904209; Derrick SC, 2011, VACCINE; DiethelmOkita BM, 1997, J INFECT DIS, V175, P382, DOI 10.1093/infdis/175.2.382; Divekar AA, 2006, J IMMUNOL, V176, P1465, DOI 10.4049/jimmunol.176.3.1465; Fearon DT, 2006, IMMUNOL REV, V211, P104, DOI 10.1111/j.0105-2896.2006.00390.x; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gazagne A, 2003, J IMMUNOL METHODS, V283, P91, DOI 10.1016/j.jim.2003.08.013; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Han S, 2010, P NATL ACAD SCI USA, V107, P20453, DOI 10.1073/pnas.1008437107; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Hua LQ, 2013, J VIROL, V87, P11884, DOI 10.1128/JVI.01461-13; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; Jeong YH, 2014, INFECT IMMUN, V82, P132, DOI 10.1128/IAI.00480-13; JUNG T, 1995, EUR J IMMUNOL, V25, P2413, DOI 10.1002/eji.1830250843; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Kruman II, 1996, CELL IMMUNOL, V173, P236, DOI 10.1006/cimm.1996.0273; Lugli E, 2013, NAT PROTOC, V8, P33, DOI 10.1038/nprot.2012.143; Mariani L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.13; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Matesanz F, 2000, EUR J IMMUNOL, V30, P3516, DOI 10.1002/1521-4141(2000012)30:12<3516::AID-IMMU3516>3.0.CO;2-S; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mosmann TR, 2009, IMMUNOL RES; Mozdzanowska K, 2000, J IMMUNOL, V164, P2635, DOI 10.4049/jimmunol.164.5.2635; Nakayama K, 2012, AIDS RES HUM RETROV, V28, P702, DOI [10.1089/aid.2011.0073, 10.1089/AID.2011.0073]; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Paixao T, 2007, IMMUNOL CELL BIOL, V85, P315, DOI 10.1038/sj.icb.7100057; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Rebhahn JA, 2008, COMPUT METH PROG BIO, V92, P54, DOI 10.1016/j.cmpb.2008.06.002; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; SAD S, 1994, J IMMUNOL, V153, P3514; Sakai H, 2012, INT IMMUNOL, V24, P5, DOI 10.1093/intimm/dxr088; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; Thaventhiran JED, 2013, CURR OPIN IMMUNOL, V25, P321, DOI 10.1016/j.coi.2013.05.010; Topham DJ, 1998, J VIROL, V72, P882, DOI 10.1128/JVI.72.1.882-885.1998; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; Veldhoen M, 2006, J IMMUNOL, V176, P6202, DOI 10.4049/jimmunol.176.10.6202; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Weaver JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057275; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Zaph C, 2006, J IMMUNOL, V177, P511, DOI 10.4049/jimmunol.177.1.511; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326	67	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95986	10.1371/journal.pone.0095986	http://dx.doi.org/10.1371/journal.pone.0095986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788814	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600060
J	Kumar, A; Fan, D; DiPette, DJ; Singh, US				Kumar, Ambrish; Fan, Daping; DiPette, Donald J.; Singh, Ugra S.			Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells	PLOS ONE			English	Article							HUMAN NEURO-BLASTOMA; ALCOHOL SPECTRUM DISORDERS; SPARGANIUM-STOLONIFERUM; CANCER-CELLS; OXIDATIVE STRESS; RODENT MODEL; EXPRESSION; DIFFERENTIATION; AMPLIFICATION; THERAPY	Neuroblastoma is one of the most common solid tumors and accounts for -15% of all the cancer related deaths in the children. Despite the standard therapy for advanced disease including chemotherapy, surgery, and radiation, the mortality rate remains high for these patients. Hence, novel therapeutic agents are desperately needed. Here we examined the anticancer activity of a novel plant-derived compound, sparstolonin B (SsnB; 8,5'-dihydroxy-4-phenyl-5,2'-oxidoisocoumarin) using neuroblastoma cell lines of different genetics. SsnB was recently isolated from an aquatic Chinese herb, Sparganium stoloniferum, and tubers of this herb have been used in traditional Chinese medicine for the treatment of several inflammatory diseases and cancers. Our cell viability and morphological analysis indicated that SsnB at 10 mu M concentration significantly inhibited the growth of both N-myc amplified (SK-N-BE(2), NGP, and IMR-32 cells) and N-myc nonamplified (SH-SY5Y and SKNF-1 cells) neuroblastoma cells. The flow cytometric analyses suggested that SsnB arrests the cell cycle progression at G2-M phase in all neuroblastoma cell lines tested. Exposure of SsnB inhibited the compact spheroid formation and reduced the tumorigenicity of SH-SY5Y cells and SK-N-BE(2) cells in in vitro 3-D cell culture assays (anchorage-independent colony formation assay and hanging drop assay). SsnB lowers the cellular level of glutathione (GSH), increases generation of reactive oxygen species and activates the cleavage of caspase-3 whereas co-incubation of a GSH precursor, N-acetylcysteine, along with SsnB attenuates the inhibitory effects of SsnB and increases the neuroblastoma cell viability. Our results for the first time demonstrate that SsnB possesses anticancer activity indicating that SsnB-induced reactive oxygen species generation promotes apoptotic cell death in neuroblastoma cells of different genetic background. Thus these data suggest that SsnB can be a promising drug candidate in neuroblastoma therapy.	[Kumar, Ambrish; Singh, Ugra S.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Fan, Daping] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC USA; [DiPette, Donald J.] Univ S Carolina, Sch Med, Dept Internal Med, Columbia, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Singh, US (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Ugra.Singh@uscmed.sc.edu	Kumar, Ambrish/B-7347-2014	Kumar, Ambrish/0000-0002-7576-561X	National Institutes of Health [R21AA016121, R21AT006767, R01HL116626]; Health Sciences Distinguished Professorship; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R21AT006767] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA016121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Sciences Distinguished Professorship; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by National Institutes of Health Grants R21AA016121 to USS, R21AT006767 and R01HL116626 to DF, and Health Sciences Distinguished Professorship financial support to DJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZAR CG, 1990, CELL GROWTH DIFFER, V1, P421; Bateman HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070500; Bell E, 2010, CANCER LETT, V293, P144, DOI 10.1016/j.canlet.2010.01.015; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; CICCARONE V, 1989, CANCER RES, V49, P219; Davidoff AM, 2012, SEMIN PEDIATR SURG, V21, P2, DOI 10.1053/j.sempedsurg.2011.10.009; Du JA, 2006, J BIOL CHEM, V281, P37416, DOI 10.1074/jbc.M605063200; GILBERT F, 1982, CANCER GENET CYTOGEN, V7, P33, DOI 10.1016/0165-4608(82)90105-4; GILBERT F, 1984, CANCER RES, V44, P5444; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Hofstra RMW, 1996, HUM GENET, V97, P362, DOI 10.1007/BF02185773; IMAMURA J, 1993, CANCER RES, V53, P4053; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Joshi S, 2007, BBA-MOL BASIS DIS, V1772, P1093, DOI 10.1016/j.bbadis.2007.05.009; Kamijo T, 2012, INT J CLIN ONCOL, V17, P190, DOI 10.1007/s10147-012-0415-7; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kawamata N, 1996, CANCER, V77, P570; Kubetzko FBB, 2004, CARCINOGENESIS, V25, P1839, DOI 10.1093/carcin/bgh190; Kumar A, 2011, MOL PHARMACOL, V80, P446, DOI 10.1124/mol.111.071126; Kumar A, 2010, ALCOHOL CLIN EXP RES, V34, P928, DOI 10.1111/j.1530-0277.2010.01166.x; Lee SY, 2010, ARCH PHARM RES, V33, P515, DOI 10.1007/s12272-010-0404-1; Li SX, 2010, J ASIAN NAT PROD RES, V12, P331, DOI 10.1080/10286021003730330; Liang QL, 2013, ARCH PHARM RES, V36, P890, DOI 10.1007/s12272-013-0120-8; Liang QL, 2011, J BIOL CHEM, V286, P26470, DOI 10.1074/jbc.M111.227934; Lin CN, 1996, J PHARM PHARMACOL, V48, P539, DOI 10.1111/j.2042-7158.1996.tb05970.x; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matthay KK, 2012, CLIN CANCER RES, V18, P2740, DOI 10.1158/1078-0432.CCR-11-1939; Morgenstern DA, 2013, J PEDIAT HEMATOL ONC, V35, P337, DOI 10.1097/MPH.0b013e318299d637; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Na Y, 2009, J PHARM PHARMACOL, V61, P707, DOI [10.1211/jpp/61.06.0002, 10.1211/jpp.61.06.0002]; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Riveiro ME, 2010, CURR MED CHEM, V17, P1325, DOI 10.2174/092986710790936284; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SCHWAB M, 1984, P NATL ACAD SCI-BIOL, V81, P4940, DOI 10.1073/pnas.81.15.4940; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Singh US, 2003, J BIOL CHEM, V278, P391, DOI 10.1074/jbc.M206361200; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; SRIVATSAN ES, 1991, PROG CLIN BIOL RES, V366, P91; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Tonini GP, 2012, CANCER LETT, V326, P128, DOI 10.1016/j.canlet.2012.08.017; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wu L, 2009, CURR MED CHEM, V16, P4236, DOI 10.2174/092986709789578187; Xiong Y, 2009, ARCH PHARM RES, V32, P717, DOI 10.1007/s12272-009-1510-9; Yin L, 2001, MOL CANCER THER, V1, P43; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhang HL, 2012, FASEB J, V26, P1442, DOI 10.1096/fj.11-199869	51	21	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96343	10.1371/journal.pone.0096343	http://dx.doi.org/10.1371/journal.pone.0096343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788776	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600095
J	Kuwahara, K; Imai, T; Nishihara, A; Nakagawa, T; Yamamoto, S; Honda, T; Miyamoto, T; Kochi, T; Eguchi, M; Uehara, A; Kuroda, R; Omoto, D; Kurotani, K; Pham, NM; Nanri, A; Kabe, I; Mizoue, T; Kunugita, N; Dohi, S				Kuwahara, Keisuke; Imai, Teppei; Nishihara, Akiko; Nakagawa, Tohru; Yamamoto, Shuichiro; Honda, Toru; Miyamoto, Toshiaki; Kochi, Takeshi; Eguchi, Masafumi; Uehara, Akihiko; Kuroda, Reiko; Omoto, Daisuke; Kurotani, Kayo; Ngoc Minh Pham; Nanri, Akiko; Kabe, Isamu; Mizoue, Tetsuya; Kunugita, Naoki; Dohi, Seitaro		Japan Epidemiology Collaboration	Overtime Work and Prevalence of Diabetes in Japanese Employees: Japan Epidemiology Collaboration on Occupational Health Study	PLOS ONE			English	Article							RISK; MELLITUS; DISEASE; GLUCOSE; SLEEP	Objective: Epidemiologic evidence on long working hour and diabetes has been conflicting. We examined the association between overtime work and prevalence of diabetes among Japanese workers. Methods: The subjects were 40,861 employees (35,170 men and 5,691 women), aged 16 to 83 years, of 4 companies in Japan. Hours of overtime were assessed using self-reported questionnaires. Diabetes was defined as a fasting plasma glucose >= 126 mg/dl (7.0 mmol/l), hemoglobin A1c >= 6.5% (48 mmol/mol), or current use of anti-diabetic drug. Multiple logistic regression analysis was used to calculate odds ratio of diabetes for each category of overtime. Results: After adjustment for age, sex, company, smoking, and BMI, there was a suggestion of U-shaped relationship between overtime work and prevalence of diabetes (P for quadratic trend = 0.07). Compared with those who worked,45 hours of overtime per month, the adjusted odds ratios (95% confidence interval) of diabetes were 0.86 (0.77-0.94), 0.69 (0.53-0.89), and 1.03 (0.72-1.46) for those who worked 45-79, 80-99, and >= 100 hours of overtime per month, respectively. In one company (n = 33,807), where other potential confounders including shift work, job position, type of department, alcohol consumption, sleep duration, leisure time physical activity, and family history of diabetes was additionally adjusted for, similar result was obtained (P for quadratic trend = 0.05). Conclusions: Long hours of overtime work may not be associated with increased prevalence of diabetes among Japanese workers.	[Kuwahara, Keisuke; Kurotani, Kayo; Nanri, Akiko; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Imai, Teppei; Nishihara, Akiko] Azbil Corp, Tokyo, Japan; [Nakagawa, Tohru; Yamamoto, Shuichiro; Honda, Toru] Hitachi Ltd, Ibaraki, Japan; [Miyamoto, Toshiaki] Nippon Steel & Sumitomo Met Corp Kimitsu Works, Chiba, Japan; [Kochi, Takeshi; Eguchi, Masafumi] Furukawa Elect Corp, Tokyo, Japan; [Uehara, Akihiko] YAMAHA Corp, Shizuoka, Japan; [Kuroda, Reiko] Univ Tokyo, Tokyo, Japan; [Omoto, Daisuke] Mitsubishi Heavy Ind Co Ltd, Aichi, Japan; [Ngoc Minh Pham] Nguyen Univ Med & Pharm, Fac Publ Hlth, Dept Epidemiol, Hanoi, Thai Nguyen Pro, Vietnam; [Kunugita, Naoki] Natl Inst Publ Hlth, Saitama, Japan; [Dohi, Seitaro] Mitsui Chem Inc, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Hitachi Limited; Nippon Steel & Sumitomo Metal Corporation; Furukawa Electric; Yamaha; University of Tokyo; Mitsubishi Heavy Industries; Thai Nguyen University; National Institute of Public Health - Japan; Mitsui Chemicals	Kuwahara, K (corresponding author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan.	kuwahara@ri.ncgm.go.jp	Nishiura, Chihiro/Q-7938-2019	Nishiura, Chihiro/0000-0002-8850-5446; Kochi, Takeshi/0000-0002-3411-1070; Kunugita, Naoki/0000-0002-6516-8379; Kuwahara, Keisuke/0000-0002-7503-1333	Industrial Health Foundation; Occupational Health Promotion Foundation	Industrial Health Foundation; Occupational Health Promotion Foundation	This study was supported by the Industrial Health Foundation (to Japan Epidemiology Collaboration on Occupational Health Study working group) and the Occupational Health Promotion Foundation (to Dr Imai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Cosgrove MP, 2012, OCCUP MED-OXFORD, V62, P167, DOI 10.1093/occmed/kqs002; Hu G, 2007, APPL PHYSIOL NUTR ME, V32, P583, DOI 10.1139/H07-030; Itani O, 2013, J OCCUP HEALTH, V55, P11, DOI 10.1539/joh.12-0034-OA; Iwasaki K, 2006, IND HEALTH, V44, P537, DOI 10.2486/indhealth.44.537; Jiang Y, 2011, EUR J EPIDEMIOL, V26, P863, DOI 10.1007/s10654-011-9617-y; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI 10.1007/s13340-012-0069-8; Kawakami N, 1999, J EPIDEMIOL COMMUN H, V53, P359, DOI 10.1136/jech.53.6.359; Kroenke CH, 2007, AM J EPIDEMIOL, V165, P175, DOI 10.1093/aje/kwj355; Lee S, 2007, WORKING TIME WORLD T; Ministry of Education Culture Sports Science and Technology Ministry of Health Labour and Welfare of Japan, 2002, ETH GUID EP RES; Nagai M, 2010, CURR CARDIOL REV, V6, P54, DOI 10.2174/157340310790231635; Nakanishi N, 2001, OCCUP ENVIRON MED, V58, P569, DOI 10.1136/oem.58.9.569; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Spurgeon A, 1997, OCCUP ENVIRON MED, V54, P367, DOI 10.1136/oem.54.6.367; van der Hulst M, 2003, SCAND J WORK ENV HEA, V29, P171, DOI 10.5271/sjweh.720; Virtanen M, 2012, AM J EPIDEMIOL, V176, P586, DOI 10.1093/aje/kws139; Weber MB, 2012, ANNU REV NUTR, V32, P417, DOI 10.1146/annurev-nutr-071811-150630; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	23	16	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95732	10.1371/journal.pone.0095732	http://dx.doi.org/10.1371/journal.pone.0095732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787995	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600050
J	Rummukainen, O; Radun, J; Virtanen, T; Pulkki, V				Rummukainen, Olli; Radun, Jenni; Virtanen, Toni; Pulkki, Ville			Categorization of Natural Dynamic Audiovisual Scenes	PLOS ONE			English	Article							ATTENTIONAL SELECTION; PERCEPTION; SOUNDSCAPES; CONSTRUCTION; MEMORY; WORLD; URBAN; MODEL; GIST	This work analyzed the perceptual attributes of natural dynamic audiovisual scenes. We presented thirty participants with 19 natural scenes in a similarity categorization task, followed by a semi-structured interview. The scenes were reproduced with an immersive audiovisual display. Natural scene perception has been studied mainly with unimodal settings, which have identified motion as one of the most salient attributes related to visual scenes, and sound intensity along with pitch trajectories related to auditory scenes. However, controlled laboratory experiments with natural multimodal stimuli are still scarce. Our results show that humans pay attention to similar perceptual attributes in natural scenes, and a two-dimensional perceptual map of the stimulus scenes and perceptual attributes was obtained in this work. The exploratory results show the amount of movement, perceived noisiness, and eventfulness of the scene to be the most important perceptual attributes in naturalistically reproduced real-world urban environments. We found the scene gist properties openness and expansion to remain as important factors in scenes with no salient auditory or visual events. We propose that the study of scene perception should move forward to understand better the processes behind multimodal scene processing in real-world environments. We publish our stimulus scenes as spherical video recordings and sound field recordings in a publicly available database.	[Rummukainen, Olli; Pulkki, Ville] Aalto Univ, Dept Signal Proc & Acoust, Espoo, Finland; [Radun, Jenni; Virtanen, Toni] Univ Helsinki, Inst Behav Sci, Helsinki, Finland	Aalto University; University of Helsinki	Rummukainen, O (corresponding author), Aalto Univ, Dept Signal Proc & Acoust, Espoo, Finland.	olli.rummukainen@aalto.fi	Radun, Jenni/AAB-3943-2021; Pulkki, Ville/G-2394-2013; Virtanen, Toni I. O./E-9181-2015	Radun, Jenni/0000-0003-3269-2999; Pulkki, Ville/0000-0003-3460-9677; Virtanen, Toni I. O./0000-0001-5191-2438	European Research Council under the European Community/ERC [240453]; Academy of Finland	European Research Council under the European Community/ERC(European Research Council (ERC)); Academy of Finland(Academy of Finland)	The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement No. 240453 and from the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; ATLASti Scientific Software Development GmbH, 2011, ATL TI V 6; Axelsson O, 2010, J ACOUST SOC AM, V128, P2836, DOI 10.1121/1.3493436; Bonebright T, 2012, 18 INT C AUD DISPL I, P1; Botteldooren D, 2011, UNDERSTANDING URBAN, P1; Botteldooren D., 2012, J ACOUST SOC AM, V131, P3382, DOI [10.1121/1.4708755, DOI 10.1121/1.4708755]; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Bregman A.S., 1994, AUDITORY SCENE ANAL; Brockmole JR, 2005, J EXP PSYCHOL HUMAN, V31, P857, DOI 10.1037/0096-1523.31.5.857; Carmi R, 2006, VISION RES, V46, P4333, DOI 10.1016/j.visres.2006.08.019; Castelhano MS, 2008, J EXP PSYCHOL HUMAN, V34, P660, DOI 10.1037/0096-1523.34.3.660; Corbin J., 2015, BASICS QUALITATIVE R; Coutrot A, 2013, 14 INT WORKSH IM AUD; Coutrot A, 2012, J EYE MOVEMENT RES, V5; Davies WJ, 2013, APPL ACOUST, V74, P224, DOI 10.1016/j.apacoust.2012.05.010; de Leeuw J, 2008, J STAT SOFTW, V31, P1; Dubois D, 2006, ACTA ACUST UNITED AC, V92, P865; Fei-Fei L, 2007, J VISION, V7, DOI 10.1167/7.1.10; FRIEDMAN A, 1979, J EXP PSYCHOL GEN, V108, P316, DOI 10.1037/0096-3445.108.3.316; GAVER WW, 1993, ECOL PSYCHOL, V5, P1, DOI 10.1207/s15326969eco0501_1; GOLDSTONE R, 1994, J EXP PSYCHOL GEN, V123, P178, DOI 10.1037/0096-3445.123.2.178; GOLDSTONE RL, 1994, COGNITION, V52, P125, DOI 10.1016/0010-0277(94)90065-5; Gomez Bolanos J, 2012, AUD ENG SOC 132 CONV, P1; Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x; Hair J. F., 2006, MULTIVARIATE DATA AN; Harding S, 2007, LECT NOTES ARTIF INT, V4840, P399; International Telecommunication Union, 1998, ITU T REC P 911 SUBJ; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kayser C, 2005, CURR BIOL, V15, P1943, DOI 10.1016/j.cub.2005.09.040; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mather M, 2011, PERSPECT PSYCHOL SCI, V6, P114, DOI 10.1177/1745691611400234; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Nardo D, 2013, HUMAN BRAIN MAPPING, V35, P1; Oksanen J., 2016, R PACKAG; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; Peltonen V, 2001, AUD ENG SOC 110 CONV, P1; Pheasant R, 2008, J ACOUST SOC AM, V123, P1446, DOI 10.1121/1.2831735; Pheasant RJ, 2010, J ENVIRON PSYCHOL, V30, P501, DOI 10.1016/j.jenvp.2010.03.006; Politis A, 2011, AUD ENG SOC 131 CONV, P1; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; Pulkki V, 2007, J AUDIO ENG SOC, V55, P503; Quigley C, 2007, J EYE MOVEMENT RES, V1; R Core Team, 2018, R LANG ENV STAT COMP; RABINOWITZ GB, 1975, AM J POLIT SCI, V19, P343, DOI 10.2307/2110441; Rouder JN, 2006, CURR DIR PSYCHOL SCI, V15, P9, DOI 10.1111/j.0963-7214.2006.00397.x; Sanocki T, 2013, J EXP PSYCHOL HUMAN, V39, P381, DOI 10.1037/a0030718; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; Tardieu J, 2008, APPL ACOUST, V69, P1224, DOI 10.1016/j.apacoust.2007.10.001; TENK (Finnish National Advisory Board on Research Ethics), 2009, ETH PRINC RES HUM SO, P1; TVERSKY B, 1983, COGNITIVE PSYCHOL, V15, P121, DOI 10.1016/0010-0285(83)90006-3; Vilkamo J, 2009, J AUDIO ENG SOC, V57, P709; Vo MLH, 2012, J VISION, V12, DOI 10.1167/12.13.3; Yantis S., 1993, CURR DIR PSYCHOL SCI, V2, P156, DOI [DOI 10.1111/1467-8721.EP10768973, 10.1111/1467, DOI 10.1111/1467]	57	9	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95848	10.1371/journal.pone.0095848	http://dx.doi.org/10.1371/journal.pone.0095848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG6EE	24788808	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600053
J	Mai, ZX; Lei, M; Yu, BL; Du, HZ; Liu, JQ				Mai, Zixin; Lei, Ming; Yu, Bolan; Du, Hongzi; Liu, Jianqiao			The Effects of Cigarette Smoke Extract on Ovulation, Oocyte Morphology and Ovarian Gene Expression in Mice	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; POLAR BODY MORPHOLOGY; ZONA-PELLUCIDA THICKNESS; OXIDATIVE STRESS; ASSISTED REPRODUCTION; EMBRYO DEVELOPMENT; TOBACCO USE; CELL-DEATH; EXPOSURE; IVF	Cigarette smoking can harm fertility, but the existing research has targeted primarily on ovarian follicles, embryos or sex hormone. In this study, we tested cigarette smoke extract on ovulation, oocyte morphology and ovarian gene expression associated with inhibition of oxidative stress using C57BL/6 mice. Mice in the experimental group were administered a cigarette smoke extract (CSE) solution (2 mg/ml) orally daily, while the blank control group was given dimethylsulfoxide (DMSO). A positive control group (menadione) was used that received an intraperitoneal injection of 15 mg/kg menadione in oil solution daily. We found that the CSE group manifested a reduced diameter of zona pellucida-free oocyte (ZP-free OD) and a morphologically misshapen first polar body (PB). Our results suggest that CSE exposure is associated with a shrink size and poor quality of oocytes. Quitting smoking is a wise choice to ensure good fertility.	[Mai, Zixin; Lei, Ming; Yu, Bolan; Du, Hongzi; Liu, Jianqiao] Guangzhou Med Univ, Dept Reprod, Key Lab Reprod Med Guangdong Prov, Med Ctr,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Liu, JQ (corresponding author), Guangzhou Med Univ, Dept Reprod, Key Lab Reprod Med Guangdong Prov, Med Ctr,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	ljq88gz@163.com			Technological and Information Bureau of Guangzhou [2012Y2-00022]	Technological and Information Bureau of Guangzhou	The source of funding that has supported the authors' study is from a scientific research project, "the study of the key technology of increasing the pregnancy rate and security of IVF-ET", of the Technological and Information Bureau of Guangzhou. The grant number is 2012Y2-00022. The URL of the funder's website is http://www.gzsi.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augood C, 1998, HUM REPROD, V13, P1532, DOI 10.1093/humrep/13.6.1532; Balaban B, 2006, REPROD BIOMED ONLINE, V12, P608, DOI 10.1016/S1472-6483(10)61187-X; Bermejo-Alvarez P, 2012, HUM REPROD, V27, P3513, DOI 10.1093/humrep/des327; Bolumar F, 1996, AM J EPIDEMIOL, V143, P578; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Cooper AR, 2008, SEMIN REPROD MED, V26, P204, DOI 10.1055/s-2008-1042959; COOPER GS, 1995, OBSTET GYNECOL, V85, P407, DOI 10.1016/0029-7844(94)00381-M; de Mouzon J, 2005, J GYNECOL OBST BIO R, V34, p3S112; Dechanet C, 2011, HUM REPROD UPDATE, V17, P76, DOI 10.1093/humupd/dmq033; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Ebner T, 2000, HUM REPROD, V15, P427, DOI 10.1093/humrep/15.2.427; Ebner T, 1999, FERTIL STERIL, V72, P599, DOI 10.1016/S0015-0282(99)00315-5; Ebner T, 2002, HUM REPROD, V17, P2415, DOI 10.1093/humrep/17.9.2415; El-Nemr A, 1998, HUM REPROD, V13, P2192, DOI 10.1093/humrep/13.8.2192; ELENBOGEN A, 1991, HUM REPROD, V6, P242, DOI 10.1093/oxfordjournals.humrep.a137314; Europe WHOROf, 2007, EUR TOB CONTR REP 20; Feugang JM, 2004, THERIOGENOLOGY, V61, P71, DOI 10.1016/S0093-691X(03)00191-2; Fraga CG, 1996, MUTAT RES-FUND MOL M, V351, P199, DOI 10.1016/0027-5107(95)00251-0; FREI B, 1991, BIOCHEM J, V277, P133, DOI 10.1042/bj2770133; Freour T, 2008, REPROD BIOMED ONLINE, V16, P96, DOI 10.1016/S1472-6483(10)60561-5; Fuentes A, 2010, FERTIL STERIL, V93, P89, DOI 10.1016/j.fertnstert.2008.09.073; Gannon AM, 2012, TOXICOL SCI, V125, P274, DOI 10.1093/toxsci/kfr279; Giovannucci E, 1996, JNCI-J NATL CANCER I, V88, P1717, DOI 10.1093/jnci/88.23.1717; Gruber I, 2008, FERTIL STERIL, V90, P1249, DOI 10.1016/j.fertnstert.2007.06.108; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Hannoun A, 2010, EUR J OBSTET GYN R B, V150, P171, DOI 10.1016/j.ejogrb.2010.02.036; HARRISON KL, 1990, AUST NZ J OBSTET GYN, V30, P340, DOI 10.1111/j.1479-828X.1990.tb02024.x; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Huang JJ, 2009, FERTIL STERIL, V92, P1456, DOI 10.1016/j.fertnstert.2008.07.1781; HUGHES EG, 1994, FERTIL STERIL, V62, P807; Hulea S, 1994, J ENV PATHOL ONCOL, V14, P173; Hull MGR, 2000, FERTIL STERIL, V74, P725, DOI 10.1016/S0015-0282(00)01501-6; Jennings PC, 2011, HUM REPROD, V26, P878, DOI 10.1093/humrep/deq393; Jin Xuan, 2011, Front Biosci (Schol Ed), V3, P680, DOI 10.2741/s180; Khalil WA, 2013, THERIOGENOLOGY, V80, P161, DOI 10.1016/j.theriogenology.2013.04.008; Kim SJ, 2008, ENVIRON HEALTH PERSP, V116, P854, DOI 10.1289/ehp.10467; Klonoff-Cohen H, 2001, HUM REPROD, V16, P1382, DOI 10.1093/humrep/16.7.1382; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; KRISTENSEN P, 1995, ENVIRON HEALTH PERSP, V103, P588, DOI 10.2307/3432435; LEE CK, 1989, ENVIRON MOL MUTAGEN, V13, P54, DOI 10.1002/em.2850130107; Lim J, 2011, BIOL REPROD, V84, P775, DOI 10.1095/biolreprod.110.088583; Lopes S, 1998, HUM REPROD, V13, P896, DOI 10.1093/humrep/13.4.896; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Madden Jill A, 2014, Toxicol Appl Pharmacol, V276, P179, DOI 10.1016/j.taap.2014.02.011; MATTISON DR, 1989, SEMIN REPROD ENDOCR, V7, P291, DOI 10.1055/s-2007-1021411; Mazurek B, 2011, HEARING RES, V277, P54, DOI 10.1016/j.heares.2011.03.011; MCLACHLAN JA, 1976, FERTIL STERIL, V27, P1204; Nampoothiri LP, 2007, ARCH TOXICOL, V81, P145, DOI 10.1007/s00204-006-0133-x; Neal MS, 2007, HUM REPROD, V22, P961, DOI 10.1093/humrep/del487; Neal MS, 2005, HUM REPROD, V20, P2531, DOI 10.1093/humrep/dei080; Ness RB, 1999, NEW ENGL J MED, V340, P333, DOI 10.1056/NEJM199902043400501; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Otoi T, 1997, THERIOGENOLOGY, V48, P769, DOI 10.1016/S0093-691X(97)00300-2; Paixao LLO, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-25; Paksy K, 1997, J APPL TOXICOL, V17, P321, DOI 10.1002/(SICI)1099-1263(199709)17:5<321::AID-JAT443>3.3.CO;2-5; Paszkowski T, 2002, HUM REPROD, V17, P921, DOI 10.1093/humrep/17.4.921; Paszkowski T, 1998, Ginekol Pol, V69, P1131; Perez G, 1997, TOXICOLOGIST, V36, P250; Potter JD, 1999, CANCER EPIDEM BIOMAR, V8, P69; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; Roth LK, 2001, AM J OBSTET GYNECOL, V184, P934, DOI 10.1067/mob.2001.112103; Sharovskaya J, 2006, EUR J CELL BIOL, V85, P387, DOI 10.1016/j.ejcb.2005.11.006; Shiloh H, 2004, HUM REPROD, V19, P157, DOI 10.1093/humrep/deh029; Siddique S, 2014, J APPL TOXICOL, V34, P224, DOI 10.1002/jat.2884; Sims TH, 2009, PEDIATRICS, V124, pE1045, DOI 10.1542/peds.2009-2121; Sobinoff AP, 2013, TOXICOL APPL PHARM, V271, P156, DOI 10.1016/j.taap.2013.05.009; Sobinoff AP, 2012, TOXICOL APPL PHARM, V260, P70, DOI 10.1016/j.taap.2012.01.028; Sobinoff AP, 2010, TOXICOL SCI, V118, P653, DOI 10.1093/toxsci/kfq272; Soldin OP, 2011, STEROIDS, V76, P653, DOI 10.1016/j.steroids.2011.02.042; Stella L, 2007, J BIOL CHEM, V282, P6372, DOI 10.1074/jbc.M609906200; STONE KK, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432235; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Tilly JL, 1997, CELL DEATH DIFFER, V4, P180, DOI 10.1038/sj.cdd.4400238; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; VanVoorhis BJ, 1996, OBSTET GYNECOL, V88, P785, DOI 10.1016/0029-7844(96)00286-4; VANVOORHIS BJ, 1992, FERTIL STERIL, V58, P981; Vidal JD, 2006, REPROD TOXICOL, V22, P731, DOI 10.1016/j.reprotox.2006.06.001; Waylen AL, 2009, HUM REPROD UPDATE, V15, P31, DOI 10.1093/humupd/dmn046; Whitcomb BW, 2010, PAEDIATR PERINAT EP, V24, P433, DOI 10.1111/j.1365-3016.2010.01131.x; Winter E, 2002, HUM REPROD, V17, P3220, DOI 10.1093/humrep/17.12.3220; World Health Organization, 2008, WHO REP GLOB TOB EP; Wright KP, 2006, HUM REPROD, V21, P2930, DOI 10.1093/humrep/del269; Yu BL, 2012, J MOL MED, V90, P1333, DOI 10.1007/s00109-012-0914-z; Zenzes MT, 2000, HUM REPROD UPDATE, V6, P122, DOI 10.1093/humupd/6.2.122; Zhou JF, 2000, BIOMED ENVIRON SCI, V13, P44	85	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95945	10.1371/journal.pone.0095945	http://dx.doi.org/10.1371/journal.pone.0095945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776817	Green Published, Green Submitted, gold			2022-12-25	WOS:000346241800020
J	Roche, K; Chainay, H				Roche, Kevin; Chainay, Hanna			Pointing Treatments Are Task Relevant: A Visuomotor Priming Study	PLOS ONE			English	Article							OBJECT AFFORDANCES; MOTOR	The present study focused on priming effects on pointing with everyday objects. In a set of four experiments, a visuomotor priming paradigm was used to investigate the nature of visuomotor processing (automatic versus task relevant). By manipulating congruency of orientation and location we found that location congruency facilitates the initiation time of pointing whereas orientation congruency does not. We provide evidence to show that motor planning is influenced by the goal of the action, and that how visual information is processed and held in memory depends on the task relevance. These data are consistent with the proposed interaction between visuomotor and higher processes during the planning and execution of actions such as pointing.	[Roche, Kevin; Chainay, Hanna] Univ Lyon 2, Lab Etud Mecanismes Cognitifs, Bron, France	Universite Lyon 2	Roche, K (corresponding author), Univ Lyon 2, Lab Etud Mecanismes Cognitifs, Bron, France.	kevin.roche@univ-lyon2.fr	Chainay, Hanna/H-1580-2017	Chainay, Hanna/0000-0001-5754-033X	LABEX Cortex of Universite de Lyon [ANR-11-LABX-0042, ANR-11-IDEX-0007]	LABEX Cortex of Universite de Lyon	This work was supported by the LABEX Cortex (ANR-11-LABX-0042) of Universite de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport DA, 1987, PERSPECTIVES PERCEPT, P395; Bekkering H, 2002, PSYCHOL SCI, V13, P370, DOI 10.1111/1467-9280.00466; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; Ellis R, 2000, BRIT J PSYCHOL, V91, P451, DOI 10.1348/000712600161934; Fagioli S, 2007, NEUROPSYCHOLOGIA, V45, P3351, DOI 10.1016/j.neuropsychologia.2007.06.012; Fischer MH, 2004, J GEN PSYCHOL, V131, P365; Gallese V, 2000, J CONSCIOUSNESS STUD, V7, P23; Glover S, 2013, EXP BRAIN RES, V226, P53, DOI 10.1007/s00221-013-3410-y; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gutteling TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017675; Handy TC, 2003, NAT NEUROSCI, V1, P1; Jeannerod M, 2005, NEUROPSYCHOLOGIA, V43, P301, DOI 10.1016/j.neuropsychologia.2004.11.016; Jeannerod M, 1999, HUM MOVEMENT SCI, V18, P201, DOI 10.1016/S0167-9457(99)00008-1; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Pavese A, 2002, VIS COGN, V9, P559, DOI 10.1080/13506280143000584; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Phillips JC, 2002, VIS COGN, V9, P540, DOI 10.1080/13506280143000575; Randerath J, 2013, CORTEX, V49, P1679, DOI 10.1016/j.cortex.2012.08.016; Ranganathan R, 2011, HUM MOVEMENT SCI, V30, P1102, DOI 10.1016/j.humov.2010.11.012; Roche K, 2013, VIS COGN, V21, P1010, DOI 10.1080/13506285.2013.851136; Symes E, 2007, ACTA PSYCHOL, V124, P238, DOI 10.1016/j.actpsy.2006.03.005; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; van Elk M, 2010, J NEUROPHYSIOL, V104, P972, DOI 10.1152/jn.01079.2009	25	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e96154	10.1371/journal.pone.0096154	http://dx.doi.org/10.1371/journal.pone.0096154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4HM	24777029	Green Published, Green Submitted, gold			2022-12-25	WOS:000346241800029
J	Medenwald, D; Kors, JA; Loppnow, H; Thiery, J; Kluttig, A; Nuding, S; Tiller, D; Greiser, KH; Werdan, K; Haerting, J				Medenwald, Daniel; Kors, Jan A.; Loppnow, Harald; Thiery, Joachim; Kluttig, Alexander; Nuding, Sebastian; Tiller, Daniel; Greiser, Karin H.; Werdan, Karl; Haerting, Johannes			Inflammation and Prolonged QT Time: Results from the Cardiovascular Disease, Living and Ageing in Halle (CARLA) Study	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; DIRECTED ACYCLIC GRAPHS; HEART-RATE-VARIABILITY; ANALYSIS SYSTEM MEANS; C-REACTIVE PROTEIN; ATRIAL-FIBRILLATION; TNF-ALPHA; VENTRICULAR MYOCYTES; CIRCULATING LEVELS; CAUSAL-DIAGRAMS	Background: Previous research found an association of CRP with QT time in population based samples. Even more, there is evidence of a substantial involvement of the tumor necrosis factor-alpha system in the pathophysiology of cardiac arrhythmia, while the role of Interleukin 6 remains inconclusive. Objective: To determine the association between inflammation with an abnormally prolonged QT-time (APQT) in men and women of the elderly general population. Methods: Data descend from the baseline examination of the prospective, population-based Cardiovascular Disease, Living and Ageing in Halle (CARLA) Study. After exclusion of subjects with atrial fibrillation and missing ECG recording the final study cohort consisted of 919 men and 797 women. Blood parameters of inflammation were the soluble TNF-Receptor 1 (sTNF-R1), the high-sensitive C-reactive protein (hsCRP), and Interleukin 6 (IL-6). In accordance with major cardiologic societies we defined an APQT above a QT time of 460 ms in women and 450 ms in men. Effect sizes and the corresponding 95% confidence intervals (CI) were estimated by performing multiple linear and logistic regression analyses including the analysis of sex differences by interaction terms. Results: After covariate adjustment we found an odds ratio (OR) of 1.89 (95% CI: 1.13, 3.17) per 1000 pg/mL increase of sTNF-R1 in women, and 0.74 (95% CI: 0.48, 1.15) in men. In the covariate adjusted linear regression sTNF-R1 was again positively associated with QT time in women (5.75 ms per 1000 pg/mL, 95% CI: 1.32, 10.18), but not in men. Taking possible confounders into account IL-6 and hsCRP were not significantly related to APQT in both sexes. Conclusion: Our findings from cross-sectional analyses give evidence for an involvement of TNF-alpha in the pathology of APQT in women.	[Medenwald, Daniel; Kluttig, Alexander; Tiller, Daniel; Haerting, Johannes] Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, D-06108 Halle, Germany; [Kors, Jan A.; Nuding, Sebastian; Werdan, Karl] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Loppnow, Harald] Univ Halle Wittenberg, Dept Med 3, D-06108 Halle, Germany; [Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04109 Leipzig, Germany; [Greiser, Karin H.] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany	Martin Luther University Halle Wittenberg; Erasmus University Rotterdam; Erasmus MC; Martin Luther University Halle Wittenberg; Leipzig University; Helmholtz Association; German Cancer Research Center (DKFZ)	Medenwald, D (corresponding author), Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, D-06108 Halle, Germany.	daniel.medenwald@uk-halle.de			Deutsche Forschungsgemeinschaft as part of the Collaborative Research Centre 598 'Heart failure in the elderly - cellular mechanisms and therapy' at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg; Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg; Ministry of Education and Cultural Affairs of Saxony-Anhalt; Federal Employment Office	Deutsche Forschungsgemeinschaft as part of the Collaborative Research Centre 598 'Heart failure in the elderly - cellular mechanisms and therapy' at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg; Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg; Ministry of Education and Cultural Affairs of Saxony-Anhalt; Federal Employment Office	The CARLA study was supported by a grant from the Deutsche Forschungsgemeinschaft as part of the Collaborative Research Centre 598 'Heart failure in the elderly - cellular mechanisms and therapy' at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg, by a grant from the Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg, by the Ministry of Education and Cultural Affairs of Saxony-Anhalt, and by the Federal Employment Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazett H. C., 1920, HEART, V7, P35; Boos CJ, 2008, HEART, V94, P133, DOI 10.1136/hrt.2007.119651; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Carpena N, 2012, ISRN CARDIOL, V2012; Clendenen TV, 2011, CYTOKINE, V56, P769, DOI 10.1016/j.cyto.2011.09.013; de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Duncan DJ, 2010, CELL CALCIUM, V47, P378, DOI 10.1016/j.ceca.2010.02.002; Fernandez-Velasco M, 2007, AM J PHYSIOL-HEART C, V293, pH238, DOI 10.1152/ajpheart.01122.2006; Gaborit N, 2010, J MOL CELL CARDIOL, V49, P639, DOI 10.1016/j.yjmcc.2010.06.005; Galetta F, 2008, EUR J ENDOCRINOL, V158, P85, DOI 10.1530/EJE-07-0357; Goldenberg I, 2006, J CARDIOVASC ELECTR, V17, P333, DOI 10.1111/j.1540-8167.2006.00408.x; Gowd BMP, 2012, CARDIOL REV, V20, P297, DOI 10.1097/CRD.0b013e318259294b; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greensmith DJ, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.93; Greiser Karin H, 2005, BMC Cardiovasc Disord, V5, P33, DOI 10.1186/1471-2261-5-33; Greiser KH, 2009, EUR J EPIDEMIOL, V24, P123, DOI 10.1007/s10654-009-9317-z; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Hijazi Z, 2013, EUR HEART J, V34, P1475, DOI 10.1093/eurheartj/eht024; Johnson JN, 2011, EUR HEART J, V32, P1114, DOI 10.1093/eurheartj/ehr021; Kazumi T, 2003, METABOLISM, V52, P1113, DOI 10.1016/S0026-0495(03)00184-7; Kim E, 2006, EUR J EPIDEMIOL, V21, P653, DOI 10.1007/s10654-006-9034-9; Kleinbongard P, 2011, HEART FAIL REV, V16, P49, DOI 10.1007/s10741-010-9180-8; Kors JA, 2009, ANN NONINVAS ELECTRO, V14, pS48, DOI 10.1111/j.1542-474X.2008.00261.x; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Loppnow Harald, 2002, Autonomic & Autacoid Pharmacology, V22, P83, DOI 10.1046/j.1474-8673.2002.00245.x; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; Ohtsuka T, 2001, J AM COLL CARDIOL, V37, P412, DOI 10.1016/S0735-1097(00)01121-9; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Park EM, 2006, J CEREBR BLOOD F MET, V26, P392, DOI 10.1038/sj.jcbfm.9600194; Petkova-Kirova PS, 2006, AM J PHYSIOL-HEART C, V290, pH2098, DOI 10.1152/ajpheart.00097.2005; Prineas R., 1982, MINNESOTA CODE MANUA; Rauchhaus M, 2000, CIRCULATION, V102, P3060; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; RICKHAM PP, 1964, BRIT MED J, V2, P173; Safranow K, 2009, TISSUE ANTIGENS, V74, P386, DOI 10.1111/j.1399-0039.2009.01332.x; Schuessler RB, 2012, HEART RHYTHM, V9, P432, DOI 10.1016/j.hrthm.2011.09.074; Sedlak T, 2012, J WOMENS HEALTH, V21, P933, DOI 10.1089/jwh.2011.3444; Severi Stefano, 2006, Hemodial Int, V10, P287, DOI 10.1111/j.1542-4758.2006.00110.x; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Stengl M, 2010, CRIT CARE MED, V38, P579, DOI 10.1097/CCM.0b013e3181cb0f61; Stice JP, 2011, ENDOCRINOLOGY, V152, P1589, DOI 10.1210/en.2010-0627; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Tiller D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059225; TorreAmione G, 1996, CIRCULATION, V93, P704, DOI 10.1161/01.CIR.93.4.704; Ueland T, 2005, J AM COLL CARDIOL, V46, P2018, DOI 10.1016/j.jacc.2005.08.039; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; VanderWeele TJ, 2007, EPIDEMIOLOGY, V18, P561, DOI 10.1097/EDE.0b013e318127181b; Viskin S, 1999, LANCET, V354, P1625, DOI 10.1016/S0140-6736(99)02107-8	49	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e95994	10.1371/journal.pone.0095994	http://dx.doi.org/10.1371/journal.pone.0095994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24770373	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736600021
J	George, DT; Mathesius, U; Behm, CA; Verma, NK				George, Divya T.; Mathesius, Ulrike; Behm, Carolyn A.; Verma, Naresh K.			The Periplasmic Enzyme, AnsB, of Shigella flexneri Modulates Bacterial Adherence to Host Epithelial Cells	PLOS ONE			English	Article							MEMBRANE PROTEIN-A; ESCHERICHIA-COLI O157-H7; L-ASPARAGINASE-II; SACCHAROMYCES-CEREVISIAE; ROLES; INACTIVATION; PATHOGENESIS; ASSOCIATION; INFECTION; RESPONSES	S. flexneri strains, most frequently linked with endemic outbreaks of shigellosis, invade the colonic and rectal epithelium of their host and cause severe tissue damage. Here we have attempted to elucidate the contribution of the periplasmic enzyme, L-asparaginase (AnsB) to the pathogenesis of S. flexneri. Using a reverse genetic approach we found that ansB mutants showed reduced adherence to epithelial cells in vitro and attenuation in two in vivo models of shigellosis, the Caenorhabditis elegans and the murine pulmonary model. To investigate how AnsB affects bacterial adherence, we compared the proteomes of the ansB mutant with its wild type parental strain using two dimensional differential in-gel electrophoresis and identified the outer membrane protein, OmpA as up-regulated in ansB mutant cells. Bacterial OmpA, is a prominent outer membrane protein whose activity has been found to be required for bacterial pathogenesis. Overexpression of OmpA in wild type S. flexneri serotype 3b resulted in decreasing the adherence of this virulent strain, suggesting that the up-regulation of OmpA in ansB mutants contributes to the reduced adherence of this mutant strain. The data presented here is the first report that links the metabolic enzyme AnsB to S. flexneri pathogenesis.	[George, Divya T.; Behm, Carolyn A.; Verma, Naresh K.] Australian Natl Univ, Div Biomed Sci & Biochem, Res Sch Biol, Canberra, ACT, Australia; [Mathesius, Ulrike] Australian Natl Univ, Div Plant Sci, Res Sch Biol, Canberra, ACT, Australia	Australian National University; Australian National University	Verma, NK (corresponding author), Australian Natl Univ, Div Biomed Sci & Biochem, Res Sch Biol, Canberra, ACT, Australia.	Naresh.Verma@anu.edu.au	Behm, Carolyn A/A-2102-2008; Verma, Naresh/C-9161-2009; Mathesius, Ulrike/C-9767-2009	Behm, Carolyn A/0000-0002-0603-221X; Verma, Naresh/0000-0001-8109-2215; Mathesius, Ulrike/0000-0002-3557-0105				Baev MV, 2006, APPL MICROBIOL BIOT, V71, P310, DOI 10.1007/s00253-006-0317-6; BRENNER S, 1974, GENETICS, V77, P71; Burton EA, 2006, APPL ENVIRON MICROB, V72, P5043, DOI 10.1128/AEM.00558-06; CHEUNG NKV, 1986, AM J PEDIAT HEMATOL, V8, P99; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; CRAVIOTO A, 1979, CURR MICROBIOL, V3, P95, DOI 10.1007/BF02602439; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Haan CPA, 2012, APPL ENVIRON MICROB, V78, P5550, DOI 10.1128/AEM.01023-12; DUNLOP PC, 1975, J BACTERIOL, V122, P1017, DOI 10.1128/JB.122.3.1017-1024.1975; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; JENNINGS MP, 1990, J BACTERIOL, V172, P1491, DOI 10.1128/jb.172.3.1491-1498.1990; JENNINGS MP, 1993, MOL MICROBIOL, V9, P165, DOI 10.1111/j.1365-2958.1993.tb01678.x; JENNINGS MP, 1993, MOL MICROBIOL, V9, P155, DOI 10.1111/j.1365-2958.1993.tb01677.x; Jennison AV, 2006, WORLD J GASTROENTERO, V12, P6683, DOI 10.3748/wjg.v12.i41.6683; Jennison AV, 2004, FEMS MICROBIOL REV, V28, P43, DOI 10.1016/j.femsre.2003.07.002; Johansen J, 2008, J MOL BIOL, V383, P1, DOI 10.1016/j.jmb.2008.06.058; Kesika P, 2011, SCAND J INFECT DIS, V43, P286, DOI 10.3109/00365548.2010.548400; Krishnan S, 2012, FEBS J, V279, P919, DOI 10.1111/j.1742-4658.2012.08482.x; Kullas AL, 2012, CELL HOST MICROBE, V12, P791, DOI 10.1016/j.chom.2012.10.018; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Leduc D, 2010, INFECT IMMUN, V78, P2782, DOI 10.1128/IAI.00149-10; MALLETT CP, 1993, VACCINE, V11, P190, DOI 10.1016/0264-410X(93)90016-Q; Mathesius U, 2001, J EXP BOT, V52, P419, DOI 10.1093/jexbot/52.suppl_1.419; MAURELLI AT, 1984, INFECT IMMUN, V43, P397, DOI 10.1128/IAI.43.1.397-401.1984; PAULING KD, 1980, BIOCHIM BIOPHYS ACTA, V616, P271, DOI 10.1016/0005-2744(80)90144-8; PAYNE JW, 1994, ADV MICROB PHYSIOL, V36, P1, DOI 10.1016/S0065-2911(08)60176-9; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Rasmussen AA, 2005, MOL MICROBIOL, V58, P1421, DOI 10.1111/j.1365-2958.2005.04911.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shibayama K, 2011, MICROBIOL IMMUNOL, V55, P408, DOI 10.1111/j.1348-0421.2011.00333.x; Shin S, 2005, BIOCHEM BIOPH RES CO, V330, P1199, DOI 10.1016/j.bbrc.2005.03.097; Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Srikhanta YN, 2013, BIOCHEM BIOPH RES CO, V436, P362, DOI 10.1016/j.bbrc.2013.05.066; Strockbine NA, 2005, BERGEYS MANUAL SYSTE; Thompson SA, 2008, CELL HOST MICROBE, V4, P409, DOI 10.1016/j.chom.2008.10.010; Torres AG, 2006, INFECT IMMUN, V74, P2676, DOI 10.1128/IAI.74.5.2676-2685.2006; Torres AG, 2003, INFECT IMMUN, V71, P4985, DOI 10.1128/IAI.71.9.4985-4995.2003; van den Broek JM, 2005, J HEALTH POPUL NUTR, V23, P259; VANDEVERG LL, 1995, INFECT IMMUN, V63, P1947, DOI 10.1128/IAI.63.5.1947-1954.1995; VOINOYASENETSKY MV, 1962, ACTA MORPHOL HUNG, V11, P439; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Watarai M, 1996, J EXP MED, V183, P991, DOI 10.1084/jem.183.3.991; Wood WB, 1988, NEMATODE CAENORHABDI; Yang J, 2006, NUCLEIC ACIDS RES, V34, pD398, DOI 10.1093/nar/gkj033; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zautner AE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-171	47	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e94954	10.1371/journal.pone.0094954	http://dx.doi.org/10.1371/journal.pone.0094954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24762742	Green Submitted, Green Published, gold			2022-12-25	WOS:000335505000012
J	Glaz, P; Sirois, P; Archambault, P; Nozais, C				Glaz, Patricia; Sirois, Pascal; Archambault, Philippe; Nozais, Christian			Impact of Forest Harvesting on Trophic Structure of Eastern Canadian Boreal Shield Lakes: Insights from Stable Isotope Analyses	PLOS ONE			English	Article							TROUT SALVELINUS-FONTINALIS; AQUATIC FOOD WEBS; BROOK TROUT; ZOOPLANKTON COMMUNITIES; CARBON ISOTOPES; REVISED MODEL; WATER-QUALITY; TERRESTRIAL; DIET; SUBSIDIES	Perturbations on ecosystems can have profound immediate effects and can, accordingly, greatly alter the natural community. Land-use such as forestry activities in the Canadian Boreal region have increased in the last decades, raising concerns about their potential impact on aquatic ecosystems. The objective of this study was to evaluate the impact of forest harvesting on trophic structure in eastern Canadian Boreal Shield lakes. We measured carbon and nitrogen stable isotopes values for aquatic primary producers, terrestrial detritus, benthic macroinvertebrates, zooplankton and brook trout (Salvelinus fontinalis) over a three-year period in eight eastern Boreal Shield lakes. Four lakes were studied before, one and two years after forest harvesting (perturbed lakes) and compared with four undisturbed reference lakes (unperturbed lakes) sampled at the same time. Stable isotope mixing models showed leaf-litter to be the main food source for benthic primary consumers in both perturbed and unperturbed lakes, suggesting no logging impact on allochthonous subsidies to the littoral food web. Brook trout derived their food mainly from benthic predatory macroinvertebrates in unperturbed lakes. However, in perturbed lakes one year after harvesting, zooplankton appeared to be the main contributor to brook trout diet. This change in brook trout diet was mitigated two years after harvesting. Size-related diet shift were also observed for brook trout, indicating a diet shift related to size. Our study suggests that carbon from terrestrial habitat may be a significant contribution to the food web of oligotrophic Canadian Boreal Shield lakes. Forest harvesting did not have an impact on the diet of benthic primary consumers. On the other hand, brook trout diet composition was affected by logging with greater zooplankton contribution in perturbed lakes, possibly induced by darker-colored environment in these lakes one year after logging.	[Glaz, Patricia; Nozais, Christian] Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada; [Glaz, Patricia; Nozais, Christian] Univ Quebec, Ctr Etud Nord, Rimouski, PQ G5L 3A1, Canada; [Sirois, Pascal] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Lab Sci Aquat, Chaire Rech Especes Aquat Exploitees, Chicoutimi, PQ, Canada; [Archambault, Philippe] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada	University of Quebec; University of Quebec; University of Quebec; University of Quebec Chicoutimi; University of Quebec	Glaz, P (corresponding author), Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada.	patoglaz@hotmail.com		Archambault, Philippe/0000-0001-5986-6149	Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT); Fonds de la recherche forestiere du Saguenay - Lac-Saint-Jean; Natural Sciences and Engineering Research Council of Canada; FQRNT	Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); Fonds de la recherche forestiere du Saguenay - Lac-Saint-Jean; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); FQRNT(FQRNT)	This research project was supported by a public grant from the Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) and the Fonds de la recherche forestiere du Saguenay - Lac-Saint-Jean to C.N., P.A. and P.S. and by a grant from the Natural Sciences and Engineering Research Council of Canada to C.N. P.G. was supported by a PhD fellowship from FQRNT. Pierre Berube from the Ministere des Ressources naturelles et de la Faune du Quebec also contributed to this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DL, 1997, SARSIA, V82, P137, DOI 10.1080/00364827.1997.10413647; ALLAN JD, 1978, VERH INT VER LIMNOL, V20, P2045; Berube P., 1998, Fisheries Management and Ecology, V5, P123, DOI 10.1046/j.1365-2400.1998.00092.x; Carignan R, 2000, CAN J FISH AQUAT SCI, V57, P105, DOI 10.1139/cjfas-57-S2-105; Carpenter SR, 2005, ECOLOGY, V86, P2737, DOI 10.1890/04-1282; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Edmondson W.T., 1959, FRESHWATER BIOL, V2 nd, P1050; Feller MC, 2005, J AM WATER RESOUR AS, V41, P785, DOI 10.1111/j.1752-1688.2005.tb04464.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; France RL, 1997, ECOL FRESHW FISH, V6, P78, DOI 10.1111/j.1600-0633.1997.tb00147.x; Glaz P, 2012, AQUAT BIOL, V17, P107, DOI 10.3354/ab00465; Grey J, 2001, ECOL FRESHW FISH, V10, P168, DOI 10.1034/j.1600-0633.2001.100306.x; Groot A, 2005, FOREST CHRON, V81, P50, DOI 10.5558/tfc81050-1; Herwig BR, 2004, CAN J FISH AQUAT SCI, V61, P12, DOI 10.1139/F03-139; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; LACASSE S, 1992, CAN J FISH AQUAT SCI, V49, P1001, DOI 10.1139/f92-112; Lake PS, 2000, J N AM BENTHOL SOC, V19, P573, DOI 10.2307/1468118; Leclerc V, 2011, BOREAL ENVIRON RES, V16, P417; Leclerc V, 2011, T AM FISH SOC, V140, P1193, DOI 10.1080/00028487.2011.607040; MAGNAN P, 1988, CAN J FISH AQUAT SCI, V45, P999, DOI 10.1139/f88-123; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; MERRIT RW, 1998, INTRO AQUATIC INSECT; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moore RD, 2005, J AM WATER RESOUR AS, V41, P763, DOI 10.1111/j.1752-1688.2005.tb04463.x; Moore RD, 2005, J AM WATER RESOUR AS, V41, P813, DOI 10.1111/j.1752-1688.2005.tb04465.x; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Pace ML, 2002, LIMNOL OCEANOGR, V47, P333, DOI 10.4319/lo.2002.47.2.0333; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Planas D, 2000, CAN J FISH AQUAT SCI, V57, P136, DOI 10.1139/cjfas-57-S2-136; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Power G, 1980, SALMONID FISHES GENU, P141; Power M, 2002, ENVIRON BIOL FISH, V64, P75, DOI 10.1023/A:1016035509246; Premke K, 2010, J N AM BENTHOL SOC, V29, P1339, DOI 10.1899/10-002.1; Quinn GP, 2003, EXPT DESIGN DATA ANA; Roberge J, 1996, IMPACTS EXPLOIATATIO; Solomon CT, 2011, ECOLOGY, V92, P1115, DOI 10.1890/i0012-9658-92-5-1115; Stainton M.P., 1977, CHEM ANAL FRESH WATE, V2nd; Sweeting CJ, 2006, RAPID COMMUN MASS SP, V20, P595, DOI 10.1002/rcm.2347; Sweka JA, 2001, T AM FISH SOC, V130, P138, DOI 10.1577/1548-8659(2001)130<0138:IOTOBT>2.0.CO;2; TREMBLAY S, 1991, CAN J FISH AQUAT SCI, V48, P857, DOI 10.1139/f91-102; TREMBLAYRIVARD I, 2007, THESIS U QUEBEC CHIC; Vander Zanden MJ, 1998, T AM FISH SOC, V127, P729, DOI 10.1577/1548-8659(1998)127<0729:AOSITT>2.0.CO;2; WELSCHMEYER NA, 1993, PROG OCEANOGR, V32, P101, DOI 10.1016/0079-6611(93)90010-B; Winkler G, 2009, BOREAL ENVIRON RES, V14, P323; Xu J, 2007, ECOSCIENCE, V14, P170, DOI 10.2980/1195-6860(2007)14[170:SSIROB]2.0.CO;2	46	7	7	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96143	10.1371/journal.pone.0096143	http://dx.doi.org/10.1371/journal.pone.0096143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763366	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000065
J	Ranpura, H; Bialonska, D; Bolton, PH				Ranpura, Harikrushan; Bialonska, Dobroslawa; Bolton, Philip H.			Finding and Characterizing the Complexes of Drug Like Molecules with Quadruplex DNA: Combined Use of an Enhanced Hydroxyl Radical Cleavage Protocol and NMR	PLOS ONE			English	Article							CAIN QUINOLINIUM; BINDING; PROMOTER; APTAMER; LIGAND; DUPLEX; IDENTIFICATION; COMBINATION; AFFINITY; SITE	Structural information on the complexes of drug like molecules with quadruplex DNAs can aid the development of therapeutics and research tools that selectively target specific quadruplex DNAs. Screening can identify candidate molecules that require additional evaluation. An enhanced hydroxyl radical cleavage protocol is demonstrated that can efficiently provide structural information on the complexes of the candidate molecules with quadruplex DNA. NMR methods have been used to offer additional structural information about the complexes as well as validate the results of the hydroxyl radical approach. This multi-step protocol has been demonstrated on complexes of the chair type quadruplex formed by the thrombin binding aptamer, d(GGTTGGTGTGGTTGG). The hydroxyl radical results indicate that NSC 176319, Cain's quinolinium that was found by screening, exhibits selective binding to the two TT loops. The NMR results are consistent with selective disruption of the hydrogen bonding between T4 and T13 as well as unstacking of these residues from the bottom quartet. Thus, the combination of screening, hydroxyl radical footprinting and NMR can find new molecules that selectively bind to quadruplex DNAs as well as provide structural information about their complexes.	[Ranpura, Harikrushan; Bialonska, Dobroslawa; Bolton, Philip H.] Wesleyan Univ, Dept Chem, Middletown, CT 06457 USA	Wesleyan University	Bolton, PH (corresponding author), Wesleyan Univ, Dept Chem, Middletown, CT 06457 USA.	pbolton@wesleyan.edu			National Institutes of Health [GM076550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM076550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grant GM076550 to PHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian M, 2012, METHODS, V57, P11, DOI 10.1016/j.ymeth.2012.05.003; Alcaro S, 2013, J MED CHEM, V56, P843, DOI 10.1021/jm3013486; Arthanari H, 1999, ANTI-CANCER DRUG DES, V14, P317; Arthanari H, 1998, NUCLEIC ACIDS RES, V26, P3724, DOI 10.1093/nar/26.16.3724; Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Bialonska D, 2011, MUTAT RES-GEN TOX EN, V726, P47, DOI 10.1016/j.mrgentox.2011.08.004; Brown RV, 2011, BIOCHEM SOC T, V39, P635, DOI 10.1042/BST0390635; Bryan TM, 2010, METHODS MOL BIOL, V608, P1, DOI 10.1007/978-1-59745-363-9_1; Chaires Jonathan B., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P339, DOI 10.2174/1568011054222292; Dai JX, 2011, J AM CHEM SOC, V133, P17673, DOI 10.1021/ja205646q; De Cian A, 2008, BIOCHIMIE, V90, P131, DOI 10.1016/j.biochi.2007.07.011; Freyer MW, 2007, BIOPHYS J, V92, P2007, DOI 10.1529/biophysj.106.097246; Halder K, 2012, METHODS, V57, P115, DOI 10.1016/j.ymeth.2012.02.005; Hampshire AJ, 2007, METHODS, V42, P128, DOI 10.1016/j.ymeth.2007.01.002; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Huppert JL, 2008, BIOCHIMIE, V90, P1140, DOI 10.1016/j.biochi.2008.01.014; Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x; Iida K, 2013, ANGEW CHEM INT EDIT, V52, P12052, DOI 10.1002/anie.201305366; Jena PV, 2009, J AM CHEM SOC, V131, P12522, DOI 10.1021/ja903408r; Laederach A, 2008, NAT PROTOC, V3, P1395, DOI 10.1038/nprot.2008.134; Largy E, 2011, ANAL BIOANAL CHEM, V400, P3419, DOI 10.1007/s00216-011-5018-z; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Liu JW, 2009, CHEM REV, V109, P1948, DOI 10.1021/cr030183i; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Marathias VM, 2000, NUCLEIC ACIDS RES, V28, P1969, DOI 10.1093/nar/28.9.1969; Martino L, 2009, J PHYS CHEM B, V113, P14779, DOI 10.1021/jp9066394; Mikami-Terao Y, 2009, EXP EYE RES, V89, P200, DOI 10.1016/j.exer.2009.03.008; Nadai M, 2013, BBA-GEN SUBJECTS, V1830, P4660, DOI 10.1016/j.bbagen.2013.05.039; Nagesh N, 2010, BIOPHYS J, V98, P2628, DOI 10.1016/j.bpj.2010.02.050; NAUJOKAITIS SA, 1981, RES COMMUN CHEM PATH, V34, P97; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Nicoludis JM, 2012, NUCLEIC ACIDS RES, V40, P5432, DOI 10.1093/nar/gks152; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Paramasivan S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn487; Parkinson GN, 2007, BIOCHEMISTRY-US, V46, P2390, DOI 10.1021/bi062244n; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; PATEL DJ, 1986, BIOPOLYMERS, V25, P707, DOI 10.1002/bip.360250413; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Phan AT, 2004, J AM CHEM SOC, V126, P8710, DOI 10.1021/ja048805k; Pothukuchy A, 2005, BIOCHEMISTRY-US, V44, P2163, DOI 10.1021/bi0485981; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Rahman KM, 2012, BIOORG MED CHEM LETT, V22, P3006, DOI 10.1016/j.bmcl.2012.02.020; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; Seenisamy J, 2004, J AM CHEM SOC, V126, P8702, DOI 10.1021/ja040022b; Sergiev P. V., 2001, Molekulyarnaya Biologiya (Moscow), V35, P559; Smith JS, 2010, METHODS MOL BIOL, V608, P207, DOI 10.1007/978-1-59745-363-9_13; Tan JH, 2008, MINI-REV MED CHEM, V8, P1163, DOI 10.2174/138955708785909880; Tullius TD, 2005, CURR OPIN CHEM BIOL, V9, P127, DOI 10.1016/j.cbpa.2005.02.009; WANG KY, 1993, BIOCHEMISTRY-US, V32, P11285, DOI 10.1021/bi00093a004; WANG KY, 1993, BIOCHEMISTRY-US, V32, P1899, DOI 10.1021/bi00059a003; Wang KY, 1996, J MOL BIOL, V260, P378, DOI 10.1006/jmbi.1996.0408; Yaku H, 2013, MOLECULES, V18, P11751, DOI 10.3390/molecules181011751; YESAIR DW, 1979, CANCER BIOCHEM BIOPH, V3, P163	56	2	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96218	10.1371/journal.pone.0096218	http://dx.doi.org/10.1371/journal.pone.0096218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763734	Green Submitted, gold, Green Published			2022-12-25	WOS:000335505000075
J	Saferali, A; Lee, J; Sin, DD; Rouhani, FN; Brantly, ML; Sandford, AJ				Saferali, Aabida; Lee, Jee; Sin, Don D.; Rouhani, Farshid N.; Brantly, Mark L.; Sandford, Andrew J.			Longer Telomere Length in COPD Patients with alpha(1)-Antitrypsin Deficiency Independent of Lung Function	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; ALPHA-1-ANTITRYPSIN DEFICIENCY; ALPHA1-ANTITRYPSIN DEFICIENCY; CARDIOVASCULAR-DISEASE; GENETIC INFLUENCES; OXIDATIVE STRESS; EMPHYSEMA SHOW; INFLAMMATION; FIBROBLASTS	Oxidative stress is involved in the pathogenesis of airway obstruction in alpha(1)-antitrypsin deficient patients. This may result in a shortening of telomere length, resulting in cellular senescence. To test whether telomere length differs in alpha(1)-antitrypsin deficient patients compared with controls, we measured telomere length in DNA from peripheral blood cells of 217 alpha(1)-antitrypsin deficient patients and 217 control COPD patients. We also tested for differences in telomere length between DNA from blood and DNA from lung tissue in a subset of 51 controls. We found that telomere length in the blood was significantly longer in alpha(1)-antitrypsin deficient COPD patients compared with control COPD patients (p = 1x10(-29)). Telomere length was not related to lung function in alpha(1)-antitrypsin deficient patients (p = 0.3122) or in COPD controls (p = 0.1430). Although mean telomere length was significantly shorter in the blood when compared with the lungs (p = 0.0078), telomere length was correlated between the two tissue types (p = 0.0122). Our results indicate that telomere length is better preserved in alpha(1)-antitrypsin deficient COPD patients than in non-deficient patients. In addition, measurement of telomere length in the blood may be a suitable surrogate for measurement in the lung.	[Saferali, Aabida; Lee, Jee; Sin, Don D.; Sandford, Andrew J.] St Pauls Hosp, UBC James Hogg Res Ctr, Vancouver, BC V6Z 1Y6, Canada; [Rouhani, Farshid N.; Brantly, Mark L.] Univ Florida, Dept Med, Gainesville, FL USA	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; State University System of Florida; University of Florida	Sandford, AJ (corresponding author), St Pauls Hosp, UBC James Hogg Res Ctr, Vancouver, BC V6Z 1Y6, Canada.	andrew.sandford@hli.ubc.ca	Brantly, Mark/AAH-2922-2020; Sin, Don/AAC-2219-2021		Alpha-1 Foundation; CHEST Foundation Clinical Research Award; Michael Smith Foundation for Health Research Senior Scholarship award	Alpha-1 Foundation; CHEST Foundation Clinical Research Award; Michael Smith Foundation for Health Research Senior Scholarship award	This study was funded by an Alpha-1 Foundation and CHEST Foundation Clinical Research Award. AJS was the recipient of a Michael Smith Foundation for Health Research Senior Scholarship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2013, EUR RESP J; Amsellem V, 2011, AM J RESP CRIT CARE, V184, P1358, DOI 10.1164/rccm.201105-0802OC; Andersen ZJ, 2011, AM J RESP CRIT CARE, V183, P455, DOI 10.1164/rccm.201006-0937OC; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Anto JM, 2001, EUR RESPIR J, V17, P982, DOI 10.1183/09031936.01.17509820; ARTIGAS MS, 2011, NAT GENET, V43, P1082, DOI DOI 10.1038/NG.941; Atlantis E, 2013, CHEST, V144, P766, DOI 10.1378/chest.12-1911; Bosse Y, 2012, INT J CHRONIC OBSTR, V7, P607, DOI 10.2147/COPD.S35294; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Churg A, 2007, AM J RESP CELL MOL, V37, P144, DOI 10.1165/rcmb.2006-0345OC; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; DeMeo DL, 2007, THORAX, V62, P806, DOI 10.1136/thx.2006.075846; Deslee G, 2009, CHEST, V135, P965, DOI 10.1378/chest.08-2257; Ekeowa UI, 2011, EXPERT REV CLIN IMMU, V7, P243, DOI [10.1586/eci.10.95, 10.1586/ECI.10.95]; ERIKSSON S, 1964, ACTA MED SCAND, V175, P197; Fyhrquist F, 2013, NAT REV CARDIOL, V10, P274, DOI 10.1038/nrcardio.2013.30; Gardner JP, 2007, J GERONTOL A-BIOL, V62, P367, DOI 10.1093/gerona/62.4.367; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hansel NN, 2013, AM J RESP CRIT CARE, V187, P1085, DOI 10.1164/rccm.201211-1987OC; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hoen PW, 2011, PSYCHOSOM MED, V73, P541, DOI 10.1097/PSY.0b013e31821b1f6e; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Houben JMJ, 2009, RESP MED, V103, P230, DOI 10.1016/j.rmed.2008.09.003; Ikari Y, 2001, J BIOL CHEM, V276, P11798, DOI 10.1074/jbc.M008503200; Ingebrigtsen T, 2010, RESP MED, V104, P1890, DOI 10.1016/j.rmed.2010.05.004; Ingebrigtsen TS, 2011, LUNG, V189, P323, DOI 10.1007/s00408-011-9306-3; Kido T, 2011, AM J RESP CELL MOL, V44, P197, DOI 10.1165/rcmb.2009-0427OC; Lansdorp PM, 2005, TRENDS BIOCHEM SCI, V30, P388, DOI 10.1016/j.tibs.2005.05.004; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035567; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Miller J, 2013, RESP MED, V107, P1376, DOI 10.1016/j.rmed.2013.05.001; Morla M, 2006, EUR RESPIR J, V27, P525, DOI 10.1183/09031936.06.00087005; Mui TSY, 2009, J AM GERIATR SOC, V57, P2372, DOI 10.1111/j.1532-5415.2009.02589.x; Muller KC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-32; Obeidat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019382; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Patel BD, 2006, THORAX, V61, P568, DOI 10.1136/thx.2005.053827; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; REDLINE S, 1987, AM REV RESPIR DIS, V135, P217; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Rode L, 2013, THORAX, V68, P429, DOI 10.1136/thoraxjnl-2012-202544; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; SILVERMAN EK, 1989, ANN INTERN MED, V111, P982, DOI 10.7326/0003-4819-111-12-982; Stone H, 2012, EUR RESPIR J, V40, P561, DOI 10.1183/09031936.00162811; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Valdes AM, 2007, OSTEOPOROSIS INT, V18, P1203, DOI 10.1007/s00198-007-0357-5; Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP; van Eeden SF, 2008, RESPIRATION, V75, P224, DOI 10.1159/000111820; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429	58	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95600	10.1371/journal.pone.0095600	http://dx.doi.org/10.1371/journal.pone.0095600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763308	gold, Green Submitted, Green Published			2022-12-25	WOS:000335505000028
J	Gershon, AS; Khan, S; Klein-Geltink, J; Wilton, D; To, T; Crighton, EJ; Pigeau, L; MacQuarrie, J; Allard, Y; Russell, SJ; Henry, DA				Gershon, Andrea S.; Khan, Saba; Klein-Geltink, Julie; Wilton, Drew; To, Teresa; Crighton, Eric J.; Pigeau, Lisa; MacQuarrie, Jo; Allard, Yvon; Russell, Storm J.; Henry, David A.			Asthma and Chronic Obstructive Pulmonary Disease (COPD) Prevalence and Health Services Use in Ontario Metis: A Population-Based Cohort Study	PLOS ONE			English	Article							ADMINISTRATIVE DATABASES; CANADA; ALBERTA	Introduction: Chronic respiratory diseases cause a significant health and economic burden around the world. In Canada, Aboriginal populations are at increased risk of asthma and chronic obstructive pulmonary disease (COPD). There is little known, however, about these diseases in the Canadian Metis population, who have mixed Aboriginal and European ancestry. A population-based study was conducted to quantify asthma and COPD prevalence and health services use in the Metis population of Ontario, Canada's largest province. Methods: The Metis Nation of Ontario Citizenship Registry was linked to provincial health administrative databases to measure and compare burden of asthma and COPD between the Metis and non-Metis populations of Ontario between 2009 and 2012. Asthma and COPD prevalence, health services use (general physician and specialist visits, emergency department visits, hospitalizations), and mortality were measured. Results: Prevalences of asthma and COPD were 30% and 70% higher, respectively, in the Metis compared to the general Ontario population (p, 0.001). General physician and specialist visits were significantly lower in Metis with asthma, while general physician visits for COPD were significantly higher. Emergency department visits and hospitalizations were generally higher for Metis compared to non-Metis with either disease. All-cause mortality in Metis with COPD was 1.3 times higher compared to non-Metis with COPD (p = 0.01). Conclusion: There is a high burden of asthma and COPD in Ontario Metis, with significant prevalence and acute health services use related to these diseases. Lower rates of physician visits suggest barriers in access to primary care services.	[Gershon, Andrea S.] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Gershon, Andrea S.; Khan, Saba; Klein-Geltink, Julie; Wilton, Drew; To, Teresa; Crighton, Eric J.; Henry, David A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Gershon, Andrea S.; To, Teresa] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Gershon, Andrea S.; To, Teresa; Henry, David A.] Univ Toronto, Toronto, ON, Canada; [Crighton, Eric J.] Univ Ottawa, Dept Geog, Ottawa, ON K1N 6N5, Canada; [Pigeau, Lisa; MacQuarrie, Jo; Allard, Yvon; Russell, Storm J.] Metis Nation Ontario, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Ottawa	Gershon, AS (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada.	andrea.gershon@ices.on.ca	Henry, David/AAU-4650-2020; Henry, David/AAJ-4332-2020	Henry, David/0000-0001-7169-7704; Henry, David/0000-0003-2934-2242	Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC); Public Health Agency of Canada	Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Public Health Agency of Canada	This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Funding for this study was provided by the Public Health Agency of Canada. The opinions expressed in this publication are those of the authors/researchers and do not necessarily reflect the official views of the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R N, 1998, Natl Vital Stat Rep, V47, P1; ANDERSON RN, 1998, NATL VITAL STAT REP, V47, P20; Canadian Lung Association, 2005, CHRON OBSTR PULM DIS; Canadian Thoracic Society, 2012, CAN RESP GUID PULM R; Centre for Rural and Northern Health Research, 2010, UND RESP COND ONT AB; CIHR Natural Sciences and Engineering Research Council of Canada (NSERC) Social Sciences and Humanities Research Council of Canada (SSHRC), 2010, TRIC POL STAT ETH CO; Crighton EJ, 2010, INT J CIRCUMPOL HEAL, V69, P138, DOI 10.3402/ijch.v69i2.17435; Evans M, 2012, INT J CRIT INDIG STU, V5, P54, DOI DOI 10.5204/ijcis.v5i1.94; Garner Rochelle, 2008, Health Rep, V19, P45; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Iron Karey, 2011, Healthc Q, V14, P23; Janz T, 2009, ABORIGINAL PEOPLES S; Jutte DP, 2011, ANNU REV PUBL HEALTH, V32, P91, DOI 10.1146/annurev-publhealth-031210-100700; Manitoba Centre for Health Policy, 2010, PROF MET HLTH STAT H; National Lung Health Framework Partnership Secretariat, 2008, NAT LUNG HLTH FRAM; Ospina MB, 2012, CAN RESPIR J, V19, P355, DOI 10.1155/2012/825107; Roshanafshar, 2013, SELECT HLTH INDICATO; Rowe BH, 2009, CHEST, V135, P57, DOI 10.1378/chest.07-3041; Sanmartin C, 2010, HLTH 1 NATIONS LIVIN; Shah BR, 2011, DIABETES CARE, V34, P2555, DOI 10.2337/dc11-0945; Sin DD, 2002, CHEST, V121, P1841, DOI 10.1378/chest.121.6.1841; Statistics Canada, 2013, AB PEOPL CAN 1 NAT P; Tjepkema Michael, 2009, Health Rep, V20, P31; Wilkins R, 2010, PCCF VERSION 5F USER; World Health Organization, 2011, ASTHM FACT SHEET; World Health Organization, 2007, GLOB SURV PREV CONTR; World Health Organization, 2013, CHRON OBSTR PULM DIS	28	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95899	10.1371/journal.pone.0095899	http://dx.doi.org/10.1371/journal.pone.0095899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760036	gold, Green Published			2022-12-25	WOS:000335298200105
J	Ode, A; Kallen, K; Gustafsson, P; Rylander, L; Jonsson, BAG; Olofsson, P; Ivarsson, SA; Lindh, CH; Rignell-Hydbom, A				Ode, Amanda; Kallen, Karin; Gustafsson, Peik; Rylander, Lars; Jonsson, Bo A. G.; Olofsson, Per; Ivarsson, Sten A.; Lindh, Christian H.; Rignell-Hydbom, Anna			Fetal Exposure to Perfluorinated Compounds and Attention Deficit Hyperactivity Disorder in Childhood	PLOS ONE			English	Article							PERFLUOROOCTANE SULFONATE PFOS; DEFICIT/HYPERACTIVITY DISORDER; DEVELOPMENTAL NEUROTOXICITY; POLYFLUOROALKYL CHEMICALS; SERUM CONCENTRATIONS; PLACENTAL-TRANSFER; NEONATAL EXPOSURE; PRENATAL EXPOSURE; MATERNAL SMOKING; CANDIDATE GENE	Background: The association between exposure to perfluorinated compounds (PFCs) and attention deficit hyperactivity disorder (ADHD) diagnosis has been sparsely investigated in humans and the findings are inconsistent. Objectives: A matched case-control study was conducted to investigate the association between fetal exposure to PFCs and ADHD diagnosis in childhood. Methods: The study base comprised children born in Malmo, Sweden, between 1978 and 2000 that were followed up until 2005. Children with ADHD (n = 206) were identified at the Department of Child and Adolescent Psychiatry. Controls (n = 206) were selected from the study base and were matched for year of birth and maternal country of birth. PFC concentrations were measured in umbilical cord serum samples. The differences of the PFC concentrations between cases and controls were investigated using Wilcoxon's paired test. Possible threshold effects (above the upper quartile for perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) and above limit of detection [LOD] for perfluorononanoic acid (PFNA)) were evaluated by conditional logistic regression. Results: The median umbilical cord serum concentrations of PFOS were 6.92 ng/ml in the cases and 6.77 ng/ml in the controls. The corresponding concentrations of PFOA were 1.80 and 1.83 ng/ml. No associations between PFCs and ADHD were observed. Odds ratios adjusted for smoking status, parity, and gestational age were 0.81 (95% confidence interval [CI] 0.50 to 1.32) for PFOS, 1.07 (95% CI 0.67 to 1.7) for PFOA, and 1.1 (95% CI 0.75 to 1.7) for PFNA. Conclusions: The current study revealed no support for an association between fetal exposure to PFOS, PFOA, or PFNA and ADHD.	[Ode, Amanda; Kallen, Karin; Rylander, Lars; Jonsson, Bo A. G.; Lindh, Christian H.; Rignell-Hydbom, Anna] Lund Univ, Div Occupat & Environm Med, Lund, Sweden; [Gustafsson, Peik] Lund Univ, Dept Clin Sci, Child & Adolescent Psychiat Unit, Lund, Sweden; [Olofsson, Per] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Obstet & Gynecol Unit, Malmo, Sweden; [Ivarsson, Sten A.] Lund Univ, Unit Pediat Endocrinol, Dept Clin Sci, Clin Res Ctr, Malmo, Sweden	Lund University; Lund University; Lund University; Skane University Hospital; Lund University	Ode, A (corresponding author), Lund Univ, Div Occupat & Environm Med, Lund, Sweden.	amanda.ode@med.lu.se	Gustafsson, Peik/AAE-3172-2020	Gustafsson, Peik/0000-0002-6767-7169; Lindh, Christian/0000-0001-7435-9890; Kallen, Karin/0000-0001-5765-2630; Rylander, Lars/0000-0001-8288-8207; Jonsson, Bo/0000-0002-8767-0589	Swedish Research Council (via SIMSAM Early Life); Medical Faculty at Lund University	Swedish Research Council (via SIMSAM Early Life)(Swedish Research Council); Medical Faculty at Lund University	The project was funded by the Swedish Research Council (via SIMSAM Early Life) (web page: www.vr.se/) and the Medical Faculty at Lund University (web page:www.med.lu.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelberg BJ, 2007, ENVIRON SCI TECHNOL, V41, P3891, DOI 10.1021/es0700911; Austin ME, 2003, ENVIRON HEALTH PERSP, V111, P1485, DOI 10.1289/ehp.6128; BAUMGAERTEL A, 1995, J AM ACAD CHILD PSY, V34, P629, DOI 10.1097/00004583-199505000-00015; Beesoon S, 2011, ENVIRON HEALTH PERSP, V119, P1659, DOI 10.1289/ehp.1003265; Biederman J, 1997, J AM ACAD CHILD PSY, V36, P1682, DOI 10.1097/00004583-199712000-00016; Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478; Butenhoff JL, 2009, REPROD TOXICOL, V27, P319, DOI 10.1016/j.reprotox.2008.12.010; Butt CM, 2010, SCI TOTAL ENVIRON, V408, P2936, DOI 10.1016/j.scitotenv.2010.03.015; Calafat AM, 2007, ENVIRON HEALTH PERSP, V115, P1596, DOI 10.1289/ehp.10598; Carballo JJ, 2013, SOC PSYCH PSYCH EPID, V48, P1327, DOI 10.1007/s00127-013-0661-7; Chu SM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-85; Cui L, 2009, ARCH ENVIRON CON TOX, V56, P338, DOI 10.1007/s00244-008-9194-6; Das Banerjee T, 2007, ACTA PAEDIATR, V96, P1269, DOI 10.1111/j.1651-2227.2007.00430.x; Desrosiers C, 2013, NEUROTOXICOL TERATOL, V39, P84, DOI 10.1016/j.ntt.2013.07.010; Eubig PA, 2010, ENVIRON HEALTH PERSP, V118, P1654, DOI 10.1289/ehp.0901852; Faraone SV, 2006, J CLIN PSYCHIAT, V67, P13; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fei CY, 2008, ENVIRON HEALTH PERSP, V116, P1391, DOI 10.1289/ehp.11277; Fei CY, 2007, ENVIRON HEALTH PERSP, V115, P1677, DOI 10.1289/ehp.10506; Fei CY, 2011, ENVIRON HEALTH PERSP, V119, P573, DOI 10.1289/ehp.1002026; Fromme H, 2009, INT J HYG ENVIR HEAL, V212, P239, DOI 10.1016/j.ijheh.2008.04.007; Fuentes S, 2007, TOXICOLOGY, V242, P123, DOI 10.1016/j.tox.2007.09.012; George L, 2006, ACTA OBSTET GYN SCAN, V85, P1331, DOI 10.1080/00016340600935433; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; Giesy JP, 2002, ENVIRON SCI TECHNOL, V36, p146A, DOI 10.1021/es022253t; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Greaves AK, 2013, ENVIRON TOXICOL CHEM, V32, P713, DOI 10.1002/etc.2107; Gump BB, 2011, ENVIRON SCI TECHNOL, V45, P8151, DOI 10.1021/es103712g; Gustafsson P, 2000, ACTA PAEDIATR, V89, P830, DOI 10.1080/080352500750043747; Gustafsson P, 2011, DEV MED CHILD NEUROL, V53, P263, DOI 10.1111/j.1469-8749.2010.03820.x; Gutzkow KB, 2012, INT J HYG ENVIR HEAL, V215, P216, DOI 10.1016/j.ijheh.2011.08.011; Hamm MP, 2010, J EXPO SCI ENV EPID, V20, P589, DOI 10.1038/jes.2009.57; Harada K, 2007, CHEMOSPHERE, V66, P293, DOI 10.1016/j.chemosphere.2006.05.010; Haug LS, 2009, ENVIRON SCI TECHNOL, V43, P2131, DOI 10.1021/es802827u; Hoffman K, 2010, ENVIRON HEALTH PERSP, V118, P1762, DOI 10.1289/ehp.1001898; Inoue K, 2004, ENVIRON HEALTH PERSP, V112, P1204, DOI 10.1289/ehp.6864; Johansson N, 2008, NEUROTOXICOLOGY, V29, P160, DOI 10.1016/j.neuro.2007.10.008; Johansson N, 2009, TOXICOL SCI, V108, P412, DOI 10.1093/toxsci/kfp029; Kannan K, 2004, ENVIRON SCI TECHNOL, V38, P4489, DOI 10.1021/es0493446; Kim SK, 2011, ENVIRON POLLUT, V159, P169, DOI 10.1016/j.envpol.2010.09.008; Kim S, 2011, ENVIRON SCI TECHNOL, V45, P7465, DOI 10.1021/es202408a; Kissa E., 2001, FLUORINATED SURFACTA, Vsecond; Kotimaa AJ, 2003, J AM ACAD CHILD PSY, V42, P826, DOI 10.1097/01.CHI.0000046866.56865.A2; LAHEY BB, 1994, AM J PSYCHIAT, V151, P1673; Langley K, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-26; Lara C, 2009, BIOL PSYCHIAT, V65, P46, DOI 10.1016/j.biopsych.2008.10.005; Lee HG, 2012, NEUROTOXICOLOGY, V33, P314, DOI 10.1016/j.neuro.2012.01.017; Lemal DM, 2004, J ORG CHEM, V69, P1, DOI 10.1021/jo0302556; Lindh CH, 2012, CHEMOSPHERE, V88, P1269, DOI 10.1016/j.chemosphere.2012.03.049; Liu JY, 2011, ENVIRON INT, V37, P1206, DOI 10.1016/j.envint.2011.05.001; Needham LL, 2011, ENVIRON SCI TECHNOL, V45, P1121, DOI 10.1021/es1019614; Ode A, 2013, ENVIRON SCI POLLUT R, V20, P7970, DOI 10.1007/s11356-013-1573-5; Olsen GW, 2011, ENVIRON SCI TECHNOL, V45, P8022, DOI 10.1021/es1043535; Olsen GW, 2005, ENVIRON HEALTH PERSP, V113, P539, DOI 10.1289/ehp.7544; Pastor Patricia N, 2008, Vital Health Stat 10, P1; Perricone G, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-221; Skounti M, 2007, EUR J PEDIATR, V166, P117, DOI 10.1007/s00431-006-0299-5; Slotkin TA, 2008, ENVIRON HEALTH PERSP, V116, P716, DOI 10.1289/ehp.11253; Stein CR, 2011, ENVIRON HEALTH PERSP, V119, P1466, DOI 10.1289/ehp.1003538; Thapar A, 2012, ARCH DIS CHILD, V97, P260, DOI 10.1136/archdischild-2011-300482; Trudel D, 2008, RISK ANAL, V28, P251, DOI 10.1111/j.1539-6924.2008.01017.x; Washino N, 2009, ENVIRON HEALTH PERSP, V117, P660, DOI 10.1289/ehp.11681	64	52	54	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95891	10.1371/journal.pone.0095891	http://dx.doi.org/10.1371/journal.pone.0095891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760015	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200103
J	Xu, Q; Dong, QG; He, CY; Liu, WJ; Sun, LP; Liu, JW; Xing, CZ; Li, XH; Wang, BG; Yuan, Y				Xu, Qian; Dong, Qiguan; He, Caiyun; Liu, Wenjing; Sun, Liping; Liu, Jingwei; Xing, Chengzhong; Li, Xiaohang; Wang, Bengang; Yuan, Yuan			A New Polymorphism Biomarker rs629367 Associated with Increased Risk and Poor Survival of Gastric Cancer in Chinese by Up-Regulated miRNA-let-7a Expression	PLOS ONE			English	Article							POTENTIALLY FUNCTIONAL POLYMORPHISM; ALCOHOL-DRINKING; MICRORNA; SUSCEPTIBILITY; REGION; CLASSIFICATION; EPIDEMIOLOGY; METAANALYSIS; RS3746444; SEQUENCE	Background: Variant in pri-miRNA could affect miRNA expression and mature process or splicing efficiency, thus altering the hereditary susceptibility and prognosis of cancer. We aimed to assess miRNA-let-7 single nucleotide polymorphisms (SNP) associated with the risk and prognosis of gastric cancer (GC) as predicting biomarkers, and furthermore, its possible mechanisms. Methods: A two-stage case-control study was designed to screen four miRNA SNPs (pri-let-7a-2 rs629367 and rs1143770, pri-let-7a-1 rs10739971, pri-let-7f-2 rs17276588) in 107 GC patients, 107 atrophic gastritis (AG), and matched 124 controls using PCR-RFLP. Two promising SNPs were validated in another independent 1949 samples (including 579 gastric cancer patients, 649 atrophic gastritis and 721 controls) using Sequenom MassARRAY platform and sequencing. Results: We found that pri-let-7a-2 rs629367 CC variant genotype was associated with increased risks of gastric cancer and atrophic gastritis by 1.83-fold and 1.86-fold, respectively. For gastric cancer prognosis, patients with rs629367 CC genotype had significantly poorer survival than patients with AA genotype (log-rank P = 0.004). We further investigated the let-7a expression levels in serum and found that let-7a expression elevated gradually for rs629367 AA, CA, CC genotype in the atrophic gastritis group (P = 0.043). Furthermore, we confirmed these findings in vitro study by overexpressing let-7a carrying pri-let-7a-2 wild-type A or polymorphic-type C allele (P<0.001). Conclusions: pri-let-7a-2 rs629367 CC genotype could increase the risks of gastric cancer as well as atrophic gastritis and was also associated with poor survival of gastric cancer, which possibly by affecting the mature let-7a expression, and could serve as a predicting biomarker for high-risk and poor prognosis of gastric cancer.	[Xu, Qian; Dong, Qiguan; He, Caiyun; Liu, Wenjing; Sun, Liping; Liu, Jingwei; Xing, Chengzhong; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Canc Inst & Gen Surg, Tumor Etiol & Screening Dept, Shenyang, Liaoning, Peoples R China; [Xu, Qian; Dong, Qiguan; He, Caiyun; Liu, Wenjing; Sun, Liping; Liu, Jingwei; Xing, Chengzhong; Yuan, Yuan] China Med Univ, Key Lab Canc Etiol & Prevent, Liaoning Prov Educ Dept, Shenyang, Liaoning, Peoples R China; [Li, Xiaohang; Wang, Bengang] China Med Univ, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Li, Xiaohang] China Med Univ, Affiliated Hosp 1, Dept Gen Surg 4, Shenyang, Liaoning, Peoples R China; [Wang, Bengang] China Med Univ, Affiliated Hosp 1, Dept Gen Surg 1, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; China Medical University	Yuan, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Canc Inst & Gen Surg, Tumor Etiol & Screening Dept, Shenyang, Liaoning, Peoples R China.	yyuan@mail.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Key Basic Research Program of China (973 Program) [2010CB529304]; National Natural Science Foundation of China [31200968]; Science Technology Project in Liaoning Province [2011225002]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Project in Liaoning Province	This work is supported by grants from the National Key Basic Research Program of China (973 Program ref no. 2010CB529304), the National Natural Science Foundation of China (Ref No. 31200968), and the Science Technology Project in Liaoning Province (Ref No. 2011225002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Arisawa T, 2012, HUM IMMUNOL, V73, P747, DOI 10.1016/j.humimm.2012.04.011; Bensen JT, 2013, CANCER CAUSE CONTROL, V24, P1099, DOI 10.1007/s10552-013-0187-z; Brenner H, 2004, AM J EPIDEMIOL, V159, P252, DOI 10.1093/aje/kwh039; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen PS, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-90; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Fabbri M, 2013, ADV EXP MED BIOL, V754, P137, DOI 10.1007/978-1-4419-9967-2_6; Fabbri M, 2009, CARCINOGENESIS, V30, P912, DOI 10.1093/carcin/bgp063; Gong YH, 2010, EUR J CLIN MICROBIOL, V29, P907, DOI 10.1007/s10096-010-0944-9; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lao-Sirieix P, 2010, CURR OPIN GENET DEV, V20, P210, DOI 10.1016/j.gde.2010.03.002; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Long N, 2010, ASIAN PAC J CANCER P, V11, P107; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Mu YP, 2012, MED ONCOL, V29, P1723, DOI 10.1007/s12032-011-0115-6; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Salzman DW, 2013, PHARMACOL THERAPEUT, V137, P55, DOI 10.1016/j.pharmthera.2012.08.016; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Schuldt A, 2010, NAT REV MOL CELL BIO, V11, P676, DOI 10.1038/nrm2987; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; Srivastava K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050966; Stolte M, 2001, CAN J GASTROENTEROL, V15, P591, DOI 10.1155/2001/367832; Tramacere I, 2012, ANN ONCOL, V23, P287, DOI 10.1093/annonc/mdr136; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Wang F, 2013, MOL BIOL REP, V40, P109, DOI 10.1007/s11033-012-2039-4; Wang J, 2012, MOL BIOL REP, V39, P4571, DOI 10.1007/s11033-011-1247-7; Wang N, 2013, GENET MOL RES, V12, P3955, DOI 10.4238/2013.September.23.14; Wang PY, 2012, EXP THER MED, V3, P324, DOI 10.3892/etm.2011.399; Wang WN, 2013, TUMOR BIOL, V34, P1865, DOI 10.1007/s13277-013-0728-9; Wu XJ, 2013, ONKOLOGIE, V36, P573, DOI 10.1159/000355518; Xu L, 2013, PLOS ONE, V8; Xu Q, 2013, GENE, V529, P104, DOI 10.1016/j.gene.2013.07.070; Xu Q, 2009, INT J ONCOL, V35, P1313, DOI 10.3892/ijo_00000449; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Yang J, 2008, MUTAT RES-FUND MOL M, V638, P205, DOI 10.1016/j.mrfmmm.2007.08.007; Zhang YG, 2013, ASIAN PAC J CANCER P, V14, P2337, DOI 10.7314/APJCP.2013.14.4.2337; Zhou FY, 2012, DNA CELL BIOL, V31, P1290, DOI 10.1089/dna.2011.1596; Zhou J, 2013, GENE, V527, P456, DOI 10.1016/j.gene.2013.06.088; Zhu YM, 2010, WORLD J GASTROENTERO, V16, P3325, DOI 10.3748/wjg.v16.i26.3325; Zhu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079334	49	39	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95249	10.1371/journal.pone.0095249	http://dx.doi.org/10.1371/journal.pone.0095249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760009	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200042
J	Rice, LM; Donigan, M; Yang, MH; Liu, WD; Pandya, D; Joseph, BK; Sodi, V; Gearhart, TL; Yip, J; Bouchard, M; Nickels, JT				Rice, Lyndi M.; Donigan, Melissa; Yang, Muhua; Liu, Weidong; Pandya, Devanshi; Joseph, Biny K.; Sodi, Valerie; Gearhart, Tricia L.; Yip, Jenny; Bouchard, Michael; Nickels, Joseph T., Jr.			Protein Phosphatase 2A (PP2A) Regulates Low Density Lipoprotein Uptake through Regulating Sterol Response Element-binding Protein-2 (SREBP-2) DNA Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC KIDNEY-DISEASE; TRANSCRIPTION FACTORS; STATIN THERAPY; FATTY-ACID; RECEPTOR PROMOTER; CATALYTIC SUBUNIT; CHOLESTEROL; INHIBITION; EXPRESSION; PHOSPHORYLATION	LDL-cholesterol (LDL-C) uptake by Ldlr is regulated at the transcriptional level by the cleavage-dependent activation of membrane-associated sterol response element-binding protein (SREBP-2). Activated SREBP-2 translocates to the nucleus, where it binds to an LDLR promoter sterol response element (SRE), increasing LDLR gene expression and LDL-C uptake. SREBP-2 cleavage and translocation steps are well established. Several SREBP-2 phosphorylation sites have been mapped and functionally characterized. The phosphatases dephosphorylating these sites remain elusive. The phosphatase(s) regulating SREBP-2 represents a novel pharmacological target for treating hypercholesterolemia. Here we show that protein phosphatase 2A (PP2A) promotes SREBP-2 LDLR promoter binding in response to cholesterol depletion. No binding to an LDLR SRE was observed in the presence of the HMG-CoA reductase inhibitor, lovastatin, when PP2A activity was inhibited by okadaic acid or depleted by siRNA methods. SREBP-2 cleavage and nuclear translocation were not affected by loss of PP2A. PP2A activity was required for SREBP-2 DNA binding. In response to cholesterol depletion, PP2A directly interacted with SREBP-2 and altered its phosphorylation state, causing an increase in SREBP-2 binding to an LDLR SRE site. Increased binding resulted in induced LDLR gene expression and increased LDL uptake. We conclude that PP2A activity regulates cholesterol homeostasis and LDL-C uptake.	[Rice, Lyndi M.; Sodi, Valerie] Genesis Biotechnol Grp, Oncoveda Canc Inst, Hamilton, NJ 08691 USA; [Donigan, Melissa; Yang, Muhua; Liu, Weidong; Pandya, Devanshi; Joseph, Biny K.; Yip, Jenny; Nickels, Joseph T., Jr.] Genesis Biotechnol Grp, Inst Metab Disorders, Hamilton, NJ 08691 USA; [Gearhart, Tricia L.; Bouchard, Michael] Drexel Univ, Coll Med, Dept Mol Biol & Biochem, Philadelphia, PA 19129 USA	Drexel University	Nickels, JT (corresponding author), Inst Metab Disorders LLC, Genesis Biotechnol Grp, 1000 Waterview Dr, Hamilton, NJ 08691 USA.	jnickels@venenumbiodesign.com			Genesis Biotechnology Group; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER	Genesis Biotechnology Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Genesis Biotechnology Group.	Ahmed MH, 2009, DIABETES OBES METAB, V11, P188, DOI 10.1111/j.1463-1326.2008.00926.x; Bengoechea-Alonso MT, 2006, CELL CYCLE, V5, P1708, DOI 10.4161/cc.5.15.3131; Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200; Breitling R, 2007, BIOESSAYS, V29, P1085, DOI 10.1002/bies.20663; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chroinin DN, 2013, STROKE, V44, P448, DOI 10.1161/STROKEAHA.112.668277; COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; Colbert JD, 2012, CAN J CARDIOL, V28, P581, DOI 10.1016/j.cjca.2012.03.021; Datta S, 2005, J BIOL CHEM, V280, P3338, DOI 10.1074/jbc.M411222200; DeGrande ST, 2013, J BIOL CHEM, V288, P1032, DOI 10.1074/jbc.M112.426957; Elson EL, 2010, ANNU REV BIOPHYS, V39, P207, DOI 10.1146/annurev.biophys.093008.131238; Frey T, 2007, MOL MED, V13, P592, DOI 10.2119/2007-00054.Frey; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hernandez ML, 1997, BBA-LIPID LIPID MET, V1349, P233, DOI 10.1016/S0005-2760(97)00141-0; HOLEN I, 1993, EUR J BIOCHEM, V215, P113, DOI 10.1111/j.1432-1033.1993.tb18013.x; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Illingworth R, 2000, MED CLIN N AM, V84, P23, DOI 10.1016/S0025-7125(05)70205-4; Incardona JP, 2000, CURR OPIN CELL BIOL, V12, P193, DOI 10.1016/S0955-0674(99)00076-9; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jefcoate CR, 2011, MOL CELL ENDOCRINOL, V336, P53, DOI 10.1016/j.mce.2010.12.006; Jones PM, 2000, J MOL ENDOCRINOL, V24, P233, DOI 10.1677/jme.0.0240233; Jukema JW, 2012, J AM COLL CARDIOL, V60, P875, DOI 10.1016/j.jacc.2012.07.007; Katz SD, 2008, CURR ATHEROSCLER REP, V10, P318, DOI 10.1007/s11883-008-0049-4; Khoo Michael C K, 2013, IEEE Rev Biomed Eng, V6, P143, DOI 10.1109/RBME.2012.2232651; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Kotzka J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032609; Kotzka J, 2010, ATHEROSCLEROSIS, V213, P156, DOI 10.1016/j.atherosclerosis.2010.08.046; Kurachi S, 2009, P NATL ACAD SCI USA, V106, P7921, DOI 10.1073/pnas.0902191106; LEE J, 1993, J BIOL CHEM, V268, P19192; Li C, 1999, J BIOL CHEM, V274, P6747, DOI 10.1074/jbc.274.10.6747; Li YK, 2008, J VIROL, V82, P3612, DOI 10.1128/JVI.02435-07; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; LLOYD DB, 1995, J BIOL CHEM, V270, P25812, DOI 10.1074/jbc.270.43.25812; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Matsui M, 2010, CHEM BIOL, V17, P1344, DOI 10.1016/j.chembiol.2010.10.009; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mui MZ, 2010, J VIROL, V84, P4798, DOI 10.1128/JVI.02434-09; Nagoshi E, 2001, MOL CELL BIOL, V21, P2779, DOI 10.1128/MCB.21.8.2779-2789.2001; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Pak YK, 1996, BIOCHEM MOL BIOL INT, V38, P31; Pallai R, 2012, TRANSCR-AUSTIN, V3, P323, DOI 10.4161/trns.22518; Palmer SC, 2012, ANN INTERN MED, V157, P263, DOI 10.7326/0003-4819-157-4-201208210-00007; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Roth G, 2000, J BIOL CHEM, V275, P33302, DOI 10.1074/jbc.M005425200; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sato Ken-Ichi, 2008, Open Biochem J, V2, P49, DOI 10.2174/1874091X00802010049; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shen Ling, 2012, J Vis Exp, DOI 10.3791/3917; Sonnino S, 2013, CURR MED CHEM, V20, P4; Stein EA, 2013, CURR OPIN LIPIDOL, V24, P510, DOI 10.1097/MOL.0000000000000021; Stein O, 2005, ATHEROSCLEROSIS, V178, P217, DOI 10.1016/j.atherosclerosis.2004.10.008; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tenenbaum A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-125; Upadhyay A, 2012, ANN INTERN MED, V157, P251, DOI 10.7326/0003-4819-157-4-201208210-00005; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; WANG XD, 1993, J BIOL CHEM, V268, P14497; Wong RHF, 2010, CURR OPIN PHARMACOL, V10, P684, DOI 10.1016/j.coph.2010.08.004; Wood WG, 2011, J NEUROCHEM, V116, P684, DOI 10.1111/j.1471-4159.2010.07017.x; Yoon YS, 2009, J BIOL CHEM, V284, P10446, DOI 10.1074/jbc.M900096200; Zhang ZY, 2011, J VIROL, V85, P286, DOI 10.1128/JVI.01381-10	66	13	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17268	17279		10.1074/jbc.M114.570390	http://dx.doi.org/10.1074/jbc.M114.570390			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24770487	hybrid, Green Published			2022-12-25	WOS:000338016200058
J	Mandal, S; Locke, C; Tanaka, M; Yamazaki, H				Mandal, Sandip; Locke, Christopher; Tanaka, Mamoru; Yamazaki, Hidekatsu			Observations and Models of Highly Intermittent Phytoplankton Distributions	PLOS ONE			English	Article							SCALE SPATIAL STRUCTURE; SIMPLE PLANKTON MODEL; IN-VIVO FLUORESCENCE; MARINE-PHYTOPLANKTON; IMAGING FLUOROMETER; BANK REGION; UPPER OCEAN; DYNAMICS; ECOSYSTEMS; ACCLIMATION	The measurement of phytoplankton distributions in ocean ecosystems provides the basis for elucidating the influences of physical processes on plankton dynamics. Technological advances allow for measurement of phytoplankton data to greater resolution, displaying high spatial variability. In conventional mathematical models, the mean value of the measured variable is approximated to compare with the model output, which may misinterpret the reality of planktonic ecosystems, especially at the microscale level. To consider intermittency of variables, in this work, a new modelling approach to the planktonic ecosystem is applied, called the closure approach. Using this approach for a simple nutrient-phytoplankton model, we have shown how consideration of the fluctuating parts of model variables can affect system dynamics. Also, we have found a critical value of variance of overall fluctuating terms below which the conventional non-closure model and the mean value from the closure model exhibit the same result. This analysis gives an idea about the importance of the fluctuating parts of model variables and about when to use the closure approach. Comparisons of plot of mean versus standard deviation of phytoplankton at different depths, obtained using this new approach with real observations, give this approach good conformity.	[Mandal, Sandip; Locke, Christopher; Tanaka, Mamoru; Yamazaki, Hidekatsu] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Minato Ku, Tokyo, Japan	Tokyo University of Marine Science & Technology	Yamazaki, H (corresponding author), Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Minato Ku, Tokyo, Japan.	hide@kaiyodai.ac.jp	Tanaka, Mamoru/AAT-1131-2020		JST Crest	JST Crest(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work is supported by a fund made available from JST Crest. The funding agency has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KH, 2010, P ROY SOC B-BIOL SCI, V277, P795, DOI 10.1098/rspb.2009.1512; Armstrong RA, 2003, DEEP-SEA RES PT II, V50, P2895, DOI 10.1016/j.dsr2.2003.07.003; Azam F, 2004, SCIENCE, V303, P1622, DOI 10.1126/science.1093892; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Clark DR, 2000, P ROY SOC B-BIOL SCI, V267, P953, DOI 10.1098/rspb.2000.1096; Davis CS, 2005, LIMNOL OCEANOGR-METH, V3, P59, DOI 10.4319/lom.2005.3.59; DENMAN KL, 1995, ANNU REV FLUID MECH, V27, P225, DOI 10.1146/annurev.fl.27.010195.001301; Denman KL, 1999, DEEP-SEA RES PT II, V46, P2877, DOI 10.1016/S0967-0645(99)00087-9; Desiderio RA, 1997, APPL OPTICS, V36, P1289, DOI 10.1364/AO.36.001289; Doney SC, 1996, DEEP-SEA RES PT II, V43, P591, DOI 10.1016/0967-0645(95)00104-2; Doubell MJ, 2014, DEEP-SEA RES PT II, V101, P207, DOI 10.1016/j.dsr2.2012.12.009; Doubell MJ, 2009, J PLANKTON RES, V31, P1441, DOI 10.1093/plankt/fbp092; Doubell MJ, 2006, APPL ENVIRON MICROB, V72, P4475, DOI 10.1128/AEM.02959-05; Edwards AM, 2001, J PLANKTON RES, V23, P389, DOI 10.1093/plankt/23.4.389; Edwards CA, 2000, J PLANKTON RES, V22, P1619, DOI 10.1093/plankt/22.9.1619; EPPLEY RW, 1969, LIMNOL OCEANOGR, V14, P912, DOI 10.4319/lo.1969.14.6.0912; Fasham M., 1993, GLOBAL CARBON CYCLE, V15, P457; Flynn KJ, 2003, PROG OCEANOGR, V56, P249, DOI 10.1016/S0079-6611(03)00006-5; Franks PJS, 2005, MAR ECOL PROG SER, V294, P295, DOI 10.3354/meps294295; FRANKS PJS, 1986, MAR BIOL, V91, P121, DOI 10.1007/BF00397577; Franks PJS, 2002, J OCEANOGR, V58, P379, DOI 10.1023/A:1015874028196; Franks PJS, 2001, MAR ECOL PROG SER, V220, P59, DOI 10.3354/meps220059; Franks PJS, 1997, ICES J MAR SCI, V54, P161, DOI 10.1006/jmsc.1996.0191; Gentleman WC, 2008, J PLANKTON RES, V30, P1215, DOI 10.1093/plankt/fbn078; Huisman J, 2006, NATURE, V439, P322, DOI 10.1038/nature04245; Ji RB, 2009, MAR ECOL PROG SER, V384, P187, DOI 10.3354/meps08032; Katz J, 1999, DEEP-SEA RES PT I, V46, P1455, DOI 10.1016/S0967-0637(99)00011-4; Kishi MJ, 2011, J OCEANOGR, V67, P3, DOI 10.1007/s10872-011-0009-4; LEHMAN JT, 1975, LIMNOL OCEANOGR, V20, P343, DOI 10.4319/lo.1975.20.3.0343; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Loreau M, 2001, P ROY SOC B-BIOL SCI, V268, P303, DOI 10.1098/rspb.2000.1366; MACISAAC JJ, 1969, DEEP-SEA RES, V16, P45, DOI 10.1016/0011-7471(69)90049-7; Malkiel E, 2006, J PLANKTON RES, V28, P149, DOI 10.1093/plankt/fbi107; Mandal S, 2006, ECOL MODEL, V197, P498, DOI 10.1016/j.ecolmodel.2006.03.020; Poulin FJ, 2010, J PLANKTON RES, V32, P1121, DOI 10.1093/plankt/fbp145; Prairie J. C., 2011, LIMNOLOGY OCEANOGRAP, V1, P75, DOI DOI 10.1215/21573698-1267403; Prairie JC, 2010, LIMNOL OCEANOGR, V55, P1943, DOI 10.4319/lo.2010.55.5.1943; Segura AM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01037; STEELE JH, 1981, AM NAT, V117, P676, DOI 10.1086/283752; Stegert C, 2012, J PLANKTON RES, V34, P18, DOI 10.1093/plankt/fbr084; Waters RL, 2003, MAR ECOL PROG SER, V251, P49, DOI 10.3354/meps251049; Waters RL, 2002, MAR ECOL PROG SER, V237, P51, DOI 10.3354/meps237051; Wolk F., 2001, J TOKYO U FISH, V87, P13; Young WR, 2001, NATURE, V412, P328, DOI 10.1038/35085561	44	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94797	10.1371/journal.pone.0094797	http://dx.doi.org/10.1371/journal.pone.0094797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787740	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700018
J	Elser, JJ; Elser, TJ; Carpenter, SR; Brock, WA				Elser, James J.; Elser, Timothy J.; Carpenter, Stephen R.; Brock, William A.			Regime Shift in Fertilizer Commodities Indicates More Turbulence Ahead for Food Security	PLOS ONE			English	Article							PHOSPHORUS; OIL; AGRICULTURE; SYSTEM; CYCLE	Recent human population increase has been enabled by a massive expansion of global agricultural production. A key component of this "Green Revolution'' has been application of inorganic fertilizers to produce and maintain high crop yields. However, the long-term sustainability of these practices is unclear given the eutrophying effects of fertilizer runoff as well as the reliance of fertilizer production on finite non-renewable resources such as mined phosphate-and potassium-bearing rocks. Indeed, recent volatility in food and agricultural commodity prices, especially phosphate fertilizer, has raised concerns about emerging constraints on fertilizer production with consequences for its affordability in the developing world. We examined 30 years of monthly prices of fertilizer commodities (phosphate rock, urea, and potassium) for comparison with three food commodities (maize, wheat, and rice) and three non-agricultural commodities (gold, nickel, and petroleum). Here we show that all commodity prices, except gold, had significant change points between 2007-2009, but the fertilizer commodities, and especially phosphate rock, showed multiple symptoms of nonlinear critical transitions. In contrast to fertilizers and to rice, maize and wheat prices did not show significant signs of nonlinear dynamics. From these results we infer a recent emergence of a scarcity price in global fertilizer markets, a result signaling a new high price regime for these essential agricultural inputs. Such a regime will challenge on-going efforts to establish global food security but may also prompt fertilizer use practices and nutrient recovery strategies that reduce eutrophication.	[Elser, James J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Elser, Timothy J.] Flyr Inc, San Francisco, CA USA; [Carpenter, Stephen R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Brock, William A.] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Brock, William A.] Univ Missouri, Dept Econ, Columbia, MO USA	Arizona State University; Arizona State University-Tempe; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Missouri System; University of Missouri Columbia	Elser, JJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	j.elser@asu.edu	Elser, James/A-7082-2008; Elser, James J/AAL-6199-2020; Carpenter, Stephen/AAQ-6404-2020	Elser, James/0000-0002-1460-2155; Elser, James J/0000-0002-1460-2155; 	Arizona State University Sustainable Phosphorus Initiative; US National Science Foundation (NSF); NSF from North Temperate Lakes LTER; Water Sustainability and Climate program; Vilas Trust; NSF Center for Robust Decision Making on Climate Change and Energy Policy; Direct For Biological Sciences [1440297] Funding Source: National Science Foundation; Division Of Earth Sciences [1038759] Funding Source: National Science Foundation	Arizona State University Sustainable Phosphorus Initiative; US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF from North Temperate Lakes LTER; Water Sustainability and Climate program; Vilas Trust; NSF Center for Robust Decision Making on Climate Change and Energy Policy; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	J.J.E. is grateful for support from the Arizona State University Sustainable Phosphorus Initiative and the US National Science Foundation (NSF). S.R.C. acknowledges support of the NSF from North Temperate Lakes LTER and the Water Sustainability and Climate program. W. B. is supported by the Vilas Trust and the NSF Center for Robust Decision Making on Climate Change and Energy Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, WORLD AGR 2030 2050, DOI DOI 10.22004/AG.ECON.288998; Ashley RA, 2000, NONLINEAR TIME SERIE; Baffes J, 2007, RESOUR POLICY, V32, P126, DOI 10.1016/j.resourpol.2007.08.004; Baffes J, 2010, APPL ECON LETT, V17, P1555, DOI 10.1080/13504850903120683; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Brock W.A., 1991, NONLINEAR DYNAMICS C; Brock WA, 1996, ECONOMET REV, V15, P197, DOI [10.1080/07474939608800353, DOI 10.1080/07474939608800353]; Burnham K. P., 1998, MODEL SELECTION INFE; Burt D., 2013, PHOSPHORUS FOOD OUR, P40; Campbell J., 1997, ECONOMETRICS FINANCI; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter S R, 2003, REGIME SHIFTS LAKE E; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Childers DL, 2011, BIOSCIENCE, V61, P117, DOI 10.1525/bio.2011.61.2.6; Cooper J, 2011, RESOUR CONSERV RECY, V57, P78, DOI 10.1016/j.resconrec.2011.09.009; Cordell D, 2011, CHEMOSPHERE, V84, P747, DOI 10.1016/j.chemosphere.2011.02.032; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Dasgupta P., 1979, EC THEORY EXHAUSTIBL; Elser J, 2011, NATURE, V478, P29, DOI 10.1038/478029a; Evans M, 2012, PHOSPHATE RESOURCES; Figuerola-Ferretti I, 2008, J FUTURES MARKETS, V28, P935, DOI 10.1002/fut.20338; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gaxiola RA, 2011, CHEMOSPHERE, V84, P840, DOI 10.1016/j.chemosphere.2011.01.062; Hamilton JD, 2013, HDB ENERGY CLIMATE C, P39; Hassouneh I, 2012, ENERG ECON, V34, P1507, DOI 10.1016/j.eneco.2012.06.027; Hering JG, 2012, SCIENCE, V337, P623, DOI 10.1126/science.1227092; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Lopez-Arredondo DL, 2012, NAT BIOTECHNOL, V30, P889, DOI 10.1038/nbt.2346; Metson GS, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044043; Rittmann BE, 2011, CHEMOSPHERE, V84, P846, DOI 10.1016/j.chemosphere.2011.02.001; Scheffer M., 2009, CRITICAL TRANSITIONS; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Scholz RW, 2013, GLOBAL ENVIRON CHANG, V23, P11, DOI 10.1016/j.gloenvcha.2012.10.013; Serra T, 2011, AGR ECON-BLACKWELL, V42, P35, DOI 10.1111/j.1574-0862.2010.00464.x; Smith JL, 2012, ENERG POLICY, V44, P68, DOI 10.1016/j.enpol.2012.01.014; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Van Kauwenbergh S., 2010, WORLD PHOSPHATE ROCK, V75; Wyant KA, 2013, PHOSPHORUS FOOD OUT	42	36	36	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e93998	10.1371/journal.pone.0093998	http://dx.doi.org/10.1371/journal.pone.0093998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG6EE	24787624	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600008
J	Masson, GS; Costa, TSR; Yshii, L; Fernandes, DC; Soares, PPS; Laurindo, FR; Scavone, C; Michelini, LC				Masson, Gustavo S.; Costa, Tassia S. R.; Yshii, Lidia; Fernandes, Denise C.; Silva Soares, Pedro Paulo; Laurindo, Francisco R.; Scavone, Cristoforo; Michelini, Lisete C.			Time-Dependent Effects of Training on Cardiovascular Control in Spontaneously Hypertensive Rats: Role for Brain Oxidative Stress and Inflammation and Baroreflex Sensitivity	PLOS ONE			English	Article							FACTOR-KAPPA-B; NUCLEUS-TRACTUS-SOLITARII; ANGIOTENSIN-II; PARAVENTRICULAR NUCLEUS; HEART-RATE; RECEPTOR EXPRESSION; INDUCED ACTIVATION; INDUCED PLASTICITY; BLOOD-PRESSURE; NADPH OXIDASE	Baroreflex dysfunction, oxidative stress and inflammation, important hallmarks of hypertension, are attenuated by exercise training. In this study, we investigated the relationships and time-course changes of cardiovascular parameters, pro-inflammatory cytokines and pro-oxidant profiles within the hypothalamic paraventricular nucleus of the spontaneously hypertensive rats (SHR). Basal values and variability of arterial pressure and heart rate and baroreflex sensitivity were measured in trained (T, low-intensity treadmill training) and sedentary (S) SHR at weeks 0, 1, 2, 4 and 8. Paraventricular nucleus was used to determine reactive oxygen species (dihydroethidium oxidation products, HPLC), NADPH oxidase subunits and pro-inflammatory cytokines expression (Real time PCR), p38 MAPK and ERK1/2 expression (Western blotting), NF-kappa B content (electrophoretic mobility shift assay) and cytokines immunofluorescence. SHR-S vs. WKY-S (Wistar Kyoto rats as time control) showed increased mean arterial pressure (172 +/- 3 mmHg), pressure variability and heart rate (358 +/- 7 b/min), decreased baroreflex sensitivity and heart rate variability, increased p47(phox) and reactive oxygen species production, elevated NF-kappa B activity and increased TNF-alpha and IL-6 expression within the paraventricular nucleus of hypothalamus. Two weeks of training reversed all hypothalamic changes, reduced ERK1/2 phosphorylation and normalized baroreflex sensitivity (4.04 +/- 0.31 vs. 2.31 +/- 0.19 b/min/mmHg in SHR-S). These responses were followed by increased vagal component of heart rate variability (1.9-fold) and resting bradycardia (-13%) at the 4th week, and, by reduced vasomotor component of pressure variability (-28%) and decreased mean arterial pressure (-7%) only at the 8th week of training. Our findings indicate that independent of the high pressure levels in SHR, training promptly restores baroreflex function by disrupting the positive feedback between high oxidative stress and increased pro-inflammatory cytokines secretion within the hypothalamic paraventricular nucleus. These early adaptive responses precede the occurrence of training-induced resting bradycardia and blood pressure fall.	[Masson, Gustavo S.; Costa, Tassia S. R.; Michelini, Lisete C.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Yshii, Lidia; Scavone, Cristoforo] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil; [Fernandes, Denise C.; Laurindo, Francisco R.] Univ Sao Paulo, Inst Heart, Vasc Biol Lab, Sao Paulo, Brazil; [Silva Soares, Pedro Paulo] Univ Fed Fluminense, Dept Physiol & Pharmacol, Niteroi, RJ, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal Fluminense	Michelini, LC (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	michelin@usp.br	Scavone, Cristoforo/C-1580-2012; Scavone, Cristoforo/AFK-9950-2022; da Silva Soares, Pedro Paulo/AAM-7383-2021; Yshii, Lidia M/I-6039-2013; Yshii, Lidia/GQA-4796-2022; Scavone, Cristoforo/ABB-8279-2021; Laurindo, Francisco R/J-6575-2015	Scavone, Cristoforo/0000-0002-1206-0882; Scavone, Cristoforo/0000-0002-1206-0882; da Silva Soares, Pedro Paulo/0000-0001-9589-4294; Yshii, Lidia M/0000-0002-1988-6855; Scavone, Cristoforo/0000-0002-1206-0882; Santos Rodrigues da Costa, Tassia/0000-0002-7717-6202; de Castro Fernandes, Denise/0000-0003-0213-4291	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/54299-1]; Conselho Nacional de Pesquisa (CNPq) [304060/2011-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, research grant 09/54299-1), Conselho Nacional de Pesquisa (CNPq, research Grant 304060/2011-9) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, fellowship to GSM). L. C. Michelini is a research fellow from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; Amaral SL, 2011, BRAZ J MED BIOL RES, V44, P814, DOI 10.1590/S0100-879X2011000900001; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; BRISTOW JD, 1969, J PHYSIOL-LONDON, V202, pP45; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; Cavalleri MT, 2011, AM J PHYSIOL-REG I, V301, pR958, DOI 10.1152/ajpregu.00104.2011; Ceroni A, 2009, EXP PHYSIOL, V94, P630, DOI 10.1113/expphysiol.2008.046128; Felix JVC, 2007, HYPERTENSION, V50, P780, DOI 10.1161/HYPERTENSIONAHA.107.094474; Chan SHH, 2007, J HYPERTENS, V25, P1845, DOI 10.1097/HJH.0b013e328217b286; Cohuet G, 2006, PHARMACOL THERAPEUT, V111, P81, DOI 10.1016/j.pharmthera.2005.09.002; Cruz JC, 2013, EXP PHYSIOL, V98, P386, DOI 10.1113/expphysiol.2012.065888; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Gao L, 2007, CIRCULATION, V115, P3095, DOI 10.1161/CIRCULATIONAHA.106.677989; Guggilam A, 2008, EUR J HEART FAIL, V10, P625, DOI 10.1016/j.ejheart.2008.05.004; Higa KT, 2002, AM J PHYSIOL-REG I, V282, pR537, DOI 10.1152/ajpregu.00806.2000; Higa-Taniguchi KT, 2009, EXP PHYSIOL, V94, P1103, DOI 10.1113/expphysiol.2009.049262; Johansson M, 2007, J HYPERTENS, V25, P163, DOI 10.1097/01.hjh.0000254377.18983.eb; Kang YM, 2011, BASIC RES CARDIOL, V106, P1087, DOI 10.1007/s00395-011-0215-7; Krieger EM, 2001, ANN NY ACAD SCI, V940, P338, DOI 10.1111/j.1749-6632.2001.tb03689.x; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; Martins AS, 2005, HYPERTENSION, V46, P1004, DOI 10.1161/01.HYP.0000175812.03322.59; Michelini LC, 2009, EXP PHYSIOL, V94, P947, DOI 10.1113/expphysiol.2009.047449; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; Moraes-Silva IC, 2010, CLIN EXP PHARMACOL P, V37, pe114, DOI 10.1111/j.1440-1681.2009.05333.x; Munhoz CD, 2006, J NEUROSCI, V26, P3813, DOI 10.1523/JNEUROSCI.4398-05.2006; Oliveira-Sales EB, 2009, AM J HYPERTENS, V22, P484, DOI 10.1038/ajh.2009.17; Ormezzano O, 2008, J HYPERTENS, V26, P1373, DOI 10.1097/HJH.0b013e3283015e5a; Pan YX, 2007, HYPERTENSION, V49, P519, DOI 10.1161/01.HYP.0000256955.74461.93; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Rahmouni K, 2011, CELL METAB, V14, P3, DOI 10.1016/j.cmet.2011.06.006; Rong YQ, 1996, J NEUROCHEM, V67, P662; Shi Z, 2011, ACTA PHYSIOL, V203, P289, DOI 10.1111/j.1748-1716.2011.02313.x; Sriramula S, 2013, PLOS ONE, V15, pe638; Szeto A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1495, DOI 10.1152/ajpendo.90718.2008; Takagishi M, 2010, AM J PHYSIOL-REG I, V298, pR183, DOI 10.1152/ajpregu.00176.2009; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; Wei SG, 2009, AM J PHYSIOL-HEART C, V296, pH1425, DOI 10.1152/ajpheart.00942.2008; Zimmerman MC, 2004, PROG BIOPHYS MOL BIO, V84, P125, DOI 10.1016/j.pbiomolbio.2003.11.009	39	59	67	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94927	10.1371/journal.pone.0094927	http://dx.doi.org/10.1371/journal.pone.0094927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788542	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600021
J	Kim, B; Kim, JH; Kim, MK; Lee, KS; Kim, Y; Choi, TK; Kim, YT; Lee, SH				Kim, Borah; Kim, Jeong Hoon; Kim, Min-Kyoung; Lee, Kang Soo; Kim, Youngki; Choi, Tai Kiu; Kim, Yun Tai; Lee, Sang-Hyuk			Frontal White Matter Alterations in Short-Term Medicated Panic Disorder Patients without Comorbid Conditions: A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							SOCIAL ANXIETY DISORDER; CEREBRAL-BLOOD-FLOW; OBSESSIVE-COMPULSIVE DISORDER; TRAUMATIC BRAIN-INJURY; 1ST 6 MONTHS; BENZODIAZEPINE-RECEPTOR; STRUCTURAL CONNECTIVITY; OCCIPITAL FASCICULUS; MAJOR DEPRESSION; CORPUS-CALLOSUM	The frontal cortex might play an important role in the fear network, and white matter (WM) integrity could be related to the pathophysiology of panic disorder (PD). A few studies have investigated alterations of WM integrity in PD. The aim of this study was to determine frontal WM integrity differences between patients with PD without comorbid conditions and healthy control (HC) subjects by using diffusion tensor imaging. Thirty-six patients with PD who had used medication within 1 week and 27 age-and sex-matched HC subjects participated in this study. Structural brain magnetic resonance imaging was performed on all participants. Panic Disorder Severity Scale and Beck Anxiety Inventory (BAI) scores were assessed. Tract-based spatial statistics (TBSS) was used for image analysis. TBSS analysis showed decreased fractional anisotropy (FA) in frontal WM and WM around the frontal lobe, including the corpus callosum of both hemispheres, in patients with PD compared to HC subjects. Moreover, voxel-wise correlation analysis revealed that the BAI scores for patients with PD were positively correlated with their FA values for regions showing group differences in the FA of frontal WM of both hemispheres. Altered integrity in frontal WM of patients with PD without comorbid conditions might represent the structural pathophysiology in these patients, and these changes could be related to clinical symptoms of PD.	[Kim, Borah; Kim, Min-Kyoung; Choi, Tai Kiu; Lee, Sang-Hyuk] CHA Univ, Dept Psychiat, CHA Bundang Med Ctr, Songnam, Gyeonggi Do, South Korea; [Kim, Jeong Hoon] Bundang Jaesaeng Hosp, Dept Psychiat, Songnam, Gyeonggi Do, South Korea; [Lee, Kang Soo] CHA Univ, Dept Psychiat, CHA Gangnam Med Ctr, Seoul, South Korea; [Kim, Youngki] Sujiyonsei Psychiat Clin, Yongin, Gyeonggi Do, South Korea; [Kim, Yun Tai] CHA Univ, Coll Life Sci, Dept Appl Biosci, Pocheon Si, Gyeonggi Do, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University	Kim, YT (corresponding author), CHA Univ, Coll Life Sci, Dept Appl Biosci, Pocheon Si, Gyeonggi Do, South Korea.	ytkim@cha.ac.kr; leesanghyuk@yahoo.com			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2011-0023359]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0023359) to S. H. Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RP, 2008, J NEUROSCI, V28, P6211, DOI 10.1523/JNEUROSCI.1246-08.2008; Asami T, 2009, PSYCHIAT RES-NEUROIM, V173, P128, DOI 10.1016/j.pscychresns.2008.10.004; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Baur V, 2013, HUM BRAIN MAPP, V34, P437, DOI 10.1002/hbm.21447; Baur V, 2011, J PSYCHIATR RES, V45, P1366, DOI 10.1016/j.jpsychires.2011.05.007; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bremner JD, 2000, BIOL PSYCHIAT, V47, P96, DOI 10.1016/S0006-3223(99)00188-2; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Compton RJ, 2008, EMOTION, V8, P684, DOI 10.1037/a0012910; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; de Carvalho MR, 2010, EXPERT REV NEUROTHER, V10, P291, DOI [10.1586/ern.09.161, 10.1586/ERN.09.161]; Dresler T, 2012, J PSYCHIATR RES, V46, P1627, DOI 10.1016/j.jpsychires.2012.09.004; EDMONSTONE Y, 1994, ACTA PSYCHIAT SCAND, V90, P298, DOI 10.1111/j.1600-0447.1994.tb01597.x; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; First M. B., 2014, SCID 5 105 STRUCTURE; Fischer H, 1998, NEUROSCI LETT, V251, P137, DOI 10.1016/S0304-3940(98)00503-5; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Han DH, 2008, J PSYCHIATR RES, V42, P399, DOI 10.1016/j.jpsychires.2007.03.002; Hasler G, 2008, ARCH GEN PSYCHIAT, V65, P1166, DOI 10.1001/archpsyc.65.10.1166; Kaasinen V, 2001, P NATL ACAD SCI USA, V98, P13272, DOI 10.1073/pnas.231313198; Kang EH, 2012, NEUROPSYCHOBIOLOGY, V66, P106, DOI 10.1159/000337740; Kent JM, 2005, AM J PSYCHIAT, V162, P1379, DOI 10.1176/appi.ajp.162.7.1379; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P415, DOI 10.1001/archpsyc.63.4.415; Kim B, 2013, PROG NEURO-PSYCHOPH, V43, P188, DOI 10.1016/j.pnpbp.2012.12.022; Kim B, 2013, J AFFECT DISORDERS, V147, P64, DOI 10.1016/j.jad.2012.10.009; Kim ZS., 1997, KOREAN J CLIN PSYCHO, V16, P185; Lai CH, 2013, J AFFECT DISORDERS, V150, P330, DOI 10.1016/j.jad.2013.04.014; Lai CH, 2013, J AFFECT DISORDERS, V146, P378, DOI 10.1016/j.jad.2012.09.022; Lai CH, 2012, J AFFECT DISORDERS, V140, P285, DOI 10.1016/j.jad.2012.01.049; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; Lim YJ, 2007, DEPRESS ANXIETY, V24, P95, DOI 10.1002/da.20206; Maddock RJ, 2003, NEUROREPORT, V14, P325, DOI 10.1097/01.wnr.0000059776.23521.25; MARKOWITZ JS, 1989, ARCH GEN PSYCHIAT, V46, P984; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Miao W, 2012, AJNR AM J NEURORADIO; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nikolaus S, 2010, REV NEUROSCIENCE, V21, P119; Ohta H, 2008, DEPRESS ANXIETY, V25, P1053, DOI 10.1002/da.20463; Parraga HC, 2003, INT J PSYCHIAT MED, V33, P107, DOI 10.2190/D4Y1-WNBX-HQW8-HDPL; Pillay SS, 2006, J AFFECT DISORDERS, V94, P173, DOI 10.1016/j.jad.2006.04.007; Roy-Byrne PP, 1999, J CLIN PSYCHIAT; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Shear MK, 2001, J PSYCHIAT RES, V35, P293, DOI 10.1016/S0022-3956(01)00028-0; Shergill SS, 2007, AM J PSYCHIAT, V164, P467, DOI 10.1176/appi.ajp.164.3.467; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sobanski T, 2010, PSYCHOL MED, V40, P1879, DOI 10.1017/S0033291709991930; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; STEWART RS, 1988, AM J PSYCHIAT, V145, P442; Tromp DPM, 2012, ARCH GEN PSYCHIAT, V69, P925, DOI 10.1001/archgenpsychiatry.2011.2178; Uhlmann C., 2013, PSYCHOL MED, P1; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P922, DOI 10.1001/archpsyc.62.8.922; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Walterfang M, 2009, J AFFECT DISORDERS, V115, P411, DOI 10.1016/j.jad.2008.10.010; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; WOODS SW, 1988, LANCET, V2, P678	63	12	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95279	10.1371/journal.pone.0095279	http://dx.doi.org/10.1371/journal.pone.0095279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788587	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917300010
J	Touchton, JM; Seddon, N; Tobias, JA				Touchton, Janeene M.; Seddon, Nathalie; Tobias, Joseph A.			Captive Rearing Experiments Confirm Song Development without Learning in a Tracheophone Suboscine Bird	PLOS ONE			English	Article							LONG-TAILED MANAKIN; SEXUAL SELECTION; VOCAL DISTINCTIVENESS; EVOLUTION; DIVERGENCE; PASSERINE; SONGBIRDS; ANTBIRD; DRIVE; VOCALIZATIONS	The origin of vocal learning in animals has long been the subject of debate, but progress has been limited by uncertainty regarding the distribution of learning mechanisms across the tree of life, even for model systems such as birdsong. In particular, the importance of learning is well known in oscine songbirds, but disputed in suboscines. Members of this diverse group (similar to 1150 species) are generally assumed not to learn their songs, but empirical evidence is scarce, with previous studies restricted to the bronchophone (non-tracheophone) clade. Here, we conduct the first experimental study of song development in a tracheophone suboscine bird by rearing spotted antbird (Hylophylax naevioides) chicks in soundproofed aviaries. Individuals were raised either in silence with no tutor or exposed to standardized playback of a heterospecific tutor. All individuals surviving to maturity took a minimum of 79 days to produce a crystallized version of adult song, which in all cases was indistinguishable from wild song types of their own species. These first insights into song development in tracheophone suboscines suggest that adult songs are innate rather than learnt. Given that empirical evidence for song learning in suboscines is restricted to polygamous and lek-mating species, whereas tracheophone suboscines are mainly monogamous with long-term social bonds, our results are consistent with the view that sexual selection promotes song learning in birds.	[Touchton, Janeene M.] Smithsonian Trop Res Inst, Balboa, Panama; [Touchton, Janeene M.] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Seddon, Nathalie; Tobias, Joseph A.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	Smithsonian Institution; Smithsonian Tropical Research Institute; Max Planck Society; University of Oxford	Touchton, JM (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.	touchtonj@gmail.com		Seddon, Nathalie/0000-0002-1880-6104; Tobias, Joseph/0000-0003-2429-6179	Royal Society [ATJCZRJ2]; Smithsonian Institution Fellowship	Royal Society(Royal Society of London); Smithsonian Institution Fellowship(Smithsonian InstitutionSmithsonian National Museum of Natural History)	This research was funded by a Royal Society Research Grant (ATJCZRJ2) to J.A.T., a Royal Society Research Fellowship to N.S., and a Smithsonian Institution Fellowship to J.M.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2013, P BIOL SCI, V280, DOI [10.1086/508809, DOI 10.1086/508809]; Bard SC, 2002, CONDOR, V104, P387, DOI 10.1650/0010-5422(2002)104[0387:VDARTC]2.0.CO;2; Beecher MD, 2000, ANIM BEHAV, V59, P21, DOI 10.1006/anbe.1999.1276; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Botero CA, 2009, ANIM BEHAV, V77, P701, DOI 10.1016/j.anbehav.2008.11.020; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; Cadena CD, 2007, IBIS, V149, P814, DOI 10.1111/j.1474-919X.2007.00717.x; Chesser RT, 2004, MOL PHYLOGENET EVOL, V32, P11, DOI 10.1016/j.ympev.2003.11.015; Cockburn A, 2009, BEHAV ECOL; CODY ML, 1969, CONDOR, V71, P223, DOI 10.2307/1366300; Coleman SW, 2007, BIOL LETTERS, V3, P463, DOI 10.1098/rsbl.2007.0234; Cortopassi K, 2006, AUTOMATED ROBUST MEA; Derryberry EP, 2009, AM NAT, V174, P24, DOI 10.1086/599298; Derryberry EP, 2012, EVOLUTION, V66, P2784, DOI 10.1111/j.1558-5646.2012.01642.x; Fitzsimmons LP, 2008, AUK, V125, P908, DOI 10.1525/auk.2008.07128; Fleischer RC, 1997, CONDOR, V99, P512, DOI 10.2307/1369957; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Haavie J, 2004, J EVOLUTION BIOL, V17, P227, DOI 10.1111/j.1420-9101.2003.00682.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HANSEN P, 1979, ANIM BEHAV, V27, P1270, DOI 10.1016/0003-3472(79)90073-3; Hau M, 2000, GEN COMP ENDOCR, V117, P20, DOI 10.1006/gcen.1999.7390; HELB HW, 1985, Z TIERPSYCHOL, V69, P27; Isler ML, 1998, AUK, V115, P577, DOI 10.2307/4089407; Isler PR, 2002, SONGS ANTBIRDS; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Katz PS, 2011, PHILOS T R SOC B, V366, P2086, DOI 10.1098/rstb.2010.0336; KROODSMA DE, 1984, AUK, V101, P13, DOI 10.1093/auk/101.1.13; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; Kroodsma D, 2013, WILSON J ORNITHOL, V125, P1; Kroodsma D, 2011, AUK, V128, P789, DOI 10.1525/auk.2011.128.4.789; Laiolo P, 2012, J ANIM ECOL, V81, P594, DOI 10.1111/j.1365-2656.2011.01946.x; LAMPE HM, 1995, P ROY SOC B-BIOL SCI, V262, P163, DOI 10.1098/rspb.1995.0191; Lindell C, 1998, WILSON BULL, V110, P368; Liu WC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3082; MacDougall-Shackleton SA, 1997, CURR ORNITHOL, V14, P81; Marler P, 1982, ACOUSTIC COMMUNICATI, P25; Moore BR, 2004, BIOL REV, V79, P301, DOI 10.1017/S1464793103006225; Nicholls JA, 2006, EVOLUTION, V60, P1279; Ripmeester EAP, 2010, BEHAV ECOL, V21, P876, DOI 10.1093/beheco/arq075; Saranathan V, 2007, MOL ECOL, V16, P3689, DOI 10.1111/j.1365-294X.2007.03415.x; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; Seddon N, 2006, BEHAV ECOL, V17, P73, DOI 10.1093/beheco/ari096; Seddon N, 2010, P ROY SOC B-BIOL SCI, V277, P2475, DOI 10.1098/rspb.2010.0210; Soma M, 2011, BEHAV ECOL, V22, P363, DOI 10.1093/beheco/arq219; Styrsky J, 2003, LIFE HIST EVOLUTION; Styrsky JN, 2005, ECOLOGY, V86, P3238, DOI 10.1890/04-1613; Tobias JA, 2011, J EVOLUTION BIOL, V24, P2118, DOI 10.1111/j.1420-9101.2011.02345.x; Tobias JA, 2009, J EVOLUTION BIOL, V22, P623, DOI 10.1111/j.1420-9101.2008.01678.x; Tobias JA, 2012, ORNITOL NEOTROP, V23, P259; Tobias JA, 2014, NATURE, V506, P359, DOI 10.1038/nature12874; Tobias JA, 2010, EVOLUTION, V64, P2820, DOI 10.1111/j.1558-5646.2010.01067.x; Tobias JA, 2009, EVOLUTION, V63, P3168, DOI 10.1111/j.1558-5646.2009.00795.x; Trainer JM, 2001, WILSON BULL, V113, P431, DOI 10.1676/0043-5643(2001)113[0431:UOLTMS]2.0.CO;2; Trainer JM, 2002, BEHAV ECOL, V13, P65, DOI 10.1093/beheco/13.1.65; TRAINER JM, 1993, CONDOR, V95, P769, DOI 10.2307/1369416; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vokurkova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060172; Willis EO, 1972, ORNITHOLOGICAL MONOG, V10, P162; Winn D, 2002, J WILDLIFE REHABIL, V25, P13; Winn D, 2008, WILDLIFE REHABILITAT, V26, P1	61	42	43	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95746	10.1371/journal.pone.0095746	http://dx.doi.org/10.1371/journal.pone.0095746			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788343	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917300017
J	Yin, XX; Ng, BWH; He, J; Zhang, YC; Abbott, D				Yin, Xiaoxia; Ng, Brian W-H; He, Jing; Zhang, Yanchun; Abbott, Derek			Accurate Image Analysis of the Retina Using Hessian Matrix and Binarisation of Thresholded Entropy with Application of Texture Mapping	PLOS ONE			English	Article							BLOOD-VESSEL SEGMENTATION; ALGORITHM; ARTERY; SET	In this paper, we demonstrate a comprehensive method for segmenting the retinal vasculature in camera images of the fundus. This is of interest in the area of diagnostics for eye diseases that affect the blood vessels in the eye. In a departure from other state-of-the-art methods, vessels are first pre-grouped together with graph partitioning, using a spectral clustering technique based on morphological features. Local curvature is estimated over the whole image using eigenvalues of Hessian matrix in order to enhance the vessels, which appear as ridges in images of the retina. The result is combined with a binarized image, obtained using a threshold that maximizes entropy, to extract the retinal vessels from the background. Speckle type noise is reduced by applying a connectivity constraint on the extracted curvature based enhanced image. This constraint is varied over the image according to each region's predominant blood vessel size. The resultant image exhibits the central light reflex of retinal arteries and veins, which prevents the segmentation of whole vessels. To address this, the earlier entropy-based binarization technique is repeated on the original image, but crucially, with a different threshold to incorporate the central reflex vessels. The final segmentation is achieved by combining the segmented vessels with and without central light reflex. We carry out our approach on DRIVE and REVIEW, two publicly available collections of retinal images for research purposes. The obtained results are compared with state-of-the-art methods in the literature using metrics such as sensitivity (true positive rate), selectivity (false positive rate) and accuracy rates for the DRIVE images and measured vessel widths for the REVIEW images. Our approach out-performs the methods in the literature.	[Yin, Xiaoxia; He, Jing; Zhang, Yanchun] Victoria Univ, Ctr Appl Informat, Melbourne, Vic 8001, Australia; [Yin, Xiaoxia; He, Jing; Zhang, Yanchun] Victoria Univ, Coll Engn & Sci, Melbourne, Vic 8001, Australia; [Ng, Brian W-H; Abbott, Derek] Univ Adelaide, Ctr Biomed Engn CBME, Adelaide, SA, Australia; [Ng, Brian W-H; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	Victoria University; Victoria University; University of Adelaide; University of Adelaide	Yin, XX (corresponding author), Victoria Univ, Ctr Appl Informat, Melbourne, Vic 8001, Australia.	xiaoxia.yin@vu.edu.au	Abbott, Derek/E-8352-2011; Yin, Xiaoxia/R-9289-2019; Ng, Brian W.-H./D-3700-2018	Abbott, Derek/0000-0002-0945-2674; Ng, Brian W.-H./0000-0002-8316-4996; He, Jing/0000-0001-6488-1052	Nanjing Nandian Technology PTY LTD, China	Nanjing Nandian Technology PTY LTD, China	Nanjing Nandian Technology PTY LTD, China, is the source of funding that has supported the work. The URL of funder's website is: http://3150724.czvv.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff Michael D, 2010, IEEE Rev Biomed Eng, V3, P169, DOI 10.1109/RBME.2010.2084567; Al-Diri B, 2009, IEEE T MED IMAGING, V28, P1488, DOI 10.1109/TMI.2009.2017941; Ayala G, 2005, IEEE T FUZZY SYST, V13, P384, DOI 10.1109/TFUZZ.2004.839667; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; Bhuiyan A, 2013, COMPUT METH PROG BIO, V111, P104, DOI 10.1016/j.cmpb.2013.02.004; CHAUDHURI S, 1989, IEEE T MED IMAGING, V8, P263, DOI 10.1109/42.34715; Delibasis KK, 2010, COMPUT METH PROG BIO, V100, P108, DOI 10.1016/j.cmpb.2010.03.004; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P407, DOI 10.1016/j.cmpb.2012.03.009; FREEMAN WT, 1991, IEEE T PATTERN ANAL, V13, P891, DOI 10.1109/34.93808; Ghorbanihaghjo A, 2008, MOL VIS, V14, P1692; GREGSON PH, 1995, COMPUT BIOMED RES, V28, P291, DOI 10.1006/cbmr.1995.1020; Hammond Stephen, 2006, J Clin Hypertens (Greenwich), V8, P221, DOI 10.1111/j.1524-6175.2005.04147.x; Honale SS, 2012, INT J ENG RES TECHNO, V1, P1; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; ISI, 2013, DRIVE DIG RET IM VES; Jiang XY, 2003, IEEE T PATTERN ANAL, V25, P131, DOI 10.1109/TPAMI.2003.1159954; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kumar S, 2010, WORLD ACAD SCI ENG T, V40, P393; LAM L, 1992, IEEE T PATTERN ANAL, V14, P869, DOI 10.1109/34.161346; Lowell J, 2004, IEEE T MED IMAGING, V23, P1196, DOI 10.1109/TMI.2004.830524; Mahadevan V, 2004, IEEE T INF TECHNOL B, V8, P360, DOI 10.1109/TITB.2004.834410; Martinez-Perez ME, 2007, MED IMAGE ANAL, V11, P47, DOI 10.1016/j.media.2006.11.004; Martinez-Perez ME, 1999, LECT NOTES COMPUT SC, V1679, P90; Mendonca AM, 2006, IEEE T MED IMAGING, V25, P1200, DOI 10.1109/TMI.2006.879955; Miri MS, 2011, IEEE T BIO-MED ENG, V58, P1183, DOI 10.1109/TBME.2010.2097599; NEKOVEI R, 1995, IEEE T NEURAL NETWOR, V6, P64, DOI 10.1109/72.363449; Nguyen UTV, 2013, PATTERN RECOGN, V46, P703, DOI 10.1016/j.patcog.2012.08.009; Nooshabadi S., 1997, 14th Australian Microelectronics Conference. Microelectronics: Technology Today for the Future. MICRO '97 Proceedings, P29; Pajak R, 2003, OPTO-ELECTRON REV, V11, P237; PAL NR, 1991, IEEE T SYST MAN CYB, V21, P1260, DOI 10.1109/21.120079; Ricci E, 2007, IEEE T MED IMAGING, V26, P1357, DOI 10.1109/TMI.2007.898551; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Simo A, 2001, PATTERN RECOGN, V34, P795, DOI 10.1016/S0031-3203(00)00032-7; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Sparavigna A, 2010, SKIN RES TECHNOL, V16, P161, DOI 10.1111/j.1600-0846.2009.00413.x; Spencer W.H., 1996, OPHTHALMIC PATHOLOGY; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Sum KW, 2008, IEEE T BIO-MED ENG, V55, P358, DOI 10.1109/TBME.2007.896587; Teng T, 2002, MED BIOL ENG COMPUT, V40, P2, DOI 10.1007/BF02347689; Tolias YA, 1998, IEEE T MED IMAGING, V17, P263, DOI 10.1109/42.700738; University of Lincoln, 2013, RET IM COMP UND; Vazquez SG, 2013, MACH VISION APPL, V24, P919, DOI 10.1007/s00138-012-0442-4; Vermeer KA, 2004, COMPUT BIOL MED, V34, P209, DOI 10.1016/S0010-4825(03)00055-6; Villalobos-Castaldi FM, 2010, J VISUAL-JAPAN, V13, P263, DOI 10.1007/s12650-010-0037-y; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Xu XY, 2011, IEEE T MED IMAGING, V30, P1184, DOI 10.1109/TMI.2010.2103566; Yin XX, 2012, MED BIOL ENG COMPUT, V50, P91, DOI 10.1007/s11517-011-0772-9; Zana F, 2001, IEEE T IMAGE PROCESS, V10, P1010, DOI 10.1109/83.931095; ZHOU LA, 1994, IEEE T MED IMAGING, V13, P619, DOI 10.1109/42.363106	50	31	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e95943	10.1371/journal.pone.0095943	http://dx.doi.org/10.1371/journal.pone.0095943			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781033	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000335504900013
J	Sato, C; Hoshino, M; Ikumi, N; Oba, K; Koike, A; Shouno, O; Sekiguchi, T; Kobayashi, T; Machida, T; Matsumoto, G; Furudate, H; Kimura, T				Sato, Chika; Hoshino, Masato; Ikumi, Naori; Oba, Kentarou; Koike, Akiko; Shouno, Osamu; Sekiguchi, Tatsuhiko; Kobayashi, Tetsuya; Machida, Takeo; Matsumoto, Gen; Furudate, Hiroyuki; Kimura, Tetsuya			Contribution of Nucleus Accumbens Core (AcbC) to Behavior Control during a Learned Resting Period: Introduction of a Novel Task and Lesion Experiments	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; PAVLOVIAN APPROACH BEHAVIOR; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; VENTRAL STRIATUM; DIFFERENTIAL INVOLVEMENT; FUNCTIONAL CONNECTIVITY; LOCOMOTOR SENSITIZATION; ELECTROLYTIC LESIONS; INHIBITORY CONTROL	In recent years, the study of resting state neural activity has received much attention. To better understand the roles of different brain regions in the regulation of behavioral activity in an arousing or a resting period, we developed a novel behavioral paradigm (8-arm food-foraging task; 8-arm FFT) using the radial 8-arm maze and examined how AcbC lesions affect behavioral execution and learning. Repetitive training on the 8-arm FFT facilitated motivation of normal rats to run quickly to the arm tips and to the center platform before the last-reward collection. Importantly, just after this point and before confirmation of no reward at the next arm traverse, locomotor activity decreased. This indicates that well-trained rats can predict the absence of the reward at the end of food seeking and then start another behavior, namely planned resting. Lesions of the AcbC after training selectively impaired this reduction of locomotor activity after the last-reward collection without changing activity levels before the last-reward collection. Analysis of arm-selection patterns in the lesioned animals suggests little influence of the lesion in the ability to predict the reward absence. AcbC lesions did not change exploratory locomotor activity in an open-field test in which there were no rewards. This suggests that the AcbC controls the activity level of planned resting behavior shaped by the 8-arm FFT. Rats receiving training after AcbC lesioning showed a reduction in motivation for reward seeking. Thus, the AcbC also plays important roles not only in controlling the activity level after the last-reward collection but also in motivational learning for setting the activity level of reward-seeking behavior.	[Ikumi, Naori; Shouno, Osamu; Matsumoto, Gen; Furudate, Hiroyuki; Kimura, Tetsuya] RIKEN Brain Sci Inst, Lab Brain Operat Express, Saitama, Japan; [Sato, Chika; Ikumi, Naori; Oba, Kentarou; Koike, Akiko; Kobayashi, Tetsuya; Machida, Takeo; Furudate, Hiroyuki] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Area Regulatory Biol, Saitama 3388570, Japan; [Hoshino, Masato; Shouno, Osamu; Sekiguchi, Tatsuhiko] Honda Res Inst Japan Co Ltd, Saitama, Japan; [Kimura, Tetsuya] RIKEN Brain Sci Inst, Lab Alzheimers Dis, Saitama, Japan; [Kimura, Tetsuya] Natl Ctr Geriatr & Gerontol, Dept Aging Neurobiol, Obu, Aichi, Japan	RIKEN; Saitama University; Honda Motor Company; RIKEN; National Center for Geriatrics & Gerontology	Furudate, H (corresponding author), RIKEN Brain Sci Inst, Lab Brain Operat Express, Saitama, Japan.	furudate@mail.saitama-u.ac.jp; kimura_t@ncgg.go.jp			National Center for Geriatrics and Gerontology, Japan [26-27]	National Center for Geriatrics and Gerontology, Japan	This work was partially supported by Research Funding for Longevity Sciences Grant 26-27 from the National Center for Geriatrics and Gerontology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cardinal RN, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-37; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; CAREY RJ, 1982, BEHAV BRAIN RES, V5, P43, DOI 10.1016/0166-4328(82)90089-4; Chiong W, 2013, BRAIN, V136, P1929, DOI 10.1093/brain/awt066; COUSINS MS, 1994, PHARMACOL BIOCHEM BE, V49, P85, DOI 10.1016/0091-3057(94)90460-X; Day JJ, 2010, BIOL PSYCHIAT, V68, P306, DOI 10.1016/j.biopsych.2010.03.026; Eagle DM, 2003, BEHAV BRAIN RES, V146, P131, DOI 10.1016/j.bbr.2003.09.022; Fritz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026761; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Guillem K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024049; Haber SN, 2000, J NEUROSCI, V20, P2369; Halabi C, 2013, ALZ DIS ASSOC DIS, V27, P74, DOI 10.1097/WAD.0b013e31824a7df4; Ito R, 2008, J NEUROSCI, V28, P6950, DOI 10.1523/JNEUROSCI.1615-08.2008; Jongen-Relo AL, 2003, BEHAV NEUROSCI, V117, P150, DOI 10.1037/0735-7044.117.1.150; Jongen-Relo AL, 2002, NEUROSCIENCE, V111, P95, DOI 10.1016/S0306-4522(01)00521-8; Karahanoglu FI, 2013, NEUROIMAGE, V73, P121, DOI 10.1016/j.neuroimage.2013.01.067; Kelsey JE, 2006, BEHAV NEUROSCI, V120, P600, DOI 10.1037/0735-7044.120.3.600; Kelsey JE, 2009, BEHAV NEUROSCI, V123, P577, DOI 10.1037/a0015573; Klein S, 2004, NEUROSCIENCE, V128, P229, DOI 10.1016/j.neuroscience.2004.06.041; Koch M, 2000, BEHAV BRAIN RES, V117, P153, DOI 10.1016/S0166-4328(00)00299-0; Krause M, 2010, J NEUROSCI, V30, P4746, DOI 10.1523/JNEUROSCI.0197-10.2010; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Mastrovito D, 2013, J NEUROSCI, V33, P12912, DOI 10.1523/JNEUROSCI.2580-13.2013; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; Murphy ER, 2008, EUR J NEUROSCI, V28, P353, DOI 10.1111/j.1460-9568.2008.06309.x; Nowend KL, 2001, PHARMACOL BIOCHEM BE, V69, P373, DOI 10.1016/S0091-3057(01)00524-X; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Phillips AG, 2008, PHARMACOL BIOCHEM BE, V90, P236, DOI 10.1016/j.pbb.2007.10.014; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; READING PJ, 1995, EXP BRAIN RES, V105, P76; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Russell VA, 2000, NEUROSCI BIOBEHAV R, V24, P133, DOI 10.1016/S0149-7634(99)00056-1; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P461, DOI 10.1007/s00213-006-0668-9; Schaub CL, 1997, BEHAV BRAIN RES, V84, P129, DOI 10.1016/S0166-4328(96)00142-8; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Setlow B, 1997, J NEUROSCI RES, V49, P515; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sokolowski JD, 1998, NEUROSCIENCE, V86, P1001, DOI 10.1016/S0306-4522(98)00066-9; Sotiropoulos I, 2011, J NEUROSCI, V31, P7840, DOI 10.1523/JNEUROSCI.0730-11.2011; Sugam JA, 2012, BIOL PSYCHIAT, V71, P199, DOI 10.1016/j.biopsych.2011.09.029; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Taha SA, 2005, J NEUROSCI, V25, P1193, DOI 10.1523/JNEUROSCI.3975-04.2005; Tran AH, 2005, P NATL ACAD SCI USA, V102, P2117, DOI 10.1073/pnas.0409726102; Tran AH, 2002, P NATL ACAD SCI USA, V99, P8986, DOI 10.1073/pnas.132284599; WHISHAW IQ, 1993, BEHAV BRAIN RES, V55, P283, DOI 10.1016/0166-4328(93)90123-8; ZAHM DS, 1992, NEUROSCIENCE, V50, P751, DOI 10.1016/0306-4522(92)90202-D; Zhang S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00172; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	57	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95941	10.1371/journal.pone.0095941	http://dx.doi.org/10.1371/journal.pone.0095941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776793	gold, Green Published, Green Submitted			2022-12-25	WOS:000346241800019
J	Lu, WW; Wan, XH; Liu, B; Rong, XF; Zhu, L; Li, PP; Li, J; Wang, L; Cui, LY; Wang, XL				Lu, Wenwen; Wan, Xinhua; Liu, Bin; Rong, Xianfang; Zhu, Lei; Li, Pingping; Li, Jiang; Wang, Ling; Cui, Liying; Wang, Xiaoliang			Specific Changes of Serum Proteins in Parkinson's Disease Patients	PLOS ONE			English	Article							APOLIPOPROTEIN A-IV; CEREBROSPINAL-FLUID; ALPHA-SYNUCLEIN; OXIDATIVE STRESS; POTENTIAL BIOMARKERS; PROTEOME ANALYSIS; FIBRINOGEN; DIAGNOSIS; IDENTIFICATION; PATHOGENESIS	The aim of this study is to identify and validate protein change in the serum from PD patients. We used serum samples from 21 PD patients and 20 age-matched normal people as control to conduct a comparative proteomic study. We performed 2-DE and analyzed the differentially expressed protein spots by LC-MS/MS. In PD group 13 spots were shown to be differentially expressed compared to control group. They were identified as 6 proteins. Among these, 3 proteins were confirmed by Western blot analysis. It showed that the frequency of fibrinogen c-chain (FGG) appeared 70% in PD, which could not be detected in control group. The protein of inter-alpha-trypsin inhibitor heavy chain H4 (ITI-H4) was found to exist two forms in serum. The full size (120 kDa) of the protein was increased and the fragmented ITI-H4 (35 kDa) was decreased in PD group. The ratio of full size ITI-H4 to fragmented ITI-H4 in PD patients was 3.85 +/- 0.29-fold higher than in control group. Furthermore, fragmented Apo A-IV (similar to 26 kDa) was mainly detected in control group, while it was rare to be found in PD group. Above findings might be useful for diagnosis of PD. When the expressions of FGG and 120 kDa ITI-H4 are increase, as well as similar to 26 kDa Apo A-IV disappear would provide strong evidence for PD.	[Lu, Wenwen; Liu, Bin; Rong, Xianfang; Zhu, Lei; Li, Pingping; Li, Jiang; Wang, Ling; Wang, Xiaoliang] Chinese Acad Med Sci, Inst Mat Med, Dept Pharmacol, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Lu, Wenwen; Wan, Xinhua; Liu, Bin; Rong, Xianfang; Zhu, Lei; Li, Pingping; Li, Jiang; Wang, Ling; Cui, Liying; Wang, Xiaoliang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wan, Xinhua; Cui, Liying] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Cui, LY (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China.	pumchcuily@sina.com; wangxl@imm.ac.cn	Li, Ping/GYV-4914-2022		National 973 Fundamental Project of China [2011CB504100]; National Major Special Project on New Drug Innovation of China [2012ZX09301002-004]	National 973 Fundamental Project of China(National Basic Research Program of China); National Major Special Project on New Drug Innovation of China	This work was supported by the National 973 Fundamental Project of China, No. 2011CB504100. This study is also supported by National Major Special Project on New Drug Innovation of China (No 2012ZX09301002-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio T, 2012, IUBMB LIFE, V64, P846, DOI 10.1002/iub.1073; Asanuma M, 2004, CURR PHARM DESIGN, V10, P695, DOI 10.2174/1381612043453072; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Chen H, 2008, AM J EPIDEMIOL, V167, P90, DOI 10.1093/aje/kwm260; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Chung YC, 2010, BMB REP, V43, P225, DOI 10.5483/BMBRep.2010.43.4.225; Cui YJ, 2011, AM J PATHOL, V178, P1298, DOI 10.1016/j.ajpath.2010.11.057; De Iuliis A, 2005, CLIN CHIM ACTA, V357, P202, DOI 10.1016/j.cccn.2005.03.028; Diamandis EP, 2006, J PROTEOME RES, V5, P2079, DOI 10.1021/pr060225u; FUJIMOTO K, 1993, J CLIN INVEST, V91, P1830, DOI 10.1172/JCI116395; Gerlach M, 2012, J NEURAL TRANSM, V119, P39, DOI 10.1007/s00702-011-0682-x; Gille G, 2004, ANN NY ACAD SCI, V1018, P533, DOI 10.1196/annals.1296.066; Goldknopf IL, 2009, BIOCHEM BIOPH RES CO, V389, P321, DOI 10.1016/j.bbrc.2009.08.150; GONZALEZRAMON N, 1995, FEBS LETT, V371, P227, DOI 10.1016/0014-5793(95)00882-A; Guo JG, 2009, CELL RES, V19, P1401, DOI 10.1038/cr.2009.131; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Hald Andreas, 2007, Subcell Biochem, V42, P249; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ishida Y, 2006, J NEUROPATH EXP NEUR, V65, P66, DOI 10.1097/01.jnen.0000195941.48033.eb; Jankovic J, 2000, ARCH NEUROL-CHICAGO, V57, P369, DOI 10.1001/archneur.57.3.369; Kamath S, 2003, QJM-INT J MED, V96, P711, DOI 10.1093/qjmed/hcg129; Karp NA, 2007, MOL CELL PROTEOMICS, V6, P1354, DOI 10.1074/mcp.M600274-MCP200; Kim MS, 2011, MOL BIOSYST, V7, P1430, DOI 10.1039/c0mb00219d; Klegeris A, 2007, CURR OPIN NEUROL, V20, P351, DOI 10.1097/WCO.0b013e3280adc943; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Maarouf CL, 2012, NEUROL RES, V34, P669, DOI 10.1179/1743132812Y.0000000063; Markopoulou K, 1999, NEUROLOGY, V53, P1382, DOI 10.1212/WNL.53.7.1382; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Mila S, 2009, BIOMARK MED, V3, P117, DOI 10.2217/BMM.09.4; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mosesson MW, 2003, J THROMB HAEMOST, V1, P231, DOI 10.1046/j.1538-7836.2003.00063.x; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Owen AD, 1996, ANN NY ACAD SCI, V786, P217, DOI 10.1111/j.1749-6632.1996.tb39064.x; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Park JY, 2012, J BIOCHEM, V151, P291, DOI 10.1093/jb/mvr137; Pineiro M, 1999, BIOCHEM BIOPH RES CO, V263, P224, DOI 10.1006/bbrc.1999.1349; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rite I, 2007, J NEUROSCI RES, V85, P3607, DOI 10.1002/jnr.21452; Sinha A, 2009, CLIN CHIM ACTA, V400, P14, DOI 10.1016/j.cca.2008.09.026; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanaka H, 2013, J NEUROL, V260, P1782, DOI 10.1007/s00415-013-6877-3; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Tso P, 2001, ANNU REV NUTR, V21, P231, DOI 10.1146/annurev.nutr.21.1.231; Ugarova TP, 2001, ANN NY ACAD SCI, V936, P368; Wang ES, 2010, ACTA NEUROL SCAND, V122, P350, DOI 10.1111/j.1600-0404.2009.01318.x; Wang Z, 2004, CLIN CHEM, V50, P1939, DOI 10.1373/clinchem.2004.036871; Wong KT, 2010, NEUROEPIDEMIOLOGY, V34, P50, DOI 10.1159/000260070; Xie HR, 2011, NEUROL SCI, V32, P221, DOI 10.1007/s10072-010-0340-3; Yang MH, 2012, J PROTEOMICS, V75, P3617, DOI 10.1016/j.jprot.2012.04.017; Zhao X, 2010, NEUROSCI LETT, V479, P175, DOI 10.1016/j.neulet.2010.05.063	53	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e95684	10.1371/journal.pone.0095684	http://dx.doi.org/10.1371/journal.pone.0095684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769800	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736600009
J	von Lassberg, C; Beykirch, KA; Mohler, BJ; Bulthoff, HH				von Lassberg, Christoph; Beykirch, Karl A.; Mohler, Betty J.; Buelthoff, Heinrich H.			Intersegmental Eye-Head-Body Interactions during Complex Whole Body Movements	PLOS ONE			English	Article							VESTIBULOOCULAR REFLEX; SMOOTH-PURSUIT; OCULAR REFLEX; COORDINATION; HABITUATION; ADAPTATION; SOMERSAULT	Using state-of-the-art technology, interactions of eye, head and intersegmental body movements were analyzed for the first time during multiple twisting somersaults of high-level gymnasts. With this aim, we used a unique combination of a 16-channel infrared kinemetric system; a three-dimensional video kinemetric system; wireless electromyography; and a specialized wireless sport-video-oculography system, which was able to capture and calculate precise oculomotor data under conditions of rapid multiaxial acceleration. All data were synchronized and integrated in a multimodal software tool for three-dimensional analysis. During specific phases of the recorded movements, a previously unknown eye-head-body interaction was observed. The phenomenon was marked by a prolonged and complete suppression of gaze-stabilizing eye movements, in favor of a tight coupling with the head, spine and joint movements of the gymnasts. Potential reasons for these observations are discussed with regard to earlier findings and integrated within a functional model.	[von Lassberg, Christoph] Univ Leipzig, Inst Gen Kinesiol & Athlet Training, D-04109 Leipzig, Germany; [von Lassberg, Christoph] Univ Tubingen Hosp, Dept Sports Med, Tubingen, Germany; [Beykirch, Karl A.; Mohler, Betty J.; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, D-72076 Tubingen, Germany; [Beykirch, Karl A.] AMST Syst Tech GmbH, Ranshofen, Austria; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Leipzig University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; Korea University	Bulthoff, HH (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Spemannstr 38, D-72076 Tubingen, Germany.	heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; 	Bundesinstitut fur Sportwissenschaft in Bonn (German Institute for Sport Science) [AZ: IIA1-070603/11]; WCU (World Class University) program - Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-10008]; Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	Bundesinstitut fur Sportwissenschaft in Bonn (German Institute for Sport Science); WCU (World Class University) program - Ministry of Education, Science and Technology through the National Research Foundation of Korea; Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	This study was supported by the Bundesinstitut fur Sportwissenschaft in Bonn (German Institute for Sport Science; AZ: IIA1-070603/11) and by WCU (World Class University) program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (R31-10008). Part of Heinrich Bulthoff's research was supported by the Brain Korea 21 PLUS Program through the National Research Foundation of Korea funded by the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SC, 2003, AVIAT SPACE ENVIR MD, V74, P285; Alpini D, 2009, SPORT SCI HLTH, V5, P129, DOI DOI 10.1007/S1S1332-009-00888-4; Anastasopoulos D, 2009, EXP BRAIN RES, V193, P323, DOI 10.1007/s00221-008-1627-y; BALOH RW, 1982, AM J OTOLARYNG, V3, P235, DOI 10.1016/S0196-0709(82)80061-6; BARLOW D, 1980, ACTA OTO-LARYNGOL, V89, P487, DOI 10.3109/00016488009127166; BARNES GR, 1979, ACTA OTO-LARYNGOL, V88, P79, DOI 10.3109/00016487909137143; BECKER W, 1985, EXP BRAIN RES, V57, P562; Bizzi E., 1981, HDB PHYSL, V1, P1321; BRANDT T, 1977, EXP BRAIN RES, V30, P331; BRONSTEIN AM, 1991, BRAIN, V114, P1; CARL JR, 1987, J NEUROPHYSIOL, V57, P1446, DOI 10.1152/jn.1987.57.5.1446; Clement G, 2008, EXP BRAIN RES, V190, P307, DOI 10.1007/s00221-008-1471-0; Davlin CD, 2001, MOTOR CONTROL, V5, P337, DOI 10.1123/mcj.5.4.337; GAUTHIER GM, 1976, EXP BRAIN RES, V26, P121; Heinen T, 2011, MOTOR CONTROL, V15, P267, DOI 10.1123/mcj.15.2.267; Hollands MA, 2004, EXP BRAIN RES, V154, P261, DOI 10.1007/s00221-003-1718-8; Hondzinski JM, 2001, MOTOR CONTROL, V5, P281, DOI 10.1123/mcj.5.3.281; Kandel E., 2000, PRINCIPLES NEURAL SC; KASAI T, 1978, BRAIN RES, V144, P123, DOI 10.1016/0006-8993(78)90439-0; Kelders WPA, 2003, J PHYSIOL-LONDON, V553, P311, DOI 10.1113/jphysiol.2003.049338; Krug J, 2002, P 20 INT SOC BIOM SP, P535; Lackner JR, 1984, SENSORY EXPERIENCE A, P281; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; LEE DN, 1992, J EXP PSYCHOL HUMAN, V18, P1195, DOI 10.1037/0096-1523.18.4.1195; Lee MY, 2004, LARYNGOSCOPE, V114, P897, DOI 10.1097/00005537-200405000-00021; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Luis M, 2008, MOTOR CONTROL, V12, P210, DOI 10.1123/mcj.12.3.210; Mergner T, 1998, EXP BRAIN RES, V120, P450, DOI 10.1007/s002210050418; Merleti R, 1999, J ELECTROMYOGR KINES, V9, pIII; SCHWARZ U, 1989, AVIAT SPACE ENVIR MD, V60, P755; Tanguy S, 2008, EUR J APPL PHYSIOL, V104, P1031, DOI 10.1007/s00421-008-0859-7; Tweed D, 1998, SCIENCE, V281, P1363, DOI 10.1126/science.281.5381.1363; Vickers J. N., 2007, HUMAN KINETICS; von Labberg C, 2003, EUR WORKSH MOV SCI M, P108; von Lassberg C, 2007, OKULOMOTORISCHE ORIE, P192; von Lassberg C, 2009, P 14 ANN C EUR COLL, P402; von Lassberg C, 2013, J ELECTROMYOGR KINES, V23, P1124, DOI 10.1016/j.jelekin.2013.07.006; von Lassberg C, 2012, MOTOR CONTROL, V16, P176, DOI 10.1123/mcj.16.2.176; WARABI T, 1978, NEUROSCI LETT, V9, P267, DOI 10.1016/0304-3940(78)90084-8; Zupan LH, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S03	40	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95450	10.1371/journal.pone.0095450	http://dx.doi.org/10.1371/journal.pone.0095450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763143	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000019
J	Aslam, MF; Frazer, DM; Faria, N; Bruggraber, SFA; Wilkins, SJ; Mirciov, C; Powell, JJ; Anderson, GJ; Pereira, DIA				Aslam, Mohamad F.; Frazer, David M.; Faria, Nuno; Bruggraber, Sylvaine F. A.; Wilkins, Sarah J.; Mirciov, Cornel; Powell, Jonathan J.; Anderson, Greg J.; Pereira, Dora I. A.			Ferroportin mediates the intestinal absorption of iron from a nanoparticulate ferritin core mimetic in mice	FASEB JOURNAL			English	Article						nanoiron; basolateral export; iron homeostasis; hepcidin; knockout mice	TRANSFERRIN-BOUND IRON; FERROUS SULFATE; GUT MICROBIOTA; HEPCIDIN; METABOLISM; EXPRESSION; IREG1; TOLERABILITY; SUPPLEMENTS; HEPHAESTIN	The ferritin core is composed of fine nanoparticulate Fe3+ oxohydroxide, and we have developed a synthetic mimetic, nanoparticulate Fe3+ polyoxohydroxide (nanoFe(3+)). The aim of this study was to determine how dietary iron derived in this fashion is absorbed in the duodenum. Following a 4 wk run-in on an Fe-deficient diet, mice with intestinal-specific disruption of the Fpn-1 gene (Fpn-KO), or littermate wild-type (WT) controls, were supplemented with Fe2+ sulfate (FeSO4), nanoFe(3+), or no added Fe for a further 4 wk. A control group was Fe sufficient throughout. Direct intestinal absorption of nanoFe(3+) was investigated using isolated duodenal loops. Our data show that FeSO4 and nanoFe(3+) are equally bioavailable in WT mice, and at wk 8 the mean +/- SEM hemoglobin increase was 18 +/- 7 g/L in the FeSO4 group and 30 +/- 5 g/L in the nanoFe(3+) group. Oral iron failed to be utilized by Fpn-KO mice and was retained in enterocytes, irrespective of the iron source. In summary, although nanoFe(3+) is taken up directly by the duodenum its homeostasis is under the normal regulatory control of dietary iron absorption, namely via ferroportin-dependent efflux from enterocytes, and thus offers potential as a novel oral iron supplement.-Aslam, M. F., Frazer, D. M., Faria, N., Bruggraber, S. F. A., Wilkins, S. J., Mirciov, C., Powell, J. J., Anderson, G. J., Pereira, D. I. A. Ferroportin mediates the intestinal absorption of iron from a nanoparticulate ferritin core mimetic in mice.	[Aslam, Mohamad F.; Faria, Nuno; Bruggraber, Sylvaine F. A.; Powell, Jonathan J.; Pereira, Dora I. A.] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge CB1 9NL, England; [Frazer, David M.; Wilkins, Sarah J.; Mirciov, Cornel; Anderson, Greg J.] Berghofer Med Res Inst, Queensland Inst Med Res, Iron Metab Lab, Brisbane, Qld, Australia; [Anderson, Greg J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Anderson, Greg J.] Univ Queensland, Sch Med, Brisbane, Qld, Australia	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland	Pereira, DIA (corresponding author), Elsie Widdowson Lab, MRC Human Nutr Res, 120 Fulbourn Rd, Cambridge CB1 9NL, England.	dora.pereira@mrc-hnr.cam.ac.uk	Anderson, Gregory J/G-4148-2013; Frazer, David M/L-3570-2014; Pereira, Dora I A/D-4634-2012	Anderson, Gregory J/0000-0002-8814-5866; Frazer, David M/0000-0003-4098-1379; Pereira, Dora I A/0000-0001-5688-4448; Mirciov, Cornel/0000-0002-9083-2614	UK Medical Research Council [U105960399]; MRC; National Health and Medical Research Council of Australia; Australian Liver Foundation; MRC [MC_U105960399] Funding Source: UKRI; Medical Research Council [1197759, MC_U105960399] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Liver Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (U105960399). M. F. A. is supported by an MRC Ph.D. studentship. G. J. A. is supported by a Senior Research Fellowship from the National Health and Medical Research Council of Australia. D. M. F. is the recipient of a fellowship from the Australian Liver Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest but note that D. I. A. P., S. F. A. B., N. F., and J. J. P. are inventors on a patent detailing novel Fe<SUP>3+</SUP> polyoxohydroxide structures, as described herein, and that may have further potential as commercial dietary supplements (57). M. F. A., D. M. F., G. J. A., J. J. P., and D. I. A. P. designed the research; S. F. A. B. and N. J. R. F. provided the nanoFe<SUP>3+</SUP> materials; M. F. A., D. M. F., S. J. W., and C. M. conducted the research; M. F. A., D. M. F., and D. I. A. P. analyzed data; M. F. A., J. J. P., and D. I. A. P. had primary responsibility for final content. All authors read, provided input to, and approved the final manuscript.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Antileo E, 2013, AM J PHYSIOL-GASTR L, V304, pG655, DOI 10.1152/ajpgi.00472.2012; BARRAND MA, 1990, J PHARM PHARMACOL, V42, P279, DOI 10.1111/j.2042-7158.1990.tb05408.x; Bregman DB, 2013, AM J HEMATOL, V88, P97, DOI 10.1002/ajh.23354; BUNTING H, 1949, STAIN TECHNOL, V24, P109, DOI 10.3109/10520294909139590; Chen HJ, 2003, BLOOD, V102, P1893, DOI 10.1182/blood-2003-02-0347; COPLIN M, 1991, CLIN THER, V13, P606; Darshan D, 2011, GASTROENTEROLOGY, V141, P300, DOI 10.1053/j.gastro.2011.04.012; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; DOREY C, 1993, BRIT J NUTR, V70, P157, DOI 10.1079/BJN19930113; Dostal A, 2012, J NUTR, V142, P271, DOI 10.3945/jn.111.148643; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Dresow B, 2008, BIOMETALS, V21, P273, DOI 10.1007/s10534-007-9116-5; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Frazer DM, 2003, GUT, V52, P340, DOI 10.1136/gut.52.3.340; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hurrell RF, 2011, ANN NUTR METAB, V59, P64, DOI 10.1159/000332140; Cancelo-Hidalgo MJ, 2013, CURR MED RES OPIN, V29, P291, DOI 10.1185/03007995.2012.761599; Kalgaonkar S, 2009, J NUTR BIOCHEM, V20, P304, DOI 10.1016/j.jnutbio.2008.04.003; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lomer MCE, 2012, BRIT J NUTR, V107, P1806, DOI 10.1017/S0007114511004971; Martin CDS, 2008, J NUTR, V138, P659, DOI 10.1093/jn/138.4.659; Mckie AT, 2008, BIOCHEM SOC T, V36, P1239, DOI 10.1042/BST0361239; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Miret S, 2003, ANNU REV NUTR, V23, P283, DOI 10.1146/annurev.nutr.23.011702.073139; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Pan YH, 2009, J STRUCT BIOL, V166, P22, DOI 10.1016/j.jsb.2008.12.001; Pena-Rosas Juan P., 2012, COCHRANE DB SYST REV; Pereira DIA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081250; Powell J., 2008, UK patent, Patent No. [WO/2008/096130, 2008096130]; Powell JJ, 2005, BRIT J NUTR, V94, P804, DOI 10.1079/BJN20051542; Powell JJ, 2014, NANOMED-NANOTECHNOL, V10, P1529, DOI 10.1016/j.nano.2013.12.011; Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219; Radulescu S, 2012, CELL REP, V2, P270, DOI 10.1016/j.celrep.2012.07.003; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Schumann K, 2012, FOOD NUTR BULL, V33, P128, DOI 10.1177/156482651203300206; Seril DN, 2002, DIGEST DIS SCI, V47, P1266, DOI 10.1023/A:1015362228659; SIMPSON RJ, 1990, BRIT J NUTR, V63, P79, DOI 10.1079/BJN19900093; Theil EC, 2004, ANNU REV NUTR, V24, P327, DOI 10.1146/annurev.nutr.24.012003.132212; Theil EC, 2012, J NUTR, V142, P478, DOI 10.3945/jn.111.145854; Tosha T, 2012, J BIOL CHEM, V287, P13016, DOI 10.1074/jbc.M111.332734; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; WHO, 2008, GLOB DAT AN; WOLLENBERG P, 1987, N-S ARCH PHARMACOL, V336, P578; World Health Organisation, 2008, GLOB TUB CONTR SURV, P1; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zimmermann MB, 2011, BRIT J NUTR, V105, P1245, DOI 10.1017/S0007114510004903; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	57	33	38	0	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3671	3678		10.1096/fj.14-251520	http://dx.doi.org/10.1096/fj.14-251520			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24776745	Green Published, hybrid			2022-12-25	WOS:000340265400034
J	Li, XH; Thompson, D; Kumar, B; DeMartino, GN				Li, Xiaohua; Thompson, David; Kumar, Brajesh; DeMartino, George N.			Molecular and Cellular Roles of PI31 (PSMF1) Protein in Regulation of Proteasome Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26 S PROTEASOME; 20S PROTEASOME; HUMAN-ERYTHROCYTES; STRUCTURAL BASIS; SUBSTRATE ENTRY; CORE PARTICLE; CDNA CLONING; AAA SUBUNITS; ATP BINDING; C-TERMINI	We investigated molecular features and cellular roles of PI31 (PSMF1) on regulation of proteasome function. PI31 has a C-terminal HbYX (where Hb is a hydrophobic amino acid, Y is tyrosine, and X is any amino acid) motif characteristic of several proteasome activators. Peptides corresponding to the PI31 C terminus also bind to and activate the 20 S proteasome in an HbYX-dependent manner, but intact PI31protein inhibits in vitro 20 S activity. Binding to and inhibition of the proteasome by PI31 are conferred by the HbYX-containing proline-rich C-terminal domain but do not require HbYX residues. Thus, multiple regions of PI31 bind independently to the proteasome and collectively determine effects on activity. PI31 blocks the ATP-dependent in vitro assembly of 26 S proteasome from 20 S proteasome and PA700 subcomplexes but has no effect on in vitro activity of the intact 26 S proteasome. To determine the physiologic significance of these in vitro effects, we assessed multiple aspects of cellular proteasome content and function after altering PI31 levels. We detected no change in overall cellular proteasome content or function when PI31 levels were either increased by moderate ectopic overexpression or decreased by RNA interference (RNAi). We also failed to identify a role of PI31 ADP-ribosylation as a mechanism for regulation of overall 26 S proteasome content and function, as recently proposed. Thus, despite its in vitro effects on various proteasome activities and its structural relationship to established proteasome regulators, cellular roles and mechanisms of PI31 in regulation of proteasome function remain unclear and require future definition.	[Li, Xiaohua; Thompson, David; Kumar, Brajesh; DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	george.demartino@utsouthwestern.edu			National Institutes of Health (NIDDK) [DK46181]; Welch Foundation [I-1500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046181, R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46181 (NIDDK; to G. N. D.). This work was also supported by the Welch Foundation (I-1500; to G. N. D.).	Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; AKIYAMA KY, 1994, SCIENCE, V265, P1231, DOI 10.1126/science.8066462; Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; Dange T, 2011, J BIOL CHEM, V286, P42830, DOI 10.1074/jbc.M111.300178; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; Djakovic SN, 2012, J NEUROSCI, V32, P5126, DOI 10.1523/JNEUROSCI.4427-11.2012; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gaczynska M, 1996, J BIOL CHEM, V271, P17275, DOI 10.1074/jbc.271.29.17275; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; GRAY CW, 1994, J MOL BIOL, V236, P7, DOI 10.1006/jmbi.1994.1113; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kim YC, 2013, J BIOL CHEM, V288, P3334, DOI 10.1074/jbc.M112.424788; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kumar B, 2010, J BIOL CHEM, V285, P39523, DOI 10.1074/jbc.M110.153627; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; MA CP, 1994, J BIOL CHEM, V269, P3539; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; MA CP, 1992, J BIOL CHEM, V267, P10515; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; MCGUIRE MJ, 1986, BIOCHIM BIOPHYS ACTA, V873, P279, DOI 10.1016/0167-4838(86)90055-5; Murata S, 2008, CURR OPIN IMMUNOL, V20, P192, DOI 10.1016/j.coi.2008.03.002; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Sasaki K, 2010, MOL CELL BIOL, V30, P3864, DOI 10.1128/MCB.00216-10; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Stadtmueller BM, 2012, J BIOL CHEM, V287, P37371, DOI 10.1074/jbc.M112.367003; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang ZG, 1998, P NATL ACAD SCI USA, V95, P2807, DOI 10.1073/pnas.95.6.2807	53	39	42	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17392	17405		10.1074/jbc.M114.561183	http://dx.doi.org/10.1074/jbc.M114.561183			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24770418	Green Published, hybrid			2022-12-25	WOS:000338018100009
J	Zielonka, J; Cheng, G; Zielonka, M; Ganesh, T; Sun, AM; Joseph, J; Michalski, R; O'Brien, WJ; Lambeth, JD; Kalyanaraman, B				Zielonka, Jacek; Cheng, Gang; Zielonka, Monika; Ganesh, Thota; Sun, Aiming; Joseph, Joy; Michalski, Radoslaw; O'Brien, William J.; Lambeth, J. David; Kalyanaraman, Balaraman			High-throughput Assays for Superoxide and Hydrogen Peroxide DESIGN OF A SCREENING WORKFLOW TO IDENTIFY INHIBITORS OF NADPH OXIDASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SPECIES GENERATION; REACTIVE OXYGEN; 4 NOX4; OXIDATIVE STRESS; HYDROETHIDINE; PEROXYNITRITE; DISEASE; TARGETS; PROBES; MITOCHONDRIA	Recent progress characterizing the reaction mechanism(s) of fluorescent probes with reactive oxygen species has made it possible to rigorously analyze these reactive species in biological systems. We have developed rapid high throughput-compatible assays for monitoring cellular production of superoxide radical anion and hydrogen peroxide using hydropropidine and coumarin boronic acid probes, respectively. Coupling plate reader-based fluorescence measurements with HPLC-based simultaneous monitoring of superoxide radical anion and hydrogen peroxide provides the basis for the screening protocol for NADPH oxidase (Nox) inhibitors. Using this newly developed approach along with the medium-throughput plate reader-based oximetry and EPR spin trapping as confirmatory assays, it is now eminently feasible to rapidly and reliably identify Nox enzyme inhibitors with a markedly lower rate of false positives. These methodological advances provide an opportunity to discover selective inhibitors of Nox isozymes, through enhanced conceptual understanding of their basic mechanisms of action.	[Zielonka, Jacek; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [O'Brien, William J.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Ganesh, Thota] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Lambeth, J. David] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Sun, Aiming] Yerkes Natl Primate Res Ctr, Emory Inst Drug Dev, Atlanta, GA 30322 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Emory University; Emory University	Zielonka, J (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jzielonk@mcw.edu; balarama@mcw.edu	Zielonka, Jacek/N-9546-2014; Michalski, Radoslaw/X-1505-2018	Zielonka, Jacek/0000-0002-2524-0145; Michalski, Radoslaw/0000-0001-5601-0839	National Institutes of Health [R01 HL063119, R01 HL073056]; Harry R. and Angeline E. Quadracci endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073056, R01HL063119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI102197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry R. and Angeline E. Quadracci endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL063119 and R01 HL073056 (to B. K.). This work was also supported by the Harry R. and Angeline E. Quadracci endowment (to B. K.).	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Choi DH, 2012, ANTIOXID REDOX SIGN, V16, P1033, DOI 10.1089/ars.2011.3960; Cifuentes-Pagano E, 2013, MEDCHEMCOMM, V4, P1085, DOI 10.1039/c3md00061c; Cifuentes-Pagano E, 2012, CELL MOL LIFE SCI, V69, P2315, DOI 10.1007/s00018-012-1009-2; Dranka BP, 2013, NEUROSCI LETT, V549, P57, DOI 10.1016/j.neulet.2013.05.034; Dranka BP, 2012, J NEUROCHEM, V122, P941, DOI 10.1111/j.1471-4159.2012.07836.x; FAULKNER K, 1993, FREE RADICAL BIO MED, V15, P447, DOI 10.1016/0891-5849(93)90044-U; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003; Hecker L, 2012, CELL MOL LIFE SCI, V69, P2365, DOI 10.1007/s00018-012-1012-7; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Jaquet V, 2009, J LEUKOCYTE BIOL, V86, P461, DOI 10.1189/jlb.0409243; Kalyanaraman B, 2014, BBA-GEN SUBJECTS, V1840, P739, DOI 10.1016/j.bbagen.2013.05.008; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kalyanaraman B, 2011, BIOCHEM SOC T, V39, P1221, DOI 10.1042/BST0391221; Koto T, 2014, FREE RADICAL RES, V48, P478, DOI 10.3109/10715762.2014.886774; Krause KH, 2012, CELL MOL LIFE SCI, V69, P2279, DOI 10.1007/s00018-012-1006-5; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Liochev SI, 1997, ARCH BIOCHEM BIOPHYS, V337, P115, DOI 10.1006/abbi.1997.9766; Maghzal GJ, 2014, J BIOL CHEM, V289, P5580, DOI 10.1074/jbc.M113.539486; McCann SK, 2008, J NEUROSCI RES, V86, P2524, DOI 10.1002/jnr.21700; Michalski R, 2014, FREE RADICAL BIO MED, V67, P278, DOI 10.1016/j.freeradbiomed.2013.10.816; Michalski R, 2013, FREE RADICAL BIO MED, V54, P135, DOI 10.1016/j.freeradbiomed.2012.09.018; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Rivera J, 2010, REDOX REP, V15, P50, DOI 10.1179/174329210X12650506623401; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Sikora A, 2011, CHEM RES TOXICOL, V24, P687, DOI 10.1021/tx100439a; Streeter J, 2013, CARDIOVASC THER, V31, P125, DOI 10.1111/j.1755-5922.2011.00310.x; Sun QA, 2012, FREE RADICAL BIO MED, V52, P1897, DOI 10.1016/j.freeradbiomed.2012.02.046; Teufelhofer O, 2003, TOXICOL SCI, V76, P376, DOI 10.1093/toxsci/kfg234; Topchiy E, 2013, DEV NEUROSCI-BASEL, V35, P293, DOI 10.1159/000350502; Varga ZV, 2013, J MOL CELL CARDIOL, V62, P111, DOI 10.1016/j.yjmcc.2013.05.009; Williams HC, 2007, J CARDIOVASC PHARM, V50, P9, DOI 10.1097/FJC.0b013e318063e820; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao BZ, 2012, FREE RADICAL BIO MED, V53, P1080, DOI 10.1016/j.freeradbiomed.2012.06.034; Zielonka J, 2005, FREE RADICAL BIO MED, V39, P853, DOI 10.1016/j.freeradbiomed.2005.05.001; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2006, FREE RADICAL BIO MED, V41, P1050, DOI 10.1016/j.freeradbiomed.2006.04.017; Zielonka J, 2013, FREE RADICAL BIO MED, V65, P1310, DOI 10.1016/j.freeradbiomed.2013.09.017; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	54	53	54	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16176	16189		10.1074/jbc.M114.548693	http://dx.doi.org/10.1074/jbc.M114.548693			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764302	Green Published, hybrid			2022-12-25	WOS:000337965700023
J	Hebert, M; Licursi, M; Jensen, B; Baker, A; Milway, S; Malsbury, C; Grant, VL; Adamec, R; Hirasawa, M; Blundell, J				Hebert, Mark; Licursi, Maria; Jensen, Brittany; Baker, Ashley; Milway, Steve; Malsbury, Charles; Grant, Virginia L.; Adamec, Robert; Hirasawa, Michiru; Blundell, Jacqueline			Single Rapamycin Administration Induces Prolonged Downward Shift in Defended Body Weight in Rats	PLOS ONE			English	Article							INSULIN-RESISTANCE; MTOR INHIBITION; FOOD-INTAKE; OBESITY; NUCLEUS; INJURY; MEMORY; MICE; DIET	Manipulation of body weight set point may be an effective weight loss and maintenance strategy as the homeostatic mechanism governing energy balance remains intact even in obese conditions and counters the effort to lose weight. However, how the set point is determined is not well understood. We show that a single injection of rapamycin (RAP), an mTOR inhibitor, is sufficient to shift the set point in rats. Intraperitoneal RAP decreased food intake and daily weight gain for several days, but surprisingly, there was also a long-term reduction in body weight which lasted at least 10 weeks without additional RAP injection. These effects were not due to malaise or glucose intolerance. Two RAP administrations with a two-week interval had additive effects on body weight without desensitization and significantly reduced the white adipose tissue weight. When challenged with food deprivation, vehicle and RAP-treated rats responded with rebound hyperphagia, suggesting that RAP was not inhibiting compensatory responses to weight loss. Instead, RAP animals defended a lower body weight achieved after RAP treatment. Decreased food intake and body weight were also seen with intracerebroventricular injection of RAP, indicating that the RAP effect is at least partially mediated by the brain. In summary, we found a novel effect of RAP that maintains lower body weight by shifting the set point long-term. Thus, RAP and related compounds may be unique tools to investigate the mechanisms by which the defended level of body weight is determined; such compounds may also be used to complement weight loss strategy.	[Hebert, Mark; Jensen, Brittany; Baker, Ashley; Milway, Steve; Malsbury, Charles; Grant, Virginia L.; Adamec, Robert; Blundell, Jacqueline] Mem Univ Newfoundland, Dept Psychol, St John, NF, Canada; [Licursi, Maria; Hirasawa, Michiru] Mem Univ Newfoundland, Div Biomed Sci, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Hirasawa, M (corresponding author), Mem Univ Newfoundland, Div Biomed Sci, St John, NF, Canada.	michiru@mun.ca; jblundell@mun.ca			National Alliance for Research on Schizophrenia and Depression Young Investigator Award; Natural Sciences and Engineering Research Council of Canada; Canadian Institute for Health Research [ROP 91548, MOP 84409]; Memorial University	National Alliance for Research on Schizophrenia and Depression Young Investigator Award(NARSAD); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Memorial University	This work was supported by the National Alliance for Research on Schizophrenia and Depression Young Investigator Award (JB), Natural Sciences and Engineering Research Council of Canada (JB), Canadian Institute for Health Research (ROP 91548, REA; MOP 84409, MH), and Memorial University psychology departmental funding. ML is a CIHR/RDC Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blouet C, 2012, CELL METAB, V16, P579, DOI 10.1016/j.cmet.2012.10.003; Blundell J, 2008, NEUROBIOL LEARN MEM, V90, P28, DOI 10.1016/j.nlm.2007.12.004; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Deblon N, 2012, BRIT J PHARMACOL, V165, P2325, DOI 10.1111/j.1476-5381.2011.01716.x; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Fifield K, 2013, BEHAV BRAIN RES, V256, P457, DOI 10.1016/j.bbr.2013.08.047; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Huang S, 2001, CANCER METAST REV, V20, P69, DOI 10.1023/A:1013167315885; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Martins L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046923; Ryan KK, 2012, CELL METAB, V15, P137, DOI 10.1016/j.cmet.2011.12.013; Varela L, 2012, J PATHOL, V227, P209, DOI 10.1002/path.3984; WADDEN TA, 1989, INT J OBESITY, V13, P39; Wang CY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000143; Yanez JA, 2008, CANCER CHEMOTH PHARM, V61, P133, DOI 10.1007/s00280-007-0458-z; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; YATSCOFF RW, 1995, THER DRUG MONIT, V17, P666, DOI 10.1097/00007691-199512000-00020; Zhang WZ, 2013, EXP PHYSIOL, V98, P1696, DOI 10.1113/expphysiol.2013.074930; Zhou H, CURR PROTEIN PEPT SC, V11, P409	25	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e93691	10.1371/journal.pone.0093691	http://dx.doi.org/10.1371/journal.pone.0093691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787262	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700007
J	Ou, LX; Chen, J; Assareh, H; Hollis, SJ; Hillman, K; Flabouris, A				Ou, Lixin; Chen, Jack; Assareh, Hassan; Hollis, Stephanie J.; Hillman, Ken; Flabouris, Arthas			Trends and Variations in the Rates of Hospital Complications, Failure-to-Rescue and 30-Day Mortality in Surgical Patients in New South Wales, Australia, 2002-2009	PLOS ONE			English	Article							ADVERSE EVENTS; CANCER-SURGERY; OUTCOMES; QUALITY; SAFETY; RISK; MEDICARE; EUROPE; VOLUME; DEATH	Background: Despite the increased acceptance of failure-to-rescue (FTR) as an important patient safety indicator (defined as the percentage of deaths among surgical patients with treatable complications), there has not been any large epidemiological study reporting FTR in an Australian setting nor any evaluation on its suitability as a performance indicator. Methods: We conducted a population-based study on elective surgical patients from 82 public acute hospitals in New South Wales, Australia between 2002 and 2009, exploring the trends and variations in rates of hospital complications, FTR and 30-day mortality. We used Poisson regression models to derive relative risk ratios (RRs) after adjusting for a range of patient and hospital characteristics. Results: The average rates of complications, FTR and 30-day mortality were 13.8 per 1000 admissions, 14.1% and 6.1 per 1000 admission, respectively. The rates of complications and 30-day mortality were stable throughout the study period however there was a significant decrease in FTR rate after 2006, coinciding with the establishment of national and state-level peak patient safety agencies. There were marked variations in the three rates within the top 20% of hospitals (best) and bottom 20% of hospitals (worst) for each of the four peer-hospital groups. The group comprising the largest volume hospitals (principal referral/teaching hospitals) had a significantly higher rate of FTR in comparison to the other three groups of smaller-sized peer hospital groups (RR = 0.78, 0.57, and 0.61, respectively). Adjusted rates of complications, FTR and 30-day mortality varied widely for individual surgical procedures between the best and worst quintile hospitals within the principal referral hospital group. Conclusions: The decrease in FTR rate over the study period appears to be associated with a wide range of patient safety programs. The marked variations in the three rates between-and within-peer hospital groups highlight the potential for further quality improvement intervention opportunities.	[Ou, Lixin; Chen, Jack; Assareh, Hassan; Hollis, Stephanie J.; Hillman, Ken] Univ New S Wales, Simpson Ctr Hlth Serv Res, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Ou, Lixin; Chen, Jack; Assareh, Hassan; Hollis, Stephanie J.; Hillman, Ken] Univ New S Wales, Australian Inst Hlth Innovat, Sydney, NSW, Australia; [Flabouris, Arthas] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA 5000, Australia; [Flabouris, Arthas] Univ Adelaide, Fac Hlth Sci, Sch Med, Adelaide, SA, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Royal Adelaide Hospital; University of Adelaide	Ou, LX (corresponding author), Univ New S Wales, Simpson Ctr Hlth Serv Res, South Western Sydney Clin Sch, Sydney, NSW, Australia.	lixin.ou@unsw.edu.au	Flabouris, Arthas/L-1347-2019; Ou, Lixin/AAF-2698-2020; Chen, Jack/AAR-7346-2020; Hillman, Ken/P-6539-2015; Flabouris, Arthas/AAF-9477-2019	Flabouris, Arthas/0000-0002-1535-9441; Hillman, Ken/0000-0001-8241-0166; Chen, Jack/0000-0003-4693-5234	Australian Government National Health and Medical Research Council [APP1009916, APP1020660]	Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by grant (APP1009916 & APP1020660) from Australian Government National Health and Medical Research Council. web: www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2007, PAT SAF IND PSI VERS; Agency for Healthcare Research and Quality(AHRQ), 2013, PAT SAF IND V4 5 BEN; Aiken LH, 2012, J NURS ADM S, V42, pS10; Aiken LH, 2013, HEALTH SERV RES, V48, P931, DOI 10.1111/1475-6773.12018; Almoudaris AM, 2013, JAMA SURG, V148, P272, DOI 10.1001/jamasurg.2013.791; Azzam DG, 2013, MED J AUSTRALIA, V199, P539, DOI 10.5694/mja13.10256; Bell TM, 2013, J TRAUMA ACUTE CARE, V75, P728, DOI 10.1097/TA.0b013e3182a53aaa; Bellomo R, 2002, MED J AUSTRALIA, V176, P216, DOI 10.5694/j.1326-5377.2002.tb04376.x; Benning A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d195; Carney DE, 2011, ISR MED ASSOC J, V13, P694; Carthon JMB, 2012, J AM GERIATR SOC, V60, P1078, DOI 10.1111/j.1532-5415.2012.03990.x; Chen J, 2009, CRIT CARE MED, V37, P148, DOI 10.1097/CCM.0b013e3181928ce3; Dacey MJ, 2007, CRIT CARE MED, V35, P2076, DOI 10.1097/01.CCM.0000281518.17482.EE; Dimick JB, 2012, HEALTH SERV RES, V47, P1861, DOI 10.1111/j.1475-6773.2012.01407.x; Downey JR, 2012, HEALTH SERV RES, V47, P414, DOI 10.1111/j.1475-6773.2011.01361.x; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Friese CR, 2010, SURGERY, V147, P602, DOI 10.1016/j.surg.2009.03.014; Ghaferi AA, 2009, ANN SURG, V250, P1029, DOI 10.1097/SLA.0b013e3181bef697; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Gopaldas RR, 2013, ANN THORAC SURG, V95, P1064, DOI 10.1016/j.athoracsur.2012.10.038; Griffiths P, 2013, INT J NURS STUD, V50, P292, DOI 10.1016/j.ijnurstu.2012.10.016; Hammer JA, 2012, J NURS CARE QUAL, V27, P352, DOI 10.1097/NCQ.0b013e31825a8e2f; Health N, 2010, NSW HLTH SERV COMP D; Henneman D, 2013, ANN SURG ONCOL, V20, P3370, DOI 10.1245/s10434-013-3037-z; IEZZONI LI, 1994, HEALTH SERV RES, V29, P435; Kable AK, 2002, INT J QUAL HEALTH C, V14, P269, DOI 10.1093/intqhc/14.4.269; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Lighthall GK, 2012, CRIT CARE MED, V40, P2509, DOI 10.1097/CCM.0b013e31825adc46; Mell MW, 2011, J VASC SURG, V54, P346, DOI 10.1016/j.jvs.2011.01.030; Moriarty JP, 2010, QUAL SAF HEALTH CARE, V19, P65, DOI 10.1136/qshc.2007.025981; Needleman J, 2013, MED CARE, V51, P722, DOI 10.1097/MLR.0b013e31829808de; Nicely KLW, 2013, HEALTH SERV RES, V48, P972, DOI 10.1111/1475-6773.12004; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Trinh QD, 2013, EUR UROL, V63, P1107, DOI 10.1016/j.eururo.2012.08.069; Roberts R, 2004, AUSTR EXPERIENCE ICD; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Scarborough JE, 2012, ANN SURG, V256, P453, DOI 10.1097/SLA.0b013e31826578fb; Schmid A, 2007, J NURS ADMIN, V37, P188, DOI 10.1097/01.NNA.0000266838.23814.65; Sermeus W, 2011, BMC NURS, V10, DOI 10.1186/1472-6955-10-6; Silber JH, 2007, MED CARE, V45, P918, DOI 10.1097/MLR.0b013e31812e01cc; Silber JH, 2009, ARCH SURG-CHICAGO, V144, P113, DOI 10.1001/archsurg.2008.569; SILBER JH, 1992, MED CARE, V30, P615, DOI 10.1097/00005650-199207000-00004; Simpson KR, 2006, JOGNN-J OBST GYN NEO, V35, P432, DOI 10.1111/J.1552-6909.2006.00060.x; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Taenzer AH, 2011, ANESTHESIOLOGY, V115, P421, DOI 10.1097/ALN.0b013e318219d633; Talsma A, 2010, J NURS ADMIN, V40, P417, DOI 10.1097/NNA.0b013e3181f2eb5b; Trinh VQ, 2013, BJU INT, V112, pE20, DOI 10.1111/bju.12214; Unruh LY, 2012, NURS RES, V61, P3, DOI 10.1097/NNR.0b013e3182358968; Victorian Government Health Information, 2006, PAT SAF IND TRANSL T; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307; Wennberg JE, 2013, BMJ-BRIT MED J, P346; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wright JD, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.006; Wright JD, 2012, J CLIN ONCOL, V30, P3976, DOI 10.1200/JCO.2012.43.2906; Yasunaga H, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-129	58	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96164	10.1371/journal.pone.0096164	http://dx.doi.org/10.1371/journal.pone.0096164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG6EE	24788787	gold, Green Submitted, Green Published			2022-12-25	WOS:000335510600081
J	Xiao, N; Huang, WN; Zhang, XX; Gao, Y; Li, AH; Dai, Y; Yu, L; Liu, GQ; Pan, CH; Li, YH; Dai, ZY; Chen, JM				Xiao, Ning; Huang, Wei-nan; Zhang, Xiao-xiang; Gao, Yong; Li, Ai-hong; Dai, Yi; Yu, Ling; Liu, Guang-qing; Pan, Cun-hong; Li, Yu-hong; Dai, Zheng-yuan; Chen, Jian-min			Fine Mapping of qRC10-2, a Quantitative Trait Locus for Cold Tolerance of Rice Roots at Seedling and Mature Stages	PLOS ONE			English	Article							LOW-TEMPERATURE GERMINABILITY; RECOMBINANT INBRED LINES; BOOTING STAGE; QTL ANALYSIS; MAJOR QTL; ORYZA-RUFIPOGON; CHILLING INJURY; IDENTIFICATION; JAPONICA; POLYMORPHISM	Cold stress causes various injuries to rice seedlings in low-temperature and high-altitude areas and is therefore an important factor affecting rice production in such areas. In this study, root conductivity (RC) was used as an indicator to map quantitative trait loci (QTLs) of cold tolerance in Oryza rufipogon Griff., Dongxiang wild rice (DX), at its two-leaf stage. The correlation coefficients between RC and the plant survival rate (PSR) at the seedling and maturity stages were -0.85 and -0.9 (P = 0.01), respectively, indicating that RC is a reliable index for evaluating cold tolerance of rice. A preliminary mapping group was constructed from 151 BC2F1 plants using DX as a cold-tolerant donor and the indica variety Nanjing 11 (NJ) as a recurrent parent. A total of 113 codominant simple-sequence repeat (SSR) markers were developed, with a parental polymorphism of 17.3%. Two cold-tolerant QTLs, named qRC10-1 and qRC10-2 were detected on chromosome 10 by composite interval mapping. qRC10-1 (LOD = 3.1, RM171-RM1108) was mapped at 148.3 cM, and qRC10-2 (LOD = 6.1, RM25570-RM304) was mapped at 163.3 cM, which accounted for 9.4% and 32.1% of phenotypic variances, respectively. To fine map the major locus qRC10-2, NJ was crossed with a BC4F2 plant (L188-3), which only carried the QTL qRC10-2, to construct a large BC5F2 fine-mapping population with 13,324 progenies. Forty-five molecular markers were designed to evenly cover qRC10-2, and 10 markers showed polymorphisms between DX and NJ. As a result, qRC10-2 was delimited to a 48.5-kb region between markers qc45 and qc48. In this region, Os10g0489500 and Os10g0490100 exhibited different expression patterns between DX and NJ. Our results provide a basis for identifying the gene(s) underlying qRC10-2, and the markers developed here may be used to improve low-temperature tolerance of rice seedling and maturity stages via marker-assisted selection (MAS). Key Message: With root electrical conductivity used as a cold-tolerance index, the quantitative trait locus qRC10-2 was fine mapped to a 48.5-kb candidate region, and Os10g0489500 and Os10g0490100 were identified as differently expressed genes for qRC10-2.	[Xiao, Ning; Huang, Wei-nan; Gao, Yong; Dai, Yi; Chen, Jian-min] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Jiangsu, Peoples R China; [Xiao, Ning; Huang, Wei-nan; Gao, Yong; Dai, Yi; Chen, Jian-min] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Yangzhou, Jiangsu, Peoples R China; [Xiao, Ning; Zhang, Xiao-xiang; Li, Ai-hong; Yu, Ling; Liu, Guang-qing; Pan, Cun-hong; Li, Yu-hong; Dai, Zheng-yuan] Natl Rice Ind Technol Syst Yangzhou Comprehens Ex, Lixiahe Agr Res Inst Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Chen, JM (corresponding author), Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Yangzhou, Jiangsu, Peoples R China.	yzxiaoning@gmail.com; jmchen@yzu.edu.cn	chen, zongyan/ABG-9170-2021		Natural Science Foundation of Jiangsu Province [BK2011426, BK2011427]; Priority Academic Program Development of Jiangsu Higher Education Institutions; International Atomic Energy Agency [12228/RO]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions; International Atomic Energy Agency(International Atomic Energy Agency)	This study was supported by the Natural Science Foundation(BK2011426 and BK2011427) of Jiangsu Province, and the Priority Academic Program Development of Jiangsu Higher Education Institutions and International Atomic Energy Agency (12228/RO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andaya VC, 2006, THEOR APPL GENET, V113, P467, DOI 10.1007/s00122-006-0311-5; Andaya VC, 2003, J EXP BOT, V54, P2579, DOI 10.1093/jxb/erg243; Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Andaya VC, 2007, MOL BREEDING, V20, P349, DOI 10.1007/s11032-007-9096-8; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Cai HW, 2002, THEOR APPL GENET, V104, P1217, DOI 10.1007/s00122-001-0819-7; Cao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046944; Dai LY, 2004, BREEDING SCI, V54, P253, DOI 10.1270/jsbbs.54.253; DELORENZO G, 1991, PHYSIOL MOL PLANT P, V39, P335, DOI 10.1016/0885-5765(91)90015-A; Ji SL, 2009, PLANT BREEDING, V128, P387, DOI 10.1111/j.1439-0523.2008.01533.x; Jiang L, 2008, J CEREAL SCI, V48, P173, DOI 10.1016/j.jcs.2007.08.013; Jiang L, 2006, FIELD CROP RES, V98, P68, DOI 10.1016/j.fcr.2005.12.015; Koseki M, 2010, MOL GENET GENOMICS, V284, P45, DOI 10.1007/s00438-010-0548-1; Kuroki M, 2007, THEOR APPL GENET, V115, P593, DOI 10.1007/s00122-007-0589-y; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; LEE TM, 1995, CROP SCI, V35, P502, DOI 10.2135/cropsci1995.0011183X003500020037x; Li F, 2010, PLANT CELL REP, V29, P977, DOI 10.1007/s00299-010-0883-z; LINCOLN S, 1992, MAPPING GENES CONTRO; Liu FX, 2013, MOL PLANT, V6, P757, DOI 10.1093/mp/sss161; Liu HH, 2014, PLANT CELL ENVIRON, V37, P1144, DOI 10.1111/pce.12223; Lou QJ, 2007, EUPHYTICA, V158, P87, DOI 10.1007/s10681-007-9431-5; LYONS JM, 1973, ANNU REV PLANT PHYS, V24, P445, DOI 10.1146/annurev.pp.24.060173.002305; Maclean J.L., 2002, RICE ALMANAC SOURCE, P6; Mao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047275; Miura K, 2001, BREEDING SCI, V51, P293, DOI 10.1270/jsbbs.51.293; MURATA N, 1992, NATURE, V356, P710, DOI 10.1038/356710a0; MURATA N, 1995, BIOCHEM J, V308, P1; Nakagahra M, 1997, PLANT MOL BIOL, V35, P69, DOI 10.1023/A:1005784431759; OKA HI, 1988, DEV CROP SCI, V14; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; Qian Q, 2000, CHINESE SCI BULL, V45, P448, DOI 10.1007/BF02884949; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Saito K, 2004, THEOR APPL GENET, V109, P515, DOI 10.1007/s00122-004-1667-z; Saito K, 2001, THEOR APPL GENET, V103, P862, DOI 10.1007/s001220100661; Saito K, 2010, PLANT SCI, V179, P97, DOI 10.1016/j.plantsci.2010.04.004; Saltveit ME, 2001, POSTHARVEST BIOL TEC, V21, P169, DOI 10.1016/S0925-5214(00)00132-0; SARUYAMA H, 1995, PLANT SCI, V109, P105, DOI 10.1016/0168-9452(95)04156-O; SECOND G, 1982, JPN J GENET, V57, P25, DOI 10.1266/jjg.57.25; Shirasawa S, 2012, THEOR APPL GENET, V124, P937, DOI 10.1007/s00122-011-1758-6; Solecka D, 2008, ANN BOT-LONDON, V101, P521, DOI 10.1093/aob/mcm329; Suh JP, 2012, EUPHYTICA, V184, P101, DOI 10.1007/s10681-011-0575-y; Suh JP, 2010, THEOR APPL GENET, V120, P985, DOI 10.1007/s00122-009-1226-8; Teng S, 2001, CHINESE SCI BULL, V46, P1800, DOI 10.1007/BF02900554; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Tian F, 2006, THEOR APPL GENET, V112, P570, DOI 10.1007/s00122-005-0165-2; Wang S., 2007, WINDOWS QTL CARTOGRA; Wang ZF, 2011, EUPHYTICA, V181, P405, DOI 10.1007/s10681-011-0469-z; WANG ZY, 1992, THEOR APPL GENET, V83, P565, DOI 10.1007/BF00226900; Xiao N, 2011, GENET RESOUR CROP EV, V58, P1177, DOI 10.1007/s10722-010-9651-8; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; YOSHIDA H, 1994, BREEDING SCI, V44, P361; Yu Jing, 2008, Acta Agronomica Sinica, V34, P2019; Zhang F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-461; Zhang ZH, 2005, PLANT SCI, V168, P527, DOI 10.1016/j.plantsci.2004.09.021; Zhou L, 2010, THEOR APPL GENET, V121, P895, DOI 10.1007/s00122-010-1358-x	59	16	22	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96046	10.1371/journal.pone.0096046	http://dx.doi.org/10.1371/journal.pone.0096046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788204	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600068
J	Tomasi, D; Volkow, ND				Tomasi, Dardo; Volkow, Nora D.			Mapping Small-World Properties through Development in the Human Brain: Disruption in Schizophrenia	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; RESTING-STATE; LOW-FREQUENCY; TEST-RETEST; NETWORKS; ORGANIZATION; DYNAMICS; MRI; COMORBIDITY; ACTIVATION	Evidence from imaging studies suggests that the human brain has a small-world network topology that might be disrupted in certain brain disorders. However, current methodology is based on global graph theory measures, such as clustering, C, characteristic path length, L, and small-worldness, S, that lack spatial specificity and are insufficient to identify regional brain abnormalities. Here we propose novel ultra-fast methodology for mapping local properties of brain network topology such as local C, L and S (lC, lL and lS) in the human brain at 3-mm isotropic resolution from 'resting-state' magnetic resonance imaging data. Test-retest datasets from 40 healthy children/adolescents were used to demonstrate the overall good reliability of the measures across sessions and computational parameters (intraclass correlation >0.5 for lC and lL) and their low variability across subjects (< 29%). Whereas regions with high local functional connectivity density (lFCD; local degree) in posterior parietal and occipital cortices demonstrated high lC and short lL, subcortical regions (globus pallidus, thalamus, hippocampus and amygdala), cerebellum (lobes and vermis), cingulum and temporal cortex also had high, lS, demonstrating stronger small-world topology than other hubs. Children/adolescents had stronger lFCD, higher lC and longer lL in most cortical regions and thalamus than 74 healthy adults, consistent with pruning of functional connectivity during maturation. In contrast, lFCD, lC and lL were weaker in thalamus and midbrain, and lL was shorter in frontal cortical regions and cerebellum for 69 schizophrenia patients than for 74 healthy controls, suggesting exaggerated pruning of connectivity in schizophrenia. Follow up correlation analyses for seeds in thalamus and midbrain uncovered lower positive connectivity of these regions in thalamus, putamen, cerebellum and frontal cortex (cingulum, orbitofrontal, inferior frontal) and lower negative connectivity in auditory, visual, motor, premotor and somatosensory cortices for schizophrenia patients than for controls, consistent with prior findings of thalamic disconnection in schizophrenia.	[Tomasi, Dardo; Volkow, Nora D.] NIAAA, Bethesda, MD 20892 USA; [Volkow, Nora D.] NIDA, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Tomasi, D (corresponding author), NIAAA, Bethesda, MD 20892 USA.	tomasidg@mail.nih.gov	Tomasi, Dardo/J-2127-2015		National Institutes of Alcohol Abuse and Alcoholism [2RO1AA09481]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009481, ZIAAA000550] Funding Source: NIH RePORTER	National Institutes of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was accomplished with support from the National Institutes of Alcohol Abuse and Alcoholism (2RO1AA09481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aron AR, 2006, NEUROIMAGE, V29, P1000, DOI 10.1016/j.neuroimage.2005.08.010; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Beu M, 2009, J NEUROSCI METH, V176, P263, DOI 10.1016/j.jneumeth.2008.08.036; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Boksa P, 2012, J PSYCHIATR NEUROSCI, V37, P75, DOI 10.1503/jpn.120007; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Copeland JRM, 1998, SCHIZOPHRENIA BULL, V24, P153, DOI 10.1093/oxfordjournals.schbul.a033307; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; FARKAS T, 1984, ARCH GEN PSYCHIAT, V41, P293; Fitzsimmons J, 2013, CURR OPIN PSYCHIATR, V26, P172, DOI 10.1097/YCO.0b013e32835d9e6a; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Hadley J, 2013, NEUROPSYCHOPHARMACOL, DOI [10.1038/npp.2013.1305, DOI 10.1038/NPP.2013.1305]; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jolles DD, 2011, CEREB CORTEX, V21, P385, DOI 10.1093/cercor/bhq104; Kanaan RAA, 2005, BIOL PSYCHIAT, V58, P921, DOI 10.1016/j.biopsych.2005.05.015; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kong J, 2007, NEUROIMAGE, V34, P1171, DOI 10.1016/j.neuroimage.2006.10.019; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Laursen TM, 2009, J CLIN PSYCHIAT, V70, P1432, DOI 10.4088/JCP.08m04807; Linden DEJ, 2011, CEREB CORTEX, V21, P330, DOI 10.1093/cercor/bhq097; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mannell MV, 2010, HUM BRAIN MAPP, V31, P424, DOI 10.1002/hbm.20876; Marenco S, 2012, NEUROPSYCHOPHARMACOL, V37, P499, DOI 10.1038/npp.2011.215; Oertel-Knochel V, 2013, SCHIZOPHR RES, V147, P331, DOI 10.1016/j.schres.2013.04.024; Ottet MC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00402; PARK SK, 1988, COMMUN ACM, V31, P1192, DOI 10.1145/63039.63042; Paus Tomas, 2008, Nat Rev Neurosci, V9, P947, DOI 10.1038/nrn2513; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rasetti R, 2011, ARCH GEN PSYCHIAT, V68, P1207, DOI 10.1001/archgenpsychiatry.2011.103; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Tomasi D., 2012, CEREB CORTEX; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Tomasi D, 2012, HUM BRAIN MAPP, V33, P849, DOI 10.1002/hbm.21252; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Voineskos AN, 2010, BRAIN, V133, P1494, DOI 10.1093/brain/awq040; VOLKOW ND, 1988, SCHIZOPHR RES, V1, P47, DOI 10.1016/0920-9964(88)90039-4; Volkow ND, 2002, PSYCHIAT RES-NEUROIM, V114, P39, DOI 10.1016/S0925-4927(01)00130-5; VOLKOW ND, 1986, J CEREBR BLOOD F MET, V6, P441, DOI 10.1038/jcbfm.1986.77; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Yu QB, 2012, CURR TOP MED CHEM, V12, P2415, DOI 10.2174/156802612805289890; Yu QB, 2011, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00007, 10.3389/fnsys.2011.00103]	74	45	47	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96176	10.1371/journal.pone.0096176	http://dx.doi.org/10.1371/journal.pone.0096176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788815	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917300030
J	Noyce, AJ; Nagy, A; Acharya, S; Hadavi, S; Bestwick, JP; Fearnley, J; Lees, AJ; Giovannoni, G				Noyce, Alastair J.; Nagy, Anna; Acharya, Shami; Hadavi, Shahrzad; Bestwick, Jonathan P.; Fearnley, Julian; Lees, Andrew J.; Giovannoni, Gavin			Bradykinesia-Akinesia Incoordination Test: Validating an Online Keyboard Test of Upper Limb Function	PLOS ONE			English	Article							PARKINSON DISEASE; BRAIN TEST; RISK	Background: The Bradykinesia Akinesia Incoordination (BRAIN) test is a computer keyboard-tapping task that was developed for use in assessing the effect of symptomatic treatment on motor function in Parkinson's disease (PD). An online version has now been designed for use in a wider clinical context and the research setting. Methods: Validation of the online BRAIN test was undertaken in 58 patients with Parkinson's disease (PD) and 93 age-matched, non-neurological controls. Kinesia scores (KS30, number of key taps in 30 seconds), akinesia times (AT30, mean dwell time on each key in milliseconds), incoordination scores (IS30, variance of travelling time between key presses) and dysmetria scores (DS30, accuracy of key presses) were compared between groups. These parameters were correlated against total motor scores and sub-scores from the Unified Parkinson's Disease Rating Scale (UPDRS). Results: Mean KS30, AT30 and IS30 were significantly different between PD patients and controls (p <= 0.0001). Sensitivity for 85% specificity was 50% for KS30, 40% for AT30 and 29% for IS30. KS30, AT30 and IS30 correlated significantly with UPDRS total motor scores (r = -0.53, r = 0.27 and r = 0.28 respectively) and motor UPDRS sub-scores. The reliability of KS30, AT30 and DS30 was good on repeated testing. Conclusions: The BRAIN test is a reliable, convenient test of upper limb motor function that can be used routinely in the outpatient clinic, at home and in clinical trials. In addition, it can be used as an objective longitudinal measurement of emerging motor dysfunction for the prediction of PD in at-risk cohorts.	[Noyce, Alastair J.; Lees, Andrew J.] UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, London, England; [Noyce, Alastair J.; Nagy, Anna; Acharya, Shami; Hadavi, Shahrzad; Giovannoni, Gavin] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Bestwick, Jonathan P.] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England; [Fearnley, Julian] Royal London Hosp, Barts Hlth NHS Trust, London E1 1BB, England	University of London; University College London; University of London; Queen Mary University London; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital	Noyce, AJ (corresponding author), UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, London, England.	a.noyce@ucl.ac.uk	Lees, Andrew J/A-6605-2009	Lees, Andrew J/0000-0002-2476-4385; Noyce, Alastair/0000-0003-3027-5497	Parkinson's UK Innovation Grant [K-1006]; National Institute of Health Research Academic Clinical Fellowship; PSP Association; Weston Trust-Reta Lila Howard Foundation; Novartis; Teva; Meda; Boehringer Ingelheim; GSK; Ipsen; Lundbeck; Allergan; Orion; BIAL; Noscira; Roche; Merck-Serono; Biogen-Idec; Ironwood; Genentech; Sanofi-Aventis; UCB Pharmaceuticals; Vertex; Eisai; Elan; Fiveprime; Bayer-Schering; Synthon BV; Genyme; GW Pharma; Merz	Parkinson's UK Innovation Grant; National Institute of Health Research Academic Clinical Fellowship; PSP Association; Weston Trust-Reta Lila Howard Foundation; Novartis(Novartis); Teva(Teva Pharmaceutical Industries); Meda; Boehringer Ingelheim(Boehringer Ingelheim); GSK(GlaxoSmithKline); Ipsen(Ipsen); Lundbeck(Lundbeck Corporation); Allergan(AbbVieAllergan); Orion; BIAL(Bial Group); Noscira; Roche(Roche Holding); Merck-Serono(Merck & Company); Biogen-Idec(Biogen); Ironwood; Genentech(Roche HoldingGenentech); Sanofi-Aventis(Sanofi-Aventis); UCB Pharmaceuticals(UCB Pharma SA); Vertex(Vertex Pharmaceuticals); Eisai(Eisai Co Ltd); Elan; Fiveprime; Bayer-Schering(Bayer AG); Synthon BV(Oce-Technologies BV); Genyme; GW Pharma; Merz	The authors have read the journal's policy and report the following conflicts: AJ Noyce declares the following: consultancy, Elan/Prothena Pharmaceuticals; Grants, Parkinson's UK Innovation Grant (reference number K-1006), and National Institute of Health Research Academic Clinical Fellowship. A Nagy, S Acharya, S Hadavi, JP Bestwick, and J Fearnley declare no competing interests. AJ Lees declares the following: board membership, Novartis, Teva, Meda, Boehringer Ingelheim, GSK, Ipsen, Lundbeck, Allergan, Orion, BIAL, Noscira, Roche; consultancy, Genus; employment, UCH/UCLH; grants/grants pending, PSP Association, Weston Trust-Reta Lila Howard Foundation; speaking fees, Novartis, Teva, Meda, Boehringer Ingelheim, GSK, Ipsen, Lundbeck, Allergan, Orion, BIAL, Noscira, Roche. G Giovannoni declares the following: consultancy fees, Merck-Serono, Biogen-Idec, Ironwood, Genentech, Teva, GSK, Sanofi-Aventis, Novartis, Roche, UCB Pharmaceuticals, Vertex, Eisai, Elan, Fiveprime, Bayer-Schering, Synthon BV, and Genyme; grants/grants pending from Biogen-Idec, Bayer-Schering, GW Pharma, Merck-Serono, Merz, Novartis, Teva, Sanofi-Aventis. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Berg D, 2012, MOVEMENT DISORD, V27, P656, DOI 10.1002/mds.24985; Berg D, 2011, ARCH NEUROL-CHICAGO, V68, P932, DOI 10.1001/archneurol.2011.141; BURNS BD, 1960, NEUROLOGY, V10, P1096, DOI 10.1212/WNL.10.12.1096; de Lau LML, 2006, ARCH NEUROL-CHICAGO, V63, P362, DOI 10.1001/archneur.63.3.noc50312; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Giovannoni G, 1999, J NEUROL NEUROSUR PS, V67, P624, DOI 10.1136/jnnp.67.5.624; Goetz CG, 2009, MOVEMENT DISORD, V24, P551, DOI 10.1002/mds.22379; Homann CN, 2000, MOVEMENT DISORD, V15, P641, DOI 10.1002/1531-8257(200007)15:4<641::AID-MDS1007>3.0.CO;2-2; LEES AJ, 1992, MOVEMENT DISORD, V7, P110, DOI 10.1002/mds.870070203; Ling H, 2012, BRAIN, V135, P1141, DOI 10.1093/brain/aws038; Noyce AJ, 2014, J NEUROL NEUROSUR PS, V85, P31, DOI 10.1136/jnnp-2013-305420; Noyce AJ, 2012, MOVEMENT DISORD, V27, P157, DOI 10.1002/mds.23947; Postuma RB, 2012, BRAIN, V135, P1860, DOI 10.1093/brain/aws093; Ross GW, 2012, PARKINSONISM RELA S1, V18, pS199, DOI DOI 10.1016/S1353-8020(11)70062-1; Siderowf A, 2012, MOVEMENT DISORD, V27, P406, DOI 10.1002/mds.24892; Yokoe M, 2009, PARKINSONISM RELAT D, V15, P440, DOI 10.1016/j.parkreldis.2008.11.003	16	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96260	10.1371/journal.pone.0096260	http://dx.doi.org/10.1371/journal.pone.0096260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781810	Green Published, Green Submitted, gold			2022-12-25	WOS:000335504900026
J	Atsatt, PR; Whiteside, MD				Atsatt, Peter R.; Whiteside, Matthew D.			Novel Symbiotic Protoplasts Formed by Endophytic Fungi Explain Their Hidden Existence, Lifestyle Switching, and Diversity within the Plant Kingdom	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; GENUS MYCOSPHAERELLA; POULTRY FEEDS; SP-NOV.; PHYLOGENY; EVOLUTION; IDENTIFICATION; RHODOTORULA; TRICHODERMA; ASPERGILLUS	Diverse fungi live all or part of their life cycle inside plants as asymptomatic endophytes. While endophytic fungi are increasingly recognized as significant components of plant fitness, it is unclear how they interact with plant cells; why they occur throughout the fungal kingdom; and why they are associated with most fungal lifestyles. Here we evaluate the diversity of endophytic fungi that are able to form novel protoplasts called mycosomes. We found that mycosomes cultured from plants and phylogenetically diverse endophytic fungi have common morphological characteristics, express similar developmental patterns, and can revert back to the free-living walled state. Observed with electron microscopy, mycosome ontogeny within Aureobasidium pullulans may involve two organelles: double membrane-bounded promycosome organelles (PMOs) that form mycosomes, and multivesicular bodies that may form plastid-infecting vesicles. Cultured mycosomes also contain a double membrane-bounded organelle, which may be homologous to the A. pullulans PMO. The mycosome PMO is often expressed as a vacuole-like organelle, which alternatively may contain a lipoid body or a starch grain. Mycosome reversion to walled cells occurs within the PMO, and by budding from lipid or starch-containing mycosomes. Mycosomes discovered in chicken egg yolk provided a plant-independent source for analysis: they formed typical protoplast stages, contained fungal ITS sequences and reverted to walled cells, suggesting mycosome symbiosis with animals as well as plants. Our results suggest that diverse endophytic fungi express a novel protoplast phase that can explain their hidden existence, lifestyle switching, and diversity within the plant kingdom. Importantly, our findings outline "what, where, when and how'', opening the way for cell and organelle-specific tests using in situ DNA hybridization and fluorescent labels. We discuss developmental, ecological and evolutionary contexts that provide a robust framework for continued tests of the mycosome phase hypothesis.	[Atsatt, Peter R.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Whiteside, Matthew D.] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada; [Whiteside, Matthew D.] Univ British Columbia Okanagan, Inst Species Risk & Habitat Studies, Kelowna, BC, Canada	University of California System; University of California Irvine; University of British Columbia; University of British Columbia Okanagan; University of British Columbia; University of British Columbia Okanagan	Atsatt, PR (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	peter.atsatt@uci.edu	Atsatt, Peter/Q-8529-2019					Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Aly AH, 2011, APPL MICROBIOL BIOT, V90, P1829, DOI 10.1007/s00253-011-3270-y; [Anonymous], 2006, MICROBIAL ROOT ENDOP; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2009, SYST BIOL, V58, P283, DOI 10.1093/sysbio/syp001; Arnold AE, 2008, TROPICAL FOREST COMM, P254; Atsatt PR, 2003, INT MICROBIOL, V6, P17, DOI 10.1007/s10123-003-0103-6; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Barrow JR, 2001, MYCORRHIZA, V11, P199, DOI 10.1007/s005720100111; BERCH SM, 1983, CAN J BOT, V61, P899, DOI 10.1139/b83-100; Bidartondo MI, 2011, BIOL LETTERS, V7, P574, DOI 10.1098/rsbl.2010.1203; Biller SJ, 2014, SCIENCE, V343, P183, DOI 10.1126/science.1243457; Bills Gerald F., 1996, P31; Brillouet JM, 2013, ANN BOT-LONDON, V112, P1003, DOI 10.1093/aob/mct168; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Casadevall A, 2009, TRENDS MICROBIOL, V17, P158, DOI 10.1016/j.tim.2008.12.005; Crous PW, 2009, FUNGAL DIVERS, V38, P1; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Declerck S, 1998, MYCOLOGIA, V90, P579, DOI 10.2307/3761216; Desiro A, 2013, P ROYAL SOC B, V280, P1; Domsch K.H., 1980, COMPENDIUM SOIL FUNG; Doty SL, 2011, FOR SCI, V80, P151, DOI 10.1007/978-94-007-1599-8_9; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Duckett JG, 2006, AM J BOT, V93, P797, DOI 10.3732/ajb.93.6.797; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Gadanho M, 2002, FEMS YEAST RES, V2, P47, DOI 10.1111/j.1567-1364.2002.tb00068.x; GARRISON RG, 1978, MYCOPATHOLOGIA, V64, P29, DOI 10.1007/BF00443085; GARRISON RG, 1977, ANN INST PASTEUR MIC, VB128, P319; GEMEINHARDT H, 1985, ZBL MIKROBIOL, V140, P375, DOI 10.1016/S0232-4393(85)80033-0; Guard-Petter J, 2001, ENVIRON MICROBIOL, V3, P421, DOI 10.1046/j.1462-2920.2001.00213.x; Gueidan C, 2008, STUD MYCOL, P111, DOI 10.3114/sim.2008.61.11; Hamilton CE, 2012, FUNGAL DIVERS, V54, P1, DOI 10.1007/s13225-012-0158-9; Hermosa R, 2012, MICROBIOL-SGM, V158, P17, DOI 10.1099/mic.0.052274-0; Herrera J, 2011, MICROB ECOL, V61, P239, DOI 10.1007/s00248-010-9744-0; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Huang CH, 2012, YEAST, V29, P531, DOI 10.1002/yea.2933; Humber RA, 2008, J INVERTEBR PATHOL, V98, P262, DOI 10.1016/j.jip.2008.02.017; Isaeva OV, 2010, BIOL BULL+, V37, P26, DOI 10.1134/S1062359010010048; Jacques N, 2009, INT J SYST EVOL MICR, V59, P1242, DOI 10.1099/ijs.0.004325-0; James TY, 2006, MYCOLOGIA, V98, P860, DOI 10.3852/mycologia.98.6.860; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; James TY, 2013, CURR BIOL, V23, P1548, DOI 10.1016/j.cub.2013.06.057; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kusari S, 2011, J NAT PROD, V74, P764, DOI 10.1021/np1008398; Letcher PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056232; Lucero ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017693; Magnoli C, 1998, MYCOPATHOLOGIA, V142, P27, DOI 10.1023/A:1006981523027; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nicola AM, 2009, EUKARYOT CELL, V8, P1373, DOI 10.1128/EC.00044-09; Nikoh N, 2000, MOL BIOL EVOL, V17, P629, DOI 10.1093/oxfordjournals.molbev.a026341; OH Soon-Ok, 2006, The Plant Pathology Journal, V22, P381; Oliveira Debora L, 2010, Commun Integr Biol, V3, P533, DOI 10.4161/cib.3.6.12756; Oliveira DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011113; Pilling E, 2003, PLANT PHYSIOL, V132, P365, DOI 10.1104/pp.102.018044; POWELL MJ, 1984, MYCOLOGIA, V76, P1039, DOI 10.2307/3793019; POWELL MJ, 1993, MYCOLOGIA, V85, P1, DOI 10.2307/3760471; Promputtha I, 2007, MICROB ECOL, V53, P579, DOI 10.1007/s00248-006-9117-x; Redman RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014823; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez R, 2008, J EXP BOT, V59, P1109, DOI 10.1093/jxb/erm342; Rosa CAR, 2006, VET MICROBIOL, V113, P89, DOI 10.1016/j.vetmic.2005.10.031; ROSSIER C, 1977, EXP MYCOL, V1, P52, DOI 10.1016/S0147-5975(77)80030-3; SAUTER EA, 1981, POULTRY SCI, V60, P569, DOI 10.3382/ps.0600569; Sekimoto S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-331; Selosse MA, 2008, NEW PHYTOL, V178, P3, DOI 10.1111/j.1469-8137.2008.02390.x; Shin KS, 2006, INT J SYST EVOL MICR, V56, P2241, DOI 10.1099/ijs.0.64353-0; SINGH SL, 1979, MYCOPATHOLOGIA, V69, P43, DOI 10.1007/BF00428602; Spatafora JW, 2007, MOL ECOL, V16, P1701, DOI 10.1111/j.1365-294X.2007.03225.x; Sung GH, 2008, MOL PHYLOGENET EVOL, V49, P495, DOI 10.1016/j.ympev.2008.08.028; TEMMINK JHM, 1968, CAN J BOTANY, V46, P951, DOI 10.1139/b68-127; Uchida W, 2005, PROTOPLASMA, V226, P207, DOI 10.1007/s00709-005-0113-7; Vallejo MC, 2011, EUKARYOT CELL, V10, P343, DOI 10.1128/EC.00227-10; Veiga RSL, 2013, PLANT CELL ENVIRON, P1; Verkley GJM, 2004, MYCOL RES, V108, P1271, DOI 10.1017/S0953756204001054; Weber Roland W. S., 2002, Mycologist, V16, P10; Weber RWS, 2002, NEW PHYTOL, V154, P471, DOI 10.1046/j.1469-8137.2002.00377.x; Wei JG, 2007, FUNGAL DIVERS, V24, P55; Weiss M, 2011, PLOS ONE, V6; White JF, 2012, FUNGAL ECOL, V5, P287, DOI 10.1016/j.funeco.2012.03.003; Yuan ZL, 2010, J PLANT GROWTH REGUL, V29, P116, DOI 10.1007/s00344-009-9112-9; Zhao J, 2011, MINI-REV MED CHEM, V11, P159, DOI 10.2174/138955711794519492; Zhao JH, 2002, FEMS YEAST RES, V2, P159, DOI 10.1016/S1567-1356(02)00093-4	84	22	24	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95266	10.1371/journal.pone.0095266	http://dx.doi.org/10.1371/journal.pone.0095266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24777121	gold, Green Published			2022-12-25	WOS:000346241800010
J	Descheemaeker, M; Spruyt, A; Hermans, D				Descheemaeker, Mathilde; Spruyt, Adriaan; Hermans, Dirk			On the Relationship between the Indirectly Measured Attitude Towards Beer and Beer Consumption: The Role of Attitude Accessibility	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; PREDICTIVE-VALIDITY; AUTOMATIC ACTIVATION; ALCOHOL-CONSUMPTION; PLANNED BEHAVIOR; SOCIAL COGNITION; METAANALYSIS; EXPLICIT; DRINKING; STIMULUS	Although some studies have demonstrated that the indirectly measured attitude towards alcohol is related to alcohol use, this relationship has not always been confirmed. In the current study, we attempted to shed light on this issue by investigating whether the predictive validity of an indirect attitude measure is dependent upon attitude accessibility. In a sample of 88 students, the picture-picture naming task, an adaptation of the affective priming paradigm, was used to measure the automatically activated attitude towards beer. Attitude accessibility was measured using a speeded evaluative categorization task. Behavioral measures were the amount of beer poured and drunk during a bogus taste test and the choice between a bottle of beer or water at the end of the experiment. In line with our hypothesis, the indirectly measured attitude towards beer predicted behavior during the taste test only when it was highly accessible. In contrast, this attitude was related to choice behavior irrespective of attitude accessibility. This study confirms that indirect attitude measures can be valuable predictors of alcohol-related behavior, but that it is sometimes necessary to take attitude accessibility into account.	[Descheemaeker, Mathilde; Hermans, Dirk] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Spruyt, Adriaan] Univ Ghent, Fac Psychol & Educ Sci, B-9000 Ghent, Belgium	KU Leuven; Ghent University	Descheemaeker, M (corresponding author), Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium.	mathilde.descheemaeker@ppw.kuleuven.be	Hermans, Dirk/AAE-6657-2021; Spruyt, Adriaan/H-8554-2019	Hermans, Dirk/0000-0003-4497-3982				Burton CM, 2012, PSYCHOL ADDICT BEHAV, V26, P766, DOI 10.1037/a0028742; Cameron CD, 2012, PERS SOC PSYCHOL REV, V16, P330, DOI 10.1177/1088868312440047; Cooke R, 2004, BRIT J SOC PSYCHOL, V43, P159, DOI 10.1348/0144666041501688; Cooke R, 2004, IRISH J PSYCHOL, V25, P44; Davis CG, 2010, ADDICT BEHAV, V35, P302, DOI 10.1016/j.addbeh.2009.11.001; De Houwer J, 2002, Q J EXP PSYCHOL-B, V55, P289, DOI 10.1080/02724990244000034; De Houwer J, 2001, J EXP SOC PSYCHOL, V37, P443, DOI 10.1006/jesp.2000.1464; Deutsch R, 2009, J EXP SOC PSYCHOL, V45, P101, DOI 10.1016/j.jesp.2008.09.001; DOLL J, 1992, J PERS SOC PSYCHOL, V63, P754, DOI 10.1037/0022-3514.63.5.754; Fazio R.H., 1995, ATTITUDE STRENGTH AN, P247, DOI DOI 10.1521/SOCO.2007.25.5.603; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Field M., 2012, DRUG ABUSE ADDICTION, P35; Friese M, 2008, BRIT J SOC PSYCHOL, V47, P397, DOI 10.1348/014466607X241540; Friese M, 2010, SOC PSYCHOL PERS SCI, V1, P143, DOI 10.1177/1948550609359945; Glasman LR, 2006, PSYCHOL BULL, V132, P778, DOI 10.1037/0033-2909.132.5.778; Govan CL, 2004, J EXP SOC PSYCHOL, V40, P357, DOI 10.1016/j.jesp.2003.07.002; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hermans D, 2001, COGNITION EMOTION, V15, P143, DOI 10.1080/0269993004200033; Herring DR, 2013, PSYCHOL BULL, V139, P1062, DOI 10.1037/a0031309; Kokkinaki F, 1997, BRIT J SOC PSYCHOL, V36, P497, DOI 10.1111/j.2044-8309.1997.tb01146.x; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; Krosnick J.A., 1995, OHIO STATE U SERIES, P1; Larsen H, 2012, ADDICTION, V107, P1420, DOI 10.1111/j.1360-0443.2012.03805.x; Mitchell JP, 2003, J EXP PSYCHOL GEN, V132, P455, DOI 10.1037/0096-3445.132.3.455; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Noel X, 2010, J PSYCHOPHYSIOL, V24, P240, DOI 10.1027/0269-8803/a000037; Olson MA, 2003, PSYCHOL SCI, V14, P636, DOI 10.1046/j.0956-7976.2003.psci_1477.x; Payne BK, 2008, COGNITION EMOTION, V22, P238, DOI 10.1080/02699930701357394; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Perugini M, 2007, EXP PSYCHOL, V54, P134, DOI 10.1027/1618-3169.54.2.134; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reich RR, 2010, PSYCHOL ADDICT BEHAV, V24, P13, DOI 10.1037/a0016556; Roefs A, 2011, PSYCHOL BULL, V137, P149, DOI 10.1037/a0021729; Rooke SE, 2008, ADDICT BEHAV, V33, P1314, DOI 10.1016/j.addbeh.2008.06.009; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; Spruyt A, 2002, SOC COGNITION, V20, P227, DOI 10.1521/soco.20.3.227.21106; Spruyt A, 2007, J EXP SOC PSYCHOL, V43, P599, DOI 10.1016/j.jesp.2006.06.009; Spruyt A, 2007, MEM COGNITION, V35, P95, DOI 10.3758/BF03195946; Spruyt A, 2010, EXP PSYCHOL, V57, P36, DOI 10.1027/1618-3169/a000005; Thush C, 2007, ADDICT BEHAV, V32, P1367, DOI 10.1016/j.addbeh.2006.09.011; Vandromme H, 2011, SELF IDENTITY, V10, P32, DOI 10.1080/15298860903512149; Verhulst F, 2006, APPETITE, V46, P137, DOI 10.1016/j.appet.2005.11.004; WEBER SJ, 1972, PSYCHOL BULL, V77, P273, DOI 10.1037/h0032351	47	10	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95302	10.1371/journal.pone.0095302	http://dx.doi.org/10.1371/journal.pone.0095302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4HM	24777156	gold, Green Published, Green Accepted			2022-12-25	WOS:000346241800011
J	Zhang, S; McGoy, SL; Dawes, D; Fransua, M; Rust, G; Satcher, D				Zhang, Shun; McGoy, Shanell L.; Dawes, Daniel; Fransua, Mesfin; Rust, George; Satcher, David			The Potential for Elimination of Racial-Ethnic Disparities in HIV Treatment Initiation in the Medicaid Population among 14 Southern States	PLOS ONE			English	Article							UNITED-STATES; CARE; REGION	Objectives: The purpose of this study was to explore the racial and ethnic disparities in initiation of antiretroviral treatment (ARV treatment or ART) among HIV-infected Medicaid enrollees 18-64 years of age in 14 southern states which have high prevalence of HIV/AIDS and high racial disparities in HIV treatment access and mortality. Methods: We used Medicaid claims data from 2005 to 2007 for a retrospective cohort study. We compared frequency variances of HIV treatment uptake among persons of different racial-ethnic groups using univariate and multivariate methods. The unadjusted odds ratio was estimated through multinomial logistic regression. The multinomial logistic regression model was repeated with adjustment for multiple covariates. Results: Of the 23,801 Medicaid enrollees who met criteria for initiation of ARV treatment, only one third (34.6%) received ART consistent with national guideline treatment protocols, and 21.5% received some ARV medication, but with suboptimal treatment profiles. There was no significant difference in the proportion of people who received ARV treatment between black (35.8%) and non-Hispanic whites (35.7%), but Hispanic/Latino persons (26%) were significantly less likely to receive ARV treatment. Conclusions: Overall ARV treatment levels for all segments of the population are less than optimal. Among the Medicaid population there are no racial HIV treatment disparities between Black and White persons living with HIV, which suggests the potential relevance of Medicaid to currently uninsured populations, and the potential to achieve similar levels of equality within Medicaid for Hispanic/Latino enrollees and other segments of the Medicaid population.	[Zhang, Shun; Rust, George] Morehouse Sch Med, Natl Ctr Primary Care, Atlanta, GA 30310 USA; [McGoy, Shanell L.; Satcher, David] Morehouse Sch Med, Satcher Hlth Leadership Inst, Atlanta, GA 30310 USA; [Dawes, Daniel] Morehouse Sch Med, Off President, Atlanta, GA 30310 USA; [Fransua, Mesfin] Morehouse Sch Med, Dept Med, Atlanta, GA 30310 USA	Morehouse School of Medicine; Morehouse School of Medicine; Morehouse School of Medicine; Morehouse School of Medicine	Zhang, S (corresponding author), Morehouse Sch Med, Natl Ctr Primary Care, Atlanta, GA 30310 USA.	szhang@msm.edu		Rust, George/0000-0002-9040-9744	Agency for Healthcare Research Quality [1K18HS022444, R24HS019470]; DHHS Office of Minority Health [MPCMP121069]; National Institutes of Health/National Institute on Minority Health and Health Disparities [U54MD008173, 3U54MD007588]; National Institute of Mental Health [5R21MH067652-02]; DHHS Office of Adolescent Pregnancy Programs [APHPA006020]; Kaiser Permanente; Northrop Grumman; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K18HS022444, R24HS019470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH067652] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD008173, U54MD007588] Funding Source: NIH RePORTER	Agency for Healthcare Research Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); DHHS Office of Minority Health; National Institutes of Health/National Institute on Minority Health and Health Disparities; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DHHS Office of Adolescent Pregnancy Programs; Kaiser Permanente; Northrop Grumman; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This publication was made possible with grant support from the Agency for Healthcare Research & Quality, grant numbers 1K18HS022444 and R24HS019470, DHHS Office of Minority Health grant number MPCMP121069, National Institutes of Health/National Institute on Minority Health and Health Disparities grant numbers U54MD008173 and 3U54MD007588, National Institute of Mental Health grant number 5R21MH067652-02, and the DHHS Office of Adolescent Pregnancy Programs grant number APHPA006020. Additional support was provided by Kaiser Permanente and Northrop Grumman. The contents of this report [or web site] are solely the responsibility of the authors and do not necessarily represent the official view of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2014, AIDS, V28, P1393, DOI 10.1097/QAD.0000000000000225; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], 2009, AR RES FIL; Beale C, 2004, MEASURING RURALITY R; CDC, 2012, HIV LAT; CDC, 2012, 17 CDC HIV, V17; CDC, 2012, HIV US STAG CAR; Centers for Disease Control and Prevention, 2013, HIV AIDS PREV RES DE; Cobos DG, 2008, J ASSOC NURSE AIDS C, V19, P320, DOI 10.1016/j.jana.2008.04.006; Code U. S., TITL 8; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Fragomen AT, 1997, INT MIGR REV, V31, P438, DOI 10.2307/2547227; Frankel Martin R, 2012, Open AIDS J, V6, P67, DOI 10.2174/1874613601206010067; Grossman CI, 2013, AM PSYCHOL, V68, P237, DOI 10.1037/a0032711; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Hanna DB, 2009, AIDS LONDON ENGLAND, V26, P95; Henry J. Kaiser Family Foundation, 2011, MED HIV NAT AN; Kaiser Family Foundation, 2013, MED UN; Lyall E G, 2001, HIV Med, V2, P314, DOI 10.1046/j.1464-2662.2001.00082.x; Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085; Prejean J, 2013, J COMMUN HEALTH, V38, P414, DOI 10.1007/s10900-012-9633-1; Reif S, 2006, AM J PUBLIC HEALTH, V96, P970, DOI 10.2105/AJPH.2005.063149; Stone Valerie E, 2005, Curr HIV/AIDS Rep, V2, P189, DOI 10.1007/s11904-005-0015-5; Timmins CL, 2002, J MIDWIFERY WOM HEAL, V47, P80, DOI 10.1016/S1526-9523(02)00218-0; U.S. Citizenship and Immigration Services (USCIS), 2012, CONS DEF ACT CHILDH; U. S. Department of Health and Human Services, 2007, GUID US ANT AG HIV 1; Watts J, 1997, PERSONAL RESPONSIBIL; Zhang S, 2013, AM J PUBLIC HEALTH, V103, pE46, DOI 10.2105/AJPH.2013.301328	28	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e96148	10.1371/journal.pone.0096148	http://dx.doi.org/10.1371/journal.pone.0096148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3CM	24769625	Green Published, gold			2022-12-25	WOS:000336736600026
J	Galy, O; Chamari, K; Peyreigne, C; Mercier, J; Hue, O				Galy, Olivier; Chamari, Karim; Peyreigne, Christelle; Mercier, Jacques; Hue, Olivier			Sequential Exercise in Triathletes: Variations in GH and Water Loss	PLOS ONE			English	Article							GROWTH-HORMONE DEFICIENCY; PULMONARY DIFFUSING-CAPACITY; MAXIMAL OXYGEN-UPTAKE; PLASMA-VOLUME; BLOOD-VISCOSITY; LOCALIZATION; OSMOLALITY; INTENSITY; RESPONSES; RECEPTOR	Growth hormone (GH) may stimulate water loss during exercise by activating sweating. This study investigated GH secretion and water loss during sequential cycling and running, taking postural changes into account. The two exercise segments had similar durations and were performed at the same relative intensity to determine their respective contributions to water loss and the plasma volume variation noted in such trials. Eight elite triathletes first performed an incremental cycle test to assess maximal oxygen consumption. Then, the triathletes performed one of two trials in randomized order: constant submaximal cycling followed by treadmill running (C-1-R-2) or an inversed succession of running followed by cycling (R-1-C-2). Each segment of both trials was performed for 20 minutes at similar to 75% of maximal oxygen consumption. The second trial, reversing the segment order of the first trial, took place two weeks later. During cycling, the triathletes used their own bicycles equipped with a profiled handlebar. Blood sampling (for GH concentrations, plasma viscosity and plasma volume variation) was conducted at rest and after each segment while water loss was estimated from the post- and pre-measures. GH increases were significantly lower in R-2 than C-2 (72.2 +/- 50.1 vs. 164.0 +/- 157 ng.ml(-1).min(-1), respectively; P < 0.05). Water loss was significantly lower after C-1-R-2 than R-1-C-2 (1105 +/- 163 and 1235 +/- 153 ml, respectively; P < 0.05). Plasma volume variation was significantly negative in C-1 and R-1 (-6.15 +/- 2.0 and -3.16 +/- 5.0%, respectively; P < 0.05), not significant in C-2, and significantly positive for seven subjects in R-2 (4.05 +/- 3.1%). We concluded that the lower GH increases in R-2 may have contributed to the smaller reduction in plasma volume by reducing sweating. Moreover, this lower GH response could be explained by the postural change during the transition from cycling to running. We recommend to pay particular attention to their hydration status during R-1 which could limit a potential dehydration during C-2.	[Galy, Olivier; Hue, Olivier] Univ Guadeloupe, Fac Phys Act & Sports, Lab ACTES, EA Dept Physiol 3596, Pointe a Pitre, France; [Galy, Olivier] Univ New Caledonia, Lab CNEP, EA 4242, Noumea, New Caledonia; [Chamari, Karim] Qatar Orthopaed & Sports Med Hosp, Aspetar, Athlete Hlth & Performance Res Ctr, Doha, Qatar; [Peyreigne, Christelle; Mercier, Jacques] Univ Montpellier I, Lab INSERM U 1046, F-34006 Montpellier, France; [Peyreigne, Christelle; Mercier, Jacques] Univ Montpellier 2, Montpellier Hosp, F-34095 Montpellier 5, France; [Peyreigne, Christelle] Univ Montpellier I, Fac Phys Act & Sports EA 2991, Montpellier, France	Universite Nouvelle Caledonie; Aspetar Orthopaedic & Sports Medicine Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Galy, O (corresponding author), Univ Guadeloupe, Fac Phys Act & Sports, Lab ACTES, EA Dept Physiol 3596, Pointe a Pitre, France.	olivier.galy@univ-nc.nc	CHAMARI, Karim/AAJ-7938-2021; GALY, Olivier/D-5345-2015	CHAMARI, Karim/0000-0001-9178-7678; GALY, Olivier/0000-0002-4631-959X; Hue, Olivier/0000-0002-2155-0816				Assmussen E, 1939, SCAND ARCH PHYSL, V81, P190; Ben Abderrahman A, 2013, INT J SPORT PHYSIOL, V8, P358, DOI 10.1123/ijspp.8.4.358; Braunwald E, 1979, HDB PHYSL 2, V1, P552; BRUN JF, 1995, DIABETOLOGIA, V38, P494; CONVERTINO VA, 1981, J APPL PHYSIOL, V50, P123, DOI 10.1152/jappl.1981.50.1.123; DOFFIN J, 1984, Biorheology, P89; FONS C, 1993, CLIN HEMORHEOL, V13, P651; Galy O, 2005, INT J SPORTS MED, V26, P9, DOI 10.1055/s-2004-815817; Galy O, 2003, EUR J APPL PHYSIOL, V90, P489, DOI 10.1007/s00421-003-0900-9; Galy O, 2003, SCAND J MED SCI SPOR, V13, P185, DOI 10.1034/j.1600-0838.2003.10170.x; Galy O, 2013, INT J SPORT PHYSIOL, V8, P648, DOI 10.1123/ijspp.8.6.648; Goldsmith RL, 1997, MED SCI SPORT EXER, V29, P812, DOI 10.1097/00005768-199706000-00012; GREENLEAF JE, 1979, J APPL PHYSIOL, V47, P1031, DOI 10.1152/jappl.1979.47.5.1031; Hue O, 2000, CAN J APPL PHYSIOL, V25, P102, DOI 10.1139/h00-007; JUUL A, 1991, LANCET, V338, P887, DOI 10.1016/0140-6736(91)91543-4; JUUL A, 1993, CLIN ENDOCRINOL, V38, P237, DOI 10.1111/j.1365-2265.1993.tb01001.x; JUUL A, 1995, J CLIN ENDOCR METAB, V80, P3335, DOI 10.1210/jc.80.11.3335; KOZLOWSKI S, 1983, EUR J APPL PHYSIOL, V52, P131, DOI 10.1007/BF00429040; LOBIE PE, 1990, J ENDOCRINOL, V126, P467, DOI 10.1677/joe.0.1260467; MAIN K, 1991, SCAND J CLIN LAB INV, V51, P475, DOI 10.3109/00365519109091642; MAIN KM, 1993, J CLIN ENDOCR METAB, V77, P821, DOI 10.1210/jc.77.3.821; OAKES SR, 1992, J CLIN ENDOCR METAB, V75, P1368, DOI 10.1210/jc.75.5.1368; PEDERSEN SA, 1989, LANCET, V2, P681; Peyreigne C, 1998, CLIN HEMORHEOL MICRO, V19, P169; Peyreigne C, 2001, EUR J ENDOCRINOL, V145, P445, DOI 10.1530/eje.0.1450445; SAWKA MN, 1985, J APPL PHYSIOL, V59, P1394, DOI 10.1152/jappl.1985.59.5.1394; Sawka MN, 1996, BODY FLUID BALANCE E, P143; SCHEUER J, 1977, ANNU REV PHYSIOL, V39, P221, DOI 10.1146/annurev.ph.39.030177.001253; SNEGOVSKAYA V, 1993, INT J SPORTS MED, V14, P202, DOI 10.1055/s-2007-1021164; STRAUSS MB, 1951, J CLIN INVEST, V30, P862, DOI 10.1172/JCI102501; VANBEAUMONT W, 1972, J APPL PHYSIOL, V33, P55, DOI 10.1152/jappl.1972.33.1.55; VANDEWALLE H, 1988, INT J SPORTS MED, V9, P104, DOI 10.1055/s-2007-1024988; WELLS CL, 1987, MED SCI SPORT EXER, V19, P137	33	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96145	10.1371/journal.pone.0096145	http://dx.doi.org/10.1371/journal.pone.0096145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763386	Green Published, Green Submitted, gold			2022-12-25	WOS:000335505000066
J	Long, EF; Mandalia, R; Mandalia, S; Alistar, SS; Beck, EJ; Brandeau, ML				Long, Elisa F.; Mandalia, Roshni; Mandalia, Sundhiya; Alistar, Sabina S.; Beck, Eduard J.; Brandeau, Margaret L.			Expanded HIV Testing in Low-Prevalence, High-Income Countries: A Cost-Effectiveness Analysis for the United Kingdom	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; QUALITY-OF-LIFE; ANTIRETROVIRAL THERAPY; HETEROSEXUAL TRANSMISSION; METHADONE-MAINTENANCE; MALE CIRCUMCISION; RISK BEHAVIOR; INFECTION; PREVENTION; DIAGNOSIS	Objective: In many high-income countries with low HIV prevalence, significant numbers of persons living with HIV (PLHIV) remain undiagnosed. Identification of PLHIV via HIV testing offers timely access to lifesaving antiretroviral therapy (ART) and decreases HIV transmission. We estimated the effectiveness and cost-effectiveness of HIV testing in the United Kingdom (UK), where 25% of PLHIV are estimated to be undiagnosed. Design: We developed a dynamic compartmental model to analyze strategies to expand HIV testing and treatment in the UK, with particular focus on men who have sex with men (MSM), people who inject drugs (PWID), and individuals from HIV-endemic countries. Methods: We estimated HIV prevalence, incidence, quality-adjusted life years (QALYs), and health care costs over 10 years, and cost-effectiveness. Results: Annual HIV testing of all adults could avert 5% of new infections, even with no behavior change following HIV diagnosis because of earlier ART initiation, or up to 18% if risky behavior is halved. This strategy costs 67,000- pound 106,000 pound/QALY gained. Providing annual testing only to MSM, PWID, and people from HIV-endemic countries, and one-time testing for all other adults, prevents 4-15% of infections, requires one-fourth as many tests to diagnose each PLHIV, and costs 17,500 pound/QALY gained. Augmenting this program with increased ART access could add 145,000 QALYs to the population over 10 years, at 26,800 pound/QALY gained. Conclusions: Annual HIV testing of key populations in the UK is very cost-effective. Additional one-time testing of all other adults could identify the majority of undiagnosed PLHIV. These findings are potentially relevant to other low-prevalence, high-income countries.	[Long, Elisa F.] Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA USA; [Mandalia, Roshni; Mandalia, Sundhiya; Beck, Eduard J.] Natl Prospect Monitoring Syst HIV Hlth Econ Colla, Coordinating & Analyt Ctr, London, England; [Alistar, Sabina S.; Brandeau, Margaret L.] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Beck, Eduard J.] London Sch Hyg & Trop Med, Hlth Serv Res & Policy Dept, London WC1, England	University of California System; University of California Los Angeles; Stanford University; University of London; London School of Hygiene & Tropical Medicine	Beck, EJ (corresponding author), Natl Prospect Monitoring Syst HIV Hlth Econ Colla, Coordinating & Analyt Ctr, London, England.	becke@unaids.org	Long, Elisa/AFQ-5915-2022		United States National Institute on Drug Abuse [R01-DA15612]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	United States National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	EFL, SSA, and MLB were supported by a grant from the United States National Institute on Drug Abuse (R01-DA15612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; [Anonymous], 2009, Lancet, V373, P1820, DOI 10.1016/S0140-6736(09)61002-3; [Anonymous], HIV UK 2010 REP HLTH; [Anonymous], POP PYR DAT; [Anonymous], UNPUB; [Anonymous], HIV UK 2012 REP HLTH; [Anonymous], TACKL PROBL DRUG US; [Anonymous], UNL AN MON SURV PEOP; [Anonymous], 2011, NIC PUBL HLTH GUID 3; [Anonymous], CASE UNIVERSAL TESTI; [Anonymous], 2021, HIV TESTING NEW HIV; [Anonymous], 2010, MEASURING SEXUAL IDE; [Anonymous], ONS POP EST ETHN GRO; [Anonymous], GREAT BRIT INT LIF T; [Anonymous], GUID MAN NICE PUBL H; [Anonymous], COMMUNICATION; [Anonymous], KEY STAT DRUG SIT UK; [Anonymous], STAT HLTH CAR AD SOC; [Anonymous], HIV UK 2011 REP HLTH; [Anonymous], 2010 NAT REP 2009 DA; [Anonymous], INCONSISTENT CONDOM; [Anonymous], REV COST EFF IND LEV; [Anonymous], C AFR TRANSN RET MIG; [Anonymous], 2013, HIV UK 2013 REPORT D; [Anonymous], HLTH PROTECTION REPO; [Anonymous], POP EST UK ENGL WAL; [Anonymous], UK NAT GUID HIV TEST; [Anonymous], SO AFR HIV CLIN SOC; [Anonymous], PLOS ONE; [Anonymous], TIM TEST HIV EXP HEA; [Anonymous], HLTH SURVEY ENGLAND; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Barnighausen T, 2012, P NATL ACAD SCI USA, V109, P21271, DOI 10.1073/pnas.1209017110; Beck EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027830; Brown AE, 2013, HIV MED, V14, P563, DOI 10.1111/hiv.12066; CACERES CF, 1994, AIDS, V8, P1051, DOI 10.1097/00002030-199408000-00004; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dave SS, 2003, SEX TRANSM INFECT, V79, P499, DOI 10.1136/sti.79.6.499; Desai K, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-19; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fox J, 2009, HIV MED, V10, P432, DOI 10.1111/j.1468-1293.2009.00708.x; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gold MR, 1996, COST EFFECTIVENESS H; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; Honiden S, 2006, QUAL LIFE RES, V15, P69, DOI 10.1007/s11136-005-8485-x; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Long EF, 2013, J GEN INTERN MED, V28, P1294, DOI 10.1007/s11606-013-2417-1; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Long EF, 2009, VACCINE, V27, P5402, DOI 10.1016/j.vaccine.2009.06.063; Mastro T D, 1996, AIDS, V10 Suppl A, pS75, DOI 10.1097/00002030-199601001-00011; McDaid LM, 2013, SEX TRANSM INFECT, V89, P223, DOI 10.1136/sextrans-2012-050605; MCELRATH K, 1994, AM J PUBLIC HEALTH, V84, P1965, DOI 10.2105/AJPH.84.12.1965; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Patel P, 2010, ARCH INTERN MED, V170, P66, DOI 10.1001/archinternmed.2009.445; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Sadler KE, 2007, SEX TRANSM INFECT, V83, P523, DOI 10.1136/sti.2007.027128; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Stabile M, 2013, HEALTH AFFAIR, V32, P643, DOI 10.1377/hlthaff.2012.1252; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Tweed E, 2010, SEX TRANSM INFECT, V86, P360, DOI 10.1136/sti.2009.041293; Wagner BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041212; WALL SD, 1991, AM J ROENTGENOL, V157, P911, DOI 10.2214/ajr.157.5.1927808; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; World Health Organization, 2022, EXT DRUG RES SHIG SO; Yazdanpanah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013132; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100; Zaric GS, 2000, MANAGE SCI, V46, P1013, DOI 10.1287/mnsc.46.8.1013.12025	84	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95735	10.1371/journal.pone.0095735	http://dx.doi.org/10.1371/journal.pone.0095735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG6CB	24763373	Green Published, gold			2022-12-25	WOS:000335505000031
J	Rodriguez-Martinez, RE; Banaszak, AT; McField, MD; Beltran-Torres, AU; Alvarez-Filip, L				Rodriguez-Martinez, Rosa E.; Banaszak, Anastazia T.; McField, Melanie D.; Beltran-Torres, Aurora U.; Alvarez-Filip, Lorenzo			Assessment of Acropora palmata in the Mesoamerican Reef System	PLOS ONE			English	Article							WHITE-BAND DISEASE; CARIBBEAN CORAL; ST-JOHN; RECOVERY; COMMUNITIES; DECLINE; FACE	The once-dominant shallow reef-building coral Acropora palmata has suffered drastic geographical declines in the wider Caribbean from a disease epidemic that began in the late 1970s. At present there is a lack of quantitative data to determine whether this species is recovering over large spatial scales. Here, we use quantitative surveys conducted in 107 shallow-water reef sites between 2010 and 2012 to investigate the current distribution and abundance of A. palmata along the Mesoamerican Reef System (MRS). Using historical data we also explored how the distribution and abundance of this species has changed in the northern portion of the MRS between 1985 and 2010-2012. A. palmata was recorded in only a fifth of the surveyed reef sites in 2010-2012. In the majority of these reef sites the presence of A. palmata was patchy and rare. Only one site (Limones reef), in the northernmost portion of the MRS, presented considerably high A. palmata cover (mean: 34.7%, SD: 24.5%). At this site, the size-frequency distribution of A. palmata colonies was skewed towards small colony sizes; 84% of the colonies were healthy, however disease prevalence increased with colony size. A comparison with historical data showed that in the northern portion of the MRS, in 1985, A. palmata occurred in 74% of the 31 surveyed sites and had a mean cover of 7.7% (SD = 9.0), whereas in 2010-2012 this species was recorded in 48% of the sites with a mean cover of 2.9% (SD = 7.5). A. palmata populations along the MRS are failing to recover the distribution and abundance they had prior to the 1980s. Investigating the biological (e.g., population genetics) and environmental conditions (e.g., sources of stress) of the few standing reefs with relatively high A. palmata cover is crucial for the development of informed restoration models for this species.	[Rodriguez-Martinez, Rosa E.; Banaszak, Anastazia T.; Beltran-Torres, Aurora U.; Alvarez-Filip, Lorenzo] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos, Quintana Roo, Mexico; [McField, Melanie D.; Alvarez-Filip, Lorenzo] Hlth Reefs Initiat, Belize City, Belize	Universidad Nacional Autonoma de Mexico	Alvarez-Filip, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos, Quintana Roo, Mexico.	lorenzoaf@gmail.com	Banaszak, Anastazia Teresa/H-6362-2019; Alvarez-Filip, Lorenzo/C-9552-2011; Rodríguez-Martínez, Rosa Elisa/AAV-5363-2021	Banaszak, Anastazia Teresa/0000-0002-6667-3983; Alvarez-Filip, Lorenzo/0000-0002-5726-7238; Rodríguez-Martínez, Rosa Elisa/0000-0002-1383-1108; Beltran-Torres, Aurora Urania/0000-0002-0741-3719	Summit Foundation; Oak Foundation; JSR Foundation; Consejo Nacional de Ciencia y Tecnologia [153260]	Summit Foundation; Oak Foundation; JSR Foundation; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The Summit Foundation, Oak Foundation and JSR Foundation provide financial support to HRI. The Consejo Nacional de Ciencia y Tecnologia (project number 153260 to ATB) funded the study on Limones reef, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03486; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Alvarez-Filip L, 2009, B MAR SCI, V84, P295; Andrefouet S, 2003, REMOTE SENS ENVIRON, V88, P128, DOI 10.1016/j.rse.2003.04.005; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2008, IUCN RED LIST THREAT; Bak R.P.M., 1976, Netherlands J Sea Res, V10, P285, DOI 10.1016/0077-7579(76)90009-0; BAK RPM, 1982, MAR BIOL LETT, V3, P67; Baker DM, 2013, CORAL REEFS, V32, P691, DOI 10.1007/s00338-013-1040-2; Baker DM, 2010, GLOBAL CHANGE BIOL, V16, P2701, DOI 10.1111/j.1365-2486.2010.02167.x; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Bruckner A.W., 2002, P CAR ACR WORKSH POT; Bruckner AW, 1997, CORAL REEFS, V16, P260, DOI 10.1007/s003380050081; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Garcia-Salgado MA, 2008, P 11 INT COR REEF S, V2, P888; GLADFELTER WB, 1982, B MAR SCI, V32, P639; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Hogarth W, 2006, FED REGISTER, V71, P26853; Jackson J, STATUS TRENDS CARIBB; Jordan E., 1982, Proceedings of the International Coral Reef Symposium, P303; Jordan-Dahlgren E, 1988, ARRECIFES CORALMOS C; Jordan-Dahlgren E, 1993, ATLAS ARRECIFES CORL; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Konietschke F, 2013, NPARCOMP NPARCOMP PA; Kramer P.A., 2002, ECOREGIONAL CONSERVA; Lang JC, 2010, AGRRA PROTOCOL VERSI; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; LEWIS JB, 1984, CORAL REEFS, V3, P117, DOI 10.1007/BF00301955; Lirman D, 1999, B MAR SCI, V65, P235; Loya Y., 1978, Monographs on Oceanographic Methodology, P197; MACINTYRE IG, 1976, AAPG BULL, V60, P1054; McClanahan TR, 1998, ENVIRON CONSERV, V25, P122, DOI 10.1017/S0376892998000174; McField M., 2007, HLTH REEFS HLTH PEOP; Merino-Ibarra M., 1986, AN I CIENC MAR LIMNO, V13, P31; Miller MW, 2002, CORAL REEFS, V21, P179, DOI 10.1007/s00338-002-0228-7; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Muller EM, 2014, MAR BIOL, V161, P359, DOI 10.1007/s00227-013-2341-2; Mumby PJ, 2013, OPERATIONALIZING RES, DOI [10.1111/conl/12047, DOI 10.1111/CONL.12047]; Murray G, 2007, COAST MANAGE, V35, P339, DOI 10.1080/08920750601169600; NOAA, 2013, ELKH COR; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rogers CS, 2012, CORAL REEFS, V31, P807, DOI 10.1007/s00338-012-0898-8; Rogers CS, 2001, ENVIRON CONSERV, V28, P312, DOI 10.1017/S0376892901000340; ROGERS CS, 1982, B MAR SCI, V32, P532; SEMARNAT, 2010, PROT AMB ESP NAT MEX; Smith SG, 2011, ENVIRON MONIT ASSESS, V183, P121, DOI 10.1007/s10661-011-1912-2; SUAREZ-MORALES E., 1998, AASW NATL B, V8, P19; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143; Zubillaga AL, 2008, CORAL REEFS, V27, P63, DOI 10.1007/s00338-007-0291-1	52	38	40	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96140	10.1371/journal.pone.0096140	http://dx.doi.org/10.1371/journal.pone.0096140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763319	Green Submitted, gold, Green Published			2022-12-25	WOS:000335505000064
J	Tsai, TH; Shih, SC; Ho, TC; Ma, HI; Liu, MY; Chen, SL; Tsao, YP				Tsai, Tung-Han; Shih, Shou-Chuan; Ho, Tsung-Chuan; Ma, Hsin-I; Liu, Ming-Ying; Chen, Show-Li; Tsao, Yeou-Ping			Pigment Epithelium-Derived Factor 34-mer Peptide Prevents Liver Fibrosis and Hepatic Stellate Cell Activation through Down-Regulation of the PDGF Receptor	PLOS ONE			English	Article							GROWTH-FACTOR; FACTOR PEDF; FIBROGENESIS; MECHANISMS; EXPRESSION; INJURY; GAMMA; ANGIOGENESIS; ANTAGONISM; BINDING	Pigment epithelium-derived factor (PEDF) has been shown previously to prevent liver fibrosis and hepatic stellate cell (HSC) activation. By investigating the functional domains in PEDF, we identified a 34-mer peptide (residues Asp44-Asn77) that harbors the same function as the full-length PEDF protein. Not only did the 34-mer suppress the development of fibrosis in carbon tetrachloride (CCl4)-treated mouse liver but it also upregulated peroxisome proliferator-activated receptor-gamma (PPAR gamma) expression in HSCs in vivo. Platelet-derived growth factor (PDGF) plays a crucial role on the process of HSC activation in response to liver damage. The 34-mer suppressed PDGF-induced cell proliferation and expression of myofibroblastic marker proteins in primary rat HSC culture, increased the levels of PPAR gamma mRNA and protein in a dose-dependent manner and markedly reduced the level of active beta-catenin protein, an HSC activating factor, in HSC-T6 cells. Similarly, IWR-1, an inhibitor of the Wnt response, displayed the same effect as the 34-mer in preventing HSC-T6 activation. The Wnt signaling-mediated PPAR gamma suppression was abolished by both the IWR-1 inhibitor and a small interfering RNA (siRNA) targeting beta-catenin and the Wnt coreceptor, LRP6. Both PEDF and the 34-mer down-regulated PDGF receptor-alpha/beta expression and blocked the PDGF-induced phosphorylation of Akt and ERK. Moreover, the inhibitory effect on PDGF receptor expression was abolished by PPAR gamma antagonists and PPAR gamma siRNA. Our observations indicate that the PEDF-derived 34-mer peptide can mimic PEDF in attenuating HSC activation. Investigation of this 34-mer peptide led to the identification of a signaling mechanism involving PPAR gamma induction, suppression of Wnt/beta-catenin signaling and down-regulation of the PDGF receptor-alpha/beta.	[Tsai, Tung-Han; Ma, Hsin-I; Liu, Ming-Ying] Tri Serv Gen Hosp, Natl Def Ctr, Dept Neurosurg, Taipei, Taiwan; [Shih, Shou-Chuan] Mackay Mem Hosp, Dept Gastroenterol, Taipei, Taiwan; [Shih, Shou-Chuan] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Ho, Tsung-Chuan; Tsao, Yeou-Ping] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Chen, Show-Li] Natl Taiwan Univ, Sch Med, Dept Microbiol, Taipei 10764, Taiwan	Tri-Service General Hospital; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; National Taiwan University	Tsao, YP (corresponding author), Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.	yptsao@yahoo.com			Tri-Service General Hospital [TSGH-C101-083, TSGH-C101-084]; National Science Council, Taiwan [NSC 101-2314-B-195-006-MY3]; Mackay Memorial Hospital [MMH-E-101-006]	Tri-Service General Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This work was supported by grants from the Tri-Service General Hospital (TSGH-C101-083, TSGH-C101-084), National Science Council, Taiwan (NSC 101-2314-B-195-006-MY3) and Mackay Memorial Hospital (MMH-E-101-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Amaral J, 2010, INVEST OPHTH VIS SCI, V51, P1318, DOI 10.1167/iovs.09-4455; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Borkham-Kamphorst E, 2004, LAB INVEST, V84, P766, DOI 10.1038/labinvest.3700094; Borkham-Kamphorst E, 2008, LAB INVEST, V88, P1090, DOI 10.1038/labinvest.2008.71; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x; Ho TC, 2011, J BIOL CHEM, V286, P35943, DOI 10.1074/jbc.M111.266064; Ho TC, 2010, AM J PATHOL, V177, P1798, DOI 10.2353/ajpath.2010.091085; Kim Y, 1998, J BIOL CHEM, V273, P33750, DOI 10.1074/jbc.273.50.33750; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Lin JG, 2009, LAB INVEST, V89, P1397, DOI 10.1038/labinvest.2009.115; Marra F, 1997, GASTROENTEROLOGY, V112, P1297, DOI 10.1016/S0016-5085(97)70144-6; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Park K, 2011, MOL CELL BIOL, V31, P3038, DOI 10.1128/MCB.01211-10; PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363; Pinzani M, 1996, AM J PATHOL, V148, P785; Rockey DC, 1996, J CLIN INVEST, V98, P1381, DOI 10.1172/JCI118925; SCHMITTGRAFF A, 1991, AM J PATHOL, V138, P1233; Tangkijvanich P, 2002, J CELL PHYSIOL, V191, P351, DOI 10.1002/jcp.10112; Yang L, 2006, AM J PHYSIOL-GASTR L, V291, pG902, DOI 10.1152/ajpgi.00124.2006; Yang MD, 2012, HEPATOLOGY, V55, P1271, DOI 10.1002/hep.24792; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670	29	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95443	10.1371/journal.pone.0095443	http://dx.doi.org/10.1371/journal.pone.0095443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763086	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000018
J	Chau, LS; Prakapenka, AV; Zendeli, L; Davis, AS; Galvez, R				Chau, Lily S.; Prakapenka, Alesia V.; Zendeli, Liridon; Davis, Ashley S.; Galvez, Roberto			Training-Dependent Associative Learning Induced Neocortical Structural Plasticity: A Trace Eyeblink Conditioning Analysis	PLOS ONE			English	Article							DENDRITIC SPINES; MORPHOLOGICAL-CHANGES; PREFRONTAL CORTEX; CEREBRAL-CORTEX; SYNAPSIN I; DENSITY; HIPPOCAMPAL; RAT; EXPERIENCE; SYNAPTOGENESIS	Studies utilizing general learning and memory tasks have suggested the importance of neocortical structural plasticity for memory consolidation. However, these learning tasks typically result in learning of multiple different tasks over several days of training, making it difficult to determine the synaptic time course mediating each learning event. The current study used trace-eyeblink conditioning to determine the time course for neocortical spine modification during learning. With eyeblink conditioning, subjects are presented with a neutral, conditioned stimulus (CS) paired with a salient, unconditioned stimulus (US) to elicit an unconditioned response (UR). With multiple CS-US pairings, subjects learn to associate the CS with the US and exhibit a conditioned response (CR) when presented with the CS. Trace conditioning is when there is a stimulus free interval between the CS and the US. Utilizing trace-eyeblink conditioning with whisker stimulation as the CS (whisker-trace-eyeblink: WTEB), previous findings have shown that primary somatosensory (barrel) cortex is required for both acquisition and retention of the trace-association. Additionally, prior findings demonstrated that WTEB acquisition results in an expansion of the cytochrome oxidase whisker representation and synaptic modification in layer IV of barrel cortex. To further explore these findings and determine the time course for neocortical learning-induced spine modification, the present study utilized WTEB conditioning to examine Golgi-Cox stained neurons in layer IV of barrel cortex. Findings from this study demonstrated a training-dependent spine proliferation in layer IV of barrel cortex during trace associative learning. Furthermore, findings from this study showing that filopodia-like spines exhibited a similar pattern to the overall spine density further suggests that reorganization of synaptic contacts set the foundation for learning-induced neocortical modifications through the different neocortical layers.	[Chau, Lily S.; Prakapenka, Alesia V.; Zendeli, Liridon; Galvez, Roberto] Univ Illinois, Dept Psychol, Champaign, IL 61801 USA; [Davis, Ashley S.; Galvez, Roberto] Univ Illinois, Beckman Inst Adv Sci & Technol, Champaign, IL USA; [Galvez, Roberto] Univ Illinois, Neurosci Program, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chau, LS (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL 61801 USA.	chau6@illinois.edu		Galvez, Roberto/0000-0002-9932-2530				Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chau LS, 2013, BEHAV NEUROSCIENCE; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Comery TA, 1996, NEUROBIOL LEARN MEM, V66, P93, DOI 10.1006/nlme.1996.0049; DIAMOND MC, 1975, J NEUROSCI RES, V1, P109, DOI 10.1002/jnr.490010203; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; Eyre MD, 2003, EUR J NEUROSCI, V17, P1973, DOI 10.1046/j.1460-9568.2003.02624.x; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Galvez R, 2003, BRAIN RES, V971, P83, DOI 10.1016/S0006-8993(03)02363-1; Galvez R, 2007, LEARN MEMORY, V14, P94, DOI 10.1101/lm.418407; Galvez R, 2006, J NEUROSCI, V26, P6062, DOI 10.1523/JNEUROSCI.5582-05.2006; Galvez R, 2011, NEUROBIOL AGING, V32, P1915, DOI 10.1016/j.neurobiolaging.2009.11.014; Galvez R, 2009, J NEUROSCI METH, V177, P434, DOI 10.1016/j.jneumeth.2008.11.002; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; GLOBUS A, 1973, J COMP PHYSIOL PSYCH, V82, P175, DOI 10.1037/h0033910; GREEN EJ, 1983, BRAIN RES, V264, P233, DOI 10.1016/0006-8993(83)90821-1; GREENOUGH WT, 1973, EXP NEUROL, V41, P371, DOI 10.1016/0014-4886(73)90278-1; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Holtmaat A, 2008, BEHAV BRAIN RES, V192, P20, DOI 10.1016/j.bbr.2008.04.005; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; JONES EG, 1969, J CELL SCI, V5, P509; KIM JJ, 1995, BEHAV NEUROSCI, V109, P195, DOI 10.1037/0735-7044.109.2.195; Kleim JA, 1996, J NEUROSCI, V16, P4529; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kolb B, 2003, NEUROBIOL LEARN MEM, V79, P1, DOI 10.1016/S1074-7427(02)00021-7; Lee KJ, 2007, NEUROBIOL LEARN MEM, V88, P445, DOI 10.1016/j.nlm.2007.06.001; LOHMANN SM, 1978, P NATL ACAD SCI USA, V75, P4037, DOI 10.1073/pnas.75.8.4037; McLaughlin J, 2002, BEHAV NEUROSCI, V116, P37, DOI 10.1037//0735-7044.116.1.37; Medvedev NI, 2012, BRAIN STRUCTURE FUNC; MOORE RY, 1989, J NEUROSCI, V9, P2151; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; O'Malley A, 2000, NEUROSCIENCE, V99, P229, DOI 10.1016/S0306-4522(00)00182-2; O'Malley A, 1998, NEUROSCIENCE, V87, P607, DOI 10.1016/S0306-4522(98)00178-X; Perlini LE, 2011, J CELL SCI, V124, P3643, DOI 10.1242/jcs.086223; Ramirez-Amaya V, 1999, HIPPOCAMPUS, V9, P631, DOI 10.1002/(SICI)1098-1063(1999)9:6<631::AID-HIPO3>3.0.CO;2-3; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Takehara K, 2002, BRAIN RES, V951, P183, DOI 10.1016/S0006-8993(02)03159-1; Tseng W, 2004, HIPPOCAMPUS, V14, P58, DOI 10.1002/hipo.10157; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; Weible AP, 2000, BEHAV NEUROSCI, V114, P1058, DOI 10.1037/0735-7044.114.6.1058; Weiss C, 1999, BEHAV BRAIN RES, V99, P123, DOI 10.1016/S0166-4328(98)00096-5; Weiss C, 2011, BEHAV NEUROSCI, V125, P318, DOI 10.1037/a0023520; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wosiski-Kuhn M, 2012, SYNAPSE, V66, P661, DOI 10.1002/syn.21545	49	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95317	10.1371/journal.pone.0095317	http://dx.doi.org/10.1371/journal.pone.0095317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760074	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200047
J	Inada, S; Zhang, HG; Tellez, JO; Shibata, N; Nakazawa, K; Kamiya, K; Kodama, I; Mitsui, K; Dobrzynski, H; Boyett, MR; Honjo, H				Inada, Shin; Zhang, Henggui; Tellez, James O.; Shibata, Nitaro; Nakazawa, Kazuo; Kamiya, Kaichiro; Kodama, Itsuo; Mitsui, Kazuyuki; Dobrzynski, Halina; Boyett, Mark R.; Honjo, Haruo			Importance of Gradients in Membrane Properties and Electrical Coupling in Sinoatrial Node Pacing	PLOS ONE			English	Article							HETEROGENEOUS EXPRESSION; REGIONAL DIFFERENCES; CARDIAC PACEMAKING; RABBIT ATRIAL; CELLS; CURRENTS; EXCITABILITY; PROPAGATION; SUPPRESSION; MODELS	The sinoatrial node (SAN) is heterogeneous in terms of cell size, ion channels, current densities, connexins and electrical coupling. For example, Na(v)1.5 (responsible for I-Na) and Cx43 (responsible for electrical coupling) are absent from the centre of the SAN (normally the leading pacemaker site), but present in the periphery (at SAN-atrial muscle junction). To test whether the heterogeneity is important for the functioning of the SAN, one- and two-dimensional models of the SAN and surrounding atrial muscle were created. Normal functioning of the SAN (in terms of cycle length, position of leading pacemaker site, conduction times, activation and repolarization sequences and space constants) was observed when, from the centre to the periphery, (i) cell characteristics (cell size and ionic current densities) were changed in a gradient fashion from a central-type (lacking I-Na) to a peripheral-type (possessing I-Na) and (ii) coupling conductance was increased in a gradient fashion. We conclude that the heterogeneous nature of the node is important for its normal functioning. The presence of Na(v)1.5 and Cx43 in the periphery may be essential for the node to be able to drive the atrial muscle: Na(v)1.5 provides the necessary depolarizing current and Cx43 delivers it to the atrial muscle.	[Inada, Shin; Nakazawa, Kazuo] Natl Cerebral & Cardiovasc Ctr Res Inst, Suita, Osaka, Japan; [Zhang, Henggui; Tellez, James O.; Dobrzynski, Halina; Boyett, Mark R.] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England; [Zhang, Henggui; Tellez, James O.; Dobrzynski, Halina; Boyett, Mark R.] Univ Manchester, Biol Phys Grp, Manchester, Lancs, England; [Shibata, Nitaro] Shinjuku Mitsui Bldg Clin, Tokyo, Japan; [Kamiya, Kaichiro; Kodama, Itsuo; Honjo, Haruo] Nagoya Univ, Environm Med Res Inst, Nagoya, Aichi 464, Japan; [Mitsui, Kazuyuki] Tokyo Denki Univ, Grad Sch Adv Sci & Technol, Tokyo 101, Japan	National Cerebral & Cardiovascular Center - Japan; University of Manchester; University of Manchester; Nagoya University; Tokyo Denki University	Honjo, H (corresponding author), Nagoya Univ, Environm Med Res Inst, Nagoya, Aichi 464, Japan.	honjo@riem.nagoya-u.ac.jp	Zhang, Henggui/AAM-1043-2020; Zhang, Henggui/D-6712-2011	Boyett, Mark/0000-0003-3931-2020; Dobrzynski, Halina/0000-0003-4754-5975	Ministry of Education, Sports, Science and Technology, Japan [22136011]; Engineering and Physical Sciences Research Council [EP/J00958X/1] Funding Source: researchfish; EPSRC [EP/J00958X/1] Funding Source: UKRI	Ministry of Education, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study is financially supported by Grants-in-Aid for Scientific Research on Innovative Area 22136011 from the Ministry of Education, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLEEKER WK, 1980, CIRC RES, V46, P11, DOI 10.1161/01.RES.46.1.11; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; BOYETT MR, 1984, J PHYSIOL-LONDON, V350, P361, DOI 10.1113/jphysiol.1984.sp015206; Boyett MR, 1999, AM J PHYSIOL-HEART C, V276, pH686, DOI 10.1152/ajpheart.1999.276.2.H686; Boyett MR, 2009, CARDIAC ELECTROPHYSI, P127; Butters TD, 2010, CIRC RES, V107, P126, DOI 10.1161/CIRCRESAHA.110.219949; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; Fedorov VV, 2006, AM J PHYSIOL-HEART C, V291, pH612, DOI 10.1152/ajpheart.00022.2006; Garny A, 2003, J CARDIOVASC ELECTR, V14, pS121, DOI 10.1046/j.1540.8167.90301.x; Honjo H, 2002, CARDIOVASC RES, V53, P89, DOI 10.1016/S0008-6363(01)00421-7; Honjo H, 1996, J PHYSIOL-LONDON, V496, P795, DOI 10.1113/jphysiol.1996.sp021728; Jones SA, 2008, CIRC-ARRHYTHMIA ELEC, V1, P39, DOI 10.1161/CIRCEP.107.748467; JOYNER RW, 1986, BIOPHYS J, V50, P1157, DOI 10.1016/S0006-3495(86)83559-7; KIRCHHOF CJHJ, 1987, PFLUG ARCH EUR J PHY, V410, P198, DOI 10.1007/BF00581916; KODAMA I, 1985, PFLUG ARCH EUR J PHY, V404, P214, DOI 10.1007/BF00581242; Kodama I, 1996, J PHYSIOL-LONDON, V495, P785, DOI 10.1113/jphysiol.1996.sp021633; Kurata Y, 2008, BIOPHYS J, V95, P951, DOI 10.1529/biophysj.107.112854; Lang D, 2011, J ELECTROCARDIOL, V44, P626, DOI 10.1016/j.jelectrocard.2011.08.010; Lei M, 2001, J PHYSIOL-LONDON, V535, P703, DOI 10.1111/j.1469-7793.2001.t01-1-00703.x; Lin D, 2004, CARDIAC ELECTROPHYSI, P479; Lindblad DS, 1996, AM J PHYSIOL-HEART C, V271, pH1666, DOI 10.1152/ajpheart.1996.271.4.H1666; Noble D, 1990, OXSOFT HEART; Ren FX, 2006, CHINESE MED J-PEKING, V119, P2075, DOI 10.1097/00029330-200612020-00009; Shaw RM, 1997, CIRC RES, V81, P727; Shibata N, 2001, EXP PHYSIOL, V86, P177, DOI 10.1113/eph8602100; Tellez JO, 2006, CIRC RES, V99, P1384, DOI 10.1161/01.RES.0000251717.98379.69; VASSALLE M, 1970, CIRC RES, V27, P361, DOI 10.1161/01.RES.27.3.361; Verheule S, 1997, CIRC RES, V80, P673, DOI 10.1161/01.RES.80.5.673; Watanabe E, 1996, AM J PHYSIOL-HEART C, V271, pH2097, DOI 10.1152/ajpheart.1996.271.5.H2097; Zhang H, 2007, AM J PHYSIOL-HEART C, V292, pH165, DOI 10.1152/ajpheart.01101.2005; Zhang H, 2000, AM J PHYSIOL-HEART C, V279, pH397, DOI 10.1152/ajpheart.2000.279.1.H397; Zhang HG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00241; Zhang HG, 2002, J CARDIOVASC ELECTR, V13, P465, DOI 10.1046/j.1540-8167.2002.00465.x	33	22	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94565	10.1371/journal.pone.0094565	http://dx.doi.org/10.1371/journal.pone.0094565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759974	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200019
J	Jackson, HT; Mongodin, EF; Davenport, KP; Fraser, CM; Sandler, AD; Zeichner, SL				Jackson, Hope T.; Mongodin, Emmanuel F.; Davenport, Katherine P.; Fraser, Claire M.; Sandler, Anthony D.; Zeichner, Steven L.			Culture-Independent Evaluation of the Appendix and Rectum Microbiomes in Children with and without Appendicitis	PLOS ONE			English	Article							BACTERIAL-FLORA; APPENDECTOMY; FECALITHS; CALCULI	Purpose: The function of the appendix is largely unknown, but its microbiota likely contributes to function. Alterations in microbiota may contribute to appendicitis, but conventional culture studies have not yielded conclusive information. We conducted a pilot, culture-independent 16S rRNA-based microbiota study of paired appendix and rectal samples. Methods: We collected appendix and rectal swabs from 21 children undergoing appendectomy, six with normal appendices and fifteen with appendicitis (nine perforated). After DNA extraction, we amplified and sequenced 16S rRNA genes and analyzed sequences using CLoVR. We identified organisms differing in relative abundance using ANOVA (p<0.05) by location (appendix vs. rectum), disease (appendicitis vs. normal), and disease severity (perforated vs. non-perforated). Results: We identified 290 taxa in the study's samples. Three taxa were significantly increased in normal appendices vs. normal rectal samples: Fusibacter (p = 0.009), Selenomonas (p = 0.026), and Peptostreptococcus (p = 0.049). Five taxa were increased in abundance in normal vs. diseased appendices: Paenibacillaceae (p = 0.005), Acidobacteriaceae GP4 (p = 0.019), Pseudonocardinae (p = 0.019), Bergeyella (p = 0.019) and Rhizobium (p = 0.045). Twelve taxa were increased in the appendices of appendicitis patients vs. normal appendix: Peptostreptococcus (p = 0.0003), Bilophila (p = 0.0004), Bulleidia (p = 0.012), Fusobacterium (p = 0.018), Parvimonas (p = 0.003), Mogibacterium (p = 0.012), Aminobacterium (p = 0.019), Proteus (p = 0.028), Actinomycineae (p = 0.028), Anaerovorax (p = 0.041), Anaerofilum (p = 0.045), Porphyromonas (p = 0.010). Five taxa were increased in appendices in patients with perforated vs. nonperforated appendicitis: Bulleidia (p = 0.004), Fusibacter (p = 0.005), Prevotella (p = 0.021), Porphyromonas (p = 0.030), Dialister (p = 0.035). Three taxa were increased in rectum samples of patients with appendicitis compared to the normal patients: Bulleidia (p = 0.034), Dialister (p = 0.003), and Porphyromonas (p = 0.026). Conclusion: Specific taxa are more abundant in normal appendices compared to the rectum, suggesting that a distinctive appendix microbiota exists. Taxa with altered abundance in diseased and severely diseased (perforated) samples may contribute to appendicitis pathogenesis, and may provide microbial signatures in the rectum useful for guiding both treatment and diagnosis of appendicitis.	[Jackson, Hope T.; Davenport, Katherine P.; Sandler, Anthony D.] Childrens Natl Med Ctr, Sheikh Zayed Inst Pediat Surg Innovat, Washington, DC 20010 USA; [Mongodin, Emmanuel F.; Fraser, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Sandler, Anthony D.] Childrens Natl Med Ctr, Dept Pediat Surg, Washington, DC 20010 USA; [Zeichner, Steven L.] Childrens Natl Med Ctr, Childrens Res Inst, Ctr Canc & Immunol Res, Washington, DC 20010 USA; [Zeichner, Steven L.] George Washington Univ, Dept Pediat, Washington, DC 20052 USA; [Zeichner, Steven L.] George Washington Univ, Dept Microbiol, Washington, DC USA; [Zeichner, Steven L.] George Washington Univ, Dept Immunol, Washington, DC USA; [Zeichner, Steven L.] George Washington Univ, Dept Trop Med, Washington, DC USA	Children's National Health System; University System of Maryland; University of Maryland Baltimore; Children's National Health System; Children's National Health System; George Washington University; George Washington University; George Washington University; George Washington University	Zeichner, SL (corresponding author), Childrens Natl Med Ctr, Childrens Res Inst, Ctr Canc & Immunol Res, Washington, DC 20010 USA.	zeichner@gwu.edu	Mongodin, Emmanuel/AAF-1850-2020	Mongodin, Emmanuel/0000-0003-3833-7437; Sandler, Anthony/0000-0001-9440-2964; Fraser, Claire/0000-0003-1462-2428	NIDCR, NIH [DE021570]; NIAID, NIH [AI090571]; NCI, NIH [CA157417]; District of Columbia Developmental Center for AIDS Research from NIAID, NIH [P30AI087714]; NATIONAL CANCER INSTITUTE [R21CA157417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714, R01AI090571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE021570] Funding Source: NIH RePORTER	NIDCR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); District of Columbia Developmental Center for AIDS Research from NIAID, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by grants DE021570 from NIDCR, NIH, AI090571 from NIAID, NIH, CA157417 from NCI, NIH, and the District of Columbia Developmental Center for AIDS Research P30AI087714, from NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; BARON EJ, 1989, J GEN MICROBIOL, V135, P3405; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Bollinger RR, 2007, J THEOR BIOL, V249, P826, DOI 10.1016/j.jtbi.2007.08.032; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; BROOK I, 1980, ANN SURG, V192, P208, DOI 10.1097/00000658-198008000-00014; BUCKEL W, 1974, J BACTERIOL, V117, P1248, DOI 10.1128/JB.117.3.1248-1260.1974; Bundy DG, 2007, JAMA-J AM MED ASSOC, V298, P438, DOI 10.1001/jama.298.4.438; Dekio I, 2005, J MED MICROBIOL, V54, P1231, DOI 10.1099/jmm.0.46075-0; Dharmani P, 2011, INFECT IMMUN, V79, P2597, DOI 10.1128/IAI.05118-11; Ebringer A, 2003, SCAND J RHEUMATOL, V32, P2, DOI 10.1080/03009740310000337; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; FINEGOLD SM, 1995, ANAEROBE, V1, P3, DOI 10.1016/S1075-9964(95)80340-8; Fitz RH, 1886, PERFORATING INFLAMMA; Gearhart S.L, 2008, HARRISONS PRINCIPLES, P1914; Gebbers JO, 2004, ANN NY ACAD SCI, V1029, P337, DOI 10.1196/annals.1309.015; Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7; Goncalves LFH, 2012, J PERIODONTAL RES, V47, P711, DOI 10.1111/j.1600-0765.2012.01485.x; Guinane CM, 2013, MBIO, V4, DOI 10.1128/mBio.00366-12; Guthery SL, 2004, J PEDIATR-US, V144, P589, DOI 10.1016/j.jpeds.2004.02.029; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Humes DJ, 2006, BMJ-BRIT MED J, V333, P530, DOI 10.1136/bmj.38940.664363.AE; JONES BA, 1985, ANN SURG, V202, P80, DOI 10.1097/00000658-198507000-00013; Kalisova M, 1944, BRIT MED J, V2, P1; Kuppalli K, 2012, LANCET INFECT DIS, V12, P808, DOI 10.1016/S1473-3099(12)70089-0; Lau SKP, 2002, J CLIN PATHOL-MOL PA, V55, P182, DOI 10.1136/mp.55.3.182; LAU WY, 1984, ANN SURG, V200, P576, DOI 10.1097/00000658-198411000-00003; LEIGH DA, 1974, J CLIN PATHOL, V27, P997, DOI 10.1136/jcp.27.12.997; Murdoch DA, 1998, CLIN MICROBIOL REV, V11, P81, DOI 10.1128/CMR.11.1.81; NITECKI S, 1990, SURG GYNECOL OBSTET, V171, P185; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; PRIMATESTA P, 1994, INT J EPIDEMIOL, V23, P155, DOI 10.1093/ije/23.1.155; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rhee KJ, 2005, J EXP MED, V201, P55, DOI 10.1084/jem.20041849; Rhee KJ, 2004, J IMMUNOL, V172, P1118, DOI 10.4049/jimmunol.172.2.1118; ROBERTS JP, 1988, ARCH DIS CHILD, V63, P536, DOI 10.1136/adc.63.5.536; Sawanon S, 2011, FEMS MICROBIOL LETT, V325, P170, DOI 10.1111/j.1574-6968.2011.02427.x; Seekatz AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064212; SHAW RE, 1965, BRIT J SURG, V52, P451, DOI 10.1002/bjs.1800520613; Spiegelman D, 2005, CAN J MICROBIOL, V51, P355, DOI 10.1139/W05-003; SUNDQVIST G, 1992, ORAL MICROBIOL IMMUN, V7, P257, DOI 10.1111/j.1399-302X.1992.tb00584.x; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; SYED SA, 1981, J CLIN PERIODONTOL, V8, P45, DOI 10.1111/j.1600-051X.1981.tb02023.x; WALKER ARP, 1990, J CLIN GASTROENTEROL, V12, P127, DOI 10.1097/00004836-199004000-00002; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002; Zupancic ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043052	49	65	69	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95414	10.1371/journal.pone.0095414	http://dx.doi.org/10.1371/journal.pone.0095414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759879	Green Submitted, gold, Green Published			2022-12-25	WOS:000335298200055
J	Kuo, HC; Lauderdale, TL; Lo, DY; Chen, CL; Chen, PC; Liang, SY; Kuo, JC; Liao, YS; Liao, CH; Tsao, CS; Chiou, CS				Kuo, Hung-Chih; Lauderdale, Tsai-Ling; Lo, Dan-Yuan; Chen, Chiou-Lin; Chen, Pei-Chen; Liang, Shiu-Yun; Kuo, Jung-Che; Liao, Ying-Shu; Liao, Chun-Hsing; Tsao, Chi-Sen; Chiou, Chien-Shun			An Association of Genotypes and Antimicrobial Resistance Patterns among Salmonella Isolates from Pigs and Humans in Taiwan	PLOS ONE			English	Article							ENTERICA SEROTYPE CHOLERAESUIS; MULTIDRUG-RESISTANCE; SEROVAR TYPHIMURIUM; UNITED-STATES; CHICKEN MEAT; CONTAMINATION; PULSENET; DISEASE; FARM; SCHWARZENGRUND	We collected 110 Salmonella enterica isolates from sick pigs and determined their serotypes, genotypes using pulsed-field gel electrophoresis (PFGE), and antimicrobial susceptibility to 12 antimicrobials and compared the data with a collection of 18,280 isolates obtained from humans. The pig isolates fell into 12 common serovars for human salmonellosis in Taiwan; S. Typhimurium, S. Choleraesuis, S. Derby, S. Livingstone, and S. Schwarzengrund were the 5 most common serovars and accounted for a total of 84% of the collection. Of the 110 isolates, 106 (96%) were multidrug resistant (MDR) and 48 (44%) had PFGE patterns found in human isolates. S. Typhimurium, S. Choleraesuis, and S. Schwarzengrund were among the most highly resistant serovars. The majority of the 3 serovars were resistant to 8-11 of the tested antimicrobials. The isolates from pigs and humans sharing a common PFGE pattern displayed identical or very similar resistance patterns and Salmonella strains that caused severe infection in pigs were also capable of causing infections in humans. The results indicate that pigs are one of the major reservoirs to human salmonellosis in Taiwan. Almost all of the pig isolates were MDR, which highlights the necessity of strictly regulating the use of antimicrobials in the agriculture sector in Taiwan.	[Kuo, Hung-Chih; Lo, Dan-Yuan; Chen, Chiou-Lin] Natl Chiayi Univ, Dept Vet Med, Chiayi, Taiwan; [Lauderdale, Tsai-Ling; Chen, Pei-Chen] Natl Hlth Res Inst, Miaoli, Taiwan; [Liang, Shiu-Yun; Kuo, Jung-Che; Liao, Ying-Shu; Liao, Chun-Hsing; Tsao, Chi-Sen; Chiou, Chien-Shun] Ctr Dis Control, Taichung, Taiwan	National Chiayi University; National Health Research Institutes - Taiwan; Centers For Disease Control - Taiwan	Chiou, CS (corresponding author), Ctr Dis Control, Taichung, Taiwan.	nipmcsc@cdc.gov.tw	Lauderdale, Tsai-Ling/B-2660-2010; Chiou, Chien-Shun/I-5355-2014	Chiou, Chien-Shun/0000-0003-3674-1030; Liao, Chun-Hsing/0000-0002-4099-3487	Centers for Disease Control, Ministry of Health and Welfare, Taiwan [DOH101-DC-2201]	Centers for Disease Control, Ministry of Health and Welfare, Taiwan	This study was supported by a grant (DOH101-DC-2201) from the Centers for Disease Control, Ministry of Health and Welfare, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2007, EMERG INFECT DIS, V13, P726, DOI 10.3201/eid1305.061489; Bangtrakulnonth A, 2004, EMERG INFECT DIS, V10, P131, DOI 10.3201/eid1001.02-0781; Botteldoorn N, 2003, J APPL MICROBIOL, V95, P891, DOI 10.1046/j.1365-2672.2003.02042.x; Centers for Disease Control and Prevention (CDC), 2013, NAT SALM SURV ANN RE; Chang CC, 2005, J CLIN MICROBIOL, V43, P2798, DOI 10.1128/JCM.43.6.2798-2804.2005; Chen MH, 2010, POULTRY SCI, V89, P359, DOI 10.3382/ps.2009-00001; Chen MH, 2012, FOOD RES INT, V45, P978, DOI 10.1016/j.foodres.2011.01.039; Chen TH, 2006, J FOOD PROTECT, V69, P674, DOI 10.4315/0362-028X-69.3.674; Chen YH, 1999, INT J ADV MANUF TECH, V15, P127, DOI 10.1007/s001700050049; Chiu CH, 2004, LANCET, V363, P1285, DOI 10.1016/S0140-6736(04)16003-0; Chiu CH, 2002, NEW ENGL J MED, V346, P413, DOI 10.1056/NEJMoa012261; Chiu CH, 2004, CLIN MICROBIOL REV, V17, P311, DOI 10.1128/CMR.17.2.311-322.2004; Chiu Shun, 2004, Journal of Microbiology Immunology and Infection, V37, P99; CLSI, 2013, PERFORMANCE STANDARD; Doublet B, 2003, EMERG INFECT DIS, V9, P585, DOI 10.3201/eid0905.020609; Hopkins K L, 2010, Euro Surveill, V15, P19580; Lauderdale TL, 2006, DIAGN MICR INFEC DIS, V55, P149, DOI 10.1016/j.diagmicrobio.2006.01.002; Lucarelli C, 2010, J CLIN MICROBIOL, V48, P2103, DOI 10.1128/JCM.01371-09; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Murase T, 2001, J FOOD PROTECT, V64, P1912, DOI 10.4315/0362-028X-64.12.1912; POPPE C, 1991, EPIDEMIOL INFECT, V107, P201, DOI 10.1017/S0950268800048822; Rasschaert G, 2012, J FOOD PROTECT, V75, P859, DOI 10.4315/0362-028X.JFP-11-469; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Sandt CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077836; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Stevens MP, 2009, PHILOS T R SOC B, V364, P2709, DOI 10.1098/rstb.2009.0094; Su YC, 2011, AVIAN DIS, V55, P217, DOI 10.1637/9420-060910-Reg.1; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Swaminathan B, 2006, FOODBORNE PATHOG DIS, V3, P36, DOI 10.1089/fpd.2006.3.36; Torpdahl M, 2013, INT J FOOD MICROBIOL, V161, P69, DOI 10.1016/j.ijfoodmicro.2012.11.022; Thai TH, 2012, INT J FOOD MICROBIOL, V156, P147, DOI 10.1016/j.ijfoodmicro.2012.03.016; Yan JJ, 2005, EMERG INFECT DIS, V11, P947	33	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95772	10.1371/journal.pone.0095772	http://dx.doi.org/10.1371/journal.pone.0095772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760078	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200087
J	Li, L; Zhao, FL; Lu, J; Li, TT; Yang, H; Wu, CH; Liu, YY				Li, Li; Zhao, Fenglong; Lu, Juan; Li, Tingting; Yang, Hong; Wu, Chunhui; Liu, Yiyao			Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer through NF-kappa B Activation	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; DOWN-REGULATION; CELL INVASION; PROTEIN EXPRESSION; GROWTH; DIFFERENTIATION; INHIBITION; MIGRATION; APOPTOSIS; PROLIFERATION	The aberrant activation of Notch-1 signaling pathway has been proven to be associated with the development and progression of cancers. However, the specific roles and the underlying mechanisms of Notch-1 signaling pathway on the malignant behaviors of breast cancer are poorly understood. In this study, using multiple cellular and molecular approaches, we demonstrated that activation of Notch-1 signaling pathway promoted the malignant behaviors of MDA-MB-231 cells such as increased cell proliferation, colony formation, adhesion, migration, and invasion, and inhibited apoptosis; whereas deactivation of this signaling pathway led to the reversal of the aforementioned malignant cellular behaviors. Furthermore, we found that activation of Notch-1 signaling pathway triggered the activation of NF-kappa B signaling pathway and up-regulated the expression of NF-kappa B target genes including MMP-2/-9, VEGF, Survivin, Bcl-xL, and Cyclin D1. These results suggest that Notch-1 signaling pathway play important roles in promoting the malignant phenotype of breast cancer, which may be mediated partly through the activation of NF-kappa B signaling pathway. Our results further suggest that targeting Notch-1 signaling pathway may become a newer approach to halt the progression of breast cancer.	[Li, Li; Zhao, Fenglong; Lu, Juan; Li, Tingting; Yang, Hong; Wu, Chunhui; Liu, Yiyao] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Dept Biophys, Chengdu 610054, Sichuan, Peoples R China	University of Electronic Science & Technology of China	Liu, YY (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Dept Biophys, Chengdu 610054, Sichuan, Peoples R China.	liuyiyao@hotmail.com	Li, Tingting/T-6249-2019	Liu, Yiyao/0000-0002-7222-739X	National Natural Science Foundation of China [11272083, 81071257, 81201192, 81101147]; New Century Excellent Talents Program in Chinese Universities [NCET-09-0263]; Sichuan Youth Science and Technology Foundation of China [2010JQ0004]; Postdoctal Program of China [2011M501297, 2012T50715]; Fundamental Research Funds for Central Universities [ZYGX2010X019, ZYGX2010J101, ZYGX2011J099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents Program in Chinese Universities(Program for New Century Excellent Talents in University (NCET)); Sichuan Youth Science and Technology Foundation of China; Postdoctal Program of China; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported, in whole or in part, by the National Natural Science Foundation of China (11272083, 81071257, 81201192, 81101147), the New Century Excellent Talents Program in Chinese Universities (NCET-09-0263), the Sichuan Youth Science and Technology Foundation of China (2010JQ0004), Postdoctal Program of China (2011M501297, 2012T50715), and the Fundamental Research Funds for Central Universities (ZYGX2010X019, ZYGX2010J101, ZYGX2011J099). The authors declared that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bajaj J, 2011, CANCER RES, V71, P4888, DOI 10.1158/0008-5472.CAN-11-0543; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Hsieh TC, 2009, ANTICANCER RES, V29, P4025; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jang MS, 2004, J CELL PHYSIOL, V199, P418, DOI 10.1002/jcp.10467; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; Jundt F, 2002, BLOOD, V99, P3398, DOI 10.1182/blood.V99.9.3398; Kim S, 2008, MOLECULES, V13, P2975, DOI 10.3390/molecules13122975; Leethanakul C, 2000, ONCOGENE, V19, P3220, DOI 10.1038/sj.onc.1203703; Leong KG, 2008, DIFFERENTIATION, V76, P699, DOI 10.1111/j.1432-0436.2008.00288.x; Liu YY, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/829243; Lonsdorf AS, 2012, J BIOL CHEM, V287, P2168, DOI 10.1074/jbc.M111.269811; Ma W, 2006, ONCOGENE, V25, P4207, DOI 10.1038/sj.onc.1209450; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Pandya K, 2011, BRIT J CANCER, V105, P796, DOI 10.1038/bjc.2011.321; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Rae FK, 2000, INT J CANCER, V88, P726, DOI 10.1002/1097-0215(20001201)88:5<726::AID-IJC7>3.0.CO;2-H; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Sharp JA, 2004, CLIN EXP METASTAS, V21, P19, DOI 10.1023/B:CLIN.0000017167.17065.61; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Wang HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037764; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wang ZW, 2006, CANCER-AM CANCER SOC, V106, P2503, DOI 10.1002/cncr.21904; Wang ZW, 2011, J CELL BIOCHEM, V112, P78, DOI 10.1002/jcb.22770; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wang ZW, 2006, INT J CANCER, V118, P1930, DOI 10.1002/ijc.21589; Wu FT, 2007, FRONT BIOSCI-LANDMRK, V12, P4370, DOI 10.2741/2394; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xie TX, 2010, ONCOL REP, V23, P725, DOI 10.3892/or_00000690; Zardawi SJ, 2010, HISTOPATHOLOGY, V56, P286, DOI 10.1111/j.1365-2559.2009.03475.x; Zhang Y, 2010, CANCER-AM CANCER SOC, V116, P5207, DOI 10.1002/cncr.25449; Zhou FZ, 2012, PROG BIOCHEM BIOPHYS, V39, P352, DOI 10.3724/SP.J.1206.2011.00242	42	114	128	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95912	10.1371/journal.pone.0095912	http://dx.doi.org/10.1371/journal.pone.0095912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760075	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200107
J	Momma, H; Niu, KJ; Kobayashi, Y; Huang, C; Otomo, A; Chujo, M; Tadaura, H; Nagatomi, R				Momma, Haruki; Niu, Kaijun; Kobayashi, Yoritoshi; Huang, Cong; Otomo, Atsushi; Chujo, Masahiko; Tadaura, Hiroko; Nagatomi, Ryoichi			Leg Extension Power Is a Pre-Disaster Modifiable Risk Factor for Post-Traumatic Stress Disorder among Survivors of the Great East Japan Earthquake: A Retrospective Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; DEVASTATING TSUNAMI; ALCOHOL-CONSUMPTION; TOHOKU EARTHQUAKE; PHYSICAL-ACTIVITY; HEALTH-PROMOTION; DEPRESSION; POPULATION; RELIABILITY; SYMPTOMS	Background: Post-traumatic stress disorder (PTSD) is a common psychological problem following natural disasters. Although pre-disaster risk factors are important for early detection and proactive support, the examination of such has been limited to sociodemographic factors, which were largely unaffected by the disasters. We examined the association between pre-disaster physical functioning and lifestyle and PTSD symptoms five months after the earthquake in the Great East Japan Earthquake survivors who were participating in a pre-existing cohort study. Methods: We designed a retrospective cohort study of a cooperative association in Sendai from August 2010 to August 2011. In 2010, lifestyle, physical condition, and sociodemographic factors were examined by self-reported questionnaires completed by 522 employees of this organization. We also measured the leg extension power of all the participants. PTSD symptoms were evaluated by the Japanese version of the Impact of Event Scale-Revised (IES-R-J) following the earthquake of 2011. Results: In multivariate linear regression analysis, leg extension power (beta = -0.128, P = 0.025), daily drinking (beta = 0.203, P = 0.006), and depressive symptoms (beta = 0.139, P = 0.008) were associated with total score of the IES-R-J among men. Moreover, for the IES-R-J subscale, leg extension power was also negatively associated with Intrusion (beta = -0.114, P = 0.045) and Hyperarousal (beta = -0.163, P = 0.004) after adjusting for all other significant variables. For women, hypertension (b = 0.226, P = 0.032) and depressive symptoms (beta = 0.205, P = 0.046) were associated with the total score of the IES-R-J. Conclusions: Leg extension power is a potentially modifiable pre-disaster risk factor among men for attenuating the severity of PTSD symptoms associated with great disasters such as the Great East Japan Earthquake among men.	[Momma, Haruki; Nagatomi, Ryoichi] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Engn Hlth & Welf, Sendai, Miyagi 980, Japan; [Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Dept Epidemiol, Tianjin, Peoples R China; [Kobayashi, Yoritoshi; Huang, Cong; Otomo, Atsushi; Chujo, Masahiko; Nagatomi, Ryoichi] Tohoku Univ, Grad Sch Med, Dept Med & Sci Sports & Exercise, Sendai, Miyagi 980, Japan; [Tadaura, Hiroko] Miyagi Univ, Sch Nursing, Sendai, Miyagi, Japan	Tohoku University; Tianjin Medical University; Tohoku University; Miyagi University	Nagatomi, R (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Engn Hlth & Welf, Sendai, Miyagi 980, Japan.	nagatomi@med.tohoku.ac.jp	Nagatomi, Ryoichi/T-5296-2019; Huang, Cong/N-4401-2019; Nagatomi, Ryoichi/Q-8792-2016	Nagatomi, Ryoichi/0000-0003-3038-7202; Niu, Kaijun/0000-0002-8772-2481; Huang, Cong/0000-0002-2307-864X; Momma, Haruki/0000-0003-1134-0898	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Society for the Promotion of Science (JSPS) [25750343]; Grants-in-Aid for Scientific Research [25750343] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Oroshisho longitudinal study since 2008 including the data collection in 2010 and 2011 was supported by "Knowledge Cluster Initiative'' from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Japanese Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (B) (Grant No. 25750343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY A, 1993, ADDICT BEHAV, V18, P659, DOI 10.1016/0306-4603(93)90019-6; Aberg MAI, 2012, BRIT J PSYCHIAT, V201, P352, DOI 10.1192/bjp.bp.111.103416; Abouzeid M, 2012, J PSYCHOSOM RES, V72, P33, DOI 10.1016/j.jpsychores.2011.08.002; Ando S, 2013, PSYCHIAT CLIN NEUROS, V67, P471, DOI 10.1111/pcn.12086; [Anonymous], 2012, WORLDRISKREPORT 2012; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; BASSEY EJ, 1990, EUR J APPL PHYSIOL, V60, P385, DOI 10.1007/BF00713504; Cerda M, 2011, DRUG ALCOHOL DEPEN, V115, P1, DOI 10.1016/j.drugalcdep.2010.09.011; Dedert EA, 2010, ANN BEHAV MED, V39, P61, DOI 10.1007/s12160-010-9165-9; Ekstrom H, 2011, J AGING HEALTH, V23, P1379, DOI 10.1177/0898264311418504; Ensel WM, 2004, J COMMUNITY PSYCHOL, V32, P81, DOI 10.1002/jcop.10079; Foa EB, 2006, J CLIN PSYCHIAT, V67, P15; Fountoulakis KN, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-6; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Gerber M, 2010, PSYCHOL SPORT EXERC, V11, P286, DOI 10.1016/j.psychsport.2010.02.004; Gerber M, 2009, SCAND J PUBLIC HEALT, V37, P801, DOI 10.1177/1403494809350522; Glantz S., 1990, PRIMER APPL REGRESSI; Guo H, 2012, NUTR METAB CARDIOVAS, V22, P277, DOI 10.1016/j.numecd.2010.06.006; Ishigaki A, 2013, TOHOKU J EXP MED, V229, P287, DOI 10.1620/tjem.229.287; Ishii M, 2011, WORLD MED HEALTH POL, V3, DOI 10.2202/1948-4682.1210; Ishikawa-Takata K, 2007, J EPIDEMIOL, V17, P177; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Keyes KM, 2011, PSYCHOPHARMACOLOGY, V218, P1, DOI 10.1007/s00213-011-2236-1; Kobayashi Y, 2012, J DENT RES, V91, P479, DOI 10.1177/0022034512440707; LeardMann CA, 2011, PUBLIC HEALTH REP, V126, P371, DOI 10.1177/003335491112600311; Lee CS, 2009, SOC PSYCH PSYCH EPID, V44, P55, DOI 10.1007/s00127-008-0405-2; Levine AB, 2014, CARDIOLOGY, V127, P1, DOI 10.1159/000354910; Min JA, 2013, PSYCHIAT INVEST, V10, P307, DOI 10.4306/pi.2013.10.4.307; Momma H, 2013, J CLIN ENDOCRINOL ME; MULLER A, 1994, BEHAV RES THER, V32, P593, DOI 10.1016/0005-7967(94)90013-2; Murase N, 2002, J HLTH WELF STAT, V49, P1; Newsom JT, 1996, PSYCHOL AGING, V11, P34, DOI 10.1037/0882-7974.11.1.34; Nishimura K., 2011, Journal of the Japan Diabetes Society, V54, P724; Niu KJ, 2013, EUR J NUTR, V52, P771, DOI 10.1007/s00394-012-0383-8; Rhebergen D, 2011, ACTA PSYCHIAT SCAND, V123, P297, DOI 10.1111/j.1600-0447.2011.01677.x; Rostad FG, 1996, INT J SPORT PSYCHOL, V27, P197; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Sasaki S, 2005, SERUM BIOMARKER BASE, P10; Shibahara S, 2011, TOHOKU J EXP MED, V223, P305, DOI 10.1620/tjem.223.305; Shimizu S, 2000, ADDICTION, V95, P529, DOI 10.1046/j.1360-0443.2000.9545295.x; Sugimoto A, 2011, GENES CELLS, V16, P745, DOI 10.1111/j.1365-2443.2011.01531.x; Tsai KY, 2007, J PSYCHIATR RES, V41, P90, DOI 10.1016/j.jpsychires.2005.10.004; Turvey CL, 2009, AM J GERIAT PSYCHIAT, V17, P632, DOI 10.1097/JGP.0b013e31819c498c; Van der Velden PG, 2007, J CLIN PSYCHIAT, V68, P87, DOI 10.4088/JCP.v68n0112; van Milligen BA, 2012, J AFFECT DISORDERS, V136, P828, DOI 10.1016/j.jad.2011.09.030; Walker EA, 2003, ARCH GEN PSYCHIAT, V60, P369, DOI 10.1001/archpsyc.60.4.369; Wang HL, 2011, J AFFECT DISORDERS, V130, P213, DOI 10.1016/j.jad.2010.09.026; Weiss D.S., 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1037/T12199-000	50	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96131	10.1371/journal.pone.0096131	http://dx.doi.org/10.1371/journal.pone.0096131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG3EI	24760054	gold, Green Submitted, Green Published			2022-12-25	WOS:000335298200141
J	Telschow, A; Hilgenboecker, K; Hammerstein, P; Werren, JH				Telschow, Arndt; Hilgenboecker, Kirsten; Hammerstein, Peter; Werren, John H.			Dobzhansky-Muller and Wolbachia-Induced Incompatibilities in a Diploid Genetic System	PLOS ONE			English	Article							UNIDIRECTIONAL CYTOPLASMIC INCOMPATIBILITY; CAUSE HYBRID LETHALITY; REPRODUCTIVE ISOLATION; MITOCHONDRIAL-DNA; HORIZONTAL TRANSFER; SPECIATION; EVOLUTION; POPULATIONS; HYMENOPTERA; INFECTION	Genetic incompatibilities are supposed to play an important role in speciation. A general (theoretical) problem is to explain the persistence of genetic diversity after secondary contact. Previous theoretical work has pointed out that Dobzhansky-Muller incompatibilities (DMI) are not stable in the face of migration unless local selection acts on the alleles involved in incompatibility. With local selection, genetic variability exists up to a critical migration rate but is lost when migration exceeds this threshold value. Here, we investigate the effect of intracellular bacteria Wolbachia on the stability of hybrid zones formed after the Dobzhansky Muller model. Wolbachia are known to cause a cytoplasmic incompatibility (CI) within and between species. Incorporating intracellular bacteria Wolbachia can lead to a significant increase of critical migration rates and maintenance of divergence, primarily because Wolbachia-induced incompatibility acts to reduce frequencies of F1 hybrids. Wolbachia infect up to two-thirds of all insect species and it is therefore likely that CI co-occurs with DMI in nature. The results indicate that both isolating mechanisms strengthen each other and under some circumstances act synergistically. Thus they can drive speciation processes more forcefully than either when acting alone.	[Telschow, Arndt] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Telschow, Arndt] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Hilgenboecker, Kirsten; Hammerstein, Peter] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany; [Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Kyoto University; University of Munster; Humboldt University of Berlin; University of Rochester	Telschow, A (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	a.telschow@uni-muenster.de		Werren, John/0000-0001-9353-2070	Deutsche Forschungsgemeinschaft [SFB 618, C1]; Japanese Society for Promotion of Science; Volkswagen-foundation; Humboldt foundation award; Wissenschaftskolleg zu Berlin; US NSF [DEB 1257053, DEB 0821936]; Direct For Biological Sciences [1257053] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Volkswagen-foundation(Volkswagen); Humboldt foundation award; Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF)); US NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This article was supported by Deutsche Forschungsgemeinschaft (SFB 618, C1) (KH, AT, PH), the Japanese Society for Promotion of Science (KH, AT, JW), and the Volkswagen-foundation (AT). JW was supported by Humboldt foundation award, a fellowship to the Wissenschaftskolleg zu Berlin, and by the US NSF DEB 1257053 and DEB 0821936. (http://dfg.de/, http://www.jsps.go.jp/english/, http://www.nsf.gov/, http://www.volkswagenstiftung.de/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo L, 2008, MOL ECOL, V17, P557, DOI 10.1111/j.1365-294X.2007.03608.x; Bank C, 2012, GENETICS, V191, P845, DOI 10.1534/genetics.111.137513; Bella Jose L., 2010, Journal of Orthoptera Research, V19, P205, DOI 10.1665/034.019.0206; Bengtsson B.O., 1985, P31; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Bordenstein Sr, 2003, CONT T ENT, P283; Branca A, 2009, BMC EVOLUTIONARY BIO, V9, P185; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Brucker RM, 2013, SCIENCE, V341, P667, DOI 10.1126/science.1240659; CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138; Chafee ME, 2010, MOL BIOL EVOL, V27, P501, DOI 10.1093/molbev/msp275; Coyne JA, 2004, SPECIATION, V37; Dedeine F, 2005, HEREDITY, V95, P394, DOI 10.1038/sj.hdy.6800739; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Flor M, 2007, J EVOLUTION BIOL, V20, P696, DOI 10.1111/j.1420-9101.2006.01252.x; Gavrilets S, 1997, EVOLUTION, V51, P1027, DOI 10.2307/2411031; Giordano R, 1997, P NATL ACAD SCI USA, V94, P11439, DOI 10.1073/pnas.94.21.11439; Gotoh T, 2005, HEREDITY, V94, P237, DOI 10.1038/sj.hdy.6800605; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOFFMANN AA, 1994, GENETICS, V136, P993; Hurst GDD, 1998, HEREDITY, V80, P2, DOI 10.1046/j.1365-2540.1998.00337.x; Jackel R, 2013, MOL ECOL, V22, P4241, DOI 10.1111/mec.12389; Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325; Jaenike J, 2009, OIKOS, V118, P353, DOI 10.1111/j.1600-0706.2008.17110.x; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Keller GP, 2004, MOL ECOL, V13, P2405, DOI 10.1111/j.1365-294X.2004.02213.x; Kodandaramaiah U, 2013, ECOL EVOL, V3, P5167, DOI 10.1002/ece3.886; Koehncke A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004425; Koukou K, 2006, EVOLUTION, V60, P87, DOI 10.1111/j.0014-3820.2006.tb01084.x; Kvie KS, 2013, ECOL EVOL, V3, P126, DOI 10.1002/ece3.434; LAVEN H, 1959, COLD SPRING HARB SYM, V24, P166, DOI 10.1101/SQB.1959.024.01.017; Miller WJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001214; Muller HJ, 1942, BIOL S, V6, P71; ONEILL SL, 1990, NATURE, V348, P178, DOI 10.1038/348178a0; Orr HA, 1996, GENETICS, V144, P1331; ORR HA, 1995, GENETICS, V139, P1805; ORR HA, 1992, GENET RES, V59, P73, DOI 10.1017/S0016672300030275; Orr HA, 2001, EVOLUTION, V55, P1085; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Raychoudhury R, 2012, HEREDITY, V108, P105, DOI 10.1038/hdy.2011.53; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; Rincon C, 2006, BIOL CONTROL, V36, P171, DOI 10.1016/j.biocontrol.2005.07.018; Ritter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078107; Schuler H, 2013, MOL ECOL, V22, P4101, DOI 10.1111/mec.12362; Shoemaker DD, 2000, INSECT MOL BIOL, V9, P661, DOI 10.1046/j.1365-2583.2000.00233.x; Shoemaker DD, 2003, ENVIRON ENTOMOL, V32, P1329, DOI 10.1603/0046-225X-32.6.1329; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI [10.2307/2640819, 10.1111/j.1558-5646.1999.tb04529.x]; Sinkins SP, 2005, NATURE, V436, P257, DOI 10.1038/nature03629; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Telschow A, 2005, EVOLUTION, V59, P1607, DOI 10.1111/j.0014-3820.2005.tb01812.x; Telschow A, 2005, J THEOR BIOL, V235, P265, DOI 10.1016/j.jtbi.2005.01.008; Telschow A, 2002, AM NAT, V160, pS54, DOI 10.1086/342153; Telschow A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000701; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Turelli M, 2000, GENETICS, V154, P1663; TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x; Wachi N, 2012, MOL ECOL, V21, P4681, DOI 10.1111/j.1365-294X.2012.05727.x; WAGNER A, 1994, GENETICS, V138, P533; Wang RX, 2013, J EVOLUTION BIOL, V26, P386, DOI 10.1111/jeb.12057; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren JH, 1998, ENDLESS FORMS, P245; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x; Xiao JH, 2012, EVOLUTION, V66, P1907, DOI 10.1111/j.1558-5646.2011.01561.x; YEN JH, 1973, J INVERTEBR PATHOL, V22, P242, DOI 10.1016/0022-2011(73)90141-9; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	71	10	10	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95488	10.1371/journal.pone.0095488	http://dx.doi.org/10.1371/journal.pone.0095488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759973	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200059
J	Soderquist, RS; Danilov, AV; Eastman, A				Soderquist, Ryan S.; Danilov, Alexey V.; Eastman, Alan			Gossypol Increases Expression of the Pro-apoptotic BH3-only Protein NOXA through a Novel Mechanism Involving Phospholipase A2, Cytoplasmic Calcium, and Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; LACTATE DEHYDROGENASE-X; NF-KAPPA-B; ARACHIDONIC-ACID; INTERFACIAL ACTIVATION; SENSITIZES LEUKEMIA; TELOMERASE ACTIVITY; A(2) ACTIVATION; BCL-2 INHIBITOR; CANCER CELLS	Gossypol is a putative BH3 mimetic proposed to inhibit BCL2 and BCLXL based on cell-free assays. We demonstrated previously that gossypol failed to directly inhibit BCL2 in cells or induce apoptosis in chronic lymphocytic leukemia (CLL) cells or platelets, which require BCL2 or BCLXL, respectively, for survival. Here, we demonstrate that gossypol rapidly increased activity of phospholipase A2 (PLA2), which led to an increase in cytoplasmic calcium, endoplasmic reticulum (ER) stress, and up-regulation of the BH3-only protein NOXA. Pretreatment with the PLA2 inhibitor, aristolochic acid, abrogated the increase in calcium, ER stress, and NOXA. Calcium chelation also abrogated the gossypol-induced increase in calcium, ER stress, and NOXA, but not the increase in PLA2 activity, indicating that PLA2 is upstream of these events. In addition, incubating cells with the two products of PLA2 (lysophosphatidic acid and arachidonic acid) mimicked treatment with gossypol. NOXA is a pro-apoptotic protein that functions by binding the BCL2 family proteins MCL1 and BFL1. The BCL2 inhibitor ABT-199 is currently in clinical trials for CLL. Resistance to ABT-199 can occur from up-regulation of other BCL2 family proteins, and this resistance can be mimicked by culturing CLL cells on CD154(+) stroma cells. We report here that AT-101, a derivative of gossypol in clinical trials, overcomes stroma-mediated resistance to ABT-199 in primary CLL cells, suggesting that a combination of these drugs may be efficacious in the clinic.	[Soderquist, Ryan S.; Eastman, Alan] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Lebanon, NH 03756 USA; [Danilov, Alexey V.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH 03756 USA; [Danilov, Alexey V.; Eastman, Alan] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Eastman, A (corresponding author), Norris Cotton Canc Ctr, Dept Pharmacol & Toxicol, Rubin Bldg,Level 6,1 Med Ctr Dr, Lebanon, NH 03756 USA.	alan.r.eastman@dartmouth.edu			National Institutes of Health Cancer Center Support Grant [CA23108]; Leukemia and Lymphoma Society; National Cancer Institute new faculty award (National Institutes of Health) [CA023108-31S4]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Cancer Institute new faculty award (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Cancer Center Support Grant CA23108 (to the Norris Cotton Cancer Center). This work was also supported by a translational research grant from the Leukemia and Lymphoma Society.; Supported by a National Cancer Institute new faculty award (National Institutes of Health Grant CA023108-31S4) to the Norris Cotton Cancer Center.	AKIRA S, 1994, THERIOGENOLOGY, V41, P1489, DOI 10.1016/0093-691X(94)90200-3; Albershardt TC, 2011, J BIOL CHEM, V286, P24882, DOI 10.1074/jbc.M111.255828; [Anonymous], 1978, Chin Med J (Engl), V4, P417; Arinbasarova Anna Yu, 2012, Open Biochem J, V6, P11, DOI 10.2174/1874091X01206010011; Balakrishnan K, 2013, INVEST NEW DRUG, V31, P1384, DOI 10.1007/s10637-013-0002-4; Balthazart J, 2003, EUR J NEUROSCI, V17, P1591, DOI 10.1046/j.1460-9568.2003.02598.x; Bates DJP, 2011, CANCER BIOL THER, V12, P314, DOI 10.4161/cbt.12.4.16909; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Nicholas JCA, 2007, EUR J PHARMACOL, V555, P106, DOI 10.1016/j.ejphar.2006.10.046; Cheng JS, 2003, CHINESE J PHYSIOL, V46, P117; Cheng JS, 2002, TOXICON, V40, P851, DOI 10.1016/S0041-0101(01)00194-5; Cocco T, 1999, FREE RADICAL BIO MED, V27, P51, DOI 10.1016/S0891-5849(99)00034-9; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; DEPEYSTER A, 1986, BIOCHEM PHARMACOL, V35, P3293, DOI 10.1016/0006-2952(86)90426-0; DEPEYSTER A, 1993, MUTAT RES, V297, P293, DOI 10.1016/0165-1110(93)90021-E; Ding W, 2012, BIOCHEM BIOPH RES CO, V418, P451, DOI 10.1016/j.bbrc.2012.01.037; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guijas C, 2012, J LIPID RES, V53, P2343, DOI 10.1194/jlr.M028423; HAMASAKI Y, 1985, BIOCHIM BIOPHYS ACTA, V834, P37, DOI 10.1016/0005-2760(85)90173-0; Han SK, 1998, BIOCHEM J, V331, P353, DOI 10.1042/bj3310353; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hu GX, 2009, J STEROID BIOCHEM, V115, P14, DOI 10.1016/j.jsbmb.2009.02.004; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; Jan CR, 2000, BBA-MOL CELL RES, V1496, P270, DOI 10.1016/S0167-4889(00)00033-1; Javed MH, 1999, EXP MOL MED, V31, P25, DOI 10.1038/emm.1999.4; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Liu G, 2009, CLIN CANCER RES, V15, P3172, DOI 10.1158/1078-0432.CCR-08-2985; Marchlewski L., 1899, J PRAKT CHEM, V60, P84, DOI [DOI 10.1002/PRAC.18990600108, 10.1002/prac.18990600108]; MCCLARTY GA, 1985, BIOCHEM BIOPH RES CO, V133, P300, DOI 10.1016/0006-291X(85)91875-3; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829; Mignen O, 2003, J BIOL CHEM, V278, P10174, DOI 10.1074/jbc.M212536200; Moon DO, 2008, FEBS LETT, V582, P3367, DOI 10.1016/j.febslet.2008.08.029; Ni ZH, 2013, LEUKEMIA LYMPHOMA, V54, P2263, DOI 10.3109/10428194.2013.775437; OLGIATI KL, 1984, ARCH BIOCHEM BIOPHYS, V231, P411, DOI 10.1016/0003-9861(84)90404-1; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; PENNING TM, 1984, BIOCHEM J, V222, P601, DOI 10.1042/bj2220601; Perez A, 2009, AM J PHYSIOL-CELL PH, V297, pC86, DOI 10.1152/ajpcell.00501.2008; Pyrko P, 2007, MOL CANCER THER, V6, P1262, DOI 10.1158/1535-7163.MCT-06-0629; REYES J, 1984, J BIOL CHEM, V259, P9607; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Rosenberger S, 2007, J BIOL CHEM, V282, P6126, DOI 10.1074/jbc.M610529200; Salerni BL, 2010, MOL CANCER THER, V9, P791, DOI 10.1158/1535-7163.MCT-10-0028; Senarisoy M, 2013, CELL BIOCHEM BIOPHYS, V66, P199, DOI 10.1007/s12013-012-9468-5; Soderquist R, 2013, LEUKEMIA, V27, P2262, DOI 10.1038/leu.2013.138; Soderquist R, 2014, APOPTOSIS, V19, P201, DOI 10.1007/s10495-013-0910-y; Song BC, 2013, IMMUNOPHARM IMMUNOT, V35, P615, DOI 10.3109/08923973.2013.830126; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; STEINER M, 1984, INT J ANDROL, V7, P521, DOI 10.1111/j.1365-2605.1984.tb00809.x; Stuhlmeier KM, 1997, J BIOL CHEM, V272, P24679, DOI 10.1074/jbc.272.39.24679; Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767; TANG F, 1982, CONTRACEPTION, V26, P515, DOI 10.1016/0010-7824(82)90150-0; Tatulian SA, 2001, BIOPHYS J, V80, P789, DOI 10.1016/S0006-3495(01)76058-4; Vento R, 2000, EXP EYE RES, V70, P503, DOI 10.1006/exer.1998.0810; Wang J, 2013, MOL BIOSYST, V9, P1489, DOI 10.1039/c3mb25461e; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wolter KG, 2006, NEOPLASIA, V8, P163, DOI 10.1593/neo.05691; Xu YJ, 2008, J CELL MOL MED, V12, P942, DOI 10.1111/j.1582-4934.2008.00139.x; YAO KQ, 1987, J ETHNOPHARMACOL, V20, P25; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Yu BZ, 1997, BIOCHEMISTRY-US, V36, P12400, DOI 10.1021/bi962972i; Zerp SF, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-47; Zhang MC, 2003, BIOCHEM PHARMACOL, V66, P93, DOI 10.1016/S0006-2952(03)00248-X; Zhong JT, 2012, CANCER LETT, V323, P180, DOI 10.1016/j.canlet.2012.04.009; Zhu XD, 2001, J IMMUNOL, V167, P461, DOI 10.4049/jimmunol.167.1.461	69	36	36	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16190	16199		10.1074/jbc.M114.562900	http://dx.doi.org/10.1074/jbc.M114.562900			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778183	Green Published, hybrid			2022-12-25	WOS:000337965700024
J	Ponti, D; Bellenchi, GC; Puca, R; Bastianelli, D; Maroder, M; Ragona, G; Roussel, P; Thiry, M; Mercola, D; Calogero, A				Ponti, Donatella; Bellenchi, Gian Carlo; Puca, Rosa; Bastianelli, Daniela; Maroder, Marella; Ragona, Giuseppe; Roussel, Pascal; Thiry, Marc; Mercola, Dan; Calogero, Antonella			The Transcription Factor EGR1 Localizes to the Nucleolus and Is Linked to Suppression of Ribosomal Precursor Synthesis	PLOS ONE			English	Article							RNA-POLYMERASE-I; HT1080 CELLS; GROWTH; P53; PTEN; GENE; VIVO; DIFFERENTIATION; PROGRESSION; BIOGENESIS	EGR1 is an immediate early gene with a wide range of activities as transcription factor, spanning from regulation of cell growth to differentiation. Numerous studies show that EGR1 either promotes the proliferation of stimulated cells or suppresses the tumorigenic growth of transformed cells. Upon interaction with ARF, EGR1 is sumoylated and acquires the ability to bind to specific targets such as PTEN and in turn to regulate cell growth. ARF is mainly localized to the periphery of nucleolus where is able to negatively regulate ribosome biogenesis. Since EGR1 colocalizes with ARF under IGF-1 stimulation we asked the question of whether EGR1 also relocate to the nucleolus to interact with ARF. Here we show that EGR1 colocalizes with nucleolar markers such as fibrillarin and B23 in the presence of ARF. Western analysis of nucleolar extracts from HeLa cells was used to confirm the presence of EGR1 in the nucleolus mainly as the 100 kDa sumoylated form. We also show that the level of the ribosomal RNA precursor 47S is inversely correlated to the level of EGR1 transcripts. The EGR1 iseffective to regulate the synthesis of the 47S rRNA precursor. Then we demonstrated that EGR1 binds to the Upstream Binding Factor (UBF) leading us to hypothesize that the regulating activity of EGR1 is mediated by its interaction within the transcriptional complex of RNA polymerase I. These results confirm the presence of EGR1 in the nucleolus and point to a role for EGR1 in the control of nucleolar metabolism.	[Ponti, Donatella; Puca, Rosa; Bastianelli, Daniela; Maroder, Marella; Ragona, Giuseppe; Calogero, Antonella] Univ Roma La Sapienza, Dept Medicosurg Sci & Biotechnol, Latina, Italy; [Bellenchi, Gian Carlo] Inst Genet & Biophys ABT, Naples, Italy; [Roussel, Pascal] Univ Paris 06, CNRS, FRE 3402, Paris, France; [Thiry, Marc] Univ Liege, CHU SartTilman, GIGA Neurosci, Cell Biol Unit, Liege, Belgium; [Mercola, Dan] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Liege; University of California System; University of California Irvine	Calogero, A (corresponding author), Univ Roma La Sapienza, Dept Medicosurg Sci & Biotechnol, Latina, Italy.	antonella.calogero@uniroma1.it	calogero, antonella/U-5418-2019; Roussel, Pascal/AAV-5459-2021; mercola, dan/L-4182-2013	Roussel, Pascal/0000-0001-7243-7293; mercola, dan/0000-0002-0281-9840; BELLENCHI, GIANCARLO/0000-0002-9302-0021; PONTI, Donatella/0000-0003-4764-6223	MIUR (PRIN) [Prot. 2010 ZESJWN_007]; University of Rome Sapienza (Ricerche di Ateneo); Fondazione Roma; NCI Earely Detection Research Network [UO1 CA152738]; NATIONAL CANCER INSTITUTE [U01CA152738] Funding Source: NIH RePORTER	MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Rome Sapienza (Ricerche di Ateneo); Fondazione Roma(Fondazione RomaEuropean Commission); NCI Earely Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by MIUR (PRIN 2011 Prot. 2010 ZESJWN_007), University of Rome Sapienza (Ricerche di Ateneo 2011) and Fondazione Roma and the a grant UO1 CA152738 of the NCI Earely Detection Research Network to DAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicelli AJ, 2008, MOL CELL BIOL, V28, P1068, DOI 10.1128/MCB.00484-07; Ayrault O, 2006, ONCOGENE, V25, P7577, DOI 10.1038/sj.onc.1209743; Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007147; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; BERNSTEIN SH, 1991, CELL GROWTH DIFFER, V2, P273; Boone DN, 2011, P NATL ACAD SCI USA, V108, P632, DOI 10.1073/pnas.1008848108; Brina D, 2011, CELL CYCLE, V10, P3441, DOI 10.4161/cc.10.20.17796; Calogero A, 2001, CLIN CANCER RES, V7, P2788; Calogero A, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-1; Calogero A, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-5; Chen LH, 2003, ONCOGENE, V22, P5348, DOI 10.1038/sj.onc.1206851; Ciarmatori S, 2001, MOL CELL BIOL, V21, P5806, DOI 10.1128/MCB.21.17.5806-5814.2001; de Belle I, 1999, ONCOGENE, V18, P3633, DOI 10.1038/sj.onc.1202696; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Font J, 2010, METHODS MOL BIOL, V649, P479, DOI 10.1007/978-1-60761-753-2_29; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; HUANG RP, 1995, CANCER RES, V55, P5054; Karayan L, 2001, ONCOGENE, V20, P836, DOI 10.1038/sj.onc.1204170; Karni-Schmidt O, 2007, ONCOGENE, V26, P3878, DOI 10.1038/sj.onc.1210162; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; LEVIN WJ, 1995, ONCOGENE, V11, P1261; Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70; Liu CT, 1999, J BIOL CHEM, V274, P4400, DOI 10.1074/jbc.274.7.4400; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; OCHS R, 1983, EXP CELL RES, V146, P139, DOI 10.1016/0014-4827(83)90332-4; ROTH J, 1981, J HISTOCHEM CYTOCHEM, V29, P663, DOI 10.1177/29.5.6166664; Ruggero D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003477; Sirri V, 2000, J CELL BIOL, V148, P259, DOI 10.1083/jcb.148.2.259; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Vogt PK, 2001, TRENDS MOL MED, V7, P482, DOI 10.1016/S1471-4914(01)02161-X; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Xirodimas DP, 2002, FEBS LETT, V528, P207, DOI 10.1016/S0014-5793(02)03310-0; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	42	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96037	10.1371/journal.pone.0096037	http://dx.doi.org/10.1371/journal.pone.0096037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787739	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600067
J	Huang, PC; Hsiao, YT; Kao, SY; Chen, CF; Chen, YC; Chiang, CW; Lee, CF; Lu, JC; Chern, Y; Wang, CT				Huang, Pin-Chien; Hsiao, Yu-Tien; Kao, Shao-Yen; Chen, Ching-Feng; Chen, Yu-Chieh; Chiang, Chung-Wei; Lee, Chien-fei; Lu, Juu-Chin; Chern, Yijuang; Wang, Chih-Tien			Adenosine A(2A) Receptor Up-Regulates Retinal Wave Frequency via Starburst Amacrine Cells in the Developing Rat Retina	PLOS ONE			English	Article							PROTEIN-KINASE-A; VISUAL-SYSTEM DEVELOPMENT; FRET-BASED REPORTERS; MAMMALIAN RETINA; SUBCELLULAR DYNAMICS; NEURITE OUTGROWTH; BINDING PROTEIN; CAMP-RESPONSE; P53 BLOCKAGE; PC12 CELLS	Background: Developing retinas display retinal waves, the patterned spontaneous activity essential for circuit refinement. During the first postnatal week in rodents, retinal waves are mediated by synaptic transmission between starburst amacrine cells (SACs) and retinal ganglion cells (RGCs). The neuromodulator adenosine is essential for the generation of retinal waves. However, the cellular basis underlying adenosine's regulation of retinal waves remains elusive. Here, we investigated whether and how the adenosine A(2A) receptor (A(2A)R) regulates retinal waves and whether A(2A)R regulation of retinal waves acts via presynaptic SACs. Methodology/Principal Findings: We showed that A(2A)R was expressed in the inner plexiform layer and ganglion cell layer of the developing rat retina. Knockdown of A(2A)R decreased the frequency of spontaneous Ca2+ transients, suggesting that endogenous A(2A)R may up-regulate wave frequency. To investigate whether A(2A)R acts via presynaptic SACs, we targeted gene expression to SACs by the metabotropic glutamate receptor type II promoter. Ca2+ transient frequency was increased by expressing wild-type A(2A)R (A(2A)R-WT) in SACs, suggesting that A(2A)R may up-regulate retinal waves via presynaptic SACs. Subsequent patch-clamp recordings on RGCs revealed that presynaptic A(2A)R-WT increased the frequency of wave-associated postsynaptic currents (PSCs) or depolarizations compared to the control, without changing the RGC's excitability, membrane potentials, or PSC charge. These findings suggest that presynaptic A(2A)R may not affect the membrane properties of postsynaptic RGCs. In contrast, by expressing the C-terminal truncated A(2A)R mutant (A(2A)R-Delta C) in SACs, the wave frequency was reduced compared to the A(2A)R-WT, but was similar to the control, suggesting that the full-length A(2A)R in SACs is required for A(2A)R up-regulation of retinal waves. Conclusions/Significance: A(2A)R up-regulates the frequency of retinal waves via presynaptic SACs, requiring its full-length protein structure. Thus, by coupling with the downstream intracellular signaling, A(2A)R may have a great capacity to modulate patterned spontaneous activity during neural circuit refinement.	[Huang, Pin-Chien; Hsiao, Yu-Tien; Kao, Shao-Yen; Chen, Ching-Feng; Chen, Yu-Chieh; Chiang, Chung-Wei; Wang, Chih-Tien] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Kao, Shao-Yen; Chen, Yu-Chieh; Chiang, Chung-Wei; Wang, Chih-Tien] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Wang, Chih-Tien] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Wang, Chih-Tien] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Lu, Juu-Chin] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan; [Lee, Chien-fei; Chern, Yijuang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Chang Gung University; Academia Sinica - Taiwan	Wang, CT (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	chihtienwang@ntu.edu.tw	chern, yijuang/S-7013-2018; Chen, Yu-Chieh David/AAB-2927-2019; Wang, Chih-Tien/GRE-8232-2022; Lu, Juu-Chin/ABB-3198-2020	chern, yijuang/0000-0002-5842-5429; Chen, Yu-Chieh David/0000-0002-2597-7577; Wang, Chih-Tien/0000-0001-7639-7508; Lu, Juu-Chin/0000-0001-8523-6992; Chiang, Chung-Wei/0000-0002-9443-914X	Chang Gung Medical Research Project [CMRPD1C0591]; National Science Council [NSC-101-2320-B-182-007, NSC-102-2320-B-182-022-MY3, NSC-100-2320-B-001-0110-MY3, NSC-97-2311-B-002-007-MY3, NSC-100-2321-B-002-001, NSC-100-2311-B-002-010]; National Taiwan University; National Health Research Institutes [NHRI-EX100-9718NC]	Chang Gung Medical Research Project; National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); National Health Research Institutes(National Health Research Institutes, Japan)	Funding was provided by Chang Gung Medical Research Project (CMRPD1C0591) and National Science Council (NSC-101-2320-B-182-007; NSC-102-2320-B-182-022-MY3) to JCL; National Science Council (NSC-100-2320-B-001-0110-MY3) to YC; National Taiwan University, National Science Council (NSC-97-2311-B-002-007-MY3; NSC-100-2321-B-002-001; NSC-100-2311-B-002-010) and National Health Research Institutes (NHRI-EX100-9718NC) to CTW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman JB, 2012, NATURE, V490, P219, DOI 10.1038/nature11529; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Charles MP, 2003, BIOCHEM BIOPH RES CO, V304, P795, DOI 10.1016/S0006-291X(03)00666-1; Cheng HC, 2002, J BIOL CHEM, V277, P33930, DOI 10.1074/jbc.M201206200; Chiang CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047465; Depry C, 2010, CURR PROTOC MOL BIOL; Depry C, 2011, METHODS MOL BIOL, V756, P285, DOI 10.1007/978-1-61779-160-4_16; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dunn TA, 2008, DEV NEUROBIOL, V68, P835, DOI 10.1002/dneu.20619; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Dunn TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007877; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; Ford KJ, 2012, J NEUROSCI, V32, P850, DOI 10.1523/JNEUROSCI.5309-12.2012; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Kvanta A, 1997, EXP EYE RES, V65, P595, DOI 10.1006/exer.1996.0352; Lai HL, 1997, J BIOL CHEM, V272, P4970, DOI 10.1074/jbc.272.8.4970; Lee YC, 2003, EUR J NEUROSCI, V18, P1786, DOI 10.1046/j.1460-9568.2003.02907.x; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lu JC, 2013, MOL NEUROBIOL; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Olah ME, 2000, PHARMACOL THERAPEUT, V85, P55, DOI 10.1016/S0163-7258(99)00051-0; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ribeiro JA, 2010, ACTA PHYSIOL, V199, P161, DOI 10.1111/j.1748-1716.2010.02115.x; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Schroer U, 2007, EUR J NEUROSCI, V26, P2169, DOI 10.1111/j.1460-9568.2007.05849.x; Sebastiao Ana M, 2009, Handb Exp Pharmacol, P471, DOI 10.1007/978-3-540-89615-9_16; Sexl V, 1997, J BIOL CHEM, V272, P5792, DOI 10.1074/jbc.272.9.5792; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Soda T, 2003, J NEUROSCI, V23, P6272; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Sun CN, 2006, MOL PHARMACOL, V70, P454, DOI 10.1124/mol.105.021261; Sun CN, 2010, DEV NEUROBIOL, V70, P604, DOI 10.1002/dneu.20802; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; Torborg C, 2004, VISION RES, V44, P3347, DOI 10.1016/j.visres.2004.08.015; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; Wang CT, 2007, J NEUROSCI, V27, P9130, DOI 10.1523/JNEUROSCI.1293-07.2007; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wu YC, 2013, BBA-MOL CELL RES, V1833, P3145, DOI 10.1016/j.bbamcr.2013.08.009; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; Zhou X, 2012, METHOD ENZYMOL, V504, P317, DOI 10.1016/B978-0-12-391857-4.00016-1	54	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95090	10.1371/journal.pone.0095090	http://dx.doi.org/10.1371/journal.pone.0095090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24777042	Green Published, Green Submitted, gold			2022-12-25	WOS:000346241800007
J	Jung, YW; Jeon, YJ; Rah, H; Kim, JH; Shin, JE; Choi, DH; Cha, SH; Kim, NK				Jung, Yong Wook; Jeon, Young Joo; Rah, HyungChul; Kim, Ji Hyang; Shin, Ji Eun; Choi, Dong Hee; Cha, Sun Hee; Kim, Nam Keun			Genetic Variants in MicroRNA Machinery Genes Are Associate with Idiopathic Recurrent Pregnancy Loss Risk	PLOS ONE			English	Article							POLYMORPHISMS; EXPRESSION; CELLS; WOMEN; INSUFFICIENCY; ENDOMETRIUM; PROFILE; DICER1	Objective: Key molecules involved in microRNA (miRNA) biogenesis, such as DROSHA, XPO5, and DICER, have been identified in trophoblast cells, confirming that the miRNA biogenesis pathway is active in human placenta. In addition, miRNAs regulate uterine gene expression associated with inflammatory responses during the peri-implantation period and participate in maternal-fetal immune tolerance. The purpose of this study was to demonstrate whether genetic polymorphisms in miRNA machinery genes show an association with idiopathic recurrent pregnancy loss (RPL) in Korean women. Study design: We performed a case-control study with 238 controls and 338 women who had experienced at least two consecutive pregnancy losses between 1999 and 2010. Genotypes of miRNA machinery genes, including DICER rs3742330, DROSHA rs10719, RAN GTPase (RAN) rs14035, and exportin-5 (XPO5) rs11077 were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. The logistic odds ratios (ORs) of RPL were estimated with a 95% confidence interval (CI) in multivariate analysis after maternal age adjustment. Gene-gene interactions among the loci of the four gene polymorphisms were evaluated using the multifactor dimensionality reduction (MDR) method. Results: The RAN rs14035 CC genotype and DICER rs3742330/DROSHA rs10719 GG/TC+CC, rs3742330/RAN rs14035 GG/CC, and DICER rs3742330/XPO5 rs11077 GG/AC+CC combinations were significantly associated with increased RPL risk, whereas the RAN rs14035 CT, DICER rs3742330/RAN rs14035 AA+AG/CT+TT, DROSHA rs10719/RAN rs14035 TC+CC/CT+TT, and RAN rs14035/XPO5 rs11077 CT+TT/AA combinations reduced RPL risk. The A-T-T-C and G-C-T-A allele combinations (DICER/DROSHA/RAN/XPO5) were 20 times more frequent in the RPL group than in the control group. Conclusion: Our study demonstrates the relationship between RPL development and the polymorphism of the miRNA machinery gene RAN and combined genotype of DROSHA/DICER.	[Jung, Yong Wook] CHA Univ, Dept Obstet & Gynecol, CHA Gangnam Med Ctr, Seoul, South Korea; [Jeon, Young Joo; Rah, HyungChul; Kim, Nam Keun] CHA Univ, Inst Clin Res, CHA Bundang Med Ctr, Songnam, South Korea; [Kim, Ji Hyang; Shin, Ji Eun; Choi, Dong Hee; Cha, Sun Hee] CHA Univ, Dept Obstet & Gynecol, CHA Bundang Med Ctr, Songnam, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University	Kim, NK (corresponding author), CHA Univ, Inst Clin Res, CHA Bundang Med Ctr, Songnam, South Korea.	nkkim@cha.ac.kr		Kim, Nam Keun/0000-0003-0541-3528; jung, yong wook/0000-0003-2098-8143	National Research Foundation of Korea (NRF) - Ministry of Education, Republic of Korea [2012R1A1A2007033, 2009-0093821]	National Research Foundation of Korea (NRF) - Ministry of Education, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2012R1A1A2007033 & 2009-0093821), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1103, DOI 10.1016/j.fertnstert.2012.06.048; Barch MJ, 1997, AGT CYTOGENETICS LAB; Carp H, 2001, FERTIL STERIL, V75, P678, DOI 10.1016/S0015-0282(00)01801-X; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Choi YS, 2011, EUR J OBSTET GYN R B, V158, P225, DOI 10.1016/j.ejogrb.2011.04.028; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Dai XY, 2012, CELL PHYSIOL BIOCHEM, V29, P281, DOI 10.1159/000337609; Donker RB, 2007, MOL HUM REPROD, V13, P273, DOI 10.1093/molehr/gam006; Enquobahrie Daniel A, 2011, Am J Obstet Gynecol, V204, DOI 10.1016/j.ajog.2010.09.004; Estella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041080; Forbes K, 2012, PLACENTA, V33, P581, DOI 10.1016/j.placenta.2012.03.006; Fu GD, 2013, INT J MOL SCI, V14, P5519, DOI 10.3390/ijms14035519; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Hu Y, 2011, RNA BIOL, V8, P861, DOI 10.4161/rna.8.5.16034; Jeon YJ, 2012, GENE, V494, P168, DOI 10.1016/j.gene.2011.12.026; Kim JH, 2013, FERTIL STERIL, V99, P1674, DOI 10.1016/j.fertnstert.2013.01.108; Kim JS, 2010, MOL CARCINOGEN, V49, P913, DOI 10.1002/mc.20672; Lee SK, 2011, HUM REPROD, V26, P2964, DOI 10.1093/humrep/der301; Lee SY, 2007, BIOINFORMATICS, V23, P2589, DOI 10.1093/bioinformatics/btm396; Lei B, 2011, MOL BIOL REP, V38, P3725, DOI 10.1007/s11033-010-0487-2; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051640; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Lin MB, 2012, CLIN CANCER RES, V18, P3982, DOI 10.1158/1078-0432.CCR-11-2951; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Ma HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047544; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Miyamura H, 2011, MOL HUM REPROD, V17, P447, DOI 10.1093/molehr/gar008; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Nakada C, 2011, J PATHOL, V224, P280, DOI 10.1002/path.2860; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Qin YF, 2012, REPROD BIOMED ONLINE, V24, P454, DOI 10.1016/j.rbmo.2012.01.006; Rah H, 2013, MENOPAUSE, V20, P1067, DOI [10.1097/gme.0b013e3182883907, 10.1097/GME.0b013e3182883907]; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; STIRRAT GM, 1990, LANCET, V336, P728, DOI 10.1016/0140-6736(90)92215-4; Sung H, 2011, BREAST CANCER RES TR, V130, P939, DOI 10.1007/s10549-011-1656-2; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Zhu XM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.002	44	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e95803	10.1371/journal.pone.0095803	http://dx.doi.org/10.1371/journal.pone.0095803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769857	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736600012
J	Flugel, V; Vrabel, M; Schneider, S				Fluegel, Veronika; Vrabel, Milan; Schneider, Sabine			Structural Basis for the Site-Specific Incorporation of Lysine Derivatives into Proteins	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; POSTTRANSLATIONAL MODIFICATIONS; CONFORMATIONAL STATES; FACILE SYSTEM; AMINO-ACIDS; ACTIVE-SITE; PROPIONYLATION; IDENTIFICATION; CROTONYLATION; SUCCINYLATION	Posttranslational modifications (PTMs) of proteins determine their structure-function relationships, interaction partners, as well as their fate in the cell and are crucial for many cellular key processes. For instance chromatin structure and hence gene expression is epigenetically regulated by acetylation or methylation of lysine residues in histones, a phenomenon known as the 'histone code'. Recently it was shown that these lysine residues can furthermore be malonylated, succinylated, butyrylated, propionylated and crotonylated, resulting in significant alteration of gene expression patterns. However the functional implications of these PTMs, which only differ marginally in their chemical structure, is not yet understood. Therefore generation of proteins containing these modified amino acids site specifically is an important tool. In the last decade methods for the translational incorporation of non-natural amino acids using orthogonal aminoacyl-tRNA synthetase (aaRS):tRNAaaCUA pairs were developed. A number of studies show that aaRS can be evolved to use non-natural amino acids and expand the genetic code. Nevertheless the wild type pyrrolysyl-tRNA synthetase (PylRS) from Methanosarcina mazei readily accepts a number of lysine derivatives as substrates. This enzyme can further be engineered by mutagenesis to utilize a range of non-natural amino acids. Here we present structural data on the wild type enzyme in complex with adenylated epsilon-N-alkynyl-, epsilon-N-butyryl-, epsilon-N-crotonyl- and epsilon-N-propionyl-lysine providing insights into the plasticity of the PylRS active site. This shows that given certain key features in the non-natural amino acid to be incorporated, directed evolution of this enzyme is not necessary for substrate tolerance.	[Fluegel, Veronika; Schneider, Sabine] Tech Univ Munich, Dept Chem, Garching, Germany; [Vrabel, Milan] Univ Munich, Dept Chem, Munich, Germany	Technical University of Munich; University of Munich	Schneider, S (corresponding author), Tech Univ Munich, Dept Chem, Garching, Germany.	sabine.schneider@mytum.de	Schneider, Sabine/G-2908-2013; Vrabel, Milan/G-5269-2014	Schneider, Sabine/0000-0003-1054-8689; Vrabel, Milan/0000-0001-6633-4351	Excellence Cluster CIPSM; German Research Foundation [DFG: SFB749]; Fonds der chemischen Industrie (FCI); DFG; Technische Universitat Munchen	Excellence Cluster CIPSM; German Research Foundation(German Research Foundation (DFG)); Fonds der chemischen Industrie (FCI)(Fonds der Chemischen Industrie); DFG(German Research Foundation (DFG)); Technische Universitat Munchen	This work was supported by the Excellence Cluster CIPSM, the German Research Foundation (DFG: SFB749) and the Fonds der chemischen Industrie (FCI). This work was supported by the DFG and the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnaudo AM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-24; Baugh L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053851; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Desogus G, 2000, BIOCHEMISTRY-US, V39, P8418, DOI 10.1021/bi0006722; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Gattner MJ, 2013, CHEM COMMUN, V49, P379, DOI 10.1039/c2cc37836a; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; Kaya E, 2012, ANGEW CHEM INT EDIT, V51, P4466, DOI 10.1002/anie.201109252; Kaya E, 2009, CHEMBIOCHEM, V10, P2858, DOI 10.1002/cbic.200900625; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kim CH, 2012, ANGEW CHEM INT EDIT, V51, P7246, DOI 10.1002/anie.201203349; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li GM, 2013, CANCER RES, V73, P6379, DOI 10.1158/0008-5472.CAN-13-1870; Li WT, 2009, J MOL BIOL, V385, P1156, DOI 10.1016/j.jmb.2008.11.032; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milles S, 2012, J AM CHEM SOC, V134, P5187, DOI 10.1021/ja210587q; Montellier E, 2012, BIOESSAYS, V34, P187, DOI 10.1002/bies.201100141; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pena-Altamira LE, 2013, CURR PHARM DESIGN, V19, P5085, DOI 10.2174/13816128113199990355; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x; Quintero-Ronderos P, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/593720; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Santoro SW, 2002, NAT BIOTECHNOL, V20, P1044, DOI 10.1038/nbt742; Schneider S, 2013, CHEMBIOCHEM EUROPEAN; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Takimoto JK, 2011, ACS CHEM BIOL, V6, P733, DOI 10.1021/cb200057a; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Tropberger P, 2013, NAT STRUCT MOL BIOL, V20, P657, DOI 10.1038/nsmb.2581; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wan W, 2010, ANGEW CHEM INT EDIT, V49, P3211, DOI 10.1002/anie.201000465; Wang YS, 2012, J AM CHEM SOC, V134, P2950, DOI 10.1021/ja211972x; Wang YS, 2011, MOL BIOSYST, V7, P714, DOI 10.1039/c0mb00217h; Wang ZW, 2001, ORG LETT, V3, P565, DOI 10.1021/ol006968h; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Yanagisawa T, 2008, J MOL BIOL, V378, P634, DOI 10.1016/j.jmb.2008.02.045; Yanagisawa T, 2006, ACTA CRYSTALLOGR F, V62, P1031, DOI 10.1107/S1744309106036700; Yanagisawa T, 2013, ACTA CRYSTALLOGR D, V69, P5, DOI 10.1107/S0907444912039881; Yanagisawa T, 2008, CHEM BIOL, V15, P1187, DOI 10.1016/j.chembiol.2008.10.004; Zhang Y, 2005, PROTEIN SCI, V14, P1340, DOI 10.1110/ps.041239305; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]	52	10	10	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96198	10.1371/journal.pone.0096198	http://dx.doi.org/10.1371/journal.pone.0096198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760130	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200145
J	Zeng, WJ; van den Berg, A; Huitema, S; Gouw, ASH; Molema, G; de Jong, KP				Zeng, Wenjiao; van den Berg, Anke; Huitema, Sippie; Gouw, Annette S. H.; Molema, Grietje; de Jong, Koert P.			Correlation of MicroRNA-16, MicroRNA-21 and MicroRNA-101 Expression with Cyclooxygenase-2 Expression and Angiogenic Factors in Cirrhotic and Noncirrhotic Human Hepatocellular Carcinoma	PLOS ONE			English	Article							MESSENGER-RNA; LINKING INFLAMMATION; DOWN-REGULATION; LIVER-DISEASE; CANCER; MIR-101; PROTEIN; GENE; OVEREXPRESSION; PATHWAY	Background: Hepatocellular carcinoma (HCC) is a classical example of inflammation-linked cancer and is characterized by hypervascularity suggesting rich angiogenesis. Cycloxygenase-2 (COX-2) is a potent mediator of inflammation and is considered to upregulate angiogenesis. The aims of the study are (1) to analyze expression of Cox-2 mRNA, Cox-2 protein, miR-16, miR-21 and miR-101 in HCC and adjacent liver parenchyma in cirrhotic and noncirrhotic liver, (2) to investigate the relation between COX-2 expression, miR-21 expression and angiogenic factors in these tissues and (3) to investigate the association between miR-16 and miR-101 and COX-2 expression. Methods: Tissue samples of HCC and adjacent liver parenchyma of 21 noncirrhotic livers and 20 cirrhotic livers were analyzed for COX-2 expression at the mRNA level (qRT-PCR) and at the protein level by Western blot and immunohistochemistry. Gene expression of VEGFA, VEGFR1, VEGFR2, Ang-1, Ang-2 and Tie-2 were correlated with COX-2 levels. miR-16, miR-21 and miR-101 gene expression levels were quantified in HCC tumor tissue. Results: COX-2 mRNA and protein levels were lower in HCC as compared to adjacent liver parenchyma both in cirrhotic and noncirrhotic liver. COX-2 protein localized mainly in vascular and sinusoidal endothelial cells and in Kupffer cells. At the mRNA level but not at the protein level, COX-2 correlated with mRNA levels of angiogenic factors VEGFR1, Ang-1, and Tie2. miR-21 expression was higher in cirrhotic tissues versus noncirrhotic tissues. MiR-101 expression was lower in cirrhotic versus noncirrhotic adjacent liver parenchyma. None of the miRNAs correlelated with COX-2 expression. miR-21 correlated negatively with Tie-2 receptor in adjacent liver parenchyma. Conclusions: In human HCC, COX-2 mRNA but not COX-2 protein levels are associated with expression levels of angiogenic factors. MiR-21 levels are not associated with angiogenic molecules. MiR-16 and miR-101 levels do not correlate with COX-2 mRNA and protein levels.	[Zeng, Wenjiao; van den Berg, Anke; Huitema, Sippie; Gouw, Annette S. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Molema, Grietje] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Sect, Groningen, Netherlands; [de Jong, Koert P.] Univ Groningen, Univ Med Ctr Groningen, Dept Hepatopancreatobiliary Surg & Liver Transpla, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	de Jong, KP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hepatopancreatobiliary Surg & Liver Transpla, Groningen, Netherlands.	k.p.de.jong@umcg.nl	van den Berg, Anke/H-1718-2011	van den Berg, Anke/0000-0002-8894-2638; Molema, Grietje/0000-0002-4147-6676	Bernouilli Scholarship fund of UMCG	Bernouilli Scholarship fund of UMCG	Part of this study was supported by the Bernouilli Scholarship fund of UMCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andrieu NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050935; Bihrer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026971; Breinig M, 2008, INT J CANCER, V122, P547, DOI 10.1002/ijc.23098; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Donnem T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029671; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gibcus JH, 2009, NEOPLASIA, V11, P167, DOI 10.1593/neo.08980; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Gouw ASH, 2010, HEPATOLOGY, V52, P540, DOI 10.1002/hep.23700; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hao YB, 2011, CANCER PREV RES, V4, P1073, DOI 10.1158/1940-6207.CAPR-10-0333; He XP, 2012, FEBS J, V279, P4201, DOI 10.1111/febs.12013; Hu KQ, 2003, PROSTAG LEUKOTR ESS, V69, P329, DOI 10.1016/j.plefa.2003.07.001; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Marquez RT, 2010, LAB INVEST, V90, P1727, DOI 10.1038/labinvest.2010.126; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Morinaga S, 2002, J GASTROEN HEPATOL, V17, P1110, DOI 10.1046/j.1440-1746.2002.02836.x; Okayama H, 2012, DIGEST DIS, V30, P9, DOI 10.1159/000341882; Olivieri F, 2012, MECH AGEING DEV, V133, P675, DOI 10.1016/j.mad.2012.09.004; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Sheth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051655; Strillacci A, 2009, EXP CELL RES, V315, P1439, DOI 10.1016/j.yexcr.2008.12.010; Tait CR, 2004, J PATHOL, V204, P1, DOI 10.1002/path.1618; Wu T, 2006, CANCER TREAT REV, V32, P28, DOI 10.1016/j.ctrv.2005.10.004; Zeng W, 2008, HEPATOLOGY, V48, P1517, DOI 10.1002/hep.22490; Zeng WJ, 2010, ANN SURG ONCOL, V17, P1564, DOI 10.1245/s10434-009-0900-z; Zidar N, 2008, J CELL MOL MED	41	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95826	10.1371/journal.pone.0095826	http://dx.doi.org/10.1371/journal.pone.0095826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759835	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200094
J	Kataoka, S; Baba, A; Suda, Y; Takii, R; Hashimoto, M; Kawakubo, T; Asao, T; Kadowaki, T; Yamamoto, K				Kataoka, Shinsuke; Baba, Atsuyo; Suda, Yoshimitsu; Takii, Ryosuke; Hashimoto, Munetaka; Kawakubo, Tomoyo; Asao, Tetsuji; Kadowaki, Tomoko; Yamamoto, Kenji			A novel, potent dual inhibitor of Arg-gingipains and Lys-gingipain as a promising agent for periodontal disease therapy	FASEB JOURNAL			English	Article						infectious diseases; protease; protease inhibitor; pathogen	PORPHYROMONAS-GINGIVALIS W83; CYSTEINE PROTEINASE; STRUCTURAL-CHARACTERIZATION; CANINE PERIODONTITIS; CULTURE SUPERNATANT; ANIMAL-MODELS; RAT-LIVER; VIRULENCE; PURIFICATION; CATHEPSIN	The periodontal pathogen Porphyromonas gingivalis produces a unique class of cysteine proteinases termed gingipains that comprises Arg-gingipain (Rgp) and Lys-gingipain (Kgp). Growing evidence indicates that these 2 types of gingipains synergistically contribute to the entire virulence of the organism and increase the risk of periodontal disease (PD) by disrupting the host immune system and degrading the host tissue and plasma proteins. Therefore, a dual inhibitor of both gingipains would have attractive clinical potential for PD therapy. In this study, a novel, potent, dual inhibitor of Rgp and Kgp was developed through structure-based drug design, and its biological potency was evaluated in vitro and in vivo. This inhibitor had low nanomolar inhibitory potency (K-i = 40 nM for Rgp, K-i = 0.27 nM for Kgp) and good selectivity for host proteases and exhibited potent antibacterial activity against P. gingivalis by abrogating its manifold pathophysiological functions. The therapeutic potential of this inhibitor in vivo was also verified by suppressing the vascular permeability that was enhanced in guinea pigs by the organism and the gingival inflammation in beagle dog PD models. These findings suggest that a dual inhibitor of Rgp and Kgp would exhibit noteworthy anti-inflammatory activity in the treatment of PD.	[Kataoka, Shinsuke] Lion Corp, Life Sci Res Labs, Odawara, Kanagawa, Japan; [Baba, Atsuyo; Takii, Ryosuke; Hashimoto, Munetaka; Kadowaki, Tomoko; Yamamoto, Kenji] Kyushu Univ, Grad Sch Dent Sci, Dept Pharmacol, Fukuoka 8128582, Japan; [Kawakubo, Tomoyo; Yamamoto, Kenji] Kyushu Univ, Proteolysis Res Lab, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan; [Suda, Yoshimitsu; Asao, Tetsuji] Taiho Pharmaceut Corp, Tokushima Res Planning, Tokushima, Japan	Lion Corporation; Kyushu University; Kyushu University; Taiho Pharmaceutical	Yamamoto, K (corresponding author), Kyushu Univ, Proteolysis Res Lab, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan.	kyamamot@phar.kyushu-u.ac.jp						Abe N, 2004, BIOL CHEM, V385, P1041, DOI 10.1515/BC.2004.135; Abe N, 1998, J BIOCHEM, V123, P305; Albuquerque C, 2012, VET J, V191, P299, DOI 10.1016/j.tvjl.2011.08.017; Allaker R P, 1997, J Vet Dent, V14, P127; BANDO Y, 1986, J BIOCHEM-TOKYO, V100, P35, DOI 10.1093/oxfordjournals.jbchem.a121703; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; BERGLUNDH T, 1991, J CLIN PERIODONTOL, V18, P616, DOI 10.1111/j.1600-051X.1991.tb00099.x; Darveau RP, 2009, DNA CELL BIOL, V28, P389, DOI 10.1089/dna.2009.0864; DeCarlo AA, 1997, J DENT RES, V76, P1260, DOI 10.1177/00220345970760060501; Genco CA, 1998, TRENDS MICROBIOL, V6, P444, DOI 10.1016/S0966-842X(98)01363-8; Genco R J, 1998, INFECT IMMUN, V19, P34; Grayson R, 2003, J CLIN PERIODONTOL, V30, P542, DOI 10.1034/j.1600-051X.2003.00301.x; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hardham J, 2005, VET MICROBIOL, V106, P119, DOI 10.1016/j.vetmic.2004.12.018; Hashimoto M., 2003, J BIOCH, V140, P713; Holtfreter B, 2010, J CLIN PERIODONTOL, V37, P211, DOI 10.1111/j.1600-051X.2009.01517.x; Isogai H, 1999, J VET MED B, V46, P467, DOI 10.1046/j.1439-0450.1999.00249.x; Kadowaki T, 2004, MOL PHARMACOL, V66, P1599, DOI 10.1124/mol.104.004366; Kadowaki T, 2000, J BIOCHEM, V128, P153, DOI 10.1093/oxfordjournals.jbchem.a022735; Kadowaki T, 2003, CURR PROTEIN PEPT SC, V4, P451, DOI 10.2174/1389203033486992; Kadowaki T, 1998, J BIOL CHEM, V273, P29072, DOI 10.1074/jbc.273.44.29072; KADOWAKI T, 1994, J BIOL CHEM, V269, P21371; Kadowaki T, 2003, BIOL CHEM, V384, P911, DOI 10.1515/BC.2003.102; Kadowaki T, 2007, FRONT BIOSCI-LANDMRK, V12, P4800, DOI 10.2741/2428; Kitamura Y, 2002, J PERIODONTAL RES, V37, P464, DOI 10.1034/j.1600-0765.2002.01364.x; Klein T, 2008, CLIN TECH SMALL AN P, V15, P189; Kuo LC, 2008, PUBLIC HEALTH, V122, P417, DOI 10.1016/j.puhe.2007.07.004; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Matsushita K, 2006, J PERIODONTAL RES, V41, P148, DOI 10.1111/j.1600-0765.2005.00853.x; Mezyk-Kopec R, 2005, INFECT IMMUN, V73, P1506, DOI 10.1128/IAI.73.3.1506-1514.2005; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Nakayama K, 1998, MOL MICROBIOL, V27, P51, DOI 10.1046/j.1365-2958.1998.00656.x; Okamoto K, 1998, J BIOL CHEM, V273, P21225, DOI 10.1074/jbc.273.33.21225; Okamoto K, 1996, J BIOCHEM-TOKYO, V120, P398; OKAMOTO K, 1995, ARCH BIOCHEM BIOPHYS, V316, P917, DOI 10.1006/abbi.1995.1123; PAVLOFF N, 1995, J BIOL CHEM, V270, P1007, DOI 10.1074/jbc.270.3.1007; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Potempa J, 1997, BIOL CHEM, V378, P223, DOI 10.1515/bchm.1997.378.3-4.223; POTEMPA J, 1995, INFECT IMMUN, V63, P1176, DOI 10.1128/IAI.63.4.1176-1182.1995; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Riggio MP, 2011, VET MICROBIOL, V150, P394, DOI 10.1016/j.vetmic.2011.03.001; SHAH HN, 1989, FEMS MICROBIOL LETT, V61, P213, DOI 10.1016/0378-1097(89)90199-7; Sheets SA, 2005, INFECT IMMUN, V73, P1543, DOI 10.1128/IAI.73.3.1543-1552.2005; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Tada H, 2002, INFECT IMMUN, V70, P3304, DOI 10.1128/IAI.70.6.3304-3307.2002; TOWATARI T, 1978, J BIOCHEM-TOKYO, V84, P659, DOI 10.1093/oxfordjournals.jbchem.a132171; TOWATARI T, 1976, FEBS LETT, V67, P284, DOI 10.1016/0014-5793(76)80548-0; Weinberg MA, 1999, J CLIN PERIODONTOL, V26, P335, DOI 10.1034/j.1600-051X.1999.260601.x; Yamamoto K, 1999, MCBU, P175; Yun PLW, 2005, INFECT IMMUN, V73, P1386, DOI 10.1128/IAI.73.3.1386-1398.2005	51	18	22	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3564	3578		10.1096/fj.14-252130	http://dx.doi.org/10.1096/fj.14-252130			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24776743				2022-12-25	WOS:000340265400025
J	Brewer, PD; Habtemichael, EN; Romenskaia, I; Mastick, CC; Coster, ACF				Brewer, Paul Duffield; Habtemichael, Estifanos N.; Romenskaia, Irina; Mastick, Cynthia Corley; Coster, Adelle C. F.			Insulin-regulated Glut4 Translocation MEMBRANE PROTEIN TRAFFICKING WITH SIX DISTINCTIVE STEPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR TRAFFICKING; GLUCOSE-TRANSPORT; STORAGE-VESICLES; RATE-CONSTANT; CELL-SURFACE; PROTEIN; COMPARTMENTS; MINIMIZATION; ENDOCYTOSIS; EXOCYTOSIS	The trafficking kinetics of Glut4, the transferrin (Tf) receptor, and LRP1 were quantified in adipocytes and undifferentiated fibroblasts. Six steps were identified that determine steady state cell surface Glut4: (i) endocytosis, (ii) degradation, (iii) sorting, (iv) sequestration, (v) release, and (vi) tethering/docking/fusion. Endocytosis of Glut4 is 3 times slower than the Tf receptor in fibroblasts (k(en) = 0.2 min(-1) versus 0.6 min(-1)). Differentiation decreases Glut4 k(en) 40% (k(en) = 0.12 min(-1)). Differentiation also decreases Glut4 degradation, increasing total and cell surface Glut4 3-fold. In fibroblasts, Glut4 is recycled from endosomes through a slow constitutive pathway (k(ex) = 0.025-0.038 min(-1)), not through the fast Tf receptor pathway (k(ex) = 0.2 min(-1)). The kex measured in adipocytes after insulin stimulation is similar (k(ex) = 0.027 min(-1)). Differentiation decreases the rate constant for sorting into the Glut4 recycling pathway (k(sort)) 3-fold. In adipocytes, Glut4 is also sorted from endosomes into a second exocytic pathway through Glut4 storage vesicles (GSVs). Surprisingly, transfer from endosomes into GSVs is highly regulated; insulin increases the rate constant for sequestration (k(seq)) 8-fold. Release from sequestration in GSVs is rate-limiting for Glut4 exocytosis in basal adipocytes. AS160 regulates this step. Tethering/docking/fusion of GSVs to the plasma membrane is regulated through an AS160-independent process. Insulin increases the rate of release and fusion of GSVs (k(fuseG)) 40-fold. LRP1 cycles with the Tf receptor and Glut4 in fibroblasts but predominantly with Glut4 after differentiation. Surprisingly, AS160 knockdown accelerated LRP1 exocytosis in basal and insulin-stimulated adipocytes. These data indicate that AS160 may regulate trafficking into as well as release from GSVs.	[Brewer, Paul Duffield; Romenskaia, Irina; Mastick, Cynthia Corley] Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Habtemichael, Estifanos N.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Coster, Adelle C. F.] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia	Nevada System of Higher Education (NSHE); University of Nevada Reno; Yale University; University of New South Wales Sydney	Mastick, CC (corresponding author), Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Mailstop 330, Reno, NV 89557 USA.	cmastick@unr.edu	Coster, Adelle/AAX-4829-2020; Coster, Adelle CF/A-7234-2013; Mastick, Cynthia/G-9841-2017	Coster, Adelle/0000-0002-5572-6832; Coster, Adelle CF/0000-0002-5572-6832; Mastick, Cynthia/0000-0003-4769-5412	American Diabetes Association [7-08-RA-100, 1-12-BS-132, 1-12-BS-16]; National Institutes of Health [T32 DK007058]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007058] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research supported by grants from the American Diabetes Association (7-08-RA-100, 1-12-BS-132, and 1-12-BS-16) and from the National Institutes of Health (Grant T32 DK007058 to E. N. H.)	[Anonymous], 1908, BIOMETRIKA, V6, P1; Antonescu CN, 2009, BIOSCIENCE REP, V29, P1, DOI 10.1042/BSR20080105; Blot V, 2008, MOL BIOL CELL, V19, P3477, DOI 10.1091/mbc.E08-03-0236; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Branch MA, 1999, SIAM J SCI COMPUT, V21, P1, DOI 10.1137/S1064827595289108; Brewer PD, 2011, J BIOL CHEM, V286, P26287, DOI 10.1074/jbc.M111.253880; BYRD RH, 1988, MATH PROGRAM, V40, P247, DOI 10.1007/BF01580735; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; CLARK AE, 1991, BIOCHEM J, V278, P235, DOI 10.1042/bj2780235; Coleman TF, 2001, COMPUT OPTIM APPL, V20, P61, DOI 10.1023/A:1011271406353; CORVERA, 1994, J CELL BIOL, V126, P1625; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Dormand J.R., 1980, J COMPUT APPL MATH, V6, P19, DOI [10.1016/0771-050X(80)90013-3, DOI 10.1016/0771-050X(80)90013-3]; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Fazakerley DJ, 2010, J BIOL CHEM, V285, P1653, DOI 10.1074/jbc.M109.051185; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Foster LJ, 2001, J BIOL CHEM, V276, P44212, DOI 10.1074/jbc.M102964200; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Habtemichael EN, 2011, J BIOL CHEM, V286, P10115, DOI 10.1074/jbc.M111.217935; Hatakeyama H, 2011, TRAFFIC, V12, P1805, DOI 10.1111/j.1600-0854.2011.01279.x; HOLMAN GD, 1994, J BIOL CHEM, V269, P17516; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KARNIELI E, 1981, J BIOL CHEM, V256, P4772; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; KONO T, 1981, J BIOL CHEM, V256, P6400; Lampson MA, 2001, MOL BIOL CELL, V12, P3489, DOI 10.1091/mbc.12.11.3489; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; MORE JJ, 1983, SIAM J SCI STAT COMP, V4, P553, DOI 10.1137/0904038; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Muretta JM, 2009, VITAM HORM, V80, P245, DOI 10.1016/S0083-6729(08)00610-9; Pryor PR, 2000, BIOCHEM J, V348, P83, DOI 10.1042/0264-6021:3480083; Reed SE, 2013, J CELL SCI, V126, P1931, DOI 10.1242/jcs.104307; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; SATOH S, 1993, J BIOL CHEM, V268, P17820; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2008, J BIOL CHEM, V283, P30311, DOI 10.1074/jbc.M805182200; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Sorensen DC, 1997, SIAM J OPTIMIZ, V7, P141, DOI 10.1137/S1052623494274374; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Taguchi T, 2013, J BIOCHEM, V153, P505, DOI 10.1093/jb/mvt034; Wang Y, 2009, SCI CHINA SER C, V52, P665, DOI 10.1007/s11427-009-0081-9; WILEY HS, 1982, J BIOL CHEM, V257, P4222; YANG J, 1993, J BIOL CHEM, V268, P4600; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	49	44	47	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17280	17298		10.1074/jbc.M114.555714	http://dx.doi.org/10.1074/jbc.M114.555714			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24778187	Green Published, hybrid			2022-12-25	WOS:000338018100001
J	Ceschin, J; Saint-Marc, C; Laporte, J; Labriet, A; Philippe, C; Moenner, M; Daignan-Fornier, B; Pinson, B				Ceschin, Johanna; Saint-Marc, Christelle; Laporte, Jean; Labriet, Adrien; Philippe, Chloe; Moenner, Michel; Daignan-Fornier, Bertrand; Pinson, Benoit			Identification of Yeast and Human 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAr) Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NICOTINAMIDE RIBOSIDE; GENE-EXPRESSION; SHUTTLE VECTORS; AMP; INHIBITION; PHOSPHORYLATION; SENSITIVITY; AGONISTS; THIAMIN	5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAr) is the precursor of the active monophosphate form (AICAR), a small molecule with potent anti-proliferative and low energy mimetic properties. The molecular bases for AICAR toxicity at the cellular level are poorly understood. Here, we report the isolation and characterization of several yeast AICAr-hypersensitive mutants. Identification of the cognate genes allowed us to establish that thiamine transporters Thi7 and Thi72 can efficiently take up AICAr under conditions where they are overexpressed. We establish that, under standard growth conditions, Nrt1, the nicotinamide riboside carrier, is the major AICAr transporter in yeast. A study of AICAR accumulation in human cells revealed substantial disparities among cell lines and confirmed that AICAr enters cells via purine nucleoside transporters. Together, our results point to significant differences between yeast and human cells for both AICAr uptake and AICAR accumulation.	[Ceschin, Johanna; Saint-Marc, Christelle; Laporte, Jean; Labriet, Adrien; Philippe, Chloe; Moenner, Michel; Daignan-Fornier, Bertrand; Pinson, Benoit] Univ Bordeaux, IBGC, UMR 5095 1, F-33077 Bordeaux, France; [Ceschin, Johanna; Saint-Marc, Christelle; Laporte, Jean; Labriet, Adrien; Philippe, Chloe; Moenner, Michel; Daignan-Fornier, Bertrand; Pinson, Benoit] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095 1, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Pinson, B (corresponding author), CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, 1 Rue C St Saens CS 61390, F-33077 Bordeaux, France.	benoit.pinson@ibgc.cnrs.fr		ceschin, johanna/0000-0001-7771-531X; Pinson, Benoit/0000-0003-2936-9058	Association de la Recherche contre le Cancer [SFI-2012-120-5915]; Ligue contre le Cancer du Perigord	Association de la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le Cancer du Perigord	This work was supported by Association de la Recherche contre le Cancer Grant SFI-2012-120-5915 (to B. D.-F.) and a grant from Ligue contre le Cancer du Perigord (to M. M.).	Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Huang ZW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003083; Hurlimann HC, 2011, J BIOL CHEM, V286, P30994, DOI 10.1074/jbc.M111.262659; IWASHIMA A, 1992, FEBS LETT, V311, P60, DOI 10.1016/0014-5793(92)81367-U; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Laporte D, 2011, J CELL BIOL, V192, P949, DOI 10.1083/jcb.201009028; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Lopez JM, 2003, BIOCHEM J, V370, P1027, DOI 10.1042/BJ20021053; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; Mojzita D, 2006, MOL GENET GENOMICS, V276, P147, DOI 10.1007/s00438-006-0130-z; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Nakamaru K, 2005, BIOCHEM BIOPH RES CO, V328, P449, DOI 10.1016/j.bbrc.2005.01.004; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Oishi K, 2002, HUM MOL GENET, V11, P2951, DOI 10.1093/hmg/11.23.2951; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Reidling JC, 2010, GASTROENTEROLOGY, V138, P1802, DOI 10.1053/j.gastro.2009.10.042; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Saint-Marc C, 2009, GENETICS, V183, P529, DOI 10.1534/genetics.109.105858; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Singleton CK, 1997, GENE, V199, P111, DOI 10.1016/S0378-1119(97)00354-5; SULLIVAN JE, 1994, BIOCHEM BIOPH RES CO, V200, P1551, DOI 10.1006/bbrc.1994.1627; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Thomas D, 2000, J BIOL CHEM, V275, P40718, DOI 10.1074/jbc.M005967200; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Wang CM, 2013, BIOCHEM PHARMACOL, V86, P1531, DOI 10.1016/j.bcp.2013.08.063; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007	37	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16844	16854		10.1074/jbc.M114.551192	http://dx.doi.org/10.1074/jbc.M114.551192			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24778186	Green Published, hybrid			2022-12-25	WOS:000338016200022
J	de Araujo, CB; Russo, LC; Castro, LM; Forti, FL; do Monte, ER; Rioli, V; Gozzo, FC; Colquhoun, A; Ferro, ES				de Araujo, Christiane B.; Russo, Lilian C.; Castro, Leandro M.; Forti, Fabio L.; do Monte, Elisabete R.; Rioli, Vanessa; Gozzo, Fabio C.; Colquhoun, Alison; Ferro, Emer S.			A Novel Intracellular Peptide Derived from G(1)/S Cyclin D2 Induces Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; CB1 CANNABINOID RECEPTORS; NF-KAPPA-B; THIMET OLIGOPEPTIDASE; PROTEASOME INHIBITORS; ANTIGEN PRESENTATION; NATURAL REGULATORS; MASS-SPECTROMETRY; PROTEIN-KINASE; WILD-TYPE	Intracellular peptides are constantly produced by the ubiquitin-proteasome system, and many are probably functional. Here, the peptide WELVVLGKL (pep5) from G(1)/S-specific cyclin D2 showed a 2-fold increase during the S phase of HeLa cell cycle. pep5 (25-100 mu M) induced cell death in several tumor cells only when it was fused to a cell-penetrating peptide (pep5-cpp), suggesting its intracellular function. In vivo, pep5-cpp reduced the volume of the rat C6 glioblastoma by almost 50%. The tryptophan at the N terminus of pep5 is essential for its cell death activity, and N terminus acetylation reduced the potency of pep5-cpp. WELVVL is the minimal active sequence of pep5, whereas Leu-Ala substitutions totally abolished pep5 cell death activity. Findings from the initial characterization of the cell death/signaling mechanism of pep5 include caspase 3/7 and 9 activation, inhibition of Akt2 phosphorylation, activation of p38 alpha and -gamma, and inhibition of proteasome activity. Further pharmacological analyses suggest that pep5 can trigger cell death by distinctive pathways, which can be blocked by IM-54 or a combination of necrostatin-1 and q-VD-OPh. These data further support the biological and pharmacological potential of intracellular peptides.	[de Araujo, Christiane B.; Castro, Leandro M.; do Monte, Elisabete R.; Ferro, Emer S.] Univ Sao Paulo, Inst Biomed Sci, Support Ctr Res Proteolysis & Cell Signaling NAPP, Dept Pharmacol, BR-05508000 Sao Paulo, Brazil; [Colquhoun, Alison] Univ Sao Paulo, Inst Biomed Sci, Support Ctr Res Proteolysis & Cell Signaling NAPP, Dept Cell Biol & Dev, BR-05508000 Sao Paulo, Brazil; [Russo, Lilian C.; Forti, Fabio L.] Univ Sao Paulo, Inst Chem, Support Ctr Res Proteolysis & Cell Signaling NAPP, Dept Biochem, BR-05508000 Sao Paulo, Brazil; [Rioli, Vanessa] Butantan Inst, Ctr Toxins Immune Response & Cell Signaling CETIC, Special Lab Appl Toxinol LETA, BR-05503000 Sao Paulo, Brazil; [Gozzo, Fabio C.] Univ Estadual Campinas, Inst Chem, BR-13083862 Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Universidade Estadual de Campinas	Ferro, ES (corresponding author), Univ Sao Paulo, Dept Pharmacol, Av Prof Lineu Prestes 1524,S315, BR-05508000 Sao Paulo, Brazil.	eferro@usp.br	Ferro, Emer S/D-3908-2012; Colquhoun, Alison/C-4031-2012; Rioli, Vanessa/A-7913-2013; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; FORTI, FABIO LUIS/F-8085-2012; Russo, Lilian Cristina/O-7838-2014; Castro, Leandro/O-6762-2019; Castro, Leandro/ABI-5520-2020; Rodrigues do Monte Silva, Elisabete/M-7528-2017	Ferro, Emer S/0000-0003-1651-9192; Colquhoun, Alison/0000-0002-0691-2364; FORTI, FABIO LUIS/0000-0002-2278-6396; Russo, Lilian Cristina/0000-0002-9846-1352; Castro, Leandro/0000-0002-7156-2006; Castro, Leandro/0000-0002-7156-2006; Rodrigues do Monte Silva, Elisabete/0000-0001-8480-9154; Araujo, Christiane/0000-0002-6801-4367; Rioli, Vanessa/0000-0003-3285-306X	Brazilian National Research Council (CNPq) [559698/2009-7]; Pro-Reitoria de Pesquisa, University of Sao Paulo, through the Support Center for Research in Proteolysis and Cell Signaling (NAPPS) [2012.1.17607.1.2]; CAPES; CNPq	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa, University of Sao Paulo, through the Support Center for Research in Proteolysis and Cell Signaling (NAPPS); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian National Research Council (CNPq) Grant 559698/2009-7 (Rede GENOPROT) and by the Pro-Reitoria de Pesquisa, University of Sao Paulo, through the Support Center for Research in Proteolysis and Cell Signaling (NAPPS; Grant 2012.1.17607.1.2).; Recipient of research fellowship from CAPES.; Recipient of research fellowship from CNPq. To whom correspondence should be addressed: Dept. of Pharmacology, University of Sao Paulo. Av. Prof. Lineu Prestes 1524, S315, Cid. Universitaria, SP, 05508-000, Brazil. Tel.: 55-11-3091-7493; Fax: 55-11-3091-7322; E-mail: eferro@usp.br.	Adams J, 1999, CANCER RES, V59, P2615; Arboleda MJ, 2003, CANCER RES, V63, P196; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Berti DA, 2012, PROTEOMICS, V12, P2668, DOI 10.1002/pmic.201200051; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Castro LM, 2010, AAPS J, V12, P608, DOI 10.1208/s12248-010-9224-y; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Che FY, 2005, J MASS SPECTROM, V40, P227, DOI 10.1002/jms.742; Chen BB, 2012, BLOOD, V119, P3132, DOI 10.1182/blood-2011-06-358911; Chun K T, 1996, Prog Cell Cycle Res, V2, P115; Churchill EN, 2009, TRENDS ENDOCRIN MET, V20, P25, DOI 10.1016/j.tem.2008.10.002; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dodd GT, 2010, J NEUROSCI, V30, P7369, DOI 10.1523/JNEUROSCI.5455-09.2010; Dodo K, 2005, BIOORG MED CHEM LETT, V15, P3114, DOI 10.1016/j.bmcl.2005.04.016; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; Ferguson Sherise, 2007, Current Drug Delivery, V4, P169, DOI 10.2174/156720107780362302; Ferro E. S., 2014, EUPA OPEN PROTEOMICS, V3, P143, DOI [10.1016/j.euprot.2014.02.009, DOI 10.1016/J.EUPROT.2014.02.009]; Ferro ES, 2004, J NEUROCHEM, V91, P769, DOI 10.1111/j.1471-4159.2004.02757.x; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; GALLO CJ, 1986, BIOCHEM J, V238, P37, DOI 10.1042/bj2380037; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Gelman JS, 2013, BBA-PROTEINS PROTEOM, V1834, P2408, DOI 10.1016/j.bbapap.2013.01.043; Gelman JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053263; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Gomes I, 2009, FASEB J, V23, P3020, DOI 10.1096/fj.09-132142; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; ImajohOhmi S, 1995, BIOCHEM BIOPH RES CO, V217, P1070, DOI 10.1006/bbrc.1995.2878; Jiang H, 2006, EXPERT REV ANTICANC, V6, P1585, DOI 10.1586/14737140.6.11.1585; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim Lyndon, 2006, Curr Treat Options Oncol, V7, P467, DOI 10.1007/s11864-006-0022-9; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Lee MW, 2011, CANCER SCI, V102, P1822, DOI 10.1111/j.1349-7006.2011.02025.x; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Murray RZ, 2000, ANTI-CANCER DRUG, V11, P407, DOI 10.1097/00001813-200007000-00001; Nakayama K, 1998, BIOESSAYS, V20, P1020, DOI 10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.0.CO;2-D; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rammensee HG, 2002, NATURE, V419, P443, DOI 10.1038/419443a; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Russo LC, 2012, FEBS LETT, V586, P3287, DOI 10.1016/j.febslet.2012.07.002; Russo LC, 2012, PROTEOMICS, V12, P2641, DOI 10.1002/pmic.201200032; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Shen YH, 2013, CIRC RES, V112, P618, DOI 10.1161/CIRCRESAHA.112.300735; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sodeoka M, 2010, CHEM REC, V10, P308, DOI 10.1002/tcr.201000031; Spataro V, 1998, BRIT J CANCER, V77, P448, DOI 10.1038/bjc.1998.71; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Wang GF, 2010, J AM CHEM SOC, V132, P16417, DOI 10.1021/ja106506k; Wang X, 2003, J BIOL CHEM, V278, P29184, DOI 10.1074/jbc.M301624200; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Wardman J, 2011, METHODS MOL BIOL, V768, P307, DOI 10.1007/978-1-61779-204-5_17; Wen PY, 2006, EXPERT REV ANTICANC, V6, P733, DOI 10.1586/14737140.6.5.733; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang RJ, 2002, ANAL CHEM, V74, P3662, DOI 10.1021/ac025614w; Zhou JY, 2009, BMB REP, V42, P593, DOI 10.5483/BMBRep.2009.42.9.593; Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604	84	34	36	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16711	16726		10.1074/jbc.M113.537118	http://dx.doi.org/10.1074/jbc.M113.537118			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24764300	Green Published, hybrid			2022-12-25	WOS:000338016200011
J	Lee, CC; Freinkman, E; Sabatini, DM; Ploegh, HL				Lee, Clarissa C.; Freinkman, Elizaveta; Sabatini, David M.; Ploegh, Hidde L.			The Protein Synthesis Inhibitor Blasticidin S Enters Mammalian Cells via Leucine-rich Repeat-containing Protein 8D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN; APOPTOSIS; RELEASE	Leucine-rich repeat-containing 8 (LRRC8) proteins have been identified as putative receptors involved in lymphocyte development and adipocyte differentiation. They remain poorly characterized, and no specific function has been assigned to them. There is no consensus on how this family of proteins might function because homology searches suggest that members of the LRRC8 family act not as plasma membrane receptors, but rather as channels that mediate cell-cell signaling. Here we provide experimental evidence that supports a role for LRRC8s in the transport of small molecules. We show that LRRC8D is a mammalian protein required for the import of the antibiotic blasticidin S. We characterize localization and topology of LRRC8A and LRRC8D and demonstrate that LRRC8D interacts with LRRC8A, LRRC8B, and LRRC8C. Given the suggested involvement in solute transport, our results support a model in which LRRC8s form one or more complexes that may mediate cell-cell communication by transporting small solutes.	[Lee, Clarissa C.; Freinkman, Elizaveta; Sabatini, David M.; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lee, Clarissa C.; Sabatini, David M.; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] Broad Inst, Cambridge, MA 02142 USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu		/0000-0002-1446-7256	NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA014051] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; CHASIS JA, 1992, BLOOD, V80, P1869; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; Hayashi T, 2011, BIOL PHARM BULL, V34, P1257, DOI 10.1248/bpb.34.1257; Klemm EJ, 2011, J BIOL CHEM, V286, P37602, DOI 10.1074/jbc.M111.284794; Lee CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070339; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; REDMAN CM, 1995, TRANSFUS CLIN BIOL, V2, P243, DOI 10.1016/S1246-7820(05)80090-4; Reiling JH, 2011, P NATL ACAD SCI USA, V108, P11756, DOI 10.1073/pnas.1018098108; Sawada A, 2003, J CLIN INVEST, V112, P1707, DOI 10.1172/JCI18937; Smits G, 2004, MOL IMMUNOL, V41, P561, DOI 10.1016/j.molimm.2004.04.001; Spandl J, 2011, J BIOL CHEM, V286, P5599, DOI 10.1074/jbc.M110.190785; Tominaga K, 2004, J BIOL CHEM, V279, P34840, DOI 10.1074/jbc.M312927200; Voss F. K., 2014, SCIENCE IN PRESS	19	56	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17124	17131		10.1074/jbc.M114.571257	http://dx.doi.org/10.1074/jbc.M114.571257			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24782309	Green Published, hybrid			2022-12-25	WOS:000338016200045
J	Carvalho, MR; Wilf, P; Barrios, H; Windsor, DM; Currano, ED; Labandeira, CC; Jaramillo, CA				Carvalho, Monica R.; Wilf, Peter; Barrios, Hector; Windsor, Donald M.; Currano, Ellen D.; Labandeira, Conrad C.; Jaramillo, Carlos A.			Insect Leaf-Chewing Damage Tracks Herbivore Richness in Modern and Ancient Forests	PLOS ONE			English	Article							CRETACEOUS-TERTIARY BOUNDARY; LAGUNA DEL HUNCO; CLIMATE-CHANGE; MIDDLE EOCENE; FOSSIL RECORD; PLANT; PATAGONIA; ASSOCIATIONS; EVOLUTION; ABUNDANCE	The fossil record demonstrates that past climate changes and extinctions significantly affected the diversity of insect leaf-feeding damage, implying that the richness of damage types reflects that of the unsampled damage makers, and that the two are correlated through time. However, this relationship has not been quantified for living leaf-chewing insects, whose richness and mouthpart convergence have obscured their value for understanding past and present herbivore diversity. We hypothesized that the correlation of leaf-chewing damage types (DTs) and damage maker richness is directly observable in living forests. Using canopy access cranes at two lowland tropical rainforest sites in Panama to survey 24 host-plant species, we found significant correlations between the numbers of leaf chewing insect species collected and the numbers of DTs observed to be made by the same species in feeding experiments, strongly supporting our hypothesis. Damage type richness was largely driven by insect species that make multiple DTs. Also, the rank-order abundances of DTs recorded at the Panama sites and across a set of latest Cretaceous to middle Eocene fossil floras were highly correlated, indicating remarkable consistency of feeding-mode distributions through time. Most fossil and modern host-plant pairs displayed high similarity indices for their leaf-chewing DTs, but informative differences and trends in fossil damage composition became apparent when endophytic damage was included. Our results greatly expand the potential of insect-mediated leaf damage for interpreting insect herbivore richness and compositional heterogeneity from fossil floras and, equally promisingly, in living forests.	[Carvalho, Monica R.; Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Carvalho, Monica R.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Barrios, Hector] Univ Panama, Programa Maestri Entomol, Panama City, Panama; [Windsor, Donald M.; Jaramillo, Carlos A.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Currano, Ellen D.] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA; [Labandeira, Conrad C.] Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA; [Labandeira, Conrad C.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Labandeira, Conrad C.] Univ Maryland, BEES Program, College Pk, MD 20742 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University; Universidad de Panama; Smithsonian Institution; Smithsonian Tropical Research Institute; University System of Ohio; Miami University; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Carvalho, MR (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	mjr383@cornell.edu		jaramillo, carlos/0000-0002-2616-5079; Carvalho, Monica/0000-0003-4148-7110	David and Lucile Packard Fellowship; NSF [DEB-0919071]; Division Of Environmental Biology [0919071] Funding Source: National Science Foundation	David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by a David and Lucile Packard Fellowship, with additional support from NSF DEB-0919071 (PW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2010, REV PALAEOBOT PALYNO, V162, P63, DOI 10.1016/j.revpalbo.2010.05.004; Adams JM, 2009, J ECOL, V97, P933, DOI 10.1111/j.1365-2745.2009.01523.x; Bachelot B, 2013, J ECOL, V101, P846, DOI 10.1111/1365-2745.12094; Bairstow KA, 2010, OECOLOGIA, V163, P437, DOI 10.1007/s00442-010-1606-4; Behmer S. T., 2012, INSECT OUTBREAKS REV, P3; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Bluthgen N, 2006, J TROP ECOL, V22, P35, DOI 10.1017/S0266467405002749; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Clissold FJ, 2007, ADV INSECT PHYSIOL, V34, P317, DOI 10.1016/S0065-2806(07)34006-X; Crespi BJ, 1997, ANNU REV ENTOMOL, V42, P51, DOI 10.1146/annurev.ento.42.1.51; Currano ED, 2008, P NATL ACAD SCI USA, V105, P1960, DOI 10.1073/pnas.0708646105; Currano ED, 2010, ECOL MONOGR, V80, P547, DOI 10.1890/09-2138.1; Currano ED, 2009, PALEOBIOLOGY, V35, P484, DOI 10.1666/0094-8373-35.4.484; Hochuli DF, 2001, AUSTRAL ECOL, V26, P563, DOI 10.1046/j.1442-9993.2001.01135.x; JOHNSON KR, 1989, NATURE, V340, P708, DOI 10.1038/340708a0; Johnson KR, 2002, GEOL S AM S, P329; Labandeira C. C, 2007, GUIDE INSECT OTHER D; Labandeira CC, 1997, ANNU REV ECOL SYST, V28, P153, DOI 10.1146/annurev.ecolsys.28.1.153; Labandeira CC, 2002, GEOL S AM S, P297; Labandeira CC, 2002, P NATL ACAD SCI USA, V99, P2061, DOI 10.1073/pnas.042492999; Labandeira CC, 2014, NEW PHYTOL, V202, P247, DOI 10.1111/nph.12643; Labandeira Conrad C., 2012, P269; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Petrulevicius JF, 2013, ZOOTAXA, V3616, P597, DOI 10.11646/zootaxa.3616.6.6; Petrulevicius JF, 2010, ANN SOC ENTOMOL FR, V46, P271, DOI 10.1080/00379271.2010.10697668; R Development Core Team, 2012, R LANG ENV STAT COMP; Sarzetti LC, 2008, PALAEONTOLOGY, V51, P933, DOI 10.1111/j.1475-4983.2008.00787.x; Smith DM, 2008, GEOL S AM S, V435, P89; Smith DM, 2004, BIOTROPICA, V36, P318, DOI 10.1111/j.1744-7429.2004.tb00323.x; Wappler T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040744; Wappler T, 2010, PALAEOGEOGR PALAEOCL, V292, P540, DOI 10.1016/j.palaeo.2010.04.029; Wappler T, 2009, P ROY SOC B-BIOL SCI, V276, P4271, DOI 10.1098/rspb.2009.1255; Wilf P, 2008, NEW PHYTOL, V178, P486, DOI 10.1111/j.1469-8137.2008.02395.x; Wilf P, 2000, SCIENCE, V289, P291, DOI 10.1126/science.289.5477.291; Wilf P, 2005, P NATL ACAD SCI USA, V102, P8944, DOI 10.1073/pnas.0500516102; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; Wilf P, 2006, SCIENCE, V313, P1112, DOI 10.1126/science.1129569; Wilf P, 2009, AM J BOT, V96, P2031, DOI 10.3732/ajb.0900085; Wing SL, 2009, P NATL ACAD SCI USA, V106, P18627, DOI 10.1073/pnas.0905130106; Winkler IS, 2010, J PALEONTOL, V84, P935, DOI 10.1666/09-163.1; Wright S., 2003, STUDYING FOREST CANO, P137	42	63	64	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94950	10.1371/journal.pone.0094950	http://dx.doi.org/10.1371/journal.pone.0094950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788720	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700021
J	Chen, AL; Liu, CY; Chen, CH; Wang, JF; Liao, YC; Chang, CH; Tsai, MH; Hwu, KK; Chen, KY				Chen, Ai-Lin; Liu, Chu-Yin; Chen, Chien-Hua; Wang, Jaw-Fen; Liao, Yu-Chen; Chang, Chia-Hui; Tsai, Mong-Hsun; Hwu, Kae-Kang; Chen, Kai-Yi			Reassessment of QTLs for Late Blight Resistance in the Tomato Accession L3708 Using a Restriction Site Associated DNA (RAD) Linkage Map and Highly Aggressive Isolates of Phytophthora infestans	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DENSITY GENETIC-MAP; LYCOPERSICON PIMPINELLIFOLIUM; SOLANUM-PIMPINELLIFOLIUM; SNP DISCOVERY; UNITED-STATES; PH-3 GENE; CONSTRUCTION; MARKERS; GENOME	Tomato late blight caused by the oomycete pathogen Phytophthora infestans (Mont.) de Bary is a major threat to tomato production in cool and wet environments. Intensified outbreaks of late blight have been observed globally from the 1980s, and are associated with migration of new and more aggressive populations of P. infestans in the field. The objective of this study was to reassess late blight resistance in the wild tomato accession L3708 (Solanum pimpinellifolium L.) against pathogens of different aggressiveness. An F-2:3 genetic mapping population was developed using L3708 as the paternal parent. Two isolates of P. infestans, Pi39A and Pi733, were used for inoculation. Pi733 is a highly aggressive genotype that defeats three known late blight resistance genes, Ph-1, Ph-2, and Ph-5t in tomato. In contrast, Pi39A is a less aggressive genotype that defeats only Ph-1. Restriction site Associated DNA Sequencing (RAD-Seq) technology was used to massively sequence 90 bp nucleotides adjacent to both sides of PstI restriction enzyme cutting sites in the genome for all individuals in the genetic mapping population. The RAD-seq data were used to construct a genetic linkage map containing 440 single nucleotide polymorphism markers. Quantitative trait locus (QTL) analysis identified a new disease-resistant QTL specific to Pi733 on chromosome 2. The Ph-3 gene located on chromosome 9 could be detected whichever isolates were used. This study demonstrated the feasibility and efficiency of RAD-Seq technology for conducting a QTL mapping experiment using an F-2:3 mapping population, which allowed the identification of a new late blight resistant QTL in tomato.	[Chen, Ai-Lin; Liu, Chu-Yin; Hwu, Kae-Kang; Chen, Kai-Yi] Natl Taiwan Univ, Dept Agron, Taipei, Taiwan; [Chen, Chien-Hua; Wang, Jaw-Fen] AVRDC, World Vegetable Ctr, Tainan, Taiwan; [Liao, Yu-Chen; Chang, Chia-Hui] Known You Seed Co LTD, Kaohsiung, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chen, KY (corresponding author), Natl Taiwan Univ, Dept Agron, Taipei, Taiwan.	kaiychen@ntu.edu.tw		CHEN, KAI-YI/0000-0002-6211-0198; TSAI, MONG-HSUN/0000-0001-8777-5818	Council of Agriculture, Executive Yuan, Taiwan R.O.C. [99AS-5.3.1-ST-a8, 100AS-5.3.1-ST-a9, 101AS-6.1.1-ST-a4]; National Taiwan University [99R70444, 102R350145]	Council of Agriculture, Executive Yuan, Taiwan R.O.C.; National Taiwan University(National Taiwan University)	This work was supported by grants from the Council of Agriculture, Executive Yuan, Taiwan R.O.C. (Grant No. 99AS-5.3.1-ST-a8, 100AS-5.3.1-ST-a9, and 101AS-6.1.1-ST-a4) to KKH and KYC; and grants from the National Taiwan University (Grant No. 99R70444 and 102R350145) to KYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVRDC, 2005, 2005 PROGR REP, P49; AVRDC, 2002, 2002 PROGR REP, P12; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Black L. L., 1996, Phytopathology, V86, pS24; Brouwer DJ, 2004, THEOR APPL GENET, V108, P628, DOI 10.1007/s00122-003-1469-8; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Causse M, 2001, THEOR APPL GENET, V102, P273, DOI 10.1007/s001220051644; Chen CH, 2008, PLANT DIS, V92, P751, DOI 10.1094/PDIS-92-5-0751; Chunwongse J, 2002, J HORTIC SCI BIOTECH, V77, P281, DOI 10.1080/14620316.2002.11511493; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; Foolad MR, 1998, MOL BREEDING, V4, P519, DOI 10.1023/A:1009648112491; Frary A, 2005, THEOR APPL GENET, V111, P291, DOI 10.1007/s00122-005-2023-7; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Gavino PD, 2000, PLANT DIS, V84, P731, DOI 10.1094/PDIS.2000.84.7.731; Goodwin SB, 1998, PHYTOPATHOLOGY, V88, P939, DOI 10.1094/PHYTO.1998.88.9.939; Grandillo S, 1996, THEOR APPL GENET, V92, P935, DOI 10.1007/BF00224033; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Haldane JBS, 1919, J GENET, V8, P299; Kim MJ, 2006, J AM SOC HORTIC SCI, V131, P637, DOI 10.21273/JASHS.131.5.637; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Li JM, 2011, EUPHYTICA, V179, P427, DOI 10.1007/s10681-010-0340-7; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; Merk HL, 2012, EUPHYTICA, V187, P63, DOI 10.1007/s10681-012-0729-6; Moreau P, 1998, MOL PLANT MICROBE IN, V11, P259, DOI 10.1094/MPMI.1998.11.4.259; Mueller LA, 2005, PLANT PHYSIOL, V138, P1310, DOI 10.1104/pp.105.060707; Nowicki M, 2012, PLANT DIS, V96, P4, DOI 10.1094/PDIS-05-11-0458; Peirce L. C., 1971, REP TOMATO GENET COO, V21, P30; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shirasawa K, 2010, THEOR APPL GENET, V121, P731, DOI 10.1007/s00122-010-1344-3; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Smart CD, 2007, PLANT DIS, V91, P1045, DOI 10.1094/PDIS-91-8-1045; TANKSLEY SD, 1992, GENETICS, V132, P1141; Thoquet P, 1996, MOL PLANT MICROBE IN, V9, P826, DOI 10.1094/MPMI-9-0826; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; van der Knaap E, 2003, THEOR APPL GENET, V107, P139, DOI 10.1007/s00122-003-1224-1; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Villalta I, 2005, THEOR APPL GENET, V110, P881, DOI 10.1007/s00122-004-1906-3; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Zhang CZ, 2013, THEOR APPL GENET, V126, P2643, DOI 10.1007/s00122-013-2162-1; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141	50	24	24	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96417	10.1371/journal.pone.0096417	http://dx.doi.org/10.1371/journal.pone.0096417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788810	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700089
J	Yang, XD; Yang, YP; Wang, YY; Zhan, B; Gu, Y; Cheng, YL; Zhu, XP				Yang, Xiaodi; Yang, Yaping; Wang, Yunyun; Zhan, Bin; Gu, Yuan; Cheng, Yuli; Zhu, Xinping			Excretory/Secretory Products from Trichinella spiralis Adult Worms Ameliorate DSS-Induced Colitis in Mice	PLOS ONE			English	Article							DEXTRAN SULFATE SODIUM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INFLAMMATORY-BOWEL-DISEASE; DENDRITIC CELLS; T-CELLS; INFECTION; MODULATION; PROTEINS; MECHANISMS; HELMINTHS	Background: Many evidences show the inverse correlation between helminth infection and allergic or autoimmune diseases. Identification and characterization of the active helminth-derived products responsible for the beneficial effects on allergic or inflammatory diseases will provide another feasible approach to treat these diseases. Methods and Findings: Colitis was induced in C57BL/6 mice by giving 3% DSS orally for 7 days. During this period, the mice were treated daily with the excretory/secretory products from T. spiralis adult worms (AES) intraperitoneally. The severity of colitis was monitored by measuring body weight, stool consistency or bleeding, colon length and inflammation. To determine the T. spiralis AES product-induced immunological response, Th1, Th2, Th17 and regulatory cytokine profiles were measured in lymphocytes isolated from colon, mesenteric lymph nodes (MLN), and the spleen of treated mice. The CD4(+) CD25(+) FOXP3(+) regulatory T cells (Tregs) were also measured in the spleens and MLN of treated mice. Mice treated with AES significantly ameliorated the severity of the DSS-induced colitis indicated by the reduced disease manifestations, improved macroscopic and microscopic inflammation correlated with the up-regulation of Treg response (increased regulatory cytokines IL-10, TGF-beta and regulatory T cells) and down-regulation of pro-inflammatory cytokines (IFNgamma, IL-6 and IL-17) in the spleens, MLN and colon of treated mice. Conclusions: Our results provide direct evidences that T. spiralis AES have a therapeutic potential for alleviating inflammatory colitis in mice. This effect is possibly mediated by the immunomodulation of regulatory T cells to produce regulatory and anti-inflammatory cytokines and inhibit pro-inflammatory cytokines.	[Yang, Xiaodi; Yang, Yaping; Wang, Yunyun; Gu, Yuan; Cheng, Yuli; Zhu, Xinping] Capital Med Univ, Sch Basic Med Sci, Dept Parasitol, Beijing, Peoples R China; [Yang, Xiaodi] Bengbu Med Coll, Dept Microbiol & Parasitol, Anhui Key Lab Infect & Immun, Bengbu, Anhui, Peoples R China; [Zhan, Bin] Baylor Coll Med, Dept Pediat, Sect Trop Med, Houston, TX 77030 USA	Capital Medical University; Bengbu Medical College; Baylor College of Medicine	Zhu, XP (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Parasitol, Beijing, Peoples R China.	zhuxping@ccmu.edu.cn		Wolf, Nathaniel/0000-0001-6567-2447	National Natural Science Foundation of China [81171598, 81371837]; National Science and Technology Major Project [2012ZX10004220-012]; PhD Programs Foundation of the Municipal Education Commission of Beijing [20111002503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; PhD Programs Foundation of the Municipal Education Commission of Beijing	This work was supported by grants from the National Natural Science Foundation of China (81171598, 81371837), the National Science and Technology Major Project (2012ZX10004220-012), and the PhD Programs Foundation of the Municipal Education Commission of Beijing 20111002503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Aranzamendi C, 2013, CLIN EXP ALLERGY, V43, P103, DOI 10.1111/cea.12042; Axelsson LG, 1998, ALIMENT PHARM THER, V12, P925, DOI 10.1046/j.1365-2036.1998.00357.x; Bager P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022346; Bai X, 2012, MOL CELL BIOCHEM, V360, P79, DOI 10.1007/s11010-011-1046-4; Balic A, 2004, EUR J IMMUNOL, V34, P3047, DOI 10.1002/eji.200425167; Bene L, 2011, PATHOL ONCOL RES, V17, P463, DOI 10.1007/s12253-011-9397-4; Bodammer P, 2011, DIGEST DIS SCI, V56, P70, DOI 10.1007/s10620-010-1237-y; Broadhurst MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001500; Bruschi F, 2000, INT ARCH ALLERGY IMM, V122, P58, DOI 10.1159/000024359; Bruschi F, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-42; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Chen XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049913; Cho MK, 2012, KOREAN J PARASITOL, V50, P385, DOI 10.3347/kjp.2012.50.4.385; Croese J, 2006, GUT, V55, P136, DOI 10.1136/gut.2005.079129; Del Prete G, 2008, J ALLERGY CLIN IMMUN, V122, P908, DOI 10.1016/j.jaci.2008.08.016; Du LL, 2011, DIGEST DIS SCI, V56, P2810, DOI 10.1007/s10620-011-1689-8; Elliott DE, 2008, J IMMUNOL, V181, P2414, DOI 10.4049/jimmunol.181.4.2414; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Elliott DE, 2009, ADV EXP MED BIOL, V666, P157; Elliott DE, 2003, AM J PHYSIOL-GASTR L, V284, pG385, DOI 10.1152/ajpgi.00049.2002; Elliott DE, 2000, FASEB J, V14, P1848, DOI 10.1096/fj.99-0885hyp; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Erb KJ, 2009, TRENDS IMMUNOL, V30, P75, DOI 10.1016/j.it.2008.11.005; Fabre MV, 2009, VET PARASITOL, V159, P245, DOI 10.1016/j.vetpar.2008.10.051; Flohr C, 2009, CLIN EXP ALLERGY, V39, P20, DOI 10.1111/j.1365-2222.2008.03134.x; Geiger Stefan Michael, 2011, J Parasitol Res, V2011, P512154, DOI 10.1155/2011/512154; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Gruden-Movsesijan A, 2008, EXP PARASITOL, V118, P641, DOI 10.1016/j.exppara.2007.12.003; Gruden-Movsesijan A, 2011, COMP IMMUNOL MICROB, V34, P429, DOI 10.1016/j.cimid.2011.08.004; Gruden-Movsesijan A, 2010, PARASITE IMMUNOL, V32, P450, DOI 10.1111/j.1365-3024.2010.01207.x; Ilic N, 2008, PARASITE IMMUNOL, V30, P491, DOI 10.1111/j.1365-3024.2008.01049.x; Ilic N, 2011, PARASITE IMMUNOL, V33, P572, DOI 10.1111/j.1365-3024.2011.01322.x; Ilic N, 2012, IMMUNOL RES, V52, P111, DOI 10.1007/s12026-012-8287-5; Khan WI, 2002, INFECT IMMUN, V70, P5931, DOI 10.1128/IAI.70.11.5931-5937.2002; Kim SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035447; Leung J, 2012, INFLAMM BOWEL DIS, V18, P1447, DOI 10.1002/ibd.22858; Cancado GGL, 2011, INFLAMM BOWEL DIS, V17, P2275, DOI 10.1002/ibd.21629; Martinez-Gomez F, 2009, VET PARASITOL, V162, P171, DOI 10.1016/j.vetpar.2009.02.010; Menachem Y, 2005, MICROBES INFECT, V7, P825, DOI 10.1016/j.micinf.2005.03.019; Moreels TG, 2004, GUT, V53, P99, DOI 10.1136/gut.53.1.99; Motomura Y, 2009, CLIN EXP IMMUNOL, V155, P88, DOI 10.1111/j.1365-2249.2008.03805.x; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Nagano I, 2009, PARASITOL RES, V104, P197, DOI 10.1007/s00436-008-1248-1; Navarro S, 2013, INT J PARASITOL, V43, P225, DOI 10.1016/j.ijpara.2012.11.005; Neuman MG, 2012, TRANSL RES, V160, P29, DOI 10.1016/j.trsl.2011.09.001; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Osada Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/743758; Park HK, 2011, EXP PARASITOL, V127, P539, DOI 10.1016/j.exppara.2010.10.004; Reardon C, 2001, INFECT IMMUN, V69, P4417, DOI 10.1128/IAI.69.7.4417-4423.2001; Ruyssers NE, 2009, INFLAMM BOWEL DIS, V15, P491, DOI 10.1002/ibd.20787; Saunders KA, 2007, INFECT IMMUN, V75, P397, DOI 10.1128/IAI.00664-06; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Sofronic-Milosavljevic L, 2013, MED MICROBIOL IMMUN, V202, P239, DOI 10.1007/s00430-012-0286-6; Song XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023453; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Sun SM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-186; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Weinstock JV, 2013, INT J PARASITOL, V43, P245, DOI 10.1016/j.ijpara.2012.10.016; Weinstock JV, 2012, NATURE, V491, P183, DOI 10.1038/491183a; Whelan RAK, 2012, PROTOPLASMA, V249, P871, DOI 10.1007/s00709-011-0342-x; Wu ZL, 2010, PARASITOL RES, V107, P1173, DOI 10.1007/s00436-010-1985-9; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu D, 1997, J ELECTRON MICROSC, V46, P439, DOI 10.1093/oxfordjournals.jmicro.a023540; Yang YP, 2013, VET PARASITOL, V194, P207, DOI 10.1016/j.vetpar.2013.01.057; Yang YP, 2010, VACCINE, V28, P2735, DOI 10.1016/j.vaccine.2010.01.026; Yin ZN, 2002, J IMMUNOL, V169, P2148, DOI 10.4049/jimmunol.169.4.2148	71	47	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96454	10.1371/journal.pone.0096454	http://dx.doi.org/10.1371/journal.pone.0096454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788117	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700094
J	Palm, S; Nylander, I				Palm, Sara; Nylander, Ingrid			Dopamine Release Dynamics Change during Adolescence and after Voluntary Alcohol Intake	PLOS ONE			English	Article							MONOAMINE TRANSPORTER-2 FUNCTION; CHRONIC ETHANOL EXPOSURE; NUCLEUS-ACCUMBENS; DRUG-USE; DORSAL STRIATUM; RAT STRIATUM; AGE; AMPHETAMINE; SYSTEM; PERIADOLESCENT	Adolescence is associated with high impulsivity and risk taking, making adolescent individuals more inclined to use drugs. Early drug use is correlated to increased risk for substance use disorders later in life but the neurobiological basis is unclear. The brain undergoes extensive development during adolescence and disturbances at this time are hypothesized to contribute to increased vulnerability. The transition from controlled to compulsive drug use and addiction involve long-lasting changes in neural networks including a shift from the nucleus accumbens, mediating acute reinforcing effects, to recruitment of the dorsal striatum and habit formation. This study aimed to test the hypothesis of increased dopamine release after a pharmacological challenge in adolescent rats. Potassium-evoked dopamine release and uptake was investigated using chronoamperometric dopamine recordings in combination with a challenge by amphetamine in early and late adolescent rats and in adult rats. In addition, the consequences of voluntary alcohol intake during adolescence on these effects were investigated. The data show a gradual increase of evoked dopamine release with age, supporting previous studies suggesting that the pool of releasable dopamine increases with age. In contrast, a gradual decrease in evoked release with age was seen in response to amphetamine, supporting a proportionally larger storage pool of dopamine in younger animals. Dopamine measures after voluntary alcohol intake resulted in lower release amplitudes in response to potassium-chloride, indicating that alcohol affects the releasable pool of dopamine and this may have implications for vulnerability to addiction and other psychiatric diagnoses involving dopamine in the dorsal striatum.	[Palm, Sara; Nylander, Ingrid] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden	Uppsala University	Palm, S (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden.	Sara.Palm@farmbio.uu.se			Alcohol Research Council of the Swedish Alcohol Retailing Monopoly, ERAB; European Foundation for Alcohol Research [EA 11 30]; Swedish Research Council [K2012-61X-22090-01-3]	Alcohol Research Council of the Swedish Alcohol Retailing Monopoly, ERAB; European Foundation for Alcohol Research; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Financial support from the Alcohol Research Council of the Swedish Alcohol Retailing Monopoly, ERAB: the European Foundation for Alcohol Research (EA 11 30) and the Swedish Research Council (K2012-61X-22090-01-3; IN) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adermark L, 2011, NEUROPHARMACOLOGY, V61, P1160, DOI 10.1016/j.neuropharm.2011.01.014; ANTHONY JC, 1995, DRUG ALCOHOL DEPEN, V40, P9, DOI 10.1016/0376-8716(95)01194-3; ARNETT J, 1992, DEV REV, V12, P339, DOI 10.1016/0273-2297(92)90013-R; Badanich KA, 2007, ALCOHOL CLIN EXP RES, V31, P895, DOI 10.1111/j.1530-0277.2007.00370.x; Badanich KA, 2006, EUR J PHARMACOL, V550, P95, DOI 10.1016/j.ejphar.2006.08.034; Benoit-Marand M, 2008, EUR J NEUROSCI, V27, P1364, DOI 10.1111/j.1460-9568.2008.06107.x; Budygin EA, 2003, SYNAPSE, V50, P266, DOI 10.1002/syn.10269; Budygin EA, 2007, PSYCHOPHARMACOLOGY, V193, P495, DOI 10.1007/s00213-007-0812-1; CASS WA, 1993, J NEUROCHEM, V61, P2269, DOI 10.1111/j.1471-4159.1993.tb07469.x; CASS WA, 1995, J NEUROCHEM, V65, P201; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Degenhardt L, 2009, PSYCHOL MED, V39, P157, DOI 10.1017/S0033291708003425; Dellu F, 1996, NEUROPSYCHOBIOLOGY, V34, P136, DOI 10.1159/000119305; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Everitt B.J., 2013, NEUROSCI BIOBEHAV RE; Fish RE, 2008, AM COLL LAB, P1; FRIEDEMANN MN, 1992, NEUROBIOL AGING, V13, P325, DOI 10.1016/0197-4580(92)90046-Z; Garcia-Burgos D, 2009, ALCOHOL CLIN EXP RES, V33, P722, DOI 10.1111/j.1530-0277.2008.00889.x; GAZZARA RA, 1994, NEUROCHEM RES, V19, P339, DOI 10.1007/BF00971583; Gerhardt GA, 2001, J NEUROSCI METH, V109, P13, DOI 10.1016/S0165-0270(01)00396-X; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; HOOKS MS, 1992, PHARMACOL BIOCHEM BE, V41, P203, DOI 10.1016/0091-3057(92)90083-R; Keita H, 1996, BRIT J ANAESTH, V77, P254, DOI 10.1093/bja/77.2.254; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Laviola G, 2001, PHARMACOL BIOCHEM BE, V68, P115, DOI 10.1016/S0091-3057(00)00430-5; Littrell OM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.013; Lundblad M, 2009, J NEUROCHEM, V108, P998, DOI 10.1111/j.1471-4159.2008.05848.x; Marco EM, 2011, NEUROSCI BIOBEHAV R, V35, P1722, DOI 10.1016/j.neubiorev.2011.02.011; Mathews IZ, 2009, DEV PSYCHOBIOL, V51, P417, DOI 10.1002/dev.20381; Matthews M, 2013, NEUROPSYCHOPHARMACOL, V38, P1344, DOI 10.1038/npp.2013.32; McCutcheon JE, 2009, EUR J NEUROSCI, V29, P997, DOI 10.1111/j.1460-9568.2009.06648.x; Miller EM, 2012, NEUROPHARMACOLOGY, V63, P1327, DOI 10.1016/j.neuropharm.2012.08.020; Nakano M, 1996, MECH AGEING DEV, V86, P95, DOI 10.1016/0047-6374(95)01680-5; Pascual M, 2009, J NEUROCHEM, V108, P920, DOI 10.1111/j.1471-4159.2008.05835.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Philpot RM, 2009, INT J DEV NEUROSCI, V27, P805, DOI 10.1016/j.ijdevneu.2009.08.009; Sahr AE, 2004, ALCOHOL CLIN EXP RES, V28, P702, DOI 10.1097/01.ALC.0000125344.79677.1C; Semba K, 2005, ANESTHESIOLOGY, V102, P616, DOI 10.1097/00000542-200503000-00021; Sherwood NM, 1970, STEREOTAXIC ATLAS DE, P214; Silveri MM, 2014, PHARM THER; Spanagel R, 2003, BEST PRACT RES CL GA, V17, P507, DOI 10.1016/S1521-6918(03)00031-3; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; STAMFORD JA, 1984, NEUROSCI LETT, V51, P133, DOI 10.1016/0304-3940(84)90274-X; STAMFORD JA, 1989, J NEUROCHEM, V52, P1582, DOI 10.1111/j.1471-4159.1989.tb09212.x; Steensland P, 2012, BIOL PSYCHIAT, V72, P823, DOI 10.1016/j.biopsych.2012.06.018; TEICHER MH, 1995, DEV BRAIN RES, V89, P167, DOI 10.1016/0165-3806(95)00109-Q; Truong JG, 2005, J PHARMACOL EXP THER, V314, P1087, DOI 10.1124/jpet.105.085951; Volz TJ, 2009, SYNAPSE, V63, P147, DOI 10.1002/syn.20580; Walker QD, 2010, J PHARMACOL EXP THER, V335, P124, DOI 10.1124/jpet.110.167320; WIGHTMAN RM, 1990, BRAIN RES REV, V15, P135, DOI 10.1016/0165-0173(90)90015-G; Wong WC, 2013, J NEUROSCI, V33, P4913, DOI 10.1523/JNEUROSCI.1371-12.2013; YAMAGUCHI K, 1984, AM J PUBLIC HEALTH, V74, P668, DOI 10.2105/AJPH.74.7.668; Zahniser NR, 1998, METHOD ENZYMOL, V296, P708	54	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96337	10.1371/journal.pone.0096337	http://dx.doi.org/10.1371/journal.pone.0096337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788731	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600094
J	Palsson, A; Wesolowska, N; Reynisdottir, S; Ludwig, MZ; Kreitman, M				Palsson, Arnar; Wesolowska, Natalia; Reynisdottir, Sigrun; Ludwig, Michael Z.; Kreitman, Martin			Naturally Occurring Deletions of Hunchback Binding Sites in the Even-Skipped Stripe 3+7 Enhancer	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; CIS-REGULATORY SEQUENCES; GENE-EXPRESSION; POPULATION-GENETICS; TRANSCRIPTIONAL REGULATION; FUNCTIONAL-ANALYSIS; DROSOPHILA; EVOLUTION; CONSERVATION; SEGMENTATION	Changes in regulatory DNA contribute to phenotypic differences within and between taxa. Comparative studies show that many transcription factor binding sites (TFBS) are conserved between species whereas functional studies reveal that some mutations segregating within species alter TFBS function. Consistently, in this analysis of 13 regulatory elements in Drosophila melanogaster populations, single base and insertion/deletion polymorphism are rare in characterized regulatory elements. Experimentally defined TFBS are nearly devoid of segregating mutations and, as has been shown before, are quite conserved. For instance 8 of 11 Hunchback binding sites in the stripe 3+7 enhancer of even-skipped are conserved between D. melanogaster and Drosophila virilis. Oddly, we found a 72 bp deletion that removes one of these binding sites (Hb8), segregating within D. melanogaster. Furthermore, a 45 bp deletion polymorphism in the spacer between the stripe 3+7 and stripe 2 enhancers, removes another predicted Hunchback site. These two deletions are separated by similar to 250 bp, sit on distinct haplotypes, and segregate at appreciable frequency. The Hb8 Delta is at 5 to 35% frequency in the new world, but also shows cosmopolitan distribution. There is depletion of sequence variation on the Hb8 Delta-carrying haplotype. Quantitative genetic tests indicate that Hb8 Delta affects developmental time, but not viability of offspring. The Eve expression pattern differs between inbred lines, but the stripe 3 and 7 boundaries seem unaffected by Hb8D Delta. The data reveal segregating variation in regulatory elements, which may reflect evolutionary turnover of characterized TFBS due to drift or co-evolution.	[Palsson, Arnar; Reynisdottir, Sigrun] Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland; [Palsson, Arnar; Reynisdottir, Sigrun] Univ Iceland, Inst Biol, Reykjavik, Iceland; [Palsson, Arnar] Univ Iceland, Biomed Ctr, Reykjavik, Iceland; [Palsson, Arnar; Wesolowska, Natalia; Ludwig, Michael Z.; Kreitman, Martin] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Wesolowska, Natalia] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69012 Heidelberg, Germany	University of Iceland; University of Iceland; University of Iceland; University of Chicago; European Molecular Biology Laboratory (EMBL)	Palsson, A (corresponding author), Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland.	apalsson@hi.is	Palsson, Arnar/M-2742-2015	Palsson, Arnar/0000-0002-6525-8112; Misunou, Natalia/0000-0002-4075-2595	National Institutes of Health [R01 GM61001]; Icelandic research fund [IRF 070260021]; Marie Curie international reintegration grant [MIRG-CT-2007-046510]; University of Iceland; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Icelandic research fund; Marie Curie international reintegration grant(European Commission); University of Iceland; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by the National Institutes of Health (Grant R01 GM61001 to M. K. and M.Z.L.), Icelandic research fund (IRF 070260021 to A. P.), Marie Curie international reintegration grant (MIRG-CT-2007-046510 to A. P.) and the University of Iceland research fund to A. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrioli LPM, 2002, DEVELOPMENT, V129, P4931; Arnosti DN, 2011, CURR BIOL, V21, pR859, DOI 10.1016/j.cub.2011.09.022; Arnosti DN, 2003, ANNU REV ENTOMOL, V48, P579, DOI 10.1146/annurev.ento.48.091801.112749; Arnosti DN, 1996, DEVELOPMENT, V122, P205; Balhoff JP, 2005, P NATL ACAD SCI USA, V102, P8591, DOI 10.1073/pnas.0409638102; Barriere A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002961; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Carter AJR, 2002, P ROY SOC B-BIOL SCI, V269, P953, DOI 10.1098/rspb.2002.1968; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cleary MD, 2006, GENE DEV, V20, P429, DOI 10.1101/gad.1382206; Comeron JM, 2000, GENETICS, V156, P1175; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fujioka M, 2002, DEVELOPMENT, V129, P4411; Garfield D, 2012, EVOL DEV, V14, P152, DOI 10.1111/j.1525-142X.2012.00532.x; Gerland U, 2002, J MOL EVOL, V55, P386, DOI 10.1007/s00239-002-2335-z; Gibson G, 2000, CURR BIOL, V10, pR452, DOI 10.1016/S0960-9822(00)00531-5; Goering LM, 2009, J EXP ZOOL PART B, V312B, P841, DOI 10.1002/jez.b.21299; Gould S. J., 1977, ONTOGENY PHYLOGENY; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Halfon MS, 2008, NUCLEIC ACIDS RES, V36, pD594, DOI 10.1093/nar/gkm876; He BZ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002053; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; HUDSON RR, 1994, GENETICS, V136, P1329; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2006, BIOESSAYS, V28, P1102, DOI 10.1002/bies.20494; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Kim AR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003243; Kim JK, 2009, IEEE PHOTONIC TECH L, V21, P21, DOI 10.1109/LPT.2008.2007912; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Leushkin E V, 2013, STRONG MUTATIONAL BI, P47; Lott SE, 2007, P NATL ACAD SCI USA, V104, P10926, DOI 10.1073/pnas.0701359104; Lott SE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000590; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Ludwig MZ, 2002, CURR OPIN GENET DEV, V12, P634, DOI 10.1016/S0959-437X(02)00355-6; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; Manu, 2013, GENETICS, V194, P163, DOI 10.1534/genetics.112.148205; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Mustonen V, 2005, P NATL ACAD SCI USA, V102, P15936, DOI 10.1073/pnas.0505537102; Ni XC, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001420; Nicholas K.B., 1997, EMBNEW NEWS, V4; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; Ometto L, 2005, GENETICS, V169, P1521, DOI 10.1534/genetics.104.037689; Palsson A, 2004, GENETICS, V167, P1199, DOI 10.1534/genetics.104.026252; Palsson A, 2004, GENETICS, V167, P1187, DOI 10.1534/genetics.103.021766; Papatsenko D, 2008, P NATL ACAD SCI USA, V105, P2901, DOI 10.1073/pnas.0711941105; Payankaulam S, 2010, CURR BIOL, V20, pR764, DOI 10.1016/j.cub.2010.06.037; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raff R. A., 1996, SHAPE LIFE GENES DEV; Rasband W.S., 1997, IMAGE J; Robin C, 2002, GENETICS, V162, P155; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Romano LA, 2003, DEVELOPMENT, V130, P4187, DOI 10.1242/dev.00611; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schaeffer SW, 2002, GENET RES, V80, P163, DOI 10.1017/S0016672302005955; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Shimell MJ, 2000, DEV BIOL, V218, P38, DOI 10.1006/dbio.1999.9576; Sinha S, 2005, MOL BIOL EVOL, V22, P874, DOI 10.1093/molbev/msi090; SMALL S, 1993, DEVELOPMENT, V119, P767; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stone JR, 2001, MOL BIOL EVOL, V18, P1764, DOI 10.1093/oxfordjournals.molbev.a003964; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x; Verrelli BC, 2001, GENETICS, V157, P1649; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Walser JC, 2006, PLOS GENET, V2, P1541, DOI 10.1371/journal.pgen.0020165; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wunderlich Z, 2011, CURR OPIN GENET DEV, V21, P711, DOI 10.1016/j.gde.2011.07.005; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; ZUO P, 1991, GENE DEV, V5, P254, DOI 10.1101/gad.5.2.254	94	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e91924	10.1371/journal.pone.0091924	http://dx.doi.org/10.1371/journal.pone.0091924			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24786295	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600006
J	Samiulhaq; Ahmad, S; Vieru, D; Khan, I; Shafie, S				Samiulhaq; Ahmad, Sohail; Vieru, Dumitru; Khan, Ilyas; Shafie, Sharidan			Unsteady Magnetohydrodynamic Free Convection Flow of a Second Grade Fluid in a Porous Medium with Ramped Wall Temperature	PLOS ONE			English	Article							MHD COUETTE-FLOW; VERTICAL PLATE; NATURAL-CONVECTION; HEAT-TRANSFER; MASS-TRANSFER; RADIATION; CHANNEL	Magnetic field influence on unsteady free convection flow of a second grade fluid near an infinite vertical flat plate with ramped wall temperature embedded in a porous medium is studied. It has been observed that magnitude of velocity as well as skin friction in case of ramped temperature is quite less than the isothermal temperature. Some special cases namely: (i) second grade fluid in the absence of magnetic field and porous medium and (ii) Newtonian fluid in the presence of magnetic field and porous medium, performing the same motion are obtained. Finally, the influence of various parameters is graphically shown.	[Samiulhaq] City Univ Sci & Informat Technol, Dept Math, Peshawar, Pakistan; [Ahmad, Sohail] COMSATS Inst Informat Technol, Attock, Pakistan; [Vieru, Dumitru] Tech Univ Gheorghe Asachi Iasi, Iasi, Romania; [Khan, Ilyas] Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia; [Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Johor, Malaysia	COMSATS University Islamabad (CUI); GH Asachi Technical University; Majmaah University; Universiti Teknologi Malaysia	Shafie, S (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Johor, Malaysia.	sharidan@utm.my	SHAFIE, SHARIDAN/A-2210-2013; Khan, Ilyas/C-8770-2019	SHAFIE, SHARIDAN/0000-0001-7795-2278; Khan, Ilyas/0000-0002-2056-9371				Ali F, 2012, INT J NONLIN MECH, V47, P521, DOI 10.1016/j.ijnonlinmec.2011.09.027; Chandran P., 2001, International Journal of Applied Mechanics and Engineering, V6, P573; Chandran P, 2005, HEAT MASS TRANSFER, V41, P459, DOI 10.1007/s00231-004-0568-7; Chandran P, 1998, J PHYS SOC JPN, V67, P124, DOI 10.1143/JPSJ.67.124; Erdogan AE, 2005, INT J NONLIN MECH, V40, P545, DOI 10.1016/j.ijnonlinmec.2004.07.014; Erdogan ME, 2005, INT J ENG SCI, V43, P721, DOI 10.1016/j.ijengsci.2004.12.011; Fetecau C, 2013, Z NATURFORSCH A, V68, P130, DOI 10.5560/ZNA.2012-0083; Ganesan P, 2003, HEAT MASS TRANSFER, V39, P277, DOI [10.1007/S00231-002-0380-1, 10.1007/s00231-002-0380-1]; GHOSH SK, 1993, J PHYS SOC JPN, V62, P3893, DOI 10.1143/JPSJ.62.3893; Hayat T, 2008, CHAOS SOLITON FRACT, V38, P556, DOI 10.1016/j.chaos.2006.12.004; Hayat T, 2008, J POROUS MEDIA, V11, P389, DOI 10.1615/JPorMedia.v11.i4.50; Hayat T, 2010, INT J HEAT MASS TRAN, V53, P4780, DOI 10.1016/j.ijheatmasstransfer.2010.06.014; Hayat T, 2010, Z NATURFORSCH A, V65, P1111, DOI 10.1515/zna-2010-1216; Hayat T, 2010, Z NATURFORSCH A, V65, P231, DOI 10.1515/zna-2010-0312; Hussain M, 2010, NONLINEAR ANAL-REAL, V11, P2403, DOI 10.1016/j.nonrwa.2009.07.016; JANA RN, 1977, J PHYS SOC JPN, V42, P1034, DOI 10.1143/JPSJ.42.1034; Jha BK, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.104401; KATAGIRI M, 1962, J PHYS SOC JPN, V17, P393, DOI 10.1143/JPSJ.17.393; Khan M, 2011, SPEC TOP REV POROUS, V2, P125, DOI 10.1615/SpecialTopicsRevPorousMedia.v2.i2.60; MANDAL G, 1983, J PHYS SOC JPN, V52, P470, DOI 10.1143/JPSJ.52.470; Mustafa N, 2008, CHEM ENG COMMUN, V195, P209, DOI 10.1080/00986440701569127; Narahari M, 2010, AIP CONF PROC, V1225, P743, DOI 10.1063/1.3464923; RAJAGOPAL KR, 1982, INT J NONLINEAR MECH, V17, P369, DOI 10.1016/0020-7462(82)90006-3; RAPTIS A, 1985, MECH RES COMMUN, V12, P31, DOI 10.1016/0093-6413(85)90032-1; RAPTIS A, 1983, INT COMMUN HEAT MASS, V10, P313, DOI 10.1016/0735-1933(83)90016-7; SACHETI NC, 1994, INT COMMUN HEAT MASS, V21, P131, DOI 10.1016/0735-1933(94)90090-6; Samiulhaq, 2012, Z NATURFORSCH A, V67, P572, DOI 10.5560/ZNA.2012-0070; Samiulhaq, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.044401; Seth GS, 2011, HEAT MASS TRANSFER, V47, P551, DOI 10.1007/s00231-010-0740-1; Seth GS., 2010, INT J APPL MECH ENG, V15, P199, DOI DOI 10.1007/S0023I-0I0-07,740-1; Shercliff JA., 1965, TXB MAGNETOHYDRODYNA; Srinivasa R.K., 2013, J MATH IOSR JM, V7, P5; STEHFEST H, 1970, COMMUN ACM, V13, P47, DOI 10.1145/361953.361969; Tan WC, 2005, INT J NONLIN MECH, V40, P515, DOI 10.1016/j.ijnonlinmec.2004.07.016; Tawari AK., 2009, ADV THEOR APPL MECH, V2, P23	35	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e88766	10.1371/journal.pone.0088766	http://dx.doi.org/10.1371/journal.pone.0088766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24785147	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600003
J	Hummel, N; Hufner, K; Stephan, T; Linn, J; Kremmyda, O; Brandt, T; Flanagin, VL				Hummel, Nadine; Huefner, Katharina; Stephan, Thomas; Linn, Jennifer; Kremmyda, Olympia; Brandt, Thomas; Flanagin, Virginia L.			Vestibular Loss and Balance Training Cause Similar Changes in Human Cerebral White Matter Fractional Anisotropy	PLOS ONE			English	Article							SUBJECT DIFFUSION DATA; HIPPOCAMPAL-FORMATION; SPATIAL STATISTICS; VOXELWISE ANALYSIS; MENIERES-DISEASE; INTEGRITY; ATROPHY; REHABILITATION; DISORDERS; HORMONES	Patients with bilateral vestibular loss suffer from severe balance deficits during normal everyday movements. Ballet dancers, figure skaters, or slackliners, in contrast, are extraordinarily well trained in maintaining balance for the extreme balance situations that they are exposed to. Both training and disease can lead to changes in the diffusion properties of white matter that are related to skill level or disease progression respectively. In this study, we used diffusion tensor imaging (DTI) to compare white matter diffusivity between these two study groups and their age-and sex-matched controls. We found that vestibular patients and balance-trained subjects show a reduction of fractional anisotropy in similar white matter tracts, due to a relative increase in radial diffusivity (perpendicular to the main diffusion direction). Reduced fractional anisotropy was not only found in sensory and motor areas, but in a widespread network including long-range connections, limbic and association pathways. The reduced fractional anisotropy did not correlate with any cognitive, disease-related or skill-related factors. The similarity in FA between the two study groups, together with the absence of a relationship between skill or disease factors and white matter changes, suggests a common mechanism for these white matter differences. We propose that both study groups must exert increased effort to meet their respective usual balance requirements. Since balance training has been shown to effectively reduce the symptoms of vestibular failure, the changes in white matter shown here may represent a neuronal mechanism for rehabilitation.	[Hummel, Nadine; Huefner, Katharina; Stephan, Thomas; Kremmyda, Olympia; Brandt, Thomas; Flanagin, Virginia L.] Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Hummel, Nadine; Stephan, Thomas; Flanagin, Virginia L.] Univ Munich, Grad Sch Syst Neurosci, Planegg Martinsried, Germany; [Huefner, Katharina; Stephan, Thomas; Kremmyda, Olympia] Univ Hosp Munich, Dept Neurol, Munich, Germany; [Stephan, Thomas; Brandt, Thomas] Univ Hosp Munich, Inst Clin Neurosci, Munich, Germany; [Linn, Jennifer] Univ Hosp Munich, Dept Neuroradiol, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich	Hummel, N (corresponding author), Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Campus Grosshadern, Munich, Germany.	Nadine.Hummel@lrz.uni-muenchen.de	Linn, Jennifer/AAE-1567-2021	Linn, Jennifer/0000-0003-0797-2761; Hufner, Katharina/0000-0002-5453-8792; Flanagin, Virginia/0000-0002-6677-459X	German Ministry for Education and Research [IFB 01EO0901]; Hertie Foundation [1.02.1/05/003]	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Hertie Foundation	This study was funded by grants from the German Ministry for Education and Research (http://www.bmbf.de, Grant number: IFB 01EO0901) and the Hertie Foundation (http://www.ghst.de, Grant number: 1.02.1/05/003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R, 2007, TR07JA2 FMRIB; Baddeley AD, 1994, DOORS PEOPLE TEST; Brandt T, 1999, ANN NY ACAD SCI, V871, P293, DOI 10.1111/j.1749-6632.1999.tb09193.x; Brandt T, 2005, BRAIN, V128, P2732, DOI 10.1093/brain/awh617; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Eulenburg PZ, 2010, ANN NEUROL, V68, P241, DOI 10.1002/ana.22063; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Horner KC, 2005, BRAIN RES BULL, V66, P1, DOI 10.1016/j.brainresbull.2005.04.003; Hufner K, 2011, ANN NY ACAD SCI, V1233, P177, DOI 10.1111/j.1749-6632.2011.06115.x; Hufner K, 2011, HIPPOCAMPUS, V21, P855, DOI 10.1002/hipo.20801; Hufner K, 2009, ANN NY ACAD SCI, V1164, P383, DOI 10.1111/j.1749-6632.2008.03719.x; Hugenschmidt CE, 2008, CEREB CORTEX, V18, P433, DOI 10.1093/cercor/bhm080; Hulst HE, 2013, NEUROLOGY, V80, P1025, DOI 10.1212/WNL.0b013e31828726cc; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Kang CMC, 2013, SEMIN NEUROL, V33, P276, DOI 10.1055/s-0033-1354593; Keller M, 2012, SCAND J MED SCI SPOR, V22, P471, DOI 10.1111/j.1600-0838.2010.01268.x; Kim DJ, 2009, NEUROREPORT, V20, P1032, DOI 10.1097/WNR.0b013e32832e0cdd; KREBS DE, 1993, OTOLARYNG HEAD NECK, V109, P735, DOI 10.1177/019459989310900417; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Meng JZ, 2012, J CLIN NEUROSCI, V19, P1659, DOI 10.1016/j.jocn.2011.12.031; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Nigmatullina Y, 2013, CEREB CORTEX, V26, P26; Osterhammel P, 1968, Acta Otolaryngol, V66, P221, DOI 10.3109/00016486809126289; Paoletti P, 2012, J R SOC INTERFACE, V9, P2097, DOI 10.1098/rsif.2012.0077; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Shu N, 2009, HUM BRAIN MAPP, V30, P220, DOI 10.1002/hbm.20507; Smith PF, 2005, J VESTIBUL RES-EQUIL, V15, P1; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; van Cruijsen N, 2005, OTOL NEUROTOL, V26, P1214, DOI 10.1097/01.mao.0000179528.24909.ba; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Young LR, 2012, J VESTIBUL RES-EQUIL, V22, P129, DOI 10.3233/VES-2012-0449; Zingler VC, 2009, ANN NY ACAD SCI, V1164, P505, DOI 10.1111/j.1749-6632.2009.03765.x	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95666	10.1371/journal.pone.0095666	http://dx.doi.org/10.1371/journal.pone.0095666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776524	Green Published, Green Submitted, gold			2022-12-25	WOS:000346241800013
J	Windels, D; Bielewicz, D; Ebneter, M; Jarmolowski, A; Szweykowska-Kulinska, Z; Vazquez, F				Windels, David; Bielewicz, Dawid; Ebneter, Miryam; Jarmolowski, Artur; Szweykowska-Kulinska, Zofia; Vazquez, Franck			miR393 Is Required for Production of Proper Auxin Signalling Outputs	PLOS ONE			English	Article							BOX PROTEIN TIR1; PLANT DEVELOPMENT; EXPRESSION; MICRORNAS; TRANSPORT; SYSTEM; MODULE; GENES	Auxins are crucial for plant growth and development. Auxin signalling primarily depends on four partially redundant F-box proteins of the TIR1/AFB2 Auxin Receptor (TAAR) clade to trigger the degradation of AUX/IAA transcriptional repressors. Auxin signalling is a balanced system which involves complex feedback regulations. miR393 regulation of TAAR genes is important for different developmental programs and for responses to environment. However, so far, the relevance of the two MIR393 genes for Arabidopsis leaf development and their significance for auxin signalling homeostasis have not been evaluated. First, our analyses of mir393a-1 and mir393b-1 mutants and of mir393ab double mutant show that the two genes have only partially redundant functions for leaf development. Expression analyses of typical auxin-induced reporter genes have shown that the loss of miR393 lead to several unanticipated changes in auxin signalling. The expression of DR5pro:GUS is decreased, the expression of primary AUX/IAA auxin-responsive genes is slightly increased and the degradation of the AXR3-NT:GUS reporter protein is delayed in mir393ab mutants. Additional analyses using synthetic auxin and auxin antagonists indicated that miR393 deficient mutants have higher levels of endogenous AUX/IAA proteins, which in turn create a competition for degradation. We propose that the counter-intuitive changes in the expression of AUX/IAA genes and in the accumulation of AUX/IAA proteins are explained by the intrinsic nature of AUX/IAA genes which are feedback regulated by the AUX/IAA proteins which they produce. Altogether our experiments provide an additional highlight of the complexity of auxin signaling homeostasis and show that miR393 is an important component of this homeostasis.	[Windels, David; Bielewicz, Dawid; Ebneter, Miryam; Vazquez, Franck] Univ Basel, Dept Environm Sci, Sect Plant Physiol, Zurich Basel Plant Sci Ctr, Basel, Switzerland; [Bielewicz, Dawid; Jarmolowski, Artur; Szweykowska-Kulinska, Zofia] Adam Mickiewicz Univ, Fac Biol, Dept Gene Express, Poznan, Poland	University of Basel; Adam Mickiewicz University	Vazquez, F (corresponding author), Univ Basel, Dept Environm Sci, Sect Plant Physiol, Zurich Basel Plant Sci Ctr, Basel, Switzerland.	franck.vazquez@unibas.ch		Bielewicz, Dawid/0000-0003-0488-7545; Vazquez, Franck/0000-0002-7967-3798; Szweykowska-Kulinska, Zofia/0000-0003-0032-469X	Swiss National Science Foundation (Ambizione grant) [PZ00P3_126329, PZ00P3_142106]; Rector's Conference of the Swiss Universities (SCIEX-NMS fellowship) [11.115]; Foundation for Polish Science (FNP)	Swiss National Science Foundation (Ambizione grant)(Swiss National Science Foundation (SNSF)); Rector's Conference of the Swiss Universities (SCIEX-NMS fellowship); Foundation for Polish Science (FNP)(Foundation for Polish Science)	This work was supported by the Swiss National Science Foundation (Ambizione grant PZ00P3_126329 and PZ00P3_142106 to FV) and by the Rector's Conference of the Swiss Universities (SCIEX-NMS fellowship 11.115 to F.V., Z.S.K. and D.B). The Ph.D. fellowship of DB is part of the International Ph.D. Program "From genome to phenotype: A multidisciplinary approach to functional genomics'' funded by the Foundation for Polish Science (FNP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian HW, 2012, NEW PHYTOL, V196, P149, DOI 10.1111/j.1469-8137.2012.04248.x; Villalobos LIAC, 2012, NAT CHEM BIOL, V8, P477, DOI [10.1038/NCHEMBIO.926, 10.1038/nchembio.926]; Chen H, 2012, FEBS LETT, V586, P1742, DOI 10.1016/j.febslet.2012.05.013; Chen ZH, 2011, PLANT MOL BIOL, V77, P619, DOI 10.1007/s11103-011-9838-1; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Gao P, 2011, MOL BIOL REP, V38, P237, DOI 10.1007/s11033-010-0100-8; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hayashi K, 2012, ACS CHEM BIOL, V7, P590, DOI 10.1021/cb200404c; Hayashi K, 2009, PHYTOCHEMISTRY, V70, P190, DOI 10.1016/j.phytochem.2008.12.020; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Robert-Seilaniantz A, 2011, PLANT J, V67, P218, DOI 10.1111/j.1365-313X.2011.04591.x; Scanlon MJ, 2003, PLANT PHYSIOL, V133, P597, DOI 10.1104/pp.103.026880; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Windels D, 2011, PLANT SIGNAL BEHAV, V6, P1672, DOI 10.4161/psb.6.11.17900; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xia KF, 2012, PLOS ONE, V7, P364, DOI 10.1371/journal.pone.0030039	29	35	38	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95972	10.1371/journal.pone.0095972	http://dx.doi.org/10.1371/journal.pone.0095972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763336	Green Submitted, Green Published, gold			2022-12-25	WOS:000335505000048
J	Braendstrup, P; Mortensen, BK; Justesen, S; Osterby, T; Rasmussen, M; Hansen, AM; Christiansen, CB; Hansen, MB; Nielsen, M; Vindelov, L; Buus, S; Stryhn, A				Braendstrup, Peter; Mortensen, Bo Kok; Justesen, Sune; Osterby, Thomas; Rasmussen, Michael; Hansen, Andreas Martin; Christiansen, Claus Bohn; Hansen, Morten Bagge; Nielsen, Morten; Vindelov, Lars; Buus, Soren; Stryhn, Anette			Identification and HLA-Tetramer-Validation of Human CD4(+) and CD8(+) T Cell Responses against HCMV Proteins IE1 and IE2	PLOS ONE			English	Article							MHC CLASS-II; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CYTOMEGALOVIRUS-SPECIFIC CD4(+); BONE-MARROW-TRANSPLANTATION; PEPTIDE-MHC; ADOPTIVE TRANSFER; PERIPHERAL-BLOOD; EPITOPE IDENTIFICATION; CMV INFECTION; DISEASE	Human cytomegalovirus (HCMV) is an important human pathogen. It is a leading cause of congenital infection and a leading infectious threat to recipients of solid organ transplants as well as of allogeneic hematopoietic cell transplants. Moreover, it has recently been suggested that HCMV may promote tumor development. Both CD4(+) and CD8(+) T cell responses are important for long-term control of the virus, and adoptive transfer of HCMV-specific T cells has led to protection from reactivation and HCMV disease. Identification of HCMV-specific T cell epitopes has primarily focused on CD8(+) T cell responses against the pp65 phosphoprotein. In this study, we have focused on CD4(+) and CD8(+) T cell responses against the immediate early 1 and 2 proteins (IE1 and IE2). Using overlapping peptides spanning the entire IE1 and IE2 sequences, peripheral blood mononuclear cells from 16 healthy, HLA-typed, donors were screened by ex vivo IFN-gamma ELISpot and in vitro intracellular cytokine secretion assays. The specificities of CD4(+) and CD8(+) T cell responses were identified and validated by HLA class II and I tetramers, respectively. Eighty-one CD4(+) and 44 CD8(+) T cell responses were identified representing at least seven different CD4 epitopes and 14 CD8 epitopes restricted by seven and 11 different HLA class II and I molecules, respectively, in total covering 91 and 98% of the Caucasian population, respectively. Presented in the context of several different HLA class II molecules, two epitope areas in IE1 and IE2 were recognized in about half of the analyzed donors. These data may be used to design a versatile anti-HCMV vaccine and/or immunotherapy strategy.	[Braendstrup, Peter; Mortensen, Bo Kok; Justesen, Sune; Osterby, Thomas; Rasmussen, Michael; Hansen, Andreas Martin; Buus, Soren; Stryhn, Anette] Univ Copenhagen, Fac Hlth Sci, Expt Immunol Lab, Copenhagen, Denmark; [Braendstrup, Peter; Mortensen, Bo Kok; Vindelov, Lars] Copenhagen Univ Hosp, Rigshosp, Dept Hematol, Allogene Hematopoiet Cell Transplantat Lab, Copenhagen, Denmark; [Christiansen, Claus Bohn] Copenhagen Univ Hosp, Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark; [Hansen, Morten Bagge] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark; [Nielsen, Morten] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Nielsen, Morten] Univ San Martin, Inst Invest Biotecnol, San Martin, Buenos Aires, Argentina	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Technical University of Denmark	Stryhn, A (corresponding author), Univ Copenhagen, Fac Hlth Sci, Expt Immunol Lab, Copenhagen, Denmark.	astryhn@sund.ku.dk	Nielsen, Morten/AAL-8700-2020; Buus, Soren/F-5446-2010	Nielsen, Morten/0000-0001-7885-4311; Stryhn, Anette/0000-0002-4581-3553; Buus, Soren/0000-0001-8363-1999; Braendstrup, Peter/0000-0003-3360-7725	NIH [HHSN 2009007200045C]; Danish Cancer Society; Lundbeck Foundation; Rigshospitalet; University of Copenhagen	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Rigshospitalet; University of Copenhagen	This work was supported by NIH (HHSN 2009007200045C), The Danish Cancer Society, The Lundbeck Foundation, Rigshospitalet and the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALP NJ, 1991, J VIROL, V65, P4812, DOI 10.1128/JVI.65.9.4812-4820.1991; Ameres S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003383; Boeckh M, 2004, BLOOD, V103, P2003, DOI 10.1182/blood-2003-10-3616; Boeckh M, 2003, BLOOD, V101, P407, DOI 10.1182/blood-2002-03-0993; Braendstrup P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073648; Bronke C, 2007, CLIN IMMUNOL, V124, P190, DOI 10.1016/j.clim.2007.04.016; Bunde T, 2005, J EXP MED, V201, P1031, DOI 10.1084/jem.20042384; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cobbold M, 2005, J EXP MED, V202, P379, DOI 10.1084/jem.20040613; Davignon JL, 1996, J VIROL, V70, P2162, DOI 10.1128/JVI.70.4.2162-2169.1996; Ebert S, 2012, MED MICROBIOL IMMUN, V201, P527, DOI 10.1007/s00430-012-0258-x; Einsele H, 2002, BLOOD, V99, P3916, DOI 10.1182/blood.V99.11.3916; Elkington R, 2003, J VIROL, V77, P5226, DOI 10.1128/JVI.77.9.5226-5240.2003; EMANUEL D, 1988, ANN INTERN MED, V109, P777, DOI 10.7326/0003-4819-109-10-777; Emery VC, 2001, J CLIN PATHOL, V54, P84, DOI 10.1136/jcp.54.2.84; Emery VC, 2010, INFECT DIS CLIN N AM, V24, P515, DOI 10.1016/j.idc.2010.01.004; Frankenberg N, 2002, VIROLOGY, V295, P208, DOI 10.1006/viro.2001.1335; Fuji S, 2011, BEST PRACT RES CL HA, V24, P413, DOI 10.1016/j.beha.2011.06.003; Gannage M, 2005, J IMMUNOL, V174, P8210, DOI 10.4049/jimmunol.174.12.8210; Gautier N, 1996, EUR J IMMUNOL, V26, P1110, DOI 10.1002/eji.1830260523; Ge XH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011355; Gibson L, 2007, J INFECT DIS, V195, P1789, DOI 10.1086/518042; Greaves RF, 1998, J VIROL, V72, P366, DOI 10.1128/JVI.72.1.366-379.1998; Griffiths PD, 2012, LANCET INFECT DIS, V12, P790, DOI 10.1016/S1473-3099(12)70197-4; Harndahl M, 2012, EUR J IMMUNOL, V42, P1405, DOI 10.1002/eji.201141774; Harndahl M, 2011, J IMMUNOL METHODS, V374, P5, DOI 10.1016/j.jim.2010.10.012; Harndahl M, 2009, J BIOMOL SCREEN, V14, P173, DOI 10.1177/1087057108329453; Hobeika AC, 2005, J IMMUNOTHER, V28, P63, DOI 10.1097/00002371-200501000-00008; Hoff A, 2010, CANCER IMMUNOL IMMUN, V59, P1379, DOI 10.1007/s00262-010-0867-4; Justesen Sune, 2009, Immunome Res, V5, P2, DOI 10.1186/1745-7580-5-2; Kern F, 1999, J VIROL, V73, P8179, DOI 10.1128/JVI.73.10.8179-8184.1999; Khan N, 2002, J INFECT DIS, V185, P1025, DOI 10.1086/339963; Khan N, 2007, J IMMUNOL, V178, P4455, DOI 10.4049/jimmunol.178.7.4455; Khan Z, 2014, CARCINOGENESIS, V35, P145, DOI 10.1093/carcin/bgt292; Khare M D, 2001, Expert Opin Pharmacother, V2, P1247; Kirchner A, 2008, J MED VIROL, V80, P1604, DOI 10.1002/jmv.21229; Kotturi MF, 2007, J VIROL, V81, P4928, DOI 10.1128/JVI.02632-06; Krishnan A, 2008, IMMUNOL LETT, V120, P108, DOI 10.1016/j.imlet.2008.07.010; Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5; Leen AM, 2013, BLOOD, V121, P5113, DOI 10.1182/blood-2013-02-486324; Leisner C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001678; Lilleri D, 2006, BLOOD, V108, P1406, DOI 10.1182/blood-2005-11-012864; Livingston BD, 2001, VACCINE, V19, P4652, DOI 10.1016/S0264-410X(01)00233-X; Lundegaard C, 2012, EXPERT REV VACCINES, V11, P43, DOI [10.1586/erv.11.160, 10.1586/ERV.11.160]; Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; McKinney DM, 2013, IMMUNOGENETICS, V65, P357, DOI 10.1007/s00251-013-0684-y; Nastke MD, 2005, CELL MOL LIFE SCI, V62, P77, DOI 10.1007/s00018-004-4363-x; Nepom GT, 2012, J IMMUNOL, V188, P2477, DOI 10.4049/jimmunol.1102398; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Peggs KS, 2003, BIOL BLOOD MARROW TR, V9, P198, DOI 10.1053/bbmt.2003.50010; REUSSER P, 1991, BLOOD, V78, P1373; RIDDELL SR, 1992, SCIENCE, V257, P238; Rist M, 2005, EUR J IMMUNOL, V35, P996, DOI 10.1002/eji.200425746; Rooney C, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.49; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Schmitt A, 2011, TRANSFUSION, V51, P591, DOI 10.1111/j.1537-2995.2010.02940.x; Sellar RS, 2012, EXPERT OPIN BIOL TH, V12, P1161, DOI 10.1517/14712598.2012.693471; Sette A, 2001, BIOLOGICALS, V29, P271, DOI 10.1006/biol.2001.0297; SETTE A, 1987, NATURE, V328, P395, DOI 10.1038/328395a0; Slezak SL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-17; Soderberg-Naucler C, 2013, NEW ENGL J MED, V369, P985, DOI 10.1056/NEJMc1302145; Soen Y, 2003, PLOS BIOL, V1, P429, DOI 10.1371/journal.pbio.0000065; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Stinski MF, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P241; Stone JD, 2005, P NATL ACAD SCI USA, V102, P3744, DOI 10.1073/pnas.0407019102; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Thomsen AR, 1996, J IMMUNOL, V157, P3074; Vollers SS, 2008, IMMUNOLOGY, V123, P305, DOI 10.1111/j.1365-2567.2007.02801.x; Walker CM, 2007, BIOL BLOOD MARROW TR, V13, P1106, DOI 10.1016/j.bbmt.2007.06.006; Walker S, 2007, TRANSPL INFECT DIS, V9, P165, DOI 10.1111/j.1399-3062.2006.00199.x; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x; Zhang LM, 2012, BRIEF BIOINFORM, V13, P350, DOI 10.1093/bib/bbr060	79	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94892	10.1371/journal.pone.0094892	http://dx.doi.org/10.1371/journal.pone.0094892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760079	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200026
J	Fischer, SC; Blanchard, GB; Duque, J; Adams, RJ; Arias, AM; Guest, SD; Gorfinkiel, N				Fischer, Sabine C.; Blanchard, Guy B.; Duque, Julia; Adams, Richard J.; Arias, Alfonso Martinez; Guest, Simon D.; Gorfinkiel, Nicole			Contractile and Mechanical Properties of Epithelia with Perturbed Actomyosin Dynamics	PLOS ONE			English	Article							CELL-SHAPE CHANGES; DORSAL CLOSURE; ADHERENS JUNCTIONS; LASER MICROSURGERY; MYOSIN ACTIVITY; TISSUE; MORPHOGENESIS; FORCES; ORGANIZATION; MOVEMENT	Mechanics has an important role during morphogenesis, both in the generation of forces driving cell shape changes and in determining the effective material properties of cells and tissues. Drosophila dorsal closure has emerged as a reference model system for investigating the interplay between tissue mechanics and cellular activity. During dorsal closure, the amnioserosa generates one of the major forces that drive closure through the apical contraction of its constituent cells. We combined quantitation of live data, genetic and mechanical perturbation and cell biology, to investigate how mechanical properties and contraction rate emerge from cytoskeletal activity. We found that a decrease in Myosin phosphorylation induces a fluidization of amnioserosa cells which become more compliant. Conversely, an increase in Myosin phosphorylation and an increase in actin linear polymerization induce a solidification of cells. Contrary to expectation, these two perturbations have an opposite effect on the strain rate of cells during DC. While an increase in actin polymerization increases the contraction rate of amnioserosa cells, an increase in Myosin phosphorylation gives rise to cells that contract very slowly. The quantification of how the perturbation induced by laser ablation decays throughout the tissue revealed that the tissue in these two mutant backgrounds reacts very differently. We suggest that the differences in the strain rate of cells in situations where Myosin activity or actin polymerization is increased arise from changes in how the contractile forces are transmitted and coordinated across the tissue through ECadherin-mediated adhesion. Altogether, our results show that there is an optimal level of Myosin activity to generate efficient contraction and suggest that the architecture of the actin cytoskeleton and the dynamics of adhesion complexes are important parameters for the emergence of coordinated activity throughout the tissue.	[Fischer, Sabine C.; Arias, Alfonso Martinez] Goethe Univ Frankfurt, Dept Biol Sci, Buchmann Inst Mol Life Sci, D-60054 Frankfurt, Germany; [Blanchard, Guy B.; Adams, Richard J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Guest, Simon D.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Duque, Julia; Gorfinkiel, Nicole] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Goethe University Frankfurt; University of Cambridge; University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Gorfinkiel, N (corresponding author), CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	ngorfinkiel@cbm.csic.es	Martinez Arias, Alfonso/F-1966-2010; Gorfinkiel, Nicole/F-4460-2010	Gorfinkiel, Nicole/0000-0002-6847-6721; Fischer, Sabine C/0000-0001-7237-814X; Guest, Simon/0000-0002-0152-6579; Adams, Richard/0000-0003-0280-0901; Blanchard, Guy/0000-0002-3689-0522	Ministerio de Ciencia e Innovacion [BFU-2011-25828]; Marie Curie Career Integration Grant [PCIG09-GA-2011-293479]; Biotechnology and Biological Sciences Research Council [BB/J010278/1]; Physics of Medicine Initiative; Engineering and Physical Sciences Research Council [EP/F058586/1] Funding Source: researchfish; BBSRC [BB/J010278/1] Funding Source: UKRI; EPSRC [EP/F058586/1] Funding Source: UKRI	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Marie Curie Career Integration Grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Physics of Medicine Initiative; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Ministerio de Ciencia e Innovacion (grant BFU-2011-25828), Marie Curie Career Integration Grant (PCIG09-GA-2011-293479), Biotechnology and Biological Sciences Research Council (grant BB/J010278/1), Physics of Medicine Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado J, 2013, ARXIV13022798; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Blanchard GB, 2010, DEVELOPMENT, V137, P2743, DOI 10.1242/dev.045872; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; Cavey M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002998; Davidson LA, 2011, CURR TOP DEV BIOL, V95, P215, DOI 10.1016/B978-0-12-385065-2.00007-4; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Goodman BS, 2012, TRENDS CELL BIOL, V22, P644, DOI 10.1016/j.tcb.2012.09.005; Gorfinkiel N, 2011, GENESIS, V49, P522, DOI 10.1002/dvg.20704; Gorfinkiel N, 2009, DEVELOPMENT, V136, P1889, DOI 10.1242/dev.030866; Hoffman BD, 2009, ANNU REV BIOMED ENG, V11, P259, DOI 10.1146/annurev.bioeng.10.061807.160511; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Hutson MS, 2009, BIOPHYS J, V97, P3075, DOI 10.1016/j.bpj.2009.09.034; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Kasza KE, 2010, BIOPHYS J, V99, P1091, DOI 10.1016/j.bpj.2010.06.025; Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kim YS, 2002, DEV BIOL, V249, P367, DOI 10.1006/dbio.2002.0768; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Layton AT, 2009, HFSP J, V3, P441, DOI 10.2976/1.3266062; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Lee A, 2004, MOL BIOL CELL, V15, P3285, DOI 10.1091/mbc.E04-01-0057; Ma XY, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036004; Martinez Arias Alfonso, 1993, P517; Mason FM, 2013, NAT CELL BIOL, V15, P926, DOI 10.1038/ncb2796; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Oda H, 2001, J CELL SCI, V114, P493; Rauzi M, 2011, CURR TOP DEV BIOL, V95, P93, DOI 10.1016/B978-0-12-385065-2.00004-9; Rodriguez-Diaz A, 2008, HFSP J, V2, P220, DOI 10.2976/1.2955565; Sokolow A, 2012, BIOPHYS J, V102, P969, DOI 10.1016/j.bpj.2012.01.027; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; von Dassow M, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045002; Zhang HM, 2012, J CELL SCI, V125, P3039, DOI 10.1242/jcs.093666; Zhou JA, 2010, DEVELOPMENT, V137, P2785, DOI 10.1242/dev.045997; Zhou J, 2009, DEVELOPMENT, V136, P677, DOI 10.1242/dev.026211	42	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95695	10.1371/journal.pone.0095695	http://dx.doi.org/10.1371/journal.pone.0095695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759936	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200078
J	Vianna, GMS; Meekan, MG; Bornovski, TH; Meeuwig, JJ				Vianna, Gabriel M. S.; Meekan, Mark G.; Bornovski, Tova H.; Meeuwig, Jessica J.			Acoustic Telemetry Validates a Citizen Science Approach for Monitoring Sharks on Coral Reefs	PLOS ONE			English	Article							UNDERWATER VISUAL-CENSUS; PATTERNS; RATES; IDENTIFICATION; PERFORMANCE; ABUNDANCE; BIAS	Citizen science is promoted as a simple and cost-effective alternative to traditional approaches for the monitoring of populations of marine megafauna. However, the reliability of datasets collected by these initiatives often remains poorly quantified. We compared datasets of shark counts collected by professional dive guides with acoustic telemetry data from tagged sharks collected at the same coral reef sites over a period of five years. There was a strong correlation between the number of grey reef sharks (Carcharhinus amblyrhynchos) observed by dive guides and the telemetry data at both daily and monthly intervals, suggesting that variation in relative abundance of sharks was detectable in datasets collected by dive guides in a similar manner to data derived from telemetry at these time scales. There was no correlation between the number or mean depth of sharks recorded by telemetry and the presence of tourist divers, suggesting that the behaviour of sharks was not affected by the presence of divers during our study. Data recorded by dive guides showed that current strength and temperature were important drivers of the relative abundance of sharks at monitored sites. Our study validates the use of datasets of shark abundance collected by professional dive guides in frequently-visited dive sites in Palau, and supports the participation of experienced recreational divers as contributors to long-term monitoring programs of shark populations.	[Vianna, Gabriel M. S.; Meeuwig, Jessica J.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Vianna, Gabriel M. S.; Meeuwig, Jessica J.] Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia; [Vianna, Gabriel M. S.; Meekan, Mark G.] Australian Inst Marine Sci, Perth, WA, Australia; [Bornovski, Tova H.] Micronesian Shark Fdn, Koror, Palau	University of Western Australia; University of Western Australia; Australian Institute of Marine Science	Vianna, GMS (corresponding author), Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia.	gabe.vianna@gmail.com		Meeuwig, Jessica/0000-0003-1169-8785; Meekan, Mark/0000-0002-3067-9427	Save Our Seas Foundation	Save Our Seas Foundation	Financial support for the acoustic telemetry was provided by the Save Our Seas Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bell C. D., 2009, Tourism in Marine Environments, V5, P245, DOI 10.3727/154427308788714768; Bernard ATF, 2013, J EXP MAR BIOL ECOL, V443, P75, DOI 10.1016/j.jembe.2013.02.039; Brunnschweiler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058522; Brunnschweiler JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016597; Colin P.L., 2009, MARINE ENV PALAU; Davies TK, 2012, WILDLIFE RES, V39, P696, DOI 10.1071/WR12092; deBruyn AMH, 2001, MAR ECOL PROG SER, V214, P307, DOI 10.3354/meps214307; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Friedlander AM, 2012, REV BIOL TROP, V60, P321; Goffredo S, 2010, ECOL APPL, V20, P2170, DOI 10.1890/09-1546.1; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Higby Louisa K., 2012, International Journal of Zoology, V2012, P1; Hussey NE, 2013, J MAR BIOL ASSOC UK, V93, P299, DOI 10.1017/S0025315411001160; Huveneers C, 2009, AQUAT LIVING RESOUR, V22, P255, DOI 10.1051/alr/2009046; Jaine FRA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046170; Lowry M, 2007, FISH RES, V88, P15, DOI 10.1016/j.fishres.2007.07.011; Lumley T., 2013, PACKAGE LEAPS; MacNeil MA, 2008, J FISH BIOL, V73, P1748, DOI 10.1111/j.1095-8649.2008.02067.x; Marshall AD, 2012, J FISH BIOL, V80, P1361, DOI 10.1111/j.1095-8649.2012.03244.x; McCauley DJ, 2012, ECOL APPL, V22, P385, DOI 10.1890/11-1059.1; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Nelson D, 1980, NATL GEOGR SOC RES R, V12, P479; NELSON DR, 1977, AM ZOOL, V17, P501; Richards BL, 2011, B MAR SCI, V87, P55, DOI 10.5343/bms.2010.1019; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Speed CW, 2008, J FISH BIOL, V72, P1488, DOI 10.1111/j.1095-8649.2008.01810.x; Speed CW, 2012, MAR ECOL PROG SER, V463, P231, DOI 10.3354/meps09864; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; Vianna GMS, 2012, BIOL CONSERV, V145, P267, DOI 10.1016/j.biocon.2011.11.022; Vianna GMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060331; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Ward-Paige CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025609; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	38	60	60	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95565	10.1371/journal.pone.0095565	http://dx.doi.org/10.1371/journal.pone.0095565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760081	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200065
J	Yuan, CW; Khouri, L; Grothe, B; Leibold, C				Yuan, Chun-Wei; Khouri, Leila; Grothe, Benedikt; Leibold, Christian			Neuronal Adaptation Translates Stimulus Gaps into a Population Code	PLOS ONE			English	Article							CAT VISUAL-CORTEX; INFERIOR COLLICULUS; AUDITORY-CORTEX; MOUSTACHED BAT; SYNAPTIC PROPERTIES; SOUND DURATION; MECHANISMS; DISCRIMINATION; RAT; RESPONSES	Neurons in sensory pathways exhibit a vast multitude of adaptation behaviors, which are assumed to aid the encoding of temporal stimulus features and provide the basis for a population code in higher brain areas. Here we study the transition to a population code for auditory gap stimuli both in neurophysiological recordings and in a computational network model. Independent component analysis (ICA) of experimental data from the inferior colliculus of Mongolian gerbils reveals that the network encodes different gap sizes primarily with its population firing rate within 30 ms after the presentation of the gap, where longer gap size evokes higher network activity. We then developed a computational model to investigate possible mechanisms of how to generate the population code for gaps. Phenomenological (ICA) and functional (discrimination performance) analyses of our simulated networks show that the experimentally observed patterns may result from heterogeneous adaptation, where adaptation provides gap detection at the single neuron level and neuronal heterogeneity ensures discriminable population codes for the whole range of gap sizes in the input. Furthermore, our work suggests that network recurrence additionally enhances the network's ability to provide discriminable population patterns.	[Yuan, Chun-Wei; Khouri, Leila; Grothe, Benedikt; Leibold, Christian] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Khouri, Leila] Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel	University of Munich; Hebrew University of Jerusalem	Leibold, C (corresponding author), Univ Munich, Dept Biol 2, Planegg Martinsried, Germany.	leibold@bio.lmu.de	Leibold, Christian/AAT-8895-2021; Grothe, Benedikt/A-7877-2010	Leibold, Christian/0000-0002-4859-8000; Grothe, Benedikt/0000-0001-7317-0615	German ministry of education and research (BMBF) [01GQ0981, 01EO0901]	German ministry of education and research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work has been supported by the German ministry of education and research (BMBF) under grant numbers 01GQ0981 (Bernstein Fokus Neural Basis of Learning) and 01EO0901 (Integriertes Forschungs-und Behandlungszentrum fur Schwindel, Gleichgewichts-und Okulomotorikstorungen, TR-F7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Brette R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002561; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CASSEDAY JH, 1994, SCIENCE, V264, P847, DOI 10.1126/science.8171341; Casseday JH, 1996, BRAIN BEHAV EVOLUT, V47, P311, DOI 10.1159/000113249; Chase SM, 2008, J NEUROPHYSIOL, V99, P1672, DOI 10.1152/jn.00644.2007; Cortes JM, 2012, J COMPUT NEUROSCI, V32, P387, DOI 10.1007/s10827-011-0358-4; Covey E, 1999, ANNU REV PHYSIOL, V61, P457, DOI 10.1146/annurev.physiol.61.1.457; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; EHRET G, 1988, BRAIN RES, V472, P139; Ehrlich D, 1997, J NEUROPHYSIOL, V77, P2360, DOI 10.1152/jn.1997.77.5.2360; Frisina RD, 2001, HEARING RES, V158, P1, DOI 10.1016/S0378-5955(01)00296-9; Gavert H, 2005, FASTICA FAST INDEPEN; Gewaltig MO, 2007, SCHOLARPEDIA, V2, P1430, DOI [DOI 10.4249/SCH0LARPEDIA.1430, 10.4249/scholarpedia.1430, DOI 10.4249/SCHOLARPEDIA.1430]; Hamann I, 2004, JARO-J ASSOC RES OTO, V5, P49, DOI 10.1007/s10162-003-3041-2; HEWITT MJ, 1994, J ACOUST SOC AM, V95, P2145, DOI 10.1121/1.408676; Holmstrom L, 2007, J NEUROPHYSIOL, V98, P3461, DOI 10.1152/jn.00638.2007; Kadner A, 2008, NEUROSCIENCE, V151, P868, DOI 10.1016/j.neuroscience.2007.11.008; Khouri L, 2011, J NEUROSCI, V31, P9958, DOI 10.1523/JNEUROSCI.4509-10.2011; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kuroda T, 2013, PERCEPTION, V42, P82, DOI 10.1068/p7186; LANGNER G, 1988, J NEUROPHYSIOL, V60, P1799, DOI 10.1152/jn.1988.60.6.1799; Lee CC, 2008, J NEUROPHYSIOL, V100, P317, DOI 10.1152/jn.90391.2008; Lee CC, 2010, P NATL ACAD SCI USA, V107, P372, DOI 10.1073/pnas.0907873107; Li L, 2012, FRONT COMP NEUR C BE; MITTMANN DH, 1995, HEARING RES, V90, P185, DOI 10.1016/0378-5955(95)00164-X; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Park TJ, 2004, J NEUROPHYSIOL, V92, P289, DOI 10.1152/jn.00961.2003; Popper AN, 1992, MAMMALIAN AUDITORY P; Portfors CV, 1999, J NEUROPHYSIOL, V82, P1326, DOI 10.1152/jn.1999.82.3.1326; ROVERUD RC, 1991, J COMP PHYSIOL A, V168, P259; Rybalko N, 2010, BEHAV BRAIN RES, V209, P123, DOI 10.1016/j.bbr.2010.01.028; SCHMIDT U, 1991, J COMP PHYSIOL A, V168, P45, DOI 10.1007/BF00217102; SCHREINER CE, 1988, J NEUROPHYSIOL, V60, P1823, DOI 10.1152/jn.1988.60.6.1823; SHU ZJ, 1993, NATURE, V364, P721, DOI 10.1038/364721a0; Sivaramakrishnan S, 2001, J NEUROSCI, V21, P2861, DOI 10.1523/JNEUROSCI.21-08-02861.2001; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Suta D, 2011, EXP GERONTOL, V46, P739, DOI 10.1016/j.exger.2011.05.004; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Vasilkov VA, 2012, PHY REV LETT, V108, P1799; Wallace MN, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00055; Wenstrup JJ, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00075; Xie R, 2008, NEUROSCIENCE, V154, P245, DOI 10.1016/j.neuroscience.2008.02.039; Yuan CW, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00025	45	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95705	10.1371/journal.pone.0095705	http://dx.doi.org/10.1371/journal.pone.0095705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759970	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200079
J	Gupta, M; Qi, XJ; Thakur, V; Manor, D				Gupta, Meghana; Qi, Xiaojun; Thakur, Varsha; Manor, Danny			Tyrosine Phosphorylation of Dbl Regulates GTPase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; PLECKSTRIN HOMOLOGY DOMAIN; MEDIATE TRANSFORMATION; DEPENDENT ACTIVATION; ONCOGENE PRODUCT; FAMILY PROTEINS; RHO GTPASES; PROTO-DBL; CDC42; RAS	Rho GTPases are molecular "switches" that cycle between "on" (GTP-bound) and "off" (GDP-bound) states and regulate numerous cellular activities such as gene expression, protein synthesis, cytoskeletal rearrangements, and metabolic responses. Dysregulation of GTPases is a key feature of many diseases, especially cancers. Guanine nucleotide exchange factors (GEFs) of the Dbl family are activated by mitogenic cell surface receptors and activate the Rho family GTPases Cdc42, Rac1, and RhoA. The molecular mechanisms that regulate GEFs from the Dbl family are poorly understood. Our studies reveal that Dbl is phosphorylated on tyrosine residues upon stimulation by growth factors and that this event is critical for the regulated activation of the GEF. These findings uncover a novel layer of complexity in the physiological regulation of this protein.	[Gupta, Meghana; Manor, Danny] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Gupta, Meghana; Qi, Xiaojun; Thakur, Varsha; Manor, Danny] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Manor, D (corresponding author), Case Western Reserve Univ, Sch Med, WG 48, Cleveland, OH 44106 USA.	dxm178@case.edu			National Institutes of Health [CA082391]; NATIONAL CANCER INSTITUTE [R55CA082391, R01CA082391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Award CA082391 from the National Institutes of Health.	BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; Blajecka K., PLOS ONE, V7; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Cammarano MS, 2001, J BIOL CHEM, V276, P25876, DOI 10.1074/jbc.M011345200; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Colucci-D'Amato G L, 1990, J Neurosurg Sci, V34, P187; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; DOWNWARD J, 1994, FEBS LETT, V338, P113, DOI 10.1016/0014-5793(94)80346-3; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Fields A. P., ADV ENZYME REGUL, V50, P190; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; HART MJ, 1994, J BIOL CHEM, V269, P62; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; Hynes NE, 2011, MOL CELL, V41, P5, DOI 10.1016/j.molcel.2010.12.024; Ishikawa K, 2005, AM J HUM GENET, V77, P280, DOI 10.1086/432518; Ishikawa K, 2006, NEUROPATHOLOGY, V26, P352, DOI 10.1111/j.1440-1789.2006.00719.x; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Kamynina E, 2007, MOL CELL BIOL, V27, P1809, DOI 10.1128/MCB.01051-06; Katzav S, 2009, INT J BIOCHEM CELL B, V41, P1245, DOI 10.1016/j.biocel.2008.11.006; Kauppinen KP, 2005, J BIOL CHEM, V280, P21638, DOI 10.1074/jbc.M413984200; KHOSRAVIFAR R, 1994, MOL CELL BIOL, V14, P6848, DOI 10.1128/MCB.14.10.6848; LEONARD DA, 1994, BIOCHEMISTRY-US, V33, P12323, DOI 10.1021/bi00206a040; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Minard ME, 2005, ONCOGENE, V24, P2568, DOI 10.1038/sj.onc.1208503; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; NAVARRO S, 1993, DIAGN MOL PATHOL, V2, P158, DOI 10.1097/00019606-199300020-00025; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PASTERIS NG, 1994, CELL, V79, P669; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RIDLEY AJ, 1992, COLD SPRING HARB SYM, V57, P661, DOI 10.1101/SQB.1992.057.01.072; RON D, 1988, EMBO J, V7, P2465, DOI 10.1002/j.1460-2075.1988.tb03093.x; RON D, 1991, NEW BIOL, V3, P372; Rossman KL, 2005, TRENDS BIOCHEM SCI, V30, P163, DOI 10.1016/j.tibs.2005.02.002; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Russo C, 2001, J BIOL CHEM, V276, P19524, DOI 10.1074/jbc.M009742200; SRIVASTAVA SK, 1986, P NATL ACAD SCI USA, V83, P8868, DOI 10.1073/pnas.83.23.8868; Suzuki N, 2009, J BIOL CHEM, V284, P5000, DOI 10.1074/jbc.M804073200; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Vanni C, 2004, ONCOGENE, V23, P4098, DOI 10.1038/sj.onc.1207509; VECCHIO G, 1989, ONCOGENE, V4, P897; VELASCO JA, 1995, ONCOGENE, V10, P2253; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Wu WJ, 1997, J BIOL CHEM, V272, P26153, DOI 10.1074/jbc.272.42.26153; Yohe ME, 2008, BIOCHEMISTRY-US, V47, P6827, DOI 10.1021/bi702543p; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zheng Y, 1996, J BIOL CHEM, V271, P19017, DOI 10.1074/jbc.271.32.19017	60	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17195	17202		10.1074/jbc.M114.573782	http://dx.doi.org/10.1074/jbc.M114.573782			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24778185	Green Published, hybrid			2022-12-25	WOS:000338016200052
J	Dogsa, I; Choudhary, KS; Marsetic, Z; Hudaiberdiev, S; Vera, R; Pongor, S; Mandic-Mulec, I				Dogsa, Iztok; Choudhary, Kumari Sonal; Marsetic, Ziva; Hudaiberdiev, Sanjarbek; Vera, Roberto; Pongor, Sandor; Mandic-Mulec, Ines			ComQXPA Quorum Sensing Systems May Not Be Unique to Bacillus subtilis: A Census in Prokaryotic Genomes	PLOS ONE			English	Article							GENETIC COMPETENCE; OVERLAPPING GENES; PHEROMONE; PROTEIN; COMMUNICATION; COMA; CLASSIFICATION; EXPRESSION; DIVERSITY; TOPOLOGY	The comQXPA locus of Bacillus subtilis encodes a quorum sensing (QS) system typical of Gram positive bacteria. It encodes four proteins, the ComQ isoprenyl transferase, the ComX pre-peptide signal, the ComP histidine kinase, and the ComA response regulator. These are encoded by four adjacent genes all situated on the same chromosome strand. Here we present results of a comprehensive census of comQXPA-like gene arrangements in 2620 complete and 6970 draft prokaryotic genomes (sequenced by the end of 2013). After manually checking the data for false-positive and false-negative hits, we found 39 novel com-like predictions. The census data show that in addition to B. subtilis and close relatives, 20 comQXPA-like loci are predicted to occur outside the B. subtilis clade. These include some species of Clostridiales order, but none outside the phylum Firmicutes. Characteristic gene-overlap patterns were observed in comQXPA loci, which were different for the B. subtilis-like and non-B. subtilis-like clades. Pronounced sequence variability associated with the ComX peptide in B. subtilis clade is evident also in the non-B. subtilis clade suggesting grossly similar evolutionary constraints in the underlying quorum sensing systems.	[Dogsa, Iztok; Marsetic, Ziva; Mandic-Mulec, Ines] Univ Ljubljana, Biotechn Fac, Dept Food Sci & Technol, Ljubljana, Slovenia; [Choudhary, Kumari Sonal; Hudaiberdiev, Sanjarbek; Vera, Roberto; Pongor, Sandor] Int Ctr Genet Engn & Biotechnol, Grp Prot Struct & Bioinformat, I-34012 Trieste, Italy; [Vera, Roberto; Pongor, Sandor] Pazmany Peter Catholic Univ, Fac Informat Technol & Bion, Budapest, Hungary	University of Ljubljana; International Center for Genetic Engineering & Biotechnology (ICGEB)	Pongor, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Grp Prot Struct & Bioinformat, Padriciano 99, I-34012 Trieste, Italy.	pongor@icgeb.org; ines.mandic@bf.uni-lj.si	Kumari, Sonal/AAW-7588-2020; Choudhary, Kumari Sonal/M-4517-2017	Choudhary, Kumari Sonal/0000-0001-9527-7958; Dogsa, Iztok/0000-0002-3953-702X; Svab, Ziva/0000-0003-1616-5101; Vera Alvarez, Roberto/0000-0002-4108-5982	Slovenian Research Agency [J4-3631, JP4-116]; Erasmus Placement Program; Hungarian National Innovation Office [TET 10-1-2011-0058, TAMOP-4.2.1.B-11/2/KMR-2011-0002, TAMOP-4.2.2/B-10/1-2010-0014]; University of Ljubljana; ICGEB	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Erasmus Placement Program; Hungarian National Innovation Office; University of Ljubljana; ICGEB(Department of Biotechnology (DBT) India)	ID and IMM were supported by the Slovenian Research Agency grants J4-3631 and JP4-116 awarded to IMM. ZM was supported by a 3 month grant from the Erasmus Placement Program 2012/2013. Work at Pazmany Peter Catholic University, Budapest was partially supported by Hungarian National Innovation Office grants TET 10-1-2011-0058, TAMOP-4.2.1.B-11/2/KMR-2011-0002, and TAMOP-4.2.2/B-10/1-2010-0014. Funding for open access charge and for the services of a scientific writer/editor was provided by the University of Ljubljana and ICGEB, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi M, 2002, MOL MICROBIOL, V44, P1561, DOI 10.1046/j.1365-2958.2002.02977.x; Choudhary KS, 2013, INT J MOL SCI, V14, P13727, DOI 10.3390/ijms140713727; Comella N, 2005, MOL MICROBIOL, V57, P1159, DOI 10.1111/j.1365-2958.2005.04749.x; DUBNAU D, 1991, MICROBIOL REV, V55, P395, DOI 10.1128/MMBR.55.3.395-424.1991; EDWARDS SV, 1993, EVOLUTION, V47, P1118, DOI 10.1111/j.1558-5646.1993.tb02140.x; Fukuda Y, 2003, GENE, V323, P181, DOI 10.1016/j.gene.2003.09.021; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gelencser Zsolt, 2012, ISRN Microbiol, V2012, P484176, DOI 10.5402/2012/484176; Gelencser Z, 2012, SENSORS-BASEL, V12, P5432, DOI 10.3390/s120505432; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; Lopez D, 2009, GENE DEV, V23, P1631, DOI 10.1101/gad.1813709; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416; MADDISON WP, 1991, EVOLUTION, V45, P1184, DOI [10.1111/j.1558-5646.1991.tb04385.x, 10.2307/2409726]; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; Mandic-Mulec I, 2003, FOOD TECHNOL BIOTECH, V41, P23; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Mongkolthanaruk W, 2012, J MICROBIOL BIOTECHN, V22, P1597, DOI 10.4014/jmb.1204.04013; NAKANO MM, 1991, J BACTERIOL, V173, P7269, DOI 10.1128/jb.173.22.7269-7274.1991; Okada M, 2005, NAT CHEM BIOL, V1, P23, DOI 10.1038/nchembio709; Okada M, 2008, BIOSCI BIOTECH BIOCH, V72, P914, DOI 10.1271/bbb.80006; Oslizlo A, 2014, P NATL ACAD SCI USA, V111, P1586, DOI 10.1073/pnas.1316283111; Piazza F, 1999, J BACTERIOL, V181, P4540, DOI 10.1128/JB.181.15.4540-4548.1999; Pintar A, 2003, TRENDS BIOCHEM SCI, V28, P593, DOI 10.1016/j.tibs.2003.09.004; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROGGIANI M, 1993, J BACTERIOL, V175, P3182, DOI 10.1128/JB.175.10.3182-3187.1993; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Schneider KB, 2002, J BACTERIOL, V184, P410, DOI 10.1128/JB.184.2.410-419.2002; Shank EA, 2011, CURR OPIN MICROBIOL, V14, P741, DOI 10.1016/j.mib.2011.09.016; SOLOMON JM, 1995, GENE DEV, V9, P547, DOI 10.1101/gad.9.5.547; Sonego P, 2007, NUCLEIC ACIDS RES, V35, pD232, DOI 10.1093/nar/gkl812; Stefanic P, 2012, ENVIRON MICROBIOL, V14, P1378, DOI 10.1111/j.1462-2920.2012.02717.x; Stefanic P, 2009, J BACTERIOL, V191, P1756, DOI 10.1128/JB.01290-08; Taga ME, 2003, P NATL ACAD SCI USA, V100, P14549, DOI 10.1073/pnas.1934514100; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thoendel M, 2010, ADV APPL MICROBIOL, V71, P91, DOI 10.1016/S0065-2164(10)71004-2; Tortosa P, 2001, J BACTERIOL, V183, P451, DOI 10.1128/JB.183.2.451-460.2001; Tran LSP, 2000, MOL MICROBIOL, V37, P1159, DOI 10.1046/j.1365-2958.2000.02069.x; Tsuji F, 2012, FEBS LETT, V586, P174, DOI 10.1016/j.febslet.2011.12.012; WEINRAUCH Y, 1990, GENE DEV, V4, P860, DOI 10.1101/gad.4.5.860; Zafra O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048716	41	26	25	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96122	10.1371/journal.pone.0096122	http://dx.doi.org/10.1371/journal.pone.0096122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788106	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700057
J	Hama, AT; Germano, P; Varghese, MS; Cravatt, BF; Milne, GT; Pearson, JP; Sagen, J				Hama, Aldric T.; Germano, Peter; Varghese, Matthew S.; Cravatt, Benjamin F.; Milne, G. Todd; Pearson, James P.; Sagen, Jacqueline			Fatty Acid Amide Hydrolase (FAAH) Inhibitors Exert Pharmacological Effects, but Lack Antinociceptive Efficacy in Rats with Neuropathic Spinal Cord Injury Pain	PLOS ONE			English	Article							SODIUM-CHANNEL NA(V)1.3; MECHANICAL ALLODYNIA; UP-REGULATION; MODEL; RECEPTORS; CANNABINOIDS; ANANDAMIDE; BLOCKADE; AGONIST; URB597	Amelioration of neuropathic spinal cord injury (SCI) pain is a clinical challenge. Increasing the endocannabinoid anandamide and other fatty acid amides (FAA) by blocking fatty acid amide hydrolase (FAAH) has been shown to be antinociceptive in a number of animal models of chronic pain. However, an antinociceptive effect of blocking FAAH has yet to be demonstrated in a rat model of neuropathic SCI pain. Four weeks following a SCI, rats developed significantly decreased hind paw withdrawal thresholds, indicative of below-level cutaneous hypersensitivity. A group of SCI rats were systemically treated (i.p.) with either the selective FAAH inhibitor URB597 or vehicle twice daily for seven days. A separate group of SCI rats received a single dose (p.o.) of either the selective FAAH inhibitor PF-3845 or vehicle. Following behavioral testing, levels of the FAA N-arachidonoylethanolamide, N-oleoyl ethanolamide and N-palmitoyl ethanolamide were quantified in brain and spinal cord from SCI rats. Four weeks following SCI, FAA levels were markedly reduced in spinal cord tissue. Although systemic treatment with URB597 significantly increased CNS FAA levels, no antinociceptive effect was observed. A significant elevation of CNS FAA levels was also observed following oral PF-3845 treatment, but only a modest antinociceptive effect was observed. Increasing CNS FAA levels alone does not lead to robust amelioration of below-level neuropathic SCI pain. Perhaps utilizing FAAH inhibition in conjunction with other analgesic mechanisms could be an effective analgesic therapy.	[Hama, Aldric T.; Varghese, Matthew S.; Sagen, Jacqueline] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Germano, Peter; Milne, G. Todd; Pearson, James P.] Ironwood Pharmaceut Inc, Cambridge, MA USA; [Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Physiol Chem, La Jolla, CA 92037 USA	University of Miami; Ironwood Pharmaceuticals, Inc.; Scripps Research Institute	Hama, AT (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	ahama@miami.edu	Sagen, Jacqueline/CAF-4998-2022	Sagen, Jacqueline/0000-0002-9742-7240	Ironwood Pharmaceuticals, Inc.; National Institutes of Health Neurological Disorders Stroke [NS61172]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061172] Funding Source: NIH RePORTER	Ironwood Pharmaceuticals, Inc.; National Institutes of Health Neurological Disorders Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work supported in part by Ironwood Pharmaceuticals, Inc. and by the National Institutes of Health Neurological Disorders & Stroke NS61172 (to JS). The funder provided support in the form of salaries for authors PG, GTM and JPP, and research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abraham KE, 2001, PAIN, V90, P181, DOI 10.1016/S0304-3959(00)00402-4; Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Ahmed MM, 2010, SPINE J, V10, P1049, DOI 10.1016/j.spinee.2010.08.015; Ahn K, 2011, J PHARMACOL EXP THER, V338, P114, DOI 10.1124/jpet.111.180257; Ahn K, 2009, EXPERT OPIN DRUG DIS, V4, P763, DOI 10.1517/17460440903018857; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bedi SS, 2010, J NEUROSCI, V30, P14870, DOI 10.1523/JNEUROSCI.2428-10.2010; Bridges D, 2001, BRIT J PHARMACOL, V133, P586, DOI 10.1038/sj.bjp.0704110; Brown AJ, 2007, BRIT J PHARMACOL, V152, P567, DOI 10.1038/sj.bjp.0707481; Cardenas DD, 2006, J SPINAL CORD MED, V29, P109, DOI 10.1080/10790268.2006.11753864; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chin CL, 2008, BRIT J PHARMACOL, V153, P367, DOI 10.1038/sj.bjp.0707506; Christensen MD, 1997, J NEUROTRAUM, V14, P517, DOI 10.1089/neu.1997.14.517; Cohen PJ, 2009, UTAH LAW REV, V2009, P35; Costa B, 2004, BRIT J PHARMACOL, V141, P4, DOI 10.1038/sj.bjp.0705587; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; De Vry J, 2004, J PHARMACOL EXP THER, V310, P620, DOI 10.1124/jpet.103.062836; De Vry J, 2004, BEHAV PHARMACOL, V15, P1, DOI 10.1097/00008877-200402000-00001; Drew GM, 2004, PAIN, V109, P379, DOI 10.1016/j.pain.2004.02.007; Drew GM, 2001, BRAIN RES, V893, P59, DOI 10.1016/S0006-8993(00)03288-1; Enomoto M, 2012, SPINAL CORD INJURIES, P49; Finnerup NB, 2004, EUR J NEUROL, V11, P73, DOI 10.1046/j.1351-5101.2003.00725.x; Fowler CJ, 2009, BRIT J PHARMACOL, V156, P412, DOI 10.1111/j.1476-5381.2008.00029.x; Fox A, 2001, PAIN, V92, P91, DOI 10.1016/S0304-3959(00)00474-7; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gwak YS, 2011, NEUROPHARMACOLOGY, V60, P799, DOI 10.1016/j.neuropharm.2010.12.030; Hains BC, 2005, BRAIN, V128, P2359, DOI 10.1093/brain/awh623; Hains BC, 2003, J NEUROSCI, V23, P8881; Haller VL, 2008, EUR J PHARMACOL, V600, P50, DOI 10.1016/j.ejphar.2008.08.005; Hama A, 2007, BRAIN RES, V1185, P117, DOI 10.1016/j.brainres.2007.09.013; Hama A, 2011, BRAIN RES, V1412, P44, DOI 10.1016/j.brainres.2011.07.031; Hama A, 2009, J REHABIL RES DEV, V46, P135, DOI 10.1682/JRRD.2008.04.0049; Hama AT, 2010, NEUROPHARMACOLOGY, V58, P758, DOI 10.1016/j.neuropharm.2009.12.010; Helyes Z, 2003, LIFE SCI, V73, P2345, DOI 10.1016/S0024-3205(03)00651-9; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Huestis MA, 2001, ARCH GEN PSYCHIAT, V58, P322, DOI 10.1001/archpsyc.58.4.322; Huggins JP, 2012, PAIN, V153, P1837, DOI 10.1016/j.pain.2012.04.020; Jayamanne A, 2006, BRIT J PHARMACOL, V147, P281, DOI 10.1038/sj.bjp.0706510; Karbarz MJ, 2009, ANESTH ANALG, V108, P316, DOI 10.1213/ane.0b013e31818c7cbd; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; LENZ FA, 1987, PAIN, V31, P225, DOI 10.1016/0304-3959(87)90038-8; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Liu C, 2006, J NEUROPHYSIOL, V96, P2984, DOI 10.1152/jn.00498.2006; Niforatos W, 2007, MOL PHARMACOL, V71, P1209, DOI 10.1124/mol.106.033621; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Rahn EJ, 2009, NEUROTHERAPEUTICS, V6, P713, DOI 10.1016/j.nurt.2009.08.002; Richardson D, 2007, ANAL BIOCHEM, V360, P216, DOI 10.1016/j.ab.2006.10.039; Richardson JD, 1998, EUR J PHARMACOL, V345, P145, DOI 10.1016/S0014-2999(97)01621-X; Russo Ethan B, 2008, Ther Clin Risk Manag, V4, P245; Russo R, 2007, J PHARMACOL EXP THER, V322, P236, DOI 10.1124/jpet.107.119941; Sain NMH, 2009, NEUROPHARMACOLOGY, V57, P235, DOI 10.1016/j.neuropharm.2009.06.004; Sandford P R, 2000, J Spinal Cord Med, V23, P238; Siddall PJ, 2009, SPINAL CORD, V47, P352, DOI 10.1038/sc.2008.136; Starowicz K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060040; Tallarida RJ, 2007, PHARMACOL THERAPEUT, V113, P197, DOI 10.1016/j.pharmthera.2006.08.002; Thakor DK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-14; Tuboly G, 2009, CLIN EXP PHARMACOL P, V36, P400, DOI 10.1111/j.1440-1681.2008.05081.x; Wasner G, 2007, PAIN, V131, P219, DOI 10.1016/j.pain.2007.03.005; XU XJ, 1992, PAIN, V48, P279, DOI 10.1016/0304-3959(92)90070-R; Yu W, 1997, Eur J Pain, V1, P17, DOI 10.1016/S1090-3801(97)90049-5	62	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96396	10.1371/journal.pone.0096396	http://dx.doi.org/10.1371/journal.pone.0096396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788435	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700086
J	Nixon, BJ; Katen, AL; Stanger, SJ; Schjenken, JE; Nixon, B; Roman, SD				Nixon, Belinda J.; Katen, Aimee L.; Stanger, Simone J.; Schjenken, John E.; Nixon, Brett; Roman, Shaun D.			Mouse Spermatocytes Express CYP2E1 and Respond to Acrylamide Exposure	PLOS ONE			English	Article							MALE GERM-CELLS; ADDUCT FORMATION; DNA-DAMAGE; CYTOCHROME-P450 2E1; EXCISION-REPAIR; MICE; GLYCIDAMIDE; TOXICITY; METABOLISM; GENOTOXICITY	Metabolism of xenobiotics by cytochrome P450s (encoded by the CYP genes) often leads to bio-activation, producing reactive metabolites that interfere with cellular processes and cause DNA damage. In the testes, DNA damage induced by xenobiotics has been associated with impaired spermatogenesis and adverse effects on reproductive health. We previously reported that chronic exposure to the reproductive toxicant, acrylamide, produced high levels of DNA damage in spermatocytes of Swiss mice. CYP2E1 metabolises acrylamide to glycidamide, which, unlike acrylamide, readily forms adducts with DNA. Thus, to investigate the mechanisms of acrylamide toxicity in mouse male germ cells, we examined the expression of the CYP, CYP2E1, which metabolises acrylamide. Using Q-PCR and immunohistochemistry, we establish that CYP2E1 is expressed in germ cells, in particular in spermatocytes. Additionally, CYP2E1 gene expression was upregulated in these cells following in vitro acrylamide exposure (1 mu M, 18 h). Spermatocytes were isolated and treated with 1 mu M acrylamide or 0.5 mu M glycidamide for 18 hours and the presence of DNA-adducts was investigated using the comet assay, modified to detect DNA-adducts. Both compounds produced significant levels of DNA damage in spermatocytes, with a greater response observed following glycidamide exposure. A modified comet assay indicated that direct adduction of DNA by glycidamide was a major source of DNA damage. Oxidative stress played a small role in eliciting this damage, as a relatively modest effect was found in a comet assay modified to detect oxidative adducts following glycidamide exposure, and glutathione levels remained unchanged following treatment with either compound. Our results indicate that the male germ line has the capacity to respond to xenobiotic exposure by inducing detoxifying enzymes, and the DNA damage elicited by acrylamide in male germ cells is likely due to the formation of glycidamide adducts.	[Nixon, Belinda J.; Katen, Aimee L.; Stanger, Simone J.; Schjenken, John E.; Nixon, Brett; Roman, Shaun D.] Univ Newcastle, Sch Environm & Life Sci, Reprod Sci Grp, Callaghan, NSW 2308, Australia; [Nixon, Brett; Roman, Shaun D.] Univ Newcastle, Sch Environm & Life Sci, Australian Res Council Ctr Excellence Biotechnol, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle	Roman, SD (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Reprod Sci Grp, Callaghan, NSW 2308, Australia.	shaun.roman@newcastle.edu.au	Roman, Shaun/AFR-5087-2022; Schjenken, John E/ABB-8754-2021; ROMAN, SHAUN/G-7047-2013; Nixon, Brett/B-5121-2012	Schjenken, John E/0000-0001-6293-6160; ROMAN, SHAUN/0000-0002-7758-7757; Nixon, Brett/0000-0003-2745-8188	Hunter Medical Research Institute, The Australian Research Council Centre of Excellence in Biotechnology and Development [CE0348239]; University of Newcastle; Commonwealth of Australia; Faculty of Science and Information Technology Research Training Scholarship	Hunter Medical Research Institute, The Australian Research Council Centre of Excellence in Biotechnology and Development; University of Newcastle; Commonwealth of Australia(Australian Government); Faculty of Science and Information Technology Research Training Scholarship	This work was supported by funding from Hunter Medical Research Institute, The Australian Research Council Centre of Excellence in Biotechnology and Development (CE0348239) and the University of Newcastle. B.J.N. is the recipient of an Australian Postgraduate Award from the Commonwealth of Australia. A. L. K. is the recipient of a Faculty of Science and Information Technology Research Training Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher DE, 2010, TOXICOL MECH METHOD, V20, P159, DOI 10.3109/15376511003690307; Baleato RM, 2005, DEV BIOL, V286, P78, DOI 10.1016/j.ydbio.2005.07.009; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; da Costa GG, 2003, CHEM RES TOXICOL, V16, P1328, DOI 10.1021/tx034108e; De Iuliis GN, 2009, BIOL REPROD, V81, P517, DOI 10.1095/biolreprod.109.076836; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; Exon J H, 2006, J Toxicol Environ Health B Crit Rev, V9, P397, DOI 10.1080/10937400600681430; Gates KS, 2004, CHEM RES TOXICOL, V17, P839, DOI 10.1021/tx049965c; Ghanayem BI, 2005, TOXICOL SCI, V88, P311, DOI 10.1093/toxsci/kfi307; Ghanayem BI, 2005, MUTAT RES-FUND MOL M, V578, P284, DOI 10.1016/j.mrfmmm.2005.05.004; Ghanayem BI, 2005, BIOL REPROD, V72, P157, DOI 10.1095/biolreprod.104.033308; Gonzalez FJ, 1999, CANCER LETT, V143, P199, DOI 10.1016/S0304-3835(99)00125-1; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Hansen SH, 2010, MUTAT RES-GEN TOX EN, V696, P55, DOI 10.1016/j.mrgentox.2009.12.012; Healy LN, 1999, CHEM-BIOL INTERACT, V121, P199, DOI 10.1016/S0009-2797(99)00082-4; Jansen J, 2001, NUCLEIC ACIDS RES, V29, P1791, DOI 10.1093/nar/29.8.1791; Kleene KC, 1996, MOL REPROD DEV, V43, P268, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;268::AID-MRD17&gt;3.0.CO;2-#; Liu Y, 2005, MOL ENDOCRINOL, V19, P2380, DOI 10.1210/me.2004-0418; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LoPachin RM, 2005, TOXICOL SCI, V86, P214, DOI 10.1093/toxsci/kfi197; Marchetti Francesco, 2005, Birth Defects Res C Embryo Today, V75, P112, DOI 10.1002/bdrc.20040; MARLOWE C, 1986, TOXICOL APPL PHARM, V86, P457, DOI 10.1016/0041-008X(86)90373-X; Mei N, 2008, ENV MOL MUTAGEN; Mei N, 2008, ENVIRON MOL MUTAGEN, V49, P741, DOI 10.1002/em.20429; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Nixon BJ, 2012, TOXICOL SCI, V129, P135, DOI 10.1093/toxsci/kfs178; Olsen AK, 2003, NUCLEIC ACIDS RES, V31, P1351, DOI 10.1093/nar/gkg216; Olsen AK, 2001, NUCLEIC ACIDS RES, V29, P1781, DOI 10.1093/nar/29.8.1781; Olsen AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011349; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Piver B, 2001, TOXICOL LETT, V125, P83, DOI 10.1016/S0378-4274(01)00418-0; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; SAKAMOTO J, 1986, ARCH TOXICOL, V59, P201, DOI 10.1007/BF00290538; San Agustin JT, 2001, BIOL REPROD, V65, P151, DOI 10.1095/biolreprod65.1.151; SEGA GA, 1989, MUTAT RES, V216, P221, DOI 10.1016/0165-1161(89)90008-3; SEGA GA, 1990, ENVIRON MOL MUTAGEN, V16, P137, DOI 10.1002/em.2850160302; SEGA GA, 1991, PROG CLIN BIOL RES, V372, P521; Seliskar M, 2007, BBA-GEN SUBJECTS, V1770, P458, DOI 10.1016/j.bbagen.2006.09.016; Shipp A, 2006, CRIT REV TOXICOL, V36, P481, DOI 10.1080/10408440600851377; Sickles DW, 2007, TOXICOL APPL PHARM, V222, P111, DOI 10.1016/j.taap.2007.04.006; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smith CA, 2006, COGNITION EMOTION, V20, P1, DOI 10.1080/02699930500465950; Sumner SCJ, 1999, CHEM RES TOXICOL, V12, P1110, DOI 10.1021/tx990040k; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; Thielen S, 2006, MOL NUTR FOOD RES, V50, P430, DOI 10.1002/mnfr.200500227; Tsuchiya Y, 2004, CANCER RES, V64, P3119, DOI 10.1158/0008-5472.CAN-04-0166; Tyl RW, 2003, REPROD TOXICOL, V17, P1, DOI 10.1016/S0890-6238(02)00078-3; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Xie QY, 2008, J AGR FOOD CHEM, V56, P6054, DOI 10.1021/jf0730542	51	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94904	10.1371/journal.pone.0094904	http://dx.doi.org/10.1371/journal.pone.0094904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788432	Green Submitted, Green Published, gold			2022-12-25	WOS:000336655700020
J	Bruez, E; Vallance, J; Gerbore, J; Lecomte, P; Da Costa, JP; Guerin-Dubrana, L; Rey, P				Bruez, Emilie; Vallance, Jessica; Gerbore, Jonathan; Lecomte, Pascal; Da Costa, Jean-Pierre; Guerin-Dubrana, Lucia; Rey, Patrice			Analyses of the Temporal Dynamics of Fungal Communities Colonizing the Healthy Wood Tissues of Esca Leaf-Symptomatic and Asymptomatic Vines	PLOS ONE			English	Article							TRICHODERMA-VIRIDE; VITIS-VINIFERA; EUTYPA DIEBACK; GRAPEVINE; BIODIVERSITY; DISEASES; IDENTIFICATION; SPP.; BIOCONTROL; MANAGEMENT	Esca, a Grapevine Trunk Disease (GTD), is of major concern for viticulture worldwide. Our study compares the fungal communities that inhabit the wood tissues of vines that expressed or not foliar esca-symptoms. The trunk and rootstock tissues were apparently healthy, whether the 10 year-old plants were symptomatic or not. The only difference was in the cordon, which contained white rot, a typical form of esca, in 79% of symptomatic plants. Observations over a period of one year using a fingerprint method, Single Strand Conformation Polymorphism (SSCP), and the ITS-DNA sequencing of cultivable fungi, showed that shifts occurred in the fungal communities colonizing the healthy wood tissues. However, whatever the sampling time, spring, summer, autumn or winter, the fungi colonizing the healthy tissues of asymptomatic or symptomatic plants were not significantly different. Forty-eight genera were isolated, with species of Hypocreaceae and Botryosphaeriaceae being the most abundant species. Diverse fungal assemblages, made up of potentially plant-pathogenic and -protective fungi, colonized these non-necrotic tissues. Some fungi, possibly involved in GTD, inhabited the non-necrotic wood of young plants, but no increase in necrosis areas was observed over the one-year period.	[Bruez, Emilie; Vallance, Jessica; Gerbore, Jonathan; Lecomte, Pascal; Guerin-Dubrana, Lucia; Rey, Patrice] Univ Bordeaux, ISVV, Sante & Agroecol Vignoble SAVE UMR1065, Bordeaux Sci Agro, Villenave Dornon, France; [Bruez, Emilie; Vallance, Jessica; Gerbore, Jonathan; Lecomte, Pascal; Guerin-Dubrana, Lucia; Rey, Patrice] INRA, ISVV, SAVE UMR1065, Villenave Dornon, France; [Gerbore, Jonathan] BIOVITIS, St Etienne De Chomeil, France; [Da Costa, Jean-Pierre] Univ Bordeaux, Bordeaux Sci Agro, IMS, Talence, France	UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Rey, P (corresponding author), Univ Bordeaux, ISVV, Sante & Agroecol Vignoble SAVE UMR1065, Bordeaux Sci Agro, Villenave Dornon, France.	prey@bordeaux.inra.fr		LECOMTE, Pascal/0000-0002-0479-0295; Vallance, Jessica/0000-0002-5581-4453; Da Costa, Jean-Pierre/0000-0003-2390-0047	Bordeaux Sciences Agro; Regional Council of Aquitaine; French Ministry of Agriculture, Food-processing industry and Forest [CASDAR V906]; BIOVITIS	Bordeaux Sciences Agro; Regional Council of Aquitaine; French Ministry of Agriculture, Food-processing industry and Forest; BIOVITIS	The project was funded by Bordeaux Sciences Agro, the Regional Council of Aquitaine, the French Ministry of Agriculture, Food-processing industry and Forest (programme CASDAR V906). BIOVITIS provided support in the form of a salary for author Jonathan Gerbore, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Armengol J, 2001, PLAGAS, V27, P137; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Beckman TG, 2011, J AM POMOL SOC, V65, P192; Berraf A, 2005, J INT SCI VIGNE VIN, V39, P121; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; Bills Gerald F., 1996, P31; Bruez E, 2013, THESIS U BORDEAUX; Bruez E, 2013, PHYTOPATHOL MEDITERR, V52, P262; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; Casieri L, 2009, PHYTOPATHOL MEDITERR, V48, P73; Chanderbali AS, 2001, ANN MO BOT GARD, V88, P104, DOI 10.2307/2666133; Chattaoui M, 2012, PLANT DIS, V96, P905, DOI 10.1094/PDIS-01-12-0026-PDN; Chiarappa L., 2000, Phytopathologia Mediterranea, V39, P11; Crous PW, 1996, MYCOLOGIA, V88, P786, DOI 10.2307/3760973; Edwards J, 2004, AUSTRALAS PLANT PATH, V33, P273, DOI 10.1071/AP04016; Fischer Michael, 2002, Mycological Progress, V1, P315, DOI 10.1007/s11557-006-0029-4; Fischer M, 2006, PHYTOPATHOL MEDITERR, V45, pS30; Gimenez-Jaime A, 2006, J PHYTOPATHOL, V154, P598, DOI 10.1111/j.1439-0434.2006.01153.x; Gonzalez V, 2011, FUNGAL DIVERS, V47, P29, DOI 10.1007/s13225-010-0073-x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graniti A., 2000, Phytopathologia Mediterranea, V39, P16; Grosman J., 2012, PHYTOMA, V651, P31; Hofstetter V, 2012, FUNGAL DIVERS, V54, P51, DOI 10.1007/s13225-012-0171-z; Inderbitzin P, 2008, PHYTOPATHOLOGY, V98, pS71; Krol Ewa, 2006, Acta Agrobotanica, V59, P163; Larignon P., 2001, Phytopathologia Mediterranea, V40, pS336; Larignon P, 1997, EUR J PLANT PATHOL, V103, P147, DOI 10.1023/A:1008638409410; Larignon P, 2009, CR BIOL, V332, P765, DOI 10.1016/j.crvi.2009.05.005; Lecomte P, 2012, PLANT DIS, V96, P924, DOI 10.1094/PDIS-09-11-0776-RE; Linaldeddu B. T., 2007, Micologia Italiana, V36, P22; Lorrain B, 2012, AUST J GRAPE WINE R, V18, P64, DOI 10.1111/j.1755-0238.2011.00172.x; Lynch S, 2011, PHYTOPATHOLOGY, V101, pS111; Maher N, 2012, J INT SCI VIGNE VIN, V46, P15; McLean KL, 2012, CROP PROT, V33, P94, DOI 10.1016/j.cropro.2011.11.018; Mostert L, 2000, SYDOWIA, V52, P46; Mugnai L, 1999, PLANT DIS, V83, P404, DOI 10.1094/PDIS.1999.83.5.404; Parizi TE, 2012, MICROB PATHOGENESIS, V52, P201, DOI 10.1016/j.micpath.2012.01.001; Perveen K, 2012, AFR J MICROBIOL RES, V6, P3348, DOI 10.5897/AJMR12.247; Reglinski T, 2012, FOREST PATHOL, V42, P75, DOI 10.1111/j.1439-0329.2010.00710.x; Shannon C.E., 1963, MATH THEORY COMMUNIC; Sosnowski MR, 2007, PHYTOPATHOLOGY, V97, P1284, DOI 10.1094/PHYTO-97-10-1284; Stone JK, 2004, BIODIVERSITY FUNGI I, P241, DOI DOI 10.13140/RG.2.1.2497.0726; Surico G, 2006, PHYTOPATHOL MEDITERR, V45, pS68; Surico Giuseppe, 2008, V3, P119, DOI 10.1007/978-1-4020-8571-0_6; Surico G, 2009, PHYTOPATHOL MEDITERR, V48, P5; TIEDEMANN S, 1988, J PHYTOPATHOL, V122, P147; Urbez-Torres JR, 2006, PLANT DIS, V90, P1490, DOI 10.1094/PD-90-1490; Urbez-Torres JR, 2013, PLANT DIS, V97, P1571, DOI 10.1094/PDIS-11-12-1072-RE; Vallance J, 2009, APPL ENVIRON MICROB, V75, P4790, DOI 10.1128/AEM.02643-08; Wang F, 2011, PLANT DIS, V95, P1378, DOI 10.1094/PDIS-12-10-0893; White CL, 2011, PHYTOPATHOL MEDITERR, V50, pS236; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	53	79	82	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95928	10.1371/journal.pone.0095928	http://dx.doi.org/10.1371/journal.pone.0095928			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788412	Green Published, gold			2022-12-25	WOS:000335510600056
J	Wang, MZ; Xu, BL; Wang, HR; Bu, DP; Wang, JQ; Loor, JJ				Wang, Mengzhi; Xu, Bolin; Wang, Hongrong; Bu, Dengpan; Wang, Jiaqi; Loor, Juan-Jose			Effects of Arginine Concentration on the In Vitro Expression of Casein and mTOR Pathway Related Genes in Mammary Epithelial Cells from Dairy Cattle	PLOS ONE			English	Article							MILK PROTEIN YIELD; AMINO-ACIDS; METABOLISM; LACTATION; SUPPLEMENTATION; PHOSPHORYLATION; STIMULATION; PERFORMANCE; INITIATION; GLAND	Arginine (Arg) is a conditionally-essential amino acid that is taken up by bovine mammary gland in excess of its output in milk. In this study we evaluated the effects of Arg concentration on the expression of casein and signaling pathway-related genes in mammary epithelial cells. The treatments (applied for 24 h) were designed to be devoid of Arg 0X (control; 0.00 mg/L), resemble the profile of Arg in casein (Arg 1X; 278.00 mg/L), be deficient [Arg 0.25X (69.50 mg/L) and Arg 0.5X (139.00 mg/L)], or be in excess of the amount in casein [Arg 2X (556.00 mg/L), Arg 4X (1,112 mg/L), and Arg 8X (2,224 mg/L)]. The expression of CSN1S, CSN3 and mTOR in the experimental groups was higher than those of the control group (P < 0.05). Except for Arg 0.25X and Arg 8X (P > 0.05), the expression of CSN1S2, CSN2 and JAK2 in other experimental groups was higher (P < 0.05) than those in the control group. Except for Arg 8X (P > 0.05), the expression of STAT5 in the other experimental groups was higher than those of the control (P < 0.05). It also was observed that except for Arg 0.5X, the S6K expression was higher in other experimental groups than the control (P < 0.05). In contrast, except for Arg 0.25X the other experimental groups resulted in lower 4EBP1 expression than the control (P < 0.05). Among groups, the expression of CSN1S1, CSN1S2, CSN2, CSN3, JAK2, STAT5, mTOR and S6K gene was highest with Arg 2X (P < 0.05); the reverse was true for 4EBP1 gene, with the lowest expression in this group (P < 0.05). Taken together, Arg appears to play an important role in the transcriptional regulation of casein genes and mTOR-related genes in bovine mammary epithelial cells.	[Wang, Mengzhi; Xu, Bolin; Wang, Hongrong] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Wang, Mengzhi; Bu, Dengpan; Wang, Jiaqi] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Wang, Mengzhi; Loor, Juan-Jose] Univ Illinois, Dept Anim Sci, Mammalian NutriPhysioGen, Urbana, IL 61801 USA; [Wang, Mengzhi; Loor, Juan-Jose] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA	Yangzhou University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Wang, HR (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.	hrwang@yzu.edu.cn; jqwangcaas@gmail.com	Wang, HongRong/AAH-8148-2020; Loor, Juan J./H-3760-2012	Loor, Juan J./0000-0003-1586-4365; Wang, Hongrong/0000-0002-4980-1082	Open Research Fund Projects of the State Key Laboratory of Animal Nutrition [2004DA125184F1106]; National Basic Research Program of China (973 Program) [2011CB100803]	Open Research Fund Projects of the State Key Laboratory of Animal Nutrition; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The present work was funded by The Open Research Fund Projects of the State Key Laboratory of Animal Nutrition through project no. 2004DA125184F1106, and by National Basic Research Program of China (973 Program, http://www.dairy973.com/) through project no. 2011CB100803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appuhamy JADRN, 2011, J NUTR, V141, P1209, DOI 10.3945/jn.110.136143; Bauchart-Thevret C, 2010, AM J PHYSIOL-ENDOC M, V299, pE899, DOI 10.1152/ajpendo.00068.2010; Bequette BJ, 1998, J DAIRY SCI, V81, P2540, DOI 10.3168/jds.S0022-0302(98)70147-X; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bionaz M, 2012, MILK PROTEIN, P285, DOI 10.5772/46054; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Burgos SA, 2010, J DAIRY SCI, V93, P153, DOI 10.3168/jds.2009-2444; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Corl BA, 2008, J NUTR, V138, P24, DOI 10.1093/jn/138.1.24; Doepel L, 2011, J DAIRY SCI, V94, P864, DOI 10.3168/jds.2010-3497; Gamboa A, 2008, HYPERTENSION, V51, P1531, DOI 10.1161/HYPERTENSIONAHA.107.105171; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hanigan MD, 2002, J THEOR BIOL, V217, P311, DOI 10.1006/jtbi.2002.3037; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Lapierre H, 2012, J ANIM SCI, V90, P1708, DOI 10.2527/jas.2011-4645; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Loor JJ, 2009, J ANIM SCI, V87, P813, DOI 10.2527/jas.2008-1375; Mateo R D, 2008, J Anim Sci, V86, P827, DOI 10.2527/jas.2007-0371; Mateo RD, 2007, J NUTR, V137, P652, DOI 10.1093/jn/137.3.652; O'Quinn PR, 2002, J ANIM SCI, V80, P467; Raggio G, 2004, J DAIRY SCI, V87, P3461, DOI 10.3168/jds.S0022-0302(04)73481-5; Rhoads JM, 2009, AMINO ACIDS, V37, P111, DOI 10.1007/s00726-008-0225-4; Rhoads JM, 2004, GUT, V53, P514, DOI 10.1136/gut.2003.027540; Rijnkels M, 2002, J MAMMARY GLAND BIOL, V7, P327, DOI 10.1023/A:1022808918013; Rius AG, 2010, J DAIRY SCI, V93, P3114, DOI 10.3168/jds.2009-2743; Rosen JM, 1999, ANNU REV NUTR, V19, P407, DOI 10.1146/annurev.nutr.19.1.407; Toerien CA, 2010, J NUTR, V140, P285, DOI 10.3945/jn.109.114033; Watson C J, 1996, Rev Reprod, V1, P1; Wu GY, 2007, LIVEST SCI, V112, P8, DOI 10.1016/j.livsci.2007.07.003; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 1996, ARCH BIOCHEM BIOPHYS, V336, P224, DOI 10.1006/abbi.1996.0552; Xu BoLin, 2012, Chinese Journal of Animal Nutrition, V24, P852; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004; Yang J, 2000, J ANIM SCI, V78, P3126; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867	36	40	54	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95985	10.1371/journal.pone.0095985	http://dx.doi.org/10.1371/journal.pone.0095985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788778	Green Submitted, gold, Green Published			2022-12-25	WOS:000335510600059
J	Mei, GQ; Dong, JM; Li, ZT; Liu, SL; Liu, YF; Sun, MZ; Liu, GY; Su, Z; Liu, JS				Mei, Guoqiang; Dong, Jianmei; Li, Zhaotao; Liu, Sanling; Liu, Yunfeng; Sun, Mingze; Liu, Guiyun; Su, Zhong; Liu, Jinsong			Structural Basis for the Immunomodulatory Function of Cysteine Protease Inhibitor from Human Roundworm Ascaris lumbricoides	PLOS ONE			English	Article							RAY CRYSTAL-STRUCTURE; HELMINTH INFECTIONS; CYSTATIN; MODULATION; ACTIVATION; PEPTIDASE; RESPONSES; PROTEINS; DISEASE; COMPLEX	Immunosuppression associated with infections of nematode parasites has been documented. Cysteine protease inhibitor (CPI) released by the nematode parasites is identified as one of the major modulators of host immune response. In this report, we demonstrated that the recombinant CPI protein of Ascaris lumbricoides (Al-CPI) strongly inhibited the activities of cathepsin L, C, S, and showed weaker effect to cathepsin B. Crystal structure of Al-CPI was determined to 2.1 angstrom resolution. Two segments of Al-CPI, loop 1 and loop 2, were proposed as the key structure motifs responsible for Al-CPI binding with proteases and its inhibitory activity. Mutations at loop 1 and loop 2 abrogated the protease inhibition activity to various extents. These results provide the molecular insight into the interaction between the nematode parasite and its host and will facilitate the development of anthelmintic agents or design of anti-autoimmune disease drugs.	[Mei, Guoqiang; Dong, Jianmei; Li, Zhaotao; Liu, Sanling; Liu, Yunfeng; Sun, Mingze; Liu, Guiyun; Su, Zhong; Liu, Jinsong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Mei, Guoqiang; Dong, Jianmei; Liu, Jinsong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Su, Z (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China.	su_zhong@gibh.ac.cn; liu_jinsong@gibh.ac.cn	Liu, Yunfeng/G-5315-2011	Liu, Yunfeng/0000-0002-9187-4146	National Natural Science Foundation of China [30872370]; One-Hundred-Talent Project of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One-Hundred-Talent Project of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was partially supported by grants from the National Natural Science Foundation of China (30872370) to SZ and the One-Hundred-Talent Project of the Chinese Academy of Sciences to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fernandez M, 2005, J BIOL CHEM, V280, P18221, DOI 10.1074/jbc.M411914200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRETT AJ, 1986, BIOCHEM J, V236, P312, DOI 10.1042/bj2360312; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Chapman HA, 2006, CURR OPIN IMMUNOL, V18, P78, DOI 10.1016/j.coi.2005.11.011; Dainichi T, 2001, INFECT IMMUN, V69, P7380, DOI 10.1128/IAI.69.12.7380-7386.2001; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOLENC I, 1995, J BIOL CHEM, V270, P21626, DOI 10.1074/jbc.270.37.21626; Dowling DJ, 2011, INT J PARASITOL, V41, P255, DOI 10.1016/j.ijpara.2010.09.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flohr C, 2006, J ALLERGY CLIN IMMUN, V118, P1305, DOI 10.1016/j.jaci.2006.08.035; Hansen G, 2011, STRUCTURE, V19, P919, DOI 10.1016/j.str.2011.03.025; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Janowski R, 2005, PROTEINS, V61, P570, DOI 10.1002/prot.20633; Jenko S, 2003, J MOL BIOL, V326, P875, DOI 10.1016/S0022-2836(02)01432-8; Johnston MJG, 2009, PARASITOLOGY, V136, P125, DOI 10.1017/S0031182008005210; Kabeerdoss J, 2011, ALIMENT PHARM THER, V34, P923, DOI 10.1111/j.1365-2036.2011.04824.x; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Liu SL, 2011, ACTA CRYSTALLOGR F, V67, P228, DOI 10.1107/S1744309110050773; MARTIN JR, 1995, J MOL BIOL, V246, P331, DOI 10.1006/jmbi.1994.0088; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nacher M, 2002, J PARASITOL, V88, P55, DOI 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2; Nyan OA, 2001, CLIN EXP ALLERGY, V31, P1672, DOI 10.1046/j.1365-2222.2001.00987.x; Orlikowska M, 2011, J STRUCT BIOL, V173, P406, DOI 10.1016/j.jsb.2010.11.009; Otto HH, 1997, CHEM REV, V97, P133, DOI 10.1021/cr950025u; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; RAWLINGS ND, 1990, J MOL EVOL, V30, P60, DOI 10.1007/BF02102453; Riese RJ, 2000, CURR OPIN IMMUNOL, V12, P107, DOI 10.1016/S0952-7915(99)00058-8; Salat J, 2010, BIOCHEM J, V429, P103, DOI 10.1042/BJ20100280; Santiago HC, 2011, J ALLERGY CLIN IMMUN, V127, P479, DOI 10.1016/j.jaci.2010.11.007; Schonemeyer A, 2001, J IMMUNOL, V167, P3207, DOI 10.4049/jimmunol.167.6.3207; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P16570, DOI 10.1074/jbc.M601033200; Selassie FG, 2000, CLIN EXP ALLERGY, V30, P356, DOI 10.1046/j.1365-2222.2000.00706.x; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; TURK V, 1986, BIOMED BIOCHIM ACTA, V45, P1375; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	40	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96069	10.1371/journal.pone.0096069	http://dx.doi.org/10.1371/journal.pone.0096069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781326	gold, Green Published, Green Submitted			2022-12-25	WOS:000335504900019
J	Kang, HM; Park, HY; Lee, KJ; Choi, JG; Lee, EK; Song, BM; Lee, HS; Lee, YJ				Kang, Hyun-Mi; Park, Ha-Young; Lee, Kyu-Jun; Choi, Jun-Gu; Lee, Eun-Kyoung; Song, Byung-Min; Lee, Hee-Soo; Lee, Youn-Jeong			Characterization of H7 Influenza A Virus in Wild and Domestic Birds in Korea	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; SHEDDING PATTERNS; MOLECULAR-BASIS; SOUTH-KOREA; SURVEILLANCE; VIRULENCE; DUCKS; PATHOGENICITY; CHICKENS; DISEASE	During surveillance programs in Korea between January 2006 and March 2011, 31 H7 avian influenza viruses were isolated from wild birds and domestic ducks and genetically characterized using large-scale sequence data. All Korean H7 viruses belonged to the Eurasian lineage, which showed substantial genetic diversity, in particular in the wild birds. The Korean H7 viruses from poultry were closely related to those of wild birds. Interestingly, two viruses originating in domestic ducks in our study had the same gene constellations in all segment genes as viruses originating in wild birds. The Korean H7 isolates contained avian-type receptors (Q226 and G228), no NA stalk deletion (positions 69-73), no C-terminal deletion (positions 218-230) in NS1, and no substitutions in PB2-627, PB1-368, and M2-31, compared with H7N9 viruses. In pathogenicity experiments, none of the Korean H7 isolates tested induced clinical signs in domestic ducks or mice. Furthermore, while they replicated poorly, with low titers (10(0.7-1.3)EID(50)/50 mu l) in domestic ducks, all five viruses replicated well (up to 7-10 dpi, 10(0.7-4.3)EID(50)/50 mu l) in the lungs of mice, without prior adaptation. Our results suggest that domestic Korean viruses were transferred directly from wild birds through at least two independent introductions. Our data did not indicate that wild birds carried poultry viruses between Korea and China, but rather, that wild-type H7 viruses were introduced several times into different poultry populations in eastern Asia.	[Kang, Hyun-Mi; Park, Ha-Young; Lee, Kyu-Jun; Choi, Jun-Gu; Lee, Eun-Kyoung; Song, Byung-Min; Lee, Hee-Soo; Lee, Youn-Jeong] Anim & Plant Quarantine Agcy, Avian Dis Div, Anyangsi, Gyeonggido, South Korea	Animal & Plant Quarantine Agency	Lee, YJ (corresponding author), Anim & Plant Quarantine Agcy, Avian Dis Div, Anyangsi, Gyeonggido, South Korea.	leeyj700@korea.kr			Animal and Plant Quarantine Agency, Republic of Korea [N-1541781-2008-19-01]	Animal and Plant Quarantine Agency, Republic of Korea	This work was supported by a grant from the Animal and Plant Quarantine Agency (N-1541781-2008-19-01), Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; CAMPBELL CH, 1970, J INFECT DIS, V122, P513, DOI 10.1093/infdis/122.6.513; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; Choi JG, 2012, VET MICROBIOL, V155, P147, DOI 10.1016/j.vetmic.2011.08.028; Costa TP, 2011, AVIAN PATHOL, V40, P119, DOI 10.1080/03079457.2010.540002; Driskell EA, 2010, VIROLOGY, V399, P280, DOI 10.1016/j.virol.2010.01.005; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hanson BA, 2003, AVIAN DIS, V47, P867, DOI 10.1637/0005-2086-47.s3.867; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Kang HM, 2010, J WILDLIFE DIS, V46, P878, DOI 10.7589/0090-3558-46.3.878; Kang HM, 2013, J GEN VIROL, V94, P30, DOI 10.1099/vir.0.046581-0; KIDA H, 1980, INFECT IMMUN, V30, P547; Kim HR, 2012, J GEN VIROL, V93, P1278, DOI 10.1099/vir.0.041269-0; Kim MC, 2010, VET MICROBIOL, V141, P268, DOI 10.1016/j.vetmic.2009.09.027; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Kurtz J, 1996, LANCET, V348, P901, DOI 10.1016/S0140-6736(05)64783-6; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Lebarbenchon C, 2013, EMERG INFECT DIS, V19, P1635, DOI 10.3201/eid1910.130609; Lee DH, 2010, J WILDLIFE DIS, V46, P649, DOI 10.7589/0090-3558-46.2.649; Lee MS, 2001, J VIROL METHODS, V97, P13, DOI 10.1016/S0166-0934(01)00301-9; Li YB, 2006, VIRUS GENES, V33, P117, DOI 10.1007/s11262-005-0042-8; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; OIE, 2012, MANUAL DIAGNOSTIC TE; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Wang GH, 2008, J GEN VIROL, V89, P697, DOI 10.1099/vir.0.83419-0; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WHO, 2013, CUM NUMB CONF HUM CA; World Organization for Animal Health (OIE), 2010, TERR AN HLTH COD, P556; Wu HB, 2012, ARCH VIROL, V157, P2017, DOI 10.1007/s00705-012-1370-3; Zhang PH, 2009, J VIROL, V83, P8428, DOI 10.1128/JVI.00659-09	46	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e91887	10.1371/journal.pone.0091887	http://dx.doi.org/10.1371/journal.pone.0091887			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776918	Green Published, Green Submitted, gold			2022-12-25	WOS:000346241800002
J	Byun, JI; Jung, KH; Kim, YD; Kim, JM; Roh, JK				Byun, Jung-Ick; Jung, Keun-Hwa; Kim, Young-Dae; Kim, Jeong-Min; Roh, Jae-Kyu			Cardiac Function and Outcome in Patients with Cardio-Embolic Stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; HEART-FAILURE; CARDIOEMBOLIC STROKE; CEREBRAL INFARCTION; ATRIAL-FIBRILLATION; TERM MORTALITY; PREDICTORS; REGISTRY; SUBTYPE	Background: The relationship between whole spectrum of Ejection fraction (EF) and cardioembolic stroke (CES) outcome has not been fully described yet. Notably, it remains unclear whether borderline EF (41 similar to 49%) is related with poor outcome after CES. We sought to evaluate whether lower ejection fraction and borderline EF could predict the outcome in patients with CES. Method and Results: We evaluated the relationship between EF and functional outcome in 437 consecutive patients with CES. EF was introduced as continuous and categorical (EF <= 40%, EF 41 similar to 49%, EF >= 50%) variable. Patients with CES and the subgroup with AF were evaluated separately. Poor short-term outcome (modified Rankin Score >= 3at discharge or death within 90 days after stroke onset) and long-term mortality were evaluated. A total of 165 patients (37.8%) had poor short-term outcomes. EF tends to be lower in patients with poor short-term outcome (56.8 +/- 11.0 vs. 54.8 +/- 12.0, p-value 0.086). Overall cumulative death was136 (31.1%) in all CES patients and 106 (31.7%) in the AF subgroup. In a multivariable model adjusted for possible covariates, the hazard ratio for mortality significantly decreased by 3% for every 1% increase in ejection fraction in CES patients and 2% for every 1% increase in the AF subgroup. Reduced EF (EF <= 40%) showed higher mortality (HR 2.61), and those with borderline EF (41 similar to 49%) had a tendency of higher mortality (HR 1.65, p-value 0.067) compared with those with normal EF. Conclusion: We found a strong association between lower EF and CES outcome. Echocardiographic evaluation helps to better determine the prognosis in CES patients, even in subgroup of patients with AF.	[Byun, Jung-Ick; Jung, Keun-Hwa] Seoul Natl Univ Hosp, Clin Res Inst, Dept Neurol, Seoul 110744, South Korea; [Byun, Jung-Ick; Jung, Keun-Hwa] Seoul Natl Univ, Coll Med, Program Neurosci, Seoul, South Korea; [Kim, Young-Dae] Yonsei Univ, Coll Med, Dept Neurol, Seoul 120749, South Korea; [Kim, Jeong-Min] ChungAng Univ Hosp, Dept Neurol, Seoul, South Korea; [Roh, Jae-Kyu] Armed Forces Capital Hosp, Dept Neurol, Songnam, Gyeunggido, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Chung Ang University; Chung Ang University Hospital	Jung, KH (corresponding author), Seoul Natl Univ Hosp, Clin Res Inst, Dept Neurol, Seoul 110744, South Korea.	jungkh@gmail.com; rohjk777@gmail.com		Kim, Young Dae/0000-0001-5750-2616; Jung, Keun-Hwa/0000-0003-1433-8005; Kim, Jeong-Min/0000-0001-7213-5527	Seoul National University Hospital Research Fund [04-2012-0990]	Seoul National University Hospital Research Fund	This study was supported by the Seoul National University Hospital Research Fund (04-2012-0990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Appelros P, 2002, STROKE, V33, P2357, DOI 10.1161/01.STR.0000030318.99727.FA; Arboix A, 2010, CURR CARDIOL REV, V6, P150, DOI 10.2174/157340310791658730; BOGOUSSLAVSKY J, 1991, NEUROLOGY, V41, P855, DOI 10.1212/WNL.41.6.855; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Choi BR, 2006, AM J CARDIOL, V97, P1365, DOI 10.1016/j.amjcard.2005.11.059; de Jong G, 2003, J CLIN EPIDEMIOL, V56, P262, DOI 10.1016/S0895-4356(02)00572-3; Ferro JM, 2003, LANCET NEUROL, V2, P177, DOI 10.1016/S1474-4422(03)00324-7; Georgiadis D, 2000, EUR HEART J, V21, P407, DOI 10.1053/euhj.1999.1742; Nam HS, 2012, STROKE, V43, P2948, DOI 10.1161/STROKEAHA.112.661074; Jung KH, 2012, CIRC-CARDIOVASC QUAL, V5, P327, DOI 10.1161/CIRCOUTCOMES.111.963736; Kim HC, 2009, NEUROEPIDEMIOLOGY, V32, P94, DOI 10.1159/000177034; Lamassa M, 2001, STROKE, V32, P392, DOI 10.1161/01.STR.32.2.392; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Milionis H, INT J CARDIOLOGY; Ois A, 2008, J NEUROL, V255, P385, DOI 10.1007/s00415-008-0677-1; Palumbo V, 2012, EUR J INTERN MED, V23, P552, DOI 10.1016/j.ejim.2012.03.015; Pullicino PM, 2000, NEUROLOGY, V54, P288, DOI 10.1212/WNL.54.2.288; Stead LG, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/281496; Steger C, 2004, EUR HEART J, V25, P1734, DOI 10.1016/j.ehj.2004.06.030; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Vemmos K, 2012, EUR J HEART FAIL, V14, P211, DOI 10.1093/eurjhf/hfr172	22	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95277	10.1371/journal.pone.0095277	http://dx.doi.org/10.1371/journal.pone.0095277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760037	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200045
J	Kouba, M; Bartos, L; St'astny, K				Kouba, Marek; Bartos, Ludek; St'astny, Karel			Factors Affecting Vocalization in Tengmalm's Owl (Aegolius funereus) Fledglings during Post-Fledging Dependence Period: Scramble Competition or Honest Signalling of Need?	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; YELLOW-HEADED BLACKBIRDS; SIBLING COMPETITION; BIPARENTAL CARE; FOOD ABUNDANCE; TREE SWALLOWS; STRIX-ALUCO; TAWNY OWLS; BROOD SIZE; BIRDS	Begging behaviour of nestlings has been intensively studied for several decades as a key component of parent-offspring conflict. There are essentially two main theories to account for intensity of food solicitation among offspring: that intensity of begging is related to some form of scramble competition between nest mates or that it offers honest signalling of need to parents. The vast majority of studies which have addressed begging behaviour have been based on observations of, and experiments on, nestlings and have not considered begging behaviour, during the post-fledging period. Begging vocalizations in this post-fledging phase of dependence have rarely been studied, despite the importance of vocalizations as a communication method between offspring and parents, particularly for nocturnal species. We radiotracked 39 fledglings of the Tengmalm's owl (Aegolius funereus) in two years with different availability of prey: 2010 (n = 29 fledglings) and 2011 (n = 10 fledglings) and made 1320 nightly localizations in which we recorded presence or absence of begging calls. Within years, the most important measures related to the probability of vocalization were body condition at fledging, time of night, number of surviving siblings, age and weather conditions. Begging intensity increased with age in both years; however, in the year with low prey availability fledglings vocalized significantly more often. The main factor causing these differences between years was probably the different availability of prey, affecting breeding success, post-fledging behaviour, and thus also both short-and long-term needs of offspring. We believe that our results suggest honest signalling of their fledgling's need.	[Kouba, Marek; St'astny, Karel] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague 6, Czech Republic; [Bartos, Ludek] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Anim Sci & Ethol, Prague 6, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague 10, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech Research Institute of Animal Science	Kouba, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague 6, Czech Republic.	marekkouba8@gmail.com	Kouba, Marek/A-1350-2019	Kouba, Marek/0000-0003-2262-5733	Czech University of Life Sciences Prague [IGA FZP 20100029, 20124228, CIGA ?ZU 20104205, 20144203, MSMT 1321/213205]; Ministry of Agriculture of the Czech Republic [MZERO 0714]	Czech University of Life Sciences Prague; Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This work has been supported by grants from the Czech University of Life Sciences Prague (IGA FZP 20100029 and 20124228, CIGA ?ZU 20104205 and 20144203, MSMT 1321/213205) and Ministry of Agriculture of the Czech Republic (MZERO 0714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELSLEY D. A, 1980, REGRESSION DIAGNOSTI; BUSTAMANTE J, 1990, IBIS, V132, P58, DOI 10.1111/j.1474-919X.1990.tb01016.x; BYE FN, 1992, BEHAV ECOL, V3, P266, DOI 10.1093/beheco/3.3.266; CRAMP S, 1985, BIRDS W PALAEARCTIC, V4; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Drdakova-Zarybnicka M, 2004, SYC ROUSNY USPESNY D; Drdakova-Zarybnicka M., 2005, BUTEO, V14, P37; Eldegard K, 2012, J ORNITHOL, V153, P385, DOI 10.1007/s10336-011-0753-7; Eldegard K, 2010, BEHAV ECOL SOCIOBIOL, V64, P815, DOI 10.1007/s00265-009-0898-z; Eldegard K, 2009, P ROY SOC B-BIOL SCI, V276, P1713, DOI 10.1098/rspb.2008.1775; Flousek J, 1991, SYLVIA, V28, P51; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Ganey JL, 1998, WILSON BULL, V110, P206; GODFRAY HCJ, 1995, AM NAT, V146, P1, DOI 10.1086/285784; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Granadeiro JP, 2000, BEHAV ECOL, V11, P274, DOI 10.1093/beheco/11.3.274; HARPER AB, 1986, AM NAT, V128, P99, DOI 10.1086/284542; HAYNE DW, 1949, J MAMMAL, V30, P1, DOI 10.2307/1375189; Hipkiss T, 2004, POPUL ECOL, V46, P263, DOI 10.1007/s10144-004-0195-7; Kenward RE., 2000, MANUAL WILDLIFE RADI; KILNER R, 1995, P ROY SOC B-BIOL SCI, V260, P343, DOI 10.1098/rspb.1995.0102; Klaus S., 1975, Zoologische Jb (Syst), V102, P485; Kloubec B., 1990, TICHODROMA, V3, P103; Kolliker M, 1998, ANIM BEHAV, V55, P215, DOI 10.1006/anbe.1997.0571; Konig C, 2008, OWLS WORLD; Korpimaki E, 1981, ACTA U OULUENSIS 118, V13, P1; Kouba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067034; Kouba Marek, 2012, Sylvia, V48, P115; Leonard M, 1996, BEHAV ECOL SOCIOBIOL, V38, P341, DOI 10.1007/s002650050250; Leonard ML, 2000, BEHAV ECOL, V11, P196, DOI 10.1093/beheco/11.2.196; Leonard ML, 1998, BEHAV ECOL SOCIOBIOL, V42, P431, DOI 10.1007/s002650050457; Lyons DE, 2011, J FIELD ORNITHOL, V82, P88, DOI 10.1111/j.1557-9263.2010.00311.x; MACNAIR MR, 1979, ANIM BEHAV, V27, P1202, DOI 10.1016/0003-3472(79)90067-8; Middleton HA, 2007, BEHAVIOUR, V144, P485, DOI 10.1163/156853907780713064; Mikkola H., 2020, OWLS, P97; MONDLOCH CJ, 1995, ANIM BEHAV, V49, P601; NORBERG R A, 1970, Ornis Scandinavica, V1, P51, DOI 10.2307/3676334; Pedersen D, 2013, ORNIS FENNICA, V90, P117; Penteriani V, 2005, IBIS, V147, P155, DOI 10.1111/j.1474-919x.2004.00381.x; Pokorny J., 2000, Buteo, V11, P107; Price K, 1996, AUK, V113, P963, DOI 10.2307/4088883; Price K, 1996, ANIM BEHAV, V51, P421, DOI 10.1006/anbe.1996.0039; Pykal Jiri, 1994, P537; Quillfeldt P, 2002, ANIM BEHAV, V64, P579, DOI 10.1006/anbe.2002.3090; REDONDO T, 1992, ETHOLOGY, V92, P193; Risely A, 2013, BIRD STUDY, V60, P539, DOI 10.1080/00063657.2013.846293; RodriguezGirones MA, 1996, P NATL ACAD SCI USA, V93, P14637, DOI 10.1073/pnas.93.25.14637; Roulin A, 2000, P ROY SOC B-BIOL SCI, V267, P459, DOI 10.1098/rspb.2000.1022; Roulin A, 2001, BEHAV ECOL, V12, P506, DOI 10.1093/beheco/12.4.506; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Sacchi R, 2002, BEHAV ECOL, V13, P268, DOI 10.1093/beheco/13.2.268; Stokes M.E., 2012, CATEGORICAL DATA ANA; Sunde P, 2005, OIKOS, V110, P461, DOI 10.1111/j.0030-1299.2005.14069.x; Sunde P, 2008, J AVIAN BIOL, V39, P242, DOI 10.1111/j.2008.0908-8857.04194.x; Thompson AM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0558; TRIVERS RL, 1974, AM ZOOL, V14, P249; Vacik R, 1991, SYLVIA, V28, P95; VanNieuwenhuyse D, 2008, LITTLE OWL: CONSERVATION, ECOLOGY AND BEHAVIOR OF ATHENE NOCTUA, P1; Vergara P, 2010, BEHAV ECOL, V21, P507, DOI 10.1093/beheco/arq011; Withey John C., 2001, P43, DOI 10.1016/B978-012497781-5/50004-9; Wright J, 1990, BEHAV ECOL, V1, P116, DOI 10.1093/beheco/1.2.116; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; Zarybnicka M, 2009, ACTA ORNITHOL, V44, P81, DOI 10.3161/000164509X464911	64	12	12	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95594	10.1371/journal.pone.0095594	http://dx.doi.org/10.1371/journal.pone.0095594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760102	Green Published, gold			2022-12-25	WOS:000335298200067
J	Sankari, S; O'Brian, MR				Sankari, Siva; O'Brian, Mark R.			A Bacterial Iron Exporter for Maintenance of Iron Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE REGULATOR IRR; BRADYRHIZOBIUM-JAPONICUM; HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; OXIDATIVE STRESS; GENE ENCODES; PROTEIN; TRANSPORTER; EXPRESSION; MANGANESE	Nutritional iron acquisition by bacteria is well described, but almost nothing is known about bacterial iron export even though it is likely to be an important homeostatic mechanism. Here, we show that Bradyrhizobium japonicum MbfA (Blr7895) is an inner membrane protein expressed in cells specifically under high iron conditions. MbfA contains an N-terminal ferritin-like domain (FLD) and a C-terminal domain homologous to the eukaryotic vacuolar membrane Fe2+/Mn2+ transporter CCC1. An mbfA deletion mutant is severely defective in iron export activity, contains >2-fold more intracellular iron than the parent strain, and displays an aberrant iron-dependent gene expression phenotype. B. japonicum is highly resistant to iron and H2O2 stresses, and MbfA contributes substantially to this as determined by phenotypes of the mbfA mutant strain. The N-terminal FLD was localized to the cytoplasmic side of the inner membrane. Substitution mutations in the putative iron-binding amino acid residues E20A and E107A within the N-terminal FLD abrogate iron export activity and stress response function. Purified soluble FLD oxidizes ferrous iron (Fe2+) to incorporate ferric iron (Fe3+) in a 2: 1 iron: protein ratio, which does not occur in the E20A/E107A mutant. The FLD fragment is a dimer in solution, implying that the MbfA exporter functions as a dimer. MbfA belongs to a protein family found in numerous prokaryotic genera. The findings strongly suggest that iron export plays an important role in bacterial iron homeostasis.	[Sankari, Siva; O'Brian, Mark R.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	O'Brian, MR (corresponding author), SUNY Buffalo, Dept Biochem, 140 Farber Hall, Buffalo, NY 14214 USA.	mrobrian@buffalo.edu	sankaran, Siva Sankari iyer mani/AAB-5222-2020		National Institutes of Health [R01 099667]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 099667 (to M.R. O'B.).	Anderson ES, 2011, J BACTERIOL, V193, P5359, DOI 10.1128/JB.00372-11; BAUMINGER ER, 1991, BIOCHIM BIOPHYS ACTA, V1118, P48, DOI 10.1016/0167-4838(91)90440-B; Bozzi M, 1997, J BIOL CHEM, V272, P3259, DOI 10.1074/jbc.272.6.3259; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Escamilla-Hernandez R, 2012, J BACTERIOL, V194, P3137, DOI 10.1128/JB.00071-12; FRUSTACI JM, 1991, J BACTERIOL, V173, P1145, DOI 10.1128/jb.173.3.1145-1150.1991; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Hohle TH, 2011, P NATL ACAD SCI USA, V108, P15390, DOI 10.1073/pnas.1110137108; Hohle TH, 2009, MOL MICROBIOL, V72, P399, DOI 10.1111/j.1365-2958.2009.06650.x; Jaggavarapu S, 2014, MOL MICROBIOL, V92, P609, DOI 10.1111/mmi.12584; Lapinskas PJ, 1996, MOL MICROBIOL, V21, P519, DOI 10.1111/j.1365-2958.1996.tb02561.x; LEBRUN NE, 1993, FEBS LETT, V333, P197, DOI 10.1016/0014-5793(93)80404-I; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Martinez M, 2005, MICROBIOL-SGM, V151, P3427, DOI 10.1099/mic.0.28213-0; Nicolaou SA, 2013, APPL ENVIRON MICROB, V79, P7210, DOI 10.1128/AEM.02322-13; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Puri S, 2006, J BACTERIOL, V188, P6476, DOI 10.1128/JB.00737-06; Puri S, 2010, P NATL ACAD SCI USA, V107, P10691, DOI 10.1073/pnas.1002342107; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Ruangkiattikul N, 2012, FEMS MICROBIOL LETT, V329, P87, DOI 10.1111/j.1574-6968.2012.02509.x; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; Rudolph G, 2006, FEMS MICROBIOL REV, V30, P631, DOI 10.1111/j.1574-6976.2006.00030.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sangwan I, 2008, J BACTERIOL, V190, P5172, DOI 10.1128/JB.00495-08; Serventi F, 2012, J BIOL CHEM, V287, P38812, DOI 10.1074/jbc.M112.406173; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; Small SK, 2011, J BACTERIOL, V193, P4088, DOI 10.1128/JB.05064-11; Small S, 2009, BIOMETALS, V22, P89, DOI 10.1007/s10534-008-9192-1; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; VALLEJO AN, 1994, PCR METH APPL, V4, pS123; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x	35	21	23	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16498	16507		10.1074/jbc.M114.571562	http://dx.doi.org/10.1074/jbc.M114.571562			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24782310	hybrid, Green Published			2022-12-25	WOS:000337965700051
J	Sugiyama, K; Iyori, M; Sawaguchi, A; Akashi, S; Tame, JRH; Park, SY; Yoshida, S				Sugiyama, Kanako; Iyori, Mitsuhiro; Sawaguchi, Asuka; Akashi, Satoko; Tame, Jeremy R. H.; Park, Sam-Yong; Yoshida, Shigeto			The Crystal Structure of the Active Domain of Anopheles Anti-platelet Protein, a Powerful Anti-coagulant, in Complex with an Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APTAMER ARC1779; PLATELET-AGGREGATION; THROMBUS FORMATION; COLLAGEN; MOSQUITO; AEGYPTIN; EFFICACY; SAFETY; SALIVA	Blood clotting is a vitally important process that must be carefully regulated to prevent blood loss on one hand and thrombosis on the other. Severe injury and hemophilia may be treated with pro-coagulants, whereas risk of obstructive clotting or embolism may be reduced with anti-coagulants. Anti-coagulants are an extremely important class of drug, one of the most widely used types of medication, but there remains a pressing need for novel treatments, however, as present drugs such as warfarin have significant drawbacks. Nature provides a number of examples of anti-coagulant proteins produced by blood-sucking animals, which may provide templates for the development of new small molecules with similar physiological effects. We have, therefore, studied an Anopheles anti-platelet protein from a malaria vector mosquito and report its crystal structure in complex with an antibody. Overall the protein is extremely sensitive to proteolysis, but the crystal structure reveals a stable domain built from two helices and a turn, which corresponds to the functional region. The antibody raised against Anopheles anti-platelet protein prevents it from binding collagen. Our work, therefore, opens new avenues to the development of both novel small molecule anti-clotting agents and anti-malarials.	[Sugiyama, Kanako; Tame, Jeremy R. H.; Park, Sam-Yong] Yokohama City Univ, Grad Sch Med Life Sci, Drug Design Lab, Yokohama, Kanagawa 2300045, Japan; [Iyori, Mitsuhiro; Sawaguchi, Asuka; Yoshida, Shigeto] Kanazawa Univ, Sch Pharm, Lab Vaccinol & Appl Immunol, Kanazawa, Ishikawa 9201192, Japan; [Akashi, Satoko] Yokohama City Univ, Grad Sch Med Life Sci, Struct Epigenet Lab, Yokohama, Kanagawa 2300045, Japan	Yokohama City University; Kanazawa University; Yokohama City University	Park, SY (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Drug Design Lab, 1-7-29 Suehiro, Yokohama, Kanagawa 2300045, Japan.	park@tsurumi.yokohama-cu.ac.jp; shigeto@p.kanazawa-u.ac.jp	IYORI, MITSUHIRO/D-8395-2015	IYORI, MITSUHIRO/0000-0001-9940-7342; Akashi, Satoko/0000-0002-8978-6358	Japan Society for the Promotion of Science [25305007]; Grants-in-Aid for Scientific Research [24659460] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research (B) 25305007 from the Japan Society for the Promotion of Science (to S.Y.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Calvo E, 2010, FEBS J, V277, P413, DOI 10.1111/j.1742-4658.2009.07494.x; CARTER PB, 1986, VET CLIN N AM-SMALL, V16, P1171, DOI 10.1016/S0195-5616(86)50135-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Furlan AJ, 2006, STROKE, V37, P1227, DOI 10.1161/01.STR.0000217403.66996.6d; FUSTER V, 1992, NEW ENGL J MED, V326, P310; GARDELL SJ, 1989, J BIOL CHEM, V264, P17947; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; Hayashi H, 2013, PLATELETS, V24, P324, DOI 10.3109/09537104.2012.698430; Hayashi H, 2012, THROMB RES, V129, P169, DOI 10.1016/j.thromres.2011.09.015; Huizinga EG, 1997, STRUCTURE, V5, P1147, DOI 10.1016/S0969-2126(97)00266-9; Knobl P, 2009, TRANSFUSION, V49, P2181, DOI 10.1111/j.1537-2995.2009.02232.x; Kuruvilla M, 2001, Proc (Bayl Univ Med Cent), V14, P305; Mayr FB, 2010, TRANSFUSION, V50, P1079, DOI 10.1111/j.1537-2995.2009.02554.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mizurini DM, 2013, BIOCHEM BIOPH RES CO, V436, P235, DOI 10.1016/j.bbrc.2013.05.082; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paciaroni M, 2009, EXPERT OPIN BIOL TH, V9, P773, DOI 10.1517/14712590902991497; Penz S, 2005, FASEB J, V19, P898, DOI 10.1096/fj.04-2748com; Reininger AJ, 2008, THROMB RES, V122, pS9, DOI 10.1016/S0049-3848(08)70028-8; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Ulrichts H, 2011, BLOOD, V118, P757, DOI 10.1182/blood-2010-11-317859; Uysal H, 2008, MOL IMMUNOL, V45, P2196, DOI 10.1016/j.molimm.2007.12.005; Van de Werf F, 2010, CIRCULATION, V121, P5, DOI 10.1161/CIR.0b013e3181cd3d17; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Warkentin TE, 2008, THROMB HAEMOSTASIS, V99, P830, DOI 10.1160/TH07-10-0644; Yamamoto DS, 2010, INSECT MOL BIOL, V19, P391, DOI 10.1111/j.1365-2583.2010.01000.x; Yoshida S, 2008, BLOOD, V111, P2007, DOI 10.1182/blood-2007-06-097824	34	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16303	16312		10.1074/jbc.M114.564526	http://dx.doi.org/10.1074/jbc.M114.564526			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764297	hybrid, Green Published			2022-12-25	WOS:000337965700034
J	Towle-Weicksel, JB; Dalal, S; Sohl, CD; Doublie, S; Anderson, KS; Sweasy, JB				Towle-Weicksel, Jamie B.; Dalal, Shibani; Sohl, Christal D.; Doublie, Sylvie; Anderson, Karen S.; Sweasy, Joann B.			Fluorescence Resonance Energy Transfer Studies of DNA Polymerase beta THE CRITICAL ROLE OF FINGERS DOMAIN MOVEMENTS AND A NOVEL NON-COVALENT STEP DURING NUCLEOTIDE SELECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPHOBIC HINGE REGION; CRYSTAL-STRUCTURES; TERNARY COMPLEXES; MUTATOR MUTANT; CONFORMATIONAL-CHANGES; CATALYTIC MECHANISM; NUCLEOTIDE-BINDING; BASE SUBSTITUTION; KINETIC MECHANISM; STRUCTURAL BASIS	During DNA repair, DNA polymerase beta (Pol beta) is a highly dynamic enzyme that is able to select the correct nucleotide opposite a templating base from a pool of four different deoxynucleoside triphosphates (dNTPs). To gain insight into nucleotide selection, we use a fluorescence resonance energy transfer (FRET)-based system to monitor movement of the Pol beta fingers domain during catalysis in the presence of either correct or incorrect dNTPs. By labeling the fingers domain with ((((2-iodoacetyl)amino)ethyl)amino)naphthalene-1-sulfonicacid(IAEDANS) and the DNA substrate with Dabcyl, we are able to observe rapid fingers closing in the presence of correct dNTPs as the IAEDANS comes into contact with a Dabcyl-labeled, one-base gapped DNA. Our findings show that not only do the fingers close after binding to the correct dNTP, but that there is a second conformational change associated with a non-covalent step not previously reported for Pol beta. Further analyses suggest that this conformational change corresponds to the binding of the catalytic metal into the polymerase active site. FRET studies with incorrect dNTP result in no changes in fluorescence, indicating that the fingers do not close in the presence of incorrect dNTP. Together, our results show that nucleotide selection initially occurs in an open fingers conformation and that the catalytic pathways of correct and incorrect dNTPs differ from each other. Overall, this study provides new insight into the mechanism of substrate choice by a polymerase that plays a critical role in maintaining genome stability.	[Towle-Weicksel, Jamie B.; Dalal, Shibani; Sweasy, Joann B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Sohl, Christal D.; Anderson, Karen S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	Yale University; Yale University; University of Vermont	Sweasy, JB (corresponding author), 333 Cedar St,POB 208040, New Haven, CT 06520 USA.	joann.sweasy@yale.edu		Doublie, Sylvie/0000-0002-6294-5304	National Institutes of Health [CA 080830, GM49551, GM099289]; NATIONAL CANCER INSTITUTE [R01CA080830, U19CA177547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049551, F32GM099289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 080830 (to J. B. S.), GM49551(to K. S. A.), and GM099289 (to C. D. S.).	Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; Bakhtina M, 2005, BIOCHEMISTRY-US, V44, P5177, DOI 10.1021/bi047664w; Bakhtina M, 2007, BIOCHEMISTRY-US, V46, P5463, DOI 10.1021/bi700084w; Balbo PB, 2011, BIOCHEMISTRY-US, V50, P9865, DOI 10.1021/bi200954r; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Basu RS, 2013, J BIOL CHEM, V288, P3305, DOI 10.1074/jbc.M112.387712; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Chagovetz AM, 1997, J BIOL CHEM, V272, P27501, DOI 10.1074/jbc.272.44.27501; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Eckenroth BE, 2013, J BIOL CHEM, V288, P34850, DOI 10.1074/jbc.M113.510891; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Gridley CL, 2013, BIOCHEMISTRY-US, V52, P4422, DOI 10.1021/bi301368f; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Klvana M, 2012, BIOCHEMISTRY-US, V51, P8829, DOI 10.1021/bi300783t; Kosa JL, 1999, J BIOL CHEM, V274, P35866, DOI 10.1074/jbc.274.50.35866; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; Li SX, 1999, BIOCHEMISTRY-US, V38, P4800, DOI 10.1021/bi9827058; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Lin GC, 2007, NUCLEIC ACIDS RES, V35, P2924, DOI 10.1093/nar/gkm126; Lin GC, 2009, DNA REPAIR, V8, P182, DOI 10.1016/j.dnarep.2008.10.006; Maitra M, 2002, J BIOL CHEM, V277, P35550, DOI 10.1074/jbc.M204953200; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Maxwell BA, 2013, J BIOL CHEM, V288, P11590, DOI 10.1074/jbc.M113.459982; Murphy DL, 2008, BIOCHEMISTRY-US, V47, P8048, DOI 10.1021/bi702104y; Murphy DL, 2012, BIOCHEMISTRY-US, V51, P5269, DOI 10.1021/bi3003583; Murphy DL, 2011, J AM CHEM SOC, V133, P6279, DOI 10.1021/ja111099b; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Nemec AA, 2014, J BIOL CHEM, V289, P13708, DOI 10.1074/jbc.M114.550400; Opresko PL, 1998, BIOCHEMISTRY-US, V37, P2111, DOI 10.1021/bi9722711; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12778, DOI 10.1021/bi960790i; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Perumal SK, 2013, P NATL ACAD SCI USA, V110, P99, DOI 10.1073/pnas.1212748110; PETERMAN BF, 1979, ANAL BIOCHEM, V93, P442, DOI 10.1016/S0003-2697(79)80176-1; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Shah AM, 2001, J BIOL CHEM, V276, P10824, DOI 10.1074/jbc.M008680200; Shah AM, 2001, BIOCHEMISTRY-US, V40, P11372, DOI 10.1021/bi010755y; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; Starcevic D, 2005, J BIOL CHEM, V280, P28388, DOI 10.1074/jbc.M502178200; Starcevic D, 2005, BIOCHEMISTRY-US, V44, P3775, DOI 10.1021/bi047956x; Sucato CA, 2008, BIOCHEMISTRY-US, V47, P870, DOI 10.1021/bi7014162; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Xia SL, 2011, BIOCHEMISTRY-US, V50, P9114, DOI 10.1021/bi201260h; Xu CL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000225; Yamtich J, 2010, BIOCHEMISTRY-US, V49, P2326, DOI 10.1021/bi901735a; Yamtich J, 2010, BBA-PROTEINS PROTEOM, V1804, P1136, DOI 10.1016/j.bbapap.2009.07.008; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j	59	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16541	16550		10.1074/jbc.M114.561878	http://dx.doi.org/10.1074/jbc.M114.561878			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764311	hybrid, Green Published			2022-12-25	WOS:000337965700055
J	Hamlekhan, A; Butt, A; Patel, S; Royhman, D; Takoudis, C; Sukotjo, C; Yuan, J; Jursich, G; Mathew, MT; Hendrickson, W; Virdi, A; Shokuhfar, T				Hamlekhan, Azhang; Butt, Arman; Patel, Sweetu; Royhman, Dmitry; Takoudis, Christos; Sukotjo, Cortino; Yuan, Judy; Jursich, Gregory; Mathew, Mathew T.; Hendrickson, William; Virdi, Amarjit; Shokuhfar, Tolou			Fabrication of Anti-Aging TiO2 Nanotubes on Biomedical Ti Alloys	PLOS ONE			English	Article							HYDROXYAPATITE GROWTH; OSTEOBLAST ADHESION; ANODIC-OXIDATION; CELL ATTACHMENT; TITANIUM-ALLOYS; IN-VITRO; CP-TI; SURFACE; TI6AL4V; ANODIZATION	The primary objective of this study was to fabricate a TiO2 nanotubular surface, which could maintain hydrophilicity over time (resist aging). In order to achieve non-aging hydrophilic surfaces, anodization and annealing conditions were optimized. This is the first study to show that anodization and annealing condition affect the stability of surface hydrophilicity. Our results indicate that maintenance of hydrophilicity of the obtained TiO2 nanotubes was affected by anodization voltage and annealing temperature. Annealing sharply decreased the water contact angle (WCA) of the as-synthesized TiO2 nanotubular surface, which was correlated to improved hydrophilicity. TiO2 nanotubular surfaces are transformed to hydrophilic surfaces after annealing, regardless of annealing and anodization conditions; however, WCA measurements during aging demonstrate that surface hydrophilicity of non-anodized and 20 V anodized samples decreased after only 11 days of aging, while the 60 V anodized samples maintained their hydrophilicity over the same time period. The nanotubes obtained by 60 V anodization followed by 600 degrees C annealing maintained their hydrophilicity significantly longer than nanotubes which were obtained by 60 V anodization followed by 300 degrees C annealing.	[Hamlekhan, Azhang; Shokuhfar, Tolou] Michigan Technol Univ, Dept Mech Engn Engn Mech, Multiscale Technol Inst, Houghton, MI 49931 USA; [Butt, Arman; Patel, Sweetu; Takoudis, Christos] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Royhman, Dmitry; Sukotjo, Cortino; Yuan, Judy] Univ Illinois, Coll Dent, Dept Restorat Dent, Chicago, IL USA; [Jursich, Gregory] Univ Illinois, Dept Chem Engn, Chicago, IL 60680 USA; [Mathew, Mathew T.] Rush Univ, Med Ctr, Dept Orthoped, Chicago, IL 60612 USA; [Hendrickson, William] Univ Illinois, Res Resources Ctr, Chicago, IL USA; [Virdi, Amarjit] Rush Univ, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Shokuhfar, Tolou] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL USA; [Shokuhfar, Tolou] Univ Illinois, Dept Phys, Chicago, IL 60680 USA	Michigan Technological University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shokuhfar, T (corresponding author), Michigan Technol Univ, Dept Mech Engn Engn Mech, Multiscale Technol Inst, Houghton, MI 49931 USA.	tshokuhf@mtu.edu	Shokuhfar, Tolou/AAI-9100-2020	Mathew, Mathew/0000-0003-3604-7938	Michigan Technological University	Michigan Technological University	The authors would like to thank Michigan Technological University for providing the funding to support this research. The URL of any funder's website: http://www.mtu.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2011, SURF INTERFACE ANAL, V43, P998, DOI 10.1002/sia.3683; Barao VA, 2011, J DENT RES, V90, P613, DOI 10.1177/0022034510396880; Barao VAR, 2012, CLIN ORAL IMPLAN RES, V23, P1055, DOI 10.1111/j.1600-0501.2011.02265.x; Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463; Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008; Chen GJ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015017; Chen ZX, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065003; Dai HB, 2011, CATAL TODAY, V170, P50, DOI 10.1016/j.cattod.2010.10.094; Dalton BA, 1998, J BIOMAT SCI-POLYM E, V9, P781, DOI 10.1163/156856298X00154; Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088; Dhonge BP, 2011, APPL SURF SCI, V258, P1091, DOI 10.1016/j.apsusc.2011.09.040; Ercan B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295102; Eshkeiti A, 2012, SENSOR ACTUAT B-CHEM, V171, P705, DOI 10.1016/j.snb.2012.05.060; Gao L, 2009, J BIOMED MATER RES B, V89B, P335, DOI 10.1002/jbm.b.31221; Giordano C, 2011, COLLOID SURFACE B, V88, P648, DOI 10.1016/j.colsurfb.2011.07.054; Hamlekhan A., 2011, BIOMATTER, V1, P1; Hu XX, 2011, APPL SURF SCI, V257, P1813, DOI 10.1016/j.apsusc.2010.08.082; Jimbo R, 2008, CLIN IMPLANT DENT R, V10, P55, DOI 10.1111/j.1708-8208.2007.00061.x; Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041; Kim H, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025011; Kluson P, 2005, J MOL CATAL A-CHEM, V242, P62, DOI 10.1016/j.molcata.2005.07.024; Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8; Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Macak JM, 2005, J BIOMED MATER RES A, V75A, P928, DOI 10.1002/jbm.a.30501; Masahashi N, 2012, THIN SOLID FILMS, V520, P4956, DOI 10.1016/j.tsf.2012.03.026; Massia SP, 1999, TISSUE ENG VASCULAR; Mazare A, 2012, BIOELECTROCHEMISTRY, V87, P124, DOI 10.1016/j.bioelechem.2012.01.002; Minagar S, 2012, ACTA BIOMATER, V8, P2875, DOI 10.1016/j.actbio.2012.04.005; Nguyen QT, 2002, THIN SOLID FILMS, V410, P42, DOI 10.1016/S0040-6090(02)00239-0; Niespodziana K, 2008, REV ADV MATER SCI, V18, P236; Nourmohammadzadeh M, 2013, ANAL CHEM, V85, P11240, DOI 10.1021/ac401297v; Oh S, 2006, MAT SCI ENG C-BIO S, V26, P1301, DOI 10.1016/j.msec.2005.08.014; Oh S, 2009, P NATL ACAD SCI USA, V106, pE61, DOI 10.1073/pnas.0904869106; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048; Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d; Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502; Rajyalakshmi A, 2011, INT J NANOMED, V6, P1765, DOI 10.2147/IJN.S22763; RIESGRAF DA, 1978, APPL SPECTROSC, V32, P362, DOI 10.1366/000370278774331233; SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257; Shin DH, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/31/315704; Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005; STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712; Takebe J, 2000, J BIOMED MATER RES, V51, P398, DOI 10.1002/1097-4636(20000905)51:3<398::AID-JBM14>3.0.CO;2-#; Tan AW, 2012, CERAM INT, V38, P4421, DOI 10.1016/j.ceramint.2012.03.002; Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677; Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212; von Wilmowsky C, 2012, CLIN ORAL IMPLAN RES, V23, P359, DOI 10.1111/j.1600-0501.2010.02139.x; Wan J, 2009, MATER CHARACT, V60, P1534, DOI 10.1016/j.matchar.2009.09.002; Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S; Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002; Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Woo S, 2012, MICROELECTRON ENG, V89, P89, DOI 10.1016/j.mee.2011.03.146; Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008; Yoshiya STaKH K.E.R.A., 1967, SHORT COMMUNICATION, V40, P1; Yu WQ, 2010, ORAL DIS, V16, P624, DOI 10.1111/j.1601-0825.2009.01643.x; Yu WQ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065012; Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014	60	58	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96213	10.1371/journal.pone.0096213	http://dx.doi.org/10.1371/journal.pone.0096213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788345	gold, Green Submitted, Green Published			2022-12-25	WOS:000336655700064
J	Liu, PY; Lu, HZ; Filbey, FM; Pinkham, AE; McAdams, CJ; Adinoff, B; Daliparthi, V; Cao, Y				Liu, Peiying; Lu, Hanzhang; Filbey, Francesca M.; Pinkham, Amy E.; McAdams, Carrie J.; Adinoff, Bryon; Daliparthi, Vamsi; Cao, Yan			Automatic and Reproducible Positioning of Phase-Contrast MRI for the Quantification of Global Cerebral Blood Flow	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; ROTTERDAM SCAN; METABOLIC-RATE; VELOCITY; AGREEMENT; CMRO2	Phase-Contrast MRI (PC-MRI) is a noninvasive technique to measure blood flow. In particular, global but highly quantitative cerebral blood flow (CBF) measurement using PC-MRI complements several other CBF mapping methods such as arterial spin labeling and dynamic susceptibility contrast MRI by providing a calibration factor. The ability to estimate blood supply in physiological units also lays a foundation for assessment of brain metabolic rate. However, a major obstacle before wider applications of this method is that the slice positioning of the scan, ideally placed perpendicular to the feeding arteries, requires considerable expertise and can present a burden to the operator. In the present work, we proposed that the majority of PC-MRI scans can be positioned using an automatic algorithm, leaving only a small fraction of arteries requiring manual positioning. We implemented and evaluated an algorithm for this purpose based on feature extraction of a survey angiogram, which is of minimal operator dependence. In a comparative test-retest study with 7 subjects, the blood flow measurement using this algorithm showed an inter-session coefficient of variation (CoV) of 4.07 +/- 3.03%. The Bland-Altman method showed that the automatic method differs from the manual method by between -8% and 11%, for 95% of the CBF measurements. This is comparable to the variance in CBF measurement using manually-positioned PC MRI alone. In a further application of this algorithm to 157 consecutive subjects from typical clinical cohorts, the algorithm provided successful positioning in 89.7% of the arteries. In 79.6% of the subjects, all four arteries could be planned using the algorithm. Chi-square tests of independence showed that the success rate was not dependent on the age or gender, but the patients showed a trend of lower success rate (p = 0.14) compared to healthy controls. In conclusion, this automatic positioning algorithm could improve the application of PC-MRI in CBF quantification.	[Liu, Peiying; Lu, Hanzhang; Daliparthi, Vamsi] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Liu, Peiying; Lu, Hanzhang; Pinkham, Amy E.; McAdams, Carrie J.; Adinoff, Bryon] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Filbey, Francesca M.] Univ Texas Dallas, Ctr Brain Hlth, Sch Behav & Brain Sci, Dallas, TX USA; [Pinkham, Amy E.] So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA; [Adinoff, Bryon] VA North Texas Hlth Care Syst, Dallas, TX USA; [Cao, Yan] Univ Texas Dallas, Dept Math Sci, Richardson, TX 75083 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; Southern Methodist University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Dallas	Cao, Y (corresponding author), Univ Texas Dallas, Dept Math Sci, Richardson, TX 75083 USA.	yan.cao@utdallas.edu	McAdams, Carrie J./M-6822-2017; Filbey, Francesca M./J-5163-2014; Liu, Peiying/D-7512-2017; Filbey, Francesca/V-1366-2019	McAdams, Carrie J./0000-0002-4768-6703; Liu, Peiying/0000-0003-0830-5960; Filbey, Francesca/0000-0002-7466-4796	NIH [R01 MH084021, R01 NS067015, R21 AG034318, R01 AG042753, R21 NS078656, R01 DA023203]; NSF [DMS-0914910]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS078656, R01NS067015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042753, R21AG034318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030344, R01DA023203] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported in part by NIH R01 MH084021 (to H. L.), NIH R01 NS067015 (to H. L.), NIH R21 AG034318 (to H. L.), NIH R01 AG042753 (to H. L.), NIH R21 NS078656 (to H. L.), NIH R01 DA023203 (to B. A.), and NSF DMS-0914910 (to Y.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2008, J PHYSIOL-LONDON, V586, P4005, DOI 10.1113/jphysiol.2008.158279; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Bakker CJG, 1999, JMRI-J MAGN RESON IM, V9, P119, DOI 10.1002/(SICI)1522-2586(199901)9:1<119::AID-JMRI16>3.3.CO;2-6; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Bolar DS, 2011, MAGN RESON MED, V66, P1550, DOI 10.1002/mrm.22946; Bonekamp D, 2011, MAGN RESON MED, V66, P57, DOI 10.1002/mrm.22776; Bremmer JP, 2011, MOL IMAGING BIOL, V13, P759, DOI 10.1007/s11307-010-0382-1; Dasgupta S., 2006, ALGORITHMS; EVANS AJ, 1993, INVEST RADIOL, V28, P109, DOI 10.1097/00004424-199302000-00004; Fan AP, 2012, MAGN RESON MED, V67, P669, DOI 10.1002/mrm.23050; Haccke EM, 1999, MR ANGIOGRAPHY FLOW; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Kochanowicz J, 2009, NEUROL NEUROCHIR POL, V43, P3; Liu PY, 2013, MAGN RESON MED, V69, P675, DOI 10.1002/mrm.24295; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Poels MMF, 2008, J CEREBR BLOOD F MET, V28, P1652, DOI 10.1038/jcbfm.2008.62; Rodgers ZB, 2013, J CEREBR BLOOD F MET, V33, P1514, DOI 10.1038/jcbfm.2013.110; Varela M, 2012, NMR BIOMED, V25, P1063, DOI 10.1002/nbm.2771; Vernooij MW, 2008, J CEREBR BLOOD F MET, V28, P412, DOI 10.1038/sj.jcbfm.9600526; Weber E, 2009, HEAD NECK NETTERS CO; Xu F, 2009, MAGN RESON MED, V62, P141, DOI 10.1002/mrm.21994; ZANANIRI FV, 1991, J MED ENG TECHNOL, V15, P170, DOI 10.3109/03091909109023704	24	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95721	10.1371/journal.pone.0095721	http://dx.doi.org/10.1371/journal.pone.0095721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787742	gold, Green Published, Green Submitted			2022-12-25	WOS:000336655700035
J	Stone, AEL; Mitchell, A; Brownell, J; Miklin, DJ; Golden-Mason, L; Polyak, SJ; Gale, MJ; Rosen, HR				Stone, Amy E. L.; Mitchell, Angela; Brownell, Jessica; Miklin, Daniel J.; Golden-Mason, Lucy; Polyak, Stephen J.; Gale, Michael J., Jr.; Rosen, Hugo R.			Hepatitis C Virus Core Protein Inhibits Interferon Production by a Human Plasmacytoid Dendritic Cell Line and Dysregulates Interferon Regulatory Factor-7 and Signal Transducer and Activator of Transcription (STAT) 1 Protein Expression	PLOS ONE			English	Article							CHRONIC HCV INFECTION; IFN-ALPHA PRODUCTION; RIG-I; ANTIVIRAL RESPONSE; RECOGNITION; THERAPY; IRF-7; GC1QR; INDUCTION; LIGAND	Plasmacytoid Dendritic Cells (pDCs) represent a key immune cell population in the defense against viruses. pDCs detect viral pathogen associated molecular patterns (PAMPs) through pattern recognition receptors (PRR). PRR/PAMP interactions trigger signaling events that induce interferon (IFN) production to initiate local and systemic responses. pDCs produce Type I and Type III (IFNL) IFNs in response to HCV RNA. Extracellular HCV core protein (Core) is found in the circulation in chronic infection. This study defined how Core modulates PRR signaling in pDCs. Type I and III IFN expression and production following exposure to recombinant Core or beta-galactosiade was assessed in human GEN2.2 cells, a pDC cell line. Core suppressed type I and III IFN production in response to TLR agonists and the HCV PAMP agonist of RIG-I. Core suppression of IFN induction was linked with decreased IRF-7 protein levels and increased non-phosphorylated STAT1 protein. Circulating Core protein interferes with PRR signaling by pDCs to suppress IFN production. Strategies to define and target Core effects on pDCs may serve to enhance IFN production and antiviral actions against HCV.	[Stone, Amy E. L.; Mitchell, Angela; Golden-Mason, Lucy; Rosen, Hugo R.] Univ Colorado, Integrated Dept Immunol, Denver, CO 80202 USA; [Stone, Amy E. L.; Mitchell, Angela; Golden-Mason, Lucy; Rosen, Hugo R.] Natl Jewish Hlth, Denver, CO USA; [Stone, Amy E. L.; Mitchell, Angela; Miklin, Daniel J.; Golden-Mason, Lucy; Rosen, Hugo R.] Univ Colorado, Dept Med, Hepatitis C Ctr, Div Gastroenterol & Hepatol, Denver, CO 80202 USA; [Brownell, Jessica; Polyak, Stephen J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Polyak, Stephen J.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Gale, Michael J., Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Rosen, Hugo R.] Denver Vet Affairs Med Ctr, Denver, CO USA	University of Colorado System; University of Colorado Denver; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Rosen, HR (corresponding author), Univ Colorado, Integrated Dept Immunol, Denver, CO 80202 USA.	Hugo.Rosen@UCDENVER.edu	Stone, Amy/T-7852-2019; Mitchell, Angela M/GQB-5477-2022; Mitchell, Angela/AAB-9956-2022	Golden-Mason, Lucy/0000-0003-3347-4192; STONE, AMY E/0000-0002-9140-6510; Mitchell, Angela/0000-0003-1955-5850; Golden-Mason, Lucy/0000-0002-2087-4405; Gale, Michael/0000-0002-6332-7436; Miklin, Daniel/0000-0002-3864-3672	NIH [U19 AI 1066328]; VA Merit Review grant; NIH/NCATS Colorado CTSI [TL1 TR000155]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066328, F31AI010663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review grant(US Department of Veterans Affairs); NIH/NCATS Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH U19 AI 1066328, a VA Merit Review grant and NIH/NCATS Colorado CTSI Grant Number TL1 TR000155. Contents are the authors' sole responsibility and do not necessarily represent official NIH views. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hakeem MS, 2010, J VIROL, V84, P10429, DOI 10.1128/JVI.01094-10; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Daffis S, 2008, J VIROL, V82, P8465, DOI 10.1128/JVI.00918-08; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Edlich B, 2012, HEPATOLOGY, V55, P39, DOI 10.1002/hep.24628; Florentin J, 2012, BLOOD, V120, P4544, DOI 10.1182/blood-2012-02-413286; Fortin C, 2013, J IMMUNOL, V191, P363, DOI 10.4049/jimmunol.1202714; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hagberg N, 2011, J IMMUNOL, V186, P5085, DOI 10.4049/jimmunol.1003349; Hillyer P, 2012, IMMUNOL CELL BIOL, V90, P774, DOI 10.1038/icb.2011.109; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kim HJ, 2011, INSECT MOL BIOL, V20, P723, DOI 10.1111/j.1365-2583.2011.01102.x; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Kumagai Y, 2009, J IMMUNOL, V182, P3960, DOI 10.4049/jimmunol.0804315; Lambotin M, 2010, J VIROL, V84, P8964, DOI 10.1128/JVI.00517-10; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Megjugorac NJ, 2009, J LEUKOCYTE BIOL, V86, P1359, DOI 10.1189/jlb.0509347; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; POLYAK SJ, 2011, HEPATITIS C VIRUSES; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Ray RB, 2001, FEMS MICROBIOL LETT, V202, P149, DOI 10.1111/j.1574-6968.2001.tb10796.x; Raychoudhuri A, 2010, J VIROL, V84, P10991, DOI 10.1128/JVI.00900-10; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schnell G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002839; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Soffredini R, 2004, AM J GASTROENTEROL, V99, P1738, DOI 10.1111/j.1572-0241.2004.30396.x; Solis M, 2006, BIOCHEM PHARMACOL, V72, P1469, DOI 10.1016/j.bcp.2006.06.002; Stone AEL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003316; Szabo G, 2005, IMMUNOBIOLOGY, V210, P237, DOI 10.1016/j.imbio.2005.05.018; Tacke RS, 2011, J BIOL CHEM, V286, P10847, DOI 10.1074/jbc.M110.217653; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Wertheimer AM, 2004, HEPATOLOGY, V40, P335, DOI 10.1002/hep.20306; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yao ZQ, 2004, J VIROL, V78, P6409, DOI 10.1128/JVI.78.12.6409-6419.2004; Yin ZW, 2012, J IMMUNOL, V189, P2735, DOI 10.4049/jimmunol.1102038	46	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95627	10.1371/journal.pone.0095627	http://dx.doi.org/10.1371/journal.pone.0095627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788809	Green Submitted, gold, Green Published			2022-12-25	WOS:000335510600044
J	Wolfl, C; Schweppenhauser, D; Guhring, T; Takur, C; Honer, B; Kneser, U; Grutzner, PA; Kolios, L				Woelfl, Christoph; Schweppenhaeuser, Daniela; Guehring, Thorsten; Takur, Caner; Hoener, Bernd; Kneser, Ulrich; Gruetzner, Paul Alfred; Kolios, Leila			Characteristics of Bone Turnover in the Long Bone Metaphysis Fractured Patients with Normal or Low Bone Mineral Density (BMD)	PLOS ONE			English	Article							BIOCHEMICAL MARKERS; OSTEOPOROTIC FRACTURES; SERUM OSTEOCALCIN; TIBIAL FRACTURES; DISTAL FOREARM; ELDERLY-WOMEN; HIP FRACTURE; MASS; METABOLISM; SEROLOGY	The incidence of osteoporotic fractures increases as our population ages. Until now, the exact biochemical processes that occur during the healing of metaphyseal fractures remain unclear. Diagnostic instruments that allow a dynamic insight into the fracture healing process are as yet unavailable. In the present matched pair analysis, we study the time course of the osteoanabolic markers bone specific alkaline phosphatase (BAP) and transforming growth factor beta 1 (TGF beta 1), as well as the osteocatabolic markers crosslinked C-telopeptide of type-I-collagen (beta-CTX) and serum band 5 tartrate-resistant acid phosphatase (TRAP5b), during the healing of fractures that have a low level of bone mineral density (BMD) compared with fractures that have a normal BMD. Between March 2007 and February 2009, 30 patients aged older than 50 years who suffered a metaphyseal fracture were included in our study. BMDs were verified by dual energy Xray absorptiometry (DXEA) scans. The levels of BTMs were examined over an 8-week period. Osteoanabolic BAP levels in those with low levels of BMD were significantly different from the BAP levels in those with normal BMD. BAP levels in the former group increased constantly, whereas the latter group showed an initial strong decrease in BAP followed by slowly rising values. Osteocatabolic beta-CTX increased in the bone of the normal BMD group constantly, whereas these levels decreased significantly in the bone of the group with low BMD from the first week. TRAP5b was significantly reduced in the low level BMD group. With this work, we conduct first insights into the molecular biology of the fracture healing process in patients with low levels of BMD that explains the mechanism of its fracture healing. The results may be one reason for the reduced healing qualities in bones with low BMD.	[Woelfl, Christoph; Schweppenhaeuser, Daniela; Guehring, Thorsten; Takur, Caner; Gruetzner, Paul Alfred] BG Traumactr Ludwigshafen, Dept Traumatol & Orthopaed Surg, Ludwigshafen, Germany; [Hoener, Bernd] SRH Hsch Heidelberg, Dpt Social Sci & Law, Heidelberg, Germany; [Kneser, Ulrich; Kolios, Leila] Heidelberg Univ, BG Traumactr Ludwigshafen, Dept Plast Surg, Dept Plast Reconstruct & Handsurg,Burn Care Ctr, Ludwigshafen, Germany	Ruprecht Karls University Heidelberg	Kolios, L (corresponding author), Heidelberg Univ, BG Traumactr Ludwigshafen, Dept Plast Surg, Dept Plast Reconstruct & Handsurg,Burn Care Ctr, Ludwigshafen, Germany.	lkolios@bgu-ludwigshafen.de			BG Klinik Ludiwgshafen Research Center	BG Klinik Ludiwgshafen Research Center	No external funding was used. The study was done by the cooperation partners as listed in the authors section. The funding was done by the BG Klinik Ludiwgshafen Research Center. Besides the authors no one had a role in the study design, the data collection and analysis, decision to publish, or preparation of the manuscript.	AKESSON K, 1995, BONE, V16, P427; BOSTROM MPG, 1998, CLIN ORTHOP S, V355, P124; Emami A, 1999, CLIN ORTHOP RELAT R, P220; Garnero P., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P50; Garnero P, 2008, MOL DIAGN THER, V12, P157, DOI 10.1007/BF03256280; Heiss C, 2008, UNFALLCHIRURG, V111, P695, DOI 10.1007/s00113-008-1465-1; Hoesel LM, 2005, CLIN ORTHOP RELAT R, P226, DOI 10.1097/01.blo.0000180891.03042.8d; Hoshino H, 1998, CALCIFIED TISSUE INT, V62, P36, DOI 10.1007/s002239900391; Ingle BM, 1999, OSTEOPOROSIS INT, V10, P399, DOI 10.1007/s001980050246; Ingle BM, 1999, OSTEOPOROSIS INT, V10, P408, DOI 10.1007/s001980050247; Ivaska KK, 2007, J BONE MINER RES, V22, P1155, DOI 10.1359/JBMR.070505; JOERRING S, 1992, ARCH ORTHOP TRAUM SU, V111, P265, DOI 10.1007/BF00571521; JOERRING S, 1994, ARCH ORTHOP TRAUM SU, V113, P334, DOI 10.1007/BF00426183; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Kurdy NMG, 1998, J ORTHOP TRAUMA, V12, P122, DOI 10.1097/00005131-199802000-00010; Kurdy NMG, 2000, J ORTHOP TRAUMA, V14, P48, DOI 10.1097/00005131-200001000-00010; Lill CA, 2002, OSTEOPOROSIS INT, V13, P407, DOI 10.1007/s001980200047; MALLMIN H, 1993, CLIN ORTHOP RELAT R, P259; NYMAN MT, 1991, ANN CHIR GYNAECOL, V80, P289; Obrant KJ, 2005, BONE, V36, P786, DOI 10.1016/j.bone.2005.02.009; OBRANT KJ, 1984, ACTA ORTHOP SCAND, V55, P78, DOI 10.3109/17453678408992317; Ohishi T, 1998, ARCH ORTHOP TRAUM SU, V118, P126, DOI 10.1007/s004020050331; ROSIER RN, 1998, CLIN ORTHOP S, V355, P294; Sato Y, 2001, OSTEOPOROSIS INT, V12, P445, DOI 10.1007/s001980170088; Veitch SW, 2006, OSTEOPOROSIS INT, V17, P364, DOI 10.1007/s00198-005-2025-y	25	14	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96058	10.1371/journal.pone.0096058	http://dx.doi.org/10.1371/journal.pone.0096058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788647	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600070
J	Franca, JR; Foureaux, G; Fuscaldi, LL; Ribeiro, TG; Rodrigues, LB; Bravo, R; Castilho, RO; Yoshida, MI; Cardoso, VN; Fernandes, SO; Cronemberger, S; Ferreira, AJ; Faraco, AAG				Franca, Jucara Ribeiro; Foureaux, Giselle; Fuscaldi, Leonardo Lima; Ribeiro, Tatiana Gomes; Rodrigues, Livia Bomfim; Bravo, Renata; Castilho, Rachel Oliveira; Yoshida, Maria Irene; Cardoso, Valbert Nascimento; Fernandes, Simone Odilia; Cronemberger, Sebastiao; Ferreira, Anderson Jose; Gomes Faraco, Andre Augusto			Bimatoprost-Loaded Ocular Inserts as Sustained Release Drug Delivery Systems for Glaucoma Treatment: In Vitro and In Vivo Evaluation	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; MUCOADHESIVE POLYMERS; VISUAL IMPAIRMENT; THERMAL-ANALYSIS; RISK-FACTORS; CHITOSAN; FORMULATION; ALGINATE; FILMS; ACID	The purpose of the present study was to develop and assess a novel sustained-release drug delivery system of Bimatoprost (BIM). Chitosan polymeric inserts were prepared using the solvent casting method and characterized by swelling studies, infrared spectroscopy, differential scanning calorimetry, drug content, scanning electron microscopy and in vitro drug release. Biodistribution of Tc-99m-BIM eye drops and Tc-99m-BIM-loaded inserts, after ocular administration in Wistar rats, was accessed by ex vivo radiation counting. The inserts were evaluated for their therapeutic efficacy in glaucomatous Wistar rats. Glaucoma was induced by weekly intracameral injection of hyaluronic acid. BIM-loaded inserts (equivalent to 9.0 mu g BIM) were administered once into conjunctival sac, after ocular hypertension confirmation. BIM eye drop was topically instilled in a second group of glaucomatous rats for 15 days days, while placebo inserts were administered once in a third group. An untreated glaucomatous group was used as control. Intraocular pressure (IOP) was monitored for four consecutive weeks after treatment began. At the end of the experiment, retinal ganglion cells and optic nerve head cupping were evaluated in the histological eye sections. Characterization results revealed that the drug physically interacted, but did not chemically react with the polymeric matrix. Inserts sustainedly released BIM in vitro during 8 hours. Biodistribution studies showed that the amount of Tc-99m-BIM that remained in the eye was significantly lower after eye drop instillation than after chitosan insert implantation. BIM-loaded inserts lowered IOP for 4 weeks, after one application, while IOP values remained significantly high for the placebo and untreated groups. Eye drops were only effective during the daily treatment period. IOP results were reflected in RGC counting and optic nerve head cupping damage. BIM-loaded inserts provided sustained release of BIM and seem to be a promising system for glaucoma management.	[Franca, Jucara Ribeiro; Ribeiro, Tatiana Gomes; Rodrigues, Livia Bomfim; Bravo, Renata; Castilho, Rachel Oliveira; Gomes Faraco, Andre Augusto] Univ Fed Minas Gerais, Dept Pharmaceut Prod, Belo Horizonte, MG, Brazil; [Foureaux, Giselle; Ferreira, Anderson Jose] Univ Fed Minas Gerais, Dept Morphol, Belo Horizonte, MG, Brazil; [Fuscaldi, Leonardo Lima; Cardoso, Valbert Nascimento; Fernandes, Simone Odilia] Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Belo Horizonte, MG, Brazil; [Yoshida, Maria Irene] Univ Fed Minas Gerais, Dept Chem, Belo Horizonte, MG, Brazil; [Cronemberger, Sebastiao] Univ Fed Minas Gerais, Dept Ophthalmol & Otolaryngol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Faraco, AAG (corresponding author), Univ Fed Minas Gerais, Dept Pharmaceut Prod, Belo Horizonte, MG, Brazil.	andrefaraco@ufmg.br	Fuscaldi, Leonardo Lima/V-1812-2017; Cronemberger, Sebastião/F-7225-2012; Cardoso, Valbert Nascimento/AAA-7240-2019; Faraco, Andre AG/A-8965-2009; Yoshida, Maria Irene/ABC-8143-2020; fernandes, simone/AAU-8611-2020	Fuscaldi, Leonardo Lima/0000-0001-7864-1324; Cronemberger, Sebastião/0000-0003-1466-9963; Faraco, Andre AG/0000-0002-2344-6158; Yoshida, Maria Irene/0000-0002-6795-9457; Antunes Fernandes, Simone Odilia/0000-0002-6139-5187	PRPq-UFMG; CNPq; CAPES; FAPEMIG	PRPq-UFMG; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The authors are grateful to PRPq-UFMG, CNPq (for Development Technologic fellowship and financial support), CAPES and FAPEMIG for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburahma MH, 2011, AAPS PHARMSCITECH, V12, P1335, DOI 10.1208/s12249-011-9701-3; Aggarwal D, 2005, INT J PHARMACEUT, V290, P155, DOI 10.1016/j.ijpharm.2004.10.026; Bean GW, 2008, SURV OPHTHALMOL, V53, pS69, DOI 10.1016/j.survophthal.2008.08.012; Boland MV, 2007, J GLAUCOMA, V16, P406, DOI 10.1097/IJG.0b013e31806540a1; Bouhenni RA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/692609; de Barros ALB, 2012, APPL RADIAT ISOTOPES, V70, P2440, DOI 10.1016/j.apradiso.2012.06.022; Brubaker RF, 2001, SURV OPHTHALMOL, V45, pS347, DOI 10.1016/S0039-6257(01)00213-2; Burk RM, 2007, CURR OPIN DRUG DISC, V10, P413; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; CHEN RH, 1994, CARBOHYD POLYM, V24, P41, DOI 10.1016/0144-8617(94)90115-5; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Cook C, 2012, CAN J OPHTHALMOL, V47, P223, DOI 10.1016/j.jcjo.2012.02.003; CRUZ FO, 2010, FARMACOPEIA BRASILEI; Curran MP, 2009, DRUG AGING, V26, P1049, DOI 10.2165/11203210-000000000-00000; Davies SS, 2003, J OCUL PHARMACOL TH, V19, P45, DOI 10.1089/108076803762718105; Dobaria NB, 2009, AAPS PHARMSCITECH, V10, P951, DOI 10.1208/s12249-009-9288-0; Eroglu H, 2007, DRUG DEV IND PHARM, V33, P265, DOI 10.1080/03639040600713134; Felt O, 1999, INT J PHARM, V180, P185, DOI 10.1016/S0378-5173(99)00003-4; Gaserod O, 1998, INT J PHARMACEUT, V175, P237, DOI 10.1016/S0378-5173(98)00277-4; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Gaudana R, 2009, PHARM RES-DORDR, V26, P1197, DOI 10.1007/s11095-008-9694-0; George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017; Ghate D, 2008, J GLAUCOMA, V17, P147, DOI 10.1097/IJG.0b013e31814b990d; Giarmoukakis A, 2013, EXP EYE RES, V112, P29, DOI 10.1016/j.exer.2013.04.007; Gulsen D, 2005, INT J PHARMACEUT, V292, P95, DOI 10.1016/j.ijpharm.2004.11.033; Gupta H, 2010, NANOMEDICINE NANOTEC, P6; Gupta H, 2011, J DRUG TARGET, V19, P409, DOI 10.3109/1061186X.2010.504268; Gupta SK, 2008, INDIAN J PHARMACOL, V40, P197, DOI 10.4103/0253-7613.44151; Kearns VR, 2009, EXPERT REV MED DEVIC, V6, P277, DOI [10.1586/erd.09.4, 10.1586/ERD.09.4]; Kumirska J, 2010, MAR DRUGS, V8, P1567, DOI 10.3390/md8051567; Kuno N, 2011, POLYMERS-BASEL, V3, P193, DOI 10.3390/polym3010193; Kuntner C, 2011, MOL IMAGING BIOL, V13, P222, DOI 10.1007/s11307-010-0352-7; Lavik E, 2011, EYE, V25, P578, DOI 10.1038/eye.2011.82; Lawrie G, 2007, BIOMACROMOLECULES, V8, P2533, DOI 10.1021/bm070014y; Lee SS, 2010, PHARM RES-DORDR, V27, P2043, DOI 10.1007/s11095-010-0159-x; Liang Y, 2008, BRIT J PHARMACOL, V154, P1079, DOI 10.1038/bjp.2008.142; Lisa Land D., 1994, INT CONTACT LENS CLI, V21, P212, DOI [10.1016/0892-8967(94)90053-1, DOI 10.1016/0892-8967(94)90053-1]; Ludwig A, 2005, ADV DRUG DELIVER REV, V57, P1595, DOI 10.1016/j.addr.2005.07.005; McKinnon Stuart J, 2008, Am J Manag Care, V14, pS20; Moreno MC, 2005, EXP EYE RES, V81, P71, DOI 10.1016/j.exer.2005.01.008; Mucha M, 2005, THERMOCHIM ACTA, V427, P69, DOI 10.1016/j.tca.2004.08.014; Natarajan JV, 2012, INT J NANOMED, V7, DOI 10.2147/IJN.S25468; Natu MV, 2011, INT J PHARMACEUT, V415, P73, DOI 10.1016/j.ijpharm.2011.05.047; Neto CGT, 2005, CARBOHYD POLYM, V62, P97, DOI 10.1016/j.carbpol.2005.02.022; Nunan EA, 2002, APPL RADIAT ISOTOPES, V57, P849, DOI 10.1016/S0969-8043(02)00197-5; Panomsuk SP, 1996, CHEM PHARM BULL, V44, P1039; Perumal VA, 2008, INT J PHARM, V358, P184, DOI 10.1016/j.ijpharm.2008.03.005; Rafuse PE, 2009, CAN J OPHTHALMOL, V44, pS7, DOI 10.3129/i09.080; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Robinson MR, TREATING OCULAR COND; Rodrigues LB, 2009, INT J PHARMACEUT, V368, P1, DOI 10.1016/j.ijpharm.2008.09.047; Salomao SR, 2009, AN ACAD BRAS CIENC, V81, P539, DOI 10.1590/S0001-37652009000300017; Semalty M, 2008, INDIAN J PHARM SCI, V70, P43, DOI 10.4103/0250-474X.40330; Shafiee A, 2013, CLIN OPHTHALMOL, V7, P1549, DOI 10.2147/OPTH.S48766; Takano N, 2013, EUR J PHARMACOL, V702, P56, DOI 10.1016/j.ejphar.2013.01.038; Valenta C, 2005, ADV DRUG DELIVER REV, V57, P1692, DOI 10.1016/j.addr.2005.07.004; Wadhwa S, 2009, MINI-REV MED CHEM, V9, P1639, DOI 10.2174/138955709791012292; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wilson CG, 1998, BRIT J OPHTHALMOLOGY, P82; Woodward DF, 2001, SURV OPHTHALMOL, V45, pS337, DOI 10.1016/S0039-6257(01)00224-7; Yuan X-B, 2006, CARBOHYDRATE POLYM, V65; Zambito Y, 2010, J DRUG DELIV SCI TEC, V20, P45, DOI 10.1016/S1773-2247(10)50005-4	62	54	54	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95461	10.1371/journal.pone.0095461	http://dx.doi.org/10.1371/journal.pone.0095461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788066	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917300013
J	Lottig, NR; Wagner, T; Henry, EN; Cheruvelil, KS; Webster, KE; Downing, JA; Stow, CA				Lottig, Noah R.; Wagner, Tyler; Henry, Emily Norton; Cheruvelil, Kendra Spence; Webster, Katherine E.; Downing, John A.; Stow, Craig A.			Long-Term Citizen-Collected Data Reveal Geographical Patterns and Temporal Trends in Lake Water Clarity	PLOS ONE			English	Article							RESPONSES	We compiled a lake-water clarity database using publically available, citizen volunteer observations made between 1938 and 2012 across eight states in the Upper Midwest, USA. Our objectives were to determine (1) whether temporal trends in lake-water clarity existed across this large geographic area and (2) whether trends were related to the lake-specific characteristics of latitude, lake size, or time period the lake was monitored. Our database consisted of >140,000 individual Secchi observations from 3,251 lakes that we summarized per lake-year, resulting in 21,020 summer averages. Using Bayesian hierarchical modeling, we found approximately a 1% per year increase in water clarity (quantified as Secchi depth) for the entire population of lakes. On an individual lake basis, 7% of lakes showed increased water clarity and 4% showed decreased clarity. Trend direction and strength were related to latitude and median sample date. Lakes in the southern part of our study-region had lower average annual summer water clarity, more negative long-term trends, and greater inter-annual variability in water clarity compared to northern lakes. Increasing trends were strongest for lakes with median sample dates earlier in the period of record (1938-2012). Our ability to identify specific mechanisms for these trends is currently hampered by the lack of a large, multi-thematic database of variables that drive water clarity (e. g., climate, land use/cover). Our results demonstrate, however, that citizen science can provide the critical monitoring data needed to address environmental questions at large spatial and long temporal scales. Collaborations among citizens, research scientists, and government agencies may be important for developing the data sources and analytical tools necessary to move toward an understanding of the factors influencing macro-scale patterns such as those shown here for lake water clarity.	[Lottig, Noah R.] Univ Wisconsin Madison, Ctr Limnol Trout Lake Stn, Boulder Jct, WI 54512 USA; [Wagner, Tyler] Penn State Univ, US Geol Survey, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA; [Henry, Emily Norton; Cheruvelil, Kendra Spence] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Henry, Emily Norton] Oregon State Univ, Dept Outreach & Engagement, Tillamook, OR USA; [Cheruvelil, Kendra Spence] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA; [Webster, Katherine E.] Univ Dublin Trinity Coll, Sch Nat Sci, Dublin 2, Ireland; [Downing, John A.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Stow, Craig A.] NOAA, Great Lakes Environm Res Lab, Ann Arbor, MI 48105 USA	University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; Michigan State University; Oregon State University; Michigan State University; Trinity College Dublin; Iowa State University; National Oceanic Atmospheric Admin (NOAA) - USA	Lottig, NR (corresponding author), Univ Wisconsin Madison, Ctr Limnol Trout Lake Stn, Boulder Jct, WI 54512 USA.	nrlottig@wisc.edu	Stow, Craig/AAG-8109-2020; Lottig, Noah/AAE-4650-2020	Lottig, Noah/0000-0003-1599-8144; Webster, Katherine/0000-0002-6009-0146; Downing, John/0000-0001-8547-0789; Stow, Craig/0000-0001-6171-7855	National Science Foundation [MSB-1065786, EF-1065818, EF-1065649]; NTL-LTER [DEB-0822700]; STRIVE from the Environmental Protection Agency, Ireland [2011-W-FS-7]; Direct For Biological Sciences [1065818, 1065786] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NTL-LTER; STRIVE from the Environmental Protection Agency, Ireland; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this research was provided by the National Science Foundation (MSB-1065786, EF-1065818, EF-1065649) and NTL-LTER (DEB-0822700). K. E. W. also thanks STRIVE grant 2011-W-FS-7 from the Environmental Protection Agency, Ireland for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREEN W. L., 2013, GEO WASH J ENERGY EN, V2013, P25; Bruhn LC, 2005, LAKE RESERV MANAGE, V21, P10; Canfield DE, 2002, LAKE RESERV MANAGE, V18, P1; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Cross TK, 2013, LAKE RESERV MANAGE, V29, P1, DOI 10.1080/10402381.2012.754808; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Gunn JM, 2001, ENVIRON MONIT ASSESS, V67, P69, DOI 10.1023/A:1006435721636; Heffernan JB, 2014, FRONT ECOL ENVIRON, V12, P5, DOI 10.1890/130017; Heiskary Steve, 1994, Lake and Reservoir Management, V9, P4; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Kissman CEH, 2010, LIMNOL OCEANOGR, V55, P1851, DOI 10.4319/lo.2010.55.5.1851; Lathrop RC, 1996, CAN J FISH AQUAT SCI, V53, P2250, DOI 10.1139/cjfas-53-10-2250; Link WA, 2006, CONDOR, V108, P13, DOI 10.1650/0010-5422(2006)108[0013:AHMFRA]2.0.CO;2; Lottig N, 2014, UPPER MIDWEST GREAT, DOI [10.6073/pasta/5f94d3db0f3b7f1648579bf319aefacc, DOI 10.6073/PASTA/5F94D3DB0F3B7F1648579BF319AEFACC]; Obrecht D. V., 1998, LAKE RESERV MANAGE, V14, P21, DOI [10.1080/07438149809354106, DOI 10.1080/07438149809354106]; Olmanson LG, 2008, REMOTE SENS ENVIRON, V112, P4086, DOI 10.1016/j.rse.2007.12.013; Olmanson LG, 2014, J AM WATER RESOUR AS, V50, P748, DOI 10.1111/jawr.12138; Peckham SD, 2006, LAKE RESERV MANAGE, V22, P331, DOI 10.1080/07438140609354367; Peeters ETHM, 2009, BASIC APPL ECOL, V10, P89, DOI 10.1016/j.baae.2007.12.009; Plummer M., 2011, JAGS VERSION 3 3 0 U; Qian SS, 2010, ECOLOGY, V91, P355, DOI 10.1890/09-1043.1; Ruegg J, 2014, FRONT ECOL ENVIRON, V12, P24, DOI 10.1890/120375; Schindler DW, 1996, NATURE, V379, P705, DOI 10.1038/379705a0; Soranno PA, 2014, FRONT ECOL ENVIRON, V12, P65, DOI 10.1890/120366; Stow Craig A., 2009, P111, DOI 10.1007/978-0-387-77942-3_5; Wagner T, 2008, ENVIRON MONIT ASSESS, V141, P131, DOI 10.1007/s10661-007-9883-z; Webster KE, 1998, RESPONSES LAKES DROU; Wernand MR, 2010, J EUR OPT SOC-RAPID, V5, DOI 10.2971/jeos.2010.10013s; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wilson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065408	31	58	60	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95769	10.1371/journal.pone.0095769	http://dx.doi.org/10.1371/journal.pone.0095769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788722	Green Submitted, gold, Green Published			2022-12-25	WOS:000338917300018
J	Guo, YY; Yuan, HS; Claudio, NM; Kura, S; Shakerdge, N; Mempel, TR; Bacskai, BJ; Josephson, L				Guo, Yanyan; Yuan, Hushan; Claudio, Natalie M.; Kura, Sreekanth; Shakerdge, Naomi; Mempel, Thorsten R.; Bacskai, Brian J.; Josephson, Lee			PEG-Like Nanoprobes: Multimodal, Pharmacokinetically and Optically Tunable Nanomaterials	PLOS ONE			English	Article							DRUG; PERMEABILITY; PEGYLATION; PROTEINS; SAFETY; SIZE	"PEG-like Nanoprobes'' (PN's) are pharmacokinetically and optically tunable nanomaterials whose disposition in biological systems can be determined by fluorescence or radioactivity. PN's feature a unique design where a single PEG polymer surrounds a short fluorochrome and radiometal bearing peptide, and endows the resulting nanoprobe with pharmacokinetic control (based on molecular weight of the PEG selected) and optical tunability (based on the fluorochrome selected), while the chelate provides a radiolabeling option. PN's were used to image brain capillary angiography (intravital 2-photon microscopy), tumor capillary permeability (intravital fluorescent microscopy), and the tumor enhanced permeability and retention (EPR) effect (In-111-PN and SPECT). Clinical applications of PN's include use as long blood half-life fluorochromes for intraoperative angiography, for measurements of capillary permeability in breast cancer lesions, and to image EPR by SPECT, for stratifying patient candidates for long-circulating nanomedicines that may utilize the EPR mechanism.	[Guo, Yanyan; Yuan, Hushan; Josephson, Lee] Massachusetts Gen Hosp, Ctr Adv Med Imaging Sci, Charlestown, MA 02114 USA; [Claudio, Natalie M.; Mempel, Thorsten R.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [Kura, Sreekanth; Josephson, Lee] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Shakerdge, Naomi; Bacskai, Brian J.] Massachusetts Gen Hosp, Dept Neurol, Alzheimer Res Unit, Charlestown, MA USA; [Shakerdge, Naomi; Bacskai, Brian J.] Harvard Univ, Sch Med, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Josephson, L (corresponding author), Massachusetts Gen Hosp, Ctr Adv Med Imaging Sci, Charlestown, MA 02114 USA.	ljosephson@mgh.harvard.edu	Bacskai, Brian/AAE-9583-2021		National Institutes of Health [EB009691, EB011996]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011996, R01EB009691, R01EB000768] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health R01's EB009691 and EB011996 to LJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Behe M, 2005, J NUCL MED, V46, P1012; Bertrand N, 2013, ADV DRUG DELIV REV; Choi HS, 2013, NAT BIOTECHNOL, V31, P148, DOI 10.1038/nbt.2468; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Ebert B, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3585678; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fee CJ, 2004, BIOCONJUGATE CHEM, V15, P1304, DOI 10.1021/bc049843w; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Gotthardt M, 2007, J NUCL MED, V48, P596, DOI 10.2967/jnumed.106.036020; Greish K, 2010, METHODS MOL BIOL, V624, P25, DOI 10.1007/978-1-60761-609-2_3; Gruber A, 2011, NEUROSURGERY, V68, P657, DOI 10.1227/NEU.0b013e31820777ee; Guo Y, 2013, PLOS ONE, V8, pe5829; Guo YY, 2012, J AM CHEM SOC, V134, P19338, DOI 10.1021/ja309085b; Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113; Holm C, 2010, OPEN SURG ONCOL J, V2, P37, DOI DOI 10.2174/1876504101002020037; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Kaneo Y, 1997, BIOL PHARM BULL, V20, P181; Karakoti AS, 2011, ANGEW CHEM INT EDIT, V50, P1980, DOI 10.1002/anie.201002969; Maeda H, 2011, ADV DRUG DELIVER REV, V63, P129, DOI 10.1016/j.addr.2010.05.001; Marangoni F, 2013, IMMUNITY, V38, P237, DOI 10.1016/j.immuni.2012.09.012; Melis M, 2010, J NUCL MED, V51, P973, DOI 10.2967/jnumed.109.074310; Milla P, 2012, CURR DRUG METAB, V13, P105, DOI 10.2174/138920012798356934; Orosco R, 2013, IEEE REV BIOMED ENG; Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010; Pauli J, 2013, BIOCONJUG CHEM; Payne RW, 2011, PHARM DEV TECHNOL, V16, P423, DOI 10.3109/10837450.2010.513990; Poellinger A, 2011, RADIOLOGY, V258, P409, DOI 10.1148/radiol.10100258; Rosenbaum S., 2011, BASIC PHARMACOKINETI, V1st ed.; Schneider P, 2011, ROFO-FORTSCHR RONTG, V183, P956, DOI 10.1055/s-0031-1281726; Skoch Jesse, 2004, V299, P349; Vicent MJ, 2006, TRENDS BIOTECHNOL, V24, P39, DOI 10.1016/j.tibtech.2005.11.006; Webster R, 2007, DRUG METAB DISPOS, V35, P9, DOI 10.1124/dmd.106.012419; Working PK, 1997, ACS SYM SER, V680, P45; Zenn MR, 2011, CLIN PLAST SURG, V38, P293, DOI 10.1016/j.cps.2011.03.009	35	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e95406	10.1371/journal.pone.0095406	http://dx.doi.org/10.1371/journal.pone.0095406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781778	gold, Green Published, Green Submitted			2022-12-25	WOS:000335504900005
J	Peng, ZB; Wu, P; Ge, L; Fielding, R; Cheng, XW; Su, WK; Ye, M; Shi, Y; Liao, QH; Zhou, H; Zhou, L; Li, LL; Wu, JB; Zhang, SX; Yu, ZD; Wu, XM; Ma, HW; Lu, JH; Cowling, BJ; Yu, HJ				Peng, Zhibin; Wu, Peng; Ge, Li; Fielding, Richard; Cheng, Xiaowen; Su, Weike; Ye, Min; Shi, Ying; Liao, Qiaohong; Zhou, Hang; Zhou, Lei; Li, Leilei; Wu, Jiabing; Zhang, Shunxiang; Yu, Zhangda; Wu, Xiaomin; Ma, Hanwu; Lu, Jianhua; Cowling, Benjamin J.; Yu, Hongjie			Rural Villagers and Urban Residents Exposure to Poultry in China	PLOS ONE			English	Article							INFLUENZA-A H5N1; TO-PERSON TRANSMISSION; VIRUS-INFECTION; RISK-FACTORS; HONG-KONG	Patterns of poultry exposure in rural and urban areas in China have not been systematically evaluated and compared. The objective of our study is to investigate patterns in human exposure to poultry in rural and urban China. We conducted a two-stage household-based clustered survey on population exposure to live/sick/dead poultry in Xiuning and Shenzhen. Half of the rural households (51%) in Xiuning raised poultry, mostly (78%) free-range. Around half of those households (40%) allowed poultry to stay in their living areas. One quarter of villagers reported having contact with sick or dead poultry. In Shenzhen, 37% urban residents visited live poultry markets. Among these, 40% purchased live poultry and 16% touched the poultry or cages during purchase. Our findings indicated that human exposure to poultry was different in rural and urban areas in China. This discrepancy could contribute to the observed differences in epidemiologic characteristics between urban and rural cases of influenza A(H7N9) and A(H5N1) virus infection.	[Peng, Zhibin; Shi, Ying; Zhou, Hang; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Wu, Peng; Fielding, Richard; Cowling, Benjamin J.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Ge, Li] Xiangyang Ctr Hosp, Xiangyang, Peoples R China; [Cheng, Xiaowen; Zhang, Shunxiang; Wu, Xiaomin; Ma, Hanwu; Lu, Jianhua] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Su, Weike] Xiuning Ctr Dis Control & Prevent, Xiuning, Peoples R China; [Ye, Min] Zhoushan Entry Exit Inspect & Quarantine Bur, Zhoushan, Peoples R China; [Zhou, Lei; Li, Leilei] Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing, Peoples R China; [Wu, Jiabing] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Yu, Zhangda] Huanshan Ctr Dis Control & Prevent, Huangshan, Peoples R China	Chinese Center for Disease Control & Prevention; University of Hong Kong; Shenzhen Center for Disease Control & Prevention (SZCDC); Chinese Center for Disease Control & Prevention	Yu, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.	yuhj@chinacdc.cn	Cowling, Benjamin John/C-4263-2009; su, wei/GZM-3986-2022; Yu, Hongjie/GZK-5351-2022	Cowling, Benjamin John/0000-0002-6297-7154; Wu, Peng/0000-0003-1157-9401	China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases; Ministry of Science and Technology of the People's Republic of China [2004BA519A17, 2006BAD06A02]	China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This study was supported by grants from the China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases, and from the Ministry of Science and Technology of the People's Republic of China [grant number 2004BA519A17 and 2006BAD06A02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], 2013, LANCET; Areechokchai Darin, 2006, MMWR Suppl, V55, P3; Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Chen Y, 2013, LANCET; Department of population social science and technology statistics National Bureau of Statistics of China, 2003, CHIN POP STAT YB 200; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Fielding R, 2005, EMERG INFECT DIS, V11, P677, DOI 10.3201/eid1105.041225; Fielding R, 2007, EMERG INFECT DIS, V13, P1065, DOI 10.3201/eid1307.061031; Kandeel A, 2010, EMERG INFECT DIS, V16, P1101, DOI 10.3201/eid1607.091695; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Liao QY, 2009, EPIDEMICS-NETH, V1, P207, DOI 10.1016/j.epidem.2009.09.002; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; National Health and Family Planning Commission (NHFPC) of China, 2013, NUMB CONF HUM CAS AV; National Health and Family Planning Commission (NHFPC) of China, 2013, 3 HUM CAS AV INFL A; National Health and Family Planning Commission (NHFPC) of China, 2013, OP STAT INT ASS AV I; P.R. China Bureau of Veterinary Ministry of Agriculture, 2008, POULTR AV INFL VACC; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; Thorson A, 2006, ARCH INTERN MED, V166, P119, DOI 10.1001/archinte.166.1.119; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; World Health Organization, 2013, CUM NUMB CONF HUM CA; World Health Organization, 2013, MAN IMPR BIOS FOOD S; World Health Organization, 2013, AV INFL SIT CHIN UPD, P42; World Organization for Animal Health, 2013, UPD HIGHL PATH AV IN; Wu H, 2013, N ENGL J MED; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yu HJ, 2007, EMERG INFECT DIS, V13, P1061, DOI 10.3201/eid1307.061557; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206; Zhu QY, 2006, NEW ENGL J MED, V354, P2731, DOI 10.1056/NEJMc066058	34	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e95430	10.1371/journal.pone.0095430	http://dx.doi.org/10.1371/journal.pone.0095430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769673	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736600007
J	Qeska, V; Barthel, Y; Herder, V; Stein, VM; Tipold, A; Urhausen, C; Gunzel-Apel, AR; Rohn, K; Baumgartner, W; Beineke, A				Qeska, Visar; Barthel, Yvonne; Herder, Vanessa; Stein, Veronika M.; Tipold, Andrea; Urhausen, Carola; Guenzel-Apel, Anne-Rose; Rohn, Karl; Baumgaertner, Wolfgang; Beineke, Andreas			Canine Distemper Virus Infection Leads to an Inhibitory Phenotype of Monocyte-Derived Dendritic Cells In Vitro with Reduced Expression of Co-Stimulatory Molecules and Increased Interleukin-10 Transcription	PLOS ONE			English	Article							REGULATORY T-CELLS; INCLUSION-BODY POLIOENCEPHALITIS; BLOOD MONONUCLEAR-CELLS; MEASLES-VIRUS; INDUCED IMMUNOSUPPRESSION; MESSENGER-RNA; IMMUNE-RESPONSES; GNOTOBIOTIC DOGS; FUSION PROTEIN; CNS LESIONS	Canine distemper virus (CDV) exhibits a profound lymphotropism that causes immunosuppression and increased susceptibility of affected dogs to opportunistic infections. Similar to human measles virus, CDV is supposed to inhibit terminal differentiation of dendritic cells (DCs), responsible for disturbed repopulation of lymphoid tissues and diminished antigen presenting function in dogs. In order to testify the hypothesis that CDV-infection leads to an impairment of professional antigen presenting cells, canine DCs have been generated from peripheral blood monocytes in vitro and infected with CDV. Virus infection was confirmed and quantified by transmission electron microscopy, CDV-specific immunofluorescence, and virus titration. Flow cytometric analyses revealed a significant down-regulation of the major histocompatibility complex class II and co-stimulatory molecules CD80 and CD86 in CDV-infected DCs, indicative of disturbed antigen presenting capacity. Molecular analyses revealed an increased expression of the immune inhibitory cytokine interleukin-10 in DCs following infection. Results of the present study demonstrate that CDV causes phenotypical changes and altered cytokine expression of DCs, which represent potential mechanisms to evade host immune responses and might contribute to immune dysfunction and virus persistence in canine distemper.	[Qeska, Visar; Barthel, Yvonne; Herder, Vanessa; Baumgaertner, Wolfgang; Beineke, Andreas] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Herder, Vanessa; Stein, Veronika M.; Tipold, Andrea; Baumgaertner, Wolfgang] Ctr Syst Neurosci, Hannover, Germany; [Stein, Veronika M.; Tipold, Andrea] Univ Vet Med Hannover, Dept Small Anim Med & Surg, Hannover, Germany; [Urhausen, Carola; Guenzel-Apel, Anne-Rose] Univ Vet Med Hannover, Reprod Med Unit, Small Anim Clin, Hannover, Germany; [Rohn, Karl] Univ Vet Med Hannover, Dept Biometry Epidemiol & Informat Proc, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Beineke, A (corresponding author), Univ Vet Med Hannover, Dept Pathol, Hannover, Germany.	andreas.beineke@tiho-hannover.de	Herder, Vanessa/AAG-6647-2020	Herder, Vanessa/0000-0003-4814-1382	German Research Foundation [FOR 1103, BA 815/10-2, BE 4200/1-2]	German Research Foundation(German Research Foundation (DFG))	The study was supported by the German Research Foundation (FOR 1103, BA 815/10-2 and BE 4200/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt M, 2009, J GEN VIROL, V90, P909, DOI 10.1099/vir.0.008581-0; Alter G, 2010, J CLIN INVEST, V120, P1905, DOI 10.1172/JCI40913; Andrade RM, 2012, CLIN IMMUNOL, V145, P31, DOI 10.1016/j.clim.2012.08.002; Avila M, 2014, J VIROL, V88, P2951, DOI 10.1128/JVI.03123-13; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Beineke A, 2009, VET IMMUNOL IMMUNOP, V127, P1, DOI 10.1016/j.vetimm.2008.09.023; Bjorck P, 1997, INT IMMUNOL, V9, P365, DOI 10.1093/intimm/9.3.365; Bonnefont-Rebeix C, 2006, VET IMMUNOL IMMUNOP, V109, P167, DOI 10.1016/j.vetimm.2005.08.027; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Cespedes PF, 2010, ARCH MED VET, V42, P15, DOI 10.4067/S0301-732X2010000200003; COHEN PL, 1992, IMMUNOL TODAY, V13, P427, DOI 10.1016/0167-5699(92)90066-G; Coughlin MM, 2013, REV MED VIROL, V23, P126, DOI 10.1002/rmv.1735; Cunningham AL, 2010, CURR OPIN MICROBIOL, V13, P524, DOI 10.1016/j.mib.2010.06.002; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Frisk AL, 1999, J NEUROIMMUNOL, V97, P102, DOI 10.1016/S0165-5728(99)00055-7; FugierVivier I, 1997, J EXP MED, V186, P813, DOI 10.1084/jem.186.6.813; Granucci F, 2005, ADV IMMUNOL, V88, P193, DOI 10.1016/S0065-2776(05)88006-X; Grosjean I, 1997, J EXP MED, V186, P801, DOI 10.1084/jem.186.6.801; Gutzwiller MER, 2010, VET RES, V41, DOI 10.1051/vetres/2010012; Hahm B, 2005, IMMUNITY, V22, P247, DOI 10.1016/j.immuni.2005.01.005; Harman AN, 2006, J IMMUNOL, V177, P7103, DOI 10.4049/jimmunol.177.10.7103; Herder V, 2012, J NEUROIMMUNOL, V244, P84, DOI 10.1016/j.jneuroim.2012.01.010; Hou WQ, 2007, PLOS PATHOG, V3, P1036, DOI 10.1371/journal.ppat.0030124; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Ibisch C, 2005, J IMMUNOL METHODS, V298, P175, DOI 10.1016/j.jim.2005.02.001; Johnson TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016458; Kerdiles YM, 2006, REV MED VIROL, V16, P49, DOI 10.1002/rmv.486; Klagge IM, 1999, J GEN VIROL, V80, P823, DOI 10.1099/0022-1317-80-4-823; KRAKOWKA S, 1979, AM J VET RES, V40, P669; KRAKOWKA S, 1982, J CLIN LAB IMMUNOL, V8, P187; KRAKOWKA S, 1987, VET IMMUNOL IMMUNOP, V15, P181, DOI 10.1016/0165-2427(87)90082-1; KRAKOWKA S, 1975, INFECT IMMUN, V11, P1069, DOI 10.1128/IAI.11.5.1069-1078.1975; Kushwah R, 2010, J IMMUNOL, V185, P795, DOI 10.4049/jimmunol.1000325; Lemon K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001263; Maris CH, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-8; Markus S, 2002, J NEUROIMMUNOL, V125, P30, DOI 10.1016/S0165-5728(02)00027-9; Martinic MM, 2008, TRENDS IMMUNOL, V29, P116, DOI 10.1016/j.it.2007.12.002; MATSUMOTO Y, 1994, CYTOKINE, V6, P455, DOI 10.1016/1043-4666(94)90071-X; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Moss WJ, 2002, J INFECT DIS, V186, P879, DOI 10.1086/344230; Murabayashi N, 2002, MICROBES INFECT, V4, P785, DOI 10.1016/S1286-4579(02)01598-8; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nesseler A, 1997, J COMP PATHOL, V116, P291, DOI 10.1016/S0021-9975(97)80004-7; Nesseler A, 1999, VET MICROBIOL, V69, P23, DOI 10.1016/S0378-1135(99)00083-8; Ohgimoto K, 2007, VIRUS RES, V123, P1, DOI 10.1016/j.virusres.2006.07.006; Oldstone MBA, 1999, CELL, V98, P629, DOI 10.1016/S0092-8674(00)80050-1; Plattet P, 2005, VIROLOGY, V337, P312, DOI 10.1016/j.virol.2005.04.012; Plattet P, 2007, J VIROL, V81, P11413, DOI 10.1128/JVI.01287-07; Plattet P, 2009, BIOCHEMISTRY-US, V48, P9112, DOI 10.1021/bi9008566; Puff C, 2009, VET J, V182, P100, DOI 10.1016/j.tvjl.2008.03.026; Qeska V, 2013, VET IMMUNOL IMMUNOP, V156, P215, DOI 10.1016/j.vetimm.2013.10.006; Qeska V, 2013, VET IMMUNOL IMMUNOP, V151, P181, DOI 10.1016/j.vetimm.2012.12.003; Rigopoulou EI, 2005, CLIN IMMUNOL, V117, P57, DOI 10.1016/j.clim.2005.06.003; Rinaldo CR, 2004, TRENDS MICROBIOL, V12, P337, DOI 10.1016/j.tim.2004.05.003; Rozen S, 2000, Methods Mol Biol, V132, P365; Rudd PA, 2006, J VIROL, V80, P9361, DOI 10.1128/JVI.01034-06; Schneider-Schaulies S., 2002, EXPERT REV MOL MED, P1; Schneider-Schaulies S, 2006, J GEN VIROL, V87, P1423, DOI 10.1099/vir.0.81713-0; Schwartz M, 2011, VET J, V187, P260, DOI 10.1016/j.tvjl.2009.12.001; Schwartz M, 2010, VET IMMUNOL IMMUNOP, V133, P198, DOI 10.1016/j.vetimm.2009.08.007; Sellin CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004948; Servet-Delprat C, 2000, J IMMUNOL, V164, P1753, DOI 10.4049/jimmunol.164.4.1753; Spitzbarth I, 2011, J NEUROPATH EXP NEUR, V70, P703, DOI 10.1097/NEN.0b013e3182270f8e; Stein VM, 2004, J NEUROIMMUNOL, V153, P122, DOI 10.1016/j.jneuroim.2004.05.001; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Techangamsuwan S, 2009, VIRUS RES, V144, P195, DOI 10.1016/j.virusres.2009.04.027; Tompkins MB, 2008, VET IMMUNOL IMMUNOP, V123, P45, DOI 10.1016/j.vetimm.2008.01.011; Trifilo MJ, 2006, J INFECT DIS, V194, pS3, DOI 10.1086/505355; Vandevelde M, 2005, ACTA NEUROPATHOL, V109, P56, DOI 10.1007/s00401-004-0958-4; von Smolinski D, 2005, HISTOCHEM CELL BIOL, V124, P177, DOI 10.1007/s00418-005-0013-0; WINTERS KA, 1983, VET IMMUNOL IMMUNOP, V5, P209, DOI 10.1016/0165-2427(83)90022-3; Wunschmann A, 2000, VET IMMUNOL IMMUNOP, V73, P83, DOI 10.1016/S0165-2427(99)00156-7; Wyss-Fluehmann G, 2010, ACTA NEUROPATHOL, V119, P617, DOI 10.1007/s00401-010-0644-7; Xiong WD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011074; Yoshida H, 2003, J VET MED SCI, V65, P663, DOI 10.1292/jvms.65.663; Zilliox MJ, 2006, P NATL ACAD SCI USA, V103, P3363, DOI 10.1073/pnas.0511345103; Zurbriggen A, 1998, ACTA NEUROPATHOL, V95, P71, DOI 10.1007/s004010050767	78	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e96121	10.1371/journal.pone.0096121	http://dx.doi.org/10.1371/journal.pone.0096121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769532	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000336736600024
J	Waller, RG; Stone, RP; Johnstone, J; Mondragon, J				Waller, Rhian G.; Stone, Robert P.; Johnstone, Julia; Mondragon, Jennifer			Sexual Reproduction and Seasonality of the Alaskan Red Tree Coral, Primnoa pacifica	PLOS ONE			English	Article							DEEP-SEA; FUNGIACYATHUS-MARENZELLERI; FERTILIZATION SUCCESS; WATER CORALS; ECOLOGY; REEF; GROWTH; GULF; PHYTOPLANKTON; REGENERATION	The red tree coral Primnoa pacifica is an important habitat forming octocoral in North Pacific waters. Given the prominence of this species in shelf and upper slope areas of the Gulf of Alaska where fishing disturbance can be high, it may be able to sustain healthy populations through adaptive reproductive processes. This study was designed to test this hypothesis, examining reproductive mode, seasonality and fecundity in both undamaged and simulated damaged colonies over the course of 16 months using a deepwater-emerged population in Tracy Arm Fjord. Females within the population developed asynchronously, though males showed trends of synchronicity, with production of immature spermatocysts heightened in December/January and maturation of gametes in the fall months. Periodicity of individuals varied from a single year reproductive event to some individuals taking more than the 16 months sampled to produce viable gametes. Multiple stages of gametes occurred in polyps of the same colony during most sampling periods. Mean oocyte size ranged from 50 to 200 mu m in any season, and maximum oocyte size (802 mu m) suggests a lecithotrophic larva. No brooding larvae were found during this study, though unfertilized oocytes were found adhered to the outside of polyps, where they are presumably fertilized. This species demonstrated size-dependent reproduction, with gametes first forming in colonies over 42-cm length, and steady oocyte sizes being achieved after reaching 80-cm in length. The average fecundity was 86 (+/- 12) total oocytes per polyp, and 17 (+/- 12) potential per polyp fecundity. Sub-lethal injury by removing 21-40% of colony tissue had no significant reproductive response in males or females over the course of this study, except for a corresponding loss in overall colony fecundity. The reproductive patterns and long gamete generation times observed in this study indicate that recruitment events are likely to be highly sporadic in this species increasing its vulnerability to anthropogenic disturbances.	[Waller, Rhian G.] Univ Maine, Darling Marine Ctr, Sch Marine Sci, Walpole, ME 04573 USA; [Stone, Robert P.] NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Juneau, AK USA; [Johnstone, Julia] Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA; [Mondragon, Jennifer] NOAA, Alaska Reg Off, Natl Marine Fisheries Serv, Juneau, AK USA	University of Maine System; University of Maine Orono; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; University of Maine System; University of Maine Orono; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Waller, RG (corresponding author), Univ Maine, Darling Marine Ctr, Sch Marine Sci, Walpole, ME 04573 USA.	rhian.waller@maine.edu			National Oceanic and Atmospheric Administration Alaska Fisheries Science Center; National Geographic Society	National Oceanic and Atmospheric Administration Alaska Fisheries Science Center; National Geographic Society(National Geographic Society)	This work was funded by the National Oceanic and Atmospheric Administration Alaska Fisheries Science Center, and through the National Geographic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALINO PM, 1989, B MAR SCI, V45, P697; Andrews AH, 2002, HYDROBIOLOGIA, V471, P101, DOI 10.1023/A:1016501320206; Ben-David-Zaslow R, 1999, MAR BIOL, V133, P553, DOI 10.1007/s002270050495; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; Cairns SD, 2005, B MAR SCI, V77, P225; Cairns SD, 2009, SMITHSON CONTRIB ZOO, V629; Cairns SD, 2011, SMITHSON CONTRIB ZOO, V634; Coma R, 1997, J EXP MAR BIOL ECOL, V214, P107, DOI 10.1016/S0022-0981(97)00017-8; Conway KW, 2008, 4 INT DEEP SEA COR S, P114; Crean AJ, 2009, PHILOS T R SOC B, V364, P1087, DOI 10.1098/rstb.2008.0237; Eckelbarger KJ, 1998, MAR BIOL, V132, P677, DOI 10.1007/s002270050432; Elias-Piera F, 2013, MAR ECOL PROG SER, V477, P93, DOI 10.3354/meps10152; Fabricius K, 2001, SOFT CORALS SEA FANS; Fan TY, 2005, B MAR SCI, V76, P143; Flint HC, 2007, MAR BIOL, V151, P843, DOI 10.1007/s00227-006-0539-2; Foersterra G., 2003, Zoologische Verhandelingen (Leiden), V345, P117; Freiwald A, 1997, SOC SEDIMENT GEOL SP, P141; Gori A, 2012, CORAL REEFS, V31, P823, DOI 10.1007/s00338-012-0904-1; GRANGE KR, 1981, NEW ZEAL J ZOOL, V8, P209, DOI 10.1080/03014223.1981.10427963; Gutierrez-Rodrigueza C, 2004, INVERTEBR BIOL, V123, P54; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Henry LA, 2003, CAN J ZOOL, V81, P1691, DOI 10.1139/Z03-161; Hovland M, 2003, MAR GEOL, V198, P83, DOI 10.1016/S0025-3227(03)00096-3; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kahng SE, 2008, B MAR SCI, V82, P1; Kahng SE, 2011, MAR ECOL PROG SER, V443, P265, DOI 10.3354/meps09414; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; Krieger KJ, 2001, P 1 INT S DEEP SEA C, P106; Levitan DR, 2006, INTEGR COMP BIOL, V46, P298, DOI 10.1093/icb/icj025; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Luttikhuizen PC, 2003, THESIS U GRONIGEN NE; Mercier A, 2011, CORAL REEFS, V30, P337, DOI 10.1007/s00338-011-0724-8; Mercier A, 2011, J BIOL RHYTHM, V26, P82, DOI 10.1177/0748730410391948; Mortensen PB, 2006, PROC 10 INT CORAL RE, P1849; Orejas C, 2002, MAR ECOL PROG SER, V231, P101, DOI 10.3354/meps231101; Oren U, 2001, ECOLOGY, V82, P802, DOI 10.2307/2680199; Ribes M, 2007, INVERTEBR BIOL, V126, P307, DOI 10.1111/j.1744-7410.2007.00101.x; Roberts Clive D., 2001, New Zealand Journal of Marine and Freshwater Research, V35, P661; Simpson A, 2007, N PACIFIC RES BOARD; Smith CR, 2008, DEEP-SEA RES PT II, V55, P2404, DOI 10.1016/j.dsr2.2008.06.001; Smith F, 1999, ECOLOGY, V80, P51, DOI 10.2307/176979; Stone R, 2005, 3 INT S DEEP WAT COR; Stone RP, 2007, STATE DEEP CORAL ECO, P65; Sun Z, 2010, MAR ECOL PROG SER, V410, P71, DOI 10.3354/meps08637; Waller RG, 2005, ERLANGEN EARTH C SER, P691, DOI 10.1007/3-540-27673-4_35; Waller RG, 2005, CORAL REEFS, V24, P514, DOI 10.1007/s00338-005-0501-7; Waller RG, 2013, DEEP-SEA RES PT II, V92, P201, DOI 10.1016/j.dsr2.2013.03.006; WARD S, 1995, CORAL REEFS, V14, P87, DOI 10.1007/BF00303428; Witherell D, 2005, MAR FISH REV, V67, P1; Zakai D, 2000, CORAL REEFS, V19, P185, DOI 10.1007/s003380000091; ZIEMANN DA, 1991, MAR BIOL, V109, P321, DOI 10.1007/BF01319400	53	26	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e90893	10.1371/journal.pone.0090893	http://dx.doi.org/10.1371/journal.pone.0090893			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24770675	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736600001
J	Li, J; Chen, L; Zhang, XF; Zhang, Y; Liu, HY; Sun, B; Zhao, LL; Ge, NJ; Qian, HH; Yang, YF; Wu, MC; Yin, ZF				Li, Jun; Chen, Lei; Zhang, Xiaofeng; Zhang, Yu; Liu, Huiying; Sun, Bin; Zhao, Linlin; Ge, Naijian; Qian, Haihua; Yang, Yefa; Wu, Mengchao; Yin, Zhengfeng			Detection of Circulating Tumor Cells in Hepatocellular Carcinoma Using Antibodies against Asialoglycoprotein Receptor, Carbamoyl Phosphate Synthetase 1 and Pan-Cytokeratin	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; LIGAND-BINDING; EXPRESSION; DISSEMINATION; ENRICHMENT; SURVIVAL; PROTEIN; BLOOD; LIVER	Background: Asialoglycoprotein receptor (ASGPR)-ligand-based separation combined with identification with Hep Par 1 or pan-cytokeratin (P-CK) antibody have been demonstrated to detect circulating tumor cells (CTCs) in hepatocellular carcinoma (HCC). The aim of this study was to develop an improved enrichment and identification system that allows the detection of all types of HCC CTCs. Methods: The specificity of the prepared anti-ASGPR monoclonal antibody was characterized. HCC cells were bound by ASGPR antibody and subsequently magnetically isolated by second antibody-coated magnetic beads. Isolated HCC cells were identified by immunofluorescence staining using a combination of anti-P-CK and anti-carbamoyl phosphate synthetase 1 (CPS1) antibodies. Blood samples spiked with HepG2 cells were used to determine recovery and sensitivity. CTCs were detected in blood samples from HCC patients and other patients. Results: ASGPR was exclusively expressed in human hepatoma cell line, normal hepatocytes and HCC cells in tissue specimens detected by the ASGPR antibody staining. More HCC cells could be identified by the antibody cocktail for CPS1 and P-CK compared with a single antibody. The current approach obtained a higher recovery rate of HepG2 cells and more CTC detection from HCC patients than the previous method. Using the current method CTCs were detected in 89% of HCC patients and no CTCs were found in the other test subjects. Conclusions: Our anti-ASGPR antibody could be used for specific and efficient HCC CTC enrichment, and anti-P-CK combined with anti-CPS1 antibodies is superior to identification with one antibody alone in the sensitivity for HCC CTC detection.	[Li, Jun; Chen, Lei; Zhang, Xiaofeng; Zhang, Yu; Liu, Huiying; Sun, Bin; Zhao, Linlin; Qian, Haihua; Wu, Mengchao; Yin, Zhengfeng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Mol Oncol Lab, Shanghai, Peoples R China; [Ge, Naijian; Yang, Yefa; Wu, Mengchao] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Intervent Radiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Yin, ZF (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Mol Oncol Lab, Shanghai, Peoples R China.	yinzfk@aliyun.com	sun, bin/GLR-1711-2022	sun, bin/0000-0002-5082-3326; Zhao, Linlin/0000-0003-4827-023X	China National Key Projects for Infectious Disease [2012ZX10002012-10]; National High-Tech Research and Development Program of China [2007AA02Z461]; National Nature Science Foundation of China [30772513, 81172207, 81272669]	China National Key Projects for Infectious Disease; National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from China National Key Projects for Infectious Disease (2012ZX10002012-10), the National High-Tech Research and Development Program of China (2007AA02Z461), and National Nature Science Foundation of China (30772513, 81172207 and 81272669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; ALMEIDA AP, 1980, LIFE SCI, V26, P549, DOI 10.1016/0024-3205(80)90318-5; Andreopoulou E, 2012, INT J CANCER, V130, P1590, DOI 10.1002/ijc.26111; Antolovic D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-35; ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99; Attard G, 2011, CURR OPIN GENET DEV, V21, P50, DOI 10.1016/j.gde.2010.10.010; Butler SL, 2008, LAB INVEST, V88, P78, DOI 10.1038/labinvest.3700699; Coumans FAW, 2010, ANN ONCOL, V21, P1851, DOI 10.1093/annonc/mdq030; de Boer CJ, 1999, J PATHOL, V188, P201, DOI 10.1002/(SICI)1096-9896(199906)188:2<201::AID-PATH339>3.0.CO;2-8; Deng G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2131; Dirlam-Schatz KA, 1998, J LIPID RES, V39, P402; Gazzaniga P, 2013, TUMOR BIOL, V34, P2507, DOI 10.1007/s13277-013-0752-9; Gorges TM, 2013, CANCER IMMUNOL IMMUN, V62, P931, DOI 10.1007/s00262-012-1387-1; Kallergi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2149; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Khan MS, 2011, CLIN CANCER RES, V17, P337, DOI 10.1158/1078-0432.CCR-10-1776; Lecharpentier A, 2011, BRIT J CANCER, V105, P1338, DOI 10.1038/bjc.2011.405; Lianidou ES, 2012, CANCER METAST REV, V31, P663, DOI 10.1007/s10555-012-9366-8; Liu HY, 2011, AM J PATHOL, V178, P652, DOI 10.1016/j.ajpath.2010.10.023; Nel I, 2013, TRANSL ONCOL, V6, P420, DOI 10.1593/tlo.13271; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Porcell AI, 2000, MODERN PATHOL, V13, P773, DOI 10.1038/modpathol.3880134; Proca DM, 2000, APPL IMMUNOHISTO M M, V8, P120, DOI 10.1097/00022744-200006000-00006; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Schulze K, 2013, INT J CANCER, V133, P2165, DOI 10.1002/ijc.28230; Siddiqui MT, 2002, CANCER CYTOPATHOL, V96, P49, DOI 10.1002/cncr.10311; STOCKERT RJ, 1983, HEPATOLOGY, V3, P750; Sun YF, 2013, HEPATOLOGY, V57, P1458, DOI 10.1002/hep.26151; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Timek DT, 2012, AM J CLIN PATHOL, V138, P203, DOI 10.1309/AJCPK1ZC9WNHCCMU; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Wicha MS, 2011, J CLIN ONCOL, V29, P1508, DOI 10.1200/JCO.2010.34.0026; Wragg S, 1999, J BIOL CHEM, V274, P35400, DOI 10.1074/jbc.274.50.35400; Xu W, 2011, CLIN CANCER RES, V17, P3783, DOI 10.1158/1078-0432.CCR-10-0498; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang Y, 2012, SEMIN ONCOL, V39, P449, DOI 10.1053/j.seminoncol.2012.05.012; ZIJDERHANDBLEEKEMOLEN JE, 1987, J CELL BIOL, V104, P1647, DOI 10.1083/jcb.104.6.1647	40	17	19	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96185	10.1371/journal.pone.0096185	http://dx.doi.org/10.1371/journal.pone.0096185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763545	Green Published, Green Submitted, gold			2022-12-25	WOS:000335505000071
J	Naf, S; Escote, X; Ballesteros, M; Yanez, RE; Simon-Muela, I; Gil, P; Albaiges, G; Vendrell, J; Megia, A				Naef, Silvia; Escote, Xavier; Ballesteros, Monica; Elena Yanez, Rosa; Simon-Muela, Inmaculada; Gil, Pilar; Albaiges, Gerard; Vendrell, Joan; Megia, Ana			Serum Activin A and Follistatin Levels in Gestational Diabetes and the Association of the Activin A-Follistatin System with Anthropometric Parameters in Offspring	PLOS ONE			English	Article							NEONATAL BODY-COMPOSITION; FETAL-GROWTH; MELLITUS; HOMEOSTASIS; MYOSTATIN; GLUCOSE; PROLIFERATION; PREGNANCIES; ULTRASOUND; SECRETION	Context: The Activin A-Follistatin system has emerged as an important regulator of lipid and glucose metabolism with possible repercussions on fetal growth. Objective: To analyze circulating activin A, follistatin and follistatin-like-3 (FSTL3) levels and their relationship with glucose metabolism in pregnant women and their influence on fetal growth and neonatal adiposity. Design and methods: A prospective cohort was studied comprising 207 pregnant women, 129 with normal glucose tolerance (NGT) and 78 with gestational diabetes mellitus (GDM) and their offspring. Activin A, follistatin and FSTL3 levels were measured in maternal serum collected in the early third trimester of pregnancy. Serial fetal ultrasounds were performed during the third trimester to evaluate fetal growth. Neonatal anthropometry was measured to assess neonatal adiposity. Results: Serum follistatin levels were significantly lower in GDM than in NGT pregnant women (8.21 +/- 2.32 ng/mL vs 9.22 +/- 3.41, P = 0.012) whereas serum FSTL3 and activin A levels were comparable between the two groups. Serum follistatin concentrations were negatively correlated with HOMA-IR and positively with ultrasound growth parameters such as fractional thigh volume estimation in the middle of the third trimester and percent fat mass at birth. Also, in the stepwise multiple linear regression analysis serum follistatin levels were negatively associated with HOMA-IR (beta = 20.199, P = 0.008) and the diagnosis of gestational diabetes (beta = -0.138, P = 0.049). Likewise, fractional thigh volume estimation in the middle of third trimester and percent fat mass at birth were positively determined by serum follistatin levels (beta = 0.214, P = 0.005 and beta = 0.231, P = 0.002, respectively). Conclusions: Circulating follistatin levels are reduced in GDM compared with NGT pregnant women and they are positively associated with fetal growth and neonatal adiposity. These data suggest a role of the Activin-Follistatin system in maternal and fetal metabolism during pregnancy.	[Naef, Silvia; Escote, Xavier; Elena Yanez, Rosa; Simon-Muela, Inmaculada; Gil, Pilar; Vendrell, Joan; Megia, Ana] Hosp Univ Joan XXIII, Endocrinol & Diabet Unit, Tarragona, Spain; [Ballesteros, Monica; Albaiges, Gerard] Hosp Univ Joan XXIII, Obstet & Gynecol Serv, Tarragona, Spain; [Ballesteros, Monica; Albaiges, Gerard] Univ Rovira & Virgili, IISPV, E-43007 Tarragona, Spain; [Naef, Silvia; Escote, Xavier; Elena Yanez, Rosa; Simon-Muela, Inmaculada; Gil, Pilar; Vendrell, Joan; Megia, Ana] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedas Metab A, Madrid, Spain; [Naef, Silvia; Escote, Xavier; Elena Yanez, Rosa; Simon-Muela, Inmaculada; Gil, Pilar; Vendrell, Joan; Megia, Ana] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, E-43007 Tarragona, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Naf, S (corresponding author), Hosp Univ Joan XXIII, Endocrinol & Diabet Unit, Tarragona, Spain.	snafco@hotmail.com	Escote, Xavier/G-3440-2015; Albaiges, Gerard/AAC-4400-2019; Gil, Pilar Rivera/W-6910-2019; Escoté, Xavier/AAH-2973-2020; Vendrell, Joan j/V-4034-2018; Megia, Ana/W-5556-2019; Escote, Xavier/AAC-6335-2019	Escote, Xavier/0000-0003-1172-3995; Albaiges, Gerard/0000-0001-8690-3996; Gil, Pilar Rivera/0000-0002-6587-7538; Vendrell, Joan j/0000-0002-6994-6115; Escote, Xavier/0000-0003-1172-3995; Megia, Ana/0000-0002-5101-9452	Fondo de Investigacion Sanitaria(FIS), Instituto de Salud Carlos III [PS09/02152, FIS PI12/0717]; Fondo Europeo de Desarrollo Regional (FEDER); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) [CB07/08/0012]; Universitat Rovira I Virgili [Exp.2010 FIB01004]; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Fondo de Investigacion Sanitaria(FIS), Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); Universitat Rovira I Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	This work was supported by grants Fondo de Investigacion Sanitaria(FIS) PS09/02152, and FIS PI12/0717, Instituto de Salud Carlos III, and funds from Fondo Europeo de Desarrollo Regional (FEDER) and Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) (CB07/08/0012). CIBERDEM is an initiative of the Instituto de Salud Carlos III. R.E.Y is supported by a fellowship Ajut predoctoral per a la contractacio de personal investigador novell (Exp.2010 FIB01004) from Universitat Rovira I Virgili. A.M. is grateful to the Institut d'Investigacio Sanitaria Pere Virgili (IISPV) for the 2010 grant: "Programa d'ajuts per al desenvolupament de projectes de recerca". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros M, 2011, DIABETES CARE, V34, P2418, DOI 10.2337/dc11-0788; Bobrow CS, 2002, AM J OBSTET GYNECOL, V186, P283, DOI 10.1067/mob.2002.119777; Brun T, 2004, J CELL BIOL, V167, P1123, DOI 10.1083/jcb.200405148; Carrascosa Lezcano A, 2008, An Pediatr (Barc), V68, P544; Cash JN, 2012, MOL ENDOCRINOL, V26, P1167, DOI 10.1210/me.2012-1061; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; CATALANO PM, 1995, AM J OBSTET GYNECOL, V173, P1176, DOI 10.1016/0002-9378(95)91348-3; Ciarmela P, 2003, J ENDOCRINOL INVEST, V26, P641, DOI 10.1007/BF03347022; Elliott B, 2012, ACTA PHYSIOL, V205, P324, DOI 10.1111/j.1748-1716.2012.02423.x; Flanagan JN, 2009, J CLIN ENDOCR METAB, V94, P3003, DOI 10.1210/jc.2008-2005; Florio P, 2000, J ENDOCRINOL INVEST, V23, P231, DOI 10.1007/BF03343713; Florio P, 2004, MOL CELL ENDOCRINOL, V225, P93, DOI 10.1016/j.mce.2004.02.018; Gallinelli A, 1996, EUR J ENDOCRINOL, V135, P340, DOI 10.1530/eje.0.1350340; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; HARRIS M, 1979, DIABETES, V28, P1039; Hu DX, 2012, CLIN CHIM ACTA, V413, P533, DOI 10.1016/j.cca.2011.10.029; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lee W, 2009, ULTRASOUND OBST GYN, V33, P441, DOI 10.1002/uog.6317; Lee W, 2009, ULTRASOUND OBST GYN, V33, P427, DOI 10.1002/uog.6319; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moyer-Mileur LJ, 2009, J NUTR, V139, P1772, DOI 10.3945/jn.109.109058; Mukherjee A, 2007, P NATL ACAD SCI USA, V104, P1348, DOI 10.1073/pnas.0607966104; Muttukrishna S, 2004, MOL CELL ENDOCRINOL, V225, P45, DOI 10.1016/j.mce.2004.02.012; Nanda S, 2011, PRENATAL DIAG, V31, P135, DOI 10.1002/pd.2636; PETRAGLIA F, 1995, J CLIN ENDOCR METAB, V80, P558, DOI 10.1210/jc.80.2.558; Phillips DJ, 2009, CYTOKINE GROWTH F R, V20, P153, DOI 10.1016/j.cytogfr.2009.02.007; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Sociedad espanola de ginecologia y obstetricia, 2006, AV DIABETOL, V22, P73; Thadhani R, 2010, DIABETES CARE, V33, P664, DOI 10.2337/dc09-1745; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; Ueland T, 2012, DIABETES VASC DIS RE, V9, P234, DOI 10.1177/1479164111431171; Wallace EM, 2003, BJOG-INT J OBSTET GY, V110, P306, DOI 10.1016/S1470-0328(02)02990-7; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013	34	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e92175	10.1371/journal.pone.0092175	http://dx.doi.org/10.1371/journal.pone.0092175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763182	gold, Green Published, Green Submitted			2022-12-25	WOS:000335505000003
J	Bai, XY; Li, X; Tian, JW; Zhou, ZM				Bai, Xiaoyan; Li, Xiao; Tian, Jianwei; Zhou, Zhanmei			Antiangiogenic Treatment Diminishes Renal Injury and Dysfunction via Regulation of Local AKT in Early Experimental Diabetes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR VEGF; NEPHROPATHY; EXPRESSION; ENDOSTATIN; NEPHRIN; MICE; ANGIOGENESIS; MECHANISMS; BLOCKADE	In view of increased vascular endothelial growth factor-A (VEGF-A) expression and renal dysfunction in early diabetes, we designed a study to test whether VEGF-A inhibition can prevent early renal injury and dysfunction. We investigated the relationship and mechanism between VEGF-A and AKT regulation. In vitro, VEGF-A small interfering RNA (siRNA) and AKT inhibitor MK-2206 were employed to podocytes and NRK-52 cells cultured in high glucose (30 mM). In vivo, the antiangiogenic drug endostatin was administered in 12 week-old streptozotocin-induced male Sprague Dawley rats. The levels of VEGF-A, AKT, phosphorylated Ser(473)-AKT, phosphorylated Thr(308)-AKT, nephrin, angiotensin II (Ang II), angiotensin type II receptor 1 (ATR1) were examined using quantitative real-time reverse transcription-polymerase chain reaction (RTPCR), Western blot analysis and immunohistochemistry. Interactions between phosphorylated Thr(308)-AKT and either nephrin in podocytes or Ang II in renal tubules were studied, respectively, using confocal immunofluorescence microscopy and immunoprecipitation. Silencing VEGF-A in podocytes upregulated phosphorylated Thr(308)-AKT and nephrin. Silencing VEGF-A in NRK-52E cells upregulated phosphorylated Thr(308)-AKT while downregulated Ang II and ATR1. MK-2206 enhanced VEGF-A expression in both podocytes and NRK-52E cells by inhibiting AKT activities. In diabetic rat kidneys, VEGF-A was upregulated and phosphorylated Thr(308)-AKT colocalized with either nephrin in podocytes or Ang II in renal tubules. With the endostatin treatment, the level of VEGF-A decreased while phosphorylated Thr(308)-AKT increased in both glomeruli and renal tubules. Treatment with endostatin upregulated nephrin in podocytes while downregulated Ang II and AT1R in renal tubules. Glomerular mesangial expansion was attenuated by the endostatin treatment, however, differences did not reach statistical significance. Endostatin ameliorated the interstitial fibrosis, urine albumin excretion rate (UAER) and albumin to creatinine ratio. We conclude that phosphorylated Thr(308)-AKT regulates VEGF-A expression by interacting with either nephrin in glomeruli or Ang II in renal tubules. Antiangiogenic treatment improves renal injury and function in early experimental diabetes.	[Bai, Xiaoyan; Tian, Jianwei; Zhou, Zhanmei] State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Bai, Xiaoyan; Tian, Jianwei; Zhou, Zhanmei] Natl Clin Res Ctr Kidney Dis, Guangzhou, Guangdong, Peoples R China; [Bai, Xiaoyan; Tian, Jianwei; Zhou, Zhanmei] Guangdong Prov Inst Nephrol, Guangzhou, Guangdong, Peoples R China; [Bai, Xiaoyan; Tian, Jianwei; Zhou, Zhanmei] Southern Med Univ, Nanfang Hosp, Div Nephrol, Guangzhou, Guangdong, Peoples R China; [Li, Xiao] Southern Med Univ, Nanfang Hosp, Dept Emergency, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Bai, XY (corresponding author), State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	xiaoyanbai@smu.edu.cn			National Natural Science Foundation of China [81100496]; National Natural Science Foundation of China from Nanfang Hospital, Southern Medical University [G201203]; Chinese Society of Nephrology [13030370422]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China from Nanfang Hospital, Southern Medical University; Chinese Society of Nephrology	This study was supported by National Nature and Science Young Investigator Grant (no. 81100496) from the National Natural Science Foundation of China, Matching Grant (no. G201203) of the National Natural Science Foundation of China from Nanfang Hospital, Southern Medical University, and Special Fund from Chinese Society of Nephrology (no. 13030370422) to XB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, P NATL ACAD SCI USA, V104, P14448, DOI 10.1073/pnas.0703577104; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Hara A, 2006, KIDNEY INT, V69, P1986, DOI 10.1038/sj.ki.5000439; Hohenstein B, 2006, KIDNEY INT, V69, P1654, DOI 10.1038/sj.ki.5000294; Kim YG, 2000, KIDNEY INT, V58, P2390, DOI 10.1046/j.1523-1755.2000.00422.x; Nayak B, 2005, P NATL ACAD SCI USA, V102, P17952, DOI 10.1073/pnas.0509089102; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Raptis AE, 2001, EXP CLIN ENDOCR DIAB, V109, pS424, DOI 10.1055/s-2001-18600; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Satchell SC, 2012, KIDNEY INT, V82, P949, DOI 10.1038/ki.2012.258; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Senthil D, 2003, KIDNEY INT, V64, P468, DOI 10.1046/j.1523-1755.2003.00135.x; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shichiri M, 2001, FASEB J, V15, P1044, DOI 10.1096/fj.99-1083com; Sung SH, 2006, J AM SOC NEPHROL, V17, P3093, DOI 10.1681/ASN.2006010064; Tanji N, 2000, J AM SOC NEPHROL, V11, P1656, DOI 10.1681/ASN.V1191656; Tejada T, 2008, KIDNEY INT, V73, P1385, DOI 10.1038/ki.2008.109; Thomas S, 2000, J AM SOC NEPHROL, V11, P1236, DOI 10.1681/ASN.V1171236; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Veron D, 2011, DIABETOLOGIA, V54, P1227, DOI 10.1007/s00125-010-2034-z	27	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96117	10.1371/journal.pone.0096117	http://dx.doi.org/10.1371/journal.pone.0096117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759991	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200137
J	Rizzo, C; Ronca, R; Lombardo, F; Mangano, V; Sirima, SB; Nebie, I; Fiorentino, G; Troye-Blomberg, M; Modiano, D; Arca, B				Rizzo, Cinzia; Ronca, Raffaele; Lombardo, Fabrizio; Mangano, Valentina; Sirima, Sodiomon Bienvenu; Nebie, Issa; Fiorentino, Gabriella; Troye-Blomberg, Marita; Modiano, David; Arca, Bruno			IgG1 and IgG4 Antibody Responses to the Anopheles gambiae Salivary Protein gSG6 in the Sympatric Ethnic Groups Mossi and Fulani in a Malaria Hyperhendemic Area of Burkina Faso	PLOS ONE			English	Article							ADULT FEMALE MOSQUITO; GLAND TRANSCRIPTS; HUMORAL RESPONSE; IMMUNE-RESPONSE; AEDES-AEGYPTI; ANTIGENS; EXPOSURE; MARKER; SUSCEPTIBILITY; MECHANISMS	Human antibody response to the Anopheles gambiae salivary protein gSG6 has recently emerged as a potentially useful tool for malaria epidemiological studies and for the evaluation of vector control interventions. However, the current understanding of the host immune response to mosquito salivary proteins and of the possible crosstalk with early response to Plasmodium parasites is still very limited. We report here the analysis of IgG1 and IgG4 subclasses among anti-gSG6 IgG responders belonging to Mossi and Fulani from Burkina Faso, two ethnic groups which are known for their differential humoral response to parasite antigens and for their different susceptibility to malaria. The IgG1 antibody response against the gSG6 protein was comparable in the two groups. On the contrary, IgG4 titers were significantly higher in the Fulani where, in addition, anti-gSG6 IgG4 antibodies appeared in younger children and the ratio IgG4/IgG1 stayed relatively stable throughout adulthood. Both gSG6-specific IgG1 and IgG4 antibodies showed a tendency to decrease with age whereas, as expected, the IgG response to the Plasmodium circumsporozoite protein (CSP) exhibited an opposite trend in the same individuals. These observations are in line with the idea that the An. gambiae gSG6 salivary protein induces immune tolerance, especially after intense and prolonged exposure as is the case for the area under study, suggesting that gSG6 may trigger in exposed individuals a Th2-oriented immune response.	[Rizzo, Cinzia; Lombardo, Fabrizio; Mangano, Valentina; Modiano, David; Arca, Bruno] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Parasitol Sect, Rome, Italy; [Ronca, Raffaele; Fiorentino, Gabriella; Arca, Bruno] Univ Naples Federico II, Dept Biol, Naples, Italy; [Sirima, Sodiomon Bienvenu; Nebie, Issa] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Troye-Blomberg, Marita] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Modiano, David] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Rome, Italy	Sapienza University Rome; University of Naples Federico II; Stockholm University; Fondazione Cenci Bolognetti; Sapienza University Rome	Arca, B (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Parasitol Sect, Rome, Italy.	bruno.arca@uniroma1.it	Troye-Blomberg, Marita/B-9210-2016; Fiorentino, Gabriella/E-2843-2017; Lombardo, Fabrizio/J-8511-2014; Arca, Bruno/C-8383-2012	Troye-Blomberg, Marita/0000-0002-2804-0325; Fiorentino, Gabriella/0000-0002-4089-3822; Lombardo, Fabrizio/0000-0002-8563-0612; Arca, Bruno/0000-0002-4029-0984; Nebie, Issa/0000-0003-3051-3600; Ronca, Raffaele/0000-0003-2217-3378; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Mangano, Valentina D/0000-0002-2021-6162	European Union [228421, 242095]; Ministero dell'Istruzione, dell'Universita e della Ricerca [2010C2LKKJ_004]; Infravec project; Istituto Pasteur- Fondazione Cenci-Bolognetti (Sapienza University, Rome); Skinflam project	European Union(European Commission); Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Infravec project; Istituto Pasteur- Fondazione Cenci-Bolognetti (Sapienza University, Rome)(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Skinflam project	This work was supported by the European Union funded grants INFRAVEC (228421) and EVIMalaR (242095) and partly by funds from Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2010-2011, SKINFLAM, 2010C2LKKJ_004). RR was supported by the Infravec project. CR was partly supported by a short term fellowship of Istituto Pasteur- Fondazione Cenci-Bolognetti (Sapienza University, Rome). FL was partly supported by the Skinflam project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; AALBERSE RC, 1983, J IMMUNOL, V130, P722; Andrade BB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-121; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Badu K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-318; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Bolad A, 2005, SCAND J IMMUNOL, V61, P380, DOI 10.1111/j.1365-3083.2005.01587.x; Bostrom S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-109; Brosseau L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044189; BRUMMERKORVENKONTIO H, 1994, J ALLERGY CLIN IMMUN, V93, P551, DOI 10.1016/S0091-6749(94)70066-4; Caljon G, 2006, INT J PARASITOL, V36, P1025, DOI 10.1016/j.ijpara.2006.05.002; Cherif MK, 2012, SCAND J IMMUNOL, V75, P606, DOI 10.1111/j.1365-3083.2012.02690.x; Drame PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015596; Lanfrancotti A, 2002, FEBS LETT, V517, P67, DOI 10.1016/S0014-5793(02)02578-4; Lombardo F, 2009, INSECT BIOCHEM MOLEC, V39, P457, DOI 10.1016/j.ibmb.2009.04.006; McKIEL J. A., 1959, Canadian Journal of Zoology, V37, P341, DOI 10.1139/z59-038; MELLANBY K, 1946, NATURE, V158, P554, DOI 10.1038/158554c0; Modiano D, 1998, AM J TROP MED HYG, V58, P220, DOI 10.4269/ajtmh.1998.58.220; Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206; Modiano D, 1998, AM J TROP MED HYG, V59, P336, DOI 10.4269/ajtmh.1998.59.336; Nascimento RJ, 2001, AM J TROP MED HYG, V65, P219, DOI 10.4269/ajtmh.2001.65.219; Nasr A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-43; Noh G, 2007, PEDIAT ALLERG IMM-UK, V18, P63, DOI 10.1111/j.1399-3038.2006.00478.x; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Palosuo K, 1997, INT ARCH ALLERGY IMM, V114, P367, DOI 10.1159/000237696; Peng ZK, 2004, INT ARCH ALLERGY IMM, V133, P198, DOI 10.1159/000076787; Poinsignon A, 2007, AM J TROP MED HYG, V76, P327, DOI 10.4269/ajtmh.2007.76.327; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; Proietti C, 2013, PARASITE IMMUNOL, V35, P164, DOI 10.1111/pim.12031; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; REUNALA T, 1994, INT ARCH ALLERGY IMM, V104, P366, DOI 10.1159/000236693; REUNALA T, 1994, ANN MED, V26, P301, DOI 10.3109/07853899409147906; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Rizzo C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-206; Rizzo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017980; Sanou Guillaume S, 2012, BMC Res Notes, V5, P76, DOI 10.1186/1756-0500-5-76; SCHWARTZ BS, 1990, AM J EPIDEMIOL, V132, P58, DOI 10.1093/oxfordjournals.aje.a115643; Scott-Taylor TH, 2010, PEDIAT ALLERG IMM-UK, V21, P935, DOI 10.1111/j.1399-3038.2010.01025.x; Soyer OU, 2013, ALLERGY, V68, P161, DOI 10.1111/all.12085; Stone W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040170; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Trevejo RT, 2005, AM J TROP MED HYG, V72, P481, DOI 10.4269/ajtmh.2005.72.481; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004; Wisniewski J, 2013, CLIN EXP ALLERGY, V43, P164, DOI 10.1111/cea.12016	47	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96130	10.1371/journal.pone.0096130	http://dx.doi.org/10.1371/journal.pone.0096130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760038	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200140
J	Venteris, ER; May, CJ				Venteris, Erik R.; May, Cassandra J.			Cost-Effective Mapping of Benthic Habitats in Inland Reservoirs through Split-Beam Sonar, Indicator Kriging, and Historical Geologic Data	PLOS ONE			English	Article							ABBEYSTEAD RESERVOIR; TRACE-ELEMENTS; SEDIMENTATION; LAKE; RIVER; SELECTION; GROWTH; BUDGET; FISH; OHIO	Because bottom substrate composition is an important control on the temporal and spatial location of the aquatic community, accurate maps of benthic habitats of inland lakes and reservoirs provide valuable information to managers, recreational users, and scientists. Therefore, we collected vertical, split-beam sonar data (roughness [E1], hardness [E2], and bathymetry) and sediment samples to make such maps. Statistical calibration between sonar parameters and sediment classes was problematic because the E1: E2 ratios for soft (muck and clay) sediments overlapped a lower and narrower range for hard (gravel) substrates. Thus, we used indicator kriging (IK) to map the probability that unsampled locations did not contain coarse sediments. To overcome the calibration issue we tested proxies for the natural processes and anthropogenic history of the reservoir as potential predictive variables. Of these, a geologic map proved to be the most useful. The central alluvial valley and mudflats contained mainly muck and organic-rich clays. The surrounding glacial till and shale bedrock uplands contained mainly poorly sorted gravels. Anomalies in the sonar data suggested that the organic-rich sediments also contained trapped gases, presenting additional interpretive issues for the mapping. We extended the capability of inexpensive split-beam sonar units through the incorporation of historic geologic maps and other records as well as validation with dredge samples. Through the integration of information from multiple data sets, were able to objectively identify bottom substrate and provide reservoir users with an accurate map of available benthic habitat.	[Venteris, Erik R.] Ohio Dept Nat Resources, Div Geol Survey, Columbus, OH USA; [May, Cassandra J.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Aquat Ecol Lab, Columbus, OH 43210 USA	Ohio Department of Natural Resources; Ohio State University	May, CJ (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Aquat Ecol Lab, Columbus, OH 43210 USA.	may.265@osu.edu	May, Cassie/ABA-7419-2020		ODNR Division of Wildlife, Federal Aid in Sport Fish Restoration Project, Fish Management in Ohio [F-69-P]; Central Great Lakes Geologic Mapping Coalition, United States Geological Survey [04ERAG0061]	ODNR Division of Wildlife, Federal Aid in Sport Fish Restoration Project, Fish Management in Ohio; Central Great Lakes Geologic Mapping Coalition, United States Geological Survey	Partial funding and sonar and dredge sample data were provided by the ODNR Division of Wildlife, Federal Aid in Sport Fish Restoration Project F-69-P, Fish Management in Ohio. Additional funding was provided by the Central Great Lakes Geologic Mapping Coalition, United States Geological Survey Cooperative Agreement No. 04ERAG0061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atallah L, 2002, MAR GEOPHYS RES, V23, P431, DOI 10.1023/B:MARI.0000018239.07561.76; Besser JM, 2008, ARCH ENVIRON CON TOX, V54, P557, DOI 10.1007/s00244-007-9074-5; Brown CJ, 2012, J SEA RES, V72, P1, DOI 10.1016/j.seares.2012.04.009; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Brown PJ, 2010, T AM FISH SOC, V139, P1247, DOI 10.1577/T09-049.1; Caldwell BA, 1996, HYDROBIOLOGIA, V328, P1, DOI 10.1007/BF00016897; CHIVERS RC, 1990, HYDROGRAPHIC J, V56, P8; Cholwek G., 2005, MAPPING POTENTIAL LA; CRAVEN RE, 1969, AM MIDL NAT, V82, P346, DOI 10.2307/2423783; Davidson GR, 2005, WATER AIR SOIL POLL, V163, P281, DOI 10.1007/s11270-005-0731-x; Deutsch C. V., 1998, GSLIB GEOSTATISTICAL, DOI DOI 10.2307/1270548; Evans JE, 2007, J GREAT LAKES RES, V33, P182, DOI 10.3394/0380-1330(2007)33[182:CSOTBR]2.0.CO;2; Fleituch T, 2001, HYDROBIOLOGIA, V464, P165, DOI 10.1023/A:1013951503461; FOOTE KG, 1984, J ACOUST SOC AM, V75, P612, DOI 10.1121/1.390489; Galparsoro I, 2013, ESTUAR COAST SHELF S, V131, P194, DOI 10.1016/j.ecss.2013.07.007; Greenstreet SPR, 1997, ICES J MAR SCI, V54, P939, DOI 10.1006/jmsc.1997.0220; Huang Z, 2011, CONT SHELF RES, V31, pS4, DOI 10.1016/j.csr.2010.03.012; Jackson D. C., 1998, STUDIES HIST CIVIL E, V4; James WF, 1997, HYDROBIOLOGIA, V345, P15, DOI 10.1023/A:1002979315412; Jansson MB, 2000, REGUL RIVER, V16, P279, DOI 10.1002/(SICI)1099-1646(200005/06)16:3<279::AID-RRR586>3.3.CO;2-J; JOURNEL AG, 1983, J INT ASS MATH GEOL, V15, P445, DOI 10.1007/BF01031292; Juracek KE, 2003, HYDROBIOLOGIA, V494, P277, DOI 10.1023/A:1025447223154; Kaemingk MA, 2007, RIVER RES APPL, V23, P786, DOI 10.1002/rra.1002; Le Bas TP, 2009, APPL ACOUST, V70, P1248, DOI 10.1016/j.apacoust.2008.07.010; Leighton T., 2008, HYDROACOUSTICS, V11, P203; Liikanen A, 2002, J ENVIRON QUAL, V31, P338, DOI 10.2134/jeq2002.0338; Long D., 2006, SEABED SEDIMENT CLAS; Manley PL, 2008, ENVIRON GEOL, V55, P1587, DOI 10.1007/s00254-007-1109-8; MARZOLF GR, 1965, ECOLOGY, V46, P579, DOI 10.2307/1934998; May CJ, 2012, T AM FISH SOC, V141, P215, DOI 10.1080/00028487.2012.655122; Molino B, 2001, WATER RESOUR MANAG, V15, P109, DOI 10.1023/A:1012550625107; MUNDAHL ND, 1987, ENVIRON BIOL FISH, V20, P129, DOI 10.1007/BF00005292; Ohio Department of Natural Resources Division of Wildlife, 2008, ENH HOOV RES FISH MA; Orlowski A. O., 1984, OCEANOLOGIA, V19, P61; Palmieri A, 2001, J ENVIRON MANAGE, V61, P149, DOI 10.1006/jema.2000.0392; Phelps QE, 2009, N AM J FISH MANAGE, V29, P189, DOI 10.1577/M07-110; Rankin E.T., 2006, OHIO EPA TECHNICAL B; Roseman EF, 1996, ANN ZOOL FENN, V33, P341; Rowan JS, 1995, PHYS CHEM EARTH, V20, P199, DOI 10.1016/0079-1946(95)00024-0; Rukavina N, 2001, SCI TOTAL ENVIRON, V266, P33, DOI 10.1016/S0048-9697(00)00738-5; Vanni MJ, 2005, BIOSCIENCE, V55, P155, DOI 10.1641/0006-3568(2005)055[0155:LLAFWE]2.0.CO;2; Wang XY, 2007, ENVIRON MANAGE, V40, P314, DOI 10.1007/s00267-006-0132-y; Wilding TA, 2003, ICES J MAR SCI, V60, P1373, DOI 10.1016/S1054-3139(03)00151-6	43	6	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95940	10.1371/journal.pone.0095940	http://dx.doi.org/10.1371/journal.pone.0095940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759834	Green Submitted, gold, Green Published			2022-12-25	WOS:000335298200113
J	Zafar, A; Rizvi, A; Ahmad, I; Ahmad, M				Zafar, Atif; Rizvi, Asim; Ahmad, Irshad; Ahmad, Masood			Habitat of In Vivo Transformation Influences the Levels of Free Radical Scavengers in Clinostomum complanatum: Implications for Free Radical Scavenger Based Vaccines against Trematode Infections	PLOS ONE			English	Article							MARGINATUM DIGENEA; GLUTATHIONE; IMMUNITY	Background: Since free radical scavengers of parasite origin like glutathione-S-transferase and superoxide dismutase are being explored as prospective vaccine targets, availability of these molecules within the parasite infecting different hosts as well as different sites of infection is of considerable importance. Using Clinostomum complanatum, as a model helminth parasite, we analysed the effects of habitat of in vivo transformation on free radical scavengers of this trematode parasite. Methods: Using three different animal models for in vivo transformation and markedly different sites of infection, progenetic metacercaria of C. complanatum were transformed to adult ovigerous worms. Whole worm homogenates were used to estimate the levels of lipid peroxidation, a marker of oxidative stress and free radical scavengers. Results: Site of in vivo transformation was found to drastically affect the levels of free radical scavengers in this model trematode parasite. It was observed that oxygen availability at the site of infection probably influences levels of free radical scavengers in trematode parasites. Conclusion: This is the first report showing that habitat of in vivo transformation affects levels of free radical scavengers in trematode parasites. Since free radical scavengers are prospective vaccine targets and parasite infection at ectopic sites is common, we propose that infections at different sites, may respond differently to free radical scavenger based vaccines.	[Zafar, Atif; Rizvi, Asim; Ahmad, Irshad; Ahmad, Masood] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India	Aligarh Muslim University	Ahmad, M (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India.	masood_amua@yahoo.co.in		Rizvi, Asim/0000-0003-0771-0227	University Grants Commission (India); Maulana Azad National (India)	University Grants Commission (India)(University Grants Commission, India); Maulana Azad National (India)	AR is supported by University Grants Commission: Junior Research Fellowship (India) and IA is supported by Maulana Azad National Fellowship (India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi SMA, 1987, INDIAN J PARASITOL, V11, P235; AEBI H, 1984, METHOD ENZYMOL, V105, P121; BROPHY PM, 1995, INT J PARASITOL, V25, P865, DOI 10.1016/0020-7519(95)00005-M; Buege J A, 1978, Methods Enzymol, V52, P302; Chiumiento L, 2009, PARASITOL RES, V105, P593, DOI 10.1007/s00436-009-1483-0; Chung Dong-Il, 1995, Korean Journal of Parasitology, V33, P219, DOI 10.3347/kjp.1995.33.3.219; Coulibaly N D, 1995, Sante, V5, P189; Dias MLGG, 2003, PARASITOL RES, V89, P506, DOI 10.1007/s00436-002-0796-z; Grzych JM, 1998, INFECT IMMUN, V66, P1142, DOI 10.1128/IAI.66.3.1142-1148.1998; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Henkle-Duhrsen K, 2001, MOL BIOCHEM PARASIT, V114, P129, DOI 10.1016/S0166-6851(01)00252-3; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Kitagowa N, 2003, AM J OTOLARYNG, V24, P341, DOI 10.1016/S0196-0709(03)00060-7; LARSON OR, 1990, J PARASITOL, V76, P505, DOI 10.2307/3282829; LO C-F, 1981, Fish Pathology, V15, P219; LoVerde P, 2004, MEM I OSWALDO CRUZ, V99, P37, DOI 10.1590/S0074-02762004000900007; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Park CW, 2009, KOREAN J PARASITOL, V47, P401, DOI 10.3347/kjp.2009.47.4.401; Rizvi A, 2011, THESIS ALIGARH MUSLI; Rizvi A, 2012, J HELMINTHOL, V11, P1; Rizvi A, 2012, VET PARASITOL, V185, P164, DOI 10.1016/j.vetpar.2011.10.024; SIDDIQUI A, 1982, Rivista di Parassitologia, V43, P275; SMITH NC, 1989, PARASITE IMMUNOL, V11, P161, DOI 10.1111/j.1365-3024.1989.tb00656.x; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; UGLEM GL, 1991, J PARASITOL, V77, P658, DOI 10.2307/3282694	25	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95858	10.1371/journal.pone.0095858	http://dx.doi.org/10.1371/journal.pone.0095858			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759940	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200098
J	Besnier, M; Galaup, A; Nicol, L; Henry, JP; Coquerel, D; Gueret, A; Mulder, P; Brakenhielm, E; Thuillez, C; Germain, S; Richard, V; Ouvrard-Pascaud, A				Besnier, Marie; Galaup, Ariane; Nicol, Lionel; Henry, Jean-Paul; Coquerel, David; Gueret, Alexandre; Mulder, Paul; Brakenhielm, Ebba; Thuillez, Christian; Germain, Stephane; Richard, Vincent; Ouvrard-Pascaud, Antoine			Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice	FASEB JOURNAL			English	Article						vascular growth; growth factors; cytokines	ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; IN-VIVO; APOPTOSIS; MOTILITY; RECEPTOR; 1B; PTP-1B; HETEROGENEITY; IMPROVEMENT	The protein tyrosine phosphatase 1B (PTP1B) modulates tyrosine kinase receptors, among which is the vascular endothelial growth factor receptor type 2 (VEGFR2), a key component of angiogenesis. Because PTP1B deficiency in mice improves left ventricular (LV) function 2 mo after myocardial infarction (MI), we hypothesized that enhanced angiogenesis early after MI via activated VEGFR2 contributes to this improvement. At 3 d after MI, capillary density was increased at the infarct border of PTP1B(-/-) mice [+ 7 +/- 2% vs. wild-type (WT), P = 0.05]. This was associated with increased extracellular signal-regulated kinase 2 phosphorylation and VEGFR2 activation (i.e., phosphorylated-Src/Src/VEGFR2 and dissociation of endothelial VEGFR2/VE-cadherin), together with higher infiltration of proangiogenic M2 macrophages within unchanged overall infiltration. In vitro, we showed that PTP1B inhibition or silencing using RNA interference increased VEGF-induced migration and proliferation of mouse heart microvascular endothelial cells as well as fibroblast growth factor (FGF)-induced proliferation of rat aortic smooth muscle cells. At 8 d after MI in PTP1B(-/-) mice, increased LV capillary density (+ 21 +/- 3% vs. WT; P< 0.05) and an increased number of small diameter arteries (15-50 mu m) were likely to participate in increased LV perfusion assessed by magnetic resonance imaging and improved LV compliance, indicating reduced diastolic dysfunction. In conclusion, PTP1B deficiency reduces MI-induced heart failure promptly after ischemia by enhancing angiogenesis, myocardial perfusion, and diastolic function.	[Besnier, Marie; Nicol, Lionel; Henry, Jean-Paul; Coquerel, David; Gueret, Alexandre; Mulder, Paul; Brakenhielm, Ebba; Thuillez, Christian; Richard, Vincent; Ouvrard-Pascaud, Antoine] INSERM, U1096, F-76183 Rouen, France; [Besnier, Marie; Nicol, Lionel; Henry, Jean-Paul; Coquerel, David; Gueret, Alexandre; Mulder, Paul; Brakenhielm, Ebba; Thuillez, Christian; Richard, Vincent; Ouvrard-Pascaud, Antoine] Univ Rouen, IRIB, Rouen, France; [Galaup, Ariane; Germain, Stephane] Coll France, INSERM, Ctr Interdisciplinary Res Biol, U1050, F-75231 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Ouvrard-Pascaud, A (corresponding author), INSERM, UFR Med Pharm, U1096, 22 Bd Gambetta, F-76183 Rouen, France.	antoine.ouvrard-pascaud@univ-rouen.fr	Brakenhielm, Ebba/E-9758-2011; Richard, Vincent/B-1059-2014; Germain, Stephane/E-2301-2016	Brakenhielm, Ebba/0000-0003-3378-8300; Richard, Vincent/0000-0003-0590-0158; Germain, Stephane/0000-0001-5992-1275; Mulder, Paul/0000-0002-5936-5704	Fondation de France; French Ministry of Research and Education; Region Haute Normandie	Fondation de France(Fondation de France); French Ministry of Research and Education; Region Haute Normandie(Region Normandie)	The authors thank Dr. Sebastien Banquet, Dr. Manuelle Debunne, and Ines Boukhalfa for valuable help; Dr. Michel L. Tremblay (Goodman Cancer Centre, McGill University, Montreal, QC, Canada) for providing the PTP1B-deficient mice; and Brigitte Dautreaux, Sylvanie Renet, and Laetitia Guedin for their excellent technical assistance. The study was supported in part by a grant from the Fondation de France. M. B. and A. G. are recipients of a Ph.D. grant from the French Ministry of Research and Education, and D. C. is a recipient of a Ph.D. grant from the Region Haute Normandie. The authors declare no conflicts of interest.	Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264; Bauer WR, 1996, MAGNET RESON MED, V35, P43, DOI 10.1002/mrm.1910350107; Brechot N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003950; Buckley DA, 2002, MOL CELL BIOL, V22, P1998, DOI 10.1128/MCB.22.7.1998-2010.2002; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chang YZ, 2006, ARTERIOSCL THROM VAS, V26, P501, DOI 10.1161/01.ATV.0000201070.71787.b8; Chatelain EH, 2011, CELL MOL LIFE SCI, V68, P2603, DOI 10.1007/s00018-010-0573-6; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Dimmeler S, 2000, CIRC RES, V87, P434; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fang YH, 2011, J MOL CELL CARDIOL, V51, P168, DOI 10.1016/j.yjmcc.2011.05.012; Galaup A, 2012, CIRCULATION, V125, P140, DOI 10.1161/CIRCULATIONAHA.111.049072; Gomez E, 2012, J MOL CELL CARDIOL, V52, P1257, DOI 10.1016/j.yjmcc.2012.03.003; Gonzalez-Rodriguez A, 2007, J CELL PHYSIOL, V212, P76, DOI 10.1002/jcp.21004; GUMKOWSKI F, 1987, BLOOD VESSELS, V24, P11; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Hassid A, 1999, AM J PHYSIOL-HEART C, V277, pH192, DOI 10.1152/ajpheart.1999.277.1.H192; Hassid A, 1999, AM J PHYSIOL-HEART C, V277, pH1014, DOI 10.1152/ajpheart.1999.277.3.H1014; He HH, 2012, BLOOD, V120, P3152, DOI 10.1182/blood-2012-04-422758; Kakazu A, 2008, INVEST OPHTH VIS SCI, V49, P2927, DOI 10.1167/iovs.07-0709; Kober F, 2004, MAGN RESON MED, V51, P62, DOI 10.1002/mrm.10676; LAMMERS R, 1993, J BIOL CHEM, V268, P22456; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Markova B, 2003, BIOCHEMISTRY-US, V42, P2691, DOI 10.1021/bi0265574; Merabet N, 2012, J MOL CELL CARDIOL, V52, P660, DOI 10.1016/j.yjmcc.2011.11.015; Mulder P, 2004, CIRCULATION, V109, P1674, DOI 10.1161/01.CIR.0000118464.48959.1C; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2013, CIRC RES, V112, P1624, DOI 10.1161/CIRCRESAHA.113.300890; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Song HW, 2008, APOPTOSIS, V13, P383, DOI 10.1007/s10495-008-0181-1; Stuible M, 2010, TRENDS CELL BIOL, V20, P672, DOI 10.1016/j.tcb.2010.08.013; Sun ZY, 2012, J EXP MED, V209, P1363, DOI 10.1084/jem.20111343; Vercauteren M, 2006, CIRCULATION, V114, P2498, DOI 10.1161/CIRCULATIONAHA.106.630129; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Westermann D, 2009, BASIC RES CARDIOL, V104, P499, DOI 10.1007/s00395-009-0014-6; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102	37	46	47	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3351	3361		10.1096/fj.13-245753	http://dx.doi.org/10.1096/fj.13-245753			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24760754				2022-12-25	WOS:000340265400007
J	Pfisterer, L; Meyer, R; Feldner, A; Drews, O; Hecker, M; Korff, T				Pfisterer, Larissa; Meyer, Ralph; Feldner, Anja; Drews, Oliver; Hecker, Markus; Korff, Thomas			Bortezomib protects from varicose-like venous remodeling	FASEB JOURNAL			English	Article						proteasome; myocardin; varicose veins; venous smooth muscle cell phenotype	UBIQUITIN-PROTEASOME SYSTEM; SMOOTH-MUSCLE-CELLS; RISK-FACTORS; MYOCARDIN; VEINS; DIFFERENTIATION; INSUFFICIENCY; EPIDEMIOLOGY; DEGRADATION; SUFFICIENT	Despite the high prevalence of venous diseases that are associated with and based on the structural reorganization of the venous vessel wall, not much is known about their mechanistic causes. In this context, we demonstrated that the quantity of myocardin, a transcriptional regulator of the contractile and quiescent smooth muscle cell phenotype, was diminished in proliferating synthetic venous smooth muscle cells (VSMCs) of human and mouse varicose veins by 51 and 60%, respectively. On the basis of the relevance of proteasomal activity for such phenotypic changes, we hypothesized that the observed VSMC activation is attenuated by the proteasome inhibitor bortezomib. This drug fully abolished VSMC proliferation and loss of myocardin in perfused mouse veins and blocked VSMC invasion in collagen gels by almost 80%. In line with this, topical transdermal treatment with bortezomib diminished VSMC proliferation by 80%, rescued 90% of VSMC myocardin abundance, and inhibited varicose-like venous remodeling by 67 to 72% in a mouse model. Collectively, our data indicate that the proteasome plays a pivotal role in VSMC phenotype changes during venous remodeling processes. Its inhibition protects from varicose-like vein remodeling in mice and may thus serve as a putative therapeutic strategy to treat human varicose veins.	[Pfisterer, Larissa; Meyer, Ralph; Feldner, Anja; Drews, Oliver; Hecker, Markus; Korff, Thomas] Heidelberg Univ, Inst Physiol & Pathophysiol, Div Cardiovasc Physiol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Korff, T (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Div Cardiovasc Physiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	korff@physiologie.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [SFB TR23]; German Cardiac Society (DGK); German Society of Phlebology (DGP)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cardiac Society (DGK); German Society of Phlebology (DGP)	The authors acknowledge the excellent technical assistance of Gudrun Scheib and Maria Harlacher and thank Dr. Bernhard Rumstadt (Furst-Stirum-Klinik, Bruchsal, Germany) and Dr. Stephan Rewerk (Heidelberger Praxisklinik, Heidelberg, Germany) for providing human vein samples. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB TR23, projects C5 and C6), the German Cardiac Society (DGK), and the German Society of Phlebology (DGP).	Atta HM, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/538627; Barringhaus Kurt G, 2007, Exp Clin Cardiol, V12, P119; Beebe-Dimmer JL, 2005, ANN EPIDEMIOL, V15, P175, DOI 10.1016/j.annepidem.2004.05.015; Bunn PA, 2004, CLIN CANCER RES, V10, p4263S, DOI 10.1158/1078-0432.CCR-040011; BURKITT DP, 1976, LANCET, V2, P202; Clark A, 2010, PHLEBOLOGY, V25, P236, DOI 10.1258/phleb.2009.009045; Drews O, 2010, CIRC RES, V107, P1094, DOI 10.1161/CIRCRESAHA.110.222364; Eberhardt RT, 2005, CIRCULATION, V111, P2398, DOI 10.1161/01.CIR.0000164199.72440.08; Feldner A, 2011, FASEB J, V25, P3613, DOI 10.1096/fj.11-185975; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gomes AV, 2006, ANTIOXID REDOX SIGN, V8, P1677, DOI 10.1089/ars.2006.8.1677; Herrmann J, 2007, CIRC RES, V101, P865, DOI 10.1161/CIRCRESAHA.107.152959; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Iannuzzi A, 2002, J VASC SURG, V36, P965, DOI 10.1067/mva.2002.128315; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Lee AJ, 2003, J CLIN EPIDEMIOL, V56, P171, DOI 10.1016/S0895-4356(02)00518-8; Li S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078564; Lim CS, 2009, BRIT J SURG, V96, P1231, DOI 10.1002/bjs.6798; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Pagan J, 2013, CIRC RES, V112, P1046, DOI 10.1161/CIRCRESAHA.112.300521; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pfisterer L, 2012, CARDIOVASC RES, V96, P120, DOI 10.1093/cvr/cvs247; Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; SCOTT TE, 1995, J VASC SURG, V22, P622, DOI 10.1016/S0741-5214(95)70050-1; Somers P, 2006, ANGIOLOGY, V57, P546, DOI 10.1177/0003319706293115; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Tung D, 2011, PHARMACOLOGY, V88, P100, DOI 10.1159/000330067; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Wali MA, 2002, INT ANGIOL, V21, P337; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Weathington NM, 2013, AM J RESP CRIT CARE, V188, P530, DOI 10.1164/rccm.201304-0754PP; Wilck N, 2012, ARTERIOSCL THROM VAS, V32, P1418, DOI 10.1161/ATVBAHA.112.249342; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5	36	10	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3518	3527		10.1096/fj.14-250464	http://dx.doi.org/10.1096/fj.14-250464			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24769668				2022-12-25	WOS:000340265400021
J	Gealekman, O; Gurav, K; Chouinard, M; Straubhaar, J; Thompson, M; Malkani, S; Hartigan, C; Corvera, S				Gealekman, Olga; Gurav, Kunal; Chouinard, My; Straubhaar, Juerg; Thompson, Michael; Malkani, Samir; Hartigan, Celia; Corvera, Silvia			Control of Adipose Tissue Expandability in Response to High Fat Diet by the Insulin-like Growth Factor-binding Protein-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL PROLIFERATION; FACTOR-I; OBESITY; ANGIOGENESIS; HYPOXIA; RESISTANCE; MACROPHAGES; EXPRESSION; WHITE; RAT	Adipose tissue expansion requires growth and proliferation of adipocytes and the concomitant expansion of their stromovascular network. We have used an ex vivo angiogenesis assay to study the mechanisms involved in adipose tissue expansion. In this assay, adipose tissue fragments placed under pro-angiogenic conditions form sprouts composed of endothelial, perivascular, and other proliferative cells. We find that sprouting was directly stimulated by insulin and was enhanced by prior treatment of mice with the insulin sensitizer rosiglitazone. Moreover, basal and insulin-stimulated sprouting increased progressively over 30 weeks of high fat diet feeding, correlating with tissue expansion during this period. cDNA microarrays analyzed to identify genes correlating with insulin-stimulated sprouting surprisingly revealed only four positively correlating (Fads3, Tmsb10, Depdc6, and Rasl12) and four negatively correlating (Asph, IGFbp4, Ppm1b, and Adcyap1r1) genes. Amongthe proteins encoded by these genes, IGFbp4, which suppresses IGF-1 signaling, has been previously implicated in angiogenesis, suggesting a role for IGF-1 in adipose tissue expandability. Indeed, IGF-1 potently stimulated sprouting, and the presence of activated IGF-1 receptors in the vasculature was revealed by immunostaining. Recombinant IGFbp4 blocked the effects of insulin and IGF-1 on mouse adipose tissue sprouting and also suppressed sprouting from human subcutaneous adipose tissue. These results reveal an important role of IGF-1/IGFbp4signaling in post-developmental adipose tissue expansion.	[Gealekman, Olga; Gurav, Kunal; Chouinard, My; Straubhaar, Juerg; Corvera, Silvia] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Thompson, Michael; Malkani, Samir; Hartigan, Celia] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Thompson, Michael] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Corvera, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantation St, Worcester, MA 01605 USA.	silvia.corvera@umassmed.edu	Gurav, Kunal/Y-3579-2019		University of Massachusetts Diabetes Center of Excellence; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089101] Funding Source: NIH RePORTER	University of Massachusetts Diabetes Center of Excellence; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Morphology and Bioinformatics Core Services were supported by the University of Massachusetts Diabetes Center of Excellence.	ALARID ET, 1992, ENDOCRINOLOGY, V130, P2305, DOI 10.1210/en.130.4.2305; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouloumie A, 2002, ANN ENDOCRINOL-PARIS, V63, P91; Carnesecchi S, 2006, EXP CELL RES, V312, P3413, DOI 10.1016/j.yexcr.2006.07.003; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Clemmons D. R., 2012, ENDOCRINOL METAB CLI; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Gealekman O, 2011, CIRCULATION, V123, P186, DOI 10.1161/CIRCULATIONAHA.110.970145; Goossens GH, 2011, CIRCULATION, V124, P67, DOI 10.1161/CIRCULATIONAHA.111.027813; Gousseva N, 2001, J CELL BIOCHEM, V81, P523, DOI 10.1002/1097-4644(20010601)81:3<523::AID-JCB1066>3.0.CO;2-E; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Jehle PM, 1998, J ENDOCRINOL, V159, P297, DOI 10.1677/joe.0.1590297; Jo J, 2010, BIOPHYS J, V99, P3535, DOI 10.1016/j.bpj.2010.10.009; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; Lassance L, 2013, J CLIN ENDOCR METAB, V98, pE1438, DOI 10.1210/jc.2013-1210; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; MADDOX DE, 1982, P NATL ACAD SCI-BIOL, V79, P166, DOI 10.1073/pnas.79.1.166; Mazzatti D, 2012, ARCH PHYSIOL BIOCHEM, V118, P112, DOI 10.3109/13813455.2012.654611; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Owen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032700; Pasarica M, 2010, J CLIN ENDOCR METAB, V95, P4052, DOI 10.1210/jc.2009-2377; PHILLIPS LS, 1991, DIABETES, V40, P1525, DOI 10.2337/diabetes.40.11.1525; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Qiao JG, 2005, WORLD J GASTROENTERO, V11, P5978, DOI 10.3748/wjg.v11.i38.5978; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Rojas-Rodriguez R, 2014, METHOD ENZYMOL, V537, P75, DOI 10.1016/B978-0-12-411619-1.00005-7; RUSSELLJONES DL, 1992, J MOL ENDOCRINOL, V9, P257, DOI 10.1677/jme.0.0090257; Ryan AJ, 2009, BRIT J CANCER, V101, P278, DOI 10.1038/sj.bjc.6605141; SCHEIWILLER E, 1986, NATURE, V323, P169, DOI 10.1038/323169a0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spencer M, 2011, J CLIN ENDOCR METAB, V96, pE1990, DOI 10.1210/jc.2011-1567; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Tchoukalova YD, 2009, BIOCHEM BIOPH RES CO, V380, P679, DOI 10.1016/j.bbrc.2009.01.149; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509	50	39	41	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18327	18338		10.1074/jbc.M113.545798	http://dx.doi.org/10.1074/jbc.M113.545798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24778188	Green Published, hybrid			2022-12-25	WOS:000338042000032
J	Xu, C; Liu, K; Tempel, W; Demetriades, M; Aik, W; Schofield, CJ; Min, JR				Xu, Chao; Liu, Ke; Tempel, Wolfram; Demetriades, Marina; Aik, WeiShen; Schofield, Christopher J.; Min, Jinrong			Structures of Human ALKBH5 Demethylase Reveal a Unique Binding Mode for Specific Single-stranded N-6-Methyladenosine RNA Demethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DEMETHYLATION; CRYSTAL-STRUCTURES; ALKYLATION DAMAGE; JMJD2 FAMILY; NUCLEAR-RNA; FTO GENE; PROTEIN; DNA; SUBSTRATE; OBESITY	N-6-Methyladenosine (m(6)A) is the most prevalent internal RNA modification in eukaryotes. ALKBH5 belongs to the AlkB family of dioxygenases and has been shown to specifically demethylate m6A in single-stranded RNA. Here we report crystal structures of ALKBH5 in the presence of either its cofactors or the ALKBH5 inhibitor citrate. Catalytic assays demonstrate that the ALKBH5 catalytic domain can demethylate both single-stranded RNA and single-stranded DNA. We identify the TCA cycle intermediate citrate as a modest inhibitor of ALKHB5 (IC50, similar to 488 mu M). The structural analysis reveals that a loop region of ALKBH5 is immobilized by a disulfide bond that apparently excludes the binding of dsDNA to ALKBH5. We identify the m(6)A binding pocket of ALKBH5 and the key residues involved in m(6)A recognition using mutagenesis and ITC binding experiments.	[Xu, Chao; Liu, Ke; Tempel, Wolfram; Min, Jinrong] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China; [Xu, Chao; Liu, Ke; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Liu, Ke; Min, Jinrong] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Demetriades, Marina; Aik, WeiShen; Schofield, Christopher J.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	Central China Normal University; University of Toronto; Structural Genomics Consortium; University of Oxford; University of Toronto	Min, JR (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China.	jr.min@utoronto.ca	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; , KE/0000-0002-7082-262X; Schofield, Christopher/0000-0002-0290-6565; Aik, Wei Shen/0000-0003-4414-173X	Biotechnological and Biological Research Council; AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada through Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; Biotechnology and Biological Sciences Research Council [BB/L009846/1] Funding Source: researchfish; BBSRC [BB/L009846/1] Funding Source: UKRI	Biotechnological and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnological and Biological Research Council. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada through Ontario Genomics Institute Grant OGI-055, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and Wellcome Trust Grant 092809/Z/10/Z.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aik W, 2014, NUCLEIC ACIDS RES, V42, P4741, DOI 10.1093/nar/gku085; Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Bokar JA, 1997, RNA, V3, P1233; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Feng C, 2014, J BIOL CHEM, V289, P11571, DOI 10.1074/jbc.M113.546168; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Fu D, 2013, GENE DEV, V27, P1089, DOI 10.1101/gad.215533.113; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gildea RJ, 2011, J APPL CRYSTALLOGR, V44, P1259, DOI 10.1107/S0021889811041161; Globisch D, 2011, ANGEW CHEM INT EDIT, V50, P9739, DOI 10.1002/anie.201103229; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V126, P8, DOI 10.1016/0003-9861(68)90553-5; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lu LH, 2010, NUCLEIC ACIDS RES, V38, P4415, DOI 10.1093/nar/gkq129; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Pastore C, 2012, J BIOL CHEM, V287, P2130, DOI 10.1074/jbc.M111.286187; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; SANEYOSHI M, 1969, BIOCHIM BIOPHYS ACTA, V190, P264, DOI 10.1016/0005-2787(69)90078-1; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	58	110	125	3	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17299	17311		10.1074/jbc.M114.550350	http://dx.doi.org/10.1074/jbc.M114.550350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24778178	Green Published, hybrid			2022-12-25	WOS:000338018100002
J	Rodrigues, C; de Assis, AM; Moura, DJ; Halmenschlager, G; Saffi, J; Xavier, LL; Fernandes, MD; Wink, MR				Rodrigues, Cristiano; de Assis, Adriano M.; Moura, Dinara J.; Halmenschlager, Graziele; Saffi, Jenifer; Xavier, Leder Leal; Fernandes, Marilda da Cruz; Wink, Marcia Rosangela			New Therapy of Skin Repair Combining Adipose-Derived Mesenchymal Stem Cells with Sodium Carboxymethylcellulose Scaffold in a Pre-Clinical Rat Model	PLOS ONE			English	Article							DNA-DAMAGE; COMET ASSAY; GEL TEST; GROWTH; TISSUE	Lesions with great loss of skin and extensive burns are usually treated with heterologous skin grafts, which may lead rejection. Cell therapy with mesenchymal stem cells is arising as a new proposal to accelerate the healing process. We tested a new therapy consisting of sodium carboxymethylcellulose (CMC) as a biomaterial, in combination with adipose-derived stem cells (ADSCs), to treat skin lesions in an in vivo rat model. This biomaterial did not affect membrane viability and induced a small and transient genotoxicity, only at the highest concentration tested (40 mg/mL). In a rat wound model, CMC at 10 mg/mL associated with ADSCs increased the rate of cell proliferation of the granulation tissue and epithelium thickness when compared to untreated lesions (Sham), but did not increase collagen fibers nor alter the overall speed of wound closure. Taken together, the results show that the CMC is capable to allow the growth of ADSCs and is safe for this biological application up to the concentration of 20 mg/mL. These findings suggest that CMC is a promising biomaterial to be used in cell therapy.	[Rodrigues, Cristiano; de Assis, Adriano M.; Wink, Marcia Rosangela] Univ Fed Ciencias Saude Porto Alegre, Dept Ciencias Basicas Saude, Lab Pesquisa Biol Celular, Porto Alegre, RS, Brazil; [Moura, Dinara J.; Halmenschlager, Graziele; Saffi, Jenifer] Univ Fed Ciencias Saude Porto Alegre, Dept Ciencias Basicas Saude, Porto Alegre, RS, Brazil; [de Assis, Adriano M.] Univ Fed Rio Grande do Sul, Dept Bioquim, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil; [Xavier, Leder Leal] Pontificia Univ Catolica Rio Grande do Sul, Dept Ciencias Morfofisiol, Lab Biol Celular & Tecidual, Porto Alegre, RS, Brazil; [Fernandes, Marilda da Cruz] Univ Fed Ciencias Saude Porto Alegre, Dept Ciencias Basicas Saude, Lab Pesquisa Patol, Porto Alegre, RS, Brazil	Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal de Ciencias da Saude de Porto Alegre	Wink, MR (corresponding author), Univ Fed Ciencias Saude Porto Alegre, Dept Ciencias Basicas Saude, Lab Pesquisa Biol Celular, Porto Alegre, RS, Brazil.	mwink@ufcspa.edu.br	Fernandes, Marilda/L-2819-2016; de Assis, Adriano/H-2606-2013; da Cruz Fernandes, Marilda/ABD-5348-2021; Moura, Dinara/AAX-9497-2021; Xavier, Leder Leal/G-4540-2014; Saffi, Jenifer/G-4199-2018	Fernandes, Marilda/0000-0003-4234-797X; de Assis, Adriano/0000-0002-1953-7831; Moura, Dinara/0000-0002-7232-5002; Xavier, Leder Leal/0000-0002-7213-4935; Saffi, Jenifer/0000-0002-5372-2934; Rodrigues, Cristiano/0000-0002-8614-5723	CAPES-REUNI program (Coordenacao de aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); PRONEX; PRONEM - FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul); PROBITEC-CAPES	CAPES-REUNI program (Coordenacao de aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX; PRONEM - FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul); PROBITEC-CAPES	C. Rodrigues was the recipient of a Master fellowship from CAPES-REUNI program (Coordenacao de aperfeicoamento de Pessoal de Nivel Superior); M. R. Wink, L. L. Xavier, and J. Saffi are recipients of research fellowships from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). This study was supported by PRONEX and PRONEM - FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul) and PROBITEC-CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaji S, 2012, ADV WOUND CARE, V1, P159, DOI 10.1089/wound.2012.0361; Balbino Carlos Aberto, 2005, Rev. Bras. Cienc. Farm., V41, P27, DOI 10.1590/S1516-93322005000100004; de Albuquerque RLC, 2009, INT J MORPHOL, V27, P1106; Chen Ming, 2009, Critical Reviews in Biomedical Engineering, V37, P399, DOI 10.1615/CritRevBiomedEng.v37.i4-5.50; de Souza DB, 2012, J ANDROL, V33, P735, DOI 10.2164/jandrol.111.014225; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Harding Keith G, 2005, Int Wound J, V2, P364, DOI 10.1111/j.1742-4801.2005.00149.x; Hartmann A, 1997, TOXICOL LETT, V90, P183, DOI 10.1016/S0378-4274(96)03847-7; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Jiang LY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-65; Johnson A, 2013, FASEB J, V27, P3893, DOI 10.1096/fj.12-214189; Khosrotehrani K, 2013, EXP DERMATOL, V22, P307, DOI 10.1111/exd.12141; Kim CH, 2011, J KOREAN MED SCI, V26, P726, DOI 10.3346/jkms.2011.26.6.726; Kirschner N, 2010, EUR J CELL BIOL, V89, P839, DOI 10.1016/j.ejcb.2010.07.010; Lipp C, 2010, J WOUND CARE, V19, P220, DOI 10.12968/jowc.2010.19.6.48468; LOGAN A, 1992, J NEUROSCI, V12, P3828; Meirelles LD, 2009, FRONT BIOSCI-LANDMRK, V14, P4281, DOI 10.2741/3528; Motawi TM, 2013, CELL BIOCH BIOPHYS, V13, P9698; Nadin SB, 2001, J HISTOCHEM CYTOCHEM, V49, P1183, DOI 10.1177/002215540104900912; Neuman MG, 2011, J PHARM PHARM SCI, V14, P425, DOI 10.18433/J3QS3J; Peroni D, 2008, EXP CELL RES, V314, P603, DOI 10.1016/j.yexcr.2007.10.007; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Ramli NA, 2011, INT J PHARMACEUT, V403, P73, DOI 10.1016/j.ijpharm.2010.10.023; Shimamura MK, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041804; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Speit G, 1999, METH MOL B, V113, P203; Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028; Sudhakar Y, 2006, J CONTROL RELEASE, V114, P15, DOI 10.1016/j.jconrel.2006.04.012; Thomas P, 2009, NAT PROTOC, V4, P825, DOI 10.1038/nprot.2009.53; TICE RR, 1995, STEM CELLS, V13, P207; van Zuijlen PPM, 2001, PLAST RECONSTR SURG, V108, P1938, DOI 10.1097/00006534-200112000-00014; Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Zhou SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058324; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	41	37	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96241	10.1371/journal.pone.0096241	http://dx.doi.org/10.1371/journal.pone.0096241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788779	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700067
J	Preston, JC; Jorgensen, SA; Jha, SG				Preston, Jill C.; Jorgensen, Stacy A.; Jha, Suryatapa G.			Functional Characterization of Duplicated SUPPRESSOR OF OVEREXPRESSION OF CONSTANS 1-Like Genes in Petunia	PLOS ONE			English	Article							CIRCADIAN CLOCK; FLOWERING TIME; OVEREXPRESSION; ACTIVATION; EXPRESSION; ORTHOLOG; PROTEIN; LEAF	Flowering time is strictly controlled by a combination of internal and external signals that match seed set with favorable environmental conditions. In the model plant species Arabidopsis thaliana (Brassicaceae), many of the genes underlying development and evolution of flowering have been discovered. However, much remains unknown about how conserved the flowering gene networks are in plants with different growth habits, gene duplication histories, and distributions. Here we functionally characterize three homologs of the flowering gene SUPPRESSOR OF OVEREXPRESSION OF CONSTANS 1 (SOC1) in the short-lived perennial Petunia hybrida (petunia, Solanaceae). Similar to A. thaliana soc1 mutants, co-silencing of duplicated petunia SOC1-like genes results in late flowering. This phenotype is most severe when all three SOC1-like genes are silenced. Furthermore, expression levels of the SOC1-like genes UNSHAVEN (UNS) and FLORAL BINDING PROTEIN 21 (FBP21), but not FBP28, are positively correlated with developmental age. In contrast to A. thaliana, petunia SOC1-like gene expression did not increase with longer photoperiods, and FBP28 transcripts were actually more abundant under short days. Despite evidence of functional redundancy, differential spatio-temporal expression data suggest that SOC1-like genes might fine-tune petunia flowering in response to photoperiod and developmental stage. This likely resulted from modification of SOC1-like gene regulatory elements following recent duplication, and is a possible mechanism to ensure flowering under both inductive and non-inductive photoperiods.	[Preston, Jill C.; Jorgensen, Stacy A.; Jha, Suryatapa G.] Univ Vermont, Dept Plant Biol, Burlington, VT 05405 USA	University of Vermont	Preston, JC (corresponding author), Univ Vermont, Dept Plant Biol, Burlington, VT 05405 USA.	Jill.Preston@uvm.edu			College of Agriculture and Life Sciences at the University of Vermont	College of Agriculture and Life Sciences at the University of Vermont	This work was supported by the College of Agriculture and Life Sciences at the University of Vermont. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Blazquez MA, 2002, PLANT PHYSIOL, V130, P1770, DOI 10.1104/pp.007625; Chen JC, 2004, PLANT MOL BIOL, V55, P521, DOI 10.1007/s11103-004-0590-7; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; Ding LH, 2013, PLANT CELL PHYSIOL, V54, P595, DOI 10.1093/pcp/pct026; Drea S, 2007, DEVELOPMENT, V134, P4157, DOI 10.1242/dev.013136; Ferrario S, 2004, PLANT CELL, V16, P1490, DOI 10.1105/tpc.019679; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; Huang T, 2005, SCIENCE, V309, P1694, DOI 10.1126/science.1117768; Immink RGH, 2003, MOL GENET GENOMICS, V268, P598, DOI 10.1007/s00438-002-0781-3; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Lee SY, 2004, PLANT J, V38, P754, DOI 10.1111/j.1365-313X.2004.02082.x; Ma GY, 2011, PLANT MOL BIOL REP, V29, P573, DOI 10.1007/s11105-010-0263-4; Maddison WP, 2011, MESQUITE MODULAR SYS; Mouhu K, 2013, PLANT CELL, V25, P3296, DOI 10.1105/tpc.113.115055; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; Preston JC, 2010, PLANT J, V62, P704, DOI 10.1111/j.1365-313X.2010.04184.x; Rijpkema A, 2006, ADV BOT RES, V44, P237, DOI 10.1016/S0065-2296(06)44006-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruokolainen S, 2011, ANN BOT-LONDON, V107, P1491, DOI 10.1093/aob/mcr112; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Samis KE, 2012, ECOL EVOL, V2, P1162, DOI 10.1002/ece3.262; Snowden KC, 2003, FUNCT PLANT BIOL, V30, P987, DOI 10.1071/FP03081; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zhou CM, 2013, SCIENCE, V340, P1097, DOI 10.1126/science.1234340; ZWICKL D, 2006, THESIS TX U TEXAS AU	30	10	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96108	10.1371/journal.pone.0096108	http://dx.doi.org/10.1371/journal.pone.0096108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787903	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600077
J	Saito, R; Kaneko, M; Kitamura, Y; Takata, K; Kawada, K; Okuma, Y; Nomura, Y				Saito, Ryo; Kaneko, Masayuki; Kitamura, Yoshihisa; Takata, Kazuyuki; Kawada, Koichi; Okuma, Yasunobu; Nomura, Yasuyuki			Effects of Oxidative Stress on the Solubility of HRD1, a Ubiquitin Ligase Implicated in Alzheimer's Disease	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; ER STRESS; INDUCED APOPTOSIS; PROTEIN; DEGRADATION; TAU; HYPERPHOSPHORYLATION; ACCUMULATION; INVOLVEMENT; IMPAIRMENT	The E3 ubiquitin ligase HRD1 is found in the endoplasmic reticulum membrane of brain neurons and is involved in endoplasmic reticulum-associated degradation. We previously demonstrated that suppression of HRD1 expression in neurons causes accumulation of amyloid precursor protein, resulting in amyloid beta production associated with endoplasmic reticulum stress and apoptosis. Furthermore, HRD1 levels are significantly decreased in the cerebral cortex of Alzheimer's disease patients because of its insolubility. The mechanisms that affect HRD1 solubility are not well understood. We here show that HRD1 protein was insolubilized by oxidative stress but not by other Alzheimer's disease-related molecules and stressors, such as amyloid beta, tau, and endoplasmic reticulum stress. Furthermore, we raise the possibility that modifications of HRD1 by 4-hydroxy-2-nonenal, an oxidative stress marker, decrease HRD1 protein solubility and the oxidative stress led to the accumulation of HRD1 into the aggresome. Thus, oxidative stress-induced HRD1 insolubilization might be involved in a vicious cycle of increased amyloid beta production and amyloid beta-induced oxidative stress in Alzheimer's disease pathogenesis.	[Saito, Ryo; Kaneko, Masayuki; Kawada, Koichi; Okuma, Yasunobu] Chiba Inst Sci, Fac Pharmaceut Sci, Dept Pharmacol, Choshi, Japan; [Saito, Ryo] Japan Soc Promot Sci, Tokyo, Japan; [Kaneko, Masayuki] Gifu Pharmaceut Univ, Lab Med Therapeut & Mol Therapeut, Gifu, Japan; [Kitamura, Yoshihisa; Takata, Kazuyuki] Kyoto Pharmaceut Univ, Dept Clin & Translat Physiol, Kyoto 607, Japan; [Nomura, Yasuyuki] Kurume Univ, Sch Med, Dept Pharmacol, Kurume, Fukuoka 830, Japan	Japan Society for the Promotion of Science; Gifu Pharmaceutical University; Kyoto Pharmaceutical University; Kurume University	Nomura, Y (corresponding author), Kurume Univ, Sch Med, Dept Pharmacol, Kurume, Fukuoka 830, Japan.	nomura_yasuyuki@kurume-u.ac.jp	Kawada, Koichi/X-1116-2019; Kaneko, Masayuki/F-9302-2011	Kawada, Koichi/0000-0002-9232-770X; Kaneko, Masayuki/0000-0002-0477-0171	Ministry of Education, Culture, Sports, Science and Technology, Japan [23790095, 21790089, 24300135, 21300142, 24590119, 21590101]; Research Foundation for Pharmaceutical Sciences; Grants-in-Aid for Scientific Research [23790095, 24790085] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Foundation for Pharmaceutical Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Science Research (KAKENHI) 23790095, 21790089, 24300135, 21300142, 24590119, and 21590101 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.jsps.go.jp/english/e-grants/), and by the Research Foundation for Pharmaceutical Sciences (http://www15.ocn.ne.jp/similar to yakusho/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akude E, 2010, NEUROTOX RES, V17, P28, DOI 10.1007/s12640-009-9074-5; Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Apodaca J, 2006, BIOCHEM BIOPH RES CO, V347, P319, DOI 10.1016/j.bbrc.2006.06.078; Bodur C, 2012, J CELL PHYSIOL, V227, P3556, DOI 10.1002/jcp.24057; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Costa RO, 2010, J ALZHEIMERS DIS, V20, P625, DOI 10.3233/JAD-2010-091369; Costa RO, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.04.011; Drake J, 2004, NEUROSCI LETT, V356, P155, DOI 10.1016/j.neulet.2003.11.047; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Kaneko M, 2012, BIOL PHARM BULL, V35, P269, DOI 10.1248/bpb.35.269; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kawada K, 2011, J PHARMACOL SCI, V117, P208, DOI 10.1254/jphs.11120SC; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Lee HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028033, 10.1371/journal.pone.0044670, 10.1371/journal.pone.0050296, 10.1186/1747-597X-7-11]; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; Liu ZC, 2012, J ALZHEIMERS DIS, V29, P727, DOI 10.3233/JAD-2012-111898; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Okamoto Y, 2009, NEUROREPORT, V20, P990, DOI 10.1097/WNR.0b013e32832d2e6a; Omura T, 2008, J NEUROSCI RES, V86, P1577, DOI 10.1002/jnr.21616; Omura T, 2006, J NEUROCHEM, V99, P1456, DOI 10.1111/j.1471-4159.2006.04155.x; Omura T, 2008, J PHARMACOL SCI, V106, P512, DOI 10.1254/jphs.08005FP; Pettazzoni P, 2011, FREE RADICAL BIO MED, V50, P313, DOI 10.1016/j.freeradbiomed.2010.11.011; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Roede JR, 2010, ENVIRON MOL MUTAGEN, V51, P380, DOI 10.1002/em.20553; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito R, 2010, J PHARMACOL SCI, V113, P285, DOI 10.1254/jphs.10118SC; SAJDELSULKOWSKA EM, 1984, SCIENCE, V225, P947, DOI 10.1126/science.6206567; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shen YX, 2012, CURR MOL MED, V12, P138, DOI 10.2174/156652412798889009; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Wang HP, 2011, MOL CELL BIOCHEM, V346, P137, DOI 10.1007/s11010-010-0600-9; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031	45	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94576	10.1371/journal.pone.0094576	http://dx.doi.org/10.1371/journal.pone.0094576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788773	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600014
J	Sjokvist, E; Pfeil, BE; Larsson, E; Larsson, KH				Sjokvist, Elisabet; Pfeil, Bernard E.; Larsson, Ellen; Larsson, Karl-Henrik			Stereopsidales - A New Order of Mushroom-Forming Fungi	PLOS ONE			English	Article							MAJOR CLADES; CLASSIFICATION; DIVERSITY; SEQUENCES	One new order, one new family, and one new combination are presented, as the result of molecular phylogenetic analyses. The new order Stereopsidales and the new family Stereopsidaceae are described incorporating Stereopsis radicans and S. globosa, formerly Clavulicium globosum. We show that not only do these species represent an old overlooked lineage, but both species harbor cryptic diversity. In addition, a third species, C. macounii, appears as a plausible sister to the new lineage, but there is conflict in the data. All specimens of S. radicans and S. globosa analysed here are from the South and Central Americas; several records of S. radicans have been made also from tropical Asia. We expect the true diversity in this group to be a lot higher than presented in this paper. Stereopsis radicans was formerly included in Polyporales, but a placement within that order is rejected by our data through SH tests. The dataset consisted of four nuclear markers: rpb2, tef1, LSU and SSU, each of which was analysed separately using maximum likelihood and Bayesian inference. Recombination detection tests indicate no plausible recombinations. The potential of S. radicans, S. globosa and C. macounii being amphitallic is briefly discussed.	[Sjokvist, Elisabet; Pfeil, Bernard E.; Larsson, Ellen] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Larsson, Karl-Henrik] Univ Oslo, Nat Hist Museum, Oslo, Norway	University of Gothenburg; University of Oslo	Sjokvist, E (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	elisabet.sjokvist@bioenv.gu.se	Pfeil, Bernard E/C-1108-2008	Pfeil, Bernard E/0000-0001-8179-2270; Sjoro, Elisabet/0000-0001-5890-8677	Svenska artprojektet, Artdatabanken, SLU; Kapten Carl Stenholms fond; Wilhelm och Martina Lundgrens fond; Anna och Gunnar Vid-felts fond for biologisk forskning; Swedish Research Council [2009-5206]; Royal Swedish Academy of Sciences; Lars Hiertas Minne fund; Royal Physiographic Society in Lund; Helge Ax:son Johnsons fund; Lundgrenska fund	Svenska artprojektet, Artdatabanken, SLU; Kapten Carl Stenholms fond; Wilhelm och Martina Lundgrens fond; Anna och Gunnar Vid-felts fond for biologisk forskning; Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences; Lars Hiertas Minne fund; Royal Physiographic Society in Lund; Helge Ax:son Johnsons fund; Lundgrenska fund	KHL and EL have financial support from Svenska artprojektet, Artdatabanken, SLU. ES is supported by grants from Kapten Carl Stenholms fond, Wilhelm och Martina Lundgrens fond and Anna och Gunnar Vid-felts fond for biologisk forskning. BEP is supported by grants from the Swedish Research Council (2009-5206), the Royal Swedish Academy of Sciences, Lars Hiertas Minne fund, The Royal Physiographic Society in Lund, Helge Ax:son Johnsons fund and the Lundgrenska fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Binder M, 2005, SYST BIODIVERS, V3, P113, DOI 10.1017/S1477200005001623; Binder M, 2010, MYCOLOGIA, V102, P865, DOI 10.3852/09-288; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hibbett DS, 2002, P ROY SOC B-BIOL SCI, V269, P1963, DOI 10.1098/rspb.2002.2123; Hosaka K, 2006, MYCOLOGIA, V98, P949, DOI 10.3852/mycologia.98.6.949; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kirk PM, 2008, DICT FUNGI; Larsson KH, 2007, MYCOL RES, V111, P1040, DOI 10.1016/j.mycres.2007.08.001; Larsson KH, 2004, MYCOL RES, V108, P983, DOI 10.1017/S0953756204000851; Letsch HO, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-146; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; Maureira-Butler IJ, 2008, SYST BIOL, V57, P466, DOI 10.1080/10635150802172168; Miettinen O, 2012, CLADISTICS, V28, P251, DOI 10.1111/j.1096-0031.2011.00380.x; Moncalvo JM, 2006, MYCOLOGIA, V98, P937, DOI 10.3852/mycologia.98.6.937; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; Ott M, 2007, P 2007 ACM IEEE C SU, DOI DOI 10.1145/1362622.1362628; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; PETERSEN RH, 1995, MYCOLOGIA, V87, P1, DOI 10.2307/3760940; Petersen RH, 1976, MYCOLOGIA, V68, P666; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Posada D, 2001, P NAT AC SCI US AM 9, V98; Reid DA, 1965, NOVA HEDWIGIA; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sjokvist E, 2012, MYCOLOGIA, V104, P1046, DOI 10.3852/11-174; SMITH JM, 1992, J MOL EVOL, V34, P126; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stocsits RR, 2009, TECHNICAL REPORT; White T., 1990, PCR PROTOCOLS GUIDE, P315	38	9	11	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95227	10.1371/journal.pone.0095227	http://dx.doi.org/10.1371/journal.pone.0095227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24777067	Green Published, gold			2022-12-25	WOS:000346241800009
J	Goffinet, M; Tardy, C; Boubekeur, N; Cholez, G; Bluteau, A; Oniciu, DC; Lalwani, ND; Dasseux, JLH; Barbaras, R; Baron, R				Goffinet, Marine; Tardy, Claudine; Boubekeur, Nadia; Cholez, Guy; Bluteau, Alice; Oniciu, Daniela C.; Lalwani, Narendra D.; Dasseux, Jean-Louis H.; Barbaras, Ronald; Baron, Rudi			P2Y13 Receptor Regulates HDL Metabolism and Atherosclerosis In Vivo	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; 7 ALPHA-HYDROXYLASE; BILE-ACID; CARDIOVASCULAR-DISEASE; CHOLESTEROL EFFLUX; PARTICLE NUMBER; CAROTID-ARTERY; P2Y(13); MOUSE; IDENTIFICATION	High-density lipoprotein (HDL) is known to protect against atherosclerosis by promoting the reverse cholesterol transport. A new pathway for the regulation of HDL-cholesterol (HDL-c) removal involving F1-ATPase and P2Y13 receptor (P2Y13) was described in vitro, and recently in mice. However, the physiological role of F1-ATPase/P2Y13 pathway in the modulation of vascular pathology i. e. in the development of atherosclerotic plaques is still unknown. We designed a specific novel agonist (CT1007900) of the P2Y13 that caused stimulation of bile acid secretion associated with an increased uptake of HDL-c in the liver after single dosing in mice. Repeated dose administration in mice, for 2 weeks, stimulated the apoA-I synthesis and formation of small HDL particles. Plasma samples from the agonist-treated mice had high efflux capacity for mobilization of cholesterol in vitro compared to placebo group. In apoE(-/-) mice this agonist induced a decrease of atherosclerotic plaques in aortas and carotids. The specificity of P2Y13 pathway in those mice was assessed using adenovirus encoding P2Y13-shRNA. These results demonstrate that P2Y13 plays a pivotal role in the HDL metabolism and could also be a useful therapeutic agent to decrease atherosclerosis. In this study, the up-regulation of HDL-c metabolism via activation of the P2Y13 using agonists could promote reverse cholesterol transport and promote inhibition of atherosclerosis progression in mice.	[Goffinet, Marine; Tardy, Claudine; Boubekeur, Nadia; Cholez, Guy; Bluteau, Alice; Oniciu, Daniela C.; Dasseux, Jean-Louis H.; Barbaras, Ronald; Baron, Rudi] Cerenis Therapeut SA, Labege, France; [Lalwani, Narendra D.] Cerenis Therapeut Inc, Ann Arbor, MI USA		Barbaras, R (corresponding author), Cerenis Therapeut SA, Labege, France.	barbaras@cerenis.com	Tardy, Claudine/AAE-5026-2019; Tardy, Claudine/G-2737-2017	Tardy, Claudine/0000-0002-5292-0672; 	Cerenis Therapeutics	Cerenis Therapeutics	The work was supported by Cerenis Therapeutics. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arnon R, 1998, GASTROENTEROLOGY, V115, P1223, DOI 10.1016/S0016-5085(98)70094-0; BARBARAS R, 1986, BIOCHIM BIOPHYS ACTA, V888, P143, DOI 10.1016/0167-4889(86)90015-7; Becker RC, 2010, THROMB HAEMOSTASIS, V103, P535, DOI 10.1160/TH09-07-0491; Boeynaems JM, 2010, PURINERG SIGNAL, V6, P361, DOI 10.1007/s11302-010-9211-x; BRAVO E, 1994, BBA-LIPID LIPID MET, V1215, P93, DOI 10.1016/0005-2760(94)90096-5; Briand F, 2010, J LIPID RES, V51, P763, DOI 10.1194/jlr.M001552; Brown WV, 2010, J CLIN LIPIDOL, V4, P5, DOI 10.1016/j.jacl.2009.12.005; Chatterjee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036916; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; Cromwell WC, 2007, J CLIN LIPIDOL, V1, P583, DOI 10.1016/j.jacl.2007.10.001; Dayal B, 2002, J PROTEOME RES, V1, P375, DOI 10.1021/pr010008n; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; deGoma EM, 2012, J AM COLL CARDIOL, V60, P517, DOI 10.1016/j.jacc.2012.03.058; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Fabre AC, 2010, HEPATOLOGY, V52, P1477, DOI 10.1002/hep.23897; Fumagalli M, 2004, BIOCHEM PHARMACOL, V68, P113, DOI 10.1016/j.bcp.2004.02.038; Godin D, 2000, CIRCULATION, V102, P2861; Goldberg AS, 2012, DRUG DES DEV THER, V6, P251, DOI 10.2147/DDDT.S34976; Guendouzi K, 1998, BIOCHEMISTRY-US, V37, P14974, DOI 10.1021/bi9810508; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Ivan E, 2002, CIRCULATION, V105, P2686, DOI 10.1161/01.CIR.0000016825.17448.11; Jacquet S, 2005, CELL MOL LIFE SCI, V62, P2508, DOI 10.1007/s00018-005-5194-0; Kamanna VS, 2008, AM J CARDIOL, V101, p20B, DOI 10.1016/j.amjcard.2008.02.029; Katsiki N, 2013, CURR PHARM DESIGN, V19, P3124; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kim YC, 2005, BIOCHEM PHARMACOL, V70, P266, DOI 10.1016/j.bcp.2005.04.021; Kuo MS, 2008, J LIPID RES, V49, P1353, DOI 10.1194/jlr.D700037-JLR200; Lee JMS, 2010, EXPERT REV CARDIOVAS, V8, P1325, DOI 10.1586/ERC.10.108; Lessner SM, 2004, ARTERIOSCL THROM VAS, V24, P2123, DOI 10.1161/01.ATV.0000141840.27300.fd; Mackey RH, 2012, J AM COLL CARDIOL, V60, P508, DOI 10.1016/j.jacc.2012.03.060; Martinez LO, 2004, CELL MOL LIFE SCI, V61, P2343, DOI 10.1007/s00018-004-4087-y; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Riedmuller K, 2010, ATHEROSCLEROSIS, V210, P407, DOI 10.1016/j.atherosclerosis.2010.01.009; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; SCHWARTZ CC, 1978, SCIENCE, V200, P62, DOI 10.1126/science.204996; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; TURLEY SD, 1978, J LIPID RES, V19, P924; Usui S, 2002, J LIPID RES, V43, P805; Voight Benjamin F, 2012, Lancet, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057	42	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e95807	10.1371/journal.pone.0095807	http://dx.doi.org/10.1371/journal.pone.0095807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769858	gold, Green Submitted, Green Published			2022-12-25	WOS:000336736600013
J	Berrout, J; Mamenko, M; Zaika, OL; Chen, LH; Zang, WZ; Pochynyuk, O; O'Neil, RG				Berrout, Jonathan; Mamenko, Mykola; Zaika, Oleg L.; Chen, Lihe; Zang, Wenzheng; Pochynyuk, Oleh; O'Neil, Roger G.			Emerging Role of the Calcium-Activated, Small Conductance, SK3 K+ Channel in Distal Tubule Function: Regulation by TRPV4	PLOS ONE			English	Article							CORTICAL COLLECTING DUCT; CELL-VOLUME REGULATION; RENAL EPITHELIAL-CELLS; POTASSIUM CHANNELS; ENDOTHELIAL-CELLS; CONNECTING TUBULE; CATION CHANNELS; BLOOD-PRESSURE; BK CHANNEL; FLOW	The Ca2+-activated, maxi-K (BK) K+ channel, with low Ca2+-binding affinity, is expressed in the distal tubule of the nephron and contributes to flow-dependent K+ secretion. In the present study we demonstrate that the Ca2+-activated, SK3 (K(Ca)2.3) K+ channel, with high Ca2+-binding affinity, is also expressed in the mouse kidney (RT-PCR, immunoblots). Immunohistochemical evaluations using tubule specific markers demonstrate significant expression of SK3 in the distal tubule and the entire collecting duct system, including the connecting tubule (CNT) and cortical collecting duct (CCD). In CNT and CCD, main sites for K+ secretion, the highest levels of expression were along the apical (luminal) cell membranes, including for both principal cells (PCs) and intercalated cells (ICs), posturing the channel for Ca2+-dependent K+ secretion. Fluorescent assessment of cell membrane potential in native, split-opened CCD, demonstrated that selective activation of the Ca2+-permeable TRPV4 channel, thereby inducing Ca2+ influx and elevating intracellular Ca2+ levels, activated both the SK3 channel and the BK channel leading to hyperpolarization of the cell membrane. The hyperpolarization response was decreased to a similar extent by either inhibition of SK3 channel with the selective SK antagonist, apamin, or by inhibition of the BK channel with the selective antagonist, iberiotoxin (IbTX). Addition of both inhibitors produced a further depolarization, indicating cooperative effects of the two channels on Vm. It is concluded that SK3 is functionally expressed in the distal nephron and collecting ducts where induction of TRPV4-mediated Ca2+ influx, leading to elevated intracellular Ca2+ levels, activates this high Ca2+-affinity K+ channel. Further, with sites of expression localized to the apical cell membrane, especially in the CNT and CCD, SK3 is poised to be a key pathway for Ca2+-dependent regulation of membrane potential and K+ secretion.	[Berrout, Jonathan; Mamenko, Mykola; Zaika, Oleg L.; Pochynyuk, Oleh; O'Neil, Roger G.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Integrat Biol, Houston, TX 77030 USA; [Chen, Lihe; Zang, Wenzheng] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Renal Dis & Hypertens, Sch Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	O'Neil, RG (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Integrat Biol, Houston, TX 77030 USA.	roger.g.oneil@uth.tmc.edu	Mamenko, Mykola/I-6061-2015; Chen, Lihe/N-3186-2018	Mamenko, Mykola/0000-0001-8683-0715; Chen, Lihe/0000-0002-6207-6364	NIH [R01 DK070950, R01 DK095029, R01 DK080236]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095029, R01DK070950, R01DK080236] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH Grant R01 DK070950 (to R.G.O.); NIH Grant R01 DK095029 (to O.P.); NIH Grant R01 DK080236 (to W.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absi M, 2007, BRIT J PHARMACOL, V151, P332, DOI 10.1038/sj.bjp.0707222; Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Afeli SAY, 2012, AM J PHYSIOL-RENAL, V303, pF559, DOI 10.1152/ajprenal.00615.2011; Bagher P, 2012, P NATL ACAD SCI USA, V109, P18174, DOI 10.1073/pnas.1211946109; Bailey MA, 2006, KIDNEY INT, V70, P51, DOI 10.1038/sj.ki.5000388; Barfod ET, 2001, AM J PHYSIOL-CELL PH, V280, pC836, DOI 10.1152/ajpcell.2001.280.4.C836; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Brent LH, 1996, J CELL PHYSIOL, V168, P155; Burnham MP, 2002, BRIT J PHARMACOL, V135, P1133, DOI 10.1038/sj.bjp.0704551; Campean V, 2001, AM J PHYSIOL-RENAL, V281, pF1028, DOI 10.1152/ajprenal.0148.2001; Chen LH, 2011, J AM SOC NEPHROL, V22, P1076, DOI 10.1681/ASN.2010121270; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Dawson NS, 2006, FASEB J, V20, P991, DOI 10.1096/fj.05-3923fje; Di Giusto G, 2012, J CELL BIOCHEM, V113, P3721, DOI 10.1002/jcb.24246; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Earley S, 2009, AM J PHYSIOL-HEART C, V297, pH1096, DOI 10.1152/ajpheart.00241.2009; Eichler I, 2003, BRIT J PHARMACOL, V138, P594, DOI 10.1038/sj.bjp.0705075; Favero M, 2008, J PHYSIOL-LONDON, V586, P4763, DOI 10.1113/jphysiol.2008.156588; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Filosa JA, 2013, J CARDIOVASC PHARM, V61, P113, DOI 10.1097/FJC.0b013e318279ba42; Galizia L, 2012, J CELL BIOCHEM, V113, P580, DOI 10.1002/jcb.23382; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Grunnet M, 2002, PFLUG ARCH EUR J PHY, V444, P167, DOI 10.1007/s00424-002-0782-4; Hebert SC, 1998, AM J PHYSIOL-RENAL, V275, pF325, DOI 10.1152/ajprenal.1998.275.3.F325; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Holtzclaw JD, 2011, CURR OPIN NEPHROL HY, V20, P512, DOI 10.1097/MNH.0b013e3283488889; Hopf FW, 2010, NEURON, V65, P682, DOI 10.1016/j.neuron.2010.02.015; IMAI M, 1982, KIDNEY INT, V22, P465, DOI 10.1038/ki.1982.199; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; Jin M, 2012, CELL CALCIUM, V51, P131, DOI 10.1016/j.ceca.2011.11.011; Jin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016713; Kaufman JS, 1996, MINER ELECTROL METAB, V22, P242; Koeppen B M, 1985, Soc Gen Physiol Ser, V39, P89; Koltsova SV, 2011, AM J PHYSIOL-CELL PH, V301, pC403, DOI 10.1152/ajpcell.00018.2011; Kwan HY, 2009, CIRC RES, V104, P670, DOI 10.1161/CIRCRESAHA.108.188748; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Liu W, 2007, AM J PHYSIOL-RENAL, V293, pF227, DOI 10.1152/ajprenal.00057.2007; Loffing J, 2000, AM J PHYSIOL-RENAL, V278, pF530, DOI 10.1152/ajprenal.2000.278.4.F530; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Lu M, 2000, J GEN PHYSIOL, V116, P299, DOI 10.1085/jgp.116.2.299; Ma X, 2013, HYPERTENSION; Mamenko Mykola, 2013, Methods Mol Biol, V998, P371, DOI 10.1007/978-1-62703-351-0_29; MCCARTY NA, 1992, PHYSIOL REV, V72, P1037, DOI 10.1152/physrev.1992.72.4.1037; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; O'Grady SM, 2003, AM J PHYSIOL-LUNG C, V284, pL689, DOI 10.1152/ajplung.00256.2002; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; ONEIL RG, 1977, AM J PHYSIOL, V233, pF544, DOI 10.1152/ajprenal.1977.233.6.F544; ONEIL RG, 1985, AM J PHYSIOL, V248, pF449, DOI 10.1152/ajprenal.1985.248.3.F449; ONEIL RG, 1984, AM J PHYSIOL, V247, pF14, DOI 10.1152/ajprenal.1984.247.1.F14; Parajuli SP, 2012, J PHARMACOL EXP THER, V340, P114, DOI 10.1124/jpet.111.186213; Pierce SL, 2010, AM J PHYSIOL-ENDOC M, V299, pE640, DOI 10.1152/ajpendo.00063.2010; Pluznick JL, 2005, AM J PHYSIOL-RENAL, V288, pF846, DOI 10.1152/ajprenal.00340.2004; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; Rieg T, 2007, KIDNEY INT, V72, P566, DOI 10.1038/sj.ki.5002369; Rodan AR, 2011, AM J PHYSIOL-RENAL, V300, pF821, DOI 10.1152/ajprenal.00742.2010; Rodan AR, 2009, CURR OPIN NEPHROL HY, V18, P350, DOI 10.1097/MNH.0b013e32832c75d8; SANSOM SC, 1985, AM J PHYSIOL, V248, pF858, DOI 10.1152/ajprenal.1985.248.6.F858; Sardini A, 2003, BBA-BIOMEMBRANES, V1618, P153, DOI 10.1016/j.bbamem.2003.10.008; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Sheng JZ, 2007, AM J PHYSIOL-CELL PH, V293, pC458, DOI 10.1152/ajpcell.00036.2007; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Stackman RW, 2002, J NEUROSCI, V22, P10163; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; Sullivan MN, 2013, AM J PHYSIOL-CELL PH, V305, pC999, DOI 10.1152/ajpcell.00273.2013; Taniguchi J, 2007, AM J PHYSIOL-RENAL, V292, pF667, DOI 10.1152/ajprenal.00458.2005; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Turner RW, 2011, CHANNELS, V5, P438, DOI 10.4161/chan.5.5.16473; Wang WH, 2009, PFLUG ARCH EUR J PHY, V458, P157, DOI 10.1007/s00424-008-0593-3; Wehner F, 2006, CONTRIB NEPHROL, V152, P25, DOI 10.1159/000096315; Weiger TM, 2002, J COMP PHYSIOL A, V188, P79, DOI 10.1007/s00359-002-0281-2; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; Woda CB, 2003, AM J PHYSIOL-RENAL, V285, pF629, DOI 10.1152/ajprenal.00191.2003; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786; Wolff C, 2003, J BIOMOL SCREEN, V8, P533, DOI 10.1177/1087057103257806; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Wulff H, 2013, J CARDIOVASC PHARM, V61, P102, DOI 10.1097/FJC.0b013e318279ba20; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zaika O, 2013, J AM SOC NEPHROL, V24, P604, DOI 10.1681/ASN.2012050442; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005	87	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95149	10.1371/journal.pone.0095149	http://dx.doi.org/10.1371/journal.pone.0095149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24762817	Green Published, gold			2022-12-25	WOS:000335505000015
J	Hall, EH; Liu, Y; Xiao, A; Shock, L; Brautigan, DL; Mayo, MW; Adusumilli, PS; Jones, DR				Hall, Emily H.; Liu, Yuan; Xiao, Aizhen; Shock, Lisa; Brautigan, David L.; Mayo, Marty W.; Adusumilli, Prasad S.; Jones, David R.			Inhibition of Breast Cancer Metastasis Suppressor 1 Promotes a Mesenchymal Phenotype in Lung Epithelial Cells That Express Oncogenic K-Ras(V12) and Loss of p53	PLOS ONE			English	Article							CARCINOMA METASTASIS; BRMS1; GENE; TRANSCRIPTION; MIGRATION; CHROMATIN; RELA/P65; MOTILITY; GROWTH; DRIVER	Expression of the breast cancer metastasis suppressor 1 (BRMS1) protein is dramatically reduced in non-small cell lung cancer (NSCLC) cells and in primary human tumors. Although BRMS1 is a known suppressor of metastasis, the mechanisms through which BRMS1 functions to regulate cell migration and invasion in response to specific NSCLC driver mutations are poorly understood. To experimentally address this, we utilized immortalized human bronchial epithelial cells in which p53 was knocked down in the presence of oncogenic K-Ras(V12) (HBEC3-p53KD-K-Ras(V12)). These genetic alterations are commonly found in NSCLC and are associated with a poor prognosis. To determine the importance of BRMS1 for cytoskeletal function, cell migration and invasion in our model system we stably knocked down BRMS1. Here, we report that loss of BRMS1 in HBEC3-p53KD-K-Ras(V12) cells results in a dramatic increase in cell migration and invasion compared to controls that expressed BRMS1. Moreover, the loss of BRMS1 resulted in additional morphological changes including F-actin redistribution, paxillin accumulation at the leading edge of the lamellapodium, and cellular shape changes resembling mesenchymal phenotypes. Importantly, re-expression of BRMS1 restores, in part, cell migration and invasion; however it does not fully reestablish the epithelial phenotype. These finding suggests that loss of BRMS1 results in a permanent, largely irreversible, mesenchymal phenotype associated with increased cell migration and invasion. Collectively, in NSCLC cells without p53 and expression of oncogenic K-Ras our study identifies BRMS1 as a key regulator required to maintain a cellular morphology and cytoskeletal architecture consistent with an epithelial phenotype.	[Hall, Emily H.; Xiao, Aizhen] Univ Virginia, Dept Surg, Charlottesville, VA USA; [Shock, Lisa; Mayo, Marty W.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Brautigan, David L.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA; [Brautigan, David L.] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA USA; [Liu, Yuan; Adusumilli, Prasad S.; Jones, David R.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; Memorial Sloan Kettering Cancer Center	Jones, DR (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	jonesd2@mskcc.org		Jones, David/0000-0002-3318-0146	NIH/NCI [R01 CA136705, R01 CA104397, R01 CA132580]; NATIONAL CANCER INSTITUTE [R01CA104397, R01CA132580, T32CA009109, P30CA008748, R01CA136705] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants NIH/NCI R01 CA136705 (to DRJ), R01 CA104397 (to MWM) and R01 CA132580 (to MWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva J, 2012, MOL CANCER THER, V11, P2633, DOI 10.1158/1535-7163.MCT-12-0615; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Blanco R, 2009, HUM MUTAT, V30, P1199, DOI 10.1002/humu.21028; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Delgado O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022023; Deng BW, 2013, SEMIN CANCER BIOL, V23, P65, DOI 10.1016/j.semcancer.2012.01.003; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Kauffman EC, 2003, J UROLOGY, V169, P1122, DOI 10.1097/01.ju.0000051580.89109.4b; Khotskaya YB, 2014, MOL CARCINOGEN, V53, P1011, DOI 10.1002/mc.22068; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liu Y, 2012, ONCOGENE, V31, P1143, DOI 10.1038/onc.2011.308; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; Liu Y, 2013, CANCER RES, V73, P1308, DOI 10.1158/0008-5472.CAN-12-2489; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Meehan WJ, 2003, CLIN EXP METASTAS, V20, P45, DOI 10.1023/A:1022542519586; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Nagji AS, 2010, J PATHOL, V221, P229, DOI 10.1002/path.2707; Nasir A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052187; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Samant RS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-6; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Sato M, 2013, MOL CANCER RES, V11, P638, DOI 10.1158/1541-7786.MCR-12-0634-T; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Seraj MJ, 2000, CANCER RES, V60, P2764; Sero JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028303; Shevde LA, 2002, EXP CELL RES, V273, P229, DOI 10.1006/excr.2001.5452; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith PW, 2009, CANCER LETT, V276, P196, DOI 10.1016/j.canlet.2008.11.024; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yang JY, 2008, CANCER LETT, V269, P46, DOI 10.1016/j.canlet.2008.04.016; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang S, 2006, INT J GYNECOL CANCER, V16, P522, DOI 10.1111/j.1525-1438.2006.00547.x	40	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95869	10.1371/journal.pone.0095869	http://dx.doi.org/10.1371/journal.pone.0095869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763730	Green Submitted, Green Published, gold			2022-12-25	WOS:000335505000041
J	de la Pena, FA; Kanasaki, K; Kanasaki, M; Vong, S; Rovira, C; Kalluri, R				de la Pena, Francisco Ayala; Kanasaki, Keizo; Kanasaki, Megumi; Vong, Sylvia; Rovira, Carlota; Kalluri, Raghu			Specific Activation of K-Ras(G12D) Allele in the Bladder Urothelium Results in Lung Alveolar and Vascular Defects	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; K-RAS; N-RAS; MATRIX; GROWTH; GENE; PROGRESSION; INFANTS; DISEASE; CANCER	K-ras is essential for embryogenesis and its mutations are involved in human developmental syndromes and cancer. To determine the consequences of K-ras activation in urothelium, we used uroplakin-II (UPK II) promoter driven Cre recombinase mice and generated mice with mutated Kras(G12D) allele in the urothelium (UPK II-Cre; LSL-K-ras(G12D)). The UPK II-Cre; LSL-K-ras(G12D) mice died neonatally due to lung morphogenesis defects consisting of simplification with enlargement of terminal air spaces and dysmorphic pulmonary vasculature. A significant alteration in epithelial and vascular basement membranes, together with fragmentation of laminin, points to extracellular matrix degradation as the causative mechanism of alveolar and vascular defects. Our data also suggest that altered protease activity in amniotic fluid might be associated with matrix defects in lung of UPK II-Cre; LSL-K-ras(G12). These defects resemble those observed in early stage human neonatal bronchopulmonary dysplasia (BPD), although the relevance of this new mouse model for BPD study needs further investigation.	[de la Pena, Francisco Ayala; Kanasaki, Keizo; Kanasaki, Megumi; Vong, Sylvia] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [de la Pena, Francisco Ayala; Kanasaki, Keizo; Kanasaki, Megumi; Vong, Sylvia] Harvard Univ, Sch Med, Boston, MA USA; [Rovira, Carlota] Hosp St Joan de Deu, Dept Pathol, Barcelona, Spain; [Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77030 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Barcelona; University of Texas System; UTMD Anderson Cancer Center	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77030 USA.	rkalluri@mdanderson.org	Ayala, Francisco/C-5280-2011	Ayala, Francisco/0000-0001-6311-920X	National Institutes of Health [DK62987, DK55001, AA13913, DK61688, CA125550]; Champalimaud Metastasis Program; Department of Medicine for the Division of Matrix Biology at Beth Israel Deaconess Medical Center; Fondo de Investigaciones Sanitarias (FIS), Ministry of Health, Spain [BAE-90057]; Health Service (SMS) from Comunidad Autonoma of Murcia, Spain; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA125550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055001, R01DK061688, R01DK062987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Champalimaud Metastasis Program; Department of Medicine for the Division of Matrix Biology at Beth Israel Deaconess Medical Center; Fondo de Investigaciones Sanitarias (FIS), Ministry of Health, Spain; Health Service (SMS) from Comunidad Autonoma of Murcia, Spain; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was primarily supported by National Institutes of Health Grant DK62987, DK55001, AA13913, DK61688, CA125550, Champalimaud Metastasis Program and funds from the Department of Medicine for the Division of Matrix Biology at Beth Israel Deaconess Medical Center. F. A. P. was supported by Grant BAE-90057 from the Fondo de Investigaciones Sanitarias (FIS), Ministry of Health, Spain; and by Health Service (SMS) from Comunidad Autonoma of Murcia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghai ZH, 2002, BIOL NEONATE, V81, P16, DOI 10.1159/000047179; Backstrom E, 2011, PEDIATR RES, V69, P312, DOI 10.1203/PDR.0b013e31820bcb2a; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bhandari A, 2009, PEDIATRICS, V123, P1562, DOI 10.1542/peds.2008-1962; Birkedal-Hansen Henning, 2008, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1008s40; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Cordon-Cardo C, 2008, SCAND J UROL NEPHROL, V42, P154, DOI 10.1080/03008880802291915; de la Pena FA, 2011, J BIOL CHEM, V286, P20778, DOI 10.1074/jbc.M110.198069; De Paepe ME, 2006, AM J RESP CRIT CARE, V173, P204, DOI 10.1164/rccm.200506-927OC; DeLisser HM, 2006, J BIOL CHEM, V281, P8724, DOI 10.1074/jbc.M511798200; Denayer E, 2008, J MED GENET, V45, P695, DOI 10.1136/jmg.2007.055772; Deng FM, 2001, P NATL ACAD SCI USA, V98, P154, DOI 10.1073/pnas.98.1.154; Ekekezie II, 2004, PEDIATRICS, V113, P1709, DOI 10.1542/peds.113.6.1709; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; HARDING R, 1986, J APPL PHYSIOL, V61, P68, DOI 10.1152/jappl.1986.61.1.68; Huang YJ, 2009, CANCER RES, V69, P7529, DOI 10.1158/0008-5472.CAN-08-4382; Janssen KP, 2005, BBA-REV CANCER, V1756, P145, DOI 10.1016/j.bbcan.2005.07.004; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kitagawa H, 2000, J PEDIATR SURG, V35, P1549, DOI 10.1053/jpsu.2000.18305; Laudy JAM, 2000, ULTRASOUND OBST GYN, V16, P482, DOI 10.1046/j.1469-0705.2000.00252.x; LIN JH, 1995, P NATL ACAD SCI USA, V92, P679, DOI 10.1073/pnas.92.3.679; McGowan EC, 2009, PEDIATR RES, V66, P455, DOI 10.1203/PDR.0b013e3181b3b0fa; McGuire JK, 2003, AM J PATHOL, V162, P1831, DOI 10.1016/S0002-9440(10)64318-0; Mo L, 2005, AM J PHYSIOL-RENAL, V289, pF562, DOI 10.1152/ajprenal.00368.2004; Oxford G, 2003, J UROLOGY, V170, P1987, DOI 10.1097/01.ju.0000088670.02905.78; Podowski M, 2009, AM J PATHOL, V175, P84, DOI 10.2353/ajpath.2009.080870; Roth-Kleiner M, 2005, PEDIATR PULM, V40, P113, DOI 10.1002/ppul.20252; Roy R, 2008, CLIN CANCER RES, V14, P6610, DOI 10.1158/1078-0432.CCR-08-1136; Schittny PH. J B, 2003, LUNG DEV REGENERATIO, P275; Schubbert S, 2007, MOL CELL BIOL, V27, P7765, DOI 10.1128/MCB.00965-07; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Steinestel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065189; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Wang XQ, 2009, MOL BIOL CELL, V20, P791, DOI 10.1091/mbc.E08-07-0732; Yang XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074809; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107; Zhang YH, 2006, MOL GENET METAB, V89, P164, DOI 10.1016/j.ymgme.2006.03.014; Zhang ZT, 2001, ONCOGENE, V20, P1973, DOI 10.1038/sj.onc.1204315	45	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95888	10.1371/journal.pone.0095888	http://dx.doi.org/10.1371/journal.pone.0095888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760005	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200101
J	Espinoza-Fonseca, LM; Autry, JM; Thomas, DD				Espinoza-Fonseca, L. Michel; Autry, Joseph M.; Thomas, David D.			Microsecond Molecular Dynamics Simulations of Mg2+- and K+- Bound E1 Intermediate States of the Calcium Pump	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; PARTICLE MESH EWALD; CRYSTAL-STRUCTURE; CA2+ OCCLUSION; BINDING-SITES; PK(A) VALUES; FORCE-FIELD; ATPASE; MAGNESIUM; IONS	We have performed microsecond molecular dynamics (MD) simulations to characterize the structural dynamics of cation-bound E1 intermediate states of the calcium pump (sarcoendoplasmic reticulum Ca2+-ATPase, SERCA) in atomic detail, including a lipid bilayer with aqueous solution on both sides. X-ray crystallography with 40 mM Mg2+ in the absence of Ca2+ has shown that SERCA adopts an E1 structure with transmembrane Ca2+-binding sites I and II exposed to the cytosol, stabilized by a single Mg2+ bound to a hybrid binding site I'. This Mg2+-bound E1 intermediate state, designated E1 center dot Mg2+, is proposed to constitute a functional SERCA intermediate that catalyzes the transition from E2 to E1 center dot 2Ca(2+) by facilitating H+/Ca2+ exchange. To test this hypothesis, we performed two independent MD simulations based on the E1 center dot Mg2+ crystal structure, starting in the presence or absence of initially-bound Mg2+. Both simulations were performed for 1 mu s in a solution containing 100 mM K+ and 5 mM Mg2+ in the absence of Ca2+, mimicking muscle cytosol during relaxation. In the presence of initially-bound Mg2+, SERCA site I' maintained Mg2+ binding during the entire MD trajectory, and the cytosolic headpiece maintained a semi-open structure. In the absence of initially-bound Mg2+, two K+ ions rapidly bound to sites I and I' and stayed loosely bound during most of the simulation, while the cytosolic headpiece shifted gradually to a more open structure. Thus MD simulations predict that both E1 center dot Mg2+ and E center dot 2K(+) intermediate states of SERCA are populated in solution in the absence of Ca2+, with the more open 2K(+)-bound state being more abundant at physiological ion concentrations. We propose that the E1 center dot 2K(+) state acts as a functional intermediate that facilitates the E2 to E1 center dot 2Ca(2+) transition through two mechanisms: by pre-organizing transport sites for Ca2+ binding, and by partially opening the cytosolic headpiece prior to Ca2+ activation of nucleotide binding.	[Espinoza-Fonseca, L. Michel; Autry, Joseph M.; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Espinoza-Fonseca, LM (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	espin049@umn.edu	Autry, Joseph M./X-6839-2019	Autry, Joseph M./0000-0002-1144-725X; Thomas, David D./0000-0002-8822-2040; Espinoza-Fonseca, L. Michel/0000-0002-7356-5681	American Heart Association [12SDG12060656]; NIH [GM27906]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to L.M.E-F. from the American Heart Association (12SDG12060656) and to D. D. T. from NIH (GM27906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BISHOP JE, 1988, J BIOL CHEM, V263, P1886; BLATTER LA, 1990, PFLUG ARCH EUR J PHY, V416, P238, DOI 10.1007/BF00392059; BOCK CW, 1995, J AM CHEM SOC, V117, P3754, DOI 10.1021/ja00118a012; BOCK CW, 1994, INORG CHEM, V33, P419, DOI 10.1021/ic00081a007; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; CARUGO O, 1993, J CHEM SOC DALTON, P2127, DOI 10.1039/dt9930002127; CHAMPEIL P, 1983, J BIOL CHEM, V258, P4453; Clausen JD, 2013, EMBO J, V32, P3231, DOI 10.1038/emboj.2013.250; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Espinoza-Fonseca LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026936; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; GUILLAIN F, 1982, J BIOL CHEM, V257, P7366; GUNZEL D, 1991, PFLUG ARCH EUR J PHY, V417, P446, DOI 10.1007/BF00370938; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Helm L, 2005, CHEM REV, V105, P1923, DOI 10.1021/cr030726o; Huang YQ, 2009, J COMPUT CHEM, V30, P2136, DOI 10.1002/jcc.21219; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; JONES LR, 1979, BIOCHIM BIOPHYS ACTA, V557, P230, DOI 10.1016/0005-2736(79)90105-6; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; Kekenes-Huskey PM, 2012, PROTEIN SCI, V21, P1429, DOI 10.1002/pro.2129; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; LEE AG, 1995, BIOCHEM J, V305, P225, DOI 10.1042/bj3050225; Lee AG, 2001, BIOCHEM J, V356, P665, DOI 10.1042/0264-6021:3560665; Lenoir G, 2006, BIOCHEMISTRY-US, V45, P5261, DOI 10.1021/bi0522091; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu YY, 2009, J MOL BIOL, V391, P858, DOI 10.1016/j.jmb.2009.06.044; Markham GD, 1996, J PHYS CHEM-US, V100, P3488, DOI 10.1021/jp952531t; McMullen DC, 2012, BIOL PROCED ONLINE, V14, DOI 10.1186/1480-9222-14-4; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; MOUTIN MJ, 1991, J BIOL CHEM, V266, P5580; Nagarajan A, 2012, J MOL BIOL, V422, P575, DOI 10.1016/j.jmb.2012.06.001; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Pallikkuth S, 2013, BIOPHYS J, V105, P1812, DOI 10.1016/j.bpj.2013.08.045; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poulsen H, 2012, J BIOL CHEM, V287, P15959, DOI 10.1074/jbc.M112.340406; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHULL GE, 1988, J BIOL CHEM, V263, P8646; Sugita Y, 2010, P NATL ACAD SCI USA, V107, P21465, DOI 10.1073/pnas.1015819107; TIMONIN IM, 1991, BIOCHIM BIOPHYS ACTA, V1066, P43, DOI 10.1016/0005-2736(91)90248-7; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; VILSEN B, 1992, J BIOL CHEM, V267, P25739; Weber W, 2000, J PHYS CHEM B, V104, P3668, DOI 10.1021/jp9937757; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Yu HB, 2011, NAT STRUCT MOL BIOL, V18, P1159, DOI 10.1038/nsmb.2113; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9; Zafar S, 2008, ARCH BIOCHEM BIOPHYS, V476, P87, DOI 10.1016/j.abb.2008.04.035	61	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95979	10.1371/journal.pone.0095979	http://dx.doi.org/10.1371/journal.pone.0095979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760008	gold, Green Published			2022-12-25	WOS:000335298200121
J	Yeh, CW; Yu, ZC; Chen, PH; Cheng, YC; Shieh, SY				Yeh, Chun-Wei; Yu, Zheng-Cheng; Chen, Peng-Hsu; Cheng, Yu-Che; Shieh, Sheau-Yann			Phosphorylation at Threonine 288 by Cell Cycle Checkpoint Kinase 2 (CHK2) Controls Human Monopolar Spindle 1 (Mps1) Kinetochore Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Checkpoint Control; Chromosomes; Kinetochore; Mitosis; Phosphorylation; CHK2; HEC1; Mps1; Mitotic Checkpoint	TPR DOMAIN; STABILIZATION; ANEUPLOIDY; PATHWAY; BRCA1; HEC1; ATM	Background: hMps1 and CHK2 are both required to safeguard the mitotic checkpoint, and yet the relationship between the two proteins is unclear. Results: hMps1 Thr-288 mutation causes misaligned chromosomes and polyploidy as a result of defective kinetochore localization. Conclusion: Phosphorylation of hMps1 Thr-288 by CHK2 facilitates kinetochore localization of hMps1. Significance: The study provides insights on the involvement of CHK2 in SAC through hMps1. Human Mps1 (hMps1) is a mitotic checkpoint kinase responsible for sensing the unattached and tensionless kinetochore. Despite its importance in safeguarding proper chromosome segregation, how hMps1 is recruited to the kinetochore remains incompletely understood. Here, we demonstrate that phosphorylation at Thr-288 by the cell cycle checkpoint kinase CHK2 is involved in this process. We discovered that the phosphorylation-deficient T288A mutant has an impaired ability to localize to the kinetochore and cannot reestablish the mitotic checkpoint in hMps1-depleted cells. In support, we found that nocodazole induced hMps1 phosphorylation at the previously identified CHK2 site Thr-288 and that this could be detected at the kinetochore in a CHK2-dependent manner. Mechanistically, phosphorylation at Thr-288 promoted the interaction with the KMN (KNL1-Mis12-Ndc80 network) protein HEC1. Forced kinetochore localization corrected the defects associated with the T288A mutant. Our results provide evidence of a newly identified hMps1 phosphorylation site that is involved in the mitotic checkpoint and that CHK2 contributes to chromosomal stability through hMps1.	[Yeh, Chun-Wei; Yu, Zheng-Cheng; Chen, Peng-Hsu; Cheng, Yu-Che; Shieh, Sheau-Yann] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Academia Sinica - Taiwan	Shieh, SY (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Sec 2,Acad Rd, Taipei 115, Taiwan.	sy88@ibms.sinica.edu.tw	Shieh, Sheau-Yann/N-9512-2018	Shieh, Sheau-Yann/0000-0002-5351-4430	Academia Sinica; National Science Council Taiwan	Academia Sinica(Academia Sinica - Taiwan); National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica and National Science Council Taiwan.	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Branzei D, 2006, EXP CELL RES, V312, P2654, DOI 10.1016/j.yexcr.2006.06.012; Fang X, 2011, SEMIN CELL DEV BIOL, V22, P595, DOI 10.1016/j.semcdb.2011.03.002; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Oricchio E, 2006, CELL CYCLE, V5, P88, DOI 10.4161/cc.5.1.2269; Stolz A, 2010, NAT CELL BIOL, V12, P492, DOI 10.1038/ncb2051; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Thebault P, 2012, BIOCHEM J, V448, P321, DOI 10.1042/BJ20121448; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016; Yeh YH, 2009, ONCOGENE, V28, P1366, DOI 10.1038/onc.2008.477; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhu TG, 2013, J BIOL CHEM, V288, P36149, DOI 10.1074/jbc.M113.507970	23	10	10	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15319	15327		10.1074/jbc.M114.552273	http://dx.doi.org/10.1074/jbc.M114.552273			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24764296	hybrid, Green Published			2022-12-25	WOS:000337465400016
J	Jain, P; Bhalla, US				Jain, Pragati; Bhalla, Upinder S.			Transcription Control Pathways Decode Patterned Synaptic Inputs into Diverse mRNA Expression Profiles	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; HIPPOCAMPAL PYRAMIDAL NEURONS; GATED CA2+ CHANNELS; NERVE GROWTH-FACTOR; GENE-EXPRESSION; CREB PHOSPHORYLATION; LATE-PHASE; NEUROTROPHIC FACTOR	Synaptic plasticity requires transcription and translation to establish long-term changes that form the basis for long term memory. Diverse stimuli, such as synaptic activity and growth factors, trigger synthesis of mRNA to regulate changes at the synapse. The palette of possible mRNAs is vast, and a key question is how the cell selects which mRNAs to synthesize. To address this molecular decision-making, we have developed a biochemically detailed model of synaptic-activity triggered mRNA synthesis. We find that there are distinct time-courses and amplitudes of different branches of the mRNA regulatory signaling pathways, which carry out pattern-selective combinatorial decoding of stimulus patterns into distinct mRNA subtypes. Distinct, simultaneously arriving input patterns that impinge on the transcriptional control network interact nonlinearly to generate novel mRNA combinations. Our model combines major regulatory pathways and their interactions connecting synaptic input to mRNA synthesis. We parameterized and validated the model by incorporating data from multiple published experiments. The model replicates outcomes of knockout experiments. We suggest that the pattern-selectivity mechanisms analyzed in this model may act in many cell types to confer the capability to decode temporal patterns into combinatorial mRNA expression.	[Jain, Pragati; Bhalla, Upinder S.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Jain, Pragati] Manipal Univ, Manipal, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Manipal Academy of Higher Education (MAHE)	Bhalla, US (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	bhalla@ncbs.res.in		Bhalla, Upinder/0000-0003-1722-5188	Council of Scientific & Industrial Research, India (CSIR) [09/860(0120)/2011-MR-I/16.3.2011]; NCBS/TIFR and Council of Scientific & Industrial Research, India (CSIR)	Council of Scientific & Industrial Research, India (CSIR); NCBS/TIFR and Council of Scientific & Industrial Research, India (CSIR)	Pragati Jain was supported by the Council of Scientific & Industrial Research, India (CSIR) (09/860(0120)/2011-MR-I/16.3.2011). The work was supported by the NCBS/TIFR and Council of Scientific & Industrial Research, India (CSIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay SM, 2004, EUR J NEUROSCI, V20, P2671, DOI 10.1111/j.1460-9568.2004.03725.x; Ajay SM, 2007, HFSP J, V1, P49, DOI [10.2976/1.2721383, 10.2976/1.2721383/10.2976/1]; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Altar CA, 2004, J NEUROSCI, V24, P2667, DOI 10.1523/JNEUROSCI.5377-03.2004; Bading H, 1999, EPILEPSY RES, V36, P225, DOI 10.1016/S0920-1211(99)00053-4; Bading H, 1997, BIOCHEM BIOPH RES CO, V236, P541, DOI 10.1006/bbrc.1997.7037; Barco A, 2008, TRANSCRIPTIONAL REGULATION BY NEURONAL ACTIVITY, P127, DOI 10.1007/978-0-387-73609-9_7; Batulan Z, 2003, J NEUROSCI, V23, P5789; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Bhalla US, 2002, J COMPUT NEUROSCI, V13, P49, DOI 10.1023/A:1019644427655; Bhalla US, 2002, BIOPHYS J, V83, P740, DOI 10.1016/S0006-3495(02)75205-3; Bhalla US, 2002, METHOD ENZYMOL, V345, P3; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bito H, 1998, CELL CALCIUM, V23, P143, DOI 10.1016/S0143-4160(98)90113-0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Cho IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034860; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Finsterwald C, 2010, J BIOL CHEM, V285, P28587, DOI 10.1074/jbc.M110.125740; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frick A, 2005, J NEUROBIOL, V64, P100, DOI 10.1002/neu.20148; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Glauser DA, 2006, NUCLEIC ACIDS RES, V34, P5175, DOI 10.1093/nar/gkl654; Goldie BJ, 2012, MOL NEUROBIOL, V45, P99, DOI 10.1007/s12035-011-8222-0; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Huang YWA, 2012, CELL, V148, P933, DOI 10.1016/j.cell.2012.01.036; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Jain P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000287; Kaczmarek L, 2000, ACTA NEUROBIOL EXP, V60, P419; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kasahara J, 2001, J BIOL CHEM, V276, P24044, DOI 10.1074/jbc.M100247200; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; KIESSLING M, 1993, J CEREBR BLOOD F MET, V13, P914, DOI 10.1038/jcbfm.1993.114; Kim HB, 2010, BIOCHEM BIOPH RES CO, V391, P634, DOI 10.1016/j.bbrc.2009.11.111; Kim M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000691; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lauterborn JC, 1996, J NEUROSCI, V16, P7428; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043810; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Maronde E, 1997, BIOL CELL, V89, P505, DOI 10.1016/S0248-4900(98)80006-3; MATSUDA M, 1994, MOL CELL BIOL, V14, P5495, DOI 10.1128/MCB.14.8.5495; Messaoudi E, 2002, J NEUROSCI, V22, P7453; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; Neves SR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001988; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; OKUNO S, 1994, J BIOCHEM, V116, P923, DOI 10.1093/oxfordjournals.jbchem.a124617; Okuno S, 2001, J BIOCHEM, V130, P503, DOI 10.1093/oxfordjournals.jbchem.a003013; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Racaniello M, 2010, NEUROCHEM RES, V35, P239, DOI 10.1007/s11064-009-0047-0; Ray Subhasis, 2008, Front Neuroinform, V2, P6, DOI 10.3389/neuro.11.006.2008; REGEHR WG, 1992, J NEUROSCI, V12, P4202; RIEDEL G, 2004, MESSENGERS MOL MEMOR; Ring RH, 2006, J NEUROBIOL, V66, P361, DOI 10.1002/neu.20223; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Roberson ED, 1999, J NEUROSCI, V19, P4337; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sample V, 2012, NAT CHEM BIOL, V8, P375, DOI [10.1038/NCHEMBIO.799, 10.1038/nchembio.799]; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schacher S, 1997, J NEUROSCI, V17, P597; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; Shankar DB, 2004, LEUKEMIA LYMPHOMA, V45, P265, DOI 10.1080/1042819031000151095; Sivakumaran S, 2003, BIOINFORMATICS, V19, P408, DOI 10.1093/bioinformatics/btf860; Steward O, 2002, NEURON, V36, P338, DOI 10.1016/S0896-6273(02)01006-1; STEWARD O, 1982, J NEUROSCI, V2, P284; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; Vayttaden Sharat Jacob, 2004, Sci STKE, V2004, ppl4, DOI 10.1126/stke.2192004pl4; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	100	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95154	10.1371/journal.pone.0095154	http://dx.doi.org/10.1371/journal.pone.0095154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787753	Green Submitted, Green Published, gold			2022-12-25	WOS:000335510600027
J	Formosa-Jordan, P; Ibanes, M				Formosa-Jordan, Pau; Ibanes, Marta			Competition in Notch Signaling with Cis Enriches Cell Fate Decisions	PLOS ONE			English	Article							LATERAL INHIBITION; PROPAGATION FAILURE; DELTA GENES; RECEPTOR; ACTIVATION; DYNAMICS; PROTEIN; TRAFFICKING; ROBUSTNESS; MECHANISM	Notch signaling is involved in cell fate choices during the embryonic development of Metazoa. Commonly, Notch signaling arises from the binding of the Notch receptor to its ligands in adjacent cells driving cell-to-cell communication. Yet, cell-autonomous control of Notch signaling through both ligand-dependent and ligand-independent mechanisms is known to occur as well. Examples include Notch signaling arising in the absence of ligand binding, and cis-inhibition of Notch signaling by titration of the Notch receptor upon binding to its ligands within a single cell. Increasing experimental evidences support that the binding of the Notch receptor with its ligands within a cell (cis-interactions) can also trigger a cell-autonomous Notch signal (cis-signaling), whose potential effects on cell fate decisions and patterning remain poorly understood. To address this question, herein we mathematically and computationally investigate the cell states arising from the combination of cis-signaling with additional Notch signaling sources, which are either cell-autonomous or involve cell-to-cell communication. Our study shows that cis-signaling can switch from driving cis-activation to effectively perform cis-inhibition and identifies under which conditions this switch occurs. This switch relies on the competition between Notch signaling sources, which share the same receptor but differ in their signaling efficiency. We propose that the role of cis-interactions and their signaling on fine-grained patterning and cell fate decisions is dependent on whether they drive cis-inhibition or cis-activation, which could be controlled during development. Specifically, cis-inhibition and not cis-activation facilitates patterning and enriches it by modulating the ratio of cells in the high-ligand expression state, by enabling additional periodic patterns like stripes and by allowing localized patterning highly sensitive to the precursor state and cell-autonomous bistability. Our study exemplifies the complexity of regulations when multiple signaling sources share the same receptor and provides the tools for their characterization.	[Formosa-Jordan, Pau; Ibanes, Marta] Univ Barcelona, Fac Fis, Dept Estruct & Constituents Materia, E-08028 Barcelona, Spain	University of Barcelona	Ibanes, M (corresponding author), Univ Barcelona, Fac Fis, Dept Estruct & Constituents Materia, E-08028 Barcelona, Spain.	mibanes@ub.edu	Ibanes, Marta/A-7657-2008; Formosa-Jordan, Pau/J-9423-2014	Ibanes, Marta/0000-0002-7913-7936; Formosa-Jordan, Pau/0000-0003-3005-597X	Spanish Ministerio de Economia y Competitividad [FIS2009-13360-C03-01, FIS2012-37655-C02-02]; Generalitat de Catalunya [2009SGR14]; FI fellowship - Generalitat de Catalunya; FPU fellowship - Spanish Ministerio de Educacion, Cultura y Deporte [FPU-AP2008-03325]; National Science Foundation [NSF PHY11-25915]; National Institutes of Health (NIH) [2R25GM067110-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM067110] Funding Source: NIH RePORTER	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); FI fellowship - Generalitat de Catalunya(Generalitat de Catalunya); FPU fellowship - Spanish Ministerio de Educacion, Cultura y Deporte(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by grants FIS2009-13360-C03-01 and FIS2012-37655-C02-02 by the Spanish Ministerio de Economia y Competitividad (http://www.idi.mineco.gob.es); and grant 2009SGR14 by the Generalitat de Catalunya (http://www10.gencat.net/agaur_web). PFJ acknowledges the support of FI fellowship funded by the Generalitat de Catalunya (March 2009-July 2009), the FPU fellowship (FPU-AP2008-03325) funded by the Spanish Ministerio de Educacion, Cultura y Deporte (http://www.mecd.gob.es), grant no. NSF PHY11-25915 (August 2013) funded by the National Science Foundation (http://www.nsf.gov/), and grant no. 2R25GM067110-05 (August 2013) by the National Institutes of Health (NIH, http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Axelrod JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145pe38; Barad O, 2011, CURR OPIN CELL BIOL, V23, P663, DOI 10.1016/j.ceb.2011.09.005; Barad O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000857; Becam I, 2010, CURR BIOL, V20, P554, DOI 10.1016/j.cub.2010.01.058; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Buceta J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000602; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Cheng Z, 2008, FEBS LETT, V582, P3776, DOI 10.1016/j.febslet.2008.10.005; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Cho B, 2011, DEVELOPMENT, V138, P1349, DOI 10.1242/dev.056002; Cohen M, 2011, J R SOC INTERFACE, V8, P787, DOI 10.1098/rsif.2010.0488; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Cross M., 2009, PATTERN FORMATION DY, DOI 10.1017/CBO9780511627200; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; del Alamo D, 2009, CURR BIOL, V19, pR683, DOI 10.1016/j.cub.2009.07.025; Descalzo SM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.49; Digiuni S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.54; Falix FA, 2012, BBA-MOL BASIS DIS, V1822, P988, DOI 10.1016/j.bbadis.2012.02.003; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fiuza UM, 2010, DEV DYNAM, V239, P798, DOI 10.1002/dvdy.22207; Fleming RJ, 2013, DEVELOPMENT, V140, P2039, DOI 10.1242/dev.087916; Formosa-Jordan P, 2009, J STAT MECH-THEORY E, V03; Formosa-Jordan P, 2013, INT J DEV BIOL, V57, P341, DOI 10.1387/ijdb.120259jf; Formosa-Jordan P, 2012, DEVELOPMENT, V139, P2321, DOI 10.1242/dev.076406; Fortini ME, 2009, CURR OPIN GENET DEV, V19, P323, DOI 10.1016/j.gde.2009.04.005; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Francois P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031908; Furthauer M, 2009, TRAFFIC, V10, P792, DOI 10.1111/j.1600-0854.2009.00914.x; Ghosh S, 2011, J BIOL CHEM, V286, P22678, DOI 10.1074/jbc.M111.241224; Glittenberg M, 2006, EMBO J, V25, P4697, DOI 10.1038/sj.emboj.7601337; Guantes R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000235; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Haddon C, 1998, DEVELOPMENT, V125, P359; HEITZLER P, 1993, DEVELOPMENT, V117, P1113; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Held W, 2011, CELL MOL LIFE SCI, V68, P3469, DOI 10.1007/s00018-011-0798-z; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Hori Kazuya, 2012, Commun Integr Biol, V5, P374, DOI 10.4161/cib.19995; Hsieh EH, 2012, DEV COMP IMMUNOL, V37, P306, DOI 10.1016/j.dci.2012.04.003; Hsu CP, 2006, BIOINFORMATICS, V22, P1375, DOI 10.1093/bioinformatics/btl082; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; Joshi M, 2006, DEV BIOL, V293, P64, DOI 10.1016/j.ydbio.2006.01.005; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kim Y, 2011, DEV CELL, V20, P880, DOI 10.1016/j.devcel.2011.05.009; Kim Y, 2010, CURR BIOL, V20, P446, DOI 10.1016/j.cub.2010.01.019; Kladko K, 2000, PHYS REV LETT, V84, P4505, DOI 10.1103/PhysRevLett.84.4505; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Lakhanpal A, 2010, ARXIV10054301; Lubensky DK, 2011, P NATL ACAD SCI USA, V108, P11145, DOI 10.1073/pnas.1015302108; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Miller AC, 2009, CURR BIOL, V19, P1378, DOI 10.1016/j.cub.2009.06.042; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Nikolaou N, 2009, DEVELOPMENT, V136, P2523, DOI 10.1242/dev.034736; Owen MR, 2002, PHYSICA D, V173, P59, DOI 10.1016/S0167-2789(02)00620-6; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Parks AL, 1997, MECH DEVELOP, V63, P61, DOI 10.1016/S0925-4773(97)00675-8; Plahte E, 2007, PHYSICA D, V226, P117, DOI 10.1016/j.physd.2006.11.011; Podgorski GJ, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-43; Rauskolb C, 1999, DEV BIOL, V210, P339, DOI 10.1006/dbio.1999.9273; Reed RD, 2004, DEV GENES EVOL, V214, P43, DOI 10.1007/s00427-003-0366-0; Rondelez Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.018102; Rouault H, 2012, BIOPHYS J, V102, P417, DOI 10.1016/j.bpj.2011.11.4022; Sakamoto K, 2002, DEV BIOL, V241, P313, DOI 10.1006/dbio.2001.0517; Sanders PGT, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000169; Schwanbeck R, 2011, EUR J CELL BIOL, V90, P572, DOI 10.1016/j.ejcb.2010.10.004; Shaya O, 2011, CURR OPIN GENE DEV, P1; Simakov DSA, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/046001; Sprinzak D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002069; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stamataki D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024484; Stollewerk A, 2003, NATURE, V423, P863, DOI 10.1038/nature01682; TANEMURA M, 1991, J THEOR BIOL, V153, P287, DOI 10.1016/S0022-5193(05)80571-5; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wang MM, 2011, INT J BIOCHEM CELL B, V43, P1550, DOI 10.1016/j.biocel.2011.08.005; Wang RQ, 2011, BIOINFORMATICS, V27, P3158, DOI 10.1093/bioinformatics/btr551; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; Yamada K, 2011, GENES CELLS, V16, P261, DOI 10.1111/j.1365-2443.2011.01488.x; Yamamoto S, 2012, SCIENCE, V338, P1229, DOI 10.1126/science.1228745; Zhu BT, 2005, BIOMED PHARMACOTHER, V59, P76, DOI 10.1016/j.biopha.2005.01.010	92	33	33	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e95744	10.1371/journal.pone.0095744	http://dx.doi.org/10.1371/journal.pone.0095744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781918	Green Submitted, Green Published, gold			2022-12-25	WOS:000335504900008
J	Rehman, S; Gladman, JT; Periasamy, A; Sun, YS; Mahadevan, MS				Rehman, Shagufta; Gladman, Jordan T.; Periasamy, Ammasi; Sun, Yuansheng; Mahadevan, Mani S.			Development of an AP-FRET Based Analysis for Characterizing RNA-Protein Interactions in Myotonic Dystrophy (DM1)	PLOS ONE			English	Article							ENERGY-TRANSFER MICROSCOPY; EXPANDED-REPEAT TRANSCRIPTS; 3 UNTRANSLATED REGION; NUCLEAR FOCI; MUSCLEBLIND PROTEINS; BINDING PROTEIN; MESSENGER-RNA; CUG REPEATS; MOUSE MODEL; CTG REPEAT	Forster Resonance Energy Transfer (FRET) microscopy is a powerful tool used to identify molecular interactions in live or fixed cells using a non-radiative transfer of energy from a donor fluorophore in the excited state to an acceptor fluorophore in close proximity. FRET can be a very sensitive tool to study protein-protein and/ or protein-nucleic acids interactions. RNA toxicity is implicated in a number of disorders; especially those associated with expanded repeat sequences, such as myotonic dystrophy. Myotonic dystrophy (DM1) is caused by a (CTG)(n) repeat expansion in the 3' UTR of the DMPK gene which results in nuclear retention of mutant DMPK transcripts in RNA foci. This results in toxic gain-of-function effects mediated through altered functions of RNA-binding proteins (e.g. MBNL1, hnRNPH, CUGBP1). In this study we demonstrate the potential of a new acceptor photobleaching assay to measure FRET (AP-FRET) between RNA and protein. We chose to focus on the interaction between MBNL1 and mutant DMPK mRNA in cells from DM1 patients due to the strong microscopic evidence of their co-localization. Using this technique we have direct evidence of intracellular interaction between MBNL1 and the DMPK RNA. Furthermore using the AP-FRET assay and MBNL1 mutants, we show that all four zinc-finger motifs in MBNL1 are crucial for MBNL1-RNA foci interactions. The data derived using this new assay provides compelling evidence for the interaction between RNA binding proteins and RNA foci, and mechanistic insights into MBNL1-RNA foci interaction demonstrating the power of AP-FRET in examining RNA-Protein interactions in DM1.	[Rehman, Shagufta; Gladman, Jordan T.; Mahadevan, Mani S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Periasamy, Ammasi; Sun, Yuansheng] Univ Virginia, Dept Biol, Charlottesville, VA USA	University of Virginia; University of Virginia	Mahadevan, MS (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.	mahadevan@virginia.edu			Muscular Dystrophy Association [186523]; National Institute of Health [NIAMS-R01-AR052771]; Stone Circle of Friends; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052771] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stone Circle of Friends; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by the Muscular Dystrophy Association (research grant #186523); and the National Institute of Health (NIAMS-R01-AR052771) and The Stone Circle of Friends. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Day RN, 2001, METHODS, V25, P4, DOI 10.1006/meth.2001.1211; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Grammatikakis I, 2011, NUCLEIC ACIDS RES, V39, P2769, DOI 10.1093/nar/gkq1155; Hamshere MG, 1997, P NATL ACAD SCI USA, V94, P7394, DOI 10.1073/pnas.94.14.7394; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kim DH, 2005, NUCLEIC ACIDS RES, V33, P3866, DOI 10.1093/nar/gki698; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Kino Y, 2009, NUCLEIC ACIDS RES, V37, P6477, DOI 10.1093/nar/gkp681; Langlois MA, 2003, MOL THER, V7, P670, DOI 10.1016/S1525-0016(03)00068-6; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Machuca-Tzili L, 2006, HUM GENET, V120, P487, DOI 10.1007/s00439-006-0228-8; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2005, CIRC RES, V97, P1152, DOI 10.1161/01.RES.0000193598.89753.e3; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; O'Leary DA, CURR CHEM GENOMICS, V4, P9; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Paul S, 2011, J BIOL CHEM, V286, P38427, DOI 10.1074/jbc.M111.255224; Periasamy A, 2001, J BIOMED OPT, V6, P287, DOI 10.1117/1.1383063; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Sun YS, 2011, CHEMPHYSCHEM, V12, P462, DOI 10.1002/cphc.201000664; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Tiscornia G, 2000, MOL CELL, V5, P959, DOI 10.1016/S1097-2765(00)80261-0; Tran H, J BIOL CHEM, V286, P16435; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299	41	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e95957	10.1371/journal.pone.0095957	http://dx.doi.org/10.1371/journal.pone.0095957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781112	gold, Green Published, Green Submitted			2022-12-25	WOS:000335504900015
J	Wu, J; Shen, SL; Chen, B; Nie, J; Peng, BG				Wu, Jian; Shen, Shun-Li; Chen, Bin; Nie, Jing; Peng, Bao-Gang			Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma	PLOS ONE			English	Article							NOTCH; PATHOGENESIS; RECURRENCE; SUPPRESSOR	Background: Numb is an evolutionary conserved protein that plays critical roles in cell fate determination, cell adhesion, cell migration and a number of signaling pathways, but evidence for a substantial involvement of Numb in HCC has remained unclear. The present study was aimed to investigate the clinical and prognostic significance of Numb and its role in hepatocellular carcinoma (HCC). Methodology: The expression of Numb was detected in 107 cases of clinical paraffin-embedded hepatocellular carcinoma tissues, 5 matched paris of fresh tissues and six hepatocellular cell lines by immunohistochemistry with clinicopathological analyses, RT-PCR or Western blot. Moreover, loss of function and gain of function assays were performed to evaluate the effect of Numb on cell proliferation in vitro. Conclusions: We found that Numb was obviously up-regulated in HCC tissues and cell lines (p<0.05). The Numb up-regulation correlated significantly with poor prognosis, and Numb status was identified as an independent prognostic factor. Over-expression of Numb increased proliferation in SMMC-7721 and BEL-7402 cells, while knock-down of Numb showed the opposite effect. Our study indicates that Numb up-regulation significantly correlates with cell proliferation and poor prognosis in hepatocellular carcinoma patients. It may be a useful biomarker for therapeutic strategy in hepatocellular carcinoma treatment.	[Wu, Jian; Shen, Shun-Li; Chen, Bin; Peng, Bao-Gang] Sun Yat Sen Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Nie, Jing] Southern Med Univ, Dept Nephrol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China	Nie, J (corresponding author), Southern Med Univ, Dept Nephrol, Guangzhou, Guangdong, Peoples R China.	niejing2006@126.com; pengbaogang@medmail.com.cn			National Science Foundation of China [81071892]; Natural Science Foundation of Guangdong province [S2011010005864]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This work is supported by grant 81071892 from National Science Foundation of China, and grant S2011010005864 from Natural Science Foundation of Guangdong province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Carter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-221; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Couturier L, 2013, CELL CYCLE, V12, P1647, DOI 10.4161/cc.24983; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Giebel B, 2012, CURR BIOL, V22, pR133, DOI 10.1016/j.cub.2012.01.006; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jiang YF, 2000, WORLD J GASTROENTERO, V6, P61, DOI 10.3748/wjg.v6.i1.61; Kim BM, 2009, GASTROENTEROLOGY, V137, P422, DOI 10.1053/j.gastro.2009.06.021; McKillop IH, 2006, J SURG RES, V136, P125, DOI 10.1016/j.jss.2006.04.013; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Sato K, 2011, MOL BIOL CELL, V22, P3103, DOI 10.1091/mbc.E11-03-0274; Trevisani F, 2008, CARCINOGENESIS, V29, P1299, DOI 10.1093/carcin/bgn113; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Yang YB, 2007, SURGERY, V141, P196, DOI 10.1016/j.surg.2006.06.033; Zhou Xin-Da, 2002, Hepatobiliary Pancreat Dis Int, V1, P35	21	10	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e95849	10.1371/journal.pone.0095849	http://dx.doi.org/10.1371/journal.pone.0095849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24770339	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736600017
J	Egea-Jimenez, AL; Fernandez-Martinez, AM; Perez-Lara, A; de Godos, A; Corbalan-Garcia, S; Gomez-Fernandez, JC				Egea-Jimenez, Antonio L.; Fernandez-Martinez, Ana M.; Perez-Lara, Angel; de Godos, Ana; Corbalan-Garcia, Senena; Gomez-Fernandez, Juan C.			Phosphatidylinositol-4,5-Bisphosphate Enhances Anionic Lipid Demixing by the C2 Domain of PKC alpha	PLOS ONE			English	Article							PROTEIN-KINASE-C; PLASMA-MEMBRANE; ASYMMETRIC DISTRIBUTION; BINDING-SITES; CA2+; PHOSPHOLIPIDS; TRANSLOCATION; ACTIVATION; CALCIUM; PIP2	The C2 domain of PKC alpha (C2 alpha) induces fluorescence self-quenching of NBD-PS in the presence of Ca2+, which is interpreted as the demixing of phosphatidylserine from a mixture of this phospholipid with phosphatidylcholine. Self-quenching of NBD-PS was considerably increased when phosphatidylinositol-4,5-bisphosphate (PIP2) was present in the membrane. When PIP2 was the labeled phospholipid, in the form of TopFluor-PIP2, fluorescence self-quenching induced by the C2 domain was also observed, but this was dependent on the presence of phosphatidylserine. An independent indication of the phospholipid demixing effect given by the C2 alpha domain was obtained by using H-2-NMR, since a shift of the transition temperature of deuterated phosphatidylcholine was observed as a consequence of the addition of the C2 alpha domain, but only in the presence of PIP2. The demixing induced by the C2 alpha domain may have a physiological significance since it means that the binding of PKCa to membranes is accompanied by the formation of domains enriched in activating lipids, like phosphatidylserine and PIP2. The formation of these domains may enhance the activation of the enzyme when it binds to membranes containing phosphatidylserine and PIP2.	[Egea-Jimenez, Antonio L.; Fernandez-Martinez, Ana M.; Perez-Lara, Angel; de Godos, Ana; Corbalan-Garcia, Senena; Gomez-Fernandez, Juan C.] Univ Murcia, Fac Vet, Dept Bioquim & Biol Mol A, Murcia, Spain	University of Murcia	Gomez-Fernandez, JC (corresponding author), Univ Murcia, Fac Vet, Dept Bioquim & Biol Mol A, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	jcgomez@um.es	Corbalan-Garcia, Senena/C-6477-2009; Jimenez, Antonio Luis Egea/Z-1906-2019; Gomez-Fernandez, Juan C/K-6758-2014	Corbalan-Garcia, Senena/0000-0003-1840-5578; Jimenez, Antonio Luis Egea/0000-0003-1684-2598; Gomez-Fernandez, Juan C/0000-0002-5331-9029; Perez Lara, Angel/0000-0002-2736-3501	Ministerio de Economia y Competitividad (Government of Spain) [BFU2011-22828]; European Fund for Regional Development (European Union); Fundacion Seneca, Region de Murcia, Spain [08700/PI/08]	Ministerio de Economia y Competitividad (Government of Spain); European Fund for Regional Development (European Union); Fundacion Seneca, Region de Murcia, Spain(Fundacion Seneca)	This work was supported by grant BFU2011-22828 from Ministerio de Economia y Competitividad (Government of Spain) with the co-financing of the European Fund for Regional Development (European Union) http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.00d7c011ca2a3753222b7d1001432ea0/?vgnextoid=33881f4368aef110VgnVCM1000001034e20aRCRD and by grant 08700/PI/08 (Fundacion Seneca, Region de Murcia, Spain) http://fseneca.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausili A, 2011, BBA-BIOMEMBRANES, V1808, P684, DOI 10.1016/j.bbamem.2010.11.035; Bolsover SR, 2003, J BIOL CHEM, V278, P10282, DOI 10.1074/jbc.M212145200; CHAP HJ, 1977, BIOCHIM BIOPHYS ACTA, V467, P146, DOI 10.1016/0005-2736(77)90192-4; Conesa-Zamora P, 2000, BBA-MOL CELL BIOL L, V1487, P246, DOI 10.1016/S1388-1981(00)00099-8; Conesa-Zamora P, 2001, BIOCHEMISTRY-US, V40, P13898, DOI 10.1021/bi011303o; Corbalan-Garcia S, 1999, BIOCHEM J, V337, P513, DOI 10.1042/0264-6021:3370513; Corbalan-Garcia S, 2003, J BIOL CHEM, V278, P4972, DOI 10.1074/jbc.M209385200; Corbalan-Garcia S, 2014, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbamem.2014.01.008, DOI 10.1016/J.BBAMEM.2014.01.008.]; Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015; Corbalan-Garcia Senena, 2014, Biophys Rev, V6, P3, DOI 10.1007/s12551-013-0125-z; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drucker P, 2013, J BIOL CHEM; Elvington SM, 2007, BBA-BIOMEMBRANES, V1768, P502, DOI 10.1016/j.bbamem.2006.11.013; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Falke JJ, 2012, P NATL ACAD SCI USA, V109, P1816, DOI 10.1073/pnas.1120856109; Franzin CM, 2001, BIOPHYS J, V81, P3346, DOI 10.1016/S0006-3495(01)75968-1; Garcia-Garcia J, 1999, BIOCHEMISTRY-US, V38, P9667, DOI 10.1021/bi9905765; Gomez-Fernandez JC, 2007, CHEM PHYS LIPIDS, V148, P1, DOI 10.1016/j.chemphyslip.2007.04.003; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Guillen J, 2013, P NATL ACAD SCI USA, V110, P20503, DOI 10.1073/pnas.1316179110; Hsueh YW, 2007, BIOPHYS J, V92, P1606, DOI 10.1529/biophysj.106.097345; Hsueh YW, 2005, BIOPHYS J, V88, P1799, DOI 10.1529/biophysj.104.051375; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai AL, 2011, J BIOL CHEM, V286, P25291, DOI 10.1074/jbc.M111.258848; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Marin-Vicente C, 2005, MOL BIOL CELL, V16, P2848, DOI 10.1091/mbc.E05-01-0067; Marin-Vicente C, 2008, J MOL BIOL, V377, P1038, DOI 10.1016/j.jmb.2007.12.011; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Ochoa WF, 2002, J MOL BIOL, V320, P277, DOI 10.1016/S0022-2836(02)00464-3; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rodriguez-Alfaro JA, 2004, J MOL BIOL, V335, P1117, DOI 10.1016/j.jmb.2003.10.080; Sanchez-Bautista S, 2006, J MOL BIOL, V362, P901, DOI 10.1016/j.jmb.2006.07.093; SNEL MME, 1994, BIOCHEMISTRY-US, V33, P7146, DOI 10.1021/bi00189a018; Torrecillas A, 2004, BIOCHEMISTRY-US, V43, P11727, DOI 10.1021/bi0489659; Torrecillas A, 2003, BIOCHEMISTRY-US, V42, P11669, DOI 10.1021/bi034759+; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0	50	5	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95973	10.1371/journal.pone.0095973	http://dx.doi.org/10.1371/journal.pone.0095973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763383	Green Submitted, Green Published, gold			2022-12-25	WOS:000335505000049
J	Astarita, G; McKenzie, JH; Wang, B; Strassburg, K; Doneanu, A; Johnson, J; Baker, A; Hankemeier, T; Murphy, J; Vreeken, RJ; Langridge, J; Kang, JX				Astarita, Giuseppe; McKenzie, Jennifer H.; Wang, Bin; Strassburg, Katrin; Doneanu, Angela; Johnson, Jay; Baker, Andrew; Hankemeier, Thomas; Murphy, James; Vreeken, Rob J.; Langridge, James; Kang, Jing X.			A Protective Lipidomic Biosignature Associated with a Balanced Omega-6/Omega-3 Ratio in fat-1 Transgenic Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; ARACHIDONIC-ACID; CHRONIC DISEASES; FISH-OIL; CARDIOVASCULAR-DISEASE; ANIMAL-MODELS; HUMAN PLASMA	A balanced omega-6/omega-3 polyunsaturated fatty acid (PUFA) ratio has been linked to health benefits and the prevention of many chronic diseases. Current dietary intervention studies with different sources of omega-3 fatty acids (omega-3) lack appropriate control diets and carry many other confounding factors derived from genetic and environmental variability. In our study, we used the fat-1 transgenic mouse model as a proxy for long-term omega-3 supplementation to determine, in a well-controlled manner, the molecular phenotype associated with a balanced omega-6/omega-3 ratio. The fat-1 mouse can convert omega-6 to omega-3 PUFAs, which protect against a wide variety of diseases including chronic inflammatory diseases and cancer. Both wild-type (WT) and fat-1 mice were subjected to an identical diet containing 10% corn oil, which has a high omega-6 content similar to that of the Western diet, for a six-month duration. We used a multi-platform lipidomic approach to compare the plasma lipidome between fat-1 and WT mice. In fat-1 mice, an unbiased profiling showed a significant increase in the levels of unesterified eicosapentaenoic acid (EPA), EPA-containing cholesteryl ester, and omega-3 lysophosphospholipids. The increase in omega-3 lipids is accompanied by a significant reduction in omega-6 unesterified docosapentaenoic acid (omega-6 DPA) and DPA-containing cholesteryl ester as well as omega-6 phospholipids and triacylglycerides. Targeted lipidomics profiling highlighted a remarkable increase in EPA-derived diols and epoxides formed via the cytochrome P450 (CYP450) pathway in the plasma of fat-1 mice compared with WT mice. Integration of the results of untargeted and targeted analyses has identified a lipidomic biosignature that may underlie the healthful phenotype associated with a balanced omega-6/omega-3 ratio, and can potentially be used as a circulating biomarker for monitoring the health status and the efficacy of omega-3 intervention in humans.	[Astarita, Giuseppe; Doneanu, Angela; Johnson, Jay; Baker, Andrew; Murphy, James; Langridge, James] Waters Corp, Hlth Sci, Milford, MA 01757 USA; [Astarita, Giuseppe] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC USA; [McKenzie, Jennifer H.; Wang, Bin; Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Lab Lipid Med & Technol, Boston, MA 02114 USA; [McKenzie, Jennifer H.; Wang, Bin; Kang, Jing X.] Harvard Univ, Sch Med, Boston, MA USA; [Strassburg, Katrin; Hankemeier, Thomas] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands; [Strassburg, Katrin; Hankemeier, Thomas] Leiden Univ, Netherlands Metabol Ctr, Leiden, Netherlands	Waters Corporation; Georgetown University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Astarita, G (corresponding author), Waters Corp, Hlth Sci, Milford, MA 01757 USA.	giuseppe_astarita@waters.com; kang.jing@mgh.harvard.edu	Hankemeier, Thomas/V-5407-2019; Astarita, Giuseppe/AAD-1239-2019; Vreeken, Rob/AAA-4563-2021; Astarita, Giuseppe/N-7346-2014	Hankemeier, Thomas/0000-0001-7871-2073; Vreeken, Rob/0000-0003-3568-1371; Astarita, Giuseppe/0000-0001-6700-301X; Baker, Andrew/0000-0002-1629-9444	Fortune Education Foundation; Sansun Life Sciences; Alzheimer's Association [NIRG-11-203674]; Waters Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Fortune Education Foundation; Sansun Life Sciences; Alzheimer's Association(Alzheimer's Association); Waters Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funding from the Fortune Education Foundation and Sansun Life Sciences (to JXK) and the Alzheimer's Association grant (NIRG-11-203674) (to GA). Waters Corporation provided support in the form of salaries for authors GA, AD, JJ, AB, JM and JL. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Arnold C, 2010, PHARMACOL REP, V62, P536, DOI 10.1016/S1734-1140(10)70311-X; Balogun KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082399; Bazan NG, 2013, NESTLE NUTR WORKS SE, V77, P121, DOI 10.1159/000351395; Bellenger J, 2011, DIABETES, V60, P1090, DOI 10.2337/db10-0901; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Block RC, 2010, PROSTAG LEUKOTR ESS, V82, P87, DOI 10.1016/j.plefa.2009.12.005; BRONSGEESTSCHOUTE HC, 1981, AM J CLIN NUTR, V34, P1752, DOI 10.1093/ajcn/34.9.1752; Brossard N, 1996, AM J CLIN NUTR, V64, P577, DOI 10.1093/ajcn/64.4.577; Bruins MJ, 2013, J LIPID RES, V54, P1598, DOI 10.1194/jlr.M034918; Capdevila JH, 2002, PROSTAG OTH LIPID M, V68-9, P325, DOI 10.1016/S0090-6980(02)00038-2; Conquer JA, 1996, J NUTR, V126, P3032, DOI 10.1093/jn/126.12.3032; Conquer JA, 1997, LIPIDS, V32, P341, DOI 10.1007/s11745-997-0043-y; Dalli J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01940; de Lorgeril M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-50; GRONN M, 1991, BIOCHIM BIOPHYS ACTA, V1081, P85, DOI 10.1016/0005-2760(91)90254-F; HOLUB BJ, 1987, ATHEROSCLEROSIS, V66, P11, DOI 10.1016/0021-9150(87)90174-2; Hooijmans CR, 2012, J ALZHEIMERS DIS, V28, P191, DOI 10.3233/JAD-2011-111217; Jacobson TA, 2012, J CLIN LIPIDOL, V6, P5, DOI 10.1016/j.jacl.2011.10.018; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2011, WORLD REV NUTR DIET, V102, P22, DOI 10.1159/000327787; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Katan MB, 1997, J LIPID RES, V38, P2012; Keenan AH, 2012, J LIPID RES, V53, P1662, DOI 10.1194/jlr.P025577; KOBATAKE Y, 1984, J NUTR SCI VITAMINOL, V30, P357, DOI 10.3177/jnsv.30.357; Lagarde M, 2001, J MOL NEUROSCI, V16, P201, DOI 10.1385/JMN:16:2-3:201; Loef Martin, 2013, Journal of Nutrition in Gerontology and Geriatrics, V32, P1, DOI 10.1080/21551197.2012.752335; Lopez-Vicario C, 2014, GUT, V63, P344, DOI 10.1136/gutjnl-2012-303179; Ma J, 1997, AM J CLIN NUTR, V65, P551, DOI 10.1093/ajcn/65.2.551; Merten M, 2001, CIRCULATION, V103, P2032; Mori TA, 2000, AM J CLIN NUTR, V71, P1085; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Newman JW, 2004, ENDOCRINOLOGY, V145, P5097, DOI 10.1210/en.2004-0710; Nording ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076575; NOZAKI S, 1992, INT J VITAM NUTR RES, V62, P256; Orr SK, 2010, NEUROCHEM RES, V35, P811, DOI 10.1007/s11064-010-0139-x; Ottestad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042550; PARKS JS, 1992, J LIPID RES, V33, P879; PARKS JS, 1989, J BIOL CHEM, V264, P2545; Romanatto T., 2013, BIOCHIM BIOPHYS ACTA, V1842, P186; Satoh N, 2009, HYPERTENS RES, V32, P1004, DOI 10.1038/hr.2009.145; Schofield M, 1998, CHEM PHYS LIPIDS, V95, P23, DOI 10.1016/S0009-3084(98)00065-6; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Serhan C N, 1988, Adv Exp Med Biol, V229, P1; Serhan CN, 2008, PROSTAG LEUKOTR ESS, V79, P157, DOI 10.1016/j.plefa.2008.09.012; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; SHIKANO M, 1994, BBA-LIPID LIPID MET, V1212, P211, DOI 10.1016/0005-2760(94)90255-0; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stark KD, 2004, AM J CLIN NUTR, V79, P765; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; SUBBAIAH PV, 1993, AM J CLIN NUTR, V58, P360, DOI 10.1093/ajcn/58.3.360; THORNBURG JT, 1995, J LIPID RES, V36, P277; VANROLLINS M, 1995, J PHARMACOL EXP THER, V274, P798; von Lossonczy T O, 1978, Am J Clin Nutr, V31, P1340; VONSCHACKY C, 1985, J CLIN INVEST, V76, P2446, DOI 10.1172/JCI112261; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wassall SR, 2008, CHEM PHYS LIPIDS, V153, P57, DOI 10.1016/j.chemphyslip.2008.02.010; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhang LA, 2010, NUTRITION, V26, P829, DOI 10.1016/j.nut.2009.08.018; Zock PL, 1997, AM J EPIDEMIOL, V145, P1114, DOI 10.1093/oxfordjournals.aje.a009074	72	25	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96221	10.1371/journal.pone.0096221	http://dx.doi.org/10.1371/journal.pone.0096221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760204	Green Submitted, gold, Green Published			2022-12-25	WOS:000335298200147
J	Brown, LAM; Jin, JJ; Ferrell, D; Sadic, E; Obregon, D; Smith, AJ; Tan, J; Giunta, B				Brown, Lecia A. M.; Jin, Jingji; Ferrell, Darren; Sadic, Edin; Obregon, Demian; Smith, Adam J.; Tan, Jun; Giunta, Brian			Efavirenz Promotes beta-Secretase Expression and Increased A beta(1-40,42) via Oxidative Stress and Reduced Microglial Phagocytosis: Implications for HIV Associated Neurocognitive Disorders (HAND)	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; INDUCED MITOCHONDRIAL DYSFUNCTION; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; A-BETA; HEPATIC CELLS; ANTIRETROVIRAL THERAPY; CLINICAL-IMPLICATIONS; INITIAL TREATMENT; INFECTED PATIENTS	Efavirenz (EFV) is among the most commonly used antiretroviral drugs globally, causes neurological symptoms that interfere with adherence and reduce tolerability, and may have central nervous system (CNS) effects that contribute in part to HIV associated neurocognitive disorders (HAND) in patients on combination antiretroviral therapy (cART). Thus we evaluated a commonly used EFV containing regimen: EFV/zidovudine (AZT)/lamivudine (3TC) in murine N2a cells transfected with the human "Swedish'' mutant form of amyloid precursor protein (SweAPP N2a cells) to assess for promotion of amyloid-beta (A beta) production. Treatment with EFV or the EFV containing regimen generated significantly increased soluble amyloid beta (A beta), and promoted increased beta-secretase-1 (BACE-1) expression while 3TC, AZT, or, vehicle control did not significantly alter these endpoints. Further, EFV or the EFV containing regimen promoted significantly more mitochondrial stress in SweAPP N2a cells as compared to 3TC, AZT, or vehicle control. We next tested the EFV containing regimen in A beta - producing Tg2576 mice combined or singly using clinically relevant doses. EFV or the EFV containing regimen promoted significantly more BACE-1 expression and soluble A beta generation while 3TC, AZT, or vehicle control did not. Finally, microglial A beta phagocytosis was significantly reduced by EFV or the EFV containing regimen but not by AZT, 3TC, or vehicle control alone. These data suggest the majority of A beta promoting effects of this cART regimen are dependent upon EFV as it promotes both increased production, and decreased clearance of A beta peptide.	[Brown, Lecia A. M.; Jin, Jingji; Ferrell, Darren; Sadic, Edin; Giunta, Brian] Univ S Florida, Morsani Coll Med, Neuroimmunol Lab, Dept Psychiat & Behav Neurosci, Tampa, FL 33606 USA; [Brown, Lecia A. M.; Ferrell, Darren; Tan, Jun; Giunta, Brian] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL USA; [Obregon, Demian; Smith, Adam J.; Tan, Jun] Univ S Florida, Morsani Coll Med, Silver Child Dev Ctr, Dept Psychiat & Neurosci,Rashid Dev Neurobiol Lab, Tampa, FL USA; [Tan, Jun; Giunta, Brian] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL USA; [Tan, Jun; Giunta, Brian] James A Haley Vet Adm Hosp, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Giunta, B (corresponding author), Univ S Florida, Morsani Coll Med, Neuroimmunol Lab, Dept Psychiat & Behav Neurosci, Tampa, FL 33606 USA.	bgiunta@health.usf.edu		Brown, Lecia/0000-0002-8050-473X	NIMH/NIH grant [1R01MH098737-02 (PI)]; NIH grants [1R41AG031586-01, 1R43AG033417-01, 1R43AT004871-01]; Veterans Administration grant [MH080168]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R43AT004871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH080168, R01MH098737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R43AG033417, R41AG031586] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001143] Funding Source: NIH RePORTER	NIMH/NIH grant; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration grant; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	BG is supported by NIMH/NIH grant (1R01MH098737-02) (PI). JT is supported by NIH grants (1R41AG031586-01), (1R43AG033417-01), and 1R43AT004871-01 as well as a Veterans Administration grant (MH080168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim CL, 2009, J NEUROIMMUNE PHARM, V4, P190, DOI 10.1007/s11481-009-9152-8; Alisky JM, 2007, MED HYPOTHESES, V69, P1140, DOI 10.1016/j.mehy.2007.02.030; Ances BM, 2010, NEUROLOGY, V75, P111, DOI 10.1212/WNL.0b013e3181e7b66e; Ances BM, 2012, ARCH NEUROL-CHICAGO, V69, P72, DOI 10.1001/archneurol.2011.761; Anthony IC, 2006, ACTA NEUROPATHOL, V111, P529, DOI 10.1007/s00401-006-0037-0; Apostolova N, 2013, J HEPATOL, V59, P780, DOI 10.1016/j.jhep.2013.06.005; Apostolova N, 2011, TRENDS PHARMACOL SCI, V32, P715, DOI 10.1016/j.tips.2011.07.007; Apostolova N, 2011, AUTOPHAGY, V7, P1402, DOI 10.4161/auto.7.11.17653; Apostolova N, 2011, HEPATOLOGY, V54, P1009, DOI 10.1002/hep.24459; Apostolova N, 2011, CURR PHARM DESIGN, V17, P2130, DOI 10.2174/138161211796904731; Balani SK, 1999, DRUG METAB DISPOS, V27, P41; Blas-Garcia A, 2011, CURR MED CHEM, V18, P2186, DOI 10.2174/092986711795656180; Blas-Garcia A, 2011, CURR PHARM DESIGN, V17, P4076, DOI 10.2174/138161211798764951; Blas-Garcia A, 2010, HEPATOLOGY, V52, P115, DOI 10.1002/hep.23647; Bradt BM, 1998, J EXP MED, V188, P431, DOI 10.1084/jem.188.3.431; Brew BJ, 2005, NEUROLOGY, V65, P1490, DOI 10.1212/01.wnl.0000183293.95787.b7; Chandra S, 2009, CAN J PHYSIOL PHARM, V87, P300, DOI 10.1139/Y09-014; Ciccarelli N, 2011, NEUROLOGY, V76, P1403, DOI 10.1212/WNL.0b013e31821670fb; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Clifford DB, 2009, NEUROLOGY, V73, P1982, DOI 10.1212/WNL.0b013e3181c5b445; Cossarizza A, 2004, AIDS, V18, P137, DOI 10.1097/00002030-200401230-00002; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Dragicevic N, 2011, J ALZHEIMERS DIS, V26, P507, DOI 10.3233/JAD-2011-101629; Esiri MM, 1998, J NEUROL NEUROSUR PS, V65, P29, DOI 10.1136/jnnp.65.1.29; Fagan AM, 2009, EMBO MOL MED, V1, P371, DOI 10.1002/emmm.200900048; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Gibbs JE, 2006, J PHARMACOL EXP THER, V317, P746, DOI 10.1124/jpet.105.098459; Gisslen M, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-63; Giunta B, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-23; Giunta B, 2010, NEUROSCI LETT, V471, P134, DOI 10.1016/j.neulet.2010.01.026; Giunta B, 2009, INT J CLIN EXP PATHO, V2, P433; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; Gomez-Sucerquia LJ, 2012, ANTIVIR RES, V94, P232, DOI 10.1016/j.antiviral.2012.04.003; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; Green DA, 2005, AIDS, V19, P407, DOI 10.1097/01.aids.0000161770.06158.5c; Grimmer T, 2009, BIOL PSYCHIAT, V65, P927, DOI 10.1016/j.biopsych.2009.01.027; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hirschel B, 2008, NEW ENGL J MED, V358, P2170, DOI 10.1056/NEJMe0803013; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huse JT, 2000, MOL NEUROBIOL, V22, P81; Jacobsen J Steven, 2005, NeuroRx, V2, P612; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013102, 10.1371/journal.pone.0011875]; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Lewis W, 2006, AIDS, V20, P675, DOI 10.1097/01.aids.0000216367.23325.58; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Manda KR, 2011, FREE RADICAL BIO MED, V50, P801, DOI 10.1016/j.freeradbiomed.2010.12.029; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murakami K, 2005, J AM CHEM SOC, V127, P15168, DOI 10.1021/ja054041c; Okonkwo OC, 2011, ARCH NEUROL-CHICAGO, V68, P113, DOI 10.1001/archneurol.2010.334; PIZZO PA, 1988, NEW ENGL J MED, V319, P889, DOI 10.1056/NEJM198810063191401; RAUSCH DM, 1994, ADV NEUROIMMUNOL, V4, P233, DOI 10.1016/S0960-5428(06)80261-5; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Rodrigue KM, 2013, JAMA NEUROL, V70, P600, DOI 10.1001/jamaneurol.2013.1342; Romao PRT, 2011, NEUROTOX RES, V19, P73, DOI 10.1007/s12640-009-9141-y; Sambamurti K, 2002, NEUROMOL MED, V1, P1, DOI 10.1385/NMM:1:1:1; SCHENK D, 1995, NEUROBIOL AGING, V16, P711, DOI 10.1016/0197-4580(95)00081-O; SCHMITT FA, 1988, NEW ENGL J MED, V319, P1573, DOI 10.1056/NEJM198812153192404; Schouten Erik J, 2011, J Int AIDS Soc, V14 Suppl 1, pS4, DOI 10.1186/1758-2652-14-S1-S4; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Selkoe DJ, 1996, COLD SPRING HARB SYM, V61, P587; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Steiner H, 1999, BIOCHEM SOC T, V27, P234, DOI 10.1042/bst0270234; Suo ZM, 1998, BRAIN RES, V807, P110, DOI 10.1016/S0006-8993(98)00780-X; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Torres SM, 2010, CARDIOVASC TOXICOL, V10, P87, DOI 10.1007/s12012-010-9065-z; Velasco M, MED CLIN BARC, V136, P103; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Waters L, 2011, AIDS, V25, P65, DOI 10.1097/QAD.0b013e328341685b; Winston A, 2010, CLIN INFECT DIS, V50, P920, DOI 10.1086/650743; Wintergerst U, 2008, J ANTIMICROB CHEMOTH, V61, P1336, DOI 10.1093/jac/dkn112; Wynn HE, 2002, CNS DRUGS, V16, P595, DOI 10.2165/00023210-200216090-00002	78	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95500	10.1371/journal.pone.0095500	http://dx.doi.org/10.1371/journal.pone.0095500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759994	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200060
J	Gronwall, C; Charles, ED; Dustin, LB; Rader, C; Silverman, GJ				Groenwall, Caroline; Charles, Edgar D.; Dustin, Lynn B.; Rader, Christoph; Silverman, Gregg J.			Selection of Apoptotic Cell Specific Human Antibodies from Adult Bone Marrow	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; B-CELLS; NATURAL ANTIBODIES; IMMUNOLOGICAL MEMORY; REPERTOIRE CLONING; IGM ANTIBODIES; IMMUNE-SYSTEM; TLR RESPONSES; V-H; AUTOANTIBODIES	Autoreactive antibodies that recognize neo-determinants on apoptotic cells in mice have been proposed to have protective, homeostatic and immunoregulatory properties, although our knowledge about the equivalent antibodies in humans has been much more limited. In the current study, human monoclonal antibodies with binding specificity for apoptotic cells were isolated from the bone marrow of healthy adults using phage display technology. These antibodies were shown to recognize phosphorylcholine (PC)-associated neo-determinants. Interestingly, three of the four identified apoptotic cell-specific antibody clones were encoded by VH3 region rearrangements with germline or nearly germline configuration without evidence of somatic hypermutation. Importantly, the different identified antibody clones had diverse heavy chain CDR3 and deduced binding surfaces as suggested by structure modeling. This may suggest a potentially great heterogeneity in human antibodies recognizing PC-related epitopes on apoptotic cells. To re-construct the postulated structural format of the parental anti-PC antibody, the dominant clone was also expressed as a recombinant human polymeric IgM, which revealed a substantially increased binding reactivity, with dose-dependent and antigen-inhibitable binding of apoptotic cells. Our findings may have implication for improved prognostic testing and therapeutic interventions in human inflammatory disease.	[Groenwall, Caroline; Silverman, Gregg J.] NYU, Sch Med, New York, NY 10012 USA; [Charles, Edgar D.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10021 USA; [Dustin, Lynn B.] Univ Oxford, Oxford, England; [Rader, Christoph] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Rader, Christoph] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA	New York University; Rockefeller University; University of Oxford; Scripps Research Institute; Scripps Research Institute	Silverman, GJ (corresponding author), NYU, Sch Med, New York, NY 10012 USA.	Gregg.Silverman@nyumc.org	Dustin, Lynn/G-5690-2011	Dustin, Lynn/0000-0002-2619-1867; Silverman, Gregg/0000-0001-9480-9457; Gronwall, Caroline/0000-0002-9111-5537; Rader, Christoph/0000-0001-9955-3454	National Institutes of Health [R01AI090118, R01AI068063]; American Recovery and Reinvestment Act supplement; American College of Rheumatology Research Education Foundation Within Our Reach campaign; Alliance for Lupus Research; Arthritis Foundation; The P. Robert Majumder Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090118, R01AI068063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act supplement; American College of Rheumatology Research Education Foundation Within Our Reach campaign; Alliance for Lupus Research; Arthritis Foundation; The P. Robert Majumder Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants; R01AI090118, R01AI068063, American Recovery and Reinvestment Act supplement; the American College of Rheumatology Research Education Foundation Within Our Reach campaign; the Alliance for Lupus Research; the Arthritis Foundation; and The P. Robert Majumder Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; ASMA GEM, 1986, CLIN EXP IMMUNOL, V64, P356; Avrameas S, 2013, J AUTOIMMUN, V41, P46, DOI 10.1016/j.jaut.2013.01.006; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; BROWN M, 1984, J IMMUNOL, V132, P1323; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; CHANG SP, 1984, J IMMUNOL, V132, P1550; CHANG SP, 1982, J IMMUNOL, V128, P702; Charles ED, 2011, J IMMUNOL METHODS, V363, P210, DOI 10.1016/j.jim.2010.09.022; Chen YF, 2009, J IMMUNOL, V183, P1346, DOI 10.4049/jimmunol.0900948; Choi YS, 2012, EUR J IMMUNOL, V42, P120, DOI 10.1002/eji.201141890; de Faire U, 2010, J AUTOIMMUN, V34, P73, DOI 10.1016/j.jaut.2009.05.003; DIGHIERO G, 1985, J IMMUNOL, V134, P765; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Elkon KB, 2012, ADV EXP MED BIOL, V750, P14, DOI 10.1007/978-1-4614-3461-0_2; Friedman P, 2002, J BIOL CHEM, V277, P7010, DOI 10.1074/jbc.M108860200; GEARHART PJ, 1977, J EXP MED, V145, P876, DOI 10.1084/jem.145.4.876; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Gronwall C, 2012, P NATL ACAD SCI USA, V109, P19745, DOI 10.1073/pnas.1211868109; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Gronwall C, 2012, CLIN IMMUNOL, V142, P390, DOI 10.1016/j.clim.2012.01.002; Gronlund H, 2009, EUR J CARDIOV PREV R, V16, P382, DOI 10.1097/HJR.0b013e32832a05df; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4; Herzenberg LA, 2000, CURR TOP MICROBIOL, V252, P3; Kantor AB, 1997, J IMMUNOL, V158, P1175; Kwong KY, 2008, J MOL BIOL, V384, P1143, DOI 10.1016/j.jmb.2008.09.008; Kwong KY, 2009, CURR PROTOC PROTEIN; LERNER RA, 1991, P NATL ACAD SCI USA, V88, P9705, DOI 10.1073/pnas.88.21.9705; Meijer Per-Johan, 2009, V525, P261, DOI 10.1007/978-1-59745-554-1_13; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Padilla ND, 2004, J IMMUNOL METHODS, V293, P1, DOI 10.1016/j.jim.2004.06.011; Peraldi-Roux Sylvie, 2012, Methods Mol Biol, V907, P73, DOI 10.1007/978-1-61779-974-7_4; PERSSON MAA, 1991, P NATL ACAD SCI USA, V88, P2432, DOI 10.1073/pnas.88.6.2432; Rader Christoph, 2012, Methods Mol Biol, V901, P53, DOI 10.1007/978-1-61779-931-0_4; Reason DC, 1997, INFECT IMMUN, V65, P261, DOI 10.1128/IAI.65.1.261-266.1997; Roben P, 1996, J CLIN INVEST, V98, P2827, DOI 10.1172/JCI119111; SANZ I, 1991, J IMMUNOL, V147, P1720; SASSO EH, 1989, J IMMUNOL, V142, P2778; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; SCOTT MG, 1987, J IMMUNOL, V138, P3325; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Shaw PX, 2003, J IMMUNOL, V170, P6151, DOI 10.4049/jimmunol.170.12.6151; SIGAL NH, 1975, J IMMUNOL, V114, P1354; Silverman GJ, 2008, CLIN EXP IMMUNOL, V153, P102, DOI 10.1111/j.1365-2249.2008.03680.x; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; Silverman GJ, 2013, NAT REV RHEUMATOL, V9, P291, DOI 10.1038/nrrheum.2013.30; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Smith K, 2013, IMMUNOBIOLOGY, V218, P745, DOI 10.1016/j.imbio.2012.08.278; STEIN LD, 1984, J IMMUNOL, V132, P1329; Su J, 2008, RHEUMATOLOGY, V47, P1144, DOI 10.1093/rheumatology/ken120; Vas J, 2012, ARTHRITIS RHEUM-US, V64, P3388, DOI 10.1002/art.34537; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Whitelegg NRJ, 2000, PROTEIN ENG, V13, P819, DOI 10.1093/protein/13.12.819; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	60	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95999	10.1371/journal.pone.0095999	http://dx.doi.org/10.1371/journal.pone.0095999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760047	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200124
J	Kit, D; Katz, L; Sullivan, B; Snyder, K; Ballard, D; Hayhoe, M				Kit, Dmitry; Katz, Leor; Sullivan, Brian; Snyder, Kat; Ballard, Dana; Hayhoe, Mary			Eye Movements, Visual Search and Scene Memory, in an Immersive Virtual Environment	PLOS ONE			English	Article							REAL-WORLD SCENES; LONG-TERM-MEMORY; ATTENTIONAL CAPTURE; COLOR SINGLETON; NATURAL SCENES; OBJECTS; GUIDANCE; PRIORITIZATION; FEATURES; SALIENCY	Visual memory has been demonstrated to play a role in both visual search and attentional prioritization in natural scenes. However, it has been studied predominantly in experimental paradigms using multiple two-dimensional images. Natural experience, however, entails prolonged immersion in a limited number of three-dimensional environments. The goal of the present experiment was to recreate circumstances comparable to natural visual experience in order to evaluate the role of scene memory in guiding eye movements in a natural environment. Subjects performed a continuous visual-search task within an immersive virtual-reality environment over three days. We found that, similar to two-dimensional contexts, viewers rapidly learn the location of objects in the environment over time, and use spatial memory to guide search. Incidental fixations did not provide obvious benefit to subsequent search, suggesting that semantic contextual cues may often be just as efficient, or that many incidentally fixated items are not held in memory in the absence of a specific task. On the third day of the experience in the environment, previous search items changed in color. These items were fixated upon with increased probability relative to control objects, suggesting that memory-guided prioritization (or Surprise) may be a robust mechanisms for attracting gaze to novel features of natural environments, in addition to task factors and simple spatial saliency.	[Kit, Dmitry] Univ Bath, Dept Comp Sci, Bath BA2 7AY, Avon, England; [Katz, Leor] Univ Texas Austin, Inst Neurosci, Ctr Perceptual Syst, Austin, TX 78712 USA; [Sullivan, Brian] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; [Snyder, Kat; Hayhoe, Mary] Univ Texas Austin, Dept Psychol, Ctr Perceptual Syst, Austin, TX 78712 USA; [Ballard, Dana] Univ Texas Austin, Dept Comp Sci, Ctr Perceptual Syst, Austin, TX 78712 USA	University of Bath; University of Texas System; University of Texas Austin; The Smith-Kettlewell Eye Research Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Kit, D (corresponding author), Univ Bath, Dept Comp Sci, Bath BA2 7AY, Avon, England.	dkit@cs.utexas.edu; leor.katz@utexas.edu		Hayhoe, Mary/0000-0002-6671-5207; Sullivan, Brian/0000-0002-5275-3931	NIH [EY05729, EY019174]; NATIONAL EYE INSTITUTE [R01EY019174, R01EY005729] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by NIH Grants EY05729 and EY019174. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2008, IEEE T PATTERN ANAL, V30, P555, DOI 10.1109/TPAMI.2007.70825; Antic B, 2011, IEEE I CONF COMP VIS, P2415, DOI 10.1109/ICCV.2011.6126525; Becker MW, 2008, J EXP PSYCHOL LEARN, V34, P1325, DOI 10.1037/a0013650; Becker SI, 2011, ACTA PSYCHOL, V136, P290, DOI 10.1016/j.actpsy.2010.12.002; Black J., 2003, P IEEE INT WORKSH VI, P125; Brockmole JR, 2008, VIS COGN, V16, P375, DOI 10.1080/13506280701453623; Brockmole JR, 2005, PSYCHON B REV, V12, P1061, DOI 10.3758/BF03206444; Brockmole JR, 2005, J EXP PSYCHOL HUMAN, V31, P857, DOI 10.1037/0096-1523.31.5.857; Brooks DI, 2010, J EXP PSYCHOL HUMAN, V36, P1406, DOI 10.1037/a0019257; Bruce NDB, 2009, J VISION, V9, DOI 10.1167/9.3.5; Castelhano MS, 2007, J EXP PSYCHOL HUMAN, V33, P753, DOI 10.1037/0096-1523.33.4.753; Droll JA, 2009, VIS COGN, V17, P1159, DOI 10.1080/13506280902797125; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Hollingworth A, 2003, J EXP PSYCHOL HUMAN, V29, P388, DOI 10.1037/0096-1523.29.2.388; Hollingworth A, 2002, J EXP PSYCHOL HUMAN, V28, P113, DOI 10.1037//0096-1523.28.1.113; Hollingworth A, 2006, VIS COGN, V14, P781, DOI 10.1080/13506280500193818; Hollingworth A, 2012, J EXP PSYCHOL HUMAN, V38, P1596, DOI 10.1037/a0030237; Horstmann G, 2005, J EXP PSYCHOL HUMAN, V31, P1039, DOI 10.1037/0096-1523.31.5.1039; Horstmann G, 2002, PSYCHOL SCI, V13, P499, DOI 10.1111/1467-9280.00488; Inui T, 1996, INTEGRATION ACCUMULA; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2006, VISION RES, V18, P547, DOI [DOI 10.1016/J.VISRES.2008.09.007, DOI 10.1016/j.visres.2008.09.007]; Itti L, 2007, COMPUTATIONAL VISION IN NEURAL AND MACHINE SYSTEMS, P183; Jovancevic J, 2006, J VISION, V6, P1431, DOI 10.1167/6.12.9; Karacan H, 2008, VIS COGN, V16, P356, DOI 10.1080/13506280701453854; Kit DM, 2012, THESIS U TEXAS; Kit D, 2011, IEEE INT C INT ROBOT, P1194, DOI 10.1109/IROS.2011.6048401; Konkle T, 2008, J VISION, V8, P694; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Mack SC, 2011, J VISION, V11, DOI 10.1167/11.9.9; Matsukura M, 2009, VIS COGN, V17, P835, DOI 10.1080/13506280902868660; Melcher D, 2006, J VISION, V6, P8, DOI 10.1167/6.1.2; Melcher D, 2001, VISION RES, V41, P3597, DOI 10.1016/S0042-6989(01)00203-6; Montello DR, 2004, HUMAN SPATIAL MEMORY: REMEMBERING WHERE, P251; Morris RG, 2004, HUMAN SPATIAL MEMORY: REMEMBERING WHERE, P217; Ohlsson S, 2003, PERSON PLACE INUENCE; Rao RPN, 2002, VISION RES, V42, P1447, DOI 10.1016/S0042-6989(02)00040-8; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Rensink RA, 2000, DYNAMIC REPRESENTATI, DOI [10.1080/135062800394667, DOI 10.1080/135062800394667]; Rosenholtz R, 1999, VISION RES, V39, P3157, DOI 10.1016/S0042-6989(99)00077-2; Rosenholtz R, 2005, COMPUTATIONAL FORM S, DOI [10.1167/5.8.777, DOI 10.1167/5.8.777]; Rothkopf C.A., 2004, P 2004 S EYE TRACK R, P123, DOI DOI 10.1145/968363.968388; Rothkopf CA, 2007, J VISION, V7, DOI 10.1167/7.14.16; Schutz A. C., 2011, J VISION, V11; Simons D, 2000, VISUAL COGNITION SER; Stirk JA, 2007, J VISION, V7, DOI 10.1167/7.10.3; Summerfield JJ, 2006, NEURON, V49, P905, DOI 10.1016/j.neuron.2006.01.021; SWAIN MJ, 1991, INT J COMPUT VISION, V7, P11, DOI 10.1007/BF00130487; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Tatler BW, 2013, J VISION, V13; Thomas LE, 2010, COGNITION, V117, P80, DOI 10.1016/j.cognition.2010.07.002; Torralba A, 2003, J OPT SOC AM A, V20, P1407, DOI 10.1364/JOSAA.20.001407; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Treisman A., 1993, ATTENTION SELECTION, P5; Vo MLH, 2013, COGNITION, V126, P198, DOI 10.1016/j.cognition.2012.09.017; Vo MLH, 2012, J EXP PSYCHOL HUMAN, V38, P23, DOI 10.1037/a0024147; Wolfe JM, 1999, INATTENTIONAL AMNESI, DOI [10.1162/0898929053747685, DOI 10.1162/0898929053747685]; Wolfe JM, 1994, GUIDED SEARCH 2 0 RE, DOI [10.3758/BF03200774, DOI 10.3758/BF03200774]; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32	61	38	38	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94362	10.1371/journal.pone.0094362	http://dx.doi.org/10.1371/journal.pone.0094362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG3EI	24759905	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200016
J	Amandio, AR; Gaspar, P; Whited, JL; Janody, F				Amandio, Ana Rita; Gaspar, Pedro; Whited, Jessica L.; Janody, Florence			Subunits of the Drosophila Actin-Capping Protein Heterodimer Regulate Each Other at Multiple Levels	PLOS ONE			English	Article							HIPPO PATHWAY; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; BARBED END; F-ACTIN; CAP-Z; FILAMENT; CYTOSKELETON; EXPRESSION; GROWTH	The actin-Capping Protein heterodimer, composed of the alpha and beta subunits, is a master F-actin regulator. In addition to its role in many cellular processes, Capping Protein acts as a main tumor suppressor module in Drosophila and in humans, in part, by restricting the activity of Yorkie/YAP/TAZ oncogenes. We aimed in this report to understand how both subunits regulate each other in vivo. We show that the levels and capping activities of both subunits must be tightly regulated to control F-actin levels and consequently growth of the Drosophila wing. Overexpressing capping protein alpha and beta decreases both F-actin levels and tissue growth, while expressing forms of Capping Protein that have dominant negative effects on F-actin promote tissue growth. Both subunits regulate each other's protein levels. In addition, overexpressing one of the subunit in tissues knocked-down for the other increases the mRNA and protein levels of the subunit knocked-down and compensates for its loss. We propose that the ability of the alpha and beta subunits to control each other's levels assures that a pool of functional heterodimer is produced in sufficient quantities to restrict the development of tumor but not in excess to sustain normal tissue growth.	[Amandio, Ana Rita; Gaspar, Pedro; Whited, Jessica L.; Janody, Florence] Inst Gulbenkian Ciencias, Oeiras, Portugal	Instituto Gulbenkian de Ciencia	Janody, F (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	fjanody@igc.gulbenkian.pt	Janody, Florence/A-4378-2017; Janody, Florence/AAT-1367-2020	Janody, Florence/0000-0003-4326-0163; Gaspar, Pedro/0000-0003-4376-4169	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-BCM/121455/2010]; FCT [SFRH/BD/47261/2008]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/121455/2010] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by grants from Fundacao para a Ciencia e Tecnologia (FCT) (Grants PTDC/BIA-BCM/121455/2010). Pedro Gaspar was the recipients of fellowships from FCT SFRH/BD/47261/2008. The funders had no role n study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATRUDA JF, 1992, J CELL BIOL, V119, P1151, DOI 10.1083/jcb.119.5.1151; ANKENBAUER T, 1989, NATURE, V342, P822, DOI 10.1038/342822a0; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; BARRONCASELLA EA, 1995, J BIOL CHEM, V270, P21472, DOI 10.1074/jbc.270.37.21472; Calleja M, 1996, AIDS RES HUM RETRO S, V274, P253; CASELLA JF, 1994, J BIOL CHEM, V269, P6992; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Delalle I, 2005, GENETICS, V171, P1757, DOI 10.1534/genetics.105.049213; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Fowler VM, 1996, CURR OPIN CELL BIOL, V8, P86, DOI 10.1016/S0955-0674(96)80052-4; Frank DJ, 2006, MOL BIOL CELL; Gates J, 2009, DEV BIOL, V333, P90, DOI 10.1016/j.ydbio.2009.06.030; Hart MC, 1997, CELL MOTIL CYTOSKEL, V38, P120, DOI 10.1002/(SICI)1097-0169(1997)38:2<120::AID-CM2>3.0.CO;2-B; Hart MC, 1999, J CELL BIOL, V147, P1287, DOI 10.1083/jcb.147.6.1287; Hopmann R, 1996, J CELL BIOL, V133, P1293, DOI 10.1083/jcb.133.6.1293; Hurst S, 1998, MOL REPROD DEV, V49, P81, DOI 10.1002/(SICI)1098-2795(199801)49:1&lt;81::AID-MRD9&gt;3.0.CO;2-K; Janody F, 2006, DEVELOPMENT, V133, P3349, DOI 10.1242/dev.02511; Jezowska B, 2011, DEV BIOL, V360, P143, DOI 10.1016/j.ydbio.2011.09.016; Johnson RI, 2008, J CELL BIOL, V180, P1191, DOI 10.1083/jcb.200706108; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; Klein T, 1998, DEV BIOL, V194, P196, DOI 10.1006/dbio.1997.8829; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; Lee YJ, 2013, INT J ONCOL, V42, P1569, DOI 10.3892/ijo.2013.1867; Lucas EP, 2013, J CELL BIOL, V201, P875, DOI 10.1083/jcb.201210073; Mahadev K, 2002, EXP CELL RES, V279, P40, DOI 10.1006/excr.2002.5583; Mammoto A, 2009, CURR OPIN CELL BIOL, V21, P864, DOI 10.1016/j.ceb.2009.08.001; Remmert K, 2000, PROTEIN EXPRES PURIF, V18, P11, DOI 10.1006/prep.1999.1132; Rudrapatna VA, 2013, ONCOGENE; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; SCHAFER DA, 1994, J CELL BIOL, V127, P453, DOI 10.1083/jcb.127.2.453; SCHAFER DA, 1995, J CELL BIOL, V128, P61, DOI 10.1083/jcb.128.1.61; SCHAFER DA, 1992, J CELL BIOL, V118, P335, DOI 10.1083/jcb.118.2.335; senberg G, 1980, NATURE, V288, P455; Shah V, 1998, SOMAT CELL MOLEC GEN, V24, P273, DOI 10.1023/B:SCAM.0000007130.08611.fc; Soeno Y, 1998, J MUSCLE RES CELL M, V19, P639, DOI 10.1023/A:1005329114263; Stevenson RP, 2012, J CELL SCI, V125, P1073, DOI 10.1242/jcs.093799; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yamamoto N, 2009, DEVELOPMENT, V136, P1977, DOI 10.1242/dev.030718; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167	48	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96326	10.1371/journal.pone.0096326	http://dx.doi.org/10.1371/journal.pone.0096326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788460	gold, Green Published			2022-12-25	WOS:000336655700074
J	Fan, CH; Liu, HL; Ting, CY; Lee, YH; Huang, CY; Ma, YJ; Wei, KC; Yen, TC; Yeh, CK				Fan, Ching-Hsiang; Liu, Hao-Li; Ting, Chien-Yu; Lee, Ya-Hsuan; Huang, Chih-Ying; Ma, Yan-Jung; Wei, Kuo-Chen; Yen, Tzu-Chen; Yeh, Chih-Kuang			Submicron-Bubble-Enhanced Focused Ultrasound for Blood-Brain Barrier Disruption and Improved CNS Drug Delivery	PLOS ONE			English	Article							INERTIAL CAVITATION; CONTRAST AGENT; BBB DISRUPTION; HIGH-FREQUENCY; DEPENDENCE; MICROBUBBLES; ACTIVATION; THRESHOLD; SAFETY	The use of focused ultrasound (FUS) with microbubbles has been proven to induce transient blood-brain barrier opening (BBB-opening). However, FUS-induced inertial cavitation of microbubbles can also result in erythrocyte extravasations. Here we investigated whether induction of submicron bubbles to oscillate at their resonant frequency would reduce inertial cavitation during BBB-opening and thereby eliminate erythrocyte extravasations in a rat brain model. FUS was delivered with acoustic pressures of 0.1-4.5 MPa using either in-house manufactured submicron bubbles or standard SonoVue microbubbles. Wideband and subharmonic emissions from bubbles were used to quantify inertial and stable cavitation, respectively. Erythrocyte extravasations were evaluated by in vivo post-treatment magnetic resonance susceptibility-weighted imaging, and finally by histological confirmation. We found that excitation of submicron bubbles with resonant frequency-matched FUS (10 MHz) can greatly limit inertial cavitation while enhancing stable cavitation. The BBB-opening was mainly caused by stable cavitation, whereas the erythrocyte extravasation was closely correlated with inertial cavitation. Our technique allows extensive reduction of inertial cavitation to induce safe BBB-opening. Furthermore, the safety issue of BBB-opening was not compromised by prolonging FUS exposure time, and the local drug concentrations in the brain tissues were significantly improved to 60 times (BCNU; 18.6 mu g versus 0.3 mu g) by using chemotherapeutic agent-loaded submicron bubbles with FUS. This study provides important information towards the goal of successfully translating FUS brain drug delivery into clinical use.	[Fan, Ching-Hsiang; Ting, Chien-Yu; Lee, Ya-Hsuan; Yeh, Chih-Kuang] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Liu, Hao-Li; Huang, Chih-Ying; Ma, Yan-Jung] Chang Gung Univ, Dept Elect Engn, Tao Yuan, Taiwan; [Wei, Kuo-Chen] Chang Gung Univ, Coll Med, Dept Neurosurg, Tao Yuan, Taiwan; [Wei, Kuo-Chen; Yen, Tzu-Chen] Mem Hosp, Tao Yuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Univ, Coll Med, Dept Nucl Med, Tao Yuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Univ, Coll Med, Mol Imaging Ctr, Tao Yuan, Taiwan	National Tsing Hua University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Yen, TC (corresponding author), Chang Gung Univ, Coll Med, Dept Nucl Med, Tao Yuan, Taiwan.	yentc1110@gmail.com; ckyeh@mx.nthu.edu.tw		Wei, Kuochen/0000-0003-3505-2196; Yeh, Chih-Kuang/0000-0002-2880-6327	National Science Council of Taiwan [NSC 99-2218-E-182-002, 100-2218-E-182-001, 101-2221-E-007-035-MY3]; National Tsing Hua University [102N2046E1]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University	The authors acknowledge the supports of National Science Council of Taiwan (NSC 99-2218-E-182-002, 100-2218-E-182-001, 101-2221-E-007-035-MY3) and National Tsing Hua University (102N2046E1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitis CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045783; Baseri B, 2010, ULTRASOUND MED BIOL, V36, P1445, DOI 10.1016/j.ultrasmedbio.2010.06.005; Bickel U, 1995, NIDA Res Monogr, V154, P28; Bing KF, 2009, ULTRASOUND MED BIOL, V35, P1298, DOI 10.1016/j.ultrasmedbio.2009.03.012; Chen WS, 2003, ULTRASOUND MED BIOL, V29, P739, DOI 10.1016/S0301-5629(03)00029-2; Choi JJ, 2010, IEEE T BIO-MED ENG, V57, P145, DOI 10.1109/TBME.2009.2034533; Chopra R, 2010, ACS CHEM NEUROSCI, V1, P391, DOI 10.1021/cn9000445; De Vries LS, 2004, J PEDIATR-US, V144, P815, DOI 10.1016/j.jpeds.2004.03.034; Deng JM, 2012, J MOL NEUROSCI, V46, P677, DOI 10.1007/s12031-011-9629-9; Doolittle ND, 2000, CANCER, V88, P637, DOI 10.1002/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y; Emerich DF, 2001, CRIT REV THER DRUG, V18, P265; Farny CH, 2009, ULTRASOUND MED BIOL, V35, P603, DOI 10.1016/j.ultrasmedbio.2008.09.025; Fukuda S, 2006, PEDIATRICS, V117, P1, DOI 10.1542/peds.2004-1719; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Goertz DE, 2005, IEEE T ULTRASON FERR, V52, P495, DOI 10.1109/TUFFC.2005.1417273; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Inder TE, 2003, AM J NEURORADIOL, V24, P805; Jalali S, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-114; Jordao JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010549; Kang ST, 2011, ULTRASON SONOCHEM, V18, P327, DOI 10.1016/j.ultsonch.2010.06.014; Lai CY, 2006, ULTRASOUND MED BIOL, V32, P1931, DOI 10.1016/j.ultrasmedbio.2006.06.020; Liu HL, 2008, ULTRASOUND MED BIOL, V34, P598, DOI 10.1016/j.ultrasmedbio.2008.01.011; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; McDannold N, 2006, PHYS MED BIOL, V51, P793, DOI 10.1088/0031-9155/51/4/003; McDannold N, 2008, ULTRASOUND MED BIOL, V34, P834, DOI 10.1016/j.ultrasmedbio.2007.10.016; MILLER DL, 1987, ULTRASOUND MED BIOL, V13, P443, DOI 10.1016/0301-5629(87)90110-4; Miller DL, 2004, ULTRASOUND MED BIOL, V30, P973, DOI 10.1016/j.ultrasmedbio.2004.05.010; O'Reilly MA, 2012, RADIOLOGY, V263, P96, DOI 10.1148/radiol.11111417; Samiotaki G, 2012, MAGN RESON MED, V67, P769, DOI 10.1002/mrm.23063; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Sheikov N, 2008, ULTRASOUND MED BIOL, V34, P1093, DOI 10.1016/j.ultrasmedbio.2007.12.015; Shi WT, 1999, ULTRASOUND MED BIOL, V25, P275, DOI 10.1016/S0301-5629(98)00163-X; Sun Y, 2005, IEEE T ULTRASON FERR, V52, P1981, DOI 10.1109/TUFFC.2005.1561667; Ting CY, 2012, BIOMATERIALS, V33, P704, DOI 10.1016/j.biomaterials.2011.09.096; Tung YS, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3580763; Tung YS, 2010, PHYS MED BIOL, V55, P6141, DOI 10.1088/0031-9155/55/20/007; Tung YS, 2010, ULTRASOUND MED BIOL, V36, P840, DOI 10.1016/j.ultrasmedbio.2010.02.009; van der Meer SM, 2004, ULTRASON, P343; Wang ST, 2014, ULTRASOUND MED BIOL, V40, P130, DOI 10.1016/j.ultrasmedbio.2013.09.015; Yang FY, 2007, ULTRASOUND MED BIOL, V33, P1421, DOI 10.1016/j.ultrasmedbio.2007.04.006; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038	42	49	49	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96327	10.1371/journal.pone.0096327	http://dx.doi.org/10.1371/journal.pone.0096327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788566	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700075
J	Fragata, I; Simoes, P; Lopes-Cunha, M; Lima, M; Kellen, B; Barbaro, M; Santos, J; Rose, MR; Santos, M; Matos, M				Fragata, Ines; Simoes, Pedro; Lopes-Cunha, Miguel; Lima, Margarida; Kellen, Barbara; Barbaro, Margarida; Santos, Josiane; Rose, Michael R.; Santos, Mauro; Matos, Margarida			Laboratory Selection Quickly Erases Historical Differentiation	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER POPULATIONS; EXPERIMENTAL EVOLUTION; CALLOSOBRUCHUS-MACULATUS; GENETIC ARCHITECTURE; ADAPTIVE LANDSCAPES; STRESS RESISTANCE; REVERSE EVOLUTION; UNIFORM SELECTION; ESCHERICHIA-COLI; RAPID EVOLUTION	The roles of history, chance and selection have long been debated in evolutionary biology. Though uniform selection is expected to lead to convergent evolution between populations, contrasting histories and chance events might prevent them from attaining the same adaptive state, rendering evolution somewhat unpredictable. The predictability of evolution has been supported by several studies documenting repeatable adaptive radiations and convergence in both nature and laboratory. However, other studies suggest divergence among populations adapting to the same environment. Despite the relevance of this issue, empirical data is lacking for real-time adaptation of sexual populations with deeply divergent histories and ample standing genetic variation across fitness-related traits. Here we analyse the real-time evolutionary dynamics of Drosophila subobscura populations, previously differentiated along the European cline, when colonizing a new common environment. By analysing several life-history, physiological and morphological traits, we show that populations quickly converge to the same adaptive state through different evolutionary paths. In contrast with other studies, all analysed traits fully converged regardless of their association with fitness. Selection was able to erase the signature of history in highly differentiated populations after just a short number of generations, leading to consistent patterns of convergent evolution.	[Fragata, Ines; Simoes, Pedro; Lopes-Cunha, Miguel; Lima, Margarida; Kellen, Barbara; Barbaro, Margarida; Santos, Josiane; Matos, Margarida] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Fragata, Ines; Simoes, Pedro; Lopes-Cunha, Miguel; Lima, Margarida; Kellen, Barbara; Barbaro, Margarida; Santos, Josiane; Matos, Margarida] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Lisbon, Portugal; [Rose, Michael R.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Santos, Mauro] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain	Universidade de Lisboa; Universidade de Lisboa; University of California System; University of California Irvine; Autonomous University of Barcelona	Fragata, I (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal.	irfragata@fc.ul.pt; pmsimoes@fc.ul.pt	Matos, Margarida/K-2365-2012; Santos, Josiane/E-4774-2011; Simões, Pedro/F-7220-2015; Santos, Mauro/A-8044-2008; Fragata, Inês/I-9876-2014	Matos, Margarida/0000-0001-6998-5133; Santos, Josiane/0000-0002-7206-9627; Simões, Pedro/0000-0002-4253-1200; Santos, Mauro/0000-0002-6478-6570; Fragata, Inês/0000-0001-6865-1510; Reis, AlessanRSS/0000-0001-8486-7469; Rose, Michael/0000-0002-7766-0731	Portuguese National Funds through "Fundacao para a Ciencia e a Tecnologia" (FCT) [PTDC/BIA-BDE/65733/2006, PTDC/BIA-BEC/098213/2008]; FCT [PTDC/BIA-BDE/65733/2006, SFRH/BD/60734/2009, SFRH/BD/28498/2006]; Post-Doc grant; BI grant [PTDC/BIA-BEC/098213/2008]; Ministerio de Ciencia e Innovacion (Spain) [CGL2010-15395]; ICREA Academia program	Portuguese National Funds through "Fundacao para a Ciencia e a Tecnologia" (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Post-Doc grant; BI grant; Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA Academia program(ICREA)	This study was partially financed by Portuguese National Funds through "Fundacao para a Ciencia e a Tecnologia" (FCT, http://www.fct.pt/) within the projects ref. PTDC/BIA-BDE/65733/2006 and ref. PTDC/BIA-BEC/098213/2008. BK and ML had BTI grants from FCT within the project ref. PTDC/BIA-BDE/65733/2006. PS had a Post-Doc grant and ML-C had a BI grant within the project ref. PTDC/BIA-BEC/098213/2008. IF had a PhD grant (SFRH/BD/60734/2009) and JS had a PhD grant (SFRH/BD/28498/2006) from FCT. MS is supported by grant CGL2010-15395 from the Ministerio de Ciencia e Innovacion (Spain), and by the ICREA Academia program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2009, EVOLUTION, V63, P1143, DOI 10.1111/j.1558-5646.2009.00649.x; Adler D, 2012, RGL 3D VISUALIZATION; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Bedhomme S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-46; Bell G, 2013, BIOL LETT, V9, P2013; Benjamini Y, 2001, ANN STAT, V29, P1165; Bieri J, 2003, EVOLUTION, V57, P274, DOI 10.1111/j.0014-3820.2003.tb00262.x; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Burke MK, 2010, NATURE, V467, P587, DOI 10.1038/nature09352; Chippindale AK, 2006, EVOL GENET, P482; COHAN FM, 1989, AM NAT, V134, P613, DOI 10.1086/285000; COHAN FM, 1986, GENETICS, V114, P145; Colegrave N, 2008, HEREDITY, V100, P464, DOI 10.1038/sj.hdy.6801095; Colegrave N, 2005, BIOESSAYS, V27, P1167, DOI 10.1002/bies.20292; Collins S, 2006, EVOLUTION, V60, P1392, DOI 10.1111/j.0014-3820.2006.tb01218.x; Conte GL, 2012, P ROY SOC B-BIOL SCI, V279, P5039, DOI 10.1098/rspb.2012.2146; DEJONG G, 1992, AM NAT, V139, P749, DOI 10.1086/285356; Elmer KR, 2011, TRENDS ECOL EVOL, V26, P298, DOI 10.1016/j.tree.2011.02.008; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fisher R.A., 1930, GENETICAL THEORY NAT; Flatt T, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P1; Flores-Moya A, 2008, NATURWISSENSCHAFTEN, V95, P697, DOI 10.1007/s00114-008-0372-1; Fox CW, 2011, EVOL BIOL, V38, P182, DOI 10.1007/s11692-011-9116-9; Gavrilets Sergey, 2010, P45; Gilchrist GW, 2008, EVOL APPL, V1, P513, DOI 10.1111/j.1752-4571.2008.00040.x; Gould S. J., 1989, WONDERFUL LIFE BURGE; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Griffiths JA, 2005, J EVOLUTION BIOL, V18, P213, DOI 10.1111/j.1420-9101.2004.00782.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Johnson MA, 2010, EVOLUTION, V64, P1151, DOI 10.1111/j.1558-5646.2009.00881.x; Joshi A, 2003, J GENET, V82, P147, DOI 10.1007/BF02715815; Kawecki TJ, 2006, J EVOLUTION BIOL, V19, P1265, DOI 10.1111/j.1420-9101.2005.01071.x; Kawecki TJ, 2003, ECOL ENTOMOL, V28, P449, DOI 10.1046/j.1365-2311.2003.00526.x; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Krimbas C.B., 1980, Evolutionary Biology (New York), V12, P163; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Lee CE, 2011, EVOLUTION, V65, P2229, DOI 10.1111/j.1558-5646.2011.01308.x; Lenormand T, 2009, TRENDS ECOL EVOL, V24, P157, DOI 10.1016/j.tree.2008.09.014; Lobkovsky Alexander E., 2012, Frontiers in Genetics, V3, P246, DOI 10.3389/fgene.2012.00246; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Martin A, 2013, EVOLUTION, V67, P1235, DOI 10.1111/evo.12081; Matos M, 2004, EVOLUTION, V58, P1503; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; Melnyk AH, 2011, EVOLUTION, V65, P3048, DOI 10.1111/j.1558-5646.2011.01333.x; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; MONCLUS M, 1971, EVOLUTION, V25, P214, DOI 10.1111/j.1558-5646.1971.tb01873.x; R CDT, 2008, R LANG ENV STAT COMP; Rezende EL, 2010, CLIM RES, V43, P103, DOI 10.3354/cr00869; Roff DA, 2006, EVOLUTION, V60, P1981, DOI 10.1111/j.0014-3820.2006.tb01836.x; Rose M.R., 2004, METHUSELAH FLIES CAS; Santos J, 2012, J EVOLUTION BIOL, V25, P2607, DOI 10.1111/jeb.12008; Santos M, 2007, J EVOLUTION BIOL, V20, P2361, DOI 10.1111/j.1420-9101.2007.01408.x; Santos M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-7; Santos M, 2010, THEOR BIOSCI, V129, P97, DOI 10.1007/s12064-010-0086-8; Saxer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014184; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SERVICE PM, 1985, EVOLUTION, V39, P943, DOI [10.2307/2408694, 10.1111/j.1558-5646.1985.tb00436.x]; SERVICE PM, 1987, PHYSIOL ZOOL, V60, P321, DOI 10.1086/physzool.60.3.30162285; Simoes P, 2007, J EVOLUTION BIOL, V20, P758, DOI 10.1111/j.1420-9101.2006.01244.x; Simoes P, 2008, EVOLUTION, V62, P1817, DOI 10.1111/j.1558-5646.2008.00423.x; Spor A, 2013, EVOLUTION, P1; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Teotonio H, 2000, NATURE, V408, P463, DOI 10.1038/35044070; Teotonio H, 2002, J EVOLUTION BIOL, V15, P608, DOI 10.1046/j.1420-9101.2002.00424.x; Teotonio H, 2001, EVOLUTION, V55, P653, DOI 10.1554/0014-3820(2001)055[0653:PRE]2.0.CO;2; Teotonio H, 2009, NAT GENET, V41, P251, DOI 10.1038/ng.289; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wood TE, 2005, GENETICA, V123, P157, DOI 10.1007/s10709-003-2738-9; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Wright S, 1931, EVOLUTION MENDELIAN; Young KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004740	77	25	25	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96227	10.1371/journal.pone.0096227	http://dx.doi.org/10.1371/journal.pone.0096227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788553	Green Submitted, Green Published, gold			2022-12-25	WOS:000336655700065
J	Hu, XT; Xuan, H; Du, HP; Jiang, H; Huang, JW				Hu, Xiaotong; Xuan, Han; Du, Huaping; Jiang, Hao; Huang, Jinwen			Down-Regulation of CD9 by Methylation Decreased Bortezomib Sensitivity in Multiple Myeloma	PLOS ONE			English	Article							MEDIATED DRUG-RESISTANCE; ADHESION KINASE PHOSPHORYLATION; DIPHTHERIA-TOXIN RECEPTOR; BREAST-CANCER; MONOCLONAL-ANTIBODY; PROTEIN-1 MRP-1/CD9; TUMOR-SUPPRESSOR; COLON-CANCER; BONE-MARROW; CELL-LINES	Bortezomib therapy has been proven successful for the treatment of relapsed and/or refractory multiple myeloma ( MM). However, both intrinsic and acquired resistance has already been observed. In this study, we explored the relationship between CD9 expression and bortezomib sensitivity in MM. We found that down-regulation of CD9 by methylation decreased bortezomib sensitivity in multiple myeloma. CD9 expression obviously increased bortezomib sensitivity through inducing apoptosis, significantly inhibiting U266 cells' adhesion to HS-5 and primary bone marrow stromal cells, but increasing U266 cells' adhesion to fibronectin. CD9 expression also significantly inhibited U266 cell migration. The mechanisms may include: the endoplasmic reticulum stress pathway, cell adhesion related signaling pathway and osteoclast differentiation related signaling pathway. Combination therapy with de-methylation reagent 5-Aza-2-deoxycytidine may prove useful to the development of novel strategies for the treatment of bortezomib-resistant MM patients.	[Hu, Xiaotong] Zhejiang Univ, Sir Run Run Shaw Hosp, Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Xiaotong] Key Lab Biotherapy Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Xuan, Han; Du, Huaping; Jiang, Hao; Huang, Jinwen] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Hu, XT (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	hxt_hangzhou@sina.com; huangjinwen@gmail.com	Hu, Xiao-tong/K-5820-2019		Zhejiang Provincial Natural Science Foundation of China [R2100213]; National Natural Science Foundation of China [81372622]; Major Projects in Zhejiang Province [2012C13014-1]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Projects in Zhejiang Province	This work was supported by grants from the Zhejiang Provincial Natural Science Foundation of China [No. R2100213], and the National Natural Science Foundation of China [No. 81372622] and Major Projects in Zhejiang Province [No. 2012C13014-1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Kenneth C, 2004, Curr Hematol Rep, V3, P65; Barrena S, 2005, LEUKEMIA, V19, P1376, DOI 10.1038/sj.leu.2403822; BOUCHEIX C, 1983, FEBS LETT, V161, P289, DOI 10.1016/0014-5793(83)81027-8; BOUCHEIX C, 1991, J BIOL CHEM, V266, P117; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Buim MEC, 2010, ORAL ONCOL, V46, P166, DOI 10.1016/j.oraloncology.2009.11.009; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; De Bruyne E, 2008, CLIN CANCER RES, V14, P2918, DOI 10.1158/1078-0432.CCR-07-4489; Drucker L, 2006, CARCINOGENESIS, V27, P197, DOI 10.1093/carcin/bgi209; Fan J, 2010, MOL CARCINOGEN, V49, P85, DOI 10.1002/mc.20580; Hashida H, 2003, BRIT J CANCER, V89, P158, DOI 10.1038/sj.bjc.6601015; Hazlehurst LA, 2001, CANCER METAST REV, V20, P43, DOI 10.1023/A:1013156407224; Heller G, 2008, CANCER RES, V68, P44, DOI 10.1158/0008-5472.CAN-07-2531; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Higashiyama M, 1997, INT J CANCER, V74, P205, DOI 10.1002/(SICI)1097-0215(19970422)74:2<205::AID-IJC12>3.0.CO;2-C; Huang CI, 1998, AM J PATHOL, V153, P973, DOI 10.1016/S0002-9440(10)65639-8; IWAMOTO R, 1991, J BIOL CHEM, V266, P20463; KERSEY JH, 1981, J EXP MED, V153, P726, DOI 10.1084/jem.153.3.726; LANZA F, 1991, J BIOL CHEM, V266, P10638; Li ZW, 2006, BLOOD REV, V20, P333, DOI 10.1016/j.blre.2005.08.003; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; MITAMURA T, 1992, J CELL BIOL, V118, P1389, DOI 10.1083/jcb.118.6.1389; Miyake M, 1996, CANCER RES, V56, P1244; Mori M, 1998, CLIN CANCER RES, V4, P1507; Mujtaba T, 2011, DISCOV MED, V12, P471; Murray PG, 2004, ONCOGENE, V23, P1326, DOI 10.1038/sj.onc.1207313; Nagaharu K, 2011, AM J PATHOL, V178, P754, DOI 10.1016/j.ajpath.2010.10.015; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Neri P, 2012, CURR CANCER DRUG TAR, V12, P776, DOI 10.2174/156800912802429337; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; PELLETIER AJ, 1995, J BIOL CHEM, V270, P18133, DOI 10.1074/jbc.270.30.18133; Richardson MM, 2011, CLIN EXP METASTAS, V28, P261, DOI 10.1007/s10585-010-9365-5; Rubinstein E, 1996, EUR J IMMUNOL, V26, P2657, DOI 10.1002/eji.1830261117; Sho M, 1998, INT J CANCER, V79, P509, DOI 10.1002/(SICI)1097-0215(19981023)79:5<509::AID-IJC11>3.0.CO;2-X; Su B, 2013, ONCOGENE, V32, P2016, DOI 10.1038/onc.2012.218; Wang HX, 2011, BIOCHEM SOC T, V39, P547, DOI 10.1042/BST0390547; Won WJ, 2002, J IMMUNOL, V168, P5605, DOI 10.4049/jimmunol.168.11.5605; Yanamandra N, 2006, CLIN CANCER RES, V12, P591, DOI 10.1158/1078-0432.CCR-05-1792; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Zheng R, 2005, ONCOL RES, V15, P365, DOI 10.3727/096504005776449699; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	43	11	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95765	10.1371/journal.pone.0095765	http://dx.doi.org/10.1371/journal.pone.0095765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788635	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700038
J	Virkus, RA; Lokkegaard, E; Lidegaard, O; Langhoff-Roos, J; Nielsen, AK; Rothman, KJ; Bergholt, T				Virkus, Rie Adser; Lokkegaard, Ellen; Lidegaard, Ojvind; Langhoff-Roos, Jens; Nielsen, Anne Kristine; Rothman, Kenneth J.; Bergholt, Thomas			Risk Factors for Venous Thromboembolism in 1.3 Million Pregnancies: A Nationwide Prospective Cohort	PLOS ONE			English	Article							PULMONARY-EMBOLISM; POSTPARTUM PERIOD; THROMBOSIS; PUERPERIUM; WOMEN	Objective: To quantify risk factors for venous thromboembolism during pregnancy and the puerperal period. Design: In a nationwide prospective cohort study we followed pregnant and puerperal women in Denmark from 1995 to 2009 for venous thromboembolism. Information on risk factors and confounders was retrieved from national registries. The diagnosis of venous thromboembolism was confirmed through medical charts. We calculated adjusted incidence rates per 10,000 women years and used Poisson regression to estimate effects during pregnancy and the puerperal period. Results: We studied 1,297,037 pregnancies and related puerperal periods, during which there were 748 venous thromboembolisms. The incidence rate for venous thromboembolism during a pregnancy with and without hospitalization for hyperemesis was 15.2/10,000 yr and 6.3/10,000 yr, respectively, (adjusted rate ratio: 2.5 (95%-confidence interval; 1.4-4.5)). The incidence rate among women with multiple pregnancies was 18.2/10,000 yr and 6.3/10,000 yr in singletons (adjusted rate ratio: 2.8 (1.9-4.2)). Increased risk was found with hospitalization during pregnancy or the puerperal period with incidence rates of 42.1/10.000 and 54.7/10.000, respectively, (rate ratios: 12.2 (8.7-17) and 5.9 (4.0-8.8)). Women hospitalized with infections during pregnancy had incidence rates of 25.9/10,000 yr and 29.3/10,000 yr during pregnancy and the puerperal period, respectively, and of 62.7/10,000 yr if hospitalized with infection in the puerperal period. Puerperal venous thromboembolism was associated with hospitalization for preeclampsia and intrauterine growth restriction/fetal death with incidence rates of 45.8/10,000 yr and 18.3/10,000 yr, respectively (rate ratio: 5.0 (3.1-7.8) and 1.9 (0.9-4.4)). Additionally puerperal venous thromboembolism was associated with obesity, elective and acute caesarean sections and major postpartum bleeding with incidence rates of 25.5/10,000 yr, 23.2/10,000 yr, 34.0/10,000 yr and 20.3/10,000 yr, respectively (rate ratios 1.7 (1.1-2.7), 2.1 (1.4-3.1), 3.0 (2.3-4.0) and 1.4 (1.0-2.1)). Conclusions: Important risk factors for venous thromboembolism during pregnancy or the puerperal period were hospitalization, infection, hyperemesis, multiple pregnancies, preeclampsia, obesity, caesarean section, major postpartum bleeding, and intrauterine growth restriction or fetal death.	[Virkus, Rie Adser; Lokkegaard, Ellen; Bergholt, Thomas] Univ Copenhagen, Hillerod Hosp, Dept Obstet & Gynecol, Hillerod, Denmark; [Lidegaard, Ojvind; Nielsen, Anne Kristine] Univ Copenhagen, Rigshosp, Gynecol Clin, DK-2100 Copenhagen, Denmark; [Langhoff-Roos, Jens] Univ Copenhagen, Rigshosp, Obstetr Clin, DK-2100 Copenhagen, Denmark; [Rothman, Kenneth J.] Res Triangle Inst, Res Triangle Pk, NC 27709 USA	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Research Triangle Institute	Lokkegaard, E (corresponding author), Univ Copenhagen, Hillerod Hosp, Dept Obstet & Gynecol, Hillerod, Denmark.	ELOE0002@regionh.dk	Bergholt, Thomas/J-4130-2013	Bergholt, Thomas/0000-0002-7284-6094; Lokkegaard, Ellen/0000-0003-4149-5663; Langhoff-Roos, Jens/0000-0003-2838-2533	research foundation at Hillerod Hospital, University of Copenhagen; Novo Nordisk Fonden [NNF14OC0011645] Funding Source: researchfish	research foundation at Hillerod Hospital, University of Copenhagen; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was funded by the research foundation at Hillerod Hospital, University of Copenhagen which had no role in the study study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BS, 1998, ACTA OBSTET GYN SCAN, V77, P170, DOI 10.1034/j.1600-0412.1998.770207.x; Bodker B, 2009, ACTA OBSTET GYN SCAN, V88, P556, DOI 10.1080/00016340902897992; Brown HL, 1996, CLIN OBSTET GYNECOL, V39, P87, DOI 10.1097/00003081-199603000-00009; Carr M H, 1997, J Matern Fetal Med, V6, P264, DOI 10.1002/(SICI)1520-6661(199709/10)6:5<264::AID-MFM4>3.0.CO;2-E; Danilenko-Dixon DR, 2001, AM J OBSTET GYNECOL, V184, P104, DOI 10.1067/mob.2001.107919; Gherman RB, 1999, OBSTET GYNECOL, V94, P730, DOI 10.1016/S0029-7844(99)00426-3; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Henriksson P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8632; Jackson E, 2011, OBSTET GYNECOL, V117, P691, DOI 10.1097/AOG.0b013e31820ce2db; Jacobsen AF, 2008, J THROMB HAEMOST, V6, P905, DOI 10.1111/j.1538-7836.2008.02961.x; Jacobsen AF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.041; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; James AH, 2010, CRIT CARE MED, V38, pS57, DOI 10.1097/CCM.0b013e3181c9e2bb; Jensen TB, 2013, PHARMACOEPIDEMIOL DR; Knight M, 2008, BJOG-INT J OBSTET GY, V115, P453, DOI 10.1111/j.1471-0528.2007.01622.x; Kovacevich GJ, 2000, AM J OBSTET GYNECOL, V182, P1089, DOI 10.1067/mob.2000.105405; Larsen TB, 2007, THROMB RES, V120, P505, DOI 10.1016/j.thromres.2006.12.003; Lindqvist P, 1999, OBSTET GYNECOL, V94, P595, DOI 10.1016/S0029-7844(99)00308-7; Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870; Martineau M, 2009, POSTGRAD MED J, V85, P489, DOI 10.1136/pgmj.2009.079822; McColl MD, 1997, THROMB HAEMOSTASIS, V78, P1183; Morris JM, 2010, J THROMB HAEMOST, V8, P998, DOI 10.1111/j.1538-7836.2010.03794.x; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Pomp ER, 2008, J THROMB HAEMOST, V6, P632, DOI 10.1111/j.1538-7836.2008.02921.x; Prasad A, 2002, CIRCULATION, V106, P184, DOI 10.1161/01.CIR.0000021125.83697.21; Robinson HE, 2005, OBSTET GYNECOL, V106, P1357, DOI 10.1097/01.AOG.0000188387.88032.41; Ros HS, 2002, AM J OBSTET GYNECOL, V186, P198, DOI 10.1067/mob.2002.119177; ROTHMAN KJ, 1981, AM J EPIDEMIOL, V114, P253, DOI 10.1093/oxfordjournals.aje.a113189; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Sultan A, 2013, BMJ, V347; Sultan AA, 2013, BLOOD, V121, P3953, DOI 10.1182/blood-2012-11-469551; Virkus RA, 2013, ACTA OBSTET GYN SCAN, V92, P1135, DOI 10.1111/aogs.12223; Virkus RA, 2011, THROMB HAEMOSTASIS, V106, P304, DOI 10.1160/TH10-12-0823	33	48	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96495	10.1371/journal.pone.0096495	http://dx.doi.org/10.1371/journal.pone.0096495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788753	gold, Green Published, Green Submitted			2022-12-25	WOS:000336655700100
J	Thomas, R; Hubbard, AE; McHale, CM; Zhang, LP; Rappaport, SM; Lan, Q; Rothman, N; Vermeulen, R; Guyton, KZ; Jinot, J; Sonawane, BR; Smith, MT				Thomas, Reuben; Hubbard, Alan E.; McHale, Cliona M.; Zhang, Luoping; Rappaport, Stephen M.; Lan, Qing; Rothman, Nathaniel; Vermeulen, Roel; Guyton, Kathryn Z.; Jinot, Jennifer; Sonawane, Babasaheb R.; Smith, Martyn T.			Characterization of Changes in Gene Expression and Biochemical Pathways at Low Levels of Benzene Exposure	PLOS ONE			English	Article							TESTING ASSOCIATION; VARIABLE IMPORTANCE; METABOLISM; IDENTIFICATION; PHENOL; BIOMARKERS; LEUKEMIA; ADDUCTS; COMPLEX; WORKERS	Benzene, a ubiquitous environmental pollutant, causes acute myeloid leukemia (AML). Recently, through transcriptome profiling of peripheral blood mononuclear cells (PBMC), we reported dose-dependent effects of benzene exposure on gene expression and biochemical pathways in 83 workers exposed across four airborne concentration ranges (from < 1 ppm to > 10 ppm) compared with 42 subjects with non-workplace ambient exposure levels. Here, we further characterize these dose-dependent effects with continuous benzene exposure in all 125 study subjects. We estimated air benzene exposure levels in the 42 environmentally-exposed subjects from their unmetabolized urinary benzene levels. We used a novel nonparametric, data-adaptive model selection method to estimate the change with dose in the expression of each gene. We describe non-parametric approaches to model pathway responses and used these to estimate the dose responses of the AML pathway and 4 other pathways of interest. The response patterns of majority of genes as captured by mean estimates of the first and second principal components of the dose-response for the five pathways and the profiles of 6 AML pathway response-representative genes (identified by clustering) exhibited similar apparent supra-linear responses. Responses at or below 0.1 ppm benzene were observed for altered expression of AML pathway genes and CYP2E1. Together, these data show that benzene alters disease-relevant pathways and genes in a dose-dependent manner, with effects apparent at doses as low as 100 ppb in air. Studies with extensive exposure assessment of subjects exposed in the low-dose range between 10 ppb and 1 ppm are needed to confirm these findings.	[Thomas, Reuben; Hubbard, Alan E.; McHale, Cliona M.; Zhang, Luoping; Rappaport, Stephen M.; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Superfund Res Program, Berkeley, CA 94704 USA; [Lan, Qing; Rothman, Nathaniel] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD USA; [Guyton, Kathryn Z.; Jinot, Jennifer; Sonawane, Babasaheb R.] US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Washington, DC 20460 USA; [Vermeulen, Roel] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands	University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Environmental Protection Agency; Utrecht University	Thomas, R (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Superfund Res Program, Berkeley, CA 94704 USA.	reuben.thomas@berkeley.edu	Vermeulen, Roel/F-8037-2011	Vermeulen, Roel/0000-0003-4082-8163	National Institutes of Health, National Institute of Environmental Health Sciences [R01ES01896, P42 ES004705]; Environment Protection Agency [EP-11-001398]; NATIONAL CANCER INSTITUTE [ZIACP010121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Environment Protection Agency; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Original data generated through funding from National Institutes of Health grants R01ES01896 and P42 ES004705 from the National Institute of Environmental Health Sciences with additional statistical analyses being funded in part by Environment Protection Agency contract number EP-11-001398. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS LS, 1979, LIFE SCI, V25, P567, DOI 10.1016/0024-3205(79)90550-2; Barjesteh van Waalwijk van Doorn-Khosrovani Sahar, 2003, Hematol J, V4, P31; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolen CR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-258; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen X, 2008, BIOINFORMATICS, V24, P2474, DOI 10.1093/bioinformatics/btn458; Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090; Cleveland W, 1991, PACIFIC GROVE CH LOC, P309; Dai B., 2008, IME4 LINEAR MIXED EF; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gelman A., 2010, ARM DATA ANAL USING; Gill RD, 2001, ANN STAT, V29, P1785; Goeman JJ, 2005, BIOINFORMATICS, V21, P1950, DOI 10.1093/bioinformatics/bti267; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Khalade A, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-31; Kim S, 2006, CARCINOGENESIS, V27, P772, DOI 10.1093/carcin/bgi297; KOOP DR, 1989, TOXICOL APPL PHARM, V98, P278, DOI 10.1016/0041-008X(89)90233-0; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lan Q, 2006, SCIENCE, V312, P998; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; Lorsbach RB, 2001, INT J HEMATOL, V74, P258, DOI 10.1007/BF02982058; Ma S, 2009, BIOINFORMATICS, V25, P882, DOI 10.1093/bioinformatics/btp085; McHale CM, 2012, CARCINOGENESIS, V33, P240, DOI 10.1093/carcin/bgr297; McHale CM, 2011, ENVIRON HEALTH PERSP, V119, P628, DOI 10.1289/ehp.1002546; Metzeler KH, 2012, BLOOD, V120, P2118, DOI 10.1182/blood-2012-02-411827; Mizuki M, 2003, BLOOD, V101, P3164, DOI 10.1182/blood-2002-06-1677; Nedelcheva V, 1999, ARCH TOXICOL, V73, P33, DOI 10.1007/s002040050583; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pollard K.S., 2010, HOPACH HIERARCHICAL; Polley E.C., 2010, SUPERLEARNER SUPER L; Powley MW, 2000, J BIOCHEM MOL TOXIC, V14, P303, DOI 10.1002/1099-0461(2000)14:6<303::AID-JBT2>3.0.CO;2-8; Powley MW, 2002, INHAL TOXICOL, V14, P569, DOI 10.1080/08958370290084502; Qu QS, 2002, AM J IND MED, V42, P275, DOI 10.1002/ajim.10121; Rappaport SM, 2005, CHEM-BIOL INTERACT, V153, P103, DOI 10.1016/j.cbi.2005.03.014; Rappaport SM, 2002, J CHROMATOGR B, V778, P367, DOI 10.1016/S0378-4347(01)00457-1; Rappaport SM, 2009, ENVIRON HEALTH PERSP, V117, P946, DOI 10.1289/ehp.0800510; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; SAMMETT D, 1979, J TOXICOL ENV HEALTH, V5, P785, DOI 10.1080/15287397909529789; Sheets PL, 2004, J BIOCHEM MOL TOXIC, V18, P92, DOI 10.1002/jbt.20010; Silva FPG, 2003, ONCOGENE, V22, P538, DOI 10.1038/sj.onc.1206141; Smith MT, 2011, CHEMICOBIOLOGICAL IN; Steffen B, 2005, CRIT REV ONCOL HEMAT, V56, P195, DOI 10.1016/j.critrevonc.2004.10.012; Steinmaus C, 2008, OCCUP ENVIRON MED, V65, P371, DOI 10.1136/oem.2007.036913; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; SUBRAHMANYAM VV, 1991, FREE RADICAL RES COM, V15, P285, DOI 10.3109/10715769109105224; SUBRAHMANYAM VV, 1990, TOXICOLOGY, V62, P107, DOI 10.1016/0300-483X(90)90035-F; Team RDC, 2004, R LANG ENV STAT COMP; Thomas R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r44; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Vermeulen R, 2004, ANN OCCUP HYG, V48, P105, DOI 10.1093/annhyg/meh005; Vlaanderen J, 2010, ENVIRON HEALTH PERSP, V118, P526, DOI 10.1289/ehp.0901127; Wotton S, 2002, CANCER RES, V62, P7181; Zhang LP, 2010, CHEM-BIOL INTERACT, V184, P86, DOI 10.1016/j.cbi.2009.12.011	63	37	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e91828	10.1371/journal.pone.0091828	http://dx.doi.org/10.1371/journal.pone.0091828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24786086	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600005
J	Cenci, A; D'Avenio, G; Tavoschi, L; Chiappi, M; Becattini, S; Narino, MD; Picconi, O; Bernasconi, D; Fanales-Belasio, E; Vardas, E; Sukati, H; Lo Presti, A; Ciccozzi, M; Monini, P; Ensoli, B; Grigioni, M; Butto, S				Cenci, Alessandra; D'Avenio, Giuseppe; Tavoschi, Lara; Chiappi, Michele; Becattini, Simone; Narino, Maria del Pilar; Picconi, Orietta; Bernasconi, Daniela; Fanales-Belasio, Emanuele; Vardas, Eftyhia; Sukati, Hosea; Lo Presti, Alessandra; Ciccozzi, Massimo; Monini, Paolo; Ensoli, Barbara; Grigioni, Mauro; Butto, Stefano			Molecular Characterization of HIV-1 Subtype C gp-120 Regions Potentially Involved in Virus Adaptive Mechanisms	PLOS ONE			English	Article							N-LINKED GLYCOSYLATION; GP120 ENVELOPE GLYCOPROTEIN; NEUTRALIZING ANTIBODY-RESPONSES; TYPE-1 GP120; VIRAL INFECTIVITY; CORECEPTOR USAGE; CD4 RECEPTOR; V3 REGION; CLADE-C; IDENTIFICATION	The role of variable regions of HIV-1 gp120 in immune escape of HIV has been investigated. However, there is scant information on how conserved gp120 regions contribute to virus escaping. Here we have studied how molecular sequence characteristics of conserved C3, C4 and V3 regions of clade C HIV-1 gp120 that are involved in HIV entry and are target of the immune response, are modulated during the disease course. We found an increase of "shifting" putative N-glycosylation sites (PNGSs) in the alpha 2 helix (in C3) and in C4 and an increase of sites under positive selection pressure in the alpha 2 helix during the chronic stage of disease. These sites are close to CD4 and to co-receptor binding sites. We also found a negative correlation between electric charges of C3 and V4 during the late stage of disease counteracted by a positive correlation of electric charges of alpha 2 helix and V5 during the same stage. These data allow us to hypothesize possible mechanisms of virus escape involving constant and variable regions of gp120. In particular, new mutations, including new PNGSs occurring near the CD4 and CCR5 binding sites could potentially affect receptor binding affinity and shield the virus from the immune response.	[Cenci, Alessandra; Tavoschi, Lara; Chiappi, Michele; Becattini, Simone; Narino, Maria del Pilar; Picconi, Orietta; Bernasconi, Daniela; Fanales-Belasio, Emanuele; Monini, Paolo; Ensoli, Barbara; Butto, Stefano] Natl AIDS Ctr, Ist Super Sanita, Rome, Italy; [D'Avenio, Giuseppe; Grigioni, Mauro] Ist Super Sanita, Dept Technol & Hlth, I-00161 Rome, Italy; [Vardas, Eftyhia] Univ Stellenbosch, Div Med Virol, ZA-7600 Stellenbosch, South Africa; [Sukati, Hosea] Natl Ctr Publ Hlth Lab, Manzini, Eswatini; [Lo Presti, Alessandra; Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; [Vardas, Eftyhia] Lancet Labs, Johannesburg, South Africa; [Ciccozzi, Massimo] Univ Biomed Campus, Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Stellenbosch University; Istituto Superiore di Sanita (ISS)	Butto, S (corresponding author), Natl AIDS Ctr, Ist Super Sanita, Rome, Italy.	stefano.butto@iss.it	Grigioni, Mauro/J-8744-2016; Ensoli, Barbara/J-9169-2016; BELASIO, EMANUELE FANALES/C-7718-2016; D'AVENIO, GIUSEPPE/E-6673-2015; Ciccozzi, Massimo/AAC-3271-2022; Tavoschi, Lara/K-1729-2018; D'Avenio, Giuseppe/AAC-2775-2020; Monini, Paolo/K-1429-2016; CICCOZZI, MASSIMO/C-6484-2016; Buttò, Stefano/J-9324-2018; Lo Presti, Alessandra/K-1451-2016; Picconi, Orietta/L-4613-2016	Grigioni, Mauro/0000-0002-8231-8156; Ensoli, Barbara/0000-0002-0545-8737; BELASIO, EMANUELE FANALES/0000-0003-2369-9996; D'AVENIO, GIUSEPPE/0000-0002-9717-2487; Ciccozzi, Massimo/0000-0003-3866-9239; Tavoschi, Lara/0000-0002-2217-4664; D'Avenio, Giuseppe/0000-0002-9717-2487; Monini, Paolo/0000-0002-4941-6854; CICCOZZI, MASSIMO/0000-0003-3866-9239; Lo Presti, Alessandra/0000-0001-7611-5021; Picconi, Orietta/0000-0003-3626-9952; Chiappi, Michele/0000-0002-1548-2706; Butto, Stefano/0000-0002-3289-2686; Becattini, Simone/0000-0001-5985-0403; Vardas, Eftyhia/0000-0002-7804-878X	Italian National Programme on AIDS Research [3H06]; AIDS Vaccine Integrated Project (AVIP) [LSHP-CT-2004-503487]	Italian National Programme on AIDS Research; AIDS Vaccine Integrated Project (AVIP)	The work was supported by funds from the Italian National Programme on AIDS Research, 2010-2013, 3H06 (to S. B.) and the AIDS Vaccine Integrated Project (AVIP; contract LSHP-CT-2004-503487) (to B. E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasa-Chapman MMI, 2006, J VIROL, V80, P10884, DOI 10.1128/JVI.01030-06; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; [Anonymous], 2006, SWAZ DEM HLTH SURV 2; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Auwerx J, 2008, VIROLOGY, V382, P10, DOI 10.1016/j.virol.2008.09.010; Bernasconi D, 2010, J CLIN VIROL, V48, P180, DOI 10.1016/j.jcv.2010.04.010; Bhatta H, 2009, J MICROBIOL METH, V77, P77, DOI 10.1016/j.mimet.2009.01.011; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Carducci F, 2009, RETROVIROLOGY, V6, P4; Cenci A, 2012, J AIDS CLIN RES, VS8-006; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Coetzer M, 2007, AIDS RES HUM RETROV, V23, P316, DOI 10.1089/aid.2006.0207; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Felsovalyi K, 2006, AIDS RES HUM RETROV, V22, P703, DOI 10.1089/aid.2006.22.703; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gnanakaran S, 2007, J VIROL, V81, P4886, DOI 10.1128/JVI.01954-06; GOUDSMIT J, 1991, FASEB J, V5, P2427, DOI 10.1096/fasebj.5.10.2065891; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang X, 2012, VIROLOGY, V423, P97, DOI 10.1016/j.virol.2011.11.023; JUKES T H, 1969, P21; KORBER BTM, 1994, J VIROL, V68, P6730, DOI 10.1128/JVI.68.10.6730-6744.1994; Kumar R, 2011, VACCINE, V29, P9064, DOI 10.1016/j.vaccine.2011.09.057; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Li HL, 2008, J IMMUNOL, V180, P4011, DOI 10.4049/jimmunol.180.6.4011; Lin NH, 2011, JAIDS-J ACQ IMM DEF, V57, P46, DOI 10.1097/QAI.0b013e318214fe27; Liu Y, 2008, VIROLOGY, V374, P229, DOI 10.1016/j.virol.2008.01.029; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Ogert RA, 2001, J VIROL, V75, P5998, DOI 10.1128/JVI.75.13.5998-6006.2001; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Patel MB, 2008, J VIROL, V82, P903, DOI 10.1128/JVI.01444-07; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Peut V, 2006, CURR HIV RES, V4, P191, DOI 10.2174/157016206776055110; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; Sokal R. R, 1981, BIOMETRY; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Sterjovski J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-89; Suligoi B, 2008, J CLIN VIROL, V41, P288, DOI 10.1016/j.jcv.2007.11.020; Tscherning C, 1998, VIROLOGY, V241, P181, DOI 10.1006/viro.1997.8980; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Yamaguchi-Kabata Y, 2000, J VIROL, V74, P4335, DOI 10.1128/JVI.74.9.4335-4350.2000; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang H, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-67; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	62	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95183	10.1371/journal.pone.0095183	http://dx.doi.org/10.1371/journal.pone.0095183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788065	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917300009
J	Lim, W; Song, G				Lim, Whasun; Song, Gwonhwa			Identification of Novel Regulatory Genes in Development of the Avian Reproductive Tracts	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; BINDING-PROTEIN; GERM-CELLS; TRANSCRIPTIONAL REPRESSOR; RETINOL-BINDING; MESSENGER-RNA; E-CADHERIN; RECEPTOR; MICRORNA; ESTROGEN	The chicken reproductive system is unique in maintaining its functions including production of eggs or sperm, fertilization of the egg by sperm maintained in sperm nests, production of hormones regulating its growth, development and function, and reproduction. Development of the reproductive organs is a highly regulated process that results in differentiation and proliferation of germ cells in response to predominant regulatory factors such as hormones and transcription factors. However, only a few genes are known to determine morphogenesis of the chicken reproductive tract and their mechanisms are unknown. Therefore, in the present study, we investigated the expression patterns of four genes including SNCA, TOM1L1, TTR and ZEB1 in the gonads at embryonic days 14 and 18, and in immature (12-week-old) and mature (50-week-old) chickens, as well as the reproductive tract including ovary, oviduct and testes of the respective sexes by qRT-PCR, in situ hybridization and immunofluorescence analyses. The expression of SNCA, TOM1L1 and ZEB1 genes was higher in immature and mature female reproductive tracts than expression of TTR. In addition, different temporal and spatial patterns of expression of the four genes were observed during maturation of testis in chickens. Specifically, SNCA, TOM1L1 and TTR were highly expressed in testes of 12-week-old chickens. Moreover, several chicken specific microRNAs (miRs) were demonstrated to affect expression of target gene mRNAs by directly binding to the 3'-UTR of their target genes through actions at the post-transcriptional level as follows: miR-153 and miR-1643 for SNCA; miR-1680* for TTR; and miR-200b and miR-1786 for ZEB1. These results suggest that four-selected genes play an important role in development of the male and female reproductive tract in chickens and expression of most candidate genes is regulated at the post-transcriptional level through specific microRNAs.	[Lim, Whasun; Song, Gwonhwa] Korea Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea	Korea University	Song, G (corresponding author), Korea Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea.	ghsong@korea.ac.kr	Lim, Whasun/AAP-3156-2020; gwonhwa, song/H-3208-2015; Song, Gwonhwa/H-3647-2015	Lim, Whasun/0000-0002-1328-0465; 	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2013R1A1A2A10005948]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008142]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This research was funded by Basic Science Research Program (2013R1A1A2A10005948) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology, and also by a grant from the Next-Generation BioGreen 21 Program (No. PJ008142), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anose BM, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/903918; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BLANER WS, 1987, BIOL REPROD, V36, P130, DOI 10.1095/biolreprod36.1.130; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; CALLEBAU.M, 1967, J EMBRYOL EXP MORPH, V18, P299; CARLON N, 1985, ARCH ANAT MICROSC MO, V74, P52; Chamberlain EM, 1999, MOL CELL BIOL, V19, P3600; Chue J, 2011, FEBS J, V278, P1027, DOI 10.1111/j.1742-4658.2011.08032.x; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Diaz FJ, 2011, MOL REPROD DEV, V78, P212, DOI 10.1002/mrd.21288; DUAN W, 1991, EUR J BIOCHEM, V200, P679, DOI 10.1111/j.1432-1033.1991.tb16232.x; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Elmarghani A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/416298; FERGUSON RN, 1975, BIOCHEMISTRY-US, V14, P282, DOI 10.1021/bi00673a014; Franco M, 2006, MOL CELL BIOL, V26, P1932, DOI 10.1128/MCB.26.5.1932-1947.2006; FUJIMOTO T, 1976, ANAT REC, V185, P139, DOI 10.1002/ar.1091850203; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gonzalez-Moran MG, 2008, DOMEST ANIM ENDOCRIN, V35, P371, DOI 10.1016/j.domaniend.2008.08.001; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Ha Y, 2008, INT J DEV BIOL, V52, P1135, DOI 10.1387/ijdb.072441yh; Hartman VN, 2001, NEUROREPORT, V12, P943, DOI 10.1097/00001756-200104170-00016; Huang P, 2010, ACTA BIOCH BIOPH SIN, V42, P522, DOI 10.1093/abbs/gmq061; HUGHES GC, 1963, J EMBRYOL EXP MORPH, V11, P513; Jeong W, 2012, PLOS ONE, V7; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; Lee JS, 2012, PLOS ONE, V7; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li WJ, 2005, J BIOL CHEM, V280, P6036, DOI 10.1074/jbc.M406546200; Lim W, 2012, PLOS ONE, V7; LIM W, 2011, REPROD BIOL ENDOCRIN, V9; Lim W, 2012, BIOCHEM BIOPH RES CO, V422, P494, DOI 10.1016/j.bbrc.2012.05.026; Lim W, 2012, GEN COMP ENDOCR, V175, P65, DOI 10.1016/j.ygcen.2011.09.019; Lim W, 2011, BIOL REPROD, V85, P1260, DOI 10.1095/biolreprod.111.093526; Liu NS, 2009, EMBO J, V28, P3485, DOI 10.1038/emboj.2009.282; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livera G, 2002, REPRODUCTION, V124, P173, DOI 10.1530/rep.0.1240173; Masliah E, 1996, AM J PATHOL, V148, P201; Ocon-Grove OM, 2012, REPRODUCTION, V143, P825, DOI 10.1530/REP-11-0271; PALMITER RD, 1971, J CELL BIOL, V50, P598, DOI 10.1083/jcb.50.3.598; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Schutz G, 1978, Cold Spring Harb Symp Quant Biol, V42 Pt 2, P617; Sekido R, 1996, GENE, V173, P227, DOI 10.1016/0378-1119(96)00185-0; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Tiunova AA, 2000, MECH DEVELOP, V99, P195, DOI 10.1016/S0925-4773(00)00484-6; Torley KJ, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-2; Tripurani SK, 2010, ANIM REPROD SCI, V120, P16, DOI 10.1016/j.anireprosci.2010.03.001; UKESHIMA A, 1991, ANAT REC, V230, P378, DOI 10.1002/ar.1092300311; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; VIEIRA AV, 1995, J BIOL CHEM, V270, P2952, DOI 10.1074/jbc.270.7.2952; Whittow GC, 2000, STURKIES AVIAN PHYSL, Vxiii; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	56	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96175	10.1371/journal.pone.0096175	http://dx.doi.org/10.1371/journal.pone.0096175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763497	Green Submitted, Green Published, gold			2022-12-25	WOS:000335505000069
J	Akirav, EM; Henegariu, O; Preston-Hurlburt, P; Schmidt, AM; Clynes, R; Herold, KC				Akirav, Eitan M.; Henegariu, Octavian; Preston-Hurlburt, Paula; Schmidt, Ann Marie; Clynes, Raphael; Herold, Kevan C.			The Receptor for Advanced Glycation End Products ( RAGE) Affects T Cell Differentiation in OVA Induced Asthma	PLOS ONE			English	Article							ACTIVATION; BLOCKADE; HMGB1	The receptor for glycation end products (RAGE) has been previously implicated in shaping the adaptive immune response. RAGE is expressed in T cells after activation and constitutively in T cells from patients with diabetes. The effects of RAGE on adaptive immune responses are not clear: Previous reports show that RAGE blockade affects Th1 responses. To clarify the role of RAGE in adaptive immune responses and the mechanisms of its effects, we examined whether RAGE plays a role in T cell activation in a Th2 response involving ovalbumin (OVA)-induced asthma in mice. WT and RAGE deficient wild-type and OT-II mice, expressing a T cell receptor specific for OVA, were immunized intranasally with OVA. Lung cellular infiltration and T cell responses were analyzed by immunostaining, FACS, and multiplex bead analyses for cytokines. RAGE deficient mice showed reduced cellular infiltration in the bronchial alveolar lavage fluid and impaired T cell activation in the mediastinal lymph nodes when compared with WT mice. In addition, RAGE deficiency resulted in reduced OT-II T cell infiltration of the lung and impaired IFNc and IL-5 production when compared with WT mice and reduced infiltration when transferred into WT hosts. When cultured under conditions favoring the differentiation of T cells subsets, RAGE deficient T cells showed reduced production of IFNc but increased production of IL-17. Our data show a stimulatory role for RAGE in T activation in OVA-induced asthma. This role is largely mediated by the effects of RAGE on T cell proliferation and differentiation. These findings suggest that RAGE may play a regulatory role in T cell responses following immune activation.	[Akirav, Eitan M.] Winthrop Univ Hosp, Res Inst, New York, NY USA; [Akirav, Eitan M.] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA; [Henegariu, Octavian; Preston-Hurlburt, Paula; Herold, Kevan C.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Schmidt, Ann Marie] NYU, Sch Med, Dept Med, New York, NY USA; [Clynes, Raphael] Columbia Univ, Dept Med, New York, NY USA; [Herold, Kevan C.] Yale Univ, Sch Med, New Haven, CT USA	Winthrop University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yale University; New York University; Columbia University; Yale University	Herold, KC (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	Kevan.herold@yale.edu			JDRF [2004-808]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541] Funding Source: NIH RePORTER	JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was support by JDRF grant 2004-808. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034698; Chen YL, 2008, J IMMUNOL, V181, P4272, DOI 10.4049/jimmunol.181.6.4272; Chen YL, 2004, J IMMUNOL, V173, P1399, DOI 10.4049/jimmunol.173.2.1399; Constant SL, 2002, J CLIN INVEST, V110, P1441, DOI 10.1172/JCI200216109; Huang WC, 2012, INFLAMMATION, V35, P350, DOI 10.1007/s10753-011-9325-5; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Miniati M, RESP RES, V12, P37; Moser B, 2007, J IMMUNOL, V179, P8051, DOI 10.4049/jimmunol.179.12.8051; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Watanabe T, RESP MED, V105, P519; Wu XJ, 2013, MOL CELL BIOCHEM, V380, P249, DOI 10.1007/s11010-013-1680-0; Xu D, 2013, ACS CHEM BIOL; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831	15	26	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95678	10.1371/journal.pone.0095678	http://dx.doi.org/10.1371/journal.pone.0095678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759895	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200076
J	Laido, G; Marone, D; Russo, MA; Colecchia, SA; Mastrangelo, AM; De Vita, P; Papa, R				Laido, Giovanni; Marone, Daniela; Russo, Maria A.; Colecchia, Salvatore A.; Mastrangelo, Anna M.; De Vita, Pasquale; Papa, Roberto			Linkage Disequilibrium and Genome-Wide Association Mapping in Tetraploid Wheat (Triticum turgidum L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GRAIN PROTEIN-CONTENT; BREAD WHEAT; POPULATION-STRUCTURE; GENETIC DIVERSITY; RESISTANCE; GERMPLASM; REGIONS; DOMESTICATION; SELECTION	Association mapping is a powerful tool for the identification of quantitative trait loci through the exploitation of the differential decay of linkage disequilibrium (LD) between marker loci and genes of interest in natural and domesticated populations. Using a sample of 230 tetraploid wheat lines (Triticum turgidum ssp), which included naked and hulled accessions, we analysed the pattern of LD considering 26 simple sequence repeats and 970 mostly mapped diversity array technology loci. In addition, to validate the potential for association mapping in durum wheat, we evaluated the same genotypes for plant height, heading date, protein content, and thousand-kernel weight. Molecular and phenotypic data were used to: (i) investigate the genetic and phenotypic diversity; (ii) study the dynamics of LD across the durum wheat genome, by investigating the patterns of LD decay; and (iii) test the potential of our panel to identify marker-trait associations through the analysis of four quantitative traits of major agronomic importance. Moreover, we compared and validated the association mapping results with outlier detection analysis based on population divergence. Overall, in tetraploid wheat, the pattern of LD is extremely population dependent and is related to the domestication and breeding history of durum wheat. Comparing our data with several other studies in wheat, we confirm the position of many major genes and quantitative trait loci for the traits considered. Finally, the analysis of the selection signature represents a very useful complement to validate marker-trait associations.	[Laido, Giovanni; Marone, Daniela; Russo, Maria A.; Colecchia, Salvatore A.; Mastrangelo, Anna M.; De Vita, Pasquale; Papa, Roberto] Consiglio Ric & Sperimentaz Agr, Cereal Res Ctr, Foggia, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Papa, R (corresponding author), Consiglio Ric & Sperimentaz Agr, Cereal Res Ctr, Foggia, Italy.	roberto.papa@entecra.it	Colecchia, Salvatore Antonio/AAG-4730-2021; papa, roberto/F-9510-2014	Mastrangelo, Anna Maria/0000-0002-3618-0301; papa, roberto/0000-0001-9598-3131; Marone, Daniela/0000-0002-2365-6091; Colecchia, Salvatore Antonio/0000-0002-0790-442X; De Vita, Pasquale/0000-0002-9573-0510	research project Mappa 5A, Esplora, Biomassval from the Ministry of Agricultural, Food and Forestry Policies (Italy)	research project Mappa 5A, Esplora, Biomassval from the Ministry of Agricultural, Food and Forestry Policies (Italy)	This work has been funded by the research project Mappa 5A, Esplora, Biomassval from the Ministry of Agricultural, Food and Forestry Policies (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baga M, 2009, J EXP BOT, V60, P3575, DOI 10.1093/jxb/erp199; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanco A, 2006, THEOR APPL GENET, V112, P1195, DOI 10.1007/s00122-006-0221-6; Blanco A, 2012, MOL BREEDING, V30, P79, DOI 10.1007/s11032-011-9600-z; Borner A, 2002, THEOR APPL GENET, V105, P921, DOI 10.1007/s00122-002-0994-1; Breseghello F, 2006, CROP SCI, V46, P1323, DOI 10.2135/cropsci2005.09-0305; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fu YB, 2006, THEOR APPL GENET, V112, P1239, DOI 10.1007/s00122-006-0225-2; Fu YB, 2005, THEOR APPL GENET, V110, P1505, DOI 10.1007/s00122-005-1988-6; Gervais L, 2003, THEOR APPL GENET, V106, P961, DOI 10.1007/S00122-002-1160-5; Golovnina KA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-168; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Gupta PK, 2010, MOL BREEDING, V26, P145, DOI 10.1007/s11032-009-9359-7; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Hanocq E, 2004, THEOR APPL GENET, V110, P106, DOI 10.1007/s00122-004-1799-1; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Kohn MH, 2003, GENETICS, V164, P1055; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Laido G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067280; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Le Gouis J, 2012, THEOR APPL GENET, V124, P597, DOI 10.1007/s00122-011-1732-3; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Marone D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-562; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; Marone D, 2009, MOL BREEDING, V24, P25, DOI 10.1007/s11032-009-9268-9; Morrell PL, 2005, P NATL ACAD SCI USA, V102, P2442, DOI 10.1073/pnas.0409804102; Navabi A, 2005, GENOME, V48, P97, DOI [10.1139/g04-100, 10.1139/G04-100]; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Olmos S, 2003, THEOR APPL GENET, V107, P1243, DOI 10.1007/s00122-003-1377-y; Panio G, 2013, ANN APPL BIOL, V162, P258, DOI 10.1111/aab.12018; Papa R, 2007, ANN BOT-LONDON, V100, P1039, DOI 10.1093/aob/mcm151; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Rafalski JA, 2002, PLANT SCI, V162, P329, DOI 10.1016/S0168-9452(01)00587-8; Reif JC, 2011, THEOR APPL GENET, V123, P283, DOI 10.1007/s00122-011-1583-y; Reif JC, 2011, THEOR APPL GENET, V122, P961, DOI 10.1007/s00122-010-1502-7; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Schwarzenbacher H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-48; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Sun XC, 2010, THEOR APPL GENET, V120, P1041, DOI 10.1007/s00122-009-1232-x; Todorovska E, 2009, BIOTECHNOL BIOTEC EQ, V23, P1417, DOI 10.2478/V10133-009-0006-6; Toth B, 2003, THEOR APPL GENET, V107, P509, DOI 10.1007/s00122-003-1275-3; Tsilo TJ, 2010, THEOR APPL GENET, V121, P717, DOI 10.1007/s00122-010-1343-4; Uauy C, 2006, J EXP BOT, V57, P2785, DOI 10.1093/jxb/erl047; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; Weir B. S., 1996, GENETIC DATA ANAL; Yu H, 2012, J GENOM, V1, P78; Yu JM, 2009, PLANT GENOME-US, V2, P63, DOI 10.3835/plantgenome2008.09.0009; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang JA, 2011, PLANTA, V234, P891, DOI 10.1007/s00425-011-1434-8; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	73	50	50	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95211	10.1371/journal.pone.0095211	http://dx.doi.org/10.1371/journal.pone.0095211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759998	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200040
J	Wang, X; Hu, JF; Tan, YH; Cui, JW; Wang, GJ; Mrsny, RJ; Li, W				Wang, Xu; Hu, Ji-Fan; Tan, Yehui; Cui, Jiuwei; Wang, Guanjun; Mrsny, Randall J.; Li, Wei			Cancer Stem Cell Marker Musashi-1 rs2522137 Genotype Is Associated with an Increased Risk of Lung Cancer	PLOS ONE			English	Article							RNA-BINDING PROTEIN; HEMATOPOIETIC STEM; INDIVIDUAL RISK; BREAST-CANCER; EP-CAM; EXPRESSION; EPCAM; IDENTIFICATION; MODEL; COLON	Gene single nucleotide polymorphisms (SNPs) have been extensively studied in association with development and prognosis of various malignancies. However, the potential role of genetic polymorphisms of cancer stem cell (CSC) marker genes with respect to cancer risk has not been examined. We conducted a case-control study involving a total of 1000 subjects (500 lung cancer patients and 500 age-matched cancer-free controls) from northeastern China. Lung cancer risk was analyzed in a logistic regression model in association with genotypes of four lung CSC marker genes (CD133, ALDH1, Musashi-1, and EpCAM). Using univariate analysis, the Musashi-1 rs2522137 GG genotype was found to be associated with a higher incidence of lung cancer compared with the TT genotype. No significant associations were observed for gene variants of CD133, ALDH1, or EpCAM. In multivariate analysis, Musashi-1 rs2522137 was still significantly associated with lung cancer when environmental and lifestyle factors were incorporated in the model, including lower BMI; family history of cancer; prior diagnosis of chronic obstructive pulmonary disease, pneumonia, or pulmonary tuberculosis; occupational exposure to pesticide; occupational exposure to gasoline or diesel fuel; heavier smoking; and exposure to heavy cooking emissions. The value of the area under the receiver-operating characteristic (ROC) curve (AUC) was 0.7686. To our knowledge, this is the first report to show an association between a Musashi-1 genotype and lung cancer risk. Further, the prediction model in this study may be useful in determining individuals with high risk of lung cancer.	[Wang, Xu; Hu, Ji-Fan; Tan, Yehui; Cui, Jiuwei; Wang, Guanjun; Li, Wei] Jilin Univ, Affiliated Hosp 1, Canc & Stem Cell Ctr, Changchun, Jilin, Peoples R China; [Wang, Xu; Hu, Ji-Fan] Stanford Univ, VA Palo Alto Hlth Care Syst, Sch Med, Palo Alto, CA 94304 USA; [Mrsny, Randall J.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	Jilin University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Bath	Hu, JF (corresponding author), Jilin Univ, Affiliated Hosp 1, Canc & Stem Cell Ctr, Changchun, Jilin, Peoples R China.	Jifan@stanford.edu; jdyylw@163.com	Hu, Jifan/Q-3003-2019		National Natural Science Foundation of China [81071920, 81372835, 81272294]; Jilin Provincial Science and Technology Department [201201023]; Key Clinical Project of the Ministry of Health of the People's Republic of China [2001133]; National Institutes of Health [1R43CA103553-01]; California Institute of Regenerative Medicine (CIRM) [RT2-01942]; Jilin International Collaboration Grant [20120720]; Key Project of Chinese Ministry of Education [311015]; NATIONAL CANCER INSTITUTE [R43CA103553] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Provincial Science and Technology Department; Key Clinical Project of the Ministry of Health of the People's Republic of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Jilin International Collaboration Grant; Key Project of Chinese Ministry of Education(Ministry of Education, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China grants (81071920, 81372835), Jilin Provincial Science and Technology Department Grant (201201023), the Key Clinical Project of the Ministry of Health of the People's Republic of China Grant (2001133), National Institutes of Health grant (1R43CA103553-01), California Institute of Regenerative Medicine (CIRM) grant (RT2-01942), Jilin International Collaboration Grant (20120720), the National Natural Science Foundation of China grant (81272294), and the grant of Key Project of Chinese Ministry of Education 311015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amos W, 2011, P ROY SOC B-BIOL SCI, V278, P1183, DOI 10.1098/rspb.2010.1920; Barr MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054193; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Clarke MF, 2005, CANCER CHEMOTH PHARM, V56, pS64, DOI 10.1007/s00280-005-0097-1; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Fan LF, 2010, INT J COLORECTAL DIS, V25, P17, DOI 10.1007/s00384-009-0791-2; Gerger A, 2011, CLIN CANCER RES, V17, P6934, DOI 10.1158/1078-0432.CCR-11-1180; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kanemura Y, 2001, DIFFERENTIATION, V68, P141, DOI 10.1046/j.1432-0436.2001.680208.x; Kemper K, 2010, ONCOTARGET, V1, P387, DOI 10.18632/oncotarget.173; Keysar SB, 2010, MOL CANCER THER, V9, P2450, DOI 10.1158/1535-7163.MCT-10-0530; Kim Y, 2009, ANTICANCER RES, V29, P1817; Kimura M, 2011, CANCER SCI, V102, P983, DOI 10.1111/j.1349-7006.2011.01891.x; Koren A, 2013, CELL ONCOL, V36, P265, DOI 10.1007/s13402-013-0141-9; Leng SG, 2012, CANCER RES, V72, P707, DOI 10.1158/0008-5472.CAN-11-3194; Liang D, 2012, MED ONCOL, V29, P633, DOI 10.1007/s12032-011-9933-9; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Marhaba R, 2008, CURR MOL MED, V8, P784, DOI 10.2174/156652408786733667; Meng XX, 2012, LUNG CANCER, V77, P24, DOI 10.1016/j.lungcan.2012.02.015; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Moreira AL, 2010, MODERN PATHOL, V23, P889, DOI 10.1038/modpathol.2010.68; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Nishimura S, 2003, DIGEST DIS SCI, V48, P1523, DOI 10.1023/A:1024763723240; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Raji OY, 2010, CANCER PREV RES, V3, P664, DOI 10.1158/1940-6207.CAPR-09-0141; Ratajczak MZ, 2005, FOLIA HISTOCHEM CYTO, V43, P175; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sales KM, 2007, STEM CELL REV, V3, P249, DOI 10.1007/s12015-007-9002-0; Serrano D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-96; Shien K, 2012, LUNG CANCER, V77, P162, DOI 10.1016/j.lungcan.2012.02.006; Shu HJ, 2002, BIOCHEM BIOPH RES CO, V293, P150, DOI 10.1016/S0006-291X(02)00175-4; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Soltanian S, 2011, TUMOR BIOL, V32, P425, DOI 10.1007/s13277-011-0155-8; Soltysova A, 2005, NEOPLASMA, V52, P435; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Vo DT, 2012, MOL CANCER RES, V10, P143, DOI 10.1158/1541-7786.MCR-11-0208; Vo DT, 2011, RNA BIOL, V8, P817, DOI 10.4161/rna.8.5.16041; Wang T, 2011, BRIT J CANCER, V105, P658, DOI 10.1038/bjc.2011.287; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Young RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016476; Young RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005302; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	54	4	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95915	10.1371/journal.pone.0095915	http://dx.doi.org/10.1371/journal.pone.0095915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787949	gold, Green Published, Green Submitted			2022-12-25	WOS:000336655700046
J	Feigelson, HS; Zeng, C; Pawloski, PA; Onitilo, AA; Richards, CS; Johnson, MA; Kauffman, TL; Webster, J; Nyirenda, C; Alexander, GL; Hwang, C; Cross, D; McCarty, CA; Davis, RL; Schwarzkopf, D; Williams, AE; Honda, S; Daida, Y; Kushi, LH; Delate, T; Goddard, KAB				Feigelson, Heather Spencer; Zeng, Chan; Pawloski, Pamala A.; Onitilo, Adedayo A.; Richards, C. Sue; Johnson, Monique A.; Kauffman, Tia L.; Webster, Jennifer; Nyirenda, Carsie; Alexander, Gwen L.; Hwang, Clara; Cross, Deanna; McCarty, Catherine A.; Davis, Robert L.; Schwarzkopf, Denise; Williams, Andrew E.; Honda, Stacey; Daida, Yihe; Kushi, Lawrence H.; Delate, Thomas; Goddard, Katrina A. B.		CERGEN Study Team	Does KRAS Testing in Metastatic Colorectal Cancer Impact Overall Survival? A Comparative Effectiveness Study in a Population-Based Sample	PLOS ONE			English	Article							MUTATIONS; CETUXIMAB; NONINFERIORITY; CHEMOTHERAPY; ONCOLOGY; THERAPY; BENEFIT; TRIALS	Purpose: Epidermal growth factor receptor (EGFR) inhibitors are approved for treating metastatic colorectal cancer (CRC); KRAS mutation testing is recommended prior to treatment. We conducted a non-inferiority analysis to examine whether KRAS testing has impacted survival in CRC patients. Patients and Methods: We included 1186 metastatic CRC cases from seven health plans. A cutpoint of July, 2008, was used to define two KRAS testing time period groups: "pre-testing'' (n = 760 cases) and "post-testing'' (n = 426 cases). Overall survival (OS) was estimated, and the difference in median OS between the groups was calculated. The lower bound of the one-sided 95% confidence interval (CI) for the difference in survival was used to test the null hypothesis of post-testing inferiority. Multivariable Cox regression models were constructed to adjust for covariates. Results: The median unadjusted OS was 15.4 months (95% CI: 14.0-17.5) and 12.8 months (95% CI: 10.0-15.2) in the pre- and post-testing groups, respectively. The OS difference was -2.6 months with one-sided 95% lower confidence bound of -5.13 months, which was less than the non-inferiority margin (-5.0 months, unadjusted p = 0.06), leading to a failure to reject inferiority of OS in the post-testing period. In contrast, in the adjusted analysis, OS non-inferiority was identified in the post-testing period (p = 0.001). Sensitivity analyses using cutpoints before and after July, 2008, also met the criteria for non-inferiority. Conclusion: Implementation of KRAS testing did not influence CRC OS. Our data support the use of KRAS testing to guide administration of EGFR inhibitors for treatment of metastatic CRC without diminished OS.	[Feigelson, Heather Spencer; Zeng, Chan; Nyirenda, Carsie] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80231 USA; [Pawloski, Pamala A.] HealthPartners Inst Educ & Res, Bloomington, MN USA; [Onitilo, Adedayo A.] Marshfield Clin Weston Ctr, Dept Hematol Oncol, Weston, WI USA; [Onitilo, Adedayo A.; Cross, Deanna] Marshfield Clin Res Fdn, Weston, WI USA; [Onitilo, Adedayo A.] Univ Queensland, Sch Populat Hlth, Clin Epidemiol Unit, Brisbane, Qld, Australia; [Richards, C. Sue; Johnson, Monique A.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Kauffman, Tia L.; Webster, Jennifer; Schwarzkopf, Denise; Goddard, Katrina A. B.] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA; [Alexander, Gwen L.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Hwang, Clara] Henry Ford Hlth Syst, Div Hematol Oncol, Dept Internal Med, Detroit, MI USA; [McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN USA; [Davis, Robert L.] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN USA; [Williams, Andrew E.; Honda, Stacey; Daida, Yihe] Kaiser Permanente Hawaii, Ctr Hlth Res, Honolulu, HI USA; [Kushi, Lawrence H.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Delate, Thomas] Kaiser Permanente Colorado, Dept Pharm, Denver, CO USA	Kaiser Permanente; HealthPartners Institute for Education & Research; University of Queensland; Oregon Health & Science University; Kaiser Permanente; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of Tennessee System; University of Tennessee Health Science Center; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente	Feigelson, HS (corresponding author), Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80231 USA.	heather.s.feigelson@kp.org	Hwang, Clara/AAF-5302-2022; Hwang, Clara/AFJ-8520-2022	Hwang, Clara/0000-0002-0998-323X; Hwang, Clara/0000-0002-0998-323X; Kushi, Lawrence/0000-0001-9136-1175; McCarty, Catherine/0000-0003-1089-0142	National Cancer Institute [5UC2CA148471, U24 CA171524, U19 CA079689]; NATIONAL CANCER INSTITUTE [U19CA079689, U24CA171524, UC2CA148471, RC2CA148471] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG007243] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by resources developed through a grant from the National Cancer Institute (5UC2CA148471) and was conducted at multiple sites of the HMO Cancer Research Network (CRN). The CRN is supported through grants from the National Cancer Institute (U24 CA171524 and U19 CA079689). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; American Cancer Society, 2012, CANC FACTS FIG 2010; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Dahabreh IJ, 2011, ANN INTERN MED, V154, P37, DOI 10.7326/0003-4819-154-1-201101040-00006; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Feigelson Heather Spencer, 2012, BMC Res Notes, V5, P196, DOI 10.1186/1756-0500-5-196; Hornbrook MC, 2005, J NATL CANC I MONOGR, V35, P12, DOI DOI 10.1093/JNCIMONOGRAPHS/LGI033; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lin JS, 2011, AM J CANCER RES, V1, P650; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Tanaka S, 2012, CLIN CANCER RES, V18, P1837, DOI 10.1158/1078-0432.CCR-11-1653; Tunes da Silva G, 2009, BIOL BLOOD MARROW S, V15, P120, DOI 10.1016/j.bbmt.2008.10.004; U.S. Food and Drug Administration, 2010, CET ERB PAN VECT; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; WAGNER EH, 2005, J NATL CANC I MONOGR, V35, P3, DOI DOI 10.1093/JNCIMONOGRAPHS/LGI032; Webster J, 2013, CANCER EPIDEM BIOMAR, V22, P91, DOI 10.1158/1055-9965.EPI-12-0545; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97	21	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94977	10.1371/journal.pone.0094977	http://dx.doi.org/10.1371/journal.pone.0094977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788807	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600022
J	Samb-Ba, B; Mazenot, C; Gassama-Sow, A; Dubourg, G; Richet, H; Hugon, P; Lagier, JC; Raoult, D; Fenollar, F				Samb-Ba, Bissoume; Mazenot, Catherine; Gassama-Sow, Amy; Dubourg, Gregory; Richet, Herve; Hugon, Perrine; Lagier, Jean-Christophe; Raoult, Didier; Fenollar, Florence			MALDI-TOF Identification of the Human Gut Microbiome in People with and without Diarrhea in Senegal	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; FINISHED GENOME SEQUENCE; DESORPTION IONIZATION-TIME; RESISTANT STAPHYLOCOCCUS-AUREUS; ASSISTED-LASER-DESORPTION/IONIZATION; MASSILIENSE SP-NOV; TIMONENSIS SP-NOV; CLINICAL MICROBIOLOGY; ROUTINE IDENTIFICATION; BACTERIA	Background: In Africa, there are several problems with the specific identification of bacteria. Recently, MALDI-TOF mass spectrometry has become a powerful tool for the routine microbial identification in many clinical laboratories. Methodology/Principal Findings: This study was conducted using feces from 347 individuals (162 with diarrhea and 185 without diarrhea) sampled in health centers in Dakar, Senegal. Feces were transported from Dakar to Marseille, France, where they were cultured using different culture conditions. The isolated colonies were identified using MALDI-TOF. If a colony was unidentified, 16S rRNA sequencing was performed. Overall, 2,753 isolates were tested, allowing for the identification of 189 bacteria from 5 phyla, including 2 previously unknown species, 11 species not previously reported in the human gut, 10 species not previously reported in humans, and 3 fungi. 2,718 bacterial isolates (98.8%) out of 2,750 yielded an accurate identification using mass spectrometry, as did the 3 Candida albicans isolates. Thirty-two bacterial isolates not identified by MALDI-TOF (1.2%) were identified by sequencing, allowing for the identification of 2 new species. The number of bacterial species per fecal sample was significantly higher among patients without diarrhea (8.6 +/- 3) than in those with diarrhea (7.3 +/- 3.4; P = 0.0003). A modification of the gut microbiota was observed between the two groups. In individuals with diarrhea, major commensal bacterial species such as E. coli were significantly decreased (85% versus 64%), as were several Enterococcus spp. (E. faecium and E. casseliflavus) and anaerobes, such as Bacteroides spp. (B. uniformis and B. vulgatus) and Clostridium spp. (C. bifermentans, C. orbiscindens, C. perfringens, and C. symbosium). Conversely, several Bacillus spp. (B. licheniformis, B. mojavensis, and B. pumilus) were significantly more frequent among patients with diarrhea. Conclusions/Significance: MALDI-TOF is a potentially powerful tool for routine bacterial identification in Africa, allowing for a quick identification of bacterial species.	[Samb-Ba, Bissoume; Mazenot, Catherine; Dubourg, Gregory; Richet, Herve; Hugon, Perrine; Lagier, Jean-Christophe; Raoult, Didier; Fenollar, Florence] Aix Marseille Univ, INSERM 1095, Unite Rech Malad Infect & Trop Emergentes, CNRS 7278,IRD 198,UM63, Marseille, France; [Samb-Ba, Bissoume; Gassama-Sow, Amy] Inst Pasteur, Unite Bacteriol Expt, Dakar, Senegal	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Fenollar, F (corresponding author), Aix Marseille Univ, INSERM 1095, Unite Rech Malad Infect & Trop Emergentes, CNRS 7278,IRD 198,UM63, Marseille, France.	florence.fenollar@univ-amu.fr	Lagier, Jean-Christophe/AAY-3837-2021; RAOULT, Didier/A-8434-2008; Dubourg, Grégory/D-4270-2017	Lagier, Jean-Christophe/0000-0003-0771-8245; RAOULT, Didier/0000-0002-0633-5974; 	Institut Hospitalo-Universitaire Mediterranee-Infection	Institut Hospitalo-Universitaire Mediterranee-Infection	This work was supported by the Institut Hospitalo-Universitaire Mediterranee-Infection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT MJ, 1978, J MED MICROBIOL, V11, P137, DOI 10.1099/00222615-11-2-137; Balamurugan R, 2008, J PEDIATR GASTR NUTR, V46, P514, DOI 10.1097/MPG.0b013e31815ce599; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Camara JE, 2007, ANAL BIOANAL CHEM, V389, P1633, DOI 10.1007/s00216-007-1558-7; Chan JFW, 2012, J CLIN MICROBIOL, V50, P2525, DOI 10.1128/JCM.00212-12; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Drancourt M, 2004, J CLIN MICROBIOL, V42, P2197, DOI 10.1128/JCM.42.5.2197-2202.2004; Dridi B, 2012, APMIS, V120, P85, DOI 10.1111/j.1600-0463.2011.02833.x; Du ZM, 2002, ANAL CHEM, V74, P5487, DOI 10.1021/ac020109k; Dubourg G, 2013, EUR J CLIN MICROBIOL, V32, P637, DOI 10.1007/s10096-012-1787-3; Edwards-Jones V, 2000, J MED MICROBIOL, V49, P295, DOI 10.1099/0022-1317-49-3-295; Fernandez-Olmos A, 2012, J CLIN MICROBIOL, V50, P1096, DOI 10.1128/JCM.05730-11; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gouriet F, 2012, EUR J CLIN MICROBIOL, V31, P2469, DOI 10.1007/s10096-012-1599-5; Hartemink R, 1997, J MICROBIOL METH, V29, P77, DOI 10.1016/S0167-7012(97)00025-0; Hrabak J, 2011, J CLIN MICROBIOL, V49, P3222, DOI 10.1128/JCM.00984-11; Jackson KA, 2005, J MICROBIOL METH, V62, P273, DOI 10.1016/j.mimet.2005.04.015; Kempf M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031676; Kokcha S, 2012, STAND GENOMIC SCI, V7, P233, DOI 10.4056/sigs.3256677; Kokcha S, 2012, STAND GENOMIC SCI, V6, P346, DOI 10.4056/sigs.2776064; La Scola B, 2011, ANAEROBE, V17, P106, DOI 10.1016/j.anaerobe.2011.05.010; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lagier JC, 2012, STAND GENOMIC SCI, V7, P258, DOI 10.4056/sigs.3316719; Lagier JC, 2012, STAND GENOMIC SCI, V7, P200, DOI 10.4056/sigs.3086474; Lagier JC, 2012, STAND GENOMIC SCI, V6, P315, DOI [10.4056/sigs.2685917, 10.4056/sigs.2685971]; Lagier JC, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00136; Lagier JC, 2012, STAND GENOMIC SCI, V6, P116, DOI 10.4056/sigs.2415480; Lee S, 2011, APPL ENVIRON MICROB, V77, P7433, DOI 10.1128/AEM.05490-11; Lo CI, 2013, STAND GENOMIC SCI, V9, P14, DOI 10.4056/sigs.4097825; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Majcherczyk PA, 2006, FEMS MICROBIOL LETT, V255, P233, DOI 10.1111/j.1574-6968.2005.00060.x; Mishra AK, 2012, STAND GENOMIC SCI, V7, P70, DOI [10.4056/sigs.2956294, 10.4056/sigs.3056450]; Mishra AK, 2012, STAND GENOMIC SCI, V7, P320, DOI 10.4056/sigs.3076460; Mishra AK, 2012, STAND GENOMIC SCI, V6, P386, DOI 10.4056/sigs.2766062; Patel R, 2013, CLIN INFECT DIS, V57, P564, DOI 10.1093/cid/cit247; Pfleiderer A, 2013, EUR J CLIN MICROBIOL, V32, P1471, DOI 10.1007/s10096-013-1900-2; Ramasamy D, 2012, STAND GENOMIC SCI, V7, P246, DOI 10.4056/sigs.3306717; Seng P, 2013, J CLIN MICROBIOL, V51, P2182, DOI 10.1128/JCM.00492-13; Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI 10.2217/FMB.10.127; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sparbier K, 2012, J CLIN MICROBIOL, V50, P927, DOI 10.1128/JCM.05737-11; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/00207713-52-3-1043; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P3482, DOI 10.1128/JCM.00687-09; Tani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040784; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; Walker J, 2002, J MICROBIOL METH, V48, P117, DOI 10.1016/S0167-7012(01)00316-5; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	49	37	40	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e87419	10.1371/journal.pone.0087419	http://dx.doi.org/10.1371/journal.pone.0087419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24784934	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600002
J	Ge, XM; Zhang, YF; Park, S; Cong, XF; Gerrard, DE; Jiang, HL				Ge, Xiaomei; Zhang, Yafei; Park, Sungwon; Cong, Xiaofei; Gerrard, David E.; Jiang, Honglin			Stac3 Inhibits Myoblast Differentiation into Myotubes	PLOS ONE			English	Article							GROWTH-FACTOR-I; SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; STEM-CELLS; GENE; MYOD; PROGRAM; DOMAINS; MICE; SH3	The functionally undefined Stac3 gene, predicted to encode a SH3 domain- and C1 domain-containing protein, was recently found to be specifically expressed in skeletal muscle and essential to normal skeletal muscle development and contraction. In this study we determined the potential role of Stac3 in myoblast proliferation and differentiation, two important steps of muscle development. Neither siRNA-mediated Stac3 knockdown nor plasmid-mediated Stac3 overexpression affected the proliferation of C2C12 myoblasts. Stac3 knockdown promoted the differentiation of C2C12 myoblasts into myotubes as evidenced by increased fusion index, increased number of nuclei per myotube, and increased mRNA and protein expression of myogenic markers including myogenin and myosin heavy chain. In contrast, Stac3 overexpression inhibited the differentiation of C2C12 myoblasts into myotubes as evidenced by decreased fusion index, decreased number of nuclei per myotube, and decreased mRNA and protein expression of myogenic markers. Compared to wild-type myoblasts, myoblasts from Stac3 knockout mouse embryos showed accelerated differentiation into myotubes in culture as evidenced by increased fusion index, increased number of nuclei per myotube, and increased mRNA expression of myogenic markers. Collectively, these data suggest an inhibitory role of endogenous Stac3 in myoblast differentiation. Myogenesis is a tightly controlled program; myofibers formed from prematurely differentiated myoblasts are dysfunctional. Thus, Stac3 may play a role in preventing precocious myoblast differentiation during skeletal muscle development.	[Ge, Xiaomei; Zhang, Yafei; Park, Sungwon; Cong, Xiaofei; Gerrard, David E.; Jiang, Honglin] Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Jiang, HL (corresponding author), Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA.	hojiang@vt.edu	Cong, Xiaofei/W-3872-2019; gerrard, david/AAG-7507-2019	Cong, Xiaofei/0000-0001-6618-906X; , Honglin/0000-0001-9540-5788; gerrard, david/0000-0002-3482-1400	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2012-67015-19452]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This work was supported by Agriculture and Food Research Initiative Competitive Grant no. 2012-67015-19452 from the USDA National Institute of Food and Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya KB, 2008, DEV BIOL, V321, P123, DOI 10.1016/j.ydbio.2008.06.023; Bentzinger CF, 2012, COLD SPRING HARB PER, V4; Bower NI, 2012, J BIOL CHEM, V287, P43936, DOI 10.1074/jbc.M112.361311; DLUGOSZ AA, 1983, CANCER RES, V43, P2780; Ge X, 2012, J ANIM SCI, V90, P1126, DOI 10.2527/jas.2011-4358; Ge XM, 2013, MOL CELL ENDOCRINOL, V372, P23, DOI 10.1016/j.mce.2013.03.017; Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Horstick EJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2952; Kablar B, 2003, DEV BIOL, V258, P307, DOI 10.1016/S0012-1606(03)00139-8; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Legha W, 2010, GENE EXPR PATTERNS, V10, P368, DOI 10.1016/j.gep.2010.08.003; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Mayer BJ, 2001, J CELL SCI, V114, P1253; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Myer A, 2001, DEV BIOL, V229, P340, DOI 10.1006/dbio.2000.9985; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nelson BR, 2013, P NATL ACAD SCI USA, V110, P11881, DOI 10.1073/pnas.1310571110; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reinholt BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062760; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Springer ML, 1997, SOMAT CELL MOLEC GEN, V23, P203, DOI 10.1007/BF02721371; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Vinciguerra M, 2010, ADV EXP MED BIOL, V694, P211	25	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95926	10.1371/journal.pone.0095926	http://dx.doi.org/10.1371/journal.pone.0095926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788338	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917300022
J	Pham, CK; Ramirez-Llodra, E; Alt, CHS; Amaro, T; Bergmann, M; Canals, M; Company, JB; Davies, J; Duineveld, G; Galgani, F; Howell, KL; Huvenne, VAI; Isidro, E; Jones, DOB; Lastras, G; Morato, T; Gomes-Pereira, JN; Purser, A; Stewart, H; Tojeira, I; Tubau, X; Van Rooij, D; Tyler, PA				Pham, Christopher K.; Ramirez-Llodra, Eva; Alt, Claudia H. S.; Amaro, Teresa; Bergmann, Melanie; Canals, Miquel; Company, Joan B.; Davies, Jaime; Duineveld, Gerard; Galgani, Francois; Howell, Kerry L.; Huvenne, Veerle A. I.; Isidro, Eduardo; Jones, Daniel O. B.; Lastras, Galderic; Morato, Telmo; Gomes-Pereira, Jose Nuno; Purser, Autun; Stewart, Heather; Tojeira, Ines; Tubau, Xavier; Van Rooij, David; Tyler, Paul A.			Marine Litter Distribution and Density in European Seas, from the Shelves to Deep Basins	PLOS ONE			English	Article							PLASTIC DEBRIS; NORTHEAST ATLANTIC; CONTINENTAL-SHELF; COASTAL WATERS; BEACH DEBRIS; ABUNDANCE; INGESTION; FLOOR; IMPACTS; CALIFORNIA	Anthropogenic litter is present in all marine habitats, from beaches to the most remote points in the oceans. On the seafloor, marine litter, particularly plastic, can accumulate in high densities with deleterious consequences for its inhabitants. Yet, because of the high cost involved with sampling the seafloor, no large-scale assessment of distribution patterns was available to date. Here, we present data on litter distribution and density collected during 588 video and trawl surveys across 32 sites in European waters. We found litter to be present in the deepest areas and at locations as remote from land as the Charlie-Gibbs Fracture Zone across the Mid-Atlantic Ridge. The highest litter density occurs in submarine canyons, whilst the lowest density can be found on continental shelves and on ocean ridges. Plastic was the most prevalent litter item found on the seafloor. Litter from fishing activities (derelict fishing lines and nets) was particularly common on seamounts, banks, mounds and ocean ridges. Our results highlight the extent of the problem and the need for action to prevent increasing accumulation of litter in marine environments.	[Pham, Christopher K.; Isidro, Eduardo; Morato, Telmo; Gomes-Pereira, Jose Nuno] Univ Azores, Ctr Inst Marine Res IMAR, Horta, Portugal; [Pham, Christopher K.; Isidro, Eduardo; Morato, Telmo; Gomes-Pereira, Jose Nuno] Univ Azores, Dept Oceanog & Fisheries, Horta, Portugal; [Pham, Christopher K.; Isidro, Eduardo; Morato, Telmo; Gomes-Pereira, Jose Nuno] Lab Robot & Syst Engn & Sci LARSyS, Lisbon, Portugal; [Ramirez-Llodra, Eva; Company, Joan B.] Inst Ciencies Mar ICM CSIC, Barcelona, Spain; [Ramirez-Llodra, Eva] Norwegian Inst Water Res NIVA, Marine Biol Sect, Oslo, Norway; [Alt, Claudia H. S.; Huvenne, Veerle A. I.; Jones, Daniel O. B.; Tyler, Paul A.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Amaro, Teresa] Norwegian Inst Water Res, Bergen, Norway; [Bergmann, Melanie] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Bremerhaven, Germany; [Canals, Miquel; Lastras, Galderic; Tubau, Xavier] Univ Barcelona, Fac Geol, Dept Estratig Paleontol & Geociencies Marines, GRC Geociencies Marines, Barcelona, Spain; [Davies, Jaime; Howell, Kerry L.] Univ Plymouth, Inst Marine, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Duineveld, Gerard] Netherlands Inst Sea Res NIOZ, Texel, Netherlands; [Galgani, Francois] IFREMER, F-20600 Bastia, France; [Purser, Autun] Jacobs Univ Bremen, OceanLab, D-28759 Bremen, Germany; [Stewart, Heather] British Geol Survey, Edinburgh, Midlothian, Scotland; [Tojeira, Ines] Portuguese Task Grp Extens Continental Shelf EMEP, Paco De Arcos, Portugal; [Van Rooij, David] Univ Ghent, Dept Geol & Soil Sci, RCMG, B-9000 Ghent, Belgium	Universidade dos Acores; Universidade dos Acores; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Norwegian Institute for Water Research (NIVA); NERC National Oceanography Centre; University of Southampton; Norwegian Institute for Water Research (NIVA); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Barcelona; University of Plymouth; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Ifremer; Jacobs University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Ghent University	Pham, CK (corresponding author), Univ Azores, Ctr Inst Marine Res IMAR, Horta, Portugal.	phamchristopher@uac.pt	Van Rooij, David/A-7938-2014; Company, Joan B./K-7274-2014; Pham, Christopher K./I-9182-2014; Pereira, José/B-8237-2011; Pham, Christopher/A-6057-2013; Morato, Telmo/A-4548-2009; galgani, francois/A-1973-2011; Tojeira, Ines/GYU-7749-2022; Jones, Daniel/A-3412-2009; Canals, Miquel/F-4922-2013; Amaro, Teresa/G-7033-2011; Lastras, Galderic/A-6487-2013; Bergmann, Melanie/H-3347-2015	Van Rooij, David/0000-0003-3633-3344; Company, Joan B./0000-0002-5878-7155; Pham, Christopher K./0000-0002-3556-0492; Morato, Telmo/0000-0003-2393-4773; galgani, francois/0000-0001-8770-6054; Tojeira, Ines/0000-0001-5778-6196; Jones, Daniel/0000-0001-5218-1649; Canals, Miquel/0000-0001-5267-7601; Amaro, Teresa/0000-0002-1995-2808; Lastras, Galderic/0000-0002-8756-3855; Isidro, Eduardo/0000-0003-2108-7363; Purser, Autun/0000-0001-5427-0151; Bergmann, Melanie/0000-0001-5212-9808; Huvenne, Veerle A.I./0000-0001-7135-6360; Howell, Kerry/0000-0003-3359-1778; Gomes-Pereira, Jose Nuno/0000-0002-4351-3522; Stewart, Heather Ann/0000-0002-5590-6972; Ramirez-Llodra, Eva/0000-0003-0137-1906	European Community's Seventh Framework Programme (FP7) under the HERMIONE project [226354]; Condor project; Iceland, Liechtenstein, Norway through the EEA Financial Mechanism [PT0040/2008]; Corazon (COMPETE/QREN) [FCT/PTDC/MAR/72169/2006]; CoralFISH [FP7 ENV/2007/1/21314 4]; EC [287600]; ESF project BIOFUN [CTM2007-28739-E]; Spanish projects PROMETEO [CTM2007-66316-C02/MAR]; DOS MARES [CTM2010-21810-C03-01]; la Caixa grant "Oasis del Mar"; Generalitat de Catalunya grant [2009 SGR 1305]; UK's Natural Environment Research Council (NERC) as part of the Ecosystems of the Mid-Atlantic Ridge at the Sub-Polar Front and Charlie-Gibbs Fracture Zone (ECOMAR) project; Marine Environmental Mapping Programme (MAREMAP); ERC (Starting Grant project CODEMAP) [258482]; Joint Nature Conservation Committee (JNCC); Lenfest Ocean Program (PEW Foundation); Department for Business, Enterprise and Regulatory Reform through Strategic Environmental Assessment 7; Department for Environment, Food and Rural Affairs; Joint Nature Conservation Committee; offshore Special Areas for Conservation programme; BELSPO; RBINS-OD Nature (Belgian Federal Government) for R/V Belgica shiptime; FCT-IP/MEC; IMAR-University of the Azores (RDU) [531]; Thematic Area E, through the Strategic Project (COMPETE, QREN) [PEst-OE/EEI/LA0009/2011-2014]; Government of Azores FRCT; Portuguese Science Foundation (COMPETE/QREN) [SFRH/BD/66404/2009]; Statoil as part of the CORAMM project; DFG Leibniz programme; Regional Directorate for Science, Technology and Communications (DRCTC) of the Regional Government of the Azores [M3.1.2/F/062/2011]; CSIC-JAE-postdocotral grant; European Social Fund; IFREMER; NERC [NE/C51300X/1, NE/C513018/1, bgs05015, noc010011, noc010009, NE/C51297X/1, NE/C512996/1, NE/C512988/1, NE/C512961/1] Funding Source: UKRI; Natural Environment Research Council [NE/C51300X/1, NE/C51297X/1, NE/C512961/1, NE/C513018/1, NE/C512996/1, bgs05015, noc010011, noc010009, NE/C512988/1] Funding Source: researchfish	European Community's Seventh Framework Programme (FP7) under the HERMIONE project; Condor project; Iceland, Liechtenstein, Norway through the EEA Financial Mechanism; Corazon (COMPETE/QREN); CoralFISH; EC(European CommissionEuropean Commission Joint Research Centre); ESF project BIOFUN; Spanish projects PROMETEO; DOS MARES; la Caixa grant "Oasis del Mar"; Generalitat de Catalunya grant(Generalitat de Catalunya); UK's Natural Environment Research Council (NERC) as part of the Ecosystems of the Mid-Atlantic Ridge at the Sub-Polar Front and Charlie-Gibbs Fracture Zone (ECOMAR) project; Marine Environmental Mapping Programme (MAREMAP); ERC (Starting Grant project CODEMAP); Joint Nature Conservation Committee (JNCC); Lenfest Ocean Program (PEW Foundation); Department for Business, Enterprise and Regulatory Reform through Strategic Environmental Assessment 7; Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Joint Nature Conservation Committee; offshore Special Areas for Conservation programme; BELSPO(Belgian Federal Science Policy Office); RBINS-OD Nature (Belgian Federal Government) for R/V Belgica shiptime; FCT-IP/MEC; IMAR-University of the Azores (RDU); Thematic Area E, through the Strategic Project (COMPETE, QREN); Government of Azores FRCT; Portuguese Science Foundation (COMPETE/QREN); Statoil as part of the CORAMM project; DFG Leibniz programme(German Research Foundation (DFG)); Regional Directorate for Science, Technology and Communications (DRCTC) of the Regional Government of the Azores; CSIC-JAE-postdocotral grant; European Social Fund(European Social Fund (ESF)); IFREMER; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under the HERMIONE project, Grant agreement (GA) no. 226354. The authors would like to acknowledge further funds from the Condor project (supported by a grant from Iceland, Liechtenstein, Norway through the EEA Financial Mechanism (PT0040/2008)), Corazon (FCT/PTDC/MAR/72169/2006; COMPETE/QREN), CoralFISH (FP7 ENV/2007/1/21314 4), EC funded PERSEUS project (GA no. 287600), the ESF project BIOFUN (CTM2007-28739-E), the Spanish projects PROMETEO (CTM2007-66316-C02/MAR) and DOS MARES (CTM2010-21810-C03-01), la Caixa grant "Oasis del Mar", the Generalitat de Catalunya grant to excellence research group number 2009 SGR 1305, UK's Natural Environment Research Council (NERC) as part of the Ecosystems of the Mid-Atlantic Ridge at the Sub-Polar Front and Charlie-Gibbs Fracture Zone (ECOMAR) project, the Marine Environmental Mapping Programme (MAREMAP), the ERC (Starting Grant project CODEMAP, no 258482), the Joint Nature Conservation Committee (JNCC), the Lenfest Ocean Program (PEW Foundation), the Department for Business, Enterprise and Regulatory Reform through Strategic Environmental Assessment 7 (formerly the Department for Trade and Industry) and the Department for Environment, Food and Rural Affairs through their advisors, the Joint Nature Conservation Committee, the offshore Special Areas for Conservation programme, BELSPO and RBINS-OD Nature (Belgian Federal Government) for R/V Belgica shiptime. The footage from the HAUSGARTEN observatory was taken during expeditions ARK XVIII/1, ARK XX/1, ARK XXII/1, ARK XXIII/2 and ARK XXVI/2 of the German research icebreaker "Polarstern". The authors also acknowledge funds provided by FCT-IP/MEC to LARSyS Associated Laboratory and IMAR-University of the Azores (R&DU #531), Thematic Area E, through the Strategic Project (PEst-OE/EEI/LA0009/2011 2014, COMPETE, QREN) and by the Government of Azores FRCT multiannual funding. CKP was supported by the doctoral grant from the Portuguese Science Foundation (SFRH/BD/66404/2009; COMPETE/QREN). AP was supported by Statoil as part of the CORAMM project. MB would like to thank Antje Boetius for financial support through the DFG Leibniz programme. JNGP was supported by the doctoral grant (M3.1.2/F/062/2011) from the Regional Directorate for Science, Technology and Communications (DRCTC) of the Regional Government of the Azores. ERLL was supported by a CSIC-JAE-postdocotral grant with co-funding from the European Social Fund. Publication fees for this open access publication were supported by IFREMER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliani S, 2003, MAR POLLUT BULL, V46, P1142, DOI 10.1016/S0025-326X(03)00192-9; Allen R, 2012, MAR POLLUT BULL, V64, P2815, DOI 10.1016/j.marpolbul.2012.09.005; Amaro T, 2010, BIOGEOSCIENCES, V7, P2419, DOI 10.5194/bg-7-2419-2010; Anastasopoulou A, 2013, DEEP-SEA RES PT I, V74, P11, DOI 10.1016/j.dsr.2012.12.008; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Ariza E, 2008, WASTE MANAGE, V28, P2604, DOI 10.1016/j.wasman.2007.11.012; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Barnes DKA, 2005, MAR BIOL, V146, P815, DOI 10.1007/s00227-004-1474-8; Barnes DKA, 2002, NATURE, V416, P808, DOI 10.1038/416808a; Bergmann M, 2012, MAR POLLUT BULL, V64, P2734, DOI 10.1016/j.marpolbul.2012.09.018; BJORNDAL KA, 1994, MAR POLLUT BULL, V28, P154, DOI 10.1016/0025-326X(94)90391-3; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brown J, 2007, MAR POLICY, V31, P488, DOI 10.1016/j.marpol.2006.10.007; Bullimore RD, 2013, ICES J MAR SCI, V70, P511, DOI 10.1093/icesjms/fss195; CARR A, 1987, MAR POLLUT BULL, V18, P352, DOI 10.1016/S0025-326X(87)80025-5; Carr H. Arnold, 1997, P141; Carson HS, 2013, MAR POLLUT BULL, V74, P170, DOI 10.1016/j.marpolbul.2013.07.008; Chiappone M, 2005, BIOL CONSERV, V121, P221, DOI 10.1016/j.biocon.2004.04.023; Cho DO, 2011, MAR POLICY, V35, P610, DOI 10.1016/j.marpol.2011.01.022; Clark MR, 2008, SEAMOUNTS ECOLOGY FI, P413; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; Corcoran PL, 2009, MAR POLLUT BULL, V58, P80, DOI 10.1016/j.marpolbul.2008.08.022; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Engler RE, 2012, ENVIRON SCI TECHNOL, V46, P12302, DOI 10.1021/es3027105; Farrell P, 2013, ENVIRON POLLUT, V177, P1, DOI 10.1016/j.envpol.2013.01.046; Fiorentini L, 1999, AQUAT LIVING RESOUR, V12, P187, DOI 10.1016/S0990-7440(00)88470-3; GABRIELIDES GP, 1991, MAR POLLUT BULL, V23, P437, DOI 10.1016/0025-326X(91)90713-3; GALGANI F, 1995, MAR POLLUT BULL, V30, P58, DOI 10.1016/0025-326X(94)00101-E; Galgani F, 1996, MAR ECOL PROG SER, V142, P225, DOI 10.3354/meps142225; GALGANI F, 1995, MAR POLLUT BULL, V30, P713, DOI 10.1016/0025-326X(95)00055-R; Galgani F, 2013, ICES J MAR SCI, V70, P1055, DOI 10.1093/icesjms/fst122; Galgani F, 2000, MAR POLLUT BULL, V40, P516, DOI 10.1016/S0025-326X(99)00234-9; Galgani F, 2004, REPORTS POLAR MARINE, V488, P260; GALIL BS, 1995, MAR POLLUT BULL, V30, P22, DOI 10.1016/0025-326X(94)00103-G; Graham ER, 2009, J EXP MAR BIOL ECOL, V368, P22, DOI 10.1016/j.jembe.2008.09.007; Halfar J, 2007, SCIENCE, V316, P987, DOI 10.1126/science.1138289; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; He GW, 2011, ACTA OCEANOL SIN, V30, P63, DOI 10.1007/s13131-011-0120-9; Hess NA, 1999, MAR POLLUT BULL, V38, P885, DOI 10.1016/S0025-326X(99)00087-9; Hinojosa IA, 2009, MAR POLLUT BULL, V58, P341, DOI 10.1016/j.marpolbul.2008.10.020; Huvenne VAI, 2011, 04 NAT OC CTR; Kanehiro H, 1996, FISH ENG, V32, P211; Katsanevakis S, 2004, WATER AIR SOIL POLL, V159, P325, DOI 10.1023/B:WATE.0000049183.17150.df; Keller AA, 2010, MAR POLLUT BULL, V60, P692, DOI 10.1016/j.marpolbul.2009.12.006; KIDD RB, 1981, OCEANOL ACTA, V4, P99; Kornilios S, 1998, MAR POLLUT BULL, V36, P989, DOI 10.1016/S0025-326X(98)00102-7; Kuriyama Y, 2003, NIPPON SUISAN GAKK, V69, P770; Lavaleye MSS, 2011, CORALFISH HERMIONE C, P47; Lee DI, 2006, ESTUAR COAST SHELF S, V70, P187, DOI 10.1016/j.ecss.2006.06.003; Martinez-Ribes L, 2007, SCI MAR, V71, P305, DOI 10.3989/scimar.2007.71n2305; Martins J, 2011, MAR POLLUT BULL, V62, P2649, DOI 10.1016/j.marpolbul.2011.09.028; MCCOY FW, 1988, MAR POLLUT BULL, V19, P25, DOI 10.1016/0025-326X(88)90749-7; Miyake H., 2011, INTERDISCIPLINARY ST, P261; Moore SL, 2000, MAR POLLUT BULL, V40, P83, DOI 10.1016/S0025-326X(99)00175-7; Moore SL, 2001, MAR POLLUT BULL, V42, P241, DOI 10.1016/S0025-326X(00)00148-X; Mordecai G, 2011, DEEP-SEA RES PT II, V58, P2489, DOI 10.1016/j.dsr2.2011.08.009; MORRIS RJ, 1980, MAR POLLUT BULL, V11, P125, DOI 10.1016/0025-326X(80)90073-9; MOSER ML, 1992, COLON WATERBIRD, V15, P83, DOI 10.2307/1521357; Murray F, 2011, MAR POLLUT BULL, V62, P1207, DOI 10.1016/j.marpolbul.2011.03.032; NASH AD, 1992, MAR POLLUT BULL, V24, P150, DOI 10.1016/0025-326X(92)90243-Y; Neilson JL, 2009, J BIOGEOGR, V36, P452, DOI 10.1111/j.1365-2699.2007.01820.x; Oigman-Pszczol SS, 2007, J COASTAL RES, V23, P421, DOI [10.2112/1551-5036(2007)23[421:QACOML]2.0.CO;2, 10.2112/04-0278.1]; Pages F, 2007, DEEP-SEA RES PT I, V54, P2170, DOI 10.1016/j.dsr.2007.09.002; Pham CK, 2013, DEEP-SEA RES PT II, V98, P204, DOI 10.1016/j.dsr2.2013.01.011; Purser A, 2013, CONT SHELF RES, V54, P37, DOI 10.1016/j.csr.2012.12.013; Ramirez-Llodra E, 2013, PROG OCEANOGR, V118, P273, DOI 10.1016/j.pocean.2013.07.027; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Revill AS, 2003, FISH RES, V64, P107, DOI 10.1016/S0165-7836(03)00209-1; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; RYAN PG, 1988, MAR POLLUT BULL, V19, P125, DOI 10.1016/0025-326X(88)90708-4; Sanchez P, 2013, SCI MAR, V77, P247, DOI 10.3989/scimar03702.10A; Sarda F, 1998, FISHERIES SCI, V64, P492, DOI 10.2331/fishsci.64.492; Schlining K, 2013, DEEP-SEA RES PT I, V79, P96, DOI 10.1016/j.dsr.2013.05.006; SCHREY E, 1987, MAR POLLUT BULL, V18, P350, DOI 10.1016/S0025-326X(87)80024-3; Sheavly SB, 2007, J POLYM ENVIRON, V15, P301, DOI 10.1007/s10924-007-0074-3; SHIBER JG, 1982, MAR POLLUT BULL, V13, P409, DOI 10.1016/0025-326X(82)90014-5; Silva-Iniguez L, 2003, MAR POLLUT BULL, V46, P132, DOI 10.1016/S0025-326X(02)00216-3; Spengler A, 2008, MAR POLLUT BULL, V56, P226, DOI 10.1016/j.marpolbul.2007.09.040; Stefatos A, 1999, MAR POLLUT BULL, V38, P389, DOI 10.1016/S0025-326X(98)00141-6; Thiel M, 2003, MAR POLLUT BULL, V46, P224, DOI 10.1016/S0025-326X(02)00365-X; Thiel M, 2011, J SEA RES, V65, P368, DOI 10.1016/j.seares.2011.03.002; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Tomas J, 2002, MAR POLLUT BULL, V44, P211, DOI 10.1016/S0025-326X(01)00236-3; Topcu NE, 2013, MAR ENVIRON RES, V85, P21, DOI 10.1016/j.marenvres.2012.12.006; Tubau X, 2012, 3 ANN HERM M FAR POR, P21; UNEP, 2009, MAR LITT GLOB CHALL; Van Cauwenberghe L, 2013, ENVIRON POLLUT, V182, P495, DOI 10.1016/j.envpol.2013.08.013; Van Cauwenberghe L, 2013, MAR POLLUT BULL, V73, P161, DOI 10.1016/j.marpolbul.2013.05.026; Van Rooij D, 2011, MAR GEOL, V282, P102, DOI 10.1016/j.margeo.2010.08.012; VAUK GJM, 1987, MAR POLLUT BULL, V18, P316, DOI 10.1016/S0025-326X(87)80018-8; Vetter EW, 1998, DEEP-SEA RES PT II, V45, P25, DOI 10.1016/S0967-0645(97)00048-9; Watters DL, 2010, MAR POLLUT BULL, V60, P131, DOI 10.1016/j.marpolbul.2009.08.019; Williams R, 2011, MAR POLLUT BULL, V62, P1303, DOI 10.1016/j.marpolbul.2011.02.029; Willoughby NG, 1997, MAR POLLUT BULL, V34, P469, DOI 10.1016/S0025-326X(96)00141-5; WINSTON JE, 1982, MAR POLLUT BULL, V13, P348, DOI 10.1016/0025-326X(82)90038-8; Wright SL, 2013, ENVIRON POLLUT, V178, P783; Zhou P, 2011, MAR POLLUT BULL, V62, P1998, DOI 10.1016/j.marpolbul.2011.06.018	99	368	380	11	192	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95839	10.1371/journal.pone.0095839	http://dx.doi.org/10.1371/journal.pone.0095839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788771	Green Published, Green Accepted, gold			2022-12-25	WOS:000338917300019
J	Sade, H; Baumgartner, C; Hugenmatter, A; Moessner, E; Freskgard, PO; Niewoehner, J				Sade, Hadassah; Baumgartner, Claudia; Hugenmatter, Adrian; Moessner, Ekkehard; Freskgard, Per-Ola; Niewoehner, Jens			A Human Blood-Brain Barrier Transcytosis Assay Reveals Antibody Transcytosis Influenced by pH-Dependent Receptor Binding	PLOS ONE			English	Article							HUMAN TRANSFERRIN RECEPTOR; ENDOTHELIAL-CELL LINE; IN-VITRO; MEDIATED ENDOCYTOSIS; CRYSTAL-STRUCTURE; TRANSPORT; EXPRESSION; PERMEABILITY; CAPILLARIES; HCMEC/D3	We have adapted an in vitro model of the human blood-brain barrier, the immortalized human cerebral microvascular endothelial cells (hCMEC/D3), to quantitatively measure protein transcytosis. After validating the receptor-mediated transport using transferrin, the system was used to measure transcytosis rates of antibodies directed against potential brain shuttle receptors. While an antibody to the insulin-like growth factor 1 receptor (IGF1R) was exclusively recycled to the apical compartment, the fate of antibodies to the transferrin receptor (TfR) was determined by their relative affinities at extracellular and endosomal pH. An antibody with reduced affinity at pH5.5 showed significant transcytosis, while pH-independent antibodies of comparable affinities at pH 7.4 remained associated with intracellular vesicular compartments and were finally targeted for degradation.	[Sade, Hadassah; Baumgartner, Claudia; Niewoehner, Jens] Roche, Large Mol Res, Pharma Res & Early Dev pRED, Penzberg, Germany; [Hugenmatter, Adrian; Moessner, Ekkehard] Roche, Large Mol Res, Pharma Res & Early Dev pRED, Schlieren, Switzerland; [Freskgard, Per-Ola] F Hoffmann La Roche & Co Ltd, Neurosci Discovery & Translat Area, Pharma Res & Early Dev pRED, CH-4002 Basel, Switzerland	Roche Holding; Roche Holding; Roche Holding	Niewoehner, J (corresponding author), Roche, Large Mol Res, Pharma Res & Early Dev pRED, Penzberg, Germany.	jens.niewoehner@roche.com	Freskgård, Per-Ola/AAY-4194-2021		Roche	Roche(Roche Holding)	The work was funded by Roche. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; Carl SM, 2010, MOL PHARMACEUT, V7, P1057, DOI 10.1021/mp900178j; Dan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081051; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Demeule M, 2002, J NEUROCHEM, V83, P924, DOI 10.1046/j.1471-4159.2002.01201.x; Descamps L, 1996, AM J PHYSIOL-HEART C, V270, pH1149, DOI 10.1152/ajpheart.1996.270.4.H1149; DUFFY KR, 1988, METABOLISM, V37, P136, DOI 10.1016/S0026-0495(98)90007-5; Eckenroth BE, 2011, P NATL ACAD SCI USA, V108, P13089, DOI 10.1073/pnas.1105786108; FISHMAN JB, 1987, J NEUROSCI RES, V18, P299, DOI 10.1002/jnr.490180206; Friden PM, 1996, J PHARMACOL EXP THER, V278, P1491; FRIDEN PM, 1993, SCIENCE, V259, P373, DOI 10.1126/science.8420006; FRIDEN PM, 1991, P NATL ACAD SCI USA, V88, P4771, DOI 10.1073/pnas.88.11.4771; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; Hsu VW, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3332; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kania KD, 2011, BRAIN RES; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; LESLEY J, 1989, EXP CELL RES, V182, P215, DOI 10.1016/0014-4827(89)90293-0; Mairey E, 2006, J EXP MED, V203, P1939, DOI 10.1084/jem.20060482; Markoutsa E, 2011, EUR J PHARM BIOPHARM, V77, P265, DOI 10.1016/j.ejpb.2010.11.015; Nazer B, 2008, NEUROBIOL DIS, V30, P94, DOI 10.1016/j.nbd.2007.12.005; Niederfellner G, 2011, BLOOD, V118, P358, DOI 10.1182/blood-2010-09-305847; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; PARDRIDGE WM, 1991, J PHARMACOL EXP THER, V259, P66; PARDRIDGE WM, 1987, METABOLISM, V36, P892, DOI 10.1016/0026-0495(87)90099-0; PARDRIDGE WM, 1995, PHARMACEUT RES, V12, P807, DOI 10.1023/A:1016244500596; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; RAUB TJ, 1991, J CELL PHYSIOL, V149, P141, DOI 10.1002/jcp.1041490118; REINHARDT RR, 1994, ENDOCRINOLOGY, V135, P1753, DOI 10.1210/en.135.5.1753; RISAU W, 1986, DEV BIOL, V117, P537, DOI 10.1016/0012-1606(86)90321-0; SKARLATOS S, 1995, BRAIN RES, V683, P164, DOI 10.1016/0006-8993(95)00363-U; Steere AN, 2012, BIOCHEMISTRY-US, V51, P2113, DOI 10.1021/bi3001038; Tai LM, 2010, J CELL MOL MED, V14, P1101, DOI 10.1111/j.1582-4934.2009.00717.x; Wang P, 2010, CELL MOL NEUROBIOL, V30, P717, DOI 10.1007/s10571-010-9496-x; Wang ZH, 2010, BIOMATERIALS, V31, P908, DOI 10.1016/j.biomaterials.2009.09.104; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230	41	66	78	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96340	10.1371/journal.pone.0096340	http://dx.doi.org/10.1371/journal.pone.0096340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788759	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917300037
J	Natt, D; Agnvall, B; Jensen, P				Natt, Daniel; Agnvall, Beatrix; Jensen, Per			Large Sex Differences in Chicken Behavior and Brain Gene Expression Coincide with Few Differences in Promoter DNA-Methylation	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; RED JUNGLEFOWL; TYROSINE-HYDROXYLASE; DOSAGE COMPENSATION; NONCODING RNA; EVOLUTION; BUDGETS; MOUSE; RESPONSES; TRAITS	While behavioral sex differences have repeatedly been reported across taxa, the underlying epigenetic mechanisms in the brain are mostly lacking. Birds have previously shown to have only limited dosage compensation, leading to high sex bias of Z-chromosome gene expression. In chickens, a male hyper-methylated region (MHM) on the Z-chromosome has been associated with a local type of dosage compensation, but a more detailed characterization of the avian methylome is limiting our interpretations. Here we report an analysis of genome wide sex differences in promoter DNA-methylation and gene expression in the brain of three weeks old chickens, and associated sex differences in behavior of Red Junglefowl (ancestor of domestic chickens). Combining DNA-methylation tiling arrays with gene expression microarrays we show that a specific locus of the MHM region, together with the promoter for the zinc finger RNA binding protein (ZFR) gene on chromosome 1, is strongly associated with sex dimorphism in gene expression. Except for this, we found few differences in promoter DNA-methylation, even though hundreds of genes were robustly differentially expressed across distantly related breeds. Several of the differentially expressed genes are known to affect behavior, and as suggested from their functional annotation, we found that female Red Junglefowl are more explorative and fearful in a range of tests performed throughout their lives. This paper identifies new sites and, with increased resolution, confirms known sites where DNA-methylation seems to affect sexually dimorphic gene expression, but the general lack of this association is noticeable and strengthens the view that birds do not have dosage compensation.	[Natt, Daniel; Agnvall, Beatrix; Jensen, Per] Linkoping Univ, IFM Biol, AVIAN Behav & Genom Grp, Linkoping, Sweden; [Natt, Daniel] Linkoping Univ, Dept Clin & Expt Med, Lab Integrat & Behav Neurosci, Linkoping, Sweden	Linkoping University; Linkoping University	Natt, D (corresponding author), Linkoping Univ, IFM Biol, AVIAN Behav & Genom Grp, Linkoping, Sweden.	daniel.natt@liu.se	Nätt, Daniel/E-9693-2011; Natt, Daniel/AAR-3928-2021	Nätt, Daniel/0000-0002-3801-5705; Natt, Daniel/0000-0001-9182-9401	Swedish Research Council [2008-14496-59340-36]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS [221-2007-838]; European Research Council (ERC) [322206 GENEWELL]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS(Swedish Research Council Formas); European Research Council (ERC)(European Research Council (ERC)European Commission)	Grant support came from The Swedish Research Council (2008-14496-59340-36), The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS (221-2007-838), and the European Research Council (ERC grant 322206 GENEWELL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnvall B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035162; Alverdes F, 1927, SOCIAL LIFE ANIMAL W; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Basu R, 2011, GENESIS, V49, P821, DOI 10.1002/dvg.20792; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisoni L, 2005, CHROMOSOME RES, V13, P205, DOI 10.1007/s10577-005-1505-4; BOROWICZ VA, 1986, BEHAV PROCESS, V12, P125, DOI 10.1016/0376-6357(86)90051-3; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; BOYD LE, 1988, APPL ANIM BEHAV SCI, V21, P19, DOI 10.1016/0168-1591(88)90099-8; Cavanaugh BL, 2010, PHYSIOL BEHAV, V100, P381, DOI 10.1016/j.physbeh.2010.03.020; Collias NE, 1996, ANIM BEHAV, V51, P1337, DOI 10.1006/anbe.1996.0137; COLLIAS NE, 1967, CONDOR, V69, P360, DOI 10.2307/1366199; Crooks L, 2013, G3 GENES GENOMES GEN; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Enoch MA, 2008, PHARMACOL BIOCHEM BE, V90, P95, DOI 10.1016/j.pbb.2008.03.007; Evans CS, 1999, ANIM BEHAV, V58, P307, DOI 10.1006/anbe.1999.1143; Goerlich VC, 2012, HORM BEHAV, V61, P711, DOI 10.1016/j.yhbeh.2012.03.006; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; HOFFMAN SG, 1983, ECOLOGY, V64, P798, DOI 10.2307/1937203; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; JOHNSON ROBERT A., 1963, WILSON BULL, V75, P270; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; KRUIJT JP, 1966, PHILOS T ROY SOC B, V251, P479, DOI 10.1098/rstb.1966.0039; Lee SI, 2009, POULTRY SCI, V88, P1003, DOI 10.3382/ps.2008-00197; Lenz KM, 2012, FRONTIERS NEUROSCIEN; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mank JE, 2009, HEREDITY, V102, P312, DOI 10.1038/hdy.2008.116; McBride G., 1969, Animal Behaviour Monographs, V2, P127; McKeegan DEF, 1997, APPL ANIM BEHAV SCI, V51, P159, DOI 10.1016/S0168-1591(96)01096-9; Melamed E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r202; Natt D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-59; Naurin S, 2010, TRENDS GENET, V26, P15, DOI 10.1016/j.tig.2009.11.006; Palanza P, 2001, PHYSIOL BEHAV, V73, P411, DOI 10.1016/S0031-9384(01)00494-2; Pawlak CR, 2008, NEUROSCI BIOBEHAV R, V32, P1544, DOI 10.1016/j.neubiorev.2008.06.007; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Raymond CS, 1999, DEV BIOL, V215, P208, DOI 10.1006/dbio.1999.9461; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Roeszler KN, 2012, DEV BIOL, V366, P317, DOI 10.1016/j.ydbio.2012.03.025; Schutz KE, 2004, BEHAV GENET, V34, P121, DOI 10.1023/B:BEGE.0000009481.98336.fc; SULLIVAN MS, 1991, APPL ANIM BEHAV SCI, V30, P381, DOI 10.1016/0168-1591(91)90143-L; Taborsky M, 1998, ANIM BEHAV, V56, P1375, DOI 10.1006/anbe.1998.0918; Teranishi M, 2001, CHROMOSOME RES, V9, P147, DOI 10.1023/A:1009235120741; Tochigi M, 2006, NEUROSCI RES, V54, P180, DOI 10.1016/j.neures.2005.11.003; Westphal NJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1878, DOI 10.2741/1931; Yasukochi Y, 2010, P NATL ACAD SCI USA, V107, P3704, DOI 10.1073/pnas.0914812107; Zhang SBO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-13	49	29	29	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96376	10.1371/journal.pone.0096376	http://dx.doi.org/10.1371/journal.pone.0096376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24782041	gold, Green Published, Green Submitted			2022-12-25	WOS:000335504900030
J	Das, M; Boerma, M; Goree, JR; Lavoie, EG; Fausther, M; Gubrij, IB; Pangle, AK; Johnson, LG; Dranoff, JA				Das, Mita; Boerma, Marjan; Goree, Jessica R.; Lavoie, Elise G.; Fausther, Michel; Gubrij, Igor B.; Pangle, Amanda K.; Johnson, Larry G.; Dranoff, Jonathan A.			Pathological Changes in Pulmonary Circulation in Carbon Tetrachloride (CCl4)-Induced Cirrhotic Mice	PLOS ONE			English	Article							PORTAL-HYPERTENSION; PORTOPULMONARY HYPERTENSION; PRESSURE; MODELS; LUNG	Rationale: Lack of an experimental model of portopulmonary hypertension (POPH) has been a major obstacle in understanding of pathophysiological mechanisms underlying the disease. Objective: We investigated the effects of CCl4-mediated cirrhosis on the pulmonary vasculature, as an initial step towards an improved understanding of POPH. Methods and Results: Male C57BL/6 mice received intraperitoneal injection of either sterile olive oil or CCl4 3 times/week for 12 weeks. Cirrhosis and portal hypertension were confirmed by evidence of bridging fibrosis and nodule formation in CCl4-treated liver determined by trichrome/picrosirius red staining and an increase in spleen weight/body weight ratio, respectively. Staining for the oxidative stress marker, 4-hydroxynonenal (4-HNE), was strong in the liver but was absent in the lung, suggesting that CCl4 did not directly induce oxidative injury in the lung. Pulmonary acceleration time (PAT) and the ratio of PAT/pulmonary ejection time (PET) measured by echocardiography were significantly decreased in cirrhotic mice. Increase in right ventricle (RV) weight/body weight as well as in the weight ratio of RV/(left ventricle + septum) further demonstrated the presence of pathological changes in the pulmonary circulation in these mice. Histological examination revealed that lungs of cirrhotic mice have excessive accumulation of perivascular collagen and thickening of the media of the pulmonary artery. Conclusion: Collectively, our data demonstrate that chronic CCl4 treatment induces pathological changes in pulmonary circulation in cirrhotic mice. We propose that this murine cirrhotic model provides an exceptional tool for future studies of the molecular mechanisms mediating pulmonary vascular diseases associated with cirrhosis and for evaluation of novel therapeutic interventions.	[Das, Mita; Goree, Jessica R.; Lavoie, Elise G.; Fausther, Michel; Dranoff, Jonathan A.] Univ Arkansas Med Sci, Div Gastroenterol & Hepatol, Dept Internal Med, Little Rock, AR 72205 USA; [Johnson, Larry G.] Univ Arkansas Med Sci, Div Pulm & Crit Care, Little Rock, AR 72205 USA; [Boerma, Marjan] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Gubrij, Igor B.; Pangle, Amanda K.; Johnson, Larry G.; Dranoff, Jonathan A.] Cent Arkansas Vet Hlth Serv, Res Serv, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Das, M (corresponding author), Univ Arkansas Med Sci, Div Gastroenterol & Hepatol, Dept Internal Med, Little Rock, AR 72205 USA.	mita.das5000@gmail.com; jadranoff@uams.edu		Fausther, Michel/0000-0002-5673-9360	NIH/NIDDK [R01 DK 76735]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076735] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge the following sources of grant support: NIH/NIDDK R01 DK 76735 to JAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Avalos G, 2013, AM J CASE REP, V14, P354, DOI 10.12659/AJCR.889261; Berzigotti A, 2013, GASTROENTEROLOGY, V144, P102, DOI 10.1053/j.gastro.2012.10.001; Boerma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070479; Das Mita, 2012, Pulm Circ, V2, P415, DOI 10.4103/2045-8932.105030; Ferrari RS, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/486190; Fix OK, 2007, LIVER TRANSPLANT, V13, P875, DOI 10.1002/lt.21174; Ganie SA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-17; Geerts AM, 2008, INT J EXP PATHOL, V89, P251, DOI 10.1111/j.1365-2613.2008.00597.x; Hartley DP, 1999, TOXICOL APPL PHARM, V161, P23, DOI 10.1006/taap.1999.8788; HENKEL M, 1994, LEBER MAGEN DARM, V24, P10; Kim SG, 1996, J PHARMACOL EXP THER, V277, P1058; Kolosionek E, 2013, PULM CIRC, V3, P356, DOI 10.4103/2045-8932.114764; Krowka MJ, 2012, CHEST, V141, P906, DOI 10.1378/chest.11-0160; Krowka MJ, 2012, SEMIN RESP CRIT CARE, V33, P17, DOI 10.1055/s-0032-1301731; Ma CQ, 2013, LIVER TRANSPLANT, V19, P741, DOI 10.1002/lt.23632; Machicao VI, 2014, HEPATOLOGY, V59, P1627, DOI 10.1002/hep.26745; Marques TG, 2012, ACTA CIR BRAS, V27, P589, DOI 10.1590/S0102-86502012000800013; Mizuguchi S, 2006, BIOFACTORS, V26, P81, DOI 10.1002/biof.5520260108; Moon SB, 2008, WORLD J SURG, V32, P483, DOI 10.1007/s00268-007-9356-0; Mukhtar NA, 2011, J CLIN GASTROENTEROL, V45, P703, DOI 10.1097/MCG.0b013e31820656bd; Rydell-Tormanen K, 2013, PULM PHARMACOL THER, V26, P13, DOI 10.1016/j.pupt.2012.04.003; Sulica Roxana, 2004, Congest Heart Fail, V10, P192, DOI 10.1111/j.1527-5299.2004.03378.x; Traiger GL, 2007, CRIT CARE NURS Q, V30, P20, DOI 10.1097/00002727-200701000-00004; Tsiakalos A, 2011, HEPATOB PANCREAT DIS, V10, P393, DOI 10.1016/S1499-3872(11)60066-0; Urboniene D, 2010, AM J PHYSIOL-LUNG C, V299, pL401, DOI 10.1152/ajplung.00114.2010; Yared K, 2011, J AM SOC ECHOCARDIOG, V24, P687, DOI 10.1016/j.echo.2011.03.008	26	18	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96043	10.1371/journal.pone.0096043	http://dx.doi.org/10.1371/journal.pone.0096043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763616	Green Published, Green Submitted, gold			2022-12-25	WOS:000335505000055
J	Hardiman, KM; Liu, JH; Feng, Y; Greenson, JK; Fearon, ER				Hardiman, Karin M.; Liu, Jianhua; Feng, Ying; Greenson, Joel K.; Fearon, Eric R.			Rapamycin Inhibition of Polyposis and Progression to Dysplasia in a Mouse Model	PLOS ONE			English	Article							CANCER	Familial adenomatous polyposis (FAP) is often due to adenomatous polyposis coli (APC) gene germline mutations. Somatic APC defects are found in about 80% of colorectal cancers (CRCs) and adenomas. Rapamycin inhibits mammalian target of rapamycin (mTOR) protein, which is often expressed in human adenomas and CRCs. We sought to assess the effects of rapamycin in a mouse polyposis model in which both Apc alleles were conditionally inactivated in colon epithelium. Two days after inactivating Apc, mice were given rapamycin or vehicle in cycles of two weeks on and two weeks off. Polyps were scored endoscopically. Mice were euthanized at time points or when moribund, and tissue analyses were performed. In other studies, mice with demonstrable Apc-defective colon polyps were given rapamycin, followed by analysis of their colon tissues. The median survival of mice receiving rapamycin treatment cycles was 21.5 versus 6.5 weeks in control mice (p = 0.03), and rapamycin-treated mice had a significantly lower percentage of their colon covered with polyps (4.3+/- 2 vs 56.5+/- 10.8 percent, p = 0.001). Mice with Apc-deficient colon tissues that developed high grade dysplasia treated with rapamycin underwent treatment for significantly longer than mice treated with vehicle (15.8 vs 5.1 weeks, p = 0.003). In Apc-defective colon tissues, rapamycin treatment was linked to decreased levels of beta-catenin and Sox9 at 7 weeks. Other effects of rapamycin in Apc-defectivecolon tissues included decreased proliferation and increased numbers of differentiated goblet cells at 7 weeks. Rapamycin did not affect beta-catenin-regulated gene expression in cultured intestinal epithelial cells. Rapamycin has potent inhibitory effects in a mouse colon polyposis model, and mTOR inhibition is linked to decreased proliferation and increased expression of differentiation markers in Apc-mutant colon epithelium and delays development of dysplasia. Our findings highlight the possibility that mTOR inhibitors may have relevance for polyposis inhibition approaches in FAP patients.	[Hardiman, Karin M.; Liu, Jianhua] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Feng, Ying; Fearon, Eric R.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Fearon, Eric R.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA; [Greenson, Joel K.; Fearon, Eric R.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hardiman, KM (corresponding author), Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA.	kmha@med.umich.edu			National Cancer Institute at the National Institutes of Health [R01CA082223-11A2]; NATIONAL CANCER INSTITUTE [R01CA082223] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grant R01CA082223-11A2 from the National Cancer Institute at the National Institutes of Health, and the authors have no other financial conflicts or disclosures related to the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alayev A, 2013, J CELL PHYSL; Bonjer HJ, 2009, LANCET ONCOL, V10, P44, DOI 10.1016/S1470-2045(08)70310-3; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Hildebrandt W, 2004, J MOL MED, V82, P336, DOI 10.1007/s00109-004-0532-5; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Knaus J, 1999, Int J Surg Investig, V1, P263; Koehl GE, 2010, ONCOGENE, V29, P1553, DOI 10.1038/onc.2009.435; Miller SJ, 2012, TRANSL ONCOL, V5, P313, DOI 10.1593/tlo.12226; Nozawa H, 2007, CANCER LETT, V251, P105, DOI 10.1016/j.canlet.2006.11.008; Piso P, 2004, J SURG ONCOL, V86, P115, DOI 10.1002/jso.20062; Ponnurangam S, 2013, MOL CANC THER; Rodel F, 2004, STRAHLENTHER ONKOL, V180, P194, DOI 10.1007/s00066-004-1237-y; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Tuech JJ, 2004, INT J COLORECTAL DIS, V19, P569, DOI 10.1007/s00384-004-0586-4	18	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96023	10.1371/journal.pone.0096023	http://dx.doi.org/10.1371/journal.pone.0096023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763434	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000051
J	Kellner, H; Luis, P; Pecyna, MJ; Barbi, F; Kapturska, D; Kruger, D; Zak, DR; Marmeisse, R; Vandenbol, M; Hofrichter, M				Kellner, Harald; Luis, Patricia; Pecyna, Marek J.; Barbi, Florian; Kapturska, Danuta; Krueger, Dirk; Zak, Donald R.; Marmeisse, Roland; Vandenbol, Micheline; Hofrichter, Martin			Widespread Occurrence of Expressed Fungal Secretory Peroxidases in Forest Soils	PLOS ONE			English	Article							ATMOSPHERIC NITRATE DEPOSITION; MANGANESE PEROXIDASE; ENZYME-ACTIVITY; ORGANIC-MATTER; HUMIC ACIDS; LEAF-LITTER; LIGNIN; DEGRADATION; TRANSFORMATION; DECOMPOSITION	Fungal secretory peroxidases mediate fundamental ecological functions in the conversion and degradation of plant biomass. Many of these enzymes have strong oxidizing activities towards aromatic compounds and are involved in the degradation of plant cell wall (lignin) and humus. They comprise three major groups: class II peroxidases (including lignin peroxidase, manganese peroxidase, versatile peroxidase and generic peroxidase), dye-decolorizing peroxidases, and hemethiolate peroxidases (e. g. unspecific/aromatic peroxygenase, chloroperoxidase). Here, we have repeatedly observed a widespread expression of all major peroxidase groups in leaf and needle litter across a range of forest ecosystems (e. g. Fagus, Picea, Acer, Quercus, and Populus spp.), which are widespread in Europe and North America. Manganese peroxidases and unspecific peroxygenases were found expressed in all nine investigated forest sites, and dye-decolorizing peroxidases were observed in five of the nine sites, thereby indicating biological significance of these enzymes for fungal physiology and ecosystem processes. Transcripts of selected secretory peroxidase genes were also analyzed in pure cultures of several litter-decomposing species and other fungi. Using this information, we were able to match, in environmental litter samples, two manganese peroxidase sequences to Mycena galopus and Mycena epipterygia and one unspecific peroxygenase transcript to Mycena galopus, suggesting an important role of this litter-and coarse woody debris-dwelling genus in the disintegration and transformation of litter aromatics and organic matter formation.	[Kellner, Harald; Pecyna, Marek J.; Kapturska, Danuta; Hofrichter, Martin] Tech Univ Dresden, Int Inst Zittau, Dept Bio & Environm Sci, Zittau, Germany; [Luis, Patricia; Barbi, Florian; Marmeisse, Roland] Univ Lyon 1, USC INRA 1364, UMR CNRS 5557, F-69622 Villeurbanne, France; [Kapturska, Danuta; Krueger, Dirk] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Zak, Donald R.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Vandenbol, Micheline] Univ Liege, Gembloux Agrobio Tech, Unite Microbiol & Genom, Gembloux, Belgium	Technische Universitat Dresden; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Michigan System; University of Michigan; University of Liege	Kellner, H (corresponding author), Tech Univ Dresden, Int Inst Zittau, Dept Bio & Environm Sci, Zittau, Germany.	mail@haraldkellner.com	Kellner, Harald/B-8729-2009; Krüger, Dirk/C-3316-2012	Krüger, Dirk/0000-0002-7305-5104; Hofrichter, Martin/0000-0001-5174-7604; Barbi, Florian/0000-0002-5547-935X; Marmeisse, Roland/0000-0003-1653-3517; Luis, Patricia/0000-0001-7002-6212; Zak, Donald/0000-0002-9730-7337	Deutsche Forschungsgemeinschaft - DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories'' [HO 1961/4-1, KR 3587/1-1]; Gembloux Agro-Bio Tech; Fonds de la Recherche Scientific - FNRS [2.4503.08]; French Research Foundation (EC2CO program MicrobiEn) [ANR-06-BDIV- 006 Fundiv]; French Research Foundation (EC2CO program MicrobiEn); US National Science Foundation's Long-Term Research in Environmental Biology program; US Department of Energy's Biological and Environmental Research Division; European Union integrated project "Peroxicats'' [KBBE-2010-4-265397]; Division Of Environmental Biology [1251529] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft - DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories''(German Research Foundation (DFG)); Gembloux Agro-Bio Tech; Fonds de la Recherche Scientific - FNRS(Fonds de la Recherche Scientifique - FNRS); French Research Foundation (EC2CO program MicrobiEn); French Research Foundation (EC2CO program MicrobiEn); US National Science Foundation's Long-Term Research in Environmental Biology program; US Department of Energy's Biological and Environmental Research Division(United States Department of Energy (DOE)); European Union integrated project "Peroxicats''; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work has been funded by the Deutsche Forschungsgemeinschaft - DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories'' (HO 1961/4-1, KR 3587/1-1), Gembloux Agro-Bio Tech and Fonds de la Recherche Scientific - FNRS (Grant No 2.4503.08), French Research Foundation (EC2CO program MicrobiEn 2009 and project ANR-06-BDIV- 006 Fundiv), US National Science Foundation's Long-Term Research in Environmental Biology program and the US Department of Energy's Biological and Environmental Research Division, and European Union integrated project "Peroxicats'' (KBBE-2010-4-265397). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard V, 2008, GLOBAL CHANGE BIOL, V14, P714, DOI 10.1111/j.1365-2486.2008.01539.x; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Baldrian P, 2011, FUNGAL ECOL, V4, P359, DOI 10.1016/j.funeco.2011.06.001; Baldrian P, 2009, OECOLOGIA, V161, P657, DOI 10.1007/s00442-009-1433-7; Bodeker ITM, 2009, ISME J, V3, P1387, DOI 10.1038/ismej.2009.77; Criquet S, 2000, SOIL BIOL BIOCHEM, V32, P1505, DOI 10.1016/S0038-0717(00)00027-4; Cullings K, 2009, OECOLOGIA, V161, P661, DOI 10.1007/s00442-009-1434-6; DeForest JL, 2005, SOIL SCI SOC AM J, V69, P1233, DOI 10.2136/sssaj2004.0283; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Dickson R. E., 2000, NC214 USDA FOR SERV; Edwards IP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020421; Eichlerova I, 2012, CHEMOSPHERE, V88, P1154, DOI 10.1016/j.chemosphere.2012.03.019; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Fritsche W, 2004, ENV BIOTECHNOLOGY, P203; Ghosh A, 2003, MYCOL RES, V107, P996, DOI 10.1017/S0953756203008177; Grobe G, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-31; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HARVEY PJ, 1992, BIOCHEM SOC T, V20, P345, DOI 10.1042/bst0200345; Hofrichter M, 1997, APPL MICROBIOL BIOT, V47, P566, DOI 10.1007/s002530050974; Hofrichter M, 2002, ENZYME MICROB TECH, V30, P454, DOI 10.1016/S0141-0229(01)00528-2; Hofrichter M, 2009, RUNGGESPRACHE KOMMIS, V37, P81; Hofrichter M, 2010, MYCOTA, V10, P425; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Jee SH, 2010, WATER SCI TECHNOL, V62, P340, DOI 10.2166/wst.2010.248; Kaiser K, 2002, J PLANT NUTR SOIL SC, V165, P451, DOI 10.1002/1522-2624(200208)165:4<451::AID-JPLN451>3.0.CO;2-B; Kapich AN, 2005, BIOCHEM BIOPH RES CO, V330, P371, DOI 10.1016/j.bbrc.2005.02.167; Kastner M., 2001, BIOPOLYMERS, V1, P349; Kellner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010971; Kellner H, 2009, SOIL BIOL BIOCHEM, V41, P1380, DOI 10.1016/j.soilbio.2009.03.012; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Koua D, 2009, NUCLEIC ACIDS RES, V37, pD261, DOI 10.1093/nar/gkn680; Laitat E, 1999, FOREST ECOSYSTEM MODELLING, UPSCALING AND REMOTE SENSING, P33; Larson JL, 2002, SOIL SCI SOC AM J, V66, P1848, DOI 10.2136/sssaj2002.1848; Liers C, 2011, FEMS MICROBIOL ECOL, V78, P91, DOI 10.1111/j.1574-6941.2011.01144.x; Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7; Luis P, 2005, GEODERMA, V128, P18, DOI 10.1016/j.geoderma.2004.12.023; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Maijala P, 2003, MYCOLOGIA, V95, P209, DOI 10.2307/3762032; Morgenstern I, 2008, J MOL EVOL, V66, P243, DOI 10.1007/s00239-008-9079-3; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Pecyna MJ, 2009, APPL MICROBIOL BIOT, V84, P885, DOI 10.1007/s00253-009-2000-1; Ranger J, 2006, SITE EXPT FORET BREU, P51; Robert C, 2010, CURR DRUG METAB, V11, P162, DOI 10.2174/138920010791110845; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Snajdr J, 2011, FEMS MICROBIOL ECOL, V75, P291, DOI 10.1111/j.1574-6941.2010.00999.x; Steffen KT, 2007, RES MICROBIOL, V158, P447, DOI 10.1016/j.resmic.2007.04.002; Steffen KT, 2002, APPL ENVIRON MICROB, V68, P3442, DOI 10.1128/AEM.68.7.3442-3448.2002; Steffen KT, 2000, APPL MICROBIOL BIOT, V54, P819, DOI 10.1007/s002530000473; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torres E, 2010, BIOCATALYSIS BASED H, P358; Ulrich R, 2004, APPL ENVIRON MICROB, V70, P4575, DOI 10.1128/AEM.70.8.4575-4581.2004; Valaskova V, 2007, SOIL BIOL BIOCHEM, V39, P2651, DOI 10.1016/j.soilbio.2007.05.023; WARIISHI H, 1989, J BIOL CHEM, V264, P3335; Weber CF, 2011, ENVIRON MICROBIOL, V13, P2778, DOI 10.1111/j.1462-2920.2011.02548.x; Wunderwald U, 2000, APPL MICROBIOL BIOT, V53, P441, DOI 10.1007/s002530051639; Yoshida T, 2011, FEBS J, V278, P2387, DOI 10.1111/j.1742-4658.2011.08161.x; Zamocky M, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P7, DOI 10.1007/978-3-642-12627-7_2	58	68	70	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95557	10.1371/journal.pone.0095557	http://dx.doi.org/10.1371/journal.pone.0095557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763280	Green Published, gold			2022-12-25	WOS:000335505000027
J	Lowe, DE; Ya, J; Glomski, IJ				Lowe, David E.; Ya, Jason; Glomski, Ian J.			In Trans Complementation of Lethal Factor Reveal Roles in Colonization and Dissemination in a Murine Mouse Model	PLOS ONE			English	Article							ANTHRAX PROTECTIVE ANTIGEN; BACILLUS-ANTHRACIS; INHALATIONAL ANTHRAX; EUKARYOTIC CELLS; VIRULENCE FACTOR; TOXIN RECEPTOR; SPORE SURFACE; EDEMA TOXIN; DELIVERY; GERMINATION	Lethal factor (LF) is a component of the B. anthracis exotoxin and critical for pathogenesis. The roles of LF in early anthrax pathogenesis, such as colonization and dissemination from the initial site of infection, are poorly understood. In mice models of infection, LF-deficient strains either have altered dissemination patterns or do not colonize, precluding analysis of the role of LF in colonization and dissemination from the portal of entry. Previous reports indicate rabbit and guinea pig models infected with LF-deficient strains have decreased virulence, yet the inability to use bioluminescent imaging techniques to track B. anthracis growth and dissemination in these hosts makes analysis of early pathogenesis challenging. In this study, the roles of LF early in infection were analyzed using bioluminescent signature tagged libraries of B. anthracis with varying ratios of LF-producing and LF-deficient clones. Populations where all clones produced LF and populations where only 40% of clones produce LF were equally virulent. The 40% LF-producing clones trans complimented the LF mutants and permitted them to colonize and disseminate. Decreases of the LF producing strains to 10% or 0.3% of the population led to increased host survival and decreased trans complementation of the LF mutants. A library with 10% LF producing clones could replicate and disseminate, but fewer clones disseminated and the mutant clones were less competitive than wild type. The inoculum with 0.3% LF producing clones could not colonize the host. This strongly suggests that between 10% and 0.3% of the population must produce LF in order to colonize. In total, these findings suggest that a threshold of LF must be produced in order for colonization and dissemination to occur in vivo. These observations suggest that LF has a major role in the early stages of colonization and dissemination.	[Lowe, David E.; Ya, Jason; Glomski, Ian J.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA	University of Virginia	Glomski, IJ (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	ijg2b@virginia.edu			NIH NIAID [5R03AI090205, 5T35AI060528]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432, T35AI060528, T32AI007046, R03AI090205] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH NIAID 5R03AI090205 and NIH NIAID 5T35AI060528. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Bakardjiev AI, 2006, PLOS PATHOG, V2, P623, DOI 10.1371/journal.ppat.0020066; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Corre JP, 2013, J INFECT DIS, V207, P450, DOI 10.1093/infdis/jis686; Cote CK, 2009, J MED MICROBIOL, V58, P816, DOI 10.1099/jmm.0.008656-0; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Dumetz F, 2011, AM J PATHOL, V178, P2523, DOI 10.1016/j.ajpath.2011.02.027; EZZELL JW, 1992, J GEN MICROBIOL, V138, P543, DOI 10.1099/00221287-138-3-543; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Guidi-Rontani C, 2002, TRENDS MICROBIOL, V10, P405, DOI 10.1016/S0966-842X(02)02422-8; Ha SD, 2010, J BIOL CHEM, V285, P2120, DOI 10.1074/jbc.M109.065813; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Ireland JAW, 2002, J BACTERIOL, V184, P1296, DOI 10.1128/JB.184.5.1296-1303.2002; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Levy H, 2012, INFECT IMMUN, V80, P2623, DOI 10.1128/IAI.00244-12; Levy H, 2011, MICROB PATHOGENESIS, V51, P345, DOI 10.1016/j.micpath.2011.07.004; Liu SH, 2013, NATURE, V501, P63, DOI 10.1038/nature12510; Lovchik JA, 2012, INFECT IMMUN, V80, P2414, DOI 10.1128/IAI.06340-11; Loving CL, 2009, INFECT IMMUN, V77, P255, DOI 10.1128/IAI.00633-08; Lowe DE, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00076; Lowe DE, 2013, INFECT IMMUN; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; MEYNELL GG, 1957, J GEN MICROBIOL, V16, P38, DOI 10.1099/00221287-16-1-38; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Moayeri M, 2007, INFECT IMMUN, V75, P5175, DOI 10.1128/IAI.00719-07; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; National Research Council, 2011, GUIDE CARE USE LAB A; Plaut RD, 2012, INFECT IMMUN, V80, P3189, DOI 10.1128/IAI.00515-12; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; RISTROPH JD, 1983, INFECT IMMUN, V39, P483, DOI 10.1128/IAI.39.1.483-486.1983; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sirard JC, 1995, RES MICROBIOL, V146, P729, DOI 10.1016/0923-2508(96)81069-2; SMITH H, 1962, J GEN MICROBIOL, V29, P517, DOI 10.1099/00221287-29-3-517; STANLEY JL, 1960, J GEN MICROBIOL, V22, P206, DOI 10.1099/00221287-22-1-206; Sylvestre P, 2005, J BACTERIOL, V187, P5122, DOI 10.1128/JB.187.15.5122-5128.2005; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; Team RDC, 2019, R LANG ENV STAT COMP; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Walsh JJ, 2007, CLIN INFECT DIS, V44, P968, DOI 10.1086/512372; Weiner ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030201; Weiner ZP, 2012, INFECT IMMUN, V80, P1626, DOI 10.1128/IAI.06061-11; Weiner ZP, 2014, CELL MICROBIOL; WELKOS SL, 1993, MICROB PATHOGENESIS, V14, P381, DOI 10.1006/mpat.1993.1037; WHO, 2008, ANTHRAX HUMANS ANIMA; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	51	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95950	10.1371/journal.pone.0095950	http://dx.doi.org/10.1371/journal.pone.0095950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763227	gold, Green Submitted, Green Published			2022-12-25	WOS:000335505000044
J	Schutsky, K; Portocarrero, C; Hooper, DC; Dietzschold, B; Faber, M				Schutsky, Keith; Portocarrero, Carla; Hooper, D. Craig; Dietzschold, Bernhard; Faber, Milosz			Limited Brain Metabolism Changes Differentiate between the Progression and Clearance of Rabies Virus	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ATTENUATED RECOMBINANT RABIES; L-CARNITINE; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; TRANSGENIC MICE; HPA AXIS; IN-VIVO; INFECTION; EXPRESSION	Central nervous system (CNS) metabolic profiles were examined from rabies virus (RABV)-infected mice that were either mock-treated or received post-exposure treatment (PET) with a single dose of the live recombinant RABV vaccine TriGAS. CNS tissue harvested from mock-treated mice at middle and late stage infection revealed numerous changes in energy metabolites, neurotransmitters and stress hormones that correlated with replication levels of viral RNA. Although the large majority of these metabolic changes were completely absent in the brains of TriGAS-treated mice most likely due to the strong reduction in virus spread, TriGAS treatment resulted in the up-regulation of the expression of carnitine and several acylcarnitines, suggesting that these compounds are neuroprotective. The most striking change seen in mock-treated RABV-infected mice was a dramatic increase in brain and serum corticosterone levels, with the later becoming elevated before clinical signs or loss of body weight occurred. We speculate that the rise in corticosterone is part of a strategy of RABV to block the induction of immune responses that would otherwise interfere with its spread. In support of this concept, we show that pharmacological intervention to inhibit corticosterone biosynthesis, in the absence of vaccine treatment, significantly reduces the pathogenicity of RABV. Our results suggest that widespread metabolic changes, including hypothalamic-pituitary-adrenal axis activation, contribute to the pathogenesis of RABV and that preventing these alterations early in infection with PET or pharmacological blockade helps protect brain homeostasis, thereby reducing disease mortality.	[Schutsky, Keith; Dietzschold, Bernhard; Faber, Milosz] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Portocarrero, Carla; Hooper, D. Craig] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Faber, M (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	milosz.faber@jefferson.edu		Hooper, Douglas/0000-0002-8578-5104	National Institutes of Health [R01AI093666, 2R56AI060686-06, UO1AI083045, R01AI093369]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093369, R56AI060686, R01AI093666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by grants R01AI093666 (to MF), 2R56AI060686-06 (to BD), and UO1AI083045 and R01AI093369 (to DCH) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beliakov N A, 2012, Vestn Ross Akad Med Nauk, P4; Chopy DM, 2012, Patent Application, Patent No. [PCT/EP2012/061536, PCT2012061536]; de la Monte SM, 2012, DRUGS, V72, P49, DOI 10.2165/11597760-000000000-00000; De Simone C, 1982, Acta Vitaminol Enzymol, V4, P135; Dhingra V, 2007, J NEUROVIROL, V13, P107, DOI 10.1080/13550280601178226; Dietzschold B, 2008, FUTURE VIROL, V3, P481, DOI 10.2217/17460794.3.5.481; ENRIGHT JB, 1970, J AM VET MED ASSOC, V156, P765; Faber M, 2005, J VIROL, V79, P14141, DOI 10.1128/JVI.79.22.14141-14148.2005; Faber M, 2009, ZOONOSES PUBLIC HLTH, V56, P262, DOI 10.1111/j.1863-2378.2008.01215.x; Faber M, 2007, J VIROL, V81, P7041, DOI 10.1128/JVI.00357-07; Faber M, 2009, P NATL ACAD SCI USA, V106, P11300, DOI 10.1073/pnas.0905640106; Fu ZF, 2008, DEV BIOLOGICALS, V131, P83; FU ZF, 1993, J VIROL, V67, P6674; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Hemachudha T, 1994, Curr Top Microbiol Immunol, V187, P121; Hooper DC, 1998, J VIROL, V72, P3711, DOI 10.1128/JVI.72.5.3711-3719.1998; Jackson AC, 1997, J VIROL, V71, P5603, DOI 10.1128/JVI.71.7.5603-5607.1997; Jackson AC, 2011, CAN J NEUROL SCI, V38, P689, DOI 10.1017/S0317167100054056; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; JANIRI L, 1991, J NEURAL TRANSM-GEN, V86, P135, DOI 10.1007/BF01250574; JIRILLO E, 1993, MEDIAT INFLAMM, V2, pS17, DOI 10.1155/S0962935193000699; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kawamata J, 2011, J ALZHEIMERS DIS, V24, P95, DOI 10.3233/JAD-2011-110173; Kawashima H, 2006, INT J NEUROSCI, V116, P927, DOI 10.1080/00207450600550519; Klingen Y, 2008, J VIROL, V82, P237, DOI 10.1128/JVI.01342-07; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; LENTZ TL, 1983, YALE J BIOL MED, V56, P315; Li JW, 2012, J VIROL, V86, P3200, DOI 10.1128/JVI.06699-11; Li JW, 2011, ADV VIRUS RES, V79, P115, DOI 10.1016/B978-0-12-387040-7.00007-X; Malaguarnera M, 2008, DIGEST DIS SCI, V53, P3018, DOI 10.1007/s10620-008-0238-6; Marcovina SM, 2013, TRANSL RES, V161, P73, DOI 10.1016/j.trsl.2012.10.006; MURPHY FA, 1977, ARCH VIROL, V54, P279, DOI 10.1007/BF01314774; O'Sullivan A, 2013, J PROTEOME RES, V12, P481, DOI 10.1021/pr3009176; Olah J, 2008, FEBS J, V275, P4740, DOI 10.1111/j.1742-4658.2008.06612.x; Osio M, 2006, J PERIPHER NERV SYST, V11, P72, DOI 10.1111/j.1085-9489.2006.00066.x; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Reinke SN, 2013, J INFECT DIS, V207, P1451, DOI 10.1093/infdis/jis479; Roy A, 2007, J VIROL, V81, P7993, DOI 10.1128/JVI.00710-07; Roy A, 2007, J VIROL, V81, P1110, DOI 10.1128/JVI.01964-06; Roy A, 2008, J NEUROVIROL, V14, P401, DOI 10.1080/13550280802235924; SATO M, 1977, ARCH VIROL, V53, P269, DOI 10.1007/BF01314672; Schutsky K, 2013, J VIROL, V87, P1834, DOI 10.1128/JVI.02589-12; Scott CA, 2008, J VIROL, V82, P513, DOI 10.1128/JVI.01677-07; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Silverman MN, 2005, VIRAL IMMUNOL, V18, P41, DOI 10.1089/vim.2005.18.41; Smets LA, 1999, ADV EXP MED BIOL, V457, P607; SZABO C, 1994, P NATL ACAD SCI USA, V91, P271, DOI 10.1073/pnas.91.1.271; Tait AS, 2008, J LEUKOCYTE BIOL, V84, P924, DOI 10.1189/jlb.0208104; TSIANG H, 1979, J NEUROPATH EXP NEUR, V38, P286, DOI 10.1097/00005072-197905000-00008; WHO, 2004, WHO TECHN REP SER; Wikoff WR, 2008, J CLIN INVEST, V118, P2661, DOI 10.1172/JCI34138; Wilde H, 2007, VACCINE, V25, P7605, DOI 10.1016/j.vaccine.2007.08.054; Xu XH, 2012, NEUROSCI BULL, V28, P641, DOI 10.1007/s12264-012-1272-0; Yan XZ, 2001, J NEUROVIROL, V7, P518, DOI 10.1080/135502801753248105	56	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e87180	10.1371/journal.pone.0087180	http://dx.doi.org/10.1371/journal.pone.0087180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763072	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000001
J	Cheishvili, D; Dietrich, P; Maayan, C; Even, A; Weil, M; Dragatsis, I; Razin, A				Cheishvili, David; Dietrich, Paula; Maayan, Channa; Even, Aviel; Weil, Miguel; Dragatsis, Ioannis; Razin, Aharon			IKAP Deficiency in an FD Mouse Model and in Oligodendrocyte Precursor Cells Results in Downregulation of Genes Involved in Oligodendrocyte Differentiation and Myelin Formation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RILEY-DAY SYNDROME; B KINASE COMPLEX; FAMILIAL DYSAUTONOMIA; ELONGATOR COMPLEX; IKBKAP GENE; TRANSCRIPTIONAL ELONGATION; SURAL NERVE; RAT-BRAIN; IN-VIVO	The splice site mutation in the IKBKAP gene coding for IKAP protein leads to the tissue-specific skipping of exon 20, with concomitant reduction in IKAP protein production. This causes the neurodevelopmental, autosomal-recessive genetic disorder - Familial Dysautonomia (FD). The molecular hallmark of FD is the severe reduction of IKAP protein in the nervous system that is believed to be the main reason for the devastating symptoms of this disease. Our recent studies showed that in the brain of two FD patients, genes linked to oligodendrocyte differentiation and/or myelin formation are significantly downregulated, implicating IKAP in the process of myelination. However, due to the scarcity of FD patient tissues, these results awaited further validation in other models. Recently, two FD mouse models that faithfully recapitulate FD were generated, with two types of mutations resulting in severely low levels of IKAP expression. Here we demonstrate that IKAP deficiency in these FD mouse models affects a similar set of genes as in FD patients' brains. In addition, we identified two new IKAP target genes involved in oligodendrocyte cells differentiation and myelination, further underscoring the essential role of IKAP in this process. We also provide proof that IKAP expression is needed cell-autonomously for the regulation of expression of genes involved in myelin formation since knockdown of IKAP in the Oli-neu oligodendrocyte precursor cell line results in similar deficiencies. Further analyses of these two experimental models will compensate for the lack of human postmortem tissues and will advance our understanding of the role of IKAP in myelination and the disease pathology.	[Cheishvili, David; Maayan, Channa] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pediat, Familial Dysauton Ctr, IL-91010 Jerusalem, Israel; [Dietrich, Paula; Dragatsis, Ioannis] Univ Tennessee, Coll Med, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Even, Aviel; Weil, Miguel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Lab Neurodegenerat Dis & Personalized Med, IL-69978 Tel Aviv, Israel; [Cheishvili, David; Razin, Aharon] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; University of Tennessee System; University of Tennessee Health Science Center; Tel Aviv University; Hebrew University of Jerusalem	Dragatsis, I (corresponding author), Univ Tennessee, Coll Med, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA.	idragatsis@uthsc.edu; aharonr@ekmd.huji.ac.il	Cheishvili, David/AAL-1915-2020		Israeli Familial Dysautonomia Foundation; National Institutes of Health [NS061842]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061842] Funding Source: NIH RePORTER	Israeli Familial Dysautonomia Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by the Israeli Familial Dysautonomia Foundation to AR. This work was supported by the National Institutes of Health [NS061842] to ID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUAYO AJ, 1971, ARCH NEUROL-CHICAGO, V24, P106, DOI 10.1001/archneur.1971.00480320034003; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Awatramani R, 1997, J NEUROSCI, V17, P6657; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Axelrod FB, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-39; Axelrod FB, 2010, J NEUROL, V257, P198, DOI 10.1007/s00415-009-5293-1; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bochner R, 2013, HUM MOL GENET, V22, P2785, DOI 10.1093/hmg/ddt126; Carmel I, 2004, RNA, V10, P828, DOI 10.1261/rna.5196404; Cheishvili D, 2007, HUM MOL GENET, V16, P2097, DOI 10.1093/hmg/ddm157; Cheishvili D, 2011, HUM MOL GENET, V20, P1585, DOI 10.1093/hmg/ddr036; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Coli R, 2001, GENE, V279, P81, DOI 10.1016/S0378-1119(01)00737-5; Cuajungco MP, 2003, AM J HUM GENET, V72, P749, DOI 10.1086/368263; Cuajungco MP, 2001, DNA CELL BIOL, V20, P579, DOI 10.1089/104454901317094990; Dietrich P, 2012, HUM MOL GENET, V21, P5078, DOI 10.1093/hmg/dds354; Dietrich P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027015; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; FOGELSON MH, 1967, ARCH NEUROL-CHICAGO, V17, P103, DOI 10.1001/archneur.1967.00470250107012; Ganfornina MD, 2010, GLIA, V58, P1320, DOI 10.1002/glia.21010; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Groom M, 1997, J NEURO-OPHTHALMOL, V17, P101; GUZZETTA F, 1986, DEV MED CHILD NEUROL, V28, P62; HARDY R, 1993, J NEUROSCI RES, V36, P121, DOI 10.1002/jnr.490360202; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hilz MJ, 2000, CLIN AUTON RES, V10, P177, DOI 10.1007/BF02291353; Hims MM, 2007, GENOMICS, V90, P389, DOI 10.1016/j.ygeno.2007.05.012; Hirata T, 2007, BRAIN RES, V1130, P214, DOI 10.1016/j.brainres.2006.10.077; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Huizing Marjan, 2005, Pediatr Endocrinol Rev, V3, P97; Hunnicutt BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032050; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Joubert L, 2010, J NEUROSCI RES, V88, P2546, DOI 10.1002/jnr.22434; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; MAAYAN C, 1987, CLIN GENET, V32, P106; Macefield VG, 2011, BRAIN, V134, P3198, DOI 10.1093/brain/awr168; Mitew S, 2013, NEUROSCIENCE; Murakami K, 2013, NEUROSCIENCE, V236, P1, DOI 10.1016/j.neuroscience.2012.12.073; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; PEARSON J, 1978, J NEUROL SCI, V35, P77, DOI 10.1016/0022-510X(78)90103-X; PEARSON J, 1975, J NEUROPATH EXP NEUR, V34, P413, DOI 10.1097/00005072-197509000-00004; Pereira GB, 2011, J NEUROSCI RES, V89, P1070, DOI 10.1002/jnr.22625; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; RILEY CM, 1949, PEDIATRICS, V3, P468; Schnaar RL, 1998, ANN NY ACAD SCI, V845, P92, DOI 10.1111/j.1749-6632.1998.tb09664.x; Seidl AH, 2013, NEUROSCIENCE, DOI 10.1016/j.neuroscience.2013.06.047; Sim FJ, 2000, NEUROSCIENCE, V100, P131, DOI 10.1016/S0306-4522(00)00252-9; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Tzakos AG, 2005, CURR MED CHEM, V12, P1569, DOI 10.2174/0929867054039026; Woodward K, 2001, PHARMACOGENOMICS, V2, P263, DOI 10.1517/14622416.2.3.263	57	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94612	10.1371/journal.pone.0094612	http://dx.doi.org/10.1371/journal.pone.0094612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760006	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200021
J	Mavromatidis, V; Varga, Z; Waczek, F; Orfi, Z; Orfi, L; Keri, G; Mosialos, G				Mavromatidis, Vassilis; Varga, Zoltan; Waczek, Frigyes; Orfi, Zoltan; Orfi, Laszlo; Keri, Gyoergy; Mosialos, George			Identification of Protein Kinase Inhibitors with a Selective Negative Effect on the Viability of Epstein-Barr Virus Infected B Cell Lines	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; TYROSINE KINASE; BURKITTS-LYMPHOMA; CROSS-LINKING; ACTIVATION; LCK; 2A; EXPRESSION; SURVIVAL; LATENCY	Epstein-Barr virus (EBV) is a human herpesvirus, which is causally associated with the development of several B lymphocytic malignancies that include Burkitt's lymphomas, Hodgkin's disease, AIDS and posttransplant associated lymphomas. The transforming activity of EBV is orchestrated by several latent viral proteins that mimic and modulate cellular growth promoting and antiapoptotic signaling pathways, which involve among others the activity of protein kinases. In an effort to identify small molecule inhibitors of the growth of EBV-transformed B lymphocytes a library of 254 kinase inhibitors was screened. This effort identified two tyrosine kinase inhibitors and two MEK inhibitors that compromised preferentially the viability of EBV-infected human B lymphocytes. Our findings highlight the possible dependence of EBV-infected B lymphocytes on specific kinase-regulated pathways underlining the potential for the development of small molecule-based therapeutics that could target selectively EBV-associated human B lymphocyte malignancies.	[Mavromatidis, Vassilis; Mosialos, George] Aristotle Univ Thessaloniki, Sch Biol, GR-54006 Thessaloniki, Greece; [Varga, Zoltan; Waczek, Frigyes; Orfi, Laszlo; Keri, Gyoergy] Vichem Chem Ltd, Budapest, Hungary; [Orfi, Zoltan] Max Planck Inst Biochem, Dept Mol Biol, Martinsried, Germany; [Orfi, Laszlo] Semmelweis Univ, Dept Pharmaceut Chem, H-1085 Budapest, Hungary; [Keri, Gyoergy] Semmelweis Univ, Dept Med Chem, MTA SE Pathobiochem Res Grp, H-1085 Budapest, Hungary	Aristotle University of Thessaloniki; Vichem Chemie Research Ltd.; Max Planck Society; Semmelweis University; Semmelweis University	Mosialos, G (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, GR-54006 Thessaloniki, Greece.	gmosialo@bio.auth.gr	Orfi, Laszlo/A-2116-2008	Orfi, Laszlo/0000-0001-6149-2385; Orfi, Zoltan/0000-0001-6099-2206	European Union [LSHC-CT-2005-018704]; Leukemia and Lymphoma Society Scholarship; National Research and Technology Agency of Hungary [NKTH-STEMKILL OM-0010/2008]; Vichem Chemie Ltd.	European Union(European Commission); Leukemia and Lymphoma Society Scholarship(Leukemia and Lymphoma Society); National Research and Technology Agency of Hungary; Vichem Chemie Ltd.	This work was supported by the Sixth Research Framework Programme of the European Union (Project INCA, LSHC-CT-2005-018704), a Leukemia and Lymphoma Society Scholarship (GM) and a grant by the National Research and Technology Agency of Hungary (NKTH-STEMKILL OM-0010/2008 to GK. Vichem Chemie Ltd., provided support in the form of salaries for authors ZV, FW, LO and GK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Anderson LJ, 2008, J GEN VIROL, V89, P1563, DOI 10.1099/vir.0.2008/001461-0; Apollonio B, 2013, BLOOD, V121, P3879, DOI 10.1182/blood-2012-12-474718; Arnold LD, 2000, BIOORG MED CHEM LETT, V10, P2167, DOI 10.1016/S0960-894X(00)00441-8; Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; Bieging KT, 2010, CELL CYCLE, V9, P901, DOI 10.4161/cc.9.5.10840; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; Chen SY, 2002, J VIROL, V76, P9556, DOI 10.1128/JVI.76.18.9556-9561.2002; Ciruela A, 2003, BRIT J PHARMACOL, V138, P751, DOI 10.1038/sj.bjp.0705103; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fruehling S, 1998, J VIROL, V72, P7796, DOI 10.1128/JVI.72.10.7796-7806.1998; GOLD MR, 1994, J IMMUNOL, V153, P2369; Gururajan M, 2006, J IMMUNOL, V176, P5715, DOI 10.4049/jimmunol.176.10.5715; Harr MW, 2010, CELL DEATH DIFFER, V17, P1381, DOI 10.1038/cdd.2010.25; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Katano H, 2004, P NATL ACAD SCI USA, V101, P4960, DOI 10.1073/pnas.0305149101; Keri G, 2006, CURR SIGNAL TRANSD T, V1, P67, DOI 10.2174/157436206775269190; Kong L, 2011, MOL CELL BIOCHEM, V348, P11, DOI 10.1007/s11010-010-0632-1; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lenoir G M, 1985, IARC Sci Publ, P309; Majolini MB, 1998, BLOOD, V91, P3390, DOI 10.1182/blood.V91.9.3390.3390_3390_3396; Mancao C, 2007, BLOOD, V110, P3715, DOI 10.1182/blood-2007-05-090142; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; MILLER CL, 1994, P NATL ACAD SCI USA, V91, P772, DOI 10.1073/pnas.91.2.772; MILLER CL, 1993, J VIROL, V67, P3087, DOI 10.1128/JVI.67.6.3087-3094.1993; Pang MF, 2009, CELL MOL BIOL LETT, V14, P222, DOI 10.2478/s11658-008-0045-2; Robak T, 2012, EXPERT OPIN INV DRUG, V21, P921, DOI 10.1517/13543784.2012.685650; Roberts ML, 1998, VIROLOGY, V240, P93, DOI 10.1006/viro.1997.8901; ROBERTSON E, 1995, J VIROL, V69, P983, DOI 10.1128/JVI.69.2.983-993.1995; Soni V, 2007, ADV EXP MED BIOL, V597, P173; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Stachlewitz RF, 2005, J PHARMACOL EXP THER, V315, P36, DOI 10.1124/jpet.105.089169; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; Sun XP, 2010, P NATL ACAD SCI USA, V107, P3146, DOI 10.1073/pnas.0910717107; VonKnethen A, 1997, LEUKEMIA LYMPHOMA, V26, P551; Wauson EM, 2013, BIOCHEMISTRY-US, V52, P5164, DOI 10.1021/bi4007644; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002	43	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95688	10.1371/journal.pone.0095688	http://dx.doi.org/10.1371/journal.pone.0095688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759913	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200077
J	Zhou, ZH; Huang, CC; Shung, KK; Tsui, PH; Fang, J; Ma, HY; Wu, SC; Lin, CC				Zhou, Zhuhuang; Huang, Chih-Chung; Shung, K. Kirk; Tsui, Po-Hsiang; Fang, Jui; Ma, Hsiang-Yang; Wu, Shuicai; Lin, Chung-Chih			Entropic Imaging of Cataract Lens: An In Vitro Study	PLOS ONE			English	Article							ULTRASONIC NEEDLE TRANSDUCER; WAVE-FORMS; STATISTICAL-MODEL; SHANNON ENTROPY; HARDNESS; FEASIBILITY	Phacoemulsification is a common surgical method for treating advanced cataracts. Determining the optimal phacoemulsification energy depends on the hardness of the lens involved. Previous studies have shown that it is possible to evaluate lens hardness via ultrasound parametric imaging based on statistical models that require data to follow a specific distribution. To make the method more system-adaptive, nonmodel-based imaging approach may be necessary in the visualization of lens hardness. This study investigated the feasibility of applying an information theory derived parameter - Shannon entropy from ultrasound backscatter to quantify lens hardness. To determine the physical significance of entropy, we performed computer simulations to investigate the relationship between the signal-to-noise ratio (SNR) based on the Rayleigh distribution and Shannon entropy. Young's modulus was measured in porcine lenses, in which cataracts had been artificially induced by the immersion in formalin solution in vitro. A 35-MHz ultrasound transducer was used to scan the cataract lenses for entropy imaging. The results showed that the entropy is 4.8 when the backscatter data form a Rayleigh distribution corresponding to an SNR of 1.91. The Young's modulus of the lens increased from approximately 8 to 100 kPa when we increased the immersion time from 40 to 160 min (correlation coefficient r = 0.99). Furthermore, the results indicated that entropy imaging seemed to facilitate visualizing different degrees of lens hardening. The mean entropy value increased from 2.7 to 4.0 as the Young's modulus increased from 8 to 100 kPa (r = 0.85), suggesting that entropy imaging may have greater potential than that of conventional statistical parametric imaging in determining the optimal energy to apply during phacoemulsification.	[Zhou, Zhuhuang; Wu, Shuicai] Beijing Univ Technol, Ctr Biomed Engn, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Huang, Chih-Chung] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Shung, K. Kirk] Univ So Calif, Dept Biomed Engn, NIH Resource Med Ultrason Transducer Technol, Los Angeles, CA 90089 USA; [Tsui, Po-Hsiang; Ma, Hsiang-Yang] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Univ, Inst Radiol Res, Taoyuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Mem Hosp, Taoyuan, Taiwan; [Fang, Jui] Chang Gung Univ, PhD Program Biomed Engn, Taoyuan, Taiwan; [Ma, Hsiang-Yang] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Lin, Chung-Chih] Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan	Beijing University of Technology; National Cheng Kung University; University of Southern California; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Tsui, PH (corresponding author), Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.	tsuiph@mail.cgu.edu.tw	Zhou, Zhuhuang/M-3301-2019; Tsui, Po-Hsiang/AHE-7426-2022; Huang, Chih-Chung/AAL-2138-2021	Zhou, Zhuhuang/0000-0003-0570-8473; Huang, Chih-Chung/0000-0003-3482-2646; Tsui, Po-Hsiang/0000-0002-5604-1800; Fang, Jui/0000-0003-0234-1397	National Science Council (Taiwan) [NSC 102-2221-E-182-008]; Chang Gung Medical Research Program (CMRP) for Proton Therapy Basic Research [CMRPD1C0661]; Doctoral Fund of Innovation of Beijing University of Technology; National Natural Science Foundation of China [81127006]; National Institutes of Health (NIH) [P41-EB002182]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002182] Funding Source: NIH RePORTER	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Chang Gung Medical Research Program (CMRP) for Proton Therapy Basic Research; Doctoral Fund of Innovation of Beijing University of Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Science Council (Taiwan) under Grant No. NSC 102-2221-E-182-008 and the Chang Gung Medical Research Program (CMRP) for Proton Therapy Basic Research (Grant No. CMRPD1C0661). This work was also supported by the Doctoral Fund of Innovation of Beijing University of Technology and in part by the National Natural Science Foundation of China (Grant No. 81127006). KKS was supported partially by National Institutes of Health (NIH) Grant # P41-EB002182. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christensen DA, 1988, ULTRASONIC BIOINSTRU; Coleman DJ, 2006, ULTRASONOGRAPHY EYE, V2nd; Fontaine I, 1999, BIOPHYS J, V77, P2387, DOI 10.1016/S0006-3495(99)77076-1; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063543; Ho MC, 2012, ULTRASONICS, V52, P215, DOI 10.1016/j.ultras.2011.08.005; Huang CC, 2007, ULTRASOUND MED BIOL, V33, P1971, DOI 10.1016/j.ultrasmedbio.2007.06.004; Huang CC, 2007, ULTRASOUND MED BIOL, V33, P1609, DOI 10.1016/j.ultrasmedbio.2007.05.002; Huang CC, 2009, PHYS MED BIOL, V54, P5981, DOI 10.1088/0031-9155/54/19/021; Hughes MS, 2007, J ACOUST SOC AM, V121, P3542, DOI 10.1121/1.2722050; Hughes MS, 2013, J ACOUST SOC AM, V133, P283, DOI 10.1121/1.4770245; HUGHES MS, 1994, J ACOUST SOC AM, V95, P2582, DOI 10.1121/1.409828; HUGHES MS, 1993, J ACOUST SOC AM, V93, P892, DOI 10.1121/1.405451; Kanski JJ, 2006, CLIN DIAGNOSIS OPHTH; Kapur J. N., 1992, ENTROPY OPTIMIZATION; Shankar PM, 2000, IEEE T ULTRASON FERR, V47, P727, DOI 10.1109/58.842062; Smolikova R, 2004, COMPUT BIOL MED, V34, P355, DOI 10.1016/S0010-4825(03)00072-6; Sugiura T, 1999, J CATARACT REFR SURG, V25, P615, DOI 10.1016/S0886-3350(99)00002-4; Tabandeh H, 2000, J CATARACT REFR SURG, V26, P838, DOI 10.1016/S0886-3350(00)00305-9; Tsui PH, 2007, PHYS MED BIOL, V52, P6413, DOI 10.1088/0031-9155/52/21/005; Tsui PH, 2007, ULTRASOUND MED BIOL, V33, P608, DOI 10.1016/j.ultrasmedbio.2006.10.005; Tsui PH, 2011, PHYSIOL MEAS, V32, P513, DOI 10.1088/0967-3334/32/5/002; Tsui PH, 2011, MED PHYS, V38, P2019, DOI 10.1118/1.3562899; Zhang SY, 2012, J ACOUST SOC AM, V131, P4836, DOI 10.1121/1.4711005	23	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96195	10.1371/journal.pone.0096195	http://dx.doi.org/10.1371/journal.pone.0096195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760103	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200144
J	Macalady, AK; Bugmann, H				Macalady, Alison K.; Bugmann, Harald			Growth-Mortality Relationships in Pinon Pine (Pinus edulis) during Severe Droughts of the Past Century: Shifting Processes in Space and Time	PLOS ONE			English	Article							INDUCED TREE MORTALITY; CARBON-ISOTOPE DISCRIMINATION; DIE-OFF; CLIMATE-CHANGE; ENVIRONMENTAL-STRESS; WHITEBARK-PINE; UNITED-STATES; BARK BEETLES; FOREST; DEATH	The processes leading to drought-associated tree mortality are poorly understood, particularly long-term predisposing factors, memory effects, and variability in mortality processes and thresholds in space and time. We use tree rings from four sites to investigate Pinus edulis mortality during two drought periods in the southwestern USA. We draw on recent sampling and archived collections to (1) analyze P. edulis growth patterns and mortality during the 1950s and 2000s droughts; (2) determine the influence of climate and competition on growth in trees that died and survived; and (3) derive regression models of growth-mortality risk and evaluate their performance across space and time. Recent growth was 53% higher in surviving vs. dying trees, with some sites exhibiting decades-long growth divergences associated with previous drought. Differential growth response to climate partly explained growth differences between live and dead trees, with responses wet/cool conditions most influencing eventual tree status. Competition constrained tree growth, and reduced trees' ability to respond to favorable climate. The best predictors in growth-mortality models included long-term (15-30 year) average growth rate combined with a metric of growth variability and the number of abrupt growth increases over 15 and 10 years, respectively. The most parsimonious models had high discriminatory power (ROC>0.84) and correctly classified similar to 70% of trees, suggesting that aspects of tree growth, especially over decades, can be powerful predictors of widespread drought-associated die-off. However, model discrimination varied across sites and drought events. Weaker growth-mortality relationships and higher growth at lower survival probabilities for some sites during the 2000s event suggest a shift in mortality processes from longer-term growth-related constraints to shorter-term processes, such as rapid metabolic decline even in vigorous trees due to acute drought stress, and/or increases in the attack rate of both chronically stressed and more vigorous trees by bark beetles.	[Macalady, Alison K.] Univ Arizona, Sch Geog & Dev, Tucson, AZ 85721 USA; [Macalady, Alison K.] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA; [Bugmann, Harald] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland	University of Arizona; University of Arizona; Swiss Federal Institutes of Technology Domain; ETH Zurich	Macalady, AK (corresponding author), Univ Arizona, Sch Geog & Dev, Tucson, AZ 85721 USA.	amacalad@email.arizona.edu	Bugmann, Harald/A-1252-2008		US Department of Energy; National Science Foundation; University of Arizona, Laboratory of Tree-Ring Research; Swiss National Science Foundation	US Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); University of Arizona, Laboratory of Tree-Ring Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	AKM was supported by a US Department of Energy Graduate Research Environmental Fellowship (GREF) and the GK-12 Graduate Fellows Program of the National Science Foundation. HB was supported by a Haury Fellowship from the University of Arizona, Laboratory of Tree-Ring Research. This work is also a contribution to the Swiss National Center of Competence in Research (NCCR) 'Climate', funded by the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2013, GLOBAL CHANGE BIOL, V19, P1188, DOI 10.1111/gcb.12100; Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; [Anonymous], 2003, ROC GRAPHS NOTES PRA; APPLEQUIST M. B., 1958, JOUR FOREST, V56, P141; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Bigler C, 2006, ECOSYSTEMS, V9, P330, DOI 10.1007/s10021-005-0126-2; Bigler C, 2004, ECOL APPL, V14, P902, DOI 10.1890/03-5011; Bigler C, 2004, ECOL MODEL, V174, P225, DOI 10.1016/j.ecolmodel.2003.09.025; Bigler C, 2003, CAN J FOREST RES, V33, P210, DOI [10.1139/x02-180, 10.1139/X02-180]; Bigler C, 2007, OIKOS, V116, P1983, DOI 10.1111/j.2007.0030-1299.16034.x; Biondi F, 2008, ECOLOGY, V89, P1056, DOI 10.1890/07-0783.1; Biondi F, 2008, TREE-RING RES, V64, P81, DOI 10.3959/2008-6.1; Bonan G, 2008, NAT GEOSCI, V1, P645, DOI 10.1038/ngeo328; Boone CK, 2011, CAN J FOREST RES, V41, P1174, DOI [10.1139/X11-041, 10.1139/x11-041]; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Breshears DD, 2011, AMBIO, V40, P256, DOI 10.1007/s13280-010-0106-4; Breshears DD, 2009, FRONT ECOL ENVIRON, V7, P185, DOI 10.1890/080016; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Carbone MS, 2013, NEW PHYTOL, V200, P1145, DOI 10.1111/nph.12448; Linares JC, 2010, J ECOL, V98, P592, DOI 10.1111/j.1365-2745.2010.01645.x; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Clifford MJ, 2013, NEW PHYTOL, V200, P413, DOI 10.1111/nph.12362; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Das AJ, 2007, CAN J FOREST RES, V37, P580, DOI 10.1139/X06-262; Dobbertin M, 2005, EUR J FOREST RES, V124, P319, DOI 10.1007/s10342-005-0085-3; Fettig CJ, 2007, FOREST ECOL MANAG, V238, P24, DOI 10.1016/j.foreco.2006.10.011; Fisher R, 2010, NEW PHYTOL, V187, P666, DOI 10.1111/j.1469-8137.2010.03340.x; Floyd ML, 2009, ECOL APPL, V19, P1223, DOI 10.1890/08-1265.1; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; FRITTS HC, 1965, ECOLOGY, V46, P393, DOI 10.2307/1934872; Galiano L, 2011, NEW PHYTOL, V190, P750, DOI 10.1111/j.1469-8137.2010.03628.x; Gaylord ML, 2013, NEW PHYTOL, V198, P567, DOI 10.1111/nph.12174; Greenwood DL, 2008, FOREST ECOL MANAG, V255, P2129, DOI 10.1016/j.foreco.2007.12.048; Guerard N, 2007, ANN FOREST SCI, V64, P601, DOI 10.1051/forest:2007038; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; Hacke UG, 2001, PLANT PHYSIOL, V125, P779, DOI 10.1104/pp.125.2.779; Harrell FE, 2001, REGRESSION MODELING; Hawkes C, 2000, ECOL MODEL, V126, P225, DOI 10.1016/S0304-3800(00)00267-2; Heres AM, 2012, TREES-STRUCT FUNCT, V26, P621, DOI 10.1007/s00468-011-0628-9; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Keane RE, 2001, CLIMATIC CHANGE, V51, P509, DOI 10.1023/A:1012539409854; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Landhausser SM, 2012, TREES-STRUCT FUNCT, V26, P653, DOI 10.1007/s00468-011-0633-z; Levanic T, 2011, TREE PHYSIOL, V31, P298, DOI 10.1093/treephys/tpq111; Manion PD, 1991, TREE DIS CONCEPTS; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2013, NEW PHYTOL, V200, P304, DOI 10.1111/nph.12465; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; McDowell NG, 2010, GLOBAL CHANGE BIOL, V16, P399, DOI 10.1111/j.1365-2486.2009.01994.x; McDowell NG, 2011, PLANT PHYSIOL, V155, P1051, DOI 10.1104/pp.110.170704; Millar CI, 2007, CAN J FOREST RES, V37, P2508, DOI 10.1139/X07-097; Millar CI, 2012, CAN J FOREST RES, V42, P749, DOI [10.1139/X2012-031, 10.1139/x2012-031]; Negron JF, 2003, WEST N AM NATURALIST, V63, P440; Ogle K, 2000, ECOLOGY, V81, P3237, DOI 10.1890/0012-9658(2000)081[3237:TRVIPP]2.0.CO;2; Paik M. C., 2013, STAT METHODS RATES P; Pedersen BS, 1998, ECOLOGY, V79, P79, DOI 10.1890/0012-9658(1998)079[0079:TROSIT]2.0.CO;2; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Perkins DL, 1996, CAN J FOREST RES, V26, P2123, DOI 10.1139/x26-241; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plaut JA, 2013, NEW PHYTOL, V200, P375, DOI 10.1111/nph.12392; Poyatos R, 2013, NEW PHYTOL, V200, P388, DOI 10.1111/nph.12278; R Core Team, 2021, R LANG ENV STAT COMP; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Richardson AD, 2013, NEW PHYTOL, V197, P850, DOI 10.1111/nph.12042; Rogers TJ, 1993, RM236 USDA FOR SERV, P42; Ruiz-Benito P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056843; Sala A, 2010, NEW PHYTOL, V186, P274, DOI 10.1111/j.1469-8137.2009.03167.x; Santos MJ, 2010, ENVIRON MANAGE, V45, P239, DOI 10.1007/s00267-009-9413-6; Seidl R, 2011, ECOL MODEL, V222, P903, DOI 10.1016/j.ecolmodel.2010.09.040; Sthultz CM, 2009, GLOBAL CHANGE BIOL, V15, P1949, DOI 10.1111/j.1365-2486.2009.01901.x; Stokes M.A., 1968, INTRO TREE RING DATI; Strackee J., 1992, Dendrochronologia, P121; Suarez ML, 2004, J ECOL, V92, P954, DOI 10.1111/j.1365-2745.2004.00941.x; Swetnam TW, 1998, J CLIMATE, V11, P3128, DOI 10.1175/1520-0442(1998)011<3128:MDAERT>2.0.CO;2; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; WARING RH, 1987, BIOSCIENCE, V37, P569, DOI 10.2307/1310667; Weiss JL, 2009, J CLIMATE, V22, P5918, DOI 10.1175/2009JCLI2905.1; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Wood S. L., 1982, The bark and ambrosia beetles of North and Central America (Coleoptera : Scolytidae), a taxonomic monograph.; Wunder J, 2007, THESIS ETH ZURICH ZU; Wunder J, 2008, OIKOS, V117, P815, DOI 10.1111/j.0030-1299.2008.16371.x; Wunder J, 2008, J ECOL, V96, P174, DOI 10.1111/j.1365-2745.2007.01316.x; Wunder J, 2007, J VEG SCI, V18, P525, DOI 10.1111/j.1654-1103.2007.tb02567.x; Wyckoff PH, 2002, J ECOL, V90, P604, DOI 10.1046/j.1365-2745.2002.00691.x; Zeppel MJB, 2011, NEW PHYTOL, V192, P800, DOI 10.1111/j.1469-8137.2011.03960.x; Zuur Alain F., 2009, P1	99	51	52	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e92770	10.1371/journal.pone.0092770	http://dx.doi.org/10.1371/journal.pone.0092770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24786646	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700005
J	Nesbitt, AMI; McCurdy, RD; Bryant, SM; Alter, MD				Nesbitt, Addie May I.; McCurdy, Richard D.; Bryant, Sharell M.; Alter, Mark D.			Total Levels of Hippocampal Histone Acetylation Predict Normal Variability in Mouse Behavior	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; MEMORY FORMATION; EPIGENETIC REGULATION; SYNAPTIC PLASTICITY; STRUCTURAL PLASTICITY; DNA METHYLATION; NERVOUS-SYSTEM; CHROMATIN; STRESS; MODEL	Background: Genetic, pharmacological, and environmental interventions that alter total levels of histone acetylation in specific brain regions can modulate behaviors and treatment responses. Efforts have been made to identify specific genes that are affected by alterations in total histone acetylation and to propose that such gene specific modulation could explain the effects of total histone acetylation levels on behavior - the implication being that under naturalistic conditions variability in histone acetylation occurs primarily around the promoters of specific genes. Methods/Results: Here we challenge this hypothesis by demonstrating with a novel flow cytometry based technique that normal variability in open field exploration, a hippocampus-related behavior, was associated with total levels of histone acetylation in the hippocampus but not in other brain regions. Conclusions: Results suggest that modulation of total levels of histone acetylation may play a role in regulating biological processes. We speculate in the discussion that endogenous regulation of total levels of histone acetylation may be a mechanism through which organisms regulate cellular plasticity. Flow cytometry provides a useful approach to measure total levels of histone acetylation at the single cell level. Relating such information to behavioral measures and treatment responses could inform drug delivery strategies to target histone deacetylase inhibitors and other chromatin modulators to places where they may be of benefit while avoiding areas where correction is not needed and could be harmful.	[Nesbitt, Addie May I.; McCurdy, Richard D.; Bryant, Sharell M.; Alter, Mark D.] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Alter, Mark D.] Univ Penn, Dept Pharmacol & Psychiat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Alter, MD (corresponding author), Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	markalter1968@gmail.com			National Institute of Mental Health (NIMH) [5K08MH080228-01]; Simons Foundation; University of Pennsylvania [T32-MH14654]; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH080228, T32MH014654] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; University of Pennsylvania; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Mark Alter was funded by 5K08MH080228-01 from the National Institute of Mental Health (NIMH). Dr. McCurdy was funded by a Simons Foundation Explorer Award. Dr. Nesbitt was funded by a T32 training grant in Neuropsychopharmacology at the University of Pennsylvania T32-MH14654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian, 2008, J VIS EXP, DOI 10.3791/914; Alter MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003344; Balu Darrick T., 2009, Journal of Pharmacological and Toxicological Methods, V59, P100, DOI 10.1016/j.vascn.2008.12.002; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Casa Valentina, 2012, Frontiers in Genetics, V3, P199, DOI 10.3389/fgene.2012.00199; Colvis CM, 2005, J NEUROSCI, V25, P10379, DOI 10.1523/JNEUROSCI.4119-05.2005; Czaplicka A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01223; Damelin M, 2007, MOL CELL BIOL, V27, P3891, DOI 10.1128/MCB.00036-07; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Duman RS, 2007, BIOL PSYCHIAT, V62, P1, DOI 10.1016/j.biopsych.2007.04.037; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Hunter RG, 2013, EPIGENOMICS-UK, V5, P177, DOI [10.2217/EPI.13.8, 10.2217/epi.13.8]; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; LEVENSON JM, 2006, CELL MOL LIFE SCI; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; MCCLUNG CA, 2007, NEUROPSYCHOPHARMACOL; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Serrano L, 2013, EXP BIOL MED, V238, P259, DOI 10.1177/1535370213480718; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; TURNER BM, 1989, EXP CELL RES, V182, P206, DOI 10.1016/0014-4827(89)90292-9; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wu X, 2013, NEUROSCI B; Wylie CJ, 2010, J NEUROSCI, V30, P670, DOI 10.1523/JNEUROSCI.4656-09.2010	40	2	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94224	10.1371/journal.pone.0094224	http://dx.doi.org/10.1371/journal.pone.0094224			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788142	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700010
J	Peng, J; Xia, ZH; Chen, L; Shi, MJ; Pu, JJ; Guo, JR; Fan, ZF				Peng, Jun; Xia, Zihao; Chen, Ling; Shi, Minjing; Pu, Jinji; Guo, Jianrong; Fan, Zaifeng			Rapid and Efficient Isolation of High-Quality Small RNAs from Recalcitrant Plant Species Rich in Polyphenols and Polysaccharides	PLOS ONE			English	Article							MOLECULAR-WEIGHT RNA; TRANS-ACTING SIRNAS; SINGLE-STEP METHOD; RT-PCR; BIOGENESIS; ARABIDOPSIS; PROTOCOL; TISSUES; DNA; QUANTIFICATION	Small RNAs, including microRNAs (miRNAs) and small interfering RNAs (siRNAs), are important regulators of plant development and gene expression. The acquisition of high-quality small RNAs is the first step in the study of its expression and function analysis, yet the extraction method of small RNAs in recalcitrant plant tissues with various secondary metabolites is not well established, especially for tropical and subtropical plant species rich in polysaccharides and polyphenols. Here, we developed a simple and efficient method for high quality small RNAs extraction from recalcitrant plant species. Prior to RNA isolation, a precursory step with a CTAB-PVPP buffer system could efficiently remove compounds and secondary metabolites interfering with RNAs from homogenized lysates. Then, total RNAs were extracted by Trizol reagents followed by a differential precipitation of high-molecular-weight (HMW) RNAs using polyethylene glycol (PEG) 8000. Finally, small RNAs could be easily recovered from supernatant by ethanol precipitation without extra elimination steps. The isolated small RNAs from papaya showed high quality through a clear background on gel and a distinct northern blotting signal with miR159a probe, compared with other published protocols. Additionally, the small RNAs extracted from papaya were successfully used for validation of both predicted miRNAs and the putative conserved tasiARFs. Furthermore, the extraction method described here was also tested with several other subtropical and tropical plant tissues. The purity of the isolated small RNAs was sufficient for such applications as end-point stem-loop RT-PCR and northern blotting analysis, respectively. The simple and feasible extraction method reported here is expected to have excellent potential for isolation of small RNAs from recalcitrant plant tissues rich in polyphenols and polysaccharides.	[Peng, Jun; Xia, Zihao; Chen, Ling; Fan, Zaifeng] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Peng, Jun; Xia, Zihao; Chen, Ling; Fan, Zaifeng] China Agr Univ, Minist Agr Key Lab Plant Pathol, Beijing 100094, Peoples R China; [Peng, Jun; Pu, Jinji; Guo, Jianrong] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Minist Agr, Key Lab Integrated Pest Management Trop Crops, Haikou, Hainan, Peoples R China; [Shi, Minjing] Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Key Lab Rubber Biol, Danzhou, Hainan, Peoples R China	China Agricultural University; China Agricultural University; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Fan, ZF (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	fanzf@cau.edu.cn		Xia, Zihao/0000-0001-7905-106X	National Natural Science Foundation of China [31301628]; Program for Changjiang Scholars and Innovative Research Team in the University (PCSIRT) [IRT1042]; Open Project Fund of Key Laboratory of Rubber Biology and Genetic Resource Utilization, Ministry of Agriculture/State Key Laboratory of [RRI-KLOF1401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in the University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Open Project Fund of Key Laboratory of Rubber Biology and Genetic Resource Utilization, Ministry of Agriculture/State Key Laboratory of	This work was supported by the National Natural Science Foundation of China (31301628), the Program for Changjiang Scholars and Innovative Research Team in the University (PCSIRT, No. IRT1042), and Open Project Fund of Key Laboratory of Rubber Biology and Genetic Resource Utilization, Ministry of Agriculture/State Key Laboratory of Breeding Base of Cultivation & Physiology for Tropical Crops/Danzhou Investigation & Experiment Station of Tropical Crops, Ministry of Agriculture (RRI-KLOF1401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Asif MH, 2000, PLANT MOL BIOL REP, V18, P109, DOI 10.1007/BF02824018; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bekesiova I, 1999, PLANT MOL BIOL REP, V17, P269, DOI 10.1023/A:1007627509824; Carra A, 2007, ANAL BIOCHEM, V360, P318, DOI 10.1016/j.ab.2006.09.022; Carra A, 2009, PLANT J, V59, P750, DOI 10.1111/j.1365-313X.2009.03906.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng Han, 2010, International Journal of Plant Biology, V1, P70; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Rosas-Cardenas FD, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-4; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Gehrig HH, 2000, PLANT MOL BIOL REP, V18, P369, DOI 10.1007/BF02825065; Ghangal R, 2009, PLANT PHYSIOL BIOCH, V47, P1113, DOI 10.1016/j.plaphy.2009.09.004; Iandolino AB, 2004, PLANT MOL BIOL REP, V22, P269, DOI 10.1007/BF02773137; Japelaghi RH, 2011, MOL BIOTECHNOL, V49, P129, DOI 10.1007/s12033-011-9384-8; JOHN ME, 1992, NUCLEIC ACIDS RES, V20, P2381, DOI 10.1093/nar/20.9.2381; Kiefer E, 2000, PLANT MOL BIOL REP, V18, P33, DOI 10.1007/BF02825291; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kolosova N, 2004, BIOTECHNIQUES, V36, P821, DOI 10.2144/04365ST06; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lakhvir Lal, 2001, Plant Molecular Biology Reporter, V19, P181, DOI 10.1007/BF02772161; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Porter BW, 2008, PLANT SCI, V174, P38, DOI 10.1016/j.plantsci.2007.09.013; Salzman RA, 1999, PLANT MOL BIOL REP, V17, P11, DOI 10.1023/A:1007520314478; Song CN, 2010, AFR J BIOTECHNOL, V9, P8726; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang MyeongHyeon, 2001, Plant Molecular Biology Reporter, V19, P187, DOI 10.1007/BF02772164; Wang XC, 2008, MOL BIOTECHNOL, V38, P57, DOI 10.1007/s12033-007-0073-6; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Xu J, 2010, PHYTOCHEM ANALYSIS, V21, P395, DOI 10.1002/pca.1205; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818	52	26	31	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95687	10.1371/journal.pone.0095687	http://dx.doi.org/10.1371/journal.pone.0095687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787387	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600047
J	Ardeljan, D; Wang, Y; Park, S; Shen, D; Chu, XK; Yu, CR; Abu-Asab, M; Tuo, J; Eberhart, CG; Olsen, TW; Mullins, RF; White, G; Wadsworth, S; Scaria, A; Chan, CC				Ardeljan, Daniel; Wang, Yujuan; Park, Stanley; Shen, Defen; Chu, Xi Kathy; Yu, Cheng-Rong; Abu-Asab, Mones; Tuo, Jingsheng; Eberhart, Charles G.; Olsen, Timothy W.; Mullins, Robert F.; White, Gary; Wadsworth, Sam; Scaria, Abraham; Chan, Chi-Chao			Interleukin-17 Retinotoxicity Is Prevented by Gene Transfer of a Soluble Interleukin-17 Receptor Acting as a Cytokine Blocker: Implications for Age-Related Macular Degeneration	PLOS ONE			English	Article							NLRP3 INFLAMMASOME; PIGMENT EPITHELIUM; THERAPEUTIC LEVELS; MICE; COMPLEMENT; ACTIVATION; EXPRESSION; INDUCTION; PROMOTER; MODEL	Age-related macular degeneration (AMD) is a common yet complex retinal degeneration that causes irreversible central blindness in the elderly. Pathology is widely believed to follow loss of retinal pigment epithelium (RPE) and photoreceptor degeneration. Here we report aberrant expression of interleukin-17A (IL17A) and the receptor IL17RC in the macula of AMD patients. In vitro, IL17A induces RPE cell death characterized by the accumulation of cytoplasmic lipids and autophagosomes with subsequent activation of pro-apoptotic Caspase-3 and Caspase-9. This pathology is reduced by siRNA knockdown of IL17RC. IL17-dependent retinal degeneration in a mouse model of focal retinal degeneration can be prevented by gene therapy with adeno-associated virus vector encoding soluble IL17 receptor. This intervention rescues RPE and photoreceptors in a MAPK-dependent process. The IL17 pathway plays a key role in RPE and photoreceptor degeneration and could hold therapeutic potential in AMD.	[Ardeljan, Daniel; Wang, Yujuan; Park, Stanley; Shen, Defen; Chu, Xi Kathy; Tuo, Jingsheng; Chan, Chi-Chao] NEI, Immunopathol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Ardeljan, Daniel] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Wang, Yujuan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Park, Stanley] Howard Hughes Med Inst, Chevy Chase, MD USA; [Yu, Cheng-Rong] NEI, Mol Immunol Sect, Immunol Lab, NIH, Bethesda, MD USA; [Abu-Asab, Mones] NEI, Histol Core, Immunol Lab, NIH, Bethesda, MD USA; [Eberhart, Charles G.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Olsen, Timothy W.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Mullins, Robert F.] Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [White, Gary; Wadsworth, Sam; Scaria, Abraham] Genzyme Corp, Framingham, MA 01701 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University; Sun Yat Sen University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University; Emory University; University of Iowa; Sanofi-Aventis; Genzyme Corporation	Chan, CC (corresponding author), NEI, Immunopathol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.	chanc@nei.nih.gov	Mullins, Robert F/I-6717-2013; wang, yujuan/C-8428-2016	Yu, Cheng-Rong/0000-0001-7246-0362; Ardeljan, Daniel/0000-0002-5593-421X; Mullins, Robert/0000-0002-5006-0891	National Eye Institute Intramural Research Program; Genzyme; NATIONAL EYE INSTITUTE [ZICEY000461, ZIAEY000222, ZIAEY000418] Funding Source: NIH RePORTER	National Eye Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Genzyme(Sanofi-AventisGenzyme Corporation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The National Eye Institute Intramural Research Program & Genzyme funded the work. The funder Genzyme provided support in the form of salaries for authors GW, SW, and AS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067263; Ardeljan D, 2013, PROG RETIN EYE RES, V37, P68, DOI 10.1016/j.preteyeres.2013.07.003; Ben-Shabat S, 2001, BIOORG MED CHEM LETT, V11, P1533, DOI 10.1016/S0960-894X(01)00314-6; Campbell M, 2013, J MOL MED, V91, P1059, DOI 10.1007/s00109-013-1050-0; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061381; Chen Y, 2011, MOL VIS, V17, P3072; Chu XK, 2013, BIOENGINEERED, V4, P130, DOI 10.4161/bioe.22949; Chu XK, 2013, ARVO SEATTL WA; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Curcio CA, 1996, INVEST OPHTH VIS SCI, V37, P1236; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Dridi S, 2012, P NATL ACAD SCI USA, V109, P13781, DOI 10.1073/pnas.1206494109; Dungan LS, 2011, CYTOKINE, V56, P126, DOI 10.1016/j.cyto.2011.07.007; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; Klettner A, 2013, INT J BIOCHEM CELL B, V45, P1457, DOI 10.1016/j.biocel.2013.04.013; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Liu BY, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-111; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mills KHG, 2013, J LEUKOCYTE BIOL, V93, P489, DOI 10.1189/jlb.1012543; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P1994; Pechan P, 2009, GENE THER, V16, P10, DOI 10.1038/gt.2008.115; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; Popp N, 2013, J CLIN EXP OPHTHALMO, V4; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Rosenbaum JT, 2012, NEW ENGL J MED, V367, P768, DOI 10.1056/NEJMcibr1204973; Ross RJ, 2008, EXP EYE RES, V86, P675, DOI 10.1016/j.exer.2008.01.014; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Shen DF, 2011, INVEST OPHTH VIS SCI, V52, P2897, DOI 10.1167/iovs.10-6114; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Tuo JS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-59; Vincent KA, 1997, J VIROL, V71, P1897, DOI 10.1128/JVI.71.3.1897-1905.1997; Wang Y, 2013, ARVO SEATTL WA; Wei L, 2012, CELL REP, V2, P1151, DOI 10.1016/j.celrep.2012.10.013; Xu LF, 2001, HUM GENE THER, V12, P563, DOI 10.1089/104303401300042500; Ziegler RJ, 2004, MOL THER, V9, P231, DOI 10.1016/j.ymthe.2003.11.015; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	47	32	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e95900	10.1371/journal.pone.0095900	http://dx.doi.org/10.1371/journal.pone.0095900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24780906	Green Published, gold, Green Submitted			2022-12-25	WOS:000335504900011
J	von Dassow, M; Miller, CJ; Davidson, LA				von Dassow, Michelangelo; Miller, Callie Johnson; Davidson, Lance A.			Biomechanics and the Thermotolerance of Development	PLOS ONE			English	Article							XENOPUS-LAEVIS EMBRYOS; REVERSE AXIS POLARITY; MATERNAL HYPERTHERMIA; HUMAN-NEUTROPHILS; CORTICAL TENSION; TEMPERATURE; CELL; MORPHOGENESIS; MECHANICS; ASPIRATION	Successful completion of development requires coordination of patterning events with morphogenetic movements. Environmental variability challenges this coordination. For example, developing organisms encounter varying environmental temperatures that can strongly influence developmental rates. We hypothesized that the mechanics of morphogenesis would have to be finely adjusted to allow for normal morphogenesis across a wide range of developmental rates. We formulated our hypothesis as a simple model incorporating time-dependent application of force to a viscoelastic tissue. This model suggested that the capacity to maintain normal morphogenesis across a range of temperatures would depend on how both tissue viscoelasticity and the forces that drive deformation vary with temperature. To test this model we investigated how the mechanical behavior of embryonic tissue (Xenopus laevis) changed with temperature; we used a combination of micropipette aspiration to measure viscoelasticity, electrically induced contractions to measure cellular force generation, and confocal microscopy to measure endogenous contractility. Contrary to expectations, the viscoelasticity of the tissues and peak contractile tension proved invariant with temperature even as rates of force generation and gastrulation movements varied three-fold. Furthermore, the relative rates of different gastrulation movements varied with temperature: the speed of blastopore closure increased more slowly with temperature than the speed of the dorsal-to-ventral progression of involution. The changes in the relative rates of different tissue movements can be explained by the viscoelastic deformation model given observed viscoelastic properties, but only if morphogenetic forces increase slowly rather than all at once.	[von Dassow, Michelangelo; Miller, Callie Johnson; Davidson, Lance A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [von Dassow, Michelangelo] Duke Univ, Marine Lab, Beaufort, NC 28516 USA; [Davidson, Lance A.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA; [Davidson, Lance A.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	von Dassow, M (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	mvondass@gmail.com; lad43@pitt.edu			Hartwell Foundation; NIH [R01 HD044750, R21 ES019259]; NSF [CAREER IOS-0845775, CMMI-1100515]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019259] Funding Source: NIH RePORTER	Hartwell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by The Hartwell Foundation (postdoctoral fellowship to M.V.) and supported by grants from the NIH (R01 HD044750 and R21 ES019259) and the NSF (CAREER IOS-0845775 and CMMI-1100515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs N, 2005, BIRTH DEFECTS RES A, V73, P989, DOI 10.1002/bdra.20195; Aoki T, 1997, ANN BIOMED ENG, V25, P581, DOI 10.1007/BF02684197; ATLAS MEYER, 1935, PHYSIOL ZOOL, V8, P290; BACHMANN K, 1969, AM NAT, V103, P115, DOI 10.1086/282588; Bingham BL, 1997, TEMPERATURE ADAPTION; Black SD, 1996, DEV GENES EVOL, V206, P147, DOI 10.1007/s004270050040; BLACK SD, 1989, DEV BIOL, V134, P376, DOI 10.1016/0012-1606(89)90109-7; Boudou T, 2006, J BIOMECH, V39, P1677, DOI 10.1016/j.jbiomech.2005.04.026; Chan K, 2010, MOL BIOL CELL, V21, P2161, DOI 10.1091/mbc.E09-07-0614; Davidson LA, 2011, CURR TOP DEV BIOL, V95, P215, DOI 10.1016/B978-0-12-385065-2.00007-4; Edwards MJ, 2006, BIRTH DEFECTS RES A, V76, P507, DOI 10.1002/bdra.20277; Efron B., 1994, INTRO BOOTSTRAP; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; Findley J.S., 1976, MAT INTRO LINEAR VIS; FUJISAWA H, 1993, DEV GROWTH DIFFER, V35, P395; Gorfinkiel N, 2011, CURR OPIN CELL BIOL, V23, P531, DOI 10.1016/j.ceb.2011.06.002; Graham JM, 1998, TERATOLOGY, V58, P209, DOI 10.1002/(SICI)1096-9926(199811)58:5<209::AID-TERA8>3.0.CO;2-Q; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Hosako H, 2009, BIRTH DEFECTS RES B, V86, P40, DOI 10.1002/bdrb.20180; Jarosik V, 2004, P ROY SOC B-BIOL SCI, V271, pS219, DOI 10.1098/rsbl.2003.0145; Joshi Sagar D, 2012, Methods Mol Biol, V917, P477, DOI 10.1007/978-1-61779-992-1_27; Joshi SD, 2010, EXP CELL RES, V316, P103, DOI 10.1016/j.yexcr.2009.08.005; Kawai M, 2000, BIOPHYS J, V78, P3112, DOI 10.1016/S0006-3495(00)76848-2; Keller R., 2004, P171; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Keller R, 2008, PHILOS T R SOC B, V363, P1317, DOI 10.1098/rstb.2007.2250; Kiebling TR, 2013, NEW J PHYS, V15; Kim HY, 2011, J CELL SCI, V124, P635, DOI 10.1242/jcs.067579; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Lieber AD, 2013, CURR BIOL, V23, P1409, DOI 10.1016/j.cub.2013.05.063; Litman Pninit, 2000, BMC Cell Biology, V1, P1, DOI 10.1186/1471-2121-1-1; Liu B, 2007, BIOPHYS J, V93, P2923, DOI 10.1529/biophysj.107.105346; Luu O, 2011, P NATL ACAD SCI USA, V108, P4000, DOI 10.1073/pnas.1010331108; Merryman WD, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049821; Miller MW, 2013, BIRTH DEFECTS RES C, V99, P50, DOI 10.1002/bdrc.21025; Mirkes PE, 1997, TERATOLOGY, V56, P210; MITCHISON JM, 1954, J EXP BIOL, V31, P461; Moretti ME, 2005, EPIDEMIOLOGY, V16, P216, DOI 10.1097/01.ede.0000152903.55579.15; NELSON L, 1982, J EXP ZOOL, V222, P103, DOI 10.1002/jez.1402220114; Nieuwkoop PD, 1967, NORMAL TABLES XENOPU; Norris CH, 1940, J CELL COMPAR PHYSL, V16, P313, DOI 10.1002/jcp.1030160307; Picard C, 2009, EUR PHYS J E, V30, P127, DOI 10.1140/epje/i2009-10473-y; Podolsky RD, 2003, INTEGR COMP BIOL, V43, P450, DOI 10.1093/icb/43.3.450; RALL JA, 1990, AM J PHYSIOL, V259, pR197, DOI 10.1152/ajpregu.1990.259.2.R197; Rico F, 2010, BIOPHYS J, V99, P1387, DOI 10.1016/j.bpj.2010.06.037; Rueden CT, 2007, BIOTECHNIQUES, V43, P31, DOI 10.2144/000112511; Ryan FJ, 1941, BIOL BULL-US, V81, P432, DOI 10.2307/1537916; SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183; SCHIRONE RC, 1968, J EXP ZOOL, V169, P43, DOI 10.1002/jez.1401690106; SHIH J, 1992, DEVELOPMENT, V116, P915; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Skoglund P, 2008, DEVELOPMENT, V135, P2435, DOI 10.1242/dev.014704; STEPHENS RE, 1972, BIOL BULL, V142, P132, DOI 10.2307/1540251; Stuurman N., 2007, MICROSC TODAY, V15, P42, DOI DOI 10.1017/S1551929500055541; SUNG KLP, 1982, BIOPHYS J, V39, P101, DOI 10.1016/S0006-3495(82)84495-0; Sunyer R, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025009; Tyler A, 1936, BIOL BULL-US, V71, P59, DOI 10.2307/1537409; van der Have TM, 2002, OIKOS, V98, P141, DOI 10.1034/j.1600-0706.2002.980115.x; von Dassow M, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045002; von Dassow M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015359; von Dassow M, 2009, DEV DYNAM, V238, P2, DOI 10.1002/dvdy.21809; Wiebe C, 2005, J BIOMECH, V38, P2087, DOI 10.1016/j.jbiomech.2004.09.005; YONEDA M, 1976, DEV GROWTH DIFFER, V18, P387; Zar, 2011, BIOSTAT ANAL; Zhou EH, 2010, BIOMECH MODEL MECHAN, V9, P563, DOI 10.1007/s10237-010-0197-7; Zhou JA, 2010, DEVELOPMENT, V137, P2785, DOI 10.1242/dev.045997; Zhou J, 2009, DEVELOPMENT, V136, P677, DOI 10.1242/dev.026211	68	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95670	10.1371/journal.pone.0095670	http://dx.doi.org/10.1371/journal.pone.0095670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776615	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000346241800014
J	Sun, YN; Liu, YJ; Zhang, L; Ye, Y; Lin, LX; Li, YM; Yan, YQ; Chen, ZP				Sun, Yi-na; Liu, Yuan-jun; Zhang, Lu; Ye, Yan; Lin, Lai-xiang; Li, Yong-mei; Yan, Yu-qin; Chen, Zu-pei			Expression of Organic Anion Transporting Polypeptide 1c1 and Monocarboxylate Transporter 8 in the Rat Placental Barrier and the Compensatory Response to Thyroid Dysfunction	PLOS ONE			English	Article							MATERNAL HYPOTHYROXINEMIA; HORMONE TRANSPORTERS; NEUROPSYCHOLOGICAL DEVELOPMENT; PLASMA-MEMBRANE; CEREBRAL-CORTEX; FREE-THYROXINE; IDENTIFICATION; HYPOTHYROIDISM; DEFICIENCY; PREGNANCY	Thyroid hormones (THs) must pass from mother to fetus for normal fetal development and require the expression of placental TH transporters. We investigate the compensatory effect of placental organic anion transporting polypeptide 1c1 (Oatp1c1) and monocarboxylate transporter 8 (Mct8) on maternal thyroid dysfunction. We describe the expressions of these two transporters in placental barriers and trophoblastic cell populations in euthyroidism and thyroid dysfunction resulting from differential iodine nutrition at gestation day (GD) 16 and 20, that is, before and after the onset of fetal thyroid function. Immunohistochemistry revealed that in the blood-placenta barrier, these two TH transporters were strongly expressed in the villous interstitial substance and were weakly expressed in trophoblast cells. Levels of Oatp1c1 protein obviously increased in the placental fetal portion during maternal thyroid deficiency at GD16. Under maternal thyroid deficiency after the production of endogenous fetal TH, quantitative PCR analysis revealed down-regulation of Oatp1c1 occurred along with up-regulation of Mct8 in trophoblast cell populations isolated by laser capture microdissection (LCM); this was consistent with the protein levels in the fetal portion of the placenta. In addition, decreased D3 mRNA at GD16 and increased D2 mRNA on two gestational days were observed in trophoblast cells with thyroid dysfunction. However, levels of Oatp1c1 mRNA at GD16 and D3 mRNA at GD20 were too low to be detectable in trophoblast cells. In conclusion, placental Oatp1c1 plays an essential compensatory role when the transplacental passage of maternal THs is insufficient at the stage before the fetal TH production. In addition, the coordinated effects of Oatp1c1, Mct8, D2 and D3 in the placental barrier may regulate both transplacental TH passage and the development of trophoblast cells during thyroid dysfunction throughout the pregnancy.	[Sun, Yi-na; Ye, Yan; Lin, Lai-xiang; Li, Yong-mei; Yan, Yu-qin; Chen, Zu-pei] Tianjin Med Univ, Metab Dis Hosp, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China; [Sun, Yi-na; Ye, Yan; Lin, Lai-xiang; Li, Yong-mei; Yan, Yu-qin; Chen, Zu-pei] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China; [Liu, Yuan-jun] Tianjin Med Univ, Gen Hosp, Dept Dermatovenereol, Tianjin, Peoples R China; [Zhang, Lu] Logist Univ Chinese Peoples Armed Police Forces, Sci Res Dept, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Sun, YN (corresponding author), Tianjin Med Univ, Metab Dis Hosp, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China.	wssyn2003@126.com	li, yong/HDN-3885-2022		National Natural Science Foundation of China [30901460, 31100138, 30671816]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants (30901460, 31100138, and 30671816) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma S, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-29; Auso E, 2004, ENDOCRINOLOGY, V145, P4037, DOI 10.1210/en.2004-0274; Babu S, 2011, EXP NEUROL, V228, P91, DOI 10.1016/j.expneurol.2010.12.012; Barber KJ, 2005, J CLIN ENDOCR METAB, V90, P1655, DOI 10.1210/jc.2004-0785; Baumann NA, 2007, AM J CLIN PATHOL, V128, P158, DOI 10.1309/69A5AV266W230AUA; Burmeister LA, 1997, ENDOCRINOLOGY, V138, P5231, DOI 10.1210/en.138.12.5231; Calvo RM, 2002, J CLIN ENDOCR METAB, V87, P1768, DOI 10.1210/jc.87.4.1768; Capelo LP, 2009, THYROID, V19, P171, DOI 10.1089/thy.2008.0120; Chan SY, 2006, J ENDOCRINOL, V189, P465, DOI 10.1677/joe.1.06582; Chan SY, 2009, NAT CLIN PRACT ENDOC, V5, P45, DOI 10.1038/ncpendmet1026; Chen ZP, 2010, BEST PRACT RES CL EN, V24, P39, DOI 10.1016/j.beem.2009.08.014; COSTA A, 1991, J ENDOCRINOL INVEST, V14, P559, DOI 10.1007/BF03346869; Cuevas E, 2005, EUR J NEUROSCI, V22, P541, DOI 10.1111/j.1460-9568.2005.04243.x; de Escobar GM, 2004, BEST PRACT RES CL EN, V18, P225, DOI 10.1016/j.beem.2004.03.012; de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; de Escobar GM, 2000, J CLIN ENDOCR METAB, V85, P3975, DOI 10.1210/jc.85.11.3975; DEESCOBAR GM, 1985, ENDOCRINOLOGY, V117, P1890, DOI 10.1210/endo-117-5-1890; Dumitrescu AM, 2006, ENDOCRINOLOGY, V147, P4036, DOI 10.1210/en.2006-0390; EMERSON CH, 1988, ENDOCRINOLOGY, V122, P809, DOI 10.1210/endo-122-3-809; Friedrichsen S, 2003, ENDOCRINOLOGY, V144, P777, DOI 10.1210/en.2002-220715; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Grijota-Martinez C, 2011, ENDOCRINOLOGY, V152, P1713, DOI 10.1210/en.2010-1014; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Hagenbuch B, 2007, BEST PRACT RES CL EN, V21, P209, DOI 10.1016/j.beem.2007.03.004; HENNEMANN G, 1986, ENDOCRINOLOGY, V119, P1870, DOI 10.1210/endo-119-4-1870; Hennemann G, 2001, ENDOCR REV, V22, P451, DOI 10.1210/er.22.4.451; James SR, 2007, BEST PRACT RES CL EN, V21, P253, DOI 10.1016/j.beem.2007.03.001; Jooste PL, 2010, BEST PRACT RES CL EN, V24, P77, DOI 10.1016/j.beem.2009.08.006; Kinne A, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S7; Kogai T, 2010, J BIOL CHEM, V285, P27279, DOI 10.1074/jbc.M110.123158; Kooistra L, 2006, PEDIATRICS, V117, P161, DOI 10.1542/peds.2005-0227; Landers KA, 2009, J CLIN ENDOCR METAB, V94, P2610, DOI 10.1210/jc.2009-0048; Lavado-Autric R, 2003, J CLIN INVEST, V111, P1073, DOI 10.1172/JCI200316262; Loubiere LS, 2012, ENDOCRINOLOGY, V153, P6126, DOI 10.1210/en.2012-1753; Loubiere LS, 2010, PLACENTA, V31, P295, DOI 10.1016/j.placenta.2010.01.013; Luton D, 2009, ANN BIOL CLIN-PARIS, V67, P299, DOI 10.1684/abc.2009.0321; Mayerl S, 2012, ENDOCRINOLOGY, V153, P1528, DOI 10.1210/en.2011-1633; Mortimer RH, 1996, J CLIN ENDOCR METAB, V81, P2247, DOI 10.1210/jc.81.6.2247; Oki N, 2004, J CLIN ENDOCR METAB, V89, P5213, DOI 10.1210/jc.2004-0352; Patel J, 2011, TRENDS ENDOCRIN MET, V22, P164, DOI 10.1016/j.tem.2011.02.002; Pizzagalli F, 2002, MOL ENDOCRINOL, V16, P2283, DOI 10.1210/me.2001-0309; Pop VJ, 2003, CLIN ENDOCRINOL, V59, P282, DOI 10.1046/j.1365-2265.2003.01822.x; Przybyla-Zawislak BD, 2005, ANN NY ACAD SCI, V1053, P162, DOI 10.1196/annals.1344.014; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Roberts LM, 2008, ENDOCRINOLOGY, V149, P6251, DOI 10.1210/en.2008-0378; Sato K, 2003, PLACENTA, V24, P144, DOI 10.1053/plac.2002.0907; Silvestri E, 2008, AM J PHYSIOL-ENDOC M, V294, pE1160, DOI 10.1152/ajpendo.00044.2008; Sugiyama D, 2003, J BIOL CHEM, V278, P43489, DOI 10.1074/jbc.M306933200; Svoboda M, 2011, CURR DRUG METAB, V12, P139, DOI 10.2174/138920011795016863; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Tohyama K, 2004, ENDOCRINOLOGY, V145, P4384, DOI 10.1210/en.2004-0058; Vasilopoulou E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065402; Visser WE, 2008, TRENDS ENDOCRIN MET, V19, P50, DOI 10.1016/j.tem.2007.11.003; VULSMA T, 1989, NEW ENGL J MED, V321, P13, DOI 10.1056/NEJM198907063210103; Williams GR, 2008, J NEUROENDOCRINOL, V20, P784, DOI 10.1111/j.1365-2826.2008.01733.x; YOSHIDA K, 1985, METABOLISM, V34, P535, DOI 10.1016/0026-0495(85)90190-8; Zhang L, 2011, BIOL TRACE ELEM RES, V143, P1629, DOI 10.1007/s12011-011-8991-3	58	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96047	10.1371/journal.pone.0096047	http://dx.doi.org/10.1371/journal.pone.0096047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763672	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000056
J	Baloglu, MC; Eldem, V; Hajyzadeh, M; Unver, T				Baloglu, Mehmet Cengiz; Eldem, Vahap; Hajyzadeh, Mortaza; Unver, Turgay			Genome-Wide Analysis of the bZIP Transcription Factors in Cucumber	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; LEUCINE-ZIPPER PROTEIN; ABSCISIC-ACID; GENE-EXPRESSION; DROUGHT TOLERANCE; BINDING FACTOR; STRESS-RESPONSE; FACTOR FAMILY; SALT STRESS; ARABIDOPSIS	bZIP proteins are one of the largest transcriptional regulators playing crucial roles in plant development, physiological processes, and biotic/abiotic stress responses. Despite the availability of recently published draft genome sequence of Cucumis sativus, no comprehensive investigation of these family members has been presented for cucumber. We have identified 64 bZIP transcription factor-encoding genes in the cucumber genome. Based on structural features of their encoded proteins, CsbZIP genes could be classified into 6 groups. Cucumber bZIP genes were expanded mainly by segmental duplication rather than tandem duplication. Although segmental duplication rate of the CsbZIP genes was lower than that of Arabidopsis, rice and sorghum, it was observed as a common expansion mechanism. Some orthologous relationships and chromosomal rearrangements were observed according to comparative mapping analysis with other species. Genome-wide expression analysis of bZIP genes indicated that 64 CsbZIP genes were differentially expressed in at least one of the ten sampled tissues. A total of 4 CsbZIP genes displayed higher expression values in leaf, flowers and root tissues. The in silico micro-RNA (miRNA) and target transcript analyses identified that a total of 21 CsbZIP genes were targeted by 38 plant miRNAs. CsbZIP20 and CsbZIP22 are the most targeted by miR165 and miR166 family members, respectively. We also analyzed the expression of ten CsbZIP genes in the root and leaf tissues of drought-stressed cucumber using quantitative RT-PCR. All of the selected CsbZIP genes were measured as increased in root tissue at 24th h upon PEG treatment. Contrarily, the down-regulation was observed in leaf tissues of all analyzed CsbZIP genes. CsbZIP12 and CsbZIP44 genes showed gradual induction of expression in root tissues during time points. This genome-wide identification and expression profiling provides new opportunities for cloning and functional analyses, which may be used in further studies for improving stress tolerance in plants.	[Baloglu, Mehmet Cengiz] Kastamonu Univ, Fac Engn & Architecture, Dept Genet & Bioengn, Kastamonu, Turkey; [Eldem, Vahap] Istanbul Univ, Fac Sci, Dept Biol, Istanbul, Turkey; [Hajyzadeh, Mortaza; Unver, Turgay] Cankiri Karatekin Univ, Fac Sci, Dept Biol, Cankiri, Turkey	Kastamonu University; Istanbul University; Cankiri Karatekin University	Baloglu, MC (corresponding author), Kastamonu Univ, Fac Engn & Architecture, Dept Genet & Bioengn, Kastamonu, Turkey.	mcbaloglu@gmail.com	hajyzadeh, mortaza/ABD-6823-2020; Baloglu, Mehmet Cengiz/P-2803-2019; Unver, Turgay/B-4819-2009; Baloglu, Mehmet Cengiz/P-7411-2016; Eldem, Vahap/A-9160-2018	Baloglu, Mehmet Cengiz/0000-0003-2976-7224; Unver, Turgay/0000-0001-6760-443X; Baloglu, Mehmet Cengiz/0000-0003-2976-7224; Eldem, Vahap/0000-0003-3767-5661; HAJYZADEH, MORTAZA/0000-0002-8808-6974	Ministry of Development of Turkey [DPT2010K120720]	Ministry of Development of Turkey(Turkiye Cumhuriyeti Kalkinma Bakanligi)	The study was supported by Ministry of Development of Turkey with grant no. DPT2010K120720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; AGUAN K, 1993, MOL GEN GENET, V240, P1, DOI 10.1007/BF00276876; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bailey T.L., 1994, P 2 INT C INT SYST M; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chuang CF, 1999, GENE DEV, V13, P334, DOI 10.1101/gad.13.3.334; Ciceri P, 1999, PLANT PHYSIOL, V121, P1321, DOI 10.1104/pp.121.4.1321; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guan YC, 2009, PLANT J, V60, P207, DOI 10.1111/j.1365-313X.2009.03948.x; Correa LGG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002944; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Gupta S, 1998, PLANT MOL BIOL, V37, P629, DOI 10.1023/A:1005934200545; HOAGLAND D. R., 1938, Annual Report of the Smithsonian Institution, P461; Hossain MA, 2010, J PLANT PHYSIOL, V167, P1512, DOI 10.1016/j.jplph.2010.05.008; Hossain MA, 2010, PLANT MOL BIOL, V72, P557, DOI 10.1007/s11103-009-9592-9; Hsieh TH, 2010, PLANTA, V231, P1459, DOI 10.1007/s00425-010-1147-4; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang XS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-230; Iida K, 2005, DNA RES, V12, P247, DOI 10.1093/dnares/dsi011; Innark P, 2013, SCI HORTIC-AMSTERDAM, V162, P278, DOI 10.1016/j.scienta.2013.08.029; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Jin ZW, 2014, PLANTA, V239, P299, DOI 10.1007/s00425-013-1979-9; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Kobayashi F, 2008, PHYSIOL PLANTARUM, V134, P74, DOI 10.1111/j.1399-3054.2008.01107.x; KUSANO T, 1995, MOL GEN GENET, V248, P507, DOI 10.1007/BF02423445; Lara P, 2003, J BIOL CHEM, V278, P21003, DOI 10.1074/jbc.M210538200; Lee SC, 2006, PLANTA, V224, P1209, DOI 10.1007/s00425-006-0302-4; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Liao Y, 2008, J INTEGR PLANT BIOL, V50, P221, DOI 10.1111/j.1744-7909.2007.00593.x; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Liu JX, 2008, PLANT CELL ENVIRON, V31, P1735, DOI 10.1111/j.1365-3040.2008.01873.x; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Miao H, 2011, EUPHYTICA, V182, P167, DOI 10.1007/s10681-011-0410-5; Mukherjee K, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-18; Muthamilarasan M, 2013, CURR SCI INDIA, V105, P155; Neill SJ, 1999, PLANT GROWTH REGUL, V29, P23, DOI 10.1023/A:1006251631570; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rodriguez-Uribe L, 2006, J EXP BOT, V57, P1391, DOI 10.1093/jxb/erj118; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shen HS, 2007, BIOCHEM BIOPH RES CO, V362, P425, DOI 10.1016/j.bbrc.2007.08.026; Shimizu H, 2005, PLANT CELL PHYSIOL, V46, P1623, DOI 10.1093/pcp/pci178; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Silveira AB, 2007, PLANT SCI, V172, P1148, DOI 10.1016/j.plantsci.2007.03.003; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang XR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003091; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Walsh J, 1998, GENE DEV, V12, P208, DOI 10.1101/gad.12.2.208; Wang JZ, 2011, J INTEGR PLANT BIOL, V53, P212, DOI 10.1111/j.1744-7909.2010.01017.x; Warren AJ, 2002, CURR OPIN STRUC BIOL, V12, P107, DOI 10.1016/S0959-440X(02)00296-8; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Weltmeier F, 2006, EMBO J, V25, P3133, DOI 10.1038/sj.emboj.7601206; Weltmeier F, 2009, PLANT MOL BIOL, V69, P107, DOI 10.1007/s11103-008-9410-9; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xue GP, 2004, PLANT J, V37, P326, DOI 10.1046/j.1365-313X.2003.01963.x; Yanez M, 2009, PLANT CELL REP, V28, P1497, DOI 10.1007/s00299-009-0749-4; Yang O, 2009, GENE, V436, P45, DOI 10.1016/j.gene.2009.02.010; Yang XQ, 2014, EUPHYTICA, V196, P341, DOI 10.1007/s10681-013-1037-5; Yang ZF, 2008, J MOL EVOL, V67, P266, DOI 10.1007/s00239-008-9143-z; Yilmaz A, 2009, PLANT PHYSIOL, V149, P171, DOI 10.1104/pp.108.128579; Yin YH, 1997, EMBO J, V16, P5247, DOI 10.1093/emboj/16.17.5247; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Yun KY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-16; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang WW, 2012, THEOR APPL GENET, V124, P249, DOI 10.1007/s00122-011-1701-x; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zou MJ, 2008, PLANT MOL BIOL, V66, P675, DOI 10.1007/s11103-008-9298-4	91	127	142	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96014	10.1371/journal.pone.0096014	http://dx.doi.org/10.1371/journal.pone.0096014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760072	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200125
J	Moldovan, L; Anghelina, M; Kantor, T; Jones, D; Ramadan, E; Xiang, Y; Huang, K; Kolipaka, A; Malarkey, W; Ghasemzadeh, N; Mohler, PJ; Quyyumi, A; Moldovan, NI				Moldovan, Leni; Anghelina, Mirela; Kantor, Taylor; Jones, Desiree; Ramadan, Enass; Xiang, Yang; Huang, Kun; Kolipaka, Arunark; Malarkey, William; Ghasemzadeh, Nima; Mohler, Peter J.; Quyyumi, Arshed; Moldovan, Nicanor I.			A Module of Human Peripheral Blood Mononuclear Cell Transcriptional Network Containing Primitive and Differentiation Markers Is Related to Specific Cardiovascular Health Variables	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; GENE-EXPRESSION; STEM-CELLS; BONE-MARROW; VASCULAR FUNCTION; AORTIC STIFFNESS; MESSENGER-RNA; T-CELLS; SYSTEM; PRESSURE	Peripheral blood mononuclear cells (PBMCs), including rare circulating stem and progenitor cells (CSPCs), have important yet poorly understood roles in the maintenance and repair of blood vessels and perfused organs. Our hypothesis was that the identities and functions of CSPCs in cardiovascular health could be ascertained by analyzing the patterns of their co-expressed markers in unselected PBMC samples. Because gene microarrays had failed to detect many stem cell-associated genes, we performed quantitative real-time PCR to measure the expression of 45 primitive and tissue differentiation markers in PBMCs from healthy and hypertensive human subjects. We compared these expression levels to the subjects' demographic and cardiovascular risk factors, including vascular stiffness. The tested marker genes were expressed in all of samples and organized in hierarchical transcriptional network modules, constructed by a bottom-up approach. An index of gene expression in one of these modules (metagene), defined as the average standardized relative copy numbers of 15 pluripotency and cardiovascular differentiation markers, was negatively correlated (all p<0.03) with age (R-2 = -0.23), vascular stiffness (R-2 = -0.24), and central aortic pressure (R-2 = -0.19) and positively correlated with body mass index (R-2 = 0.72, in women). The co-expression of three neovascular markers was validated at the single-cell level using mRNA in situ hybridization and immunocytochemistry. The overall gene expression in this cardiovascular module was reduced by 72 +/- 22% in the patients compared with controls. However, the compactness of both modules was increased in the patients' samples, which was reflected in reduced dispersion of their nodes' degrees of connectivity, suggesting a more primitive character of the patients' CSPCs. In conclusion, our results show that the relationship between CSPCs and vascular function is encoded in modules of the PBMCs transcriptional network. Furthermore, the coordinated gene expression in these modules can be linked to cardiovascular risk factors and subclinical cardiovascular disease; thus, this measure may be useful for their diagnosis and prognosis.	[Moldovan, Leni; Kantor, Taylor; Jones, Desiree; Ramadan, Enass; Kolipaka, Arunark; Mohler, Peter J.; Moldovan, Nicanor I.] Ohio State Univ, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Moldovan, Leni; Anghelina, Mirela; Kolipaka, Arunark; Malarkey, William; Mohler, Peter J.; Moldovan, Nicanor I.] Ohio State Univ, Dept Internal Med, Wexner Med Ctr, Columbus, OH 43210 USA; [Xiang, Yang; Huang, Kun] Ohio State Univ, Dept Biomed Informat, Wexner Med Ctr, Columbus, OH 43210 USA; [Ghasemzadeh, Nima; Quyyumi, Arshed] Emory Univ, Cardiovasc Clin Res Inst, Atlanta, GA 30322 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Emory University	Moldovan, NI (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA.	moldovan.6@osu.edu	Huang, Kun/E-3272-2011	Moldovan, Leni/0000-0003-1967-2408	National Institutes of Health [RC2 AG-036559, R01 HL-65983]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health grants RC2 AG-036559 and R01 HL-65983 (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-61; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; AtCorMedical, 2013, CLIN GUID PULS WAV A; Balber AE, 2011, STEM CELLS, V29, P570, DOI 10.1002/stem.613; Banerji CRS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03039; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bastian M., 2009, P 3 INT C WEBLOGS SO, DOI DOI 10.13140/2.1.1341.1520; Bellows CF, 2011, CANCER EPIDEM BIOMAR, V20, P2461, DOI 10.1158/1055-9965.EPI-11-0556; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cheng S, 2012, ATHEROSCLEROSIS, V220, P145, DOI 10.1016/j.atherosclerosis.2011.10.015; Damughatla AR, 2015, J MAGN RESON IMAGING, V41, P44, DOI 10.1002/jmri.24506; de Ciuceis C, 2011, BLOOD PRESSURE, V20, P77, DOI 10.3109/08037051.2010.535973; de Jong S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039498; Dong Chunming, 2007, J Interv Cardiol, V20, P93, DOI 10.1111/j.1540-8183.2007.00251.x; Duda DG, 2007, NAT PROTOC, V2, P805, DOI 10.1038/nprot.2007.111; Durik M, 2012, CLIN SCI, V123, P205, DOI 10.1042/CS20110660; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; Fadini GP, 2012, EXP DIABETES RES, DOI 10.1155/2012/921685; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Garcia-Ortiz L, 2012, HYPERTENS RES, V35, P617, DOI 10.1038/hr.2012.3; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Harrison DG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00128; Heinemann DEH, 2000, IMMUNOBIOLOGY, V202, P68, DOI 10.1016/S0171-2985(00)80054-6; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Joehanes R, 2013, ARTERIOSCL THROM VAS, V33, P1418, DOI 10.1161/ATVBAHA.112.301169; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Kang BH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003624; Kohane IS, 2012, BIOINFORMATICS, V28, P538, DOI 10.1093/bioinformatics/btr713; Kolipaka A, 2012, J MAGN RESON IMAGING, V35, P582, DOI 10.1002/jmri.22866; Kucia M, 2006, LEUKEMIA, V20, P18, DOI 10.1038/sj.leu.2404011; Lewis CE, 2007, CANCER RES, V67, P8429, DOI 10.1158/0008-5472.CAN-07-1684; Li L, 2011, CANCER CELL, V20, P591, DOI 10.1016/j.ccr.2011.09.011; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liu E, 2010, CELL CYCLE, V9, P2108, DOI 10.4161/cc.9.11.11864; Liu XL, 2010, AM J PATHOL, V176, P504, DOI 10.2353/ajpath.2010.081152; Magalhaes DAR, 2006, CLIN DEV IMMUNOL, V13, P81, DOI 10.1080/17402520600877091; Miyanishi M, 2013, STEM CELL REP, V1, P198, DOI 10.1016/j.stemcr.2013.07.001; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Obokata H, 2014, NATURE, V505, P641, DOI 10.1038/nature12968; Oliveras A, 2008, BLOOD PRESSURE, V17, P298, DOI 10.1080/08037050802584446; Palmer NP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r71; Palombo C, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-88; Penn MS, 2010, AM J PATHOL, V177, P2166, DOI 10.2353/ajpath.2010.100803; Quesenberry Peter J, 2012, Trans Am Clin Climatol Assoc, V123, P152; Radu A, 2010, NEW ENGL J MED, V363, P1621, DOI 10.1056/NEJMoa1001283; Ratajczak MZ, 2008, STEM CELL REV, V4, P89, DOI 10.1007/s12015-008-9018-0; Ratajczak MZ, 2004, LEUKEMIA, V18, P29, DOI 10.1038/sj.leu.2403184; Richardson MR, 2011, J MOL CELL CARDIOL, V50, P266, DOI 10.1016/j.yjmcc.2010.07.009; Riggio S, 2010, EUR J CLIN INVEST, V40, P250, DOI 10.1111/j.1365-2362.2010.02260.x; Rouhl RPW, 2012, STROKE, V43, P256, DOI 10.1161/STROKEAHA.111.632208; Saito S, 2003, J BIOL CHEM, V278, P26474, DOI 10.1074/jbc.M213223200; Shibata R, 2008, FEBS LETT, V582, P1607, DOI 10.1016/j.febslet.2008.04.006; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Tura O, 2013, STEM CELLS, V31, P338, DOI 10.1002/stem.1280; West J, 2013, P NATL ACAD SCI USA, V110, P14138, DOI 10.1073/pnas.1307242110; Wojakowski W, 2009, J AM COLL CARDIOL, V53, P1, DOI 10.1016/j.jacc.2008.09.029; Xiang Y, 2012, NETW MODEL ANAL HLTH, V1, P103, DOI 10.1007/s13721-012-0009-3; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022	68	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95124	10.1371/journal.pone.0095124	http://dx.doi.org/10.1371/journal.pone.0095124			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759906	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200036
J	Xu, T; Xie, JS; Zhu, BJ; Liu, X; Wu, XZ				Xu, Ting; Xie, Jiasong; Zhu, Baojian; Liu, Xiao; Wu, Xinzhong			Allograft Inflammatory Factor 1 Functions as a Pro-Inflammatory Cytokine in the Oyster, Crassostrea ariakensis	PLOS ONE			English	Article							RICKETTSIA-LIKE ORGANISM; FACTOR-I AIF-1; RAT CARDIAC ALLOGRAFTS; SMOOTH-MUSCLE-CELLS; TOLL-LIKE RECEPTORS; MOLECULAR-CLONING; IMMUNE-RESPONSES; INNATE IMMUNITY; EXPRESSION; IDENTIFICATION	The oyster Crassostrea ariakensis is an economically important bivalve species in China, unfortunately it has suffered severe mortalities in recent years caused by rickettsia-like organism (RLO) infection. Prevention and control of this disease is a priority for the development of oyster aquaculture. Allograft inflammatory factor-1 (AIF-1) was identified as a modulator of the immune response during macrophage activation and a key gene in host immune defense reaction and inflammatory response. Therefore we investigated the functions of C. ariakensis AIF-1 (Ca-AIF1) and its antibody (anti-CaAIF1) in oyster RLO/LPS-induced disease and inflammation. Ca-AIF1 encodes a 149 amino acid protein containing two typical Ca2+ binding EF-hand motifs and shares a 48-95% amino acid sequence identity with other animal AIF-1s. Tissue-specific expression analysis indicates that Ca-AIF1 is highly expressed in hemocytes. Significant and continuous up-regulation of Ca-AIF1 is detected when hemocytes are stimulated with RLO/LPS (RLO or LPS). Treatment with recombinant Ca-AIF1 protein significantly up-regulates the expression levels of LITAF, MyD88 and TGFb. When anti-CaAIF1 antibody is added to RLO/LPS-challenged hemocyte monolayers, a significant reduction of RLO/LPS-induced LITAF is observed at 1.5-12 h after treatment, suggesting that interference with Ca-AIF1 can suppress the inflammatory response. Furthermore, flow cytometric analysis indicated that anti-CaAIF1 administration reduces RLO/LPS-induced apoptosis and necrosis rates of hemocytes. Collectively these findings suggest that Ca-AIF1 functions as a pro-inflammatory cytokine in the oyster immune response and is a potential target for controlling RLO infection and LPS-induced inflammation.	[Xu, Ting; Xie, Jiasong; Wu, Xinzhong] Zhejiang Univ, Coll Anim Sci, Lab Marine Life Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Ting] Zhejiang Inst Freshwater Fishery, Huzhou, Zhejiang, Peoples R China; [Zhu, Baojian] Anhui Agr Univ, Coll Life Sci, Hefei, Anhui, Peoples R China; [Liu, Xiao] Ningbo Univ, Ningbo 315211, Zhejiang, Peoples R China	Zhejiang University; Anhui Agricultural University; Ningbo University	Wu, XZ (corresponding author), Zhejiang Univ, Coll Anim Sci, Lab Marine Life Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China.	wuxz@zju.edu.cn	Zhu, Baojian/ABG-4522-2021		National Natural Science Foundation of China [31272682]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the National Natural Science Foundation of China (31272682). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Austin B, 1988, MARINE MICROBIOLOGY; Auteri M, 2000, TRANSPLANTATION, V69, pS231; Autieri MV, 1996, BIOCHEM BIOPH RES CO, V228, P29, DOI 10.1006/bbrc.1996.1612; Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; BONAMI JR, 1980, EXPERIENTIA, V36, P180, DOI 10.1007/BF01953718; Brauner A, 2003, PERITON DIALYSIS INT, V23, P5; Canesi L, 2004, GEN COMP ENDOCR, V138, P58, DOI 10.1016/j.ygcen.2004.05.004; Chen SC, 2000, J FISH DIS, V23, P415, DOI 10.1046/j.1365-2761.2000.00250.x; Chen X, 2004, ARTERIOSCL THROM VAS, V24, P1217, DOI 10.1161/01.ATV.0000130024.50058.de; COMPS M, 1977, CR ACAD SCI D NAT, V285, P427; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; De Zoysa M, 2010, FISH SHELLFISH IMMUN, V29, P319, DOI 10.1016/j.fsi.2010.04.006; Deininger MH, 2002, FEBS LETT, V514, P115, DOI 10.1016/S0014-5793(02)02430-4; FEDERICI BA, 1974, APPL MICROBIOL, V28, P885, DOI 10.1128/AEM.28.5.885-886.1974; Fryer J. L., 1996, Annual Review of Fish Diseases, V6, P3, DOI 10.1016/S0959-8030(96)90002-2; Fujiki K, 1999, IMMUNOGENETICS, V49, P909, DOI 10.1007/s002510050573; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hooper C, 2007, FISH SHELLFISH IMMUN, V22, P363, DOI 10.1016/j.fsi.2006.06.009; Jiang JB, 1982, INVERTEBRATE ZOOLOGY; Kimura M, 2007, J IMMUNOL, V178, P3316, DOI 10.4049/jimmunol.178.5.3316; Klein J, 1997, SCAND J IMMUNOL, V46, P558, DOI 10.1046/j.1365-3083.1997.d01-164.x; Koshiba H, 2005, J CLIN ENDOCR METAB, V90, P529, DOI 10.1210/jc.2004-0871; Kruse M, 1999, J CELL SCI, V112, P4305; Kuschel R, 2000, J NEUROPATH EXP NEUR, V59, P323, DOI 10.1093/jnen/59.4.323; Lacoste A, 2002, J CELL SCI, V115, P761; Li DF, 2004, AQUACULTURE, V234, P29, DOI 10.1016/j.aquaculture.2003.11.019; LI T, 2011, BREAST CANC RES TREA; Liu S, 2008, CANCER SCI, V99, P952, DOI 10.1111/j.1349-7006.2008.00787.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Luo M, 2012, FISH SHELLFISH IMMUN, V33, P294, DOI 10.1016/j.fsi.2012.05.009; Luoviksson BR, 2003, SCAND J IMMUNOL, V58, P129, DOI 10.1046/j.1365-3083.2003.01297.x; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miyata M, 2001, AQUACULTURE, V194, P63, DOI 10.1016/S0044-8486(00)00517-2; PAPERNA I, 1977, AQUACULTURE, V10, P169, DOI 10.1016/0044-8486(77)90018-7; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Rosa RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025594; Schluesener HJ, 1998, GLIA, V24, P244, DOI 10.1002/(SICI)1098-1136(199810)24:2<244::AID-GLIA9>3.0.CO;2-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sun JF, 2004, J INVERTEBR PATHOL, V86, P77, DOI 10.1016/j.jip.2004.04.004; Takano T, 2006, DEV COMP IMMUNOL, V30, P807, DOI 10.1016/j.dci.2005.11.003; Tang XR, 2005, P NATL ACAD SCI USA, V102, P5132, DOI 10.1073/pnas.0501159102; UTANS U, 1995, J CLIN INVEST, V95, P2954, DOI 10.1172/JCI118003; Utans U, 1996, TRANSPLANTATION, V61, P1387, DOI 10.1097/00007890-199605150-00018; UTANS U, 1994, J CELL BIOCHEM, P281; Wang DY, 2004, INT IMMUNOPHARMACOL, V4, P1083, DOI 10.1016/j.intimp.2004.05.008; Watano K, 2001, IMMUNOLOGY, V104, P307, DOI 10.1046/j.1365-2567.2001.01301.x; Wu X. Z., 2003, STATUS AQUACULTURE C, P29; Wu XZ, 2000, J FISH DIS, V23, P409, DOI 10.1046/j.1365-2761.2000.00243.x; Xu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050789; Xu T, 2012, FISH SHELLFISH IMMUN, V32, P1106, DOI 10.1016/j.fsi.2012.03.012; Yang SB, 2010, DEV COMP IMMUNOL, V34, P538, DOI 10.1016/j.dci.2009.12.014; Yang SB, 2009, FISH SHELLFISH IMMUN, V27, P130, DOI 10.1016/j.fsi.2008.11.020; Yang ZF, 2005, INT IMMUNOL, V17, P1391, DOI 10.1093/intimm/dxh316; Zhang L, 2011, FISH SHELLFISH IMMUN, V30, P148, DOI 10.1016/j.fsi.2010.09.021; Zhu BJ, 2008, DEV COMP IMMUNOL, V32, P1572, DOI 10.1016/j.dci.2008.05.012; Zhu BJ, 2008, MOL IMMUNOL, V45, P3198, DOI 10.1016/j.molimm.2008.02.026	58	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95859	10.1371/journal.pone.0095859	http://dx.doi.org/10.1371/journal.pone.0095859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759987	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200099
J	Neppl, RL; Kataoka, M; Wang, DZ				Neppl, Ronald L.; Kataoka, Masaharu; Wang, Da-Zhi			Crystallin-alpha B Regulates Skeletal Muscle Homeostasis via Modulation of Argonaute2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELL QUIESCENCE; ARTERIOGENIC RESPONSE; MICRORNAS; CHAPERONE; MICE; RNAI; DISEASE; CARDIOMYOPATHY; AGGREGATION; BIOGENESIS	The core functional machinery of the RNAi pathway is the RNA-induced silencing complex (RISC), wherein Argonaute2 (Ago2) is essential for siRNA-directed endonuclease activity and RNAi/microRNA-mediated gene silencing. Crystallin-alpha B (CryAB) is a small heat shock protein involved in preventing protein aggregation. We demonstrate that CryAB interacts with the N and C termini of Ago2, not the catalytic site defined by the convergence of the PAZ, MID, and PIWI domains. We further demonstrate significantly reduced Ago2 activity in the absence of CryAB, highlighting a novel role of CryAB in the mammalian RNAi/microRNA pathway. In skeletal muscle of CryAB null mice, we observe a shift in the hypertrophy-atrophy signaling axis toward atrophy under basal conditions. Moreover, loss of CryAB altered the capability of satellite cells to regenerate skeletal muscle. These studies establish that CryAB is necessary for normal Ago2/RISC activity and cellular homeostasis in skeletal muscle.	[Neppl, Ronald L.; Kataoka, Masaharu; Wang, Da-Zhi] Harvard Univ, Dept Cardiol, Sch Med, Boston Childrens Hosp, Boston, MA 02115 USA; [Neppl, Ronald L.; Kataoka, Masaharu; Wang, Da-Zhi] Harvard Univ, Dept Pediat, Sch Med, Boston, MA 02115 USA; [Wang, Da-Zhi] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Neppl, RL (corresponding author), Harvard Univ, Dept Cardiol, Sch Med, Boston Childrens Hosp, John Enders Res Bldg,320 Longwood Ave, Boston, MA 02115 USA.	rneppl@enders.tch.harvard.edu; dwang@enders.tch.harvard.edu	Neppl, Ronald L/AAW-1257-2020	Neppl, Ronald L/0000-0003-1497-6058	National Institutes of Health [HL110666, HL085635, HL116919]; March of Dimes Foundation; Banyu Life Science Foundation International; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116919, R01HL085635, F32HL110666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Banyu Life Science Foundation International(Banyu Life Science Foundation International); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health Grant HL110666 (to R. L. N.), as well as National Institutes of Health Grants HL085635 and HL116919 (to D. Z. W.) and the March of Dimes Foundation (to D. Z. W.). This work was also supported by Banyu Life Science Foundation International (to M. K.).	Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Huang ZP, 2011, METHODS MOL BIOL, V709, P197, DOI 10.1007/978-1-61737-982-6_12; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688	42	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17240	17248		10.1074/jbc.M114.549584	http://dx.doi.org/10.1074/jbc.M114.549584			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24782307	hybrid, Green Published			2022-12-25	WOS:000338016200056
J	Theiler, R; Fujita, M; Nagae, M; Yamaguchi, Y; Maeda, Y; Kinoshita, T				Theiler, Romina; Fujita, Morihisa; Nagae, Masamichi; Yamaguchi, Yoshiki; Maeda, Yusuke; Kinoshita, Taroh			The alpha-Helical Region in p24 gamma(2) Subunit of p24 Protein Cargo Receptor Is Pivotal for the Recognition and Transport of Glycosylphosphatidylinositol-anchored Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPII-COATED VESICLES; ENDOPLASMIC-RETICULUM; ER EXIT; COMPLEX; FAMILY; EMP24P; COMPONENT; ERV25P	Glycosylphosphatidylinositol-anchored proteins (GPI-APs) are group of proteins that depend on p24 cargo receptors for their transport from the endoplasmic reticulum to the Golgi apparatus. The GPI anchor is expected to act as a sorting and transport signal, but so far little is known about the recognition mechanism. In the present study we investigate the GPI-AP transport in cell knockdown of p24 gamma, the most diverse p24 subfamily. Knockdown of p24 gamma(2) but not of other p24 gamma family members impaired the transport of a reporter GPI-AP. Restoration of the knockdown-induced phenotype using chimeric constructs between p24 gamma(2) and the related p24 gamma(1) further implied a role of the alpha-helical region of p24 gamma(2) but not its GOLD domain in the specific binding of GPI-APs. We conclude that motifs in the membrane-adjacent alpha-helical region of p24 gamma(2) are involved in recognition of GPI-APs and are consequently responsible for the incorporation of these proteins into coat protein complex II-coated transport vesicles.	[Theiler, Romina; Fujita, Morihisa; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, World Premier Int WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Theiler, Romina; Fujita, Morihisa; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Nagae, Masamichi; Yamaguchi, Yoshiki] RIKEN Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Syst Glycobiol Res Grp, Struct Glycobiol Team, Wako, Saitama 3510198, Japan	Osaka University; Osaka University; RIKEN	Kinoshita, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	tkinoshi@biken.osaka-u.ac.jp	Kinoshita, Taroh/C-7353-2009; Yamaguchi, Yoshiki/N-5246-2015; Fujita, Morihisa/AAM-4142-2020	Yamaguchi, Yoshiki/0000-0003-0100-5439; Nagae, Masamichi/0000-0002-5470-3807	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japanese Government scholarship (Ministry of Education, Culture, Sports, Science, and Technology of Japan); Grants-in-Aid for Scientific Research [25460054] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government scholarship (Ministry of Education, Culture, Sports, Science, and Technology of Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. K. and M. F.).; Supported by a Japanese Government scholarship (Ministry of Education, Culture, Sports, Science, and Technology of Japan).	Anantharaman V, 2002, GENOME BIOL, V3; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Hirata R, 2013, J BIOL CHEM, V288, P37057, DOI 10.1074/jbc.M113.518340; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Marzioch M, 1999, MOL BIOL CELL, V10, P1923, DOI 10.1091/mbc.10.6.1923; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Strating JRPM, 2009, MOL BIOL EVOL, V26, P1707, DOI 10.1093/molbev/msp099; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200	23	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16835	16843		10.1074/jbc.M114.568311	http://dx.doi.org/10.1074/jbc.M114.568311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24778190	hybrid, Green Published			2022-12-25	WOS:000338016200021
J	Xu, H; Li, HG; Woo, SL; Kim, SM; Shende, VR; Neuendorff, N; Guo, X; Guo, T; Qi, T; Pei, Y; Zhao, Y; Hu, X; Zhao, JJ; Chen, LL; Chen, LL; Ji, JY; Alaniz, RC; Earnest, DJ; Wu, CD				Xu, Hang; Li, Honggui; Woo, Shih-Lung; Kim, Sam-Moon; Shende, Vikram R.; Neuendorff, Nichole; Guo, Xin; Guo, Ting; Qi, Ting; Pei, Ya; Zhao, Yan; Hu, Xiang; Zhao, Jiajia; Chen, Lili; Chen, Lulu; Ji, Jun-Yuan; Alaniz, Robert C.; Earnest, David J.; Wu, Chaodong			Myeloid Cell-specific Disruption of Period1 and Period2 Exacerbates Diet-induced Inflammation and Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA ACTIVATION; REV-ERB-ALPHA; HIGH-FAT DIET; ADIPOSE-TISSUE; INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE; PPAR-GAMMA; MACROPHAGE POLARIZATION; CIRCADIAN CLOCK; ENERGY-BALANCE; OBESITY	The circadian clockworks gate macrophage inflammatory responses. Given the association between clock dysregulation and metabolic disorders, we conducted experiments to determine the extent to which over-nutrition modulates macrophage clock function and whether macrophage circadian dysregulation is a key factor linking over-nutrition to macrophage proinflammatory activation, adipose tissue inflammation, and systemic insulin resistance. Our results demonstrate that 1) macrophages from high fat diet-fed mice are marked by dysregulation of the molecular clockworks in conjunction with increased proinflammatory activation, 2) global disruption of the clock genes Period1 (Per1) and Per2 recapitulates this amplified macrophage proinflammatory activation, 3) adoptive transfer of Per1/2-disrupted bone marrow cells into wild-type mice potentiates high fat diet-induced adipose and liver tissue inflammation and systemic insulin resistance, and 4) Per1/2-disrupted macrophages similarly exacerbate inflammatory responses and decrease insulin sensitivity in co-cultured adipocytes in vitro. Furthermore, PPAR gamma levels are decreased in Per1/2-disrupted macrophages and PPAR gamma 2 overexpression ameliorates Per1/2 disruption-associated macrophage proinflammatory activation, suggesting that this transcription factor may link the molecular clockworks to signaling pathways regulating macrophage polarization. Thus, macrophage circadian clock dysregulation is a key process in the physiological cascade by which diet-induced obesity triggers macrophage proinflammatory activation, adipose tissue inflammation, and insulin resistance.	[Xu, Hang; Li, Honggui; Woo, Shih-Lung; Guo, Xin; Guo, Ting; Qi, Ting; Pei, Ya; Zhao, Yan; Hu, Xiang; Zhao, Jiajia; Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA; [Kim, Sam-Moon; Shende, Vikram R.; Neuendorff, Nichole; Earnest, David J.] Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Coll Med, Bryan, TX 77807 USA; [Hu, Xiang; Chen, Lulu] Huazhong Univ Sci & Technol, Dept Endocrinol, Union Hosp, Tongji Coll Med, Wuhan 430022, Hubei, Peoples R China; [Zhao, Jiajia; Chen, Lili] Huazhong Univ Sci & Technol, Dept Stomatol, Union Hosp, Tongji Coll Med, Wuhan 430022, Hubei, Peoples R China; [Ji, Jun-Yuan] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Alaniz, Robert C.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Earnest, DJ (corresponding author), Texas A&M Hlth Sci Ctr, 8447 State Highway 47, Bryan, TX 77807 USA.	DEARNEST@medicine.tamhsc.edu; cdwu@tamu.edu	Shende, Vikram/M-2816-2017; zhao, yan/N-6096-2014	Ji, Jun-yuan/0000-0002-4483-4336; Earnest, David/0000-0003-4433-6481	National Institutes of Health [1R01DK095828, 1R01DK095862]; American Diabetes Association [1-10-JF-54, 1-13-BS-214-BR]; American Heart Association [12BGIA9050003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095013, R01DK095862, R01DK095828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01DK095828 and 1R01DK095862) (NIDDK; to C. W.). This work was also supported, in whole or in part, by American Diabetes Association Grants 1-10-JF-54 and 1-13-BS-214-BR, American Heart Association Grant 12BGIA9050003 (to C. W.).	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Boden G, 2002, AM J PHYSIOL-ENDOC M, V283, pE12, DOI 10.1152/ajpendo.00429.2001; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cheung AT, 2000, DIABETES, V49, P810, DOI 10.2337/diabetes.49.5.810; Cheung AT, 1998, ENDOCRINOLOGY, V139, P4928, DOI 10.1210/en.139.12.4928; Farnell YF, 2011, EUR J NEUROSCI, V33, P1533, DOI 10.1111/j.1460-9568.2011.07629.x; Fontaine C, 2008, MOL ENDOCRINOL, V22, P1797, DOI 10.1210/me.2007-0439; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Guo X, 2013, J NUTR BIOCHEM, V24, P770, DOI 10.1016/j.jnutbio.2012.04.007; Guo X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039286; Guo X, 2010, J BIOL CHEM, V285, P23711, DOI 10.1074/jbc.M110.123174; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Huo YQ, 2012, J BIOL CHEM, V287, P21492, DOI 10.1074/jbc.M112.370379; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Jensen MK, 2008, CIRCULATION, V117, P3062, DOI 10.1161/CIRCULATIONAHA.107.759951; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Ko ML, 2011, J BIOL RHYTHM, V26, P412, DOI 10.1177/0748730411414170; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	54	51	53	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16374	16388		10.1074/jbc.M113.539601	http://dx.doi.org/10.1074/jbc.M113.539601			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24770415	Green Published, hybrid			2022-12-25	WOS:000337965700040
J	Kandeel, M; Al-Taher, A; Nakashima, R; Sakaguchi, T; Kandeel, A; Nagaya, Y; Kitamura, Y; Kitade, Y				Kandeel, Mahmoud; Al-Taher, Abdullah; Nakashima, Remi; Sakaguchi, Tomoya; Kandeel, Ali; Nagaya, Yuki; Kitamura, Yoshiaki; Kitade, Yukio			Bioenergetics and Gene Silencing Approaches for Unraveling Nucleotide Recognition by the Human EIF2C2/Ago2 PAZ Domain	PLOS ONE			English	Article							RNA INTERFERENCE; 3'-END RECOGNITION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MODIFIED SIRNAS; ARGONAUTE; BINDING; PIRNA; INSIGHTS; REVEALS	Gene silencing and RNA interference are major cellular processes that control gene expression via the cleavage of target mRNA. Eukaryotic translation initiation factor 2C2 (EIF2C2, Argonaute protein 2, Ago2) is considered to be the major player of RNAi as it is the core component of RISC complexes. While a considerable amount of research has focused on RNA interference and its associated mechanisms, the nature and mechanisms of nucleotide recognition by the PAZ domain of EIF2C2/Ago2 have not yet been characterized. Here, we demonstrate that the EIF2C2/Ago2 PAZ domain has an inherent lack of binding to adenine nucleotides, a feature that highlights the poor binding of 3'-adenylated RNAs with the PAZ domain as well as the selective high trimming of the 3'-ends of miRNA containing adenine nucleotides. We further show that the PAZ domain selectively binds all ribonucleotides (except adenosine), whereas it poorly recognizes deoxyribonucleotides. In this context, the modification of dTMP to its ribonucleotide analogue gave a drastic improvement of binding enthalpy and, hence, binding affinity. Additionally, higher in vivo gene silencing efficacy was correlated with the stronger PAZ domain binders. These findings provide new insights into the nature of the interactions of the EIF2C2/Ago2 PAZ domain.	[Nakashima, Remi; Kitamura, Yoshiaki; Kitade, Yukio] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan; [Sakaguchi, Tomoya; Nagaya, Yuki; Kitade, Yukio] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 50111, Japan; [Kandeel, Mahmoud; Al-Taher, Abdullah] King Faisal Univ, Fac Vet Med & Anim Resources, Dept Physiol Biochem & Pharmacol, Alhofuf, Alahsa, Saudi Arabia; [Kandeel, Mahmoud] Kafrelshikh Univ, Fac Vet Med, Dept Pharmacol, Kafrelshikh, Egypt; [Kandeel, Ali] King Abdulaziz Univ, Fac Sci & Arts, Dept Biol, Alkamil Branch, Alkamil, Saudi Arabia; [Kandeel, Ali] Zagazig Univ, Fac Vet Med, Zagazig, Egypt	Gifu University; Gifu University; King Faisal University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Zagazig University	Kitade, Y (corresponding author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan.	ykkitad@gifu-u.ac.jp	Kandeel, Mahmoud/G-3636-2016; Kitamura, Yoshiaki/ABE-4680-2020; altaher, abdulla/P-6246-2016; Kitamura, Yoshiaki/L-5138-2018; Kandeel, Ali/F-9505-2014	Kandeel, Mahmoud/0000-0003-3668-5147; Kitamura, Yoshiaki/0000-0002-5785-6892; altaher, abdulla/0000-0002-0831-6486; Kitamura, Yoshiaki/0000-0002-5785-6892; Kandeel, Ali/0000-0003-4747-7458	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) [24390025]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Research support from Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Grants-in-Aid for scientific Research (Grant no. 24390025) from the Japan Society for the Promotion of Science (JSPS). http://www.mext.go. jp/english/http://www.jsps.go.jp/english/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagasra O, 2005, EXPERT OPIN BIOL TH, V5, P1463, DOI 10.1517/14712598.5.11.1463; Bian ZQ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-275; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Courties G, 2009, EXPERT OPIN BIOL TH, V9, P535, DOI [10.1517/14712590902926089 , 10.1517/14712590902926089]; Gu S, 2012, CURR BIOL, V22, P1536, DOI 10.1016/j.cub.2012.06.040; Haney SA, 2007, EXPERT OPIN THER TAR, V11, P1429, DOI 10.1517/14728222.11.11.1429; Ho T, 2010, PROTEIN CELL, V1, P847, DOI 10.1007/s13238-010-0100-4; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Juvvuna PK, 2012, NUCLEIC ACIDS RES, V40, P6808, DOI 10.1093/nar/gks293; Kandeel M, 2013, J COMPUT AID MOL DES, V27, P605, DOI 10.1007/s10822-013-9665-3; Kandeel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057140; Kandeel M, 2011, BIOL PHARM BULL, V34, P173, DOI 10.1248/bpb.34.173; Kandeel M, 2011, J MOL RECOGNIT, V24, P322, DOI 10.1002/jmr.1074; Kandeel M, 2010, J BIOENERG BIOMEMBR, V42, P361, DOI 10.1007/s10863-010-9304-9; Kandeel M, 2009, BIOL PHARM BULL, V32, P1321, DOI 10.1248/bpb.32.1321; Kubowicz P, 2013, RNAI CLIN STUDIES CU; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Maiti M, 2011, CHEM-EUR J, V17, P1519, DOI 10.1002/chem.201000765; Mathupala SP, 2007, DNA CELL BIOL, V26, P301, DOI 10.1089/dna.2006.0560; Montgomery Mary K, 2004, Methods Mol Biol, V265, P3; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Petri S, 2011, RNA, V17, P737, DOI 10.1261/rna.2348111; Popescu FD, 2007, BIOL-TARGETS THER, V1, P271; Ramachandran PV, 2013, APPL BIOCH BIOTECHNO; Riedmann LT, 2010, RNA BIOL, V7, P133, DOI 10.4161/rna.7.2.11288; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Simon B, 2011, STRUCTURE, V19, P172, DOI 10.1016/j.str.2010.11.015; Somoza A, 2010, CHEM COMMUN, V46, P4270, DOI 10.1039/c003221b; Song JJ, 2006, CURR OPIN STRUC BIOL, V16, P5, DOI 10.1016/j.sbi.2006.01.010; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Taniho K, 2012, BIOORG MED CHEM LETT, V22, P2518, DOI 10.1016/j.bmcl.2012.01.132; Tian YA, 2011, P NATL ACAD SCI USA, V108, P903, DOI 10.1073/pnas.1017762108; Ueno Y, 2008, BIOORG MED CHEM LETT, V18, P5194, DOI 10.1016/j.bmcl.2008.08.086; Ueno Y, 2008, BIOORGAN MED CHEM, V16, P7698, DOI 10.1016/j.bmc.2008.07.010; Ueno Y, 2009, BIOORGAN MED CHEM, V17, P1974, DOI 10.1016/j.bmc.2009.01.033; Wang QC, 2003, WORLD J GASTROENTERO, V9, P1657, DOI 10.3748/wjg.v9.i8.1657; Wooddell CI, 2013, MOL THERAPY J AM SOC; Wu W, 2012, INT J MOL MED, V30, P63, DOI 10.3892/ijmm.2012.963; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yang YJ, 2012, VIRUS RES, V169, P169, DOI 10.1016/j.virusres.2012.07.024; Zeng L, 2011, PROTEINS, V79, P2004, DOI 10.1002/prot.23003; Zhang M, 2013, INT J GYNECOLOGICAL	47	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94538	10.1371/journal.pone.0094538	http://dx.doi.org/10.1371/journal.pone.0094538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788663	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700012
J	Lu, Y; Zhao, HY; Sun, J; Liu, YQ; Zhou, XP; Beier, RC; Wu, GJ; Hou, XL				Lu, Yan; Zhao, Hongyu; Sun, Jian; Liu, Yuqi; Zhou, Xuping; Beier, Ross C.; Wu, Guojuan; Hou, Xiaolin			Characterization of Multidrug-Resistant Salmonella enterica Serovars Indiana and Enteritidis from Chickens in Eastern China	PLOS ONE			English	Article							GENE CASSETTES; CLASS-1 INTEGRONS; DIVERSITY; ANIMALS	A total of 310 Salmonella isolates were isolated from 6 broiler farms in Eastern China, serotyped according to the Kauffmann-White classification. All isolates were examined for susceptibility to 17 commonly used antimicrobial agents, representative isolates were examined for resistance genes and class I integrons using PCR technology. Clonality was determined by pulsed-field gel electrophoresis (PFGE). There were two serotypes detected in the 310 Salmonella strains, which included 133 Salmonella enterica serovar Indiana isolates and 177 Salmonella enterica serovar Enteritidis isolates. Antimicrobial sensitivity results showed that the isolates were generally resistant to sulfamethoxazole, ampicillin, tetracycline, doxycycline and trimethoprim, and 95% of the isolates sensitive to amikacin and polymyxin. Among all Salmonella enterica serovar Indiana isolates, 108 (81.2%) possessed the bla(TEM), floR, tetA, strA and aac (6')-Ib-cr resistance genes. The detected carriage rate of class 1 integrons was 66.5% (206/310), with 6 strains carrying gene integron cassette dfr17-aadA5. The increasing frequency of multidrug resistance rate in Salmonella was associated with increasing prevalence of int1 genes (r(s) = 0.938, P = 0.00039). The int1, bla(TEM), floR, tetA, strA and aac (6')-Ib-cr positive Salmonella enterica serovar Indiana isolates showed five major patterns as determined by PFGE. Most isolates exhibited the common PFGE patterns found from the chicken farms, suggesting that many multidrug-resistant isolates of Salmonella enterica serovar Indiana prevailed in these sources. Some isolates with similar antimicrobial resistance patterns represented a variety of Salmonella enterica serovar Indiana genotypes, and were derived from a different clone.	[Lu, Yan; Liu, Yuqi; Zhou, Xuping; Wu, Guojuan; Hou, Xiaolin] Beijing Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Zhao, Hongyu] Natl Inst Biol Sci, Beijing, Peoples R China; [Sun, Jian] Beijing Vocat Coll Agr, Dept Anim Husb & Vet Med, Beijing, Peoples R China; [Beier, Ross C.] USDA ARS, Southern Plains Agr Res Ctr, Food & Feed Safety Res Unit, College Stn, TX USA	Beijing University of Agriculture; National Institute of Biological Sciences, Beijing; United States Department of Agriculture (USDA)	Hou, XL (corresponding author), Beijing Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	hxlsx@163.com		lu, yan/0000-0001-8941-3896	National Natural Science Foundation of China [31201949, 31172362]; Scientific Research Improvement Foundation of Beijing University of Agriculture [GJB2012003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Improvement Foundation of Beijing University of Agriculture	This study was supported by the National Natural Science Foundation of China (31201949), the National Natural Science Foundation of China (31172362); it was also supported by the Scientific Research Improvement Foundation of Beijing University of Agriculture (GJB2012003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biendo M, 2005, INT J ANTIMICROB AG, V26, P219, DOI 10.1016/j.ijantimicag.2005.05.003; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Chen Ling, 2008, Chinese Journal of Veterinary Medicine, V44, P6; Clinical and Laboratory Standards Institute, 2020, M100 CLSI, V30th; CLSI, 2007, M100S17 CLSI; Fan W, 2007, MOL CELL PROBE, V21, P245, DOI 10.1016/j.mcp.2006.12.005; Fluit AC, 1999, EUR J CLIN MICROBIOL, V18, P761, DOI 10.1007/s100960050398; Graziani C, 2008, VET MICROBIOL, V128, P414, DOI 10.1016/j.vetmic.2007.10.017; Hu X., 2009, WORLD NOTES ANTIBIOT, V30, P255; Kang HY, 2005, J ANTIMICROB CHEMOTH, V55, P639, DOI 10.1093/jac/dki076; Kennedy FC, 2010, J BASIC MICROB, V50, P1; Lu Y, 2011, FOODBORNE PATHOG DIS, V8, P45, DOI 10.1089/fpd.2010.0605; Meunier D, 2002, EMERG INFECT DIS, V8, P430; Molla B, 2007, ACTA TROP, V103, P142, DOI 10.1016/j.actatropica.2007.05.018; Muhammad I, 2011, BRAZ J MICROBIOL, V42, P462, DOI 10.1590/S1517-83822011000200008; Nemergut DR, 2004, APPL ENVIRON MICROB, V70, P1160, DOI 10.1128/AEM.70.2.1160-1168.2004; O'Hare C, 2004, Commun Dis Public Health, V7, P193; Peters EDJ, 2001, ANTIMICROB AGENTS CH, V45, P2961, DOI 10.1128/AAC.45.10.2961-2964.2001; Popoff M.Y., 1992, ANTIGENIC FORMULAS S, V6th; Rostagno MH, 2006, POULTRY SCI, V85, P1838, DOI 10.1093/ps/85.10.1838; Shan X, 2010, MED RECAPITULATE, V16, P354; Shi L, 2007, CHINESE J ANTIBIOT, V32, P951; Shu CH, 2006, INT J ANTIMICROB AG, V27, P383; Threlfall EJ, 2002, FEMS MICROBIOL REV, V26, P141, DOI 10.1016/S0168-6445(02)00092-X; Wang Maoqi, 2004, Wei Sheng Yan Jiu, V33, P49; Xia LN, 2010, FOODBORNE PATHOG DIS, V7, P207, DOI 10.1089/fpd.2009.0378	27	36	43	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96050	10.1371/journal.pone.0096050	http://dx.doi.org/10.1371/journal.pone.0096050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788434	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700053
J	So, MY; Tian, ZP; Phoon, YS; Sha, S; Antoniou, MN; Zhang, JW; Wu, RSS; Tan-Un, KC				So, Mei Yu; Tian, ZhiPeng; Phoon, Yong Shian; Sha, Sha; Antoniou, Michael N.; Zhang, Jiang Wen; Wu, Rudolf S. S.; Tan-Un, Kian C.			Gene Expression Profile and Toxic Effects in Human Bronchial Epithelial Cells Exposed to Zearalenone	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RECEPTOR SIGNALING PATHWAYS; MYCOTOXIN ZEARALENONE; HISTONE DEACETYLASE; OXIDATIVE STRESS; IN-VITRO; DNA; CANCER; FUSARIUM; METHYLATION	Zearalenone (ZEA), a mycoestrogen produced by Fusarium fungal species, is mainly found in cereal crops such as maize, wheat and barley. Although ZEA has been reported to be present in air, little is known about the health risk or the molecular basis of action when lung cells are exposed to ZEA. As ZEA has a similar structure to estrogen, its potential risk as an endocrine disrupting chemical (EDC) has thus aroused both environmental and public health concerns. The purpose of this study is to identify the responses and underlying molecular changes that occur when human bronchial epithelial BEAS-2B cells are exposed to ZEA. Differential gene expression profiles were identified in cells that were treated with 40 mu M ZEA for 6 h and 24 h by high-throughput microarray analysis using Affymetrix Human Gene 2.0 GeneChip. The array results showed that after ZEA treatment, 262 genes at 6 h and 1073 genes at 24 h were invovled in the differential regulation. Pathway analysis revealed that diverse cellular processes were affected when lung cells were exposed to ZEA resulting in impaired response to DNA damage, cell cycle arrest, down-regulation of inflammatory responses and alterations of epigenetic marks. Results of further experiments indicated that 40 mu M ZEA decreased cell viability, induced apoptosis and promoted reactive oxygen species (ROS) generation in a time-dependent manner. Immuno-suppressive effects of ZEA were further revealed through the suppression of lipopolysaccharide (LPS)-induced expression of pro-inflammatory cytokines (IL-6, IL-8 and IL-1 beta). Interestingly, the level of global DNA methylation was markedly decreased after 24 h exposure to ZEA. Collectively, these observations suggested that a broad range of toxic effects are elicited by ZEA. Particularly, ROS may play a pivotal role in ZEA-induced cell death. These adverse effects observed in lung cells suggest that exposure to ZEA may increase susceptibility of lung cells to diseases and required further investigations.	[So, Mei Yu; Tian, ZhiPeng; Phoon, Yong Shian; Sha, Sha; Zhang, Jiang Wen; Wu, Rudolf S. S.; Tan-Un, Kian C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Tian, ZhiPeng; Tan-Un, Kian C.] Univ Hong Kong, Sch Profess & Continuing Educ, Hong Kong, Hong Kong, Peoples R China; [Antoniou, Michael N.] Guys Hosp, Kings Coll London, Sch Med, Dept Med & Mol Genet,Gene Express & Therapy Grp, London SE1 9RT, England	University of Hong Kong; University of Hong Kong; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Tan-Un, KC (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	kctanun@hku.hk	Zhang, Jiangwen/A-7654-2013	Zhang, Jiangwen/0000-0002-2911-8446	Seed Funding Programme for Basic Research; CRCG; HKU School of Professional and Continuing Education (SPACE)	Seed Funding Programme for Basic Research; CRCG; HKU School of Professional and Continuing Education (SPACE)	The work was supported by the Seed Funding Programme for Basic Research and CRCG grants for postgraduate students of the University of Hong Kong as well as funding from HKU School of Professional and Continuing Education (SPACE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid-Essefi S, 2004, TOXICOL IN VITRO, V18, P467, DOI 10.1016/j.tiv.2003.12.011; Abid-Essefi S, 2012, EXP TOXICOL PATHOL, V64, P689, DOI 10.1016/j.etp.2010.12.012; Abid-Essefi S, 2003, TOXICOLOGY, V192, P237, DOI 10.1016/S0300-483X(03)00329-9; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arrigo AP, 2005, METHODS, V35, P126, DOI 10.1016/j.ymeth.2004.08.003; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Barnes PJ, 2006, CHEST, V129, P151, DOI 10.1378/chest.129.1.151; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Ben Salah-Abbes J, 2008, J PHARM PHARMACOL, V60, P761, DOI 10.1211/jpp.60.6.0012; Ben Salah-Abbes J, 2010, J PHARM PHARMACOL, V62, P231, DOI [10.1211/jpp.62.02.0011, 10.1211/jpp/62.02.0011]; Busk OL, 2011, TOXICON, V58, P533, DOI 10.1016/j.toxicon.2011.08.015; CALDWELL RW, 1970, APPL MICROBIOL, V20, P31, DOI 10.1128/AEM.20.1.31-34.1970; Cavalieri E, 2006, ANN NY ACAD SCI, V1089, P286, DOI 10.1196/annals.1386.042; CHANG K, 1979, AM J VET RES, V40, P1260; Dornbusch HJ, 2005, J CLIN MICROBIOL, V43, P1998, DOI 10.1128/JCM.43.4.1998-2001.2004; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Fleck Stefanie C, 2012, Mycotoxin Res, V28, P267, DOI 10.1007/s12550-012-0143-x; Hassen W, 2007, TOXICOLOGY, V232, P294, DOI 10.1016/j.tox.2007.01.015; HEPBURN PA, 1991, J BIOL CHEM, V266, P7985; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Marin DE, 2010, TOXICON, V56, P956, DOI 10.1016/j.toxicon.2010.06.020; Marquez-Garban DC, 2007, STEROIDS, V72, P135, DOI 10.1016/j.steroids.2006.11.019; Minervini F, 2005, TOXICOL LETT, V159, P272, DOI 10.1016/j.toxlet.2005.05.017; Numazawa Satoshi, 2004, J Toxicol Sci, V29, P81, DOI 10.2131/jts.29.81; Olsen M, 1989, TOPICS SECONDARY MET; Pfeiffer E, 2009, MOL NUTR FOOD RES, V53, P1123, DOI 10.1002/mnfr.200800584; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; REDDEL RR, 1988, CANCER RES, V48, P1904; Ruh MF, 1998, ENDOCRINE, V9, P207, DOI 10.1385/ENDO:9:2:207; Ruiz C, 2004, CANCER RES, V64, P7377, DOI 10.1158/0008-5472.CAN-04-1234; RUZSAS C, 1979, ACTA BIOL ACAD SCI H, V30, P335; Salah-Abbes Jalila Ben, 2008, J Appl Toxicol, V28, P6, DOI 10.1002/jat.1240; Schmal H, 1996, J IMMUNOL, V156, P1963; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; SHEEHAN DM, 1984, TERATOLOGY, V29, P383, DOI 10.1002/tera.1420290309; Siegfried JM, 2001, LANCET ONCOL, V2, P506, DOI 10.1016/S1470-2045(01)00457-0; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sweeney MJ, 1998, INT J FOOD MICROBIOL, V43, P141, DOI 10.1016/S0168-1605(98)00112-3; Tam A, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-24; TAN NW, 1990, BIOCHEMISTRY-US, V29, P9234, DOI 10.1021/bi00491a018; Tangni EK, 2007, J SCI FOOD AGR, V87, P1263, DOI 10.1002/jsfa.2838; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; TURK PW, 1995, CARCINOGENESIS, V16, P1253, DOI 10.1093/carcin/16.5.1253; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang YL, 2008, ENVIRON RES, V107, P139, DOI 10.1016/j.envres.2008.01.008; WEI X, 1993, P NATL ACAD SCI USA, V90, P2117, DOI 10.1073/pnas.90.6.2117; WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yan XX, 2013, PEDIATR DERMATOL, V30, pE43, DOI 10.1111/pde.12054; Zhou LM, 2003, AM J RESP CELL MOL, V28, P762, DOI 10.1165/rcmb.2002-0261OC; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030	61	33	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96404	10.1371/journal.pone.0096404	http://dx.doi.org/10.1371/journal.pone.0096404			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788721	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700088
J	Torcasio, A; Jahn, K; Van Guyse, M; Spaepen, P; Tami, AE; Vander Sloten, J; Stoddart, MJ; van Lenthe, GH				Torcasio, Antonia; Jaehn, Katharina; Van Guyse, Maarten; Spaepen, Pieter; Tami, Andrea E.; Vander Sloten, Jos; Stoddart, Martin J.; van Lenthe, G. Harry			Trabecular Bone Adaptation to Low-Magnitude High-Frequency Loading in Microgravity	PLOS ONE			English	Article							CULTURE-SYSTEM; SPACE-FLIGHT; IN-VITRO; METABOLISM; STRAIN; REST; MUSCLE	Exposure to microgravity causes loss of lower body bone mass in some astronauts. Low-magnitude high-frequency loading can stimulate bone formation on earth. Here we hypothesized that low-magnitude high-frequency loading will also stimulate bone formation under microgravity conditions. Two groups of six bovine cancellous bone explants were cultured at microgravity on a Russian Foton-M3 spacecraft and were either loaded dynamically using a sinusoidal curve or experienced only a static load. Comparable reference groups were investigated at normal gravity. Bone structure was assessed by histology, and mechanical competence was quantified using mu CT and FE modelling; bone remodelling was assessed by fluorescent labelling and secreted bone turnover markers. Statistical analyses on morphometric parameters and apparent stiffness did not reveal significant differences between the treatment groups. The release of bone formation marker from the groups cultured at normal gravity increased significantly from the first to the second week of the experiment by 90.4% and 82.5% in response to static and dynamic loading, respectively. Bone resorption markers decreased significantly for the groups cultured at microgravity by 7.5% and 8.0% in response to static and dynamic loading, respectively. We found low strain magnitudes to drive bone turnover when applied at high frequency, and this to be valid at normal as well as at microgravity. In conclusion, we found the effect of mechanical loading on trabecular bone to be regulated mainly by an increase of bone formation at normal gravity and by a decrease in bone resorption at microgravity. Additional studies with extended experimental time and increased samples number appear necessary for a further understanding of the anabolic potential of dynamic loading on bone quality and mechanical competence.	[Torcasio, Antonia; Van Guyse, Maarten; Spaepen, Pieter; Vander Sloten, Jos; van Lenthe, G. Harry] Katholieke Univ Leuven, Biomech Sect, Louvain, Belgium; [Jaehn, Katharina; Tami, Andrea E.; Stoddart, Martin J.] AO Res Inst, Davos, Switzerland; [van Lenthe, G. Harry] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland	KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich	van Lenthe, GH (corresponding author), Katholieke Univ Leuven, Biomech Sect, Louvain, Belgium.	harry.vanlenthe@mech.kuleuven.be	Stoddart, Martin J/E-3240-2013; van Lenthe, Harry (GH)/C-1030-2008	Stoddart, Martin J/0000-0002-9538-1517; van Lenthe, Harry (GH)/0000-0001-8303-4959; Jahn-Rickert, Katharina/0000-0002-9338-831X	Belgium PRODEX-9 project [C90346]; ESA MAP grant [AO99-122]	Belgium PRODEX-9 project; ESA MAP grant	This study was financially supported by grant C90346 (Belgium PRODEX-9 project) and the ESA MAP grant #AO99-122. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbenz P, 2008, INT J NUMER METH ENG, V73, P927, DOI 10.1002/nme.2101; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyd SK, 2006, BONE, V39, P854, DOI 10.1016/j.bone.2006.04.017; David V, 2008, TISSUE ENG PT A, V14, P117, DOI 10.1089/ten.a.2007.0051; Davies CM, 2006, EUR CELLS MATER, V11, P57, DOI 10.22203/eCM.v011a07; Demets R., 2002, BIOL EXPT BION 10 SA; Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9; GENTY C, 1993, J BONE MINER RES, V8, pS367; HARRIS WH, 1962, J BONE JOINT SURG AM, V44, P1308, DOI 10.2106/00004623-196244070-00003; Hill P A, 1998, Br J Orthod, V25, P101; HULTH ANDERS, 1962, ACTA SOC MED UPSALIENSIS, V67, P219; Judex S, 2003, ANN BIOMED ENG, V31, P12, DOI 10.1114/1.1535414; Kaspar D, 2002, J BIOMECH, V35, P873, DOI 10.1016/S0021-9290(02)00058-1; LaMothe JM, 2004, J APPL PHYSIOL, V96, P1788, DOI 10.1152/japplphysiol.01145.2003; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; LeBlanc A, 2000, J APPL PHYSIOL, V89, P2158, DOI 10.1152/jappl.2000.89.6.2158; LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33; LISKOVA M, 1971, Folia Morphologica (Prague), V19, P301; Loomer PM, 2001, CRIT REV ORAL BIOL M, V12, P252, DOI 10.1177/10454411010120030401; OCONNOR JA, 1982, J BIOMECH, V15, P767, DOI 10.1016/0021-9290(82)90092-6; OLERUD S, 1970, J BONE JOINT SURG AM, VA 52, P274, DOI 10.2106/00004623-197052020-00008; Richards RG, 2007, ALTEX-ALTERN TIEREXP, V24, P56; Roux W., 1881, BEITRAG VERVOLLSTAND; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Simpson AE, 2009, CELL BIOCHEM FUNCT, V27, P23, DOI 10.1002/cbf.1529; Smith SM, 2005, J BONE MINER RES, V20, P208, DOI 10.1359/JBMR.041105; Srinivasan S, 2002, J BONE MINER RES, V17, P1613, DOI 10.1359/jbmr.2002.17.9.1613; SUN YQ, 1995, CALCIFIED TISSUE INT, V57, P456, DOI 10.1007/BF00301950; Szwedowski TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036231; Taylor WR, 2003, P I MECH ENG H, V217, P349, DOI 10.1243/095441103770802513; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Van Guyse M, 2006, P IEEE EMBS BEN S 59, P59; van Lenthe GH, 2001, J BONE MINER RES, V16, P550, DOI 10.1359/jbmr.2001.16.3.550; Vico L, 1998, BONE, V22, p95S, DOI 10.1016/S8756-3282(98)00017-9; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0	35	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e93527	10.1371/journal.pone.0093527	http://dx.doi.org/10.1371/journal.pone.0093527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787094	Green Submitted, Green Published, gold			2022-12-25	WOS:000336655700006
J	Yin, L; Zhu, JA; Xue, Q; Wang, NS; Hu, ZL; Huang, YX; Liu, F; Hu, B				Yin, Lu; Zhu, Jiaan; Xue, Qin; Wang, Niansong; Hu, Zhenlong; Huang, Yunxia; Liu, Fang; Hu, Bing			MicroPure Imaging for the Evaluation of Microcalcifications in Gouty Arthritis Involving the First Metatarsophalangeal Joint: A Preliminary Study	PLOS ONE			English	Article							ULTRASONOGRAPHY	Objective: To assess the value of MicroPure, a new ultrasound image processing technique, in identifying microcalcifications (formed by monosodium urate crystals) in the first metatarsophalangeal joints attacked by gout compared to gray-scale ultrasound images. Materials and Methods: Thirty-six patients who fulfilled the study inclusion criteria underwent gray-scale ultrasound and MicroPure examinations of the first metatarsophalangeal joints attacked by gout. Static images of the target areas were acquired using gray-scale ultrasound and MicroPure. Two independent and blinded investigators analyzed the images to determine the number of microcalcifications and to score for image quality and artifacts. Results: The two investigators observed significantly more microcalcifications with MicroPure compared to gray-scale ultrasound (rho<0.001). The level of agreement between the investigators consistently increased from gray-scale ultrasound to MicroPure imaging (gray-scale interclass correlation coefficient of 0.69 vs. MicroPure interclass correlation coefficient of 0.81). One investigator preferred the MicroPure image quality over gray-scale ultrasound (rho<0.001), but the other investigator disagreed (rho<0.001). Both investigators observed fewer artifacts with MicroPure than with gray-scale ultrasound (rho<0.009). Conclusion: MicroPure imaging identified significantly more microcalcifications than gray-scale ultrasound.	[Yin, Lu; Zhu, Jiaan; Hu, Zhenlong; Huang, Yunxia; Liu, Fang; Hu, Bing] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Inst Ultrasound Med, Dept Ultrasound, Shanghai 200030, Peoples R China; [Xue, Qin; Wang, Niansong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Rheumatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhu, JA (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Inst Ultrasound Med, Dept Ultrasound, Shanghai 200030, Peoples R China.	zhuja@sjtu.edu.cn		zhu, Jiaan/0000-0001-8700-639X	National Natural Science Foundation of China [81171353/H1805]; Training Programs of Excellent Academic Leaders of Health System in Shanghai [XBR2013102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Training Programs of Excellent Academic Leaders of Health System in Shanghai	This work was supported by National Natural Science Foundation of China (No. 81171353/H1805) and the Training Programs of Excellent Academic Leaders of Health System in Shanghai (No. XBR2013102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carter JD, 2009, RHEUMATOLOGY, V48, P1442, DOI 10.1093/rheumatology/kep278; Chowalloor PV, 2013, ANN RHEUM DIS, V72, P638, DOI 10.1136/annrheumdis-2012-202301; GRAHAME R, 1970, ANN RHEUM DIS, V29, P461, DOI 10.1136/ard.29.5.461; Kamiyama N, 2008, J MED ULTRASON, V35, P97, DOI 10.1007/s10396-008-0183-1; Kurita T, 2010, CLIN USEFULNESS FUTU, P1; Lai KL, 2011, J MED ULTRASOUND, V19, P7, DOI 10.1016/j.jmu.2011.01.003; Mansour SM, 2012, EGYPT J RADIOL NUC M, V43, P499, DOI 10.1016/j.ejrnm.2012.07.001; MCCARTY DJ, 1961, ANN INTERN MED, V54, P452, DOI 10.7326/0003-4819-54-3-452; Perez-Ruiz F, 2007, CURR OPIN RHEUMATOL, V19, P128, DOI 10.1097/BOR.0b013e32801450b7; Perez-Ruiz F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2687; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Schlesinger N, 1999, Curr Opin Rheumatol, V11, P441, DOI 10.1097/00002281-199909000-00020; Wakefield R, 2007, SEMIN ARTHRITIS RHEU, V37, P133, DOI 10.1016/j.semarthrit.2007.03.007; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320	14	11	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95743	10.1371/journal.pone.0095743	http://dx.doi.org/10.1371/journal.pone.0095743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788200	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700037
J	Corkrey, R; McMeekin, TA; Bowman, JP; Ratkowsky, DA; Olley, J; Ross, T				Corkrey, Ross; McMeekin, Tom A.; Bowman, John P.; Ratkowsky, David A.; Olley, June; Ross, Tom			Protein Thermodynamics Can Be Predicted Directly from Biological Growth Rates	PLOS ONE			English	Article							UPPER TEMPERATURE LIMIT; LAST COMMON ANCESTOR; HEAT-SHOCK RESPONSE; ESCHERICHIA-COLI; BACILLUS-STEAROTHERMOPHILUS; FOLDING THERMODYNAMICS; THERMOPHILIC PROTEINS; STABILITY; MECHANISM; LIFE	Life on Earth is capable of growing from temperatures well below freezing to above the boiling point of water, with some organisms preferring cooler and others hotter conditions. The growth rate of each organism ultimately depends on its intracellular chemical reactions. Here we show that a thermodynamic model based on a single, rate-limiting, enzyme-catalysed reaction accurately describes population growth rates in 230 diverse strains of unicellular and multicellular organisms. Collectively these represent all three domains of life, ranging from psychrophilic to hyperthermophilic, and including the highest temperature so far observed for growth (122 degrees C). The results provide credible estimates of thermodynamic properties of proteins and obtain, purely from organism intrinsic growth rate data, relationships between parameters previously identified experimentally, thus bridging a gap between biochemistry and whole organism biology. We find that growth rates of both unicellular and multicellular life forms can be described by the same temperature dependence model. The model results provide strong support for a single highly-conserved reaction present in the last universal common ancestor (LUCA). This is remarkable in that it means that the growth rate dependence on temperature of unicellular and multicellular life forms that evolved over geological time spans can be explained by the same model.	[Corkrey, Ross; McMeekin, Tom A.; Bowman, John P.; Ratkowsky, David A.; Olley, June; Ross, Tom] Univ Tasmania, Sch Agr Sci, Tasmanian Inst Agr, Hobart, Tas, Australia	University of Tasmania	Corkrey, R (corresponding author), Univ Tasmania, Sch Agr Sci, Tasmanian Inst Agr, Hobart, Tas, Australia.	scorkrey@utas.edu.au	Bowman, John P/C-2414-2014; Bowman, John P./ABF-5108-2020; Corkrey, Stephen/C-2424-2014	Bowman, John P/0000-0002-4528-9333; Bowman, John P./0000-0002-4528-9333; Ross, Tom/0000-0001-9916-7772; Corkrey, Stephen/0000-0002-2242-2891				ALBER SA, 1992, APPL ENVIRON MICROB, V58, P3337, DOI 10.1128/AEM.58.10.3337-3342.1992; [Anonymous], 1973, CHEM KINETICS ENZYME; Ashenberg O, 2013, P NATL ACAD SCI USA; Becerra A, 2007, ANNU REV ECOL EVOL S, V38, P361, DOI 10.1146/annurev.ecolsys.38.091206.095825; Berezovsky IN, 2005, P NATL ACAD SCI USA, V102, P12742, DOI 10.1073/pnas.0503890102; BILLING E, 1974, J APPL BACTERIOL, V37, P643, DOI 10.1111/j.1365-2672.1974.tb00488.x; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Boussau B, 2008, NATURE, V456, P942, DOI 10.1038/nature07393; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Brooks SP, 1998, J ROY STAT SOC D-STA, V47, P69, DOI 10.1111/1467-9884.00117; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; Cherry JL, 2010, MOL BIOL EVOL, V27, P735, DOI 10.1093/molbev/msp270; Collins T, 2003, J MOL BIOL, V328, P419, DOI 10.1016/S0022-2836(03)00287-0; Cordova J, 2008, ENZYME MICROB TECH, V42, P278, DOI 10.1016/j.enzmictec.2007.10.007; Corkrey R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032003; COULTATE TP, 1975, J BACTERIOL, V121, P55, DOI 10.1128/JB.121.1.55-64.1975; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; Das Rajdeep, 2000, Functional and Integrative Genomics, V1, P76, DOI 10.1007/s101420050009; Davidson G, 2003, J APPL MICROBIOL, V94, P816, DOI 10.1046/j.1365-2672.2003.01871.x; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Drake JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000520; Ellis RJ, 2003, CURR BIOL, V13, pR881, DOI 10.1016/j.cub.2003.10.051; Feller G, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/512840; Ferrer M, 2004, APPL ENVIRON MICROB, V70, P4499, DOI 10.1128/AEM.70.8.4499-4504.2004; FISCHER G, 1990, BIOCHEMISTRY-US, V29, P2205, DOI 10.1021/bi00461a001; Forterre P, 1996, CELL, V85, P789, DOI 10.1016/S0092-8674(00)81262-3; Franks F., 1988, CHARACTERIZATION PRO; Gilks W.R., 1996, MARKOV CHAIN MONTE C, P89; GILKS WR, 1994, STATISTICIAN, V43, P179, DOI 10.2307/2348942; Glansdorff N, 2000, MOL MICROBIOL, V38, P177, DOI 10.1046/j.1365-2958.2000.02126.x; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; Graziano G, 1998, THERMOCHIM ACTA, V321, P23, DOI 10.1016/S0040-6031(98)00435-3; Groussin M, 2013, LETTERS, V9; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; HANUS FJ, 1968, J BACTERIOL, V95, P736, DOI 10.1128/JB.95.2.736-737.1968; Hirata A, 2012, INTECH, P249; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Hollien J, 1999, BIOCHEMISTRY-US, V38, P3831, DOI 10.1021/bi982684h; Honda S, 2004, STRUCTURE, V12, P1507, DOI 10.1016/j.str.2004.05.022; Huchet V, 2013, FOOD MICROBIOL, V36, P254, DOI 10.1016/j.fm.2013.06.004; Humphrey A.E., 1979, ANN NY ACAD SCI, V326, P17; INGRAHAM JL, 1958, J BACTERIOL, V76, P75, DOI 10.1128/JB.76.1.75-80.1958; Jarosik V, 2004, P ROY SOC B-BIOL SCI, V271, pS219, DOI 10.1098/rsbl.2003.0145; Jiang X, 2000, PROTEIN SCI, V9, P403; JOHNSON FH, 1946, J CELL COMPAR PHYSL, V28, P47, DOI 10.1002/jcp.1030280104; Kashefi K, 2003, SCIENCE, V301, P934, DOI 10.1126/science.1086823; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kort R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-590; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Laidler K., 1997, NEW BEER OLD BOTTLE, P127; LEE JH, 1980, BIOTECHNOL LETT, V2, P141, DOI 10.1007/BF00162935; Liu L, 2000, BIOPHYS CHEM, V84, P239, DOI 10.1016/S0301-4622(00)00130-7; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; MAKHATADZE GI, 1993, J MOL BIOL, V232, P639, DOI 10.1006/jmbi.1993.1416; McCrary BS, 1996, J MOL BIOL, V264, P784, DOI 10.1006/jmbi.1996.0677; McMeekin TA, 1993, PREDICTIVE MICROBIOL; MENNETT RH, 1971, APPL MICROBIOL, V22, P772, DOI 10.1128/AEM.22.5.772-776.1971; Mukaiyama A, 2009, INT J MOL SCI, V10, P1369, DOI 10.3390/ijms10031369; MURPHY KP, 1990, SCIENCE, V247, P559, DOI 10.1126/science.2300815; NG H, 1962, J BACTERIOL, V84, P331, DOI 10.1128/JB.84.2.331-339.1962; Ng TM, 1997, APPL ENVIRON MICROB, V63, P1237, DOI 10.1128/AEM.63.4.1237-1243.1997; NOJIMA H, 1977, J MOL BIOL, V116, P429, DOI 10.1016/0022-2836(77)90078-X; Okajima T, 2002, BIOSCI BIOTECH BIOCH, V66, P2112, DOI 10.1271/bbb.66.2112; Pena MI, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.43; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; PRIVALOV PL, 1993, J MOL BIOL, V232, P660, DOI 10.1006/jmbi.1993.1417; Ragone R, 2004, PROTEINS, V54, P323, DOI 10.1002/prot.10574; Raison J K, 1973, Symp Soc Exp Biol, V27, P485; RAISON JK, 1973, J BIOENERG, V4, P285, DOI 10.1007/BF01516063; Ratkowsky DA, 1996, J APPL BACTERIOL, V80, P131, DOI 10.1111/j.1365-2672.1996.tb03200.x; Ratkowsky DA, 2005, J THEOR BIOL, V233, P351, DOI 10.1016/j.jtbi.2004.10.016; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Rothman JE, 2011, CELL, V146, P851, DOI 10.1016/j.cell.2011.08.041; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Sawano M, 2008, BIOCHEMISTRY-US, V47, P721, DOI 10.1021/bi701761m; SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0; Serra A, 2005, INT J FOOD MICROBIOL, V104, P257, DOI 10.1016/j.ijfoodmicro.2005.03.006; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; SHAW MK, 1967, J BACTERIOL, V93, P1332, DOI 10.1128/JB.93.4.1332-1336.1967; Sibly R. M., 2012, METABOLIC ECOLOGY SC; Stegelmann C, 2009, J AM CHEM SOC, V131, P8077, DOI 10.1021/ja9000097; Svingor A, 2001, J BIOL CHEM, V276, P28121, DOI 10.1074/jbc.M104432200; Takai K, 2008, P NATL ACAD SCI USA, V105, P10949, DOI 10.1073/pnas.0712334105; Takano K, 2013, BIOCHEMISTRY-US, V52, P4774, DOI 10.1021/bi400652c; TANSEY MR, 1972, P NATL ACAD SCI USA, V69, P2426, DOI 10.1073/pnas.69.9.2426; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Urit T, 2013, APPL MICROBIOL BIOT, V97, P10359, DOI 10.1007/s00253-013-5278-y; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wiggins P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001406; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Ye X, 2013, P NATL ACAD SCI USA, V110, pE4289, DOI 10.1073/pnas.1317702110	98	29	29	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96100	10.1371/journal.pone.0096100	http://dx.doi.org/10.1371/journal.pone.0096100			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787650	Green Submitted, Green Published, gold			2022-12-25	WOS:000335510600076
J	Guevara, DR; El-Kereamy, A; Yaish, MW; Yong, MB; Rothstein, SJ				Guevara, David R.; El-Kereamy, Ashraf; Yaish, Mahmoud W.; Yong Mei-Bi; Rothstein, Steven J.			Functional Characterization of the Rice UDP-glucose 4-epimerase 1, OsUGE1: A Potential Role in Cell Wall Carbohydrate Partitioning during Limiting Nitrogen Conditions	PLOS ONE			English	Article							GENE-EXPRESSION; SUCROSE SYNTHASE; PHOSPHOMANNOSE-ISOMERASE; GALACTOSE 4-EPIMERASE; CELLULOSE SYNTHESIS; SELECTABLE MARKER; CARBON; PHOTOSYNTHESIS; LIMITATION; PLANTS	Plants grown under inadequate mineralized nitrogen (N) levels undergo N and carbon (C) metabolic re-programming which leads to significant changes in both soluble and insoluble carbohydrate profiles. However, relatively little information is available on the genetic factors controlling carbohydrate partitioning during adaptation to N-limitation conditions in plants. A gene encoding a uridine-diphospho-(UDP)-glucose 4-epimerase (OsUGE-1) from rice (Oryza sativa) was found to be N-responsive. We developed transgenic rice plants to constitutively over-express the OsUGE-1 gene (OsUGE1-OX1-2). The transgenic rice lines were similar in size to wild-type plants at the vegetative stage and at maturity regardless of the N-level tested. However, OsUGE1-OX lines maintained 18-24% more sucrose and 12-22% less cellulose in shoots compared to wildtype when subjected to sub-optimal N-levels. Interestingly, OsUGE1-OX lines maintained proportionally more galactose and glucose in the hemicellulosic polysaccharide profile of plants compared to wild-type plants when grown under low N. The altered cell wall C-partitioning during N-limitation in the OsUGE1-OX lines appears to be mediated by OsUGE1 via the repression of the cellulose synthesis associated genes, OsSus1, OsCesA4, 7, and 9. This relationship may implicate a novel control point for the deposition of UDP-glucose to the complex polysaccharide profiles of rice cell walls. However, a direct relationship between OsUGE1 and cell wall C-partitioning during N-limitation requires further investigation.	[Yaish, Mahmoud W.] Sultan Qaboos Univ, Coll Sci, Dept Biol, Muscat, Oman; [Guevara, David R.; El-Kereamy, Ashraf; Yong Mei-Bi; Rothstein, Steven J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	Sultan Qaboos University; University of Guelph	Yaish, MW (corresponding author), Sultan Qaboos Univ, Coll Sci, Dept Biol, Muscat, Oman.	myaish@squ.edu.om	EL-KEREAMY, ASHRAF/GON-9302-2022; Rothstein, Steven J/A-4947-2013; Yaish, Mahmoud W/F-7168-2014	Rothstein, Steven J/0000-0003-0737-1878; Yaish, Mahmoud W/0000-0002-5171-3014	Natural Sciences and Engineering Research Council of Canada; Syngenta Biotechnology Inc.; Ministry of Research and Innovation Post-Doctoral Fellowship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Syngenta Biotechnology Inc.(Syngenta); Ministry of Research and Innovation Post-Doctoral Fellowship	This work was partially supported by the Natural Sciences and Engineering Research Council of Canada and Syngenta Biotechnology Inc. to SJR, and by the Ministry of Research and Innovation Post-Doctoral Fellowship to D.R.G. There are no products in development or marketed products to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquisti C, 2009, MOL BIOL EVOL, V26, P953, DOI 10.1093/molbev/msp038; Barber C, 2006, J BIOL CHEM, V281, P17276, DOI 10.1074/jbc.M512727200; Bi YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-281; Bi YM, 2009, PLANT CELL ENVIRON, V32, P1749, DOI 10.1111/j.1365-3040.2009.02032.x; Chen X, 1999, BIOTECHNOL LETT, V21, P1131, DOI 10.1023/A:1005678225031; Coleman HD, 2009, P NATL ACAD SCI USA, V106, P13118, DOI 10.1073/pnas.0900188106; Dormann P, 1998, PLANT J, V13, P641, DOI 10.1046/j.1365-313X.1998.00067.x; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; FREDEEN AL, 1991, PLANT CELL ENVIRON, V14, P963, DOI 10.1111/j.1365-3040.1991.tb00966.x; Fujii S, 2010, PLANT CELL PHYSIOL, V51, P294, DOI 10.1093/pcp/pcp190; GIBEAUT DM, 1993, P NATL ACAD SCI USA, V90, P3850, DOI 10.1073/pnas.90.9.3850; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Hakeem KR, 2011, ENVIRON SCI POLLUT R, V18, P1184, DOI 10.1007/s11356-010-0434-8; Hirose T, 2008, PLANT SCI, V174, P534, DOI 10.1016/j.plantsci.2008.02.009; KATO Y, 1982, PLANT CELL PHYSIOL, V23, P351, DOI 10.1093/oxfordjournals.pcp.a076357; Kim SK, 2009, J KOREAN SOC APPL BI, V52, P315, DOI 10.3839/jksabc.2009.056; Kotake T, 2009, BIOCHEM J, V424, P169, DOI 10.1042/BJ20091025; Lawlor DW, 2002, J EXP BOT, V53, P773, DOI 10.1093/jexbot/53.370.773; Lian XM, 2006, PLANT MOL BIOL, V60, P617, DOI 10.1007/s11103-005-5441-7; Liu HL, 2007, J PLANT PHYSIOL, V164, P1384, DOI 10.1016/j.jplph.2007.03.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Negrotto D, 2000, PLANT CELL REP, V19, P798, DOI 10.1007/s002999900187; NIDETZKY B, 1994, BIOCHEM J, V303, P817, DOI 10.1042/bj3030817; Oliveira IC, 1999, PLANT PHYSIOL, V121, P301, DOI 10.1104/pp.121.1.301; Oomen RJFJ, 2004, PLANT SCI, V166, P1097, DOI 10.1016/j.plantsci.2003.12.033; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Paul MJ, 1997, PLANT CELL ENVIRON, V20, P110, DOI 10.1046/j.1365-3040.1997.d01-17.x; Peng MS, 2007, PLANT MOL BIOL, V65, P775, DOI 10.1007/s11103-007-9241-0; Reed J, 2001, IN VITRO CELL DEV-PL, V37, P127; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Rothstein SJ, 2007, PLANT CELL, V19, P2695, DOI 10.1105/tpc.107.053074; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Tarpley L, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-8; Tschoep H, 2009, PLANT CELL ENVIRON, V32, P300, DOI 10.1111/j.1365-3040.2008.01921.x; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Westman EL, 2007, BIOCHEM J, V405, P123, DOI 10.1042/BJ20070017; Zhang QS, 2006, BIOCHEM J, V394, P115, DOI 10.1042/BJ20051329; Zhu GH, 2009, PLANT CELL PHYSIOL, V50, P644, DOI 10.1093/pcp/pcp022	41	24	26	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96158	10.1371/journal.pone.0096158	http://dx.doi.org/10.1371/journal.pone.0096158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788752	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600080
J	Nadarajan, J; Pritchard, HW				Nadarajan, Jayanthi; Pritchard, Hugh W.			Biophysical Characteristics of Successful Oilseed Embryo Cryoprotection and Cryopreservation Using Vacuum Infiltration Vitrification: An Innovation in Plant Cell Preservation	PLOS ONE			English	Article							SHOOT TIPS; DROPLET-VITRIFICATION; INTERCELLULAR SPACES; RECALCITRANT SEEDS; STORAGE PHYSIOLOGY; DESICCATION; L.; CITRUS; GERMINATION; VIABILITY	Heterogeneity in morphology, physiology and cellular chemistry of plant tissues can compromise successful cryoprotection and cryopreservation. Cryoprotection is a function of exposure time x temperature x permeability for the chosen protectant and diffusion pathway length, as determined by specimen geometry, to provide sufficient dehydration whilst avoiding excessive chemical toxicity. We have developed an innovative method of vacuum infiltration vitrification (VIV) at 381 mm (15 in) Hg (50 kPa) that ensures the rapid (5 min), uniform permeation of Plant Vitrification Solution 2 (PVS2) cryoprotectant into plant embryos and their successful cryopreservation, as judged by regrowth in vitro. This method was validated on zygotic embryos/embryonic axes of three species (Carica papaya, Passiflora edulis and Laurus nobilis) up to 1.6 mg dry mass and 5.6 mm in length, with varying physiology (desiccation tolerances) and 80 degrees C variation in lipid thermal profiles, i.e., visco-elasticity properties, as determined by differential scanning calorimetry. Comparisons between the melting features of cryoprotected embryos and embryo regrowth indicated an optimal internal PVS2 concentration of about 60% of full strength. The physiological vigour of surviving embryos was directly related to the proportion of survivors. Compared with conventional vitrification, VIV-cryopreservation offered a similar to 10-fold reduction in PVS2 exposure times, higher embryo viability and regrowth and greater effectiveness at two pre-treatment temperatures (0 degrees C and 25 degrees C). VIV-cryopreservation may form the basis of a generic, high throughput technology for the ex situ conservation of plant genetic resources, aiding food security and protection of species from diverse habitats and at risk of extinction.	[Nadarajan, Jayanthi; Pritchard, Hugh W.] Royal Bot Gardens Kew, Seed Conservat Dept, Ardingly, W Sussex, England	Royal Botanic Gardens, Kew	Nadarajan, J (corresponding author), Royal Bot Gardens Kew, Seed Conservat Dept, Wellcome Trust Millennium Bldg, Ardingly, W Sussex, England.	j.nadarajan@kew.org	Nadarajan, Jayanthi/I-9359-2017	Nadarajan, Jayanthi/0000-0002-2132-5395	Millennium Commission; Wellcome Trust; Orange plc.; DEFRA, UK	Millennium Commission; Wellcome Trust(Wellcome TrustEuropean Commission); Orange plc.; DEFRA, UK(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by the Millennium Commission, The Wellcome Trust and Orange plc. The Royal Botanic Gardens Kew receives grant-in-aid from DEFRA, UK. All funders acknowledged in our manuscript had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANCHORDOGUY TJ, 1992, BIOCHIM BIOPHYS ACTA, V1104, P117, DOI 10.1016/0005-2736(92)90139-D; Azimi M, 2005, ACTA HORTIC, P43, DOI 10.17660/ActaHortic.2005.692.4; Baek HJ, 2003, CRYOLETTERS, V24, P381; Beck CB, 2009, INTRO PLANT STRUCTUR; BECWAR MR, 1983, J AM SOC HORTIC SCI, V108, P613; Beis SH, 2006, J AM OIL CHEM SOC, V83, P953, DOI 10.1007/s11746-006-5052-8; Chen S, 2012, J SCI FOOD AGR, V90, P1317; CHIN H F, 1989, Acta Horticulturae (Wageningen), P107; Cho EG, 2002, CRYOLETTERS, V23, P317; Chua SP, 2011, CRYOLETTERS, V32, P506; Crane J, 2006, PLANTA, V223, P1081, DOI 10.1007/s00425-005-0157-0; Crane J, 2003, PLANTA, V217, P699, DOI 10.1007/s00425-003-1036-1; Daws MI, 2006, SEED SCI TECHNOL, V34, P475, DOI 10.15258/sst.2006.34.2.22; Gonzalez-Benito ME, 2009, CRYOLETTERS, V30, P142; Ellis R. H., 1991, Seed Science Research, V1, P69, DOI 10.1017/S0960258500000659; Elmoazzen HY, 2005, CRYOBIOLOGY, V51, P85, DOI 10.1016/j.cryobiol.2005.05.003; Escudero J, 2003, MOL MICROBIOL, V47, P891, DOI 10.1046/j.1365-2958.2003.03328.x; Fang JY, 2011, AFR J AGR RES, V6, P3954; GROUT BWW, 1983, ANN BOT-LONDON, V52, P381, DOI 10.1093/oxfordjournals.aob.a086586; HALL AC, 1982, J MEMBRANE BIOL, V68, P47, DOI 10.1007/BF01872253; Hamilton KN, 2009, CRYOLETTERS, V30, P268; Hor YL, 2005, ANN BOT-LONDON, V95, P1153, DOI 10.1093/aob/mci126; Ikram-Ul-Haq, 2004, PLANT MOL BIOL REP, V22, P279, DOI 10.1007/BF02773138; Isbell SA, 1997, CRYOBIOLOGY, V35, P165, DOI 10.1006/cryo.1997.2037; Karran G, 1996, HUM REPROD, V11, P2681; Kim HH, 2012, CRYOLETTERS, V33, P271; Konstantinidou E, 2008, EUR J FOREST RES, V127, P125, DOI 10.1007/s10342-007-0189-z; Leelavathi S, 2004, PLANT CELL REP, V22, P465, DOI 10.1007/s00299-003-0710-x; LITCHFIELD C, 1967, LIPIDS, V2, P345, DOI 10.1007/BF02532124; Liu SC, 2008, INT J FOOD SCI NUTR, V59, P706, DOI 10.1080/09637480801931128; Mabberley D. J., 1997, PLANT BOOK PORTABLE; MAGILL W, 1994, P ROY SOC EDINB B, V102, P439, DOI 10.1017/S0269727000014457; Michael W, 1999, ANN BOT-LONDON, V84, P665, DOI 10.1006/anbo.1998.0964; Mohanty P, 2012, PLANT CELL TISS ORG, V109, P297, DOI 10.1007/s11240-011-0095-4; Muldrew K, 2004, LIFE IN THE FROZEN STATE, P67, DOI 10.1201/9780203647073.ch2; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nadarajan J, 2008, CRYOLETTERS, V29, P95; Nguyen H, 2006, LIPIDS, V97, P20; Nyanzi SA, 2005, J AM OIL CHEM SOC, V82, P41, DOI 10.1007/s11746-005-1040-2; Ogawa Y, 2012, PLANT CELL PHYSIOL, V53, P943, DOI 10.1093/pcp/pcs038; Ospina JA, 2000, CRYOPRESERVATION TRO, P378; Ozcan B, 2010, J ENVIRON BIOL, V31, P637; Panis B, 2005, PLANT SCI, V168, P45, DOI 10.1016/j.plantsci.2004.07.022; Paynter SJ, 1999, HUM REPROD, V14, P2338, DOI 10.1093/humrep/14.9.2338; Pritchard H.W., 1993, SELBYANA, V14, P89; PRITCHARD HW, 1986, J EXP BOT, V37, P1388, DOI 10.1093/jxb/37.9.1388; PRITCHARD HW, 1991, ANN BOT-LONDON, V67, P43, DOI 10.1093/oxfordjournals.aob.a088098; Puangsri I, 2005, J FOOD LIPIDS, V12, P62, DOI 10.1111/j.1745-4522.2005.00006.x; Ranal Marli A., 2009, Braz. J. Bot., V32, P849, DOI 10.1590/S0100-84042009000400022; Reed Barbara M., 2008, P3, DOI 10.1007/978-0-387-72276-4_1; Roach T, 2008, PHYSIOL PLANTARUM, V133, P131, DOI 10.1111/j.1399-3054.2007.00986.x; Routray P, 2002, THERIOGENOLOGY, V58, P1483, DOI 10.1016/S0093-691X(02)01076-2; Rustan AC., 2005, FATTY ACIDS STRUCTUR; Sakai A, 2004, LIFE IN THE FROZEN STATE, P329, DOI 10.1201/9780203647073.ch10; SAKAI A, 1990, PLANT CELL REP, V9, P30, DOI 10.1007/BF00232130; Sakai Akira, 2008, P33, DOI 10.1007/978-0-387-72276-4_3; Sakai A, 2007, CRYOLETTERS, V28, P151; Sari A, 2003, ENERG CONVERS MANAGE, V44, P2277, DOI 10.1016/S0196-8904(02)00251-0; Sari AO, 2006, NEW FOREST, V31, P403, DOI 10.1007/s11056-005-8678-8; Soejima K, 2012, CRYOBIOLOGY, V65, P21, DOI 10.1016/j.cryobiol.2012.03.006; Song, 2003, PLANT BIOLOGY, V20, P235, DOI [10.1155/2013/986273, DOI 10.5511/PLANTBIOTECHNOLOGY.20.235]; Sum AK, 2003, BIOPHYS J, V85, P3636, DOI 10.1016/S0006-3495(03)74781-X; Takagi H, 1997, PLANT CELL REP, V16, P594, DOI [10.1007/BF01275498, 10.1007/s002990050285]; Takos IA, 2001, NEW FOREST, V21, P105, DOI 10.1023/A:1011875725469; Takos IA, 2002, P 2002 ANN M IUFRO C, P178; Taylor MJ, 2004, LIFE IN THE FROZEN STATE, P603, DOI 10.1201/9780203647073.ch22; Tiau K.H., 2009, AM EURASIAN J SUSTAI, V3, P280; Tilki F, 2004, J ENVIRON BIOL, V25, P157; Tweddle JC, 2003, J ECOL, V91, P294, DOI 10.1046/j.1365-2745.2003.00760.x; Volk GM, 2007, PROTOPLASMA, V231, P215, DOI 10.1007/s00709-007-0251-1; Volk GM, 2006, CRYOBIOLOGY, V52, P48, DOI 10.1016/j.cryobiol.2005.09.004; Wesley-Smith J, 2014, ANN BOT-LONDON, V113, P695, DOI 10.1093/aob/mct284; Wood CB, 2000, SEED SCI RES, V10, P135; WOOLLEY JT, 1983, PLANT PHYSIOL, V72, P989, DOI 10.1104/pp.72.4.989	74	28	29	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96169	10.1371/journal.pone.0096169	http://dx.doi.org/10.1371/journal.pone.0096169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788797	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600082
J	Ono, H; Basson, MD; Ito, H				Ono, Hiroaki; Basson, Marc D.; Ito, Hiromichi			PTK6 Promotes Cancer Migration and Invasion in Pancreatic Cancer Cells Dependent on ERK Signaling	PLOS ONE			English	Article							BREAST-TUMOR KINASE; PROTEIN-TYROSINE KINASE; LONG-TERM SURVIVAL; GASTROINTESTINAL-TRACT; POOR-PROGNOSIS; GROWTH-FACTOR; EXPRESSION; CARCINOMA; BRK; IDENTIFICATION	Protein Tyrosine Kinase 6 (PTK6) is a non-receptor type tyrosine kinase that may be involved in some cancers. However, the biological role and expression status of PTK6 in pancreatic cancer is unknown. Therefore in this study, we evaluated the functional role of PTK6 on pancreatic cancer invasion. Five pancreatic cancer cell lines expressed PTK6 at varying levels. PTK6 expression was also observed in human pancreatic adenocarcinomas. PTK6 suppression by siRNA significantly reduced both cellular migration and invasion (0.59/0.49 fold for BxPC3, 0.61/0.62 for Panc1, 0.42/0.39 for MIAPaCa2, respectively, p < 0.05 for each). In contrast, forced overexpression of PTK6 by transfection of a PTK6 expression vector in Panc1 and MIAPaCa2 cells increased cellular migration and invasion (1.57/1.67 fold for Panc1, 1.44/1.57 for MIAPaCa2, respectively, p < 0.05). Silencing PTK6 reduced ERK1/2 activation, but not AKT or STAT3 activation, while PTK6 overexpression increased ERK1/2 activation. U0126, a specific inhibitor of ERK1/2, completely abolished the effect of PTK6 overexpression on cellular migration and invasion. These results suggest that PTK6 regulates cellular migration and invasion in pancreatic cancer via ERK signaling. PTK6 may be a novel therapeutic target for pancreatic cancer.	[Ono, Hiroaki; Basson, Marc D.; Ito, Hiromichi] Michigan State Univ, Coll Human Med, Dept Surg, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Human Medicine	Ito, H (corresponding author), Michigan State Univ, Coll Human Med, Dept Surg, E Lansing, MI 48824 USA.	Hiromichi.Ito@hc.msu.edu	Ito, Hiromichi/AAV-8369-2020					Aubele M, 2008, BRIT J CANCER, V99, P1089, DOI 10.1038/sj.bjc.6604660; Aubele M, 2007, BRIT J CANCER, V96, P801, DOI 10.1038/sj.bjc.6603613; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Born M, 2005, J PATHOL, V205, P592, DOI 10.1002/path.1720; Castro NE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2622; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Harvey AJ, 2003, ONCOGENE, V22, P5006, DOI 10.1038/sj.onc.1206577; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Irie HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011729; Ito H, 2004, CANCER RES, V64, P7439, DOI 10.1158/0008-5472.CAN-04-1177; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kelber JA, 2012, CANCER RES, V72, P2554, DOI 10.1158/0008-5472.CAN-11-3552; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Liu LN, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-140; Liu XK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-59; Llor X, 1999, CLIN CANCER RES, V5, P1767; Ma S, 2012, GASTROENTEROLOGY, V143, P675, DOI 10.1053/j.gastro.2012.06.007; Miah S, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.11; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Neuzillet C, 2013, CANCER METAST REV, V32, P147, DOI 10.1007/s10555-012-9396-2; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; VASIOUKHIN V, 1995, ONCOGENE, V10, P349; Zhang P, 2005, J BIOL CHEM, V280, P1982, DOI 10.1074/jbc.M412038200; Zhao C, 2013, ONCOTARGETS THER, V6, P183, DOI 10.2147/OTT.S41283; Zheng Y, 2013, CANCER RES, V73, P5426, DOI 10.1158/0008-5472.CAN-13-0443	33	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96060	10.1371/journal.pone.0096060	http://dx.doi.org/10.1371/journal.pone.0096060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788754	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600071
J	Ou, XC; Li, Q; Xia, H; Pang, Y; Wang, SF; Zhao, B; Song, YY; Zhou, Y; Zheng, Y; Zhang, ZJ; Zhang, ZY; Li, JC; Dong, HY; Zhang, J; Kam, KM; Chi, JY; Huan, ST; Chin, DP; Zhao, YL				Ou, Xichao; Li, Qiang; Xia, Hui; Pang, Yu; Wang, Shengfen; Zhao, Bing; Song, Yuanyuan; Zhou, Yang; Zheng, Yang; Zhang, Zhijian; Zhang, Zhiying; Li, Junchen; Dong, Haiyan; Zhang, Jack; Kam, Kai Man; Chi, Junying; Huan, Shitong; Chin, Daniel P.; Zhao, Yanlin			Diagnostic Accuracy of the PURE-LAMP Test for Pulmonary Tuberculosis at the County-Level Laboratory in China	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; POLYMERASE-CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS; SPUTUM SAMPLES; RESISTANCE	Background: Early and effective detection of Mycobacterium tuberculosis (MTB), particularly in smear-negative tuberculosis (TB), is a priority for global TB control. Loop-mediated isothermal amplification with a procedure for ultra rapid DNA extraction (PURE-LAMP) can detect TB in sputum samples rapidly and with high sensitivity and specificity. However, the PURE-LAMP test has not been effectively evaluated, especially in resource-limited laboratories. In this study, we evaluated the performance of the PURE-LAMP test for TB detection in TB suspects from two county-level TB dispensaries in China. Methodology/Principal Findings: From April 2011 to February 2012, patients with suspected TB were continuously enrolled from two county-level TB laboratories in China. Three sputum samples (spot, night, and morning sputum) were collected from each recruited patient. Detection of MTB by PURE-LAMP was compared to a reference standard L-J culture. The results showed that the sensitivity of the PURE-LAMP test based on spot sputum for MTB detection was 70.67%, while the sensitivity of the PURE-LAMP test based on spot sputum for MTB detection in smear positive and culture positive patients and smear negative and culture positive patients was 92.12% and 53.81%, respectively. The specificity of PURE-LAMP based on spot sputum for MTB detection was 98.32%. The sensitivity and specificity of the PURE-LAMP test based on three sputa combination for MTB detection was 88.80% and 96.86%, respectively. The results also showed that the PURE-LAMP test had a significantly lower contamination rate than did solid culture. Conclusions/Significance: The study suggested that, in peripheral-level TB laboratories in China, the PURE-LAMP test showed high sensitivity and specificity for TB detection in TB suspects, making it a more effective, rapid, and safe method worthy of broader use in the future.	[Ou, Xichao; Li, Qiang; Xia, Hui; Pang, Yu; Wang, Shengfen; Zhao, Bing; Song, Yuanyuan; Zhou, Yang; Zheng, Yang; Zhao, Yanlin] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Zhang, Zhiying; Li, Junchen; Dong, Haiyan; Zhang, Jack] PATH, China Off, Beijing, Peoples R China; [Kam, Kai Man] Chinese Univ Hong Kong, Fac Med, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Chi, Junying; Huan, Shitong; Chin, Daniel P.] Bill & Melinda Gates Fdn, China Off, Beijing, Peoples R China; [Zhang, Zhijian] Chinese Peoples Liberat Army Gen Hosp, Resp Dis Dept Nanlou, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese University of Hong Kong; Chinese People's Liberation Army General Hospital	Chin, DP (corresponding author), Bill & Melinda Gates Fdn, China Off, Beijing, Peoples R China.	daniel.chin@gatesfoundation.org; zhaoyanlin@chinatb.org	KAM, Kai Man/K-4546-2012	KAM, Kai Man/0000-0003-0579-0307	The Bill & Melinda Gates Foundation	The Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Bill & Melinda Gates Foundation support this program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE C, 1993, J CLIN MICROBIOL, V31, P3270, DOI 10.1128/JCM.31.12.3270-3274.1993; Adhikari BR, 2009, JPN J INFECT DIS, V62, P212; [Anonymous], GLOB TUB CONTR WHO R; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Chinese Ministry of Health Disease Control and Prevention Bureau Center for Disease Control and Prevention, 2009, CHIN TB CONTR PROGR; Chinese Ministry of Health Disease Control and Prevention Bureau Center for Disease Control and Prevention, 2008, GUID IMPL NAT TUB CO; ELLIOTT AM, 1993, J TROP MED HYG, V96, P1; Guo Y, 2009, INT J TUBERC LUNG D, V13, P914; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Huggett JF, 2003, INT J BIOCHEM CELL B, V35, P1407, DOI 10.1016/S1357-2725(03)00102-X; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; KLEIN NC, 1989, CHEST, V95, P1190, DOI 10.1378/chest.95.6.1190; Mitarai S, 2011, INT J TUBERC LUNG D, V15, P1211, DOI 10.5588/ijtld.10.0629; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P423, DOI 10.1586/14737159.6.3.423; Pandey BD, 2008, J MED MICROBIOL, V57, P439, DOI 10.1099/jmm.0.47499-0; Sarmiento OL, 2003, J CLIN MICROBIOL, V41, P3233, DOI 10.1128/JCM.41.7.3233-3240.2003; Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496; Suffys P, 2000, INT J TUBERC LUNG D, V4, P179; World Health Organization, 1998, LAB SERV TUB CONTR 3	21	37	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94544	10.1371/journal.pone.0094544	http://dx.doi.org/10.1371/journal.pone.0094544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788724	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600013
J	Protti, A; Fortunato, F; Caspani, ML; Pluderi, M; Lucchini, V; Grimoldi, N; Solimeno, LP; Fagiolari, G; Ciscato, P; Zella, SMA; Moggio, M; Comi, GP; Gattinoni, L				Protti, Alessandro; Fortunato, Francesco; Caspani, Maria L.; Pluderi, Mauro; Lucchini, Valeria; Grimoldi, Nadia; Solimeno, Luigi P.; Fagiolari, Gigliola; Ciscato, Patrizia; Zella, Samis M. A.; Moggio, Maurizio; Comi, Giacomo P.; Gattinoni, Luciano			Mitochondrial Changes in Platelets Are Not Related to Those in Skeletal Muscle during Human Septic Shock	PLOS ONE			English	Article							METFORMIN OVERDOSE; OXYGEN-CONSUMPTION; CHAIN DYSFUNCTION; FAST-TWITCH; COMPLEX-I; SEPSIS; SLOW; SENSITIVITY; ACTIVATION; BIOMARKER	Platelets can serve as general markers of mitochondrial (dys)function during several human diseases. Whether this holds true even during sepsis is unknown. Using spectrophotometry, we measured mitochondrial respiratory chain biochemistry in platelets and triceps brachii muscle of thirty patients with septic shock (within 24 hours from admission to Intensive Care) and ten surgical controls (during surgery). Results were expressed relative to citrate synthase (CS) activity, a marker of mitochondrial density. Patients with septic shock had lower nicotinamide adenine dinucleotide dehydrogenase (NADH)/CS (p = 0.015), complex I/CS (p = 0.018), complex I and III/CS (p<0.001) and complex IV/CS (p = 0.012) activities in platelets but higher complex I/CS activity (p = 0.021) in triceps brachii muscle than controls. Overall, NADH/CS (r(2) = 0.00; p = 0.683) complex I/CS (r(2) = 0.05; p = 0.173), complex I and III/CS (r(2) = 0.01; p = 0.485), succinate dehydrogenase (SDH)/CS (r(2) = 0.00; p = 0.884), complex II and III/CS (r(2) = 0.00; p = 0.927) and complex IV/CS (r(2) = 0.00; p = 0.906) activities in platelets were not associated with those in triceps brachii muscle. In conclusion, several respiratory chain enzymes were variably inhibited in platelets, but not in triceps brachii muscle, of patients with septic shock. Sepsis-induced mitochondrial changes in platelets do not reflect those in other organs.	[Protti, Alessandro; Caspani, Maria L.; Gattinoni, Luciano] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Terapia Intens Emma Vecla, Milan, Italy; [Fortunato, Francesco; Comi, Giacomo P.] Univ Milan, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, UO Neurol,Ctr Dino Ferrari, Milan, Italy; [Pluderi, Mauro; Grimoldi, Nadia; Zella, Samis M. A.] Univ Milan, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, UO Neurochirurg, Milan, Italy; [Lucchini, Valeria; Fagiolari, Gigliola; Ciscato, Patrizia; Moggio, Maurizio] Univ Milan, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, UO Malattie Neuromuscolari,Ctr Dino Ferrari, Milan, Italy; [Solimeno, Luigi P.] Univ Milan, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, UO Traumatol, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Protti, A (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Terapia Intens Emma Vecla, Milan, Italy.	alessandro.protti@policlinico.mi.it	pluderi, mauro/AGF-6499-2022; Protti, Alessandro/AAC-3122-2020; Comi, Giacomo P/K-5702-2016	pluderi, mauro/0000-0002-2981-9277; Comi, Giacomo P/0000-0002-1383-5248; Gattinoni, Luciano/0000-0001-5380-2494; Protti, Alessandro/0000-0002-0172-6079	Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; European Society of Intensive Care Medicine (Clinical Research Award, Alessandro Protti); Associazione Amici del Centro Dino Ferrari - Universita degli Studi di Milano, Milan, Italy; Telethon Genetic Biobanks Network [GTB07001ER]; Eurobiobank project [QLTR-2001-02769]	Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; European Society of Intensive Care Medicine (Clinical Research Award, Alessandro Protti); Associazione Amici del Centro Dino Ferrari - Universita degli Studi di Milano, Milan, Italy; Telethon Genetic Biobanks Network(Fondazione Telethon); Eurobiobank project	This work was funded in part by Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; European Society of Intensive Care Medicine (Clinical Research Award 2007, Alessandro Protti); Associazione Amici del Centro Dino Ferrari - Universita degli Studi di Milano, Milan, Italy; Telethon Genetic Biobanks Network GTB07001ER; Eurobiobank project QLTR-2001-02769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; ANGERAS U, 1991, METABOLISM, V40, P1147, DOI 10.1016/0026-0495(91)90208-E; Belikova I, 2007, CRIT CARE MED, V35, P2702, DOI 10.1097/01.CCM.0000295593.25106.C4; BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boulos M, 2003, CRIT CARE MED, V31, P353, DOI 10.1097/01.CCM.0000050074.82486.B2; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; BRESOLIN N, 1985, NEUROLOGY, V35, P802, DOI 10.1212/WNL.35.6.802; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Cavaillon JM, 2006, J ENDOTOXIN RES, V12, P151, DOI 10.1179/096805106X102246; Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Fredriksson K, 2006, AM J PHYSIOL-ENDOC M, V291, pE1044, DOI 10.1152/ajpendo.00218.2006; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; GASPARETTO A, 1983, LANCET, V2, P1486; Grundler K, 2014, CRIT CARE, V18, DOI 10.1186/cc13724; Hottz ED, 2013, J THROMB HAEMOST, V11, P951, DOI 10.1111/jth.12178; Jackman MR, 1996, AM J PHYSIOL-CELL PH, V270, pC673, DOI 10.1152/ajpcell.1996.270.2.C673; Jeger V, 2013, EUR J CLIN INVEST, V43, P532, DOI 10.1111/eci.12069; Lorente L, 2011, CRIT CARE MED, V39, P1289, DOI 10.1097/CCM.0b013e31820ee20c; Peruchi BB, 2011, J SURG RES, V167, pE333, DOI 10.1016/j.jss.2010.11.893; Piantadosi CA, 2012, FREE RADICAL BIO MED, V53, P2043, DOI 10.1016/j.freeradbiomed.2012.09.014; Pich MM, 1996, FEBS LETT, V380, P176, DOI 10.1016/0014-5793(96)00037-3; Protti Alessandro, 2007, Novartis Found Symp, V280, P7; Protti A, 2012, CRIT CARE, V16, DOI 10.1186/cc11663; Protti A, 2012, CRIT CARE, V16, DOI 10.1186/cc11332; Ran JM, 2009, PLATELETS, V20, P588, DOI 10.3109/09537100903288422; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; SJOGAARD G, 1982, HISTOCHEMISTRY, V76, P547, DOI 10.1007/BF00489909; Sjovall F, 2010, CRIT CARE, V14, DOI 10.1186/cc9337; Tiao G, 1997, AM J PHYSIOL-REG I, V272, pR849, DOI 10.1152/ajpregu.1997.272.3.R849; Trumbeckaite S, 2001, EUR J BIOCHEM, V268, P1422, DOI 10.1046/j.1432-1327.2001.02012.x; Vanhorebeek I, 2005, LANCET, V365, P53, DOI 10.1016/S0140-6736(04)17665-4; Vanhorebeek I, 2012, J CLIN ENDOCR METAB, V97, pE59, DOI 10.1210/jc.2011-1760; VARY TC, 1992, AM J PHYSIOL, V262, pC1513, DOI 10.1152/ajpcell.1992.262.6.C1513; Zharikov S, 2013, BIOCHEM SOC T, V41, P118, DOI 10.1042/BST20120327	41	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96205	10.1371/journal.pone.0096205	http://dx.doi.org/10.1371/journal.pone.0096205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787741	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600086
J	Rivera-Torres, N; Strouse, B; Bialk, P; Niamat, RA; Kmiec, EB				Rivera-Torres, Natalia; Strouse, Bryan; Bialk, Pawel; Niamat, Rohina A.; Kmiec, Eric B.			The Position of DNA Cleavage by TALENs and Cell Synchronization Influences the Frequency of Gene Editing Directed by Single-Stranded Oligonucleotides	PLOS ONE			English	Article							MAMMALIAN-CELLS; SEQUENCE CORRECTION; CYCLE PROGRESSION; CHIMERIC RNA/DNA; DISEASE-MODELS; REPAIR; REPLICATION; EFFECTORS; NUCLEASES; EVOLUTION	With recent technological advances that enable DNA cleavage at specific sites in the human genome, it may now be possible to reverse inborn errors, thereby correcting a mutation, at levels that could have an impact in a clinical setting. We have been developing gene editing, using single-stranded DNA oligonucleotides (ssODNs), as a tool to direct site specific single base changes. Successful application of this technique has been demonstrated in many systems ranging from bacteria to human (ES and somatic) cells. While the frequency of gene editing can vary widely, it is often at a level that does not enable clinical application. As such, a number of stimulatory factors such as double-stranded breaks are known to elevate the frequency significantly. The majority of these results have been discovered using a validated HCT116 mammalian cell model system where credible genetic and biochemical readouts are available. Here, we couple TAL-Effector Nucleases (TALENs) that execute specific ds DNA breaks with ssODNs, designed specifically to repair a missense mutation, in an integrated single copy eGFP gene. We find that proximal cleavage, relative to the mutant base, is key for enabling high frequencies of editing. A directionality of correction is also observed with TALEN activity upstream from the target base being more effective in promoting gene editing than activity downstream. We also find that cells progressing through S phase are more amenable to combinatorial gene editing activity. Thus, we identify novel aspects of gene editing that will help in the design of more effective protocols for genome modification and gene therapy in natural genes.	[Rivera-Torres, Natalia; Strouse, Bryan; Bialk, Pawel; Niamat, Rohina A.; Kmiec, Eric B.] Delaware State Univ, Dept Chem, Dover, DE 19901 USA	Delaware State University	Kmiec, EB (corresponding author), Delaware State Univ, Dept Chem, Dover, DE 19901 USA.	ekmiec@desu.edu		Rivera-Torres, Natalia/0000-0001-7655-3865	NIH [5R01CA89325-12]; NATIONAL CANCER INSTITUTE [R01CA089325] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant 5R01CA89325-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2011, GENE THER, V18, P213, DOI 10.1038/gt.2010.161; Aarts M, 2010, J CELL MOL MED, V14, P1657, DOI 10.1111/j.1582-4934.2009.00847.x; Andersen MS, 2002, J MOL MED-JMM, V80, P770, DOI 10.1007/s00109-002-0393-8; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bonner M, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.9; Bonner M, 2009, MUTAT RES-FUND MOL M, V669, P85, DOI 10.1016/j.mrfmmm.2009.05.004; Borjigin M, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.51; Brachman EE, 2005, DNA REPAIR, V4, P445, DOI 10.1016/j.dnarep.2004.11.007; Brachman EE, 2002, CURR OPIN MOL THER, V4, P171; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Engstrom JU, 2008, CELL CYCLE, V7, P1402, DOI 10.4161/cc.7.10.5826; Engstrom JU, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199/8/9; Engstrom JU, 2009, BIOESSAYS, V31, P159, DOI 10.1002/bies.200800119; Ferrara L, 2004, NUCLEIC ACIDS RES, V32, P5239, DOI 10.1093/nar/gkh822; Ferrara L, 2004, EXP CELL RES, V300, P170, DOI 10.1016/j.yexcr.2004.06.021; Gamper HB, 2000, NUCLEIC ACIDS RES, V28, P4332, DOI 10.1093/nar/28.21.4332; Huen MSY, 2006, NUCLEIC ACIDS RES, V34, P6183, DOI 10.1093/nar/gkl852; Igoucheva O, 2001, GENE THER, V8, P391, DOI 10.1038/sj.gt.3301414; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Lamb BM, 2013, NUCLEIC ACIDS RES, V41, P9779, DOI 10.1093/nar/gkt754; Liu J, 2010, J BIOL CHEM, V285, P23196, DOI 10.1074/jbc.M110.123844; Liu L, 2002, MOL CELL BIOL, V22, P3852, DOI 10.1128/MCB.22.11.3852-3863.2002; Mak A, 2012, CURR OPIN STRUC BIOL, V23, P1; Miyaoka Y, 2014, NAT METHODS, DOI 10.1038; Morozov V, 2008, GENE THER, V15, P468, DOI 10.1038/sj.gt.3303088; Olsen PA, 2005, J GENE MED, V7, P1534, DOI 10.1002/jgm.804; Olsen PA, 2005, GENE THER, V12, P546, DOI 10.1038/sj.gt.3302454; Papaioannou I, 2009, J GENE MED, V11, P267, DOI 10.1002/jgm.1296; Parekh-Olmedo H, 2007, GENE THER, V14, P1675, DOI 10.1038/sj.gt.3303053; Qiu ZW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt258; Radecke F, 2006, MOL THER, V14, P798, DOI 10.1016/j.ymthe.2006.06.008; Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Strouse B, 2014, SCI REP-UK, V4, DOI 10.1038/srep03791; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Voit RA, 2013, NUCLEIC ACIDS RES, P1; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	47	18	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96483	10.1371/journal.pone.0096483	http://dx.doi.org/10.1371/journal.pone.0096483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788536	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600104
J	Aissani, C; Martinerie, J; Yahia-Cherif, L; Paradis, AL; Lorenceau, J				Aissani, Charles; Martinerie, Jacques; Yahia-Cherif, Lydia; Paradis, Anne-Lise; Lorenceau, Jean			Beta, but Not Gamma, Band Oscillations Index Visual Form-Motion Integration	PLOS ONE			English	Article							NEURONAL SYNCHRONY; APERTURE PROBLEM; CORTICAL AREAS; DYNAMICS; CORTEX; RESPONSES; EEG; V1; FREQUENCY; MT	Electrophysiological oscillations in different frequency bands co-occur with perceptual, motor and cognitive processes but their function and respective contributions to these processes need further investigations. Here, we recorded MEG signals and seek for percept related modulations of alpha, beta and gamma band activity during a perceptual form/motion integration task. Participants reported their bound or unbound perception of ambiguously moving displays that could either be seen as a whole square-like shape moving along a Lissajou's figure (bound percept) or as pairs of bars oscillating independently along cardinal axes (unbound percept). We found that beta (15-25 Hz), but not gamma (55-85 Hz) oscillations, index perceptual states at the individual and group level. The gamma band activity found in the occipital lobe, although significantly higher during visual stimulation than during base line, is similar in all perceptual states. Similarly, decreased alpha activity during visual stimulation is not different for the different percepts. Trial-by-trial classification of perceptual reports based on beta band oscillations was significant in most observers, further supporting the view that modulation of beta power reliably index perceptual integration of form/motion stimuli, even at the individual level.	[Aissani, Charles; Martinerie, Jacques; Paradis, Anne-Lise; Lorenceau, Jean] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, CNRS UMR7225, Paris, France; [Yahia-Cherif, Lydia] Univ Paris 06, Ctr Rech, CENIR, Inst Cerveau & Moelle Epiniere,CNRS UMR7225,INSER, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Lorenceau, J (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, CNRS UMR7225, Paris, France.	jean.lorenceau@upmc.fr	Paradis, Anne-Lise/F-2109-2013; Lorenceau, Jean/F-5274-2012	Paradis, Anne-Lise/0000-0002-5933-0448; 	Agence Nationale pour la Recherche (ANR) ViMAGINE [BLAN08-2_317597]; Ministere de l'Enseignement Superieur et de la Recherche (MESR)	Agence Nationale pour la Recherche (ANR) ViMAGINE(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France)	This study was funded by Agence Nationale pour la Recherche (ANR) ViMAGINE noBLAN08-2_317597 to J.L. (http://www.agence-nationale-recherche.fr/); C.A. was supported by a grant from the Ministere de l'Enseignement Superieur et de la Recherche (MESR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aissani C, 2011, BRAIN RES, V1408, P27, DOI 10.1016/j.brainres.2011.05.051; [Anonymous], 1987, DIGITAL SPECTRAL ANA; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Bosman CA, 2009, J NEUROSCI, V29, P9471, DOI 10.1523/JNEUROSCI.1193-09.2009; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Caclin A, 2012, J VISION, V12, DOI 10.1167/12.7.11; Donner TH, 2007, J NEUROPHYSIOL, V98, P345, DOI 10.1152/jn.01141.2006; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Doppelmayr M, 1998, BIOL CYBERN, V79, P49, DOI 10.1007/s004220050457; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Flevaris AV, 2013, J VISION, V13, DOI 10.1167/13.13.17; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Guo K, 2006, NEUROSCIENCE, V138, P1397, DOI 10.1016/j.neuroscience.2005.12.016; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; KOVACS I, 1993, P NATL ACAD SCI USA, V90, P7495, DOI 10.1073/pnas.90.16.7495; Kramer MA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000169; Lorenceau J, 2001, NAT NEUROSCI, V4, P745, DOI 10.1038/89543; LORENCEAU J, 1992, VISION RES, V32, P263, DOI 10.1016/0042-6989(92)90137-8; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Marinkovic K, 2004, Neurol Clin Neurophysiol, V2004, P30; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Muller MM, 1997, NEUROREPORT, V8, P2575; Muller-Gerking J, 2000, CLIN NEUROPHYSIOL, V111, P1353, DOI 10.1016/S1388-2457(00)00345-X; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Naber M, 2011, J VISION, V11, DOI 10.1167/11.4.8; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Okazaki M, 2008, NEUROSCI RES, V61, P319, DOI 10.1016/j.neures.2008.03.010; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Palanca BJA, 2005, NEURON, V46, P333, DOI 10.1016/j.neuron.2005.03.002; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Pei F, 2002, J VISION, V2, DOI 10.1167/2.9.1; Piantoni G, 2010, J VISION, V10, DOI 10.1167/10.13.18; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Romei V, 2011, CURR BIOL, V21, P334, DOI 10.1016/j.cub.2011.01.035; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Salenius S, 2003, CURR OPIN NEUROBIOL, V13, P678, DOI 10.1016/j.conb.2003.10.008; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sehatpour P, 2006, NEUROIMAGE, V29, P605, DOI 10.1016/j.neuroimage.2005.07.049; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shiffrar M, 1996, VISION RES, V36, P2061, DOI 10.1016/0042-6989(95)00283-9; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Swettenham JB, 2009, J NEUROPHYSIOL, V102, P1241, DOI 10.1152/jn.91044.2008; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tsui JMG, 2010, J NEUROPHYSIOL, V103, P3123, DOI 10.1152/jn.00654.2009; VANESSEN DC, 1983, TRENDS NEUROSCI, V6, P370, DOI 10.1016/0166-2236(83)90167-4; VanRullen R, 2012, CURR BIOL, V22, P995, DOI 10.1016/j.cub.2012.03.050; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Yazdanbakhsh A, 2006, NAT NEUROSCI, V9, P697, DOI 10.1038/nn1693; YO C, 1992, VISION RES, V32, P1263, DOI 10.1016/0042-6989(92)90221-4; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	71	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e95541	10.1371/journal.pone.0095541	http://dx.doi.org/10.1371/journal.pone.0095541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781862	Green Submitted, Green Published, gold			2022-12-25	WOS:000335504900007
J	Rodriguez, JS; Rueda, JOV; Salas, M; Becerra, R; Di Carlo, MN; Said, M; Vittone, L; Rinaldi, G; Portiansky, EL; Mundina-Weilenmann, C; Palomeque, J; Mattiazzi, A				Rodriguez, Jesica S.; Velez Rueda, J. Omar; Salas, Margarita; Becerra, Romina; Di Carlo, Mariano N.; Said, Matilde; Vittone, Leticia; Rinaldi, Gustavo; Portiansky, Enrique L.; Mundina-Weilenmann, Cecilia; Palomeque, Julieta; Mattiazzi, Alicia			Increased Na+/Ca2+ Exchanger Expression/Activity Constitutes a Point of Inflection in the Progression to Heart Failure of Hypertensive Rats	PLOS ONE			English	Article							VENTRICULAR MYOCYTES; CARDIOMYOCYTE APOPTOSIS; GENE-EXPRESSION; HYPERTROPHY; CA2+; PHOSPHORYLATION; TRANSITION; MECHANISMS; PROTEINS; ATORVASTATIN	Spontaneously hypertensive rat (SHR) constitutes a genetic model widely used to study the natural evolution of hypertensive heart disease. Ca2+-handling alterations are known to occur in SHR. However, the putative modifications of Ca2+-handling proteins during the progression to heart failure (HF) are not well established. Moreover, the role of apoptosis in SHR is controversial. We investigated intracellular Ca2+, Ca2+-handling proteins and apoptosis in SHR vs. control Wistar rats (W) from 3 to 15 months (mo). Changes associated with the transition to HF (i. e. lung edema and decrease in midwall fractional shortening), occurred at 15 mo in 38% of SHR (SHRF). In SHRF, twitch and caffeine-induced Ca2+ transients, significantly decreased relative to 6/9 mo and 15 mo without HF signs. This decrease occurred in association with a decrease in the time constant of caffeine-Ca2+ transient decay and an increase in Na+/Ca2+ exchanger (NCX) abundance (p<0.05) with no changes in SERCA2a expression/activity. An increased Ca2+-calmodulin-kinase II activity, associated with an enhancement of apoptosis (TUNEL and Bax/Bcl2) was observed in SHR relative to W from 3 to 15 mo. Conclusions: 1. Apoptosis is an early and persistent event that may contribute to hypertrophic remodeling but would not participate in the contractile impairment of SHRF. 2. The increase in NCX expression/activity, associated with an increase in Ca2+ efflux from the cell, constitutes a primary alteration of Ca2+-handling proteins in the evolution to HF. 3. No changes in SERCA2a expression/activity are observed when HF signs become evident.	[Rodriguez, Jesica S.; Velez Rueda, J. Omar; Salas, Margarita; Becerra, Romina; Di Carlo, Mariano N.; Said, Matilde; Vittone, Leticia; Rinaldi, Gustavo; Mundina-Weilenmann, Cecilia; Palomeque, Julieta; Mattiazzi, Alicia] Univ Nacl La Plata, Fac Med, CONICET La Plata, Ctr Invest Cardiovasc, La Plata, Argentina; [Portiansky, Enrique L.] Univ Nacl La Plata, Fac Ciencias Vet, Lab Anal Imagenes, La Plata, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata	Mundina-Weilenmann, C (corresponding author), Univ Nacl La Plata, Fac Med, CONICET La Plata, Ctr Invest Cardiovasc, La Plata, Argentina.	cmundweil@med.unlp.edu.ar; julip@med.unlp.edu.ar	Mattiazzi, Alicia/L-1512-2019		Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina) [PIP 2139]; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [PICT 2634, PICT 1795]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT)	This work was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina) Grant PIP 2139 to AM, and Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) grants PICT 2634 to CM-W and PICT 1795 to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; ATKINS FL, 1995, HYPERTENSION, V26, P78, DOI 10.1161/01.HYP.26.1.78; Baartscheer A, 2003, CARDIOVASC RES, V57, P986, DOI 10.1016/S0008-6363(02)00848-9; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; BING OHL, 1991, CIRC RES, V68, P1390, DOI 10.1161/01.RES.68.5.1390; Boknik P, 2001, CARDIOVASC RES, V51, P717, DOI 10.1016/S0008-6363(01)00346-7; Braunwald E, 2000, CIRCULATION, V102, P14; Brooks WW, 2000, HYPERTENSION, V35, P1203, DOI 10.1161/01.HYP.35.6.1203; BROOKSBY P, 1993, CARDIOVASC RES, V27, P1268, DOI 10.1093/cvr/27.7.1268; Byrne MJ, 2008, GENE THER, V15, P1550, DOI 10.1038/gt.2008.120; Chen-Izu Y, 2007, AM J PHYSIOL-HEART C, V293, pH3301, DOI 10.1152/ajpheart.00259.2007; Chen-Izu Y, 2007, AM J PHYSIOL-HEART C, V293, pH2409, DOI 10.1152/ajpheart.00562.2007; DAVIDDUFILHO M, 1986, J CARDIOVASC PHARM, V8, pS130, DOI 10.1097/00005344-198600088-00026; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; Diaz ME, 2004, CARDIOVASC RES, V62, P538, DOI 10.1016/j.cardiores.2004.01.038; Ferrero P, 2007, J MOL CELL CARDIOL, V43, P281, DOI 10.1016/j.yjmcc.2007.05.022; Fowler MR, 2005, AM J PHYSIOL-HEART C, V288, pH2431, DOI 10.1152/ajpheart.01069.2004; GERDES AM, 1991, J MOL CELL CARDIOL, V23, P833, DOI 10.1016/0022-2828(91)90216-9; Gupta RC, 2003, AM J PHYSIOL-HEART C, V285, pH2373, DOI 10.1152/ajpheart.00442.2003; Hadri L, 2011, CLIN PHARMACOL THER, V90, P620, DOI 10.1038/clpt.2011.161; Hasenfuss G, 1999, CIRCULATION, V99, P641, DOI 10.1161/01.CIR.99.5.641; Ikeda S, 1999, CLIN SCI, V97, P239, DOI 10.1042/CS19980374; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Li ZH, 1997, AM J PHYSIOL-HEART C, V272, pH2313, DOI 10.1152/ajpheart.1997.272.5.H2313; LITWIN SE, 1995, CIRCULATION, V91, P2642, DOI 10.1161/01.CIR.91.10.2642; Lu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024724; Marks AR, 2000, CIRC RES, V87, P8, DOI 10.1161/01.RES.87.1.8; MERCADIER JJ, 1990, J CLIN INVEST, V85, P305, DOI 10.1172/JCI114429; MundinaWeilenmann C, 1996, J BIOL CHEM, V271, P33561, DOI 10.1074/jbc.271.52.33561; NAKANISHI H, 1989, AM J PHYSIOL, V257, pH349, DOI 10.1152/ajpheart.1989.257.2.H349; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Palomeque J, 2007, J CARD FAIL, V13, P143, DOI 10.1016/j.cardfail.2006.11.002; Palomeque J, 2009, CIRC RES, V105, P1204, DOI 10.1161/CIRCRESAHA.109.204172; Qi M, 1997, AM J PHYSIOL-HEART C, V272, pH2416, DOI 10.1152/ajpheart.1997.272.5.H2416; Roos KP, 2007, J CARD FAIL, V13, P318, DOI 10.1016/j.cardfail.2007.01.004; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Said M, 2008, AM J PHYSIOL-HEART C, V295, pH1669, DOI 10.1152/ajpheart.00010.2008; Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Shorofsky SR, 1999, CIRC RES, V84, P424, DOI 10.1161/01.RES.84.4.424; Tamura T, 2000, J CARD FAIL, V6, P37, DOI 10.1016/S1071-9164(00)00010-5; Rueda JOV, 2012, J APPL PHYSIOL, V112, P2110, DOI 10.1152/japplphysiol.01383.2011; Vigliano CA, 2011, J AM COLL CARDIOL, V57, P1523, DOI 10.1016/j.jacc.2010.09.080; Ward ML, 2010, PFLUG ARCH EUR J PHY, V460, P991, DOI 10.1007/s00424-010-0876-3; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Yao L, 2009, BASIC RES CARDIOL, V104, P258, DOI 10.1007/s00395-008-0751-y; Zhao XY, 2010, INT HEART J, V51, P426, DOI 10.1536/ihj.51.426; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200; Zwadlo C, 2005, TOXICOL APPL PHARM, V207, P244, DOI 10.1016/j.taap.2005.01.005	51	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96400	10.1371/journal.pone.0096400	http://dx.doi.org/10.1371/journal.pone.0096400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781001	Green Published, gold, Green Submitted			2022-12-25	WOS:000335504900032
J	Soyemi, K; Medina-Marino, A; Sinkowitz-Cochran, R; Schneider, A; Njai, R; McDonald, M; Glover, M; Garcia, J; Aiello, AE				Soyemi, Kenneth; Medina-Marino, Andrew; Sinkowitz-Cochran, Ronda; Schneider, Amy; Njai, Rashid; McDonald, Marian; Glover, Maleeka; Garcia, Jocelyn; Aiello, Allison E.			Disparities among 2009 Pandemic Influenza A (H1N1) Hospital Admissions: A Mixed Methods Analysis - Illinois, April-December 2009	PLOS ONE			English	Article							HEALTH DISPARITIES; ETHNIC DISPARITIES; VIRUS-INFECTION; UNITED-STATES; RISK-FACTORS; MORTALITY; IMPACT; RESPONSES; DEATH	During late April 2009, the first cases of 2009 pandemic influenza A (H1N1) (pH1N1) in Illinois were reported. On-going, sustained local transmission resulted in an estimated 500,000 infected persons. We conducted a mixed method analysis using both quantitative (surveillance) and qualitative (interview) data; surveillance data was used to analyze demographic distribution of hospitalized cases and follow-up interview data was used to assess health seeking behavior. Invitations to participate in a telephone interview were sent to 120 randomly selected Illinois residents that were hospitalized during April-December 2009. During April-December 2009, 2,824 pH1N1 hospitalizations occurred in Illinois hospitals; median age (interquartile range) at admission was 24 (range: 6-49) years. Hospitalization rates/100,000 persons for blacks and Hispanics, regardless of age or sex were 2-3 times greater than for whites (blacks, 36/100,000 (95% Confidence Interval ([95% CI], 33-39)); Hispanics, 35/100,000 [95% CI,32-37] (; whites, 13/100,000[95% CI, 12-14); p<0.001). Mortality rates were higher for blacks (0.9/100,000; p<0.09) and Hispanics (1/100,000; p<0.04) when compared with the mortality rates for whites (0.6/100,000). Of 33 interview respondents, 31 (94%) stated that they had heard of pH1N1 before being hospitalized, and 24 (73%) did not believed they were at risk for pH1N1. On average, respondents reported experiencing symptoms for 2 days (range: 1-7) before seeking medical care. When asked how to prevent pH1N1 infection in the future, the most common responses were getting vaccinated and practicing hand hygiene. Blacks and Hispanics in Illinois experienced disproportionate pH1N1 hospitalization and mortality rates. Public health education and outreach efforts in preparation for future influenza pandemics should include prevention messaging focused on perception of risk, and ensure community wide access to prevention messages and practices.	[Soyemi, Kenneth; Medina-Marino, Andrew] Illinois Dept Publ Hlth, Div Infect Dis, Off Hlth Protect, Chicago, IL USA; [Medina-Marino, Andrew] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Surveillance Epidemiol & Lab Serv, Atlanta, GA USA; [Sinkowitz-Cochran, Ronda; Schneider, Amy] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Njai, Rashid] Ctr Dis Control & Prevent, Off Non Communicable Dis Injury & Environm Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [McDonald, Marian] Ctr Dis Control & Prevent, Off Hlth Dispar, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Glover, Maleeka] Ctr Dis Control & Prevent, Off Director, Ctr Infect Dis, Atlanta, GA USA; [Garcia, Jocelyn] Univ Miami, Miller Sch Med, Dept Obstet & Gynecol, Miami, FL 33136 USA; [Aiello, Allison E.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Miami; University of Michigan System; University of Michigan	Garcia, J (corresponding author), Univ Miami, Miller Sch Med, Dept Obstet & Gynecol, Miami, FL 33136 USA.	jgarcia10@med.miami.edu		, Andrew/0000-0002-0095-4141				Blendon RJ, MJ H SURVEY FINDS JU; Blumenshine P, 2008, EMERG INFECT DIS, V14, P709, DOI 10.3201/eid1405.071301; CDC, 2007, NAT IMM SURV AD 2007; CDC, 2008, NAT HLTH INT SURV NH; Chang M, 2009, WORLD NOW START 2009; Chen JY, 2007, J COMMUN HEALTH, V32, P5, DOI 10.1007/s10900-006-9031-7; Dee DL, 2011, ANN EPIDEMIOL, V21, P623, DOI 10.1016/j.annepidem.2011.03.002; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Fajardo-Dolci GE, 2009, SALUD PUBLICA MEXICO, V51, P361; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Frew PM, 2011, PEDIATRICS, V127, pS113, DOI 10.1542/peds.2010-1722Q; Groom AV, 2009, AM J PUBLIC HEALTH, V99, pS271, DOI 10.2105/AJPH.2008.157453; Health Protection Agency Health Protection Scotland National Public Health Service for Wales HPA Northern Ireland Swine Influenza Investigation Teams, 2009, EUROSURVEILLANCE, V14, P19232; Horney JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011226; Hutchins SS, 2009, AM J PUBLIC HEALTH, V99, pS261, DOI 10.2105/AJPH.2009.161505; IDPH, 2010, PAND 2009 H1N1 INFL; Kumar S, 2012, AM J PUBLIC HEALTH, V102, P134, DOI 10.2105/AJPH.2011.300307; Kwan-Gett TS, 2009, DISASTER MED PUBLIC, V3, pS109, DOI 10.1097/DMP.0b013e3181c6b818; LaVeist T.A., 2005, MINORITY POPULATIONS; Liu YP, 2008, INT J BIOMATH, V1, P65, DOI 10.1142/S1793524508000023; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lu P. J., 2010, Morbidity and Mortality Weekly Report, V59, P363; Maurer J, 2009, VACCINE, V27, P5732, DOI 10.1016/j.vaccine.2009.07.080; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Osztovits Janos, 2009, Orvosi Hetilap, V150, P2265, DOI 10.1556/OH.2009.28766; Plough A, 2011, J PUBLIC HEALTH MAN, V17, P20, DOI 10.1097/PHH.0b013e3181ff2ad7; Reed C AF, 2009, EMERG INFECT DIS, V15; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03; Scalera NM, 2009, POSTGRAD MED, V121, P43, DOI 10.3810/pgm.2009.09.2051; Skarbinski J, 2011, CLIN INFECT DIS, V52, pS50, DOI 10.1093/cid/ciq021; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Swedish Kristin A, 2011, Curr Infect Dis Rep, V13, P169, DOI 10.1007/s11908-010-0157-5; The Commonwealth of Massachusetts Department of Public Health, 2010, H1N1 INF DISP DAT HI, P1; Thompson DL, 2011, AM J PUBLIC HEALTH, V101, P1776, DOI 10.2105/AJPH.2011.300223; Tomizuka T, 2010, EMERG INFECT DIS, V16, P1646, DOI 10.3201/eid1610.091755; Truelove SA, 2011, J INFECT DIS, V203, P828, DOI 10.1093/infdis/jiq117; Tutuncu EE, 2010, SAUDI MED J, V31, P993; U.S. Census Bureau, 2010, POP EST; Uscher-Pines L, 2011, AM J PUBLIC HEALTH, V101, P1252, DOI 10.2105/AJPH.2011.300133; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; Valdez R, 1999, AM J PUBLIC HEALTH, V89, P1715, DOI 10.2105/AJPH.89.11.1715; Yap J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-442; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e84380	10.1371/journal.pone.0084380	http://dx.doi.org/10.1371/journal.pone.0084380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4HM	24776852	Green Published, Green Submitted, gold			2022-12-25	WOS:000346241800001
J	Yang, ZX; Xu, Y; Luo, HR; Ma, XH; Wang, Q; Wang, YC; Deng, W; Jiang, T; Sun, GQ; He, TT; Hu, JC; Li, YR; Wang, J; Li, T; Hu, X				Yang, Zhenxing; Xu, Yu; Luo, Hongrong; Ma, Xiaohong; Wang, Qiang; Wang, Yingcheng; Deng, Wei; Jiang, Tao; Sun, Guangqing; He, Tingting; Hu, Jingchu; Li, Yingrui; Wang, Jun; Li, Tao; Hu, Xun			Whole-Exome Sequencing for the Identification of Susceptibility Genes of Kashin-Beck Disease	PLOS ONE			English	Article							PROTEIN CMS/CD2AP; VARIANTS	Objective: To identify and investigate the susceptibility genes of Kashin-Beck disease (KBD) in Chinese population. Methods: Whole-exome capturing and sequencing technology was used for the detection of genetic variations in 19 individuals from six families with high incidence of KBD. A total of 44 polymorphisms from 41 genes were genotyped from a total of 144 cases and 144 controls by using MassARRAY under the standard protocol from Sequenom. Association was applied on the data by using PLINK1.07. Results: In the sequencing stage, each sample showed approximately 70-fold coverage, thus covering more than 99% of the target regions. Among the single nucleotide polymorphisms (SNPs) used in the transmission disequilibrium test, 108 had a p-value of <0.01, whereas 1056 had a p-value of <0.05. Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway analysis indicates that these SNPs focus on three major pathways: regulation of actin cytoskeleton, focal adhesion, and metabolic pathways. In the validation stage, single locus effects revealed that two of these polymorphisms (rs7745040 and rs9275295) in the human leukocyte antigen (HLA)-DRB1 gene and one polymorphism (rs9473132) in CD2-associated protein (CD2AP) gene have a significant statistical association with KBD. Conclusions: HLA-DRB1 and CD2AP gene were identified to be among the susceptibility genes of KBD, thus supporting the role of the autoimmune response in KBD and the possibility of shared etiology between osteoarthritis, rheumatoid arthritis, and KBD.	[Yang, Zhenxing; Luo, Hongrong; Ma, Xiaohong; Wang, Qiang; Wang, Yingcheng; Deng, Wei; Li, Tao] Sichuan Univ, Psychiat Lab, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Yang, Zhenxing; Luo, Hongrong; Ma, Xiaohong; Wang, Qiang; Wang, Yingcheng; Deng, Wei; Li, Tao] Sichuan Univ, Dept Psychiat, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Yang, Zhenxing; Luo, Hongrong; Ma, Xiaohong; Wang, Qiang; Wang, Yingcheng; Deng, Wei; Li, Tao; Hu, Xun] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Hu, Xun] Sichuan Univ, Biobank Ctr, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Xu, Yu; Jiang, Tao; Sun, Guangqing; He, Tingting; Hu, Jingchu; Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Beijing Genomics Institute (BGI)	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Guangdong, Peoples R China.	wangj@genomics.cn; xuntao26@hotmail.com; hxxhu99@163.com	Deng, Wei/AAU-9945-2020; Li, Yingrui/K-1064-2015; luo, hongrong/B-2714-2015; Deng, Wei/GWC-9207-2022; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	luo, hongrong/0000-0001-7994-1193; Li, Tao/0000-0003-3831-901X; Hu, Jingchu/0000-0001-6144-7226; Wang, Jun/0000-0002-8540-8931; Ma, Xiaohong/0000-0003-2627-9946; Wang, Jun/0000-0002-2113-5874	National Key Technology R & D Program of the Ministry of Science and Technology of China during the 11th Five-Year Plan [2007BA125B02]	National Key Technology R & D Program of the Ministry of Science and Technology of China during the 11th Five-Year Plan(National Key Technology R&D Program)	This work was supported by National Key Technology R & D Program of the Ministry of Science and Technology of China during the 11th Five-Year Plan (2007BA125B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Bondar J, 1968, TECHNOMETRICS, V10, P415, DOI DOI 10.1080/00401706.1968; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Downey CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000616; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Hinsenkamp M, 2001, INT ORTHOP, V25, P133, DOI 10.1007/s002640000177; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lu AL, 2011, BONE, V48, P347, DOI 10.1016/j.bone.2010.09.015; Ma WJ, 2011, PROTEOMICS; Mathieu F., 2008, Big bone disease, P11; Moreno-Reyes R, 1998, NEW ENGL J MED, V339, P1112, DOI 10.1056/NEJM199810153391604; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Ng S, 2009, NAT GENET, V42, P30; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Sanders S, 2011, CLIN GENETICS; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Shi Y, 2011, ARTHRITIS RHEUM-US, V63, P3408, DOI 10.1002/art.30526; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; van Duijn TJ, 2010, J BIOL CHEM, V285, P20137, DOI 10.1074/jbc.M109.099481; Xiong YM, 2010, OSTEOARTHR CARTILAGE, V18, P817, DOI 10.1016/j.joca.2010.02.004; Yaddanapudi S, 2012, J CLIN INVEST, V122, P780, DOI 10.1172/JCI62812; Ying M, 1982, P INT WORKSH KASH BE, P56; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022983	28	13	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e92298	10.1371/journal.pone.0092298	http://dx.doi.org/10.1371/journal.pone.0092298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776925	Green Published, Green Submitted, gold			2022-12-25	WOS:000346241800003
J	Leftin, A; Roussel, T; Frydman, L				Leftin, Avigdor; Roussel, Tangi; Frydman, Lucio			Hyperpolarized Functional Magnetic Resonance of Murine Skeletal Muscle Enabled by Multiple Tracer-Paradigm Synchronizations	PLOS ONE			English	Article							PERFUSED RAT HINDLIMB; HUMAN VISUAL-CORTEX; IN-VIVO; GLUCOSE-UPTAKE; LACTATE; C-13; STIMULATION; METABOLISM; EXERCISE; EXCHANGE	Measuring metabolism's time-and space-dependent responses upon stimulation lies at the core of functional magnetic resonance imaging. While focusing on water's sole resonance, further insight could arise from monitoring the temporal responses arising from the metabolites themselves, in what is known as functional magnetic resonance spectroscopy. Performing these measurements in real time, however, is severely challenged by the short functional timescales and low concentrations of natural metabolites. Dissolution dynamic nuclear polarization is an emerging technique that can potentially alleviate this, as it provides a massive sensitivity enhancement allowing one to probe low-concentration tracers and products in a single-scan. Still, conventional implementations of this hyperpolarization approach are not immediately amenable to the repeated acquisitions needed in real-time functional settings. This work proposes a strategy for functional magnetic resonance of hyperpolarized metabolites that bypasses this limitation, and enables the observation of real-time metabolic changes through the synchronization of stimuli-triggered, multiple-bolus injections of the metabolic tracer C-13(1)-pyruvate. This new approach is demonstrated with paradigms tailored to reveal in vivo thresholds of murine hind-limb skeletal muscle activation, involving the conversion of C-13(1)-pyruvate to C-13(1)-lactate and C-13(1)-alanine. These functional hindlimb studies revealed that graded skeletal muscle stimulation causes commensurate increases in glycolytic metabolism in a frequency-and amplitude-dependent fashion, that can be monitored on the seconds/minutes timescale using dissolution dynamic nuclear polarization. Spectroscopic imaging further allowed the in vivo visualization of uptake, transformation and distribution of the tracer and products, in fast-twitch glycolytic and in slow-twitch oxidative muscle fiber groups. While these studies open vistas in time and sensitivity for metabolic functional magnetic resonance studies in muscle, the simplicity of our approach makes this technique amenable to a wide range of functional metabolic tracer studies.	[Leftin, Avigdor; Roussel, Tangi; Frydman, Lucio] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Frydman, L (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.	lucio.frydman@weizmann.ac.il			Ministry of Education and Research, Germany [710907]; EU (through ERC) [246754]; Helen and Kimmel Award for Innovative Investigation; Perlman Family Foundation; Fulbright Program; US National Science Foundation International Postdoctoral Fellowship Program; EC Marie Curie Action ITN METAFLUX [264780]	Ministry of Education and Research, Germany; EU (through ERC); Helen and Kimmel Award for Innovative Investigation; Perlman Family Foundation; Fulbright Program; US National Science Foundation International Postdoctoral Fellowship Program; EC Marie Curie Action ITN METAFLUX	Financial support from DIP Project 710907 (Ministry of Education and Research, Germany), the EU (through ERC Advanced Grant # 246754), a Helen and Kimmel Award for Innovative Investigation and the generosity of the Perlman Family Foundation, are gratefully acknowledged. AL is grateful to the Fulbright Program and to the US National Science Foundation International Postdoctoral Fellowship Program, for respective awards. TR acknowledged the EC Marie Curie Action ITN METAFLUX (project 264780) for a stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; ARMSTRONG RB, 1985, J APPL PHYSIOL, V59, P1322, DOI 10.1152/jappl.1985.59.4.1322; ARMSTRONG RB, 1985, J EXP BIOL, V115, P201; Aslesen R, 2001, J APPL PHYSIOL, V91, P1237, DOI 10.1152/jappl.2001.91.3.1237; BRECHUE WF, 1994, J APPL PHYSIOL, V77, P223, DOI 10.1152/jappl.1994.77.1.223; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Cheng T, 2013, NMR BIOMED, V26, P1582, DOI 10.1002/nbm.2993; CLOSE R, 1964, J PHYSIOL-LONDON, V173, P74, DOI 10.1113/jphysiol.1964.sp007444; Coles L, 2004, J PHYSIOL-LONDON, V561, P253, DOI 10.1113/jphysiol.2004.073478; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Gallagher FA, 2009, PROG NUCL MAG RES SP, V55, P285, DOI 10.1016/j.pnmrs.2009.06.001; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Golman K, 2006, P NATL ACAD SCI USA, V103, P11270, DOI 10.1073/pnas.0601319103; Greene EC, 1990, THE ANATOMY OF THE R; Hill DK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071996, 10.1371/journal.pone.0074627]; Hu S, 2013, MAGN RESON IMAGING, V31, P490, DOI 10.1016/j.mri.2012.09.002; Huettel SA, 2009, FUNCTIONAL MAGNETIC; Hurd RE, 2013, MAGN RESON MED, V70, P936, DOI 10.1002/mrm.24544; Iwaki T, 2001, COLOR ATLAS SECTIONA; Janich MA, 2012, NMR BIOMED, V25, P142, DOI 10.1002/nbm.1726; Johanneson H, 2009, J MAGN RESON, V197, P167, DOI 10.1016/j.jmr.2008.12.016; Kettunen MI, 2010, MAGN RESON MED, V63, P872, DOI 10.1002/mrm.22276; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Larson PEZ, 2011, MAGN RESON MED, V65, P610, DOI 10.1002/mrm.22650; Lee FS, 1907, AM J PHYSIOL, V18, P267, DOI 10.1152/ajplegacy.1907.18.3.267; Lee P, 2013, HEPATOLOGY, V57, P515, DOI 10.1002/hep.26028; Leftin A, 2013, AM J PHYSIOL-ENDOC M, V305, pE1165, DOI 10.1152/ajpendo.00296.2013; LINDINGER MI, 1988, AM J PHYSIOL, V254, pR117, DOI 10.1152/ajpregu.1988.254.1.R117; Lindinger MI, 1987, J APPL PHYSIOL, V63; Mangia S, 2007, J CEREBR BLOOD F MET, V27, P1055, DOI 10.1038/sj.jcbfm.9600401; Mayer D, 2009, MAGN RESON MED, V62, P557, DOI 10.1002/mrm.22041; MAZZEO RS, 1986, J APPL PHYSIOL, V60, P232, DOI 10.1152/jappl.1986.60.1.232; Mishkovsky M, 2012, J CEREBR BLOOD F MET, V32, P2108, DOI 10.1038/jcbfm.2012.136; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; Py G, 2001, AM J PHYSIOL-ENDOC M, V281, pE1308, DOI 10.1152/ajpendo.2001.281.6.E1308; Schmidt R, 2013, MAGN RESON MED, V70, P382, DOI 10.1002/mrm.24470; Schroeder MA, 2011, CIRCULATION, V124, P1580, DOI 10.1161/CIRCULATIONAHA.111.024919; Stefan D, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104035; WALKER PM, 1982, EUR J APPL PHYSIOL O, V48, P163, DOI 10.1007/BF00422978; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Witney TH, 2011, J BIOL CHEM, V286, P24572, DOI 10.1074/jbc.M111.237727; Xing Y, 2013, J MAGN RESON, V234, P75, DOI 10.1016/j.jmr.2013.06.003; Yen YF, 2009, MAGN RESON MED, V62, P1, DOI 10.1002/mrm.21987	46	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e96399	10.1371/journal.pone.0096399	http://dx.doi.org/10.1371/journal.pone.0096399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769864	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736600033
J	Rosenlow, J; Isaksson, L; Mayzel, M; Lengqvist, J; Orekhov, VY				Rosenlow, Joakim; Isaksson, Linnea; Mayzel, Maxim; Lengqvist, Johan; Orekhov, Vladislav Y.			Tyrosine Phosphorylation within the Intrinsically Disordered Cytosolic Domains of the B-Cell Receptor: An NMR-Based Structural Analysis	PLOS ONE			English	Article							ANTIGEN-RECEPTOR; ALPHA-HELIX; CHEMICAL-SHIFTS; PROTEIN; BINDING; RECOGNITION; SPECTROSCOPY; STABILITY; SEQUENCE; ACTIVATION	Intrinsically disordered proteins are found extensively in cell signaling pathways where they often are targets of posttranslational modifications e. g. phosphorylation. Such modifications can sometimes induce or disrupt secondary structure elements present in the modified protein. CD79a and CD79b are membrane-spanning, signal-transducing components of the B-cell receptor. The cytosolic domains of these proteins are intrinsically disordered and each has an immunoreceptor tyrosine-based activation motif (ITAM). When an antigen binds to the receptor, conserved tyrosines located in the ITAMs are phosphorylated which initiate further downstream signaling. Here we use NMR spectroscopy to examine the secondary structure propensity of the cytosolic domains of CD79a and CD79b in vitro before and after phosphorylation. The phosphorylation patterns are identified through analysis of changes of backbone chemical shifts found for the affected tyrosines and neighboring residues. The number of the phosphorylated sites is confirmed by mass spectrometry. The secondary structure propensities are calculated using the method of intrinsic referencing, where the reference random coil chemical shifts are measured for the same protein under denaturing conditions. Our analysis revealed that CD79a and CD79b both have an overall propensity for alpha-helical structure that is greatest in the C-terminal region of the ITAM. Phosphorylation of CD79a caused a decrease in helical propensity in the C-terminal ITAM region. For CD79b, the opposite was observed and phosphorylation resulted in an increase of helical propensity in the C-terminal part.	[Rosenlow, Joakim; Isaksson, Linnea; Mayzel, Maxim; Orekhov, Vladislav Y.] Univ Gothenburg, Swedish NMR Ctr, Gothenburg, Sweden; [Lengqvist, Johan] Univ Gothenburg, Sahlgrenska Acad, Prote Core Facil, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Orekhov, VY (corresponding author), Univ Gothenburg, Swedish NMR Ctr, Gothenburg, Sweden.	orov@nmr.gu.se	Mayzel, Maksim/AAM-1393-2020; Orekhov, Vladislav/AAC-8357-2022; Orekhov, Vladislav/AAD-8464-2019	Orekhov, Vladislav/0000-0002-7892-6896	The Swedish Research Council [2011-5994]; Swedish National Infrastructure for Computing [SNIC 001/12-271]	The Swedish Research Council(Swedish Research Council); Swedish National Infrastructure for Computing	The Swedish Research Council (research grant 2011-5994 and SWEDSTRUCT program); the Swedish National Infrastructure for Computing (SNIC 001/12-271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Amata I, 2013, CHEMBIOCHEM; Andrew CD, 2002, BIOCHEMISTRY-US, V41, P1897, DOI 10.1021/bi0113216; Bertolucci CM, 2008, BIOCHEMISTRY-US, V47, P548, DOI 10.1021/bi702103n; Bienkiewicz EA, 1999, J BIOMOL NMR, V15, P203, DOI 10.1023/A:1008375029746; Byeon IJL, 2005, NAT STRUCT MOL BIOL, V12, P987, DOI 10.1038/nsmb1008; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; Cochran DAE, 2001, PROTEIN SCI, V10, P1305, DOI 10.1110/ps.50701; Cochran DAE, 2001, PROTEIN SCI, V10, P463, DOI 10.1110/ps.31001; Cordier F, 2012, J AM CHEM SOC, V134, P20533, DOI 10.1021/ja310214g; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Felli IC, 2012, IUBMB LIFE, V64, P473, DOI 10.1002/iub.1045; Forman-Kay JD, 2013, STRUCTURE, V21, P1492, DOI 10.1016/j.str.2013.08.001; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fujitani N, 2003, BIOCHEM BIOPH RES CO, V300, P223, DOI 10.1016/S0006-291X(02)02794-8; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Gaul BS, 2000, J BIOL CHEM, V275, P16174, DOI 10.1074/jbc.M909044199; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Isaksson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062947; Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o; Jaravine VA, 2006, J AM CHEM SOC, V128, P13421, DOI 10.1021/ja062146p; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; Kjaergaard M, 2012, PROG NUCL MAG RES SP, V60, P42, DOI 10.1016/j.pnmrs.2011.10.001; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Lee WY, 2013, PLOS ONE; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mayzel M, 2014, J BIOMOL NMR, V58, P129, DOI 10.1007/s10858-013-9811-1; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Modig K, 2007, FEBS LETT, V581, P4965, DOI 10.1016/j.febslet.2007.09.027; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pedersen A, 2011, NEW BIOTECHNOL, V28, P218, DOI 10.1016/j.nbt.2010.06.015; Perez Y, 2009, J MOL BIOL, V391, P136, DOI 10.1016/j.jmb.2009.06.018; PULLEN K, 1995, PROTEIN SCI, V4, P2478, DOI 10.1002/pro.5560041204; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; Tait S, 2010, P NATL ACAD SCI USA, V107, P17627, DOI 10.1073/pnas.1008242107; Theillet FX, 2012, J BIOMOL NMR, V54, P217, DOI 10.1007/s10858-012-9674-x; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vassall KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068175; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200	61	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e96199	10.1371/journal.pone.0096199	http://dx.doi.org/10.1371/journal.pone.0096199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769851	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736600030
J	Cho, H; Lee, HJ; Heo, YK; Cho, Y; Gwon, YD; Kim, MG; Park, KH; Oh, YK; Kim, YB				Cho, Hansam; Lee, Hee-Jung; Heo, Yoon-Ki; Cho, Yeondong; Gwon, Yong-Dae; Kim, Mi-Gyeong; Park, Ki Hoon; Oh, Yu-Kyoung; Kim, Young Bong			Immunogenicity of a Trivalent Human Papillomavirus L1 DNA-Encapsidated, Non-Replicable Baculovirus Nanovaccine	PLOS ONE			English	Article							INTRANASAL VACCINATION; CROSS-PROTECTION; CERVICAL-CANCER; VLP VACCINE; HPV TYPES; DELIVERY; VECTORS; WOMEN; PARTICLES; INFECTION	Previously, we developed a non-replicating recombinant baculovirus coated with human endogenous retrovirus envelope protein (AcHERV) for enhanced cellular delivery of human papillomavirus (HPV) 16L1 DNA. Here, we report the immunogenicity of an AcHERV-based multivalent HPV nanovaccine in which the L1 segments of HPV 16, 18, and 58 genes were inserted into a single baculovirus genome of AcHERV. To test whether gene expression levels were affected by the order of HPV L1 gene insertion, we compared the efficacy of bivalent AcHERV vaccines with the HPV 16L1 gene inserted ahead of the 18L1 gene (AcHERV-HP16/18L1) with that of AcHERV with the HPV 18L1 gene inserted ahead of the 16L1 gene (AcHERV-HP18/16L1). Regardless of the order, the bivalent AcHERV DNA vaccines retained the immunogenicity of monovalent AcHERV-HP16L1 and AcHERV-HP18L1 DNA vaccines. Moreover, the immunogenicity of bivalent AcHERV-HP16/ 18L1 was not significantly different from that of AcHERV-HP18/16L1. In challenge tests, both bivalent vaccines provided complete protection against HPV 16 and 18 pseudotype viruses. Extending these results, we found that a trivalent AcHERV nanovaccine encoding HPV 16L1, 18L1, and 58L1 genes (AcHERV-HP16/18/58L1) provided high levels of humoral and cellular immunogenicity against all three subtypes. Moreover, mice immunized with the trivalent AcHERV-based nanovaccine were protected from challenge with HPV 16, 18, and 58 pseudotype viruses. These results suggest that trivalent AcHERV-HPV16/18/58L1 could serve as a potential prophylactic baculoviral nanovaccine against concurrent infection with HPV 16, 18, and 58.	[Cho, Hansam; Lee, Hee-Jung; Heo, Yoon-Ki; Cho, Yeondong; Gwon, Yong-Dae; Park, Ki Hoon; Kim, Young Bong] Konkuk Univ, Dept Bioind Technol, Seoul, South Korea; [Kim, Mi-Gyeong; Oh, Yu-Kyoung] Seoul Natl Univ, Coll Pharm, Seoul, South Korea	Konkuk University; Seoul National University (SNU)	Oh, YK (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	ohyk@snu.ac.kr; kimera@konkuk.ac.kr	Oh, Yu Kyoung/G-8754-2013	Oh, Yu-Kyoung/0000-0002-0969-3339; Gwon, Yong-Dae/0000-0002-0703-4188	Korean Health Technology 3 RD Project [A092010]; iPET(Korea Institute of Planning; Evaluation for 4 Technology in Food, Agriculture, Forestry and Fisheries) from Ministry of Agriculture, Food 5 and Rural Affairs [110082-03-2-SD010, 112157-03-1-SB020]	Korean Health Technology 3 RD Project; iPET(Korea Institute of Planning; Evaluation for 4 Technology in Food, Agriculture, Forestry and Fisheries) from Ministry of Agriculture, Food 5 and Rural Affairs	This work has been financially supported by grants from the Korean Health Technology 3 R&D Project (No. A092010), and from iPET(Korea Institute of Planning and Evaluation for 4 Technology in Food, Agriculture, Forestry and Fisheries) from Ministry of Agriculture, Food 5 and Rural Affairs (110082-03-2-SD010 and 112157-03-1-SB020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ault KA, 2004, VACCINE, V22, P3004, DOI 10.1016/j.vaccine.2004.02.020; Bao YP, 2008, INT J GYNECOL CANCER, V18, P71, DOI 10.1111/j.1525-1438.2007.00959.x; Best SR, 2009, VACCINE, V27, P5450, DOI 10.1016/j.vaccine.2009.07.005; Bodles-Brakhop AM, 2008, EXPERT REV VACCINES, V7, P1085, DOI 10.1586/14760584.7.7.1085; Bolhassani A, 2011, BIOMATERIALS, V32, P4621; Bonanni P, 2009, VACCINE, V27, pA46, DOI 10.1016/j.vaccine.2008.10.085; Brandsma JL, 2004, J VIROL, V78, P116, DOI 10.1128/JVI.78.1.116-123.2004; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Chan PKS, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-17; Chan PKS, 1999, J MED VIROL, V59, P232, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;232::AID-JMV18&gt;3.0.CO;2-7; Chen CY, 2010, VACCINE, V28, P7644, DOI 10.1016/j.vaccine.2010.09.048; Cho HJ, 2011, EXPERT OPIN THER PAT, V21, P295, DOI 10.1517/13543776.2011.551114; Cho HJ, 2011, BIOMATERIALS, V32, P4621, DOI 10.1016/j.biomaterials.2011.03.004; Choi JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080762; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Daftarian P, 2006, VACCINE, V24, P5235, DOI 10.1016/j.vaccine.2006.03.079; Dell C, 2001, CELL MOL LIFE SCI, V58, P1923, DOI 10.1007/PL00000827; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; Hara H, 2004, DERMATOLOGY, V209, P218, DOI 10.1159/000079893; Herrero R, 2009, J INFECT DIS, V199, P919, DOI 10.1086/597308; Kaufmann AM, 2002, CLIN CANCER RES, V8, P3676; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Kost TA, 2002, TRENDS BIOTECHNOL, V20, P173, DOI 10.1016/S0167-7799(01)01911-4; Kuck D, 2006, J VIROL, V80, P2621, DOI 10.1128/JVI.80.6.2621-2630.2006; Kwag HL, 2012, J MICROBIOL, V50, P813, DOI 10.1007/s12275-012-2292-1; Lee HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050296; Lee HJ, 2010, VACCINE, V28, P1613, DOI 10.1016/j.vaccine.2009.11.044; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Lung O, 2002, J VIROL, V76, P5729, DOI 10.1128/JVI.76.11.5729-5736.2002; Nieto K, 2012, HUM GENE THER, V23, P733, DOI 10.1089/hum.2011.202; Ohlschlager P, 2011, INT J CANCER, V128, P473, DOI 10.1002/ijc.25344; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Scherpenisse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074797; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Wilson S, 2008, VACCINE, V26, P2451, DOI 10.1016/j.vaccine.2008.03.027; Zhang T, 2010, VACCINE, V28, P3479, DOI 10.1016/j.vaccine.2010.02.057; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	37	11	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95961	10.1371/journal.pone.0095961	http://dx.doi.org/10.1371/journal.pone.0095961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759938	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200117
J	Pruijm, M; Hofmann, L; Piskunowicz, M; Muller, ME; Zweiacker, C; Bassi, I; Vogt, B; Stuber, M; Burnier, M				Pruijm, Menno; Hofmann, Lucie; Piskunowicz, Maciej; Muller, Marie-Eve; Zweiacker, Carole; Bassi, Isabelle; Vogt, Bruno; Stuber, Matthias; Burnier, Michel			Determinants of Renal Tissue Oxygenation as Measured with BOLD-MRI in Chronic Kidney Disease and Hypertension in Humans	PLOS ONE			English	Article							INTRARENAL OXYGENATION; OXIDATIVE STRESS; HYPOXIA; RAT; CONSUMPTION; VALIDATION; TENSION; PO(2)	Experimentally renal tissue hypoxia appears to play an important role in the pathogenesis of chronic kidney disease (CKD) and arterial hypertension (AHT). In this study we measured renal tissue oxygenation and its determinants in humans using blood oxygenation level-dependent magnetic resonance imaging (BOLD-MRI) under standardized hydration conditions. Four coronal slices were selected, and a multi gradient echo sequence was used to acquire T2* weighted images. The mean cortical and medullary R2* values (= 1/T2*) were calculated before and after administration of IV furosemide, a low R2* indicating a high tissue oxygenation. We studied 195 subjects (95 CKD, 58 treated AHT, and 42 healthy controls). Mean cortical R2 and medullary R2* were not significantly different between the groups at baseline. In stimulated conditions (furosemide injection), the decrease in R2* was significantly blunted in patients with CKD and AHT. In multivariate linear regression analyses, neither cortical nor medullary R2* were associated with eGFR or blood pressure, but cortical R2* correlated positively with male gender, blood glucose and uric acid levels. In conclusion, our data show that kidney oxygenation is tightly regulated in CKD and hypertensive patients at rest. However, the metabolic response to acute changes in sodium transport is altered in CKD and in AHT, despite preserved renal function in the latter group. This suggests the presence of early renal metabolic alterations in hypertension. The correlations between cortical R2* values, male gender, glycemia and uric acid levels suggest that these factors interfere with the regulation of renal tissue oxygenation.	[Pruijm, Menno; Muller, Marie-Eve; Zweiacker, Carole; Bassi, Isabelle; Burnier, Michel] Univ Lausanne Hosp, Dept Nephrol, Lausanne, Switzerland; [Hofmann, Lucie; Vogt, Bruno] Univ Hosp Bern, Dept Hypertens & Nephrol, CH-3010 Bern, Switzerland; [Piskunowicz, Maciej] Med Univ Gdansk, Dept Radiol, Gdansk, Poland; [Stuber, Matthias] Univ Lausanne Hosp, Dept Radiol, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; Fahrenheit Universities; Medical University Gdansk; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Burnier, M (corresponding author), Univ Lausanne Hosp, Dept Nephrol, Lausanne, Switzerland.	michel.burnier@chuv.ch	Pruijm, Menno/AAA-4281-2020; Stuber, Matthias/B-2949-2010; Vogt, Bruno/AAS-2876-2020	Pruijm, Menno/0000-0003-1027-1851; Stuber, Matthias/0000-0001-9843-2028; Vogt, Bruno/0000-0002-1548-6387; Muller, Marie-Eve/0000-0002-1253-4072; Piskunowicz, Maciej/0000-0002-3154-5463	Swiss National Science Foundation [FN 32003B-132913, 149309]; Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL)	This study was supported by research grants from the Swiss National Science Foundation (FN 32003B-132913 and 149309) and by the Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines A, 2002, AM J PHYSIOL-RENAL, V283, pF286, DOI 10.1152/ajprenal.00330.2001; Burnier M, 2006, CURR HYPERTENS REP, V8, P8, DOI 10.1007/s11906-006-0035-6; Chun TY, 2008, HYPERTENSION, V52, P241, DOI 10.1161/HYPERTENSIONAHA.108.109801; Djamali A, 2007, AM J PHYSIOL-RENAL, V292, pF513, DOI 10.1152/ajprenal.00222.2006; dos Santos EA, 2007, INVEST RADIOL, V42, P157, DOI 10.1097/01.rli.0000252492.96709.36; Ebrahimi B, 2012, INVEST RADIOL, V47, P175, DOI 10.1097/RLI.0b013e318234e75b; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Gloviczki ML, 2011, HYPERTENSION, V58, P1066, DOI 10.1161/HYPERTENSIONAHA.111.171405; Haase VH, 2013, J AM SOC NEPHROL; Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hofmann L, 2006, KIDNEY INT, V70, P144, DOI 10.1038/sj.ki.5000418; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inoue T, 2011, J AM SOC NEPHROL, V22, P1429, DOI 10.1681/ASN.2010111143; Kojima I, 2007, J AM SOC NEPHROL, V18, P1218, DOI 10.1681/ASN.2006060639; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; MESSERLI FH, 1980, ANN INTERN MED, V93, P817, DOI 10.7326/0003-4819-93-6-817; Michaely HJ, 2012, KIDNEY INT, V81, P684, DOI 10.1038/ki.2011.455; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Pedersen M, 2005, KIDNEY INT, V67, P2305, DOI 10.1111/j.1523-1755.2005.00334.x; Prasad P, 2010, INVEST RADIOL, V45, P819, DOI 10.1097/RLI.0b013e3181ec9b02; Prasad PV, 2006, NEPHRON CLIN PRACT, V103, pC58, DOI 10.1159/000090610; Prasad PV, 1999, KIDNEY INT, V55, P294, DOI 10.1046/j.1523-1755.1999.00237.x; Priyadarshi A, 2002, KIDNEY INT, V61, P542, DOI 10.1046/j.1523-1755.2002.00140.x; Pruijm M, 2012, DIABETES RES CLIN PR; Pruijm M, 2010, HYPERTENSION, V55, P1116, DOI 10.1161/HYPERTENSIONAHA.109.149682; Rognant N, 2011, NEPHROL DIAL TRANSPL, V26, P1205, DOI 10.1093/ndt/gfq538; Schachinger H, 2006, HYPERTENSION, V47, P1062, DOI 10.1161/01.HYP.0000220109.98142.a3; Simon-Zoula SC, 2006, NMR BIOMED, V19, P84, DOI 10.1002/nbm.1004; Textor SC, 2012, AM J KIDNEY DIS, V59, P229, DOI 10.1053/j.ajkd.2011.09.023; Vallon V, 2009, NEPHRON PHYSIOL, V111, P30, DOI 10.1159/000208211; Wang ZJ, 2011, J MAGN RESON IMAGING, V33, P655, DOI 10.1002/jmri.22501; Welch WJ, 2001, KIDNEY INT, V59, P230, DOI 10.1046/j.1523-1755.2001.00483.x; Yin WJ, 2011, EUR J RADIOL; Zheleznova NN, 2012, PHYSIOL GENOMICS, V44, P829, DOI 10.1152/physiolgenomics.00060.2012	36	65	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95895	10.1371/journal.pone.0095895	http://dx.doi.org/10.1371/journal.pone.0095895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760031	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200104
J	Xia, F; Wu, L; Lau, WY; Li, G; Huan, HB; Qian, C; Ma, KS; Bie, P				Xia, Feng; Wu, Lin; Lau, Wan-Yee; Li, Guo; Huan, Hongbo; Qian, Cheng; Ma, Kuansheng; Bie, Ping			Positive Lymph Node Metastasis Has a Marked Impact on the Long-Term Survival of Patients with Hepatocellular Carcinoma with Extrahepatic Metastasis	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CLINICAL-FEATURES; PULMONARY METASTASECTOMY; SURGICAL RESECTION; HEPATIC RESECTION; RECURRENCE; PROGNOSIS; F-18-FDG; PET/CT	Background: The prognosis of hepatocellular carcinoma (HCC) patients with extrahepatic metastasis is extremely poor. However, what is the main risk factor for survival remains unclear for these patients. We aimed to find out the relative frequency, incidence and locations of extrahepatic metastases and the risk factors of long-term survival of the patients. Methods: 132 HCC patients with extrahepatic metastasis diagnosed by 18 F-FDG PET/CT and conventional workup were enrolled into this study. The incidence and locations of extrahepatic metastases were summarized, and the related risk factors of overall survival were analyzed. Results: The most frequent extrahepatic metastatic sites were lymph nodes in 72 (54.5%), bone in 33 (25.0%) and lung in 28 (21.2%) patients. On univariate analysis, prothrombin time, Child-Pugh grade, portal/hepatic vein invasion and lymph node metastasis were independent risk factors of overall survival. On multivariate analysis, lymph node metastasis was the only independent risk factor of overall survival. The cumulative survival rates at 1-and 3-years after diagnosis of extrahepatic metastasis of HCC were 34.4% and 9.3%, respectively. The median survival time was 7 months (range 1,38 months). The median survival time for patients with or without lymph node metastasis were 5 months (range 1,38 months) and 12 months (range 1,30 months), respectively (P = 0.036). Conclusions: This study showed lymph nodes to be the most frequent site of extrahepatic metastases for primary HCC. Lymph node metastasis was the main risk factor of overall survival in patients with HCC with extrahepatic metastasis.	[Xia, Feng; Wu, Lin; Lau, Wan-Yee; Li, Guo; Huan, Hongbo; Ma, Kuansheng; Bie, Ping] Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China; [Xia, Feng; Wu, Lin; Lau, Wan-Yee; Li, Guo; Huan, Hongbo; Qian, Cheng; Ma, Kuansheng; Bie, Ping] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Lau, Wan-Yee] Chinese Univ Hong Kong, Fac Med, Shatin, Hong Kong, Peoples R China; [Qian, Cheng] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Chinese University of Hong Kong; Army Medical University	Xia, F (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China.	frankfxia@163.com			scientific and technological project of Chongqing city [CSTC2012gg-yyjs10016]; National Natural Sciences Foundation of China [81272224]	scientific and technological project of Chongqing city; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by scientific and technological project of Chongqing city (No. CSTC2012gg-yyjs10016) and National Natural Sciences Foundation of China (No. 81272224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KM, 2009, WORLD J GASTROENTERO, V15, P5481, DOI 10.3748/wjg.15.5481; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ercolani G, 2004, ANN SURG, V239, P202, DOI 10.1097/01.sla.0000109154.00020.e0; He YX, 2008, POSTGRAD MED J, V84, P246, DOI 10.1136/pgmj.2007.066589; Ho CL, 2007, J NUCL MED, V48, P902, DOI 10.2967/jnumed.106.036673; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Katyal S, 2000, RADIOLOGY, V216, P698, DOI 10.1148/radiology.216.3.r00se24698; Kawaoka T, 2009, HEPATOL RES, V39, P134, DOI 10.1111/j.1872-034X.2008.00416.x; Kim YK, 2010, LIVER TRANSPLANT, V16, P767, DOI 10.1002/lt.22069; Kitano K, 2012, EUR J CARDIO-THORAC, V41, P376, DOI 10.1016/j.ejcts.2011.05.052; Lee CY, 2010, J SURG ONCOL, V101, P239, DOI 10.1002/jso.21487; Lee CW, 2011, ASIAN J SURG, V34, P53, DOI 10.1016/S1015-9584(11)60020-1; Lin CY, 2012, EUR J RADIOL, V81, P2417, DOI 10.1016/j.ejrad.2011.08.004; Liver Cancer Study Group of Japan, 1990, Ann Surg, V211, P277; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; Ochiai T, 2012, WORLD J SURG, V36, P136, DOI 10.1007/s00268-011-1317-y; Sakamoto M, 2010, ANN THORAC SURG, V90, P1766, DOI 10.1016/j.athoracsur.2010.07.054; Shen XH, 2010, WORLD J SURG, V34, P1028, DOI 10.1007/s00268-010-0400-0; Shuto T, 2001, DIGEST SURG, V18, P294, DOI 10.1159/000050155; Si MS, 2003, AM SURGEON, V69, P879; Sugiyama M, 2004, J GASTROENTEROL, V39, P961, DOI 10.1007/s00535-004-1427-5; Sun HC, 2007, J SURG ONCOL, V96, P37, DOI 10.1002/jso.20772; Taketomi A, 2010, ANN SURG ONCOL, V17, P2740, DOI 10.1245/s10434-010-1076-2; Tanaka K, 2008, WORLD J SURG, V32, P1738, DOI 10.1007/s00268-008-9613-x; Uka K, 2007, WORLD J GASTROENTERO, V13, P414, DOI 10.3748/wjg.v13.i3.414; Wudel LJ, 2003, AM SURGEON, V69, P117; Yoon KT, 2007, ONCOLOGY-BASEL, V72, P104, DOI 10.1159/000111715; Yoon YS, 2010, ANN SURG ONCOL, V17, P2795, DOI 10.1245/s10434-010-1073-5	29	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95889	10.1371/journal.pone.0095889	http://dx.doi.org/10.1371/journal.pone.0095889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760012	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200102
J	Zimmer, SM; Krehenwinkel, H; Schneider, JM				Zimmer, Stefanie M.; Krehenwinkel, Henrik; Schneider, Jutta M.			Rapid Range Expansion Is Not Restricted by Inbreeding in a Sexually Cannibalistic Spider	PLOS ONE			English	Article							ARGIOPE-BRUENNICHI; FERTILIZATION SUCCESS; GENETIC DIVERSITY; MATING SYSTEMS; AVOIDANCE; DEPRESSION; DISPERSAL; COPULATION; EVOLUTION; PATERNITY	Few studies investigated whether rapid range expansion is associated with an individual's short-term fitness costs due to an increased risk of inbred mating at the front of expansion. In mating systems with low male mating rates both sexes share potential inbreeding costs and general mechanisms to avoid or reduce these costs are expected. The spider Argiope bruennichi expanded its range recently and we asked whether rapid settlement of new sites exposes individuals to a risk of inbreeding. We sampled four geographically separated subpopulations, genotyped individuals, arranged matings and monitored hatching success. Hatching success was lowest in egg-sacs derived from sibling pairs and highest in egg-sacs derived from among-population crosses, while within-population crosses were intermediate. This indicates that inbreeding might affect hatching success in the wild. Unlike expected, differential hatching success of within-and among-population crosses did not correlate with genetic distance of mating pairs. In contrast, we found high genetic diversity based on 16 microsatellite markers and a fragment of the mitochondrial COI gene in all populations. Our results suggest that even a very recent settlement secures the presence of genetically different mating partners. This leads to costs of inbreeding since the population is not inbred.	[Zimmer, Stefanie M.; Schneider, Jutta M.] Univ Hamburg, Museum & Inst Zool, Biozentrum Grindel, Hamburg, Germany; [Krehenwinkel, Henrik] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany	University of Hamburg; Max Planck Society	Zimmer, SM (corresponding author), Univ Hamburg, Museum & Inst Zool, Biozentrum Grindel, Hamburg, Germany.	zimmer.steffi@googlemail.com	Schneider, Jutta M/G-3727-2010	Schneider, Jutta M/0000-0001-8523-7354	DFG [SCHN 561/8-1]	DFG(German Research Foundation (DFG))	The study was supported by a DFG grant (SCHN 561/8-1) to J.M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles L, 2006, P ROY SOC B-BIOL SCI, V273, P157, DOI 10.1098/rspb.2005.3308; BARRETT SCH, 1991, NATURE, V352, P522, DOI 10.1038/352522a0; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bell JR, 2005, B ENTOMOL RES, V95, P69, DOI 10.1079/BER2004350; Bilde T, 2007, J EVOLUTION BIOL, V20, P1237, DOI 10.1111/j.1420-9101.2006.01280.x; Bilde T, 2005, EVOLUTION, V59, P160, DOI 10.1111/j.0014-3820.2005.tb00903.x; Bilde T, 2009, MOL ECOL RESOUR, V9, P128, DOI 10.1111/j.1755-0998.2008.02296.x; BIRKHEAD TR, 1995, ANIM BEHAV, V49, P843, DOI 10.1016/0003-3472(95)80217-7; Bonte D, 2003, P ROY SOC B-BIOL SCI, V270, P1601, DOI 10.1098/rspb.2003.2432; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Bretman A, 2011, MOL ECOL, V20, P3045, DOI 10.1111/j.1365-294X.2011.05140.x; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Bukowski TC, 2002, CAN J ZOOL, V80, P193, DOI 10.1139/Z01-220; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Clarke FM, 2001, P ROY SOC B-BIOL SCI, V268, P899, DOI 10.1098/rspb.2000.1426; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Crome W., 1961, Mitteilungen aus dem Zoologischen Museum in Berlin, V37, P189; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Elgar MA, 2000, P ROY SOC B-BIOL SCI, V267, P2439, DOI 10.1098/rspb.2000.1303; Firman RC, 2008, J EVOLUTION BIOL, V21, P1524, DOI 10.1111/j.1420-9101.2008.01612.x; Foelix R. F., 2011, BIOL SPIDERS; Foellmer MW, 2003, P ROY SOC B-BIOL SCI, V270, pS183, DOI 10.1098/rsbl.2003.0042; Follner K., 1995, P 15 EUR C AR CESK B; Fromhage L, 2008, J THEOR BIOL, V250, P524, DOI 10.1016/j.jtbi.2007.10.008; Fromhage L, 2012, ECOL EVOL, V2, P2572, DOI 10.1002/ece3.372; Grueber CE, 2011, MOL ECOL, V20, P67, DOI 10.1111/j.1365-294X.2010.04930.x; Guttmann R., 1979, Bonner Zoologische Beitraege, V30, P454; Hardy OJ, 2008, BIOL J LINN SOC, V93, P465, DOI 10.1111/j.1095-8312.2007.00898.x; Herberstein ME, 2005, ETHOL ECOL EVOL, V17, P17; Jamieson IG, 2011, CONSERV BIOL, V25, P115, DOI 10.1111/j.1523-1739.2010.01574.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Krehenwinkel H, 2013, MOL ECOL, V22, P2232, DOI 10.1111/mec.12223; Kumschick S, 2011, CLIMATIC CHANGE, V109, P319, DOI 10.1007/s10584-011-0139-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; Mayr E., 1963, ANIMAL SPECIES EVOLU; Miller JA, 2007, EVOLUTION, V61, P1301, DOI 10.1111/j.1558-5646.2007.00115.x; Nessler SH, 2007, BEHAV ECOL, V18, P174, DOI 10.1093/beheco/arl074; Parker G.A., 1979, SEXUAL SELECTION REP, P123, DOI DOI 10.1016/B978-0-12-108750-0.50010-0; Pemberton J, 2004, TRENDS ECOL EVOL, V19, P613, DOI 10.1016/j.tree.2004.09.010; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Perrin N, 1999, AM NAT, V154, P282, DOI 10.1086/303236; Purcell KM, 2012, BIOL INVASIONS, V14, P2057, DOI 10.1007/s10530-012-0213-1; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; Ruch J, 2009, BIOL J LINN SOC, V98, P851, DOI 10.1111/j.1095-8312.2009.01322.x; Rutten KB, 2001, MOL ECOL NOTES, V1, P255, DOI 10.1046/j.1471-8278.2001.00096.x; SASAKI T, 1995, ANIM BEHAV, V49, P1119, DOI 10.1006/anbe.1995.0140; SCHAEFER M, 1977, Z ANGEW ENTOMOL, V83, P113; Schneider JM, 2006, ANIM BEHAV, V71, P781, DOI 10.1016/j.anbehav.2005.05.012; Schneider J, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P441, DOI 10.1007/978-3-642-02624-9_15; Schneider JM, 2009, P ROY SOC B-BIOL SCI, V276, P3105, DOI 10.1098/rspb.2009.0694; Schulte KF, 2010, ANIM BEHAV, V80, P699, DOI 10.1016/j.anbehav.2010.07.005; Scopoli J. A., 1772, ANNUS, p[70, 125]; Simmons LW, 2011, J EVOLUTION BIOL, V24, P415, DOI 10.1111/j.1420-9101.2010.02179.x; SMITH RH, 1979, HEREDITY, V43, P205, DOI 10.1038/hdy.1979.75; SUTER RB, 1991, ETHOL ECOL EVOL, V3, P13, DOI 10.1080/08927014.1991.9525385; Szulkin M, 2013, TRENDS ECOL EVOL, V28, P205, DOI 10.1016/j.tree.2012.10.016; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Uhl G, 2007, ZOOLOGY, V110, P398, DOI 10.1016/j.zool.2007.07.003; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walter A, 2005, J ARACHNOL, V33, P516, DOI 10.1636/04-78.1; Welke K, 2009, BEHAV ECOL, V20, P1056, DOI 10.1093/beheco/arp097; Welke KW, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-7; Welke KW, 2010, BIOL LETTERS, V6, P585, DOI 10.1098/rsbl.2010.0214; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; ZAR JH, 1996, BIOSTATISTICAL ANAL; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250; Zimmer SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031389	73	7	7	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95963	10.1371/journal.pone.0095963	http://dx.doi.org/10.1371/journal.pone.0095963			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759976	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200118
J	Sekar, R; Chow, BKC				Sekar, Revathi; Chow, Billy K. C.			Secretin receptor-knockout mice are resistant to high-fat diet-induced obesity and exhibit impaired intestinal lipid absorption	FASEB JOURNAL			English	Article						postprandial triglyceride release; CD36; enterocytes; positive feedback loop; long chain fatty acid	POSTPRANDIAL LIPOPROTEINS; ENTEROENDOCRINE CELLS; ADIPOSE-TISSUE; MOUSE; METABOLISM; EXPRESSION; DISEASE; BODY; CD36; ATHEROSCLEROSIS	Secretin, a classical gastrointestinal hormone released from S cells in response to acid and dietary lipid, regulates pleiotropic physiological functions, such as exocrine pancreatic secretion and gastric motility. Subsequent to recently proposed revisit on secretin's metabolic effects, we have confirmed lipolytic actions of secretin during starvation and discovered a hormone-sensitive lipase-mediated mechanistic pathway behind. In this study, a 12 wk high-fat diet (HFD) feeding to secretin receptor-knockout (SCTR-/-) mice and their wild-type (SCTR+/+) littermates revealed that, despite similar food intake, SCTR-/- mice gained significantly less weight (SCTR+/+ : 49.6 +/- 0.9 g; SCTR-/- : 44.7 +/- 1.4 g; P< 0.05) and exhibited lower body fat content. These SCTR-/- mice have corresponding alleviated HFD-associated hyperleptinemia and improved glucose/insulin tolerance. Further analyses indicate that SCTR-/- have impaired intestinal fatty acid absorption while having similar energy expenditure and locomotor activity. Reduced fat absorption in the intestine is further supported by lowered postprandial triglyceride concentrations in circulation in SCTR-/- mice. In jejunal cells, transcript and protein levels of a key fat absorption regulator, cluster of differentiation 36 (CD36), was reduced in knockout mice, while transcript of Cd36 and fatty-acid uptake in isolated enterocytes was stimulated by secretin. Based on our findings, a novel positive feedback pathway involving secretin and CD36 to enhance intestinal lipid absorption is being proposed.	[Sekar, Revathi; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chow, BKC (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	bkcc@hku.hk	Chow, Billy/D-3064-2009; Sekar, Revathi/AAE-9642-2022; Sekar, Revathi/AFE-8105-2022	Chow, Billy/0000-0003-3390-0307; Sekar, Revathi/0000-0002-6787-7742	Hong Kong Government Research Grants Council grants [7648/12]; General Research Fund (GRF) [763809]; GRF [17 105514]; Collaborative Research Fund grant [HKU6/CRF/11G]; University of Hong Kong Committee on Research and Conference Grants grant [201111159046]	Hong Kong Government Research Grants Council grants; General Research Fund (GRF); GRF; Collaborative Research Fund grant; University of Hong Kong Committee on Research and Conference Grants grant	This work was supported by Hong Kong Government Research Grants Council grants 7648/12, General Research Fund (GRF) 763809, and GRF 17 105514; Collaborative Research Fund grant HKU6/CRF/11G; and University of Hong Kong Committee on Research and Conference Grants grant 201111159046 to B. K. C. C. The authors sincerely thank Dr. Leo Lee and Dr. Ruby Hoo for their help in body composition and indirect calorimetry instrument obtainment. The authors declare no conflicts of interest.	Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Cheng CYY, 2011, NEUROPSYCHOPHARMACOL, V36, P459, DOI 10.1038/npp.2010.178; Chu JYS, 2007, MOL CELL BIOL, V27, P2499, DOI 10.1128/MCB.01088-06; Chu JYS, 2011, KIDNEY INT, V79, P280, DOI 10.1038/ki.2010.397; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; Deng QH, 2009, CHEM-EUR J, V15, P10707, DOI 10.1002/chem.200901895; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Egerod KL, 2012, ENDOCRINOLOGY, V153, P5782, DOI 10.1210/en.2012-1595; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fukuda M, 2000, JPN J PHYSIOL, V50, P215, DOI 10.2170/jjphysiol.50.215; Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009; Gomez-Ambrosi J, 2004, FASEB J, V18, P215, DOI 10.1096/fj.03-0591fje; GORDON DA, 1995, TRENDS CELL BIOL, V5, P317, DOI 10.1016/S0962-8924(00)89054-6; GREEN GM, 1989, AM J PHYSIOL, V256, pG1016, DOI 10.1152/ajpgi.1989.256.6.G1016; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; HERBERG L, 1974, J LIPID RES, V15, P580; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; JONES PJH, 1985, AM J CLIN NUTR, V42, P769, DOI 10.1093/ajcn/42.5.769; Karpe F, 1999, J INTERN MED, V246, P341, DOI 10.1046/j.1365-2796.1999.00548.x; KARPE F, 1994, ATHEROSCLEROSIS, V106, P83, DOI 10.1016/0021-9150(94)90085-X; Koves K, 2011, J MOL NEUROSCI, V43, P109, DOI 10.1007/s12031-010-9408-z; Lam IPY, 2008, INT REV CYTOL, V265, P159, DOI 10.1016/S0074-7696(07)65004-9; Lee VHY, 2010, FASEB J, V24, P5024, DOI 10.1096/fj.10-165399; Liao JF, 2005, J LIPID RES, V46, P597, DOI 10.1194/jlr.D400023-JLR200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo CM, 2010, GASTROENTEROLOGY, V138, P1997, DOI 10.1053/j.gastro.2010.01.044; LU YX, 1995, AM J PHYSIOL-GASTR L, V268, pG1012, DOI 10.1152/ajpgi.1995.268.6.G1012; Lynes M, 2011, AM J PHYSIOL-REG I, V301, pR1738, DOI 10.1152/ajpregu.00235.2011; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Mellitzer G, 2011, CURR OPIN LIPIDOL, V22, P171, DOI 10.1097/MOL.0b013e32834622a2; Mellitzer G, 2010, J CLIN INVEST, V120, P1708, DOI 10.1172/JCI40794; Miegueu P., 2012, INT J OBES LOND, V37, P366; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Ng SSM, 2002, MOL NEUROBIOL, V26, P97, DOI 10.1385/MN:26:1:097; PATSCH JR, 1992, ARTERIOSCLER THROMB, V12, P1336, DOI 10.1161/01.ATV.12.11.1336; Proctor SD, 1998, EUR J CLIN INVEST, V28, P497; Proctor SD, 2002, CURR OPIN LIPIDOL, V13, P461, DOI 10.1097/00041433-200210000-00001; Ravussin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085876; Sekar R., 2013, J LIPID RES, V55; Sekar R, 2013, GEN COMP ENDOCR, V181, P18, DOI 10.1016/j.ygcen.2012.11.017; SHIDO O, 1989, JPN J PHYSIOL, V39, P359, DOI 10.2170/jjphysiol.39.359; Shim J, 2009, J LIPID RES, V50, P491, DOI 10.1194/jlr.M800400-JLR200; Siu FKY, 2006, ANN NY ACAD SCI, V1070, P561, DOI 10.1196/annals.1317.081; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Sundaresan S, 2013, FASEB J, V27, P1191, DOI 10.1096/fj.12-217703; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; Tupone D, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00014; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Xie Y, 2003, AM J PHYSIOL-GASTR L, V285, pG735, DOI 10.1152/ajpgi.00202.2003; Yung WH, 2001, J NEUROSCI, V21, P7063, DOI 10.1523/JNEUROSCI.21-18-07063.2001	50	20	21	5	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3494	3505		10.1096/fj.13-247536	http://dx.doi.org/10.1096/fj.13-247536			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24769669				2022-12-25	WOS:000340265400019
J	Daveson, BA; Harding, R; Shipman, C; Mason, BL; Epiphaniou, E; Higginson, IJ; Ellis-Smith, C; Henson, L; Munday, D; Nanton, V; Dale, JR; Boyd, K; Worth, A; Barclay, S; Donaldson, A; Murray, S				Daveson, Barbara A.; Harding, Richard; Shipman, Cathy; Mason, Bruce L.; Epiphaniou, Eleni; Higginson, Irene J.; Ellis-Smith, Clare; Henson, Lesley; Munday, Dan; Nanton, Veronica; Dale, Jeremy R.; Boyd, Kirsty; Worth, Allison; Barclay, Stephen; Donaldson, Anne; Murray, Scott			The Real-World Problem of Care Coordination: A Longitudinal Qualitative Study with Patients Living with Advanced Progressive Illness and Their Unpaid Caregivers	PLOS ONE			English	Article							ADVANCED CANCER; METAANALYSIS; SERVICES	Objectives: To develop a model of care coordination for patients living with advanced progressive illness and their unpaid caregivers, and to understand their perspective regarding care coordination. Design: A prospective longitudinal, multi-perspective qualitative study involving a case-study approach. Methods: Serial in-depth interviews were conducted, transcribed verbatim and then analyzed through open and axial coding in order to construct categories for three cases (sites). This was followed by continued thematic analysis to identify underlying conceptual coherence across all cases in order to produce one coherent care coordination model. Participants: Fifty-six purposively sampled patients and 27 case-linked unpaid caregivers. Settings: Three cases from contrasting primary, secondary and tertiary settings within Britain. Results: Coordination is a deliberate cross-cutting action that involves high-quality, caring and well-informed staff, patients and unpaid caregivers who must work in partnership together across health and social care settings. For coordination to occur, it must be adequately resourced with efficient systems and services that communicate. Patients and unpaid caregivers contribute substantially to the coordination of their care, which is sometimes volunteered at a personal cost to them. Coordination is facilitated through flexible and patient-centered care, characterized by accurate and timely information communicated in a way that considers patients' and caregivers' needs, preferences, circumstances and abilities. Conclusions: Within the midst of advanced progressive illness, coordination is a shared and complex intervention involving relational, structural and information components. Our study is one of the first to extensively examine patients' and caregivers' views about coordination, thus aiding conceptual fidelity. These findings can be used to help avoid oversimplifying a real-world problem, such as care coordination. Avoiding oversimplification can help with the development, evaluation and implementation of real-world coordination interventions for patients and their unpaid caregivers in the future.	[Daveson, Barbara A.; Harding, Richard; Shipman, Cathy; Epiphaniou, Eleni; Higginson, Irene J.; Ellis-Smith, Clare; Henson, Lesley] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England; [Mason, Bruce L.; Boyd, Kirsty; Worth, Allison; Donaldson, Anne; Murray, Scott] Univ Edinburgh, Ctr Populat Hlth Sci, Sch Med, Edinburgh, Midlothian, Scotland; [Munday, Dan; Nanton, Veronica; Dale, Jeremy R.] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Barclay, Stephen] Inst Publ Hlth, Primary Care Unit, Cambridge, England	University of London; King's College London; University of Edinburgh; University of Warwick; University of Cambridge	Daveson, BA (corresponding author), Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England.	barbara.daveson@kcl.ac.uk	Harding, Richard/G-9729-2012; Daveson, Barbara A/G-3122-2012; Daveson, Barbara/AAO-5876-2021; Higginson, Irene Julie/C-7309-2012	Daveson, Barbara/0000-0001-8039-8749; Dale, Jeremy/0000-0001-9256-3553; Higginson, Irene Julie/0000-0002-3687-1313; Ellis-Smith, Clare/0000-0003-3453-3203; Henson, Lesley/0000-0003-4799-7365; Barclay, Stephen/0000-0002-4505-7743; Harding, Richard/0000-0001-9653-8689; Boyd, Kirsty/0000-0002-5526-1078	National Institute for Health Research; National Institute for Health Research (NIHR) Health Services and Delivery Research (HSDR) Programme; Atlantic Philanthropies; Cicely Saunders International via project BuildCARE;  [08/1813/258]; National Institute for Health Research [NF-SI-0611-10209, 08/1813/258] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Health Services and Delivery Research (HSDR) Programme(National Institute for Health Research (NIHR)); Atlantic Philanthropies; Cicely Saunders International via project BuildCARE; ; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute for Health Research. The National Institute for Health Research (NIHR) Health Services and Delivery Research (HS&DR) Programme funds research to improve the quality, effectiveness and accessibility of the National Health Service (NHS). The HS&DR Programme is the result of the merger between Service Delivery and Organisation Programme (SDO), which was the original funder of this study, and another NIHR programme. The HS&DR programme carries forward the SDO programme's original aims: to improve health outcomes for people by commissioning research evidence that improves practice in relation to the organisation and delivery of healthcare; and to build research capability and capacity amongst those who manage, organise and deliver services - improving their understanding of the research literature and how to use research evidence. Grant number: 08/1813/258, funder website: http://www.netscc.ac.uk/hsdr/index.html. Drs Daveson and Henson, and Clare Ellis-Smith were funded by the Atlantic Philanthropies and Cicely Saunders International via project BuildCARE (Building Capacity, Access, Rights and Empowerment) for the duration of this project. The Atlantic Philanthropies are dedicated to bringing about lasting changes in the lives of disadvantaged and vulnerable people. Funder website: http://www.atlanticphilanthropies.org/about-atlantic. For further information about project BuildCARE see: http://www.cicelysaundersfoundation.org/research/project-buildcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR SDO programme or the Department of Health.	Abernethy Amy P, 2010, J Support Oncol, V8, P139; Adams K, 2003, PRIOR AR NAT ACT TRA; Agency for Healthcare Research and Quality, 2011, WHAT IS CAR COORD CA; Agency for Healthcare Research and Quality, 2011, CAR COORD MEAS ATL, P286; Boyd K, 2012, BMJ SUPPORTIVE PA S1, V2; Centers for Medicare Medicaid Services, 2006, DAT COMP; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Craig P, 2008, BMJ, V337; Craig P, 2013, DEV EVALUATING COMPL, P1; Daveson BA, 2010, ARTS PSYCHOTHERAPY, V35, P280; Department of Health, 2012, NHS OUTC FRAM 2013 2; Department of Health and Human Services, 2012, MED PROGR REV PAYM B, P68891; Donabedian A, 2005, MILBANK Q, V83, P691, DOI 10.1111/j.1468-0009.2005.00397.x; Dupont Alexandra, 2009, J Support Oncol, V7, P91; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Higginson IJ, 2003, J PAIN SYMPTOM MANAG, V25, P150, DOI 10.1016/S0885-3924(02)00599-7; Higginson IJ, 2008, EUR J CANCER, V44, P1414, DOI 10.1016/j.ejca.2008.02.024; Hofmarcher M.M., 2007, IMPROVED HLTH SYSTEM; Imison C., 2011, TRANSFORMING OUR HLT; Jackson D, 2013, J REHABIL MED, V45, P653, DOI 10.2340/16501977-1178; Langhorne P, LANCET, V365, P501; Mason B, 2013, COORDINATION CARE PE, P1; Mason B, 2013, BRIT J GEN PRACT, V63, pE580, DOI 10.3399/bjgp13X670714; Mays N, 2000, BMJ-BRIT MED J, V320, P52; McDonald KM, 2004, TECHNICAL REV, V9; McGuiness C, 2003, INT J QUAL HEALTH C, V15, P309, DOI 10.1093/intqhc/mzg043; Miller J., 2004, QUALITATIVE RES THEO, P125; Pinnock H, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d142; Plsek PE, 2001, BMJ CASE REPORTS, V323; Popay J, 1998, QUAL HEALTH RES, V8, P341, DOI 10.1177/104973239800800305; Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X; Roccaforte R, 2005, EUR J HEART FAIL, V7, P1133, DOI 10.1016/j.ejheart.2005.08.005; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Shipman C, 2008, BMJ, V337; Smith C, 2012, BMJ SUPPORT PALLIAT, V2, P301, DOI 10.1136/bmjspcare-2012-000265; Smith S, 2012, BMJ-BRIT MED J, V345, P1; Strauss A., 1990, BASICS QUALITATIVE R; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wagner E H, 2001, Jt Comm J Qual Improv, V27, P63; Walsh J, 2011, EUR J CANCER CARE, V20, P220, DOI 10.1111/j.1365-2354.2010.01187.x	42	26	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95523	10.1371/journal.pone.0095523	http://dx.doi.org/10.1371/journal.pone.0095523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZS	24788451	Green Published, gold			2022-12-25	WOS:000336655700032
J	Zhang, DD; Lu, KL; Dong, ZJ; Jiang, GZ; Xu, WN; Liu, WB				Zhang, Dingdong; Lu, Kangle; Dong, Zaijie; Jiang, Guangzhen; Xu, Weina; Liu, Wenbin			The Effect of Exposure to a High-Fat Diet on MicroRNA Expression in the Liver of Blunt Snout Bream (Megalobrama amblycephala)	PLOS ONE			English	Article							LIPID-METABOLISM; BINDING-PROTEIN; DOWN-REGULATION; ADIPOSE-TISSUE; LET-7 FAMILY; PPAR-GAMMA; FETUIN-B; ACID; GENE; IDENTIFICATION	Blunt snout bream (Megalobrama amblycephala) are susceptible to hepatic steatosis when maintained in modern intensive culture systems. The aim of this study was to investigate the potential roles of microRNAs (miRNAs) in diet-induced hepatic steatosis in this species. MiRNAs, small non-coding RNAs that regulate gene expression at the posttranscriptional level, are involved in diverse biological processes, including lipid metabolism. Deep sequencing of hepatic small RNA libraries from blunt snout bream fed normal-fat and high-fat diets identified 202 (193 known and 9 novel) miRNAs, of which 12 were differentially expressed between the normal-fat and high-fat diet groups. Quantitative stem-loop reverse transcriptase-polymerase chain reaction analyses confirmed the upregulation of miR-30c and miR-30e-3p and the downregulation of miR145 and miR-15a-5p in high-fat diet-fed fish. Bioinformatics tools were used to predict the targets of these verified miRNAs and to explore potential downstream gene ontology biological process categories and Kyoto Encyclopedia of Genes and Genomes pathways. Six putative lipid metabolism-related target genes (fetuin-B, Cyp7a1, NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 2, 3-oxoacid CoA transferase 1b, stearoyl-CoA desaturase, and fatty-acid synthase) were identified as having potential important roles in the development of diet-induced hepatic steatosis in blunt snout bream. The results presented here are a foundation for future studies of miRNA-controlled lipid metabolism regulatory networks in blunt snout bream.	[Zhang, Dingdong; Lu, Kangle; Jiang, Guangzhen; Xu, Weina; Liu, Wenbin] Nanjing Agr Univ, Coll Anim Sci & Technol, Key Lab Aquat Nutr & Feed Sci Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Zhang, Dingdong; Dong, Zaijie] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Minist Agr, Key Lab Freshwater Fisheries & Germplasm Resource, Wuxi, Peoples R China; [Zhang, Dingdong; Dong, Zaijie] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Peoples R China	Nanjing Agricultural University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Liu, WB (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Key Lab Aquat Nutr & Feed Sci Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.	zj.d@163.com; wbliu@njau.edu.cn	Dong, Zaijie/AAW-9998-2020; Lu, Kang-le/I-6284-2019; DONG, Zaijie/V-2380-2019	Lu, Kang-le/0000-0002-6548-4291; DONG, Zaijie/0000-0001-5428-1053	National Natural Science Foundation of China [60901053, 31172418, 31202005]; Open Fund of Key Laboratory of Freshwater Fisheries and Germplasm Resources Utilization, Ministry of Agriculture, Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences [KF201310]; "333" Projects of Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of Key Laboratory of Freshwater Fisheries and Germplasm Resources Utilization, Ministry of Agriculture, Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences; "333" Projects of Jiangsu Province	This work was supported by National Natural Science Foundation of China (Project 60901053, 31172418 and 31202005), the Open Fund of Key Laboratory of Freshwater Fisheries and Germplasm Resources Utilization, Ministry of Agriculture, Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences (NO. KF201310) and the "333" Projects of Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, BIOCHEM BIOPH RES CO, V414, P664, DOI 10.1016/j.bbrc.2011.09.120; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Anderson SP, 2004, MOL PHARMACOL, V66, P1440, DOI 10.1124/mol.104.005496; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Buchner DA, 2011, OBESITY, V19, P917, DOI 10.1038/oby.2010.214; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; Choi JW, 2012, CELL PHYSIOL BIOCHEM, V30, P295, DOI 10.1159/000339065; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cotter DG, 2011, J BIOL CHEM, V286, P6902, DOI 10.1074/jbc.M110.192369; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Czech MP, 2006, NEW ENGL J MED, V354, P1194, DOI 10.1056/NEJMcibr060065; Enright AJ, 2004, GENOME BIOL, V5; FAAOOTU NATIONS, 2012, YB FISH AQ STAT 2010; Fukuhara T, 2013, J GASTROENTEROL, V48, P169, DOI 10.1007/s00535-012-0661-5; Georgieva B, 2012, GENOMICS, V99, P275, DOI 10.1016/j.ygeno.2012.03.003; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Her GM, 2011, BBA-MOL CELL BIOL L, V1811, P536, DOI 10.1016/j.bbalip.2011.06.011; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jopling CL, 2012, RNA BIOL, V9, DOI 10.4161/rna.18827; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; Li L, 2012, J INSECT PHYSIOL, V58, P1438, DOI 10.1016/j.jinsphys.2012.08.008; Li S, 2013, GENE, V512, P321, DOI 10.1016/j.gene.2012.10.003; Li XF, 2012, FISH SHELLFISH IMMUN, V33, P316, DOI 10.1016/j.fsi.2012.05.007; Lu KL, 2013, FISHERIES SCI, V79, P661, DOI 10.1007/s12562-013-0635-4; Matsumoto T, 2010, DIS MODEL MECH, V3, P431, DOI 10.1242/dmm.002311; Mitterberger MC, 2012, STEM CELL RES, V9, P35, DOI 10.1016/j.scr.2012.04.001; Miyaaki H, 2013, LIVER INT; Moore KJ, 2011, ANNU REV NUTR, V31, P49, DOI 10.1146/annurev-nutr-081810-160756; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Olivier E, 2000, BIOCHEM J, V350, P589, DOI 10.1042/0264-6021:3500589; Olofsson LE, 2008, J CLIN ENDOCR METAB, V93, P4880, DOI 10.1210/jc.2008-0574; Pandak WM, 2001, AM J PHYSIOL-GASTR L, V281, pG878, DOI 10.1152/ajpgi.2001.281.4.G878; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; Song M, 2011, TOXICOL SCI, V120, P98, DOI 10.1093/toxsci/kfq361; Tacer KF, 2011, J LIPIDS, V2011, DOI 10.1155/2011/783976; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wong RHF, 2010, CURR OPIN PHARMACOL, V10, P684, DOI 10.1016/j.coph.2010.08.004; Xie KP, 2013, CANCER EPIDEMIOL, V37, P998, DOI 10.1016/j.canep.2013.09.005; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925; Yi SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-754; Yuan C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-511; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang XD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-157; Zhao YH, 2011, FISH SHELLFISH IMMUN, V31, P462, DOI 10.1016/j.fsi.2011.06.024; Zheng H, 2013, INT J MOL SCI, V14, P8179, DOI 10.3390/ijms14048179; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	67	24	28	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96132	10.1371/journal.pone.0096132	http://dx.doi.org/10.1371/journal.pone.0096132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788396	gold, Green Published, Green Submitted			2022-12-25	WOS:000336655700058
J	Cardinale, CJ; Wei, Z; Li, J; Zhu, JF; Gu, MN; Baldassano, RN; Grant, SFA; Hakonarson, H				Cardinale, Christopher J.; Wei, Zhi; Li, Jin; Zhu, Junfei; Gu, Mengnan; Baldassano, Robert N.; Grant, Struan F. A.; Hakonarson, Hakon			Transcriptome Profiling of Human Ulcerative Colitis Mucosa Reveals Altered Expression of Pathways Enriched in Genetic Susceptibility Loci	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; SET; VARIANTS; NUMBER; ONSET	Human colonic mucosa altered by inflammation due to ulcerative colitis (UC) displays a drastically altered pattern of gene expression compared with healthy tissue. We aimed to understand the underlying molecular pathways influencing these differences by analyzing three publically-available, independently-generated microarray datasets of gene expression from endoscopic biopsies of the colon. Gene set enrichment analysis (GSEA) revealed that all three datasets share 87 gene sets upregulated in UC lesions and 8 gene sets downregulated (false discovery rate <0.05). The upregulated pathways were dominated by gene sets involved in immune function and signaling, as well as the control of mitosis. We applied pathway analysis to genotype data derived from genome-wide association studies (GWAS) of UC, consisting of 5,584 cases and 11,587 controls assembled from eight European-ancestry cohorts. The upregulated pathways derived from the gene expression data showed a highly significant overlap with pathways derived from the genotype data (33 of 56 gene sets, hypergeometric P = 1.49x10(-19)). This study supports the hypothesis that heritable variation in gene expression as measured by GWAS signals can influence key pathways in the development of disease, and that comparison of genetic susceptibility loci with gene expression signatures can differentiate key drivers of inflammation from secondary effects on gene expression of the inflammatory process.	[Cardinale, Christopher J.; Li, Jin; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Wei, Zhi; Zhu, Junfei; Gu, Mengnan] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Baldassano, Robert N.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Baldassano, Robert N.; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; New Jersey Institute of Technology; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Hakonarson, H (corresponding author), Univ Penn, Sch Med, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Cardinale, Christopher J./G-3351-2013; , AndyWei/H-4415-2012	Cardinale, Christopher J./0000-0001-7513-8977; Wei, Zhi/0000-0001-6059-4267	Senior Research Award from the Crohn's and Colitis Foundation of America; Edmunds Fund for Ulcerative Colitis Studies	Senior Research Award from the Crohn's and Colitis Foundation of America; Edmunds Fund for Ulcerative Colitis Studies	This work is supported by a Senior Research Award from the Crohn's and Colitis Foundation of America to H. H. and a donation from Edmunds Fund for Ulcerative Colitis Studies to the Children's Hospital of Philadelphia to R.N.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix I, 2006, GUIDE PROBE LOGARITH; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Granlund AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056818; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaser A, 2011, GASTROENTEROLOGY, V140, P1738, DOI 10.1053/j.gastro.2011.02.048; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Okahara S, 2005, ALIMENT PHARM THERAP, V21, P1091, DOI 10.1111/j.1365-2036.2005.02443.x; Olsen J, 2009, INFLAMM BOWEL DIS, V15, P1032, DOI 10.1002/ibd.20879; Planell N, 2012, GUT; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Seo J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-395; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110	31	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96153	10.1371/journal.pone.0096153	http://dx.doi.org/10.1371/journal.pone.0096153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788701	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600079
J	Tasiemski, A; Jung, SC; Boidin-Wichlacz, C; Jollivet, D; Cuvillier-Hot, V; Pradillon, F; Vetriani, C; Hecht, O; Sonnichsen, FD; Gelhaus, C; Hung, CW; Tholey, A; Leippe, M; Grotzinger, J; Gaill, F				Tasiemski, Aurelie; Jung, Sascha; Boidin-Wichlacz, Celine; Jollivet, Didier; Cuvillier-Hot, Virginie; Pradillon, Florence; Vetriani, Costantino; Hecht, Oliver; Soennichsen, Frank D.; Gelhaus, Christoph; Hung, Chien-Wen; Tholey, Andreas; Leippe, Matthias; Groetzinger, Joachim; Gaill, Francoise			Characterization and Function of the First Antibiotic Isolated from a Vent Organism: The Extremophile Metazoan Alvinella pompejana	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; IDENTIFICATION; LEECH; ADAPTATION; EVOLUTION; DEMENTIA; INSIGHTS; IMMUNITY; BRICHOS; SYSTEM	The emblematic hydrothermal worm Alvinella pompejana is one of the most thermo tolerant animal known on Earth. It relies on a symbiotic association offering a unique opportunity to discover biochemical adaptations that allow animals to thrive in such a hostile habitat. Here, by studying the Pompeii worm, we report on the discovery of the first antibiotic peptide from a deep-sea organism, namely alvinellacin. After purification and peptide sequencing, both the gene and the peptide tertiary structures were elucidated. As epibionts are not cultivated so far and because of lethal decompression effects upon Alvinella sampling, we developed shipboard biological assays to demonstrate that in addition to act in the first line of defense against microbial invasion, alvinellacin shapes and controls the worm's epibiotic microflora. Our results provide insights into the nature of an abyssal antimicrobial peptide (AMP) and into the manner in which an extremophile eukaryote uses it to interact with the particular microbial community of the hydrothermal vent ecosystem. Unlike earlier studies done on hydrothermal vents that all focused on the microbial side of the symbiosis, our work gives a view of this interaction from the host side.	[Tasiemski, Aurelie; Boidin-Wichlacz, Celine; Cuvillier-Hot, Virginie] Univ Lille 1, CNRS, UMR8198, Lab GEPV, F-59655 Villeneuve Dascq, France; [Jung, Sascha; Hecht, Oliver; Groetzinger, Joachim] Univ Kiel, Inst Biochem, Kiel, Germany; [Jollivet, Didier] Univ Paris 06, CNRS, UMR7144, Stn Biol,Lab Adaptat & Biol Invertebre Condit Ext, Roscoff, France; [Pradillon, Florence] IFREMER, Ctr Brest, REM EEP LEP, Plouzane, France; [Vetriani, Costantino] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA; [Vetriani, Costantino] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Soennichsen, Frank D.] Univ Kiel, Otto Diels Inst Organ Chem, Kiel, Germany; [Gelhaus, Christoph; Leippe, Matthias] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Hung, Chien-Wen; Tholey, Andreas] Univ Kiel, Div Systemat Proteome Res, Inst Expt Med, Kiel, Germany; [Gaill, Francoise] Univ Paris 06, CNRS, BOREA IRD, Museum Natl Hist Nat, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Lille - ISITE; Universite de Lille; University of Kiel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Ifremer; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Kiel; University of Kiel; University of Kiel; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Tasiemski, A (corresponding author), Univ Lille 1, CNRS, UMR8198, Lab GEPV, F-59655 Villeneuve Dascq, France.	aurelie.tasiemski@univ-lille1.fr	Pradillon, Florence/AAM-2992-2020; Sönnichsen, Frank D/D-8408-2011; Leippe, Matthias/AAP-1677-2020; Gelhaus, Christoph/D-8050-2011; Tholey, Andreas/B-3407-2010; Cuvillier, Virginie/AAT-7791-2020; Tasiemski, Aurelie/S-2537-2016	Pradillon, Florence/0000-0002-6473-6290; Sönnichsen, Frank D/0000-0002-4539-3755; Tholey, Andreas/0000-0002-8687-6817; Tasiemski, Aurelie/0000-0003-3559-5115; Cuvillier, Virginie/0000-0002-3433-1110; Jung, Sascha/0000-0003-4970-6904; Wichlacz, Celine/0000-0002-0242-868X	CNRS; MSER; Universite de Lille1 (BQR); Region Nord Pas-de-Calais (Emergent); Fondation pour la Recherche sur la Biodiversite (VERMER); Directorate For Geosciences [1136451] Funding Source: National Science Foundation	CNRS(Centre National de la Recherche Scientifique (CNRS)); MSER; Universite de Lille1 (BQR); Region Nord Pas-de-Calais (Emergent)(Region Hauts-de-France); Fondation pour la Recherche sur la Biodiversite (VERMER); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the CNRS, the MSER, the Universite de Lille1 (BQR 2012), the Region Nord Pas-de-Calais (Emergent 2012) and the Fondation pour la Recherche sur la Biodiversite (VERMER 2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 2008, BIOCHEM J, V410, P113, DOI 10.1042/BJ20071051; Austin B, 1988, MARINE MICROBIOLOGY; BAERT JL, 1991, EUR J BIOCHEM, V201, P191, DOI 10.1111/j.1432-1033.1991.tb16273.x; Boidin-Wichlacz C, 2012, CELL MOL LIFE SCI, V69, P1717, DOI 10.1007/s00018-011-0897-x; Bonch-Osmolovskaya EA, 2011, APPL ENVIRON MICROB, V77, P2803, DOI 10.1128/AEM.02266-10; Cary SC, 1997, APPL ENVIRON MICROB, V63, P1124, DOI 10.1128/AEM.63.3.1124-1130.1997; Cary SC, 1998, NATURE, V391, P545, DOI 10.1038/35286; CHEVALDONNE P, 1992, NATURE, V359, P593, DOI 10.1038/359593b0; Cottin D, 2008, J EXP BIOL, V211, P2196, DOI 10.1242/jeb.018606; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fedders H, 2008, DEV COMP IMMUNOL, V32, P286, DOI 10.1016/j.dci.2007.06.003; Gagniere N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-634; Girguis PR, 2006, SCIENCE, V312, P231, DOI 10.1126/science.1125286; Grzymski JJ, 2008, P NATL ACAD SCI USA, V105, P17516, DOI 10.1073/pnas.0802782105; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herbst R, 2002, J BIOL CHEM, V277, P22353, DOI 10.1074/jbc.M201475200; Herwald H, 2011, J INNATE IMMUN, V3, P435, DOI 10.1159/000330635; Hourdez S, 2000, PHYSIOL BIOCHEM ZOOL, V73, P365, DOI 10.1086/316755; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Le Bris N., 2007, Reviews in Environmental Science and Bio/Technology, V6, P197, DOI 10.1007/s11157-006-9112-1; LEIPPE M, 1991, P NATL ACAD SCI USA, V88, P7659, DOI 10.1073/pnas.88.17.7659; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Maroti G, 2011, RES MICROBIOL, V162, P363, DOI 10.1016/j.resmic.2011.02.005; Moussard H, 2006, FEMS MICROBIOL ECOL, V57, P452, DOI 10.1111/j.1574-6941.2006.00128.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Ravaux J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064074; SALZET M, 1994, EUR J BIOCHEM, V221, P269, DOI 10.1111/j.1432-1033.1994.tb18738.x; Salzet M, 2006, CURR PHARM DESIGN, V12, P3043, DOI 10.2174/138161206777947551; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Sicot FX, 2000, J MOL BIOL, V302, P811, DOI 10.1006/jmbi.2000.4505; Sperstad SV, 2011, BIOTECHNOL ADV, V29, P519, DOI 10.1016/j.biotechadv.2011.05.021; STETTER KO, 1983, SYST APPL MICROBIOL, V4, P535, DOI 10.1016/S0723-2020(83)80011-3; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Tasiemski A, 2008, INVERTEBRATE SURVIVA, V166; Tennessen JA, 2005, J EVOLUTION BIOL, V18, P1387, DOI 10.1111/j.1420-9101.2005.00925.x; Vetriani C, 2004, INT J SYST EVOL MICR, V54, P175, DOI 10.1099/ijs.0.02781-0; Willander H, 2011, FEBS J, V278, P3893, DOI 10.1111/j.1742-4658.2011.08209.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu S, 2012, DEV COMP IMMUNOL	41	25	26	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95737	10.1371/journal.pone.0095737	http://dx.doi.org/10.1371/journal.pone.0095737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776651	Green Published, Green Submitted, gold			2022-12-25	WOS:000346241800015
J	Tudor, D; Kajic, V; Rey, S; Erchova, I; Povazay, B; Hofer, B; Powell, KA; Marshall, D; Rosin, PL; Drexler, W; Morgan, JE				Tudor, Debbie; Kajic, Vedran; Rey, Sara; Erchova, Irina; Povazay, Boris; Hofer, Bernd; Powell, Kate A.; Marshall, David; Rosin, Paul L.; Drexler, Wolfgang; Morgan, James E.			Non-Invasive Detection of Early Retinal Neuronal Degeneration by Ultrahigh Resolution Optical Coherence Tomography	PLOS ONE			English	Article							CELL-DEATH; COMPLEX WAVELETS; GANGLION-CELLS; APOPTOSIS; MITOCHONDRIA; SPECKLE; IMAGES; NEURODEGENERATION; IDENTIFICATION; MICROSCOPY	Optical coherence tomography (OCT) has revolutionises the diagnosis of retinal disease based on the detection of microscopic rather than subcellular changes in retinal anatomy. However, currently the technique is limited to the detection of microscopic rather than subcellular changes in retinal anatomy. However, coherence based imaging is extremely sensitive to both changes in optical contrast and cellular events at the micrometer scale, and can generate subtle changes in the spectral content of the OCT image. Here we test the hypothesis that OCT image speckle (image texture) contains information regarding otherwise unresolvable features such as organelle changes arising in the early stages of neuronal degeneration. Using ultrahigh resolution (UHR) OCT imaging at 800 nm (spectral width 140 nm) we developed a robust method of OCT image analyses, based on spatial wavelet and texture-based parameterisation of the image speckle pattern. For the first time we show that this approach allows the non-invasive detection and quantification of early apoptotic changes in neurons within 30 min of neuronal trauma sufficient to result in apoptosis. We show a positive correlation between immunofluorescent labelling of mitochondria (a potential source of changes in cellular optical contrast) with changes in the texture of the OCT images of cultured neurons. Moreover, similar changes in optical contrast were also seen in the retinal ganglion cell-inner plexiform layer in retinal explants following optic nerve transection. The optical clarity of the explants was maintained throughout in the absence of histologically detectable change. Our data suggest that UHR OCT can be used for the non-invasive quantitative assessment of neuronal health, with a particular application to the assessment of early retinal disease.	[Tudor, Debbie; Erchova, Irina; Morgan, James E.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales; [Marshall, David; Rosin, Paul L.] Cardiff Univ, Sch Comp Sci & Informat, Cardiff CF10 3AX, S Glam, Wales; [Rey, Sara; Erchova, Irina; Powell, Kate A.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Kajic, Vedran; Povazay, Boris; Hofer, Bernd; Drexler, Wolfgang] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Morgan, James E.] Cardiff Univ, Dept Neurol & Ophthalmol, Sch Med, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University; Medical University of Vienna; Cardiff University	Morgan, JE (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales.	morganje3@cardiff.ac.uk	Morgan, James/GRO-2905-2022	Morgan, James/0000-0002-8920-1065; Drexler, Wolfgang/0000-0002-3557-6398; Povazay, Boris/0000-0001-5571-5116; Rosin, Paul/0000-0002-4965-3884; Powell, Kate/0000-0002-1826-953X	Biotechnology and Biological Sciences Research Council (BBSRC, UK) [BB/E017754/1]; BBSRC [BB/E017754/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E017754/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC, UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC, UK, BB/E017754/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie SG, 2006, P SOC PHOTO-OPT INS, V6085, P29; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H, 1980, BAYESIAN STAT, P143, DOI DOI 10.1007/BF02888350; Anantrasirichai N, 2013, I S BIOMED IMAGING, P1332; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Backman V, 2000, NATURE, V406, P35, DOI 10.1038/35017638; Bishop C.M., 2006, PATTERN RECOGNITION; Brezinski M. E., 2006, OPTICAL COHERENCE TO; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chin EK, 2012, OPHTHAL SURG LAS IM, V43, P97, DOI 10.3928/15428877-20111222-02; Cordeiro MF, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.3; Cordeiro MF, 2004, P NATL ACAD SCI USA, V101, P13352, DOI 10.1073/pnas.0405479101; Dedov VN, 1999, FEBS LETT, V456, P171, DOI 10.1016/S0014-5793(99)00951-5; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; Esmaeelpour M, 2001, INVEST OPHTH VIS SCI, V51, P5260; Farhat G, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600770; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI 10.2184/lsj.31.635; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fukunaga K, 1990, INTRO STAT PATTERN R; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gossage KW, 2003, J BIOMED OPT, V8, P570, DOI 10.1117/1.1577575; Gossage KW, 2006, PHYS MED BIOL, V51, P1563, DOI 10.1088/0031-9155/51/6/014; Gourley PL, 2005, TECHNOL CANCER RES T, V4, P585, DOI 10.1177/153303460500400602; Guo L, 2008, PROG BRAIN RES, V173, P437, DOI 10.1016/S0079-6123(08)01130-8; Hillman TR, 2006, OPT LETT, V31, P190, DOI 10.1364/OL.31.000190; Hulst H.C., 1957, LIGHT SCATTERING SMA; Karbowski M, 2010, ADV EXP MED BIOL, V687, P131; Kartakoullis A, 2010, OPT EXPRESS, V18, P9181, DOI 10.1364/OE.18.009181; Kingsbury N, 2001, APPL COMPUT HARMON A, V10, P234, DOI 10.1006/acha.2000.0343; Kingsbury N, 1999, PHILOS T R SOC A, V357, P2543, DOI 10.1098/rsta.1999.0447; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Landes T, 2011, BBA-MOL CELL RES, V1813, P540, DOI 10.1016/j.bbamcr.2011.01.021; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mourant JR, 1998, APPL OPTICS, V37, P3586, DOI 10.1364/AO.37.003586; PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188; Pasternack RM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3467501; Pitris C, 2009, J BIOPHOTONICS, V2, P364, DOI 10.1002/jbio.200910023; Quellec G, 2010, IEEE T MED IMAGING, V29, P1321, DOI 10.1109/TMI.2010.2047023; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schmitt JM, 1999, J BIOMED OPT, V4, P95, DOI 10.1117/1.429925; Schmitt JM, 1999, IEEE J SEL TOP QUANT, V5, P1205, DOI 10.1109/2944.796348; Shou TD, 2003, INVEST OPHTH VIS SCI, V44, P3005, DOI 10.1167/iovs.02-0620; Smith ZJ, 2009, APPL OPTICS, V48, pD109, DOI 10.1364/AO.48.00D109; THIJSSEN JM, 1991, ULTRASOUND MED BIOL, V17, P127, DOI 10.1016/0301-5629(91)90120-L; Torti C, 2009, OPT EXPRESS, V17, P19382, DOI 10.1364/OE.17.019382; Ursell PG, 1998, J CATARACT REFR SURG, V24, P352, DOI 10.1016/S0886-3350(98)80323-4; van der Meer FJ, 2010, LASER MED SCI, V25, P259, DOI 10.1007/s10103-009-0723-y; Weber AJ, 1998, INVEST OPHTH VIS SCI, V39, P2304; Xu J, 2012, IEEE T MED IMAGING, V31, P1337, DOI 10.1109/TMI.2011.2182618	52	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e93916	10.1371/journal.pone.0093916	http://dx.doi.org/10.1371/journal.pone.0093916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776961	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000346241800004
J	Ali, F; Wharton, DA				Ali, Farman; Wharton, David A.			Intracellular Freezing in the Infective Juveniles of Steinernema feltiae: An Entomopathogenic Nematode	PLOS ONE			English	Article							COLD-TOLERANCE MECHANISMS; FAT-BODY CELLS; ANTARCTIC-NEMATODE; CRYOPROTECTIVE DEHYDRATION; PANAGROLAIMUS-DAVIDI; SUBSTITUTION; SURVIVAL; LARVAE	Taking advantage of their optical transparency, we clearly observed the third stage infective juveniles (IJs) of Steinernema feltiae freezing under a cryo-stage microscope. The IJs froze when the water surrounding them froze at -2 degrees C and below. However, they avoid inoculative freezing at -1 degrees C, suggesting cryoprotective dehydration. Freezing was evident as a sudden darkening and cessation of IJs' movement. Freeze substitution and transmission electron microscopy confirmed that the IJs of S. feltiae freeze intracellularly. Ice crystals were found in every compartment of the body. IJs frozen at high sub-zero temperatures (-1 and -3 degrees C) survived and had small ice crystals. Those frozen at -10 degrees C had large ice crystals and did not survive. However, the pattern of ice formation was not well-controlled and individual nematodes frozen at -3 degrees C had both small and large ice crystals. IJs frozen by plunging directly into liquid nitrogen had small ice crystals, but did not survive. This study thus presents the evidence that S. feltiae is only the second freeze tolerant animal, after the Antarctic nematode Panagrolaimus davidi, shown to withstand extensive intracellular freezing.	[Ali, Farman; Wharton, David A.] Univ Otago, Dept Zool, Dunedin, New Zealand	University of Otago	Ali, F (corresponding author), Abdul Wali Khan Univ Mardan, Dept Zool, Mardan, Pakistan.	drfarman@gmail.com	Ali, Farman/GVT-3127-2022	Wharton, David/0000-0001-6369-4984	Postgraduate Otago University scholarship	Postgraduate Otago University scholarship	The Principal author acknowledges the support of a Postgraduate Otago University scholarship and a publishing bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2013, CRYOBIOLOGY, V66, P24, DOI 10.1016/j.cryobiol.2012.10.004; Asahina E, 1959, LOW TEMP SCI B, V17, P51; Brown IM, 1996, J THERM BIOL, V21, P115, DOI 10.1016/0306-4565(95)00033-X; GREENAWAY P, 1970, J EXP BIOL, V53, P147; Grout B.W.W., 1987, P147; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hayashi M, 2009, CRYOBIOLOGY CRYOTECH, V15, P115; Hayashi M, 2011, J COMP PHYSIOL B, V181, P335, DOI 10.1007/s00360-010-0541-3; Hominick WM, 1996, BIOCONTROL SCI TECHN, V6, P317, DOI 10.1080/09583159631307; HUNT CJ, 1984, CRYOBIOLOGY, V21, P385, DOI 10.1016/0011-2240(84)90077-4; Jagdale GB, 2003, INT J PARASITOL, V33, P145, DOI 10.1016/S0020-7519(02)00257-6; Kaya Harry K., 1997, P281, DOI 10.1016/B978-012432555-5/50016-6; Lee R.E. Jr, 1991, P17; LEE RE, 1993, J INSECT PHYSIOL, V39, P445, DOI 10.1016/0022-1910(93)90033-N; Muhlfeld C, 2010, METHODS MOL BIOL, V611, P87, DOI 10.1007/978-1-60327-345-9_7; Muldrew K, 2004, LIFE IN THE FROZEN STATE, P67, DOI 10.1201/9780203647073.ch2; Rasband W.S., 1997, IMAGE J; Raymond MR, 2013, J COMP PHYSIOL B, V183, P181, DOI 10.1007/s00360-012-0697-0; Robards AW, 1985, LOW TEMPERATURE METH; SALT RW, 1962, NATURE, V193, P1207, DOI 10.1038/1931207a0; SALT RW, 1959, NATURE, V184, P1426, DOI 10.1038/1841426a0; Sayre R. M., 1964, Nematologica, V10, P168; Shiurba R, 2001, INT REV CYTOL, V206, P45; Smith T, 2008, J COMP PHYSIOL B, V178, P93, DOI 10.1007/s00360-007-0202-3; Statistical Package for Social Sciences (SPSS) Inc, 2006, SPSS WINDOWS; STOREY JM, 1985, J COMP PHYSIOL B, V156, P191, DOI 10.1007/BF00695773; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; TONER M, 1990, J APPL PHYS, V67, P1582, DOI 10.1063/1.345670; TYRRELL C, 1994, PARASITOLOGY, V109, P367, DOI 10.1017/S0031182000078409; Weimer Robby M., 2006, V351, P203; Wharton D. A, 1986, FUNCTIONAL BIOL NEMA; WHARTON DA, 1995, J EXP BIOL, V198, P1381; Wharton DA, 2005, CRYOBIOLOGY, V51, P198, DOI 10.1016/j.cryobiol.2005.07.001; Wharton DA, 2005, CRYOBIOLOGY, V50, P21, DOI 10.1016/j.cryobiol.2004.09.004; WHARTON DA, 1984, J MICROSC-OXFORD, V134, P299, DOI 10.1111/j.1365-2818.1984.tb02523.x; Wharton DA, 2002, J HELMINTHOL, V76, P363, DOI 10.1079/JOH2002149; WHARTON DA, 1995, BIOL REV, V70, P161, DOI 10.1111/j.1469-185X.1995.tb01442.x; WHARTON DA, 1994, CRYO-LETT, V15, P353; Wharton DA, 2003, J EXP BIOL, V206, P215, DOI 10.1242/jeb.00083; WHARTON DA, 1991, J EXP BIOL, V155, P629; Wharton DA, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P182, DOI 10.1079/9781845936877.0182	41	10	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e94179	10.1371/journal.pone.0094179	http://dx.doi.org/10.1371/journal.pone.0094179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769523	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736600004
J	Xu, Y; Li, H; Jin, YH; Fan, J; Sun, F				Xu, Yingzhi; Li, He; Jin, Ying-Hua; Fan, Jun; Sun, Fei			Dimerization Interface of 3-Hydroxyacyl-CoA Dehydrogenase Tunes the Formation of Its Catalytic Intermediate	PLOS ONE			English	Article							CHAIN L-3-HYDROXYACYL-COA DEHYDROGENASE; PRELIMINARY CRYSTALLOGRAPHIC ANALYSIS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; A DEHYDROGENASE; PURIFICATION; CRYSTALLIZATION; DEFICIENCY; ENZYME; HYPERINSULINISM	3-hydroxyacyl-CoA dehydrogenase (HAD, EC 1.1.1.35) is a homodimeric enzyme localized in the mitochondrial matrix, which catalyzes the third step in fatty acid beta-oxidation. The crystal structures of human HAD and subsequent complexes with cofactor/substrate enabled better understanding of HAD catalytic mechanism. However, numerous human diseases were found related to mutations at HAD dimerization interface that is away from the catalytic pocket. The role of HAD dimerization in its catalytic activity needs to be elucidated. Here, we solved the crystal structure of Caenorhabditis elegans HAD (cHAD) that is highly conserved to human HAD. Even though the cHAD mutants (R204A, Y209A and R204A/Y209A) with attenuated interactions on the dimerization interface still maintain a dimerization form, their enzymatic activities significantly decrease compared to that of the wild type. Such reduced activities are in consistency with the reduced ratios of the catalytic intermediate formation. Further molecular dynamics simulations results reveal that the alteration of the dimerization interface will increase the fluctuation of a distal region (a. a. 60-80) that plays an important role in the substrate binding. The increased fluctuation decreases the stability of the catalytic intermediate formation, and therefore the enzymatic activity is attenuated. Our study reveals the molecular mechanism about the essential role of the HAD dimerization interface in its catalytic activity via allosteric effects.	[Xu, Yingzhi; Sun, Fei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Li, He; Jin, Ying-Hua] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China; [Xu, Yingzhi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Fan, Jun] City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Jilin University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; City University of Hong Kong	Fan, J (corresponding author), City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China.	junfan@cityu.edu.hk; feisun@ibp.ac.cn	Sun, Fei/AAR-3186-2020; Sun, Fei/C-4190-2015; Fan, Jun/D-3853-2013	Sun, Fei/0000-0002-0351-5144; Sun, Fei/0000-0002-0351-5144; Fan, Jun/0000-0001-8227-9671	Chinese Ministry of Science and Technology [2011CB910301, 2014CB910700]; National Natural Science Foundation of China [21261130090]; City University of Hong Kong [7200350, 9610291]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); City University of Hong Kong(City University of Hong Kong)	This work was supported by grants to FS from the Chinese Ministry of Science and Technology (2011CB910301 and 2014CB910700) and the National Natural Science Foundation of China (21261130090) and by grants to JF from City University of Hong Kong (Projects no. 7200350 and 9610291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barycki JJ, 1999, PROTEIN SCI, V8, P2010, DOI 10.1110/ps.8.10.2010; Barycki JJ, 2000, J BIOL CHEM, V275, P27186; Barycki JJ, 1999, BIOCHEMISTRY-US, V38, P5786, DOI 10.1021/bi9829027; Bennett MJ, 2006, MOL GENET METAB, V89, P74, DOI 10.1016/j.ymgme.2006.04.004; Bennett MJ, 1996, PEDIATR RES, V39, P185, DOI 10.1203/00006450-199601000-00031; Clayton PT, 2001, J CLIN INVEST, V108, P457; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Candia S, 2009, EUR J ENDOCRINOL, V160, P1019, DOI 10.1530/EJE-08-0945; Dutta D, 2012, PROTEINS, V80, P1250, DOI 10.1002/prot.24024; ELFAKHRI M, 1982, BIOCHIM BIOPHYS ACTA, V713, P270, DOI 10.1016/0005-2760(82)90244-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Harris D. C., 2010, APPL SPECTROPHOTOMET, P419; He XY, 1998, J BIOL CHEM, V273, P10741, DOI 10.1074/jbc.273.17.10741; HE XY, 1989, ANAL BIOCHEM, V180, P105, DOI 10.1016/0003-2697(89)90095-X; HOEFLER G, 1994, GENOMICS, V19, P60, DOI 10.1006/geno.1994.1013; Hussain K, 2005, J PEDIATR-US, V146, P706, DOI 10.1016/j.jpeds.2005.01.032; Kapoor RR, 2009, J CLIN ENDOCR METAB, V94, P2221, DOI 10.1210/jc.2009-0423; Kobayashi A, 1996, J BIOCHEM-TOKYO, V119, P775, DOI 10.1093/oxfordjournals.jbchem.a021307; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li ZJ, 2010, ACTA CRYSTALLOGR F, V66, P426, DOI 10.1107/S1744309110005002; LUO MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P214, DOI 10.1006/abbi.1995.1388; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Molven A, 2004, DIABETES, V53, P221, DOI 10.2337/diabetes.53.1.221; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NOYES B E, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1334, DOI 10.1073/pnas.71.4.1334; NOYES BE, 1973, J BIOL CHEM, V248, P3052; O'Brien LK, 2000, J INHERIT METAB D S1, V23, P127, DOI DOI 10.1007/978-0-387-98141-3_1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schulz N, 2011, ENDOCRINOLOGY, V152, P4641, DOI 10.1210/en.2011-1547; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vredendaal PJCM, 1998, MAMM GENOME, V9, P763, DOI 10.1007/s003359900860; Vredendaal PJCM, 1996, BIOCHEM BIOPH RES CO, V223, P718, DOI 10.1006/bbrc.1996.0961; Xu YZ, 2013, ACTA CRYSTALLOGR F, V69, P515, DOI 10.1107/S1744309113007045; Yang SY, 2005, FEBS J, V272, P4874, DOI 10.1111/j.1742-4658.2005.04911.x	39	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95965	10.1371/journal.pone.0095965	http://dx.doi.org/10.1371/journal.pone.0095965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763278	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000045
J	Zhu, CM; Ling, YH; Xi, SY; Luo, RZ; Chen, JW; Yun, JP; Xie, D; Cai, MY				Zhu, Chong-Mei; Ling, Yi-Hong; Xi, Shao-Yan; Luo, Rong-Zhen; Chen, Jie-Wei; Yun, Jing-Ping; Xie, Dan; Cai, Mu-Yan			Prognostic Significance of the pN Classification Supplemented by Vascular Invasion for Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; COLORECTAL-CANCER; PATHOLOGY; SURVIVAL; FEATURES; EDITION; BLOOD	Background: The biological behavior and clinical outcome of esophageal squamous cell carcinoma (ESCC) are difficult to predict. Methodology/Principal Findings: We investigate the prognostic impact of vascular invasion to establish a risk stratification model to predict recurrence and overall survival. We retrospectively evaluated the vascular invasion of 433 patients with ESCC treated with surgery between 2000 and 2007 at a single academic center. Those patients were assigned to a testing cohort and a validation cohort by random number generated in computer. The presence of vascular invasion was observed in 113 of 216 (52.3%) and 96 of 217 (44.2%) of ESCC in the training and validation cohorts, respectively. Further correlation analysis demonstrated that vascular invasion in ESCC was significantly correlated with more advanced pN classification and stage in both cohorts (P < 0.05). Additionally, presence of vascular invasion in ESCC patients was associated closely with poor overall and recurrence-free survival as evidenced by univariate and multivariate analysis in both cohorts (P < 0.05). In the subset of ESCC patients without lymph node metastasis, vascular invasion was evaluated as a prognostic predictor as well (P < 0.05). More importantly, the combined prognostic model with pN classification supplemented by vascular invasion can significantly stratify the risk (low, intermediate and high) for overall survival and recurrence-free survival in both cohorts (P < 0.05). The C-index to the combined model showed improved predictive ability when compared to the pN classification (0.785 vs 0.739 and 0.689 vs 0.650 for the training and validation cohorts, respectively; P < 0.05). Conclusions/Significance: The examination of vascular invasion could be used as an additional effective instrument in identifying those ESCC patients at increased risk of tumor progression. The proposed new prognostic model with the pN classification supplemented by vascular invasion might improve the ability to discriminate ESCC patients' outcome.	[Zhu, Chong-Mei; Ling, Yi-Hong; Xi, Shao-Yan; Luo, Rong-Zhen; Chen, Jie-Wei; Yun, Jing-Ping; Xie, Dan; Cai, Mu-Yan] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Chong-Mei; Ling, Yi-Hong; Xi, Shao-Yan; Luo, Rong-Zhen; Chen, Jie-Wei; Yun, Jing-Ping; Xie, Dan; Cai, Mu-Yan] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Cai, MY (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	caimuyan@hotmail.com			Nature Science Foundation of China [81302139]; Foundation for Distinguished Young Talents in Higher Education of Guangdong [84000-3211701]; Program for Excellent Young Talents in Sun Yat-sen University Cancer Center [520101210101]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Distinguished Young Talents in Higher Education of Guangdong; Program for Excellent Young Talents in Sun Yat-sen University Cancer Center	This study was supported by grants from the Nature Science Foundation of China (No. 81302139), the Foundation for Distinguished Young Talents in Higher Education of Guangdong (No. 84000-3211701) and the Program for Excellent Young Talents in Sun Yat-sen University Cancer Center (No. 520101210101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Bettendorf U, 2009, PATHOLOGE, V30, P20, DOI [10.1007/s00292-008-1121-0, 10.1007/s00292-009-1179-3]; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; FUJITA H, 1995, ANN SURG, V222, P654, DOI 10.1097/00000658-199511000-00008; IDE H, 1994, WORLD J SURG, V18, P321, DOI 10.1007/BF00316810; Inoue A, 2008, PATHOL INT, V58, P611, DOI 10.1111/j.1440-1827.2008.02279.x; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kitagawa Y, 1996, CLIN CANCER RES, V2, P909; Kojima M, 2013, J CLIN PATHOL, V66, P551, DOI 10.1136/jclinpath-2012-201076; Li HH, 2009, J THORAC CARDIOV SUR, V137, P55, DOI 10.1016/j.jtcvs.2008.05.024; Mitobe J, 2013, SCAND J GASTROENTERO, V48, P1173, DOI 10.3109/00365521.2013.832365; Nishimaki T, 1998, J AM COLL SURGEONS, V186, P306, DOI 10.1016/S1072-7515(98)00013-1; Pichler M, 2012, J UROLOGY, V187, P834, DOI 10.1016/j.juro.2011.10.155; Rahman A A, 2013, Minerva Gastroenterol Dietol, V59, P13; Ren HZ, 2010, PATHOL ONCOL RES, V16, P515, DOI 10.1007/s12253-009-9242-1; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; ROBEYCAFFERTY SS, 1991, AM J CLIN PATHOL, V95, P844, DOI 10.1093/ajcp/95.6.844; SARBIA M, 1995, INT J CANCER, V61, P333, DOI 10.1002/ijc.2910610310; Sgourakis G, 2012, AM SURGEON, V78, P195; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Sliwa B, 2013, ADV CLIN EXP MED, V22, P369; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; SUGIMACHI K, 1986, J SURG ONCOL, V31, P108, DOI 10.1002/jso.2930310207; Torres CM, 1999, MODERN PATHOL, V12, P961; Waraich N, 2011, INT J SURG, V9, P237, DOI 10.1016/j.ijsu.2010.12.002; Zhu ZF, 2013, ANN SURG ONCOL, V20, P3052, DOI 10.1245/s10434-013-2987-5	26	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96129	10.1371/journal.pone.0096129	http://dx.doi.org/10.1371/journal.pone.0096129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763284	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000063
J	Manes, G; Cheguru, P; Majumder, A; Bocquet, B; Senechal, A; Artemyev, NO; Hamel, CP; Brabet, P				Manes, Gael; Cheguru, Pallavi; Majumder, Anurima; Bocquet, Beatrice; Senechal, Audrey; Artemyev, Nikolai O.; Hamel, Christian P.; Brabet, Philippe			A Truncated Form of Rod Photoreceptor PDE6 beta-Subunit Causes Autosomal Dominant Congenital Stationary Night Blindness by Interfering with the Inhibitory Activity of the gamma-Subunit	PLOS ONE			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; HETEROZYGOUS MISSENSE MUTATION; CYCLIC-GMP PHOSPHODIESTERASE; GAF-A DOMAIN; CGMP-PHOSPHODIESTERASE; CATALYTIC SUBUNITS; MOLECULAR-MECHANISM; OUTER SEGMENTS; RHODOPSIN GENE; ALPHA-SUBUNIT	Autosomal dominant congenital stationary night blindness (adCSNB) is caused by mutations in three genes of the rod phototransduction cascade, rhodopsin (RHO), transducin a-subunit (GNAT1), and cGMP phosphodiesterase type 6 beta-subunit (PDE6B). In most cases, the constitutive activation of the phototransduction cascade is a prerequisite to cause adCSNB. The unique adCSNB-associated PDE6B mutation found in the Rambusch pedigree, the substitution p.His258Asn, leads to rod photoreceptors desensitization. Here, we report a three-generation French family with adCSNB harboring a novel PDE6B mutation, the duplication, c. 928-9_ 940dup resulting in a tyrosine to cysteine substitution at codon 314, a frameshift, and a premature termination (p. Tyr314Cysfs* 50). To understand the mechanism of the PDE6 beta 1-314fs*50 mutant, we examined the properties of its PDE6-specific portion, PDE6 beta 1-313. We found that PDE6 beta 1-313 maintains the ability to bind noncatalytic cGMP and the inhibitory c-subunit (Pc), and interferes with the inhibition of normal PDE6 alpha beta catalytic subunits by Pc. Moreover, both truncated forms of the PDE6 beta protein, PDE6 beta 1-313 and PDE6 beta 1-314fs* 50 expressed in rods of transgenic chi. laevis are targeted to the phototransduction compartment. We hypothesize that in affected family members the p.Tyr314Cysfs* 50 change results in the production of the truncated protein, which binds P gamma and causes constitutive activation of the phototransduction thus leading to the absence of rod adaptation.	[Manes, Gael; Bocquet, Beatrice; Senechal, Audrey; Hamel, Christian P.; Brabet, Philippe] INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France; [Manes, Gael; Bocquet, Beatrice; Senechal, Audrey; Hamel, Christian P.; Brabet, Philippe] Univ Montpellier I, Montpellier, France; [Manes, Gael; Bocquet, Beatrice; Senechal, Audrey; Hamel, Christian P.; Brabet, Philippe] Univ Montpellier 2, Montpellier, France; [Cheguru, Pallavi; Majumder, Anurima; Artemyev, Nikolai O.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Artemyev, Nikolai O.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Hamel, Christian P.] CHRU, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; University of Iowa; University of Iowa; Universite de Montpellier; CHU de Montpellier	Manes, G (corresponding author), INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France.	gael.manes@inserm.fr	Bocquet, Beatrice/AAY-8447-2020; Brabet, Philippe/AAO-8522-2020	Bocquet, Beatrice/0000-0002-6369-4818; Brabet, Philippe/0000-0003-2739-1622; Artemyev, Nikolai/0000-0002-5266-6854	National Institutes of Health [EY-10843, EY-12682]; UNADEV; NATIONAL EYE INSTITUTE [R01EY010843, R01EY012682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNADEV; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	N.O.A is supported by the National Institutes of Health grant EY-10843 and EY-12682. G. M. is supported by UNADEV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRRE G, 1978, SCIENCE, V201, P1133, DOI 10.1126/science.210508; al-Jandal N, 1999, HUM MUTAT, V13, P75, DOI 10.1002/(SICI)1098-1004(1999)13:1<75::AID-HUMU9>3.0.CO;2-4; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; BAEHR W, 1979, J BIOL CHEM, V254, P1669; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; Cheguru P, 2014, J NEUROCHEM, V129, P256, DOI 10.1111/jnc.12501; Danciger M, 1996, Mol Vis, V2, P10; DANCIGER M, 1995, GENOMICS, V30, P1, DOI 10.1006/geno.1995.0001; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; Dryja TP, 2000, AM J OPHTHALMOL, V130, P547, DOI 10.1016/S0002-9394(00)00737-6; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; Dvir L, 2010, AM J HUM GENET, V87, P258, DOI 10.1016/j.ajhg.2010.06.016; FARBER DB, 1976, J CYCLIC NUCL PROT, V2, P139; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Granovsky AE, 1998, J BIOL CHEM, V273, P24485, DOI 10.1074/jbc.273.38.24485; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Kroll KL, 1996, DEVELOPMENT, V122, P3173; LOLLEY RN, 1977, SCIENCE, V196, P664, DOI 10.1126/science.193183; Majumder A, 2013, J BIOL CHEM, V288, P21320, DOI 10.1074/jbc.M113.476242; Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moussaif M, 2006, J NEUROSCI, V26, P6863, DOI 10.1523/JNEUROSCI.1322-06.2006; Muradov H, 2004, VISION RES, V44, P2437, DOI 10.1016/j.visres.2004.05.013; Muradov H, 2007, BIOCHEMISTRY-US, V46, P9992, DOI 10.1021/bi700535s; Muradov H, 2009, J BIOL CHEM, V284, P32662, DOI 10.1074/jbc.M109.049916; Muradov KG, 2000, J BIOL CHEM, V275, P6969, DOI 10.1074/jbc.275.10.6969; Muradov KG, 2003, BIOCHEMISTRY-US, V42, P3305, DOI 10.1021/bi027095x; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Naeem MA, 2012, INVEST OPHTH VIS SCI, V53, P1353, DOI 10.1167/iovs.11-8026; Natochin M, 1996, J BIOL CHEM, V271, P19964, DOI 10.1074/jbc.271.33.19964; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; Singhal A, 2013, EMBO REP, V14, P520, DOI 10.1038/embor.2013.44; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; Szabo V, 2007, HUM MUTAT, V28, P741, DOI 10.1002/humu.9499; ULSHAFER RJ, 1980, INVEST OPHTH VIS SCI, V19, P1236; YARFITZ S, 1994, J BIOL CHEM, V269, P14329; Zeitz C, 2008, INVEST OPHTH VIS SCI, V49, P4105, DOI 10.1167/iovs.08-1717	48	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95768	10.1371/journal.pone.0095768	http://dx.doi.org/10.1371/journal.pone.0095768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760071	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200086
J	Hoermann, G; Blatt, K; Greiner, G; Putz, EM; Berger, A; Herrmann, H; Cerny-Reiterer, S; Gleixner, KV; Walz, C; Hoetzenecker, K; Mullauer, L; Reiter, A; Sotlar, K; Sexl, V; Valent, P; Mayerhofer, M				Hoermann, Gregor; Blatt, Katharina; Greiner, Georg; Putz, Eva Maria; Berger, Angelika; Herrmann, Harald; Cerny-Reiterer, Sabine; Gleixner, Karoline V.; Walz, Christoph; Hoetzenecker, Konrad; Muellauer, Leonhard; Reiter, Andreas; Sotlar, Karl; Sexl, Veronika; Valent, Peter; Mayerhofer, Matthias			CD52 is a molecular target in advanced systemic mastocytosis	FASEB JOURNAL			English	Article						CAMPATH-1; RAS G12V; alemtuzumab; mast cell leukemia	CHRONIC LYMPHOCYTIC-LEUKEMIA; MONOCLONAL-ANTIBODY CAMPATH-1H; NEOPLASTIC MAST-CELLS; C-KIT; THERAPEUTIC TARGET; CATALYTIC DOMAIN; ACTIVATING MUTATIONS; GENE-EXPRESSION; RAS ACTIVATION; ONCOSTATIN M	Advanced systemic mastocytosis (SM) is an aggressive hematopoietic neoplasm with poor prognosis and short survival times. So far, no curative therapy is available for affected patients. We have identified the cell surface antigen CD52 (CAMPATH-1) as a molecular target expressed abundantly on the surface of primary neoplastic mast cells (MCs) in patients with advanced SM. In contrast, neoplastic MCs of patients with indolent SM and normal MCs expressed only low levels or did not express CD52. To study the mechanisms of CD52 expression and the value of this antigen as a potential therapeutic target, we generated a human MC cell line, designated MCPV-1, by lentiviral immortalization of cord blood-derived MC progenitor cells. Functional studies revealed that activated RAS profoundly promotes surface expression of CD52. The CD52-targeting antibody alemtuzumab induced cell death in CD52(+) primary neoplastic MCs obtained from patients with SM as well as in MCPV-1 cells. NSG mice xenotransplanted with MCPV-1 cells survived significantly longer after treatment with alemtuzumab (median survival: 31 d untreated vs. 46 d treated; P = 0.0012). We conclude that CD52 is a novel marker and potential therapeutic target in neoplastic MCs in patients with advanced SM.	[Hoermann, Gregor; Greiner, Georg] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Blatt, Katharina; Cerny-Reiterer, Sabine; Gleixner, Karoline V.; Valent, Peter] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria; [Hoetzenecker, Konrad] Med Univ Vienna, Div Thorac Surg, Dept Surg, Vienna, Austria; [Muellauer, Leonhard] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Putz, Eva Maria; Berger, Angelika; Sexl, Veronika] Univ Vet Med Vienna, Inst Pharmacol & Toxicol, Vienna, Austria; [Herrmann, Harald; Cerny-Reiterer, Sabine; Valent, Peter] Ludwig Boltzmann Cluster Oncol, Vienna, Austria; [Walz, Christoph; Sotlar, Karl] Univ Munich, Inst Pathol, D-80539 Munich, Germany; [Reiter, Andreas] Univ Med Mannheim, Med Univ Klin, Mannheim, Germany; [Mayerhofer, Matthias] Hanusch Hosp, Ludwig Boltzmann Inst Osteol, A-1140 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; Ludwig Boltzmann Institute; University of Munich; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ludwig Boltzmann Institute; WGKK - Hanusch Hospital	Mayerhofer, M (corresponding author), Hanusch Hosp, Ludwig Boltzmann Inst Osteol, Heinrich Collin Str 30, A-1140 Vienna, Austria.	matthias.mayerhofer@meduniwien.ac.at	Gamperl, Susi/V-2715-2019; Hoermann, Gregor/B-8832-2016; Test, PV/U-9451-2019; König, Eva Maria/AAF-4041-2019; Test, Test/Y-7921-2019; Hermann, Harald/E-7073-2018; Valent, Peter/B-8533-2016; Müllauer, Leonhard/GSN-9884-2022; Sexl, Veronika/B-8657-2016	Gamperl, Susi/0000-0003-0456-5095; Hoermann, Gregor/0000-0002-7374-4380; König, Eva Maria/0000-0002-9990-4477; Hermann, Harald/0000-0002-5095-4641; Valent, Peter/0000-0003-0456-5095; Müllauer, Leonhard/0000-0002-3399-078X; Berger, Angelika/0000-0001-8775-2405; Sexl, Veronika/0000-0001-9363-0412; Putz, Eva Maria/0000-0002-5309-4114; Greiner, Georg/0000-0002-0917-4117; Gleixner, Karoline/0000-0001-5753-0203; Hoetzenecker, Konrad/0000-0001-6775-7460	Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich (FWF) grant [P26079-B13, SFB F4704-B20]; Austrian Science Fund (FWF) [P 26079] Funding Source: researchfish	Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich (FWF) grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors thank Elisabeth Wieser and Lukas Kenner (Department of Pathology, Medical University of Vienna, Vienna, Austria) for help with electron microscopy, Andrea Alvarez Hernandez and Ingrid Simonitsch-Klupp (Department of Pathology, Medical University of Vienna) for help with immunochemistry double staining, Hans-Peter Horny (Institute of Pathology, Ludwig Maximilians University, Munich, Germany) for reviewing immunohistochemistry data, Andreas Jung (Institute of Pathology, Ludwig Maximilians University) for help with RAS mutational analysis, and Katharina Worda (Department of Gynecology, Medical University of Vienna) for providing CB samples. The authors also thank Gunther Hofbauer and Andreas Spittler (Cell Sorting Core Unit, Medical University of Vienna) for technical support. This study was supported by the Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich (FWF) grant P26079-B13 and SFB F4704-B20. The authors declare no conflicts of interest.	Akin C, 2004, ANNU REV MED, V55, P419, DOI 10.1146/annurev.med.55.091902.103822; Akin C, 2003, EXP HEMATOL, V31, P686, DOI 10.1016/S0301-472X(03)00112-7; Arock M, 2010, EXPERT REV HEMATOL, V3, P497, DOI [10.1586/ehm.10.42, 10.1586/EHM.10.42]; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Feger F, 2002, INT ARCH ALLERGY IMM, V127, P110, DOI 10.1159/000048179; Fiordalisi JJ, 2001, METHOD ENZYMOL, V332, P3; Fritsche-Polanz R, 2001, BRIT J HAEMATOL, V113, P357, DOI 10.1046/j.1365-2141.2001.02783.x; Gao JS, 2011, FEBS LETT, V585, P693, DOI 10.1016/j.febslet.2011.01.033; Georgin-Lavialle S, 2013, BLOOD, V121, P1285, DOI 10.1182/blood-2012-07-442400; Golay J, 2004, HAEMATOLOGICA, V89, P1476; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hale C, 1996, IMMUNOLOGY, V88, P183, DOI 10.1111/j.1365-2567.1996.tb00003.x; Hale G, 2001, J BIOL REG HOMEOS AG, V15, P386; Hanssens K, 2014, HAEMATOLOGICA, V99, P830, DOI 10.3324/haematol.2013.095133; Hoermann G, 2012, FASEB J, V26, P894, DOI 10.1096/fj.11-193078; Hoermann G, 2011, AM J PATHOL, V178, P2344, DOI 10.1016/j.ajpath.2011.01.020; Horny HP AC, 2008, WHO CLASSIFICATION T, P54; Hu YP, 2009, IMMUNOLOGY, V128, P260, DOI 10.1111/j.1365-2567.2009.03115.x; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; Kondo R, 2007, BLOOD, V110, P661, DOI 10.1182/blood-2006-10-054411; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; MATTESON EL, 1995, ARTHRITIS RHEUM, V38, P1187, DOI 10.1002/art.1780380903; Mayerhofer M, 2008, J IMMUNOL, V180, P5466, DOI 10.4049/jimmunol.180.8.5466; Mone AP, 2006, LEUKEMIA, V20, P272, DOI 10.1038/sj.leu.2404014; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Osterborg A, 1996, BRIT J HAEMATOL, V93, P151, DOI 10.1046/j.1365-2141.1996.450989.x; Osterborg A, 1997, J CLIN ONCOL, V15, P1567, DOI 10.1200/JCO.1997.15.4.1567; Piao XH, 1996, P NATL ACAD SCI USA, V93, P14665, DOI 10.1073/pnas.93.25.14665; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rao SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039416; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Saito Y, 2011, LEUKEMIA, V25, P921, DOI 10.1038/leu.2011.36; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Santos DD, 2006, CLIN LYMPHOMA MYELOM, V6, P478, DOI 10.3816/CLM.2006.n.029; Schwaab J, 2013, BLOOD, V122, P2460, DOI 10.1182/blood-2013-04-496448; Siders WM, 2010, LEUKEMIA LYMPHOMA, V51, P1293, DOI 10.3109/10428191003777963; Sobering AK, 2004, CELL, V117, P637, DOI 10.1016/j.cell.2004.05.003; Stanglmaier M, 2004, ANN HEMATOL, V83, P634, DOI 10.1007/s00277-004-0917-0; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Teodosio C, 2013, J ALLERGY CLIN IMMUN, V131, P1213, DOI 10.1016/j.jaci.2012.12.674; Tsujimura T, 1999, BLOOD, V93, P1319, DOI 10.1182/blood.V93.4.1319.404k11_1319_1329; Valent P, 2004, EUR J CLIN INVEST, V34, P41, DOI 10.1111/j.0960-135X.2004.01369.x; Valent P, 2003, LEUKEMIA RES, V27, P635, DOI 10.1016/S0145-2126(02)00168-6; VALENT P, 1989, BLOOD, V73, P1778; Wilson TM, 2011, HAEMATOL-HEMATOL J, V96, P459, DOI 10.3324/haematol.2010.031690; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Zappulla JP, 2005, J EXP MED, V202, P1635, DOI 10.1084/jem.20050807; Zent CS, 2008, LEUKEMIA RES, V32, P1849, DOI 10.1016/j.leukres.2008.05.014; Zhang PL, 2007, ANN CLIN LAB SCI, V37, P148	55	20	22	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3540	3551		10.1096/fj.14-250894	http://dx.doi.org/10.1096/fj.14-250894			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24760752				2022-12-25	WOS:000340265400023
J	McDade, JR; Archambeau, A; Michele, DE				McDade, Joel R.; Archambeau, Ashley; Michele, Daniel E.			Rapid actin-cytoskeleton-dependent recruitment of plasma membrane-derived dysferlin at wounds is critical for muscle membrane repair	FASEB JOURNAL			English	Article						pHluorin; endocytosis	MUSCULAR-DYSTROPHY; VENTRICULAR MYOCYTES; STRESS; CONTRACTION; CAVEOLIN-3; EXOCYTOSIS; BINDING; PROTEIN; MG53	Deficits in membrane repair may contribute to disease progression in dysferlin-deficient muscular dystrophy. Dysferlin, a type-II transmembrane phospholipid-binding protein, is hypothesized to regulate fusion of repair vesicles with the sarcolemma to facilitate membrane repair, but the dysferlin-containing compartments involved in membrane repair and the mechanism by which these compartments contribute to resealing are unclear. A dysferlin-pHluorin [dysf-pH-sensitive green fluorescent protein (pHGFP)] muscle-specific transgenic mouse was developed to examine the dynamic behavior and subcellular localization of dysferlin during membrane repair in adult skeletal muscle fibers. Live-cell confocal microscopy of uninjured adult dysf-pHGFP muscle fibers revealed that dysferlin is highly enriched in the sarcolemma and transverse tubules. Laser-wounding induced rapid recruitment of similar to 30 mu m of local dysferlin-containing sarcolemma, leading to formation of stable dysferlin accumulations surrounding lesions, endocytosis of dysferlin, and formation of large cytoplasmic vesicles from distal regions of the fiber. Disruption of the actin cytoskeleton decreased recruitment of sarcolemma-derived dysferlin to lesions in dysf-pHGFP fibers without affecting endocytosis and impaired membrane resealing in wild-type fibers, similar to findings in dysferlin deficiency (a 2-fold increase in FM1-43 uptake). Our data support a new mechanism whereby recruitment of sarcolemma-derived dysferlin creates an active zone of high lipid-binding activity at wounds to interact with repair vesicles and facilitate membrane resealing in skeletal muscle.-McDade, J. R., Archambeau, A., Michele, D. E. Rapid actin-cytoskeleton-dependent recruitment of plasma membrane-derived dysferlin at wounds is critical for muscle membrane repair.	[McDade, Joel R.; Archambeau, Ashley; Michele, Daniel E.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Michele, Daniel E.] Univ Michigan, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Michele, DE (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, NCRC Bldg 26-214S 2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	dmichele@umich.edu		McDade, Joel/0000-0003-2182-6090; Cuttitta, Ashley/0000-0002-2400-4087	American Heart Association [12PRE12050130]; Systems and Integrative Biology Training Grant; National Heart, Lung, and Blood Institute (U.S. National Institutes of Health, Bethesda MD, USA) [HL-080388, HL-895800]; Muscular Dystrophy Association; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Systems and Integrative Biology Training Grant; National Heart, Lung, and Blood Institute (U.S. National Institutes of Health, Bethesda MD, USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank W. Filipiak and T. Saunders for preparation of TG mice and the Transgenic Animal Model Core of the University of Michigan's Biomedical Research Core Facilities. The pHluorin GFP construct was a kind gift from Dr. G. Miesenbock (Oxford University, Oxford, UK) and J. Rothman (Yale School of Medicine, Yale University, New Haven, CT, USA), and the MCK promoter was a kind gift from Drs. J. Chamberlain (University of Washington, Seattle, WA, USA) and S. Hauschka (University of Washington). The University of Michigan Microscopy and Image Analysis Laboratory (MIL) provided expert support for confocal microscopy. Core support was provided by the University of Michigan Cancer Center (P30 CA046592) and the University of Michigan Rheumatic Diseases Research Core Center (P30 AR048310). This work was supported by an American Heart Association (12PRE12050130) and Systems and Integrative Biology Training Grant (to J. M.) and National Heart, Lung, and Blood Institute (U.S. National Institutes of Health, Bethesda MD, USA) grants HL-080388 and HL-895800 and a grant from the Muscular Dystrophy Association (to D.M.).	Abreu-Blanco MT, 2011, J CELL BIOL, V193, P455, DOI 10.1083/jcb.201011018; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Azakir BA, 2012, J BIOL CHEM, V287, P27629, DOI 10.1074/jbc.M112.391722; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Becker K., 2011, ADV PROTOCOLS ANIMAL, P99, DOI 10.1007/978-3-642-20792-1_6; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Corrotte M, 2013, ELIFE, V2, DOI 10.7554/eLife.00926; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; De Morree A., 2013, J BIOL CHEM; Demonbreun AR, 2014, AM J PATHOL, V184, P248, DOI 10.1016/j.ajpath.2013.09.009; Demonbreun AR, 2011, HUM MOL GENET, V20, P779, DOI 10.1093/hmg/ddq522; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fuson K, 2014, STRUCTURE, V22, P104, DOI 10.1016/j.str.2013.10.001; Glover LE, 2010, ANN NEUROL, V67, P384, DOI 10.1002/ana.21926; Gumerson JD, 2010, AM J PHYSIOL-CELL PH, V299, pC1430, DOI 10.1152/ajpcell.00192.2010; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Hauser MA, 2000, MOL THER, V2, P16, DOI 10.1006/mthe.2000.0089; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Illarioshkin SN, 2000, NEUROLOGY, V55, P1931, DOI 10.1212/WNL.55.12.1931; Kerr JP, 2013, P NATL ACAD SCI USA, V110, P20831, DOI 10.1073/pnas.1307960110; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Lek A, 2013, J NEUROSCI, V33, P5085, DOI 10.1523/JNEUROSCI.3560-12.2013; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Mandato CA, 2001, J CELL BIOL, V154, P785, DOI 10.1083/jcb.200103105; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; McDade J. R., 2013, HUM MOL GENET; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moench I, 2013, EXP PHYSIOL, V98, P1164, DOI 10.1113/expphysiol.2013.072470; Piccolo F, 2000, ANN NEUROL, V48, P902, DOI 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.3.CO;2-Q; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Roche JA, 2011, J HISTOCHEM CYTOCHEM, V59, P964, DOI 10.1369/0022155411423274; Roostalu U, 2012, DEV CELL, V22, P515, DOI 10.1016/j.devcel.2011.12.008; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sharma A, 2010, ARTERIOSCL THROM VAS, V30, P2196, DOI 10.1161/ATVBAHA.110.208108; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Tian QH, 2012, J MOL CELL CARDIOL, V52, P113, DOI 10.1016/j.yjmcc.2011.09.001; Waddell LB, 2011, J NEUROPATH EXP NEUR, V70, P302, DOI 10.1097/NEN.0b013e31821350b0	45	57	58	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3660	3670		10.1096/fj.14-250191	http://dx.doi.org/10.1096/fj.14-250191			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24784578	Green Published, Green Submitted			2022-12-25	WOS:000340265400033
J	Moskot, M; Montefusco, S; Jakobkiewicz-Banecka, J; Mozolewski, P; Wegrzyn, A; Di Bernardo, D; Wegrzyn, G; Medina, DL; Ballabio, A; Gabig-Ciminska, M				Moskot, Marta; Montefusco, Sandro; Jakobkiewicz-Banecka, Joanna; Mozolewski, Pawel; Wegrzyn, Alicja; Di Bernardo, Diego; Wegrzyn, Grzegorz; Medina, Diego L.; Ballabio, Andrea; Gabig-Ciminska, Magdalena			The Phytoestrogen Genistein Modulates Lysosomal Metabolism and Transcription Factor EB (TFEB) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED ISOFLAVONE THERAPY; SUBSTRATE REDUCTION THERAPIES; GLYCOSAMINOGLYCAN SYNTHESIS; SANFILIPPO DISEASE; MEDIATED INHIBITION; CELLULAR CLEARANCE; EXPRESSION; MUCOPOLYSACCHARIDOSES; STORAGE; CELLS	Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) has been previously proposed as a potential drug for use in substrate reduction therapy for mucopolysaccharidoses, a group of inherited metabolic diseases caused by mutations leading to inefficient degradation of glycosaminoglycans (GAGs) in lysosomes. It was demonstrated that this isoflavone can cross the blood-brain barrier, making it an especially desirable potential drug for the treatment of neurological symptoms present in most lysosomal storage diseases. So far, no comprehensive genomic analyses have been performed to elucidate the molecular mechanisms underlying the effect elicited by genistein. Therefore, the aim of this work was to identify the genistein-modulated gene network regulating GAG biosynthesis and degradation, taking into consideration the entire lysosomal metabolism. Our analyses identified over 60 genes with known roles in lysosomal biogenesis and/or function whose expression was enhanced by genistein. Moreover, 19 genes whose products are involved in both GAG synthesis and degradation pathways were found to be remarkably differentially regulated by genistein treatment. We found a regulatory network linking genistein-mediated control of transcription factor EB (TFEB) gene expression, TFEB nuclear translocation, and activation of TFEB-dependent lysosome biogenesis to lysosomal metabolism. Our data indicate that the molecular mechanism of genistein action involves not only impairment of GAG synthesis but more importantly lysosomal enhancement via TFEB. These findings contribute to explaining the beneficial effects of genistein in lysosomal storage diseases as well as envisage new therapeutic approaches to treat these devastating diseases.	[Moskot, Marta; Gabig-Ciminska, Magdalena] Univ Gdansk, Polish Acad Sci, Inst Biochem & Biophys, Mol Biol Lab, PL-80308 Gdansk, Poland; [Montefusco, Sandro; Di Bernardo, Diego; Medina, Diego L.; Ballabio, Andrea] Telethon Inst Genet & Med TIGEM, High Content Screening Facil, I-80131 Naples, Italy; [Jakobkiewicz-Banecka, Joanna; Mozolewski, Pawel; Wegrzyn, Grzegorz] Univ Gdansk, Dept Mol Biol, PL-80308 Gdansk, Poland; [Wegrzyn, Alicja] Univ Szczecin, Dept Microbiol, PL-71412 Szczecin, Poland; [Ballabio, Andrea] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Ballabio, Andrea] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Ballabio, Andrea] Univ Naples Federico II, Dept Pediat, I-80131 Naples, Italy	Fahrenheit Universities; University of Gdansk; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Fahrenheit Universities; University of Gdansk; University of Szczecin; Baylor College of Medicine; Baylor College of Medicine; University of Naples Federico II	Medina, DL (corresponding author), Telethon Inst Genet & Med TIGEM, High Content Screening Facil, Via P Castellino 111, I-80131 Naples, Italy.	medina@tigem.it; m.gabig@biol.ug.edu.pl	Medina, Diego/AAC-9622-2020; Jakóbkiewicz-Banecka, Joanna/C-2365-2014; Gabig-Cimińska, Magdalena/E-3207-2018; di Bernardo, Diego/AAF-5881-2021; Mozolewski, Pawel/AAM-8343-2021; BALLABIO, Andrea/AAL-2672-2020; Wegrzyn, Grzegorz/ABD-6699-2020; Moskot, Marta/R-5017-2018; Wegrzyn, Grzegorz/AAL-1179-2020	Medina, Diego/0000-0002-7347-2645; Gabig-Cimińska, Magdalena/0000-0002-2664-8724; di Bernardo, Diego/0000-0002-1911-7407; BALLABIO, Andrea/0000-0003-1381-4604; Wegrzyn, Grzegorz/0000-0003-4042-7466; Moskot, Marta/0000-0002-7342-9372; Wegrzyn, Alicja/0000-0002-3073-2814; Jakobkiewicz-Banecka, Joanna/0000-0002-8846-5448	National Science Centre Project [2011/01/B/NZ1/03686, N N301 668540]; European Union [TEAM/2008-2/7]; Fondazione Telethon Funding Source: Custom	National Science Centre Project; European Union(European Commission); Fondazione Telethon(Fondazione Telethon)	This work was supported by National Science Centre Project Grants 2011/01/B/NZ1/03686 and N N301 668540 and was operated within the Foundation for Polish Science Team Programme co-financed by European Union European Regional Development Fund Grant TEAM/2008-2/7.	Antunes F, 2001, BIOCHEM J, V356, P549, DOI 10.1042/0264-6021:3560549; Arfi A, 2010, J INHERIT METAB DIS, V33, P61, DOI 10.1007/s10545-009-9029-2; Banecka-Majkutewicz Z, 2012, ARCH IMMUNOL THER EX, V60, P461, DOI 10.1007/s00005-012-0195-9; Chung MJ, 2006, J AGR FOOD CHEM, V54, P3819, DOI 10.1021/jf060510y; Delgadillo V, 2011, J INHERIT METAB DIS, V34, P1039, DOI 10.1007/s10545-011-9342-4; Dziedzic D, 2012, ACTA BIOCHIM POL, V59, P293; Dziedzic D, 2010, EUR J HUM GENET, V18, P200, DOI 10.1038/ejhg.2009.144; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Friso A, 2010, BRIT J PHARMACOL, V159, P1082, DOI 10.1111/j.1476-5381.2009.00565.x; Harlow Ed, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4531; Jakobkiewicz-Banecka J, 2011, CURR PHARM BIOTECHNO, V12, P1860, DOI 10.2174/138920111798376932; Jakobkiewicz-Banecka J, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-26; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Liang HW, 2008, NEUROSCI LETT, V438, P116, DOI 10.1016/j.neulet.2008.04.058; Malinowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014192; Malinowska M, 2009, MOL GENET METAB, V98, P235, DOI 10.1016/j.ymgme.2009.06.013; McDermott R, 2009, P NATL ACAD SCI USA, V106, P2118, DOI 10.1073/pnas.0808376106; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Narajczyk M, 2012, GENE, V504, P292, DOI 10.1016/j.gene.2012.05.006; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Piotrowska E, 2008, CURR THER RES CLIN E, V69, P166, DOI 10.1016/j.curtheres.2008.04.002; Piotrowska E, 2006, EUR J HUM GENET, V14, P846, DOI 10.1038/sj.ejhg.5201623; Platt FM, 2008, ACTA PAEDIATR, V97, P88, DOI 10.1111/j.1651-2227.2008.00656.x; Ponder KP, 2007, EXPERT OPIN BIOL TH, V7, P1333, DOI 10.1517/14712598.7.9.1333; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Rohrbach M, 2007, DRUGS, V67, P2697, DOI 10.2165/00003495-200767180-00005; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sardiello M, 2009, CELL CYCLE, V8, P4021, DOI 10.4161/cc.8.24.10263; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wegrzyn A, 2012, IUBMB LIFE, V64, P307, DOI 10.1002/iub.1007; Wegrzyn G, 2010, BIOCHEM SOC T, V38, P695, DOI 10.1042/BST0380695; Winchester B, 2000, BIOCHEM SOC T, V28, P150, DOI 10.1042/bst0280150	39	94	99	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17054	17069		10.1074/jbc.M114.555300	http://dx.doi.org/10.1074/jbc.M114.555300			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24770416	hybrid, Green Published			2022-12-25	WOS:000338016200039
J	Tabata, K; Matsumoto, K; Minami, S; Ishii, D; Nishi, M; Fujita, T; Saegusa, M; Sato, Y; Iwamura, M				Tabata, Ken-ichi; Matsumoto, Kazumasa; Minami, Sho; Ishii, Daisuke; Nishi, Morihiro; Fujita, Tetsuo; Saegusa, Makoto; Sato, Yuichi; Iwamura, Masatsugu			Nestin Is an Independent Predictor of Cancer-Specific Survival after Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder	PLOS ONE			English	Article							TRANSITIONAL-CELL-CARCINOMA; INTERMEDIATE-FILAMENT NESTIN; CISPLATIN CHEMOTHERAPY; STEM-CELLS; EXPRESSION; PROGNOSIS; INVASION; IDENTIFICATION; DOXORUBICIN	Objectives: To investigate the association between the expression of nestin, a class VI intermediate filament protein, and pathologic features or survival in patients with urothelial carcinoma of the bladder (UCB). Methods: Nestin expression in tumor cells was immunohistochemically studied in 93 patients with UCB who underwent radical cystectomy with pelvic lymphadenectomy. The associations with clinicopathologic parameters were evaluated. Kaplan-Meier survival analysis and Cox proportional hazards models were used to estimate the effect of nestin expression on survival. Results: Nestin expression in cystectomy specimens was observed in 13 of 93 patients (14.0%). Nestin expression was associated with pathologic tumor stage (p = 0.006). Nestin-negative patients had better overall survival compared with nestin-positive patients (log-rank p = 0.0148). Univariable analysis indicated that nestin expression, lymphovascular invasion, and lymph node status were significantly associated with cancer-specific survival (hazard ratios, 2.78, 2.15, and 2.80, respectively). On multivariable analysis, nestin expression and lymph node status were independent prognostic factors in cancer-specific survival (hazard ratios, 2.45 and 2.65, respectively). Conclusions: The results suggest that nestin expression is a novel independent prognostic indicator for patients with UCB and a potentially useful marker to select patients who may be candidates for adjuvant chemotherapy.	[Tabata, Ken-ichi; Matsumoto, Kazumasa; Ishii, Daisuke; Nishi, Morihiro; Fujita, Tetsuo; Iwamura, Masatsugu] Kitasato Univ, Sch Med, Dept Urol, Sagamihara, Kanagawa, Japan; [Saegusa, Makoto] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa, Japan; [Minami, Sho; Sato, Yuichi] Kitasato Univ, Grad Sch Med Sci, Dept Appl Tumor Pathol, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University; Kitasato University	Tabata, K (corresponding author), Kitasato Univ, Sch Med, Dept Urol, Sagamihara, Kanagawa, Japan.	ktabata@med.kitasato-u.ac.jp			Kitasato University [21-1]; Grants-in-Aid for Scientific Research [23590414] Funding Source: KAKEN	Kitasato University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grant-in-Aid for Third Term Comprehensive Control Research for Cancer conducted by the Ministry of Health, Labour and Welfare of Japan and All Kitasato Project Study (21-1) from Kitasato University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarimaa V, 2004, NEUROMUSCULAR DISORD, V14, P421, DOI 10.1016/j.nmd.2004.03.009; Almqvist PM, 2002, J HISTOCHEM CYTOCHEM, V50, P147, DOI 10.1177/002215540205000203; ANDERSTROM C, 1980, J UROLOGY, V124, P23, DOI 10.1016/S0022-5347(17)55272-6; Bassi P, 1999, J UROLOGY, V161, P1494, DOI 10.1016/S0022-5347(05)68936-7; Bentivegna A, 2010, CANCER SCI, V101, P416, DOI 10.1111/j.1349-7006.2009.01414.x; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; Duggal N, 2002, EXP NEUROL, V174, P89, DOI 10.1006/exnr.2001.7838; Ennis RD, 2000, J UROLOGY, V163, P1413, DOI 10.1016/S0022-5347(05)67632-X; Fabrizi E, 2010, WORLD J GASTROENTERO, V16, P3871, DOI 10.3748/wjg.v16.i31.3871; Hara S, 2001, JPN J CLIN ONCOL, V31, P399, DOI 10.1093/jjco/hye086; HEPPNER GH, 1984, CANCER RES, V44, P2259; Herr HW, 2004, J CLIN ONCOL, V22, P2781, DOI 10.1200/JCO.2004.11.024; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kawamoto M, 2009, HUM PATHOL, V40, P189, DOI 10.1016/j.humpath.2008.02.022; KIRKELS WJ, 1982, AM J CLIN PATHOL, V78, P690, DOI 10.1093/ajcp/78.5.690; Kleeberger W, 2007, CANCER RES, V67, P9199, DOI 10.1158/0008-5472.CAN-07-0806; LOGOTHETIS CJ, 1988, J CLIN ONCOL, V6, P1590, DOI 10.1200/JCO.1988.6.10.1590; Lotan Y, 2005, J CLIN ONCOL, V23, P6533, DOI 10.1200/JCO.2005.05.516; Madersbacher S, 2003, J CLIN ONCOL, V21, P690, DOI 10.1200/JCO.2003.05.101; McDermott SP, 2010, MOL ONCOL, V4, P404, DOI 10.1016/j.molonc.2010.06.005; Pasin Erik, 2008, Rev Urol, V10, P31; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ryuge S, 2011, CHEST, V139, P862, DOI 10.1378/chest.10-1121; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Strojnik T, 2007, SURG NEUROL, V68, P133, DOI 10.1016/j.surneu.2006.10.050; Herr HW, 2007, J UROLOGY, V177, P437, DOI 10.1016/j.juro.2006.09.027	30	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e91548	10.1371/journal.pone.0091548	http://dx.doi.org/10.1371/journal.pone.0091548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24785714	gold, Green Published, Green Submitted			2022-12-25	WOS:000336655700002
J	Yang, SC; Chen, JC; Tai, WC; Wu, CK; Lee, CH; Wu, KL; Chiu, YC; Wang, JH; Lu, SN; Chuah, SK				Yang, Shih-Cheng; Chen, Jen-Chieh; Tai, Wei-Chen; Wu, Cheng-Kun; Lee, Chen-Hsiang; Wu, Keng-Liang; Chiu, Yi-Chun; Wang, Jing-Houng; Lu, Sheng-Nan; Chuah, Seng-Kee			The Influential Roles of Antibiotics Prophylaxis in Cirrhotic Patients with Peptic Ulcer Bleeding after Initial Endoscopic Treatments	PLOS ONE			English	Article							PREVENTS BACTERIAL-INFECTION; GASTROINTESTINAL HEMORRHAGE; MORTALITY; RISK; NORFLOXACIN; FAILURE	The influential roles of antibiotic prophylaxis on cirrhotic patients with peptic ulcer bleeding are still not well documented. The purpose of this study is to clarify these influential roles and to identify the risk factors associated with rebleeding, bacterial infection and in-hospital mortality. A cross-sectional, chart review study was conducted on 210 cirrhotic patients with acute peptic ulcer hemorrhage who underwent therapeutic endoscopic procedures. Patients were divided into group A (with prophylactic intravenous ceftriaxone, n = 74) and group B (without antibiotics, n = 136). The outcomes were length of hospital days, prevention of infection, rebleeding rate and in-hospital mortality. Our results showed that more patients suffered from rebleeding and infection in group B than group A (31.6% vs. 5.4%; p<0.001 and 25% vs. 10.8%; p = 0.014 respectively). The risk factors for rebleeding were active alcoholism, unit of blood transfusion, Rockall score, model for end-stage liver disease score and antibiotic prophylaxis. The risk factors for infection were active alcoholism, Child-Pugh C, Rockall score and antibiotic prophylaxis. Rockall score was the predictive factor for in-hospital mortality. In conclusions, antibiotic prophylaxis in cirrhotic patients after endoscopic interventions for acute peptic ulcer hemorrhage reduced infections and rebleeding rate but not in-hospital mortality. Rockall score was the predictive factor of in-hospital mortality.	[Yang, Shih-Cheng; Chen, Jen-Chieh; Tai, Wei-Chen; Wu, Cheng-Kun; Wu, Keng-Liang; Chiu, Yi-Chun; Wang, Jing-Houng; Lu, Sheng-Nan; Chuah, Seng-Kee] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Yang, Shih-Cheng; Chen, Jen-Chieh; Tai, Wei-Chen; Wu, Cheng-Kun; Lee, Chen-Hsiang; Wu, Keng-Liang; Chiu, Yi-Chun; Wang, Jing-Houng; Lu, Sheng-Nan; Chuah, Seng-Kee] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lee, Chen-Hsiang] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chuah, SK (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.	chuahsk@seed.net.tw						[Anonymous], 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002907; BERNARD B, 1995, GASTROENTEROLOGY, V108, P1828, DOI 10.1016/0016-5085(95)90146-9; BLAISE M, 1994, HEPATOLOGY, V20, P34, DOI 10.1016/0270-9139(94)90131-7; Burroughs AK, 2009, NAT CLIN PRACT GASTR, V6, P72, DOI 10.1038/ncpgasthep1336; CHRISTENSEN E, 1981, GASTROENTEROLOGY, V81, P944; Fernandez J, 2006, GASTROENTEROLOGY, V131, P1049, DOI 10.1053/j.gastro.2006.07.010; FORREST JAH, 1974, LANCET, V2, P394; Goulis J, 1998, HEPATOLOGY, V27, P1207, DOI 10.1002/hep.510270504; Hung CH, 2003, J GASTROENTEROL, V38, P153, DOI 10.1007/s005350300025; Koulaouzidis A, 2009, WORLD J GASTROENTERO, V15, P1042, DOI 10.3748/wjg.15.1042; Lodato F, 2008, WORLD J GASTROENTERO, V14, P2980, DOI 10.3748/wjg.14.2980; Marmo R, 2008, AM J GASTROENTEROL, V103, P1639, DOI 10.1111/j.1572-0241.2008.01865.x; Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Pauwels A, 1996, HEPATOLOGY, V24, P802; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Rosa H, 2000, AM J GASTROENTEROL, V95, P1290, DOI 10.1111/j.1572-0241.2000.02026.x; Sanders DS, 2002, AM J GASTROENTEROL, V97, P630; Sarwar S, 2007, JCPSP-J COLL PHYSICI, V17, P253; SORIANO G, 1992, GASTROENTEROLOGY, V103, P1267, DOI 10.1016/0016-5085(92)91514-5; Vivas S, 2001, DIGEST DIS SCI, V46, P2752, DOI 10.1023/A:1012739815892; Wang H, 2011, ALCOHOL ALCOHOLISM, V46, P26, DOI 10.1093/alcalc/agq076; Wong F, 2005, GUT, V54, P718, DOI 10.1136/gut.2004.038679; Wu CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061666; WYKE RJ, 1987, GUT, V28, P623, DOI 10.1136/gut.28.5.623; Xu HW, 2011, SURG ENDOSC, V25, P2911, DOI 10.1007/s00464-011-1642-0	28	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96394	10.1371/journal.pone.0096394	http://dx.doi.org/10.1371/journal.pone.0096394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788341	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700085
J	Wong, CKH; Wong, WCW; Lam, CLK; Wan, YF; Wong, WHT; Chung, KL; Dai, D; Tsui, ELH; Fong, DYT				Wong, Carlos K. H.; Wong, William C. W.; Lam, Cindy L. K.; Wan, Y. F.; Wong, Winnie H. T.; Chung, K. L.; Dai, Daisy; Tsui, Eva L. H.; Fong, Daniel Y. T.			Effects of Patient Empowerment Programme (PEP) on Clinical Outcomes and Health Service Utilization in Type 2 Diabetes Mellitus in Primary Care: An Observational Matched Cohort Study	PLOS ONE			English	Article							SELF-MANAGEMENT EDUCATION; RANDOMIZED CONTROLLED-TRIAL; DIAGNOSED DESMOND PROGRAM; FOLLOW-UP; CHRONIC DISEASE; PEOPLE; INTERVENTION; METAANALYSIS; QUALITY	Background: To evaluate the effects of a large population-based patient empowerment programme (PEP) on clinical outcomes and health service utilization rates in type 2 diabetes mellitus (T2DM) patients in the primary care setting. Research Design and Subjects: A stratified random sample of 1,141 patients with T2DM enrolled to PEP between March and September 2010 were selected from general outpatient clinics (GOPC) across Hong Kong and compared with an equal number of T2DM patients who had not participated in the PEP (non-PEP group) matched by age, sex and HbA(1c) level group. Measures: Clinical outcomes of HbA(1c), SBP, DBP and LDL-C levels, and health service utilization rates including numbers of visits to GOPC, specialist outpatient clinics (SOPC), emergency department (ED) and inpatient admissions, were measured at baseline and at 12-month post-recruitment. The effects of PEP on clinical outcomes and health service utilization rates were assessed by the difference-in-difference estimation, using the generalized estimating equation models. Results: Compared with non-PEP group, PEP group achieved additional improvements in clinical outcomes over the 12-month period. A significantly greater percentage of patients in the PEP group attained HbA(1c)<= 7% or LDL-C <= 2.6 mmol/L at 12-month follow-up compared with the non-PEP group. PEP group had a mean 0.813 fewer GOPC visits in comparison with the non-PEP group. Conclusions: PEP was effective in improving the clinical outcomes and reduced the general outpatient clinic utilization rate over a 12-month period. Empowering T2DM patients on self-management of their disease can enhance the quality of diabetes care in primary care.	[Wong, Carlos K. H.; Wong, William C. W.; Lam, Cindy L. K.; Wan, Y. F.; Wong, Winnie H. T.] Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Chung, K. L.] Hong Kong Hosp Author, Hosp Author Head Off, Integrated Care Programs, Kowloon, Hong Kong, Peoples R China; [Dai, Daisy] Hong Kong Hosp Author, Hosp Author Head Off, Primary & Community Serv, Kowloon, Hong Kong, Peoples R China; [Tsui, Eva L. H.] Hong Kong Hosp Author, Hosp Author Head Off, Kowloon, Hong Kong, Peoples R China; [Fong, Daniel Y. T.] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, CKH (corresponding author), Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China.	carlosho@hku.hk	Fong, Daniel YT/C-4269-2009; Wong, Carlos King Ho/B-4322-2011	Fong, Daniel YT/0000-0001-7365-9146; Wong, Carlos King Ho/0000-0002-6895-6071	Hong Kong Hospital Authority [8011014157]; Health and Health Services Research Fund, Food and Health Bureau, HKSAR Commissioned Research on Enhancing Primary Care Study [EPC-HKU-2]	Hong Kong Hospital Authority; Health and Health Services Research Fund, Food and Health Bureau, HKSAR Commissioned Research on Enhancing Primary Care Study	This study has been funded by the Hong Kong Hospital Authority (Ref. no: 8011014157) and the Health and Health Services Research Fund, Food and Health Bureau, HKSAR Commissioned Research on Enhancing Primary Care Study (Ref. no EPC-HKU-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-467; American Diabetes Association, 2006, CLIN DIABETES, DOI DOI 10.2337/DIACLIN.24.4.154; Anderson RM, 2002, USING EMPOWERMENT AP; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; [Anonymous], 2010, MAN DIAB NAT CLIN GU; [Anonymous], 2009, NAT I HLTH CLIN EXC; Athey S, 2006, ECONOMETRICA, V74, P431, DOI 10.1111/j.1468-0262.2006.00668.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Boren SA, 2009, DIABETES EDUCATOR, V35, P72, DOI 10.1177/0145721708326774; Cheung BMY, 2009, AM J MED, V122, P443, DOI 10.1016/j.amjmed.2008.09.047; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; Deakin TA, 2006, DIABETIC MED, V23, P944, DOI 10.1111/j.1464-5491.2006.01906.x; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; Fitzner K, 2008, POPUL HEALTH MANAG, V11, P329, DOI 10.1089/pop.2008.0012; Fung CSC, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-116; Gillett M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4093; Gordon C, 2007, REV FINDINGS CHRONIC; Gucciardi E, 2009, DIABETIC MED, V26, P510, DOI 10.1111/j.1464-5491.2009.02713.x; Hawthorne K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006424.pub2; Hornsten A, 2005, DIABETES RES CLIN PR, V68, P65, DOI 10.1016/j.diabres.2004.08.003; Hornsten A, 2008, DIABETES RES CLIN PR, V81, P50, DOI 10.1016/j.diabres.2008.02.005; Huang MC, 2010, DIABETES CARE, V33, P233, DOI 10.2337/dc09-1092; Jarvis J, 2010, DIABETES OBES METAB, V12, P12, DOI 10.1111/j.1463-1326.2009.01098.x; Khunti K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2333; Loveman E, 2008, HEALTH TECHNOL ASSES, V12, pIX; Loveman E, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7220; McGowan P, 2011, CAN J DIABETES, V35, P46, DOI 10.1016/S1499-2671(11)51008-1; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P349, DOI 10.1093/heapro/13.4.349; Robbins JM, 2008, DIABETES CARE, V31, P655, DOI 10.2337/dc07-1871; Rutten G, 2005, DIABETIC MED, V22, P671, DOI 10.1111/j.1464-5491.2005.01497.x; Sun JQ, 2008, ASIA PAC J CLIN NUTR, V17, P514; Tang TS, 2010, PATIENT EDUC COUNS, V79, P178, DOI 10.1016/j.pec.2009.09.029; Trento M, 2010, DIABETES CARE, V33, P745, DOI 10.2337/dc09-2024; Tshiananga JKT, 2012, DIABETES EDUCATOR, V38, P108, DOI 10.1177/0145721711423978; Wong KW, 2012, FAM PRACT, V29, P196, DOI 10.1093/fampra/cmr060	40	46	46	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95328	10.1371/journal.pone.0095328	http://dx.doi.org/10.1371/journal.pone.0095328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG6EE	24788804	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600033
J	Ling, C; Pease, M; Shi, LL; Punj, V; Shiroishi, MS; Commins, D; Weisenberger, DJ; Wang, K; Zada, G				Ling, Chao; Pease, Matthew; Shi, Lingling; Punj, Vasu; Shiroishi, Mark S.; Commins, Deborah; Weisenberger, Daniel J.; Wang, Kai; Zada, Gabriel			A Pilot Genome-Scale Profiling of DNA Methylation in Sporadic Pituitary Macroadenomas: Association with Tumor Invasion and Histopathological Subtype	PLOS ONE			English	Article							COLORECTAL-CANCER; RAT-BRAIN; ADENOMAS; GENE; EXPRESSION; TUMORIGENESIS; INACTIVATION; SUBUNIT; HYPERMETHYLATION; LACTOTROPHS	Pituitary adenomas (PAs) are neoplasms that may cause a variety of neurological and endocrine effects. Although known causal contributors include heredity, hormonal influence and somatic mutations, the pathophysiologic mechanisms driving tumorigenesis and invasion of sporadic PAs remain unknown. We hypothesized that alterations in DNA methylation are associated with PA invasion and histopathology subtype, and that genome-scale methylation analysis may complement current classification methods for sporadic PAs. Twenty-four surgically-resected sporadic PAs with varying histopathological subtypes were assigned dichotomized Knosp invasion scores and examined using genome-wide DNA methylation profiling and RNA sequencing. PA samples clustered into subgroups according to functional status. Compared with hormonally-active PAs, nonfunctional PAs exhibited global DNA hypermethylation (mean beta-value 0.47 versus 0.42, P = 0.005); the most significant site of differential DNA methylation was within the promoter region of the potassium voltage-gated channel KCNAB2 (FDR = 5.11x10(-10)). Pathway analysis of promoter-associated CpGs showed that nonfunctional PAs are potentially associated with the ion-channel activity signal pathway. DNA hypermethylation tended to be negatively correlated with gene expression. DNA methylation analysis may be used to identify candidate genes involved in PA function and may potentially complement current standard immunostaining classification in sporadic PAs. DNA hypermethylation of KCNAB2 and downstream ion-channel activity signal pathways may contribute to the endocrine-inactive status of nonfunctional PAs.	[Ling, Chao] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China; [Ling, Chao; Shi, Lingling; Wang, Kai; Zada, Gabriel] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Pease, Matthew; Zada, Gabriel] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Weisenberger, Daniel J.] Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Shiroishi, Mark S.] Univ So Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA 90033 USA; [Commins, Deborah] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Div Bioinformat, Dept Prevent Med, Los Angeles, CA 90033 USA; [Punj, Vasu] Univ So Calif, Keck Sch Med, NCCC Bioinformat Core, Los Angeles, CA 90033 USA; [Punj, Vasu] Univ So Calif, Keck Sch Med, Div Hematol, Los Angeles, CA 90033 USA	Tianjin Medical University; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Wang, K (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	kaiwang@usc.edu; gzada@usc.edu	LING, CHAO/W-3528-2019; Weisenberger, Daniel/AAA-8314-2020	Weisenberger, Daniel/0000-0001-8303-2603; LING, CHAO/0000-0001-5328-4906	National Center for Research Resources; National Center for Advancing Translational Sciences, National Institute of Health (NIH) [KL2RR031991]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031991] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institute of Health (NIH); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The current research was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institute of Health (NIH), through Grant Award Number KL2RR031991. The content is solely the responsibility of the authors and does not necessarily represent the official view of NIH. Author Gabriel Zada is a KL2 trainee through Southern California Clinical and Translational Science Institute at University of Southern California, Keck School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli Virginia, 2008, Hum Genet, V124, P304; Bahar A, 2004, ONCOGENE, V23, P936, DOI 10.1038/sj.onc.1207193; Bassler J, 2010, MOL CELL, V38, P712, DOI 10.1016/j.molcel.2010.05.024; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BLACK PM, 1987, J NEUROSURG, V66, P244, DOI 10.3171/jns.1987.66.2.0244; Chambers TJG, 2013, ENDOCR-RELAT CANCER, V20, pR101, DOI 10.1530/ERC-13-0005; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Dai XQ, 2012, DIABETOLOGIA, V55, P1709, DOI 10.1007/s00125-012-2512-6; Desvignes T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-256; DONG W, 1995, J NEUROSCI, V15, P1778, DOI 10.1523/JNEUROSCI.15-03-01778.1995; Dudley KJ, 2009, J MOL ENDOCRINOL, V42, P461, DOI 10.1677/JME-09-0009; Duong Cuong V, 2012, Endocr Relat Cancer, V19, P805, DOI 10.1530/ERC-12-0251; Ebert MPA, 2012, NEW ENGL J MED, V366, P44, DOI 10.1056/NEJMoa1009473; Ezzat S, 2004, CANCER-AM CANCER SOC, V101, P613, DOI 10.1002/cncr.20412; Farrell WE, 2006, NEUROENDOCRINOLOGY, V84, P217, DOI 10.1159/000097486; Farrell WE, 1999, ENDOCR-RELAT CANCER, V6, P437, DOI 10.1677/erc.0.0060437; Garcia L, 1997, AM J PHYSIOL-CELL PH, V272, pC1178, DOI 10.1152/ajpcell.1997.272.4.C1178; Gonzalez-Iglesias AE, 2006, MOL ENDOCRINOL, V20, P2231, DOI 10.1210/me.2005-0363; HERMAN JG, 1995, CANCER RES, V55, P4525; HERMAN V, 1990, J CLIN ENDOCR METAB, V71, P1427, DOI 10.1210/jcem-71-6-1427; Jaffrain-Rea ML, 1999, CLIN ENDOCRINOL, V51, P317; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kekeeva TV, 2007, MOL BIOL+, V41, P70, DOI 10.1134/S0026893307010104; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; KIDOKORO Y, 1975, NATURE, V258, P741, DOI 10.1038/258741a0; KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008; McCormack K, 2002, J BIOL CHEM, V277, P13219, DOI 10.1074/jbc.M111465200; McCormack T, 1999, J BIOL CHEM, V274, P20123, DOI 10.1074/jbc.274.29.20123; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Mezzomo LC, 2012, PITUITARY, V15, P420, DOI 10.1007/s11102-011-0340-1; Nammour GM, 1997, AM J MED SCI, V314, P287, DOI 10.1097/00000441-199711000-00003; Nishioka M, 2013, INT J DEV NEUROSCI, V31, P89, DOI 10.1016/j.ijdevneu.2012.11.007; Ogino A, 2005, J NEUROPATH EXP NEUR, V64, P398, DOI 10.1093/jnen/64.5.398; Payne SR, 2009, PROSTATE, V69, P1257, DOI 10.1002/pros.20967; Pease M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082619; Piwonska M, 2008, NEUROSCIENCE, V153, P446, DOI 10.1016/j.neuroscience.2008.01.050; Qian ZR, 2007, MODERN PATHOL, V20, P1269, DOI 10.1038/modpathol.3800965; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Seemann N, 2001, J PATHOL, V193, P491, DOI 10.1002/path.833; SELMAN WR, 1986, J NEUROSURG, V64, P402, DOI 10.3171/jns.1986.64.3.0402; Simpson DJ, 1999, GENE CHROMOSOME CANC, V24, P328; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Triche TJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt090; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Weng J, 2006, J BIOL CHEM, V281, P15194, DOI 10.1074/jbc.M513809200; Woloschak M, 1997, MOL CARCINOGEN, V19, P221, DOI 10.1002/(SICI)1098-2744(199708)19:4<221::AID-MC1>3.0.CO;2-F; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Yuan YF, 2008, MODERN PATHOL, V21, P856, DOI 10.1038/modpathol.2008.60; Zada G, 2003, J NEUROSURG, V98, P350, DOI 10.3171/jns.2003.98.2.0350; Zada G, 2011, J NEUROSURG, V114, P336, DOI 10.3171/2010.8.JNS10290; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326	53	29	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96178	10.1371/journal.pone.0096178	http://dx.doi.org/10.1371/journal.pone.0096178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781529	gold, Green Published, Green Submitted			2022-12-25	WOS:000335504900022
J	Ogneva, IV; Biryukov, NS; Leinsoo, TA; Larina, IM				Ogneva, Irina V.; Biryukov, Nikolay S.; Leinsoo, Toomas A.; Larina, Irina M.			Possible Role of Non-Muscle Alpha-Actinins in Muscle Cell Mechanosensitivity	PLOS ONE			English	Article							RAT SOLEUS MUSCLE; CARDIOVASCULAR ADAPTATION; TRANSVERSAL STIFFNESS; CYTOSKELETON; CHANNEL; FORCE; MICROGRAVITY; GENE; GASTROCNEMIUS; CONTRACTILE	The main hypothesis suggested that changes in the external mechanical load would lead to different deformations of the submembranous cytoskeleton and, as a result, dissociation of different proteins from its structure (induced by increased/decreased mechanical stress). The study subjects were fibers of the soleus muscle and cardiomyocytes of Wistar rats. Changes in external mechanical conditions were reconstructed by means of antiorthostatic suspension of the animals by their tails for 6, 12, 18, 24 and 72 hours. Transversal stiffness was measured by atomic force microscopy imaging; beta-, gamma-actin, alpha-actinin 1 and alpha-actinin 4 levels in membranous and cytoplasmic fractions were quantified by Western blot analysis; expression rates of the corresponding genes were studied using RT-PCR. Results: In 6 hours, alpha-actinin 1 and alpha-actinin 4 levels decreased in the membranous fraction of proteins of cardiomyocytes and soleus muscle fibers, respectively, but increased in the cytoplasmic fraction of the abovementioned cells. After 6-12 hours of suspension, the expression rates of beta-, gamma-actin, alpha-actinin 1 and alpha-actinin 4 were elevated in the soleus muscle fibers, but the alpha-actinin 1 expression rate returned to the reference level in 72 hours. After 18-24 hours, the expression rates of beta-actin and alpha-actinin 4 increased in cardiomyocytes, while the alpha-actinin 1 expression rate decreased in soleus muscle fibers. After 12 hours, the beta-and gamma-actin content dropped in the membranous fraction and increased in the cytoplasmic protein fractions from both cardiomyocytes and soleus muscle fibers. The stiffness of both cell types decreased after the same period of time. Further, during the unloading period the concentration of nonmuscle actin and different isoforms of alpha-actinins increased in the membranous fraction from cardiomyocytes. At the same time, the concentration of the abovementioned proteins decreased in the soleus muscle fibers.	[Ogneva, Irina V.; Biryukov, Nikolay S.; Leinsoo, Toomas A.; Larina, Irina M.] Russian Acad Sci, State Sci Ctr Russian Federat Inst Biomed Problem, Dept Mol & Cell Biomed, Moscow, Russia	Russian Academy of Sciences	Ogneva, IV (corresponding author), Russian Acad Sci, State Sci Ctr Russian Federat Inst Biomed Problem, Dept Mol & Cell Biomed, Moscow, Russia.	iogneva@yandex.ru	Larina, Irina/T-5443-2017; Biryukov, Nikolay/AAE-8139-2021; Biryukov, Nikolay/L-2955-2016; Ogneva, Irina V/Q-8783-2018	Biryukov, Nikolay/0000-0001-6861-3960; Ogneva, Irina V/0000-0003-0125-5876	Russian Fond of the Basic Research (RFBR) [13-04-00755-a]	Russian Fond of the Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	The financial support of the Russian Fond of the Basic Research (RFBR grant 13-04-00755-a) is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD EK, 1987, EXP NEUROL, V96, P635, DOI 10.1016/0014-4886(87)90225-1; BARON MD, 1987, BIOCHEM SOC T, V15, P796, DOI 10.1042/bst0150796; BENOS DJ, 1995, J MEMBRANE BIOL, V143, P1; Bigbee AJ, 2006, J APPL PHYSIOL, V100, P1037, DOI 10.1152/japplphysiol.00615.2005; BOOTH FW, 1973, PFLUG ARCH EUR J PHY, V342, P231, DOI 10.1007/BF00591371; Broderick MJF, 2002, J STRUCT BIOL, V137, P184, DOI 10.1006/jsbi.2002.4465; BUNGO MW, 1987, J APPL PHYSIOL, V62, P278, DOI 10.1152/jappl.1987.62.1.278; Caiozzo VJ, 1996, J APPL PHYSIOL, V81, P123, DOI 10.1152/jappl.1996.81.1.123; CHARLES JB, 1991, J CLIN PHARMACOL, V31, P1010, DOI 10.1002/j.1552-4604.1991.tb03665.x; Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001; Crawford-Young SJ, 2006, INT J DEV BIOL, V50, P183, DOI 10.1387/ijdb.052077sc; Daniliuc S, 2003, J IMMUNOL, V171, P3225, DOI 10.4049/jimmunol.171.6.3225; DENNERLL TJ, 1988, J CELL BIOL, V107, P665, DOI 10.1083/jcb.107.2.665; DESPLANCHES D, 1990, J APPL PHYSIOL, V68, P48, DOI 10.1152/jappl.1990.68.1.48; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; Gaboyard S, 2002, NEUROREPORT, V13, P2139, DOI 10.1097/00001756-200211150-00030; Gershovich P.M., 2008, J GRAV PHYSL, V15, P203; Goffart S, 2006, CURR GENET, V49, P125, DOI 10.1007/s00294-005-0043-0; Gonzalez AM, 2001, J CELL SCI, V114, P4197; Hargens AR., 1984, PHYSIOLOGIST, V27, pS37; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Kacena MA, 2003, IN VITRO CELL DEV-AN, V39, P454; Lee K, 2004, YONSEI MED J, V45, P690; Lieber SC, 2004, AM J PHYSIOL-HEART C, V287, pH645, DOI 10.1152/ajpheart.00564.2003; Liu SC, 2000, J CELL SCI, V113, P3563; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Maximov AV, 1997, FEBS LETT, V412, P94, DOI 10.1016/S0014-5793(97)00754-0; MAXIMOV AV, 1997, BIOPHYS J 2, V72, pA226; MCDONALD KS, 1995, J APPL PHYSIOL, V79, P1796, DOI 10.1152/jappl.1995.79.5.1796; MCDONALD KS, 1992, J APPL PHYSIOL, V72, P2210, DOI 10.1152/jappl.1992.72.6.2210; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Musacchia X J, 1990, Physiologist, V33, pS46; NIXON JV, 1979, J APPL PHYSIOL, V46, P541, DOI 10.1152/jappl.1979.46.3.541; Odde DJ, 1999, J CELL SCI, V112, P3283; Ogneva IV, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/598461; Ogneva IV, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/659869; Ogneva IV, 2010, J APPL PHYSIOL, V109, P1702, DOI 10.1152/japplphysiol.00793.2010; Ogneva I.V., 2013, APPL MATH, V4, P1, DOI [10.4236/am.2013.48A001, DOI 10.4236/AM.2013.48A001]; Ogneva IV, 2010, BIOPHYS J, V98, P418, DOI 10.1016/j.bpj.2009.10.028; PARR T, 1992, EUR J BIOCHEM, V210, P801, DOI 10.1111/j.1432-1033.1992.tb17483.x; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Poch MT, 2004, TOXICOL APPL PHARM, V199, P239, DOI 10.1016/j.taap.2003.12.023; Putnam AJ, 2001, AM J PHYSIOL-CELL PH, V280, pC556, DOI 10.1152/ajpcell.2001.280.3.C556; Salmi ML, 2011, PLANTA, V233, P911, DOI 10.1007/s00425-010-1343-2; Sarkar Devanand, 1999, Environmental Medicine (Nagoya), V43, P22; SCHWIEBERT EM, 1994, J BIOL CHEM, V269, P7081; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; STEVENS L, 1993, AM J PHYSIOL, V264, pR770, DOI 10.1152/ajpregu.1993.264.4.R770; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Sun XH, 2012, BONE, V50, P581, DOI 10.1016/j.bone.2011.12.015; SUZUKI M, J MEMBR BIOL, V134, P31; THORNTON WE, 1987, AVIAT SPACE ENVIR MD, V58, pA86; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uva BM, 2002, BRAIN RES, V934, P132, DOI 10.1016/S0006-8993(02)02415-0; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; VELEZ C, 1995, P SOC EXP BIOL MED, V210, P57; Vitorino R, 2007, ANAL BIOCHEM, V366, P156, DOI 10.1016/j.ab.2007.04.009; WAITES GT, 1992, J BIOL CHEM, V267, P6263; WATENPAUGH DE, 1996, HDB PHYSIOL SECT 4, V1, P631; Widrick JJ, 2008, AM J PHYSIOL-REG I, V295, pR1585, DOI 10.1152/ajpregu.00045.2008; YOUSSOUFIAN H, 1990, AM J HUM GENET, V47, P62; Zhu J, 2009, J BIOMECH, V42, P2143, DOI 10.1016/j.jbiomech.2009.05.031	65	27	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96395	10.1371/journal.pone.0096395	http://dx.doi.org/10.1371/journal.pone.0096395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24780915	Green Published, Green Submitted, gold			2022-12-25	WOS:000335504900031
J	Cano-Penalver, JL; Griera, M; Serrano, I; Rodriguez-Puyol, D; Dedhar, S; de Frutos, S; Rodriguez-Puyol, M				Luis Cano-Penalver, Jose; Griera, Mercedes; Serrano, Isabel; Rodriguez-Puyol, Diego; Dedhar, Shoukat; de Frutos, Sergio; Rodriguez-Puyol, Manuel			Integrin-linked kinase regulates tubular aquaporin-2 content and intracellular location: a link between the extracellular matrix and water reabsorption	FASEB JOURNAL			English	Article						nephrogenic diabetes insipidus; fibrosis; chronic renal disease	RENAL COLLECTING DUCT; PRINCIPAL CELLS; INTERSTITIAL FIBROSIS; AQP2 TRAFFICKING; EPITHELIAL-CELLS; APICAL MEMBRANE; BINDING PROTEIN; UP-REGULATION; VASOPRESSIN; EXPRESSION	One of the clinical alterations observed in chronic renal disease (CRD) is the impaired urine concentration, known as diabetes insipidus (DI). Tubulointerstitial fibrosis of the kidney is also a pathological finding observed in CRD and involves composition of extracellular matrix (ECM). However, an association between these two events has not been elucidated. In this study, we showed that the extracellular-to-intracellular scaffold protein integrin-linked kinase (ILK) regulates expression of tubular water channel aquaporin-2 (AQP2) and its apical membrane presence in the renal tubule. Basally, polyuria and decreased urine osmolality were present in ILK conditional-knockdown (cKD-ILK) adult mice compared with nondepleted ILK littermates. No changes were observed in arginine-vasopressin (AVP) blood levels, renal receptor (V2R), or AQP3 expression. However, tubular AQP2 was decreased in expression and apical membrane presence in cKD-ILK mice, where the canonical V2R/cAMP axis activation is still functional, but independent of the absence of ILK. Thus, cKD-ILK constitutes a nephrogenic diabetes insipidus (NDI) model. AQP2 and ILK colocalize in cultured inner medullary collecting duct (mIMCD3) cells. Specific ILK siRNAs and collagen I (Col) decrease ILK and AQP2 levels and AQP2 presence on the membrane of tubular mIMCD3 cells, which impairs the capacity of the cells to transport water under hypotonic stress. The present work points to ILK as a therapeutic target in NDI.-Cano-Penalver, J. L., Griera, M., Serrano, I., Rodriguez-Puyol, D., Dedhar, S., de Frutos, S., Rodriguez-Puyol, M. Integrin-linked kinase regulates tubular aquaporin-2 content and intracellular location: a link between the extracellular matrix and water reabsorption.	[Luis Cano-Penalver, Jose; Griera, Mercedes; de Frutos, Sergio; Rodriguez-Puyol, Manuel] Univ Alcala De Henares, Physiol Unit, Dept Syst Biol, Madrid 28805, Spain; [Luis Cano-Penalver, Jose; Griera, Mercedes; Rodriguez-Puyol, Diego; de Frutos, Sergio; Rodriguez-Puyol, Manuel] Inst Salud Carlos III, Inst Reina Sofia Invest Renal, Madrid, Spain; [Luis Cano-Penalver, Jose; Griera, Mercedes; Rodriguez-Puyol, Diego; de Frutos, Sergio; Rodriguez-Puyol, Manuel] Inst Salud Carlos III, Red Invest Renal REDinREN, Madrid, Spain; [Serrano, Isabel; Dedhar, Shoukat] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Rodriguez-Puyol, Diego] Hosp Principe Asturias, Biomed Res Fdn, Madrid, Spain; [Rodriguez-Puyol, Diego] Hosp Principe Asturias, Dept Nephrol, Madrid, Spain	Universidad de Alcala; Instituto de Salud Carlos III; Instituto de Salud Carlos III; British Columbia Cancer Agency; Prince of Asturias University Hospital; Prince of Asturias University Hospital	de Frutos, S (corresponding author), Univ Alcala De Henares, Fac Med, Unidad Fisiol, Dept Biol Sistemas, Madrid 28805, Spain.	sergio.frutos@uah.es	Puyol, Diego Rodriguez/AAG-9752-2020; de Frutos, Sergio/AAE-7761-2021; Puyol, Manuel Rodriguez/AAG-7049-2020	Puyol, Diego Rodriguez/0000-0002-9125-9311; de Frutos, Sergio/0000-0002-1225-5911; Puyol, Manuel Rodriguez/0000-0002-5230-6664; Dedhar, Shoukat/0000-0003-4355-1657	Spanish Ministerio de Ciencia e Innovacion [SAF 2010-16198]; Spanish Ministerio de Sanidad (Fondo de Investigaciones Sanitarias) [PI1101630]; Instituto de Salud Carlos III [RD06/0016/0002, RD12/0021/0006]; Spanish Ministerio de Educacion y Ciencia; REDinREN program	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Sanidad (Fondo de Investigaciones Sanitarias); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministerio de Educacion y Ciencia(Spanish Government); REDinREN program	The authors thank Dr. N. Troyano for participating in the establishment of the cKD-ILK mouse model in our laboratory. This work was supported by grants from the Spanish Ministerio de Ciencia e Innovacion (SAF 2010-16198) and the Spanish Ministerio de Sanidad (Fondo de Investigaciones Sanitarias; PI1101630). Funding for the program Investigacion en Red Cooperativa [Red de Investigacion Renal (REDinREN)] came from Instituto de Salud Carlos III (RD06/0016/0002 and RD12/0021/0006). J. L. C.-P. was supported by a fellowship from the Spanish Ministerio de Educacion y Ciencia. S. D. F. was supported by the REDinREN program.	Borghese MFA, 2011, NEPHRON EXTRA, V1, P124, DOI 10.1159/000333066; Balasubramanian L, 2008, PFLUG ARCH EUR J PHY, V456, P747, DOI 10.1007/s00424-007-0371-7; Bouley R, 2000, J CLIN INVEST, V106, P1115, DOI 10.1172/JCI9594; Bustamante M, 2005, AM J PHYSIOL-RENAL, V288, pF334, DOI 10.1152/ajprenal.00180.2004; CAMPS J, 1983, CLIN CHEM, V29, P882; Chou CL, 2004, J BIOL CHEM, V279, P49026, DOI 10.1074/jbc.M408565200; D'Amico M, 2000, J BIOL CHEM, V275, P32649, DOI 10.1074/jbc.M000643200; De Frutos S, 2005, J AM SOC NEPHROL, V16, P2626, DOI 10.1681/ASN.2004070587; El-Aouni C, 2006, J AM SOC NEPHROL, V17, P1334, DOI 10.1681/ASN.2005090921; Gonzalez-Ramos M, 2013, FREE RADICAL BIO MED, V61, P416, DOI 10.1016/j.freeradbiomed.2013.04.029; Gonzalez-Ramos M, 2013, INT J BIOCHEM CELL B, V45, P232, DOI 10.1016/j.biocel.2012.10.001; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kim HY, 2011, AM J PHYSIOL-RENAL, V301, pF151, DOI 10.1152/ajprenal.00519.2010; LEMLEY KV, 1991, KIDNEY INT, V39, P370, DOI 10.1038/ki.1991.49; Li YJ, 2009, J AM SOC NEPHROL, V20, P1907, DOI 10.1681/ASN.2008090930; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lu HJ, 2008, AM J PHYSIOL-RENAL, V295, pF290, DOI 10.1152/ajprenal.00072.2008; Maric K, 1998, AM J PHYSIOL-RENAL, V275, pF796, DOI 10.1152/ajprenal.1998.275.5.F796; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Mistry AC, 2009, AM J PHYSIOL-RENAL, V297, pF292, DOI 10.1152/ajprenal.00196.2009; Moeller HB, 2013, ENDOCR REV, V34, P278, DOI 10.1210/er.2012-1044; Moeller HB, 2012, PFLUG ARCH EUR J PHY, V464, P133, DOI 10.1007/s00424-012-1129-4; MUALLEM S, 1992, J BIOL CHEM, V267, P17658; Nedvetsky PI, 2010, J AM SOC NEPHROL, V21, P1645, DOI 10.1681/ASN.2009111190; Pisitkun T, 2008, AM J PHYSIOL-RENAL, V295, pF1030, DOI 10.1152/ajprenal.90339.2008; Randriamboavonjy V, 2012, BLOOD, V120, P415, DOI 10.1182/blood-2011-12-399980; Rao R, 2010, J AM SOC NEPHROL, V21, P428, DOI 10.1681/ASN.2009060672; Rauchman MI, 1997, AM J PHYSIOL-RENAL, V273, pF9, DOI 10.1152/ajprenal.1997.273.1.F9; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Roos KP, 2012, AM J PHYSIOL-RENAL, V302, pF78, DOI 10.1152/ajprenal.00397.2011; Ruiz-Torres MP, 2007, INT J BIOCHEM CELL B, V39, P133, DOI 10.1016/j.biocel.2006.07.012; Serrano I, 2013, CARDIOVASC RES, V99, P535, DOI 10.1093/cvr/cvt131; Serrano I, 2012, EXP CELL RES, V318, P2470, DOI 10.1016/j.yexcr.2012.08.001; Sproul A, 2011, AM J PHYSIOL-RENAL, V301, pF44, DOI 10.1152/ajprenal.00666.2010; Tajika Y, 2004, ENDOCRINOLOGY, V145, P4375, DOI 10.1210/en.2004-0073; Takata K, 2004, J PHARMACOL SCI, V96, P255, DOI 10.1254/jphs.FMJ04004X3; Tamma G, 2001, AM J PHYSIOL-RENAL, V281, pF1092, DOI 10.1152/ajprenal.0091.2001; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V27, P739, DOI 10.1159/000330082; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Walker RJ, 2013, AM J PHYSIOL-RENAL, V304, pF300, DOI 10.1152/ajprenal.00182.2012; Wickstrom SA, 2011, TRENDS CELL BIOL, V21, P266, DOI 10.1016/j.tcb.2011.02.003; Wu W, 2009, AM J PHYSIOL-RENAL, V297, pF210, DOI 10.1152/ajprenal.90260.2008; Yamaguchi I, 2012, NEPHRON EXP NEPHROL, V120, pE20, DOI 10.1159/000332026; Yang BX, 2006, AM J PHYSIOL-RENAL, V291, pF465, DOI 10.1152/ajprenal.00494.2005; Yasuhara A, 2008, CIRCULATION, V118, P2146, DOI 10.1161/CIRCULATIONAHA.108.787259; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Zelenina M, 2000, EUR BIOPHYS J BIOPHY, V29, P165, DOI 10.1007/PL00006645; Zou LB, 2011, J CLIN ENDOCR METAB, V96, pE1399, DOI 10.1210/jc.2011-0426	50	17	20	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3645	3659		10.1096/fj.13-249250	http://dx.doi.org/10.1096/fj.13-249250			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24784577	Bronze			2022-12-25	WOS:000340265400032
J	Anoop, A; Ranganathan, S; Das Dhaked, B; Jha, NN; Pratihar, S; Ghosh, S; Sahay, S; Kumar, S; Das, S; Kombrabail, M; Agarwal, K; Jacob, RS; Singru, P; Bhaumik, P; Padinhateeri, R; Kumar, A; Maji, SK				Anoop, Arunagiri; Ranganathan, Srivastav; Das Dhaked, Bhagwan; Jha, Narendra Nath; Pratihar, Supriya; Ghosh, Saikat; Sahay, Shruti; Kumar, Santosh; Das, Subhadeep; Kombrabail, Mamata; Agarwal, Kumud; Jacob, Reeba S.; Singru, Praful; Bhaumik, Prasenjit; Padinhateeri, Ranjith; Kumar, Ashutosh; Maji, Samir K.			Elucidating the Role of Disulfide Bond on Amyloid Formation and Fibril Reversibility of Somatostatin-14 RELEVANCE TO ITS STORAGE AND SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; GROWTH-HORMONE RELEASE; CONFORMATIONAL STABILITY; AGGREGATION; GRANULES; PEPTIDES; INSULIN; BIOGENESIS; MECHANISMS; INHIBITION	The storage of protein/peptide hormones within subcellular compartments and subsequent release are crucial for their native function, and hence these processes are intricately regulated in mammalian systems. Several peptide hormones were recently suggested to be stored as amyloids within endocrine secretory granules. This leads to an apparent paradox where storage requires formation of aggregates, and their function requires a supply of non-aggregated peptides on demand. The precise mechanism behind amyloid formation by these hormones and their subsequent release remain an open question. To address this, we examined aggregation and fibril reversibility of a cyclic peptide hormone somatostatin (SST)-14 using various techniques. After proving that SST gets stored as amyloid in vivo, we investigated the role of native structure in modulating its conformational dynamics and self-association by disrupting the disulfide bridge (Cys(3)-Cys(14)) in SST. Using two-dimensional NMR, we resolved the initial structure of somatostatin-14 leading to aggregation and further probed its conformational dynamics in silico. The perturbation in native structure (S-S cleavage) led to a significant increase in conformational flexibility and resulted in rapid amyloid formation. The fibrils formed by disulfide-reduced noncyclic SST possess greater resistance to denaturing conditions with decreased monomer releasing potency. MD simulations reveal marked differences in the intermolecular interactions in SST and noncyclic SST providing plausible explanation for differential aggregation and fibril reversibility observed experimentally in these structural variants. Our findings thus emphasize that subtle changes in the native structure of peptide hormone(s) could alter its conformational dynamics and amyloid formation, which might have significant implications on their reversible storage and secretion.	[Ghosh, Saikat; Sahay, Shruti; Das, Subhadeep; Agarwal, Kumud; Jacob, Reeba S.; Bhaumik, Prasenjit; Padinhateeri, Ranjith; Kumar, Ashutosh; Maji, Samir K.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Pratihar, Supriya; Kombrabail, Mamata] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Kumar, Santosh; Singru, Praful] Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar 751005, Orissa, India; [Das, Subhadeep] Indian Inst Technol, IITB Monash Res Acad, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Tata Institute of Fundamental Research (TIFR); National Institute of Science Education & Research (NISER); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kumar, A (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	ashutoshk@iitb.ac.in; samirmaji@iitb.ac.in	JHA, NARENDRA NATH/ABI-3727-2020; Maji, Samir K. K./B-9640-2019; Das, Subhadeep/J-4038-2016; Arunagiri, Anoop/P-2528-2018	JHA, NARENDRA NATH/0000-0002-1734-7663; Maji, Samir K. K./0000-0002-9110-1565; Arunagiri, Anoop/0000-0001-9839-1860; Supriya, Pratihar/0000-0001-6779-1490; Jacob, Reeba/0000-0002-0676-834X; Das, Subhadeep/0000-0003-1870-8456; Ghosh, Saikat/0000-0003-0937-6242; Ranganathan, Srivastav/0000-0003-4364-0959	Industrial Research and Consultancy Centre at Indian Institute of Technology Bombay, India; Department of Biotechnology, Government of India [BT/PR14344Med/30/501/2010, BT/PR13359/BRB/10/752/2009]; Council of Scientific Research and Industrial Research, India [37(1404)/10/EMR-11]; Department of Science and Technology, Government of India [SR/FR/LS-032/2009]	Industrial Research and Consultancy Centre at Indian Institute of Technology Bombay, India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific Research and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by Industrial Research and Consultancy Centre at Indian Institute of Technology Bombay, India, Department of Biotechnology, Government of India, Grants BT/PR14344Med/30/501/2010 and BT/PR13359/BRB/10/752/2009, Council of Scientific Research and Industrial Research, India, Grant 37(1404)/10/EMR-11, and Department of Science and Technology Grant SR/FR/LS-032/2009 from the Government of India.	Alexandrescu A T, 2001, Pac Symp Biocomput, P67; ANDERSON RGW, 1985, CELL, V40, P635, DOI 10.1016/0092-8674(85)90212-0; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; BLOOM SR, 1974, LANCET, V2, P1106; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Castellanos MM, 2013, J PHYS CHEM B, V117, P11895, DOI 10.1021/jp402994r; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COOPER A, 1992, J MOL BIOL, V225, P939, DOI 10.1016/0022-2836(92)90094-Z; Dannies PS, 2002, MOL GENET METAB, V76, P6, DOI 10.1016/S1096-7192(02)00011-2; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; Dannies PS, 2001, MOL CELL ENDOCRINOL, V177, P87, DOI 10.1016/S0303-7207(01)00437-3; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dubois J, 1999, SCAND J IMMUNOL, V49, P376; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Grace CRR, 2005, J MED CHEM, V48, P523, DOI 10.1021/jm049518u; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hamada D, 2002, PROTEIN SCI, V11, P2417, DOI 10.1110/ps.0217702; Hernandez B, 2009, J PHYS CHEM B, V113, P12796, DOI 10.1021/jp904737v; Hua QX, 2006, J BIOL CHEM, V281, P28131, DOI 10.1074/jbc.M602616200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jain RK, 2000, J BIOL CHEM, V275, P27032; Jha NN, 2013, BIOCHEMISTRY-US, V52, P8800, DOI 10.1021/bi401398k; KAHN PC, 1968, J AM CHEM SOC, V90, P4168, DOI 10.1021/ja01017a051; Kardos J, 2011, BIOCHEMISTRY-US, V50, P3211, DOI 10.1021/bi2000017; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P278; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li Y, 2013, PROTEINS, V81, P1862, DOI 10.1002/prot.24338; Li Y, 2012, BIOCHEM BIOPH RES CO, V423, P373, DOI 10.1016/j.bbrc.2012.05.133; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LOW MJ, 1986, J BIOL CHEM, V261, P6260; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; Maeda R, 2007, BBA-PROTEINS PROTEOM, V1774, P1619, DOI 10.1016/j.bbapap.2007.08.016; Maji S. K., 2010, FUNCTIONAL AMYLOID A, P135; Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; MANDARINO L, 1981, NATURE, V291, P76, DOI 10.1038/291076a0; Melquiond A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1886725; Morel B, 2010, J PHYS CHEM B, V114, P4010, DOI 10.1021/jp9102993; Mossuto Maria Francesca, 2013, Int J Cell Biol, V2013, P318319, DOI 10.1155/2013/318319; NAIKI H, 1991, LAB INVEST, V65, P104; Narimoto T, 2004, FEBS LETT, V576, P313, DOI 10.1016/j.febslet.2004.09.024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; Ranganathan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031924; REGGIO HA, 1978, J CELL BIOL, V77, P288, DOI 10.1083/jcb.77.2.288; RORSTAD OP, 1987, PEPTIDES, V8, P849, DOI 10.1016/0196-9781(87)90071-4; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sahay S, 2014, BIOCHEMISTRY-US, V53, P807, DOI 10.1021/bi401543z; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; SILER TM, 1973, J CLIN ENDOCR METAB, V37, P632, DOI 10.1210/jcem-37-4-632; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tooze SA, 1998, BBA-MOL CELL RES, V1404, P231, DOI 10.1016/S0167-4889(98)00059-7; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Valery C, 2008, BIOPHYS J, V94, P1782, DOI 10.1529/biophysj.107.108175; Van Grondelle W, 2007, J STRUCT BIOL, V160, P211, DOI 10.1016/j.jsb.2007.08.006; Vaz DC, 2006, PROTEIN SCI, V15, P33, DOI 10.1110/ps.051593306; von Bergen Martin, 2004, V299, P175; ZANINI A, 1980, J CELL BIOL, V86, P260, DOI 10.1083/jcb.86.1.260; Zhu YL, 2002, ENDOCRINOLOGY, V143, P4243, DOI 10.1210/en.2002-220575	78	51	52	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16884	16903		10.1074/jbc.M114.548354	http://dx.doi.org/10.1074/jbc.M114.548354			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24782311	Green Published, hybrid			2022-12-25	WOS:000338016200025
J	Chen, C; Han, X; Zou, X; Li, Y; Yang, L; Cao, K; Xu, J; Long, JG; Liu, JK; Feng, ZH				Chen, Cong; Han, Xiao; Zou, Xuan; Li, Yuan; Yang, Liang; Cao, Ke; Xu, Jie; Long, Jiangang; Liu, Jiankang; Feng, Zhihui			4-Methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic Acid (C75), an Inhibitor of Fatty-acid Synthase, Suppresses the Mitochondrial Fatty Acid Synthesis Pathway and Impairs Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; LIPOIC ACID; COMPLEX-I; SACCHAROMYCES-CEREVISIAE; ANTIOXIDANT RESPONSE; ESCHERICHIA-COLI; EXPRESSION; GENE; NRF2; CANCER	4-Methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid (C75) is a synthetic fatty-acid synthase (FASN) inhibitor with potential therapeutic effects in several cancer models. Human mitochondrial beta-ketoacyl-acyl carrier protein synthase (HsmtKAS) is a key enzyme in the newly discovered mitochondrial fatty acid synthesis pathway that can produce the substrate for lipoic acid (LA) synthesis. HsmtKAS shares conserved catalytic domains with FASN, which are responsible for binding to C75. In our study, we explored the possible effect of C75 on HsmtKAS and mitochondrial function. C75 treatment decreased LA content, impaired mitochondrial function, increased reactive oxygen species content, and reduced cell viability. HsmtKAS but not FASN knockdown had an effect that was similar to C75 treatment. In addition, an LA supplement efficiently inhibited C75-induced mitochondrial dysfunction and oxidative stress. Overexpression of HsmtKAS showed cellular protection against low dose C75 addition, whereas there was no protective effect upon high dose C75 addition. In summary, the mitochondrial fatty acid synthesis pathway has a vital role in mitochondrial function. Besides FASN, C75 might also inhibit HsmtKAS, thereby reducing LA production, impairing mitochondrial function, and potentially having toxic effects. LA supplements sufficiently ameliorated the toxicity of C75, showing that a combination of C75 and LA may be a reliable cancer treatment.	Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Sch Life Sci & Technol, Key Lab Biomed Informat Engn,Minist Educ, Xian 710049, Peoples R China; Xi An Jiao Tong Univ, FIST, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Liu, JK (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Ctr Mitochondrial Biol & Med, FIST, 28 W,Xian Ning Rd, Xian 710049, Peoples R China.	j.liu@mail.xjtu.edu.cn; zhfeng@mail.xjtu.edu.cn	Zou, Xuan/A-6452-2015; Long, Jiangang/A-7835-2015; Liu, Jiankang/A-1610-2011; Feng, Zhihui/E-7408-2011; han, xiao/CAI-6839-2022	Long, Jiangang/0000-0002-6584-3880; Feng, Zhihui/0000-0002-2448-6565; han, xiao/0000-0002-4557-1304; Jiangang, Long/0000-0001-8074-957X	National Natural Science Foundation of China [31200620, 81201023, 31370844]; China Postdoctoral Science Foundation [2013M540739, 2013M542338]; New Century Excellent Talents in University; National "Twelfth Five-Year" Plan for Science & Technology Support; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National "Twelfth Five-Year" Plan for Science & Technology Support; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31200620,81201023, and 31370844, China Postdoctoral Science Foundation Grants 2013M540739 and 2013M542338, New Century Excellent Talents in University, National "Twelfth Five-Year" Plan for Science & Technology Support, and the Fundamental Research Funds for the Central Universities.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Alli PM, 2005, ONCOGENE, V24, P39, DOI 10.1038/sj.onc.1208174; Bentebibel A, 2006, BIOCHEMISTRY-US, V45, P4339, DOI 10.1021/bi052186q; Berndt J, 2007, DIABETOLOGIA, V50, P1472, DOI 10.1007/s00125-007-0689-x; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Chen ZJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005589; Christensen CE, 2007, PROTEIN SCI, V16, P261, DOI 10.1110/ps.062473707; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Flavin R, 2010, FUTURE ONCOL, V6, P551, DOI [10.2217/fon.10.11, 10.2217/FON.10.11]; Florczyk Urszula, 2010, Postepy Biochem, V56, P147; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Heath Richard J, 2004, Curr Opin Investig Drugs, V5, P146; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Huang H, 2013, PPAR RES, V2013, DOI 10.1155/2013/865604; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Liu JK, 2009, ADV DRUG DELIVER REV, V61, P1343, DOI 10.1016/j.addr.2009.06.007; Nesbitt NM, 2005, PROTEIN EXPRES PURIF, V39, P269, DOI 10.1016/j.pep.2004.10.021; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Packer L, 1997, Adv Pharmacol, V38, P79; Padmalayam I, 2009, DIABETES, V58, P600, DOI 10.2337/db08-0473; Puig T, 2008, BREAST CANCER RES TR, V109, P471, DOI 10.1007/s10549-007-9678-5; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; Smith S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047196; SULO P, 1993, J BIOL CHEM, V268, P17634; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wu M, 2011, P NATL ACAD SCI USA, V108, P5378, DOI 10.1073/pnas.1002588108; Yoshii Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064570; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200	40	28	29	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17184	17194		10.1074/jbc.M114.550806	http://dx.doi.org/10.1074/jbc.M114.550806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24784139	hybrid, Green Published			2022-12-25	WOS:000338016200051
J	Sand, KMK; Dalhus, B; Christianson, GJ; Bern, M; Foss, S; Cameron, J; Sleep, D; Bjoras, M; Roopenian, DC; Sandlie, I; Andersen, JT				Sand, Kine Marita Knudsen; Dalhus, Bjorn; Christianson, Gregory J.; Bern, Malin; Foss, Stian; Cameron, Jason; Sleep, Darrell; Bjoras, Magnar; Roopenian, Derry C.; Sandlie, Inger; Andersen, Jan Terje			Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-RELATED RECEPTOR; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-G; BINDING-PROPERTIES; IGG HOMEOSTASIS; COMPLEX; TRANSPORT; LIFE; SITE; EXOCYTOSIS	Albumin is the most abundant protein in blood and plays a pivotal role as a multitransporter of a wide range of molecules such as fatty acids, metabolites, hormones, and toxins. In addition, it binds a variety of drugs. Its role as distributor is supported by its extraordinary serum half-life of 3 weeks. This is related to its size and binding to the cellular receptor FcRn, which rescues albumin from intracellular degradation. Furthermore, the long half-life has fostered a great and increasing interest in utilization of albumin as a carrier of protein therapeutics and chemical drugs. However, to fully understand how FcRn acts as a regulator of albumin homeostasis and to take advantage of the FcRn-albumin interaction in drug design, the interaction interface needs to be dissected. Here, we used a panel of monoclonal antibodies directed towards human FcRn in combination with site-directed mutagenesis and structural modeling to unmask the binding sites for albumin blocking antibodies and albumin on the receptor, which revealed that the interaction is not only strictly pH-dependent, but predominantly hydrophobic in nature. Specifically, we provide mechanistic evidence for a crucial role of a cluster of conserved tryptophan residues that expose a pH-sensitive loop of FcRn, and identify structural differences in proximity to these hot spot residues that explain divergent cross-species binding properties of FcRn. Our findings expand our knowledge of how FcRn is controlling albumin homeostasis at a molecular level, which will guide design and engineering of novel albumin variants with altered transport properties.	[Sand, Kine Marita Knudsen; Bern, Malin; Foss, Stian; Sandlie, Inger] Univ Oslo, CIR, N-0316 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Foss, Stian; Sandlie, Inger] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Foss, Stian; Sandlie, Inger; Andersen, Jan Terje] Natl Hosp Norway, Oslo Univ Hosp, CIR, N-0424 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Foss, Stian; Sandlie, Inger; Andersen, Jan Terje] Natl Hosp Norway, Oslo Univ Hosp, Dept Immunol, N-0424 Oslo, Norway; [Sand, Kine Marita Knudsen; Dalhus, Bjorn; Bern, Malin; Foss, Stian; Bjoras, Magnar; Sandlie, Inger; Andersen, Jan Terje] Univ Oslo, N-0424 Oslo, Norway; [Dalhus, Bjorn; Bjoras, Magnar] Natl Hosp Norway, Oslo Univ Hosp, Dept Microbiol, N-0424 Oslo, Norway; [Dalhus, Bjorn; Bjoras, Magnar] Natl Hosp Norway, Oslo Univ Hosp, Dept Med Biochem, N-0424 Oslo, Norway; [Christianson, Gregory J.; Roopenian, Derry C.] Jackson Lab, Bar Harbor, ME 04609 USA; [Cameron, Jason; Sleep, Darrell] Novozymes Biopharma UK Ltd, Nottingham NG7 1FD, England	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Jackson Laboratory; Novozymes	Andersen, JT (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Ctr Immune Regulat, POB 4956, N-0424 Oslo, Norway.	j.t.andersen@ibv.uio.no	Dalhus, Bjørn/AAK-2895-2020; Bjørås, Magnar/N-9286-2017; Andersen, Jan Terje/AAB-6209-2020	Foss, Stian/0000-0001-6527-051X; Sleep, Darrell/0000-0001-8287-9538; Christianson, Gregory/0000-0001-5532-342X; Andersen, Jan Terje/0000-0003-1710-1628	Research Council of Norway through its Centres of Excellence [179573]; University of Oslo; South-Eastern Norway Regional Health Authority [2009100, 2011040, 2012085]; Research Council of Norway through programme for Global Health and Vaccination Research (GLOBVAC) Grant [143822]; Research Council of Norway [179573/V40, 230526/F20, 233710/O30]; Southeastern Norway Regional Health Authority [39375]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	Research Council of Norway through its Centres of Excellence(Research Council of Norway); University of Oslo; South-Eastern Norway Regional Health Authority; Research Council of Norway through programme for Global Health and Vaccination Research (GLOBVAC) Grant; Research Council of Norway(Research Council of Norway); Southeastern Norway Regional Health Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Research Council of Norway through its Centres of Excellence funding scheme (Project 179573). I. S., J. T. A., B. D., J. C., and D. S. are co-inventors of pending patent applications related to the data described in this work.; Supported by the University of Oslo.; Supported by the South-Eastern Norway Regional Health Authority to establish the Regional Technology Platform for Structural Biology and Bioinformatics (Grants 2009100, 2011040, and 2012085).; Supported by the Research Council of Norway through its programme for Global Health and Vaccination Research (GLOBVAC) Grant 143822.; Supported by the Research Council of Norway (Grants 179573/V40; 230526/F20, and 233710/O30) and the Southeastern Norway Regional Health Authority (Grant 39375). To whom correspondence should be addressed: Centre for Immune Regulation and Dept. of Immunology, Oslo University Hospital Rikshospitalet, P.O. Box 4956, Oslo N-0424, Norway. E-mail: j.t.andersen@ibv.uio.no.	Andersen JT, 2008, FEBS J, V275, P4097, DOI 10.1111/j.1742-4658.2008.06551.x; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2013, J BIOL CHEM, V288, P24277, DOI 10.1074/jbc.M113.463000; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2010, CLIN BIOCHEM, V43, P367, DOI 10.1016/j.clinbiochem.2009.12.001; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; [Anonymous], 1996, ALL ALBUMIN BIOCH GE; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Christianson GJ, 2012, MABS-AUSTIN, V4, P208, DOI 10.4161/mabs.4.2.19397; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993; Ghetie V, 1997, NAT BIOTECHNOL, V15, P637, DOI 10.1038/nbt0797-637; Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Kobayashi K, 2009, GASTROENTEROLOGY, V137, P1746, DOI 10.1053/j.gastro.2009.07.059; Medesan C, 1996, EUR J IMMUNOL, V26, P2533, DOI 10.1002/eji.1830261038; Mezo AR, 2010, J BIOL CHEM, V285, P27694, DOI 10.1074/jbc.M110.120667; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101; Ober RJ, 2004, J IMMUNOL, V172, P2021, DOI 10.4049/jimmunol.172.4.2021; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Popov S, 1996, MOL IMMUNOL, V33, P521, DOI 10.1016/0161-5890(96)00004-1; Prabhat P, 2007, P NATL ACAD SCI USA, V104, P5889, DOI 10.1073/pnas.0700337104; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; SIMISTER NE, 1989, COLD SPRING HARB SYM, V54, P571, DOI 10.1101/SQB.1989.054.01.068; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377; Vidarsson G, 2006, BLOOD, V108, P3573, DOI 10.1182/blood-2006-05-024539; Wani MA, 2006, P NATL ACAD SCI USA, V103, P5084, DOI 10.1073/pnas.0600548103; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m	42	33	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17228	17239		10.1074/jbc.M113.522565	http://dx.doi.org/10.1074/jbc.M113.522565			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24764301	Green Published, hybrid			2022-12-25	WOS:000338016200055
J	Asleh, R; Ward, J; Levy, NS; Safuri, S; Aronson, D; Levy, AP				Asleh, Rabea; Ward, John; Levy, Nina S.; Safuri, Shady; Aronson, Doron; Levy, Andrew P.			Haptoglobin Genotype-dependent Differences in Macrophage Lysosomal Oxidative Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ACUTE MYOCARDIAL-INFARCTION; INDUCED CELL-DEATH; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR-DISEASE; ALPHA-TOCOPHEROL; INTRAPLAQUE HEMORRHAGE; CHOLESTERYL ESTER; DIABETES-MELLITUS; MAJOR DETERMINANT	The major function of the Haptoglobin (Hp) protein is to control trafficking of extracorpuscular hemoglobin (Hb) thru the macrophage CD163 receptor with degradation of the Hb in the lysosome. There is a common copy number polymorphism in the Hp gene (Hp 2 allele) that has been associated with a sever-alfold increased incidence of atherothrombosis in multiple longitudinal studies. Increased plaque oxidation and apoptotic markers have been observed in Hp 2-2 atherosclerotic plaques, but the mechanism responsible for this finding has not been determined. We proposed that the increased oxidative injury in Hp 2-2 plaques is due to an impaired processing of Hp 2-2-Hb complexes within macrophage lysosomes, thereby resulting in redox active iron accumulation, lysosomal membrane oxidative injury, and macrophage apoptosis. We sought to test this hypothesis in vitro using purified Hp-Hb complex and cells genetically manipulated to express CD163. CD163-mediated endocytosis and lysosomal degradation of Hp-Hb were decreased for Hp 2-2-Hb complexes. Confocal microscopy using lysotropic pH indicator dyes demonstrated that uptake of Hp2-2-Hb complexes disrupted the lysosomal pH gradient. Cellular fractionation studies of lysosomes isolated from macrophages incubated with Hp 2-2-Hb complexes demonstrated increased lysosomal membrane oxidation and a loss of lysosomal membrane integrity leading to lysosomal enzyme leakage into the cytoplasm. Additionally, markers of apoptosis, DNA fragmentation, and active caspase 3 were increased in macrophages that had endocytosed Hp 2-2-Hb complexes. These data provide novel mechanistic insights into how the Hp genotype regulates lysosomal oxidative stress within macrophages after receptor-mediated endocytosis of Hb.	[Asleh, Rabea; Ward, John; Levy, Nina S.; Safuri, Shady; Levy, Andrew P.] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Asleh, Rabea; Aronson, Doron] Rambam Hlth Care Ctr, Dept Cardiol, IL-31096 Haifa, Israel; [Asleh, Rabea; Aronson, Doron] Rambam Hlth Care Ctr, Coronary Care Unit, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Rambam Health Care Campus	Asleh, R (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, 1 Efron St,Bat Galim,POB 9649, IL-31096 Haifa, Israel.	rasleh@tx.technion.ac.il	Asleh, Rabea/K-5664-2019; Aronson, Doron/F-3390-2010	Asleh, Rabea/0000-0002-0258-7402; 	National Institutes of Health [RO1DK085226]; Israel Science Foundation; Rappaport Fund for Medical Research; Slava Smolakovski Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Rappaport Fund for Medical Research; Slava Smolakovski Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK085226. This work was also supported by the Israel Science Foundation and the Rappaport Fund for Medical Research (to A. P. L.) and by a grant from the Slava Smolakovski Fund to the Rambam-Atidim Academic Excellence Program (to R. A.). Dr. Levy is an employee of the Rappaport Faculty of Medicine at the Technion-Israel Institute of Technology, which owns patents related to the use of haptoglobin typing to predict the risk of diabetic vascular complications.	Asleh R, 2005, CIRC RES, V96, P435, DOI 10.1161/01.RES.0000156653.05853.b9; Asleh R, 2003, CIRC RES, V92, P1193, DOI 10.1161/01.RES.0000076889.23082.F1; Bamm VV, 2004, BIOCHEMISTRY-US, V43, P3899, DOI 10.1021/bi0362626; BARGER AC, 1990, AM J CARDIOL, V66, pG41, DOI 10.1016/0002-9149(90)90394-G; Blum S, 2010, PHARMACOGENOMICS, V11, P675, DOI [10.2217/pgs.10.17, 10.2217/PGS.10.17]; Bowen HT, 1998, J AM COLL NUTR, V17, P171, DOI 10.1080/07315724.1998.10718743; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; BUNN HF, 1968, J BIOL CHEM, V243, P465; Doyle B, 2007, J AM COLL CARDIOL, V49, P2073, DOI 10.1016/j.jacc.2007.01.089; ELSAADANI M, 1989, J LIPID RES, V30, P627; ESTERBAUER H, 1991, AM J CLIN NUTR, V53, pS314, DOI 10.1093/ajcn/53.1.314S; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0306s07, 10.1002/0471143030.cb0309s10]; Hohn A, 2010, FREE RADICAL BIO MED, V48, P1100, DOI 10.1016/j.freeradbiomed.2010.01.030; Jerome WG, 2008, MICROSC MICROANAL, V14, P138, DOI 10.1017/S1431927608080069; Kalet-Litman S, 2010, ATHEROSCLEROSIS, V209, P28, DOI 10.1016/j.atherosclerosis.2009.09.002; Kockx MM, 1998, CIRCULATION, V97, P2307, DOI 10.1161/01.CIR.97.23.2307; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kurz T, 2010, ANTIOXID REDOX SIGN, V13, P511, DOI 10.1089/ars.2009.3005; Levy AP, 2007, ARTERIOSCL THROM VAS, V27, P134, DOI 10.1161/01.ATV.0000251020.24399.a2; Levy AP, 2000, NEW ENGL J MED, V343, P969, DOI 10.1056/NEJM200009283431313; Levy AP, 2004, ATHEROSCLEROSIS, V172, P361, DOI 10.1016/j.atherosclerosis.2003.10.014; Levy AP, 2002, J AM COLL CARDIOL, V40, P1984, DOI 10.1016/S0735-1097(02)02534-2; Li W, 2009, ATHEROSCLEROSIS, V202, P92, DOI 10.1016/j.atherosclerosis.2008.03.027; Li-Weber M, 2002, J CLIN INVEST, V110, P681, DOI [10.1172/JCI0215073, 10.1172/JCI200215073]; Littlewood TD, 2003, CURR OPIN LIPIDOL, V14, P469, DOI 10.1097/00041433-200310000-00007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu ZG, 2004, CELL RES, V14, P134, DOI 10.1038/sj.cr.7290212; Lyons NM, 2001, FREE RADICAL RES, V35, P329, DOI 10.1080/10715760100300861; Madsen M, 2001, REDOX REP, V6, P386, DOI 10.1179/135100001101536490; MAOR I, 1994, J LIPID RES, V35, P803; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Moreno PR, 2008, J AM COLL CARDIOL, V52, P1049, DOI 10.1016/j.jacc.2008.06.029; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Moreno PR, 2004, J AM COLL CARDIOL, V44, P2293, DOI 10.1016/j.jacc.2004.07.060; Moreno PR, 2004, CIRCULATION, V110, P2032, DOI 10.1161/01.CIR.0000143233.87854.23; Morgan J, 1995, J LIPID RES, V36, P2504; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; Nilsson E, 1997, HISTOCHEM J, V29, P857, DOI 10.1023/A:1026441907803; Purushothaman KR, 2012, J AM COLL CARDIOL, V60, P112, DOI 10.1016/j.jacc.2012.04.011; Roberg K, 2002, AM J PATHOL, V161, P89, DOI 10.1016/S0002-9440(10)64160-0; Roguin A, 2003, DIABETES CARE, V26, P2628, DOI 10.2337/diacare.26.9.2628; RUPAR CA, 1992, BIOCHEM CELL BIOL, V70, P486, DOI 10.1139/o92-075; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Schutt F, 2002, GRAEF ARCH CLIN EXP, V240, P983, DOI 10.1007/s00417-002-0558-8; SHAPIRO R, 1980, J BIOL CHEM, V255, P3120; Suleiman M, 2003, DIABETES CARE, V26, P2699, DOI 10.2337/diacare.26.9.2699; Tabas I, 2009, ANTIOXID REDOX SIGN, V11, P2333, DOI [10.1089/ars.2009.2469, 10.1089/ARS.2009.2469]; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Twigg SM, 2001, ENDOCRINOLOGY, V142, P1760, DOI 10.1210/endo.142.5.8141; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Wen YC, 2007, CIRC RES, V100, P1337, DOI 10.1161/CIRCRESAHA.107.151704; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6; Yuan XM, 2000, FREE RADICAL BIO MED, V28, P208, DOI 10.1016/S0891-5849(99)00220-8	55	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16313	16325		10.1074/jbc.M114.554212	http://dx.doi.org/10.1074/jbc.M114.554212			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778180	Green Published, hybrid			2022-12-25	WOS:000337965700035
J	Kim, JR; Hayes, KA; Yeung, NW; Cowie, RH				Kim, Jaynee R.; Hayes, Kenneth A.; Yeung, Norine W.; Cowie, Robert H.			Diverse Gastropod Hosts of Angiostrongylus cantonensis, the Rat Lungworm, Globally and with a Focus on the Hawaiian Islands	PLOS ONE			English	Article							GIANT AFRICAN SNAIL; EOSINOPHILIC-MENINGITIS; ACHATINA-FULICA; ENZOOTIC ANGIOSTRONGYLIASIS; EXPERIMENTAL-INFECTION; CLIMATE-CHANGE; MOLLUSKS; SLUGS; INTERMEDIATE; TRANSMISSION	Eosinophilic meningitis caused by the parasitic nematode Angiostrongylus cantonensis is an emerging infectious disease with recent outbreaks primarily in tropical and subtropical locations around the world, including Hawaii. Humans contract the disease primarily through ingestion of infected gastropods, the intermediate hosts of Angiostrongylus cantonensis. Effective prevention of the disease and control of the spread of the parasite require a thorough understanding of the parasite's hosts, including their distributions, as well as the human and environmental factors that contribute to transmission. The aim of this study was to screen a large cross section of gastropod species throughout the main Hawaiian Islands to determine which act as hosts of Angiostrongylus cantonensis and to assess the parasite loads in these species. Molecular screening of 7 native and 30 non-native gastropod species revealed the presence of the parasite in 16 species (2 native, 14 non-native). Four of the species tested are newly recorded hosts, two species introduced to Hawaii (Oxychilus alliarius, Cyclotropis sp.) and two native species (Philonesia sp., Tornatellides sp.). Those species testing positive were from a wide diversity of heterobranch taxa as well as two distantly related caenogastropod taxa. Review of the global literature showed that many gastropod species from 34 additional families can also act as hosts. There was a wide range of parasite loads among and within species, with an estimated maximum of 2.8 million larvae in one individual of Laevicaulis alte. This knowledge of the intermediate host range of Angiostrongylus cantonensis and the range of parasite loads will permit more focused efforts to detect, monitor and control the most important hosts, thereby improving disease prevention in Hawaii as well as globally.	[Kim, Jaynee R.] Univ Hawaii, Dept Biol, Honolulu, HI 96822 USA; [Kim, Jaynee R.; Hayes, Kenneth A.; Yeung, Norine W.; Cowie, Robert H.] Univ Hawaii, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Hayes, Kenneth A.] Howard Univ, Dept Biol, Washington, DC 20059 USA	University of Hawaii System; University of Hawaii System; Howard University	Cowie, RH (corresponding author), Univ Hawaii, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA.	cowie@hawaii.edu	Hayes, Kenneth A./R-6395-2018; Cowie, Robert/AAM-9509-2020	Yeung, Norine/0000-0002-6361-9009; Hayes, Kenneth/0000-0002-0814-483X	United States Department of Agriculture Cooperative Agricultural Pest Survey program; National Science Foundation [DEB-1120906]; Watson T. Yoshimoto Foundation through the Ecology, Evolutionary and Conservation Biology program at the University of Hawaii; American Malacological Society; Hawaiian Malacological Society; Division Of Environmental Biology [1120906] Funding Source: National Science Foundation	United States Department of Agriculture Cooperative Agricultural Pest Survey program; National Science Foundation(National Science Foundation (NSF)); Watson T. Yoshimoto Foundation through the Ecology, Evolutionary and Conservation Biology program at the University of Hawaii; American Malacological Society; Hawaiian Malacological Society; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by the United States Department of Agriculture Cooperative Agricultural Pest Survey program (http://www.usda.gov/wps/portal/usda/usdahome), National Science Foundation (DEB-1120906; http://www.nsf.gov/), Watson T. Yoshimoto Foundation through the Ecology, Evolutionary and Conservation Biology program at the University of Hawaii (http://www.hawaii.edu/eecb/), American Malacological Society (http://www.malacological.org/) and Hawaiian Malacological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2000, MICROBES INFECT, V2, P891, DOI 10.1016/S1286-4579(00)00389-0; AGUIAR PH, 1981, AM J TROP MED HYG, V30, P963, DOI 10.4269/ajtmh.1981.30.963; Aktipis Stephanie W., 2008, P201; ALICATA JE, 1966, CAN J ZOOLOG, V44, P1041, DOI 10.1139/z66-111; Asato R, 2004, JPN J INFECT DIS, V57, P184; ASH L R, 1976, Revista de Biologia Tropical, V24, P163; Bergey EA, 2013, BIOL INVASIONS, P1; Bieler Rudiger, 1993, Abhandlungen des Naturwissenschaftlichen Vereins in Hamburg, V30, P1; Bouchet P, 2005, MALACOLOGIA, V47, P1; BROCKELMAN C R, 1976, Southeast Asian Journal of Tropical Medicine and Public Health, V7, P30; Carreno RA, 2003, J PARASITOL, V89, P965, DOI 10.1645/GE-76R; Chen DX, 2011, PARASITOL RES, V109, P305, DOI 10.1007/s00436-011-2255-1; Chen E. R., 2007, V11, P263; Chen MX, 2011, J PARASITOL, V97, P144, DOI 10.1645/GE-2614.1; Christensen Carl C., 2012, Bishop Museum Occasional Papers, V112, P3; Cowie RH, 1995, EVOLUTION, V49, P1191, DOI 10.1111/j.1558-5646.1995.tb04446.x; Cowie RH, 1998, BIODIVERS CONSERV, V7, P349, DOI 10.1023/A:1008881712635; Cowie RH, 2008, INT J PEST MANAGE, V54, P267, DOI 10.1080/09670870802403986; Cowie Robert H., 2003, P93; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P70; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P6; Cowie Robert H., 2001, Biological Invasions, V3, P119, DOI 10.1023/A:1014529019000; CROOK JR, 1968, ANN TROP MED PARASIT, V62, P27, DOI 10.1080/00034983.1968.11686526; Deng ZH, 2012, TROP MED INT HEALTH, V17, P119, DOI 10.1111/j.1365-3156.2011.02880.x; Diaz J. H., 2010, Tropical Medicine and Health, V38, P115, DOI 10.2149/tmh.2009-20; Duffy MS, 2004, EMERG INFECT DIS, V10, P2207, DOI 10.3201/eid1012.040319; Graeff-Teixeira C, 2009, CLIN MICROBIOL REV, V22, P322, DOI 10.1128/CMR.00044-08; HADFIELD MG, 1993, AM ZOOL, V33, P610; Hata TY, 1997, CROP PROT, V16, P501, DOI 10.1016/S0261-2194(97)00034-3; Hayes Kenneth A., 2007, Bishop Museum Occasional Papers, V96, P54; Hayes Kenneth A., 2012, Bishop Museum Occasional Papers, V112, P21; Hochberg NS, 2007, EMERG INFECT DIS, V13, P1675, DOI 10.3201/eid1311.070367; Hochberg NS, 2011, AM J TROP MED HYG, V85, P685, DOI 10.4269/ajtmh.2011.11-0322; Hollingsworth RG, 2007, PAC SCI, V61, P457, DOI 10.2984/1534-6188(2007)61[457:DOPCMP]2.0.CO;2; Hollyer JR, 2010, BEST ON FARM FOOD SA, V39; HORIO S R, 1961, Hawaii Med J, V21, P139; Hu XiMin, 2007, China Tropical Medicine, V7, P1995; Ibrahim MM, 2007, PARASITE, V14, P61, DOI 10.1051/parasite/2007141061; Jarvi SI, 2012, MOL BIOCHEM PARASIT, V185, P174, DOI 10.1016/j.molbiopara.2012.08.002; Jin E, 2005, CLIN RADIOL, V60, P242, DOI 10.1016/j.crad.2004.05.012; Jurickova Lucie, 2006, Malacologica Bohemoslovaca, V5, P1; KLIKS MM, 1992, SOC SCI MED, V34, P199, DOI 10.1016/0277-9536(92)90097-A; Kwong KL, 2009, MALACOLOGIA, V51, P343, DOI 10.4002/040.051.0208; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lindo JF, 2004, AM J TROP MED HYG, V70, P425, DOI 10.4269/ajtmh.2004.70.425; Lindo JF, 2002, EMERG INFECT DIS, V8, P324, DOI 10.3201/eid0803.010316; Liu Jian, 2007, China Tropical Medicine, V7, P408; Lunn JA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-70; Lv S, 2008, EMERG INFECT DIS, V14, P161, DOI 10.3201/eid1401.061529; Lv S, 2011, FRESHWATER BIOL, V56, P717, DOI 10.1111/j.1365-2427.2011.02579.x; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Maldonado A, 2012, ZOONOSIS, P303, DOI DOI 10.5572/2125; Meyer WM, 2008, AM MALACOL BULL, V24, P117, DOI 10.4003/0740-2783-24.1.117; Meyer WM, 2010, MALACOLOGIA, V53, P135, DOI 10.4002/040.053.0106; Monks DJ, 2005, J AVIAN MED SURG, V19, P289, DOI 10.1647/2004-024.1; Morley NJ, 2010, PARASITOLOGY, V137, P1041, DOI 10.1017/S0031182010000016; Murphy Gerald S, 2013, Hawaii J Med Public Health, V72, P35; Neuhauss E, 2007, MEM I OSWALDO CRUZ, V102, P49, DOI 10.1590/S0074-02762007000100007; NEW D, 1995, NEW ENGL J MED, V332, P1105, DOI 10.1056/NEJM199504203321619; NISHIMURA K, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P595; Pilsbry H.A., 1948, ACAD NATURAL SCI PHI, V3, P521; Prociv P, 2000, INT J PARASITOL, V30, P1295, DOI 10.1016/S0020-7519(00)00133-8; PUNYAGUPTA S, 1975, AM J TROP MED HYG, V24, P921, DOI 10.4269/ajtmh.1975.24.921; Qvarnstrom Y, 2007, APPL ENVIRON MICROB, V73, P1415, DOI 10.1128/AEM.01968-06; Qvarnstrom Y, 2010, APPL ENVIRON MICROB, V76, P5287, DOI 10.1128/AEM.00546-10; RATANARAT-BROCKELMAN C, 1977, Biological Bulletin (Woods Hole), V152, P406, DOI 10.2307/1540428; RATANARATBROCKELMAN C, 1975, J INVERTEBR PATHOL, V25, P229, DOI 10.1016/0022-2011(75)90073-7; RICHARDS CS, 1967, J PARASITOL, V53, P382, DOI 10.2307/3276595; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Rosenberg G, 2006, P ACAD NAT SCI PHILA, V155, P117, DOI 10.1635/i0097-3157-155-1-117.1; Rueda Alfredo, 2002, P115, DOI 10.1079/9780851993201.0115; Sen Yong H, 2013, RAFFLES B ZOOL, P111; Slom TJ, 2002, NEW ENGL J MED, V346, P668, DOI 10.1056/NEJMoa012462; Solem A.C., 1984, P6; State of Hawaii Department of Health, 2013, 10 YEAR SUMM REP CAS; Strong EE, 2008, HYDROBIOLOGIA, V595, P149, DOI 10.1007/s10750-007-9012-6; Tesana S, 2009, AM J TROP MED HYG, V80, P983, DOI 10.4269/ajtmh.2009.80.983; Thiengo SC, 2010, ACTA TROP, V115, P194, DOI 10.1016/j.actatropica.2010.01.005; Tokiwa T, 2012, PARASITOL INT, V61, P431, DOI 10.1016/j.parint.2012.02.005; Tsai HC, 2001, AM J MED, V111, P109, DOI 10.1016/S0002-9343(01)00766-5; WALLACE G D, 1969, Malacologia, V7, P427; WALLACE GD, 1965, AM J EPIDEMIOL, V81, P52, DOI 10.1093/oxfordjournals.aje.a120497; WALLACE GD, 1969, AM J TROP MED HYG, V18, P206, DOI 10.4269/ajtmh.1969.18.206; WALLACE GD, 1969, AM J TROP MED HYG, V18, P13, DOI 10.4269/ajtmh.1969.18.13; WALLACE GD, 1969, AM J EPIDEMIOL, V89, P331, DOI 10.1093/oxfordjournals.aje.a120946; Wang J, 2010, J PARASITOL, V96, P377, DOI 10.1645/GE-2214.1; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Yang X, 2012, AM J TROP MED HYG, V86, P846, DOI 10.4269/ajtmh.2012.11-0532; YEN CM, 1990, J TROP MED HYG, V93, P347; Yeung Norine W, 2013, Hawaii J Med Public Health, V72, P83; Zhang RL, 2008, EMERG INFECT DIS, V14, P1955, DOI 10.3201/eid1412.080695; Zhang Yi, 2009, Chinese Journal of Parasitology and Parasitic Diseases, V27, P508	92	95	100	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94969	10.1371/journal.pone.0094969	http://dx.doi.org/10.1371/journal.pone.0094969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788772	Green Submitted, gold, Green Published			2022-12-25	WOS:000336655700022
J	Zhao, MH; Dong, YD; Ran, X; Wu, ZM; Guo, XX; Zhang, YM; Xing, D; Yan, T; Wang, G; Zhu, XJ; Zhang, HD; Li, CX; Zhao, TY				Zhao, Minghui; Dong, Yande; Ran, Xin; Wu, Zhiming; Guo, Xiaoxia; Zhang, Yingmei; Xing, Dan; Yan, Ting; Wang, Gang; Zhu, Xiaojuan; Zhang, Hengduan; Li, Chunxiao; Zhao, Tongyan			Point Mutations Associated with Organophosphate and Carbamate Resistance in Chinese Strains of Culex pipiens quinquefasciatus (Diptera: Culicidae)	PLOS ONE			English	Article							CONFER INSECTICIDE RESISTANCE; AMINO-ACID SUBSTITUTIONS; INSENSITIVE ACETYLCHOLINESTERASE; DROSOPHILA-MELANOGASTER; MOSQUITO; POPULATIONS	Acetylcholinesterase resistance has been well documented in many insects, including several mosquito species. We tested the resistance of five wild, Chinese strains of the mosquito Culex pipiens quinquefasciatus to two kinds of pesticides, dichlorvos and propoxur. An acetylcholinesterase gene (ace1) was cloned and sequenced from a pooled sample of mosquitoes from these five strains and the amino acids of five positions were found to vary (V185M, G247S, A328S, A391T, and T682A). Analysis of the correlation between mutation frequencies and resistance levels (LC50) suggests that two point mutations, G247S (r(2) = 0.732, P = 0.065) and A328S (r(2) = 0.891, P = 0.016), are associated with resistance to propoxur but not to dichlorvos. Although the V185M mutation was not associated with either dichlorvos or propoxur resistance, its RS genotype frequency was correlated with propoxur resistance (r(2) = 0.815, P = 0.036). And the HWE test showed the A328S mutation is linked with V185M, also with G247S mutation. This suggested that these three mutations may contribute synergistically to propoxur resistance. The T682A mutation was negatively correlated with propoxur (r(2) = 0.788, P = 0.045) resistance. Knowledge of these mutations may help design strategies for managing pesticide resistance in wild mosquito populations.	[Zhao, Minghui; Dong, Yande; Ran, Xin; Wu, Zhiming; Guo, Xiaoxia; Zhang, Yingmei; Xing, Dan; Yan, Ting; Wang, Gang; Zhu, Xiaojuan; Zhang, Hengduan; Li, Chunxiao; Zhao, Tongyan] Beijing Inst Microbiol & Epidemiol, Dept Vector Biol & Control, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China; [Zhao, Minghui; Ran, Xin] Anhui Med Univ, Hefei, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Anhui Medical University	Li, CX (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Vector Biol & Control, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China.	aedes@126.com; tongyanzhao@126.com			Infective Diseases Prevention and Cure Project of National Ministry of Public Health of China [2008ZX10004, 2012ZX10004219]	Infective Diseases Prevention and Cure Project of National Ministry of Public Health of China	This work was funded by the foundation from the Infective Diseases Prevention and Cure Project of National Ministry of Public Health of China (No. 2008ZX10004 and No. 2012ZX10004219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alout H, 2008, CHEM-BIOL INTERACT, V175, P138, DOI 10.1016/j.cbi.2008.03.018; Alout H, 2007, J MED ENTOMOL, V44, P463, DOI 10.1603/0022-2585(2007)44[463:DASCIR]2.0.CO;2; Alout H, 2007, INSECT BIOCHEM MOLEC, V37, P41, DOI 10.1016/j.ibmb.2006.10.001; Alout H, 2009, INSECT BIOCHEM MOLEC, V39, P884, DOI 10.1016/j.ibmb.2009.10.005; [Anonymous], 2009, DISC STUD 2 5 GUID; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ben Cheikh R, 2009, J MED ENTOMOL, V46, P523, DOI 10.1603/033.046.0317; Bourguet D, 1996, GENETICS, V143, P407; Cetin H, 2005, J VECTOR ECOL, V30, P151; Chandre F, 1997, J MED ENTOMOL, V34, P664, DOI 10.1093/jmedent/34.6.664; Cui F, 2006, J MED ENTOMOL, V43, P878, DOI 10.1603/0022-2585(2006)43[878:REOIAI]2.0.CO;2; Djogbenou L, 2008, ACTA TROP, V107, P272, DOI 10.1016/j.actatropica.2008.06.004; Djogbenou L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-12; FOURNIER D, 1988, FEBS LETT, V238, P333, DOI 10.1016/0014-5793(88)80507-6; Fournier D, 2005, CHEM-BIOL INTERACT, V157, P257, DOI 10.1016/j.cbi.2005.10.040; HEMINGWAY J, 1982, J ECON ENTOMOL, V75, P1055, DOI 10.1093/jee/75.6.1055; HEMINGWAY J, 1983, PESTIC BIOCHEM PHYS, V19, P167, DOI 10.1016/0048-3575(83)90136-0; Khajehali J, 2010, PEST MANAG SCI, V66, P220, DOI 10.1002/ps.1884; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kono Y, 2006, PESTIC BIOCHEM PHYS, V85, P123, DOI 10.1016/j.pestbp.2005.12.002; Kwon DH, 2010, PESTIC BIOCHEM PHYS, V96, P36, DOI 10.1016/j.pestbp.2009.08.013; Li CX, 2009, ENTOMOL NEWS, V120, P464, DOI 10.3157/021.120.0502; Li CX, 2005, STUDY GENES RESPONSI; Mayo O, 2008, TWIN RES HUM GENET, V11, P249, DOI 10.1375/twin.11.3.249; Menozzi P, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-4; MUTERO A, 1994, P NATL ACAD SCI USA, V91, P5922, DOI 10.1073/pnas.91.13.5922; Nabeshima T, 2004, BIOCHEM BIOPH RES CO, V313, P794, DOI 10.1016/j.bbrc.2003.11.141; Osta MA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-132; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Shi MA, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-5; Silman I, 1999, CHEM-BIOL INTERACT, V119, P43, DOI 10.1016/S0009-2797(99)00012-5; SMISSAERT HR, 1964, SCIENCE, V143, P129, DOI 10.1126/science.143.3602.129; Suman DS, 2010, J PESTIC SCI, V35, P27, DOI 10.1584/jpestics.G09-36; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Tantely ML, 2010, INSECT BIOCHEM MOLEC, V40, P317, DOI 10.1016/j.ibmb.2010.02.005; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; Wong DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046712	39	14	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95260	10.1371/journal.pone.0095260	http://dx.doi.org/10.1371/journal.pone.0095260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788312	gold, Green Submitted, Green Published			2022-12-25	WOS:000335510600029
J	Buckland, S; Cole, NC; Aguirre-Gutierrez, J; Gallagher, LE; Henshaw, SM; Besnard, A; Tucker, RM; Bachraz, V; Ruhomaun, K; Harris, S				Buckland, Steeves; Cole, Nik C.; Aguirre-Gutierrez, Jesus; Gallagher, Laura E.; Henshaw, Sion M.; Besnard, Aurelien; Tucker, Rachel M.; Bachraz, Vishnu; Ruhomaun, Kevin; Harris, Stephen			Ecological Effects of the Invasive Giant Madagascar Day Gecko on Endemic Mauritian Geckos: Applications of Binomial-Mixture and Species Distribution Models	PLOS ONE			English	Article							DETECTION PROBABILITIES; HIERARCHICAL-MODELS; ABUNDANCE; PHELSUMA; BIODIVERSITY; POPULATIONS; PREDICTION; ESTABLISHMENT; COMMUNITIES; COMPETITION	The invasion of the giant Madagascar day gecko Phelsuma grandis has increased the threats to the four endemic Mauritian day geckos (Phelsuma spp.) that have survived on mainland Mauritius. We had two main aims: (i) to predict the spatial distribution and overlap of P. grandis and the endemic geckos at a landscape level; and (ii) to investigate the effects of P. grandis on the abundance and risks of extinction of the endemic geckos at a local scale. An ensemble forecasting approach was used to predict the spatial distribution and overlap of P. grandis and the endemic geckos. We used hierarchical binomial mixture models and repeated visual estimate surveys to calculate the abundance of the endemic geckos in sites with and without P. grandis. The predicted range of each species varied from 85 km 2 to 376 km(2). Sixty percent of the predicted range of P. grandis overlapped with the combined predicted ranges of the four endemic geckos; 15% of the combined predicted ranges of the four endemic geckos overlapped with P. grandis. Levin's niche breadth varied from 0.140 to 0.652 between P. grandis and the four endemic geckos. The abundance of endemic geckos was 89% lower in sites with P. grandis compared to sites without P. grandis, and the endemic geckos had been extirpated at four of ten sites we surveyed with P. grandis. Species Distribution Modelling, together with the breadth metrics, predicted that P. grandis can partly share the equivalent niche with endemic species and survive in a range of environmental conditions. We provide strong evidence that smaller endemic geckos are unlikely to survive in sympatry with P. grandis. This is a cause of concern in both Mauritius and other countries with endemic species of Phelsuma.	[Buckland, Steeves; Cole, Nik C.; Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Buckland, Steeves; Gallagher, Laura E.; Henshaw, Sion M.; Bachraz, Vishnu; Ruhomaun, Kevin] Natl Pk Conservat Serv, Reduit, Mauritius; [Cole, Nik C.; Tucker, Rachel M.] Mauritian Wildlife Fdn, Vacoas, Mauritius; [Aguirre-Gutierrez, Jesus] Naturalis Biodivers Ctr, Leiden, Netherlands; [Aguirre-Gutierrez, Jesus] Univ Amsterdam, IBED, Amsterdam, Netherlands; [Besnard, Aurelien] Ctr Ecol Evolut & Fonct, Lab Biogeog & Ecol Vertebres, Montpellier, France; [Tucker, Rachel M.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Bristol; Naturalis Biodiversity Center; University of Amsterdam; Universite de Montpellier; University of Sheffield	Buckland, S (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	stvsbuckland@yahoo.com		Aguirre Gutierrez, Jesus/0000-0001-9190-3229; Besnard, Aurelien/0000-0002-2289-9761	Oregon Zoo; Chicago Herpetological Society; Sigma Xi; University of Bristol	Oregon Zoo; Chicago Herpetological Society; Sigma Xi; University of Bristol	This study was funded by Oregon Zoo, Chicago Herpetological Society and Sigma Xi. SB was supported by the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Gutierrez Jesus, 2013, PLoS One, V8, pe63708, DOI 10.1371/journal.pone.0063708; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Arnold E.N., 2000, BONN ZOOL MONOGR, V46, P309; Atkinson IAE, 2001, BIOL CONSERV, V99, P81, DOI 10.1016/S0006-3207(00)00189-0; Austin JJ, 2004, MOL PHYLOGENET EVOL, V31, P109, DOI 10.1016/j.ympev.2003.07.011; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Bomford M, 2009, BIOL INVASIONS, V11, P713, DOI 10.1007/s10530-008-9285-3; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carroll SP, 2011, EVOL APPL, V4, P184, DOI 10.1111/j.1752-4571.2010.00180.x; Carvalho SB, 2010, BIOL CONSERV, V143, P426, DOI 10.1016/j.biocon.2009.11.010; CASE TJ, 1991, EVOL ECOL, V5, P272, DOI 10.1007/BF02214232; Cayuela H, 2013, BIOL INVASIONS, V15, P2001, DOI 10.1007/s10530-013-0427-x; Chandler RB, 2011, J APPL ECOL, V48, P1038, DOI 10.1111/j.1365-2664.2011.02001.x; Charles Heather, 2007, V193, P217; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Clavero M, 2009, BIOL CONSERV, V142, P2043, DOI 10.1016/j.biocon.2009.03.034; Cole N., 2009, FIELD GUIDE REPTILES; De Wan AA, 2009, BIOL CONSERV, V142, P982, DOI 10.1016/j.biocon.2008.12.032; Dodd CK, 2004, HERPETOLOGICA, V60, P468, DOI 10.1655/03-60; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; Dorazio RM, 2007, ECOLOGY, V88, P2773, DOI 10.1890/07-0006.1; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Ficetola GF, 2010, GLOBAL CHANGE BIOL, V16, P528, DOI 10.1111/j.1365-2486.2009.01957.x; Ficetola GF, 2009, DIVERS DISTRIB, V15, P108, DOI 10.1111/j.1472-4642.2008.00516.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fiske I, 2010, MODELS DATA UNMARKED; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Gallien L, 2010, DIVERS DISTRIB, V16, P331, DOI 10.1111/j.1472-4642.2010.00652.x; Glaw Frank, 2007, P1; Goldberg SR, 2010, OCCAS PAP BERNICE P, V108, P49; Graves TA, 2011, ANIM CONSERV, V14, P652, DOI 10.1111/j.1469-1795.2011.00471.x; Hansen DM, 2007, AM NAT, V169, P534, DOI 10.1086/511960; Harmon LJ, 2007, OIKOS, V116, P1863, DOI 10.1111/j.0030-1299.2007.15958.x; Hastie T., 1999, GEN ADDITIVE MODELS; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Kery M., 2010, INTRO WINBUGS ECOLOG; Kery M, 2008, AUK, V125, P336, DOI 10.1525/auk.2008.06185; Kery M, 2009, ECOLOGY, V90, P1279, DOI 10.1890/07-1794.1; Krysko Kenneth L., 2003, Florida Scientist, V66, P222; Krysko Kenneth L., 2006, Herpetological Review, V37, P226; Kurle CM, 2008, P NATL ACAD SCI USA, V105, P3800, DOI 10.1073/pnas.0800570105; Levins R., 1968, EVOLUTION CHANGING E; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Loso JB, 2000, P NATL ACAD SCI USA, V97, P5693, DOI 10.1073/pnas.97.11.5693; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mazerolle MJ, 2007, J HERPETOL, V41, P672, DOI 10.1670/07-061.1; Mazerolle MJ, 2011, AICCMODAVG PACKAGE R; McGeoch MA, 2010, DIVERS DISTRIB, V16, P95, DOI 10.1111/j.1472-4642.2009.00633.x; McKenny HC, 2006, FOREST ECOL MANAG, V230, P186, DOI 10.1016/j.foreco.2006.04.034; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Noble T, 2011, J ZOOL, V283, P73, DOI 10.1111/j.1469-7998.2010.00751.x; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Pearson DE., 2009, P 3 INT S MIGR BIRDS, P3; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PIANKA ER, 1976, COPEIA, P125; Pike DA, 2013, GLOBAL ECOL BIOGEOGR, V22, P555, DOI 10.1111/geb.12025; Ratsoavina F, 2011, PHELSUMA GRANDIS IUC; Ridgeway G., 1999, COMPUT SCI STAT, P172; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Royle JA, 2006, J AGR BIOL ENVIR ST, V11, P249, DOI 10.1198/108571106X129153; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; RUMMEL JD, 1985, ECOLOGY, V66, P430, DOI 10.2307/1940392; Sanchez M, 2010, REUN ASS NAT O UNPUB; Schoener TW, 2002, ECOL MONOGR, V72, P383, DOI 10.1890/0012-9615(2002)072[0383:POACAL]2.0.CO;2; Schoener TW, 2001, NATURE, V412, P183, DOI 10.1038/35084071; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2013, PACKAGE BIOMOD2 SPEC; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Vinson J, 1969, Bull. Maurit. Inst., V6, P203; Virkkala R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063376; Williamson M., 1996, BIOL INVASIONS	80	17	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e88798	10.1371/journal.pone.0088798	http://dx.doi.org/10.1371/journal.pone.0088798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24785293	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917300001
J	Kunihiro, T; Veuger, B; Vasquez-Cardenas, D; Pozzato, L; Le Guitton, M; Moriya, K; Kuwae, M; Omori, K; Boschker, HTS; van Oevelen, D				Kunihiro, Tadao; Veuger, Bart; Vasquez-Cardenas, Diana; Pozzato, Lara; Le Guitton, Marie; Moriya, Kazuyoshi; Kuwae, Michinobu; Omori, Koji; Boschker, Henricus T. S.; van Oevelen, Dick			Phospholipid-Derived Fatty Acids and Quinones as Markers for Bacterial Biomass and Community Structure in Marine Sediments	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; SP-NOV.; RESPIRATORY QUINONES; GEN.-NOV.; MICROBIAL COMMUNITY; PHYLOGENETIC DIVERSITY; REDUCING BACTERIA; ACTIVATED-SLUDGE; GLOBAL PATTERNS; ORGANIC-MATTER	Phospholipid-derived fatty acids (PLFA) and respiratory quinones (RQ) are microbial compounds that have been utilized as biomarkers to quantify bacterial biomass and to characterize microbial community structure in sediments, waters, and soils. While PLFAs have been widely used as quantitative bacterial biomarkers in marine sediments, applications of quinone analysis in marine sediments are very limited. In this study, we investigated the relation between both groups of bacterial biomarkers in a broad range of marine sediments from the intertidal zone to the deep sea. We found a good log-log correlation between concentrations of bacterial PLFA and RQ over several orders of magnitude. This relationship is probably due to metabolic variation in quinone concentrations in bacterial cells in different environments, whereas PLFA concentrations are relatively stable under different conditions. We also found a good agreement in the community structure classifications based on the bacterial PLFAs and RQs. These results strengthen the application of both compounds as quantitative bacterial biomarkers. Moreover, the bacterial PLFA- and RQ profiles revealed a comparable dissimilarity pattern of the sampled sediments, but with a higher level of dissimilarity for the RQs. This means that the quinone method has a higher resolution for resolving differences in bacterial community composition. Combining PLFA and quinone analysis as a complementary method is a good strategy to yield higher resolving power in bacterial community structure.	[Kunihiro, Tadao; Veuger, Bart; Vasquez-Cardenas, Diana; Pozzato, Lara; Le Guitton, Marie; van Oevelen, Dick] Royal Netherlands Inst Sea Res NIOZ, Dept Ecosyst Studies, Yerseke, Netherlands; [Kunihiro, Tadao; Vasquez-Cardenas, Diana; Boschker, Henricus T. S.] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Microbiol, Yerseke, Netherlands; [Moriya, Kazuyoshi] Kanazawa Univ, Sch Nat Sci & Technol, Kanazawa, Ishikawa, Japan; [Kuwae, Michinobu; Omori, Koji] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Kanazawa University; Ehime University	Kunihiro, T (corresponding author), Royal Netherlands Inst Sea Res NIOZ, Dept Ecosyst Studies, Yerseke, Netherlands.	tadao.kunihiro@nioz.nl	Kuwae, Michinobu/AAG-3846-2020; Moriya, Kazuyoshi/E-4820-2016	Moriya, Kazuyoshi/0000-0003-2017-7025; Vasquez-Cardenas, Diana/0000-0002-8366-2020; Kunihiro, Tadao/0000-0001-6484-9386; Kuwae, Michinobu/0000-0002-7747-5421	MEXT of Japan [21710081, 23710010]; Japan Science Society [21-748M]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; EcoTopia Science Institute, Nagoya University [2-5]; Institute for Fermentation, Osaka (IFO)	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Society; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EcoTopia Science Institute, Nagoya University; Institute for Fermentation, Osaka (IFO)(Institute for Fermentation (IFO))	This work was partly supported by Grant-in-Aid for Young Scientists (B: 21710081 and 23710010) of MEXT of Japan, a Sasakawa Scientific Research Grant (21-748M) from the Japan Science Society, the Global COE Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the joint research program of the EcoTopia Science Institute, Nagoya University (Project No. 2-5), and the oversea research program from the Institute for Fermentation, Osaka (IFO) to T.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGAWAMATSUSHITA M, 1992, J GEN MICROBIOL, V138, P2275, DOI 10.1099/00221287-138-11-2275; ALONGI DM, 1994, HYDROBIOLOGIA, V285, P19, DOI 10.1007/BF00005650; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Arnosti C, 1998, MAR ECOL PROG SER, V165, P59, DOI 10.3354/meps165059; ATHALYE M, 1984, J GEN MICROBIOL, V130, P817; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boetius A, 1996, MAR ECOL PROG SER, V140, P239, DOI 10.3354/meps140239; Bolhuis H, 2011, ISME J, V5, P1701, DOI [10.1038/Ismej.2011.52, 10.1038/ismej.2011.52]; BOSCHKER H. T. S., 2004, MOL MICROBIAL ECOLOG, P1673; Boschker HTS, 2005, LIMNOL OCEANOGR, V50, P70, DOI 10.4319/lo.2005.50.1.0070; Boschker HTS, 2002, FEMS MICROBIOL ECOL, V40, P85, DOI 10.1111/j.1574-6941.2002.tb00940.x; BRINCHIVERSEN J, 1990, FEMS MICROBIOL ECOL, V74, P345; CAMMEN LM, 1980, MAR BIOL, V61, P9, DOI 10.1007/BF00410337; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; COLLINS MD, 1986, SYST APPL MICROBIOL, V8, P8, DOI 10.1016/S0723-2020(86)80141-2; Dauwe B, 1998, LIMNOL OCEANOGR, V43, P782, DOI 10.4319/lo.1998.43.5.0782; DEVEREUX R, 1989, J BACTERIOL, V171, P6689, DOI 10.1128/jb.171.12.6689-6695.1989; Dijkman NA, 2006, MAR ECOL PROG SER, V324, P113, DOI 10.3354/meps324113; Evrard V, 2012, MAR ECOL PROG SER, V455, P13, DOI 10.3354/meps09676; FINDLAY RH, 1990, MAR ECOL PROG SER, V62, P121, DOI 10.3354/meps062121; Fujie K, 1998, SOIL SCI PLANT NUTR, V44, P393, DOI 10.1080/00380768.1998.10414461; Gontang EA, 2007, APPL ENVIRON MICROB, V73, P3272, DOI 10.1128/AEM.02811-06; GUCKERT JB, 1985, FEMS MICROBIOL ECOL, V31, P147, DOI 10.1111/j.1574-6968.1985.tb01143.x; HAACK SK, 1994, APPL ENVIRON MICROB, V60, P2483, DOI 10.1128/AEM.60.7.2483-2493.1994; Haynes K, 2007, APPL ENVIRON MICROB, V73, P6112, DOI 10.1128/AEM.00551-07; HEDRICK DB, 1986, J MICROBIOL METH, V5, P243, DOI 10.1016/0167-7012(86)90049-7; Hiraishi A, 1999, J BIOSCI BIOENG, V88, P449, DOI 10.1016/S1389-1723(00)87658-6; HIRAISHI A, 1991, J GEN APPL MICROBIOL, V37, P57, DOI 10.2323/jgam.37.57; Hiraishi A, 2003, MICROBES ENVIRON, V18, P89, DOI [DOI 10.1264/jsme2.18.89, DOI 10.1264/JSME2.18.89]; Hoppe HG, 2002, BOOK SOIL P, P73; Hu HY, 2001, J MICROBIOL METH, V47, P17, DOI 10.1016/S0167-7012(01)00286-X; Hu HY, 2001, WATER SCI TECHNOL, V43, P99, DOI 10.2166/wst.2001.0024; Hu HY, 1999, J BIOSCI BIOENG, V87, P378, DOI 10.1016/S1389-1723(99)80049-8; Hwang CY, 2008, INT J SYST EVOL MICR, V58, P267, DOI 10.1099/ijs.0.65016-0; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; Jean WD, 2009, INT J SYST EVOL MICR, V59, P1880, DOI 10.1099/ijs.0.008235-0; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Kaur I, 2012, INT J SYST EVOL MICR, V62, P2897, DOI 10.1099/ijs.0.035691-0; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Kim HM, 2010, INT J SYST EVOL MICR, V60, P531, DOI 10.1099/ijs.0.007740-0; Knittel K, 2005, INT J SYST EVOL MICR, V55, P781, DOI 10.1099/ijs.0.63362-0; Kreyszig E., 1979, ADV ENG MATH; Kroppenstedt RM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P754, DOI 10.1007/0-387-30743-5_29; Kroppenstedt RM, 1985, CHEM METHODS BACTERI, P173; Kumhiro T, 2008, MAR POLLUT BULL, V57, P68, DOI 10.1016/j.marpolbul.2007.10.009; Kunihiro T, 2011, ISME J, V5, P1818, DOI 10.1038/ismej.2011.57; Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P84, DOI 10.1016/S0005-2728(01)00230-4; Lim JH, 2008, INT J SYST EVOL MICR, V58, P565, DOI 10.1099/ijs.0.65502-0; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; Llobet-Brossa E, 1998, APPL ENVIRON MICROB, V64, P2691; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Londry KL, 2004, APPL ENVIRON MICROB, V70, P745, DOI 10.1128/AEM.70.2.745-751.2004; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MANNHEIM W, 1978, INT J SYST BACTERIOL, V28, P7, DOI 10.1099/00207713-28-1-7; Martens T, 2006, INT J SYST EVOL MICR, V56, P1293, DOI 10.1099/ijs.0.63724-0; Mayor DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038582; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; NAKAGAWA Y, 1993, J GEN MICROBIOL, V139, P1155, DOI 10.1099/00221287-139-6-1155; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; O'Sullivan LA, 2006, INT J SYST EVOL MICR, V56, P169, DOI 10.1099/ijs.0.63941-0; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; OYAIZU H, 1981, J GEN APPL MICROBIOL, V27, P57, DOI 10.2323/jgam.27.57; Peacock AD, 2004, MICROBIAL ECOL, V47, P284, DOI 10.1007/s00248-003-1024-9; POLGLASE WJ, 1966, BIOCHIM BIOPHYS ACTA, V118, P425, DOI 10.1016/S0926-6593(66)80053-X; Polymenakou PN, 2005, MICROB ECOL, V50, P447, DOI 10.1007/s00248-005-0005-6; Polymenakou PN, 2005, MICROB ECOL, V49, P367, DOI 10.1007/s00248-004-0274-5; Pozzato L, 2012, PROKARYOTIC PROTOZOA; Pozzato L, 2013, BIOGEOSCIENCES DISCU, V10, P10399; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Romanenko LA, 2011, INT J SYST EVOL MICR, V61, P1375, DOI 10.1099/ijs.0.026047-0; Saitou K, 1999, SOIL SCI PLANT NUTR, V45, P775, DOI 10.1080/00380768.1999.10415843; Saitou K, 1999, SOIL SCI PLANT NUTR, V45, P669, DOI 10.1080/00380768.1999.10415830; Shin NR, 2012, INT J SYST EVOL MICR, V62, P1552, DOI 10.1099/ijs.0.034645-0; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Smith CJ, 2006, ENVIRON MICROBIOL, V8, P804, DOI 10.1111/j.1462-2920.2005.00963.x; Smith JL, 2008, INT J SYST EVOL MICR, V58, P1598, DOI 10.1099/ijs.0.65435-0; Takasu H, 2013, LIMNOLOGY, V14, P247, DOI 10.1007/s10201-013-0402-3; TAMAOKA J, 1983, J APPL BACTERIOL, V54, P31, DOI 10.1111/j.1365-2672.1983.tb01297.x; TAYLOR J, 1983, J GEN MICROBIOL, V129, P3303; Urakawa H, 2001, MAR ECOL PROG SER, V220, P47, DOI 10.3354/meps220047; van Oevelen D, 2006, LIMNOL OCEANOGR, V51, P1302, DOI 10.4319/lo.2006.51.3.1302; Van Trappen S, 2005, INT J SYST EVOL MICR, V55, P2571, DOI 10.1099/ijs.0.63849-0; Vancanneyt M, 1996, SYST APPL MICROBIOL, V19, P528, DOI 10.1016/S0723-2020(96)80025-7; Vandewiele S, 2009, DEEP-SEA RES PT II, V56, P376, DOI 10.1016/j.dsr2.2008.05.035; Veuger B, 2011, LIMNOL OCEANOGR, V56, P1065, DOI 10.4319/lo.2011.56.3.1065; Villanueva L, 2007, MICROB ECOL, V54, P523, DOI 10.1007/s00248-007-9224-3; Wilkinson S., 1988, MICROBIAL LIPIDS; YAMADA Y, 1976, J GEN APPL MICROBIOL, V22, P203, DOI 10.2323/jgam.22.203; Yokota A., 1992, B JFCC, V8, P136; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	93	14	14	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e96219	10.1371/journal.pone.0096219	http://dx.doi.org/10.1371/journal.pone.0096219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769853	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736600031
J	Ma, J; Hu, YM; Bu, RC; Chang, Y; Deng, HW; Qin, Q				Ma, Jun; Hu, Yuanman; Bu, Rencang; Chang, Yu; Deng, Huawei; Qin, Qin			Predicting Impacts of Climate Change on the Aboveground Carbon Sequestration Rate of a Temperate Forest in Northeastern China	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; BOREAL FOREST; ECOSYSTEM RESPONSE; FIRE DISTURBANCE; TREE MORTALITY; LANDSCAPE; GROWTH; BIOMASS; DYNAMICS; ECOTONE	The aboveground carbon sequestration rate (ACSR) reflects the influence of climate change on forest dynamics. To reveal the long-term effects of climate change on forest succession and carbon sequestration, a forest landscape succession and disturbance model (LANDIS Pro7.0) was used to simulate the ACSR of a temperate forest at the community and species levels in northeastern China based on both current and predicted climatic data. On the community level, the ACSR of mixed Korean pine hardwood forests and mixed larch hardwood forests, fluctuated during the entire simulation, while a large decline of ACSR emerged in interim of simulation in spruce-fir forest and aspen-white birch forests, respectively. On the species level, the ACSR of all conifers declined greatly around 2070s except for Korean pine. The ACSR of dominant hardwoods in the Lesser Khingan Mountains area, such as Manchurian ash, Amur cork, black elm, and ribbed birch fluctuated with broad ranges, respectively. Pioneer species experienced a sharp decline around 2080s, and they would finally disappear in the simulation. The differences of the ACSR among various climates were mainly identified in mixed Korean pine hardwood forests, in all conifers, and in a few hardwoods in the last quarter of simulation. These results indicate that climate warming can influence the ACSR in the Lesser Khingan Mountains area, and the largest impact commonly emerged in the A2 scenario. The ACSR of coniferous species experienced higher impact by climate change than that of deciduous species.	[Ma, Jun; Hu, Yuanman; Bu, Rencang; Chang, Yu; Qin, Qin] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Ma, Jun; Qin, Qin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Deng, Huawei] Shengli Oilfields Shengli Engn Co LTD, Dongying, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, YM (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	huym@iae.ac.cn	qin, qin x/GXG-6164-2022; Qin, Qin/GVT-5910-2022; Liu, Miao/AAH-9655-2021		"Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences [XDA05050201]; National Natural Science Foundation of China [30870441, 31070422, 41371198]	"Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was co-funded by the "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences (XDA05050201) and National Natural Science Foundation of China (30870441,31070422). An additional funding resource is National Natural Science Foundation of China (41371198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2004, OECOLOGIA, V140, P217, DOI 10.1007/s00442-004-1585-4; Albani M, 2006, GLOBAL CHANGE BIOL, V12, P2370, DOI 10.1111/j.1365-2486.2006.01254.x; Alexander HD, 2010, CAN J FOREST RES, V40, P716, DOI 10.1139/X10-029; AMMER U, 1995, FORSTWISS CENTRALBL, V114, P232, DOI 10.1007/BF02742227; Bent GC, 2001, FOREST ECOL MANAG, V143, P115, DOI 10.1016/S0378-1127(00)00511-9; Bernier PY, 2010, CAN J FOREST RES, V40, P109, DOI 10.1139/X09-177; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bu RC, 2006, THESIS, P30; Bu R, 2008, FOREST ECOL MANAG, V254, P407, DOI 10.1016/j.foreco.2007.09.080; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Chen QQ, 2013, CHINESE SCI BULL, V58, P1551, DOI 10.1007/s11434-012-5100-8; Chen XW, 2002, INT J SUST DEV WORLD, V9, P49; Coops NC, 2011, ECOL MODEL, V222, P2119, DOI 10.1016/j.ecolmodel.2011.03.033; Dai LM, 2013, FOREST ECOL MANAG, V300, P106, DOI 10.1016/j.foreco.2012.06.046; Deng HP, 2000, CHINESE J APPL ECOLO, V11, P4; Duchesne L, 2013, J FOREST RES-JPN, V18, P168, DOI 10.1007/s10310-012-0338-1; Feng ZW, 1993, BIOMASS PRODUCTION F; Fiorese G, 2013, RENEW ENERG, V52, P175, DOI 10.1016/j.renene.2012.09.060; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; Forster PMD, 2007, ATMOS ENVIRON, V41, P3941, DOI 10.1016/j.atmosenv.2005.11.081; Gardner R. H., 2003, MODEL VALIDATION TES; Ge J, 1990, J NE FORESTRY U, V18, P6; Goldblum D, 2005, CAN J FOREST RES, V35, P2709, DOI 10.1139/X05-185; Guarin A, 2005, FOREST ECOL MANAG, V218, P229, DOI 10.1016/j.foreco.2005.07.014; Guo R, 2010, CHINESE J APPL ECOLO, V21, P8; Gustafson EJ, 2000, CAN J FOREST RES, V30, P32, DOI 10.1139/cjfr-30-1-32; Gustafson EJ, 2010, ECOL APPL, V20, P700, DOI 10.1890/08-1693.1; He HS, 2008, FOREST ECOL MANAG, V254, P484, DOI 10.1016/j.foreco.2007.08.022; He HS, 1999, ECOL MODEL, V114, P213, DOI 10.1016/S0304-3800(98)00147-1; He HS, 2005, J BIOGEOGR, V32, P2043, DOI 10.1111/j.1365-2699.2005.01353.x; He HS, 1999, ECOLOGY, V80, P81, DOI 10.1890/0012-9658(1999)080[0081:SEASSO]2.0.CO;2; He HS, 2002, FOREST ECOL MANAG, V155, P257, DOI 10.1016/S0378-1127(01)00563-1; He SH, 2011, LANDIS SPATIALLY EXP; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; IPCC, 2007, PHYS SCI BAS; Iverson LR, 1998, ECOL MONOGR, V68, P465, DOI 10.1890/0012-9615(1998)068[0465:PAOTSF]2.0.CO;2; KASISCHKE ES, 1995, ECOL APPL, V5, P437, DOI 10.2307/1942034; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Liu ZH, 2012, GLOBAL CHANGE BIOL, V18, P2041, DOI 10.1111/j.1365-2486.2012.02649.x; Manusch C, 2012, ECOL MODEL, V243, P101, DOI 10.1016/j.ecolmodel.2012.06.008; Medvigy D, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045703; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Mladenoff D.J., 1999, SPATIAL MODELING FOR; Mladenoff DJ, 2004, ECOL MODEL, V180, P7, DOI 10.1016/j.ecolmodel.2004.03.016; Nanko K, 2008, CATENA, V72, P348, DOI 10.1016/j.catena.2007.07.002; Nanko K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033010; Ni J, 2011, REG ENVIRON CHANGE, V11, pS49, DOI 10.1007/s10113-010-0170-0; Nystrom M, 2012, REMOTE SENS ENVIRON, V123, P271, DOI 10.1016/j.rse.2012.03.008; Omeja PA, 2012, FOREST ECOL MANAG, V269, P293, DOI 10.1016/j.foreco.2011.12.044; Pan Y, 2006, ECOL APPL, V16, P125, DOI 10.1890/05-0247; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peng CH, 1999, ECOL MODEL, V122, P175, DOI 10.1016/S0304-3800(99)00137-4; Pretzsch H, 1999, FORSTWISS CENTRALBL, V118, P228, DOI 10.1007/BF02768989; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rastetter EB, 1996, BIOSCIENCE, V46, P190, DOI 10.2307/1312740; Reiners WA, 2012, ECOSYSTEMS, V15, P1351, DOI 10.1007/s10021-012-9589-0; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Sato H, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002056; Scheller RM, 2011, ECOSYSTEMS, V14, P987, DOI 10.1007/s10021-011-9462-6; Scott NA, 2004, ENVIRON MANAGE, V33, pS9, DOI 10.1007/s00267-003-9114-5; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Solberg S, 2009, FOREST ECOL MANAG, V258, P1735, DOI 10.1016/j.foreco.2008.09.057; Solomon D, 2007, GLOBAL CHANGE BIOL, V13, P511, DOI 10.1111/j.1365-2486.2006.01304.x; Subedi N, 2013, GLOBAL CHANGE BIOL, V19, P505, DOI 10.1111/gcb.12033; [孙凤华 Sun Fenghua], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P751; Wang JC, 2012, PLANT ECOL, V213, P47, DOI 10.1007/s11258-011-0005-1; Worbes M, 1999, J ECOL, V87, P391, DOI 10.1046/j.1365-2745.1999.00361.x; Xu CG, 2007, GLOBAL CHANGE BIOL, V13, P1469, DOI 10.1111/j.1365-2486.2007.01387.x; Xu CG, 2012, CLIMATIC CHANGE, V110, P53, DOI 10.1007/s10584-011-0098-5; Xu CG, 2010, LANDSCAPE ECOL, V25, P855, DOI 10.1007/s10980-010-9464-3; Xu H, 2001, NATURAL FOREST PINUS, P242; Yan X. D., 2000, ACTA PHYTOECOLOGICA, V24, P312; Yan X.D., 1999, J NAT RESOUR, V4, P372; Yan XD, 2000, ACTA PHYTOECO SINICA, V24, P8; Yan XiaoDong, 1996, Journal of Environmental Sciences, V8, P354; Yao XQ, 2009, J PLANT NUTR, V32, P772, DOI 10.1080/01904160902787875; Yu Ying, 2012, Yingyong Shengtai Xuebao, V23, P341; Zhou Y, 1994, VEGETATION SMALL KHI, P337	81	29	32	4	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96157	10.1371/journal.pone.0096157	http://dx.doi.org/10.1371/journal.pone.0096157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763409	Green Submitted, Green Published, gold			2022-12-25	WOS:000335505000067
J	Ali, HM; Urbinati, G; Chapuis, H; DesmaEle, D; Bertrand, JR; Couvreur, P; Massaad-Massade, L				Ali, Hafiz Muhammad; Urbinati, Giorgia; Chapuis, Hubert; DesmaEle, Didier; Bertrand, Jean-Remi; Couvreur, Patrick; Massaad-Massade, Liliane			Effects of siRNA on RET/PTC3 Junction Oncogene in Papillary Thyroid Carcinoma: From Molecular and Cellular Studies to Preclinical Investigations	PLOS ONE			English	Article							SQUALENE NANOPARTICLES; RET PROTOONCOGENE; RNA INTERFERENCE; DELIVERY; REARRANGEMENTS; ACTIVATION; RECEPTOR; DEATH; CELLS; THERAPEUTICS	RET/PTC3 junction oncogene is typical of radiation-induced childhood papillary thyroid carcinoma (PTC) with a short latency period. Since, RET/PTC3 is only present in the tumour cells, thus represents an interesting target for specific therapy by small interfering RNA (siRNA). Our aim is to demonstrate in vitro and in vivo molecular and cellular effects of siRNA on RET/PTC3 knockdown for therapeutic application. First, we established a novel cell line stably expressing RET/PTC3 junction oncogene, named RP3 which was found tumorigenic in nude mice compared to NIH/3T3 mouse fibroblasts. Among four siRNAs and five concentrations tested against RET/PTC3, an efficient siRNA RET/PTC3 and an appropriate dose (50 nM) were selected which showed significant inhibition (p<0.001) of gene (RT-qPCR) and protein (Western blot) expressions. This siRNA was found efficient in RP3 cells (harbouring RET/PTC3) but non-efficient in BHP10-3 SCmice cell line (harbouring RET/PTC1) showing that a specific siRNA against fusion sequence is required to target the junction oncogene. In vitro siRNA RET/PTC3 showed significant (p<0.001) inhibitory effects on RP3 cell viability (MTT assay) and on invasion/migration (IncuCyte scratch test) with blockage of cell cycle at G0/G1 phase (flow cytometry) and induced apoptosis by caspase-3 and PARP1 cleavage (WB). After intravenous injection in nude mice, respective squalene (SQ) nanoparticles (NPs) of siRNA RET/PTC3 significantly (p<0.001) reduced RP3 tumour growth, oncogene and oncoprotein expressions, induced apoptosis and partially restored differentiation (decrease in Ki67). Hence, our findings highly support the use of siRNA RET/PTC3-SQ NPs as a new promising treatment for patients affected by PTC expressing RET/PTC3.	[Ali, Hafiz Muhammad; Urbinati, Giorgia; Bertrand, Jean-Remi; Massaad-Massade, Liliane] Univ Paris 11, Lab Vectorol & Therapeut Anticanc, UMR 8203, Villejuif, France; [Ali, Hafiz Muhammad; Urbinati, Giorgia; Bertrand, Jean-Remi; Massaad-Massade, Liliane] CNRS, Lab Vectorol & Therapeut Anticanc, UMR 8203, Villejuif, France; [Ali, Hafiz Muhammad; Urbinati, Giorgia; Bertrand, Jean-Remi; Massaad-Massade, Liliane] Gustave Roussy, Lab Vectorol & Therapeut Anticanc, UMR 8203, Villejuif, France; [Chapuis, Hubert; DesmaEle, Didier; Couvreur, Patrick] Univ Paris 11, Fac Pharm, UMR CNRS 8612, Inst Galien, F-92290 Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Massaad-Massade, L (corresponding author), Univ Paris 11, Lab Vectorol & Therapeut Anticanc, UMR 8203, Villejuif, France.	liliane.massade@igr.fr	Desmaële, Didier/X-9435-2019; Massaad, Massaad-Massade or Massade or/O-7226-2017; Ali, HM/AAH-3473-2021; COUVREUR, Patrick/AAY-7568-2020; Patrick, COUVREUR/G-4844-2011	Massaad, Massaad-Massade or Massade or/0000-0002-9636-4559; Ali, HM/0000-0001-9266-408X; Patrick, COUVREUR/0000-0001-7961-5443	Agence Nationale de Recherche (ANR) [Nu NANO 00301]; European Research Council (ERC) [FP7/2009-2014]	Agence Nationale de Recherche (ANR)(French National Research Agency (ANR)); European Research Council (ERC)(European Research Council (ERC))	The research leading to these results has received fundings from the Agence Nationale de Recherche (ANR), Program P2N, grant Nu NANO 00301 and from the European Research Council (ERC), Program FP7/2009-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2008, ARCH OTOLARYNGOL, V134, P190, DOI 10.1001/archoto.2007.36; Ali HM, 2014, THYROID, V24, P327, DOI 10.1089/thy.2012.0544; Ali HM, 2012, EXPERT REV CLIN PHAR, V5, P403, DOI [10.1586/ECP.12.33, 10.1586/ecp.12.33]; Couvreur P, 2006, NANO LETT, V6, P2544, DOI 10.1021/nl061942q; Desmaele D, 2012, J CONTROL RELEASE, V161, P609, DOI 10.1016/j.jconrel.2011.07.038; Di Cristofaro J, 2005, ENDOCR-RELAT CANCER, V12, P173, DOI 10.1677/erc.1.00884; Gilbert-Sirieix M, 2010, THYROID, V20, P1053, DOI 10.1089/thy.2010.0006; Hillaireau H, 2013, BIOMATERIALS, V34, P4831, DOI 10.1016/j.biomaterials.2013.03.022; Jhiang SM, 2000, ONCOGENE, V19, P5590, DOI 10.1038/sj.onc.1203857; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Klugbauer S, 1995, ONCOGENE, V11, P2459; Lehtinen L, 2013, ONCOTARGET, V4, P48, DOI 10.18632/oncotarget.756; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LiVolsi VA, 2011, MODERN PATHOL, V24, pS1, DOI 10.1038/modpathol.2010.129; Marotta V, 2011, EUR J ENDOCRINOL, V165, P499, DOI 10.1530/EJE-11-0499; McLeod DSA, 2013, LANCET, V381, P1046, DOI 10.1016/S0140-6736(12)62205-3; Meurette O, 2007, CANCER RES, V67, P218, DOI 10.1158/0008-5472.CAN-06-1610; Nakazawa T, 2005, CANCER-AM CANCER SOC, V104, P943, DOI 10.1002/cncr.21270; Nikiforov YE, 1997, CANCER RES, V57, P1690; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Raouane M, 2012, BIOCONJUGATE CHEM, V23, P1091, DOI 10.1021/bc200422w; Raouane M, 2011, J MED CHEM, V54, P4067, DOI 10.1021/jm2000272; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Romei Cristina, 2012, Front Endocrinol (Lausanne), V3, P54, DOI 10.3389/fendo.2012.00054; SANTORO M, 1994, ONCOGENE, V9, P509; Santoro M, 2006, EUR J ENDOCRINOL, V155, P645, DOI 10.1530/eje.1.02289; SCHULZEOSTHOFF K, 1994, EMBO J, V13, P4587, DOI 10.1002/j.1460-2075.1994.tb06780.x; Tallini G, 2001, ADV ANAT PATHOL, V8, P345, DOI 10.1097/00125480-200111000-00005; Tuschl T, 2002, NAT BIOTECHNOL, V20, P446, DOI 10.1038/nbt0502-446; Vivero M, 2013, THYROID, V23, P273, DOI 10.1089/thy.2012.0369; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wilson CA, 2002, CELL DEATH DIFFER, V9, P1321, DOI 10.1038/sj.cdd.4401107; Zhu ZW, 2006, J CLIN ENDOCR METAB, V91, P3603, DOI 10.1210/jc.2006-1006	33	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95964	10.1371/journal.pone.0095964	http://dx.doi.org/10.1371/journal.pone.0095964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759995	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200119
J	Diao, Y; Yang, CZ; Yan, M; Zheng, XF; Jin, SR; Wang, YW; Hu, ZL				Diao, Ying; Yang, Chaozhu; Yan, Mi; Zheng, Xingfei; Jin, Surong; Wang, Youwei; Hu, Zhongli			De Novo Transcriptome and Small RNA Analyses of Two Amorphophallus Species	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; POTATO-TUBER; EXPRESSION; BIOGENESIS; TOOL	Konjac is one of the most important glucomannan crops worldwide. The breeding and genomic researches are largely limited by the genetic basis of Amorphophallus. In this study, the transcriptomes of A. konjac and A. bulbifer were constructed using a high-throughput Illumina sequencing platform. All 108,651 unigenes with average lengths of 430 nt in A. konjac and 119,678 unigenes with average lengths of 439 nt were generated from 54,986,020 reads and 52,334,098 reads after filtering and assembly, respectively. A total of 54,453 transcripts in A. konjac and 55,525 in A. bulbifier were annotated by comparison with Nr, Swiss-Prot, KEGG, and COG databases after removing exogenous contaminated sequences. A total of 80,332 transcripts differentially expressed between A. konjac and A. bulbifer. The majority of the genes that are associated with konjac glucomannan biosynthetic pathway were identified. Besides, the small RNAs in A. konjac leaves were also obtained by deep sequencing technology. All of 5,499,903 sequences of small RNAs were obtained with the length range between 18 and 30 nt. The potential targets for the miRNAs were also predicted according to the konjac transcripts. Our study provides a systematic overview of the konjac glucomannan biosynthesis genes that are involved in konjac leaves and should facilitate further understanding of the crucial roles of carbohydrate synthesis and other important metabolism pathways in Amorphophallus.	[Diao, Ying; Wang, Youwei] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430072, Peoples R China; [Diao, Ying; Zheng, Xingfei; Hu, Zhongli] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Yang, Chaozhu] Enshi Acad Agr Sci, Inst Konjac, Enshi, Peoples R China; [Yan, Mi] Nanan Dist Chongqing Publ Secur Bur, Criminal Tech Lab, Chongqing, Peoples R China; [Jin, Surong] Wuhan Univ Technol, Sch Sci, Wuhan 430070, Peoples R China	Wuhan University; Wuhan University; Wuhan University of Technology	Wang, YW (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430072, Peoples R China.	wyw@whu.edu.cn; huzhongli@whu.edu.cn			National Key Technologies RD Program [2011BAD33B03]; National Natural Science Foundation of China [30970195]; Science and Technology Project of Chongqing Education Commission [KJ101202]	National Key Technologies RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Chongqing Education Commission	This work was supported by the National Key Technologies R&D Program (No. 2011BAD33B03), the National Natural Science Foundation of China (No. 30970195) and the Science and Technology Project of Chongqing Education Commission (No. KJ101202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai M, 2003, SPECIAL EC ANIMALS P, V7, P23; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; BALLICORA MA, 1995, PLANT PHYSIOL, V109, P245, DOI 10.1104/pp.109.1.245; CHAUHAN K P S, 1985, Kew Bulletin, V40, P745, DOI 10.2307/4109857; [陈立贵 CHEN Ligui], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P6157; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Gille S, 2011, PLANTA, V234, P515, DOI 10.1007/s00425-011-1422-z; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; IGLESIAS AA, 1993, J BIOL CHEM, V268, P1081; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kuang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057715; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lothar E, 1996, GLYCOBIOLOGY, V6, P591; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MURATA T, 1975, AGR BIOL CHEM TOKYO, V39, P1401, DOI 10.1080/00021369.1975.10861788; Niu Y., 2005, SW HORT, V33, P22; Preiss J, 1991, OXFORD SURVEYS PLANT, V7, P59; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sheng D. X., 2008, CHINA AGR INF, V7, P39; Xu AG, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000843; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang D. H., 2009, RESOUR DEV MARK; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang XG, 2004, KONJAC BIOL, P84; Zhou Y., 2004, CHINA PLANT PROTECTI, V24, P17	33	14	14	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95428	10.1371/journal.pone.0095428	http://dx.doi.org/10.1371/journal.pone.0095428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759927	gold, Green Submitted, Green Published			2022-12-25	WOS:000335298200057
J	Nowosielski, M; DiFranco, MD; Putzer, D; Seiz, M; Recheis, W; Jacobs, AH; Stockhammer, G; Hutterer, M				Nowosielski, Martha; DiFranco, Matthew D.; Putzer, Daniel; Seiz, Marcel; Recheis, Wolfgang; Jacobs, Andreas H.; Stockhammer, Guenther; Hutterer, Markus			An Intra-Individual Comparison of MRI, [F-18]-FET and [F-18]-FLT PET in Patients with High-Grade Gliomas	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CONTRAST-ENHANCING GLIOMAS; GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMA; C-11-METHIONINE PET; CEREBRAL GLIOMAS; BRAIN-TUMORS; FET-PET; PROLIFERATION; TEMOZOLOMIDE	Objectives: Intra-individual spatial overlap analysis of tumor volumes assessed by MRI, the amino acid PET tracer [F-18]-FET and the nucleoside PET tracer [F-18]-FLT in high-grade gliomas (HGG). Methods: MRI, [F-18]-FET and [F-18]-FLT PET data sets were retrospectively analyzed in 23 HGG patients. Morphologic tumor volumes on MRI (post-contrast T1 (cT1) and T2 images) were calculated using a semi-automatic image segmentation method. Metabolic tumor volumes for [F-18]-FET and [F-18]-FLT PETs were determined by image segmentation using a threshold-based volume of interest analysis. After co-registration with MRI the morphologic and metabolic tumor volumes were compared on an intra-individual basis in order to estimate spatial overlaps using the Spearman's rank correlation coefficient and the Mann-Whitney U test. Results: [F-18]-FLT uptake was negative in tumors with no or only moderate contrast enhancement on MRI, detecting only 21 of 23 (91%) HGG. In addition, [F-18]-FLT uptake was mainly restricted to cT1 tumor areas on MRI and [F-18]-FLT volumes strongly correlated with cT1 volumes (r = 0.841, p < 0.001). In contrast, [F-18]-FET PET detected 22 of 23 (96%) HGG. [F-18]-FET uptake beyond areas of cT1 was found in 61% of cases and [F-18]-FET volumes showed only a moderate correlation with cT1 volumes (r = 0.573, p <0.001). Metabolic tumor volumes beyond cT1 tumor areas were significantly larger for [F-18]-FET compared to [F-18]-FLT tracer uptake (8.3 vs. 2.7 cm(3), p <0.001). Conclusion: In HGG [F-18]-FET but not [F-18]-FLT PET was able to detect metabolic active tumor tissue beyond contrast enhancing tumor on MRI. In contrast to [F-18]-FET, blood-brain barrier breakdown seems to be a prerequisite for [F-18]-FLT tracer uptake.	[Nowosielski, Martha; Stockhammer, Guenther; Hutterer, Markus] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [DiFranco, Matthew D.] Med Univ Innsbruck, Dept Oto Rhino & Laryngol, Visualizat Lab 4D, A-6020 Innsbruck, Austria; [Putzer, Daniel] Med Univ Innsbruck, Dept Nucl Med, A-6020 Innsbruck, Austria; [Seiz, Marcel] Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria; [Recheis, Wolfgang] Med Univ Innsbruck, Dept Radiol, A-6020 Innsbruck, Austria; [DiFranco, Matthew D.] Med Univ Vienna, Dept Radiol, Computat Image Anal & Radiol Lab CIR, Vienna, Austria; [Hutterer, Markus] Univ Hosp, Dept Neurol, Regensburg, Germany; [Hutterer, Markus] Univ Hosp, Wilhelm Sander Neurooncol Unity, Regensburg, Germany; [Hutterer, Markus] Med Sch Regensburg, Regensburg, Germany; [Jacobs, Andreas H.] Univ Munster, European Inst Mol Imaging, D-48149 Munster, Germany; [Jacobs, Andreas H.] Johanniter Krankenhaus, Evangel Kliniken, Dept Geriatr, Bonn, Germany; [Seiz, Marcel] Mannheim Med Univ, Dept Neurosurg, Mannheim, Germany	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Vienna; University of Regensburg; University of Regensburg; University of Munster	Nowosielski, M (corresponding author), Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria.	Martha.Nowosielski@i-med.ac.at	DiFranco, Matthew/M-3567-2015; Hutterer, Markus/AAG-4535-2020; Nowosielski, Martha/AAD-5442-2022; Jacobs, Andreas H./AAA-6794-2020	DiFranco, Matthew/0000-0002-5844-1154; 	DOC-fFORTE Fellowship from the Austrian Academy of Science at the Department of Neurology; Innsbruck Medical University; Oesterreichische Nationalbank Jubilaumsfond [14326]; EU Marie Curie Intra European Fellowship at the Computational Image Analysis and Radiology Lab (CIR); Department of Radiology, Medical University of Vienna [PIEF-GA-2010-275747]	DOC-fFORTE Fellowship from the Austrian Academy of Science at the Department of Neurology; Innsbruck Medical University; Oesterreichische Nationalbank Jubilaumsfond; EU Marie Curie Intra European Fellowship at the Computational Image Analysis and Radiology Lab (CIR); Department of Radiology, Medical University of Vienna	Martha Nowosielski holds a DOC-fFORTE Fellowship from the Austrian Academy of Science at the Department of Neurology, Innsbruck Medical University. Markus Hutterer holds a grant from the Oesterreichische Nationalbank Jubilaumsfond (project number 14326). Matthew D.DiFranco holds an EU Marie Curie Intra European Fellowship at the Computational Image Analysis and Radiology Lab (CIR), Department of Radiology, Medical University of Vienna (grant number PIEF-GA-2010-275747). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen W, 2007, J CLIN ONCOL, V25, P4714, DOI 10.1200/JCO.2006.10.5825; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; FELIX R, 1985, RADIOLOGY, V156, P681, DOI 10.1148/radiology.156.3.4040643; FISCHMAN AJ, 1991, J NUCL MED, V32, P2351; Floeth FW, 2006, J NUCL MED, V47, P776; Floeth FW, 2005, J NEUROSURG, V102, P318, DOI 10.3171/jns.2005.102.2.0318; Galldiks N, 2006, EUR J NUCL MED MOL I, V33, P516, DOI 10.1007/s00259-005-0002-5; Galldiks N, MOL IMAGING, V9, P40; Galldiks N., 2012, J NUCL MED; Galldiks N, 2010, EUR J NUCL MED MOL I, V37, P84, DOI 10.1007/s00259-009-1219-5; Grosu AL, 2011, INT J RAD ONCOL BIOL; HALPERIN EC, 1989, INT J RADIAT ONCOL, V17, P1347, DOI 10.1016/0360-3016(89)90548-8; Hatakeyama T, 2008, EUR J NUCL MED MOL I, V35, P2009, DOI 10.1007/s00259-008-0847-5; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Hutterer M, 2013, NEURO-ONCOLOGY, V15, P341, DOI 10.1093/neuonc/nos300; Hutterer M, 2011, J NUCL MED, V52, P856, DOI 10.2967/jnumed.110.086645; Jacobs AH, 2005, J NUCL MED, V46, P1948; Jeong SY, 2012, NUCL MED BIOL; Kunz M, 2011, NEURO-ONCOLOGY, V13, P307, DOI 10.1093/neuonc/noq196; Langen KJ, 2006, NUCL MED BIOL, V33, P287, DOI 10.1016/j.nucmedbio.2006.01.002; Lee IH, 2009, INT J RADIAT ONCOL, V73, P479, DOI 10.1016/j.ijrobp.2008.04.050; Lunsford L D, 1986, Acta Radiol Suppl, V369, P154; Muzi M, 2006, J NUCL MED, V47, P1612; Niyazi M, 2011, RADIOTHER ONCOL, V99, P44, DOI 10.1016/j.radonc.2011.03.001; Paproski RJ, 2008, MOL PHARMACOL, V74, P1372, DOI 10.1124/mol.108.048900; Pauleit D, 2005, BRAIN, V128, P678, DOI 10.1093/brain/awh399; Pauleit D, 2009, NUCL MED BIOL, V36, P779, DOI 10.1016/j.nucmedbio.2009.05.005; Pirotte BJM, 2009, NEUROSURGERY, V64, P471, DOI 10.1227/01.NEU.0000338949.94496.85; Plotkin M, 2010, EUR RADIOL, V20, P2496, DOI 10.1007/s00330-010-1819-2; Popperl G, 2006, EUR J NUCL MED MOL I, V33, P792, DOI 10.1007/s00259-005-0053-7; Popperl G, 2005, EUR J NUCL MED MOL I, V32, P1018, DOI 10.1007/s00259-005-1819-7; Popperl G, 2004, EUR J NUCL MED MOL I, V31, P1464, DOI 10.1007/s00259-004-1590-1; Rasey JS, 2002, J NUCL MED, V43, P1210; Sahm F, 2012, ARCH NEUROL-CHICAGO, V69, P523, DOI 10.1001/archneurol.2011.2910; Schwarzenberg J, 2012, J NUCL MED, V53, P29, DOI 10.2967/jnumed.111.092387; Shinomiya A, 2013, BRAIN TUMOR PATHOL; Shinomiya A, 2013, EUR J NUCL MED MOL I, V40, P175, DOI 10.1007/s00259-012-2275-9; Stockhammer F, 2008, J NEURO-ONCOL, V88, P205, DOI 10.1007/s11060-008-9551-3; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; SWETS JA, 1979, INVEST RADIOL, V14, P109, DOI 10.1097/00004424-197903000-00002; Ullrich R, 2008, CLIN CANCER RES, V14, P2049, DOI 10.1158/1078-0432.CCR-07-1553; Vesselle H, 2003, J NUCL MED, V44, P1482; Viel T, 2012, J NUCL MED, V53, P1135, DOI 10.2967/jnumed.111.101659; von Baumgarten L, 2011, CLIN CANCER RES, V17, P6192, DOI 10.1158/1078-0432.CCR-10-1868; Weber DC, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-44; Wyss MT, 2007, J NUCL MED, V48, P1047, DOI 10.2967/jnumed.106.038489; Yamamoto Y, 2012, J NUCL MED, V53, P1911, DOI 10.2967/jnumed.112.104729; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	48	51	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95830	10.1371/journal.pone.0095830	http://dx.doi.org/10.1371/journal.pone.0095830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759867	Green Published, gold, Green Submitted			2022-12-25	WOS:000335298200095
J	Varian-Ramos, CW; Swaddle, JP; Cristol, DA				Varian-Ramos, Claire W.; Swaddle, John P.; Cristol, Daniel A.			Mercury Reduces Avian Reproductive Success and Imposes Selection: An Experimental Study with Adult-or Lifetime-Exposure in Zebra Finch	PLOS ONE			English	Article							IBISES EUDOCIMUS-ALBUS; METHYLMERCURY EXPOSURE; CHEMICAL FORM; SPARROWS; BIRDS; BIOACCUMULATION; BIOAVAILABILITY; EVOLUTION; HEALTH; RISK	Mercury is a global pollutant that biomagnifies in food webs, placing wildlife at risk of reduced reproductive fitness and survival. Songbirds are the most diverse branch of the avian evolutionary tree; many are suffering persistent and serious population declines and we know that songbirds are frequently exposed to mercury pollution. Our objective was to determine the effects of environmentally relevant doses of mercury on reproductive success of songbirds exposed throughout their lives or only as adults. The two modes of exposure simulated philopatric species versus dispersive species, and are particularly relevant because of the heightened mercury-sensitivity of developing nervous systems. We performed a dosing study with dietary methylmercury in a model songbird species, the zebra finch (Taeniopygia guttata), at doses from 0.3 -2.4 parts per million. Birds were exposed to mercury either as adults only or throughout their lives. All doses of mercury reduced reproductive success, with the lowest dose reducing the number of independent offspring produced in one year by 16% and the highest dose, representing approximately half the lethal dose for this species, causing a 50% reduction. While mercury did not affect clutch size or survivorship, it had the most consistent effect on the proportion of chicks that fledged from the nest, regardless of mode of exposure. Among birds exposed as adults, mercury caused a steep increase in the latency to re-nest after loss of a clutch. Birds exposed for their entire lifetimes, which were necessarily the offspring of dosed parents, had up to 50% lower reproductive success than adult-exposed birds at low doses of methylmercury, but increased reproductive success at high doses, suggesting selection for mercury tolerance at the highest level of exposure. Our results indicate that mercury levels in prey items at contaminated sites pose a significant threat to populations of songbirds through reduced reproductive success.	[Varian-Ramos, Claire W.] Colorado State Univ, Dept Biol, Pueblo, CO 81001 USA; [Swaddle, John P.; Cristol, Daniel A.] Coll William & Mary, Dept Biol, Inst Integrat Bird Behav Studies, Williamsburg, VA 23185 USA	Colorado State University; William & Mary	Varian-Ramos, CW (corresponding author), Colorado State Univ, Dept Biol, Pueblo, CO 81001 USA.	claire.ramos@colostate-pueblo.edu			E.I. DuPont de Nemours and Company; College of William and Mary; Division Of Integrative Organismal Systems [1257590] Funding Source: National Science Foundation	E.I. DuPont de Nemours and Company; College of William and Mary; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded in part by E.I. DuPont de Nemours and Company. The College of William and Mary provided additional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2012, ENVIRON POLLUT, V162, P439, DOI 10.1016/j.envpol.2011.12.004; Albers PH, 2007, ENVIRON TOXICOL CHEM, V26, P1856, DOI 10.1897/06-592R.1; Bouland AJ, 2012, J AVIAN BIOL, V43, P244, DOI 10.1111/j.1600-048X.2012.05612.x; Brasso RL, 2008, ECOTOXICOLOGY, V17, P133, DOI 10.1007/s10646-007-0163-z; Buck K.A., 2013, THESIS COLL WILLIAM; Burger J, 1997, ENVIRON RES, V75, P160, DOI 10.1006/enrs.1997.3778; Caserta D, 2013, EUR REV MED PHARMACO, V17, P2198; Choi AL, 2008, ENVIRON CHEM, V5, P112, DOI 10.1071/EN08014; Cristol DA, 2008, SCIENCE, V320, P335, DOI 10.1126/science.1154082; Cristol DA, 2011, ECOTOXICOLOGY, V20, P1773, DOI 10.1007/s10646-011-0710-5; Depew DC, 2012, ENVIRON TOXICOL CHEM, V31, P2399, DOI 10.1002/etc.1971; Eagles-Smith CA, 2009, ENVIRON TOXICOL CHEM, V28, P568, DOI 10.1897/08-245.1; Edmonds ST, 2010, CONDOR, V112, P789, DOI 10.1525/cond.2010.100145; Edmonds ST, 2012, ENVIRON POLLUT, V171, P148, DOI [10.1016/j.envPol.2012.07.044, 10.1016/j.envpol.2012.07.044]; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; Evers DC, 2005, ECOTOXICOLOGY, V14, P193, DOI 10.1007/s10646-004-6269-7; Evers DC, 2003, ECOTOXICOLOGY, V12, P69, DOI 10.1023/A:1022593030009; Fournier F, 2002, COMP BIOCHEM PHYS A, V133, P703, DOI 10.1016/S1095-6433(02)00140-X; Frederick P., 2010, P ROY SOC LOND B BIO, V278, P1853; Hallinger KK, 2011, ECOTOXICOLOGY, V20, P39, DOI 10.1007/s10646-010-0554-4; Hallinger KK, 2010, AUK, V127, P156, DOI 10.1525/auk.2009.09058; Harding KM, 2006, ENVIRON POLLUT, V143, P529, DOI 10.1016/j.envpol.2005.11.040; Harris HH, 2003, SCIENCE, V301, P1203, DOI 10.1126/science.1085941; Heath JA, 2005, AUK, V122, P255, DOI 10.1642/0004-8038(2005)122[0255:RAMCHA]2.0.CO;2; Heinz GH, 2012, ARCH ENVIRON CON TOX, V62, P141, DOI 10.1007/s00244-011-9680-0; Heinz GH, 2010, ECOTOXICOLOGY, V19, P977, DOI 10.1007/s10646-010-0479-y; Heinz GH, 2009, ARCH ENVIRON CON TOX, V56, P129, DOI 10.1007/s00244-008-9160-3; Henny CJ, 2002, ECOTOXICOLOGY, V11, P213, DOI 10.1023/A:1016327602656; Hooper MJ, 2013, ENVIRON TOXICOL CHEM, V32, P32, DOI 10.1002/etc.2043; Jackson AK, 2011, AUK, V128, P759, DOI 10.1525/auk.2011.11106; Janssens TKS, 2009, INSECT SCI, V16, P3, DOI 10.1111/j.1744-7917.2009.00249.x; Jayasena N, 2011, AQUAT TOXICOL, V105, P321, DOI 10.1016/j.aquatox.2011.07.003; Keller RH, 2014, ECOTOXICOLOGY, V23, P304, DOI 10.1007/s10646-013-1174-6; Kim EY, 1996, ARCH ENVIRON CON TOX, V30, P259; LANGE BW, 1990, GENETICS, V126, P921; Lewis CA, 2013, ARCH ENVIRON CON TOX, V64, P327, DOI 10.1007/s00244-012-9830-z; Perera F, 2011, REPROD TOXICOL, V31, P363, DOI 10.1016/j.reprotox.2010.12.055; Reitzel AM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-6; Rice DC, 1996, NEUROTOXICOLOGY, V17, P583; Rimmer CC, 2005, ENVIRON POLLUT, V162, P439; Rimmer CC, 2010, ECOTOXICOLOGY, V19, P697, DOI 10.1007/s10646-009-0443-x; SCHEUHAMMER AM, 1988, B ENVIRON CONTAM TOX, V40, P123, DOI 10.1007/BF01689398; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Strom SM, 2011, ECOTOXICOLOGY, V20, P1694, DOI 10.1007/s10646-011-0734-x; Townsend JM, 2013, ECOTOXICOLOGY, V22, P86, DOI 10.1007/s10646-012-1005-1; Tsao DC, 2007, ARCH ENV CONTAM TOXI, V56, P292; Varian-Ramos CW, 2013, ENVIRON POLLUT, V182, P316, DOI 10.1016/j.envpol.2013.07.044; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Winder VL, 2012, ECOTOXICOLOGY, V21, P325, DOI 10.1007/s10646-011-0794-y; Zann RA., 1996, ZEBRA FINCH SYNTHESI; Zhang ZS, 2010, J ENVIRON SCI, V22, P1179, DOI 10.1016/S1001-0742(09)60235-7	51	59	59	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95674	10.1371/journal.pone.0095674	http://dx.doi.org/10.1371/journal.pone.0095674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759822	Green Published, gold			2022-12-25	WOS:000335298200074
J	Krabbe, C; Bak, ST; Jensen, P; von Linstow, C; Serrano, AM; Hansen, C; Meyer, M				Krabbe, Christina; Bak, Sara Thornby; Jensen, Pia; von Linstow, Christian; Martinez Serrano, Alberto; Hansen, Claus; Meyer, Morten			Influence of Oxygen Tension on Dopaminergic Differentiation of Human Fetal Stem Cells of Midbrain and Forebrain Origin	PLOS ONE			English	Article							NEURAL PRECURSOR CELLS; BCL-X-L; ENDOTHELIAL GROWTH-FACTOR; PARKINSONS-DISEASE; LONG-TERM; IN-VITRO; ENHANCED PROLIFERATION; LOWERED OXYGEN; CNS PRECURSORS; RODENT MODEL	Neural stem cells (NSCs) constitute a promising source of cells for transplantation in Parkinson's disease (PD), but protocols for controlled dopaminergic differentiation are not yet available. Here we investigated the influence of oxygen on dopaminergic differentiation of human fetal NSCs derived from the midbrain and forebrain. Cells were differentiated for 10 days in vitro at low, physiological (3%) versus high, atmospheric (20%) oxygen tension. Low oxygen resulted in upregulation of vascular endothelial growth factor and increased the proportion of tyrosine hydroxylase-immunoreactive (TH-ir) cells in both types of cultures (midbrain: 9.1 +/- 0.5 and 17.1 +/- 0.4 (P<0.001); forebrain: 1.9 +/- 0.4 and 3.9 +/- 0.6 (P<0.01) percent of total cells). Regardless of oxygen levels, the content of TH-ir cells with mature neuronal morphologies was higher for midbrain as compared to forebrain cultures. Proliferative Ki67-ir cells were found in both types of cultures, but the relative proportion of these cells was significantly higher for forebrain NSCs cultured at low, as compared to high, oxygen tension. No such difference was detected for midbrain-derived cells. Western blot analysis revealed that low oxygen enhanced beta-tubulin III and GFAP expression in both cultures. Up-regulation of beta-tubulin III was most pronounced for midbrain cells, whereas GFAP expression was higher in forebrain as compared to midbrain cells. NSCs from both brain regions displayed less cell death when cultured at low oxygen tension. Following mictrotransplantation into mouse striatal slice cultures predifferentiated midbrain NSCs were found to proliferate and differentiate into substantial numbers of TH-ir neurons with mature neuronal morphologies, particularly at low oxygen. In contrast, predifferentiated forebrain NSCs microtransplanted using identical conditions displayed little proliferation and contained few TH-ir cells, all of which had an immature appearance. Our data may reflect differences in dopaminergic differentiation capacity and region-specific requirements of NSCs, with the dopamine-depleted striatum cultured at low oxygen offering an attractive micro-environment for midbrain NSCs.	[Krabbe, Christina; Bak, Sara Thornby; Jensen, Pia; von Linstow, Christian; Meyer, Morten] Univ Southern Denmark, Inst Mol Med, Dept Neurobiol Res, Odense C, Denmark; [Martinez Serrano, Alberto] Univ Autonoma Madrid, CSIC, Dept Mol Biol, Madrid, Spain; [Martinez Serrano, Alberto] Univ Autonoma Madrid, CSIC, Ctr Mol Biol Severo Ochoa, Madrid, Spain; [Hansen, Claus] Univ Copenhagen, Panum Inst, IMBG, Wilhelm Johannsen Ctr Funct Genome Res,Dept Med G, DK-2200 Copenhagen, Denmark	University of Southern Denmark; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Copenhagen	Meyer, M (corresponding author), Univ Southern Denmark, Inst Mol Med, Dept Neurobiol Res, Odense C, Denmark.	mmeyer@health.sdu.dk	von Linstow, Christian/F-4088-2017; Martínez-Serrano, Alberto/J-8146-2014	von Linstow, Christian/0000-0002-5316-993X; 	Danish Parkinson Association; IMK Almene Fond; Horslev-Fonden; Kirsten og Freddy Johansens Fond; Grosserer Brogaard og Hustrus Mindefond; Fonden for Laegevidenskabens Fremme; Danish Centre for Stem Cell Research; MINECO [PLE2009-0101, SAF2010-17167, CAM S2011-BMD-2336]; Danish National Research Foundation; Lundbeck Foundation; Danish Council for Strategic Research (Program Commission on Strategic Growth Technologies)	Danish Parkinson Association; IMK Almene Fond; Horslev-Fonden; Kirsten og Freddy Johansens Fond; Grosserer Brogaard og Hustrus Mindefond; Fonden for Laegevidenskabens Fremme; Danish Centre for Stem Cell Research; MINECO(Spanish Government); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Danish Council for Strategic Research (Program Commission on Strategic Growth Technologies)	This research was supported by the Danish Parkinson Association, IMK Almene Fond, Horslev-Fonden, Kirsten og Freddy Johansens Fond, Grosserer Brogaard og Hustrus Mindefond, Fonden for Laegevidenskabens Fremme and, the Danish Centre for Stem Cell Research. Work at AMS laboratory was supported by MINECO grants PLE2009-0101 and SAF2010-17167, and CAM S2011-BMD-2336 (Neurostem-CM). CH was supported by grants from the Danish National Research Foundation, the Lundbeck Foundation and the Danish Council for Strategic Research (Program Commission on Strategic Growth Technologies). The Wilhelm Johannsen Centre for Functional Genome Research was established by the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RK, 2007, J NEUROSCI METH, V165, P55, DOI 10.1016/j.jneumeth.2007.05.019; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Budinger GRS, 2002, J BIOL CHEM, V277, P15654, DOI 10.1074/jbc.M109317200; Campbell K, 2002, TRENDS NEUROSCI, V25, P235, DOI 10.1016/S0166-2236(02)02156-2; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; Courtois ET, 2010, J BIOL CHEM, V285, P9881, DOI 10.1074/jbc.M109.054312; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; FREED CR, 1990, PROG BRAIN RES, V82, P715; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; Ganser C, 2010, EXP CELL RES, V316, P737, DOI 10.1016/j.yexcr.2010.01.001; Gramsbergen JB, 2002, BRAIN RES, V935, P47, DOI 10.1016/S0006-8993(02)02451-4; Jensen P, 2011, EXP CELL RES, V317, P1649, DOI 10.1016/j.yexcr.2011.04.012; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jorgensen JR, 2006, EXP NEUROL, V198, P427, DOI 10.1016/j.expneurol.2005.12.023; Kanaan NM, 2006, BRAIN RES, V1068, P221, DOI 10.1016/j.brainres.2005.10.078; Krabbe C, 2009, J NEUROCHEM, V110, P1908, DOI 10.1111/j.1471-4159.2009.06281.x; Larsen TR, 2008, NEUROCHEM INT, V52, P487, DOI 10.1016/j.neuint.2007.08.008; Lindvall Olle, 2004, NeuroRx, V1, P382; Liste I, 2007, CELL DEATH DIFFER, V14, P1880, DOI 10.1038/sj.cdd.4402205; Liste I, 2004, J NEUROSCI, V24, P10786, DOI 10.1523/JNEUROSCI.3208-04.2004; Liu S, 2009, BRAIN RES BULL, V80, P62, DOI 10.1016/j.brainresbull.2009.05.007; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McLeod M, 2006, EUR J NEUROSCI, V24, P361, DOI 10.1111/j.1460-9568.2006.04919.x; Meyer M, 2001, NEUROSCIENCE, V108, P273, DOI 10.1016/S0306-4522(01)00418-3; Meyer M, 2000, EXP NEUROL, V164, P82, DOI 10.1006/exnr.2000.7419; Milosevic J, 2005, J NEUROCHEM, V92, P718, DOI 10.1111/j.1471-4159.2004.02893.x; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Nishino H, 2000, EXP NEUROL, V164, P209, DOI 10.1006/exnr.2000.7426; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Petit GH, 2014, NEUROPATH APPL NEURO, V40, P60, DOI 10.1111/nan.12110; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Politis M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-1; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Sayles M, 2004, TRANSPL IMMUNOL, V12, P321, DOI 10.1016/j.trim.2003.12.012; Seiz EG, 2012, EXP CELL RES, V318, P2446, DOI 10.1016/j.yexcr.2012.07.018; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shibata T, 1997, J NEUROSCI, V17, P9212; SHIMAN R, 1971, J BIOL CHEM, V246, P1330; Stacpoole SRL, 2011, NAT PROTOC, V6, P1229, DOI 10.1038/nprot.2011.380; Stacpoole SRL, 2011, CELL DEATH DIFFER, V18, P1016, DOI 10.1038/cdd.2010.171; Stacpoole SRL, 2013, STEM CELL TRANSL MED, V2, P464, DOI 10.5966/sctm.2012-0144; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Studer L, 2000, J NEUROSCI, V20, P7377; Villa A, 2004, EXP CELL RES, V294, P559, DOI 10.1016/j.yexcr.2003.11.025; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Villa A, 2009, EXP CELL RES, V315, P1860, DOI 10.1016/j.yexcr.2009.03.011; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006	56	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96465	10.1371/journal.pone.0096465	http://dx.doi.org/10.1371/journal.pone.0096465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788190	Green Published, gold			2022-12-25	WOS:000336655700095
J	Boras-Granic, K; Dann, P; VanHouten, J; Karaplis, A; Wysolmerski, J				Boras-Granic, Kata; Dann, Pamela; VanHouten, Joshua; Karaplis, Andrew; Wysolmerski, John			Deletion of the Nuclear Localization Sequences and C-Terminus of PTHrP Impairs Embryonic Mammary Development but also Inhibits PTHrP Production	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; BREAST-CANCER CELLS; PARATHYROID-HORMONE; GLAND DEVELOPMENT; HUMORAL HYPERCALCEMIA; DUCTAL MORPHOGENESIS; GROWTH-RETARDATION; PEPTIDE PTHRP; SMOOTH-MUSCLE; MICE LACKING	Parathyroid hormone-related protein (PTHrP) can be secreted from cells and interact with its receptor, the Type 1 PTH/PTHrP Receptor (PTHR1) in an autocrine, paracrine or endocrine fashion. PTHrP can also remain inside cells and be transported into the nucleus, where its functions are unclear, although recent experiments suggest that it may broadly regulate cell survival and senescence. Disruption of either the PTHrP or PTHR1 gene results in many abnormalities including a failure of embryonic mammary gland development in mice and in humans. In order to examine the potential functions of nuclear PTHrP in the breast, we examined mammary gland development in PTHrP (1-84) knock-in mice, which express a mutant form of PTHrP that lacks the C-terminus and nuclear localization signals and which can be secreted but cannot enter the nucleus. Interestingly, we found that PTHrP (1-84) knock-in mice had defects in mammary mesenchyme differentiation and mammary duct outgrowth that were nearly identical to those previously described in PTHrP(-/-) and PTHR1-/- mice. However, the mammary buds in PTHrP (1-84) knock-in mice had severe reductions in mutant PTHrP mRNA levels, suggesting that the developmental defects were due to insufficient production of PTHrP by mammary epithelial cells and not loss of PTHrP nuclear function. Examination of the effects of nuclear PTHrP in the mammary gland in vivo will require the development of alternative animal models.	[Boras-Granic, Kata; Dann, Pamela; VanHouten, Joshua; Wysolmerski, John] Yale Univ, Sch Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Karaplis, Andrew] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	Yale University; Lady Davis Institute; McGill University	Wysolmerski, J (corresponding author), Yale Univ, Sch Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA.	john.wysolmerski@yale.edu			NIH [R01 DK55501, R01 CA153702]; DOD Breast Cancer Research Program [BC095546]; NATIONAL CANCER INSTITUTE [R01CA153702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055501] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following grants awarded to Dr. Wysolmerski: NIH R01 DK55501, NIH R01 CA153702 and DOD Breast Cancer Research Program Grant BC095546. These funding agencies had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Amizuka N, 1996, DEV BIOL, V175, P166, DOI 10.1006/dbio.1996.0104; Bhatia V, 2009, REGUL PEPTIDES, V158, P149, DOI 10.1016/j.regpep.2009.07.008; BURTIS WJ, 1987, J BIOL CHEM, V262, P7151; Chen XS, 2006, J BONE MINER RES, V21, P113, DOI 10.1359/JBMR.051005; Cormier S, 2003, GENE EXPR PATTERNS, V3, P59, DOI 10.1016/S1567-133X(02)00074-1; Cowin P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003251; Dunbar ME, 1998, DEV BIOL, V203, P75, DOI 10.1006/dbio.1998.9029; Dunbar ME, 1999, DEVELOPMENT, V126, P3485; Falzon M, 2000, ENDOCRINOLOGY, V141, P1882, DOI 10.1210/en.141.5.1882; Fiaschi-Taesch N, 2004, CIRCULATION, V110, P177, DOI 10.1161/01.CIR.0000134483.30849.B7; Fiaschi-Taesch NM, 2003, ENDOCRINOLOGY, V144, P407, DOI 10.1210/en.2002-220818; Foley J, 2001, DEVELOPMENT, V128, P513; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Hens J, 2009, DEV DYNAM, V238, P2713, DOI 10.1002/dvdy.22097; Hens JR, 2007, DEVELOPMENT, V134, P1221, DOI 10.1242/dev.000182; Hiremath M, 2013, J MAMMARY GLAND BIOL, V18, P171, DOI 10.1007/s10911-013-9283-7; Hiremath M, 2012, DEVELOPMENT, V139, P4239, DOI 10.1242/dev.080671; Jans DA, 2003, VITAM HORM, V66, P345, DOI 10.1016/S0083-6729(03)01010-0; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LEE KC, 1995, ENDOCRINOLOGY, V136, P453, DOI 10.1210/en.136.2.453; MANGIN M, 1988, P NATL ACAD SCI USA, V85, P597, DOI 10.1073/pnas.85.2.597; Miao D, 2005, J BONE MINER RES, V20, pS14; Miao DS, 2008, P NATL ACAD SCI USA, V105, P20309, DOI 10.1073/pnas.0805690105; ORLOFF JJ, 1994, ENDOCR REV, V15, P40, DOI 10.1210/er.15.1.40; Park SI, 2012, ENDOCR RELAT CANC; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; Philbrick WM, 1998, P NATL ACAD SCI USA, V95, P11846, DOI 10.1073/pnas.95.20.11846; Propper AY, 2013, J MAMMARY GLAND BIOL, V18, P93, DOI 10.1007/s10911-013-9298-0; Qian J, 2003, ENDOCRINOLOGY, V144, P1053, DOI 10.1210/en.2002-220993; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Sepulveda VAT, 2002, ENDOCRINOLOGY, V143, P596, DOI 10.1210/en.143.2.596; Shen XL, 2006, EXP CELL RES, V312, P3822, DOI 10.1016/j.yexcr.2006.08.011; Shen XL, 2004, EXP CELL RES, V294, P420, DOI 10.1016/j.yexcr.2003.11.028; Sicari BM, 2012, ENDOCRINOLOGY, V153, P861, DOI 10.1210/en.2011-1590; Spike BT, 2012, CELL STEM CELL, V10, P183, DOI 10.1016/j.stem.2011.12.018; STREWLER GJ, 1987, J CLIN INVEST, V80, P1803, DOI 10.1172/JCI113275; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Toribio RE, 2010, FASEB J, V24, P1947, DOI 10.1096/fj.09-147033; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Vasavada RC, 1996, J BIOL CHEM, V271, P1200, DOI 10.1074/jbc.271.2.1200; Vasavada RC, 2007, DIABETES, V56, P2732, DOI 10.2337/db07-0461; Wansbury O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2928; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285; Wysolmerski JJ, 2001, J CLIN ENDOCR METAB, V86, P1788, DOI 10.1210/jc.86.4.1788; Wysolmerski JJ, 2012, J CLIN ENDOCR METAB, V97, P2947, DOI 10.1210/jc.2012-2142	47	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e90418	10.1371/journal.pone.0090418	http://dx.doi.org/10.1371/journal.pone.0090418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24785493	Green Published, gold, Green Submitted			2022-12-25	WOS:000335510600004
J	Han, M; Liang, L; Liu, LR; Yue, J; Zhao, YL; Xiao, HP				Han, Min; Liang, Li; Liu, Li-rong; Yue, Jun; Zhao, Yan-lin; Xiao, He-ping			Liver X Receptor Gene Polymorphisms in Tuberculosis: Effect on Susceptibility	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; NUCLEAR RECEPTOR; METABOLIC SYNDROME; AGONIST TREATMENT; ADIPOSE-TISSUE; LXR; MICE; INFLAMMATION; ATHEROSCLEROSIS; ASSOCIATION	Objectives: The Liver X receptors (LXRs), Liver X receptor A (LXRA) and Liver X receptor B (LXRB), regulate lipid metabolism and antimicrobial response. LXRs have a crucial role in the control of Mycobacterium tuberculosis (M.tb). Lacking LXRs mice is more susceptibility to infection M.tb, developing higher bacterial burdens and an increase in the size and number of granulomatous lesions. We aimed to assess the associations between single nucleotide polymorphisms (SNPs) in LXRs and risk of tuberculosis. Methods: We sequenced the LXRs genes to detect SNPs and to examine genotypic frequencies in 600 patients and 620 healthy controls to investigate for associations with tuberculosis (TB) in the Chinese Han population. DNA re-sequencing revealed eight common variants in the LXRs genes. Results: The G allele of rs1449627 and the T allele of rs1405655 demonstrated an increased risk of developing TB (p < 0.001, p = 0.002), and the T allele of rs3758673, the T allele of rs2279238, and the C allele of rs1449626 in LXRA and the C allele of rs17373080, the G allele of rs2248949, and the C allele of rs1052677 in LXRB were protective against TB patients compared to healthy controls (p = 0.0002, p = 0.006, p < 0.001, p = 0.004, p = 0.008, p = 0.003, respectively). All SNP genotypes were significantly associated with TB. An estimation of the frequencies of haplotypes revealed two potential risk haplotypes,GGCG in LXRB (p = 0.004,) and TTCG in LXRA (p < 0.001, p = 0.004). Moreover, three protective haplotypes, TTAT and CCAT in LXRA and CATC in LXRB, were significantly "protective" (p = 0.008, p < 0.001, p = 0.031) for TB. Furthermore, we determined that the LXRs SNPs were nominally associated with the clinical pattern of disease. Conclusions: Our study data supported that LXRs play a fundamental role in the genetic susceptibility to TB and to different clinical patterns of disease. Thus, further investigation is required in larger populations and in additional areas.	[Han, Min; Liang, Li; Liu, Li-rong; Yue, Jun; Xiao, He-ping] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai Key Lab Mycobacterium TB, Shanghai 200092, Peoples R China; [Zhao, Yan-lin] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China	Tongji University; Chinese Center for Disease Control & Prevention	Yue, J (corresponding author), Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai Key Lab Mycobacterium TB, Shanghai 200092, Peoples R China.	yuejunnan@aliyun.com			National Great Research Program of China [2008zx10003-009]	National Great Research Program of China	This work was supported by National Great Research Program of China (2008zx10003-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthonisen EH, 2010, J BIOL CHEM, V285, P1607, DOI 10.1074/jbc.M109.082685; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Birrell MA, 2007, J BIOL CHEM, V282, P31882, DOI 10.1074/jbc.M703278200; Bruhn KW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000886; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Collins-Racie LA, 2009, OSTEOARTHR CARTILAGE, V17, P832, DOI 10.1016/j.joca.2008.12.011; Dahlman I, 2006, PHARMACOGENET GENOM, V16, P881, DOI 10.1097/01.fpc.0000236334.49422.48; Dahlman I, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-27; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; Geyeregger R, 2007, BLOOD, V109, P4288, DOI 10.1182/blood-2006-08-043422; Hindinger C, 2006, J NEUROSCI RES, V84, P1225, DOI 10.1002/jnr.21038; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kleyer A, 2012, J BONE MINER RES, V27, P2442, DOI 10.1002/jbmr.1702; Korf H, 2009, J CLIN INVEST, V119, P1626, DOI 10.1172/JCI35288; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Legry V, 2008, INT J OBESITY, V32, P421, DOI 10.1038/sj.ijo.0803705; Lo Sasso G, 2013, GASTROENTEROLOGY, V144, P1497, DOI 10.1053/j.gastro.2013.02.005; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Park MC, 2010, RHEUMATOLOGY, V49, P882, DOI 10.1093/rheumatology/keq007; Paterniti I, 2010, J NEUROCHEM, V112, P611, DOI 10.1111/j.1471-4159.2009.06471.x; Price ET, 2011, PHARMACOGENET GENOM, V21, P333, DOI 10.1097/FPC.0b013e3283452fec; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Ricote M, 2004, ARTERIOSCL THROM VAS, V24, P230, DOI 10.1161/01.ATV.0000103951.67680.B1; Rooki H, 2013, GENE, V532, P288, DOI 10.1016/j.gene.2013.09.107; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305; Steffensen KR, 2004, DIABETES, V53, pS36, DOI 10.2337/diabetes.53.2007.S36; Torocsik D, 2010, J IMMUNOL, V184, P5456, DOI 10.4049/jimmunol.0902399; Treuter E, 2011, BBA-MOL BASIS DIS, V1812, P909, DOI 10.1016/j.bbadis.2010.12.008; Tsezou A, 2010, J ORTHOP RES, V28, P1033, DOI 10.1002/jor.21084; Valledor AF, 2005, IMMUNOBIOLOGY, V210, P127, DOI 10.1016/j.imbio.2005.05.007; Wang YY, 2011, SURG INFECT, V12, P283, DOI 10.1089/sur.2010.066	36	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95954	10.1371/journal.pone.0095954	http://dx.doi.org/10.1371/journal.pone.0095954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788534	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600057
J	Jiang, MZ; Yao, J; Feng, GZ				Jiang, Mingzi; Yao, Jing; Feng, Ganzhu			Protective Effect of DNA Vaccine Encoding Pseudomonas Exotoxin A and PcrV against Acute Pulmonary P. aeruginosa Infection	PLOS ONE			English	Article							III PROTEIN SECRETION; V-ANTIGEN; IMMUNE-RESPONSES; LUNG INFECTIONS; CYTO-TOXICITY; ACTIVE-SITE; IN-VIVO; MICE; IMMUNIZATION; VIRULENCE	Infections with Pseudomonas aeruginosa have been a long-standing challenge for clinical therapy because of complex pathogenesis and resistance to antibiotics, thus attaching importance to explore effective vaccines for prevention and treatment. In the present study, we constructed a novel DNA vaccine by inserting mutated gene toxA(m) encoding Pseudomonas Exotoxin A and gene pcrV encoding tip protein of the type III secretion system into respective sites of a eukaryotic plasmid pIRES, named pIRES-toxA(m)-pcrV, and next evaluated the efficacy of the vaccine in murine acute Pseudomonas pneumonia models. Compared to DNA vaccines encoding single antigen, mice vaccinated with pIRES-toxA(m-pcrV) elicited higher levels of antigen-specific serum immunoglobulin G (IgG), enhanced splenic cell proliferation and cytokine secretion in response to Pseudomonas aeruginosa antigens, additionally PAO1 challenge in mice airway resulted in reduced bacteria burden and milder pathologic changes in lungs. Besides, it was observed that immunogenicity and protection could be promoted by the CpG ODN 1826 adjuvant. Taken together, it's revealed that recombinant DNA vaccine pIRES-toxAm-pcrV was a potential candidate for immunotherapy of Pseudomonas aeruginosa infection and the CpG ODN 1826 a potent stimulatory adjuvant for DNA vaccination.	[Jiang, Mingzi; Yao, Jing; Feng, Ganzhu] Nanjing Med Univ, Affiliated Hosp 2, Dept Resp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Feng, GZ (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Resp, Nanjing, Jiangsu, Peoples R China.	fenggz@njmu.edu.cn		Feng, Ganzhu/0000-0003-3926-1753	general program fund from Jiangsu Province of China [H200911]	general program fund from Jiangsu Province of China	This study was supported by general program fund (H200911) from Jiangsu Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi T, 2003, SINGLE NUCLEOTIDE PO; Allmond LR, 2004, J CLIN MICROBIOL, V42, P3857, DOI 10.1128/JCM.42.8.3857-3860.2004; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Caroline G, 2008, J BIOL CHEM, V283, P23940, DOI 10.1074/jbc.M803146200; CARROLL SF, 1987, J BIOL CHEM, V262, P8707; Challa S, 2007, VACCINE, V25, P3328, DOI 10.1016/j.vaccine.2007.01.006; Chen TY, 1999, J BIOMED SCI, V6, P357, DOI 10.1007/BF02253525; Chen TY, 1999, APPL MICROBIOL BIOT, V52, P524, DOI 10.1007/s002530051555; Chieda Y, 2011, MICROB PATHOGENESIS, V51, P407, DOI 10.1016/j.micpath.2011.09.002; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Deng W, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-29; Denis-Mize KS, 2000, FEMS IMMUNOL MED MIC, V27, P147, DOI 10.1111/j.1574-695X.2000.tb01425.x; Dibra D, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-95; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; FUKUSHIMA J, 1989, J BACTERIOL, V171, P1698, DOI 10.1128/jb.171.3.1698-1704.1989; Galle M, 2012, CURR PROTEIN PEPT SC, V13, P831, DOI 10.2174/138920312804871210; Galle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041547; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Jensen KM, 2012, INFECT IMMUN, V80, P1744, DOI 10.1128/IAI.00079-12; Jiang T, 2011, ANTIVIR RES, V89, P124, DOI 10.1016/j.antiviral.2010.11.013; JOHANSEN HK, 1994, INFECT IMMUN, V62, P3146, DOI 10.1128/IAI.62.8.3146-3155.1994; Jyot J, 2011, J INFECT DIS, V203, P1369, DOI 10.1093/infdis/jir045; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Klinman DM, 2010, VACCINE, V28, P2801, DOI 10.1016/j.vaccine.2009.11.025; Klinman DM, 2009, ADV DRUG DELIVER REV, V61, P248, DOI 10.1016/j.addr.2008.12.012; KUDOH I, 1994, AM J PHYSIOL-LUNG C, V267, pL551, DOI 10.1152/ajplung.1994.267.5.L551; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Lang AB, 2004, VACCINE, V22, pS44, DOI 10.1016/j.vaccine.2004.08.016; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; Li H, 2010, OPEN VACCINE J, V3, P127; Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x; LUKAC M, 1988, INFECT IMMUN, V56, P3095, DOI 10.1128/IAI.56.12.3095-3098.1988; LUKAC M, 1988, J BIOL CHEM, V263, P6146; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nabel GJ, 2004, NAT MED, V10, P135, DOI 10.1038/nm990; Pier G, 2005, EXPERT REV VACCINES, V4, P645, DOI 10.1586/14760584.4.5.645; Price BM, 2002, FEMS IMMUNOL MED MIC, V33, P89, DOI 10.1111/j.1574-695X.2002.tb00577.x; Price BM, 2001, INFECT IMMUN, V69, P3510, DOI 10.1128/IAI.69.5.3510-3515.2001; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Saha S, 2007, J IMMUNOL, V179, P1147, DOI 10.4049/jimmunol.179.2.1147; Saha S, 2006, VACCINE, V24, P6240, DOI 10.1016/j.vaccine.2006.05.077; Sato H, 2011, FRONTIERS MICROBIOLO, V2; Sato H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00142; Sawa T, 1998, INFECT IMMUN, V66, P3242, DOI 10.1128/IAI.66.7.3242-3249.1998; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; Schultz MJ, 2001, J MED MICROBIOL, V50, P822, DOI 10.1099/0022-1317-50-9-822; Schultz MJ, 2000, FEMS IMMUNOL MED MIC, V29, P227, DOI 10.1016/S0928-8244(00)00209-1; Sharma A, 2011, HUM VACCINES, V7, P999, DOI 10.4161/hv.7.10.16369; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Shiau JW, 2000, VACCINE, V19, P1106, DOI 10.1016/S0264-410X(00)00335-2; Staczek J, 2003, FEMS IMMUNOL MED MIC, V37, P147, DOI 10.1016/S0928-8244(03)00075-0; Tanomand Asghar, 2013, Iranian Biomedical Journal, V17, P1, DOI 10.6091/ibj.1122.2012; Uppada SB, 2011, VACCINE, V29, P9352, DOI 10.1016/j.vaccine.2011.09.129; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Veesenmeyer JL, 2009, CRIT CARE MED, V37, P1777, DOI 10.1097/CCM.0b013e31819ff137; Weimer ET, 2009, INFECT IMMUN, V77, P2356, DOI 10.1128/IAI.00054-09; Wolf P, 2009, INT J MED MICROBIOL, V299, P161, DOI 10.1016/j.ijmm.2008.08.003; Yao Y, 2013, INT REV IMMUNOL, V32, P324, DOI 10.3109/08830185.2012.762361; Yuan SJ, 2011, CANCER BIOTHER RADIO, V26, P203, DOI 10.1089/cbr.2010.0871	64	20	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96609	10.1371/journal.pone.0096609	http://dx.doi.org/10.1371/journal.pone.0096609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788626	gold, Green Published, Green Submitted			2022-12-25	WOS:000335510600109
J	Kajungu, DK; Erhart, A; Talisuna, AO; Bassat, Q; Karema, C; Nabasumba, C; Nambozi, M; Tinto, H; Kremsner, P; Meremikwu, M; D'Alessandro, U; Speybroeck, N				Kajungu, Dan K.; Erhart, Annette; Talisuna, Ambrose Otau; Bassat, Quique; Karema, Corine; Nabasumba, Carolyn; Nambozi, Michael; Tinto, Halidou; Kremsner, Peter; Meremikwu, Martin; D'Alessandro, Umberto; Speybroeck, Niko			Paediatric Pharmacovigilance: Use of Pharmacovigilance Data Mining Algorithms for Signal Detection in a Safety Dataset of a Paediatric Clinical Study Conducted in Seven African Countries	PLOS ONE			English	Article								Background: Pharmacovigilance programmes monitor and help ensuring the safe use of medicines which is critical to the success of public health programmes. The commonest method used for discovering previously unknown safety risks is spontaneous notifications. In this study we examine the use of data mining algorithms to identify signals from adverse events reported in a phase IIIb/IV clinical trial evaluating the efficacy and safety of several Artemisinin-based combination therapies (ACTs) for treatment of uncomplicated malaria in African children. Methods: We used paediatric safety data from a multi-site, multi-country clinical study conducted in seven African countries (Burkina Faso, Gabon, Nigeria, Rwanda, Uganda, Zambia, and Mozambique). Each site compared three out of four ACTs, namely amodiaquine-artesunate (ASAQ), dihydroartemisinin-piperaquine (DHAPQ), artemether-lumefantrine (AL) or chlorproguanil/dapsone and artesunate (CD+A). We examine two pharmacovigilance signal detection methods, namely proportional reporting ratio and Bayesian Confidence Propagation Neural Network on the clinical safety dataset. Results: Among the 4,116 children (6-59 months old) enrolled and followed up for 28 days post treatment, a total of 6,238 adverse events were reported resulting into 346 drug-event combinations. Nine signals were generated both by proportional reporting ratio and Bayesian Confidence Propagation Neural Network. A review of the manufacturer package leaflets, an online Multi-Drug Symptom/Interaction Checker (DoubleCheckMD) and further by therapeutic area experts reduced the number of signals to five. The ranking of some drug-adverse reaction pairs on the basis of their signal index differed between the two methods. Conclusions: Our two data mining methods were equally able to generate suspected signals using the pooled safety data from a phase IIIb/IV clinical trial. This analysis demonstrated the possibility of utilising clinical studies safety data for key pharmacovigilance activities like signal detection and evaluation. This approach can be applied to complement the spontaneous reporting systems which are limited by under reporting.	[Kajungu, Dan K.; Speybroeck, Niko] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Erhart, Annette; D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium; [Talisuna, Ambrose Otau] Univ Oxford, KEMRI Wellcome Trust Programme, Malaria Publ Hlth Dept, Nairobi, Kenya; [Talisuna, Ambrose Otau] Infect Dis Res Collaborat, Uganda Malaria Surveillance Project, Kampala, Uganda; [Bassat, Quique] Ctr Invest Saude Manhica, Maputo, Mozambique; [Bassat, Quique] Univ Barcelona, Hosp Clin Barcelona, Barcelona Ctr Int Hlth Res, CRESIB, Barcelona, Spain; [Karema, Corine] Minist Hlth, Natl Malaria Control Program TRAC Plus, Kigali, Rwanda; [Nabasumba, Carolyn] Epicentre, Paris, France; [Nabasumba, Carolyn] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda; [Nambozi, Michael] Trop Dis Res Ctr, Ndola, Zambia; [Tinto, Halidou] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Tinto, Halidou] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Meremikwu, Martin] Univ Calabar, Dept Paediat, Calabar, Nigeria; [Meremikwu, Martin] Inst Trop Dis Res & Prevent, Calabar, Nigeria; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Kajungu, Dan K.] Sante Stat & Analyt Res Inst, Kampala, Uganda; [Kremsner, Peter] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Kremsner, Peter] Ctr Rech Med Lambarene, Lambarene, Gabon	Universite Catholique Louvain; Institute of Tropical Medicine (ITM); Centro de Investigacao em Saude de Manhica; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Mbarara University of Science & Technology; Centre Muraz; University of Calabar; University of London; London School of Hygiene & Tropical Medicine; Eberhard Karls University of Tubingen	Kajungu, DK (corresponding author), Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium.	kajungu_dan@yahoo.co.uk	Kajungu, Dan/AAY-8527-2020; Meremikwu, Martin/AAO-6421-2020; Bassat, Quique/P-2341-2016; D'Alessandro, Umberto/D-3457-2015	Kajungu, Dan/0000-0002-3363-7062; Bassat, Quique/0000-0003-0875-7596; D'Alessandro, Umberto/0000-0001-6341-5009; Speybroeck, Niko/0000-0003-3322-3502; Tinto, Halidou/0000-0002-0472-3586	EDCTP	EDCTP	The main study was funded by EDCTP (www.edctp.org). This is an analysis of secondary data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AGD HTG, MED DICT REG ACT MED; Almenoff J, 2005, DRUG SAFETY, V28, P981, DOI 10.2165/00002018-200528110-00002; [Anonymous], 2013, IMP PHARM SAF MON ME; Atwine D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001119; Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; BEGAUD B, 1994, BRIT J CLIN PHARMACO, V38, P401, DOI 10.1111/j.1365-2125.1994.tb04373.x; Calabrese L, 2000, AM J MED, V108, P487, DOI 10.1016/S0002-9343(99)00408-8; Castro-Pastrana LI, 2011, J POPUL THER CLIN PH, V18, pE77; CERRITO DP, 2001, CARDIOVASC TOXICOL, V1, P177; Council for International Organizations of Medical Sciences, 2010, PRACT ASP SIGN DET P; DuMouchel W, 1999, AM STAT, V53, P177, DOI 10.2307/2686093; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; Harpaz R, 2013, CLIN PHARMACOL THER, V93, P539, DOI 10.1038/clpt.2013.24; Harpaz R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S9-S7; Hauben Manfred, 2005, Expert Opin Drug Saf, V4, P929, DOI 10.1517/14740338.4.5.929; Hauben M, 2009, DRUG SAFETY, V32, P99, DOI 10.2165/00002018-200932020-00003; ISAH AO, 2011, THER ADV DRUG SAF, P25695; ISMAIL A, 2013, PHVID R PACKAGE PHAR; Niu MT, 2001, VACCINE, V19, P4627, DOI 10.1016/S0264-410X(01)00237-7; Pirmohamed M, 1998, BRIT MED J, V316, P1295, DOI 10.1136/bmj.316.7140.1295; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; SACHS RM, 1986, AM J MED, V81, P49; Waller PC, 2003, PHARMACOEPIDEM DR S, V12, P17, DOI 10.1002/pds.773; World Health Organization, 2006, SAF MED PUBL HLTH PR	24	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96388	10.1371/journal.pone.0096388	http://dx.doi.org/10.1371/journal.pone.0096388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787710	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600096
J	Schrack, JA; Zipunnikov, V; Goldsmith, J; Bandeen-Roche, K; Crainiceanu, CM; Ferrucci, L				Schrack, Jennifer A.; Zipunnikov, Vadim; Goldsmith, Jeff; Bandeen-Roche, Karen; Crainiceanu, Ciprian M.; Ferrucci, Luigi			Estimating Energy Expenditure from Heart Rate in Older Adults: A Case for Calibration	PLOS ONE			English	Article							DOUBLY LABELED WATER; PHYSICAL-ACTIVITY QUESTIONNAIRES; ACCELEROMETRY; FITNESS	Background: Accurate measurement of free-living energy expenditure is vital to understanding changes in energy metabolism with aging. The efficacy of heart rate as a surrogate for energy expenditure is rooted in the assumption of a linear function between heart rate and energy expenditure, but its validity and reliability in older adults remains unclear. Objective: To assess the validity and reliability of the linear function between heart rate and energy expenditure in older adults using different levels of calibration. Design: Heart rate and energy expenditure were assessed across five levels of exertion in 290 adults participating in the Baltimore Longitudinal Study of Aging. Correlation and random effects regression analyses assessed the linearity of the relationship between heart rate and energy expenditure and cross-validation models assessed predictive performance. Results: Heart rate and energy expenditure were highly correlated (r = 0.98) and linear regardless of age or sex. Intra-person variability was low but inter-person variability was high, with substantial heterogeneity of the random intercept (s.d. = 0.372) despite similar slopes. Cross-validation models indicated individual calibration data substantially improves accuracy predictions of energy expenditure from heart rate, reducing the potential for considerable measurement bias. Although using five calibration measures provided the greatest reduction in the standard deviation of prediction errors (1.08 kcals/min), substantial improvement was also noted with two (0.75 kcals/min). Conclusion: These findings indicate standard regression equations may be used to make population-level inferences when estimating energy expenditure from heart rate in older adults but caution should be exercised when making inferences at the individual level without proper calibration.	[Schrack, Jennifer A.; Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA; [Schrack, Jennifer A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Zipunnikov, Vadim; Goldsmith, Jeff; Bandeen-Roche, Karen; Crainiceanu, Ciprian M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Schrack, Jennifer A.; Bandeen-Roche, Karen] Johns Hopkins Med Inst, Ctr Aging & Hlth, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Schrack, JA (corresponding author), NIA, Longitudinal Studies Sect, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.	jschrack@jhsph.edu	Schrack, Jennifer/AAJ-1772-2021	Schrack, Jennifer/0000-0001-9244-9267	National Institutes of Health, National Institute on Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000015] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute on Aging. Data for these analyses were obtained from the Baltimore Longitudinal Study of Aging, a study performed by the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bot SDM, 2000, ERGONOMICS, V43, P1578, DOI 10.1080/001401300750004005; Bouchard DR, ERGONOMICS, P663; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; CHRISTENSEN CC, 1983, AM J CLIN NUTR, V37, P468, DOI 10.1093/ajcn/37.3.468; Conway JM, 2002, AM J CLIN NUTR, V75, P519, DOI 10.1093/ajcn/75.3.519; Farinatti PTV, 2009, EUR J APPL PHYSIOL, V107, P625, DOI 10.1007/s00421-009-1162-y; Hiilloskorpi HK, 2003, INT J SPORTS MED, V24, P332; Ishikawa-Takata K, 2011, J EPIDEMIOL, V21, P114, DOI 10.2188/jea.JE20100079; Leonard WR, 2003, AM J HUM BIOL, V15, P479, DOI 10.1002/ajhb.10187; LI RW, 1993, AM J CLIN NUTR, V58, P602, DOI 10.1093/ajcn/58.5.602; Livingstone MBE, 1997, BRIT J NUTR, V78, P869, DOI 10.1079/BJN19970205; LIVINGSTONE MBE, 1990, AM J CLIN NUTR, V52, P59, DOI 10.1093/ajcn/52.1.59; Mahabir S, 2006, AM J CLIN NUTR, V84, P230, DOI 10.1093/ajcn/84.1.230; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; Manini TM, 2009, AM J EPIDEMIOL, V169, P1507, DOI 10.1093/aje/kwp069; McArdle W., 2014, EXERCISE PHYSL ENERG, P253; Neilson HK, 2008, AM J CLIN NUTR, V87, P279, DOI 10.1093/ajcn/87.2.279; Schoeller DA, 1999, J NUTR, V129, P1765, DOI 10.1093/jn/129.10.1765; Schrack JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009292; Simonsick EM, 2006, J AM GERIATR SOC, V54, P127, DOI 10.1111/j.1532-5415.2005.00530.x; Simonsick EM, 2001, J AM GERIATR SOC, V49, P1544, DOI 10.1046/j.1532-5415.2001.4911247.x; STONE JL, 1966, J GERONTOL, V21, P575, DOI 10.1093/geronj/21.4.575; Strath SJ, 2000, MED SCI SPORT EXER, V32, pS465, DOI 10.1097/00005768-200009001-00005; Wareham NJ, 1997, BRIT J NUTR, V78, P889, DOI 10.1079/BJN19970207	25	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e93520	10.1371/journal.pone.0093520	http://dx.doi.org/10.1371/journal.pone.0093520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL1WP	24787146	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917300004
J	Chen, L; Xu, YB; Zhao, JL; Zhang, ZQ; Yang, RH; Xie, JL; Liu, XS; Qi, SH				Chen, Lei; Xu, Yingbin; Zhao, Jingling; Zhang, Zhaoqiang; Yang, Ronghua; Xie, Julin; Liu, Xusheng; Qi, Shaohai			Conditioned Medium from Hypoxic Bone Marrow-Derived Mesenchymal Stem Cells Enhances Wound Healing in Mice	PLOS ONE			English	Article							SCAR TISSUE; DIFFERENTIATION; REPAIR; SKIN; PROLIFERATION; ANGIOGENESIS; REGENERATION; MECHANISMS; EXPRESSION; VEGF	Growing evidence indicates that bone marrow-derived mesenchymal stem cells (BM-MSCs) enhance wound repair via paracrine. Because the extent of environmental oxygenation affects the innate characteristics of BM-MSCs, including their stemness and migration capacity, the current study set out to elucidate and compare the impact of normoxic and hypoxic cell-culture conditions on the expression and secretion of BM-MSC-derived paracrine molecules (e.g., cytokines, growth factors and chemokines) that hypothetically contribute to cutaneous wound healing in vivo. Semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) analyses of normoxic and hypoxic BM-MSCs and their conditioned medium fractions showed that the stem cells expressed and secreted significantly higher amounts of basic fibroblast growth factor (bFGF), vascular endothelial growth factor A (VEGF-A) interleukin 6 (IL-6) and interleukin 8 (IL-8) under hypoxic conditions. Moreover, hypoxic BM-MSC-derived conditioned medium (hypoCM) vs. normoxic BM-MSC-derived conditioned medium (norCM) or vehicle control medium significantly enhanced the proliferation of keratinocytes, fibroblasts and endothelial cells, the migration of keratinocytes, fibroblasts, endothelial cells and monocytes, and the formation of tubular structures by endothelial cells cultured on Matrigel matrix. Consistent with these in vitro results, skin wound contraction was significantly accelerated in Balb/c nude mice treated with topical hypoCM relative to norCM or the vehicle control. Notably increased in vivo cell proliferation, neovascularization as well as recruitment of inflammatory macrophages and evidently decreased collagen I, and collagen III were also found in the hypoCM-treated group. These findings suggest that BM-MSCs promote murine skin wound healing via hypoxia-enhanced paracrine.	[Chen, Lei; Xu, Yingbin; Zhao, Jingling; Xie, Julin; Liu, Xusheng; Qi, Shaohai] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Burns Surg, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Zhaoqiang] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Ronghua] First Peoples Hosp Foshan, Foshan, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Qi, SH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Burns Surg, Guangzhou 510275, Guangdong, Peoples R China.	qishaohaigzburns@163.com	Qi, Shaohai/AAF-7703-2020; Chen, Lei/AAF-8797-2020; 兆强, 张/GRJ-1212-2022; Zhang, Zhaoqiang/AAE-3664-2019	Qi, Shaohai/0000-0002-6945-4137; Chen, Lei/0000-0001-7146-4636; 兆强, 张/0000-0002-9183-7273; Zhang, Zhaoqiang/0000-0002-9183-7273	Natural Science Foundation of Guangdong Province [S2013040012591]; National Natural Science Foundation of China [81272153]; Program of National Key Clinical Specialties	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of National Key Clinical Specialties	This publication was supported by grant of the Natural Science Foundation of Guangdong Province (S2013040012591), the National Natural Science Foundation of China (81272153) and Program of National Key Clinical Specialties. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badolato R, 1996, SEMIN ARTHRITIS RHEU, V26, P526, DOI 10.1016/S0049-0172(96)80041-2; Caldelari R, 2000, J INVEST DERMATOL, V114, P1064, DOI 10.1046/j.1523-1747.2000.00960-4.x; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Das R, 2010, TISSUE ENG PART B-RE, V16, P159, DOI 10.1089/ten.TEB.2009.0296; Di-Poi N, 2005, MOL CELL BIOL, V25, P1696, DOI 10.1128/MCB.25.5.1696-1712.2005; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Galeano M, 2004, DIABETES, V53, P2509, DOI 10.2337/diabetes.53.9.2509; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Javazon EH, 2007, WOUND REPAIR REGEN, V15, P350, DOI 10.1111/j.1524-475X.2007.00237.x; Kim MH, 2013, J CLIN INVEST; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kyriakides TR, 2009, MATRIX BIOL, V28, P65, DOI 10.1016/j.matbio.2009.01.001; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Li TS, 2008, CELL TRANSPLANT, V17, P695, DOI 10.3727/096368908786092702; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Meng F, 2013, J BIOMED MAT RES A; Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110; Otto WR, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-20; Park IW, 2001, BLOOD, V97, P352, DOI 10.1182/blood.V97.2.352; Potier E, 2007, BONE, V40, P1078, DOI 10.1016/j.bone.2006.11.024; Rosario CM, 1997, DEVELOPMENT, V124, P4213; Sherman Ronald A, 2009, J Diabetes Sci Technol, V3, P336; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001; Verhaegen PD, 2012, WOUND REPAIR REGEN, V20, P658, DOI 10.1111/j.1524-475X.2012.00827.x; Verhaegen PDHM, 2012, J MICROSC-OXFORD, V245, P82, DOI 10.1111/j.1365-2818.2011.03547.x; Xie JL, 2008, WOUND REPAIR REGEN, V16, P576, DOI 10.1111/j.1524-475X.2008.00405.x; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	32	120	134	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96161	10.1371/journal.pone.0096161	http://dx.doi.org/10.1371/journal.pone.0096161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781370	gold, Green Published, Green Submitted			2022-12-25	WOS:000335504900020
J	Kunutsor, SK; Seddoh, D				Kunutsor, Setor K.; Seddoh, Dorothy			Alanine Aminotransferase and Risk of the Metabolic Syndrome: A Linear Dose-Response Relationship	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; FATTY LIVER-DISEASE; GENOME-WIDE ASSOCIATION; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; GENETIC EPIDEMIOLOGY; TREND ESTIMATION; WOMEN; MEN; METAANALYSIS	Background: Elevated baseline circulating alanine aminotransferase (ALT) level has been demonstrated to be associated with an increased risk of the metabolic syndrome (MetS), but the nature of the dose-response relationship is uncertain. Methods: We performed a systematic review and meta-analysis of published prospective cohort studies to characterize in detail the nature of the dose-response relationship between baseline ALT level and risk of incident MetS in the general population. Relevant studies were identified in a literature search of MEDLINE, EMBASE, and Web of Science up to December 2013. Prospective studies in which investigators reported relative risks (RRs) of MetS for 3 or more categories of ALT levels were eligible. A potential nonlinear relationship between ALT levels and MetS was examined using restricted cubic splines. Results: Of the 489 studies reviewed, relevant data were available on 29,815 non-overlapping participants comprising 2,125 incident MetS events from five prospective cohort studies. There was evidence of a linear association (P for nonlinearity = 0.38) between ALT level and risk of MetS, characterised by a graded increase in MetS risk at ALT levels 640 U/L. The risk of MetS increased by 14% for every 5 U/L increment in circulating ALT level (95% CI: 12-17%). Evidence was lacking of heterogeneity and publication bias among the contributing studies. Conclusions: Baseline ALT level is associated with risk of the MetS in a linear dose-response manner. Studies are needed to determine whether the association represents a causal relationship.	[Kunutsor, Setor K.] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge, England; [Seddoh, Dorothy] Maranatha Univ Coll, Accra, Ghana	University of Cambridge	Kunutsor, SK (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge, England.	skk31@cantab.net	Kunutsor, Setor K/H-9807-2019	Kunutsor, Setor K/0000-0002-2625-0273				Al-Hamoudi W, 2013, DIGESTIVE DIS SCI; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Andre P, 2007, DIABETES CARE, V30, P2355, DOI 10.2337/dc07-0440; Bathum L, 2001, CLIN CHEM, V47, P81; Bee Ying Tan Jr, 2008, Malays J Nutr, V14, P65; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Clark JM, 2003, JAMA-J AM MED ASSOC, V289, P3000, DOI 10.1001/jama.289.22.3000; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Goessling W, 2008, GASTROENTEROLOGY, V135, P1935, DOI 10.1053/j.gastro.2008.09.018; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Hanley AJG, 2005, DIABETES, V54, P3140, DOI 10.2337/diabetes.54.11.3140; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9; Jo SK, 2009, CLIN CHIM ACTA, V403, P234, DOI 10.1016/j.cca.2009.03.035; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Lee JK, 2010, HEPATOLOGY, V51, P1577, DOI 10.1002/hep.23505; Lidofsky SD, 2008, CURR DIABETES REP, V8, P25, DOI 10.1007/s11892-008-0006-1; Liu ZT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080596; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; McKenzie J, 2006, CLIN ENDOCRINOL, V65, P40, DOI 10.1111/j.1365-2265.2006.02543.x; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Musso G, 2010, HEPATOLOGY, V52, P79, DOI 10.1002/hep.23623; Nakanishi N, 2004, DIABETES CARE, V27, P1427, DOI 10.2337/diacare.27.6.1427; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Rahmioglu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004435; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Sattar N, 1998, INT J OBESITY, V22, P432, DOI 10.1038/sj.ijo.0800604; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; Schindhelm RK, 2007, DIABETIC MED, V24, P430, DOI 10.1111/j.1464-5491.2007.02100.x; Schindhelm RK, 2006, DIABETES-METAB RES, V22, P437, DOI 10.1002/dmrr.666; SIEST G, 1975, CLIN CHEM, V21, P1077; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Westerbacka J, 2004, DIABETOLOGIA, V47, P1360, DOI 10.1007/s00125-004-1460-1; Whitfield JB, 2002, CLIN CHEM, V48, P1426; Xu Y, 2011, J DIABETES, V3, P38, DOI 10.1111/j.1753-0407.2010.00111.x; Yadav Dhananjay, 2013, Glob J Health Sci, V5, P142, DOI 10.5539/gjhs.v5n6p142; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	46	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96068	10.1371/journal.pone.0096068	http://dx.doi.org/10.1371/journal.pone.0096068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781277	Green Published, gold, Green Submitted			2022-12-25	WOS:000335504900018
J	Li, MF; Zhang, BC; Li, J; Sun, L				Li, Mo-fei; Zhang, Bao-cun; Li, Jun; Sun, Li			Sil: A Streptococcus iniae Bacteriocin with Dual Role as an Antimicrobial and an Immunomodulator That Inhibits Innate Immune Response and Promotes S. iniae Infection	PLOS ONE			English	Article							IMMUNOPROTECTIVE ANALYSIS; LACTOCOCCIN 972; AQUATIC PATHOGEN; SALIVARIUS K12; LIPID-II; TARGET; IDENTIFICATION; VIRULENCE; POLYSACCHARIDE; LANTIBIOTICS	Streptococcus iniae is a Gram-positive bacterium and a severe pathogen to a wide range of economically important fish species. In addition, S. iniae is also a zoonotic pathogen and can cause serious infections in humans. In this study, we identified from a pathogenic S. iniae strain a putative bacteriocin, Sil, and examined its biological activity. Sil is composed of 101 amino acid residues and shares 35.6% overall sequence identity with the lactococcin 972 of Lactococcus lactis. Immunoblot analysis showed that Sil was secreted by S. iniae into the extracellular milieu. Purified recombinant Sil (rSil) exhibited a dose-dependent inhibitory effect on the growth of Bacillus subtilis but had no impact on the growths of other 16 Gram-positive bacteria and 10 Gram-negative bacteria representing 23 different bacterial species. Treatment of rSil by heating at 50 degrees C abolished the activity of rSil. rSil bound to the surface of B. subtilis but induced no killing of the target cells. Cellular study revealed that rSil interacted with turbot (Scophthalmus maximus) head kidney monocytes and inhibited the innate immune response of the cells, which led to enhanced cellular infection of S. iniae. Antibody blocking of the extracellular Sil produced by S. iniae significantly attenuated the infectivity of S. iniae. Consistent with these in vitro observations, in vivo study showed that administration of turbot with rSil prior to S. iniae infection significantly increased bacterial dissemination and colonization in fish tissues. Taken together, these results indicate that Sil is a novel virulence-associated bacteriostatic and an immunoregulator that promotes S. iniae infection by impairing the immune defense of host fish.	[Li, Mo-fei; Zhang, Bao-cun; Li, Jun; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Li, Mo-fei; Zhang, Bao-cun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Jun] Lake Super State Univ, Sch Biol Sci, Sault Ste Marie, MI USA; [Sun, Li] Zhejiang Univ, Collaborat Innovat Ctr Deep Sea Biol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	lsun@qdio.ac.cn	LI, JUN/ABI-6941-2020	Li, Jun/0000-0002-5190-0733; Zhang, Bao-cun/0000-0001-6104-0848	Shandong Scientific and Technological Project [2010GHY10511]; National Natural Science Foundation of China [31025030]; Taishan Scholar Program of Shandong Province	Shandong Scientific and Technological Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Program of Shandong Province	This work was supported by the grants from the Shandong Scientific and Technological Project (2010GHY10511), the National Natural Science Foundation of China (31025030), and the Taishan Scholar Program of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew W, 2007, VET MICROBIOL, V122, P1, DOI 10.1016/j.vetmic.2007.03.002; Allen JP, 2012, INFECT IMMUN, V80, P1707, DOI 10.1128/IAI.00027-12; Baiano JCF, 2009, EMERG INFECT DIS, V15, P1891, DOI 10.3201/eid1512.090232; Baiano JCF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-67; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Buchanan JT, 2005, INFECT IMMUN, V73, P6935, DOI 10.1128/IAI.73.10.6935-6944.2005; Burton JP, 2006, J APPL MICROBIOL, V100, P754, DOI 10.1111/j.1365-2672.2006.02837.x; Chen C, 2013, FISH SHELLFISH IMMUN, V35, P1677, DOI 10.1016/j.fsi.2013.08.020; Cheng S, 2010, VACCINE, V28, P2636, DOI 10.1016/j.vaccine.2010.01.016; CHUNG S, 1988, COMP BIOCHEM PHYS B, V89, P539, DOI 10.1016/0305-0491(88)90171-X; Cosseau C, 2008, INFECT IMMUN, V76, P4163, DOI 10.1128/IAI.00188-08; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Du J, 2001, MODERN FISHERIES, V5, P28; Eyngor M, 2010, FEMS MICROBIOL LETT, V305, P109, DOI 10.1111/j.1574-6968.2010.01919.x; Fuller JD, 2002, INFECT IMMUN, V70, P5730, DOI 10.1128/IAI.70.10.5730-5739.2002; Guglielmetti S, 2010, APPL ENVIRON MICROB, V76, P3948, DOI 10.1128/AEM.00109-10; Hammami R, 2013, CELL MOL LIFE SCI, V70, P2947, DOI 10.1007/s00018-012-1202-3; Heng NC, 2006, NAT REV MICROBIOL, V4, P117; Heng NCK, 2007, BACTERIOCINS ECOLOGY, P5; Hou JH, 2009, J GEN APPL MICROBIOL, V55, P57, DOI 10.2323/jgam.55.57; Hu YH, 2010, FISH SHELLFISH IMMUN, V28, P678, DOI 10.1016/j.fsi.2010.01.001; Jeremy PB, 2013, PLOS ONE, V8; Jiao XD, 2009, VACCINE, V27, P5195, DOI 10.1016/j.vaccine.2009.06.071; Kjos M, 2009, MICROBIOL-SGM, V155, P2949, DOI 10.1099/mic.0.030015-0; Lee H, 2011, J MICROBIOL BIOTECHN, V21, P229, DOI 10.4014/jmb.1010.10017; Locke JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002824; Locke JB, 2007, J BACTERIOL, V189, P1279, DOI 10.1128/JB.01175-06; Lopez FE, 2007, J ANTIMICROB CHEMOTH, V59, P676, DOI 10.1093/jac/dkm009; Low D. E., 1999, Emerging infections 3., P53; Lowe BA, 2007, INFECT IMMUN, V75, P1255, DOI 10.1128/IAI.01484-06; Martin NI, 2007, FUTURE MICROBIOL, V2, P513, DOI 10.2217/17460913.2.5.513; Martinez B, 1999, MICROBIOL-SGM, V145, P3155, DOI 10.1099/00221287-145-11-3155; Martinez B, 1996, MICROBIOL-UK, V142, P2393, DOI 10.1099/00221287-142-9-2393; Martinez B, 2000, MICROBIOL-UK, V146, P949, DOI 10.1099/00221287-146-4-949; Martinez B, 2008, APPL ENVIRON MICROB, V74, P4666, DOI 10.1128/AEM.00092-08; Martinez B, 2007, MOL MICROBIOL, V64, P473, DOI 10.1111/j.1365-2958.2007.05668.x; Milani CJE, 2010, MICROBIOL-SGM, V156, P543, DOI 10.1099/mic.0.028365-0; Miller JD, 2005, INFECT IMMUN, V73, P921, DOI 10.1128/IAI.73.2.921-934.2005; Mouloud G, 2013, APPL BIOCHEM BIOTECH, V171, P2186, DOI 10.1007/s12010-013-0489-3; MURIANA PM, 1991, APPL ENVIRON MICROB, V57, P114, DOI 10.1128/AEM.57.1.114-121.1991; Nagao JI, 2006, J BIOSCI BIOENG, V102, P139, DOI 10.1263/jbb.102.139; Nishie M, 2012, BIOCONTROL SCI, V17, P1; Pasteris SE, 2013, WORLD J MICROBIOL BI; Phelan RW, 2013, MAR DRUGS, V11, P1878, DOI 10.3390/md11061878; Rihakova J, 2010, ANTIMICROB AGENTS CH, V54, P563, DOI 10.1128/AAC.00765-09; Saddam SA, 2013, J FOOD SCI, V78, P1416; Salvucci E, 2012, FOODBORNE PATHOG DIS, V9, P68, DOI 10.1089/fpd.2011.0972; Sandiford S, 2012, ANTIMICROB AGENTS CH, V56, P1539, DOI 10.1128/AAC.05397-11; Sun K, 2009, VACCINE, V27, P2733, DOI 10.1016/j.vaccine.2009.03.012; Sun Y, 2012, INFECT IMMUN, V80, P2948, DOI 10.1128/IAI.00063-12; Sun Y, 2011, VACCINE, V29, P2051, DOI 10.1016/j.vaccine.2011.01.013; Swe PM, 2009, J ANTIMICROB CHEMOTH, V63, P679, DOI 10.1093/jac/dkn552; Tagg JR, 2004, INDIAN J MED RES, V119, P13; Wang HR, 2009, VACCINE, V27, P4047, DOI 10.1016/j.vaccine.2009.04.023; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Zhang BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091324; Zhang HX, 2013, MICROBIOL IMMUNOL, V57, P746, DOI 10.1111/1348-0421.12091; Zhang M, 2008, MICROBIOL-SGM, V154, P2060, DOI 10.1099/mic.0.2008/017343-0; Zheng WJ, 2010, FISH SHELLFISH IMMUN, V28, P829, DOI 10.1016/j.fsi.2010.01.013; Zinkernagel AS, 2008, CELL HOST MICROBE, V4, P170, DOI 10.1016/j.chom.2008.07.002	62	19	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96222	10.1371/journal.pone.0096222	http://dx.doi.org/10.1371/journal.pone.0096222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781647	Green Submitted, gold, Green Published			2022-12-25	WOS:000335504900023
J	Zhang, XJ; Yuan, YC; Wei, Z; Guo, X; Guo, YP; Zhang, SQ; Zhao, JS; Zhang, GH; Song, XL; Sun, XZ				Zhang, Xingju; Yuan, Yanchao; Wei, Ze; Guo, Xian; Guo, Yuping; Zhang, Suqing; Zhao, Junsheng; Zhang, Guihua; Song, Xianliang; Sun, Xuezhen			Molecular Mapping and Validation of a Major QTL Conferring Resistance to a Defoliating Isolate of Verticillium Wilt in Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MARKER-ASSISTED SELECTION; DAHLIAE INFECTION; UPLAND COTTON; LINKAGE MAP; YIELD; EXPRESSION; GENES	Verticillium wilt (VW) caused by Verticillium dahliae Kleb is one of the most destructive diseases of cotton. Development and use of a VW resistant variety is the most practical and effective way to manage this disease. Identification of highly resistant genes/QTL and the underlining genetic architecture is a prerequisite for developing a VW resistant variety. A major QTL qVW-c6-1 conferring resistance to the defoliating isolate V991 was identified on chromosome 6 in LHB22xJM11 F-2:3 population inoculated and grown in a greenhouse. This QTL was further validated in the LHB22xNNG F-2:3 population that was evaluated in an artificial disease nursery of V991 for two years and in its subsequent F-4 population grown in a field severely infested by V991. The allele conferring resistance within the QTL qVW-c6-1 region originated from parent LHB22 and could explain 23.1-27.1% of phenotypic variation. Another resistance QTL qVW-c21-1 originated from the susceptible parent JM11 was mapped on chromosome 21, explaining 14.44% of phenotypic variation. The resistance QTL reported herein provides a useful tool for breeding a cotton variety with enhanced resistance to VW.	[Zhang, Xingju; Yuan, Yanchao; Wei, Ze; Guo, Xian; Guo, Yuping; Zhang, Suqing; Song, Xianliang; Sun, Xuezhen] Shandong Agr Univ, State Key Lab Crop Biol, Agron Coll, Tai An, Shandong, Peoples R China; [Zhao, Junsheng] Shandong Acad Agr Sci, Cotton Res Ctr, Jinan, Shandong, Peoples R China; [Zhang, Guihua] Heze Acad Agricultual Sci, Heze, Shandong, Peoples R China	Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shandong Academy of Agricultural Sciences	Song, XL (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Agron Coll, Tai An, Shandong, Peoples R China.	songxl999@163.com; sunxz@sdau.edu.cn	zhang, guihua/GVU-4494-2022		System of Modern Agriculture Industrial Technology [SDAIT-07-011-02]; Science and Technology Development Project [2012GGB01026]; Natural Science foundation [ZR2013CM005]; Agricultural Seed Project of Shandong Province	System of Modern Agriculture Industrial Technology; Science and Technology Development Project; Natural Science foundation(National Natural Science Foundation of China (NSFC)); Agricultural Seed Project of Shandong Province	This research was financially supported in part by grants from the System of Modern Agriculture Industrial Technology (SDAIT-07-011-02), the Science and Technology Development Project (2012GGB01026), the Natural Science foundation (ZR2013CM005) and the Agricultural Seed Project (cotton variety development, 2011-2013; cotton germplasm innovation, 2013) of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BejaranoAlcazar J, 1997, PLANT PATHOL, V46, P168, DOI 10.1046/j.1365-3059.1997.d01-221.x; Berlanger I., 2018, PLANT HLTH INSTRUCTO; Blenda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045739; Bolek Y, 2005, PLANT SCI, V168, P1581, DOI 10.1016/j.plantsci.2005.02.008; Cai YF, 2009, AFR J BIOTECHNOL, V8, P7363; Carpenter CW, 1914, PHYTOPATHOLOGY, V4, P393; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; DEVEY ME, 1986, CROP SCI, V26, P1, DOI 10.2135/cropsci1986.0011183X002600010001x; Du W.S., 2004, J NW SCI TECH U AGR, V32, P20, DOI DOI 10.13207/J.CNKI.JNWAFU.2004.03.005; Fang H, 2013, MOL BREEDING, V33; Fang H, 2013, EUPHYTICA, V194, P79, DOI 10.1007/s10681-013-0965-4; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Gao MW, 2008, SHANDONG AGR SCI, V1, P67; Gao W, 2013, MOL CELL PROTEOMICS, V12, P3690, DOI 10.1074/mcp.M113.031013; [高玉干 Gao Yugan], 2003, [棉花学报, Cotton Science], V15, P73; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Jiang F, 2009, SCI CHINA SER C, V52, P872, DOI 10.1007/s11427-009-0110-8; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; LANDE R, 1990, GENETICS, V124, P743; Liang Z, 1996, SCI CHINA SER C, V26, P369; Ning ZY, 2013, CROP SCI, V53, P2304, DOI 10.2135/cropsci2012.12.0694; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Song XL, 2007, SEED SCI RES, V17, P243, DOI 10.1017/S0960258507834957; Sun Q, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-852; Tjamos EC, 2000, ADVANCES IN VERTICILLIUM: RESEARCH AND DISEASE MANAGEMENT, P244; VAN OJ, 2001, JOINMAP VERSION 3 0; Wang FR, 2007, COTTON SCI, V6, P424; Wang HM, 2008, J INTEGR PLANT BIOL, V50, P174, DOI 10.1111/j.1744-7909.2007.00612.x; Wang PZ, 2009, THEOR APPL GENET, V119, P733, DOI 10.1007/s00122-009-1084-4; Wang YQ, 2004, PLANT BREEDING, V123, P454, DOI 10.1111/j.1439-0523.2004.01005.x; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yang C, 2007, MOL PLANT BREED, V5, P797; Yang C, 2008, PLANT SCI, V174, P290, DOI 10.1016/j.plantsci.2007.11.016; Yu JW, 2007, J INTEGR PLANT BIOL, V49, P716, DOI 10.1111/j.1744-7909.2007.00459.x; Zhang J, 2002, THEOR APPL GENET, V105, P1166, DOI 10.1007/s00122-002-1100-4; Zhang JF, 2012, EUPHYTICA, V187, P147, DOI 10.1007/s10681-011-0549-0; Zhang WW, 2012, PHYSIOL MOL PLANT P, V80, P50, DOI 10.1016/j.pmpp.2012.09.001; Zhang XD, 2011, J SYST ENG ELECTRON, V22, P22, DOI 10.3969/j.issn.1004-4132.2011.01.003; [甄瑞 ZHEN Rui], 2006, [棉花学报, Cotton Science], V18, P269; Zhou RH, 2005, THEOR APPL GENET, V110, P640, DOI 10.1007/s00122-004-1889-0; [周庭辉 Zhou Tinghui], 2006, [分子植物育种, Molecular Plant Breeding], V4, P593	43	9	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96226	10.1371/journal.pone.0096226	http://dx.doi.org/10.1371/journal.pone.0096226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781706	Green Submitted, gold, Green Published			2022-12-25	WOS:000335504900024
J	Leavesley, SJ; Ledkins, W; Rocic, P				Leavesley, Silas J.; Ledkins, Whitley; Rocic, Petra			A Device for Performing Automated Balloon Catheter Inflation Ischemia Studies	PLOS ONE			English	Article							CORONARY COLLATERAL GROWTH; METABOLIC SYNDROME; VESSEL DEVELOPMENT; IMPACT; ARTERY; HYPERGLYCEMIA; RAT; AKT	Coronary collateral growth (arteriogenesis) is a physiological adaptive response to transient and repetitive occlusion of major coronary arteries in which small arterioles (native collaterals) with minimal to no blood flow remodel into larger conduit arteries capable of supplying adequate perfusion to tissue distal to the site of occlusion. The ability to reliably and reproducibly mimic transient, repetitive coronary artery occlusion (ischemia) in animal models is critical to the development of therapies to restore coronary collateral development in type II diabetes and the metabolic syndrome. Current animal models for repetitive coronary artery occlusion implement a pneumatic occluder (balloon) that is secured onto the surface of the heart with the suture, which is inflated manually, via a catheter connected to syringe, to effect occlusion of the left anterior descending coronary artery (LAD). This method, although effective, presents complications in terms of reproducibility and practicality. To address these limitations, we have designed a device for automated, transient inflation of balloon catheters in coronary artery occlusion models. This device allows repeated, consistent inflation (to either specified pressure or volume) and the capability for implementing very complex, month-long protocols. This system has significantly increased the reproducibility of coronary collateral growth studies in our laboratory, resulting in a significant decrease in the numbers of animals needed to complete each study while relieving laboratory personnel from the burden of extra working hours and enabling us to continue studies over periods when we previously could not. In this paper, we present all details necessary for construction and operation of the inflator. In addition, all of the components for this device are commercially available and economical (Table S1). It is our hope that the adoption of automated balloon catheter inflation protocols will improve the experimental reliability of transient ischemia studies at many research institutions.	[Leavesley, Silas J.; Ledkins, Whitley] Univ S Alabama, Mobile, AL 36688 USA; [Leavesley, Silas J.] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA; [Rocic, Petra] New York Med Coll, Valhalla, NY 10595 USA	University of South Alabama; University of South Alabama; New York Medical College	Leavesley, SJ (corresponding author), Univ S Alabama, Mobile, AL 36688 USA.	leavesley@southalabama.edu		Rocic, Petra/0000-0002-5781-3075; Leavesley, Silas/0000-0002-2684-9534	NIH [R01 HL093052]; ISAC Scholar's Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093052] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISAC Scholar's Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to acknowledge support from NIH grant R01 HL093052 and the ISAC Scholar's Program (http://isac-net.org/ISAC-Cytometry/ISAC-Scholars.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brackbill ML, 2009, AM J CRIT CARE, V18, P468, DOI 10.4037/ajcc2009718; CHEN W, 1995, CIRC RES, V77, P424, DOI 10.1161/01.RES.77.2.424; CUI Inc, EL PROD INT WORLD; Dodd T, 2013, ARTERIOSCL THROM VAS, V33, P1339, DOI 10.1161/ATVBAHA.113.301533; Dodd T, 2011, J MOL CELL CARDIOL, V51, P1015, DOI 10.1016/j.yjmcc.2011.08.012; Hattan N, 2007, BASIC RES CARDIOL, V102, P217, DOI 10.1007/s00395-007-0646-3; Hoffmann R, 2007, AM J CARDIOL, V100, P1347, DOI 10.1016/j.amjcard.2007.06.021; Hutcheson R, 2013, ARTERIOSCL THROM VAS, V33, P727, DOI 10.1161/ATVBAHA.112.301116; Jadhav R, 2011, AM J PHYSIOL-HEART C, V300, pH1938, DOI 10.1152/ajpheart.00282.2010; Kajimoto K, 2008, METABOLIC SYNDROME P; Kim JY, 2010, YONSEI MED J, V51, P676, DOI 10.3349/ymj.2010.51.5.676; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lassaletta AD, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0243-y; Matsunaga T, 2000, CIRCULATION, V102, P3098; MOHRI M, 1989, CIRC RES, V64, P287, DOI 10.1161/01.RES.64.2.287; Mouquet F, 2009, EUR HEART J, V30, P840, DOI 10.1093/eurheartj/ehn569; Pung YF, 2012, ARTERIOSCL THROM VAS, V32, P325, DOI 10.1161/ATVBAHA.111.241802; Reed R, 2008, ARTERIOSCL THROM VAS, V28, P61, DOI 10.1161/ATVBAHA.107.154294; Reed R, 2009, AM J PHYSIOL-HEART C, V296, pH1811, DOI 10.1152/ajpheart.00920.2008; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sasmaz H, 2009, ANGIOLOGY, V60, P164, DOI 10.1177/0003319708316007; Schernthaner G., 1996, Diabetes Research and Clinical Practice, V31, pS3, DOI 10.1016/0168-8227(96)01224-7; Seiler C, 2003, HEART, V89, P1352, DOI 10.1136/heart.89.11.1352; Toyota E, 2005, CIRCULATION, V112, P2108, DOI 10.1161/CIRCULATIONAHA.104.526954; Turhan H, 2005, CORONARY ARTERY DIS, V16, P281, DOI 10.1097/00019501-200508000-00004; Weihrauch D, 2004, CIRCULATION, V109, P2343, DOI 10.1161/01.CIR.0000129225.67353.1F; YAMANISHI K, 1990, CARDIOVASC RES, V24, P271, DOI 10.1093/cvr/24.4.271; Yilmaz MB, 2006, AM J CARDIOL, V97, P636, DOI 10.1016/j.amjcard.2005.09.103	28	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e95823	10.1371/journal.pone.0095823	http://dx.doi.org/10.1371/journal.pone.0095823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769885	Green Submitted, gold, Green Published			2022-12-25	WOS:000336736600015
J	Lee, S; Lee, E; Park, MS; Kwon, BY; Kim, H; Jung, DH; Jo, KH; Jeong, MH; Rha, SW				Lee, Suji; Lee, Eunil; Park, Man Sik; Kwon, Bo Yeon; Kim, Hana; Jung, Dea Ho; Jo, Kyung Hee; Jeong, Myung Ho; Rha, Seung-Woon			Short-Term Effect of Temperature on Daily Emergency Visits for Acute Myocardial Infarction with Threshold Temperatures	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; RED-CELL COUNTS; WEATHER CONDITIONS; CHOLESTEROL LEVELS; NATIONAL REGISTRY; BLOOD-VISCOSITY; AIR-POLLUTION; HEAT; CORONARY; HEALTH	Background: The relationship between temperature and myocardial infarction has not been fully explained. In this study, we identified the threshold temperature and examined the relationship between temperature and emergency admissions due to MI in Korea. Methods: Poisson generalized additive model analyses were used to assess the short-term effects of temperature (mean, maximum, minimum, diurnal) on MI emergency visits, after controlling for meteorological variable and air pollution (PM10, NO2). We defined the threshold temperature when the inflection point showed a statistically significant difference in the regression coefficients of the generalized additive models (GAMs) analysis. The analysis was performed on the following subgroups: geographical region, gender, age (<75 years or >= 75 years), and MI status (STEMI or non-STEMI). Results: The threshold temperatures during heat exposure were for the maximum temperature as 25.5-31.5 degrees C and for the mean temperature as 27.5-28.5 degrees C. The threshold temperatures during cold exposure were for the minimum temperature as -22.5-1.5 degrees C. Relative risks (RRs) of emergency visits above hot temperature thresholds ranged from 1.02 to 1.30 and those below cold temperature thresholds ranged from 1.01 to 1.05. We also observed increased RRs ranged from 1.02 to 1.65 of emergency visits when temperatures changes on a single day or on successive days. Conclusions: We found a relationship between temperature and MI occurrence during both heat and cold exposure at the threshold temperature. Diurnal temperature or temperature change on successive days also increased MI risk.	[Lee, Suji; Lee, Eunil; Kwon, Bo Yeon] Korea Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea; [Lee, Eunil] Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea; [Park, Man Sik; Kim, Hana] Sungshin Womens Univ, Dept Stat, Coll Nat Sci, Seoul, South Korea; [Lee, Suji; Lee, Eunil; Kwon, Bo Yeon; Jung, Dea Ho; Jo, Kyung Hee] Korea Univ, Grad Sch, Grad Sch Publ Hlth, Seoul, South Korea; [Jeong, Myung Ho] Chonnam Natl Univ Hosp, Dept Cardiol, Kwangju, South Korea; [Rha, Seung-Woon] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul, South Korea	Korea University; Korea University; Korea University Medicine (KU Medicine); Sungshin Women's University; Korea University; Korea University Medicine (KU Medicine); Chonnam National University; Chonnam National University Hospital; Korea University; Korea University Medicine (KU Medicine)	Lee, E (corresponding author), Korea Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea.	eunil@korea.ac.kr; mansikpark@sungshin.ac.kr	Lee, Eunil/AAF-8926-2021; Rha, Seung-Woon/AGE-5810-2022	Rha, Seung-Woon/0000-0001-9456-9852; Lee, Eunil/0000-0003-1524-5046	Research of Korea Centers for Disease Control and Prevention [2013E2100200]; Korea Meteorological Administration Research and Development Program [CATER 2012-3110]	Research of Korea Centers for Disease Control and Prevention; Korea Meteorological Administration Research and Development Program(Korea Meteorological Administration (KMA))	This research was supported by a fund (2013E2100200) by Research of Korea Centers for Disease Control and Prevention. This work was funded by the Korea Meteorological Administration Research and Development Program under Grant CATER 2012-3110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett AG, 2005, J EPIDEMIOL COMMUN H, V59, P551, DOI 10.1136/jech.2004.028514; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; Bhaskaran K, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8050; Bhaskaran K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3823; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60929-6; Danet S, 1999, CIRCULATION, V100, pE11, DOI 10.1161/01.CIR.100.1.e1; Dilaveris P, 2006, HEART, V92, P1747, DOI 10.1136/hrt.2006.091884; Ebi KL, 2004, INT J BIOMETEOROL, V49, P48, DOI 10.1007/s00484-004-0207-5; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Gerber Y, 2006, J AM COLL CARDIOL, V48, P287, DOI 10.1016/j.jacc.2006.02.065; Goggins WB, 2013, INT J CARDIOL, V168, P243, DOI 10.1016/j.ijcard.2012.09.087; Hajat S, 2002, J EPIDEMIOL COMMUN H, V56, P367, DOI 10.1136/jech.56.5.367; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; KEATINGE WR, 1984, BMJ-BRIT MED J, V289, P1405, DOI 10.1136/bmj.289.6456.1405; KEATINGE WR, 1986, AM J MED, V81, P795, DOI 10.1016/0002-9343(86)90348-7; Lee SR, 2008, CIRC J, V72, P392, DOI 10.1253/circj.72.392; McMichael AJ, 2011, J INTERN MED, V270, P401, DOI 10.1111/j.1365-2796.2011.02415.x; McMichael T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1359; Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175; Messner Torbjorn, 2002, Int J Circumpolar Health, V61, P201; Morabito M, 2005, INT J CARDIOL, V105, P288, DOI 10.1016/j.ijcard.2004.12.047; Na Wonwoong, 2013, J Prev Med Public Health, V46, P19, DOI 10.3961/jpmph.2013.46.1.19; Ockene IS, 2004, ARCH INTERN MED, V164, P863, DOI 10.1001/archinte.164.8.863; OHLSON CG, 1991, SCAND J SOC MED, V19, P20, DOI 10.1177/140349489101900104; Ornato JP, 1996, J AM COLL CARDIOL, V28, P1684, DOI 10.1016/S0735-1097(96)00411-1; Rossi G, 1999, ARCH ENVIRON HEALTH, V54, P158, DOI 10.1080/00039899909602254; Sharovsky R, 2004, BRAZ J MED BIOL RES, V37, P1651, DOI 10.1590/S0100-879X2004001100009; Spencer FA, 1998, J AM COLL CARDIOL, V31, P1226, DOI 10.1016/S0735-1097(98)00098-9; Tam WWS, 2009, ARCH ENVIRON OCCUP H, V64, P202, DOI 10.1080/19338240903241192; Turner LR, 2012, EPIDEMIOLOGY, V23, P594, DOI 10.1097/EDE.0b013e3182572795; Wang Hongli, 2006, Hiroshima Journal of Medical Sciences, V55, P45; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Wilkinson P, 2004, BMJ-BRIT MED J, V329, P647, DOI 10.1136/bmj.38167.589907.55	35	34	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e94070	10.1371/journal.pone.0094070	http://dx.doi.org/10.1371/journal.pone.0094070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24770787	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736600003
J	Wahl, P; Jansen, F; Achtzehn, S; Schmitz, T; Bloch, W; Mester, J; Werner, N				Wahl, Patrick; Jansen, Felix; Achtzehn, Silvia; Schmitz, Theresa; Bloch, Wilhelm; Mester, Joachim; Werner, Nikos			Effects of High Intensity Training and High Volume Training on Endothelial Microparticles and Angiogenic Growth Factors	PLOS ONE			English	Article							INHIBITORY FACTOR MIF; PLATELET MICROPARTICLES; INDUCE ANGIOGENESIS; EXERCISE; CELLS; HYPOXIA; CORRELATE; RECEPTOR; LOCUS-1; IMPACT	Aims: Endothelial microparticles (EMP) are complex vesicular structures shed from activated or apoptotic endothelial cells. As endurance exercise affects the endothelium, the objective of the study was to examine levels of EMP and angiogenic growth factors following different endurance exercise protocols. Methods: 12 subjects performed 3 different endurance exercise protocols: 1. High volume training (HVT; 130 min at 55% peak power output (PPO); 2. 4x4 min at 95% PPO; 3. 4x30 sec all-out. EMPs were quantified using flow cytometry after staining platelet-poor-plasma. Events positive for Annexin-V and CD31, and negative for CD42b, were classified as EMPs. Vascular endothelial growth factor (VEGF), migratory inhibiting factor (MIF) and hepatocyte growth factor (HGF) were determined by ELISA technique. For all these measurements venous blood samples were taken pre, 0', 30', 60' and 180' after each intervention. Furthermore, in vitro experiments were performed to explore the effect of collected sera on target endothelial functions and MP uptake capacities. Results: VEGF and HGF significantly increased after HIT interventions. All three interventions caused a significant decrease in EMP levels post exercise compared to pre values. The sera taken after exercise increased the uptake of EMP in target endothelial cells compared to sera taken under resting conditions, which was shown to be phosphatidylserin-dependent. Increased EMP uptake was associated with an improved protection of target cells against apoptosis. Sera taken prior and after exercise promoted target endothelial cell migration, which was abrogated after inhibition of VEGF. Conclusion: Physical exercise leads to decreased EMP levels and promotes a phosphatidylserin-dependent uptake of EMP into target endothelial cells, which is associated with a protection of target cells against apoptosis.	[Wahl, Patrick; Achtzehn, Silvia; Mester, Joachim] German Sport Univ Cologne, Inst Training Sci & Sport Informat, Cologne, Germany; [Wahl, Patrick; Bloch, Wilhelm] German Sport Univ Cologne, Inst Cardiovasc Res & Sport Med, Dept Mol & Cellular Sport Med, Cologne, Germany; [Wahl, Patrick; Bloch, Wilhelm; Mester, Joachim] German Sport Univ Cologne, German Res Ctr Elite Sport, Cologne, Germany; [Schmitz, Theresa; Werner, Nikos] Univ Bonn, Fac Med, Dept Internal Med Cardiol Pneumol & Angiol 4, Bonn, Germany	German Sport University Cologne; German Sport University Cologne; German Sport University Cologne; University of Bonn	Wahl, P (corresponding author), German Sport Univ Cologne, Inst Training Sci & Sport Informat, Cologne, Germany.	Wahl@dshs-koeln.de	Wahl, Patrick/GRX-9246-2022	Wahl, Patrick/0000-0001-8682-5916	German Sport University Cologne	German Sport University Cologne	This work was supported by the grant funding of the German Sport University Cologne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Faraj A, 2012, RADIOLOGY, V263, P169, DOI 10.1148/radiol.11111329; Aoki M, 2005, BIOCHEM BIOPH RES CO, V333, P990, DOI 10.1016/j.bbrc.2005.06.009; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Burnier L, 2009, THROMB HAEMOSTASIS, V101, P439, DOI 10.1160/TH08-08-0521; Chaar V, 2011, CLIN HEMORHEOL MICRO, V47, P15, DOI 10.3233/CH-2010-1361; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Chironi GN, 2009, CELL TISSUE RES, V335, P143, DOI 10.1007/s00441-008-0710-9; Conway K, 2006, WOUND REPAIR REGEN, V14, P2, DOI 10.1111/j.1743-6109.2005.00081.x; Dasgupta SK, 2012, CIRCULATION, V125, P1664, DOI 10.1161/CIRCULATIONAHA.111.068833; Faille D, 2012, J CELL MOL MED, V16, P1731, DOI 10.1111/j.1582-4934.2011.01434.x; Flueck M, 2010, ENDOCRIN METAB CLIN, V39, P183, DOI 10.1016/j.ecl.2009.10.002; Fukumura D, 2001, CANCER RES, V61, P6020; Goerges AL, 2003, J BIOL CHEM, V278, P19518, DOI 10.1074/jbc.M211208200; Grieb G, 2010, DRUG NEWS PERSPECT, V23, P257, DOI 10.1358/dnp.2010.23.4.1453629; Harrison M, 2009, EUR J APPL PHYSIOL, V106, P555, DOI 10.1007/s00421-009-1050-5; Hoyer FF, 2012, J CELL MOL MED, V16, P2777, DOI 10.1111/j.1582-4934.2012.01595.x; Hunt TK, 2007, ANTIOXID REDOX SIGN, V9, P1115, DOI 10.1089/ars.2007.1674; Jansen F, 2013, CIRCULATION, V128, P2026, DOI 10.1161/CIRCULATIONAHA.113.001720; Jansen F, 2013, CARDIOVASC RES, V98, P94, DOI 10.1093/cvr/cvt013; Jansen F, 2012, ARTERIOSCL THROM VAS, V32, P1925, DOI 10.1161/ATVBAHA.112.253229; Jensen L, 2004, J PHYSIOL-LONDON, V557, P571, DOI 10.1113/jphysiol.2003.057711; Kim HR, 2007, J RHEUMATOL, V34, P927; Kraus RM, 2004, J APPL PHYSIOL, V96, P1445, DOI 10.1152/japplphysiol.01031.2003; Lekakis J, 2011, EUR J CARDIOV PREV R, V18, P775, DOI 10.1177/1741826711398179; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Ma PC, 2005, CLIN CANCER RES, V11, P2312, DOI 10.1158/1078-0432.CCR-04-1708; Mezentsev A, 2005, AM J PHYSIOL-HEART C, V289, pH1106, DOI 10.1152/ajpheart.00265.2005; Morici G, 2005, AM J PHYSIOL-REG I, V289, pR1496, DOI 10.1152/ajpregu.00338.2005; Mostefai HA, 2008, PHYSIOL RES, V57, P311, DOI 10.33549/physiolres.931533; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Rautou PE, 2011, CIRC RES, V108, P335, DOI 10.1161/CIRCRESAHA.110.237420; Rehman J, 2004, J AM COLL CARDIOL, V43, P2314, DOI 10.1016/j.jacc.2004.02.049; Riddell JR, 2011, CANCER RES, V71, P1637, DOI 10.1158/0008-5472.CAN-10-3674; Rullman E, 2007, J APPL PHYSIOL, V102, P2346, DOI 10.1152/japplphysiol.00822.2006; SCHANTZ P, 1983, CLIN PHYSIOL, V3, P141, DOI 10.1111/j.1475-097X.1983.tb00685.x; Schmidt A, 2009, BRIT J SPORT MED, V43, P195, DOI 10.1136/bjsm.2007.043208; Scott CB, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-1; Sengupta S, 2003, ARTERIOSCL THROM VAS, V23, P69, DOI 10.1161/01.ATV.0000048701.86621.D0; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Sossdorf M, 2011, MED SCI SPORT EXER, V43, P1169, DOI 10.1249/MSS.0b013e3182068645; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Suhr F, 2007, J APPL PHYSIOL, V103, P474, DOI 10.1152/japplphysiol.01160.2006; VANBEAUMONT W, 1972, J APPL PHYSIOL, V32, P712, DOI 10.1152/jappl.1972.32.5.712; Wahl P, 2010, SCHWEIZ Z SPORTMED S, V58, P125; Wahl P, 2010, WIEN MED WOCHENSCHR, V160, P627, DOI 10.1007/s10354-010-0857-3; Wahl P, 2011, EUR J APPL PHYSIOL, V111, P1405, DOI 10.1007/s00421-010-1767-1; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Willekens FLA, 2005, BLOOD, V105, P2141, DOI 10.1182/blood-2004-04-1578; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292	49	52	53	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e96024	10.1371/journal.pone.0096024	http://dx.doi.org/10.1371/journal.pone.0096024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24770423	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736600022
J	Tamamis, P; Floudas, CA				Tamamis, Phanourios; Floudas, Christodoulos A.			Molecular Recognition of CCR5 by an HIV-1 gp120 V3 Loop	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMPLICIT MEMBRANE MODELS; AMINO-TERMINAL DOMAIN; ENVELOPE GLYCOPROTEIN; DYNAMICS SIMULATIONS; COMPSTATIN VARIANTS; BRIDGING SHEET; CD4 RECEPTOR; TYPE-1 ENTRY; N-TERMINUS	The binding of protein HIV-1 gp120 to coreceptors CCR5 or CXCR4 is a key step of the HIV-1 entry to the host cell, and is predominantly mediated through the V3 loop fragment of HIV-1 gp120. In the present work, we delineate the molecular recognition of chemokine receptor CCR5 by a dual tropic HIV-1 gp120 V3 loop, using a comprehensive set of computational tools predominantly based on molecular dynamics simulations and free energy calculations. We report, what is to our knowledge, the first complete HIV-1 gp120 V3 loop : CCR5 complex structure, which includes the whole V3 loop and the N-terminus of CCR5, and exhibits exceptional agreement with previous experimental findings. The computationally derived structure sheds light into the functional role of HIV-1 gp120 V3 loop and CCR5 residues associated with the HIV-1 coreceptor activity, and provides insights into the HIV-1 coreceptor selectivity and the blocking mechanism of HIV-1 gp120 by maraviroc. By comparing the binding of the specific dual tropic HIV-1 gp120 V3 loop with CCR5 and CXCR4, we observe that the HIV-1 gp120 V3 loop residues 13-21, which include the tip, share nearly identical structural and energetic properties in complex with both coreceptors. This result paves the way for the design of dual CCR5/CXCR4 targeted peptides as novel potential anti-AIDS therapeutics.	[Tamamis, Phanourios; Floudas, Christodoulos A.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA	Princeton University	Floudas, CA (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	floudas@titan.princeton.edu		Tamamis, Phanourios/0000-0002-3342-2651	National Institutes of Health [R01 GM052032]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CAF acknowledges funding from the National Institutes of Health (R01 GM052032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellows ML, 2010, BIOPHYS J, V99, P3445, DOI 10.1016/j.bpj.2010.09.050; Bellows ML, 2010, BIOPHYS J, V98, P2337, DOI 10.1016/j.bpj.2010.01.057; Bellows-Peterson ML, 2012, J MED CHEM, V55, P4159, DOI 10.1021/jm201609k; Berro R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000548; Blanpain C, 1999, J BIOL CHEM, V274, P34719, DOI 10.1074/jbc.274.49.34719; Bozek K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002977; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chandramouli B, 2013, J BIOMOL STRUCT DYN, V31, P403, DOI 10.1080/07391102.2012.703068; Chandramouli B, 2012, J BIOMOL STRUCT DYN, V29, P879; Choi YS, 2009, PROTEINS, V77, P14, DOI 10.1002/prot.22410; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; Da LT, 2011, J CHEM INF MODEL, V51, P359, DOI 10.1021/ci1003448; Das P, 2013, J AM CHEM SOC, V135, P1882, DOI 10.1021/ja310544t; DEVICTORIA AL, 2012, PLOS ONE, V0007; Dittmar MT, 1997, NATURE, V385, P495, DOI 10.1038/385495a0; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Dragic T, 2001, J GEN VIROL, V82, P1807, DOI 10.1099/0022-1317-82-8-1807; Dragic T, 1998, J VIROL, V72, P279, DOI 10.1128/JVI.72.1.279-285.1998; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; Feig Michael, 2008, V443, P181, DOI 10.1007/978-1-59745-177-2_10; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Genoud S, 1999, J VIROL, V73, P1645, DOI 10.1128/JVI.73.2.1645-1648.1999; Gorham RD, 2013, EXP EYE RES, V116, P96, DOI 10.1016/j.exer.2013.07.023; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Hill CM, 1998, VIROLOGY, V248, P357, DOI 10.1006/viro.1998.9283; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelm S, 2010, BIOINFORMATICS, V26, P2833, DOI 10.1093/bioinformatics/btq554; Kieslich CA, 2012, CURR PHYS CHEM, V2, P324; Kieslich CA, 2013, AIDS RES HUM RETROV, V29, P1; Klepeis JL, 2004, IND ENG CHEM RES, V43, P3817, DOI 10.1021/ie0340995; Klepeis JL, 2003, J AM CHEM SOC, V125, P8422, DOI 10.1021/ja034846p; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lazaridis T, 2003, PROTEINS, V52, P176, DOI 10.1002/prot.10410; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu SQ, 2003, J MOL MODEL, V9, P329, DOI 10.1007/s00894-003-0154-9; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; MCKNIGHT A, 1995, J VIROL, V69, P3167, DOI 10.1128/JVI.69.5.3167-3170.1995; Napier KB, 2007, J MOL MODEL, V13, P29, DOI 10.1007/s00894-006-0117-z; Pan YP, 2005, J MOL BIOL, V350, P514, DOI 10.1016/j.jmb.2005.05.009; Pan YP, 2004, J BIOL CHEM, V279, P30523, DOI 10.1074/jbc.M404364200; Panahi A, 2013, J CHEM THEORY COMPUT, V9, P1709, DOI 10.1021/ct300975k; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Rabut GEE, 1998, J VIROL, V72, P3464, DOI 10.1128/JVI.72.4.3464-3468.1998; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Schnur E, 2011, J MOL BIOL, V410, P778, DOI 10.1016/j.jmb.2011.04.023; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Siciliano SJ, 1999, J BIOL CHEM, V274, P1905, DOI 10.1074/jbc.274.4.1905; Smadbeck J, 2013, JOVE-J VIS EXP, DOI 10.3791/50476; Suphaphiphat P, 2003, J VIROL, V77, P3832, DOI 10.1128/JVI.77.6.3832-3837.2003; Tamamis P, 2014, J CHEM INF MODEL, V54, P1174, DOI 10.1021/ci500069y; Tamamis P, 2014, J PHYS CHEM B, V118, P1765, DOI 10.1021/jp409988n; Tamamis P, 2013, BIOPHYS J, V105, P1502, DOI 10.1016/j.bpj.2013.07.049; Tamamis P, 2012, CHEM BIOL DRUG DES, V79, P703, DOI 10.1111/j.1747-0285.2012.01324.x; Tamamis P, 2011, PROTEINS, V79, P3166, DOI 10.1002/prot.23149; Tamamis P, 2011, J NON-CRYST SOLIDS, V357, P717, DOI 10.1016/j.jnoncrysol.2010.05.083; Tamamis P, 2010, PROTEINS, V78, P2655, DOI 10.1002/prot.22780; Tamamis P, 2009, J PHYS CHEM B, V113, P15639, DOI 10.1021/jp9066718; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tanizaki S, 2006, J PHYS CHEM B, V110, P548, DOI 10.1021/jp054694f; Weiss RA, 1996, NATURE, V381, P647, DOI 10.1038/381647a0; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xiang SH, 2013, VIROLOGY, V438, P5, DOI 10.1016/j.virol.2013.01.002; Yuzlenko O, 2013, J COMPUT CHEM, V34, P731, DOI 10.1002/jcc.23189; Zhou NM, 2000, EUR J IMMUNOL, V30, P164, DOI 10.1002/1521-4141(200001)30:1<164::AID-IMMU164>3.0.CO;2-X	82	50	53	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95767	10.1371/journal.pone.0095767	http://dx.doi.org/10.1371/journal.pone.0095767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763408	Green Published, Green Submitted, gold			2022-12-25	WOS:000335505000033
J	Lee, SH; Kim, Y; Kim, HY; Kim, YH; Kim, MS; Kong, JY; Lee, MH; Kim, DJ; Ahn, YG				Lee, Sang-Hyun; Kim, YoungSoo; Kim, Hye Yun; Kim, Young Hoon; Kim, Maeng Sup; Kong, Jae Yang; Lee, Mun-Han; Kim, Dong Jin; Ahn, Young Gil			Aminostyrylbenzofuran Directly Reduces Oligomeric Amyloid-beta and Reverses Cognitive Deficits in Alzheimer Transgenic Mice	PLOS ONE			English	Article							MOUSE MODEL; DISEASE; STRATEGIES; IMPAIRMENT; INHIBITORS; CASCADE; MEMORY	Alzheimer's disease is an irreversible neurodegenerative disorder that is characterized by the abnormal aggregation of amyloid-beta into neurotoxic oligomers and plaques. Although many disease-modifying molecules are currently in Alzheimer clinical trials, a small molecule that inhibits amyloid-b aggregation and ameliorates the disorder has not been approved to date. Herein, we report the effects of a potent small molecule, 6-methoxy-2-(4-dimethylaminostyryl) benzofuran (KMS88009), that directly disrupts amyloid-b oligomerization, preserving cognitive behavior when used prophylactically and reversing declines in cognitive behavior when used therapeutically. KMS88009 exhibited excellent pharmacokinetic profiles with extensive brain uptake and a high level of safety. When orally administered before and after the onset of Alzheimer's disease symptoms, KMS88009 significantly reduced assembly of amyloid-b oligomers and improved cognitive behaviors in the APP/ PS1 double transgenic mouse model. The unique dual mode of action indicates that KMS88009 may be a powerful therapeutic candidate for the treatment of Alzheimer's disease.	[Lee, Sang-Hyun; Kim, Young Hoon; Kim, Maeng Sup; Ahn, Young Gil] Hanmi Pharmaceut Co Ltd, Hanmi Res Ctr, Hwaseong Si, Gyonggi Do, South Korea; [Lee, Sang-Hyun; Lee, Mun-Han] Seoul Natl Univ, Coll Vet Med, Dept Biochem, Seoul, South Korea; [Kim, YoungSoo; Kim, Hye Yun; Kim, Dong Jin] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul, South Korea; [Kim, YoungSoo; Kim, Hye Yun] Univ Sci & Technol, Biol Chem Program, Taejon, South Korea; [Kim, Hye Yun] Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul, South Korea; [Kong, Jae Yang] Keimyung Univ, Coll Pharm, Taegu, South Korea	Hanmi Pharmaceutical; Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Keimyung University	Kim, DJ (corresponding author), Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul, South Korea.	djk2991@kist.re.kr; ygahn@hanmi.co.kr	Kim, YoungSoo/AAO-1970-2020	Kim, YoungSoo/0000-0001-5029-7082	Ministry of Trade, Industry and Energy of Korea [2M28110]; Hanmi Pharmaceutical Co., Ltd.; KIST Institutional Programs [2E24582]	Ministry of Trade, Industry and Energy of Korea; Hanmi Pharmaceutical Co., Ltd.; KIST Institutional Programs	This work was supported by Ministry of Trade, Industry and Energy of Korea (2M28110), Hanmi Pharmaceutical Co., Ltd. and KIST Institutional Programs (2E24582). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Byun JH, 2008, BIOORG MED CHEM LETT, V18, P5591, DOI 10.1016/j.bmcl.2008.08.111; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Dineley KT, 2010, J NEUROSCI RES, V88, P2923, DOI 10.1002/jnr.22445; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Gervais F, 2007, NEUROBIOL AGING, V28, P537, DOI 10.1016/j.neurobiolaging.2006.02.015; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Liu YH, 2012, NAT REV NEUROL, V8, P465, DOI 10.1038/nrneurol.2012.118; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Salomone S, 2012, BRIT J CLIN PHARMACO, V73, P504, DOI 10.1111/j.1365-2125.2011.04134.x; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541	18	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95733	10.1371/journal.pone.0095733	http://dx.doi.org/10.1371/journal.pone.0095733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760018	Green Submitted, gold, Green Published			2022-12-25	WOS:000335298200083
J	Martin, DL; Goodhew, B; Czaicki, N; Foster, K; Rajbhandary, S; Hunter, S; Brubaker, SA				Martin, Diana L.; Goodhew, Brook; Czaicki, Nancy; Foster, Kawanda; Rajbhandary, Srijana; Hunter, Shawn; Brubaker, Scott A.			Trypanosoma cruzi Survival following Cold Storage: Possible Implications for Tissue Banking	PLOS ONE			English	Article							CHAGAS-DISEASE; TRANSFUSION TRANSMISSION; INFECTED MICE; UNITED-STATES; BLOOD-DONORS; LOS-ANGELES; TRANSPLANTATION; BONE; EXPERIENCE; RECIPIENTS	While Trypanosoma cruzi, the etiologic agent of Chagas disease, is typically vector-borne, infection can also occur through solid organ transplantation or transfusion of contaminated blood products. The ability of infected human cells, tissues, and cellular and tissue-based products (HCT/Ps) to transmit T. cruzi is dependent upon T. cruzi surviving the processing and storage conditions to which HCT/Ps are subjected. In the studies reported here, T. cruzi trypomastigotes remained infective 24 hours after being spiked into blood and stored at room temperature (N = 20); in 2 of 13 parasite-infected cultures stored 28 days at 4 degrees C; and in samples stored 365 days at -80 degrees C without cryoprotectant (N = 28), despite decreased viability compared to cryopreserved parasites. Detection of viable parasites after multiple freeze/thaws depended upon the duration of frozen storage. The ability of T. cruzi to survive long periods of storage at +4 and -80 degrees C suggests that T. cruzi-infected tissues stored under these conditions are potentially infectious.	[Martin, Diana L.; Goodhew, Brook] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Czaicki, Nancy] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Foster, Kawanda] Univ Georgia, Athens, GA 30602 USA; [Rajbhandary, Srijana] Ctr Med Technol Policy, Baltimore, MD USA; [Hunter, Shawn] Ctr Tissue Innovat & Res, Kettering, OH USA; [Brubaker, Scott A.] Amer Assoc Tissue Banks, Mclean, VA USA	Centers for Disease Control & Prevention - USA; University of California System; University of California Berkeley; University System of Georgia; University of Georgia	Martin, DL (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	hzx3@cdc.gov			Scientific and Technical Affairs Committee of the American Association of Tissue Banks (AATB)	Scientific and Technical Affairs Committee of the American Association of Tissue Banks (AATB)	This research was supported by a grant from the Scientific and Technical Affairs Committee of the American Association of Tissue Banks (AATB, www.aatb.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AATB, 2010, AM ASS TISS BANKS AA; Andrade LO, 2005, NAT REV MICROBIOL, V3, P819, DOI 10.1038/nrmicro1249; Andrade LO, 1999, MOL BIOCHEM PARASIT, V100, P163, DOI 10.1016/S0166-6851(99)90035-X; Anez N, 1999, AM J TROP MED HYG, V60, P726, DOI 10.4269/ajtmh.1999.60.726; Benjamin RJ, 2012, TRANSFUSION, V52, P1913, DOI 10.1111/j.1537-2995.2011.03554.x; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; Buckner FS, 1999, INFECT IMMUN, V67, P403, DOI 10.1128/IAI.67.1.403-409.1999; Cantey PT, 2012, TRANSFUSION, V52, P1922, DOI 10.1111/j.1537-2995.2012.03581.x; Centers for Disease Control and Prevention, 2002, MMWR MORB MORTAL WKL, V51, P210; CONNOR RJ, 1987, BIOMETRICS, V43, P207, DOI 10.2307/2531961; DEFARIA JBL, 1993, TRANSPLANTATION, V56, P1583; Department of Health and Human Services (DHHS) FaDAF Center for Biologics Evaluation and Research (CBER), 2009, GUID IND US IN PRESS; Dictar M, 1998, BONE MARROW TRANSPL, V21, P391, DOI 10.1038/sj.bmt.1701107; Duffy T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002000; Ferraz A. S., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P461, DOI 10.1590/S0036-46651993000500013; FISHER RA, 1945, NATURE, V156, P388, DOI 10.1038/156388a0; Fores R, 2007, BONE MARROW TRANSPL, V39, P127, DOI 10.1038/sj.bmt.1705551; Huprikar S, 2013, AM J TRANSPLANT; Leiby DA, 2002, TRANSFUSION, V42, P549, DOI 10.1046/j.1537-2995.2002.00077.x; Lenzi IL, 1996, EXP PARASITOL, V84, P16, DOI 10.1006/expr.1996.0086; Mascola L., 2006, Morbidity and Mortality Weekly Report, V55, P798; McCormack L, 2012, AM J TRANSPLANT, V12, P2832, DOI 10.1111/j.1600-6143.2012.04160.x; Morocoima A, 2006, PARASITOL RES, V99, P663, DOI 10.1007/s00436-006-0211-2; POLGE C, 1957, TRANS ROY SOC TROP MED AND HYG, V51, P519, DOI 10.1016/0035-9203(57)90041-X; Riarte A, 1999, CLIN INFECT DIS, V29, P561, DOI 10.1086/598634; VAZQUEZ MC, 1993, TRANSPL P, V25, P3259; Vazquez MC, 1996, TRANSPL P, V28, P3301; VILLALBA R, 1992, CLIN INFECT DIS, V14, P594, DOI 10.1093/clinids/14.2.594; WENDEL S, 1992, ISBT BRAS 92 SBHH; Wendel S, 2010, ACTA TROP, V115, P28, DOI 10.1016/j.actatropica.2009.12.006	30	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95398	10.1371/journal.pone.0095398	http://dx.doi.org/10.1371/journal.pone.0095398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759837	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200054
J	Hartlieb, E; Rotzer, V; Radeva, M; Spindler, V; Waschke, J				Hartlieb, Eva; Roetzer, Vera; Radeva, Mariya; Spindler, Volker; Waschke, Jens			Desmoglein 2 Compensates for Desmoglein 3 but Does Not Control Cell Adhesion via Regulation of p38 Mitogen-activated Protein Kinase in Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEMPHIGUS-VULGARIS; EPIDERMAL-GROWTH; DESMOSOME; CYTOSKELETON; PLAKOGLOBIN; INHIBITION; PHENOTYPE; MECHANISM; FOLIACEUS; DISEASE	Desmosomal cadherins are transmembrane adhesion molecules that provide cell adhesion by interacting in the intercellular space of adjacent cells. In keratinocytes, several desmoglein (Dsg1-4) and desmocollin (Dsc1-3) isoforms are coexpressed. We have shown previously that Dsg2 is less important for keratinocyte cohesion compared with Dsg3 and that the latter forms a complex with p38 MAPK. In this study, we compared the involvement of Dsg2 and Dsg3 in the p38 MAPK-dependent regulation of keratinocyte cohesion. We show that loss of cell adhesion and keratin filament retraction induced by Dsg3 depletion is ameliorated by specific p38 MAPK inhibition. Furthermore, in contrast to depletion of Dsg2, siRNA-mediated silencing of Dsg3 induced p38 MAPK activation, which is in line with immunoprecipitation experiments demonstrating the interaction of activated p38 MAPK with Dsg3 but not with Dsg2. Cell fractionation into a cytoskeleton-unbound and a cytoskeleton-anchored desmosome-containing pool revealed that Dsg3, in contrast to Dsg2, is present in relevant amounts in the unbound pool in which activated p38 MAPK is predominantly detectable. Moreover, because loss of cell adhesion by Dsg3 depletion was partially rescued by p38 MAPK inhibition, we conclude that, besides its function as an adhesion molecule, Dsg3 is strengthening cell cohesion via modulation of p38 MAPK-dependent keratin filament reorganization. Nevertheless, because subsequent targeting of Dsg3 in Dsg2-depleted cells led to drastically enhanced keratinocyte dissociation and Dsg2 was enhanced at the membrane in Dsg3 knockout cells, we conclude that Dsg2 compensates for Dsg3 loss of function.	[Hartlieb, Eva; Roetzer, Vera; Radeva, Mariya; Spindler, Volker; Waschke, Jens] Univ Munich, Inst Anat & Cell Biol, Dept 1, D-80336 Munich, Germany	University of Munich	Waschke, J (corresponding author), Jens Waschke Inst Anat & Cell Biol, Pettenkoferstr 11, D-80336 Munich, Germany.	jens.waschke@med.uni-muenchen.de	Spindler, Volker/G-1704-2019	Spindler, Volker/0000-0002-1302-5421				Baron S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050024; Bektas M, 2013, J BIOL CHEM, V288, P9447, DOI 10.1074/jbc.M112.438010; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brennan D, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/410278; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Getsios Spiro, 2010, J Invest Dermatol, V130, P1764, DOI 10.1038/jid.2010.111; Grando SA, 2009, EXP DERMATOL, V18, P764, DOI 10.1111/j.1600-0625.2009.00934.x; Hartlieb E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053739; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Heupel WM, 2009, J BIOL CHEM, V284, P8589, DOI 10.1074/jbc.M808813200; Heupel WM, 2009, AM J PATHOL, V174, P475, DOI 10.2353/ajpath.2009.080392; Hotchin N. A., 2010, PLOS ONE, V5; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Khan K, 2006, BRIT J CANCER, V95, P1367, DOI 10.1038/sj.bjc.6603453; Kitajima Y, 2013, KAOHSIUNG J MED SCI, V29, P1, DOI 10.1016/j.kjms.2012.08.001; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Kolegraff K, 2011, MOL BIOL CELL, V22, P1121, DOI 10.1091/mbc.E10-10-0845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVER WF, 1953, MEDICINE, V32, P1; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; Spindler V, 2007, AM J PATHOL, V171, P906, DOI 10.2353/ajpath.2007.070028; Spindler V, 2014, J INVEST DERMATOL, V134, P1655, DOI 10.1038/jid.2014.21; Spindler V, 2013, J CLIN INVEST, V123, P800, DOI 10.1172/JCI60139; Spindler V, 2011, ANN ANAT, V193, P177, DOI 10.1016/j.aanat.2011.02.003; Spindler V, 2010, J IMMUNOL, V185, P6831, DOI 10.4049/jimmunol.1002675; Spindler V, 2009, J BIOL CHEM, V284, P30556, DOI 10.1074/jbc.M109.024810; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Tsang SM, 2012, J PATHOL, V227, P81, DOI 10.1002/path.3982; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; Wu H, 2000, NEW ENGL J MED, V343, P31, DOI 10.1056/NEJM200007063430105	40	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17043	17053		10.1074/jbc.M113.489336	http://dx.doi.org/10.1074/jbc.M113.489336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24782306	Green Published, hybrid			2022-12-25	WOS:000338016200038
J	Choi, SG; Wang, Q; Jia, JJ; Pincas, H; Turgeon, JL; Sealfon, SC				Choi, Soon Gang; Wang, Qian; Jia, Jingjing; Pincas, Hanna; Turgeon, Judith L.; Sealfon, Stuart C.			Growth Differentiation Factor 9 (GDF9) Forms an Incoherent Feed-forward Loop Modulating Follicle-stimulating Hormone beta-Subunit (FSH beta) Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GONADOTROPIN-RELEASING-HORMONE; CYCLASE-ACTIVATING POLYPEPTIDE; PITUITARY; GNRH; RECEPTOR; TRANSCRIPTION; FOLLISTATIN; OVARIAN; ACTIVIN; PACAP	Gonadotropin-releasing hormone (GnRH) is secreted in brief pulses from the hypothalamus and regulates follicle-stimulating hormone beta-subunit (FSH beta) gene expression in pituitary gonadotropes in a frequency-sensitive manner. The mechanisms underlying its preferential and paradoxical induction of FSH beta by low frequency GnRH pulses are incompletely understood. Here, we identify growth differentiation factor 9 (GDF9) as a GnRH-suppressed autocrine inducer of FSH beta gene expression. GDF9 gene transcription and expression were preferentially decreased by high frequency GnRH pulses. GnRH regulation of GDF9 was concentration-dependent and involved ERK and PKA. GDF9 knockdown or immunoneutralization reduced FSH beta mRNA expression. Conversely, exogenous GDF9 induced FSH beta expression in immortalized gonadotropes and in mouse primary pituitary cells. GDF9 exposure increased FSH secretion in rat primary pituitary cells. GDF9 induced Smad2/3 phosphorylation, which was impeded by ALK5 knockdown and by activin receptor-like kinase (ALK) receptor inhibitor SB-505124, which also suppressed FSH beta expression. Smad2/3 knockdown indicated that FSH beta induction by GDF9 involved Smad2 and Smad3. FSH beta mRNA induction by GDF9 and GnRH was synergistic. We hypothesized that GDF9 contributes to a regulatory loop that tunes the GnRH frequency-response characteristics of the FSH beta gene. To test this, we determined the effects of GDF9 knockdown on FSH beta induction at different GnRH pulse frequencies using a parallel perifusion system. Reduction of GDF9 shifted the characteristic pattern of GnRH pulse frequency sensitivity. These results identify GDF9 as contributing to an incoherent feed-forward loop, comprising both intracellular and secreted components, that regulates FSH beta expression in response to activation of cell surface GnRH receptors.	[Choi, Soon Gang; Wang, Qian; Jia, Jingjing; Pincas, Hanna; Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Ctr Translat Syst Biol, New York, NY 10029 USA; [Choi, Soon Gang; Wang, Qian; Jia, Jingjing; Pincas, Hanna; Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Turgeon, Judith L.] Univ Calif Davis, Sch Med, Dept Internal Med, Div Endocrinol, Davis, CA 95616 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California Davis	Sealfon, SC (corresponding author), Icahn Sch Med Mt Sinai, Ctr Translat Syst Biol, Annenberg 14-94,Box 1137,1 Gustave L Levy Pl, New York, NY 10029 USA.	stuart.sealfon@mssm.edu	Wang, Qian/AAJ-6823-2021; choi, soon gang/AAE-3187-2019	Wang, Qian/0000-0001-5504-0008; choi, soon gang/0000-0003-0314-3958; SEALFON, Stuart/0000-0001-5791-1217	National Institutes of Health [DK46943]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046943, R01DK046943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46943.	Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bertram R, 2008, B MATH BIOL, V70, P2211, DOI 10.1007/s11538-008-9341-2; Besecke LM, 1996, ENDOCRINOLOGY, V137, P3667, DOI 10.1210/en.137.9.3667; Burrin JM, 1998, ENDOCRINOLOGY, V139, P1731, DOI 10.1210/en.139.4.1731; Choi SG, 2012, J BIOL CHEM, V287, P21550, DOI 10.1074/jbc.M112.348607; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; Counis R, 2007, PEPTIDES, V28, P1797, DOI 10.1016/j.peptides.2007.05.011; CULLER MD, 1991, ENDOCRINOLOGY, V129, P2260, DOI 10.1210/endo-129-4-2260; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Ferris HA, 2007, BIOL REPROD, V77, P1073, DOI 10.1095/biolreprod.107.064139; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Fitzpatrick SL, 1998, ENDOCRINOLOGY, V139, P2571, DOI 10.1210/en.139.5.2571; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Grafer CM, 2009, MOL ENDOCRINOL, V23, P1022, DOI 10.1210/me.2008-0477; Grosse R, 2000, J BIOL CHEM, V275, P9193, DOI 10.1074/jbc.275.13.9193; Hosoe M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-33; Hreinsson JG, 2002, J CLIN ENDOCR METAB, V87, P316, DOI 10.1210/jc.87.1.316; HSIEH KP, 1992, MOL ENDOCRINOL, V6, P1673, DOI 10.1210/me.6.10.1673; KAISER UB, 1992, ENDOCRINOLOGY, V130, P3048, DOI 10.1210/en.130.5.3048; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Kanasaki H, 2005, ENDOCRINOLOGY, V146, P5503, DOI 10.1210/en.2004-1317; Kanasaki H, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105601; Kanasaki H, 2009, BIOL REPROD, V81, P465, DOI 10.1095/biolreprod.108.074765; Kashtan N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031909; Krakauer DC, 2002, J THEOR BIOL, V218, P457, DOI 10.1006/jtbi.2002.3092; Li QL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002320; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Liu FJ, 2002, J BIOL CHEM, V277, P32099, DOI 10.1074/jbc.M203639200; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; MARSHALL JC, 1986, NEW ENGL J MED, V315, P1459; Marshall JC, 2001, MOL CELL ENDOCRINOL, V183, P29, DOI 10.1016/S0303-7207(01)00611-6; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P653, DOI 10.1210/me.2003-0393; McGillivray SM, 2007, ENDOCRINOLOGY, V148, P762, DOI 10.1210/en.2006-0952; Mistry DS, 2011, MOL ENDOCRINOL, V25, P1387, DOI 10.1210/me.2011-0032; NAOR Z, 1986, J BIOL CHEM, V261, P2506; Nguyen KA, 2010, ENDOCRINOLOGY, V151, P4882, DOI 10.1210/en.2009-1483; Nunez L, 2003, J PHYSIOL-LONDON, V549, P835, DOI 10.1113/jphysiol.2003.040758; Peng J, 2013, P NATL ACAD SCI USA, V110, pE776, DOI 10.1073/pnas.1218020110; Purwana IN, 2011, BIOL REPROD, V84, P996, DOI 10.1095/biolreprod.110.088526; Reddy GR, 2013, MOL ENDOCRINOL, V27, P253, DOI 10.1210/me.2012-1168; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; Sharma TP, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098442; She XW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-269; SHIMONAKA M, 1991, ENDOCRINOLOGY, V128, P3313, DOI 10.1210/endo-128-6-3313; Silva-Rocha R, 2011, MOL BIOSYST, V7, P2982, DOI 10.1039/c1mb05264k; Thompson IR, 2013, MOL ENDOCRINOL, V27, P606, DOI 10.1210/me.2012-1281; Tsutsumi R, 2010, J BIOL CHEM, V285, P20262, DOI 10.1074/jbc.M110.132662; TURGEON JL, 1990, ENDOCRINOLOGY, V127, P773, DOI 10.1210/endo-127-2-773; Turgeon JL, 2001, ENDOCRINOLOGY, V142, P4479, DOI 10.1210/en.142.10.4479; Vitt UA, 2000, ENDOCRINOLOGY, V141, P3814, DOI 10.1210/en.141.10.3814; Wang Q, 2013, MOL ENDOCRINOL, V27, P224, DOI 10.1210/me.2012-1310; Wang Y, 2009, J ENDOCRINOL, V202, P419, DOI 10.1677/JOE-08-0563; Winters SJ, 2007, MOL CELL ENDOCRINOL, V271, P45, DOI 10.1016/j.mce.2007.03.006; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101	55	16	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16164	16175		10.1074/jbc.M113.537696	http://dx.doi.org/10.1074/jbc.M113.537696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778184	Green Published, hybrid			2022-12-25	WOS:000337965700022
J	Kuuluvainen, E; Hakala, H; Havula, E; Estime, MS; Ramet, M; Hietakangas, V; Makela, TP				Kuuluvainen, Emilia; Hakala, Heini; Havula, Essi; Estime, Michelle Sahal; Ramet, Mika; Hietakangas, Ville; Makela, Tomi P.			Cyclin-dependent Kinase 8 Module Expression Profiling Reveals Requirement of Mediator Subunits 12 and 13 for Transcription of Serpent-dependent Innate Immunity Genes in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPITZ-KAVEGGIA-SYNDROME; RNA-POLYMERASE-II; COLORECTAL-CANCER; MED12 MUTATIONS; TARGET GENES; CDK8; COMPLEX; IDENTIFICATION; PROTEIN; DIFFERENTIATION	The Cdk8 (cyclin-dependent kinase 8) module of Mediator integrates regulatory cues from transcription factors to RNA polymerase II. It consists of four subunits where Med12 and Med13 link Cdk8 and cyclinC(CycC) to core Mediator. Here we have investigated the contributions of the Cdk8 module subunits to transcriptional regulation using RNA interference in Drosophila cells. Genome-wide expression profiling demonstrated separation of Cdk8-CycC and Med12-Med13 profiles. However, transcriptional regulation by Cdk8-CycC was dependent on Med12-Med13. This observation also revealed that Cdk8-CycC and Med12-Med13 often have opposite transcriptional effects. Interestingly, Med12 and Med13 profiles overlapped significantly with that of the GATA factor Serpent. Accordingly, mutational analyses indicated that GATA sites are required for Med12-Med13 regulation of Serpent-dependent genes. Med12 and Med13 were also found to be required for Serpent-activated innate immunity genes in defense to bacterial infection. The results reveal a novel role for the Cdk8 module in Serpent-dependent transcription and innate immunity.	[Kuuluvainen, Emilia; Hakala, Heini; Havula, Essi; Estime, Michelle Sahal; Hietakangas, Ville; Makela, Tomi P.] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; [Havula, Essi; Hietakangas, Ville] Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland; [Ramet, Mika] Univ Tampere, Inst Biomed Technol, Tampere 33014, Finland; [Ramet, Mika] Univ Tampere, BioMediTech, Tampere 33014, Finland; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, Tampere 22521, Finland; [Ramet, Mika] Univ Oulu, Dept Pediat, Inst Clin Med, Oulu 90014, Finland; [Ramet, Mika] Univ Oulu, Med Res Ctr Oulu, Oulu 90014, Finland; [Ramet, Mika] Oulu Univ Hosp, Dept Children & Adolescents, Oulu 90029, Finland	University of Helsinki; University of Helsinki; Tampere University; Tampere University; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; University of Oulu	Makela, TP (corresponding author), Univ Helsinki, Inst Biotechnol, POB 56, Helsinki 00014, Finland.	tomi.makela@helsinki.fi	; makela, tomi/B-3734-2009	Kuuluvainen, Emilia/0000-0003-0227-4331; Havula, Essi/0000-0002-9253-5816; makela, tomi/0000-0002-4869-8044; Hietakangas, Ville/0000-0002-9900-7549	Academy of Finland; Biocentrum Helsinki; Sigrid Juselius Foundation; Finnish Cancer Organisations	Academy of Finland(Academy of Finland); Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organisations	This work was supported by grants from the Academy of Finland, Biocentrum Helsinki, the Sigrid Juselius Foundation, and the Finnish Cancer Organisations.	Adler AS, 2012, CANCER RES, V72, P2129, DOI 10.1158/0008-5472.CAN-11-3886; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Bonke M, 2013, G3-GENES GENOM GENET, V3, P75, DOI 10.1534/g3.112.004283; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Chen JD, 2012, RNA, V18, P2148, DOI 10.1261/rna.035725.112; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045580; Cheng G, 2009, J INTERF CYTOK RES, V29, P461, DOI 10.1089/jir.2008.0078; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Davis MA, 2013, GENE DEV, V27, P151, DOI 10.1101/gad.207720.112; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Ferjoux G, 2007, DEV BIOL, V305, P726, DOI 10.1016/j.ydbio.2007.03.010; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Gesellchen V, 2005, EMBO REP, V6, P979, DOI 10.1038/sj.embor.7400530; Gobert V, 2010, MOL CELL BIOL, V30, P2837, DOI 10.1128/MCB.01625-09; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Holcroft CE, 2013, J CELL SCI, V126, P3823, DOI 10.1242/jcs.117994; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Janody F, 2011, DEV DYNAM, V240, P2051, DOI 10.1002/dvdy.22705; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Kampjarvi K, 2012, BRIT J CANCER, V107, P1761, DOI 10.1038/bjc.2012.428; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Keightley MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023845; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Petersen UM, 1999, EMBO J, V18, P4013, DOI 10.1093/emboj/18.14.4013; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Rump P, 2011, CLIN GENET, V79, P183, DOI 10.1111/j.1399-0004.2010.01449.x; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Schaaf CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006202; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Senger K, 2006, P NATL ACAD SCI USA, V103, P15957, DOI 10.1073/pnas.0607608103; Shi GX, 2013, CELL SIGNAL, V25, P2060, DOI 10.1016/j.cellsig.2013.06.002; Stramer B, 2008, EMBO REP, V9, P465, DOI 10.1038/embor.2008.34; Tamura T, 2010, J NEUROSCI, V30, P14091, DOI 10.1523/JNEUROSCI.1319-10.2010; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Tingvall TO, 2001, P NATL ACAD SCI USA, V98, P3884, DOI 10.1073/pnas.061230198; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Tsutsui T, 2011, GENES CELLS, V16, P1208, DOI 10.1111/j.1365-2443.2011.01565.x; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Vanpoucke G, 2004, NUCLEIC ACIDS RES, V32, P4155, DOI 10.1093/nar/gkh727; Vogl MR, 2013, J NEUROSCI, V33, P6679, DOI 10.1523/JNEUROSCI.5178-12.2013; Westerling T, 2007, MOL CELL BIOL, V27, P6177, DOI 10.1128/MCB.01302-06; With S, 2003, GENESIS, V35, P143, DOI 10.1002/gene.10177; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19763, DOI 10.1073/pnas.1121120109	59	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16252	16261		10.1074/jbc.M113.541904	http://dx.doi.org/10.1074/jbc.M113.541904			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778181	Green Published, hybrid			2022-12-25	WOS:000337965700029
J	Chamakh-Ayari, R; Bras-Goncalves, R; Bahi-Jaber, N; Petitdidier, E; Markikou-Ouni, W; Aoun, K; Moreno, J; Carrillo, E; Salotra, P; Kaushal, H; Negi, NS; Arevalo, J; Falconi-Agapito, F; Privat, A; Cruz, M; Pagniez, J; Papierok, GM; Rhouma, FBH; Torres, P; Lemesre, JL; Chenik, M; Meddeb-Garnaoui, A				Chamakh-Ayari, Rym; Bras-Goncalves, Rachel; Bahi-Jaber, Narges; Petitdidier, Elodie; Markikou-Ouni, Wafa; Aoun, Karim; Moreno, Javier; Carrillo, Eugenia; Salotra, Poonam; Kaushal, Himanshu; Negi, Narender Singh; Arevalo, Jorge; Falconi-Agapito, Francesca; Privat, Angela; Cruz, Maria; Pagniez, Julie; Papierok, Gerard-Marie; Rhouma, Faten Bel Haj; Torres, Pilar; Lemesre, Jean-Loup; Chenik, Mehdi; Meddeb-Garnaoui, Amel			In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; GRANZYME-B; IMMUNE-RESPONSE; PSA GP46; T-CELLS; L-MAJOR; CROSS-PROTECTION; GENE FAMILY; DNA VACCINE	PSA (Promastigote Surface Antigen) belongs to a family of membrane-bound and secreted proteins present in several Leishmania (L.) species. PSA is recognized by human Th1 cells and provides a high degree of protection in vaccinated mice. We evaluated humoral and cellular immune responses induced by a L. amazonensis PSA protein (LaPSA-38S) produced in a L. tarentolae expression system. This was done in individuals cured of cutaneous leishmaniasis due to L. major (CCLm) or L. braziliensis (CCLb) or visceral leishmaniasis due to L. donovani (CVLd) and in healthy individuals. Healthy individuals were subdivided into immune (HHR-Lm and HHR-Li: Healthy High Responders living in an endemic area for L. major or L. infantum infection) or non immune/naive individuals (HLR: Healthy Low Responders), depending on whether they produce high or low levels of IFN-gamma in response to Leishmania soluble antigen. Low levels of total IgG antibodies to LaPSA-38S were detected in sera from the studied groups. Interestingly, LaPSA-38S induced specific and significant levels of IFN-gamma, granzyme B and IL-10 in CCLm, HHR-Lm and HHR-Li groups, with HHR-Li group producing TNF-alpha in more. No significant cytokine response was observed in individuals immune to L. braziliensis or L. donovani infection. Phenotypic analysis showed a significant increase in CD4+ T cells producing IFN-gamma after LaPSA-38S stimulation, in CCLm. A high positive correlation was observed between the percentage of IFN-gamma-producing CD4+ T cells and the released IFN-gamma. We showed that the LaPSA-38S protein was able to induce a mixed Th1 and Th2/Treg cytokine response in individuals with immunity to L. major or L. infantum infection indicating that it may be exploited as a vaccine candidate. We also showed, to our knowledge for the first time, the capacity of Leishmania PSA protein to induce granzyme B production in humans with immunity to L. major and L. infantum infection.	[Chamakh-Ayari, Rym; Markikou-Ouni, Wafa; Aoun, Karim; Chenik, Mehdi; Meddeb-Garnaoui, Amel] Inst Pasteur, Lab Med Parasitol Biotechnol & Biomol, IPT LR11 06, Tunis, Tunisia; [Bras-Goncalves, Rachel; Petitdidier, Elodie; Pagniez, Julie; Lemesre, Jean-Loup] CIRAD INTERTRYP, IRD, UMR 177, Montpellier, France; [Bahi-Jaber, Narges; Rhouma, Faten Bel Haj] Inst Pasteur, Lab Transmiss Control & Immunobiol Infect, IPT LR11 02, Tunis, Tunisia; [Bahi-Jaber, Narges] UPSP EGEAL Inst Polytech LaSalle Beauvais, Beauvais, France; [Moreno, Javier; Carrillo, Eugenia] Inst Salud Carlos III, Ctr Nacl Microbiol, WHO Collaborating Ctr Leishmaniasis, Madrid, Spain; [Salotra, Poonam; Kaushal, Himanshu; Negi, Narender Singh] Natl Inst Pathol ICMR, New Delhi, India; [Arevalo, Jorge; Falconi-Agapito, Francesca; Privat, Angela; Cruz, Maria] UPCH, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Papierok, Gerard-Marie] BVT VIRBAC, La Seyne Sur Mer, France; [Torres, Pilar] Ctr Transfus Comunidad Madrid, Madrid, Spain	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; CIRAD; Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); Universidad Peruana Cayetano Heredia	Meddeb-Garnaoui, A (corresponding author), Inst Pasteur, Lab Med Parasitol Biotechnol & Biomol, IPT LR11 06, Tunis, Tunisia.	amel.garnaoui@pasteur.rns.tn	Falconi, Francesca/F-4347-2016; Carrillo, Eugenia/F-2058-2018; Kaushal, Himanshu/AAY-9369-2020; Maldonado, Angela Privat/Y-1107-2019; Moreno, Javier/AAB-5386-2021; Bras-Gonçalves, Rachel/I-8520-2016	Carrillo, Eugenia/0000-0002-7869-7915; Maldonado, Angela Privat/0000-0002-5616-8182; Bras-Gonçalves, Rachel/0000-0002-3089-4530; Kaushal, Dr. Himanshu/0000-0003-0935-9039; CRUZ SALDARRIAGA, MARIA EDELMIRA/0000-0002-2124-2629; PETITDIDIER, ELODIE/0000-0002-8554-8424; Moreno, Javier/0000-0003-0087-4659; Arevalo, Jorge/0000-0003-3837-2849; Falconi, Francesca/0000-0003-2359-7439; PAGNIEZ, Julie/0000-0002-2151-3572; Salotra, Poonam/0000-0002-4057-4872	EU [223341]	EU(European Commission)	This study received financial support from EU's Seventh Framework Programme (FP7) (RAPSODI project, grant agreement number 223341). URL of funder's website: http://cordis.europa.eu/fp7/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Aguilar-Be I, 2005, INFECT IMMUN, V73, P812, DOI 10.1128/IAI.73.2.812-819.2005; Ajdary S, 2000, INFECT IMMUN, V68, P1760, DOI 10.1128/IAI.68.4.1760-1764.2000; Alexander J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00080; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Aoun K, 2009, MED MALADIES INFECT, V39, P775, DOI 10.1016/j.medmal.2009.08.010; Beetham JK, 1997, J BIOL CHEM, V272, P17360, DOI 10.1074/jbc.272.28.17360; Beetham JK, 2003, MOL BIOCHEM PARASIT, V131, P109, DOI 10.1016/S0166-6851(03)00197-X; Ben Salah A, 2007, INT J EPIDEMIOL, V36, P991, DOI 10.1093/ije/dym125; Boceta C, 2000, PARASITE IMMUNOL, V22, P55, DOI 10.1046/j.1365-3024.2000.00269.x; Bousoffara T, 2004, J INFECT DIS, V189, P1265, DOI 10.1086/382031; Breitling R, 2002, PROTEIN EXPRES PURIF, V25, P209, DOI 10.1016/S1046-5928(02)00001-3; BURNS JM, 1991, J IMMUNOL, V146, P742; CARVALHO EM, 1995, AM J TROP MED HYG, V53, P273, DOI 10.4269/ajtmh.1995.53.273; CHAMPSI J, 1988, INFECT IMMUN, V56, P3272, DOI 10.1128/IAI.56.12.3272-3279.1988; Coler RN, 2007, INFECT IMMUN, V75, P4648, DOI 10.1128/IAI.00394-07; den Boer M, 2011, CLIN MICROBIOL INFEC, V17, P1471, DOI 10.1111/j.1469-0691.2011.03635.x; Devault A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-292; Dondji B, 2008, EUR J IMMUNOL, V38, P706, DOI 10.1002/eji.200737660; Goto Y, 2009, VACCINE, V27, P2884, DOI 10.1016/j.vaccine.2009.02.079; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Handman E, 1995, MOL BIOCHEM PARASIT, V74, P189, DOI 10.1016/0166-6851(95)02500-6; HANDMAN E, 1995, INFECT IMMUN, V63, P4261, DOI 10.1128/IAI.63.11.4261-4267.1995; HANEKAMP T, 1991, MOL BIOCHEM PARASIT, V48, P27, DOI 10.1016/0166-6851(91)90161-X; Hernandez-Ruiz J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000871; Hiebert PR, 2012, TRENDS MOL MED, V18, P732, DOI 10.1016/j.molmed.2012.09.009; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Jimenez-Ruiz A, 1998, EUR J BIOCHEM, V251, P389, DOI 10.1046/j.1432-1327.1998.2510389.x; Kedzierski L, 2004, J IMMUNOL, V172, P4902, DOI 10.4049/jimmunol.172.8.4902; Kemp M, 1998, FEMS IMMUNOL MED MIC, V20, P209, DOI 10.1111/j.1574-695X.1998.tb01129.x; Kharazmi A, 1999, IMMUNOL LETT, V65, P105, DOI 10.1016/S0165-2478(98)00132-1; Kushawaha PK, 2011, J IMMUNOL, V187, P6417, DOI 10.4049/jimmunol.1102081; Lemesre J., 1994, International publication, Patent No. [WO94/226899, 94226899]; Lemesre JL, 2007, VACCINE, V25, P4223, DOI 10.1016/j.vaccine.2007.02.083; Lemesre JL, 2005, VACCINE, V23, P2825, DOI 10.1016/j.vaccine.2004.11.061; Lincoln LM, 2004, MOL BIOCHEM PARASIT, V137, P185, DOI 10.1016/j.molbiopara.2004.05.004; LOHMAN KL, 1990, P NATL ACAD SCI USA, V87, P8393, DOI 10.1073/pnas.87.21.8393; Lucas CM, 1998, AM J TROP MED HYG, V59, P312, DOI 10.4269/ajtmh.1998.59.312; Magnani CF, 2011, EUR J IMMUNOL, V41, P1652, DOI 10.1002/eji.201041120; Mansueto P, 2007, INT J IMMUNOPATH PH, V20, P435, DOI 10.1177/039463200702000302; Marty P, 2011, B ACAD NAT MED PARIS, V195, P181, DOI 10.1016/S0001-4079(19)32115-6; MCMAHONPRATT D, 1993, INFECT IMMUN, V61, P3351, DOI 10.1128/IAI.61.8.3351-3359.1993; MCMAHONPRATT D, 1992, MOL BIOCHEM PARASIT, V50, P151, DOI 10.1016/0166-6851(92)90252-F; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; Merlen T, 1999, AM J TROP MED HYG, V60, P41, DOI 10.4269/ajtmh.1999.60.41; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; MURRAY PJ, 1991, J BIOL CHEM, V266, P24477; MURRAY PJ, 1989, J IMMUNOL, V143, P4221; Myung KS, 2002, J BIOL CHEM, V277, P16489, DOI 10.1074/jbc.M200174200; Nylen S, 2010, J GLOB INFECT DIS, V2, P135, DOI 10.4103/0974-777X.62876; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Ramirez L, 2013, VACCINE, V31, P1312, DOI 10.1016/j.vaccine.2012.12.071; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Salay G, 2007, CLIN VACCINE IMMUNOL, V14, P1173, DOI 10.1128/CVI.00060-07; Santos CDS, 2013, J INVEST DERMATOL, V133, P1533, DOI 10.1038/jid.2013.4; Sassi A, 1999, CLIN EXP IMMUNOL, V116, P127; Singh OP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001874; Sjolander A, 1998, J IMMUNOL, V160, P3949; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; SYMONS FM, 1994, MOL BIOCHEM PARASIT, V67, P103, DOI 10.1016/0166-6851(94)90100-7; Tonui WK, 2007, AM J TROP MED HYG, V76, P579, DOI 10.4269/ajtmh.2007.76.579; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343	64	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e92708	10.1371/journal.pone.0092708	http://dx.doi.org/10.1371/journal.pone.0092708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24786587	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700004
J	Choi, JA; Han, K; Kwon, HS				Choi, Jin A.; Han, Kyungdo; Kwon, Hyuk-Sang			Association between Urinary Albumin Excretion and Intraocular Pressure in Type 2 Diabetic Patients without Renal Impairment	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CARDIOVASCULAR EVENTS; METABOLIC SYNDROME; MICROALBUMINURIA; HYPERTENSION; MELLITUS; DISEASE; RISK; ABNORMALITIES; POPULATION	Background: To assess the relationship between urinary albumin excretion and intraocular pressure (IOP) in type 2 diabetes patients without renal impairment. Methods: We explored the effects of albuminuria on high IOP in 402 non-glaucomatous type 2 diabetes without renal impairment who participated in the 2011 Korean National Health and Nutrition Examination Survey (KNHANES). Multiple logistic regression analysis was used to assess the relationship between log-transformed albumin/creatinine ratio (ACR) tertiles and an IOP of >= 18 mmHg after adjusting for age, gender, hypertension, body mass index, triglycerides, area of residence, and education level. Results: Subjects with a high IOP >= 18 mmHg were more likely to be current smokers (P = 0.038), heavy drinkers (P = 0.006), and to have high systolic blood pressure (P = 0.016), triglycerides (P = 0.008), and a higher log-transformed ACR (P = 0.022). In multivariate regression analysis, ACR tertile was associated with the prevalence of high IOP significantly (P = 0.022). The associations between ACR tertiles and high IOP were significant in overweight patients and those with abdominal obesity (P = 0.003 and 0.003, respectively). In contrast, there were no associations in the subgroup of patients who were not overweight and those without abdominal obesity (P = 0.291 and 0.561, respectively). Conclusions: Urinary albumin excretion is associated with high IOP in the type 2 diabetes population without renal insufficiency. The effect of the albuminuria on IOP was evident in a subgroup of patients with components of metabolic syndrome.	[Choi, Jin A.] Catholic Univ Korea, Coll Med, Dept Internal Med, St Vincent Hosp,Dept Ophthalmol,Div Endocrinol &, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Internal Med, St Vincent Hosp,Dept Biostat,Div Endocrinol & Met, Seoul, South Korea; [Kwon, Hyuk-Sang] Catholic Univ Korea, Coll Med, Dept Internal Med, Yeouido St Marys Hosp,Div Endocrinol & Metab, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Kwon, HS (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Yeouido St Marys Hosp,Div Endocrinol & Metab, Seoul, South Korea.	drkwon@catholic.ac.kr	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anavekar NS, 2004, KIDNEY INT, V66, pS50, DOI 10.1111/j.1523-1755.2004.09213.x; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Basi S, 2008, DIABETES CARE, V31, pS194, DOI 10.2337/dc08-s249; Berrut G, 1997, CLIN NEPHROL, V48, P92; Biswas Sayantan, 2011, J Prev Med Public Health, V44, P157, DOI 10.3961/jpmph.2011.44.4.157; Broadway DC, 1998, BRIT J OPHTHALMOL, V82, P862, DOI 10.1136/bjo.82.8.862; Chang YC, 2010, EYE, V24, P1037, DOI 10.1038/eye.2009.247; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Cosson E, 2006, DIABETES CARE, V29, P107, DOI 10.2337/diacare.29.1.107; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gomes MB, 2001, CLIN CHIM ACTA, V304, P117, DOI 10.1016/S0009-8981(00)00414-9; Ibsen H, 2004, J HYPERTENS, V22, P1805, DOI 10.1097/00004872-200409000-00026; Jeganathan VSE, 2008, DIABETES CARE, V31, P1905, DOI 10.2337/dc08-0342; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; KLEIN R, 1992, DIABETES CARE, V15, P1875, DOI 10.2337/diacare.15.12.1875; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1217, DOI 10.1001/archopht.1994.01090210105023; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Liang YB, 2011, INVEST OPHTH VIS SCI, V52, P8250, DOI 10.1167/iovs.11-7472; Matsuoka M, 2012, CLIN OPHTHALMOL, V6, P1005, DOI 10.2147/OPTH.S33131; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Nongpiur ME, 2010, OPHTHALMOLOGY, V117, P477, DOI 10.1016/j.ophtha.2009.07.029; Papaioannou GI, 2004, AM J CARDIOL, V94, P294, DOI 10.1016/j.amjcard.2004.04.022; PHELPS CD, 1985, INVEST OPHTH VIS SCI, V26, P1105; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; Resch H, 2009, ACTA OPHTHALMOL, V87, P4, DOI 10.1111/j.1755-3768.2007.01167.x; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; Tsioufis C, 2004, AM J HYPERTENS, V17, P470, DOI 10.1016/j.amjhyper.2004.02.008; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96335	10.1371/journal.pone.0096335	http://dx.doi.org/10.1371/journal.pone.0096335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788677	Green Submitted, Green Published, gold			2022-12-25	WOS:000336655700076
J	Raberg, M; Voigt, B; Hecker, M; Steinbuchel, A				Raberg, Matthias; Voigt, Birgit; Hecker, Michael; Steinbuechel, Alexander			A Closer Look on the Polyhydroxybutyrate- (PHB-) Negative Phenotype of Ralstonia eutropha PHB(-)4	PLOS ONE			English	Article							GRANULE-ASSOCIATED PROTEINS; BETA-HYDROXYBUTYRIC ACID; DEHYDROGENASE MULTIENZYME COMPLEX; ALCALIGENES-EUTROPHUS; ESCHERICHIA-COLI; H16; IDENTIFICATION; BIOSYNTHESIS; METABOLISM; SYNTHASE	The undefined poly(3-hydroxybutyrate)- (PHB-) negative mutant R. eutropha PHB(-)4 was generated in 1970 by 1-nitroso-3-nitro-1-methylguanidine (NMG) treatment. Although being scientific relevant, its genotype remained unknown since its isolation except a recent first investigation. In this study, the mutation causing the PHA-negative phenotype of R. eutropha PHB(-)4 was confirmed independently: sequence analysis of the phaCAB operon identified a G320A mutation in phaC yielding a stop codon, leading to a massively truncated PhaC protein of 106 amino acids (AS) in R. eutropha PHB(-)4 instead of 589 AS in the wild type. No other mutations were observed within the phaCAB operon. As further mutations probably occurred in the genome of mutant PHB(-)4 potentially causing secondary effects on the cells' metabolism, the main focus of the study was to perform a 2D PAGE-based proteome analysis in order to identify differences in the proteomes of the wild type and mutant PHB(-)4. A total of 20 differentially expressed proteins were identified which provide valuable insights in the metabolomic changes of mutant PHB(-)4. Besides excretion of pyruvate, mutant PHB(-)4 encounters the accumulation of intermediates such as pyruvate and acetyl-CoA by enhanced expression of the observed protein species: (i) ThiJ supports biosynthesis of cofactor TPP and thereby reinforces the 2-oxoacid dehydrogenase complexes as PDHC, ADHC and OGDHC in order to convert pyruvate at a higher rate and the (ii) 3-isopropylmalate dehydrogenase LeuB3 apparently directs pyruvate to synthesis of several amino acids. Different (iii) acylCoA-transferases enable transfer reactions between organic acid intermediates, and (iv) citrate lyase CitE4 regenerates oxaloacetate from citrate for conversion with acetyl-CoA in the TCC in an anaplerotic reaction. Substantial amounts of reduction equivalents generated in the TCC are countered by (v) synthesis of more ubiquinones due to enhanced synthesis of MenG2 and MenG3, thereby improving the respiratory chain which accepts electrons from NADH and succinate.	[Raberg, Matthias; Steinbuechel, Alexander] Univ Munster, Inst Mol Mikrobiol & Biotechnol, D-48149 Munster, Germany; [Steinbuechel, Alexander] King Abdulaziz Univ, Dept Environm Sci, Jeddah 21413, Saudi Arabia; [Voigt, Birgit; Hecker, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol, Greifswald, Germany	University of Munster; King Abdulaziz University; Ernst Moritz Arndt Universitat Greifswald	Steinbuchel, A (corresponding author), Univ Munster, Inst Mol Mikrobiol & Biotechnol, D-48149 Munster, Germany.	steinbu@uni-muenster.de			Bundesministerium fur Bildung und Forschung (BMBF) [FKZ-0313751]; Deutsche Forschungsgemeinschaft; University of Munster	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Munster	The R. eutropha genome project and subsequent analyses and studies were part of the Competence Network Gottingen "Genome research on bacteria" (GenoMik and Genomik Plus) initiatively financed by the Bundesministerium fur Bildung und Forschung (BMBF, FKZ-0313751) which is gratefully acknowledged. Furthermore, we acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Munster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEvarsson A, 1999, NAT STRUCT BIOL, V6, P785; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; ARAGNO M, 1977, ARCH MICROBIOL, V114, P93, DOI 10.1007/BF00410769; Aragno M., 1992, The prokaryotes: a handbook on the biology of bacteria: ecophysiology, isolation, identification, applications, vol. 1., P344; Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOWIEN B, 1981, ANNU REV MICROBIOL, V35, P405, DOI 10.1146/annurev.mi.35.100181.002201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNS RO, 1963, BIOCHEMISTRY-US, V2, P1053, DOI 10.1021/bi00905a024; COOK AM, 1978, ARCH MICROBIOL, V119, P231, DOI 10.1007/BF00405400; Cramm R, 2009, J MOL MICROB BIOTECH, V16, P38, DOI 10.1159/000142893; de Kok A, 1998, BBA-PROTEIN STRUCT M, V1385, P353, DOI 10.1016/S0167-4838(98)00079-X; DIMROTH P, 1977, EUR J BIOCHEM, V80, P479, DOI 10.1111/j.1432-1033.1977.tb11903.x; DOI Y, 1990, NATO ADV SCI I E-APP, V186, P37; FRUND C, 1989, J BACTERIOL, V171, P6539; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HAYWOOD GW, 1989, FEMS MICROBIOL LETT, V57, P1; HAYWOOD GW, 1988, FEMS MICROBIOL LETT, V52, P259, DOI 10.1111/j.1574-6968.1988.tb02607.x; Heider J, 2001, FEBS LETT, V509, P345, DOI 10.1016/S0014-5793(01)03178-7; HERSH LB, 1967, J BIOL CHEM, V242, P3468; Hocking P.J., 1994, CHEM TECHNOLOGY BIOD, P48; HOLZER H, 1961, ANGEW CHEM INT EDIT, V73, P721, DOI 10.1002/ange.19610732202; IZUMI Y, 1982, AGR BIOL CHEM TOKYO, V46, P2673, DOI 10.1080/00021369.1982.10865515; Jung YM, 1997, J MICROBIOL BIOTECHN, V7, P215; Kalousek S, 1992, FEMS MICROBIOL REV, V103, P426; Kersters K., 1984, BERGEYS MANUAL SYSTE, P361; KIHLBERG R, 1972, ANNU REV MICROBIOL, V26, P427, DOI 10.1146/annurev.mi.26.100172.002235; Knapp JE, 2000, PROTEIN SCI, V9, P37; KUNIOKA M, 1988, POLYM COMMUN, V29, P174; Lee PT, 1997, J BACTERIOL, V179, P1748, DOI 10.1128/jb.179.5.1748-1754.1997; Lemoigne M., 1926, B SOC CHIM BIOL, V8, P770; LIEBERGESELL M, 1992, FEMS MICROBIOL LETT, V99, P227, DOI 10.1111/j.1574-6968.1992.tb05572.x; Lindenkamp N, 2010, APPL ENVIRON MICROB, V97, P7699; Lindenkamp N, 2013, APPL MICROBIOL BIOT, V97, P7699, DOI 10.1007/s00253-012-4624-9; Lutke-Eversloh T, 2001, MICROBIOL-UK, V147, P11; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; McCool GJ, 2001, J BACTERIOL, V183, P4235, DOI 10.1128/JB.183.14.4235-4243.2001; Mifune J, 2008, CAN J CHEM, V86, P621, DOI 10.1139/V08-047; Milne JLS, 2006, J BIOL CHEM, V281, P4364, DOI 10.1074/jbc.M504363200; MIZOTE T, 1989, J BACTERIOL, V171, P3228, DOI 10.1128/jb.171.6.3228-3232.1989; OEDING V, 1973, BIOCHEM J, V134, P239, DOI 10.1042/bj1340239; OPPERMANN FB, 1991, J BACTERIOL, V173, P757, DOI 10.1128/jb.173.2.757-767.1991; PEOPLES OP, 1989, J BIOL CHEM, V264, P15293; PEOPLES OP, 1989, J BIOL CHEM, V264, P15298; Peplinski K, 2010, MICROBIOL-SGM, V156, P2136, DOI 10.1099/mic.0.038380-0; Pfeiffer D, 2012, J BACTERIOL, V194, P5909, DOI 10.1128/JB.00779-12; Pfeiffer D, 2011, MICROBIOL-SGM, V157, P2795, DOI 10.1099/mic.0.051508-0; PIEPER U, 1992, FEMS MICROBIOL LETT, V96, P73, DOI 10.1016/0378-1097(92)90459-2; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Potter M, 2004, MICROBIOL-SGM, V150, P2301, DOI 10.1099/mic.0.26970-0; Raberg M, 2008, APPL ENVIRON MICROB, V62, P2540; Raberg M, 2011, APPL ENVIRON MICROB, V77, P2254, DOI 10.1128/AEM.02360-10; Rabilloud T, 1999, PROTEOME RES 2 DIMEN; Rehm BHA, 1999, INT J BIOL MACROMOL, V25, P3, DOI 10.1016/S0141-8130(99)00010-0; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Rehm BHA, 2002, BBA-PROTEIN STRUCT M, V1594, P178, DOI 10.1016/S0167-4838(01)00299-0; REHM BHA, 2001, BIOPOLYMERS, P173; Reinecke F, 2009, J MOL MICROB BIOTECH, V16, P91, DOI 10.1159/000142897; Rodrigues MFA, 1995, APPL MICROBIOL BIOT, V53, P453; Ruhr EM, 1977, THESIS U GOTTINGEN; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schlegel H.G., 1971, ADV BIOCHEM ENG, V1, P143, DOI [10.1007/BFB0044733, DOI 10.1007/BFB0044733]; SCHLEGEL HG, 1970, EXPERIENTIA, V26, P554, DOI 10.1007/BF01898510; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; SCHLEGEL HG, 1970, ARCH MIKROBIOL, V71, P283, DOI 10.1007/BF00410161; SCHUBERT P, 1988, J BACTERIOL, V170, P5837, DOI 10.1128/jb.170.12.5837-5847.1988; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Slater S, 1998, J BACTERIOL, V180, P1979, DOI 10.1128/JB.180.8.1979-1987.1998; STEINBUCHEL A, 1991, MOL MICROBIOL, V5, P535, DOI 10.1111/j.1365-2958.1991.tb00725.x; Steinbuchel A, 2001, ADV BIOCHEM ENG BIOT, V71, P81; STEINBUCHEL A, 1989, APPL MICROBIOL BIOT, V31, P168, DOI 10.1007/BF00262457; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O; Taguchi S, 2001, FEMS MICROBIOL LETT, V198, P65, DOI 10.1016/S0378-1097(01)00125-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIMM A, 1990, APPL ENVIRON MICROB, V56, P3360, DOI 10.1128/AEM.56.11.3360-3367.1990; VALENTIN HE, 1993, APPL MICROBIOL BIOT, V39, P309, DOI 10.1007/BF00192084; Voigt B, 2006, PROTEOMICS, V6, P268, DOI 10.1002/pmic.200500091; WIECZOREK R, 1995, J BACTERIOL, V177, P2425, DOI 10.1128/jb.177.9.2425-2435.1995; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604	82	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95907	10.1371/journal.pone.0095907	http://dx.doi.org/10.1371/journal.pone.0095907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787649	Green Published, gold			2022-12-25	WOS:000336655700044
J	Wang, SC; Ma, ZX; Xu, XH; Wang, Z; Sun, LX; Zhou, YH; Lin, XS; Hong, WJ; Wang, TL				Wang, Shicong; Ma, Zexu; Xu, Xiaohui; Wang, Zhen; Sun, Lixiang; Zhou, Yunhe; Lin, Xiaosi; Hong, Wanjin; Wang, Tuanlao			A Role of Rab29 in the Integrity of the Trans-Golgi Network and Retrograde Trafficking of Mannose-6-Phosphate Receptor	PLOS ONE			English	Article							RAB34 INTERACTION; ENDOSOMES; CARGO; MAINTENANCE; RETROMER; EFFECTOR; TIP47	Rab29 (also referred as Rab7L1) is a novel Rab protein, and is recently demonstrated to regulate phagocytosis and traffic from the Golgi to the lysosome. However, its roles in membrane trafficking have not been investigated extensively. Our results in this study revealed that Rab29 is associated with the trans-Golgi network (TGN), and is essential for maintaining the integrity of the TGN, because inhibition of the activity of Rab29 or depletion of Rab29 resulted in fragmentation of the TGN marked by TGN46. Expression of the dominant negative form Rab29T21N or shRNA-Rab29 also altered the distribution of mannose-6-phosphate receptor (M6PR), and interrupted the retrograde trafficking of M6PR through monitoring the endocytosis of CD8-tagged calcium dependent M6PR (cdM6PR) or calcium independent M6PR (ciM6PR), but without significant effects on the anterograde trafficking of vesicular stomatitis virus G protein (VSV-G). Our results suggest that Rab29 is essential for the integrity of the TGN and participates in the retrograde trafficking of M6PRs.	[Wang, Shicong; Ma, Zexu; Xu, Xiaohui; Wang, Zhen; Sun, Lixiang; Zhou, Yunhe; Lin, Xiaosi; Hong, Wanjin; Wang, Tuanlao] Xiamen Univ, Sch Pharmaceut Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Hong, Wanjin] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore	Xiamen University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Wang, TL (corresponding author), Xiamen Univ, Sch Pharmaceut Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	xmuibrwtl@xmu.edu.cn	ma, zexu/AAG-1431-2019		National Natural Science Foundation of China [31071176, 30971442, 30928011]; International S & T Cooperation Program of China [2013DFG32730]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International S & T Cooperation Program of China	This work was supported by National Natural Science Foundation of China (No. 31071176, No. 30971442 and No. 30928011); International S & T Cooperation Program of China (No. 2013DFG32730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Brown FC, 2011, J CELL BIOL, V194, P779, DOI 10.1083/jcb.201104019; Caster AH, 2013, J BIOL CHEM, V288, P14788, DOI 10.1074/jbc.M113.453621; Chen L, 2010, MOL MEMBR BIOL, V27, P23, DOI 10.3109/09687680903417470; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Hinners I, 2003, J CELL SCI, V116, P763, DOI 10.1242/jcs.00270; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Le Borgne R, 1998, BBA-MOL CELL RES, V1404, P195, DOI 10.1016/S0167-4889(98)00057-3; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; Lippincott-Schwartz J, 1998, TRENDS CELL BIOL, V8, P16, DOI 10.1016/S0962-8924(97)01199-9; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; McKenzie JE, 2012, TRAFFIC, V13, P1140, DOI 10.1111/j.1600-0854.2012.01374.x; Ng EL, 2007, BIOCHEM BIOPH RES CO, V361, P751, DOI 10.1016/j.bbrc.2007.07.076; Pfeffer SR, 2013, CURR OPIN CELL BIOL; Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075; Progida C, 2010, J CELL SCI, V123, P1480, DOI 10.1242/jcs.051474; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Rodriguez-Gabin AG, 2010, J NEUROSCI RES, V88, P589, DOI 10.1002/jnr.22236; Rodriguez-Gabin AG, 2009, EXP CELL RES, V315, P2215, DOI 10.1016/j.yexcr.2009.03.020; Schultz ML, 2011, TRENDS NEUROSCI, V34, P401, DOI 10.1016/j.tins.2011.05.006; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; van Ijzendoorn SCD, 2003, INT REV CYTOL, V232, P59, DOI 10.1016/S0074-7696(03)32002-9; Vieira OV, 2005, J CELL BIOL, V170, P521, DOI 10.1083/jcb.200503078; Wang TL, 2005, METHOD ENZYMOL, V403, P675, DOI 10.1016/S0076-6879(05)03058-2; Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Zhang T, 2001, J BIOL CHEM, V276, P27480, DOI 10.1074/jbc.M102786200	36	50	53	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96242	10.1371/journal.pone.0096242	http://dx.doi.org/10.1371/journal.pone.0096242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788816	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700068
J	Westwood, JA; Hunnam, TCUP; Pegram, HJ; Hicks, RJ; Darcy, PK; Kershaw, MH				Westwood, Jennifer A.; Hunnam, Titaina C. U. Potdevin; Pegram, Hollie J.; Hicks, Rodney J.; Darcy, Phillip K.; Kershaw, Michael H.			Routes of Delivery for CpG and Anti-CD137 for the Treatment of Orthotopic Kidney Tumors in Mice	PLOS ONE			English	Article							RENAL-CELL-CARCINOMA; DRUG-EVALUATION; NUDE-MICE; PHASE-I; CANCER; MODELS; THERAPY; COMBINATION; SITES; TLR9	We have found previously that the tumor cell lines, Renca (a renal cancer) and MC38 (a colon tumor) which had been injected subcutaneously in mice, could be successfully treated with a combination therapy of an oligodeoxynucleotide (CpG1826) (injected intratumorally) and anti-CD137 antibody (injected intraperitoneally). Thus the combination treatment was expected to initiate a "danger" signal via TLR9 on immune cells, and the anti-CD137 was expected to further activate T cells. In the present study, we found that several other tumor types injected subcutaneously could also be successfully treated with this combination therapy. In addition, we wished to determine if the treatment could work as effectively in an orthotopic metastatic model, which is more physiologically relevant to cancer in humans. Renca was selected as we were familiar with injecting this orthotopically into the outer cortex of the kidney in mice, and it spontaneously metastasizes to lung and abdominal sites. We tested various routes of delivery of CpG combined with intraperitoneal delivery of anti-CD137. Orthotopic tumors were injected with CpG intratumorally, using ultrasound-guided delivery on multiple occasions, combined with anti-CD137 intraperitoneally. A reduction in primary tumor size was observed following intratumoral injection of CpG compared to other treatments. We found that there was a statistically significant increase in survival of mice with orthotopic Renca tumor following intratumoral injection of CpG. However, we determined that the most effective route of delivery of CpG was intravenous, which led to further significantly enhanced survival of mice when combined with anti-CD137 intraperitoneally, likely due to inhibition of metastatic disease. Our data supports future development of this combination therapy for cancer.	[Westwood, Jennifer A.; Hunnam, Titaina C. U. Potdevin; Pegram, Hollie J.; Darcy, Phillip K.; Kershaw, Michael H.] Peter MacCallum Canc Ctr, Div Canc Res, East Melbourne, Australia; [Hicks, Rodney J.] Peter MacCallum Canc Ctr, Ctr Canc Imaging, East Melbourne, Australia; [Darcy, Phillip K.; Kershaw, Michael H.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Darcy, Phillip K.; Kershaw, Michael H.] Monash Univ, Dept Immunol, Prahran, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Monash University	Kershaw, MH (corresponding author), Peter MacCallum Canc Ctr, Div Canc Res, St Andrews Pl, East Melbourne, Australia.	michael.kershaw@petermac.org		Darcy, Phillip/0000-0002-5303-9561; Kershaw, Michael/0000-0002-2697-487X; Hicks, Rodney/0000-0002-0758-0824	Bob Parker Memorial Fund; Peter MacCallum Cancer Centre Foundation; Cancer Council Victoria; National Health and Medical Research Council of Australia (NHMRC); NHMRC [1013668]	Bob Parker Memorial Fund; Peter MacCallum Cancer Centre Foundation; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding from the Bob Parker Memorial Fund, The Peter MacCallum Cancer Centre Foundation, Cancer Council Victoria, and the National Health and Medical Research Council of Australia (NHMRC). MHK and PKD were supported by Senior Research Fellowships from the NHMRC. MK, PD, and JW were funded by NHMRC, Grant #1013668. URL: www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos SM, 2011, CANCER IMMUNOL IMMUN, V60, P671, DOI 10.1007/s00262-011-0984-8; Bianchi M, 2012, ANN ONCOL, V23, P973, DOI 10.1093/annonc/mdr362; Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Bult W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052178; Devaud C, 2014, MOL THER, V22, P18, DOI 10.1038/mt.2013.219; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Furi I, 2013, WORLD J GASTROENTERO, V19, P4119, DOI 10.3748/wjg.v19.i26.4119; Graves EE, 2010, CLIN CANCER RES, V16, P4843, DOI 10.1158/1078-0432.CCR-10-1206; Hackl C, 2013, GUT, V62, P259, DOI 10.1136/gutjnl-2011-301585; Jager W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059536; Jahrsdorfer Bernd, 2008, Update Cancer Ther, V3, P27, DOI 10.1016/j.uct.2007.11.003; Kahn J, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-223; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Kim YH, 2010, J AM ACAD DERMATOL, V63, P975, DOI 10.1016/j.jaad.2009.12.052; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Kudo-Saito C, 2007, CLIN CANCER RES, V13, P1936, DOI 10.1158/1078-0432.CCR-06-2398; KUO TH, 1993, ANTICANCER RES, V13, P627; Li SY, 2013, CLIN PHARMACOL-ADV A, V5, P47, DOI 10.2147/CPAA.S46199; Lin LW, 2003, WORLD J GASTROENTERO, V9, P701, DOI 10.3748/wjg.v9.i4.701; Lou YY, 2011, J IMMUNOTHER, V34, P279, DOI 10.1097/CJI.0b013e31820d2a05; Mason KA, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00101; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Millward M, 2013, BRIT J CANCER, V108, P1998, DOI 10.1038/bjc.2013.227; MURPHY GP, 1973, JNCI-J NATL CANCER I, V50, P1013, DOI 10.1093/jnci/50.4.1013; Nierkens S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008368; Norian LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031085; Ota S, 2013, TARGET ONCOL, V8, P145, DOI 10.1007/s11523-013-0273-x; Pulkkanen KJ, 2002, CANCER GENE THER, V9, P908, DOI 10.1038/sj.cgt.7700519; Ruggeri BA, 2014, BIOCHEM PHARMACOL, V87, P150, DOI 10.1016/j.bcp.2013.06.020; Sin JI, 2013, CANCER LETT, V330, P190, DOI 10.1016/j.canlet.2012.11.045; Smith SE, 2011, CANCER IMMUNOL IMMUN, V60, P1775, DOI 10.1007/s00262-011-1075-6; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929; Teng MWL, 2010, CANCER RES, V70, P2665, DOI 10.1158/0008-5472.CAN-09-1574; Uno T, 2006, NAT MED, V12, P693, DOI 10.1038/nm1405; Vinay DS, 2012, MOL CANCER THER, V11, P1062, DOI 10.1158/1535-7163.MCT-11-0677; von Beust BR, 2005, EUR J IMMUNOL, V35, P1869, DOI 10.1002/eji.200526124; Westwood JA, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-42; Westwood JA, 2009, CLIN CANCER RES, V15, P7624, DOI 10.1158/1078-0432.CCR-09-2201; WILMANNS C, 1992, INT J CANCER, V52, P98, DOI 10.1002/ijc.2910520118; WILMANNS C, 1993, INT J ONCOL, V3, P413; Zent CS, 2012, LEUKEMIA LYMPHOMA, V53, P211, DOI 10.3109/10428194.2011.608451	41	11	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95847	10.1371/journal.pone.0095847	http://dx.doi.org/10.1371/journal.pone.0095847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788789	Green Published, gold			2022-12-25	WOS:000336655700040
J	Dang, YA; Ren, W; Tao, B; Chen, GS; Lu, CQ; Yang, J; Pan, SF; Wang, GD; Li, SQ; Tian, HQ				Dang, Yaai; Ren, Wei; Tao, Bo; Chen, Guangsheng; Lu, Chaoqun; Yang, Jia; Pan, Shufen; Wang, Guodong; Li, Shiqing; Tian, Hanqin			Climate and Land Use Controls on Soil Organic Carbon in the Loess Plateau Region of China	PLOS ONE			English	Article							AGRICULTURAL SOILS; STORAGE; SEQUESTRATION; VEGETATION; IMPACTS; MULTIFACTOR; CATCHMENT; AFFORESTATION; ACCUMULATION; MANAGEMENT	The Loess Plateau of China has the highest soil erosion rate in the world where billion tons of soil is annually washed into Yellow River. In recent decades this region has experienced significant climate change and policy-driven land conversion. However, it has not yet been well investigated how these changes in climate and land use have affected soil organic carbon (SOC) storage on the Loess Plateau. By using the Dynamic Land Ecosystem Model (DLEM), we quantified the effects of climate and land use on SOC storage on the Loess Plateau in the context of multiple environmental factors during the period of 1961-2005. Our results show that SOC storage increased by 0.27 Pg C on the Loess Plateau as a result of multiple environmental factors during the study period. About 55% (0.14 Pg C) of the SOC increase was caused by land conversion from cropland to grassland/forest owing to the government efforts to reduce soil erosion and improve the ecological conditions in the region. Historical climate change reduced SOC by 0.05 Pg C (approximately 19% of the total change) primarily due to a significant climate warming and a slight reduction in precipitation. Our results imply that the implementation of "Grain for Green" policy may effectively enhance regional soil carbon storage and hence starve off further soil erosion on the Loess Plateau.	[Dang, Yaai; Li, Shiqing] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Dang, Yaai; Ren, Wei; Tao, Bo; Chen, Guangsheng; Lu, Chaoqun; Yang, Jia; Pan, Shufen; Tian, Hanqin] Auburn Univ, Sch Forestry & Wildlife Sci, Int Ctr Climate & Global Change Res, Auburn, AL 36849 USA; [Dang, Yaai; Wang, Guodong] Northwest A&F Univ, Coll Sci, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Auburn University System; Auburn University; Northwest A&F University - China	Tian, HQ (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Int Ctr Climate & Global Change Res, Auburn, AL 36849 USA.	tianhan@auburn.edu	Chen, Guangsheng/AAC-4462-2022; Tian, Hanqin/A-6484-2012; Yang, Jia/A-6483-2012; Lu, Chaoqun/A-6497-2012; Lu, Chaoqun/D-6694-2018; Ren, Wei/I-4048-2014; Lu, Chaoqun/HCH-9102-2022; Ren, Wei/G-8317-2016; TAO, BO/I-4166-2014	Tian, Hanqin/0000-0002-1806-4091; Yang, Jia/0000-0003-2019-9603; Lu, Chaoqun/0000-0002-1526-0513; Ren, Wei/0000-0002-4840-4835; Lu, Chaoqun/0000-0002-1526-0513; pan, shufen/0000-0001-7920-1427	NASA Land Cover and Land Use Change Program [NNX08AL73G]; NASA Interdisciplinary Science Program [NNG04GM39C]; Chinese Universities Scientific Fund [z10921007]; US National Science Foundation [AGS-1243220, CNS-1059376]; State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau Foundation [K318009902-1410]; Shaanxi Administration of Foreign Expert Affairs Science and Technology Activities Fundation [201327]	NASA Land Cover and Land Use Change Program(National Aeronautics & Space Administration (NASA)); NASA Interdisciplinary Science Program(National Aeronautics & Space Administration (NASA)); Chinese Universities Scientific Fund; US National Science Foundation(National Science Foundation (NSF)); State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau Foundation; Shaanxi Administration of Foreign Expert Affairs Science and Technology Activities Fundation	This study was supported by NASA Land Cover and Land Use Change Program (NNX08AL73G), NASA Interdisciplinary Science Program (NNG04GM39C), Chinese Universities Scientific Fund (z10921007), US National Science Foundation Grants (AGS-1243220, CNS-1059376), State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau Foundation (K318009902-1410), and Shaanxi Administration of Foreign Expert Affairs Science and Technology Activities Fundation (201327). Study design was supported by NASA Land Cover and Land Use Change Program (NNX08AL73G), NASA Interdisciplinary Science Program (NNG04GM39C), and Chinese Universities Scientific Fund (z10921007). Data collection and analysis was supported by NASA Land Cover and Land Use Change Program (NNX08AL73G), NASA Interdisciplinary Science Program (NNG04GM39C), and State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau Foundation (K318009902-1410). Preparation of the manuscript was supported by NASA Land Cover and Land Use Change Program (NNX08AL73G), US National Science Foundation Grants (AGS-1243220, CNS-1059376), and State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau Foundation (K318009902-1410).	Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Chang RY, 2011, ENVIRON MANAGE, V48, P1158, DOI 10.1007/s00267-011-9682-8; Chen H, 2006, J ENVIRON QUAL, V35, P1533, DOI 10.2134/jeq2005.0198; Chen LD, 2007, ECOL RES, V22, P641, DOI 10.1007/s11284-006-0065-1; Cheng LS, 2011, AFR J BIOTECHNOL, V10, P2230; Dermody O, 2006, NEW PHYTOL, V172, P598, DOI 10.1111/j.1469-8137.2006.01921.x; Eglin T, 2010, TELLUS B, V62, P700, DOI 10.1111/j.1600-0889.2010.00499.x; Fang JY, 2007, SCI CHINA SER D, V50, P92, DOI 10.1007/s11430-007-2031-3; Feng X, 2013, ECOLOGICAL RESTORATI, V3; Fu BJ, 2006, CATENA, V65, P41, DOI 10.1016/j.catena.2005.07.005; Fu BJ, 2009, PROG PHYS GEOG, V33, P793, DOI 10.1177/0309133309350264; Fu XL, 2010, GEODERMA, V155, P31, DOI 10.1016/j.geoderma.2009.11.020; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Han FP, 2010, GEODERMA, V154, P261, DOI 10.1016/j.geoderma.2009.10.011; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Jiang JP, 2009, PEDOSPHERE, V19, P735, DOI 10.1016/S1002-0160(09)60169-7; King JA, 2004, SOIL USE MANAGE, V20, P394, DOI 10.1079/SUM2004270; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R., 1999, ENV SCI POLICY, V2, P177; Lehmann J, 2008, NAT GEOSCI, V1, P832, DOI 10.1038/ngeo358; Li KR, 2004, SCI CHINA SER D, V47, P49, DOI 10.1360/02yd0029; Li R., 2008, RES FUTURE PROSPECTS; Li Z, 2009, J HYDROL, V377, P35, DOI 10.1016/j.jhydrol.2009.08.007; Liu JY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021649; Liu ML, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003687; LIU S, 2003, GLOBAL BIOGEOCHEMICA, V17; Liu X, 2010, PEDOSPHERE, V20, P146, DOI 10.1016/S1002-0160(10)60002-1; Liu ZP, 2011, AGR ECOSYST ENVIRON, V142, P184, DOI 10.1016/j.agee.2011.05.002; Martin D, 2010, AGR ECOSYST ENVIRON, V138, P64, DOI 10.1016/j.agee.2010.04.001; Paul E.A., 1997, SOIL ORGANIC MATTER; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Piao SL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003339; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Post WM, 1982, SOIL CARBON POOLS WO; Ren W, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008521; Ren W, 2012, GLOBAL CHANGE BIOL, V18, P2945, DOI 10.1111/j.1365-2486.2012.02741.x; Ren W, 2011, TELLUS B, V63, P222, DOI 10.1111/j.1600-0889.2010.00522.x; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Schimel J., 2001, GLOBAL BIOGEOCHEM CY, P177, DOI [10.1016/b978-012631260-7/50015-7, DOI 10.1016/B978-012631260-7/50015-7]; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; [宋怡 SONG Yi], 2007, [中国沙漠, Journal of Desert Research], V27, P89; Tian HQ, 2012, ECOSYSTEMS, V15, P674, DOI 10.1007/s10021-012-9539-x; Tian HQ, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001393; Tian HQ, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003838; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Tian HQ, 2010, FOREST ECOL MANAG, V259, P1311, DOI 10.1016/j.foreco.2009.10.009; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Wang GY, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013372; Wang SQ, 2003, TELLUS B, V55, P416, DOI 10.1034/j.1600-0889.2003.00039.x; Wang XK, 2001, FOREST ECOL MANAG, V148, P117, DOI 10.1016/S0378-1127(00)00482-5; Wang YF, 2011, CATENA, V85, P58, DOI 10.1016/j.catena.2010.12.003; Xiao Y, 1990, ACTA PHYTOECOLOGICA, V14; Xin Z, 2009, SCI GEOGRAPHICA SINI, V29, P89; Xin ZB, 2008, SCI CHINA SER D, V51, P67, DOI 10.1007/s11430-007-0137-2; Xu X, 2010, BIOGEOSCIENCES DISCU, V7, P5383, DOI [10.5194/bgd-7-5383-2010, DOI 10.5194/BGD-7-5383-2010]; [徐香兰 Xu Xianglan], 2003, [水土保持学报, Journal of Soil and Water Conservation], V17, P13; Xu XL, 2011, AGR ECOSYST ENVIRON, V140, P372, DOI 10.1016/j.agee.2010.12.018; Yan HM, 2007, AGR ECOSYST ENVIRON, V121, P325, DOI 10.1016/j.agee.2006.11.008; Zhang C, 2008, ECOSYSTEMS, V11, P1211, DOI 10.1007/s10021-006-0126-x; Zhang K, 2010, LAND DEGRAD DEV, V21, P13, DOI 10.1002/ldr.954; Zhang XP, 2008, HYDROL PROCESS, V22, P1996, DOI 10.1002/hyp.6784; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011	67	66	67	9	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95548	10.1371/journal.pone.0095548	http://dx.doi.org/10.1371/journal.pone.0095548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788559	Green Published, gold			2022-12-25	WOS:000335510600040
J	Chen, LY; Qu, C; Chen, H; Xu, LT; Qi, Q; Luo, JM; Wang, K; Meng, ZQ; Chen, Z; Wang, P; Liu, LM				Chen, Lianyu; Qu, Chao; Chen, Hao; Xu, Litao; Qi, Qi; Luo, Jianmin; Wang, Kun; Meng, Zhiqiang; Chen, Zhen; Wang, Peng; Liu, Luming			Chinese Herbal Medicine Suppresses Invasion-Promoting Capacity of Cancer-Associated Fibroblasts in Pancreatic Cancer	PLOS ONE			English	Article							INFLAMMATORY CYTOKINES CXCL1; TUMOR STROMA; CLINICAL-SIGNIFICANCE; ALTERNATIVE MEDICINE; QINGYIHUAJI FORMULA; LIVER METASTASES; BREAST-CANCER; IN-VIVO; CELLS; EXPRESSION	Pancreatic cancer remains one of the leading causes of cancer-related deaths, due to aggressive growth, high metastatic rates during the early stage and the lack of an effective therapeutic approach. We previously showed that Qingyihuaji (QYHJ), a seven-herb Chinese medicine formula, exhibited significant anti-cancer effects in pancreatic cancer, associated with modifications in the tumor microenvironment, particularly the inhibition of cancer-associated fibroblast (CAF) activation. In the present study, we generated CAF and paired normal fibroblast (NF) cultures from resected human pancreatic cancer tissues. We observed that CAFs exhibited an enhanced capacity for inducing pancreatic cancer cell migration and invasion compared with NFs, while QYHJ-treated CAFs exhibited decreased migration and invasion-promoting capacities in vitro. The results of further analyses indicated that compared with NFs, CAFs exhibit increased CXCL1, 2 and 8 expression, contributing to the enhanced invasion-promoting capacities of these cells, while QYHJ treatment significantly suppressed CAF proliferation activities and the production of CAF-derived CXCL1, 2 and 8. These in vitro observations were confirmed in mice models of human pancreatic cancer. Taken together, these results suggested that suppressing the tumor-promoting capacity of CAFs through Chinese herbal medicine attenuates pancreatic cancer cell invasion.	[Chen, Lianyu; Qu, Chao; Chen, Hao; Xu, Litao; Qi, Qi; Wang, Kun; Meng, Zhiqiang; Chen, Zhen; Wang, Peng; Liu, Luming] Fudan Univ, Shanghai Canc Ctr, Dept Integrat Oncol, Shanghai 200433, Peoples R China; [Chen, Lianyu; Qu, Chao; Chen, Hao; Xu, Litao; Qi, Qi; Luo, Jianmin; Wang, Kun; Meng, Zhiqiang; Chen, Zhen; Wang, Peng; Liu, Luming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Chen, Z (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Integrat Oncol, Shanghai 200433, Peoples R China.	cz.chenzhen@gmail.com; wangp413@163.com; llm1010@yahoo.com.cn	Meng, Zhiqiang/ABE-7747-2021; Luo, jian/HGE-7331-2022	Chen, Zhen/0000-0002-4502-0801	National Science Fundation of China [81001061, 81370068, 81273953, 81173461]; Shanghai Nature Science Fund, Shanghai, China [09ZR1406800]; Doctoral Programs Foundation of Ministry of Education of China [20090071120076]; Shanghai Science and Technology Committee Rising-Star Program [11QA1401300]; Medical Talents Training Program of Health Bureau of Shanghai [XYQ2011008]; Fudan University Zhuo-Xue program	National Science Fundation of China; Shanghai Nature Science Fund, Shanghai, China; Doctoral Programs Foundation of Ministry of Education of China(Ministry of Education, China); Shanghai Science and Technology Committee Rising-Star Program; Medical Talents Training Program of Health Bureau of Shanghai; Fudan University Zhuo-Xue program	This study was supported by National Science Fundation of China (81001061, 81370068, 81273953, 81173461); Shanghai Nature Science Fund, Shanghai, China (09ZR1406800); Doctoral Programs Foundation of Ministry of Education of China (20090071120076); Shanghai Science and Technology Committee Rising-Star Program (11QA1401300); Medical Talents Training Program of Health Bureau of Shanghai (XYQ2011008); and Fudan University Zhuo-Xue program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandapalli OR, 2012, CYTOKINE, V57, P46, DOI 10.1016/j.cyto.2011.10.019; Benelli R, 2013, PROSTATE, V73, P941, DOI 10.1002/pros.22640; Chang KH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-196; Chen Z, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/635702; Chen Z, 2008, J ALTERN COMPLEM MED, V14, P1049, DOI 10.1089/acm.2008.0039; Dong QM, 2011, WORLD J GASTROENTERO, V17, P2658, DOI 10.3748/wjg.v17.i21.2658; Feng Q, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/184358; Frick VO, 2008, PANCREATOLOGY, V8, P488, DOI 10.1159/000151776; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ino Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055146; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kavandi L, 2012, J CELL BIOCHEM, V113, P3143, DOI 10.1002/jcb.24191; Killian PH, 2012, CARCINOGENESIS, V33, P2507, DOI 10.1093/carcin/bgs312; Kinoshita T, 2013, CANCER SCI, V104, P409, DOI 10.1111/cas.12099; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P2521, DOI 10.4161/cc.10.15.16584; Merika EE, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/781765; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Nishikawa R, 2012, EUR J GYNAECOL ONCOL, V33, P138; Ouyang HQ, 2011, PANCREAS, V40, P120, DOI 10.1097/MPA.0b013e3181e6e398; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Quiros RM, 2008, GYNECOL ONCOL, V110, P99, DOI 10.1016/j.ygyno.2008.03.006; Sato N, 2004, CANCER RES, V64, P6950, DOI 10.1158/0008-5472.CAN-04-0677; Schoppmann SF, 2013, CLIN EXP METASTAS, V30, P441, DOI 10.1007/s10585-012-9549-2; Tchou J, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-39; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Walter K, 2008, CANCER BIOL THER, V7, P882, DOI 10.4161/cbt.7.6.5869; Wang P, 2013, ONCOGENE; Wang P, 2010, INTEGR CANCER THER, V9, P50, DOI 10.1177/1534735409359179; Wang P, 2009, CARCINOGENESIS, V30, P1497, DOI 10.1093/carcin/bgp154; Yin JH, 2012, INTEGR CANCER THER, V11, P37, DOI 10.1177/1534735411400315; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070334; Zhu QC, 2012, J MOL HISTOL, V43, P699, DOI 10.1007/s10735-012-9435-x	36	23	25	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96177	10.1371/journal.pone.0096177	http://dx.doi.org/10.1371/journal.pone.0096177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781445	Green Submitted, gold, Green Published			2022-12-25	WOS:000335504900021
J	Choi, YM; Suh, Y; Shin, S; Lee, K				Choi, Young Min; Suh, Yeunsu; Shin, Sangsu; Lee, Kichoon			Skeletal Muscle Characterization of Japanese Quail Line Selectively Bred for Lower Body Weight as an Avian Model of Delayed Muscle Growth with Hypoplasia	PLOS ONE			English	Article							MYOSIN ISOFORM TRANSITIONS; FIBER CHARACTERISTICS; SATELLITE CELLS; YOLK PRECURSOR; MEAT QUALITY; EXPRESSION; CONSEQUENCES; MYOGENESIS; MYOD; HISTOCHEMISTRY	This study was designed to extensively characterize the skeletal muscle development in the low weight (LW) quail selected from random bred control (RBC) Japanese quail in order to provide a new avian model of impaired and delayed growth in physically normal animals. The LW line had smaller embryo and body weights than the RBC line in all age groups (P<0.05). During 3 to 42 d post-hatch, the LW line exhibited approximately 60% smaller weight of pectoralis major muscle (PM), mainly resulting from lower fiber numbers compared to the RBC line (P<0.05). During early post-hatch period when myotubes are still actively forming, the LW line showed impaired PM growth with prolonged expression of Pax7 and lower expression levels of MyoD, Myf-5, and myogenin (P<0.05), likely leading to impairment of myogenic differentiation and consequently, reduced muscle fiber formation. Additionally, the LW line had delayed transition of neonatal to adult myosin heavy chain isoform, suggesting delayed muscle maturation. This is further supported by the finding that the LW line continued to grow unlike the RBC line; difference in the percentages of PMW to body weights between both quail lines diminished with increasing age from 42 to 75 d post-hatch. This delayed muscle growth in the LW line is accompanied by higher levels of myogenin expression at 42 d (P<0.05), higher percentage of centered nuclei at 42 d (P<0.01), and greater rate of increase in fiber size between 42 and 75 d post-hatch (P<0.001) compared to the RBC line. Analysis of physiological, morphological, and developmental parameters during muscle development of the LW quail line provided a well-characterized avian model for future identification of the responsible genes and for studying mechanisms of hypoplasia and delayed muscle growth.	[Choi, Young Min; Suh, Yeunsu; Shin, Sangsu; Lee, Kichoon] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Lee, K (corresponding author), Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA.	lee.2626@osu.edu	Choi, Young Min/J-6027-2014; Lee, Kichoon/G-2234-2012	Choi, Young Min/0000-0003-3015-6316; , Young Min Choi/0000-0003-2376-7784	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2010-65206-20716]; National Research Foundation of Korea; Agenda Program [PJ009457]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; National Research Foundation of Korea(National Research Foundation of Korea); Agenda Program	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2010-65206-20716 from the USDA National Institute of Food and Agriculture, and the National Research Foundation of Korea and the Agenda Program no. PJ009457. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERLE ED, 1979, POULTRY SCI, V58, P1210, DOI 10.3382/ps.0581210; Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Al-Musawi SL, 2011, DIFFERENTIATION, V82, P127, DOI 10.1016/j.diff.2011.05.012; de Almeida FLA, 2010, MICRON, V41, P997, DOI 10.1016/j.micron.2010.06.012; BANDMAN E, 1988, DEV BIOL, V130, P220, DOI 10.1016/0012-1606(88)90428-9; BREDMAN JJ, 1992, HISTOCHEM J, V24, P260, DOI 10.1007/BF01046840; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Cassar-Malek I, 2003, ANN M BRIT SOC ANIM; Chamberlain JS, 2010, CELL, V143, P1040, DOI 10.1016/j.cell.2010.12.005; Chiang W, 2008, MEAT SCI, V80, P615, DOI 10.1016/j.meatsci.2008.02.012; Choi YM, 2013, ANIMAL, V7, P1665, DOI 10.1017/S1751731113001298; Choi YM, 2013, LIVEST SCI, V155, P123, DOI 10.1016/j.livsci.2013.02.009; Choi YM, 2013, POULTRY SCI, V92, P1870, DOI 10.3382/ps.2012-02892; Choi YM, 2009, LIVEST SCI, V122, P105, DOI 10.1016/j.livsci.2008.08.015; FARKASBARGETON E, 1978, J NEUROL SCI, V39, P17, DOI 10.1016/0022-510X(78)90184-3; FARKASBARGETON E, 1988, J NEUROL SCI, V83, P145, DOI 10.1016/0022-510X(88)90064-0; FASS, 1999, FED AN SCI SOC; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Gondret F, 1996, J MUSCLE RES CELL M, V17, P657, DOI 10.1007/BF00154060; Kay's Simon Kayemba, 2006, Pediatr Endocrinol Rev, V3, P365; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; Kovacs CE, 2000, J MORPHOL, V244, P109, DOI 10.1002/(SICI)1097-4687(200005)244:2<109::AID-JMOR2>3.0.CO;2-0; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee A, 2012, POULTRY SCI, V91, P2872, DOI 10.3382/ps.2012-02232; LILJA C, 1987, GROWTH DEVELOP AGING, V51, P301; Lin CY, 2006, DEV BIOL, V299, P594, DOI 10.1016/j.ydbio.2006.08.042; LIND A, 1991, J HISTOCHEM CYTOCHEM, V39, P589, DOI 10.1177/39.5.1826695; Marotta M, 2007, NEUROMUSCULAR DISORD, V17, P707, DOI 10.1016/j.nmd.2007.05.007; National Research Council, 1998, NUTR REQ POULTR; Nestor KE, 2002, POULTRY SCI, V81, P160, DOI 10.1093/ps/81.2.160; NESTOR KE, 1982, POULTRY SCI, V61, P12, DOI 10.3382/ps.0610012; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Picard B, 2006, LIVEST SCI, V102, P107, DOI 10.1016/j.livsci.2005.12.001; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; PICARD B, 1994, J MUSCLE RES CELL M, V15, P473, DOI 10.1007/BF00122120; Quiniou N, 2002, LIVEST PROD SCI, V78, P63, DOI 10.1016/S0301-6226(02)00181-1; RAYNE J, 1975, J ANAT, V119, P347; Reddish JM, 2005, POULTRY SCI, V84, P1729, DOI 10.1093/ps/84.11.1729; Rehfeldt C, 2008, LIVEST SCI, V116, P30, DOI 10.1016/j.livsci.2007.08.017; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rehfeldt C, 2000, LIVEST PROD SCI, V66, P177, DOI 10.1016/S0301-6226(00)00225-6; Rehfeldt C., 1999, BASIC APPL MYOL, V9, P235; Riuzzi F, 2012, J CELL SCI, V125, P1440, DOI 10.1242/jcs.092163; Ropka-Molik K, 2011, GENE EXPR PATTERNS, V11, P79, DOI 10.1016/j.gep.2010.09.005; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SAS Institute Inc, 2009, SAS US GUID STAT VER; Scheuermann GN, 2004, POULTRY SCI, V83, P1404, DOI 10.1093/ps/83.8.1404; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Serr J, 2011, J ANIM SCI, V89, P3490, DOI 10.2527/jas.2011-3897; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064483; STOCKDALE FE, 1987, DEV BIOL, V123, P1, DOI 10.1016/0012-1606(87)90420-9; SUMMERS PJ, 1994, GROWTH DEVELOP AGING, V58, P135; Tobalske BW, 1997, J EXP ZOOL, V279, P313, DOI 10.1002/(SICI)1097-010X(19971101)279:4<313::AID-JEZ1>3.0.CO;2-R; Wick M, 2003, POULTRY SCI, V82, P1980, DOI 10.1093/ps/82.12.1980; Yang SJ, 2013, LIPIDS, V48, P13, DOI 10.1007/s11745-012-3742-6	57	19	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95932	10.1371/journal.pone.0095932	http://dx.doi.org/10.1371/journal.pone.0095932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763754	Green Submitted, gold, Green Published			2022-12-25	WOS:000335505000043
J	Qian, LX; Zhang, MS; Wu, SM; Zhong, Y; Van Tol, E; Cai, W				Qian, Linxi; Zhang, Mingshun; Wu, Shengmei; Zhong, Yan; Van Tol, Eric; Cai, Wei			Alkylglycerols Modulate the Proliferation and Differentiation of Non-Specific Agonist and Specific Antigen-Stimulated Splenic Lymphocytes	PLOS ONE			English	Article							B-CELL ACTIVATION; HUMAN-MILK; LIVER OIL; 1-O-ALKYLGLYCEROLS; RECEPTOR; INFLAMMATION; CARCINOMA; CYTOKINES; CALCIUM; BINDING	Alkylglycerols (AKGs) are ether-linked glycerols derived from shark liver oil and found in small amounts in human milk. Previous studies showed that oral AKGs administration significantly increased the immune response in mice. The aim of the present study was to investigate the in vitro immunomodulatory effect of AKGs on stimulating splenic lymphocyte responses. C57BL/6 mice were immunized with hepatitis B surface antigen (HBsAg). Splenic B cells were purified and stimulated with anti-BCR and anti-CD38. Meanwhile, splenic CD4+ T cells were purified and stimulated with anti-CD3 and anti-CD28. For antigen specific stimulation, the purified CD4+ T cells were cocultured with HBsAg -pulsed dendritic cells. The stimulated lymphocytes were treated with different concentrations of AKGs. The cell proliferation was assessed by [H-3]-thymidine incorporation assay. The maturation of B cells was assessed by examining the germline (GL) transcription of IgG (gamma 1) mRNA expression, and the surface expressions of CD80/CD86 markers were examined by flow cytometry analysis. Th1/Th2 polarity was assessed by T-BET (Th1)/GATA-3 (Th2) flow cytometry assay and by characteristic cytokines ELISA assay (TNF-alpha and IFN-gamma for Th1; IL-4 and IL-10 for Th2). It was found that AKGs significantly increased the BCR/CD38 -stimulated B cell proliferation. The T cell proliferation in response to CD3/CD28 or specific antigen stimulation was also increased by AKGs. The transcriptional level of IgG (gamma 1) and the expressions of CD80/CD86 molecules were markedly increased by AKGs in BCR/CD38 -stimulated B cells. Meanwhile, the results showed that AKGs increased the expression of T-BET transcriptional factor and the production of Th1 cytokines (TNF-alpha and IFN-gamma) upon CD3/CD28 stimulation; whereas, levels of Th2 cytokines (IL-4 and IL-10) were decreased by AKGs. Our study demonstrated that AKGs can modulate immune responses by boosting the proliferation and maturation of murine lymphocytes in vitro.	[Qian, Linxi; Wu, Shengmei; Cai, Wei] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China; [Qian, Linxi; Cai, Wei] Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai, Peoples R China; [Zhang, Mingshun] Nanjing Med Univ, Dept Immunol, Nanjing, Jiangsu, Peoples R China; [Zhong, Yan] Mead Johnson Pediat Nutr Inst, Shanghai, Peoples R China; [Van Tol, Eric] Mead Johnson Pediat Nutr Inst, Nijmegen, Netherlands	Shanghai Jiao Tong University; Nanjing Medical University	Cai, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China.	caiw1978@163.com			Mead Johnson Nutrition; National Natural Science Foundation of China [81000242, 30901472, 30772270]; Program for Innovative Research Team of Shanghai Municipal Education Commission; Rising-Star Foundation of Shanghai Scientific Bureau [11QA1405400]; Junior Scientist Foundation of Shanghai Health Bureau [2010Y157]; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition [11DZ2260500]	Mead Johnson Nutrition; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team of Shanghai Municipal Education Commission; Rising-Star Foundation of Shanghai Scientific Bureau; Junior Scientist Foundation of Shanghai Health Bureau; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition	Supported by Mead Johnson Nutrition (to LXQ), 81000242, 30901472 and 30772270 National Natural Science Foundation of China (to LXQ and WC), Program for Innovative Research Team of Shanghai Municipal Education Commission (to WC), 11QA1405400 Rising-Star Foundation of Shanghai Scientific Bureau (to LXQ), 2010Y157 Junior Scientist Foundation of Shanghai Health Bureau (to LXQ), 11DZ2260500 Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition (to WC). Mead Johnson Nutrition had roles in data collection and analysis. Others had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo R., 2006, VACCINE S2, V24; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Azar ST, 1999, CLIN DIAGN LAB IMMUN, V6, P306, DOI 10.1128/CDLI.6.3.306-310.1999; Blewett HJH, 2008, ADV FOOD NUTR RES, V54, P45, DOI 10.1016/S1043-4526(07)00002-2; Bordier CG, 1996, LIPIDS, V31, P521, DOI 10.1007/BF02522646; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; BROHULT A, 1970, ACTA CHEM SCAND, V24, P730, DOI 10.3891/acta.chem.scand.24-0730; CAMBIER JC, 1991, J IMMUNOL, V146, P2075; Chakir H, 2003, J IMMUNOL METHODS, V278, P157, DOI 10.1016/S0022-1759(03)00200-X; Chini EN, 2009, CURR PHARM DESIGN, V15, P57, DOI 10.2174/138161209787185788; CLARK KJ, 1995, J BIOL CHEM, V270, P7097, DOI 10.1074/jbc.270.13.7097; Embleton ND, 2013, WORLD REV NUTR DIET, V106, P26, DOI 10.1159/000342553; Esposito S, 2009, EARLY HUM DEV, V85, pS43, DOI 10.1016/j.earlhumdev.2009.08.011; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; HALLGREN B, 1974, ACTA CHEM SCAND B, VB 28, P1029, DOI 10.3891/acta.chem.scand.28b-1029; Hichami A, 1997, EUR J BIOCHEM, V250, P242, DOI 10.1111/j.1432-1033.1997.0242a.x; Jackson KM, 2006, J AM OSTEOPATH ASSOC, V106, P203; Jakobsen H, 2006, EUR J IMMUNOL, V36, P287, DOI 10.1002/eji.200535102; JAYARAMAN T, 1995, P NATL ACAD SCI USA, V92, P6007, DOI 10.1073/pnas.92.13.6007; JUTO P, 1985, ARCH DIS CHILD, V60, P610, DOI 10.1136/adc.60.7.610; LANGEN P, 1979, ACTA BIOL MED GER, V38, P965; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lewkowicz Przemyslaw, 2005, Pol Merkur Lekarski, V18, P686; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Min L, 2009, P NATL ACAD SCI USA, V106, P21143, DOI 10.1073/pnas.0911309106; Mitre R, 2005, BRIT J NUTR, V94, P753, DOI 10.1079/BJN20051569; NGWENYA BZ, 1991, P SOC EXP BIOL MED, V196, P69; Pedrono F, 2004, LIFE SCI, V74, P2793, DOI 10.1016/j.lfs.2003.11.002; Rau FC, 2009, J IMMUNOL, V183, P7661, DOI 10.4049/jimmunol.0803783; RISTIMAKI A, 1991, J CLIN ENDOCR METAB, V72, P623, DOI 10.1210/jcem-72-3-623; Saha A, 2004, CANCER RES, V64, P4995, DOI 10.1158/0008-5472.CAN-04-0626; Schulze-Koops H, 2001, BEST PRACT RES CL RH, V15, P677, DOI 10.1053/berh.2001.0187; Silfverdal SA, 2006, SCAND J IMMUNOL, V63, P371, DOI 10.1111/j.1365-3083.2006.01746.x; Wu J, 1997, J EXP MED, V185, P1877, DOI 10.1084/jem.185.10.1877; YAMAMOTO N, 1988, CANCER RES, V48, P6044; Zhang K, 2003, J LEUKOCYTE BIOL, V73, P323, DOI 10.1189/jlb.0702339; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	37	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96207	10.1371/journal.pone.0096207	http://dx.doi.org/10.1371/journal.pone.0096207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763671	Green Published, gold, Green Submitted			2022-12-25	WOS:000335505000073
J	Wang, JB; Liu, BH; Xiao, Q; Li, HL; Sun, JH				Wang, Jiabao; Liu, Baohua; Xiao, Qian; Li, Huanling; Sun, Jinhua			Cloning and Expression Analysis of Litchi (Litchi Chinensis Sonn.) Polyphenol Oxidase Gene and Relationship with Postharvest Pericarp Browning	PLOS ONE			English	Article							MOLECULAR-CLONING; FRUIT; (-)-EPICATECHIN; IDENTIFICATION; SUBSTRATE; PCR	Polyphenol oxidase (PPO) plays a key role in the postharvest pericarp browning of litchi fruit, but its underlying mechanism remains unclear. In this study, we cloned the litchi PPO gene (LcPPO, JF926153), and described its expression patterns. The LcPPO cDNA sequence was 2120 bps in length with an open reading frame (ORF) of 1800 bps. The ORF encoded a polypeptide with 599 amino acid residues, sharing high similarities with other plant PPO. The DNA sequence of the ORF contained a 215-bp intron. After carrying out quantitative RT-PCR, we proved that the LcPPO expression was tissue-specific, exhibiting the highest level in the flower and leaf. In the pericarp of newly-harvested litchi fruits, the LcPPO expression level was relatively high compared with developing fruits. Regardless of the litchi cultivar and treatment conditions, the LcPPO expression level and the PPO activity in pericarp of postharvest fruits exhibited the similar variations. When the fruits were stored at room temperature without packaging, all the pericarp browning index, PPO activity and the LcPPO expression level of litchi pericarps were reaching the highest in Nandaowuhe (the most rapid browning cultivar), but the lowest in Ziniangxi (the slowest browning cultivar) within 2 d postharvest. Preserving the fruits of Feizixiao in 0.2-mm plastic bag at room temperature would decrease the rate of pericarp water loss, delay the pericarp browning, and also cause the reduction of the pericarp PPO activity and LcPPO expression level within 3 d postharvest. In addition, postharvest storage of Feizixiao fruit stored at 4 degrees C delayed the pericarp browning while decreasing the pericarp PPO activity and LcPPO expression level within 2 d after harvest. Thus, we concluded that the up-regulation of LcPPO expression in pericarp at early stage of postharvest storage likely enhanced the PPO activity and further accelerated the postharvest pericarp browning of litchi fruit.	[Wang, Jiabao; Liu, Baohua; Xiao, Qian; Li, Huanling; Sun, Jinhua] Chinese Acad Trop Agr Sci, Environm & Plant Protect Res Inst, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences	Wang, JB (corresponding author), Chinese Acad Trop Agr Sci, Environm & Plant Protect Res Inst, Haikou, Hainan, Peoples R China.	fdabo@163.com	SUN, JIN/GPX-9641-2022		Special Funds of the Modern Agricultural Industry Technology System of China [CARS-33-02]; National Natural Science Foundation [30960233]	Special Funds of the Modern Agricultural Industry Technology System of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the Special Funds of the Modern Agricultural Industry Technology System of China (CARS-33-02) and the National Natural Science Foundation (30960233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JV, 2010, J AGR FOOD CHEM, V58, P10597, DOI 10.1021/jf102625a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao J., 2007, EXPT GUIDANCE POSTHA; Chevalier T, 1999, PLANT PHYSIOL, V119, P1261, DOI 10.1104/pp.119.4.1261; Gooding PS, 2001, PLANTA, V213, P748, DOI 10.1007/s004250100553; Jiang J. P., 1986, Acta Phytophysiologica Sinica, V12, P95; Jiang YM, 2005, LWT-FOOD SCI TECHNOL, V38, P757, DOI 10.1016/j.lwt.2004.09.004; Jiang YM, 2004, FOOD CHEM, V88, P443, DOI 10.1016/j.foodchem.2004.02.004; Jiang YM, 1997, POSTHARVEST BIOL TEC, V10, P221, DOI 10.1016/S0925-5214(96)01404-4; Jiang YM, 2000, J SCI FOOD AGR, V80, P305, DOI 10.1002/1097-0010(200002)80:3&lt;305::AID-JSFA518&gt;3.0.CO;2-H; Kong JH, 2011, CHINESE WILD PLANT R, V30, P13; Li GuiQin, 2011, Frontiers of Agriculture in China, V5, P40, DOI 10.1007/s11703-010-1058-y; LI MIN-CHIH, 1963, ACTA BOT SINICA, V11, P329; Li XY, 2006, SUBTROPICAL PLANT SC, V1, P1; Liu L, 2007, J AGR FOOD CHEM, V55, P7140, DOI 10.1021/jf070964a; Liu SX, 1991, CAS, V7, P95; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Murata M, 2001, BIOSCI BIOTECH BIOCH, V65, P383, DOI 10.1271/bbb.65.383; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; SCOTT KJ, 1982, SCI HORTIC-AMSTERDAM, V16, P253, DOI 10.1016/0304-4238(82)90073-5; Stewart RJ, 2001, AUST J PLANT PHYSIOL, V28, P181, DOI 10.1071/PP00094; Sun J, 2008, FOOD CHEM, V108, P818, DOI 10.1016/j.foodchem.2007.11.036; Sun J, 2007, J FOOD BIOCHEM, V31, P300, DOI 10.1111/j.1745-4514.2007.00114.x; Sun J, 2006, FOOD RES INT, V39, P864, DOI 10.1016/j.foodres.2006.05.001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan Xing-jie, 1984, Acta Phytophysiologica Sinica, V10, P339; Tan XJ, 1987, ACTA PHYTOPHYS SIN, V13, P197; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Thipyapong P, 2004, PLANTA, V220, P105, DOI 10.1007/s00425-004-1330-6; UNDERHILL SJR, 1995, AUST J PLANT PHYSIOL, V22, P627, DOI 10.1071/PP9950627; Wang JB, 2010, ACTA HORTIC, V863, P613, DOI 10.17660/ActaHortic.2010.863.86; Wang JB, 2006, J AGR BIOTECHNOLOGY, V6, P036; Wang JiaBao, 2010, Agricultural Science & Technology - Hunan, V11, P10; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; [尤有利 You Youli], 2010, [生物技术通报, Biotechnology Bulletin], P112; Zhang DL, 2000, POSTHARVEST BIOL TEC, V19, P165, DOI 10.1016/S0925-5214(00)00084-3; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8	37	13	14	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e93982	10.1371/journal.pone.0093982	http://dx.doi.org/10.1371/journal.pone.0093982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763257	gold, Green Published, Green Submitted			2022-12-25	WOS:000335505000005
J	Andley, UP; Malone, JP; Townsend, RR				Andley, Usha P.; Malone, James P.; Townsend, R. Reid			In Vivo Substrates of the Lens Molecular Chaperones alpha A-Crystallin and alpha B-Crystallin	PLOS ONE			English	Article							AGE-RELATED-CHANGES; HEAT-SHOCK-PROTEIN; COMPARATIVE PROTEOMIC ANALYSIS; BETA-CRYSTALLIN; MOUSE MODEL; EYE LENS; MUTATION; MECHANISM; CATARACT; ALBUMIN	alpha A-crystallin and alpha B-crystallin are members of the small heat shock protein family and function as molecular chaperones and major lens structural proteins. Although numerous studies have examined their chaperone-like activities in vitro, little is known about the proteins they protect in vivo. To elucidate the relationships between chaperone function, substrate binding, and human cataract formation, we used proteomic and mass spectrometric methods to analyze the effect of mutations associated with hereditary human cataract formation on protein abundance in alpha A-R49C and alpha B-R120G knock-in mutant lenses. Compared with age-matched wild type lenses, 2-day-old alpha A-R49C heterozygous lenses demonstrated the following: increased crosslinking (15-fold) and degradation (2.6-fold) of alpha A-crystallin; increased association between alpha A-crystallin and filensin, actin, or creatine kinase B; increased acidification of beta B1-crystallin; increased levels of grifin; and an association between beta A3/A1-crystallin and alpha A-crystallin. Homozygous alpha A-R49C mutant lenses exhibited increased associations between alpha A-crystallin and beta B3-, beta A4-, beta A2-crystallins, and grifin, whereas levels of beta B1-crystallin, gelsolin, and calpain 3 decreased. The amount of degraded glutamate dehydrogenase, alpha-enolase, and cytochrome c increased more than 50-fold in homozygous alpha A-R49C mutant lenses. In alpha B-R120G mouse lenses, our analyses identified decreased abundance of phosphoglycerate mutase, several beta- and gamma-crystallins, and degradation of alpha A- and alpha B-crystallin early in cataract development. Changes in the abundance of hemoglobin and histones with the loss of normal alpha-crystallin chaperone function suggest that these proteins also play important roles in the biochemical mechanisms of hereditary cataracts. Together, these studies offer a novel insight into the putative in vivo substrates of alpha A- and alpha B-crystallin.	[Andley, Usha P.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Andley, Usha P.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Townsend, R. Reid] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Malone, James P.; Townsend, R. Reid] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Andley, UP (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	andley@vision.wustl.edu		Andley, Usha/0000-0001-7049-7591	National Institutes of Health (NIH) [R01EY05681-29, EY02687]; Research to Prevent Blindness; National Center for Advancing Translational Sciences (NCATS) of the NIH [UL1 TR000448]; National Center for Research Resources [5P41RR000954-35]; National Institute of General Medical Sciences [8 P41 GM103422-35]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002687, R01EY005681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Center for Advancing Translational Sciences (NCATS) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health (NIH) Grant R01EY05681-29 to U.P.A.; Core Grant EY02687; Research to Prevent Blindness grants to the Department of Ophthalmology and Visual Sciences at Washington University School of Medicine, Washington University Institute of Clinical and Translational Sciences; Grant UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the NIH; grants from the National Center for Research Resources (5P41RR000954-35); and a grant from the National Institute of General Medical Sciences (8 P41 GM103422-35). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajaz MS, 1997, J BIOL CHEM, V272, P11250; Amacher DE, 2005, CLIN CHEM, V51, P1796, DOI 10.1373/clinchem.2005.049908; Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Andley UP, 2008, BIOCHEMISTRY-US, V47, P9697, DOI 10.1021/bi800594t; Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Andley Usha P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000111; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Andley UP, 2013, BIOCHEMISTRY-US, V52, P2933, DOI 10.1021/bi400180d; Andley UP, 2011, INVEST OPHTH VIS SCI, V52, P8330, DOI 10.1167/iovs.11-7633; Andley UP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017671; Andley UP, 2010, EXP EYE RES, V90, P699, DOI 10.1016/j.exer.2010.02.009; Asherie N, 2011, P NATL ACAD SCI USA, V108, P437, DOI 10.1073/pnas.1017543108; Banerjee PR, 2011, P NATL ACAD SCI USA, V108, P574, DOI 10.1073/pnas.1014653107; Barton KA, 2009, BIOCHEMISTRY-US, V48, P3956, DOI 10.1021/bi802203a; Bates GP, 2006, SCIENCE, V311, P1385, DOI 10.1126/science.1125246; Bhat SP, 2001, BIOSCIENCE REP, V21, P537, DOI 10.1023/A:1017952128502; Bhattacharyya J, 2007, BIOCHEMISTRY-US, V46, P14682, DOI 10.1021/bi701326b; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Clark TJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040486; Delcourt C, 2005, ARCH OPHTHALMOL-CHIC, V123, P225, DOI 10.1001/archopht.123.2.225; Dolinska MB, 2009, BIOCHEMISTRY-US, V48, P9684, DOI 10.1021/bi9013984; Dorsaz N, 2009, J PHYS CHEM B, V113, P1693, DOI 10.1021/jp807103f; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Ghosh JG, 2008, INT J BIOCHEM CELL B, V40, P954, DOI 10.1016/j.biocel.2007.10.035; Ghosh JG, 2007, BIOCHEMISTRY-US, V46, P6308, DOI 10.1021/bi700149h; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gokhin DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048734; Grey AC, 2009, INVEST OPHTH VIS SCI, V50, P4319, DOI 10.1167/iovs.09-3522; Hoehenwarter W, 2005, PROTEOMICS, V5, P245, DOI 10.1002/pmic.200300878; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hsu CD, 2006, INVEST OPHTH VIS SCI, V47, P2036, DOI 10.1167/iovs.05-0524; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Huang QL, 2009, INVEST OPHTH VIS SCI, V50, P2919, DOI 10.1167/iovs.08-3070; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Koteiche HA, 1999, J MOL BIOL, V294, P561, DOI 10.1006/jmbi.1999.3242; Koteiche HA, 2006, J BIOL CHEM, V281, P14273, DOI 10.1074/jbc.M512938200; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lampi KJ, 2006, BIOCHEMISTRY-US, V45, P3146, DOI 10.1021/bi052051k; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Marionneau C, 2009, CHANNELS, V3, P284; Mchaourab HS, 2007, FEBS LETT, V581, P1939, DOI 10.1016/j.febslet.2007.04.005; Mendelsohn BA, 2009, COMP BIOCHEM PHYS D, V4, P21, DOI 10.1016/j.cbd.2008.09.003; Michiel M, 2010, EXP EYE RES, V90, P688, DOI 10.1016/j.exer.2010.02.007; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; OHRLOFF C, 1983, OPHTHALMIC RES, V15, P293, DOI 10.1159/000265275; Pande A, 2008, HIGH RESOLUTION NMR, P284; Putilina T, 2003, J BIOL CHEM, V278, P13747, DOI 10.1074/jbc.M208157200; Robinson ML, 1996, INVEST OPHTH VIS SCI, V37, P2276; Sabah J, 2005, EXP EYE RES, V80, P31, DOI 10.1016/j.exer.2004.08.005; Sabah J, 2004, MOL VIS, V10, P254; Sabah JR, 2007, INVEST OPHTH VIS SCI, V48, P1237, DOI 10.1167/iovs.06-0620; Sharma K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014654; Srivastava OP, 2004, J BIOL CHEM, V279, P10901, DOI 10.1074/jbc.M308884200; St-Amand J, 2001, FASEB J, V15, P684, DOI 10.1096/fj.00-0150com; Stradner A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.198103; Sultana R, 2006, NEUROBIOL AGING, V27, P1564, DOI 10.1016/j.neurobiolaging.2005.09.021; Takata T, 2005, BIOCHEM BIOPH RES CO, V334, P1022, DOI 10.1016/j.bbrc.2005.06.195; Toyama BH, 2013, NAT REV MOL CELL BIO, V14, P55, DOI 10.1038/nrm3496; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XH, 2004, INVEST OPHTH VIS SCI, V45, P3608, DOI 10.1167/iovs.04-0423; Wang Z, 2014, AGING CELL, V13, P226, DOI 10.1111/acel.12164; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Xia CH, 2006, INVEST OPHTH VIS SCI, V47, P3004, DOI 10.1167/iovs.06-0178	64	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95507	10.1371/journal.pone.0095507	http://dx.doi.org/10.1371/journal.pone.0095507			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760011	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200061
J	Soltesz, F; Suckling, J; Lawrence, P; Tait, R; Ooi, C; Bentley, G; Dodds, CM; Miller, SR; Wille, DR; Byrne, M; McHugh, SM; Bellgrove, MA; Croft, RJ; Lu, B; Bullmore, ET; Nathan, PJ				Soltesz, Fruzsina; Suckling, John; Lawrence, Phil; Tait, Roger; Ooi, Cinly; Bentley, Graham; Dodds, Chris M.; Miller, Sam R.; Wille, David R.; Byrne, Misha; McHugh, Simon M.; Bellgrove, Mark A.; Croft, Rodney J.; Lu, Bai; Bullmore, Edward T.; Nathan, Pradeep J.			Identification of BDNF Sensitive Electrophysiological Markers of Synaptic Activity and Their Structural Correlates in Healthy Subjects Using a Genetic Approach Utilizing the Functional BDNF Val66Met Polymorphism	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; ACTIVITY-DEPENDENT SECRETION; NEUROTROPHIC FACTOR GENE; ALZHEIMERS-DISEASE; CORTICAL PLASTICITY; HIPPOCAMPAL VOLUME; MET ALLELE; MEMORY; P300; EEG	Increasing evidence suggests that synaptic dysfunction is a core pathophysiological hallmark of neurodegenerative disorders. Brain-derived neurotropic factor (BDNF) is key synaptogenic molecule and targeting synaptic repair through modulation of BDNF signalling has been suggested as a potential drug discovery strategy. The development of such "synaptogenic'' therapies depend on the availability of BDNF sensitive markers of synaptic function that could be utilized as biomarkers for examining target engagement or drug efficacy in humans. Here we have utilized the BDNF Val66Met genetic polymorphism to examine the effect of the polymorphism and genetic load (i.e. Met allele load) on electrophysiological (EEG) markers of synaptic activity and their structural (MRI) correlates. Sixty healthy adults were prospectively recruited into the three genetic groups (Val/Val, Val/Met, Met/Met). Subjects also underwent fMRI, tDCS/TMS, and cognitive assessments as part of a larger study. Overall, some of the EEG markers of synaptic activity and brain structure measured with MRI were the most sensitive markers of the polymorphism. Met carriers showed decreased oscillatory activity and synchrony in the neural network subserving error-processing, as measured during a flanker task (ERN); and showed increased slow-wave activity during resting. There was no evidence for a Met load effect on the EEG measures and the polymorphism had no effects on MMN and P300. Met carriers also showed reduced grey matter volume in the anterior cingulate and in the (left) prefrontal cortex. Furthermore, anterior cingulate grey matter volume, and oscillatory EEG power during the flanker task predicted subsequent behavioural adaptation, indicating a BDNF dependent link between brain structure, function and behaviour associated with error processing and monitoring. These findings suggest that EEG markers such as ERN and resting EEG could be used as BDNF sensitive functional markers in early clinical development to examine target engagement or drug related efficacy of synaptic repair therapies in humans.	[Soltesz, Fruzsina; Lawrence, Phil; Bentley, Graham; Miller, Sam R.; Wille, David R.; McHugh, Simon M.] GlaxoSmithKline, Clin Unit Cambridge, Cambridge, England; [Suckling, John; Tait, Roger; Ooi, Cinly; Bullmore, Edward T.; Nathan, Pradeep J.] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 1TN, England; [Dodds, Chris M.] Univ Exeter, Dept Psychol, Exeter EX4 4RJ, Devon, England; [Byrne, Misha; Croft, Rodney J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Bellgrove, Mark A.; Nathan, Pradeep J.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Lu, Bai] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Nathan, Pradeep J.] UCB Pharma, New Med, Brussels, Belgium	GlaxoSmithKline; University of Cambridge; University of Exeter; University of Queensland; Monash University; Tsinghua University; UCB Pharma SA	Soltesz, F (corresponding author), GlaxoSmithKline, Clin Unit Cambridge, Cambridge, England.	fruzsina.x.soltesz@gsk.com; pn254@cam.ac.uk	Suckling, John/ABD-7246-2021; Bullmore, Ed/C-1706-2012; Bellgrove, Mark/AAB-3114-2019	Suckling, John/0000-0002-5098-1527; Bullmore, Ed/0000-0002-8955-8283; Byrne, Mykolas (Misha)/0000-0002-4128-5001; Croft, Rodney/0000-0002-5986-9136; Bellgrove, Mark/0000-0003-0186-8349; Lu, Bai/0000-0001-5418-9759	GlaxoSmithKline; National Institute for Health Research [NF-SI-0513-10051] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded and conducted by GlaxoSmithKline. The funder provided support in the form of salaries for authors FS, PL, GB, SRM, DRW & SMH. UCB Pharma provided support in the form of a salary for author PJN. Otherwise, these organisations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contribution' section.	Andersson J.L.R, 2007, TR07JA2 FMRIB; Ando S, 2002, J NEUROSCI RES, V70, P519, DOI 10.1002/jnr.10443; [Anonymous], 1978, BRAIN EVENT RELATED; Antal A, 2010, BRAIN STIMUL, V3, P230, DOI 10.1016/j.brs.2009.12.003; Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; Ashford JW, 2011, J ALZHEIMERS DIS, V26, P229, DOI 10.3233/JAD-2011-0061; Bath KG, 2012, NEUROPSYCHOPHARMACOL, V37, P1297, DOI 10.1038/npp.2011.318; Benjamini Y, 2001, ANN STAT, V29, P1165; Beste C, 2009, NEUROSCIENCE, V159, P143, DOI 10.1016/j.neuroscience.2008.12.030; Beste C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000086; Beste C, 2010, J NEUROSCI, V30, P10727, DOI 10.1523/JNEUROSCI.2493-10.2010; Bolton MM, 2000, J NEUROSCI, V20, P3221, DOI 10.1523/JNEUROSCI.20-09-03221.2000; Brazdil M, 2002, EXP BRAIN RES, V146, P460, DOI 10.1007/s00221-002-1201-y; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Cirillo J, 2012, EUR J NEUROSCI, V36, P2640, DOI 10.1111/j.1460-9568.2012.08177.x; Cohen J., 1983, APPL MULTIPLE REGRES; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dennis NA, 2011, HIPPOCAMPUS, V21, P980, DOI 10.1002/hipo.20809; Di Lazzaro V, 2012, J NEURAL TRANSM, V119, P1499, DOI 10.1007/s00702-012-0845-4; Dodds C, 2013, PLOS ONE IN PRESS; Dodds CM, 2013, NEUROSCI BIOBEHAV R, V37, P739, DOI 10.1016/j.neubiorev.2013.01.019; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; DUFFY FH, 1984, ANN NEUROL, V16, P439, DOI 10.1002/ana.410160404; Durany N, 2000, INT J DEV NEUROSCI, V18, P807, DOI 10.1016/S0736-5748(00)00046-0; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Eriksen CW, 1995, VISUAL SELECTIVE ATTENTION, P101; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; Gatt JM, 2008, BIOL PSYCHOL, V79, P275, DOI 10.1016/j.biopsycho.2008.07.004; Gehring W. J., 1990, PSYCHOPHYSIOLOGY, V27, pS34, DOI DOI 10.1111/J.1469-8986.1990.TB02175.X; Getzmann S, 2013, NEUROIMAGE, V64, P290, DOI 10.1016/j.neuroimage.2012.08.079; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GUIDI M, 1989, PSYCHIAT RES, V29, P403, DOI 10.1016/0165-1781(89)90102-9; Hashimoto R, 2008, NEUROSCI RES, V61, P360, DOI 10.1016/j.neures.2008.04.003; Hentschke H, 2011, EUR J NEUROSCI, V34, P1887, DOI 10.1111/j.1460-9568.2011.07902.x; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; Ito Junko, 2005, Pathophysiology, V12, P97, DOI 10.1016/j.pathophys.2005.02.003; Laje G, 2012, BIOL PSYCHIAT, V72, pE27, DOI 10.1016/j.biopsych.2012.05.031; Lee MS, 2013, PROG NEURO-PSYCHOPH, V40, P62, DOI 10.1016/j.pnpbp.2012.08.009; Lim YY, 2013, NEUROBIOL AGING, V34, P2457, DOI 10.1016/j.neurobiolaging.2013.05.006; Liu RJ, 2012, BIOL PSYCHIAT, V71, P996, DOI 10.1016/j.biopsych.2011.09.030; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Mandelman SD, 2012, GENES BRAIN BEHAV, V11, P127, DOI 10.1111/j.1601-183X.2011.00738.x; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Mathalon DH, 2003, NEUROBIOL AGING, V24, P675, DOI 10.1016/S0197-4580(02)00154-9; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Mizuno M, 2003, LEARN MEMORY, V10, P108, DOI 10.1101/lm.56003; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Naatanen R, 1997, AUDIOL NEURO-OTOL, V2, P341; Naatanen R, 2012, CLIN NEUROPHYSIOL, V123, P424, DOI 10.1016/j.clinph.2011.09.020; Naatanen R, 2009, INT J NEUROPSYCHOPH, V12, P125, DOI 10.1017/S1461145708009322; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Ninan I, 2014, NEUROPHARMACOLOGY, V76, P684, DOI 10.1016/j.neuropharm.2013.04.011; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; Pattwell SS, 2012, J NEUROSCI, V32, P2410, DOI 10.1523/JNEUROSCI.5205-11.2012; Pekkonen E, 2000, AUDIOL NEURO-OTOL, V5, P216, DOI 10.1159/000013883; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Preacher K. J., 2002, CALCULATION TEST DIF; RABBITT PMA, 1966, NATURE, V212, P438, DOI 10.1038/212438a0; Rowe DL, 2004, J THEOR BIOL, V231, P413, DOI 10.1016/j.jtbi.2004.07.004; Sanchez MM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.47; Schachar RJ, 2004, J ABNORM CHILD PSYCH, V32, P285, DOI 10.1023/B:JACP.0000026142.11217.f2; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Scheff SW, 2006, J ALZHEIMERS DIS, V9, P101; Schofield PR, 2009, BIOL PSYCHOL, V80, P176, DOI 10.1016/j.biopsycho.2008.09.001; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Tartaglia N, 2001, J BIOL CHEM, V276, P37585, DOI 10.1074/jbc.M101683200; Teo JTH, 2013, INT J NEURO IN PRESS; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Voti PL, 2011, EXP BRAIN RES, V212, P91, DOI 10.1007/s00221-011-2700-5; Witte AV, 2012, J NEUROSCI, V32, P4553, DOI 10.1523/JNEUROSCI.6010-11.2012; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	98	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95558	10.1371/journal.pone.0095558	http://dx.doi.org/10.1371/journal.pone.0095558			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760076	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000335298200064
J	Terayama, H; Yoshimoto, T; Hirai, S; Naito, M; Qu, N; Hatayama, N; Hayashi, S; Mitobe, K; Furusawa, J; Mizoguchi, I; Kezuka, T; Goto, H; Suyama, K; Moriyama, H; Sakabe, K; Itoh, M				Terayama, Hayato; Yoshimoto, Takayuki; Hirai, Shuichi; Naito, Munekazu; Qu, Ning; Hatayama, Naoyuki; Hayashi, Shogo; Mitobe, Kana; Furusawa, Jun-ichi; Mizoguchi, Izuru; Kezuka, Takeshi; Goto, Hiroshi; Suyama, Kaori; Moriyama, Hiroshi; Sakabe, Kou; Itoh, Masahiro			Contribution of IL-12/IL-35 Common Subunit p35 to Maintaining the Testicular Immune Privilege	PLOS ONE			English	Article							REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ORCHITIS; IL-12 FAMILY; TUBULI RECTI; TESTIS; CYTOKINE; MACROPHAGES; IL-35; MICE; INFILTRATION	The testis is an organ with immune privilege. The comprehensive blood-testis barrier formed by Sertoli cells protects autoimmunogenic spermatozoa and spermatids from attack by the body's immune system. The interleukin (IL)-6/IL-12 family cytokines IL-12 (p35/p40), IL-23 (p19/p40), IL-27 (p28/Epstein-Barr virus-induced gene 3 [EBI3]), and IL-35 (p35/EBI3) play critical roles in the regulation of various immune responses, but their roles in testicular immune privilege are not well understood. In the present study, we investigated whether these cytokines are expressed in the testes and whether they function in the testicular immune privilege by using mice deficient in their subunits. Expression of EBI3 was markedly increased at both mRNA and protein levels in the testes of 10- or 12-week-old wild-type mice as compared with levels in 2-week-old mice, whereas the mRNA expression of p40 was markedly decreased and that of p35 was conserved between these two groups. Lack of EBI3, p35, and IL-12 receptor beta 2 caused enhanced infiltration of lymphocytes into the testicular interstitium, with increased interferon-gamma expression in the testes and autoantibody production against mainly acrosomal regions of spermatids. Spermatogenic disturbance was more frequently observed in the seminiferous tubules, especially when surrounded by infiltrating lymphocytes, of these deficient mice than in those of wild-type mice. In particular, p35-deficient mice showed the most severe spermatogenic disturbance. Immunohistochemical analyses revealed that endothelial cells and peritubular cells in the interstitium were highly positive for p35 at both ages, and CD163(+) resident macrophages positive for p35 and EBI3, possibly producing IL-35, were also detected in the interstitium of 12-week-old mice but not those of 2-week-old mice. These results suggest that p35 helps in maintaining the testicular immune privilege, in part in an IL-35-dependent manner.	[Terayama, Hayato; Hirai, Shuichi; Naito, Munekazu; Qu, Ning; Hatayama, Naoyuki; Hayashi, Shogo; Itoh, Masahiro] Tokyo Med Univ, Dept Anat, Tokyo 1608402, Japan; [Terayama, Hayato; Suyama, Kaori; Sakabe, Kou] Tokai Univ, Sch Med, Dept Anat, Hiratsuka, Kanagawa 25912, Japan; [Yoshimoto, Takayuki; Mitobe, Kana; Furusawa, Jun-ichi; Mizoguchi, Izuru] Tokyo Med Univ, Inst Med Sci, Dept Immunoregulat, Tokyo 1608402, Japan; [Kezuka, Takeshi; Goto, Hiroshi] Tokyo Med Univ, Dept Ophthalmol, Tokyo 1608402, Japan; [Moriyama, Hiroshi] Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan	Tokyo Medical University; Tokai University; Tokyo Medical University; Tokyo Medical University; Showa University	Yoshimoto, T (corresponding author), Tokyo Med Univ, Inst Med Sci, Dept Immunoregulat, Tokyo 1608402, Japan.	yoshimot@tokyo-med.ac.jp	HIRAI, SHUICHI/AAQ-6081-2020; Yoshimoto, Takayuki/AAN-7995-2020; Qu, Ning/X-1827-2019; Hayashi, Shogo/K-7268-2015	Hayashi, Shogo/0000-0003-0302-7658; Yoshimoto, Takayuki/0000-0002-2847-0341	Japan Ministry of Education, Culture, Sports, Science and Technology [25340050, 24791234]; Japan Health and Labor Sciences; Grants-in-Aid for Scientific Research [25118727] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health and Labor Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research (C: 25340050) and Young Scientists (B: 24791234) from the Japan Ministry of Education, Culture, Sports, Science and Technology and by the Japan Health and Labor Sciences research grant (to Kou Sakabe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi I, 2005, BLOOD, V106, P3846, DOI 10.1182/blood-2005-05-2034; Bhushan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028452; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; DECESARIS P, 1992, BIOCHEM BIOPH RES CO, V186, P1639; Duan YG, 2011, INT J ANDROL, V34, pE536, DOI 10.1111/j.1365-2605.2010.01137.x; Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x; Guttek K, 2013, CYTOKINE, V64, P46, DOI 10.1016/j.cyto.2013.04.037; Hall AO, 2012, ADV IMMUNOL, V115, P1, DOI 10.1016/B978-0-12-394299-9.00001-1; Hedger MP, 2002, J REPROD IMMUNOL, V57, P19, DOI 10.1016/S0165-0378(02)00016-5; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Itoh M, 2005, J REPROD IMMUNOL, V67, P57, DOI 10.1016/j.jri.2005.06.007; Itoh M, 1999, AM J REPROD IMMUNOL, V42, P321; Jacobo P, 2009, J REPROD IMMUNOL, V81, P44, DOI 10.1016/j.jri.2009.04.005; Jacobo P, 2011, REPRODUCTION, V141, P249, DOI 10.1530/REP-10-0362; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; KERN S, 1995, J REPROD IMMUNOL, V28, P189, DOI 10.1016/0165-0378(95)91391-Q; KERN S, 1995, BIOL REPROD, V53, P1407, DOI 10.1095/biolreprod53.6.1407; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Li MWM, 2009, CYTOKINE GROWTH F R, V20, P329, DOI 10.1016/j.cytogfr.2009.07.007; Li N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00152; Mao HT, 2013, HUM IMMUNOL, V74, P872, DOI 10.1016/j.humimm.2013.04.010; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Meinhardt A, 2011, MOL CELL ENDOCRINOL, V335, P60, DOI 10.1016/j.mce.2010.03.022; Naito M, 2008, AM J REPROD IMMUNOL, V59, P55, DOI 10.1111/j.1600-0897.2007.00556.x; Naito M, 2012, MED MOL MORPHOL, V45, P185, DOI 10.1007/s00795-012-0587-2; Naito M, 2009, MED MOL MORPHOL, V42, P230, DOI 10.1007/s00795-009-0469-4; Natwar R K, 1995, Acta Eur Fertil, V26, P45; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; Riccioli A, 2000, J IMMUNOL, V165, P743, DOI 10.4049/jimmunol.165.2.743; Rival C, 2007, MOL HUM REPROD, V13, P853, DOI 10.1093/molehr/gam067; Rodriguez MG, 2006, ASIAN J ANDROL, V8, P576, DOI 10.1111/j.1745-7262.2006.00146.x; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Su LL, 2011, J ENDOCRINOL, V209, P337, DOI 10.1530/JOE-10-0474; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; TAGUCHI O, 1981, CLIN EXP IMMUNOL, V46, P425; Terayama H, 2011, J REPROD DEVELOP, V57, P296, DOI 10.1262/jrd.10-121N; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Tung KSK, 1997, BIOL REPROD, V56, P1133, DOI 10.1095/biolreprod56.5.1133; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wheeler K, 2011, P NATL ACAD SCI USA, V108, P7511, DOI 10.1073/pnas.1017615108; Winnall WR, 2013, J REPROD IMMUNOL, V97, P147, DOI 10.1016/j.jri.2013.01.001; Winnall WR, 2011, J LEUKOCYTE BIOL, V90, P133, DOI 10.1189/jlb.1010557; Wirtz S, 2011, GASTROENTEROLOGY, V141, P1875, DOI 10.1053/j.gastro.2011.07.040; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221; Yoshimoto T, 2009, IMMUNOTHERAPY-UK, V1, P825, DOI [10.2217/imt.09.46, 10.2217/IMT.09.46]; Zandian M, 2011, GENE THER, V18, P734, DOI 10.1038/gt.2011.32	50	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96120	10.1371/journal.pone.0096120	http://dx.doi.org/10.1371/journal.pone.0096120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760014	gold, Green Submitted, Green Published			2022-12-25	WOS:000335298200139
J	Liu, HW; Hou, PP; Guo, XY; Zhao, ZW; Hu, B; Li, X; Wang, LY; Ding, JP; Wang, S				Liu, Hao-Wen; Hou, Pan-Pan; Guo, Xi-Ying; Zhao, Zhi-Wen; Hu, Bin; Li, Xia; Wang, Lu-Yang; Ding, Jiu-Ping; Wang, Sheng			Structural Basis for Calcium and Magnesium Regulation of a Large Conductance Calcium-activated Potassium Channel with beta 1 Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; BK CHANNELS; CHROMAFFIN CELLS; MOLECULAR-BASIS; VOLTAGE SENSOR; INACTIVATION; CA2+; CLONING; HKCNMB3; DOMAINS	Large conductance Ca2+- and voltage-activated potassium (BK) channels, composed of pore-forming alpha subunits and auxiliary beta subunits, play important roles in diverse physiological activities. The beta 1 is predominately expressed in smooth muscle cells, where it greatly enhances the Ca2+ sensitivity of BK channels for proper regulation of smooth muscle tone. However, the structural basis underlying dynamic interaction between BK mSlo1 alpha and beta 1 remains elusive. Using macroscopic ionic current recordings in various Ca2+ and Mg2+ concentrations, we identified two binding sites on the cytosolic N terminus of beta 1, namely the electrostatic enhancing site (mSlo1(K392,R393)-beta 1(E13,T14)), increasing the calcium sensitivity of BK channels, and the hydrophobic site (mSlo1(L906,L908)-beta 1(L5,V6,M7)), passing the physical force from the Ca2+ bowl onto the enhancing site and S6 C-linker. Dynamic binding of these sites affects the interaction between the cytosolic domain and voltage-sensing domain, leading to the reduction of Mg2+ sensitivity. A comprehensive structural model of the BK(mSlo1 alpha-beta 1) complex was reconstructed based on these functional studies, which provides structural and mechanistic insights for understanding BK gating.	[Liu, Hao-Wen; Hou, Pan-Pan; Guo, Xi-Ying; Zhao, Zhi-Wen; Hu, Bin; Li, Xia; Ding, Jiu-Ping; Wang, Sheng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Hubei, Peoples R China; [Wang, Lu-Yang] Univ Toronto, SickKids Res Inst, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Wang, Lu-Yang] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada	Huazhong University of Science & Technology; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Ding, JP (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Hubei, Peoples R China.	jpding@mail.hust.edu.cn; shengwang@mail.hust.edu.cn	Hu, Bin/AAF-5908-2019; Hou, Panpan/Q-2941-2019	Hu, Bin/0000-0003-0646-0182; Hou, Panpan/0000-0001-7694-2262	National Basic Research Program of China [2010CB529804]; Fundamental Research Funds for the Central Universities [2014TS087]; National Science Foundation of China [30971179, 31170814, 31028006]; Canadian Institutes of Health Research; China-Canada Joint Health Research Initiative grant; Canada Research Chair	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); China-Canada Joint Health Research Initiative grant; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by National Basic Research Program of China Grant 2010CB529804 (to J. P. D.); Fundamental Research Funds for the Central Universities Grant 2014TS087 (to S. W.); National Science Foundation of China Grants 30971179, 31170814, and 31028006 (to J. P. D.); and individual Operating Grants from the Canadian Institutes of Health Research, a China-Canada Joint Health Research Initiative grant, and the Canada Research Chair (to L. Y. W.).	Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Case DA, 2012, AMBER; Chen MR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002114; Ding JP, 1998, BIOPHYS J, V74, P268, DOI 10.1016/S0006-3495(98)77785-9; FUCHS PA, 1992, J NEUROSCI, V12, P800; Hou PP, 2013, SCI REP-UK, V3, DOI 10.1038/srep01666; Hu L, 2003, P NATL ACAD SCI USA, V100, P10488, DOI 10.1073/pnas.1834300100; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Liu GX, 2008, P NATL ACAD SCI USA, V105, P10727, DOI 10.1073/pnas.0805212105; MCMANUS OB, 1991, J PHYSIOL-LONDON, V443, P739, DOI 10.1113/jphysiol.1991.sp018861; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Morrow JP, 2006, P NATL ACAD SCI USA, V103, P5096, DOI 10.1073/pnas.0600907103; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Qian X, 2003, P NATL ACAD SCI USA, V100, P10061, DOI 10.1073/pnas.1731650100; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Sun XH, 2013, J NEUROSCI, V33, P11253, DOI 10.1523/JNEUROSCI.0620-13.2013; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932	40	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16914	16923		10.1074/jbc.M114.557991	http://dx.doi.org/10.1074/jbc.M114.557991			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24764303	hybrid, Green Published			2022-12-25	WOS:000338016200027
J	Moroishi, T; Yamauchi, T; Nishiyama, M; Nakayama, KI				Moroishi, Toshiro; Yamauchi, Takayoshi; Nishiyama, Masaaki; Nakayama, Keiichi I.			HERC2 Targets the Iron Regulator FBXL5 for Degradation and Modulates Iron Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMERYTHRIN-LIKE DOMAIN; CELL-CYCLE CONTROL; PROTEIN 5 FBXL5; F-BOX PROTEINS; UBIQUITIN LIGASES; BETA-CATENIN; E3 LIGASE; HOMEOSTASIS; MECHANISMS; RECRUITMENT	FBXL5 (F-box and leucine-rich repeat protein 5) is the F-box protein subunit of, and therefore responsible for substrate recognition by, the SCFFBXL5 ubiquitin-ligase complex, which targets iron regulatory protein 2 (IRP2) for proteasomal degradation. IRP2 plays a central role in the maintenance of cellular iron homeostasis in mammals through posttranscriptional regulation of proteins that contribute to control of the intracellular iron concentration. The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo, given that mice lacking FBXL5 die during early embryogenesis as a result of unrestrained IRP2 activity and oxidative stress attributable to excessive iron accumulation. Despite its pivotal role in the control of iron homeostasis, however, little is known of the upstream regulation of FBXL5 activity. We now show that FBXL5 undergoes constitutive ubiquitin-dependent degradation at the steady state. With the use of a proteomics approach to the discovery of proteins that regulate the stability of FBXL5, we identified the large HECT-type ubiquitin ligase HERC2 (HECT and RLD domain containing E3 ubiquitin protein ligase 2) as an FBXL5-associated protein. Inhibition of the HERC2-FBXL5 interaction or depletion of endogenous HERC2 by RNA interference resulted in the stabilization of FBXL5 and a consequent increase in its abundance. Such accumulation of FBXL5 in turn led to a decrease in the intracellular content of ferrous iron. Our results thus suggest that HERC2 regulates the basal turnover of FBXL5, and that this ubiquitin-dependent degradation pathway contributes to the control of mammalian iron metabolism.	[Moroishi, Toshiro; Yamauchi, Takayoshi; Nishiyama, Masaaki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Nishiyama, Masaaki/GWU-5575-2022	Moroishi, Toshiro/0000-0001-6419-3882				Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Berthelet S, 2010, GENETICS, V185, P1111, DOI 10.1534/genetics.110.117531; Chollangi S, 2012, J BIOL CHEM, V287, P23710, DOI 10.1074/jbc.M112.360404; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Evstatiev R, 2012, GUT, V61, P933, DOI 10.1136/gut.2010.214312; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hochrainer K, 2005, GENOMICS, V85, P153, DOI 10.1016/j.ygeno.2004.10.006; Ji YG, 2000, GENOME RES, V10, P319, DOI 10.1101/gr.10.3.319; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; MAHLER HR, 1954, J BIOL CHEM, V210, P165; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nishiyama M, 2012, MOL CELL BIOL, V32, P501, DOI 10.1128/MCB.06409-11; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Prohaska R, 2012, NEUROBIOL DIS, V46, P607, DOI 10.1016/j.nbd.2012.03.006; Puffenberger EG, 2012, HUM MUTAT, V33, P1639, DOI 10.1002/humu.22237; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tahara-Hanaoka S, 2002, EXP HEMATOL, V30, P11, DOI 10.1016/S0301-472X(01)00761-5; Thompson JW, 2012, BBA-MOL CELL RES, V1823, P1484, DOI 10.1016/j.bbamcr.2012.02.003; Thompson JW, 2012, J BIOL CHEM, V287, P7357, DOI 10.1074/jbc.M111.308684; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Yumimoto K, 2012, J PROTEOME RES, V11, P3175, DOI 10.1021/pr201216u	34	32	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16430	16441		10.1074/jbc.M113.541490	http://dx.doi.org/10.1074/jbc.M113.541490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24778179	Green Published, hybrid			2022-12-25	WOS:000337965700045
J	Sunryd, JC; Cheon, B; Graham, JB; Giorda, KM; Fissore, RA; Hebert, DN				Sunryd, Johan C.; Cheon, Banyoon; Graham, Jill B.; Giorda, Kristina M.; Fissore, Rafael A.; Hebert, Daniel N.			TMTC1 and TMTC2 Are Novel Endoplasmic Reticulum Tetratricopeptide Repeat-containing Adapter Proteins Involved in Calcium Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; ER; OSCILLATIONS; DEGRADATION; CALNEXIN; COMPLEX; PREDICTION; PATHWAYS	The endoplasmic reticulum (ER) is organized in part by adapter proteins that nucleate the formation of large protein complexes. Tetratricopeptide repeats (TPR) are well studied protein structural motifs that support intermolecular protein-protein interactions. TMTC1 and TMTC2 were identified by an in silico search as TPR-containing proteins possessing N-terminal ER targeting signal sequences and multiple hydrophobic segments, suggestive of polytopic membrane proteins that are targeted to the secretory pathway. A variety of cell biological and biochemical assays was employed to demonstrate that TMTC1 and TMTC2 are both ER resident integral membrane proteins with multiple clusters of TPR domains oriented within the ER lumen. Proteomic analysis followed by co-immunoprecipitation verification found that both proteins associated with the ER calcium uptake pump SERCA2B, and TMTC2 also bound to the carbohydrate-binding chaperone calnexin. Live cell calcium measurements revealed that overexpression of either TMTC1 or TMTC2 caused a reduction of calcium released from the ER following stimulation, whereas the knockdown of TMTC1 or TMTC2 increased the stimulated calcium released. Together, these results implicate TMTC1 and TMTC2 as ER proteins involved in ER calcium homeostasis.	[Sunryd, Johan C.; Graham, Jill B.; Giorda, Kristina M.; Hebert, Daniel N.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Cheon, Banyoon; Fissore, Rafael A.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Sunryd, Johan C.; Cheon, Banyoon; Graham, Jill B.; Giorda, Kristina M.; Fissore, Rafael A.; Hebert, Daniel N.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hebert, DN (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 240 Thatcher Rd, Amherst, MA 01003 USA.	dhebert@biochem.umass.edu			National Institutes of Health from USPHS [GM086874, HD051872]; National Institutes of Health [GM008515]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086874, T32GM008515] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM086874 (to D. N. H.) and HD051872 (to R. A. F.) from USPHS.; Supported in part by National Institutes of Health Training Grant GM008515.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Giorda KM, 2012, J VIROL, V86, P3180, DOI 10.1128/JVI.07047-11; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; Luo D, 2001, J BIOL CHEM, V276, P5613, DOI 10.1074/jbc.M007524200; Lynes EM, 2013, J CELL SCI, V126, P3893, DOI 10.1242/jcs.125856; Magliery TJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-240; MOSTOV KE, 1981, NATURE, V292, P87, DOI 10.1038/292087a0; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simpson JC, 2012, NAT CELL BIOL, V14, P764, DOI 10.1038/ncb2510; Svedine S, 2004, J CELL SCI, V117, P2937, DOI 10.1242/jcs.01154; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Tamura T, 2011, J BIOL CHEM, V286, P24906, DOI 10.1074/jbc.M111.243998; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu XY, 2002, J BIOL CHEM, V277, P13597, DOI 10.1074/jbc.M110881200; Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006	44	44	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16085	16099		10.1074/jbc.M114.554071	http://dx.doi.org/10.1074/jbc.M114.554071			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764305	Green Published, hybrid			2022-12-25	WOS:000337965700017
J	De Vita, S; Schneider, RK; Garcia, M; Wood, J; Gavillet, M; Ebert, BL; Gerbaulet, A; Roers, A; Levine, RL; Mullally, A; Williams, DA				De Vita, Serena; Schneider, Rebekka K.; Garcia, Michael; Wood, Jenna; Gavillet, Mathilde; Ebert, Benjamin L.; Gerbaulet, Alexander; Roers, Axel; Levine, Ross L.; Mullally, Ann; Williams, David A.			Loss of Function of TET2 Cooperates with Constitutively Active KIT in Murine and Human Models of Mastocytosis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MAST-CELL; C-KIT; SYSTEMIC MASTOCYTOSIS; WILD-TYPE; URTICARIA PIGMENTOSA; ACTIVATING MUTATIONS; DASATINIB BMS-354825; KINASE INHIBITOR; TYROSINE KINASE	Systemic Mastocytosis (SM) is a clonal disease characterized by abnormal accumulation of mast cells in multiple organs. Clinical presentations of the disease vary widely from indolent to aggressive forms, and to the exceedingly rare mast cell leukemia. Current treatment of aggressive SM and mast cell leukemia is unsatisfactory. An imatinib-resistant activating mutation of the receptor tyrosine kinase KIT (KIT D816V) is most frequently present in transformed mast cells and is associated with all clinical forms of the disease. Thus the etiology of the variable clinical aggressiveness of abnormal mast cells in SM is unclear. TET2 appears to be mutated in primary human samples in aggressive types of SM, suggesting a possible role in disease modification. In this report, we demonstrate the cooperation between KIT D816V and loss of function of TET2 in mast cell transformation and demonstrate a more aggressive phenotype in a murine model of SM when both mutations are present in progenitor cells. We exploit these findings to validate a combination treatment strategy targeting the epigenetic deregulation caused by loss of TET2 and the constitutively active KIT receptor for the treatment of patients with aggressive SM.	[De Vita, Serena; Garcia, Michael; Wood, Jenna; Gavillet, Mathilde; Williams, David A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Schneider, Rebekka K.; Ebert, Benjamin L.; Mullally, Ann] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA; [Gerbaulet, Alexander; Roers, Axel] Tech Univ Dresden, Inst Immunol, Med Fac Carl Gustav Carus, Dresden, Germany; [Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Williams, DA (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	DAWilliams@childrens.harvard.edu	levine, ross/AAE-7658-2019	Wood, Jenna/0000-0001-6715-0626	NIH [5R01DK062757-11]; American Italian Cancer Foundation (AICF); NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Italian Cancer Foundation (AICF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant NIH 5R01DK062757-11 to D. A. W. and by an American Italian Cancer Foundation (AICF) postdoctoral fellowship to S. D. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2009, BLOOD, V114, P5342, DOI 10.1182/blood-2008-08-175190; Akin C, 2003, EXP HEMATOL, V31, P686, DOI 10.1016/S0301-472X(03)00112-7; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; BUTTERFIELD JH, 1988, ARCH OTO-RHINO-LARYN, V245, P88, DOI 10.1007/BF00481442; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Estey EH, 2013, LEUKEMIA, V27, P1803, DOI 10.1038/leu.2013.173; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; Gerbaulet A, 2011, BLOOD, V117, P2012, DOI 10.1182/blood-2008-11-189605; Ghanim V, 2012, BLOOD, V119, P4242, DOI 10.1182/blood-2011-09-382770; Gotlib J, 2012, BLOOD; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Horny HP, 2001, LEUKEMIA RES, V25, P543, DOI 10.1016/S0145-2126(01)00021-2; Horny HP, 2004, J CLIN PATHOL, V57, P604, DOI 10.1136/jcp.2003.014860; IHLE JN, 1983, J IMMUNOL, V131, P282; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kitayama H, 1996, BLOOD, V88, P995; Klco JM, 2013, BLOOD, V121, P1633, DOI 10.1182/blood-2012-09-459313; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Langemeijer SMC, 2011, LEUKEMIA, V25, P189, DOI 10.1038/leu.2010.243; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; LEWIS HM, 1995, J ROY SOC MED, V88, pP530; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Ma YS, 2002, BLOOD, V99, P1741, DOI 10.1182/blood.V99.5.1741; Masserot C, 2008, PEDIATR BLOOD CANCER, V51, P444, DOI 10.1002/pbc.21640; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Pardanani A, 2009, BLOOD, V114, P3769, DOI 10.1182/blood-2009-05-220145; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; RAZIN E, 1984, J IMMUNOL, V132, P1479; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Shah NP, 2006, BLOOD, V108, P286, DOI 10.1182/blood-2005-10-3969; Soucie E, 2012, BLOOD, V120, P4846, DOI 10.1182/blood-2011-12-397588; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Tefferi A, 2009, LEUKEMIA, V23, P900, DOI 10.1038/leu.2009.37; Traina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043090; TRAVIS WD, 1988, CANCER, V62, P965, DOI 10.1002/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Verstovsek S, 2008, CLIN CANCER RES, V14, P3906, DOI 10.1158/1078-0432.CCR-08-0366; Wilson TM, 2011, HAEMATOL-HEMATOL J, V96, P459, DOI 10.3324/haematol.2010.031690; Xiang ZF, 2007, MOL CELL BIOL, V27, P267, DOI 10.1128/MCB.01153-06; Yavuz AS, 2002, BLOOD, V100, P661, DOI 10.1182/blood-2002-01-0203	46	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96209	10.1371/journal.pone.0096209	http://dx.doi.org/10.1371/journal.pone.0096209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788138	gold, Green Published, Green Submitted			2022-12-25	WOS:000336655700062
J	Sun, BQ; Zheng, PY; Wei, NL; Huang, HM; Zeng, GQ				Sun, Baoqing; Zheng, Peiyan; Wei, Nili; Huang, Huimin; Zeng, Guangqiao			Co-Sensitization to Silkworm Moth (Bombyx mori) and 9 Inhalant Allergens among Allergic Patients in Guangzhou, Southern China	PLOS ONE			English	Article							IGE CROSS-REACTIVITY; BLOMIA-TROPICALIS; WILD SILK; ASCARIS-LUMBRICOIDES; OCCUPATIONAL ASTHMA; MITE ALLERGENS; BED QUILTS; COCKROACH; PREVALENCE	Objectives: This study aimed to investigate the profile of sensitization to silkworm moth (Bombyx mori) and other 9 common inhalant allergens among patients with allergic diseases in southern China. Methods: A total of 175 patients were tested for serum sIgE against silkworm moth in addition to combinations of other allergens: Dermatophagoides pteronyssinus, Dermatophagoides farinae, Blomia tropicalis, Blattella germanica, Periplaneta americana, cat dander, dog dander, Aspergillus fumigatus and Artemisia vulgaris by using the ImmunoCAP system. Correlation between sensitization to silkworm moth and to the other allergens was analyzed. Results: Of the 175 serum samples tested, 86 (49.14%) were positive for silkworm moth sIgE. With high concordance rates, these silkworm moth sensitized patients were concomitantly sensitized to Dermatophagoides pteronyssinus (94.34%), Dermatophagoides farinae (86.57%), Blomia tropicalis (93.33%), Blattella germanica (96.08%), and Periplaneta americana (79.41%). Moreover, there was a correlation in serum sIgE level between silkworm moth and Dermatophagoides pteronyssinus (r = 0.518), Dermatophagoides farinae (r = 0.702), Blomia tropicalis (r = 0.701), Blattella germanica (r = 0.878), and Periplaneta americana (r = 0.531) among patients co-sensitized to silkworm moth and each of these five allergens. Conclusion: In southern Chinese patients with allergic diseases, we showed a high prevalence of sensitization to silkworm moth, and a co-sensitization between silkworm moth and other five common inhalant allergens. Further serum inhibition studies are warranted to verify whether cross-reactivity exists among these allergens.	[Sun, Baoqing; Zheng, Peiyan; Wei, Nili; Huang, Huimin; Zeng, Guangqiao] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis,Natl Clin Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Zeng, GQ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis,Natl Clin Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China.	zgqiao@vip.163.com			Guangdong Industry Technology and Development Fund [2011B061200040]; Guangdong Natural Science Foundation [S2013010014728]; Science Foundation of Guangzhou Medical University [2013A06]	Guangdong Industry Technology and Development Fund; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science Foundation of Guangzhou Medical University	The authors have no financial issues related to this article. This work was supported by Guangdong Industry Technology and Development Fund (Project No.: 2011B061200040), Guangdong Natural Science Foundation (Project No.: S2013010014728) and Science Foundation of Guangzhou Medical University (Project No.: 2013A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aalberse RC, 2001, ALLERGY, V56, P27, DOI 10.1034/j.1398-9995.2001.00909.x; Acevedo N, 2011, PARASITE IMMUNOL, V33, P309, DOI 10.1111/j.1365-3024.2011.01288.x; Bircher AJ, 2005, DERMATOLOGY, V210, P119, DOI 10.1159/000082567; Borelli S, 1999, ALLERGY, V54, P900, DOI 10.1034/j.1398-9995.1999.00280.x; Caraballo Luis, 2011, Front Biosci (Elite Ed), V3, P51, DOI 10.2741/e219; Cardona G, 2005, J INVEST ALLERG CLIN, V15, P259; Chaoming W, 1990, ANN ALLERGY, V65, P375; Chew FT, 1999, CLIN EXP ALLERGY, V29, P982, DOI 10.1046/j.1365-2222.1999.00543.x; Cullinan P, 1997, CLIN EXP ALLERGY, V27, P41, DOI 10.1111/j.1365-2222.1997.tb01825.x; DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9; EBNER H, 1987, WIEN KLIN WOCHENSCHR, V99, P542; Fedoskova T. G., 2005, Gigiena i Sanitariya, P25; HACKI M, 1982, DEUT MED WOCHENSCHR, V107, P166, DOI 10.1055/s-2008-1069892; Hales BJ, 2007, CLIN EXP ALLERGY, V37, P1357, DOI 10.1111/j.1365-2222.2007.02786.x; HARINDRANATH N, 1985, ANN ALLERGY, V55, P511; Hoflehner E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042026; Johansson E, 1997, CLIN EXP ALLERGY, V27, P691, DOI 10.1111/j.1365-2222.1997.tb01198.x; JOHANSSON SGO, 1985, J ALLERGY CLIN IMMUN, V75, P452, DOI 10.1016/S0091-6749(85)80017-8; Larsson S, 2009, ALLERGY, V64, P493, DOI 10.1111/j.1398-9995.2008.01898.x; Li ChaoPin, 2000, Zhongguo Meijieshengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V11, P225; Li CP, 2000, YIXUE DONGWU FANGZHI, V16, P305; Liu ZG, 2009, INT ARCH ALLERGY IMM, V150, P8, DOI 10.1159/000210375; Lopata AL, 2010, CLIN EXP ALLERGY, V40, P850, DOI 10.1111/j.1365-2222.2010.03513.x; Morgan MS, 1996, ANN ALLERG ASTHMA IM, V77, P386, DOI 10.1016/S1081-1206(10)63337-6; Okuda Minoru, 2002, Nihon Jibiinkoka Gakkai Kaiho, V105, P1181; Puerta L, 2005, ALLERGY, V60, P41, DOI 10.1111/j.1398-9995.2004.00636.x; Santos ABR, 2008, J ALLERGY CLIN IMMUN, V121, P1040, DOI 10.1016/j.jaci.2007.12.1147; Spiegel W, 2004, LANCET, V363, P1438, DOI 10.1016/S0140-6736(04)16103-5; Sun BQ, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-2; Sun BQ, 2010, CHINESE MED J-PEKING, V123, P3540, DOI 10.3760/cma.j.issn.0366-6999.2010.24.007; Sun BQ, 2008, GUOJI HUXI ZAZHI, V28, P193; TWAROG FJ, 1977, J ALLERGY CLIN IMMUN, V59, P154, DOI 10.1016/0091-6749(77)90218-4; Wu AYY, 2012, J THORAC DIS, V4, P198, DOI 10.3978/j.issn.2072-1439.2011.07.03; Wu CH, 1997, ALLERGY, V52, P411, DOI 10.1111/j.1398-9995.1997.tb01020.x; WUTHRICH B, 1985, SCHWEIZ MED WSCHR, V115, P1387; Yu CJ, 2003, J IMMUNOL, V170, P445, DOI 10.4049/jimmunol.170.1.445	36	22	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94776	10.1371/journal.pone.0094776	http://dx.doi.org/10.1371/journal.pone.0094776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24787549	Green Submitted, Green Published, gold			2022-12-25	WOS:000335510600018
J	Etulain, J; Negrotto, S; Tribulatti, MV; Croci, DO; Carabelli, J; Campetella, O; Rabinovich, GA; Schattner, M				Etulain, Julia; Negrotto, Soledad; Virginia Tribulatti, Maria; Omar Croci, Diego; Carabelli, Julieta; Campetella, Oscar; Adrian Rabinovich, Gabriel; Schattner, Mirta			Control of Angiogenesis by Galectins Involves the Release of Platelet-Derived Proangiogenic Factors	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; ALPHA-GRANULES; EXPRESSION; CELLS; VEGF; ACTIVATION; PROTEINS; LOCALIZATION; MODULATION; ENDOSTATIN	Platelets contribute to vessel formation through the release of angiogenesis-modulating factors stored in their alpha-granules. Galectins, a family of lectins that bind beta-galactoside residues, are up-regulated in inflammatory and cancerous tissues, trigger platelet activation and mediate vascularization processes. Here we aimed to elucidate whether the release of platelet-derived proangiogenic molecules could represent an alternative mechanism through which galectins promote neovascularization. We show that different members of the galectin family can selectively regulate the release of angiogenic molecules by human platelets. Whereas Galectin (Gal)-1, -3, and -8 triggered vascular endothelial growth factor (VEGF) release, only Gal-8 induced endostatin secretion. Release of VEGF induced by Gal-8 was partially prevented by COX-1, PKC, p38 and Src kinases inhibitors, whereas Gal-1-induced VEGF secretion was inhibited by PKC and ERK blockade, and Gal-3 triggered VEGF release selectively through a PKC-dependent pathway. Regarding endostatin, Gal-8 failed to stimulate its release in the presence of PKC, Src and ERK inhibitors, whereas aspirin or p38 inhibitor had no effect on endostatin release. Despite VEGF or endostatin secretion, platelet releasates generated by stimulation with each galectin stimulated angiogenic responses in vitro including endothelial cell proliferation and tubulogenesis. The platelet angiogenic activity was independent of VEGF and was attributed to the concerted action of other proangiogenic molecules distinctly released by each galectin. Thus, secretion of platelet-derived angiogenic molecules may represent an alternative mechanism by which galectins promote angiogenic responses and its selective blockade may lead to the development of therapeutic strategies for angiogenesis-related diseases.	[Etulain, Julia; Negrotto, Soledad; Schattner, Mirta] CONICET Natl Acad Med, Inst Expt Med, Lab Expt Thrombosis, Buenos Aires, DF, Argentina; [Virginia Tribulatti, Maria; Carabelli, Julieta; Campetella, Oscar] Natl Univ San Martin, CONICET, Technol Inst Chascomus, Inst Biotechnol Invest, Buenos Aires, DF, Argentina; [Omar Croci, Diego; Adrian Rabinovich, Gabriel] Consejo Nacl Invest Cient & Tecn, Inst Biol & Expt Med IBYME, Immunopathol Lab, RA-1033 Buenos Aires, DF, Argentina; [Adrian Rabinovich, Gabriel] Univ Buenos Aires, Fac Exact & Nat Sci, Lab Funct Glyc, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Schattner, M (corresponding author), CONICET Natl Acad Med, Inst Expt Med, Lab Expt Thrombosis, Buenos Aires, DF, Argentina.	mschattner@hematologia.anm.edu.ar	Croci, Diego/AAJ-5709-2021	Croci, Diego/0000-0002-8623-0645; Campetella, Oscar/0000-0002-7018-375X; Tribulatti, Maria Virginia/0000-0003-0507-065X; Carabelli, Julieta/0000-0003-2329-3996; , Mirta/0000-0001-9439-2161	National Agency for Science and Technology Promotion (ANPCYT); National Council of Scientific and Technical Research (CONICET)	National Agency for Science and Technology Promotion (ANPCYT)(ANPCyT); National Council of Scientific and Technical Research (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was supported by grants from the National Agency for Science and Technology Promotion (ANPCYT) and the National Council of Scientific and Technical Research (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ansari S, 2009, TRENDS CARDIOVAS MED, V19, P164, DOI 10.1016/j.tcm.2009.10.001; Romaniuk MA, 2011, IUBMB LIFE, V63, P521, DOI 10.1002/iub.483; Romaniuk MA, 2010, BIOCHEM J, V432, P535, DOI 10.1042/BJ20100538; Bambace NM, 2010, PLATELETS, V21, P85, DOI 10.3109/09537100903470298; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Bidon-Wagner N, 2002, GLYCOCONJUGATE J, V19, P557, DOI 10.1023/B:GLYC.0000014086.38343.98; Delgado VMC, 2011, FASEB J, V25, P242, DOI 10.1096/fj.09-144907; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cervi D, 2008, BLOOD, V111, P1201, DOI 10.1182/blood-2007-04-084798; Chatterjee M, 2011, BLOOD, V117, P3907, DOI 10.1182/blood-2010-12-327007; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Croci DO, 2012, J EXP MED, V209, P1985, DOI 10.1084/jem.20111665; Etulain J, 2013, BRIT J PHARMACOL, V170, P255, DOI 10.1111/bph.12250; Heusschen R, 2014, BBA-MOL BASIS DIS, V1842, P284, DOI 10.1016/j.bbadis.2013.12.003; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Norling LV, 2009, J ENDOCRINOL, V201, P169, DOI 10.1677/JOE-08-0512; Pacienza N, 2008, FASEB J, V22, P1113, DOI 10.1096/fj.07-9524com; Pannerden HVT, 2010, BLOOD, V116, P1147, DOI 10.1182/blood-2010-02-268680; Patzelt J, 2012, CURR VASC PHARMACOL, V10, P570, DOI 10.2174/157016112801784648; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rafii DC, 2008, ARTERIOSCL THROM VAS, V28, P217, DOI 10.1161/ATVBAHA.107.151159; Romaniuk MA, 2012, FASEB J, V26, P2788, DOI 10.1096/fj.11-197541; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Satelli A, 2008, ONCOL REP, V19, P587; Sehgal S, 2007, J THROMB HAEMOST, V5, P2009, DOI 10.1111/j.1538-7836.2007.02698.x; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Tribulatti MV, 2012, J IMMUNOL, V188, P2991, DOI 10.4049/jimmunol.1102182; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zaslavsky A, 2010, BLOOD, V115, P4605, DOI 10.1182/blood-2009-09-242065	36	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96402	10.1371/journal.pone.0096402	http://dx.doi.org/10.1371/journal.pone.0096402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788652	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917300040
J	Slagter, SN; van Vliet-Ostaptchouk, JV; Vonk, JM; Boezen, HM; Dullaart, RPF; Kobold, ACM; Feskens, EJM; van Beek, AP; van der Klauw, MM; Wolffenbuttel, BHR				Slagter, Sandra N.; van Vliet-Ostaptchouk, Jana V.; Vonk, Judith M.; Boezen, H. Marieke; Dullaart, Robin P. F.; Kobold, Anneke C. Muller; Feskens, Edith J. M.; van Beek, Andre P.; van der Klauw, Melanie M.; Wolffenbuttel, Bruce H. R.			Combined Effects of Smoking and Alcohol on Metabolic Syndrome: The LifeLines Cohort Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NUTRITION EXAMINATION SURVEY; CORONARY-HEART-DISEASE; BODY-MASS INDEX; BLOOD-PRESSURE; WAIST CIRCUMFERENCE; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; DIETARY-INTAKE	Introduction: The development of metabolic syndrome (MetS) is influenced by environmental factors such as smoking and alcohol consumption. We determined the combined effects of smoking and alcohol on MetS and its individual components. Methods: 64,046 participants aged 18-80 years from the LifeLines Cohort study were categorized into three body mass index (BMI) classes (BMI<25, normal weight; BMI 25-30, overweight; BMI >= 30 kg/m(2), obese). MetS was defined according to the revised criteria of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP III). Within each BMI class and smoking subgroup (non-smoker, former smoker <20 and >= 20 g tobacco/day), the cross-sectional association between alcohol and individual MetS components was tested using regression analysis. Results: Prevalence of MetS varied greatly between the different smoking-alcohol subgroups (1.7-71.1%). HDL cholesterol levels in all alcohol drinkers were higher than in non-drinkers (0.02 to 0.29 mmol/L, P values<0.001). HDL cholesterol levels were lower when they were also a former or current smoker (<20 and >= 20 g tobacco/day). Consumption of <= 1 drink/day indicated a trend towards lower triglyceride levels (non-significant). Concurrent use alcohol (>1 drink/day) and tobacco showed higher triglycerides levels. Up to 2 drinks/day was associated with a smaller waist circumference in overweight and obese individuals. Consumption of >2 drinks/day increased blood pressure, with the strongest associations found for heavy smokers. The overall metabolic profile of wine drinkers was better than that of non-drinkers or drinkers of beer or spirits/mixed drinks. Conclusion: Light alcohol consumption may moderate the negative associations of smoking with MetS. Our results suggest that the lifestyle advice that emphasizes smoking cessation and the restriction of alcohol consumption to a maximum of 1 drink/day, is a good approach to reduce the prevalence of MetS.	[Slagter, Sandra N.; van Vliet-Ostaptchouk, Jana V.; Dullaart, Robin P. F.; van Beek, Andre P.; van der Klauw, Melanie M.; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Vonk, Judith M.; Boezen, H. Marieke] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Kobold, Anneke C. Muller] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Feskens, Edith J. M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Wageningen University & Research	Wolffenbuttel, BHR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands.	bwo@umcg.nl	Feskens, Edith/ABI-1446-2020; Vonk, Judith M/ABA-3009-2020; van Beek, André P/O-3753-2014; Muller Kobold, Anna/HHC-2189-2022; Vonk, Judith/K-8477-2019; van der Klauw, Melanie/A-2138-2014	Feskens, Edith/0000-0001-5819-2488; Vonk, Judith M/0000-0001-7531-4547; van Beek, André P/0000-0002-0335-8177; Vonk, Judith/0000-0001-7531-4547; van der Klauw, Melanie/0000-0001-7178-009X; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921	Netherlands Organization for Scientific Research (NWO) [175.010.2007.006]; Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; National Consortium for Healthy Ageing; BioSHaRE-EU consortium [261433]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; National Consortium for Healthy Ageing; BioSHaRE-EU consortium	The LifeLines Cohort Study was supported by the Netherlands Organization for Scientific Research (NWO) [grant 175.010.2007.006]; the Economic Structure Enhancing Fund (FES) of the Dutch government; the Ministry of Economic Affairs; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the Northern Netherlands Collaboration of Provinces (SNN); the Province of Groningen; University Medical Center Groningen; the University of Groningen; the Dutch Kidney Foundation; and the Dutch Diabetes Research Foundation. This work was supported by the National Consortium for Healthy Ageing, and the BioSHaRE-EU consortium (KP7, project reference 261433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455; Barrio-Lopez MT, 2012, CLIN NUTR; COLDITZ GA, 1991, AM J CLIN NUTR, V54, P49, DOI 10.1093/ajcn/54.1.49; Cowey S, 2006, AM J PATHOL, V169, P1505, DOI 10.2353/ajpath.2006.051090; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Djousse L, 2004, OBES RES, V12, P1375, DOI 10.1038/oby.2004.174; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Eliasson B, 2003, PROG CARDIOVASC DIS, V45, P405, DOI 10.1053/pcad.2003.00103; Ellison RC, 2004, AM HEART J, V147, P529, DOI 10.1016/j.ahj.2003.10.033; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Gigleux I, 2006, J NUTR, V136, P3027, DOI 10.1093/jn/136.12.3027; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Kidambi S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-27; Kloner RA, 2007, CIRCULATION, V116, P1306, DOI 10.1161/CIRCULATIONAHA.106.678375; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Lukasiewicz E, 2005, PUBLIC HEALTH NUTR, V8, P315, DOI 10.1079/PHN2004680; McCann SE, 2003, NUTR METAB CARDIOVAS, V13, P2, DOI 10.1016/S0939-4753(03)80162-X; Narkiewicz K, 2005, BLOOD PRESSURE, V14, P69, DOI 10.1080/08037050510034202; Navis G, 2010, NEPHROL DIAL TRANSPL, V25, P1382, DOI 10.1093/ndt/gfq091; Park SH, 2012, SUBST USE MISUSE, V47, P442, DOI 10.3109/10826084.2011.648043; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Parks EJ, 2001, J NUTR, V131, p2772S, DOI 10.1093/jn/131.10.2772S; Puddey IB, 2006, CLIN EXP PHARMACOL P, V33, P847, DOI 10.1111/j.1440-1681.2006.04452.x; Rabaeus M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-196; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Saami SE, 2009, AM J PUBLIC HEALTH, V99, P348, DOI 10.2105/AJPH.2007.123851; Santos AC, 2007, PREV MED, V44, P328, DOI 10.1016/j.ypmed.2006.11.016; Schroder H, 2007, EUR J NUTR, V46, P369, DOI 10.1007/s00394-007-0674-7; Slagter SN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-195; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Streppel MT, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-75; Studts JL, 2006, CANCER EPIDEM BIOMAR, V15, P1825, DOI 10.1158/1055-9965.EPI-06-0393; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047791; Taylor B, 2009, ADDICTION, V104, P1981, DOI 10.1111/j.1360-0443.2009.02694.x; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Vadstrup ES, 2003, INT J OBESITY, V27, P238, DOI 10.1038/sj.ijo.802203; Villegas R, 2004, Ir Med J, V97, P300; Wakabayashi I, 2010, J ATHEROSCLER THROMB, V17, P695, DOI 10.5551/jat.3517; Weltzels JJL, 2003, ADDICTION, V98, P1755, DOI 10.1111/j.1360-0443.2003.00553.x; Whitfield JB, 2013, ALCOHOL CLIN EXP RES, V37, P575, DOI 10.1111/acer.12015; Wu DM, 2001, EUR J EPIDEMIOL, V17, P629, DOI 10.1023/A:1015599129080; Yoon YS, 2004, AM J CLIN NUTR, V80, P217	50	57	61	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96406	10.1371/journal.pone.0096406	http://dx.doi.org/10.1371/journal.pone.0096406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG6CA	24781037	Green Published, Green Submitted, gold			2022-12-25	WOS:000335504900033
J	Zhu, YJ; Lu, Q; Shen, JK; Zhang, L; Gao, YS; Shen, X; Xie, B				Zhu, Yanji; Lu, Qing; Shen, Jikui; Zhang, Ling; Gao, Yushuo; Shen, Xi; Xie, Bing			Improvement and Optimization of Standards for a Preclinical Animal Test Model of Laser Induced Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AGE-RELATED MACULOPATHY; BLUE MOUNTAINS EYE; MACULAR DEGENERATION; IN-VIVO; PHOTODYNAMIC THERAPY; BRUCHS MEMBRANE; ANGIOGENESIS; ESTROGEN; EXPRESSION	Background: As the murine model of laser-induced choroidal neovascularization (CNV) is becoming the most established and commonly utilized model worldwide for studying the pathogenesis of CNV and its response to treatment, specific operating standards are yet to be clarified. The purpose of this study is to compare the lesion size of CNV in mice with different ages, sex, durations of CNV process, and treated positions of laser spots, to make recommendations that may improve and optimize the quality of the model. Methods and Results: C57/BL6 mice of different ages were treated with diode laser photocoagulation per eye and perfused with PBS containing fluorescein-labeled dextran at different time of observation. Choroid flat mounts, were then examined by fluorescence microscopy for the measurement of CNV area. Messenger-RNA expression levels of several angiogenic cytokines in eye cups of male and female C57BL/6 mice at 5-8 and 16-20 week-old were analyzed by real-time RT-PCR assay. The results showed significantly more CNV area in eyes of female mice compared to male mice with the expression level of several angiogenic cytokines elevated. 16-20-week-old female mice developed the biggest area of CNV. The mean area of CNV increased significantly at the 14(th) day after photocoagulation. Laser spots delivered 1PD away from the optic disc induced the biggest area of CNV compared to those 2PD or 3PD away. Interaction of NV was observed in laser spots delivered less than 1PD away from each other. Conclusion: The current results suggest that 16-20-week-old female C57BL/6 mice developed the most distinct CNV lesion size with laser spots delivered 1PD away from the optic disc. The best time to observe and analyze is the 14(th) day after photocoagulation.	[Zhu, Yanji; Lu, Qing; Gao, Yushuo; Shen, Xi; Xie, Bing] Shanghai Jiao Tong Univ, Sch Med, Dept Ophthalmol, Ruijin Hosp, Shanghai 200030, Peoples R China; [Shen, Jikui; Zhang, Ling] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	Shanghai Jiao Tong University; Johns Hopkins University	Shen, X (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Ophthalmol, Ruijin Hosp, Shanghai 200030, Peoples R China.	carl_shen2005@126.com; bingxie1@gmail.com		Xie, Bing/0000-0003-2335-5966	Rising-Star Program of Science and Technology Commission of Shanghai Municipality, China [10QA1404600]; National Natural Science Foundation of China [81100682, 81170860]; Shanghai Nature Science Foundation [11ZR1422000]; Shanghai Charity Cancer Research Center Program	Rising-Star Program of Science and Technology Commission of Shanghai Municipality, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Foundation; Shanghai Charity Cancer Research Center Program	This work was supported by Rising-Star Program of Science and Technology Commission of Shanghai Municipality 10QA1404600, China and National Natural Science Foundation of China 81100682 and 81170860, Shanghai Nature Science Foundation Grant 11ZR1422000, Shanghai Charity Cancer Research Center Program 2011 and 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DM, 2010, ARCH OPHTHALMOL-CHIC, V128, P212, DOI 10.1001/archophthalmol.2009.395; Albrecht ED, 2003, FRONT BIOSCI-LANDMRK, V8, pD416, DOI 10.2741/1001; Ando A, 2002, J CELL PHYSIOL, V191, P116, DOI 10.1002/jcp.10083; Ashcroft GS, 2002, J CLIN INVEST, V110, P615, DOI 10.1172/JCI200215704; Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395; Bird AC, 2003, EYE, V17, P457, DOI 10.1038/sj.eye.6700562; CLARKSON JG, 1982, SURV OPHTHALMOL, V26, P235, DOI 10.1016/0039-6257(82)90158-8; Dong ZY, 2013, MOL VIS, V19, P536; Dot C, 2009, MOL VIS, V15, P670; Espinosa-Heidmann DG, 2005, EXP EYE RES, V80, P413, DOI 10.1016/j.exer.2004.10.008; Feng Y, 2008, CELL PHYSIOL BIOCHEM, V21, P129, DOI 10.1159/000113755; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; FREUND KB, 1993, AM J OPHTHALMOL, V115, P786, DOI 10.1016/S0002-9394(14)73649-9; Fujimoto J, 1997, ANN CLIN BIOCHEM, V34, P91, DOI 10.1177/000456329703400114; Fujimura S, 2012, INVEST OPHTH VIS SCI, V53, P1999, DOI 10.1167/iovs.11-8232; Garvin S, 2003, CANCER RES, V63, P8742; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Grossniklaus HE, 1998, ARCH OPHTHALMOL-CHIC, V116, P745, DOI 10.1001/archopht.116.6.745; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Grossniklaus HE, 2002, MOL VIS, V8, P119; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hoerster R, 2012, GRAEF ARCH CLIN EXP, V250, P1579, DOI 10.1007/s00417-012-1990-z; HOLZ FG, 1994, ARCH OPHTHALMOL-CHIC, V112, P402, DOI 10.1001/archopht.1994.01090150132035; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2007, OPHTHAL EPIDEMIOL, V14, P184, DOI 10.1080/09286580701344381; Kobayashi K, 2002, RETINA-J RET VIT DIS, V22, P418, DOI 10.1097/00006982-200208000-00004; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Losordo DW, 2001, ARTERIOSCL THROM VAS, V21, P6, DOI 10.1161/01.ATV.21.1.6; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; MILLER H, 1993, ARCH OPHTHALMOL-CHIC, V111, P855, DOI 10.1001/archopht.1993.01090060145039; MILLER JW, 1995, ARCH OPHTHALMOL-CHIC, V113, P810, DOI 10.1001/archopht.1995.01100060136048; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Prasad Anita G, 2005, Curr Opin Ophthalmol, V16, P364, DOI 10.1097/01.icu.0000188321.61101.93; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; Rubanyi GM, 2002, VASC PHARMACOL, V38, P89, DOI 10.1016/S0306-3623(02)00131-3; Rubanyi GM, 2002, VASC PHARMACOL, V38, P81, DOI 10.1016/S0306-3623(02)00130-1; Ryan S J, 1979, Trans Am Ophthalmol Soc, V77, P707; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Smith W, 1997, AUST NZ J OPHTHALMOL, V25, pS13; Soubrane G, 2008, SURV OPHTHALMOL, V53, P121, DOI 10.1016/j.survophthal.2007.12.004; Soybir G, 2003, SURG TODAY, V33, P896, DOI 10.1007/s00595-003-2621-3; Swift ME, 2001, J INVEST DERMATOL, V117, P1027, DOI 10.1046/j.0022-202x.2001.01539.x; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Toma HS, 2010, MICROVASC RES, V80, P295, DOI 10.1016/j.mvr.2010.05.011; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Waisbourd M, 2007, DRUG AGING, V24, P643, DOI 10.2165/00002512-200724080-00003; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Xie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053329; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001	55	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e94743	10.1371/journal.pone.0094743	http://dx.doi.org/10.1371/journal.pone.0094743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781648	Green Published, gold, Green Submitted			2022-12-25	WOS:000335504900003
J	Mizanur, RM; Stafford, RG; Ahmed, SA				Mizanur, Rahman M.; Stafford, Robert G.; Ahmed, S. Ashraf			Cleavage of SNAP25 and Its Shorter Versions by the Protease Domain of Serotype A Botulinum Neurotoxin	PLOS ONE			English	Article							A LIGHT-CHAIN; ENDOPEPTIDASE ACTIVITY; SUBSTRATE RECOGNITION; CATALYTIC DOMAIN; C-TERMINUS; IN-VITRO; IDENTIFICATION; INHIBITORS; SNAP-25; REQUIREMENTS	Various substrates, catalysts, and assay methods are currently used to screen inhibitors for their effect on the proteolytic activity of botulinum neurotoxin. As a result, significant variation exists in the reported results. Recently, we found that one source of variation was the use of various catalysts, and have therefore evaluated its three forms. In this paper, we characterize three substrates under near uniform reaction conditions using the most active catalytic form of the toxin. Bovine serum albumin at varying optimum concentrations stimulated enzymatic activity with all three substrates. Sodium chloride had a stimulating effect on the full length synaptosomal-associated protein of 25 kDa (SNAP25) and its 66-mer substrates but had an inhibitory effect on the 17-mer substrate. We found that under optimum conditions, full length SNAP25 was a better substrate than its shorter 66-mer or 17-mer forms both in terms of k(cat), K-m, and catalytic efficiency k(cat)/K-m. Assay times greater than 15 min introduced large variations and significantly reduced the catalytic efficiency. In addition to characterizing the three substrates, our results identify potential sources of variations in previous published results, and underscore the importance of using well-defined reaction components and assay conditions.	[Mizanur, Rahman M.; Stafford, Robert G.; Ahmed, S. Ashraf] US Army Med Res Inst Infect Dis, Mol & Translat Sci Div, Dept Cell Biol & Biochem, Ft Detrick, MD 21702 USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army	Ahmed, SA (corresponding author), US Army Med Res Inst Infect Dis, Mol & Translat Sci Div, Dept Cell Biol & Biochem, Ft Detrick, MD 21702 USA.	syed.a.ahmed.civ@mail.mil			Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense [JSTOCBD3.10012_06_RD_B, CB3849]; National Research Council (NRC)	Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency); National Research Council (NRC)	This project received support from the Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense (Grant #JSTOCBD3.10012_06_RD_B and CB3849). Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the U. S. Army. The authors also acknowledge National Research Council (NRC) for their support to RMM through their research associateship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2000, TOXICON, V38, P1381, DOI 10.1016/S0041-0101(99)00231-7; Ahmed SA, 2008, PROTEIN J, V27, P151, DOI 10.1007/s10930-007-9118-8; Ahmed SA, 2003, BIOCHEMISTRY-US, V42, P12539, DOI 10.1021/bi030062c; Ahmed SA, 2000, J PROTEIN CHEM, V19, P475, DOI 10.1023/A:1026549431380; Ahmed SA, 2013, RECENT RES DEV ANAL, P43; AULD DS, 1995, METHOD ENZYMOL, V248, P228; Bagramyan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002041; Baldwin MR, 2004, PROTEIN EXPRES PURIF, V37, P187, DOI 10.1016/j.pep.2004.05.009; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Boldt GE, 2006, ORG LETT, V8, P1729, DOI 10.1021/ol0603211; Borio L, 2001, JAMA-J AM MED ASSOC, V286, P2554, DOI 10.1001/jama.286.20.2554; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Cai SW, 2010, TOXICON, V55, P818, DOI 10.1016/j.toxicon.2009.11.017; Cai SW, 2001, BIOCHEMISTRY-US, V40, P4693, DOI 10.1021/bi0025363; Capkova K, 2007, BIOORG MED CHEM LETT, V17, P6463, DOI 10.1016/j.bmcl.2007.09.103; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Copeland R. A., 2005, EVALUATION ENZYME IN; Creighton T. E., 1984, PROTEINS STRUCTURES, V2nd; Dickerson TJ, 2006, ACS CHEM BIOL, V1, P359, DOI 10.1021/cb600179d; Ekong TAN, 1997, MICROBIOL-SGM, V143, P3337, DOI 10.1099/00221287-143-10-3337; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; FORAN P, 1995, BIOCHEMISTRY-US, V34, P5494, DOI 10.1021/bi00016a021; Gilsdorf J, 2006, PROTEIN EXPRES PURIF, V46, P256, DOI 10.1016/j.pep.2005.09.024; Glass PJ, 2003, J VIROL, V77, P3569, DOI 10.1128/JVI.77.6.3569-3577.2003; Gul N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012872; Hale M, 2011, J BIOL CHEM, V286, P1802, DOI 10.1074/jbc.M110.146464; Hatheway C. L., 1988, LAB DIAGNOSIS INFECT, V1, P112; Henkel JS, 2009, BIOCHEMISTRY-US, V48, P2522, DOI 10.1021/bi801686b; Hermone AR, 2008, CHEMMEDCHEM, V3, P1905, DOI 10.1002/cmdc.200800241; Jensen MJ, 2003, TOXICON, V41, P691, DOI 10.1016/S0041-0101(03)00042-4; Kumar G, 2012, ACTA CRYSTALLOGR D, V68, P511, DOI 10.1107/S0907444912003551; Kumaran D, 2008, J BIOL CHEM, V283, P18883, DOI 10.1074/jbc.M801240200; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Li L, 2000, BIOCHEMISTRY-US, V39, P10581, DOI 10.1021/bi0007472; Ludivico M., 2009, BOTULINUM J, V1, P297; Ma HZ, 2006, TOXICON, V47, P901, DOI 10.1016/j.toxicon.2006.03.003; Mizanur RM, 2013, J BIOL CHEM, V288, P24223, DOI 10.1074/jbc.M113.451286; Mizanur Rahman M, 2012, Int J Biochem Mol Biol, V3, P313; Molles BE, 2010, 47 INT BOT RES COORD; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Rasooly R, 2008, APPL ENVIRON MICROB, V74, P4309, DOI 10.1128/AEM.00617-08; Rowe B, 2010, ANAL BIOCHEM, V396, P188, DOI 10.1016/j.ab.2009.09.034; Roxas-Duncan V, 2009, ANTIMICROB AGENTS CH, V53, P3478, DOI 10.1128/AAC.00141-09; Ruge DR, 2011, ANAL BIOCHEM, V411, P200, DOI 10.1016/j.ab.2011.01.002; Sadoul K, 1997, BIOL CHEM, V378, P1171; Schmidt JJ, 2005, BIOCHEMISTRY-US, V44, P4067, DOI 10.1021/bi0477642; Schmidt JJ, 1995, J PROTEIN CHEM, V14, P703, DOI 10.1007/BF01886909; Schmidt JJ, 2003, APPL ENVIRON MICROB, V69, P297, DOI 10.1128/AEM.69.1.297-303.2003; Schmidt JJ, 2002, FEBS LETT, V532, P423, DOI 10.1016/S0014-5793(02)03738-9; Schmidt JJ, 1998, FEBS LETT, V435, P61, DOI 10.1016/S0014-5793(98)01041-2; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Sharma SK, 2004, BIOCHEMISTRY-US, V43, P4791, DOI 10.1021/bi0355544; SHONE CC, 1994, EUR J BIOCHEM, V225, P263, DOI 10.1111/j.1432-1033.1994.00263.x; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Toth S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00102; Toth SI, 2009, J PHARM SCI-US, V98, P3302, DOI 10.1002/jps.21676; Zuniga JE, 2008, STRUCTURE, V16, P1588, DOI 10.1016/j.str.2008.07.011	57	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e95188	10.1371/journal.pone.0095188	http://dx.doi.org/10.1371/journal.pone.0095188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769566	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736600005
J	Cluet, D; Stebe, PN; Riche, S; Spichty, M; Delattre, M				Cluet, David; Stebe, Pierre-Nicolas; Riche, Soizic; Spichty, Martin; Delattre, Marie			Automated High-Throughput Quantification of Mitotic Spindle Positioning from DIC Movies of Caenorhabditis Embryos	PLOS ONE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; CELL-DIVISION; FORCE; OSCILLATIONS; REVEAL	The mitotic spindle is a microtubule-based structure that elongates to accurately segregate chromosomes during anaphase. Its position within the cell also dictates the future cell cleavage plan, thereby determining daughter cell orientation within a tissue or cell fate adoption for polarized cells. Therefore, the mitotic spindle ensures at the same time proper cell division and developmental precision. Consequently, spindle dynamics is the matter of intensive research. Among the different cellular models that have been explored, the one-cell stage C. elegans embryo has been an essential and powerful system to dissect the molecular and biophysical basis of spindle elongation and positioning. Indeed, in this large and transparent cell, spindle poles (or centrosomes) can be easily detected from simple DIC microscopy by human eyes. To perform quantitative and high-throughput analysis of spindle motion, we developed a computer program ACT for Automated-Centrosome- Tracking from DIC movies of C. elegans embryos. We therefore offer an alternative to the image acquisition and processing of transgenic lines expressing fluorescent spindle markers. Consequently, experiments on large sets of cells can be performed with a simple setup using inexpensive microscopes. Moreover, analysis of any mutant or wild-type backgrounds is accessible because laborious rounds of crosses with transgenic lines become unnecessary. Last, our program allows spindle detection in other nematode species, offering the same quality of DIC images but for which techniques of transgenesis are not accessible. Thus, our program also opens the way towards a quantitative evolutionary approach of spindle dynamics. Overall, our computer program is a unique macro for the image-and movie-processing platform ImageJ. It is user-friendly and freely available under an open-source licence. ACT allows batch-wise analysis of large sets of mitosis events. Within 2 minutes, a single movie is processed and the accuracy of the automated tracking matches the precision of the human eye.	[Cluet, David; Stebe, Pierre-Nicolas; Riche, Soizic; Spichty, Martin; Delattre, Marie] Ecole Normale Super Lyon, CNRS, Mol Cell Biol Lab, F-69364 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Spichty, M (corresponding author), Ecole Normale Super Lyon, CNRS, Mol Cell Biol Lab, F-69364 Lyon, France.	martin.spichty@ens-lyon.fr; marie.delattre@ens-lyon.fr	Delattre, Marie/AAJ-1491-2020; Delattre, Marie/CAG-5526-2022; CLUET, David/HGU-1452-2022	Delattre, Marie/0000-0003-1640-0300; Delattre, Marie/0000-0003-1640-0300; CLUET, David/0000-0002-8018-8765; Spichty, Martin/0000-0002-2533-9073	CNRS (ATIP); Grand Equipement National de Calcul Intensif (GENCI) [x2013076381]; Region Rhone-Alpes	CNRS (ATIP)(Centre National de la Recherche Scientifique (CNRS)); Grand Equipement National de Calcul Intensif (GENCI); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This project has been funded by grants from the CNRS (ATIP) to M.D. and from the Grand Equipement National de Calcul Intensif (GENCI, x2013076381) to M.S.; S.R. and P-N.S. are supported by a PhD fellowship from the Region Rhone-Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauchle M, 2009, DEV BIOL; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Jaensch S, 2010, BIOINFORMATICS, V26, pi13, DOI 10.1093/bioinformatics/btq190; Kimura A, 2005, DEV CELL, V8, P765, DOI 10.1016/j.devcel.2005.03.007; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Riche S, 2013, J CELL BIOL, V201, P653, DOI 10.1083/jcb.201210110	11	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e93718	10.1371/journal.pone.0093718	http://dx.doi.org/10.1371/journal.pone.0093718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763198	Green Submitted, Green Published, gold			2022-12-25	WOS:000335505000004
J	Norris, CA; He, M; Kang, LI; Ding, MQ; Radder, JE; Haynes, MM; Yang, Y; Paranjpe, S; Bowen, WC; Orr, A; Michalopoulos, GK; Stolz, DB; Mars, WM				Norris, Callie A.; He, Mu; Kang, Liang-I; Ding, Michael Qi; Radder, Josiah E.; Haynes, Meagan M.; Yang, Yu; Paranjpe, Shirish; Bowen, William C.; Orr, Anne; Michalopoulos, George K.; Stolz, Donna B.; Mars, Wendy M.			Synthesis of IL-6 by Hepatocytes Is a Normal Response to Common Hepatic Stimuli	PLOS ONE			English	Article							FACTOR-KAPPA-B; LIVER-REGENERATION; GROWTH-FACTOR; PARTIAL-HEPATECTOMY; INTERLEUKIN-6-DEFICIENT MICE; GENE-EXPRESSION; ACTIVATION; MET; LIPOPOLYSACCHARIDE; TRANSCRIPTION	Exogenous interleukin 6 (IL-6), synthesized at the initiation of the acute phase response, is considered responsible for signaling hepatocytes to produce acute phase proteins. It is widely posited that IL-6 is either delivered to the liver in an endocrine fashion from immune cells at the site of injury, or alternatively, in a paracrine manner by hepatic immune cells within the liver. A recent publication showed there was a muted IL-6 response in lipopolysaccharide (LPS)-injured mice when nuclear NF kappa B was specifically inactivated in the hepatocytes. This indicates hepatocellular signaling is also involved in regulating the acute phase production of IL-6. Herein, we present extensive in vitro and in vivo evidence that normal hepatocytes are directly induced to synthesize IL-6 mRNAs and protein by challenge with LPS, a bacterial hepatotoxin, and by HGF, an important regulator of hepatic homeostasis. As the IL-6 receptor is found on the hepatocyte, these results reveal that induction of the acute phase response can be regulated in an autocrine as well as endocrine/paracrine fashion. Further, herein we provide data indicating that following partial hepatectomy (PHx), HGF differentially regulates IL-6 production in hepatocytes (induces) versus immune cells (suppresses), signifying disparate regulation of the cell sources involved in IL-6 production is a biologically relevant mechanism that has previously been overlooked. These findings have wide ranging ramifications regarding how we currently interpret a variety of in vivo and in vitro biological models involving elements of IL-6 signaling and the hepatic acute phase response.	[Norris, Callie A.; He, Mu; Kang, Liang-I; Ding, Michael Qi; Radder, Josiah E.; Haynes, Meagan M.; Yang, Yu; Paranjpe, Shirish; Bowen, William C.; Orr, Anne; Michalopoulos, George K.; Mars, Wendy M.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mars, WM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	wmars@pitt.edu		Ding, Michael/0000-0001-8306-6379; He, Mu/0000-0002-3812-6165; Radder, Josiah/0000-0003-3545-3125; Kang, Liang-I/0000-0001-7025-3095	National Institutes of Health [CA103958, CA035373, CA76541, HL094295]; NATIONAL CANCER INSTITUTE [R29CA076541, R01CA076541, R01CA103958, R01CA035373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health grants CA103958, CA035373, CA76541, HL094295. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldeguer X, 2002, HEPATOLOGY, V35, P40, DOI 10.1053/jhep.2002.30081; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Braissant O, 1998, BIOCHEMICA, V1, P10; CORNELL RP, 1990, HEPATOLOGY, V11, P916, DOI 10.1002/hep.1840110603; Coudriet GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015384; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429; DANI C, 1984, EUR J BIOCHEM, V145, P299, DOI 10.1111/j.1432-1033.1984.tb08552.x; GAULDIE J, 1992, RES IMMUNOL, V143, P755, DOI 10.1016/0923-2494(92)80018-G; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Gkretsi V, 2008, HEPATOLOGY, V48, P1932, DOI 10.1002/hep.22537; Hong F, 2002, ONCOGENE, V21, P32, DOI 10.1038/sj.onc.1205016; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Kaido T, 1997, FEBS LETT, V411, P378, DOI 10.1016/S0014-5793(97)00744-8; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; KOST DP, 1991, J CELL PHYSIOL, V147, P274, DOI 10.1002/jcp.1041470212; Lagoa CE, 2005, HEPATOLOGY, V42, P390, DOI 10.1002/hep.20797; Li J, 2002, J NUTR, V132, P3286, DOI 10.1093/jn/132.11.3286; Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Miyazawa K, 1998, J BIOL CHEM, V273, P7620, DOI 10.1074/jbc.273.13.7620; Muller M, 2002, MOL CELL BIOL, V22, P1060, DOI 10.1128/MCB.22.4.1060-1072.2002; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Paranjpe S, 2007, HEPATOLOGY, V45, P1471, DOI 10.1002/hep.21570; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sakamoto T, 1999, HEPATOLOGY, V29, P403, DOI 10.1002/hep.510290244; Schoedel KE, 2003, MODERN PATHOL, V16, P14, DOI 10.1097/01.MP.0000043521.96995.DB; Scotte M, 1997, CYTOKINE, V9, P859, DOI 10.1006/cyto.1997.0273; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Selzner N, 2003, GASTROENTEROLOGY, V124, P692, DOI 10.1053/gast.2003.50098; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; SMEDSROD B, 1985, CELL TISSUE RES, V241, P639; Stolz DB, 1999, CANCER RES, V59, P3954; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2	40	72	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96053	10.1371/journal.pone.0096053	http://dx.doi.org/10.1371/journal.pone.0096053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763697	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000335505000057
J	Seuter, S; Neme, A; Carlberg, C				Seuter, Sabine; Neme, Antonio; Carlberg, Carsten			Characterization of Genomic Vitamin D Receptor Binding Sites through Chromatin Looping and Opening	PLOS ONE			English	Article							REGULATORY ELEMENTS; CHIP-SEQ; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; CELL-LINE; DIFFERENTIATION; ORGANIZATION; ACETYLATION; MACROPHAGE; LOCATIONS; HORMONE	The vitamin D receptor (VDR) is a transcription factor that mediates the genomic effects of 1 alpha,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3). Genome-wide there are several thousand binding sites and hundreds of primary 1,25(OH)(2)D-3 target genes, but their functional relation is largely elusive. In this study, we used ChIA-PET data of the transcription factor CTCF in combination with VDR ChIP-seq data, in order to map chromatin domains containing VDR binding sites. In total, we found 1,599 such VDR containing chromatin domains and studied in THP-1 human monocytic leukemia cells four representatives of them. Our combined ChIP-seq and FAIRE-seq time course data showed that each of these four domains contained a master VDR binding site, where an increase of VDR binding pairs with 1,25(OH)(2)D-3-promoted chromatin opening and the presence of a highly significant DR3-type sequence below the peak summit. These sites differed in their relative VDR binding but not in their kinetics, while other loci either had a weaker and delayed VDR association or could not be confirmed at all. All studied chromatin domains contained at least one primary 1,25(OH)(2)D-3 target gene demonstrating a characteristic slope of mRNA increase, while neighboring genes responded delayed, if at all. In conclusion, the observation of ligand-inducible VDR binding and chromatin opening combined with a DR3-type sequence highlighted genome-wide 160 VDR loci that have within their chromatin domain a more than 4-fold increased likelihood to identify a primary 1,25(OH)(2)D-3 target gene than in the vicinity of other genomic VDR binding sites.	[Seuter, Sabine; Neme, Antonio; Carlberg, Carsten] Univ Eastern Finland, Inst Biomed, Sch Med, Kuopio, Finland	University of Eastern Finland	Carlberg, C (corresponding author), Univ Eastern Finland, Inst Biomed, Sch Med, Kuopio, Finland.	carsten.carlberg@uef.fi	Neme, Antonio/A-8999-2018; Carlberg, Carsten/C-9075-2011	Neme, Antonio/0000-0002-9952-1943; Carlberg, Carsten/0000-0003-2633-0684	Academy of Finland [267067]; Juselius Foundation	Academy of Finland(Academy of Finland); Juselius Foundation	This work was supported by the Academy of Finland (grant no. 267067 to CC) and the Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; Carlberg C, 1998, CRIT REV EUKAR GENE, V8, P19, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.20; Carlberg C, 2013, STEROIDS, V78, P127, DOI 10.1016/j.steroids.2012.10.019; Carlberg C, 2012, CURR TOP MED CHEM, V12, P528, DOI 10.2174/156802612799436623; Carlberg C, 2012, ANTICANCER RES, V32, P271; Carlberg C, 2010, CHROMOSOMA, V119, P479, DOI 10.1007/s00412-010-0283-8; Colca JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061551; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gynther P, 2011, BBA-MOL CELL RES, V1813, P810, DOI 10.1016/j.bbamcr.2011.01.037; Handel AE, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-163; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519; Jakobsen JS, 2013, GENOME RES; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Malinen M, 2008, NUCLEIC ACIDS RES, V36, P121, DOI 10.1093/nar/gkm913; Matilainen JM, 2010, BBA-MOL CELL RES, V1803, P1276, DOI 10.1016/j.bbamcr.2010.07.009; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Polly P, 2000, FASEB J, V14, P1455, DOI 10.1096/fj.14.10.1455; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Seuter S, 2013, BBA-GENE REGUL MECH, V1829, P1266, DOI 10.1016/j.bbagrm.2013.10.003; Seuter S, 2013, NUCLEIC ACIDS RES, V41, P110, DOI 10.1093/nar/gks959; Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053766; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; SZOSTECKI C, 1990, J IMMUNOL, V145, P4338; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Xue J, 2004, BIOCHEM J, V381, P753, DOI 10.1042/BJ20040455	52	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e96184	10.1371/journal.pone.0096184	http://dx.doi.org/10.1371/journal.pone.0096184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763502	Green Published, gold			2022-12-25	WOS:000335505000070
J	Tiemann, L; Heitmann, H; Schulz, E; Baumkotter, J; Ploner, M				Tiemann, Laura; Heitmann, Henrik; Schulz, Enrico; Baumkoetter, Jochen; Ploner, Markus			Dopamine Precursor Depletion Influences Pain Affect Rather than Pain Sensation	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; LASER-EVOKED POTENTIALS; LONG-TERM NOCICEPTION; D2 RECEPTOR-BINDING; PARKINSONS-DISEASE; LEVODOPA; PERCEPTION; BRAIN; TIME; STIMULATION	Pain is a multidimensional experience, which includes sensory, cognitive, and affective aspects. Converging lines of evidence indicate that dopaminergic neurotransmission plays an important role in human pain perception. However, the precise effects of dopamine on different aspects of pain perception remain to be elucidated. To address this question, we experimentally decreased dopaminergic neurotransmission in 22 healthy human subjects using Acute Phenylalanine and Tyrosine Depletion (APTD). During APTD and a control condition we applied brief painful laser stimuli to the hand, assessed different aspects of pain perception, and recorded electroencephalographic responses. APTD-induced decreases of cerebral dopaminergic activity did not influence sensory aspects of pain perception. In contrast, APTD yielded increases of pain unpleasantness. The increases of unpleasantness ratings positively correlated with effectiveness of APTD. Our finding of an influence of dopaminergic neurotransmission on affective but not sensory aspects of phasic pain suggests that analgesic effects of dopamine might be mediated by indirect effects on pain affect rather than by direct effects on ascending nociceptive signals. These findings contribute to our understanding of the complex relationship between dopamine and pain perception, which may play a role in various clinical pain states.	[Tiemann, Laura; Heitmann, Henrik; Schulz, Enrico; Ploner, Markus] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany; [Tiemann, Laura; Heitmann, Henrik; Schulz, Enrico; Ploner, Markus] Tech Univ Munich, TUM Neuroimaging Ctr, D-80290 Munich, Germany; [Baumkoetter, Jochen] Tech Univ Munich, Dept Pediat, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Tiemann, L (corresponding author), Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany.	tiemann@lrz.tu-muenchen.de	Schulz, Enrico/AAM-3590-2020; Ploner, Markus/C-3281-2013	Schulz, Enrico/0000-0001-8188-380X; Ploner, Markus/0000-0002-7767-7170; Tiemann, Laura/0000-0002-5261-5459	Else Kroner-Fresenius-Stiftung [2011_A82]; Deutsche Forschungsgemeinschaft [PL 321/6-1]	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Else Kroner-Fresenius-Stiftung (2011_A82) and the Deutsche Forschungsgemeinschaft (PL 321/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Badaway AAB, 2005, J PSYCHOPHARMACOL, V19, P429, DOI 10.1177/0269881105053312; Badawy AA, 2005, J PSYCHOPHARMACOL, V19, P431; Becker S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080766; Becker S, 2012, NEUROSCI LETT, V520, P182, DOI 10.1016/j.neulet.2012.03.013; BLEULER E, 1911, TXB PSYCHIAT; Blumensohn R, 2002, J NERV MENT DIS, V190, P481, DOI 10.1097/00005053-200207000-00011; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Brefel-Courbon C, 2005, MOVEMENT DISORD, V20, P1557, DOI 10.1002/mds.20629; Coffeen U, 2008, EUR J PAIN, V12, P535, DOI 10.1016/j.ejpain.2007.08.008; Djaldetti R, 2004, NEUROLOGY, V62, P2171, DOI 10.1212/01.WNL.0000130455.38550.9D; Ertas M, 1998, PAIN, V75, P257, DOI 10.1016/S0304-3959(98)00003-7; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gerdelat-Mas A, 2007, J NEUROL NEUROSUR PS, V78, P1140, DOI 10.1136/jnnp.2007.120212; Ha AD, 2012, MOVEMENT DISORD, V27, P485, DOI 10.1002/mds.23959; Hagelberg N, 2003, PAIN, V106, P43, DOI 10.1016/S0304-3959(03)00275-6; Hagelberg N, 2003, PAIN, V101, P149, DOI 10.1016/S0304-3959(02)00323-8; Hagelberg N, 2002, PAIN, V99, P273, DOI 10.1016/S0304-3959(02)00121-5; Holman AJ, 2005, ARTHRITIS RHEUM-US, V52, P2495, DOI 10.1002/art.21191; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Jaaskelainen SK, 2001, PAIN, V90, P257, DOI 10.1016/S0304-3959(00)00409-7; Jarcho JM, 2012, PAIN, V153, P744, DOI 10.1016/j.pain.2012.01.002; KERNBAUM S, 1981, Journal of the American Medical Association, V246, P132, DOI 10.1001/jama.246.2.132; Koob GF, 1996, MOL PSYCHIATR, V1, P186; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Leyton M, 2000, NEUROPSYCHOPHARMACOL, V22, P52, DOI 10.1016/S0893-133X(99)00086-X; Leyton M, 2010, ENCY PSYCHOPHARMACOL; Lopez-Avila A, 2004, PAIN, V111, P136, DOI 10.1016/j.pain.2004.06.010; Lorenz J, 2003, NEUROPHYSIOL CLIN, V33, P293, DOI 10.1016/j.neucli.2003.10.004; Martikainen IK, 2005, NEUROSCI LETT, V376, P149, DOI 10.1016/j.neulet.2004.11.045; Melzack R., 1968, SENSORY MOTIVATIONAL; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Nandhagopal R, 2010, PAIN MED, V11, P834, DOI 10.1111/j.1526-4637.2010.00866.x; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Pertovaara A, 2004, EUR J NEUROSCI, V20, P1587, DOI 10.1111/j.1460-9568.2004.03622.x; Potvin S, 2009, SYNAPSE, V63, P390, DOI 10.1002/syn.20616; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schestatsky P, 2007, NEUROLOGY, V69, P2162, DOI 10.1212/01.wnl.0000295669.12443.d3; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Schulz E, 2011, CEREB CORTEX, V21, P2408, DOI 10.1093/cercor/bhr027; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Singh Manpreet K, 2006, J Psychiatr Pract, V12, P90, DOI 10.1097/00131746-200603000-00004; Tiemann L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035068; Tiemann L, 2010, PAIN, V150, P302, DOI 10.1016/j.pain.2010.05.014; Tinazzi M, 2008, PAIN, V136, P117, DOI 10.1016/j.pain.2007.06.022; Tinazzi M, 2010, MOVEMENT DISORD, V25, P213, DOI 10.1002/mds.22932; Treister R, 2013, NEUROSCI LETT, V548, P115, DOI 10.1016/j.neulet.2013.05.041; Treister R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063808; Wasner G, 2012, NAT REV NEUROL, V8, P284, DOI 10.1038/nrneurol.2012.54; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; Wood PB, 2007, J PAIN, V8, P51, DOI 10.1016/j.jpain.2006.05.014; Wood Patrick B, 2008, Expert Rev Neurother, V8, P781, DOI 10.1586/14737175.8.5.781	54	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96167	10.1371/journal.pone.0096167	http://dx.doi.org/10.1371/journal.pone.0096167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760082	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200143
J	AbuAli, G; Chaisaklert, W; Stelloo, E; Pazarentzos, E; Hwang, MS; Qize, D; Harding, SV; Al-Rubaish, A; Alzahrani, A; Al-Ali, A; Sanders, TAB; Aboagye, EO; Grimm, S				AbuAli, G.; Chaisaklert, W.; Stelloo, E.; Pazarentzos, E.; Hwang, M-S; Qize, D.; Harding, S. V.; Al-Rubaish, A.; Alzahrani, Aj; Al-Ali, A.; Sanders, T. A. B.; Aboagye, E. O.; Grimm, S.			The anticancer gene ORCTL3 targets stearoyl-CoA desaturase-1 for tumour-specific apoptosis	ONCOGENE			English	Article							CANCER-CELL METABOLISM; PROTEIN; DEATH; MEMBRANE; OBESITY; IDENTIFICATION; TRANSFORMATION; PROLIFERATION; METASTASIS; ADHESION	ORCTL3 is a member of a group of genes, the so-called anticancer genes, that cause tumour-specific cell death. We show that this activity is triggered in isogenic renal cells upon their transformation independently of the cells' proliferation status. For its cell death effect ORCTL3 targets the enzyme stearoyl-CoA desaturase-1 (SCD1) in fatty acid metabolism. This is caused by transmembrane domains 3 and 4, which are more efficacious in vitro than a low molecular weight drug against SCD1, and critically depend on their expression level. SCD1 is found upregulated upon renal cell transformation indicating that its activity, while not impacting proliferation, represents a critical bottleneck for tumourigenesis. An adenovirus expressing ORCTL3 leads to growth inhibition of renal tumours in vivo and to substantial destruction of patients' kidney tumour cells ex vivo. Our results indicate fatty acid metabolism as a target for tumour-specific apoptosis in renal tumours and suggest ORCTL3 as a means to accomplish this.	[AbuAli, G.; Chaisaklert, W.; Stelloo, E.; Pazarentzos, E.; Hwang, M-S; Qize, D.; Grimm, S.] Univ London Imperial Coll Sci Technol & Med, Div Expt Med, London W12 0NN, England; [Harding, S. V.; Sanders, T. A. B.] Kings Coll London, Diabet & Nutr Sci Div, London, England; [Al-Rubaish, A.; Alzahrani, Aj; Al-Ali, A.] Univ Dammam, Coll Med, Prince Mohammed Ctr Res & Consultat Studies, Dammam, Saudi Arabia; [Aboagye, E. O.] Univ London Imperial Coll Sci Technol & Med, Div Canc, London W12 0NN, England	Imperial College London; University of London; King's College London; Imam Abdulrahman Bin Faisal University; Imperial College London	Grimm, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Pharmacol & Therapeut, Du Cane Rd, London W12 0NN, England.	s.grimm@imperial.ac.uk	Harding, Scott/K-9005-2012	Harding, Scott/0000-0002-7728-2339; Sanders, Thomas/0000-0001-9529-095X; Pazarentzos, Evangelos/0000-0002-5453-1646; Al-Rubaish, Abdullah Mohammed/0000-0002-9136-2853; ABOAGYE, Eric/0000-0003-2276-6771	Ministry of Higher Education in Saudi Arabia; Cancer Research UK; Development and Promotion of Science and Technology Talents Project (DPST), Royal Thai Government, Thailand; AstraZeneca Ltd.; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; MRC [MR/J007986/1] Funding Source: UKRI; Cancer Research UK [12011, 10337, 16584] Funding Source: researchfish; Medical Research Council [MR/J007986/1] Funding Source: researchfish; National Institute for Health Research [NIHR/CS/009/009] Funding Source: researchfish	Ministry of Higher Education in Saudi Arabia; Cancer Research UK(Cancer Research UK); Development and Promotion of Science and Technology Talents Project (DPST), Royal Thai Government, Thailand; AstraZeneca Ltd.(AstraZeneca); National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	GA was supported by the Ministry of Higher Education in Saudi Arabia. EP was supported by the Cancer Research UK, WC by the Development and Promotion of Science and Technology Talents Project (DPST), Royal Thai Government, Thailand and MSH by a stipend from AstraZeneca Ltd. We thank Joel Abraham for in vivo work and the Imperial's tissue bank, Dr David Hrouda, Ms Taneisha McFarlane, and Prof Gerry Thomas, for help. Tissue samples were provided by the Imperial College Healthcare NHS Trust Tissue Bank. Other investigators may have received samples from these same tissues. The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the author (s) and not necessarily those of the NHS, the NIHR or the Department of Health. We thank Mr Robert Gray for lipid extraction and primary GC analysis.	Brown JM, 2010, CURR OPIN LIPIDOL, V21, P192, DOI 10.1097/MOL.0b013e32833854ac; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Ceschi M, 2007, SWISS MED WKLY, V137, P50; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; DanenVanOorschot AAAM, 1997, P NATL ACAD SCI USA, V94, P5843; FUJITA J, 1988, CANCER RES, V48, P5251; Funaki NO, 2001, ONCOL REP, V8, P527; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gong ZH, 2007, CANCER-AM CANCER SOC, V109, P1192, DOI 10.1002/cncr.22534; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Grimm S, 2010, TRENDS MOL MED, V16, P88, DOI 10.1016/j.molmed.2009.12.002; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Irshad S, 2009, CELL DEATH DIFFER, V16, P890, DOI 10.1038/cdd.2009.21; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; LEPAGE G, 1986, J LIPID RES, V27, P114; Linehan WM, 2011, CANC PRINCIPLES PRAC, P1161; Mahul-Mellier AL, 2012, CELL DEATH DIFFER, V19, P891, DOI 10.1038/cdd.2011.185; Meter Van, 2011, CELL CYCLE, V10, P3153; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Muthana M, 2013, CANCER RES, V73, P490, DOI 10.1158/0008-5472.CAN-12-3056; Nalca A, 1999, J BIOL CHEM, V274, P29976, DOI 10.1074/jbc.274.42.29976; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nevels Michael, 2007, Methods Mol Med, V131, P187; Noon AP, 2010, CANCER-AM CANCER SOC, V116, P780, DOI 10.1002/cncr.24841; Rohn JL, 2002, J BIOL CHEM, V277, P50820, DOI 10.1074/jbc.M208557200; Singer EA, 2011, CURR OPIN ONCOL, V23, P283, DOI 10.1097/CCO.0b013e32834479c0; Su ZZ, 1998, P NATL ACAD SCI USA, V95, P14400, DOI 10.1073/pnas.95.24.14400; Valente MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019337; WESSELS HP, 1988, CELL, V55, P61, DOI 10.1016/0092-8674(88)90009-8; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zeisig R, 2007, ARCH BIOCHEM BIOPHYS, V459, P98, DOI 10.1016/j.abb.2006.09.030	38	10	10	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 26	2015	34	13					1718	1728		10.1038/onc.2014.93	http://dx.doi.org/10.1038/onc.2014.93			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE5CS	24769897	Green Accepted			2022-12-25	WOS:000351848400012
J	Fay, MM; Clegg, JM; Uchida, KA; Powers, MA; Ullman, KS				Fay, Marta M.; Clegg, James M.; Uchida, Kimberly A.; Powers, Matthew A.; Ullman, Katharine S.			Enhanced Arginine Methylation of Programmed Cell Death 4 Protein during Nutrient Deprivation Promotes Tumor Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR PDCD4; EUKARYOTIC TRANSLATION; STRUCTURAL BASIS; EXPRESSION; BINDING; CANCER; TRANSFORMATION; INITIATION; INVASION; PHOSPHORYLATION	The role of programmed cell death 4 (PDCD4) in tumor biology is context-dependent. PDCD4 is described as a tumor suppressor, but its coexpression with protein arginine methyltransferase 5 (PRMT5) promotes accelerated tumor growth. Here, we report that PDCD4 is methylated during nutrient deprivation. Methylation occurs because of increased stability of PDCD4 protein as well as increased activity of PRMT5 toward PDCD4. During nutrient deprivation, levels of methylated PDCD4 promote cell viability, which is dependent on an enhanced interaction with eIF4A. Upon recovery from nutrient deprivation, levels of methylated PDCD4 are regulated by phosphorylation, which controls both the localization and stability of methylated PDCD4. This study reveals that, in response to particular environmental cues, the role of PDCD4 is up-regulated and is advantageous for cell viability. These findings suggest that the methylated form of PDCD4 promotes tumor viability during nutrient deprivation, ultimately allowing the tumor to grow more aggressively.	[Fay, Marta M.; Clegg, James M.; Uchida, Kimberly A.; Powers, Matthew A.; Ullman, Katharine S.] Univ Utah, Oncol Sci Dept, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Uchida, Kimberly A.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ullman, KS (corresponding author), Univ Utah, Oncol Sci Dept, Huntsman Canc Inst, 2000 Circle Hope Dr, Salt Lake City, UT 84112 USA.	katie.ullman@hci.utah.edu		Ullman, Katharine/0000-0003-3693-2830	NCI, National Institutes of Health [R21 CA173064]; National Institutes of Health through the Huntsman Cancer Institute [P30 CA042014]; Huntsman Cancer Foundation; graduate research fellowship from the graduate school at the University of Utah; National Institutes of Health Multidisciplinary Cancer Research Training Grant [T32 CA093247]; Undergraduate Research Opportunities Program at the University of Utah; NATIONAL CANCER INSTITUTE [P30CA042014, R21CA173064] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health through the Huntsman Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntsman Cancer Foundation; graduate research fellowship from the graduate school at the University of Utah; National Institutes of Health Multidisciplinary Cancer Research Training Grant; Undergraduate Research Opportunities Program at the University of Utah; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant R21 CA173064 and by shared resources supported in part by National Institutes of Health Grant P30 CA042014 through the Huntsman Cancer Institute. This work was also supported by the Huntsman Cancer Foundation.; Supported by a graduate research fellowship from the graduate school at the University of Utah and National Institutes of Health Multidisciplinary Cancer Research Training Grant T32 CA093247.; Supported by the Undergraduate Research Opportunities Program at the University of Utah.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fassan M, 2010, ONCOL REP, V24, P135, DOI 10.3892/or_00000838; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gao F, 2009, J CELL MOL MED, V13, P4257, DOI 10.1111/j.1582-4934.2008.00497.x; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kakade D, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-2; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kumar N, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2012.37; LaRonde-LeBlanc N, 2007, MOL CELL BIOL, V27, P147, DOI 10.1128/MCB.00867-06; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Nakashima M, 2010, BBA-MOL CELL RES, V1803, P1020, DOI 10.1016/j.bbamcr.2010.05.002; Olson CM, 2013, ELIFE, V2, DOI 10.7554/eLife.00542; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Powers MA, 2011, CANCER RES, V71, P5579, DOI 10.1158/0008-5472.CAN-11-0458; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Santhanam AN, 2010, ONCOGENE, V29, P3921, DOI 10.1038/onc.2010.158; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Song XG, 2013, AUTOPHAGY, V9, P743, DOI 10.4161/auto.24069; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Tsai WW, 2013, P NATL ACAD SCI USA, V110, P8870, DOI 10.1073/pnas.1304602110; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang XY, 2008, ANTICANCER RES, V28, P2991; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Waters LC, 2011, J BIOL CHEM, V286, P17270, DOI 10.1074/jbc.M110.166157; Waters LC, 2010, BIOMOL NMR ASSIGN, V4, P49, DOI 10.1007/s12104-009-9205-1; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	51	15	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17541	17552		10.1074/jbc.M113.541300	http://dx.doi.org/10.1074/jbc.M113.541300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24764298	Green Published, hybrid			2022-12-25	WOS:000338018100020
J	Guo, H; Xiong, Y; Witkowski, P; Cui, JQ; Wang, LJ; Sun, JH; Lara-Lemus, R; Haataja, L; Hutchison, K; Shan, SO; Arvan, P; Liu, M				Guo, Huan; Xiong, Yi; Witkowski, Piotr; Cui, Jingqing; Wang, Ling-jia; Sun, Jinhong; Lara-Lemus, Roberto; Haataja, Leena; Hutchison, Kathryn; Shan, Shu-ou; Arvan, Peter; Liu, Ming			Inefficient Translocation of Preproinsulin Contributes to Pancreatic beta Cell Failure and Late-onset Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE; PRION PROTEIN; ESCHERICHIA-COLI; INS GENE; POSTTRANSLATIONAL TRANSLOCATION; CYTOPLASMIC MEMBRANE; INSULIN-BIOSYNTHESIS; HYDROPHOBIC SEGMENT; SECRETORY PROTEINS	Among the defects in the early events of insulin biosynthesis, proinsulin misfolding and endoplasmic reticulum (ER) stress have drawn increasing attention as causes of beta cell failure. However, no studies have yet addressed potential defects at the cytosolic entry point of preproinsulin into the secretory pathway. Here, we provide the first evidence that inefficient translocation of preproinsulin (caused by loss of a positive charge in the n region of its signal sequence) contributes to beta cell failure and diabetes. Specifically, we find that, after targeting to the ER membrane, preproinsulin signal peptide (SP) mutants associated with autosomal dominant late-onset diabetes fail to be fully translocated across the ER membrane. The newly synthesized, untranslocated preproinsulin remains strongly associated with the ER membrane, exposing its proinsulin moiety to the cytosol. Rather than accumulating in the ER and inducing ER stress, untranslocated preproinsulin accumulates in a juxtanuclear compartment distinct from the Golgi complex, induces the expression of heat shock protein 70 (HSP70), and promotes beta cell death. Restoring an N-terminal positive charge to the mutant preproinsulin SP significantly improves the translocation defect. These findings not only reveal a novel molecular pathogenesis of beta cell failure and diabetes but also provide the first evidence of the physiological and pathological significance of the SP n region positive charge of secretory proteins.	[Guo, Huan; Xiong, Yi; Cui, Jingqing; Sun, Jinhong; Lara-Lemus, Roberto; Haataja, Leena; Hutchison, Kathryn; Arvan, Peter; Liu, Ming] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Witkowski, Piotr; Wang, Ling-jia] Univ Chicago, Div Organ Transplantat, Chicago, IL 60637 USA; [Cui, Jingqing; Liu, Ming] Tianjin Med Univ, Gen Hosp, Div Metab, Tianjin 300052, Peoples R China; [Lara-Lemus, Roberto] Natl Inst Resp Dis Ismael Cosio Villegas, Dept Res Biochem, Mexico City 14080, DF, Mexico; [Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	University of Michigan System; University of Michigan; University of Chicago; Tianjin Medical University; California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	sshan@caltech.edu; parvan@umich.edu; mingli@umich.edu	Lara-Lemus, Roberto/J-4531-2013	Lara-Lemus, Roberto/0000-0001-5419-4283; Liu, Ming/0000-0003-2665-4072; Witkowski, Andrzej/0000-0002-0442-4586	National Institutes of Health [RO1-DK088856, RO1-DK-48280, RO1 GM078024, P60-DK-20572]; National Natural Science Foundation of China [81070629]; March of Dimes Foundation; Protein Folding Disease Initiatives of the University of Michigan; University of Chicago DRTC Grant [P30-DK020595]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048280, P30DK020572, R01DK088856, P30DK020595, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); March of Dimes Foundation(March of Dimes); Protein Folding Disease Initiatives of the University of Michigan; University of Chicago DRTC Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK088856 (to M.L.), RO1-DK-48280 (to P.A.), RO1 GM078024 (to S.S.), and P60-DK-20572 (to the Molecular Biology and DNA Sequencing Core of the Diabetes Research and Training Center). This work was also supported by National Natural Science Foundation of China Research Grant 81070629 (to M.L.), by a research grant from the March of Dimes Foundation (to M.L.), and by the Protein Folding Disease Initiatives of the University of Michigan. Human pancreatic islet processing was supported by Illinois Department of Public Health Grant "Pancreatic Islets Transplantation."; Supported by University of Chicago DRTC Grant P30-DK020595.	ALARCON C, 1995, J CLIN INVEST, V95, P1032, DOI 10.1172/JCI117748; ANDERSSON H, 1994, EMBO J, V13, P2267, DOI 10.1002/j.1460-2075.1994.tb06508.x; Bionda T, 2010, J MOL BIOL, V402, P510, DOI 10.1016/j.jmb.2010.07.052; Boesgaard TW, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-42; Debure L, 2003, J CELL SCI, V116, P3109, DOI 10.1242/jcs.00619; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fujita H, 2010, MOL BIOL CELL, V21, P2045, DOI 10.1091/mbc.E09-12-1060; Garin I, 2010, P NATL ACAD SCI USA, V107, P3105, DOI 10.1073/pnas.0910533107; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; IINO T, 1987, J BIOL CHEM, V262, P7412; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaufman RJ, 2011, NEW ENGL J MED, V365, P1931, DOI 10.1056/NEJMcibr1109442; Kocik L, 2012, J MOL BIOL, V424, P368, DOI 10.1016/j.jmb.2012.10.010; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2012, DIABETES, V61, P828, DOI 10.2337/db11-0878; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; Miesbauer M, 2010, CURR ISSUES MOL BIOL, V12, P109; OKUN MM, 1992, J BIOL CHEM, V267, P11476; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Park SY, 2010, BIOCHEM BIOPH RES CO, V391, P1449, DOI 10.1016/j.bbrc.2009.12.090; PARKS GD, 1991, CELL, V64, P777, DOI 10.1016/0092-8674(91)90507-U; PATZELT C, 1978, P NATL ACAD SCI USA, V75, P1260, DOI 10.1073/pnas.75.3.1260; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; Pilon M, 1998, MOL BIOL CELL, V9, P3455, DOI 10.1091/mbc.9.12.3455; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rane NS, 2010, J CELL BIOL, V188, P515, DOI 10.1083/jcb.200911115; Reiner T, 2011, P NATL ACAD SCI USA, V108, P12815, DOI 10.1073/pnas.1109859108; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; SASAKI S, 1990, J BIOL CHEM, V265, P4358; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Strom A, 2007, LAB INVEST, V87, P139, DOI 10.1038/labinvest.3700500; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Viswanathan J, 2011, TRAFFIC, V12, P330, DOI 10.1111/j.1600-0854.2010.01149.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1986, J MOL BIOL, V192, P287, DOI 10.1016/0022-2836(86)90365-7; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Weiss MA, 2013, FEBS LETT, V587, P1942, DOI 10.1016/j.febslet.2013.04.044; WOLIN SL, 1993, J CELL BIOL, V121, P1211, DOI 10.1083/jcb.121.6.1211; Zhang BY, 2003, J BIOL CHEM, V278, P3687, DOI 10.1074/jbc.M209474200	62	39	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16290	16302		10.1074/jbc.M114.562355	http://dx.doi.org/10.1074/jbc.M114.562355			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24770419	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000337965700033
J	Montague, C; Ngcobo, N; Mahlase, G; Frohlich, J; Pillay, C; Yende-Zuma, N; Humphries, H; Dellar, R; Naidoo, K; Karim, QA				Montague, Carl; Ngcobo, Nelisiwe; Mahlase, Gethwana; Frohlich, Janet; Pillay, Cheryl; Yende-Zuma, Nonhlanhla; Humphries, Hilton; Dellar, Rachael; Naidoo, Kogieleum; Karim, Quarraisha Abdool			Implementation of Adolescent-Friendly Voluntary Medical Male Circumcision Using a School Based Recruitment Program in Rural KwaZulu-Natal, South Africa	PLOS ONE			English	Article							HIV PREVENTION; ACCEPTABILITY; PREVALENCE; INFECTION; RISK; BEHAVIORS; HIV/AIDS; HEALTH; MEN	Background: Epidemiological data from South Africa demonstrate that risk of human immunodeficiency virus (HIV) infection in males increases dramatically after adolescence. Targeting adolescent HIV-negative males may be an efficient and cost-effective means of maximising the established HIV prevention benefits of voluntary medical male circumcision (VMMC) in high HIV prevalence-, low circumcision practice-settings. This study assessed the feasibility of recruiting male high school students for VMMC in such a setting in rural KwaZulu-Natal. Methods and Findings: Following community and key stakeholder consultations on the acceptability of VMMC recruitment through schools, information and awareness raising sessions were held in 42 high schools in Vulindlela. A three-phase VMMC demand-creation strategy was implemented in partnership with a local non-governmental organization, ZimnadiZonke, that involved: (i) community consultation and engagement; (ii) in-school VMMC awareness sessions and centralized HIV counselling and testing (HCT) service access; and (iii) peer recruitment and decentralized HCT service access. Transport was provided for volunteers to the Centre for the AIDS Programme of Research in South Africa (CAPRISA) clinic where the forceps-guided VMMC procedure was performed on consenting HIV-negative males. HIV infected volunteers were referred to further care either at the CAPRISA clinic or at public sector clinics. Between March 2011 and February 2013, a total of 5165 circumcisions were performed, the majority (71%) in males aged between 15 and 19 years. Demand-creation strategies were associated with an over five-fold increase in VMMC uptake from an average of 58 procedures/month in initial community engagement phases, to an average of 308 procedures/month on initiation of the peer recruitment-decentralized service phase. Post-operative adverse events were rare (1.2%), mostly minor and self-resolving. Conclusions: Optimizing a high volume, adolescent-targeted VMMC program was feasible, acceptable and safe in this setting. Adaptive demand-creation strategies are required to sustain high uptake.	[Montague, Carl; Ngcobo, Nelisiwe; Frohlich, Janet; Pillay, Cheryl; Yende-Zuma, Nonhlanhla; Humphries, Hilton; Dellar, Rachael; Naidoo, Kogieleum; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Nelson R Mandela Sch Med, Durban, South Africa; [Mahlase, Gethwana] ZimnadiZonke, Pietermaritzburg, South Africa; [Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	University of Kwazulu Natal; Columbia University	Montague, C (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Nelson R Mandela Sch Med, Durban, South Africa.	Montague@ukzn.ac.za	Abdool Karim, Quarraisha/GVS-1160-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X; Montague, Carl/0000-0001-5411-9291; Naidoo, Kogieleum/0000-0002-8874-6661	President's Emergency Plan for AIDS Relief (PEPFAR) through the Center for Disease Control and Prevention (CDC) [5U2GPS001350]; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS001350] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the Center for Disease Control and Prevention (CDC); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Center for Disease Control and Prevention (CDC; www.cdc.gov) under the terms of 5U2GPS001350. The funders had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bertrand JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027562; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Department of Health Republic of South Africa, 2011, 2011 NAT ANT SENT HI; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gummerson E, 2013, AIDS, V27, P2657, DOI 10.1097/01.aids.0000433235.55937.10; Halperin DT, 2005, SEX TRANSM DIS, V32, P238, DOI 10.1097/01.olq.0000149782.47456.5b; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019814; Kebaabetswe P, 2003, SEX TRANSM INFECT, V79, P214, DOI 10.1136/sti.79.3.214; Kharsany ABM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-231; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Lagarde E, 2003, AIDS, V17, P89, DOI 10.1097/00002030-200301030-00012; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Mwandi Z, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001130; Padian NS, 2011, PLOS MED, V60, pS22; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Shisana O, 2004, SAMJ S AFR MED J, V94, P283; South African National AIDS Council, 2011, NAT STRAT PLAN HIV S; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WHO-PEPFAR, 2010, CONS IMPL MOD OPT VO; WHO-UNAIDS, 2008, OP GUID SCAL MAL CIR; WHO-UNAIDS-JHPIEGO, 2009, MAN MED CIRC LOC AN	26	30	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96468	10.1371/journal.pone.0096468	http://dx.doi.org/10.1371/journal.pone.0096468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788339	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700096
J	Zonszein, S; Alvarez-Anorve, LI; Vazquez-Nunez, RJ; Calcagno, ML				Zonszein, Sergio; Alvarez-Anorve, Laura I.; Vazquez-Nunez, Roberto J.; Calcagno, Mario L.			The Tertiary Origin of the Allosteric Activation of E. coli Glucosamine-6-Phosphate Deaminase Studied by Sol-Gel Nanoencapsulation of Its T Conformer	PLOS ONE			English	Article							GLUCOSAMINE 6-PHOSPHATE DEAMINASE; ESCHERICHIA-COLI; ASPARTATE TRANSCARBAMOYLASE; SITE; TRANSITION; MECHANISMS; ENZYME; STATE; CONFORMATIONS; COOPERATIVITY	The role of tertiary conformational changes associated to ligand binding was explored using the allosteric enzyme glucosamine-6-phosphate (GlcN6P) deaminase from Escherichia coli (EcGNPDA) as an experimental model. This is an enzyme of amino sugar catabolism that deaminates GlcN6P, giving fructose 6-phosphate and ammonia, and is allosterically activated by N-acetylglucosamine 6-phosphate (GlcNAc6P). We resorted to the nanoencapsulation of this enzyme in wet silica sol-gels for studying the role of intrasubunit local mobility in its allosteric activation under the suppression of quaternary transition. The gel-trapped enzyme lost its characteristic homotropic cooperativity while keeping its catalytic properties and the allosteric activation by GlcNAc6P. The nanoencapsulation keeps the enzyme in the T quaternary conformation, making possible the study of its allosteric activation under a condition that is not possible to attain in a soluble phase. The involved local transition was slowed down by nanoencapsulation, thus easing the fluorometric analysis of its relaxation kinetics, which revealed an induced-fit mechanism. The absence of cooperativity produced allosterically activated transitory states displaying velocity against substrate concentration curves with apparent negative cooperativity, due to the simultaneous presence of subunits with different substrate affinities. Reaction kinetics experiments performed at different tertiary conformational relaxation times also reveal the sequential nature of the allosteric activation. We assumed as a minimal model the existence of two tertiary states, t and r, of low and high affinity, respectively, for the substrate and the activator. By fitting the velocity-substrate curves as a linear combination of two hyperbolic functions with K-t and K-r as K-M values, we obtained comparable values to those reported for the quaternary conformers in solution fitted to MWC model. These results are discussed in the background of the known crystallographic structures of T and R EcGNPDA conformers. These results are consistent with the postulates of the Tertiary Two-States (TTS) model.	[Zonszein, Sergio; Alvarez-Anorve, Laura I.; Vazquez-Nunez, Roberto J.; Calcagno, Mario L.] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Calcagno, ML (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Ciudad Univ, Mexico City 04510, DF, Mexico.	calcagno@unam.mx			CONACyT, Mexico [99857-Q, 116074]; program PAPIIT-UNAM [IN206009, IN213312]; CONACyT; SNI-CONACyT	CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); program PAPIIT-UNAM; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SNI-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding for this research was provided by CONACyT, Mexico (grants 99857-Q and 116074) and financial support from the program PAPIIT-UNAM (grants IN206009 and IN213312). SZ also acknowledges a doctoral fellowship from CONACyT and RJVN a student fellowship from SNI-CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAMIRANO MM, 1994, EUR J BIOCHEM, V220, P409, DOI 10.1111/j.1432-1033.1994.tb18638.x; ALTAMIRANO MM, 1991, BIOCHIM BIOPHYS ACTA, V1076, P266, DOI 10.1016/0167-4838(91)90277-7; ALTAMIRANO MM, 1992, BIOCHEMISTRY-US, V31, P1153, DOI 10.1021/bi00119a026; BETTATI S, 2004, ENCY NANOSCIENCE NAN, V9, P81; Bruno S, 2001, PROTEIN SCI, V10, P2401, DOI 10.1110/ps.20501; Bustos-Jaimes I, 2005, BIOCHEMISTRY-US, V44, P1127, DOI 10.1021/bi048514o; Bustos-Jaimes I, 2002, J MOL BIOL, V319, P183, DOI 10.1016/S0022-2836(02)00096-7; Bustos-Jaimes I, 2001, ARCH BIOCHEM BIOPHYS, V394, P156, DOI 10.1006/abbi.2001.2523; CALCAGNO M, 1984, BIOCHIM BIOPHYS ACTA, V787, P165, DOI 10.1016/0167-4838(84)90076-1; Cisneros DA, 2004, ARCH BIOCHEM BIOPHYS, V421, P77, DOI 10.1016/j.abb.2003.09.041; Eaton WA, 2007, IUBMB LIFE, V59, P586, DOI 10.1080/15216540701272380; ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257; Fasman G.D., 1996, CIRCULAR DICHROISM C; Henry ER, 2002, BIOPHYS CHEM, V98, P149, DOI 10.1016/S0301-4622(02)00091-1; Hiromi K, 1979, KINETIC FAST ENZYME; Horjales E, 1999, STRUCTURE, V7, P527, DOI 10.1016/S0969-2126(99)80069-0; Lara-Gonzalez S, 2000, J MOL BIOL, V301, P219, DOI 10.1006/jmbi.2000.3937; LELOIR LF, 1962, METHOD ENZYMOL, V5, P418, DOI 10.1016/S0076-6879(62)05252-0; LELOIR LF, 1956, BIOCHIM BIOPHYS ACTA, V20, P33, DOI 10.1016/0006-3002(56)90259-1; Ludwig HC, 1999, J PROTEIN CHEM, V18, P533, DOI 10.1023/A:1020647116022; McIninch JK, 2001, BBA-PROTEIN STRUCT M, V1547, P320, DOI 10.1016/S0167-4838(01)00203-5; MIDELFORT CF, 1977, BIOCHEMISTRY-US, V16, P1590, DOI 10.1021/bi00627a010; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Montero-Moran GM, 1998, BIOCHEMISTRY-US, V37, P7844, DOI 10.1021/bi972755x; MOZZARELLI A, 1991, NATURE, V351, P416, DOI 10.1038/351416a0; Oliva G, 1995, STRUCTURE, V3, P1323, DOI 10.1016/S0969-2126(01)00270-2; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Pioselli B, 2005, FEBS LETT, V579, P2197, DOI 10.1016/j.febslet.2005.03.011; Rudino-Pinera E, 2002, ACTA CRYSTALLOGR D, V58, P10, DOI 10.1107/S0907444901016699; Schrodinger L., 2020, PYMOL; SHIBAYAMA N, 1995, J MOL BIOL, V251, P203, DOI 10.1006/jmbi.1995.0427; Sosa-Peinado A, 2005, BIOCHEMISTRY-US, V44, P15083, DOI 10.1021/bi050306o; Stieglitz K, 2004, J MOL BIOL, V341, P853, DOI 10.1016/j.jmb.2004.06.002; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101; West JM, 2003, J AM CHEM SOC, V125, P9924, DOI 10.1021/ja0360440; WYMAN J, 1948, ADV PROTEIN CHEM, V4, P407, DOI 10.1016/S0065-3233(08)60011-X	37	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96536	10.1371/journal.pone.0096536	http://dx.doi.org/10.1371/journal.pone.0096536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787711	gold, Green Published, Green Submitted			2022-12-25	WOS:000336655700110
J	Knyphausen, FZ; Scheufele, R; Kucherer, C; Jansen, K; Somogyi, S; Dupke, S; Jessen, H; Schurmann, D; Hamouda, O; Meixenberger, K; Bartmeyer, B				Knyphausen, Fabia Zu; Scheufele, Ramona; Kuecherer, Claudia; Jansen, Klaus; Somogyi, Sybille; Dupke, Stephan; Jessen, Heiko; Schuermann, Dirk; Hamouda, Osamah; Meixenberger, Karolin; Bartmeyer, Barbara			First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study	PLOS ONE			English	Article							THERAPY-NAIVE PATIENTS; ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; PREVALENCE; TRANSMISSION; MUTATIONS; VARIANTS; EPIDEMIOLOGY; INDIVIDUALS; FREQUENCY	Background: Transmission of drug-resistant HIV-1 (TDR) can impair the virologic response to antiretroviral combination therapy. Aim of the study was to assess the impact of TDR on treatment success of resistance test-guided first-line therapy in the German HIV-1 Seroconverter Cohort for patients infected with HIV between 1996 and 2010. An update of the prevalence of TDR and trend over time was performed. Methods: Data of 1,667 HIV-infected individuals who seroconverted between 1996 and 2010 were analysed. The WHO drug resistance mutations list was used to identify resistance-associated HIV mutations in drug-naive patients for epidemiological analysis. For treatment success analysis the Stanford algorithm was used to classify a subset of 323 drug-naive genotyped patients who received a first-line cART into three resistance groups: patients without TDR, patients with TDR and fully active cART and patients with TDR and non-fully active cART. The frequency of virologic failure 5 to 12 months after treatment initiation was determined. Results: Prevalence of TDR was stable at a high mean level of 11.9% (198/1,667) in the HIV-1 Seroconverter Cohort without significant trend over time. Nucleotide reverse transcriptase inhibitor resistance was predominant (6.0%) and decreased significantly over time (OR = 0.92, CI = 0.87-0.98, p = 0.01). Non-nucleoside reverse transcriptase inhibitor (2.4%; OR = 1.00, CI = 0.92-1.09, p = 0.96) and protease inhibitor resistance (2.0%; OR = 0.94, CI = 0.861.03, p = 0.17) remained stable. Virologic failure was observed in 6.5% of patients with TDR receiving fully active cART, 5,6% of patients with TDR receiving non-fully active cART and 3.2% of patients without TDR. The difference between the three groups was not significant (p = 0.41). Conclusion: Overall prevalence of TDR remained stable at a rather high level. No significant differences in the frequency of virologic failure were identified during first-line cART between patients with TDR and fully-active cART, patients with TDR and non-fully active cART and patients without TDR.	[Knyphausen, Fabia Zu] Charite, Dept Nephrol, D-13353 Berlin, Germany; [Scheufele, Ramona; Jansen, Klaus; Hamouda, Osamah; Bartmeyer, Barbara] Robert Koch Inst, Dept Infect Dis Epidemiol HIV AIDS STI & Blood Bo, Berlin, Germany; [Kuecherer, Claudia; Somogyi, Sybille; Meixenberger, Karolin] Robert Koch Inst, Dept Infect Dis HIV & Other Retroviruses, Berlin, Germany; [Dupke, Stephan] Med Care Ctr, Berlin, Germany; [Jessen, Heiko] Med Care Ctr Jessen, Berlin, Germany; [Schuermann, Dirk] Charite, Dept Infect Dis & Pulm Med, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bartmeyer, B (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol HIV AIDS STI & Blood Bo, Berlin, Germany.	Gunsenheimer-BartmeyerB@rki.de	Jessen, Heiko/P-2192-2019	Schurmann, Dirk/0000-0002-6879-9213	German Ministry of Health; German public health institute [83-917]	German Ministry of Health; German public health institute	The study was funded by a grant of the German Ministry of Health. The HIV-1 serooconverter cohort is conducted by the Robert Koch-Institute which is the German public health institute. The grant number is 83-917. The URL of the funding ministry of health is: http://www.bmg.bund.de/praevention/gesundheitsgefahren/hivaids.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EPIDEMIOLOGISCHES B, V47; [Anonymous], 2010, DTSCH OSTERREICHISCH; Audelin AM, 2009, ANTIVIR THER, V14, P995, DOI 10.3851/IMP1412; Babic DZ, 2006, COLLEGIUM ANTROPOL, V30, P25; Balotta C, 2000, ANTIVIR THER, V5, P7; Bannister WP, 2008, JAIDS-J ACQ IMM DEF, V48, P324, DOI 10.1097/QAI.0b013e31817ae5c0; Bansi L, 2010, JAIDS-J ACQ IMM DEF, V53, P633, DOI 10.1097/QAI.0b013e3181c070d2; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bezemer D, 2004, AIDS, V18, P1571, DOI 10.1097/01.aids.0000131357.52457.33; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Brenner B, 2004, AIDS, V18, P1653, DOI 10.1097/01.aids.0000131377.28694.04; Burns S, 2007, AIDS, V21, P1035, DOI 10.1097/QAD.0b013e3280b07761; Cane P, 2005, BMJ-BRIT MED J, V331, P1368, DOI 10.1136/bmj.38665.534595.55; Chaix ML, 2007, ANTIVIR THER, V12, P1305; Chaix ML, 2009, AIDS, V23, P717, DOI 10.1097/QAD.0b013e328326ca77; Colafigli M, 2012, Clin Microbiol Infect, V18, pE299, DOI 10.1111/j.1469-0691.2012.03847.x; de Mendoza C, 2005, CLIN INFECT DIS, V41, P1350, DOI 10.1086/496982; de Mendoza C, 2002, AIDS, V16, P1830, DOI 10.1097/00002030-200209060-00019; De Mendoza C, 2007, AIDS RES HUM RETROV, V23, P879, DOI 10.1089/aid.2005.0072; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; Descamps D, 2013, J ANTIMICROB CHEMOTH; Duwe S, 2001, J ACQ IMMUN DEF SYND, V26, P266, DOI 10.1097/00126334-200103010-00010; Gandhi RT, 2003, CLIN INFECT DIS, V37, P1693, DOI 10.1086/379773; Garcia F, 2011, ANTIVIR RES, V91, P150, DOI 10.1016/j.antiviral.2011.05.010; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Hoffmann C, 2013, ANTIRETROVIRALE THER; Jacobson M A, 1998, AIDS, V12 Suppl A, pS157; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Karlsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033484; Kearney M, 2008, AIDS, V22, P497, DOI 10.1097/QAD.0b013e3282f29478; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Lohse N, 2006, ANTIVIR THER, V11, P591; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Oette M, 2007, DEUT MED WOCHENSCHR, V132, P977, DOI 10.1055/s-2007-979365; Oette M, 2006, JAIDS-J ACQ IMM DEF, V41, P573, DOI 10.1097/01.qai.0000214805.52723.c1; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paraskevis D, 2005, VIRUS RES, V112, P115, DOI 10.1016/j.virusres.2005.03.004; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Payne BAI, 2008, J ANTIMICROB CHEMOTH, V62, P464, DOI 10.1093/jac/dkn228; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Poggensee G, 2007, HIV MED, V8, P511, DOI 10.1111/j.1468-1293.2007.00504.x; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Sagir A, 2007, J ANTIMICROB CHEMOTH, V60, P843, DOI 10.1093/jac/dkm274; Shet A, 2006, JAIDS-J ACQ IMM DEF, V41, P439, DOI 10.1097/01.qai.0000219290.49152.6a; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Turner D, 2004, JAIDS-J ACQ IMM DEF, V37, P1627, DOI 10.1097/00126334-200412150-00017; Vercauteren J, 2008, AIDS RES HUM RETROV, V24, P355, DOI 10.1089/aid.2007.0212; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; Walter H, 1999, J CLIN VIROL, V13, P71, DOI 10.1016/S1386-6532(99)00010-4; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Yebra G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026757; Yerly S, 1998, J VIROL, V72, P3520, DOI 10.1128/JVI.72.5.3520-3523.1998; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685	67	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95956	10.1371/journal.pone.0095956	http://dx.doi.org/10.1371/journal.pone.0095956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788613	Green Published, gold			2022-12-25	WOS:000335510600058
J	D'Arcy, P; Maruwge, W; Wolahan, B; Ma, LM; Brodin, B				D'Arcy, Padraig; Maruwge, Wessen; Wolahan, Barry; Ma, Limin; Brodin, Bertha			Oncogenic Functions of the Cancer-Testis Antigen SSX on the Proliferation, Survival, and Signaling Pathways of Cancer Cells	PLOS ONE			English	Article							SYT; EXPRESSION; GENES; PROTEINS; FUSION; IDENTIFICATION; CATENIN	SSX is a transcription factor with elusive oncogenic functions expressed in a variety of human tumors of epithelial and mesenchymal origin. It has raised substantial interest as a target for cancer therapy since it elicits humoral responses and displays restricted expression to cancer, spermatogonia and mesenchymal stem cells. Here, we investigated the oncogenic properties of SSX by employing a RNA interference to knock-down the endogenous expression of SSX in melanoma and osteosarcoma cell lines. Depletion of SSX expression resulted in reduced proliferation with cells accumulating in the G1 phase of the cell cycle. We found that the growth promoting and survival properties of SSX are mediated in part though modulation of MAPK/Erk and Wnt signaling pathways, since SSX silencing inhibited Erk-mediated signaling and transcription of cMYC and Akt-1. We also found that SSX forms a transient complex with beta-catenin at the G1-S phase boundary resulting in the altered expression of beta-catenin target genes such as E-cadherin, snail-2 and vimentin, involved in epithelial-mesenchymal transitions. Importantly the silencing of SSX expression in in vivo significantly impaired the growth of melanoma tumor xenografts. Tumor biopsies from SSX silenced tumors displayed reduced cyclin A staining, indicative of low proliferation and predominantly cycloplasmic beta-catenin compared to SSX expressing tumors. The present study demonstrates a previously unknown function of SSX, that as an oncogene and as a tumor target for the development of novel anti-cancer drugs.	[D'Arcy, Padraig; Maruwge, Wessen; Wolahan, Barry; Ma, Limin; Brodin, Bertha] Canc Ctr Karolinska, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Brodin, B (corresponding author), Canc Ctr Karolinska, Dept Oncol Pathol, Stockholm, Sweden.	Bertha.Brodin@.ki.se	D'Arcy, Pádraig/F-7633-2018; D'Arcy, Pádraig/AAB-5045-2019	D'Arcy, Pádraig/0000-0001-6671-7600; D'Arcy, Pádraig/0000-0001-6671-7600; Brodin, Bertha/0000-0003-0551-7976	Swedish Children Cancer Foundation; Lillian Sagens och Curt Ericssons Forskningsstiftelse; Stockholm Cancer Foundation	Swedish Children Cancer Foundation; Lillian Sagens och Curt Ericssons Forskningsstiftelse; Stockholm Cancer Foundation	This work was supported by grants from the Swedish Children Cancer Foundation, the Lillian Sagens och Curt Ericssons Forskningsstiftelse, and the Stockholm Cancer Foundation to Bertha Brodin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyoub M, 2002, J IMMUNOL, V168, P1717, DOI 10.4049/jimmunol.168.4.1717; Caballero OL, 2013, ONCOTARGET, V4, P531, DOI 10.18632/oncotarget.921; Chen L, 2012, INT J ONCOL, V40, P1986, DOI 10.3892/ijo.2012.1369; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; Cronwright G, 2005, CANCER RES, V65, P2207, DOI 10.1158/0008-5472.CAN-04-1882; Cuffel C, 2011, INT J CANCER, V128, P2625, DOI 10.1002/ijc.25607; de Bruijn DRH, 2008, ONCOGENE, V27, P653, DOI 10.1038/sj.onc.1210688; dos Santos NR, 2000, EXP CELL RES, V256, P192, DOI 10.1006/excr.2000.4813; dos Santos NR, 2000, CANCER RES, V60, P1654; dosSantos NR, 1997, HUM MOL GENET, V6, P1549, DOI 10.1093/hmg/6.9.1549; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Gure AO TO, 1987, INT J CANCER, V72, P965; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Lim FL, 1998, ONCOGENE, V17, P2013, DOI 10.1038/sj.onc.1202122; Lim J, 2011, J PATHOL, V224, P473, DOI 10.1002/path.2919; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Neumann F, 2011, CANCER IMMUNOL IMMUN, V60, P1333, DOI 10.1007/s00262-011-1030-6; Pretto D, 2006, ONCOGENE, V25, P3661, DOI 10.1038/sj.onc.1209413; SalazarOnfray F, 1997, CANCER RES, V57, P4348; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Smith HA, 2011, CANCER RES, V71, P6785, DOI 10.1158/0008-5472.CAN-11-2127; Smith HA, 2011, J IMMUNOTHER, V34, P569, DOI 10.1097/CJI.0b013e31822b5b1d; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Taylor BJ, 2005, J IMMUNOTHER, V28, P564, DOI 10.1097/01.cji.0000175685.36239.e5; Tureci O, 1998, INT J CANCER, V77, P19, DOI 10.1002/(SICI)1097-0215(19980703)77:1<19::AID-IJC4>3.0.CO;2-2	27	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95136	10.1371/journal.pone.0095136	http://dx.doi.org/10.1371/journal.pone.0095136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24787708	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917300008
J	Bjornstad, P; McQueen, RB; Snell-Bergeon, JK; Cherney, D; Pyle, L; Perkins, B; Rewers, M; Maahs, DM				Bjornstad, Petter; McQueen, R. Brett; Snell-Bergeon, Janet K.; Cherney, David; Pyle, Laura; Perkins, Bruce; Rewers, Marian; Maahs, David M.			Fasting Blood Glucose-A Missing Variable for GFR-Estimation in Type 1 Diabetes?	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CYSTATIN-C; RENAL-FUNCTION; FUNCTION DECLINE; MORTALITY RISK; CREATININE; HYPERGLYCEMIA; HYPERFILTRATION; DISEASE; NEPHROPATHY	Objective: Estimation of glomerular filtration rate (eGFR) is one of the current clinical methods for identifying risk for diabetic nephropathy in subjects with type 1 diabetes (T1D). Hyperglycemia is known to influence GFR in T1D and variability in blood glucose at the time of eGFR measurement could introduce bias in eGFR. We hypothesized that simultaneously measured blood glucose would influence eGFR in adults with T1D. Methods: Longitudinal multivariable mixed-models were employed to investigate the relationships between blood glucose and eGFR by CKD-EPI eGFR(CYSTATIN) (C) over 6-years in the Coronary Artery Calcification in Type 1 diabetes (CACTI) study. All subjects with T1D and complete data including blood glucose and cystatin C for at least one of the three visits (n = 616, 554, and 521, respectively) were included in the longitudinal analyses. Results: In mixed-models adjusting for sex, HbA1c, ACEi/ARB, protein and sodium intake positive associations were observed between simultaneous blood glucose and eGFR(CYSTATIN) (C) (beta +/- SE: 0.14 +/- 0.04 per 10 mg/dL of blood glucose, p<0.0001), and hyperfiltration as a dichotomous outcome (OR: 1.04, 95% CI: 1.01-1.07 per 10 mg/dL of blood glucose, p = 0.02). Conclusions: In our longitudinal data in subjects with T1D, simultaneous blood glucose has an independent positive effect on eGFR(CYSTATIN) (C). The associations between blood glucose and eGFR(CYSTATIN) (C) may bias the accurate detection of early diabetic nephropathy, especially in people with longitudinal variability in blood glucose.	[Bjornstad, Petter; Snell-Bergeon, Janet K.; Rewers, Marian; Maahs, David M.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [McQueen, R. Brett] Univ Colorado, Sch Pharm, Aurora, CO USA; [Snell-Bergeon, Janet K.; Rewers, Marian; Maahs, David M.] Univ Colorado, Sch Med, Barbara Davis Ctr Diabet, Aurora, CO USA; [Cherney, David] Univ Toronto, Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON M5S 1A1, Canada; [Pyle, Laura] Univ Colorado Denver, Dept Biostat, Aurora, CO USA; [Perkins, Bruce] Univ Toronto, Mt Sinai Hosp, Div Endocrinol, Dept Med, Toronto, ON M5S 1A1, Canada	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bjornstad, P (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.	Petter.Bjornstad@childrenscolorado.org	Perkins, Bruce A/L-3726-2017; Pyle, Laura/I-8733-2019; Bjornstad, Petter/U-6892-2019	Pyle, Laura/0000-0001-5577-8221; Bjornstad, Petter/0000-0002-5160-2947; Snell-Bergeon, Janet/0000-0002-9337-3740; Maahs, David/0000-0002-4602-7909	NHLBI [R01 HL61753, HL79611]; DERC Clinical Investigation Core [P30 DK57516]; JDRF [17-2013-313]; Barbara Davis Center for Childhood Diabetes [NIH-M01-RR00051]; Colorado Heart Imaging Center in Denver, CO [NIH-M01-RR00051]; American Diabetes Association Junior Faculty Award [1-10-JF-50]; PhRMA Foundation; Kidney Foundation of Canada Scholarship; Canadian Diabetes Association-KRESCENT Program Joint New Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113029, R01HL079611, R01HL061753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DERC Clinical Investigation Core; JDRF(Juvenile Diabetes Research Foundation); Barbara Davis Center for Childhood Diabetes; Colorado Heart Imaging Center in Denver, CO; American Diabetes Association Junior Faculty Award(American Diabetes Association); PhRMA Foundation; Kidney Foundation of Canada Scholarship; Canadian Diabetes Association-KRESCENT Program Joint New Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for this study was provided by NHLBI grant R01 HL61753, HL79611, DERC Clinical Investigation Core P30 DK57516, and JDRF grant 17-2013-313. The study was performed at the Adult CTRC at UCD support by NIH-M01-RR00051, at the Barbara Davis Center for Childhood Diabetes and at Colorado Heart Imaging Center in Denver, CO. Dr. Snell-Bergeon was supported by an American Diabetes Association Junior Faculty Award (1-10-JF-50). Dr. McQueen was supported by a Post-Doctoral Grant from the PhRMA Foundation. D.Z.I.C. was supported by a Kidney Foundation of Canada Scholarship and a Canadian Diabetes Association-KRESCENT Program Joint New Investigator Award. Drs. Bjornstad, McQueen, Snell-Bergeon, Cherney, Perkins, Rewers and Maahs have no conflict of interest to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Bjornstad P, 2013, DIABETES CARE; Cameron A.C., 2010, MICROECONOMETRICS US, V2; Cherney DZI, 2010, DIABETIC MED, V27, P1358, DOI 10.1111/j.1464-5491.2010.03121.x; Cherney D, 2013, NEW ENGL J MED, V369, P2458, DOI 10.1056/NEJMc1312801; Cherney DZI, 2013, DIABETOLOGIA, V56, P2308, DOI 10.1007/s00125-013-3000-3; Cherney DZI, 2013, DIABETES CARE, V36, P1290, DOI 10.2337/dc12-1305; Cherney DZI, 2010, DIABETES CARE, V33, P1344, DOI 10.2337/dc09-2340; Cherney DZ, 2013, CIRCULATION; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; GREENE SA, 1987, KIDNEY INT, V32, P896, DOI 10.1038/ki.1987.292; Hedeker D., 2006, LONGITUDINAL DATA AN; HUSDAN H, 1968, CLIN CHEM, V14, P222; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Krolewski AS, 2014, DIABETES CARE, V37, P226, DOI 10.2337/dc13-0985; LERVANG HH, 1988, DIABETOLOGIA, V31, P723, DOI 10.1007/BF00274773; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Maahs DM, 2007, DIABETES, V56, P2774, DOI 10.2337/db07-0539; Maahs DM, 2006, J CLIN ENDOCR METAB, V91, P3757, DOI 10.1210/jc.2006-1730; Maahs DM, 2011, CLIN J AM SOC NEPHRO, V6, P1952, DOI 10.2215/CJN.11271210; Maahs DM, 2005, DIABETES CARE, V28, P301, DOI 10.2337/diacare.28.2.301; Melsom T, 2011, DIABETES CARE, V34, P1546, DOI 10.2337/dc11-0235; Miller JA, 1999, J AM SOC NEPHROL, V10, P1778; Miller JA, 1996, CLIN SCI, V90, P189, DOI 10.1042/cs0900189; Odutayo A, 2012, CLIN NEPHROL, V78, P64, DOI 10.5414/CN107324; Orchard TJ, 2010, DIABETOLOGIA, V53, P2312, DOI 10.1007/s00125-010-1860-3; Perkins BA, 2007, J AM SOC NEPHROL, V18, P1353, DOI 10.1681/ASN.2006080872; Perkins BA, 2012, CLIN EXP HYPERTENS, V34, P606, DOI 10.3109/10641963.2012.681732; Perkins BA, 2009, CURR OPIN NEPHROL HY, V18, P233, DOI 10.1097/MNH.0b013e3283293db1; Premaratne E, 2008, DIABETES CARE, V31, P971, DOI 10.2337/dc07-1588; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; Shlipak MG, 2009, AM J NEPHROL, V30, P171, DOI 10.1159/000212381; Silveiro SP, 2011, DIABETES CARE, V34, P2353, DOI 10.2337/dc11-1282; Skupien J, 2013, AM J KIDNEY DIS, V62, P184, DOI 10.1053/j.ajkd.2013.03.029; Snell-Bergeon JK, 2009, DIABETOLOGIA, V52, P801, DOI 10.1007/s00125-009-1280-4; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Sunder-Plassmann G, 2004, AM J KIDNEY DIS, V43, P396, DOI 10.1053/j.ajkd.2003.11.017; WISEMAN MJ, 1985, NEW ENGL J MED, V312, P617, DOI 10.1056/NEJM198503073121004; Yang GK, 2013, RENAL HYPER IN PRESS; Yip JW, 1996, DIABETES, V45, P1729, DOI 10.2337/diabetes.45.12.1729	43	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96264	10.1371/journal.pone.0096264	http://dx.doi.org/10.1371/journal.pone.0096264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781861	Green Published, Green Submitted, gold			2022-12-25	WOS:000335504900027
J	Gruben, N; Vergara, MA; Kloosterhuis, NJ; van der Molen, H; Stoelwinder, S; Youssef, S; de Bruin, A; Delsing, DJ; Kuivenhoven, JA; van de Sluis, B; Hofker, MH; Koonen, DPY				Gruben, Nanda; Vergara, Marcela Aparicio; Kloosterhuis, Niels J.; van der Molen, Henk; Stoelwinder, Stefan; Youssef, Sameh; de Bruin, Alain; Delsing, Dianne J.; Kuivenhoven, Jan Albert; van de Sluis, Bart; Hofker, Marten H.; Koonen, Debby P. Y.			Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice	PLOS ONE			English	Article							GLUCOSE-INTOLERANCE; METABOLIC SYNDROME; KNOCKOUT MICE; MOUSE MODELS; CHEMERIN; OBESITY; STEATOHEPATITIS; EXPRESSION; ADIPOKINE; GENE	The adipokine chemerin and its receptor, chemokine-like receptor 1 (Cmklr1), are associated with insulin resistance and nonalcoholic fatty liver disease (NAFLD), which covers a broad spectrum of liver diseases, ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). It is possible that chemerin and/or Cmklr1 exert their effects on these disorders through inflammation, but so far the data have been controversial. To gain further insight into this matter, we studied the effect of whole-body Cmklr1 deficiency on insulin resistance and NAFLD. In view of the primary role of macrophages in hepatic inflammation, we also transplanted bone marrow from Cmklr1 knock-out (Cmklr1(-/-)) mice and wild type (WT) mice into low-density lipoprotein receptor knock-out (Ldlr(-/-)) mice, a mouse model for NASH. All mice were fed a high fat, high cholesterol diet containing 21% fat from milk butter and 0.2% cholesterol for 12 weeks. Insulin resistance was assessed by an oral glucose tolerance test, an insulin tolerance test, and by measurement of plasma glucose and insulin levels. Liver pathology was determined by measuring hepatic inflammation, fibrosis, lipid accumulation and the NAFLD activity score (NAS). Whole-body Cmklr1 deficiency did not affect body weight gain or food intake. In addition, we observed no differences between WT and Cmklr1(-/-) mice for hepatic inflammatory and fibrotic gene expression, immune cell infiltration, lipid accumulation or NAS. In line with this, we detected no differences in insulin resistance. In concordance with whole-body Cmklr1 deficiency, the absence of Cmklr1 in bone marrow-derived cells in Ldlr(-/-) mice did not affect their insulin resistance or liver pathology. Our results indicate that Cmklr1 is not involved in the pathogenesis of insulin resistance or NAFLD. Thus, we recommend that the associations reported between Cmklr1 and insulin resistance or NAFLD should be interpreted with caution.	[Gruben, Nanda; Vergara, Marcela Aparicio; Kloosterhuis, Niels J.; van der Molen, Henk; Stoelwinder, Stefan; Kuivenhoven, Jan Albert; van de Sluis, Bart; Hofker, Marten H.; Koonen, Debby P. Y.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Mol Genet Sect, Groningen, Netherlands; [Youssef, Sameh; de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dutch Mol Pathol Ctr, Utrecht, Netherlands; [Delsing, Dianne J.] Merck Res Labs, MSD, Dept Immune Therapeut, Oss, Netherlands	University of Groningen; Utrecht University; Merck & Company	Koonen, DPY (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Mol Genet Sect, Groningen, Netherlands.	d.p.y.koonen@umcg.nl	de Bruin, Alain/AAL-9195-2020	van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365; youssef, sameh/0000-0002-6402-9975; de Bruin, Alain/0000-0001-8579-2649	project PREDICCt [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation [2009.80.016, 2004.00.018]; Dutch Kidney Foundation	project PREDICCt; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation	This study was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104), and supported by the Dutch Heart Foundation, the Dutch Diabetes Research Foundation (grant 2009.80.016; 2004.00.018) and the Dutch Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru S, 2006, LIVER INT, V26, P39, DOI 10.1111/j.1478-3231.2005.01191.x; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Becker M, 2010, DIABETES, V59, P2898, DOI 10.2337/db10-0362; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Bondue B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002358; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Catalan V, 2013, SURG OBES RELAT DIS, V9, P306, DOI 10.1016/j.soard.2011.11.001; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Deng YJ, 2013, ENDOCRINOLOGY, V154, P1794, DOI 10.1210/en.2012-2126; Docke S, 2013, EUR J ENDOCRINOL, V169, P547, DOI 10.1530/EJE-13-0112; Ernst MC, 2012, ENDOCRINOLOGY, V153, P672, DOI 10.1210/en.2011-1490; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; Fatima SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057113; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Graham KL, 2009, J IMMUNOL, V183, P6717, DOI 10.4049/jimmunol.0803435; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kukla M, 2010, SCAND J GASTROENTERO, V45, P235, DOI 10.3109/00365520903443852; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Parlee SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051072; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Rouger L, 2013, J ENDOCRINOL, V219, P279, DOI 10.1530/JOE-13-0106; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Wanninger J, 2012, MOL CELL ENDOCRINOL, V349, P248, DOI 10.1016/j.mce.2011.10.032; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zoetelief J, 2001, INT J RADIAT BIOL, V77, P817, DOI 10.1080/09553000110050605	35	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e96345	10.1371/journal.pone.0096345	http://dx.doi.org/10.1371/journal.pone.0096345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781986	Green Published, gold, Green Submitted			2022-12-25	WOS:000335504900029
J	Laursen, K; Moller, AP				Laursen, Karsten; Moller, Anders Pape			Long-Term Changes in Nutrients and Mussel Stocks Are Related to Numbers of Breeding Eiders Somateria mollissima at a Large Baltic Colony	PLOS ONE			English	Article							WADDEN SEA; WATER TEMPERATURE; WINTER; MASS; TIME	Background: The Baltic/Wadden Sea eider Somateria mollissima flyway population is decreasing, and this trend is also reflected in the large eider colony at Christianso situated in the Baltic Sea. This colony showed a 15-fold increase from 1925 until the mid-1990's, followed by a rapid decline in recent years, although the causes of this trend remain unknown. Most birds from the colony winter in the Wadden Sea, from which environmental data and information on the size of the main diet, the mussel Mytilus edulis stock exists. We hypothesised that changes in nutrients and water temperature in the Wadden Sea had an effect on the ecosystem affecting the size of mussel stocks, the principal food item for eiders, thereby influencing the number of breeding eider in the Christianso colony. Methodology/Principal Finding: A positive relationship between the amount of fertilizer used by farmers and the concentration of phosphorus in the Wadden Sea (with a time lag of one year) allowed analysis of the predictions concerning effects of nutrients for the period 1925-2010. There was (1) increasing amounts of fertilizer used in agriculture and this increased the amount of nutrients in the marine environment thereby increasing the mussel stocks in the Wadden Sea. (2) The number of eiders at Christianso increased when the amount of fertilizer increased. Finally (3) the number of eiders in the colony at Christianso increased with the amount of mussel stocks in the Wadden Sea. Conclusions/Significance: The trend in the number of eiders at Christianso is representative for the entire flyway population, and since nutrient reduction in the marine environment occurs in most parts of Northwest Europe, we hypothesize that this environmental candidate parameter is involved in the overall regulation of the Baltic/Wadden Sea eider population during recent decades.	[Laursen, Karsten] Aarhus Univ, Inst Biosci, Ronde, Denmark; [Moller, Anders Pape] Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France	Aarhus University; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Laursen, K (corresponding author), Aarhus Univ, Inst Biosci, Ronde, Denmark.	kl@dmu.dk	Moller, Anders/O-6665-2016	Moller, Anders/0000-0003-3739-4675	'15-June Fondation'	'15-June Fondation'	Financial support was received from the '15-June Fondation'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUKEMA JJ, 1993, NETH J SEA RES, V31, P319, DOI 10.1016/0077-7579(93)90051-S; BSEP, 2009, BALT SEA ENV P B; Camphuysen CJ, 2002, BIOL CONSERV, V106, P303, DOI 10.1016/S0006-3207(01)00256-7; Carstensen J, 2011, ENVIRON SCI TECHNOL, V45, P9122, DOI 10.1021/es202351y; Chaulk KG, 2012, POLAR BIOL, V35, P645, DOI 10.1007/s00300-011-1110-2; Christensen TK, 1997, WILDLIFE BIOL, V3, P125, DOI 10.2981/wlb.1997.008; Christensen Thomas Kjaer, 2011, Dansk Ornitologisk Forenings Tidsskrift, V105, P195; Colijn F, 2003, J SEA RES, V49, P83, DOI 10.1016/S1385-1101(03)00002-9; Delany S, 2006, WATERBIRD POPULATION; Desholm M., 2002, Wildfowl, V53, P167; Duus K., 2000, GEOGRAFISTATISTIK 20; Ekroos J, 2012, ORNIS FENNICA, V89, P81; Franzmann N-E, 1980, EDERFUGLENES SOMATER; Hario M., 2002, DAN REV GAME BIOL, V16, P33; Hario M, 2009, ORNIS FENNICA, V86, P81; Hjort M, 2010, 760 DMU; Honkoop PJC, 1997, J EXP MAR BIOL ECOL, V212, P277, DOI 10.1016/S0022-0981(96)02757-8; Jonsson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067093; Kats R. K. H., 2007, COMMON EIDERS SOMATE; Kilpi Mikael, 2002, Suomen Riista, V48, P27; Kristensen PS, 2000, 7200 DFU DAN FISH RE; Laursen K., 2010, WADDEN SEA ECOSYSTEM; Laursen K, 2009, J SEA RES, V62, P22, DOI 10.1016/j.seares.2009.02.004; Laursen K, 2008, WILDLIFE BIOL, V14, P423, DOI 10.2981/0909-6396-14.4.423; Lehikoinen A, 2006, GLOBAL CHANGE BIOL, V12, P1355, DOI 10.1111/j.1365-2486.2006.01162.x; Lenhart H, 2001, BER ZENT MEERES KL B, V40, P1; Lyngs Peter, 2000, Dansk Ornitologisk Forenings Tidsskrift, V94, P12; MacKenzie BR, 2007, J MARINE SYST, V68, P405, DOI 10.1016/j.jmarsys.2007.01.003; McClave J., 2003, STATISTICS; Meijer T, 1999, IBIS, V141, P399, DOI 10.1111/j.1474-919X.1999.tb04409.x; Moller AP, 2007, J ANIM ECOL, V76, P515, DOI 10.1111/j.1365-2656.2007.01235.x; Moller AP, 2013, INTEGR ZOOL, V8, P136, DOI 10.1111/1749-4877.12006; Nehls G., 2009, QUALITY STATUS REPOR; Nehls G., 2002, DAN REV GAME BIOL, V16, P47; Nielsen E, 1996, ICES J MAR SCI, V53, P988, DOI 10.1006/jmsc.1996.0123; Nixon SW, 2002, ESTUARIES, V25, P782, DOI 10.1007/BF02804905; NOER H, 1991, Danish Review of Game Biology, V14, P1; Ost M, 2008, J ANIM ECOL, V77, P315, DOI 10.1111/j.1365-2656.2007.01348.x; Pedersen K, 2003, J WILDLIFE DIS, V39, P808, DOI 10.7589/0090-3558-39.4.808; Petersen I.K., 2006, 606 DMU; Philippart CJM, 2007, ECOSYSTEMS, V10, P95, DOI 10.1007/s10021-006-9006-7; Rahbek, 2006, DANSK TRAEKFUGLEATLA; REED A, 1975, Ornis Scandinavica, V6, P41, DOI 10.2307/3676278; Rigou Y, 2010, WATERBIRDS, V33, P314, DOI 10.1675/063.033.0307; Ronka M, 2011, WILDLIFE BIOL, V17, P225, DOI 10.2981/09-064; SAS, 2010, SAS ENT GUID 5 1; Stanners D, 1995, EUROPES ENV DOBIRS A; SWENNEN C, 1990, ORNIS SCAND, V21, P17, DOI 10.2307/3676374; Van Aken HM, 2001, ICES MARINE SCI S, V219, P359; van Beusekom JEE, 2009, J SEA RES, V61, P26, DOI 10.1016/j.seares.2008.06.005; Waldeck P, 2013, J EXP MAR BIOL ECOL, V444, P24, DOI 10.1016/j.jembe.2013.03.007	51	30	34	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e95851	10.1371/journal.pone.0095851	http://dx.doi.org/10.1371/journal.pone.0095851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24781984	Green Published, Green Submitted, gold			2022-12-25	WOS:000335504900010
J	Su, YW; Lin, YH; Pai, MH; Lo, AC; Lee, YC; Fang, IC; Lin, J; Hsieh, RK; Chang, YF; Chen, CL				Su, Ying-Wen; Lin, Yun-Ho; Pai, Man-Hui; Lo, An-Chi; Lee, Yu-Chieh; Fang, I-Chih; Lin, Johnson; Hsieh, Ruey-Kuen; Chang, Yi-Fang; Chen, Chi-Long			Association between Phosphorylated AMP-Activated Protein Kinase and Acetyl-CoA Carboxylase Expression and Outcome in Patients with Squamous Cell Carcinoma of the Head and Neck	PLOS ONE			English	Article							CANCER-CELLS; BREAST-CANCER; METABOLIC SYNDROME; DIABETES-MELLITUS; ORAL LEUKOPLAKIA; BRCT DOMAINS; GROWTH; INHIBITION; SURVIVAL; EPIDEMIOLOGY	Background: Epidemiological studies have indicated that impaired glucose metabolism may increase the risk of squamous cell carcinoma of the head and neck (SCCHN). AMP-activated protein kinase (AMPK) regulates glucose and lipid metabolism via the phosphorylation and subsequent inactivation of its downstream target acetyl-CoA carboxylase (ACC). Thus, we analyzed the expression of pAMPK and its downstream target phosphorylated acetyl-CoA carboxylase (pACC), as well as their impact on the survival of patients with resected SCCHN. Methods: One hundred eighteen patients with surgically resected SCCHN were enrolled. Immunohistochemical (IHC) staining for pAMPK and pACC was performed using tissue microarrays of operative specimens of SCCHN. The expression was divided into two or three groups according to the IHC score [pAMPK: negative (0), positive (1-3); pACC: negative (0), low expression (1, 2), and high expression (3)]. Statistical analysis was performed to determine the association of pAMPK expression with clinicopathological features and pACC and pErk expression. Results: The positive rates of pAMPK and pACC expression were 64.4% (76/118) and 68.6% (81/118), respectively. pAMPK was significantly higher in patients aged younger than 60 years (P=0.024; chi(2) test) and those with early-stage (T1/T2; P = 0.02; chi(2) test) and oral cavity (P = 0.026; Fisher's exact test) tumors. In multivariate analysis, pAMPK expression was not significantly correlated with overall survival (OS) (adjusted hazard ratio [HR]: 0.66; 95% confidence interval [CI]: 0.35-1.23), whereas high pACC expression was independently associated with worse OS in node-positive patients (adjusted HR: 17.58; 95% CI: 3.50-88.18). Conclusions: Strong expression of pACC was found to be an independent prognostic marker for patients with node-positive SCCHN. Our results suggest that pACC may play a role in tumor progression of SCCHN and may help to identify patient subgroups at high risk for poor disease outcome.	[Su, Ying-Wen; Lin, Johnson; Hsieh, Ruey-Kuen; Chang, Yi-Fang] Mackay Mem Hosp, Dept Internal Med, Div Hematol & Med Oncol, Taipei, Taiwan; [Lin, Yun-Ho] Taipei Med Univ Hosp, Dept Dent, Div Oral Pathol, Taipei, Taiwan; [Pai, Man-Hui] Taipei Med Univ, Dept Anat, Taipei, Taiwan; [Lo, An-Chi; Fang, I-Chih; Chang, Yi-Fang] Mackay Mem Hosp, Good Clin Res Ctr, Taipei, Taiwan; [Lee, Yu-Chieh] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Chen, Chi-Long] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan	Mackay Memorial Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Mackay Memorial Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Chen, CL (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan.	chencl@tmu.edu.tw			Taipei Medical University/Wan Fang Hospital [100TMU-WFH-09]; National Science Council of Taiwan [NSC 101-2314-B-195-019-MY2, DOH102-TD-C-111-008]; Mackay Memorial Hospital [MMH-102-34]	Taipei Medical University/Wan Fang Hospital; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This study was supported by grants from Taipei Medical University/Wan Fang Hospital (grant number: 100TMU-WFH-09), the National Science Council of Taiwan (grant number: NSC 101-2314-B-195-019-MY2, DOH102-TD-C-111-008) and Mackay Memorial Hospital (grant number: MMH-102-34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; ALBRECHT M, 1992, J ORAL PATHOL MED, V21, P364, DOI 10.1111/j.1600-0714.1992.tb01366.x; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chu PY, 2012, ANTICANCER RES, V32, P3987; Dietrich T, 2004, ORAL ONCOL, V40, P158, DOI 10.1016/S1368-8375(03)00145-3; Dikshit RP, 2006, INT J CANCER, V118, P453, DOI 10.1002/ijc.21345; Edge S, 2010, AJCC CANC STAGING MA, V7th; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frederick MJ, 2011, AM J PATHOL, V178, P548, DOI 10.1016/j.ajpath.2010.10.044; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Hadad SM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-307; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Jin Q, 2007, CANCER RES, V67, P11630, DOI 10.1158/0008-5472.CAN-07-2401; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Lee CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050163; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915; Mehanna H, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4684; Mehra Ranee, 2008, Clin Adv Hematol Oncol, V6, P742; Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Rattan R, 2011, J CELL MOL MED, V15, P166, DOI 10.1111/j.1582-4934.2009.00954.x; Ronnebaum SM, 2008, J BIOL CHEM, V283, P14248, DOI 10.1074/jbc.M800119200; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Shen Y, 2008, BIOCHEMISTRY-US, V47, P5767, DOI 10.1021/bi800314m; Stott-Miller M, 2012, CANCER EPIDEM BIOMAR, V21, P294, DOI 10.1158/1055-9965.EPI-11-0590; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Swinnen JV, 2005, CANCER RES, V65, P2441, DOI 10.1158/0008-5472.CAN-04-3025; Temam S, 2007, J CLIN ONCOL, V25, P2164, DOI 10.1200/JCO.2006.06.6605; Vitale-Cross L, 2012, CANCER PREV RES, V5, P562, DOI 10.1158/1940-6207.CAPR-11-0502; William WN, 2012, ANN ONCOL, V23, P78, DOI 10.1093/annonc/mdr036; Zu XY, 2013, MOLECULES, V18, P1704, DOI 10.3390/molecules18021704	36	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e96183	10.1371/journal.pone.0096183	http://dx.doi.org/10.1371/journal.pone.0096183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CM	24769813	Green Submitted, gold, Green Published			2022-12-25	WOS:000336736600029
J	Zee, PC; Bever, JD				Zee, Peter C.; Bever, James D.			Joint Evolution of Kin Recognition and Cooperation in Spatially Structured Rhizobium Populations	PLOS ONE			English	Article							OPINE-LIKE COMPOUND; BACTERIAL MOTILITY; ALFALFA NODULES; MELILOTI; RHIZOPINE; MUTUALISM; ALTRUISM; MODEL; CATABOLISM; SANCTIONS	In the face of costs, cooperative interactions maintained over evolutionary time present a central question in biology. What forces maintain this cooperation? Two potential ways to explain this problem are spatially structured environments (kin selection) and kin-recognition (directed benefits). In a two-locus population genetic model, we investigated the relative roles of spatial structure and kin recognition in the maintenance of cooperation among rhizobia within the rhizobia-legume mutualism. In the case where the cooperative and kin recognition loci are independently inherited, spatial structure alone maintains cooperation, while kin recognition decreases the equilibrium frequency of cooperators. In the case of co-inheritance, spatial structure remains a stronger force, but kin recognition can transiently increase the frequency of cooperators. Our results suggest that spatial structure can be a dominant force in maintaining cooperation in rhizobium populations, providing a mechanism for maintaining the mutualistic nodulation trait. Further, our model generates unique and testable predictions that could be evaluated empirically within the legume-rhizobium mutualism.	[Zee, Peter C.; Bever, James D.] Indiana Univ, Dept Biol, Bloomington, IN USA	Indiana University System; Indiana University Bloomington	Zee, PC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	peterzee@stanford.edu			Indiana University National Institutes of Health Genetics, Cellular, and Molecular Sciences [T32-GM007757]; NSF [DEB-0919434]; National Science Foundation [DEB-1050237, NIH-5 R01 GM092660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092660, T32GM007757] Funding Source: NIH RePORTER	Indiana University National Institutes of Health Genetics, Cellular, and Molecular Sciences; NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Indiana University National Institutes of Health Genetics, Cellular, and Molecular Sciences Training Grant T32-GM007757 (PCZ), and NSF DEB-0919434, National Science Foundation DEB-1050237 and NIH-5 R01 GM092660 (JDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, P ROY SOC B-BIOL SCI, V268, P1099, DOI 10.1098/rspb.2001.1611; AMES P, 1981, J BACTERIOL, V148, P728, DOI 10.1128/JB.148.2.728-729.1981; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bever JD, 2000, HEREDITY, V85, P366, DOI 10.1046/j.1365-2540.2000.00772.x; BOIVIN C, 1991, J BACTERIOL, V173, P2809, DOI 10.1128/JB.173.9.2809-2817.1991; Crozier RH, 1987, KIN RECOGNITION ANIM; Dawkins R, 1976, SELFISH GENE; Dechesne A, 2010, P NATL ACAD SCI USA, V107, P14369, DOI 10.1073/pnas.1008392107; Denison RF, 2000, AM NAT, V156, P567, DOI 10.1086/316994; Fletcher DJC, 1989, KIN RECOGNITION ANIM; Gardener BBM, 1998, APPL ENVIRON MICROB, V64, P4944; Gardner A, 2010, EVOLUTION, V64, P25, DOI 10.1111/j.1558-5646.2009.00842.x; GRAFEN A, 1990, ANIM BEHAV, V39, P42, DOI 10.1016/S0003-3472(05)80724-9; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; HARTWIG UA, 1991, PLANT PHYSIOL, V95, P797, DOI 10.1104/pp.95.3.797; Heath KD, 2009, EVOLUTION, V63, P652, DOI 10.1111/j.1558-5646.2008.00582.x; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; JIMENEZ J, 1989, J HERED, V80, P335, DOI 10.1093/oxfordjournals.jhered.a110867; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Long SR, 1992, BIOL NITROGEN FIXATI; Mack KML, 2012, OIKOS, V121, P442, DOI 10.1111/j.1600-0706.2011.19420.x; MURPHY PJ, 1988, P NATL ACAD SCI USA, V85, P9133, DOI 10.1073/pnas.85.23.9133; MURPHY PJ, 1987, P NATL ACAD SCI USA, V84, P493, DOI 10.1073/pnas.84.2.493; MURPHY PJ, 1995, SOIL BIOL BIOCHEM, V27, P525, DOI 10.1016/0038-0717(95)98627-Z; OLIVIERI I, 1994, J HERED, V85, P46; PARCO SZ, 1994, SOIL BIOL BIOCHEM, V26, P297, DOI 10.1016/0038-0717(94)90170-8; Platt TG, 2012, EVOLUTION, V66, P1953, DOI 10.1111/j.1558-5646.2011.01571.x; Platt TG, 2012, P ROY SOC B-BIOL SCI, V279, P1691, DOI 10.1098/rspb.2011.2002; Platt TG, 2009, TRENDS ECOL EVOL, V24, P370, DOI 10.1016/j.tree.2009.02.009; QUELLER DC, 1992, EVOLUTION, V46, P376, DOI 10.1111/j.1558-5646.1992.tb02045.x; RAO JP, 1995, MICROBIOL-UK, V141, P1683, DOI 10.1099/13500872-141-7-1683; ROSSBACH S, 1995, MOL PLANT MICROBE IN, V8, P549, DOI 10.1094/MPMI-8-0549; Rousset F, 2007, EVOLUTION, V61, P2320, DOI 10.1111/j.1558-5646.2007.00191.x; Sachs JL, 2010, J EVOLUTION BIOL, V23, P1919, DOI 10.1111/j.1420-9101.2010.02056.x; SHERMAN PW, 1997, BEHAV ECOLOGY; Simms EL, 1998, P ROY SOC B-BIOL SCI, V265, P1713, DOI 10.1098/rspb.1998.0493; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; TEMPE J, 1982, CR ACAD SCI III-VIE, V295, P413; Van Dyken JD, 2010, EVOLUTION, V64, P2840, DOI 10.1111/j.1558-5646.2010.01033.x; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; WADE MJ, 1985, AM NAT, V125, P61, DOI 10.1086/284328; WADE MJ, 1980, EVOLUTION, V34, P844, DOI 10.1111/j.1558-5646.1980.tb04023.x; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878	46	8	8	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95141	10.1371/journal.pone.0095141	http://dx.doi.org/10.1371/journal.pone.0095141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24762776	Green Published, Green Submitted, gold			2022-12-25	WOS:000335505000014
J	Dyment, NA; Hagiwara, Y; Matthews, BG; Li, YC; Kalajzic, I; Rowe, DW				Dyment, Nathaniel A.; Hagiwara, Yusuke; Matthews, Brya G.; Li, Yingcui; Kalajzic, Ivo; Rowe, David W.			Lineage Tracing of Resident Tendon Progenitor Cells during Growth and Natural Healing	PLOS ONE			English	Article							STEM-CELLS; PATELLAR TENDON; IDENTIFICATION; SCLERAXIS; CARTILAGE; REPAIR; GENE	Unlike during embryogenesis, the identity of tissue resident progenitor cells that contribute to postnatal tendon growth and natural healing is poorly characterized. Therefore, we utilized 1) an inducible Cre driven by alpha smooth muscle actin (SMACreERT2), that identifies mesenchymal progenitors, 2) a constitutively active Cre driven by growth and differentiation factor 5 (GDF5Cre), a critical regulator of joint condensation, in combination with 3) an Ai9 Cre reporter to permanently label SMA9 and GDF5-9 populations and their progeny. In growing mice, SMA9+ cells were found in peritendinous structures and scleraxis-positive (ScxGFP+) cells within the tendon midsubstance and myotendinous junction. The progenitors within the tendon midsubstance were transiently labeled as they displayed a 4-fold expansion from day 2 to day 21 but reduced to baseline levels by day 70. SMA9+ cells were not found within tendon entheses or ligaments in the knee, suggesting a different origin. In contrast to the SMA9 population, GDF5-9+ cells extended from the bone through the enthesis and into a portion of the tendon midsubstance. GDF5-9+ cells were also found throughout the length of the ligaments, indicating a significant variation in the progenitors that contribute to tendons and ligaments. Following tendon injury, SMA9+ paratenon cells were the main contributors to the healing response. SMA9+ cells extended over the defect space at 1 week and differentiated into ScxGFP+ cells at 2 weeks, which coincided with increased collagen signal in the paratenon bridge. Thus, SMA9-labeled cells represent a unique progenitor source that contributes to the tendon midsubstance, paratenon, and myotendinous junction during growth and natural healing, while GDF5 progenitors contribute to tendon enthesis and ligament development. Understanding the mechanisms that regulate the expansion and differentiation of these progenitors may prove crucial to improving future repair strategies.	[Dyment, Nathaniel A.; Hagiwara, Yusuke; Matthews, Brya G.; Li, Yingcui; Kalajzic, Ivo; Rowe, David W.] Univ Connecticut, Ctr Hlth, Coll Dent Med, Dept Reconstruct Sci, Farmington, CT 06030 USA; [Li, Yingcui] Univ Hartford, Coll Arts & Sci, Dept Biol, Hartford, CT USA	University of Connecticut; University of Hartford	Dyment, NA (corresponding author), Univ Connecticut, Ctr Hlth, Coll Dent Med, Dept Reconstruct Sci, Farmington, CT 06030 USA.	dyment@uchc.edu	Dyment, Nathaniel/AAD-6747-2021; Matthews, Brya/B-9812-2013	Dyment, Nathaniel/0000-0001-8708-112X; Matthews, Brya/0000-0002-4145-4696	NIH [R01-AR54713, R01-AR052374, R01-AR055607, T90-DE021989]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052374, R01AR055607, R01AR054713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by NIH R01-AR54713, R01-AR052374, R01-AR055607, and T90-DE021989. http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Blitz E, 2013, DEVELOPMENT, V140, P2680, DOI 10.1242/dev.093906; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Charvet Benjamin, 2012, Muscles Ligaments Tendons J, V2, P53; Chhabra A, 2003, J ORTHOP RES, V21, P826, DOI 10.1016/S0736-0266(03)00049-4; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dyment NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059944; Dyment NA, 2012, J ORTHOP RES, V30, P28, DOI 10.1002/jor.21484; Grcevic D, 2012, STEM CELLS, V30, P187, DOI 10.1002/stem.780; Kalajzic Z, 2008, BONE, V43, P501, DOI 10.1016/j.bone.2008.04.023; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matthews BG, 2014, J BONE MINE IN PRESS; Miguel SMS, 2010, J PERIODONTAL RES, V45, P60, DOI 10.1111/j.1600-0765.2009.01201.x; Ni M, 2012, J ORTHOP RES, V30, P613, DOI 10.1002/jor.21559; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Roguljic H, 2013, J DENT RES, V92, P709, DOI 10.1177/0022034513493434; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-274; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Tan Q, 2013, STEM CELLS DEV, V22, P3128, DOI 10.1089/scd.2013.0073; Tempfer H, 2009, HISTOCHEM CELL BIOL, V131, P733, DOI 10.1007/s00418-009-0581-5; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122	28	92	94	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e96113	10.1371/journal.pone.0096113	http://dx.doi.org/10.1371/journal.pone.0096113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759953	gold, Green Published			2022-12-25	WOS:000335298200136
J	Nguyen, CV; Lovell, DR; Adcock, M; La Salle, J				Nguyen, Chuong V.; Lovell, David R.; Adcock, Matt; La Salle, John			Capturing Natural-Colour 3D Models of Insects for Species Discovery and Diagnostics	PLOS ONE			English	Article							DIGITIZATION; COLLECTIONS; BIODIVERSITY; TAXONOMY; SHAPE	Collections of biological specimens are fundamental to scientific understanding and characterization of natural diversity-past, present and future. This paper presents a system for liberating useful information from physical collections by bringing specimens into the digital domain so they can be more readily shared, analyzed, annotated and compared. It focuses on insects and is strongly motivated by the desire to accelerate and augment current practices in insect taxonomy which predominantly use text, 2D diagrams and images to describe and characterize species. While these traditional kinds of descriptions are informative and useful, they cannot cover insect specimens "from all angles'' and precious specimens are still exchanged between researchers and collections for this reason. Furthermore, insects can be complex in structure and pose many challenges to computer vision systems. We present a new prototype for a practical, cost-effective system of off-the-shelf components to acquire natural-colour 3D models of insects from around 3 mm to 30 mm in length. ("Natural-colour'' is used to contrast with "false-colour'', i.e., colour generated from, or applied to, gray-scale data post-acquisition.) Colour images are captured from different angles and focal depths using a digital single lens reflex (DSLR) camera rig and two-axis turntable. These 2D images are processed into 3D reconstructions using software based on a visual hull algorithm. The resulting models are compact (around 10 megabytes), afford excellent optical resolution, and can be readily embedded into documents and web pages, as well as viewed on mobile devices. The system is portable, safe, relatively affordable, and complements the sort of volumetric data that can be acquired by computed tomography. This system provides a new way to augment the description and documentation of insect species holotypes, reducing the need to handle or ship specimens. It opens up new opportunities to collect data for research, education, art, entertainment, biodiversity assessment and biosecurity control.	[Nguyen, Chuong V.; Lovell, David R.; Adcock, Matt; La Salle, John] CSIRO, Canberra, ACT, Australia; [La Salle, John] Atlas Living Australia, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Nguyen, CV (corresponding author), CSIRO, Canberra, ACT, Australia.	chuong.nguyen@csiro.au	La Salle, John/B-9544-2008; Nguyen, Chuong/B-7993-2009; Lovell, David/A-4558-2009	La Salle, John/0000-0002-8816-9569; Nguyen, Chuong/0000-0002-3167-3422; Lovell, David/0000-0002-3938-7586	CSIRO OCE Science; CSIRO Tranformational Biology TCP; CSIRO Computational Informatics BSA	CSIRO OCE Science; CSIRO Tranformational Biology TCP(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Computational Informatics BSA	The work is funded by CSIRO OCE Science, CSIRO Tranformational Biology TCP, CSIRO Computational Informatics BSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkari N, 2013, ZOOKEYS, P5, DOI 10.3897/zookeys.328.5763; Ang Y, 2013, SYST ENTOMOL, V38, P637, DOI 10.1111/syen.12015; Atsushi K, 2011, COMPUT AIDED DESIGN, V43, P1045, DOI 10.1016/j.cad.2011.01.019; Balke M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-55; Beaman RS, 2012, ZOOKEYS, P7, DOI 10.3897/zookeys.209.3313; Blagoderov V, 2012, ZOOKEYS, P133, DOI 10.3897/zookeys.209.3178; Cheung DKB, 2013, ZOOKEYS, P47, DOI 10.3897/zookeys.328.5768; Nguyen C, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION WORKSHOPS (ICCVW), P161, DOI 10.1109/ICCVW.2013.27; Creative Dimension Software Ltd, 2013, 3DSOM; D'Angelo P, 2013, HUGIN ENFUSE; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Forbes K, 2009, VISUAL HULLS UNCALIB; Franco J.-S., 2003, BRIT MACH VIS C BMVC, V1, P329, DOI [DOI 10.5244/C.17.32, 10.5244/C.17.32]; Furukawa Y., 2010, CLUSTERING VIEWS MUL; Furukawa Y, 2010, IEEE T PATTERN ANAL, V32, P1362, DOI 10.1109/TPAMI.2009.161; Gallo A, 2013, J CULTURAL IN PRESS; GigaPan Systems, 2013, GIGAPAN STOR PROD SO; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Goesele M., 2006, PROC IEEE COMPUT SOC, V2, P2402, DOI [10.1109/CVPR.2006.199, DOI 10.1109/CVPR.2006.199]; Hadley A., 2010, COMBINEZP; Hartley Richard, 2004, MULTIPLE VIEW GEOMET, V2, DOI [10.1017/CBO9780511811685, DOI 10.1017/CBO9780511811685, DOI 10.1017/CB09780511811685]; HeliconSoft, 2013, HEL FOC; Hernandez C, 2010, STUD COMPUT INTELL, V285, P281; Johnson L, 2013, ZOOKEYS, P77, DOI 10.3897/zookeys.276.4207; Kutulakos KN, 2000, INT J COMPUT VISION, V38, P199, DOI 10.1023/A:1008191222954; Kuzminsky SC, 2012, J ARCHAEOL SCI, V39, P2744, DOI 10.1016/j.jas.2012.04.020; La Salle J, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2217.1.3; LAURENTINI A, 1994, IEEE T PATTERN ANAL, V16, P150, DOI 10.1109/34.273735; Mantle BL, 2012, ZOOKEYS, P147, DOI 10.3897/zookeys.209.3169; McNally R. S., 1993, J AM I CONSERVATION, V32, P231, DOI DOI 10.2307/3179546; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Murakawa Jun, 2006, P EUR C SKETCH BAS I, P67, DOI [10.2312/SBM/SBM06/067-074, DOI 10.2312/SBM/SBM06/067-074]; NextEngine, 2013, NEXTENGINE 3D SCANN; Nguyen C, 2014, INSECT COLLECTIONS G, DOI [10.4225/08/531FE0104C11A, DOI 10.4225/08/531FE0104C11A]; Nguyen C, 2014, 3D RECONSTRUCTION MU, DOI [10.4225/08/531E56D86DDD5, DOI 10.4225/08/531E56D86DDD5]; Nguyen CV, 2013, DEMO NATURAL COLOR 3; Ortery, 2013, PHOT 5000 AUT 3D PRO; Polo ME, 2012, SENSORS-BASEL, V12, P9046, DOI 10.3390/s120709046; Ritz M, 2012, COMPUT GRAPH-UK, V36, P16, DOI 10.1016/j.cag.2011.10.004; Seitz S.M., 2006, P IEEE COMPUTER SOC, P519; Sinha SN, 2005, IEEE I CONF COMP VIS, P349; Smith VS, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.209.3699; Snavely N, 2010, BUNLDER STRUCTURE MO; Szeliski R, 2011, TEXTS COMPUT SCI, P181, DOI 10.1007/978-1-84882-935-0_4; Tola E, 2012, MACH VISION APPL, V23, P903, DOI 10.1007/s00138-011-0346-8; Wheeler Q, 2012, ZOOKEYS, P193, DOI 10.3897/zookeys.209.3486; X3DOM, 2014, X3DOM INST 3D HTML W; Zhang X, 2010, CONTR AUT ROB VIS IC	48	81	87	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94346	10.1371/journal.pone.0094346	http://dx.doi.org/10.1371/journal.pone.0094346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759838	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200014
J	Wang, J; Gu, SS; Pang, N; Wang, FQ; Pang, F; Cui, HS; Wu, XY; Wu, FA				Wang, Jun; Gu, Shuang-Shuang; Pang, Na; Wang, Fang-Qin; Pang, Fei; Cui, Hong-Sheng; Wu, Xiang-Yang; Wu, Fu-An			Alkyl Caffeates Improve the Antioxidant Activity, Antitumor Property and Oxidation Stability of Edible Oil	PLOS ONE			English	Article							ACID PHENETHYL ESTER; CANCER-CELL-LINES; CAFFEIC ACID; HYDROXYCINNAMIC ACIDS; IN-VITRO; DERIVATIVES; BIODIESEL; (E)-3-(3,4-DIHYDROXYPHENYL)ACRYLATE; PROPOLIS; LIPASE	Caffeic acid (CA) is distributed widely in nature and possesses strong antioxidant activity. However, CA has lower solubility in non-polar media, which limits its application in fat-soluble food. To increase the lipophilicity of natural antioxidant CA, a series of alkyl caffeates were synthesized and their antioxidant and antitumor activities were investigated. The antioxidant parameters, including the induction period, acid value and unsaturated fatty acid content, of the alkyl caffeates in edible oil were firstly investigated. The results indicated that alkyl caffeates had a lower DPPH IC50 (14-23 mu M) compared to CA, dibutyl hydroxy toluene (BHT) and Vitamin C (24-51 mu M), and significantly inhibited four human cancer cells (SW620, SW480, SGC7901 and HepG2) with inhibition ratio of 71.4-78.0% by a MTT assay. With regard to the induction period and acid value assays, methyl and butyl caffeates had higher abilities than BHT to restrain the oxidation process and improve the stability of edible oil. The addition of ethyl caffeate to oil allowed maintenance of a higher unsaturated fatty acid methyl ester content (68.53%) at high temperatures. Overall, the alkyl caffeats with short chain length (n<5) assessed better oxidative stability than those with long chain length. To date, this is the first report to the correlations among the antioxidant activity, anticancer activity and oxidative stability of alkyl caffeates.	[Wang, Jun; Gu, Shuang-Shuang; Pang, Na; Wang, Fang-Qin; Pang, Fei; Cui, Hong-Sheng; Wu, Fu-An] Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Peoples R China; [Wang, Jun; Wu, Xiang-Yang] Jiangsu Univ, Sch Environm, Zhenjiang, Peoples R China; [Wang, Jun; Wu, Fu-An] Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang, Peoples R China	Jiangsu University of Science & Technology; Jiangsu University; Chinese Academy of Agricultural Sciences	Wang, J (corresponding author), Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Peoples R China.	jimwang_js@hotmail.com; wuxy@ujs.edu.cn	WANG, JUN/F-6128-2012	WANG, JUN/0000-0003-2569-1461	Natural Science Foundation of China [21206061]; China Postdoctoral Science Foundation Funded Projects [2012M510124, 2013T60505]; Natural Science Foundation of Jiangsu Province [BK2009213]; Qing Lan Project of Jiangsu Province; Undergraduate Innovation Project of Jiangsu Province [2012JSSPITP1482]; Graduate Innovation Project of Jiangsu Province [CXZZ13_0713]; Postdoctoral Science Foundation [1143002085]; Start Project for Introduced Talent at Jiangsu University of Science and Technology [35211002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation Funded Projects(China Postdoctoral Science Foundation); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Qing Lan Project of Jiangsu Province; Undergraduate Innovation Project of Jiangsu Province; Graduate Innovation Project of Jiangsu Province; Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Start Project for Introduced Talent at Jiangsu University of Science and Technology	This work was supported by the Natural Science Foundation of China (21206061, www.nsfc.gov.cn), the China Postdoctoral Science Foundation Funded Projects (2012M510124, 2013T60505, www.chinapostdoctor.org.cn), the Natural Science Foundation of Jiangsu Province (BK2009213, www.jsnsf.gov.cn), the Qing Lan Project of Jiangsu Province (2010, www.ec.js.edu.cn), the Undergraduate Innovation Project of Jiangsu Province (2012JSSPITP1482, www.ec.js.edu.cn), the Graduate Innovation Project of Jiangsu Province (CXZZ13_0713, www.ec.js.edu.cn), the Postdoctoral Science Foundation Funded Project of Jiangsu University (1143002085, www.ujs.edu.cn), and the Start Project for Introduced Talent at Jiangsu University of Science and Technology (35211002, www.just.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banskota AH, 2002, J ETHNOPHARMACOL, V80, P67, DOI 10.1016/S0378-8741(02)00022-3; Barron C, 2007, J CEREAL SCI, V45, P88, DOI 10.1016/j.jcs.2006.07.004; Buzzi FD, 2009, EUR J MED CHEM, V44, P4596, DOI 10.1016/j.ejmech.2009.06.029; Cardenas M, 2006, BIOORGAN MED CHEM, V14, P2966, DOI 10.1016/j.bmc.2005.12.021; Choe E, 2009, COMPR REV FOOD SCI F, V8, P345, DOI 10.1111/j.1541-4337.2009.00085.x; Chou DA, 2012, FOOD CHEM, V131, P1460, DOI 10.1016/j.foodchem.2011.10.027; Damasceno SS, 2013, FUEL, V107, P641, DOI 10.1016/j.fuel.2012.11.045; Ferreira FD, 2013, ELECTROCHIM ACTA, V110, P634, DOI 10.1016/j.electacta.2013.04.148; Fiuza SM, 2004, BIOORGAN MED CHEM, V12, P3581, DOI 10.1016/j.bmc.2004.04.026; Garrido J, 2012, BIOCHIMIE, V94, P961, DOI 10.1016/j.biochi.2011.12.015; Gawlik-Dziki U, 2013, FOOD CHEM TOXICOL, V57, P154, DOI 10.1016/j.fct.2013.03.023; Gawlik-Dziki U, 2012, FOOD RES INT, V49, P469, DOI 10.1016/j.foodres.2012.08.010; Gulcin I, 2006, TOXICOLOGY, V217, P213, DOI 10.1016/j.tox.2005.09.011; Jain S, 2010, RENEW SUST ENERG REV, V14, P763, DOI 10.1016/j.rser.2009.10.005; KAHL R, 1993, Z LEBENSM UNTERS FOR, V196, P329, DOI 10.1007/BF01197931; Kalogeropoulos N, 2009, FOOD CHEM, V116, P452, DOI 10.1016/j.foodchem.2009.02.060; Kartal M, 2003, J ETHNOPHARMACOL, V86, P69, DOI 10.1016/S0378-8741(03)00042-4; Kivevele TT, 2011, FUEL PROCESS TECHNOL, V92, P1244, DOI 10.1016/j.fuproc.2011.02.009; Knothe G, 2007, FUEL PROCESS TECHNOL, V88, P669, DOI 10.1016/j.fuproc.2007.01.005; Kumar A, 2011, BIORESOURCE TECHNOL, V102, P2162, DOI 10.1016/j.biortech.2010.10.027; Lin MY, 1999, J AGR FOOD CHEM, V47, P1460, DOI 10.1021/jf981149l; Maurya DK, 2010, FOOD CHEM TOXICOL, V48, P3369, DOI 10.1016/j.fct.2010.09.006; McCormick RL, 2007, FUEL PROCESS TECHNOL, V88, P651, DOI 10.1016/j.fuproc.2007.01.006; Pang N, 2013, BIORESOURCE TECHNOL, V139, P337, DOI 10.1016/j.biortech.2013.04.057; Rhodes DI, 2002, J CEREAL SCI, V36, P67, DOI 10.1006/jcrs.2001.0449; Roche M, 2005, ORG BIOMOL CHEM, V3, P423, DOI 10.1039/b416101g; Tang HY, 2010, ENERG FUEL, V24, P2028, DOI 10.1021/ef9012032; Uwai K, 2008, BIOORGAN MED CHEM, V16, P7795, DOI 10.1016/j.bmc.2008.07.006; Wang J, 2014, BIORESOURCE TECHNOL, V158, P39, DOI 10.1016/j.biortech.2014.01.145; Wang J, 2013, J SERB CHEM SOC, V78, P1023, DOI 10.2298/JSC120802101W; Wang J, 2013, EUR J LIPID SCI TECH, V115, P791, DOI 10.1002/ejlt.201200324; Wang J, 2012, ACTA CRYSTALLOGR E, V68, pO78, DOI 10.1107/S1600536811051671; Wang J, 2011, ACTA CRYSTALLOGR E, V67, pO2871, DOI 10.1107/S1600536811040499; Wu WM, 2007, FOOD CHEM, V105, P107, DOI 10.1016/j.foodchem.2007.03.049; Yadav MP, 2007, J AGR FOOD CHEM, V55, P943, DOI 10.1021/jf0624493	35	15	21	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95909	10.1371/journal.pone.0095909	http://dx.doi.org/10.1371/journal.pone.0095909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24760050	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200106
J	Burk, RF; Hill, KE; Motley, AK; Winfrey, VP; Kurokawa, S; Mitchell, SL; Zhang, WQ				Burk, Raymond F.; Hill, Kristina E.; Motley, Amy K.; Winfrey, Virginia P.; Kurokawa, Suguru; Mitchell, Stuart L.; Zhang, Wanqi			Selenoprotein P and apolipoprotein E receptor-2 interact at the blood-brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration	FASEB JOURNAL			English	Article						choroid plexus; megalin	NEUROLOGICAL DYSFUNCTION; MOUSE-BRAIN; EXPRESSION; MAINTENANCE; DELETION; MICE; TRANSPORT; BINDING; KIDNEY; DOMAIN	Selenoprotein P (Sepp1) and its receptor, apolipoprotein E receptor 2 (apoER2), account for brain retaining selenium better than other tissues. The primary sources of Sepp1 in plasma and brain are hepatocytes and astrocytes, respectively. ApoER2 is expressed in varying amounts by tissues; within the brain it is expressed primarily by neurons. Knockout of Sepp1 or apoER2 lowers brain selenium from similar to 120 to similar to 50 ng/g and leads to severe neurodegeneration and death in mild selenium deficiency. Interactions of Sepp1 and apoER2 that protect against this injury have not been characterized. We studied Sepp1, apoER2, and brain selenium in knockout mice. Immunocytochemistry showed that apoER2 mediates Sepp1 uptake at the blood-brain barrier. When Sepp1(-/-) or apoER2(-/-) mice developed severe neurodegeneration caused by mild selenium deficiency, brain selenium was similar to 35 ng/g. In extreme selenium deficiency, however, brain selenium of similar to 12 ng/g was tolerated when both Sepp1 and apoER2 were intact in the brain. These findings indicate that tandem Sepp1-apoER2 interactions supply selenium for maintenance of brain neurons. One interaction is at the blood-brain barrier, and the other is within the brain. We postulate that Sepp1 inside the blood-brain barrier is taken up by neurons via apoER2, concentrating brain selenium in them.-Burk, R. F., Hill, K. E., Motley, A. K., Winfrey, V. P., Kurokawa, S., Mitchell, S. L., Zhang, W. Selenoprotein P and apolipoprotein E receptor-2 interact at the blood-brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration.	[Burk, Raymond F.; Hill, Kristina E.; Motley, Amy K.; Winfrey, Virginia P.; Kurokawa, Suguru; Mitchell, Stuart L.; Zhang, Wanqi] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA	Vanderbilt University	Burk, RF (corresponding author), Vanderbilt Univ Sch Med, 1030C Med Res Bldg 4, Nashville, TN 37232 USA.	raymond.burk@vanderbilt.edu	Mitchell, Stuart L/S-3419-2017; 张, 万起/M-5158-2019	Mitchell, Stuart L/0000-0001-9066-1088; 	U.S. National Institutes of Health [R37 ES-002497, 5P30 DK-058404, 5P30 ES-000267]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002497, P30ES000267] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors are grateful to Teri D. Stevenson for animal husbandry and to Dr. William E. Valentine for a critical reading of the manuscript and helpful suggestions for its improvement. The work reported here was supported by U.S. National Institutes of Health grants R37 ES-002497, 5P30 DK-058404, and 5P30 ES-000267. The authors declare no conflicts of interest.	BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Burk RF, 2013, FASEB J, V27, P3249, DOI 10.1096/fj.13-231852; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Chiu-Ugalde J, 2010, BIOCHEM J, V431, P103, DOI 10.1042/BJ20100779; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Clatworthy AE, 1999, NEUROSCIENCE, V90, P903, DOI 10.1016/S0306-4522(98)00489-8; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hill KE, 2007, J BIOL CHEM, V282, P10972, DOI 10.1074/jbc.M700436200; Hill KE, 2012, J BIOL CHEM, V287, P40414, DOI 10.1074/jbc.M112.421404; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; KOH TS, 1983, J ASSOC OFF ANA CHEM, V66, P918; Kurokawa S, 2014, J BIOL CHEM, V289, P9195, DOI 10.1074/jbc.M114.549014; Kurokawa S, 2014, FREE RADICAL BIO MED, V69, P67, DOI 10.1016/j.freeradbiomed.2014.01.010; Kurokawa S, 2012, J BIOL CHEM, V287, P28717, DOI 10.1074/jbc.M112.383521; May P, 2005, CELL MOL LIFE SCI, V62, P2325, DOI 10.1007/s00018-005-5231-z; Michalke B, 2011, J ANAL ATOM SPECTROM, V26, P165, DOI 10.1039/c0ja00106f; Nakayama A, 2007, J NUTR, V137, P690, DOI 10.1093/jn/137.3.690; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Peters MM, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-12; Pitts MW, 2012, NEUROSCIENCE, V208, P58, DOI 10.1016/j.neuroscience.2012.02.017; Renko K, 2008, BIOCHEM J, V409, P741, DOI 10.1042/BJ20071172; Scharpf M, 2007, J NEURAL TRANSM, V114, P877, DOI 10.1007/s00702-006-0617-0; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; SHEEHAN TMT, 1990, CLIN CHEM, V36, P2124; Spector R, 2006, PHARM RES-DORDR, V23, P2515, DOI 10.1007/s11095-006-9091-5; Trotter JH, 2011, J NEUROSCI, V31, P14413, DOI 10.1523/JNEUROSCI.3135-11.2011; Valentine WM, 2008, J NEUROPATH EXP NEUR, V67, P68, DOI 10.1097/NEN.0b013e318160f347; WALLACE E, 1983, GAMETE RES, V7, P377, DOI 10.1002/mrd.1120070409; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Yang XG, 2000, BBA-GEN SUBJECTS, V1474, P390, DOI 10.1016/S0304-4165(00)00035-0; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531, DOI 10.1177/42.4.7510321	35	80	81	4	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3579	3588		10.1096/fj.14-252874	http://dx.doi.org/10.1096/fj.14-252874			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24760755	Bronze, Green Published			2022-12-25	WOS:000340265400026
J	Tian, S; Hui, XW; Fan, ZZ; Li, QS; Zhang, JW; Yang, X; Ma, XL; Huang, BR; Chen, D; Chen, H				Tian, Shuo; Hui, Xiwu; Fan, Zhenzhen; Li, Qinshan; Zhang, Junwen; Yang, Xia; Ma, Xiaoli; Huang, Bingren; Chen, Deng; Chen, Hong			Suppression of hepatocellular carcinoma proliferation and hepatitis B surface antigen secretion with interferon-lambda 1 or PEG-interferon-lambda 1	FASEB JOURNAL			English	Article						tumor apoptosis; antitumor therapy	ANTITUMOR-ACTIVITY; VIRAL-HEPATITIS; GENE-EXPRESSION; ALPHA THERAPY; TUMOR-GROWTH; IN-VIVO; VIRUS; LAMBDA; RECURRENCE; APOPTOSIS	Hepatocellular carcinoma (HCC) is a common cancer associated with chronic hepatitis B virus (HBV) infection. Conventional interferon-alpha (IFN-alpha) and pegylated IFNs (PEG-IFNs) approved for chronic HBV infection treatment can reduce the risk of HCC but are not suitable for the majority of patients and cause significant side effects. IFN-lambda 1 is a type III IFN with antiviral, antiproliferative, and immunomodulatory functions similar to type I IFNs but with fewer side effects. However, the tolerability and antitumor activity of PEG-IFN-lambda 1 in HCC xenograft mice are unknown. In vitro IFN-lambda 1 treatment of Hep3B and Huh7 human hepatoma cell lines increased MHC class I expression, activated JAK-STAT signaling pathways, induced IFN-stimulated gene expression, and inhibited hepatitis B surface antigen (HBsAg) expression. IFN-lambda 1 treatment also caused 23.2 and 19.9% growth inhibition of Hep3B and Huh7 cells, respectively, and promoted cellular apoptosis. PEG-IFN-lambda 1, but not IFN-lambda 1 treatment, significantly suppressed tumor growth (P = 0.002) and induced tumor cell apoptosis in a Hep3B cell xenograft mouse model without significant weight loss or toxicity. PEG-IFN-lambda 1 also significantly inhibited (P = 0.000) serum HBsAg secretion from Hep3B xenograft tumors in vivo. Thus, PEG-IFN-lambda 1 can suppress Hep3B xenograft tumor growth and inhibit HBsAg production and may be a potential treatment for HBV-related HCC.	[Tian, Shuo; Hui, Xiwu; Fan, Zhenzhen; Li, Qinshan; Zhang, Junwen; Yang, Xia; Ma, Xiaoli; Huang, Bingren; Chen, Deng; Chen, Hong] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; [Tian, Shuo; Hui, Xiwu; Fan, Zhenzhen; Li, Qinshan; Zhang, Junwen; Yang, Xia; Ma, Xiaoli; Huang, Bingren; Chen, Deng; Chen, Hong] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Hui, Xiwu] CSPC ZhongQi Pharmaceut Technol, Shijiazhuang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, H (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	chendeng2001@hotmail.com; hchen@public.bta.net.cn	hui, xiwu/AAO-3650-2021		National Laboratory of Medical Molecular Biology of China	National Laboratory of Medical Molecular Biology of China	The authors are grateful to the National Laboratory of Medical Molecular Biology of China for grant support.	Abushahba W, 2010, CANCER IMMUNOL IMMUN, V59, P1059, DOI 10.1007/s00262-010-0831-3; Bell SJ, 2008, BIOCONJUGATE CHEM, V19, P299, DOI 10.1021/bc070131q; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Chae SY, 2010, MOL CANCER THER, V9, P1719, DOI 10.1158/1535-7163.MCT-09-1076; Chen HC, 1997, ANTIVIR RES, V34, P137, DOI 10.1016/S0166-3542(97)01031-0; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Guenterberg KD, 2010, MOL CANCER THER, V9, P510, DOI 10.1158/1535-7163.MCT-09-0461; Hong SH, 2007, VIRUS RES, V126, P245, DOI 10.1016/j.virusres.2007.03.006; HSU SL, 1993, J BIOL CHEM, V268, P23093; Hui XW, 2011, CANCER LETT, V311, P141, DOI 10.1016/j.canlet.2011.07.004; Ikeda K, 2005, J GASTROEN HEPATOL, V20, P95, DOI 10.1111/j.1440-1746.2004.03527.x; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kim TH, 2011, BIOCONJUGATE CHEM, V22, P1631, DOI 10.1021/bc200187k; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; La QH, 2010, EUR J CANCER, V46, P180, DOI 10.1016/j.ejca.2009.10.002; Lee D, 2012, DIGEST DIS, V30, P568, DOI 10.1159/000343068; Li W, 2008, CELL PROLIFERAT, V41, P960, DOI 10.1111/j.1365-2184.2008.00558.x; Lin SM, 1999, HEPATOLOGY, V29, P971, DOI 10.1002/hep.510290312; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Marcellin P, 2005, J VIRAL HEPATITIS, V12, P333, DOI 10.1111/j.1365-2893.2005.00599.x; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Michielsen P, 2011, ACTA GASTRO-ENT BELG, V74, P4; Miller DM, 2009, ANN NY ACAD SCI, V1182, P80, DOI 10.1111/j.1749-6632.2009.05241.x; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Qu LS, 2010, J SURG ONCOL, V102, P796, DOI 10.1002/jso.21741; Qu LS, 2010, J GASTROINTEST SURG, V14, P1111, DOI 10.1007/s11605-010-1211-1; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Someya T, 2006, J GASTROENTEROL, V41, P1206, DOI 10.1007/s00535-006-1912-0; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Wang L, 2000, HEPATOLOGY, V32, P43, DOI 10.1053/jhep.2000.8525; Wang YJ, 2010, J CONTROL RELEASE, V145, P306, DOI 10.1016/j.jconrel.2010.04.021; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Xie YF, 2007, J BIOTECHNOL, V129, P472, DOI 10.1016/j.jbiotec.2007.01.018; Yan YL, 2013, CANCER BIOTHER RADIO, V28, P124, DOI 10.1089/cbr.2012.1247; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06; Zhuang PY, 2010, J CANCER RES CLIN, V136, P1891, DOI 10.1007/s00432-010-0848-1; Zitzmann K, 2006, BIOCHEM BIOPH RES CO, V344, P1334, DOI 10.1016/j.bbrc.2006.04.043	46	9	12	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3528	3539		10.1096/fj.14-250704	http://dx.doi.org/10.1096/fj.14-250704			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24769671				2022-12-25	WOS:000340265400022
J	Di Filippo, M; Marcais, C; Charriere, S; Marmontel, O; Broyer, M; Delay, M; Merlin, M; Nollace, A; Valero, R; Lagarde, M; Pruneta-Deloche, V; Moulin, P; Sassolas, A				Di Filippo, Mathilde; Marcais, Christophe; Charriere, Sybil; Marmontel, Oriane; Broyer, Martine; Delay, Mireille; Merlin, Micheline; Nollace, Axel; Valero, Rene; Lagarde, Michel; Pruneta-Deloche, Valerie; Moulin, Philippe; Sassolas, Agnes			Post-Heparin LPL Activity Measurement Using VLDL As a Substrate: A New Robust Method for Routine Assessment of Plasma Triglyceride Lipolysis Defects	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE DEFICIENCY; APOLIPOPROTEIN C-II; HEPATIC LIPASE; SEVERE HYPERTRIGLYCERIDEMIA; SELECTIVE MEASUREMENT; ASSAY; MUTATIONS; HYPERCHYLOMICRONEMIA; METABOLISM; GENETICS	Background: Determination of lipoprotein lipase (LPL) activity is important for hyperchylomicronemia diagnosis, but remains both unreliable and cumbersome with current methods. Consequently by using human VLDL as substrate we developed a new LPL assay which does not require sonication, radioactive or fluorescent particles. Methods: Post-heparin plasma was added to the VLDL substrate prepared by ultracentrifugation of heat inactivated normolipidemic human serums, diluted in buffer, pH 8.15. Following incubation at 37 degrees c, the NEFA (non esterified fatty acids) produced were assayed hourly for 4 hours. LPL activity was expressed as mmol/l/min after subtraction of hepatic lipase (HL) activity, obtained following LPL inhibition with NaCl 1.5 mmol/l. Molecular analysis of LPL, GPIHBP1, APOA5, APOC2, APOE genes was available for 62 patients. Results: Our method was reproducible (coefficient of variation (CV): intra-assay 5.6%, inter-assay 7.1%), and tightly correlated with the conventional radiolabelled triolein emulsion method (n = 26, r = 0.88). Normal values were established at 34.8 +/- 12.8 mu mol/l/min (mean +/- SD) from 20 control subjects. LPL activities obtained from 71 patients with documented history of major hypertriglyceridemia showed a trimodal distribution. Among the 11 patients with a very low LPL activity (<10 mu mol/l/min), 5 were homozygous or compound heterozygous for LPL or GPIHBP1 deleterious mutations, 3 were compound heterozygous for APOA5 deleterious mutations and the p.S19W APOA5 susceptibility variant, and 2 were free of any mutations in the usual candidate genes. No homozygous gene alteration in LPL, GPIHBP1 and APOC2 genes was found in any of the patients with LPL activity >10 mu mol/l/min. Conclusion: This new reproducible method is a valuable tool for routine diagnosis and reliably identifies LPL activity defects.	[Di Filippo, Mathilde; Marmontel, Oriane; Broyer, Martine; Nollace, Axel; Sassolas, Agnes] Hosp Civils Lyon, Ctr Biol & Pathol Est, Lab Biol Med Multi Sites, UF Dyslipidemies Cardiobiol, Bron, France; [Di Filippo, Mathilde; Marcais, Christophe; Charriere, Sybil; Lagarde, Michel; Pruneta-Deloche, Valerie; Moulin, Philippe; Sassolas, Agnes] Univ Lyon 1, INRA U1235, INSERM U1060, INSA Lyon, Villeurbanne, Oullins, France; [Marcais, Christophe; Delay, Mireille; Merlin, Micheline] Hosp Civils Lyon, Lab Biol Med Multi Sites, Ctr Hosp Lyon Sud, Ctr Biol Sud,Lab Biochim Specialisee, Pierre Benite, France; [Charriere, Sybil; Moulin, Philippe] Hosp Civils Lyon, Hop Louis Pradel, Bron, France; [Valero, Rene] Aix Marseille Univ, Hop La Timone, APHM, Dept Nutr, Marseille, France	CHU Lyon; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Di Filippo, M (corresponding author), Hosp Civils Lyon, Ctr Biol & Pathol Est, Lab Biol Med Multi Sites, UF Dyslipidemies Cardiobiol, Bron, France.	mathilde.di-filippo@chu-lyon.fr	Carmen, Team1/Y-7382-2019; charriere, sybil/AAG-1603-2021; Carmen, Team2/Y-7383-2019; Di Filippo, Mathilde/C-2234-2016	Carmen, Team1/0000-0003-4234-1746; Carmen, Team2/0000-0001-9867-5724; VALERO, RENE/0000-0002-2176-3280; Lab, Carmen/0000-0002-5935-3236; Di Filippo, Mathilde/0000-0001-6206-5908				BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P326, DOI 10.1161/01.ATV.9.3.326; BAGINSKY ML, 1979, J LIPID RES, V20, P548; Basu D, 2011, J LIPID RES, V52, P826, DOI 10.1194/jlr.D010744; BIALE Y, 1969, CLIN CHIM ACTA, V23, P413, DOI 10.1016/0009-8981(69)90341-6; BLACHE D, 1983, CLIN CHEM, V29, P154; BOBERG J, 1964, CLIN CHIM ACTA, V10, P420, DOI 10.1016/0009-8981(64)90171-8; Charriere S, 2009, ATHEROSCLEROSIS, V207, P150, DOI 10.1016/j.atherosclerosis.2009.04.021; Charriere S, 2011, J CLIN ENDOCR METAB, V96, pE1675, DOI 10.1210/jc.2011-1444; Coca-Prieto I, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-46; Dallinga-Thie GM, 2010, ATHEROSCLEROSIS, V211, P1, DOI 10.1016/j.atherosclerosis.2009.12.027; Davies BSJ, 2012, CURR OPIN LIPIDOL, V23, P35, DOI 10.1097/MOL.0b013e32834d0b33; DOUSSET N, 1988, LIPIDS, V23, P605, DOI 10.1007/BF02535605; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; Eriksson JW, 2003, ATHEROSCLEROSIS, V166, P359, DOI 10.1016/S0021-9150(02)00366-0; Gotoda T, 2012, J ATHEROSCLER THROMB, V19, P1; HAYDEN MR, 1992, MOL CELL BIOCHEM, V113, P171; HENDERSON AD, 1993, CLIN CHEM, V39, P218; HENDRICKSON HS, 1994, ANAL BIOCHEM, V219, P1, DOI 10.1006/abio.1994.1223; Henriksen FL, 2001, CLIN CHEM LAB MED, V39, P263, DOI 10.1515/CCLM.2001.041; HUTTUNEN JK, 1975, CLIN CHIM ACTA, V63, P335, DOI 10.1016/0009-8981(75)90055-8; Imamura S, 2008, J LIPID RES, V49, P1431, DOI 10.1194/jlr.M700528-JLR200; Johansen CT, 2011, J LIPID RES, V52, P189, DOI 10.1194/jlr.R009720; Marcais C, 2005, J CLIN INVEST, V115, P2862, DOI 10.1172/JCI24471; Marcais C, 2000, DIABETOLOGIA, V43, P1346, DOI 10.1007/s001250051537; MCFARLAND JT, 1986, BIOCHIM BIOPHYS ACTA, V876, P438, DOI 10.1016/0005-2760(86)90030-5; NICOLL A, 1980, EUR J CLIN INVEST, V10, P487, DOI 10.1111/j.1365-2362.1980.tb02090.x; Nilsson-Ehle P, 1972, CLIN CHIM ACTA, V1972, P383; NILSSONEHLE P, 1976, J LIPID RES, V17, P536; OLIVECRONA G, 1995, CURR OPIN LIPIDOL, V6, P291, DOI 10.1097/00041433-199510000-00009; Ooi EMM, 2012, ARTERIOSCL THROM VAS, V32, P459, DOI 10.1161/ATVBAHA.111.238493; Panteghini M, 2001, ANN CLIN BIOCHEM, V38, P365, DOI 10.1258/0004563011900876; POSNER I, 1983, BIOCHEMISTRY-US, V22, P4041, DOI 10.1021/bi00286a008; Pruneta-Deloche V, 2005, J CLIN ENDOCR METAB, V90, P3995, DOI 10.1210/jc.2005-0205; Rahalkar AR, 2009, CAN J PHYSIOL PHARM, V87, P151, DOI [10.1139/Y09-005, 10.1139/y09-005]; RAWYLER A, 1989, BIOCHIM BIOPHYS ACTA, V1004, P337, DOI 10.1016/0005-2760(89)90082-9; SCHOTZ MC, 1970, J LIPID RES, V11, P68; Surendran RP, 2012, J INTERN MED, V272, P185, DOI 10.1111/j.1365-2796.2012.02516.x; Wicher I, 1996, J IMMUNOL METHODS, V192, P1, DOI 10.1016/0022-1759(95)00260-X	38	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96482	10.1371/journal.pone.0096482	http://dx.doi.org/10.1371/journal.pone.0096482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788417	Green Published, gold			2022-12-25	WOS:000336655700097
J	McKernan, KJ; Spangler, J; Zhang, L; Tadigotla, V; McLaughlin, S; Warner, J; Zare, A; Boles, RG				McKernan, Kevin J.; Spangler, Jessica; Zhang, Lei; Tadigotla, Vasisht; McLaughlin, Stephen; Warner, Jason; Zare, Amir; Boles, Richard G.			Expanded Genetic Codes in Next Generation Sequencing Enable Decontamination and Mitochondrial Enrichment	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CPG METHYLATION; DNA; GENOME; 5-HYDROXYMETHYLCYTOSINE; DELETIONS; FAMILY; BRAIN; BASE; PCR	We have developed a PCR method, coined Deja vu PCR, that utilizes six nucleotides in PCR with two methyl specific restriction enzymes that respectively digest these additional nucleotides. Use of this enzyme-and-nucleotide combination enables what we term a "DNA diode", where DNA can advance in a laboratory in only one direction and cannot feedback into upstream assays. Here we describe aspects of this method that enable consecutive amplification with the introduction of a 5th and 6th base while simultaneously providing methylation dependent mitochondrial DNA enrichment. These additional nucleotides enable a novel DNA decontamination technique that generates ephemeral and easy to decontaminate DNA.	[McKernan, Kevin J.; Spangler, Jessica; Zhang, Lei; Tadigotla, Vasisht; McLaughlin, Stephen; Warner, Jason; Zare, Amir; Boles, Richard G.] Courtagen Life Sci, Woburn, MA USA		McKernan, KJ (corresponding author), Courtagen Life Sci, Woburn, MA USA.	Kevin.McKernan@courtagen.com		McKernan, Kevin/0000-0002-3908-1122				Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029; Cohen-Karni D, 2011, P NATL ACAD SCI USA, V108, P11040, DOI 10.1073/pnas.1018448108; Cui H, GENET MED; Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500; Falk MJ, 2012, DISCOV MED, V14, P389; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Holman CM, 2012, NAT BIOTECHNOL, V30, P240, DOI 10.1038/nbt.2146; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Hong EE, 2013, MOL CELL BIOL, V33, P2683, DOI 10.1128/MCB.00220-13; Horton JR, 2012, NUCLEIC ACIDS RES, V40, P9763, DOI 10.1093/nar/gks719; Igartua C, 2010, CURR PROTOC HUM GENE, V18; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Keith JM, 2004, BIOINFORMATICS, V20, P2401, DOI 10.1093/bioinformatics/bth258; Keith JM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh022; Keller I, 2007, PLOS GENET, V3, P185, DOI 10.1371/journal.pgen.0030022; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Kraus TFJ, 2012, INT J CANCER, V131, P1577, DOI 10.1002/ijc.27429; KREUDER J, 1995, EUR J PEDIATR, V154, P996, DOI 10.1007/BF01958647; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lalueza-Fox C, 2011, CURR BIOL, V21, pR1002, DOI 10.1016/j.cub.2011.11.021; Lay MJ, 1997, CLIN CHEM, V43, P2262; Lee K, 2014, DEV BIOL, V386, P86, DOI 10.1016/j.ydbio.2013.11.024; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Li MK, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks499; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKernan KJ, 2013, NAT BIOTECHNOL, V31, P884, DOI 10.1038/nbt.2703; McMurray AA, 1998, GENOME RES, V8, P562, DOI 10.1101/gr.8.5.562; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; Munzel M, 2011, ANGEW CHEM INT EDIT, V50, P6460, DOI 10.1002/anie.201101547; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nestor C, 2010, BIOTECHNIQUES, V48, P317, DOI 10.2144/000113403; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; PEAK MJ, 1995, J BACTERIOL, V177, P6316, DOI 10.1128/jb.177.21.6316-6318.1995; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tarnopoisky M, 2013, AM J MED GENET A, V161, P2020, DOI 10.1002/ajmg.a.36000; Trakadis YJ, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-31; von Ahsen N, 2001, CLIN CHEM, V47, P1956; Wang H, 2011, NUCLEIC ACIDS RES, V39, P9294, DOI 10.1093/nar/gkr607; Wardle J, 2008, NUCLEIC ACIDS RES, V36, P705, DOI 10.1093/nar/gkm1023; Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438	48	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96492	10.1371/journal.pone.0096492	http://dx.doi.org/10.1371/journal.pone.0096492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788618	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700098
J	Miko, I; Copeland, RS; Balhoff, JP; Yoder, MJ; Deans, AR				Miko, Istvan; Copeland, Robert S.; Balhoff, James P.; Yoder, Matthew J.; Deans, Andrew R.			Folding Wings like a Cockroach: A Review of Transverse Wing Folding Ensign Wasps (Hymenoptera: Evaniidae: Afrevania and Trissevania)	PLOS ONE			English	Article							FUNCTIONAL-MORPHOLOGY; BASE; INSECTA	We revise two relatively rare ensign wasp genera, whose species are restricted to Sub-Saharan Africa: Afrevania and Trissevania. Afrevania longipetiolata sp. nov., Trissevania heatherae sp. nov., T. hugoi sp. nov., T. mrimaensis sp. nov. and T. slideri sp. nov. are described, males and females of T. anemotis and Afrevania leroyi are redescribed, and an identification key for Trissevaniini is provided. We argue that Trissevania mrimaensis sp. nov. and T. heatherae sp. nov. populations are vulnerable, given their limited distributions and threats from mining activities in Kenya. We hypothesize that these taxa together comprise a monophyletic lineage, Trissevaniini, tr. nov., the members of which share the ability to fold their fore wings along two intersecting fold lines. Although wing folding of this type has been described for the hind wing of some insects four-plane wing folding of the fore wing has never been documented. The wing folding mechanism and the pattern of wing folds of Trissevaniini is shared only with some cockroach species (Blattodea). It is an interesting coincidence that all evaniids are predators of cockroach eggs. The major wing fold lines of Trissevaniini likely are not homologous to any known longitudinal anatomical structures on the wings of other Evaniidae. Members of the new tribe share the presence of a coupling mechanism between the fore wing and the mesosoma that is composed of a setal patch on the mesosoma and the retinaculum of the fore wing. While the setal patch is an evolutionary novelty, the retinaculum, which originally evolved to facilitate fore and hind wing coupling in Hymenoptera, exemplifies morphological exaptation. We also refine and clarify the Semantic Phenotype approach used in previous taxonomic revisions and explore the consequences of merging new with existing data. The way that semantic statements are formulated can evolve in parallel, alongside improvements to the ontologies themselves.	[Miko, Istvan; Deans, Andrew R.] Penn State Univ, Frost Entomol Museum, University Pk, PA 16802 USA; [Copeland, Robert S.] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Copeland, Robert S.] Natl Museums Kenya, Nairobi, Kenya; [Balhoff, James P.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Balhoff, James P.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Yoder, Matthew J.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; International Centre of Insect Physiology & Ecology (ICIPE); The National Evolutionary Synthesis Center; University of North Carolina; University of North Carolina Chapel Hill; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Miko, I (corresponding author), Penn State Univ, Frost Entomol Museum, University Pk, PA 16802 USA.	istvan.miko@gmail.com	Deans, Andrew R./AAG-4166-2021	Deans, Andrew R./0000-0002-2119-4663; Balhoff, James/0000-0002-8688-6599; Miko, Istvan/0000-0001-9719-0215	U.S. National Science Foundation [DBI-0850223, DEB-0842289]; Phenotype Research Coordination Network [NSF DEB-0956049]; Direct For Biological Sciences [0956049] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1321620] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Phenotype Research Coordination Network; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the U.S. National Science Foundation (grants DBI-0850223, DEB-0842289) and by the Phenotype Research Coordination Network (NSF DEB-0956049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balhoff JP, 2013, SYST BIOL, V62, P639, DOI 10.1093/sysbio/syt028; Basibuyuk HH, 1997, J NAT HIST, V31, P1563, DOI 10.1080/00222939700770831; Basibuyuk HH, 2002, INSECT SYST EVOL, V33, P23, DOI 10.1163/187631202X00037; Baur H, 2011, SYST BIOL, V60, P813, DOI 10.1093/sysbio/syr061; Burgess ND, 1998, BIOL J LINN SOC, V64, P337, DOI 10.1111/j.1095-8312.1998.tb00337.x; CROSSKEY R. W., 1951, TRANS ROY ENT SOC LONDON, V102, P247; DANFORTH BN, 1988, ANN ENTOMOL SOC AM, V81, P342, DOI 10.1093/aesa/81.2.342; Deans AR, 2006, SYST ENTOMOL, V31, P517, DOI 10.1111/j.1365-3113.2006.00327.x; Deans AR, 2012, TRENDS ECOL EVOL, V27, P78, DOI 10.1016/j.tree.2011.11.007; Deans AR, 2003, P ENTOMOL SOC WASH, V105, P859; EADY RD, 1968, PROC R ENTOMOL SOC A, V43, P66, DOI 10.1111/j.1365-3032.1968.tb01029.x; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Haas F, 1996, P ROY SOC B-BIOL SCI, V263, P1651, DOI 10.1098/rspb.1996.0241; Haas F, 2001, ZOOL-ANAL COMPLEX SY, V104, P123, DOI 10.1078/0944-2006-00017; Haas F, 2012, ARTHROPOD SYST PHYLO, V70, P95; Haas Fabian, 2006, Arthropod Systematics & Phylogeny, V64, P149; Hadley A, 2013, COMBINE ZP NEWS; Hansson C, 2012, ZOOKEYS, P79, DOI 10.3897/zookeys.173.2653; Harris R.A., 1979, California Department of Food and Agriculture Laboratory Services-Entomology Occasional Papers, P1; IUCN, 2012, IUCN RED LIST CAT CR; Kieffer J.J, 1913, INSECTES HYMENOPTERE, V1, P1; LANHAM UN, 1977, J NEW YORK ENTOMOL S, V85, P98; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; MASON WRM, 1986, P ENTOMOL SOC WASH, V88, P1; Mullins PL, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.223.3572; Pacific Wildcat Resources Corporation, 2014, MRIM HILL MRIM HILL; Peters RS, 2011, ZOOTAXA, P1; Prentice, 1998, THESIS U CALIFORNIA; Richards O.W., 1977, HANDBOOKS; Stocks IC, 2010, J MORPHOL, V271, P152, DOI 10.1002/jmor.10788; Vilhelmsen L, 2010, ZOOL J LINN SOC-LOND, V159, P22, DOI 10.1111/j.1096-3642.2009.00576.x; Vogt L, 2013, J MORPHOL, V274, P793, DOI 10.1002/jmor.20138; WOOTTON RJ, 1979, SYST ENTOMOL, V4, P81, DOI 10.1111/j.1365-3113.1979.tb00614.x; WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553; Yoshizawa K, 2012, ENTOMOL SCI, V15, P408, DOI 10.1111/j.1479-8298.2012.00528.x; Yoshizawa K, 2011, SYST ENTOMOL, V36, P377, DOI 10.1111/j.1365-3113.2011.00572.x	36	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94056	10.1371/journal.pone.0094056	http://dx.doi.org/10.1371/journal.pone.0094056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24787704	Green Published, gold, Green Submitted			2022-12-25	WOS:000336655700009
J	Ohoka, Y; Yokota-Nakatsuma, A; Maeda, N; Takeuchi, H; Iwata, M				Ohoka, Yoshiharu; Yokota-Nakatsuma, Aya; Maeda, Naoko; Takeuchi, Hajime; Iwata, Makoto			Retinoic Acid and GM-CSF Coordinately Induce Retinal Dehydrogenase 2 (RALDH2) Expression through Cooperation between the RAR/RXR Complex and Sp1 in Dendritic Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; T-CELLS; SMALL-INTESTINE; BETA-CATENIN; TNF-ALPHA; ALL-TRANS; RECEPTOR; MATURATION; DIFFERENTIATION; CYTOKINE	Retinoic acid (RA)-producing dendritic cells (DCs) play critical roles in gut immunity. Retinal dehydrogenase 2 (RALDH2) encoded by Aldh1a2 is a key enzyme for generating RA in DCs. Granulocyte-macrophage colony-stimulating factor (GM-CSF) potently induces RALDH2 expression in DCs in an RA-dependent manner, and RA alone weakly induces the expression. However, how GM-CSF and RA induce RALDH2 expression remains unclear. Here, we show that GM-CSF-induced activation of the transcription factor Sp1 and RA-dependent signaling via the RA receptor (RAR)/retinoid X receptor (RXR) complex contribute to Aldh1a2 expression. The RAR antagonist LE540 and the Sp1 inhibitor mithramycin A inhibited GM-CSF-induced Aldh1a2 expression in fms-related tyrosine kinase 3 ligand-generated bone marrow-derived DCs (BM-DCs). ERK and p38 MAPK inhibitors suppressed GM-CSF-induced nuclear translocation of Sp1 and Aldh1a2 expression. Sp1 and the RAR alpha/RXR alpha complex bound to GC-rich Sp1-binding sites and an RA response element (RARE) half-site, respectively, near the TATA box in the mouse Aldh1a2 promoter. The DNA sequences around these sites were highly conserved among different species. In the presence of RA, ectopic expression of RAR alpha/RXR alpha and Sp1 synergistically enhanced Aldh1a2 promoter-reporter activity. GM-CSF did not significantly induce Aldh1a2 expression in plasmacytoid DCs, peritoneal macrophages, or T cells, and the Aldh1a2 promoter in these cells was mostly unmethylated. These results suggest that GM-CSF/RA-induced RALDH2 expression in DCs requires cooperative binding of Sp1 and the RAR/RXR complex to the Aldh1a2 promoter, and can be regulated by a DNA methylation-independent mechanism.	[Ohoka, Yoshiharu; Yokota-Nakatsuma, Aya; Maeda, Naoko; Takeuchi, Hajime; Iwata, Makoto] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Immunol Lab, Sanuki, Kagawa, Japan; [Ohoka, Yoshiharu; Yokota-Nakatsuma, Aya; Maeda, Naoko; Takeuchi, Hajime; Iwata, Makoto] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan	Tokushima Bunri University; Japan Science & Technology Agency (JST)	Ohoka, Y (corresponding author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Immunol Lab, Sanuki, Kagawa, Japan.	ookay@kph.bunri-u.ac.jp; iwatam@kph.bunri-u.ac.jp			JSPS [24590106]; MEXT [23390023, 25111514]; Uehara Memorial Foundation; JST, CREST	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by JSPS KAKENHI Grant Number 24590106 (Y. O.), MEXT KAKENHI Grant Number 23390023 and 25111514 (M. I.), and grants from Uehara Memorial Foundation (M. I.) and JST, CREST (M. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bhat PV, 1998, FEBS LETT, V426, P260, DOI 10.1016/S0014-5793(98)00355-X; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Brown AL, 2012, DIFFERENTIATION, V83, P47, DOI 10.1016/j.diff.2011.08.003; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Dawson HD, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-27; Dickerson SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000356; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; Elgueta R, 2008, J IMMUNOL, V180, P6501, DOI 10.4049/jimmunol.180.10.6501; Fukuzawa H, 2003, BIOCHEM BIOPH RES CO, V312, P897, DOI 10.1016/j.bbrc.2003.11.009; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Hsu LC, 2000, BBA-GENE STRUCT EXPR, V1492, P289, DOI 10.1016/S0167-4781(00)00108-1; Huang GH, 2013, J IMMUNOL, V191, P650, DOI 10.4049/jimmunol.1300398; Huq MDM, 2006, EMBO J, V25, P3203, DOI 10.1038/sj.emboj.7601181; Husmann M, 2000, BIOCHEM J, V352, P763, DOI 10.1042/0264-6021:3520763; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jaensson-Gyllenback E, 2011, MUCOSAL IMMUNOL, V4, P438, DOI 10.1038/mi.2010.91; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Michelsen KS, 2001, J BIOL CHEM, V276, P25680, DOI 10.1074/jbc.M011615200; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Ohoka Y, 2011, J IMMUNOL, V186, P733, DOI 10.4049/jimmunol.1000913; Pilette C, 2010, IMMUNOL CELL BIOL, V88, P486, DOI 10.1038/icb.2009.120; Sato K, 1999, J IMMUNOL, V162, P3865; Sato T, 2013, J IMMUNOL, V191, P3152, DOI 10.4049/jimmunol.1203517; Sennikov SV, 2002, J GASTROENTEROL, V37, P1048, DOI 10.1007/s005350200176; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Stock A, 2011, J EXP MED, V208, P761, DOI 10.1084/jem.20101967; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki Y, 1999, BRAIN DEV-JPN, V21, P1; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Villablanca EJ, 2011, GASTROENTEROLOGY, V141, P176, DOI 10.1053/j.gastro.2011.04.010; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wang S, 2011, J IMMUNOL, V187, P141, DOI 10.4049/jimmunol.1003740; Wang XS, 2001, GENOMICS, V74, P245, DOI 10.1006/geno.2001.6546; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003	53	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96512	10.1371/journal.pone.0096512	http://dx.doi.org/10.1371/journal.pone.0096512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788806	Green Submitted, Green Published, gold			2022-12-25	WOS:000336655700102
J	Ouyang, M; Li, YX; Ye, S; Ma, JY; Lu, LM; Lv, WM; Chang, GQ; Li, XX; Li, Q; Wang, SM; Wang, WJ				Ouyang, Mao; Li, Yongxin; Ye, Sheng; Ma, Jieyi; Lu, Liming; Lv, Weiming; Chang, Guangqi; Li, Xiaoxi; Li, Qing; Wang, Shenming; Wang, Wenjian			MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; DOWN-REGULATION; CONFERS RESISTANCE; COLORECTAL-CANCER; UP-REGULATION; INCREASES; CISPLATIN; EXPRESSION; PROMOTES; GROWTH	Objective: Triple-negative breast cancer (TNBC) patients with truly chemosensitive disease still represent a minority among all TNBC patients. The aim of the present study is to identify microRNAs (miRNAs) that correlate with TNBC chemoresistance. Methods: In this study, we conducted miRNAs profile comparison between triple-negative breast cancer (TNBCs) and normal breast tissues by microRNA array. Quantitative real-time PCR (qRT-PCR) was utilized to confirm the specific deregulated miRNAs change trend. We used starBase 2.1 and GOrilla to predict the potential targets of the specific miRNAs. Cells viability and apoptosis assays were employed to determine the effect of alteration of the specific miRNAs in TNBC cells on the chemosensitivity. Results: We identified 11 specific deregulated miRNAs, including 5 up-regulated miRNAs (miR-155-5p, miR-21-3p, miR-181a-5p, miR-181b-5p, and miR-183-5p) and 6 down-regulated miRNAs (miR-10b-5p, miR-451a, miR-125b-5p, miR-31-5p, miR-195-5p and miR-130a-3p). Thereafter, this result was confirmed by qRT-PCR. We predicted the potential targets of the candidate miRNAs and found that they are involved in cancer-associated pathways. For the first time, we found that miR-130a-3p and miR-451a were down-regulated in TNBC. 9 of the 11 specific deregulated miRNAs were found to be associated with chemoresistance. In vitro assays, we found that up-regulation of either miR-130a-3p or miR-451a in MDA-MB-231 cells significantly changed the cells sensitivity to doxorubicin. The results suggest that TNBC chemotherapy might be affected by a cluster of miRNAs. Conclusion: The abnormal expression miRNAs in TNBC are mainly chemoresistance related. This might be part of reason that TNBC likely to evade from chemotherapy resulting in early relapse and high risk of death. To alter their expression status might be a potential therapeutic strategy to improve the outcome of chemotherapy for TNBC patients.	[Ouyang, Mao; Li, Yongxin; Ma, Jieyi; Wang, Wenjian] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Dept Surg, Guangzhou 510275, Guangdong, Peoples R China; [Ouyang, Mao; Li, Qing] Ctr Cellular & Struct Biol, Guangzhou, Guangdong, Peoples R China; [Ouyang, Mao] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Clin Lab, Guangzhou 510275, Guangdong, Peoples R China; [Ye, Sheng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Liming] Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Lv, Weiming; Chang, Guangqi; Li, Xiaoxi; Wang, Shenming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Thyroid & Breast Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, Q (corresponding author), Ctr Cellular & Struct Biol, Guangzhou, Guangdong, Peoples R China.	liqing66@mail.sysu.edu.cn; shenminggz@126.com; w166w2000@aliyun.com			Introduced Innovation R&D Team Leadership of Guangdong Province [2011Y038]; Natural Science Foundation of Guangdong Province, China [S2013010016539]	Introduced Innovation R&D Team Leadership of Guangdong Province; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	The work was supported by grant from Introduced Innovation R&D Team Leadership of Guangdong Province (Grant No. 2011Y038) and the Natural Science Foundation of Guangdong Province, China (Grant No. S2013010016539). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds195; [Anonymous], 1938, N ENGL J MED, V363, P1938; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; Bian HB, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-20; Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55; Cai BB, 2013, ONCOL REP, V29, P1769, DOI 10.3892/or.2013.2297; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041574; Chen YR, 2014, EXP CELL RES, V320, P12, DOI 10.1016/j.yexcr.2013.10.014; Falkenberg N, 2013, BRIT J CANCER, V109, P2714, DOI 10.1038/bjc.2013.625; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Fassan M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2348; Jiao Y, 2012, MOL BIOL CELL, V23, P1404, DOI 10.1091/mbc.E11-11-0960; Kong FF, 2011, J HUAZHONG U SCI-MED, V31, P543, DOI 10.1007/s11596-011-0487-z; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Lei L, 2013, ONCOL REP, V30, P2897, DOI 10.3892/or.2013.2755; Li HY, 2013, ASIAN PAC J CANCER P, V14, P3631, DOI 10.7314/APJCP.2013.14.6.3631; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li P, 2010, J BIOMED RES, V24, P436, DOI 10.1016/S1674-8301(10)60058-9; Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053; Ling N, 2013, ONCOL REP, V30, P2111, DOI 10.3892/or.2013.2685; Liu M, 2013, BIOCHEM BIOPH RES CO, V441, P364, DOI 10.1016/j.bbrc.2013.10.051; Mitamura T, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.3; Nishida N, 2012, ANN SURG ONCOL, V19, P3065, DOI 10.1245/s10434-012-2246-1; Oakman C, 2011, BREAST, V20, pS135, DOI 10.1016/S0960-9776(11)70311-3; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; Pu J, 2012, BIOCHEM BIOPH RES CO, V428, P210, DOI 10.1016/j.bbrc.2012.09.126; Rehman SK, 2014, CANCER RES, V74, P363, DOI 10.1158/0008-5472.CAN-13-2016; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wu ZS, 2011, CANCER-AM CANCER SOC, V117, P2842, DOI 10.1002/cncr.25860; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Yang GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078355; Yang LY, 2012, ONCOL REP, V28, P592, DOI 10.3892/or.2012.1823; Yu Y, 2010, MOL CANCER RES, V8, P1633, DOI 10.1158/1541-7786.MCR-10-0362	39	144	148	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96228	10.1371/journal.pone.0096228	http://dx.doi.org/10.1371/journal.pone.0096228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788655	Green Published, Green Submitted, gold			2022-12-25	WOS:000336655700066
J	Morris, JP; Greer, R; Russ, HA; von Figura, G; Kim, GE; Busch, A; Lee, J; Hertel, KJ; Kim, S; Mcmanus, M; Hebrok, M				Morris, John P.; Greer, Renee; Russ, Holger A.; von Figura, Guido; Kim, Grace E.; Busch, Anke; Lee, Jonghyeob; Hertel, Klemens J.; Kim, Seung; Mcmanus, Michael; Hebrok, Matthias			Dicer Regulates Differentiation and Viability during Mouse Pancreatic Cancer Initiation	PLOS ONE			English	Article							MICRORNA EXPRESSION; ONCOGENIC KRAS; INTRAEPITHELIAL NEOPLASIA; DUCTAL ADENOCARCINOMA; PROGENITOR CELLS; GENE-EXPRESSION; ADULT MICE; TUMORIGENESIS; PROGRESSION; PATHWAY	miRNA levels are altered in pancreatic ductal adenocarcinoma (PDA), the most common and lethal pancreatic malignancy, and intact miRNA processing is essential for lineage specification during pancreatic development. However, the role of miRNA processing in PDA has not been explored. Here we study the role of miRNA biogenesis in PDA development by deleting the miRNA processing enzyme Dicer in a PDA mouse model driven by oncogenic Kras. We find that loss of Dicer accelerates Kras driven acinar dedifferentiation and acinar to ductal metaplasia (ADM), a process that has been shown to precede and promote the specification of PDA precursors. However, unconstrained ADM also displays high levels of apoptosis. Dicer loss does not accelerate development of Kras driven PDA precursors or PDA, but surprisingly, we observe that mouse PDA can develop without Dicer, although at the expense of proliferative capacity. Our data suggest that intact miRNA processing is involved in both constraining pro-tumorigenic changes in pancreatic differentiation as well as maintaining viability during PDA initiation.	[Morris, John P.; Greer, Renee; Russ, Holger A.; von Figura, Guido; Mcmanus, Michael; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94117 USA; [Kim, Grace E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Busch, Anke; Hertel, Klemens J.] Univ Calif San Francisco, Dept Microbiol & Mol Genet, San Francisco, CA 94143 USA; [Lee, Jonghyeob; Kim, Seung] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University	Hebrok, M (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94117 USA.	mhebrok@diabetes.ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Kim, Grace/0000-0003-4603-9448; Kim, Seung/0000-0001-6135-7810; Hertel, Klemens/0000-0002-7560-9529	AACR Pancreatic Cancer Action Network; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062287] Funding Source: NIH RePORTER	AACR Pancreatic Cancer Action Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in Matthias Hebrok's Group was supported by a grant from the AACR Pancreatic Cancer Action Network. www.pancan.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; Ali S, 2012, BRIT J CANCER, V107, P1354, DOI 10.1038/bjc.2012.383; Arrate MP, 2010, CANCER RES, V70, P6083, DOI 10.1158/0008-5472.CAN-09-4736; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Carriere C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027725; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; De La O JP, 2009, CELL CYCLE, V8, P1860, DOI 10.4161/cc.8.12.8744; De La OJ, 2008, P NATL ACAD SCI US; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hamidi T, 2012, CLIN CANCER RES, V18, P5234, DOI 10.1158/1078-0432.CCR-12-0026; Hamidi T, 2012, J CLIN INVEST, V122, P2092, DOI 10.1172/JCI60144; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Heravi-Moussavi A, 2012, NEW ENGL J MED, V366, P234, DOI 10.1056/NEJMoa1102903; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Kopp JL, 2012, CANC CELL; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Morita S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004212; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Nittner D, 2012, NAT CELL BIOL, V14, P958, DOI 10.1038/ncb2556; Norris AM, 2012, ONCOGENE; Parikh Abhirath, 2012, Biomol Concepts, V3, P57; Prevot P.P., 2013, GASTROENTEROLOGY; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Ravi A, 2012, CANCER CELL, V21, P848, DOI 10.1016/j.ccr.2012.04.037; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Sekine S, 2009, GASTROENTEROLOGY, V136, P2304, DOI 10.1053/j.gastro.2009.02.067; Shi G, 2012, ONCOGENE; Shi GL, 2009, GASTROENTEROLOGY, V136, P1368, DOI 10.1053/j.gastro.2008.12.066; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; von Figura G., 2013, GUT; Wang XW, 2012, BIOCHEM BIOPH RES CO, V425, P51, DOI 10.1016/j.bbrc.2012.07.047; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yu J, 2012, CLIN CANCER RES, V18, P981, DOI 10.1158/1078-0432.CCR-11-2347	56	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95486	10.1371/journal.pone.0095486	http://dx.doi.org/10.1371/journal.pone.0095486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788257	Green Published, gold			2022-12-25	WOS:000335510600039
J	Thomason, ME; Brown, JA; Dassanayake, MT; Shastri, R; Marusak, HA; Hernandez-Andrade, E; Yeo, L; Mody, S; Berman, S; Hassan, SS; Romero, R				Thomason, Moriah E.; Brown, Jesse A.; Dassanayake, Maya T.; Shastri, Rupal; Marusak, Hilary A.; Hernandez-Andrade, Edgar; Yeo, Lami; Mody, Swati; Berman, Susan; Hassan, Sonia S.; Romero, Roberto			Intrinsic Functional Brain Architecture Derived from Graph Theoretical Analysis in the Human Fetus	PLOS ONE			English	Article							RESTING-STATE NETWORKS; DEFAULT MODE NETWORK; HEMODYNAMIC-RESPONSES; MODULAR ORGANIZATION; LOW-FREQUENCY; CONNECTIVITY; FMRI; BOLD; CONNECTOME; INFANTS	The human brain undergoes dramatic maturational changes during late stages of fetal and early postnatal life. The importance of this period to the establishment of healthy neural connectivity is apparent in the high incidence of neural injury in preterm infants, in whom untimely exposure to ex-uterine factors interrupts neural connectivity. Though the relevance of this period to human neuroscience is apparent, little is known about functional neural networks in human fetal life. Here, we apply graph theoretical analysis to examine human fetal brain connectivity. Utilizing resting state functional magnetic resonance imaging (fMRI) data from 33 healthy human fetuses, 19 to 39 weeks gestational age (GA), our analyses reveal that the human fetal brain has modular organization and modules overlap functional systems observed postnatally. Age-related differences between younger (GA <31 weeks) and older (GA >= 31 weeks) fetuses demonstrate that brain modularity decreases, and connectivity of the posterior cingulate to other brain networks becomes more negative, with advancing GA. By mimicking functional principles observed postnatally, these results support early emerging capacity for information processing in the human fetal brain. Current technical limitations, as well as the potential for fetal fMRI to one day produce major discoveries about fetal origins or antecedents of neural injury or disease are discussed.	[Thomason, Moriah E.; Marusak, Hilary A.] Wayne State Univ, Merrill Palmer Skillman Inst Child & Family Dev, Detroit, MI 48202 USA; [Thomason, Moriah E.; Mody, Swati] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Thomason, Moriah E.; Hernandez-Andrade, Edgar; Yeo, Lami; Hassan, Sonia S.; Romero, Roberto] NICHD, Perinatol Res Branch, NIH, DHHS, Bethesda, MD USA; [Brown, Jesse A.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA USA; [Dassanayake, Maya T.; Shastri, Rupal] Wayne State Univ, Sch Med, Basic Med Sci Program, Detroit, MI USA; [Marusak, Hilary A.] Wayne State Univ, Dept Psychiat & Behav Neurosci, Detroit, MI 48207 USA; [Hernandez-Andrade, Edgar; Yeo, Lami; Berman, Susan; Hassan, Sonia S.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Mody, Swati] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA	Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Francisco; Wayne State University; Wayne State University; Wayne State University; Wayne State University	Thomason, ME (corresponding author), Wayne State Univ, Merrill Palmer Skillman Inst Child & Family Dev, Detroit, MI 48202 USA.	moriah@wayne.edu	Thomason, Moriah E/AAW-9511-2021; Romero, Roberto/A-5268-2019	Romero, Roberto/0000-0002-4448-5121; Thomason, Moriah/0000-0001-9745-1147	Merrill Palmer Skillman Institute for Child and Family Development; Department of Pediatrics, Wayne State University (WSU) School of Medicine; WSU Perinatal Initiative; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Department of Health and Human Services [N01-HD-2-3342]; WSU's Perinatology Virtual Discovery Grant (W.K. Kellogg Foundation) [P3018205]; WSU's Research Grant Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES026022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110793] Funding Source: NIH RePORTER	Merrill Palmer Skillman Institute for Child and Family Development; Department of Pediatrics, Wayne State University (WSU) School of Medicine; WSU Perinatal Initiative; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Department of Health and Human Services; WSU's Perinatology Virtual Discovery Grant (W.K. Kellogg Foundation); WSU's Research Grant Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported, in part, by the Merrill Palmer Skillman Institute for Child and Family Development, by the Department of Pediatrics, Wayne State University (WSU) School of Medicine, by the WSU Perinatal Initiative, and by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Department of Health and Human Services through contract N01-HD-2-3342. This project was also supported by WSU's Perinatology Virtual Discovery Grant (made possible by W.K. Kellogg Foundation award P3018205) and WSU's Research Grant Program awards (to MET). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NICHD or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Arichi T, 2012, NEUROIMAGE, V63, P663, DOI 10.1016/j.neuroimage.2012.06.054; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Colonnese MT, 2008, NAT NEUROSCI, V11, P72, DOI 10.1038/nn2017; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; De Wilde JP, 2005, PROG BIOPHYS MOL BIO, V87, P335, DOI 10.1016/j.pbiomolbio.2004.08.010; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; Fransson P, 2009, PEDIATR RES, V66, P301, DOI 10.1203/PDR.0b013e3181b1bd84; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Huang H, 2013, CEREB CORTEX; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Ingalhalikar M, 2012, LECT NOTES COMPUT SC, V7512, P468, DOI 10.1007/978-3-642-33454-2_58; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Leopold DA, 2012, NEUROIMAGE, V62, P2190, DOI 10.1016/j.neuroimage.2011.10.059; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Rudie JD, 2013, NEUROIMAGE-CLIN, V2, P79, DOI 10.1016/j.nicl.2012.11.006; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Satterthwaite TD, 2013, NEUROIMAGE, V83, P45, DOI 10.1016/j.neuroimage.2013.06.045; Satterthwaite TD, 2013, J NEUROSCI, V33, P16249, DOI 10.1523/JNEUROSCI.2345-13.2013; Schopf V, 2012, INT J DEV NEUROSCI, V30, P11, DOI 10.1016/j.ijdevneu.2011.10.006; Serag A, 2012, NEUROIMAGE, V59, P2255, DOI 10.1016/j.neuroimage.2011.09.062; Sheppard JP, 2012, J COGNITIVE NEUROSCI, V24, P1087, DOI 10.1162/jocn_a_00210; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; Thomason ME, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004978; Thomason ME, 2011, NEUROIMAGE, V55, P165, DOI 10.1016/j.neuroimage.2010.11.080; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Welsh Robert C, 2011, Top Magn Reson Imaging, V22, P119, DOI 10.1097/RMR.0b013e318267f932; Whitfield-Gabrieli S, 2012, BRAIN CONNECTIVITY; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Worbe Y, 2012, BRAIN, V135, P1937, DOI 10.1093/brain/aws056; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	59	66	67	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94423	10.1371/journal.pone.0094423	http://dx.doi.org/10.1371/journal.pone.0094423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788455	Green Published, Green Submitted, gold			2022-12-25	WOS:000335510600012
J	Chiu, SS; Lo, JYC; Chan, KH; Chan, ELY; So, LY; Wu, P; Cowling, BJ; Chen, R; Peiris, JSM				Chiu, Susan S.; Lo, Janice Y. C.; Chan, Kwok-Hung; Chan, Eunice L. Y.; So, Lok-Yee; Wu, Peng; Cowling, Benjamin J.; Chen, Robin; Peiris, J. S. Malik			Population-Based Hospitalization Burden of Influenza A Virus Subtypes and Antigenic Drift Variants in Children in Hong Kong (2004-2011)	PLOS ONE			English	Article							RESPIRATORY VIRUSES; SEASONAL INFLUENZA; RAPID DIAGNOSIS; H1N1 INFLUENZA; YOUNG-CHILDREN; B-VIRUS; INFECTION; MORTALITY; INFANTS; EPIDEMIOLOGY	Objectives: We aim to document and analyze influenza hospitalization burden in light of antigenic changes in circulating influenza viruses in Hong Kong. Methods: The pediatric age-specific rates of influenza A hospitalization in Hong Kong for 2004-2011 which encompassed the emergence of H1N1pdm09 were extrapolated from admissions to 2 hospitals that together catered for 72.5% of all pediatric admissions on Hong Kong Island. Influenza A was detected by immunofluorescence, culture and/or PCR on nasopharyngeal aspirates. Results: Influenza A caused high rates of hospitalization in children with year to year fluctuations. The highest hospitalization burden was seen with H1N1pdm09 in 2009. Additional factors affecting hospitalization were the proportion of viral circulation among different subtypes, and antigenic drifts. Taking these into effect, an H3N2 dominated year was not always associated with more hospitalizations than a 'seasonal' H1N1 year. Hospitalization burden was higher in seasons when drifted viruses of H1N1 or H3N2 dominated. No hospitalization was documented in infants <6 months of age during years when an undrifted virus circulated (2006 for H1N1 and 2008 for H3N2) but significant hospitalization was observed with a drifted or shifted virus (2004, 2005, 2007 and 2010 for H3N2, and 2009 for H1N1pdm09). Conclusions: We documented a consistently high pediatric hospitalization burden of influenza A. Knowledge of antigenic changes and their proportion of circulation aids in the interpretation of impact of the subtypes. Year-to-year variation in hospitalization rates in young infants appeared to correlate with antigenic variation, lending support to the role of protection from maternal antibodies.	[Chiu, Susan S.; Chan, Eunice L. Y.; Chen, Robin] Univ Hong Kong, Dept Pediat & Adolescent Med, Pokfulam, Hong Kong, Peoples R China; [Lo, Janice Y. C.] Ctr Hlth Protect, Dept Hlth, Publ Hlth Lab, Serv Branch, Kowloon, Hong Kong, Peoples R China; [Chan, Kwok-Hung] Univ Hong Kong, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [So, Lok-Yee] Pamela Youde Nethersole Eastern Hosp, Dept Pediat & Adolescent Med, Chaiwan, Hong Kong, Peoples R China; [Wu, Peng; Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Div Epidemiol & Biostat, Pokfulam, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Sch Publ Hlth, Influenza Res Ctr, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; University of Hong Kong; University of Hong Kong	Peiris, JSM (corresponding author), Univ Hong Kong, Sch Publ Hlth, Influenza Res Ctr, Pokfulam, Hong Kong, Peoples R China.	malik@hkucc.hku.hk	Chan, Kwok Hung/ABD-5399-2021; Cowling, Benjamin John/C-4263-2009; Chiu, Susan Shui Seng/C-4247-2009	Cowling, Benjamin John/0000-0002-6297-7154; Chiu, Susan Shui Seng/0000-0002-3908-1974; Wu, Peng/0000-0003-1157-9401	Area of Excellence Scheme of the University Grants Committee of Hong Kong [AoE/M-12/06]	Area of Excellence Scheme of the University Grants Committee of Hong Kong	This work was supported by Area of Excellence Scheme of the University Grants Committee of Hong Kong (grant no. AoE/M-12/06). The authors also want to clarify that no funding from MedImmune Inc. was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 30 GOV HONG KONG SPE; Campbell CNJ, 2011, EPIDEMIOL INFECT, V139, P1560, DOI 10.1017/S0950268810002657; Centers for Disease Control and Prevention (CDC), 2007, 100705 CDC; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chan KH, 2002, J CLIN MICROBIOL, V40, P1675, DOI 10.1128/JCM.40.5.1675-1680.2002; Chan KH, 2008, J CLIN MICROBIOL, V46, P2195, DOI 10.1128/JCM.00315-08; CHIN TDY, 1960, PUBLIC HEALTH REP, V75, P149, DOI 10.2307/4590751; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Chiu SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021837; Chiu SS, 2009, CLIN INFECT DIS, V49, P1016, DOI 10.1086/605570; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; Dawood FS, 2010, J PEDIATR-US, V157, P808, DOI 10.1016/j.jpeds.2010.05.012; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; Jules A, 2012, INFLUENZA OTHER RESP, V6, pe63, DOI 10.1111/j.1750-2659.2012.00343.x; KIM HW, 1979, AM J EPIDEMIOL, V109, P464, DOI 10.1093/oxfordjournals.aje.a112704; Kumar S, 2010, VIRUSES-BASEL, V2, P782, DOI 10.3390/v2040782; Lau JTF, 2010, VACCINE, V28, P5389, DOI 10.1016/j.vaccine.2010.05.071; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Lo JYC, 2005, EMERG INFECT DIS, V11, P1738, DOI 10.3201/eid1111.050729; LUI KJ, 1987, AM J PUBLIC HEALTH, V77, P712, DOI 10.2105/AJPH.77.6.712; Monto AS, 2008, VACCINE, V26, pD45, DOI 10.1016/j.vaccine.2008.07.066; MONTO AS, 1975, AM J EPIDEMIOL, V102, P553, DOI 10.1093/oxfordjournals.aje.a112193; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Moral L, 2011, ENFERM INFEC MICR CL, V29, P497, DOI 10.1016/j.eimc.2011.01.015; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Poehling KA, 2013, PEDIATRICS, V131, P207, DOI 10.1542/peds.2012-1255; Proff R, 2009, EMERG INFECT DIS, V15, P892, DOI 10.3201/eid1506.081645; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Sebastian R, 2008, VACCINE, V26, P1397, DOI 10.1016/j.vaccine.2007.11.090; Silvennoinen H, 2011, PEDIATR INFECT DIS J, V30, pE24, DOI 10.1097/INF.0b013e3181fe37c8; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Tarrant M, 2012, MATERN CHILD HLTH J, DOI [10.1007/s10995.011-0943-1, DOI 10.1007/S10995.011-0943-1]; To KKW, 2010, POSTGRAD MED J, V86, P515, DOI 10.1136/pgmj.2009.096206; van Gageldonk-Lafeber AB, 2011, INFLUENZA OTHER RESP, V5, pR513, DOI 10.1111/j.1750-2659.2011.00260.x; Wu JT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001103; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e92914	10.1371/journal.pone.0092914	http://dx.doi.org/10.1371/journal.pone.0092914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24786780	Green Submitted, gold, Green Published			2022-12-25	WOS:000338917300002
J	van der Mark, M; Nijssen, PCG; Vlaanderen, J; Huss, A; Mulleners, WM; Sas, AMG; van Laar, T; Kromhout, H; Vermeulen, R				van der Mark, Marianne; Nijssen, Peter C. G.; Vlaanderen, Jelle; Huss, Anke; Mulleners, Wim M.; Sas, Antonetta M. G.; van Laar, Teus; Kromhout, Hans; Vermeulen, Roel			A Case-Control Study of the Protective Effect of Alcohol, Coffee, and Cigarette Consumption on Parkinson Disease Risk: Time-Since-Cessation Modifies the Effect of Tobacco Smoking	PLOS ONE			English	Article							LUNG-CANCER; INTENSITY; EXPOSURE; METAANALYSIS; PERSONALITY; NICOTINE; TWINS	The aim of this study was to investigate the possible reduced risk of Parkinson Disease (PD) due to coffee, alcohol, and/or cigarette consumption. In addition, we explored the potential effect modification by intensity, duration and time-since-cessation of smoking on the association between cumulative pack-years of cigarette smoking (total smoking) and PD risk. Data of a hospital based case-control study was used including 444 PD patients, diagnosed between 2006 and 2011, and 876 matched controls from 5 hospitals in the Netherlands. A novel modeling method was applied to derive unbiased estimates of the potential modifying effects of smoking intensity, duration, and time-since-cessation by conditioning on total exposure. We observed no reduced risk of PD by alcohol consumption and only a weak inverse association between coffee consumption and PD risk. However, a strong inverse association of total smoking with PD risk was observed (OR = 0.27 (95%CI: 0.18-0.42) for never smokers versus highest quartile of tobacco use). The observed protective effect of total smoking was significantly modified by time-since-cessation with a diminishing protective effect after cessation of smoking. No effect modification by intensity or duration of smoking was observed indicating that both intensity and duration have an equal contribution to the reduced PD risk. Understanding the dynamics of the protective effect of smoking on PD risk aids in understanding PD etiology and may contribute to strategies for prevention and treatment.	[van der Mark, Marianne; Vlaanderen, Jelle; Huss, Anke; Kromhout, Hans; Vermeulen, Roel] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Nijssen, Peter C. G.] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands; [Nijssen, Peter C. G.] TweeSteden Hosp, Dept Neurol, Tilburg, Netherlands; [Mulleners, Wim M.] Canisius Wilhelmina Hosp, Dept Neurol, Nijmegen, Netherlands; [Sas, Antonetta M. G.] Vlietland Hosp, Dept Neurol, Schiedam, Netherlands; [van Laar, Teus] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Vermeulen, Roel] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Elisabeth-TweeSteden Ziekenhuis (ETZ); Elisabeth-TweeSteden Ziekenhuis (ETZ); Canisius-Wilhelmina Hospital; University of Groningen; Utrecht University; Utrecht University Medical Center	Vermeulen, R (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	r.c.h.vermeulen@uu.nl	Mulleners, Wim/ABC-7853-2021; Kromhout, Hans/A-9159-2008; van Laar, Teus/AAO-3906-2021; Vermeulen, Roel/F-8037-2011	Kromhout, Hans/0000-0002-4233-1890; Vermeulen, Roel/0000-0003-4082-8163; Vlaanderen, Jelle/0000-0002-9096-692X; van Laar, Teus/0000-0001-5088-480X; Huss, Anke/0000-0001-9268-1867	Stichting Internationaal Parkinson Fonds; Netherlands Organization for Health Research (ZonMW) within the program Electromagnetic Fields and Health Research [85800001]	Stichting Internationaal Parkinson Fonds; Netherlands Organization for Health Research (ZonMW) within the program Electromagnetic Fields and Health Research	This work was supported by Stichting Internationaal Parkinson Fonds (www.parkinsonfonds.nl); and The Netherlands Organization for Health Research (ZonMW) within the program Electromagnetic Fields and Health Research under grant number 85800001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam MF, 2004, MOVEMENT DISORD, V19, P614, DOI 10.1002/mds.20029; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; Costa J, 2010, J ALZHEIMERS DIS, V20, pS221, DOI 10.3233/JAD-2010-091525; Dagher A, 2009, NEURON, V61, P502, DOI 10.1016/j.neuron.2009.01.031; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Ishihara L, 2005, NUTR RES REV, V18, P259, DOI 10.1079/NRR2005108; Ishihara L, 2006, MOVEMENT DISORD, V21, P1066, DOI 10.1002/mds.20980; Jenner P, 2009, PARKINSONISM RELAT D, V15, P406, DOI [10.1016/j.parkreldis.2008.12.006, 10.1016/S1353-8020(09)70829-6]; Liu R, 2012, AM J EPIDEMIOL, V175, P1200, DOI 10.1093/aje/kwr451; Lubin JH, 2006, CANCER EPIDEM BIOMAR, V15, P517, DOI 10.1158/1055-9965.EPI-05-0863; Menza M, 2000, Curr Psychiatry Rep, V2, P421, DOI 10.1007/s11920-000-0027-1; Oostenbrink J B, 2006, Health Care Manag Sci, V9, P287, DOI 10.1007/s10729-006-9096-y; Quik M, 2008, MOVEMENT DISORD, V23, P1641, DOI 10.1002/mds.21900; Quik M, 2012, MOVEMENT DISORD, V27, P947, DOI 10.1002/mds.25028; Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P111; Savica R, 2010, ARCH NEUROL-CHICAGO, V67, P798, DOI 10.1001/archneurol.2010.135; Tanner CM, 2002, NEUROLOGY, V58, P581, DOI 10.1212/WNL.58.4.581; Thacker EL, 2007, NEUROLOGY, V68, P764, DOI 10.1212/01.wnl.0000256374.50227.4b; Vlaanderen J, 2014, AM J EPIDEMIOL, V179, P290, DOI 10.1093/aje/kwt273; Wirdefeldt K, 2005, ANN NEUROL, V57, P27, DOI 10.1002/ana.20307; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6	22	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95297	10.1371/journal.pone.0095297	http://dx.doi.org/10.1371/journal.pone.0095297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788751	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917300011
J	Yao, LJ; Dong, H; Luo, YQ; Du, JP; Hu, W				Yao, Lijuan; Dong, Hang; Luo, Yiqin; Du, Jianping; Hu, Wen			Net Platelet Angiogenic Activity (NPAA) Correlates with Progression and Prognosis of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; THROMBOSPONDIN LEVELS; THROMBOCYTOSIS; METASTASIS	Circulating platelets are abundant sources of angiogensis molecules for the tumor vasculature affecting tumor growth and metastasis. The relationship between non-small cell lung cancer (NSCLC) and intra-platelet levels of VEGF, TSP-1 and net platelet angiogenic activity (NPAA) is unclear. The aim of this study was to better understand the role of these factors in the progression of NSCLC cancer and to assess its clinical significance. Platelet VEGF and TSP-1 and NPAA were measured preoperatively in 68 patients with NSCLC by ELISA or Capillary tube formation assay. VEGF, TSP-1 and NPAA distributions in cancer patients and healthy volunteers were compared using the Mann-Whitney U test. The Kaplan-Meier method, univariate and multivariate regression analysis was used to analyze the correlation between these factors and clinicopathological features, overall survival and disease-free survival. Mean intra-platelet TSP-1 level was slightly higher in patients than in healthy subjects (p = 0.092). Intra-platelet TSP-1 levels were significantly higher in patients with involvement greater than T2 or stage III, compared to other patients. Mean intra-platelet VEGF level was 40.8 pg/10(6) in patients compared to 21.9 ng/10(6) in healthy subjects (p = 0.041). Median value of NPAA in patients was significantly higher than that in healthy controls (p<0.001). Patients with high NPAA are more likely to exhibit aggressive clinical pathological features. NPAA greater than the median are associated with poor prognosis. The elevated NPAA have better correlation with tumor microvessel density (MVD) than platelet-derived VEGF. The areas under receiver operating curve (AUROC) of NPAA were higher than that of platelet derived VEGF in different groups. A multivariate analysis showed that NPAA are independent prognostic factors. These results indicated that NPAA may be a clinically useful indicator for diagnostic and prognostic evaluation in NSCLC patients.	[Yao, Lijuan; Dong, Hang; Luo, Yiqin] Anhui Med Univ, Affiliated Anhui Prov Hosp, Dept Lab Med, Hefei, Peoples R China; [Du, Jianping] Anhui Med Univ, Affiliated Anhui Prov Hosp, Ctr Tumor Therapy, Hefei, Peoples R China; [Hu, Wen] Anhui Med Univ, Affiliated Anhui Prov Hosp, Dept Pathol, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Luo, YQ (corresponding author), Anhui Med Univ, Affiliated Anhui Prov Hosp, Dept Lab Med, Hefei, Peoples R China.	luoyiqin2004@hotmail.com			Educational Commission of Anhui Province of China [KJ2011A163]; Natural Science Foundation of Anhui Province of China [11040606M208]; Natural Science Foundation of China [30672437]	Educational Commission of Anhui Province of China; Natural Science Foundation of Anhui Province of China(Natural Science Foundation of Anhui Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Educational Commission of Anhui Province of China (Grant KJ2011A163), Natural Science Foundation of Anhui Province of China (Grant 11040606M208), and the Natural Science Foundation of China (Grant 30672437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, AM J CLIN PATHOL, V77, P123; BASTIDA E, 1988, HAEMOSTASIS, V18, P29; de Fraipont F, 2001, TRENDS MOL MED, V7, P401, DOI 10.1016/S1471-4914(01)02102-5; Folkman J, 2001, THROMB HAEMOSTASIS, V86, P23; Fontanini G, 1997, CLIN CANCER RES, V3, P861; Gonzalez FJ, 2004, INT J BIOL MARKER, V19, P221, DOI 10.1177/172460080401900307; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Ikeda M, 2002, ANN SURG ONCOL, V9, P287, DOI 10.1245/aso.2002.9.3.287; Kaya M, 2000, CLIN CANCER RES, V6, P572; Larrivee Bruno, 2005, Methods Mol Biol, V290, P315; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; NATHAN FE, 1994, CANCER, V73, P2853, DOI 10.1002/1097-0142(19940601)73:11<2853::AID-CNCR2820731131>3.0.CO;2-9; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; O'Byrne KJ, 2000, BRIT J CANCER, V82, P1427, DOI 10.1054/bjoc.1999.1129; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pedersen LM, 1996, EUR RESPIR J, V9, P1826; PEPE MS, 2003, STAT EVALUATION MED, P66; Peterson JE, 2012, ANGIOGENESIS, V15, P265, DOI 10.1007/s10456-012-9259-z; Takeda A, 2000, ONCOL REP, V7, P333; TARABOLETTI G, 1990, J CELL BIOL, V111, P765, DOI 10.1083/jcb.111.2.765; TUSZYNSKI GP, 1992, THROMB HAEMOSTASIS, V67, P607; Verheul HMW, 2000, CLIN CANCER RES, V6, P166; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Zhang S-W, 2007, B CHIN CANC, V16, P494	25	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96206	10.1371/journal.pone.0096206	http://dx.doi.org/10.1371/journal.pone.0096206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788022	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917300032
J	Sall, KM; Casabona, MG; Bordi, C; Huber, P; de Bentzmann, S; Attree, I; Elsen, S				Sall, Khady Mayebine; Casabona, Maria Guillermina; Bordi, Christophe; Huber, Philippe; de Bentzmann, Sophie; Attree, Ina; Elsen, Sylvie			A gacS Deletion in Pseudomonas aeruginosa Cystic Fibrosis Isolate CHA Shapes Its Virulence	PLOS ONE			English	Article							SMALL COLONY VARIANTS; III SECRETION; VI SECRETION; ALGINATE SYNTHESIS; BIOFILM FORMATION; ABC TRANSPORTER; REGULATORY RNA; IN-VIVO; EXPRESSION; SYSTEM	Pseudomonas aeruginosa, a human opportunistic pathogen, is capable of provoking acute and chronic infections that are associated with defined sets of virulence factors. During chronic infections, the bacterium accumulates mutations that silence some and activate other genes. Here we show that the cystic fibrosis isolate CHA exhibits a unique virulence phenotype featuring a mucoid morphology, an active Type III Secretion System (T3SS, hallmark of acute infections), and no Type VI Secretion System (H1-T6SS). This virulence profile is due to a 426 bp deletion in the 39 end of the gacS gene encoding an essential regulatory protein. The absence of GacS disturbs the Gac/Rsm pathway leading to depletion of the small regulatory RNAs RsmY/RsmZ and, in consequence, to expression of T3SS, while switching off the expression of H1-T6SS and Pel polysaccharides. The CHA isolate also exhibits full ability to swim and twitch, due to active flagellum and Type IVa pili. Thus, unlike the classical scheme of balance between virulence factors, clinical strains may adapt to a local niche by expressing both alginate exopolysaccharide, a hallmark of membrane stress that protects from antibiotic action, host defences and phagocytosis, and efficient T3S machinery that is considered as an aggressive virulence factor.	[Sall, Khady Mayebine; Casabona, Maria Guillermina; Huber, Philippe; Attree, Ina; Elsen, Sylvie] INSERM, UMR S 1036, Grenoble, France; [Sall, Khady Mayebine; Casabona, Maria Guillermina; Huber, Philippe; Attree, Ina; Elsen, Sylvie] CNRS, ERL 5261, Grenoble, France; [Sall, Khady Mayebine; Casabona, Maria Guillermina; Huber, Philippe; Attree, Ina; Elsen, Sylvie] UJF Grenoble 1, Grenoble, France; [Sall, Khady Mayebine; Casabona, Maria Guillermina; Huber, Philippe; Attree, Ina; Elsen, Sylvie] CEA, DSV iRTSV, Grenoble, France; [Bordi, Christophe; de Bentzmann, Sophie] Aix Marseille Univ, CNRS, Lab Ingn Systs Macromol, UMR 7255, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Elsen, S (corresponding author), INSERM, UMR S 1036, Grenoble, France.	sylvie.elsen@cea.fr	Huber, Philippe/C-7971-2019; Christophe, Bordi/AAD-2447-2022	Huber, Philippe/0000-0002-4153-7694; Elsen, Sylvie/0000-0003-4611-4719; Attree, Ina/0000-0002-2580-764X	University of Grenoble; Fondation innovations en infectiologie (FINOVI); Alliance nationale pour les sciences de la vie et de la sante (AVIESAN); Commissariat a l'energie atomique et aux energies alternatives (CEA); Centre national de la recherche scientifique (CNRS); Institut national de la sante et de la recherche medicale (INSERM)	University of Grenoble; Fondation innovations en infectiologie (FINOVI); Alliance nationale pour les sciences de la vie et de la sante (AVIESAN); Commissariat a l'energie atomique et aux energies alternatives (CEA)(French Atomic Energy Commission); Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut national de la sante et de la recherche medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	KM Sall is a PhD student supported by the University of Grenoble. This work was in part supported by grants from Fondation innovations en infectiologie (FINOVI), Alliance nationale pour les sciences de la vie et de la sante (AVIESAN), Commissariat a l'energie atomique et aux energies alternatives (CEA), Centre national de la recherche scientifique (CNRS) and Institut national de la sante et de la recherche medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader F, 2005, INFECT IMMUN, V73, P4263, DOI 10.1128/IAI.73.7.4263-4271.2005; Bastonero S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005357; Bezuidt OKI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-416; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Burrowes E, 2005, RES MICROBIOL, V156, P7, DOI 10.1016/j.resmic.2004.07.004; Casabona MG, 2013, ENVIRON MICROBIOL, V15, P471, DOI 10.1111/j.1462-2920.2012.02816.x; Cattoir V, 2012, MBIO, V3, DOI 10.1128/mBio.00410-12; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Chuanchuen R, 2002, BIOTECHNIQUES, V33, P760, DOI 10.2144/02334bm08; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Cramer N, 2011, ENVIRON MICROBIOL, V13, P1690, DOI 10.1111/j.1462-2920.2011.02483.x; Dacheux D, 1999, INFECT IMMUN, V67, P6164, DOI 10.1128/IAI.67.11.6164-6167.1999; Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Davies JA, 2007, FEMS MICROBIOL ECOL, V59, P32, DOI 10.1111/j.1574-6941.2006.00196.x; De Soyza A, 2013, MICROBIOLOGYOPEN, V2, P1010, DOI 10.1002/mbo3.141; DelicAttree I, 1996, MICROBIOL-UK, V142, P2785, DOI 10.1099/13500872-142-10-2785; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fito-Boncompte L, 2011, INFECT IMMUN, V79, P1176, DOI 10.1128/IAI.00850-10; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Gibson J, 2009, APPL ENVIRON MICROB, V75, P504, DOI 10.1128/AEM.01037-08; Giraud C, 2010, ENV MICROBIOL REP, V2, P343, DOI 10.1111/j.1758-2229.2009.00070.x; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Hunter RC, 2010, J BACTERIOL, V192, P5962, DOI 10.1128/JB.01021-10; Intile PJ, 2014, J BACTERIOL, V196, P357, DOI 10.1128/JB.01199-13; Jones AK, 2010, J BACTERIOL, V192, P5709, DOI 10.1128/JB.00526-10; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Marden JN, 2013, P NATL ACAD SCI USA, V110, P15055, DOI 10.1073/pnas.1307217110; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Mikkelsen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029113; Mikkelsen H, 2011, ENVIRON MICROBIOL, V13, P1666, DOI 10.1111/j.1462-2920.2011.02495.x; MOHR CD, 1990, MOL MICROBIOL, V4, P2103, DOI 10.1111/j.1365-2958.1990.tb00571.x; Morris ER, 2013, STRUCTURE, V21, P1659, DOI 10.1016/j.str.2013.07.007; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Nelson LK, 2010, MICROBIOL-SGM, V156, P3699, DOI 10.1099/mic.0.040824-0; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; Pulcrano G, 2012, NEW MICROBIOL, V35, P295; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x; Rodriguez-Rojas A, 2012, J INFECT DIS, V205, P121, DOI 10.1093/infdis/jir690; Roux L, LADS HYBRID HI UNPUB; Roy PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008842; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; Shen DK, 2006, INFECT IMMUN, V74, P1121, DOI 10.1128/IAI.74.2.1121-1129.2006; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Tart AH, 2005, J BACTERIOL, V187, P7955, DOI 10.1128/JB.187.23.7955-7962.2005; Thibault J, 2009, J BIOL CHEM, V284, P15762, DOI 10.1074/jbc.M109.003533; TOUSSAINT B, 1993, BIOCHEM BIOPH RES CO, V196, P416, DOI 10.1006/bbrc.1993.2265; TUMMLER B, 1991, J CLIN MICROBIOL, V29, P1265; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898; van den Broek D, 2005, J BACTERIOL, V187, P593, DOI 10.1128/JB.187.2.593-600.2005; van den Broek D, 2005, ENVIRON MICROBIOL, V7, P1686, DOI 10.1111/j.1462-2920.2005.00912.x; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Wolfgang MC, 2004, P NATL ACAD SCI USA, V101, P6664, DOI 10.1073/pnas.0307553101; Workentine ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060225; Wu WH, 2004, J BACTERIOL, V186, P7575, DOI 10.1128/JB.186.22.7575-7585.2004; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x	73	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2014	9	4							e95936	10.1371/journal.pone.0095936	http://dx.doi.org/10.1371/journal.pone.0095936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CA	24780952	gold, Green Published, Green Submitted			2022-12-25	WOS:000335504900012
J	Feng, HX; Li, X; Chan, V; Chen, WN				Feng, Huixing; Li, Xi; Chan, Vincent; Chen, Wei Ning			Proteomics Based Identification of Cell Migration Related Proteins in HBV Expressing HepG2 Cells	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; B-VIRUS REPLICATION; HEPATITIS-B; HEPATOCELLULAR-CARCINOMA; BINDING PROTEIN-1; ANNEXIN A2; IQGAP1; CANCER; PROLIFERATION; INVOLVEMENT	Proteomics study was performed to investigate the specific protein expression profiles of HepG2 cells transfected with mutant HBV compared with wildtype HBV genome, aiming to identify the specific functions of SH3 binding domain (proline rich region) located in HBx. In addition to the cell movement and kinetics changes due to the expression of HBV genome we have observed previously, here we further targeted to explore the specific changes of cellular proteins and potential intracellular protein interactions, which might provide more information of the potential cellular mechanism of the differentiated cell movements. Specific changes of a number of proteins were shown in global protein profiling in HepG2 cells expressing wildtype HBV, including cell migration related proteins, and interestingly the changes were found recovered by SH3 binding domain mutated HBV. The distinctive expressions of proteins were validated by Western blot analysis.	[Feng, Huixing; Li, Xi; Chan, Vincent; Chen, Wei Ning] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chen, WN (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.	WNChen@ntu.edu.sg	Chan, Vincent/AHB-8464-2022; Chan, Vincent/G-6197-2010	Chan, Vincent/0000-0003-2149-4479; , Yang/0000-0002-6620-8897	Ministry of Education Singapore [RG42/05]; Nanyang Technological University, Singapore	Ministry of Education Singapore(Ministry of Education, Singapore); Nanyang Technological University, Singapore(Nanyang Technological University)	The work was supported by Grant RG42/05, Ministry of Education Singapore (Wei Ning Chen). Huixing Feng and Xi Li are recipients of graduate research scholarships from the Nanyang Technological University, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosch B, 2010, VIRUSES-BASEL, V2, P1504, DOI 10.3390/v2081504; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Bouchard MJ, 2001, SCIENCE, V294, P2376, DOI 10.1126/science.294.5550.2376; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Chen F, 2010, EXP MOL MED, V42, P477, DOI 10.3858/emm.2010.42.7.049; Chen WN, 2000, AM J GASTROENTEROL, V95, P1098; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Clark HP, 2005, RADIOGRAPHICS, V25, pS3, DOI 10.1148/rg.25si055507; Cristea IM, 2010, J VIROL, V84, P6720, DOI 10.1128/JVI.01983-09; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Feng HX, 2010, J PROTEOMICS, V73, P1421, DOI 10.1016/j.jprot.2009.12.004; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Impens F, 2012, BIOL CHEM, V393, P915, DOI 10.1515/hsz-2012-0168; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kurella VB, 2009, J BIOL CHEM, V284, P14857, DOI 10.1074/jbc.M808974200; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Li X, 2010, BIOMATERIALS, V31, P1894, DOI 10.1016/j.biomaterials.2009.11.031; Lokman NA, 2011, CANCER MICROENVIRON, V4, P199, DOI 10.1007/s12307-011-0064-9; MacDonald MR, 2007, J VIROL, V81, P13509, DOI 10.1128/JVI.00402-07; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Narayan R, 2009, J PROTEOME RES, V8, P118, DOI 10.1021/pr800562j; Ou DP, 2007, INT J CANCER, V120, P1208, DOI 10.1002/ijc.22452; Parker F, 1996, MOL CELL BIOL, V16, P2561; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Song MN, 2012, ARCH PHARM RES, V35, P1839, DOI 10.1007/s12272-012-1018-6; Stradal T, 1998, FEBS LETT, V431, P134, DOI 10.1016/S0014-5793(98)00751-0; Sugimoto N, 2001, J HUM GENET, V46, P21, DOI 10.1007/s100380170119; Sun Y, 2012, CARCINOGENESIS; Tan TL, 2008, BBA-MOL CELL RES, V1783, P360, DOI 10.1016/j.bbamcr.2007.10.024; Tan TL, 2006, BBA-MOL BASIS DIS, V1762, P755, DOI 10.1016/j.bbadis.2006.06.016; Tarn C, 2001, J BIOL CHEM, V276, P34671, DOI 10.1074/jbc.M104105200; Tong AP, 2008, PROTEOMICS, V8, P2012, DOI 10.1002/pmic.200700849; Tong AP, 2009, J PROTEOME RES, V8, P1037, DOI 10.1021/pr8008622; Wang ZQ, 2010, ACTA BIOCH BIOPH SIN, V42, P358, DOI 10.1093/abbs/gmq024; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Yanez M, 2012, ADV EXP MED BIOL, V740, P461, DOI 10.1007/978-94-007-2888-2_19; Yi ZG, 2006, BIOCHEM BIOPH RES CO, V350, P174, DOI 10.1016/j.bbrc.2006.09.027; Yi ZG, 2011, J VIROL, V85, P6996, DOI 10.1128/JVI.00013-11; Yu FL, 2005, J HEPATOL, V42, P520, DOI 10.1016/j.jhep.2004.11.031; Zhai HY, 2011, J NEUROSCI, V31, P14346, DOI 10.1523/JNEUROSCI.3299-11.2011; Zhang XH, 2012, CLIN TRANSL ONCOL, V14, P634, DOI 10.1007/s12094-012-0855-6; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	46	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95621	10.1371/journal.pone.0095621	http://dx.doi.org/10.1371/journal.pone.0095621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24763314	Green Published, gold			2022-12-25	WOS:000335505000029
J	Fiz-Palacios, O; Leander, BS; Heger, TJ				Fiz-Palacios, Omar; Leander, Brian S.; Heger, Thierry J.			Old Lineages in a New Ecosystem: Diversification of Arcellinid Amoebae (Amoebozoa) and Peatland Mosses	PLOS ONE			English	Article							TESTATE AMEBAS; REVISED CLASSIFICATION; PHYLOGENY; DIVERSITY; REVEALS; RATES	Arcellinid testate amoebae (Amoebozoa) form a group of free-living microbial eukaryotes with one of the oldest fossil records known, yet several aspects of their evolutionary history remain poorly understood. Arcellinids occur in a range of terrestrial, freshwater and even brackish habitats; however, many arcellinid morphospecies such as Hyalosphenia papilio are particularly abundant in Sphagnum-dominated peatlands, a relatively new ecosystem that appeared during the diversification of Sphagnum species in the Miocene (5-20 Myr ago). Here, we reconstruct divergence times in arcellinid testate amoebae after selecting several fossils for clock calibrations and then infer whether or not arcellinids followed a pattern of diversification that parallels the pattern described for Sphagnum. We found that the diversification of core arcellinids occurred during the Phanerozoic, which is congruent with most arcellinid fossils but not with the oldest known amoebozoan fossil (i.e. at ca. 662 or ca. 750 Myr). Overall, Sphagnum and the Hyalospheniidae exhibit different patterns of diversification. However, an extensive molecular phylogenetic analysis of distinct clades within H. papilio species complex demonstrated a correlation between the recent diversification of H. papilio, the recent diversification of Sphagnum mosses, and the establishment of peatlands.	[Fiz-Palacios, Omar] Evolutionary Biol Ctr, Dept Organismal Biol, Systemat Biol Program, Uppsala, Sweden; [Leander, Brian S.; Heger, Thierry J.] Univ British Columbia, Dept Zool, Biodivers Res Ctr, Vancouver, BC, Canada; [Leander, Brian S.; Heger, Thierry J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Fiz-Palacios, O (corresponding author), Evolutionary Biol Ctr, Dept Organismal Biol, Systemat Biol Program, Uppsala, Sweden.	fizpal@gmail.com	Heger, Thierry/GRS-4038-2022	Heger, Thierry/0000-0003-3614-0964	Swedish Research Council; Swiss NSF [PA00P3 145374]; National Science and Engineering Research Council of Canada [NSERC 283091-09]; Tula Foundation's Centre for Microbial Diversity and Evolution at the University of British Columbia	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swiss NSF(Swiss National Science Foundation (SNSF)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tula Foundation's Centre for Microbial Diversity and Evolution at the University of British Columbia	This work was funded by Swedish Research Council Linne grant to OFP; the Swiss NSF project PA00P3 145374 to TJH; the National Science and Engineering Research Council of Canada (NSERC 283091-09); and the Tula Foundation's Centre for Microbial Diversity and Evolution at the University of British Columbia. BSL is a Fellow of the Canadian Institute for Advanced Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Booth RK, 2005, DIVERS DISTRIB, V11, P577, DOI 10.1111/j.1366-9516.2005.00154.x; Bosak T, 2011, EARTH PLANET SC LETT, V308, P29, DOI 10.1016/j.epsl.2011.05.030; Brenner Gilbert J., 1996, P91, DOI 10.1007/978-0-585-23095-5_5; Cavalier-Smith T, 2009, J EUKARYOT MICROBIOL, V56, P26, DOI 10.1111/j.1550-7408.2008.00373.x; Charret R, 1964, B BIOL FRANCE BELGIQ, VXCVIII, P369; DEFLANDRE GEORGES, 1936, ANN PROTISTOLOGIE, V5, P201; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Farooqui A., 2010, Earth Science India, V3, P146; Fiz-Palacios O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074374; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fontaneto D, 2013, MOL ECOL, V22, P5053, DOI 10.1111/mec.12507; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Girard V, 2011, EUR J PROTISTOL, V47, P59, DOI 10.1016/j.ejop.2010.12.003; Golemansky Vassil, 2007, Monographiae Biologicae, V82, P555; Gomaa F, 2012, PROTIST, V163, P389, DOI 10.1016/j.protis.2011.12.001; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heger TJ, 2013, MOL ECOL, V22, P5172, DOI 10.1111/mec.12449; Hubers M, 2012, GEOLOGY, V40, P755, DOI 10.1130/G33122.1; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knoll AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016121; Kosakyan A, 2013, EUR J PROTISTOL, V49, P222, DOI 10.1016/j.ejop.2012.08.006; Kosakyan A, 2012, PROTIST, V163, P415, DOI 10.1016/j.protis.2011.10.003; Kumar A, 2011, J MICROPALAEONTOL, V30, P1, DOI 10.1144/0262-821X10-018; Lahr DJG, 2013, PROTIST, V164, P323, DOI 10.1016/j.protis.2013.02.003; Lahr DJG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022780; Lara E, 2008, PROTIST, V159, P165, DOI 10.1016/j.protis.2007.09.003; Magallon S, 2006, EVOLUTION, V60, P2411; MEDIOLI FS, 1990, NATO ADV SCI I C-MAT, V327, P813; Meisterfeld R, 2002, ILLUSTRATED GUIDE PR, P827; Mitchell EAD, 2003, MICROB ECOL, V46, P187, DOI 10.1007/s00248-002-0008-5; Mitchell EAD, 2008, BIODIVERS CONSERV, V17, P2115, DOI 10.1007/s10531-007-9221-3; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Newton AE, 2007, SYST ASSOC SPEC VOL, V71, P337; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Porter SM, 2000, PALEOBIOLOGY, V26, P360, DOI 10.1666/0094-8373(2000)026<0360:TAITNE>2.0.CO;2; Porter S, 2011, GEOLOGY, V39, P607, DOI 10.1130/focus062011.1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Development Core Team, 2010, LANG ENV STAT COMP; Rabosky Daniel L., 2006, Evolutionary Bioinformatics Online, V2, P257; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubinstein CV, 2010, NEW PHYTOL, V188, P365, DOI 10.1111/j.1469-8137.2010.03433.x; Schmidt AR, 2006, NATURE, V444, P835, DOI 10.1038/444835a; Schmidt AR, 2004, PALAEONTOLOGY, V47, P185, DOI 10.1111/j.0031-0239.2004.00368.x; Shaw AJ, 2010, MOL PHYLOGENET EVOL, V55, P1139, DOI 10.1016/j.ympev.2010.01.020; Smirnov AV, 2011, PROTIST, V162, P545, DOI 10.1016/j.protis.2011.04.004; van Hengstum PJ, 2007, J FORAMIN RES, V37, P300, DOI 10.2113/gsjfr.37.4.300; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	53	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e95238	10.1371/journal.pone.0095238	http://dx.doi.org/10.1371/journal.pone.0095238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24762929	Green Published, Green Submitted, gold			2022-12-25	WOS:000335505000016
J	van Engelen, A; Niessen, WJ; Klein, S; Groen, HC; Verhagen, HJM; Wentzel, JJ; van der Lugt, A; de Bruijne, M				van Engelen, Arna; Niessen, Wiro J.; Klein, Stefan; Groen, Harald C.; Verhagen, Hence J. M.; Wentzel, Jolanda J.; van der Lugt, Aad; de Bruijne, Marleen			Atherosclerotic Plaque Component Segmentation in Combined Carotid MRI and CTA Data Incorporating Class Label Uncertainty	PLOS ONE			English	Article							RICH NECROTIC CORE; IN-VIVO SEGMENTATION; INTRAPLAQUE HEMORRHAGE; HIGH-RESOLUTION; QUANTITATIVE-EVALUATION; CEREBROVASCULAR EVENTS; NATURAL-HISTORY; FIBROUS CAP; VESSEL WALL; HIGH-RISK	Atherosclerotic plaque composition can indicate plaque vulnerability. We segment atherosclerotic plaque components from the carotid artery on a combination of in vivo MRI and CT-angiography (CTA) data using supervised voxelwise classification. In contrast to previous studies the ground truth for training is directly obtained from 3D registration with histology for fibrous and lipid-rich necrotic tissue, and with mu CT for calcification. This registration does, however, not provide accurate voxelwise correspondence. We therefore evaluate three approaches that incorporate uncertainty in the ground truth used for training: I) soft labels are created by Gaussian blurring of the original binary histology segmentations to reduce weights at the boundaries between components, and are weighted by the estimated registration accuracy of the histology and in vivo imaging data (measured by overlap), II) samples are weighted by the local contour distance of the lumen and outer wall between histology and in vivo data, and III) 10% of each class is rejected by Gaussian outlier rejection. Classification was evaluated on the relative volumes (% of tissue type in the vessel wall) for calcified, fibrous and lipid-rich necrotic tissue, using linear discriminant (LDC) and support vector machine (SVM) classification. In addition, the combination of MRI and CTA data was compared to using only one imaging modality. Best results were obtained by LDC and outlier rejection: the volume error per vessel was 0.9 +/- 1.0% for calcification, 12.7 +/- 7.6% for fibrous and 12.1 +/- 8.1% for necrotic tissue, with Spearman rank correlation coefficients of 0.91 (calcification), 0.80 (fibrous) and 0.81 (necrotic). While segmentation using only MRI features yielded low accuracy for calcification, and segmentation using only CTA features yielded low accuracy for necrotic tissue, the combination of features from MRI and CTA gave good results for all studied components.	[van Engelen, Arna; Niessen, Wiro J.; Klein, Stefan; de Bruijne, Marleen] Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Med Informat, Rotterdam, Netherlands; [van Engelen, Arna; Niessen, Wiro J.; Klein, Stefan; Groen, Harald C.; van der Lugt, Aad; de Bruijne, Marleen] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Niessen, Wiro J.] Delft Univ Technol, Fac Sci Appl, Dept Imaging Sci & Technol, Delft, Netherlands; [Groen, Harald C.; Wentzel, Jolanda J.] Erasmus MC, Dept Biomed Engn, Rotterdam, Netherlands; [Groen, Harald C.] Erasmus MC, Dept Nucl Med, Rotterdam, Netherlands; [Verhagen, Hence J. M.] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands; [de Bruijne, Marleen] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Copenhagen	van Engelen, A (corresponding author), Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Med Informat, Rotterdam, Netherlands.	arna.vanengelen@gmail.com	de Bruijne, Marleen/G-2662-2010	de Bruijne, Marleen/0000-0002-6328-902X; Klein, Stefan/0000-0003-4449-6784; Niessen, Wiro/0000-0002-5822-1995	CTMM, the Center for Translational Molecular Medicine, project PARISk [01C-202]; Dutch Heart Foundation; Netherlands Organisation for Scientific Research (NWO); Interuniversity Cardiology Institute of the Netherlands	CTMM, the Center for Translational Molecular Medicine, project PARISk; Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Interuniversity Cardiology Institute of the Netherlands	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PARISk (grant 01C-202), and supported by the Dutch Heart Foundation. Wiro Niessen, Stefan Klein and Marleen de Bruijne were financially supported by the Netherlands Organisation for Scientific Research (NWO). Harald Groen was financially supported by the Interuniversity Cardiology Institute of the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022835; Arias A, 2012, MICCAI WORKSH MED CO; Bouveyron C, 2009, PATTERN RECOGN, V42, P2649, DOI 10.1016/j.patcog.2009.03.027; Brazzelli M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003359; Breen MS, 2003, J MAGN RESON IMAGING, V18, P90, DOI 10.1002/jmri.10324; Brott TG, 2011, STROKE, V42, pE420, DOI 10.1161/STR.0b013e3182112d08; Cai JM, 2005, CIRCULATION, V112, P3437, DOI 10.1161/CIRCULATIONAHA.104.528174; Cai JM, 2002, CIRCULATION, V106, P1368, DOI 10.1161/01.CIR.0000028591.44554.F9; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen X.-W., 2010, P 19 ACM INT C INF K, P349; Dauguet J, 2007, J NEUROSCI METH, V164, P191, DOI 10.1016/j.jneumeth.2007.04.017; Davis MH, 1997, IEEE T MED IMAGING, V16, P317, DOI 10.1109/42.585766; de Monye C, 2005, RADIOLOGY, V237, P555, DOI 10.1148/radiol.2372040653; de Weert TT, 2006, ARTERIOSCL THROM VAS, V26, P2366, DOI 10.1161/01.ATV.0000240518.90124.57; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Duin R, 2007, PRTOOLS4 1 MATLAB TO; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Groen HC, 2010, J BIOMECH, V43, P2087, DOI 10.1016/j.jbiomech.2010.04.005; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Haraguchi K, 2008, MINIM INVAS NEUROSUR, V51, P91, DOI 10.1055/s-2007-1022550; Hastie T, 2003, ELEMENTS STAT LEARNI; Hatsukami TS, 2000, CIRCULATION, V102, P959, DOI 10.1161/01.CIR.102.9.959; Hodge VJ, 2004, ARTIF INTELL REV, V22, P85, DOI 10.1023/B:AIRE.0000045502.10941.a9; Hofman JMA, 2006, MAGN RESON MED, V55, P790, DOI 10.1002/mrm.20828; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; Kerwin William, 2007, Top Magn Reson Imaging, V18, P371; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Klein S, 2009, INT J COMPUT VISION, V81, P227, DOI 10.1007/s11263-008-0168-y; Kwee RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042472; Kwee RM, 2010, J VASC SURG, V51, P1015, DOI 10.1016/j.jvs.2009.08.072; Kyriacou EC, 2012, IEEE T INF TECHNOL B, V16, P966, DOI 10.1109/TITB.2012.2192446; Li FY, 2010, J MAGN RESON IMAGING, V31, P168, DOI 10.1002/jmri.22014; Liu F, 2006, MAGN RESON MED, V55, P659, DOI 10.1002/mrm.20814; Lovett JK, 2005, STROKE, V36, P1085, DOI 10.1161/01.STR.0000160749.61763.95; Muhlenbruch G, 2010, EUR RADIOL, V20, P469, DOI 10.1007/s00330-009-1547-7; Nieuwstadt HA, 2013, MAGNETIC RESONANCE M; Ota H, 2010, RADIOLOGY, V254, P551, DOI 10.1148/radiol.09090535; Paraskevas KI, 2012, J VASC SURG, V55, P1504, DOI 10.1016/j.jvs.2012.01.084; Rohr K, 2001, IEEE T MED IMAGING, V20, P526, DOI 10.1109/42.929618; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31; Saam T, 2007, RADIOLOGY, V244, P64, DOI 10.1148/radiol.2441051769; Saam T, 2013, J AM COLL CARDIOL, V62, P1081, DOI 10.1016/j.jacc.2013.06.015; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; SEEGER JM, 1995, J SURG RES, V58, P330, DOI 10.1006/jsre.1995.1051; Shaalan WE, 2004, J VASC SURG, V40, P262, DOI 10.1016/j.jvs.2004.04.025; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Sun J, 2013, RADIOLOGY, V268, P61, DOI 10.1148/radiol.13121702; Takaya N, 2006, STROKE, V37, P818, DOI 10.1161/01.STR.0000204638.91099.91; Takaya N, 2006, J MAGN RESON IMAGING, V24, P203, DOI 10.1002/jmri.20599; Tardif JC, 2013, CAN J CARDIOL, V29, P297, DOI 10.1016/j.cjca.2012.09.017; Tax D., 2012, DDTOOLS DATA DESCRIP; ten Kate GL, 2010, CURR PROB CARDIOLOGY, V35, P556, DOI 10.1016/j.cpcardiol.2010.09.002; Thevenaz P, 2000, IEEE T IMAGE PROCESS, V9, P2083, DOI 10.1109/83.887976; Thiel C, 2008, LECT NOTES ARTIF INT, V5177, P65, DOI 10.1007/978-3-540-85563-7_14; Truijman M, 2013, INT J STROKE; U-King-Im JM, 2010, STROKE, V41, P1623, DOI 10.1161/STROKEAHA.110.579474; Ukwatta E, 2013, IEEE T MED IMAGING, V32, P770, DOI 10.1109/TMI.2013.2237784; van den Bouwhuijsen QJA, 2012, EUR HEART J, V33, P221, DOI 10.1093/eurheartj/ehr227; van Engelen A, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P246, DOI 10.1109/ISBI.2012.6235530; van Engelen A, 2012, PHYS MED BIOL, V57, P241, DOI 10.1088/0031-9155/57/1/241; van 't Klooster R, 2012, AM J NEURORADIOL, V33, P1621, DOI 10.3174/ajnr.A3028; van 't Klooster R, 2012, J MAGN RESON IMAGING, V35, P156, DOI 10.1002/jmri.22809; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Vos PC, 2008, MED PHYS, V35, P888, DOI 10.1118/1.2836419; Ward AD, 2012, RADIOLOGY, V263, P856, DOI 10.1148/radiol.12102294; Wasserman BA, 2002, RADIOLOGY, V223, P566, DOI 10.1148/radiol.2232010659; Wintermark M, 2008, AM J NEURORADIOL, V29, P875, DOI 10.3174/ajnr.A0950; Yamada K, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-81; Yang Q, 2009, J MAGN RESON IMAGING, V30, P357, DOI 10.1002/jmri.21859; Yoshimura S, 2013, J STROKE CEREBROVASC, V22, P1082, DOI 10.1016/j.jstrokecerebrovasdis.2012.07.018; Yuan C, 2001, CIRCULATION, V104, P2051, DOI 10.1161/hc4201.097839; Zhao HL, 2013, EUR J RADIOL, V82, pE465, DOI 10.1016/j.ejrad.2013.04.014; Zhao XH, 2010, INVEST RADIOL, V45, P36, DOI 10.1097/RLI.0b013e3181beada7	75	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2014	9	4							e94840	10.1371/journal.pone.0094840	http://dx.doi.org/10.1371/journal.pone.0094840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6CB	24762678	Green Published, gold			2022-12-25	WOS:000335505000011
J	Mire, CE; Geisbert, JB; Agans, KN; Satterfield, BA; Versteeg, KM; Fritz, EA; Feldmann, H; Hensley, LE; Geisbert, TW				Mire, Chad E.; Geisbert, Joan B.; Agans, Krystle N.; Satterfield, Benjamin A.; Versteeg, Krista M.; Fritz, Elizabeth A.; Feldmann, Heinz; Hensley, Lisa E.; Geisbert, Thomas W.			Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates	PLOS ONE			English	Article							ATTENUATED RECOMBINANT VACCINE; EBOLA-VIRUS; HEMORRHAGIC-FEVER; IMMUNE-RESPONSES; IMMUNIZATION; PROTECTION; CHALLENGE; VECTORS; LIVE; GLYCOPROTEINS	The filoviruses, Marburg virus (MARV) and Ebola virus, causes severe hemorrhagic fever with high mortality in humans and nonhuman primates. A promising filovirus vaccine under development is based on a recombinant vesicular stomatitis virus (rVSV) that expresses individual filovirus glycoproteins (GPs) in place of the VSV glycoprotein (G). These vaccines have shown 100% efficacy against filovirus infection in nonhuman primates when challenge occurs 28-35 days after a single injection immunization. Here, we examined the ability of a rVSV MARV-GP vaccine to provide protection when challenge occurs more than a year after vaccination. Cynomolgus macaques were immunized with rVSV-MARV-GP and challenged with MARV approximately 14 months after vaccination. Immunization resulted in the vaccine cohort of six animals having anti-MARV GP IgG throughout the pre-challenge period. Following MARV challenge none of the vaccinated animals showed any signs of clinical disease or viremia and all were completely protected from MARV infection. Two unvaccinated control animals exhibited signs consistent with MARV infection and both succumbed. Importantly, these data are the first to show 100% protective efficacy against any high dose filovirus challenge beyond 8 weeks after final vaccination. These findings demonstrate the durability of VSV-based filovirus vaccines.	[Mire, Chad E.; Geisbert, Joan B.; Agans, Krystle N.; Satterfield, Benjamin A.; Versteeg, Krista M.; Fritz, Elizabeth A.; Geisbert, Thomas W.] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA; [Mire, Chad E.; Geisbert, Joan B.; Agans, Krystle N.; Satterfield, Benjamin A.; Versteeg, Krista M.; Fritz, Elizabeth A.; Geisbert, Thomas W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA; [Hensley, Lisa E.] NIAID, Integrated Res Facil Ft Detrick, Div Clin Res, NIH, Frederick, MD USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Geisbert, TW (corresponding author), Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA.	twgeisbe@utmb.edu	Mire, Chad/Z-6338-2019	Mire, Chad/0000-0001-7596-1808; Satterfield, Benjamin/0000-0002-7798-0938; Hensley, Lisa/0000-0003-1188-4342	US Army Medical Research Acquisition Activity [WX81XWH-10-2-0050]; Department of Health and Human Services, NIH [AI098817]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089, ZIAAI001163, UC7AI094660, R01AI098817] Funding Source: NIH RePORTER	US Army Medical Research Acquisition Activity; Department of Health and Human Services, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an award from the US Army Medical Research Acquisition Activity to TG (award number WX81XWH-10-2-0050). Some non-animal portions of the work were also supported by the Department of Health and Human Services, NIH, grant AI098817 to Dr. John Eldridge and TWG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askling HH, 2012, VACCINE, V30, P499, DOI 10.1016/j.vaccine.2011.11.061; Bautista-Lopez N, 2000, VACCINE, V18, P1393, DOI 10.1016/S0264-410X(99)00396-5; Behrman A, 2013, J CLIN VIROL, V57, P109, DOI 10.1016/j.jcv.2013.01.015; Crum-Cianflone NF, 2011, J INFECT DIS, V203, P1815, DOI 10.1093/infdis/jir180; Daddario-DiCaprio KM, 2006, J VIROL, V80, P9659, DOI 10.1128/JVI.00959-06; Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2; Falzarano D, 2011, EXPERT REV VACCINES, V10, P63, DOI [10.1586/erv.10.152, 10.1586/ERV.10.152]; Feldmann H., 2013, FIELDS VIROLOGY, V1, P923; Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004; Geisbert TW, 2007, J INFECT DIS, V196, pS372, DOI 10.1086/520608; Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349; Geisbert TW, 2010, REV MED VIROL, V20, P344, DOI 10.1002/rmv.661; Geisbert TW, 2010, EMERG INFECT DIS, V16, P1119, DOI 10.3201/eid1607.100159; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Geisbert TW, 2008, VACCINE, V26, P6894, DOI 10.1016/j.vaccine.2008.09.082; Geisbert TW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000225; Gunther S, 2011, J INFECT DIS, V204, pS785, DOI 10.1093/infdis/jir298; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; HERRMANN KL, 1982, JAMA-J AM MED ASSOC, V247, P193, DOI 10.1001/jama.247.2.193; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kaslow DC, 2007, HUM VACCINES, V3, P1; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Lodmell DL, 2002, VACCINE, V20, P2221, DOI 10.1016/S0264-410X(02)00143-3; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Mbonye A, 2012, AFR HEALTH SCI, V12, P579, DOI 10.4314/ahs.v12i4.31; Mire CE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001567; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Schmaljohn AL, 2013, CURR HIV RES, V11, P345, DOI 10.2174/1570162X113116660057; SMITH DH, 1982, LANCET, V1, P816; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; WEIBEL ROBERT E., 1968, J AMER MED ASS, V203, P14, DOI 10.1001/jama.203.1.14	33	52	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e94355	10.1371/journal.pone.0094355	http://dx.doi.org/10.1371/journal.pone.0094355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759889	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200015
J	Xiao, YH; Yan, Q; Ding, H; Luo, M; Hou, L; Zhang, M; Yao, D; Liu, HS; Li, X; Zhao, J; Pei, Y				Xiao, Yue-Hua; Yan, Qian; Ding, Hui; Luo, Ming; Hou, Lei; Zhang, Mi; Yao, Dan; Liu, Hou-Sheng; Li, Xin; Zhao, Jia; Pei, Yan			Transcriptome and Biochemical Analyses Revealed a Detailed Proanthocyanidin Biosynthesis Pathway in Brown Cotton Fiber	PLOS ONE			English	Article							PIGMENTATION; FLAVONOIDS; EVOLUTION; GENES; COLOR	Brown cotton fiber is the major raw material for colored cotton industry. Previous studies have showed that the brown pigments in cotton fiber belong to proanthocyanidins (PAs). To clarify the details of PA biosynthesis pathway in brown cotton fiber, gene expression profiles in developing brown and white fibers were compared via digital gene expression profiling and qRT-PCR. Compared to white cotton fiber, all steps from phenylalanine to PA monomers (flavan-3-ols) were significantly up-regulated in brown fiber. Liquid chromatography mass spectrometry analyses showed that most of free flavan-3-ols in brown fiber were in 2, 3-trans form (gallocatechin and catechin), and the main units of polymeric PAs were trihydroxylated on B ring. Consistent with monomeric composition, the transcript levels of flavonoid 3', 5'-hydroxylase and leucoanthocyanidin reductase in cotton fiber were much higher than their competing enzymes acting on the same substrates (dihydroflavonol 4-reductase and anthocyanidin synthase, respectively). Taken together, our data revealed a detailed PA biosynthesis pathway wholly activated in brown cotton fiber, and demonstrated that flavonoid 3', 5'-hydroxylase and leucoanthocyanidin reductase represented the primary flow of PA biosynthesis in cotton fiber.	[Xiao, Yue-Hua; Yan, Qian; Ding, Hui; Luo, Ming; Hou, Lei; Zhang, Mi; Yao, Dan; Liu, Hou-Sheng; Li, Xin; Zhao, Jia; Pei, Yan] Southwest Univ, Biotechnol Res Ctr, Chongqing, Peoples R China	Southwest University - China	Xiao, YH (corresponding author), Southwest Univ, Biotechnol Res Ctr, Chongqing, Peoples R China.	xiaoyuehua@swu.edu.cn	li, xia/HHZ-7468-2022; Xiao, Yun/A-8359-2013; Fan, Huihui/AGB-0221-2022	Fan, Huihui/0000-0003-4233-5389; Zhang, Mi/0000-0001-8180-2029; Ping, Yanyan/0000-0002-1810-1200; Arana, Tania/0000-0002-8121-2085	National Natural Science Foundation of China [31130039, 30971713, 31271769]; Genetically Modified Organisms Breeding Major Project of China [2013ZX08005005-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Project of China	This work was partially supported by the National Natural Science Foundation of China (31130039 to P.Y., 30971713 and 31271769 to X.Y.H) and by the Genetically Modified Organisms Breeding Major Project of China (2013ZX08005005-001 to X.Y.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Castellarin SD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-12; Chaudhary B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-378; Efe Lale, 2009, Pak J Biol Sci, V12, P1346, DOI 10.3923/pjbs.2009.1346.1352; Feng HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058820; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gu LW, 2002, J AGR FOOD CHEM, V50, P4852, DOI 10.1021/jf020214v; HALLOIN JM, 1982, NEW PHYTOL, V90, P651, DOI 10.1111/j.1469-8137.1982.tb03274.x; He F, 2008, MOLECULES, V13, P2674, DOI 10.3390/molecules13102674; Hellstrom JK, 2008, J AGR FOOD CHEM, V56, P7617, DOI 10.1021/jf801336s; Hua SJ, 2007, CROP SCI, V47, P1540, DOI 10.2135/cropsci2006.12.0835; Hua SJ, 2009, CROP SCI, V49, P983, DOI 10.2135/cropsci2008.06.0371; Hustvedt G, 2005, J COTTON SCI, V9, P47; Jiang HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036522; Kimmel LB, 2001, AATCC REV, V1, P32; Li YJ, 2013, J PROTEOMICS, V78, P374, DOI 10.1016/j.jprot.2012.10.005; Ming L, 2003, J GENET GENOMICS, V30, P8; Murthy M.S.S., 2001, RESONANCE, V6, P29, DOI [10.1007/BF02913764, DOI 10.1007/BF02913764]; Parmar MS, 2001, TEXT RES J, V71, P1099, DOI 10.1177/004051750107101211; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tan JF, 2013, PLANT PHYSIOL, V162, P86, DOI 10.1104/pp.112.212142; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Woo HH, 2005, BIOTECHNOL LETT, V27, P365, DOI 10.1007/s10529-005-1521-7; Xiao YH, 2007, BIOCHEM BIOPH RES CO, V358, P73, DOI 10.1016/j.bbrc.2007.04.084; Yokozawa T, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/623879; Zhang ZS, 2005, EUPHYTICA, V144, P91, DOI 10.1007/s10681-005-4629-x; Zhao J, 2010, PLANT PHYSIOL, V153, P437, DOI 10.1104/pp.110.155432; Zhu YQ, 2003, PLANT PHYSIOL, V133, P580, DOI 10.1104/pp.103.027052	34	95	101	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86344	10.1371/journal.pone.0086344	http://dx.doi.org/10.1371/journal.pone.0086344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24776767	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500233
J	Liu, WY; Wu, SM; Xiong, Y; Li, TY; Wen, Z; Yan, MZ; Qin, K; Liu, YL; Wu, JG				Liu, Weiyong; Wu, Shimin; Xiong, Ying; Li, Tongya; Wen, Zhou; Yan, Mingzhe; Qin, Kai; Liu, Yingle; Wu, Jianguo			Co-Circulation and Genomic Recombination of Coxsackievirus A16 and Enterovirus 71 during a Large Outbreak of Hand, Foot, and Mouth Disease in Central China	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; CLINICAL-FEATURES; ETIOLOGIC CHARACTERISTICS; INTRATYPIC RECOMBINATION; FREQUENT RECOMBINATION; PULMONARY-EDEMA; HONG-KONG; GROUP-A; INFECTION; TAIWAN	A total of 1844 patients with hand, foot, and mouth disease (HFMD), most of them were children of age 1-3-year-old, in Central China were hospitalized from 2011 to 2012. Among them, 422 were infected with coxsackievirus A16 (CVA16), 334 were infected with enterovirus 71 (EV71), 38 were co-infected with EV71 and CVA16, and 35 were infected with other enteroviruses. Molecular epidemiology analysis revealed that EV71 and CVA16 were detected year-round, but EV71 circulated mainly in July and CVA16 circulated predominantly in November, and incidence of HFMD was reduced in January and February and increased in March. Clinical data showed that hyperglycemia and neurologic complications were significantly higher in EV71-infected patients, while upper respiratory tract infection and C-reactive protein were significantly higher in CVA16-associated patients. 124 EV71 and 80 CVA16 strains were isolated, among them 56 and 68 EV71 strains were C4a and C4b, while 25 and 55 CVA16 strains were B1a and B1b, respectively. Similarity plots and bootscan analyses based on entire genomic sequences revealed that the three C4a sub-genotype EV71 strains were recombinant with C4b sub-genotype EV71 in 2B-2C region, and the three CVA16 strains were recombinant with EV71 in 2A-2B region. Thus, CVA16 and EV71 were the major causative agents in a large HFMD outbreak in Central China. HFMD incidence was high for children among household contact and was detected year-round, but outbreak was seasonal dependent. CVA16 B1b and EV71 C4b reemerged and caused a large epidemic in China after a quiet period of many years. Moreover, EV71 and CVA16 were co-circulated during the outbreak, which may have contributed to the genomic recombination between the pathogens. It should gain more attention as there may be an upward trend in co-circulation of the two pathogens globally and the new role recombination plays in the emergence of new enterovirus variants.	[Liu, Weiyong; Xiong, Ying; Li, Tongya; Wen, Zhou; Yan, Mingzhe; Qin, Kai; Liu, Yingle; Wu, Jianguo] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Weiyong; Xiong, Ying; Li, Tongya; Wen, Zhou; Yan, Mingzhe; Qin, Kai; Liu, Yingle; Wu, Jianguo] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Wu, Shimin] Wuhan Med Treatment Ctr, Dept Clin Lab, Wuhan, Peoples R China	Wuhan University; Wuhan University	Liu, YL (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China.	mvlwu@whu.edu.cn; jwu@whu.edu.cn		Wu, Jianguo/0000-0002-8326-2895	Major State Basic Research Development Program (973 Program) [2012CB518900]; National Natural Science Foundation of China [31230005, 812111146, 81171525]; National Mega Project on Major Infectious Disease Prevention [2012ZX10002006-003, 2012ZX10004-207]; National Mega Project on Major Drug Development [2011ZX09401-302]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Disease Prevention; National Mega Project on Major Drug Development	This work was supported by research grants from Major State Basic Research Development Program (973 Program) (No. 2012CB518900; http://www.973.gov.cn/Default_3.aspx), National Natural Science Foundation of China (Nos. 31230005, 812111146, and 81171525; http://www.nsfc.gov.cn/Portal0/default152.htm), the National Mega Project on Major Infectious Disease Prevention (2012ZX10002006-003 and 2012ZX10004-207; http://www.chinapop.gov.cn/zhuzhan/index.shtml), National Mega Project on Major Drug Development (No. 2011ZX09401-302; http://www.chinapop.gov.cn/zhuzhan/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; BLOMBERG J, 1974, LANCET, V2, P112; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Bracho MA, 2011, EMERG INFECT DIS, V17, P2223, DOI 10.3201/eid1712.110395; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chatproedprai S, 2010, JPN J INFECT DIS, V63, P229; Chen HL, 2008, VACCINE, V26, P2882, DOI 10.1016/j.vaccine.2008.03.041; Chen SP, 2010, J MICROBIOL IMMUNOL, V43, P99, DOI 10.1016/S1684-1182(10)60016-3; Chen SC, 2007, AM J TROP MED HYG, V77, P188, DOI 10.4269/ajtmh.2007.77.188; Chua K B, 2007, Malays J Pathol, V29, P69; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Deshpande JM, 2003, CURR SCI INDIA, V84, P1350; Doraisingham S, 1987, Ann Acad Med Singap, V16, P243; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; GOLDBERG MF, 1963, J PEDIATR-US, V62, P762, DOI 10.1016/S0022-3476(63)80047-5; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Guan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044386; HAGIWARA A, 1984, ARCH VIROL, V79, P273, DOI 10.1007/BF01310816; Han JF, 2012, EMERG INFECT DIS, V18, P351, DOI 10.3201/eid1802.111524; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; HIRST GK, 1962, COLD SPRING HARB SYM, V27, P303, DOI 10.1101/SQB.1962.027.001.028; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; ISHIMARU Y, 1980, ARCH DIS CHILD, V55, P583, DOI 10.1136/adc.55.8.583; Iwai M, 2009, JPN J INFECT DIS, V62, P254; Ji BY, 2011, MOD PREVENTIVE MED, V13, P4226; Kapusinszky B, 2010, VIRUS GENES, V40, P163, DOI 10.1007/s11262-009-0440-4; Kim Kyung Hyo, 2010, Korean J Pediatr, V53, P616, DOI 10.3345/kjp.2010.53.5.616; Kliegman R, 2011, NELSON TXB PEDIAT, P242; Komatsu H, 1999, PEDIATR NEUROL, V20, P17, DOI 10.1016/S0887-8994(98)00087-3; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Ku ZQ, 2012, J VIROL METHODS, V186, P193, DOI 10.1016/j.jviromet.2012.06.025; Lan YC, 2011, SCAND J INFECT DIS, V43, P354, DOI 10.3109/00365548.2010.545995; LEDINKO N, 1963, VIROLOGY, V20, P107, DOI 10.1016/0042-6822(63)90145-4; Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Liang ZL, 2013, HUM VACCIN IMMUNOTHE, V9; Liu LJ, 2012, ARCH VIROL, V157, P2219, DOI 10.1007/s00705-012-1396-6; Liu LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054451; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Ma E, 2010, JPN J INFECT DIS, V63, P422; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Mandell GL, 2010, MANDELL DOUGLAS BENN, P172; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Ni HX, 2012, J CLIN VIROL, V54, P342, DOI 10.1016/j.jcv.2012.04.021; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; Pallansch M., 2007, FIELDS VIROL, P839; POYRY T, 1994, VIROLOGY, V202, P982, DOI 10.1006/viro.1994.1423; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Racaniello V. R., 2007, FIELDS VIROLOGY, P796; ROBINSON C R, 1958, Can Med Assoc J, V79, P615; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Schuffenecker I, 2011, J CLIN VIROL, V50, P50, DOI 10.1016/j.jcv.2010.09.019; Shekhar K, 2005, Med J Malaysia, V60, P297; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; SICKLES GM, 1955, P SOC EXP BIOL MED, V90, P529, DOI 10.3181/00379727-90-22088; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tian H, 2012, MED PRIN PRACT, V21, P355, DOI 10.1159/000334619; Urashima M, 2003, JPN J INFECT DIS, V56, P48; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang CY, 2004, PEDIATR INFECT DIS J, V23, P275, DOI 10.1097/01.inf.0000115950.63906.78; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048069, 10.1371/journal.pone.0051667, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0032405, 10.1371/journal.pone.0036274]; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Wen HL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-115; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; WRIGHT HT, 1963, NEW ENGL J MED, V268, P1041, DOI 10.1056/NEJM196305092681904; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yan JJ, 2001, J MED VIROL, V65, P331, DOI 10.1002/jmv.2038; Yan XF, 2012, SCAND J INFECT DIS, V44, P297, DOI 10.3109/00365548.2011.634433; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yip CCY, 2011, J VIROL, V85, P12098, DOI 10.1128/JVI.05944-11; Yip CCY, 2010, ARCH VIROL, V155, P1413, DOI 10.1007/s00705-010-0722-0; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10; Zeng M, 2012, EPIDEMIOL INFECT, V140, P1122, DOI 10.1017/S0950268811001622; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhou XB, 2013, HUM VACCIN IMMUNOTHE, V9; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1; Zhu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037206; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	119	113	136	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e96051	10.1371/journal.pone.0096051	http://dx.doi.org/10.1371/journal.pone.0096051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776922	gold, Green Submitted, Green Published			2022-12-25	WOS:000346241800025
J	Zheng, Z; Lee, KS; Zhang, XL; Nguyen, C; Hsu, CY; Wang, JZ; Rackohn, TM; Enjamuri, DR; Murphy, M; Ting, K; Soo, C				Zheng, Zhong; Lee, Kevin S.; Zhang, Xinli; Nguyen, Calvin; Hsu, Chingyun; Wang, Joyce Z.; Rackohn, Todd Matthew; Enjamuri, Dwarak Reddy; Murphy, Maxwell; Ting, Kang; Soo, Chia			Fibromodulin-Deficiency Alters Temporospatial Expression Patterns of Transforming Growth Factor-beta Ligands and Receptors during Adult Mouse Skin Wound Healing	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; TGF-BETA; EXTRACELLULAR-MATRIX; SCAR FORMATION; COLLAGEN FIBRILLOGENESIS; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; DECORIN; LUMICAN; GROWTH-FACTOR-BETA-1	Fibromodulin (FMOD) is a small leucine-rich proteoglycan required for scarless fetal cutaneous wound repair. Interestingly, increased FMOD levels have been correlated with decreased transforming growth factor (TGF)-beta 1 expression in multiple fetal and adult rodent models. Our previous studies demonstrated that FMOD-deficiency in adult animals results in delayed wound closure and increased scar size accompanied by loose package collagen fiber networks with increased fibril diameter. In addition, we found that FMOD modulates in vitro expression and activities of TGF-beta ligands in an isoform-specific manner. In this study, temporospatial expression profiles of TGF-beta ligands and receptors in FMOD-null and wild-type (WT) mice were compared by immunohistochemical staining and quantitative reverse transcriptase-polymerase chain reaction using a full-thickness, primary intention wound closure model. During the inflammatory stage, elevated inflammatory infiltration accompanied by increased type I TGF-beta receptor levels in individual inflammatory cells was observed in FMOD-null wounds. This increased inflammation was correlated with accelerated epithelial migration during the proliferative stage. On the other hand, significantly more robust expression of TGF-beta 3 and TGF-beta receptors in FMOD-null wounds during the proliferative stage was associated with delayed dermal cell migration and proliferation, which led to postponed granulation tissue formation and wound closure and increased scar size. Compared with WT controls, expression of TGF-beta ligands and receptors by FMOD-null dermal cells was markedly reduced during the remodeling stage, which may have contributed to the declined collagen synthesis capability and unordinary collagen architecture. Taken together, this study demonstrates that a single missing gene, FMOD, leads to conspicuous alternations in TGF-beta ligand and receptor expression at all stages of wound repair in various cell types. Therefore, FMOD critically coordinates temporospatial distribution of TGF-beta ligands and receptors in vivo, suggesting that FMOD modulates TGF-beta bioactivity in a complex way beyond simple physical binding to promote proper wound healing.	[Zheng, Zhong; Lee, Kevin S.; Zhang, Xinli; Nguyen, Calvin; Hsu, Chingyun; Rackohn, Todd Matthew; Murphy, Maxwell; Ting, Kang] Univ Calif Los Angeles, Sch Dent, Dent & Craniofacial Res Inst, Los Angeles, CA 90024 USA; [Zheng, Zhong; Lee, Kevin S.; Zhang, Xinli; Nguyen, Calvin; Hsu, Chingyun; Rackohn, Todd Matthew; Murphy, Maxwell; Ting, Kang] Univ Calif Los Angeles, Sch Dent, Sect Orthodont, Los Angeles, CA 90024 USA; [Wang, Joyce Z.] SUNY Downstate, Kings Country Hosp Ctr, Dept Emergency Med, New York, NY USA; [Enjamuri, Dwarak Reddy] Univ Calif Los Angeles, Dept Psychobiol, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Orthopaed Hosp Dept Orthopaed Surg, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Orthopaed Hosp Res Ctr, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ting, K (corresponding author), Univ Calif Los Angeles, Sch Dent, Dent & Craniofacial Res Inst, Los Angeles, CA 90024 USA.	kting@dentistry.ucla.edu; bsoo@ucla.edu	Liu, Chunji/B-5243-2009; Zheng, Zhi/C-4110-2017; Zheng, Zhong/AAZ-9647-2020; Yan, Guijun/A-9809-2011	Zheng, Zhi/0000-0002-1493-1995; Yan, Guijun/0000-0001-9628-1211; Kilian, Andrzej/0000-0002-2730-7462	Plastic Surgery Research Foundation; NIH-NIAMS (SBIR grant) [1R43-AR064126]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR064126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R44DE024692] Funding Source: NIH RePORTER	Plastic Surgery Research Foundation; NIH-NIAMS (SBIR grant); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Plastic Surgery Research Foundation (2013 National Endowment for Plastic Surgery Research Grant Program) and NIH-NIAMS (SBIR grant 1R43-AR064126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN A, 2002, NOVEL TECHNIQUE COMP; [Anonymous], 2011, JUV FAILS LAT STAG T; Baghy K, 2012, J HISTOCHEM CYTOCHEM, V60, P262, DOI 10.1369/0022155412438104; Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111; Beanes Steven R., 2003, Expert Reviews in Molecular Medicine, V5, P1, DOI 10.1017/S1462399403005817; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bossi F, 2011, MOL IMMUNOL, V48, P1676, DOI 10.1016/j.molimm.2011.06.254; BRANDES ME, 1991, J BIOL CHEM, V266, P19697; BRANDES ME, 1991, J IMMUNOL, V147, P1600; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Chaudhury A, 2009, IUBMB LIFE, V61, P929, DOI 10.1002/iub.239; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; Clark R. A. F., 1988, MOL CELLULAR BIOL WO; CUI W, 1995, GENE DEV, V9, P945, DOI 10.1101/gad.9.8.945; DANIELPOUR D, 1990, J BIOL CHEM, V265, P6973; Decline F, 2003, CELL MOTIL CYTOSKEL, V54, P64, DOI 10.1002/cm.10086; Denton CP, 2009, J INVEST DERMATOL, V129, P194, DOI 10.1038/jid.2008.171; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; Goldberg M, 2006, J HISTOCHEM CYTOCHEM, V54, P525, DOI 10.1369/jhc.5A6650.2005; GRANDE J, 1993, LAB INVEST, V69, P387; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; Han GW, 2012, INT J BIOL SCI, V8, P228, DOI 10.7150/ijbs.8.228; HEBDA PA, 1988, J INVEST DERMATOL, V91, P440, DOI 10.1111/1523-1747.ep12476480; Heegaard AM, 2004, J CELL BIOCHEM, V93, P463, DOI 10.1002/jcb.20189; Henry G, 2003, SURG CLIN N AM, V83, P483, DOI 10.1016/S0039-6109(02)00200-1; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Honardoust D, 2012, J BURN CARE RES, V33, P218, DOI 10.1097/BCR.0b013e3182335980; Honardoust D, 2011, WOUND REPAIR REGEN, V19, P368, DOI 10.1111/j.1524-475X.2011.00677.x; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iozzo RV, 2011, BIOL EXTRACELL MATR, P197, DOI 10.1007/978-3-642-16555-9_6; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; Jian J, 2013, BIOCH BIOPHYSICAL RE, V436; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Khorasani H, 2011, AM J PATHOL, V178, P621, DOI 10.1016/j.ajpath.2010.10.019; Kolb M, 2001, AM J PHYSIOL-LUNG C, V280, pL1327, DOI 10.1152/ajplung.2001.280.6.L1327; Lagraoui M, 1997, CELL MOL BIOL, V43, P313; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Levens E, 2005, MOL HUM REPROD, V11, P489, DOI 10.1093/molehr/gah187; LEVINE JH, 1993, AM J PATHOL, V143, P368; Li X, 2006, POULTRY SCI, V85, P326, DOI 10.1093/ps/85.2.326; LIN RY, 1995, ANN SURG, V222, P146, DOI 10.1097/00000658-199508000-00006; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; Lorenz HP, 2008, WOUNDS BIOL PATHOLOG; Mariano JM, 1998, INT J DEV BIOL, V42, P1125; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mayr C, 2005, BLOOD, V105, P1566, DOI 10.1182/blood-2004-04-1233; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Mikaelsson E, 2005, BLOOD, V105, P4828, DOI 10.1182/blood-2004-10-3941; Murata H, 1997, J INVEST DERMATOL, V108, P258, DOI 10.1111/1523-1747.ep12286451; Niewiarowska J, 2011, THROMB RES, V128, P452, DOI 10.1016/j.thromres.2011.06.011; Occleston NL, 2008, J BIOMAT SCI-POLYM E, V19, P1047, DOI 10.1163/156856208784909345; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; PARALKAR VM, 1991, DEV BIOL, V143, P303, DOI 10.1016/0012-1606(91)90081-D; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Qian H, 2004, ORAL DIS, V10, P233, DOI 10.1111/j.1601-0825.2004.00996.x; Ranjzad P, 2009, GENE THER, V16, P1154, DOI 10.1038/gt.2009.63; ROBERTS AB, 1996, MOL CELLULAR BIOL WO, P275; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; SHAH M, 1995, J CELL SCI, V108, P985; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sinno H, 2013, J DERMATOL TREAT, V24, P141, DOI 10.3109/09546634.2011.631977; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Soo C, 2003, AM J PATHOL, V163, P2459, DOI 10.1016/S0002-9440(10)63601-2; Soo C, 2000, AM J PATHOL, V157, P423, DOI 10.1016/S0002-9440(10)64555-5; Soo C, 2001, SURG FORUM, V52, P578; Stoff A, 2007, J MOL MED-JMM, V85, P481, DOI 10.1007/s00109-006-0148-z; Sun T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008515; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Viola M, 2007, CONNECT TISSUE RES, V48, P141, DOI 10.1080/03008200701276133; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Wu LC, 1997, ARCH SURG-CHICAGO, V132, P753; Xiao YQ, 2009, INVEST OPHTH VIS SCI, V50, P1698, DOI 10.1167/iovs.08-1675; Yamanaka O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082730; Zhang Z, 2007, BURNS, V33, P634, DOI 10.1016/j.burns.2006.08.018; Zhang Z, 2009, BURNS, V35, P527, DOI 10.1016/j.burns.2008.08.021; Zheng Z, 2012, BIOMATERIALS, V33, P5821, DOI 10.1016/j.biomaterials.2012.04.049; Zheng Z, 2011, J INVEST DERMATOL, V131, P769, DOI 10.1038/jid.2010.381	86	56	61	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90817	10.1371/journal.pone.0090817	http://dx.doi.org/10.1371/journal.pone.0090817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603701	gold, Green Submitted, Green Published			2022-12-25	WOS:000332483600088
J	Zheng, Z; Kilian, A; Yan, GJ; Liu, CJ				Zheng, Zhi; Kilian, Andrzej; Yan, Guijun; Liu, Chunji			QTL Conferring Fusarium Crown Rot Resistance in the Elite Bread Wheat Variety EGA Wylie	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; DISEASE; BARLEY; MAP; IDENTIFICATION; GRAMINEARUM; SEEDLINGS; SEVERITY	Fusarium crown rot (FCR) is one of the most damaging cereal diseases in semi-arid regions worldwide. The genetics of FCR resistance in the bread wheat (Triticum eastivum L.) variety EGA Wylie, the most resistant commercial variety available, was studied by QTL mapping. Three populations of recombinant inbred lines were developed with this elite variety as the resistant parent. Four QTL conferring FCR resistance were detected and resistance alleles of all of them were derived from the resistant parent EGA Wylie. One of these loci was located on the short arm of chromosome 5D (designated as Qcrs.cpi-5D). This QTL explains up to 31.1% of the phenotypic variance with an LOD value of 9.6. The second locus was located on the long arm of chromosome 2D (designated as Qcrs.cpi-2D) and explained up to 20.2% of the phenotypic variance with an LOD value of 4.5. Significant effects of both Qcrs.cpi-5D and Qcrs.cpi-2D were detected in each of the three populations assessed. Another two QTL (designated as Qcrs.cpi-4B. 1 and Qcrs.cpi-4B.2, respectively) were located on the short arm of chromosome 4B. These two QTL explained up to 16.9% and 18.8% of phenotypic variance, respectively. However, significant effects of Qcrs.cpi-4B.1 and Qcrs.cpi-4B.2 were not detected when the effects of plant height was accounted for by covariance analysis. The elite characteristics of this commercial variety should facilitate the incorporation of the resistance loci it contains into breeding programs.	[Zheng, Zhi; Liu, Chunji] Commenwealth Sci & Ind Res Org CSIRO Plant Ind, St Lucia, Qld, Australia; [Zheng, Zhi; Yan, Guijun; Liu, Chunji] Univ Western Australia, Sch Plant Biol, Fac Sci, Perth, WA 6009, Australia; [Zheng, Zhi; Yan, Guijun; Liu, Chunji] Univ Western Australia, UWA Inst Agr, Perth, WA 6009, Australia; [Zheng, Zhi] Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Natl Foxtail Millet Improvement Ctr, Shijiazhuang, Peoples R China; [Kilian, Andrzej] Divers Arrays Technol Pty Ltd, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Western Australia; Hebei Academy of Agricultural & Forestry Sciences	Liu, CJ (corresponding author), Commenwealth Sci & Ind Res Org CSIRO Plant Ind, St Lucia, Qld, Australia.	Chunji.liu@csiro.au	Liu, Chunji/B-5243-2009; Zheng, Zhi/C-4110-2017; Zheng, Zhong/AAZ-9647-2020; Yan, Guijun/A-9809-2011	Zheng, Zhi/0000-0002-1493-1995; Yan, Guijun/0000-0001-9628-1211; Kilian, Andrzej/0000-0002-2730-7462	Commonwealth Scientific & Industrial Organisation of Australia (CSIRO); University of Western Australia; China Scholarship Council (CSC); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR064126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R44DE024692] Funding Source: NIH RePORTER	Commonwealth Scientific & Industrial Organisation of Australia (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Western Australia; China Scholarship Council (CSC)(China Scholarship Council); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for the study was provided by the Commonwealth Scientific & Industrial Organisation of Australia (CSIRO). Z. Zheng is grateful to the University of Western Australia and China Scholarship Council (CSC) for his PhD scholarships. No additional external funding was received or used for this study. CSIRO determines the research priorities of all research that it funds. Publication of research is subject to review by CSIRO officials. Specific study design, data collection, data analysis, and preparation of the manuscript is under the control of the individual researchers.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Akinsanmi OA, 2004, AUST J AGR RES, V55, P97, DOI 10.1071/AR03090; Anderson JA, 1992, THEOR APPL GENET, V83, P1035, DOI 10.1007/BF00232969; [Anonymous], 2013, QUEENSLAND WHEAT VAR; Bovill WD, 2006, PLANT BREEDING, V125, P538, DOI 10.1111/j.1439-0523.2006.01251.x; Bovill WD, 2010, THEOR APPL GENET, V121, P127, DOI 10.1007/s00122-010-1296-7; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Chakraborty S, 2006, AUSTRALAS PLANT PATH, V35, P643, DOI 10.1071/AP06068; Chen GD, 2014, BMC PLANT BIOL, V14, DOI [10.1186/1471-2229-14-22, 10.1186/1471-2458-14-754]; Chen GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058040; Li HB, 2009, THEOR APPL GENET, V118, P903, DOI 10.1007/s00122-008-0948-3; Li HB, 2010, THEOR APPL GENET, V121, P941, DOI 10.1007/s00122-010-1363-0; Li XM, 2008, J PHYTOPATHOL, V156, P751, DOI 10.1111/j.1439-0434.2008.01425.x; Liu CJ, 2011, CZECH J GENET PLANT, V47, pS109, DOI 10.17221/3264-CJGPB; Liu YX, 2010, PHYTOPATHOLOGY, V100, P1276, DOI 10.1094/PHYTO-05-10-0142; Ma J, 2010, THEOR APPL GENET, V120, P1119, DOI 10.1007/s00122-009-1239-3; Mudge AM, 2006, PHYSIOL MOL PLANT P, V69, P73, DOI 10.1016/j.pmpp.2007.01.003; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Poole GJ, 2012, THEOR APPL GENET, V125, P91, DOI 10.1007/s00122-012-1818-6; PURSS G. S., 1966, Queensland Journal of Agricultural and Animal Sciences, V23, P475; Smiley RW, 2005, PLANT DIS, V89, P595, DOI 10.1094/PD-89-0595; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Van Ooijen JW, 2004, MAPQTL 5; Van Ooijen JW, 2006, JOINTMAP 4; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wallwork H, 2004, AUSTRALAS PLANT PATH, V33, P1, DOI 10.1071/AP03073; WILDERMUTH GB, 1994, PLANT DIS, V78, P949, DOI 10.1094/PD-78-0949; Xie GQ, 2007, AUST J EXP AGR, V47, P603, DOI 10.1071/EA05250; Yan W, 2011, PLANT PATHOL, V60, P506, DOI 10.1111/j.1365-3059.2011.02426.x	30	56	61	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e96011	10.1371/journal.pone.0096011	http://dx.doi.org/10.1371/journal.pone.0096011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24603701	Green Submitted, gold, Green Published			2022-12-25	WOS:000346241800024
J	Xiao, Y; Camarillo, C; Ping, YY; Arana, TB; Zhao, HY; Thompson, PM; Xu, CH; Su, BB; Fan, HH; Ordonez, J; Wang, L; Mao, CX; Zhang, YP; Cruz, D; Escamilla, MA; Li, X; Xu, C				Xiao, Yun; Camarillo, Cynthia; Ping, Yanyan; Arana, Tania Bedard; Zhao, Hongying; Thompson, Peter M.; Xu, Chaohan; Su, Bin Brenda; Fan, Huihui; Ordonez, Javier; Wang, Li; Mao, Chunxiang; Zhang, Yunpeng; Cruz, Dianne; Escamilla, Michael A.; Li, Xia; Xu, Chun			The DNA Methylome and Transcriptome of Different Brain Regions in Schizophrenia and Bipolar Disorder	PLOS ONE			English	Article							RNA-SEQ; PSYCHIATRIC-DISORDERS; PREFRONTAL CORTEX; MAJOR DEPRESSION; POSTMORTEM-BRAIN; GENE-EXPRESSION; MESSENGER-RNA; METHYLATION; PROMOTER; REELIN	Extensive changes in DNA methylation have been observed in schizophrenia (SC) and bipolar disorder (BP), and may contribute to the pathogenesis of these disorders. Here, we performed genome-scale DNA methylation profiling using methylated DNA immunoprecipitation followed by sequencing (MeDIP-seq) on two brain regions (including frontal cortex and anterior cingulate) in 5 SC, 7 BP and 6 normal subjects. Comparing with normal controls, we identified substantial differentially methylated regions (DMRs) in these two brain regions of SC and BP. To our surprise, different brain regions show completely distinct distributions of DMRs across the genomes. In frontal cortex of both SC and BP subjects, we observed widespread hypomethylation as compared to normal controls, preferentially targeting the terminal ends of the chromosomes. In contrast, in anterior cingulate, both SC and BP subjects displayed extensive gain of methylation. Notably, in these two brain regions of SC and BP, only a few DMRs overlapped with promoters, whereas a greater proportion occurs in introns and intergenic regions. Functional enrichment analysis indicated that important psychiatric disorder-related biological processes such as neuron development, differentiation and projection may be altered by epigenetic changes located in the intronic regions. Transcriptome analysis revealed consistent dysfunctional processes with those determined by DMRs. Furthermore, DMRs in the same brain regions from SC and BP could successfully distinguish BP and/or SC from normal controls while differentially expressed genes could not. Overall, our results support a major role for brain-region-dependent aberrant DNA methylation in the pathogenesis of these two disorders.	[Arana, Tania Bedard; Escamilla, Michael A.; Xu, Chun] Texas Tech Univ Hlth Sci Ctr, Dept Psychiat, El Paso, TX USA; [Xiao, Yun; Ping, Yanyan; Zhao, Hongying; Xu, Chaohan; Su, Bin Brenda; Fan, Huihui; Wang, Li; Zhang, Yunpeng; Li, Xia; Xu, Chun] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Camarillo, Cynthia; Ordonez, Javier; Escamilla, Michael A.; Xu, Chun] Texas Tech Univ Hlth Sci Ctr, Ctr Excellence Neurosci, El Paso, TX USA; [Thompson, Peter M.; Cruz, Dianne] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, Southwest Brain Bank, San Antonio, TX 78229 USA; [Mao, Chunxiang] Univ Toronto, Toronto, ON, Canada	Texas Tech University System; Texas Tech University Health Science Center; Harbin Medical University; Texas Tech University System; Texas Tech University Health Science Center; University of Texas System; University of Texas Health San Antonio; University of Toronto	Li, X (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China.	lixia@hrbmu.edu.cn; chun.xu@ttuhsc.edu	li, xia/HHZ-7468-2022; Xiao, Yun/A-8359-2013; Fan, Huihui/AGB-0221-2022	Fan, Huihui/0000-0003-4233-5389; Zhang, Mi/0000-0001-8180-2029; Ping, Yanyan/0000-0002-1810-1200; Arana, Tania/0000-0002-8121-2085	National Natural Science Foundation of China [91129710, 31200997, 61170154]; National Science Foundation of Heilongjiang Province [C201207]; Center of Excellence in Neuroscience of the Paul L. Foster School of Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Heilongjiang Province; Center of Excellence in Neuroscience of the Paul L. Foster School of Medicine	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 91129710, 31200997, and 61170154), the National Science Foundation of Heilongjiang Province (Grant Nos. C201207) and the Center of Excellence in Neuroscience of the Paul L. Foster School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Carlson M., GO DB SET ANNOTATION; Catts VS, 2000, SCHIZOPHR RES, V41, P405, DOI 10.1016/S0920-9964(99)00077-8; Chen C, 2013, MOL PSYCHIATR, V18, P1308, DOI 10.1038/mp.2012.146; Chen C., 2012, MOL PSYCHIAT; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Gavin DP, 2010, NEUROSCI BIOBEHAV R, V34, P882, DOI 10.1016/j.neubiorev.2009.10.010; Glatt SJ, 2003, AM J PSYCHIAT, V160, P469, DOI 10.1176/appi.ajp.160.3.469; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Guintivano J, 2013, EPIGENETICS-US, V8, P290, DOI 10.4161/epi.23924; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jung S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052626; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; KINGSBURY AE, 1995, MOL BRAIN RES, V28, P311, DOI 10.1016/0169-328X(94)00219-5; Labrie V, 2012, TRENDS GENET, V28, P427, DOI 10.1016/j.tig.2012.04.002; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lam LL, 2012, P NATL ACAD SCI USA, V109, P17253, DOI 10.1073/pnas.1121249109; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Mill J, 2006, AM J MED GENET B, V141B, P421, DOI 10.1002/ajmg.b.30316; Miller CL, 2004, BIOTECHNIQUES, V36, P628, DOI 10.2144/04364ST03; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishioka M, 2012, GENOME MED, V4, DOI 10.1186/gm397; Nohesara S, 2011, J PSYCHIATR RES, V45, P1432, DOI 10.1016/j.jpsychires.2011.06.013; Nothen Markus M, 2010, Dialogues Clin Neurosci, V12, P85; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290; Orozco IJ, 2014, MOL CELL NEUROSCI, V58, P76, DOI 10.1016/j.mcn.2013.12.003; Porton B, 2011, SEMIN CELL DEV BIOL, V22, P416, DOI 10.1016/j.semcdb.2011.07.007; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P323, DOI 10.1093/cercor/5.4.323; Rajkowska G, 2001, BIOL PSYCHIAT, V49, P741, DOI 10.1016/S0006-3223(01)01080-0; Rodriguez-Murillo L, 2012, ANNU REV MED, V63, P63, DOI 10.1146/annurev-med-072010-091100; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Strand AD, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030059; Tamura Y, 2007, MOL PSYCHIATR, V12, P593, DOI 10.1038/sj.mp.4001965; The Gene Ontology C, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI [10.1093/nar/gkp1018, DOI 10.1093/NAR/GKP1018]; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Veldic M, 2004, P NATL ACAD SCI USA, V101, P348, DOI 10.1073/pnas.2637013100; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	61	95	101	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95875	10.1371/journal.pone.0095875	http://dx.doi.org/10.1371/journal.pone.0095875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776767	gold, Green Published, Green Submitted			2022-12-25	WOS:000346241800018
J	Miao, HX; Sun, PG; Liu, WX; Xu, BY; Jin, ZQ				Miao, Hongxia; Sun, Peiguang; Liu, Weixin; Xu, Biyu; Jin, Zhiqiang			Identification of Genes Encoding Granule-Bound Starch Synthase Involved in Amylose Metabolism in Banana Fruit	PLOS ONE			English	Article							MOLECULAR-CLONING; POTATO; EXPRESSION; GELATINIZATION; BIOSYNTHESIS; EVOLUTION; ISOFORMS; CDNAS; FOOD	Granule-bound starch synthase (GBSS) is responsible for amylose synthesis, but the role of GBSS genes and their encoded proteins remains poorly understood in banana. In this study, amylose content and GBSS activity gradually increased during development of the banana fruit, and decreased during storage of the mature fruit. GBSS protein in banana starch granules was approximately 55.0 kDa. The protein was up-regulated expression during development while it was down-regulated expression during storage. Six genes, designated as MaGBSSI-1, MaGBSSI-2, MaGBSSI-3, MaGBSSI-4, MaGBSSII-1, and MaGBSSII-2, were cloned and characterized from banana fruit. Among the six genes, the expression pattern of MaGBSSI-3 was the most consistent with the changes in amylose content, GBSS enzyme activity, GBSS protein levels, and the quantity or size of starch granules in banana fruit. These results suggest that MaGBSSI-3 might regulate amylose metabolism by affecting the variation of GBSS levels and the quantity or size of starch granules in banana fruit during development or storage.	[Miao, Hongxia; Liu, Weixin; Xu, Biyu; Jin, Zhiqiang] China Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Trop Crop Biotechnol, Minist Agr, Haikou, Hainan, Peoples R China; [Sun, Peiguang; Jin, Zhiqiang] China Acad Trop Agr Sci, Key Lab Genet Improvement Bananas, Haikou Expt Stn, Haikou, Hainan, Peoples R China; [Liu, Weixin] Hainan Univ, Dept Agr, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences; Hainan University	Xu, BY (corresponding author), China Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Trop Crop Biotechnol, Minist Agr, Haikou, Hainan, Peoples R China.	biyuxu@126.com; 18689846976@163.com		Wu, Jianguo/0000-0002-8326-2895	Ministry of Science and Technology of the People's Republic of China [2011AA10020605]; Modern Agro-industry Technology Research System [nycytx-33]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Modern Agro-industry Technology Research System	The work is financially supported by the Ministry of Science and Technology of the People's Republic of China (NO. 2011AA10020605) and the Modern Agro-industry Technology Research System (nycytx-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio-Saguilan A, 2013, CYTA-J FOOD, V11, P90, DOI 10.1080/19476337.2012.760653; Bansal A, 2012, PLANT CELL TISS ORG, V109, P247, DOI 10.1007/s11240-011-0090-9; Buleon A, 1997, PLANT PHYSIOL, V115, P949, DOI 10.1104/pp.115.3.949; Cheng J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030088, 10.1371/journal.pone.0042436]; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; DRY I, 1992, PLANT J, V2, P193; Edwards A, 2002, PLANT CELL, V14, P1767, DOI 10.1105/tpc.002907; Jiang H, 2013, GENET MOL RES; Jobling S, 2004, CURR OPIN PLANT BIOL, V7, P210, DOI 10.1016/j.pbi.2003.12.001; Juansang J, 2012, FOOD CHEM, V131, P500, DOI 10.1016/j.foodchem.2011.09.013; Juarez-Garcia E, 2013, J SCI FOOD AGR, V93, P2660, DOI 10.1002/jsfa.6054; Kimura T, 2010, BIOSCI BIOTECH BIOCH, V74, P667, DOI 10.1271/bbb.90765; Ko YT, 2009, J AGR FOOD CHEM, V57, P4426, DOI 10.1021/jf900127u; Krishnan HB, 2013, J AGR FOOD CHEM, V61, P5404, DOI 10.1021/jf4014372; Liu J, 2013, FOOD CHEM, V141, P3103, DOI 10.1016/j.foodchem.2013.05.155; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meenakshisundaram P., 2011, Crop Improvement, V38, P155; Nakamura T, 1998, PLANT PHYSIOL, V118, P451, DOI 10.1104/pp.118.2.451; Otani M, 2007, PLANT CELL REP, V26, P1801, DOI 10.1007/s00299-007-0396-6; Park YJ, 2009, BREEDING SCI, V59, P351, DOI 10.1270/jsbbs.59.351; SHURE M, 1983, CELL, V35, P225, DOI 10.1016/0092-8674(83)90225-8; SLACK PT, 1980, J I BREWING, V86, P74, DOI 10.1002/j.2050-0416.1980.tb03961.x; Stover RH, 1987, BANANAS, P192; Vrinten PL, 2000, PLANT PHYSIOL, V122, P255, DOI 10.1104/pp.122.1.255; Wang ZY, 2011, INFLAMM RES, V60, P525, DOI 10.1007/s00011-010-0298-x; Williams PN, 2007, ENVIRON SCI TECHNOL, V41, P6854, DOI 10.1021/es070627i; Xu BY, 2007, PLANTA, V226, P529, DOI 10.1007/s00425-007-0502-6; Yang J. H., 1992, Acta Agronomica Sinica, V18, P366; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zou W, 2012, CARBOHYD POLYM, V87, P1583, DOI 10.1016/j.carbpol.2011.09.060	30	113	136	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88077	10.1371/journal.pone.0088077	http://dx.doi.org/10.1371/journal.pone.0088077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24776922	Green Published, Green Submitted, gold			2022-12-25	WOS:000336971300050
J	Shen, XY; Cheng, YL; Cai, CJ; Fan, L; Gao, J; Hou, CL				Shen, Xiao-Ye; Cheng, Yan-Lin; Cai, Chun-Ju; Fan, Li; Gao, Jian; Hou, Cheng-Lin			Diversity and Antimicrobial Activity of Culturable Endophytic Fungi Isolated from Moso Bamboo Seeds	PLOS ONE			English	Article							DERIVATIVES; TAXOL; SPOT	Bamboos, regarded as therapeutic agents in ethnomedicine, have been used to inhibit inflammation and enhance natural immunity for a long time in Asia, and there are many bamboo associated fungi with medical and edible value. In the present study, a total of 350 fungal strains were isolated from the uncommon moso bamboo (Phyllostachys edulis) seeds for the first time. The molecular diversity of these endophytic fungi was investigated and bioactive compound producers were screened for the first time. All the fungal endophytes were categorized into 69 morphotypes according to culturable characteristics and their internal transcriber spacer (ITS) regions were analyzed by BLAST search with the NCBI database. The fungal isolates showed high diversity and were divided in Ascomycota (98.0%) and Basidiomycota (2.0%), including at least 19 genera in nine orders. Four particular genera were considered to be newly recorded bambusicolous fungi, including Leptosphaerulina, Simplicillium, Sebacina and an unknown genus in Basidiomycetes. Furthermore, inhibitory effects against clinical pathogens and phytopathogens were screened preliminarily and strains B09 (Cladosporium sp.), B34 (Curvularia sp.), B35 (undefined genus 1), B38 (Penicillium sp.) and zzz816 (Shiraia sp.) displayed broad-spectrum activity against clinical bacteria and yeasts by the agar diffusion method. The crude extracts of isolates B09, B34, B35, B38 and zzz816 under submerged fermentation, also demonstrated various levels of bioactivities against bambusicolous pathogenic fungi. This study is the first report on the antimicrobial activity of endophytic fungi associated with moso bamboo seeds, and the results show that they could be exploited as a potential source of bioactive compounds and plant defense activators. In addition, it is the first time that strains of Shiraia sp. have been isolated and cultured from moso bamboo seeds, and one of them (zzz816) could produce hypocrellin A at high yield, which is significantly different from the other strains published.	[Shen, Xiao-Ye; Cheng, Yan-Lin; Fan, Li; Hou, Cheng-Lin] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Cai, Chun-Ju; Gao, Jian] Int Ctr Bamboo & Rattan, Key Lab Bamboo & Rattan Sci & Technol SFA, Beijing, Peoples R China	Capital Normal University; International Centre for Bamboo & Rattan	Gao, J (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	gaojian@icbr.ac.cn; chenglin.hou@gmail.com		Shyam, Rajalekshmy/0000-0003-2154-4173	Key Program of Science and Technology Development Project of Beijing Municipal Education Commission [KZ201110028036]; National Science and Technology [2012BAD23B0503]; National Nature Science Foundation of China [31170019]; Beijing Natural Science Foundation [5133033, 5132009]; NATIONAL EYE INSTITUTE [P30EY001792, R01EY018828, R01EY005628] Funding Source: NIH RePORTER	Key Program of Science and Technology Development Project of Beijing Municipal Education Commission; National Science and Technology; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by Key Program of Science and Technology Development Project of Beijing Municipal Education Commission (KZ201110028036), The "Twelfth Five-Year Plan'' of National Science and Technology Support Project (2012BAD23B0503), National Nature Science Foundation of China (No. 31170019), and Beijing Natural Science Foundation (5133033 and 5132009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SM, 2002, INT J ONCOL, V21, P1229; Cai CJ, 2008, CHINESE AGR SCI B, V12; Cai L, 2003, FUNGAL DIVERS, V13, P1; Cai YJ, 2011, NEW BIOTECHNOL, V28, P588, DOI 10.1016/j.nbt.2011.02.001; CARROLL G, 1988, ECOLOGY, V69, P2, DOI 10.2307/1943154; Chen RS, 2008, PLANT DIS, V92, P1589, DOI 10.1094/PDIS-92-11-1589C; Chunguang R, 2008, FOREST PEST DIS, V1; de Medeiros LS, 2011, HELV CHIM ACTA, V94, P1077, DOI 10.1002/hlca.201000387; de Siqueira VM, 2011, SYMBIOSIS, V53, P89, DOI 10.1007/s13199-011-0113-7; Faeth SH, 2002, INTEGR COMP BIOL, V42, P360, DOI 10.1093/icb/42.2.360; Ganley RJ, 2006, MYCOL RES, V110, P318, DOI 10.1016/j.mycres.2005.10.005; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gure A, 2005, FOREST PATHOL, V35, P23, DOI 10.1111/j.1439-0329.2004.00387.x; HARA C, 1995, FOOD REV INT, V11, P225, DOI 10.1080/87559129509541037; Hino I., 1961, ICONES FUNGORUM BAMB; Hormazabal E, 2009, WORLD J MICROB BIOT, V25, P813, DOI 10.1007/s11274-008-9953-6; Hyde KD, 2002, FUNGAL DIVERS, V11, P109; Hyde KD, 2002, FUNGAL DIVERS, V9, P1; John CK, 2002, CURR SCI INDIA, V82, P261; Jordaan A, 2006, S AFR J BOT, V72, P245, DOI 10.1016/j.sajb.2005.09.007; Joshee S, 2009, MYCOL RES, V113, P1003, DOI 10.1016/j.mycres.2009.06.004; Kharkwal A. C., 2007, V11, P247; Li Xiang-min, 2009, Forest Research, V22, P279; [刘凤 LIU Feng], 2009, [种子, Seed], P12; Liu JK, 2002, HELV CHIM ACTA, V85, P1439, DOI 10.1002/1522-2675(200205)85:5&lt;1439::AID-HLCA1439&gt;3.0.CO;2-X; Ma GY, 2004, ANTIMICROB AGENTS CH, V48, P4450, DOI 10.1128/AAC.48.11.4450-4452.2004; Ma Y, 2008, BIOL CONTROL, V44, P24, DOI 10.1016/j.biocontrol.2007.10.005; Mohanan C., 1991, Commonwealth Forestry Review, V70, P133; Mohanan C, 1990, BAMBOOS CURRENT RES, P173; Mohanan C, 1997, DIS BAMBOOS ASIA ILL; Morakotkarn D, 2008, MYCOSCIENCE, V49, P258, DOI 10.1007/s10267-008-0419-3; Morakotkarn D, 2007, FEMS MICROBIOL LETT, V266, P10, DOI 10.1111/j.1574-6968.2006.00489.x; Nicoletti R, 2007, MYCOPATHOLOGIA, V163, P295, DOI 10.1007/s11046-007-9015-x; PETRINI O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Pezzuto J, 1996, NAT BIOTECHNOL, V14, P1083, DOI 10.1038/nbt0996-1083; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; Shen XY, 2012, BANGL J PHARMACOL, V7, P249, DOI 10.3329/bjp.v7i4.12068; Shukla A. N., 1988, Indian Forester, V114, P714; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; THAL WM, 1986, PHYTOPATHOLOGY, V76, P190, DOI 10.1094/Phyto-76-190; Trisuwan K, 2011, ARCH PHARM RES, V34, P709, DOI 10.1007/s12272-011-0502-8; U'ren JM, 2009, MYCOL RES, V113, P432, DOI 10.1016/j.mycres.2008.11.015; Varma GB, 2006, PHYTOCHEMISTRY, V67, P1925, DOI 10.1016/j.phytochem.2006.05.032; Wan XY., 1981, CHINESE SCI BULL, V26, P1040; Wilson D, 2000, BOOK SOIL P, P389; Xia LM, 1995, J NANJING FORESTRY U, V19, P23; Xu Mei-qing, 2006, Forest Research, V19, P692; Yang HL, 2009, DYES PIGMENTS, V82, P142, DOI 10.1016/j.dyepig.2008.12.012; Zhan ZJ, 2003, ACTA BOT SIN, V45, P248; Zhang P, 2009, CURR MICROBIOL, V59, P227, DOI 10.1007/s00284-008-9270-1; Zhang SX, 1995, J NANJING FORESTRY U, V1, P1; Zhou LH, 2010, CHINESE J CHEM ENG, V18, P122, DOI 10.1016/S1004-9541(08)60332-8; Zhou Zhong-bo, 2005, Journal of Fungal Research, V3, P35	53	55	58	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95838	10.1371/journal.pone.0095838	http://dx.doi.org/10.1371/journal.pone.0095838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24732711	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200096
J	Qiu, Y; Shen, X; Shyam, R; Yue, BYJT; Ying, HY				Qiu, Ye; Shen, Xiang; Shyam, Rajalekshmy; Yue, Beatrice Y. J. T.; Ying, Hongyu			Cellular Processing of Myocilin	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; UBIQUITIN-PROTEASOME SYSTEM; ENDOPLASMIC-RETICULUM STRESS; TRABECULAR MESHWORK CELLS; RETINAL GANGLION-CELLS; MOLECULAR-BIOLOGY; QUALITY-CONTROL; NON-SECRETION; PROTEINS; MUTATIONS	Background: Myocilin (MYOC) is a gene linked directly to juvenile-and adult-onset open angle glaucoma. Mutations including Pro370Leu (P370L) and Gln368stop (Q368X) have been identified in patients. In the present study, we investigated the processing of myocilin in human trabecular meshwork (TM) cells as well as in inducible, stable RGC5 cell lines. Methodology/Principal Findings: The turnover and photoactivation experiments revealed that the endogenous myocilin in human trabecular meshwork (TM) cells was a short-lived protein. It was found that the endogenous myocilin level in TM cells was increased by treatment of lysosomal and proteasomal inhibitors, but not by autophagic inhibitor. Multiple bands immunoreactive to anti-ubiquitin were seen in the myocilin pull down, indicating that myocilin was ubiquitinated. In inducible cell lines, the turnover rate of overexpressed wild-type and mutant P370L and Q368X myocilin-GFP fusion proteins was much prolonged. The proteasome function was compromised and autophagy was induced. A decreased PSMB5 level and an increased level of autophagic marker, LC3, were demonstrated. Conclusions/Significance: The current study provided evidence that in normal homeostatic situation, the turnover of endogenous myocilin involves ubiquitin-proteasome and lysosomal pathways. When myocilin was upregulated or mutated, the ubiquitin-proteasome function is compromised and autophagy is induced. Knowledge of the degradation pathways acting on myocilin can help in design of novel therapeutic strategies for myocilin-related glaucoma.	[Qiu, Ye; Shen, Xiang; Shyam, Rajalekshmy; Yue, Beatrice Y. J. T.; Ying, Hongyu] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yue, BYJT (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago Coll Med, Chicago, IL 60607 USA.	beatyue@uic.edu; hying@uic.edu		Shyam, Rajalekshmy/0000-0003-2154-4173	National Eye Institute, Bethesda, MD [EY005628, EY018828, EY001792]; Research to Prevent Blindness, New York, NY; Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago; NATIONAL EYE INSTITUTE [P30EY001792, R01EY018828, R01EY005628] Funding Source: NIH RePORTER	National Eye Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The present study was supported by grants EY005628, EY018828, and EY001792 (core) from the National Eye Institute, Bethesda, MD, an unrestricted departmental grant from Research to Prevent Blindness, New York, NY, as well as the Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Agarwal N, 2013, INVEST OPHTH VIS SCI, V54, P7884, DOI 10.1167/iovs.13-13292; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Anholt RRH, 2013, TRENDS MOL MED, V19, P586, DOI 10.1016/j.molmed.2013.06.005; Aoun P, 2003, INVEST OPHTH VIS SCI, V44, P2999, DOI 10.1167/iovs.02-1060; Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Aroca-Aguilar JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054385; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Berthoud VA, 2004, CARDIOVASC RES, V62, P256, DOI 10.1016/j.cardiores.2003.12.021; Bikkavilli RK, 2010, J CELL SCI, V123, P1352, DOI 10.1242/jcs.056176; BILL A, 1975, INVEST OPHTH VISUAL, V14, P1; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Caballero M, 2004, BIOCHEM BIOPH RES CO, V323, P1048, DOI 10.1016/j.bbrc.2004.08.195; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Chau KY, 2009, J NEUROCHEM, V110, P1005, DOI 10.1111/j.1471-4159.2009.06191.x; Choi J, 2005, INVEST OPHTH VIS SCI, V46, P214, DOI 10.1167/iovs.04-0765; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Dunlop RA, 2009, IUBMB LIFE, V61, P522, DOI 10.1002/iub.189; Ezzat MK, 2008, EXP EYE RES, V87, P376, DOI 10.1016/j.exer.2008.07.002; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Fukasawa H, 2012, CLIN EXP NEPHROL, V16, P507, DOI 10.1007/s10157-012-0643-1; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Harvey R, 2007, INVEST OPHTH VIS SCI, V48, P1884, DOI 10.1167/iovs.06-0990; He LQ, 2005, CELL RES, V15, P455, DOI 10.1038/sj.cr.7290314; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Janen SB, 2010, GLIA, V58, P1766, DOI 10.1002/glia.21047; Krishnamoorthy RR, 2013, INVEST OPHTH VIS SCI, V54, P5712, DOI 10.1167/iovs.13-12085; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lippincott-Schwartz J, 2008, METHOD CELL BIOL, V85, P45, DOI 10.1016/S0091-679X(08)85003-0; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; NODA T, 1992, J CELL BIOL, V119, P85, DOI 10.1083/jcb.119.1.85; Olanow CW, 2006, MOVEMENT DISORD, V21, P1806, DOI 10.1002/mds.21013; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Plantier JL, 2005, THROMB HAEMOSTASIS, V93, P824, DOI 10.1160/TH04-09-0579; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Resch ZT, 2009, EXP EYE RES, V88, P704, DOI 10.1016/j.exer.2008.08.011; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Riederer BM, 2011, EXP BIOL MED, V236, P268, DOI 10.1258/ebm.2010.010327; Rozsa F W, 1998, Mol Vis, V4, P20; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Shen XA, 2011, J BIOL CHEM, V286, P3618, DOI 10.1074/jbc.M110.175810; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Sohn S, 2009, MOL VIS, V15, P545; Stamer WD, 2012, CURR OPIN OPHTHALMOL, V23, P135, DOI 10.1097/ICU.0b013e32834ff23e; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tamm ER, 2002, PROG RETIN EYE RES; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Ueda J, 2000, J HISTOCHEM CYTOCHEM, V48, P1321, DOI 10.1177/002215540004801003; Valero RA, 2010, TRAFFIC, V11, P1221, DOI 10.1111/j.1600-0854.2010.01091.x; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Van der Horst DJ, 2009, MOL CELL BIOCHEM, V326, P105, DOI 10.1007/s11010-008-0011-3; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Wiggs JL, 2012, INVEST OPHTH VIS SCI, V53, P2467, DOI 10.1167/iovs.12-9483e; Wu WKK, 2010, DRUG RESIST UPDATE, V13, P87, DOI 10.1016/j.drup.2010.04.003; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Ying HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047307; Yue Beatrice Y J T, 2011, Taiwan J Ophthalmol, V1, P6	71	55	58	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e92845	10.1371/journal.pone.0092845	http://dx.doi.org/10.1371/journal.pone.0092845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732711	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400004
J	Sun, XR; Sun, Z; Zhu, Z; Guan, HX; Zhang, JY; Zhang, YN; Xu, HM; Sun, MJ				Sun, Xuren; Sun, Zhe; Zhu, Zhi; Guan, Haixia; Zhang, Junyan; Zhang, Yining; Xu, Huimian; Sun, Mingjun			Clinicopathological Significance and Prognostic Value of Lactate Dehydrogenase A Expression in Gastric Cancer Patients	PLOS ONE			English	Article							AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; LDH-A; CELLS; GROWTH	Introduction: LDH-A, the enzyme responsible for transforming pyruvate into lactate, has been demonstrated to be up-regulated in many types of cancer and to give rise to more aggressive behavior by regulating proliferation and antiapoptosis. However, its expression in gastric cancer (GC) has not been characterized thoroughly. The purpose of this study was to clarify the expression and potential impact of LDH-A in GC. Methods: We examined LDH-A expression by immunohistochemistry on GC tissue microarray (TMA) and using Western blot on fresh GC tissues and cell lines. Prognostic value and correlation with other clinicopathologic factors were evaluated. We transfected siRNA into GC cells against LDH-A. LDH-A was analyzed by Western blotting and real-time RT-PCR. Cell growth was evaluated in vitro and in vivo. Lactate and ATP production by cells were determined. Results: There was significantly higher LDH-A expression in carcinoma than in non-neoplastic mucosa (NNM). There was a positive correlation of LDH-A expression with age, histological type and Lymph node metastases. Survival analysis demonstrated that high expression of LDH-A in GC was associated with lower overall survival (OS). When stratified by Lauren grade and histological classification, significance appeared in diffuse type and undifferentiated type GC. In multivariate analysis, the LDH-A expression in GC was an independent prognostic risk factor for OS (hazard ratio = 1.829, 95% CI 1.375-2.433, P<0.0001). Specific siRNA against LDH-A in GC cell line retarded cell growth both in vitro and in mouse models. LDH-A knockdown also reduced lactate and ATP production in GC cells. Conclusions: Our study indicated the oncogenic role of LDH-A in GC. LDH-A expression is an independent prognostic risk factor in GC patients and up-regulated expression of LDH-A could be predictive of poor outcomes in diffuse type and undifferentiated type GC. Our results suggested that LDH-A might be a potential therapeutic target in gastric cancer.	[Sun, Xuren; Sun, Mingjun] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China; [Sun, Zhe; Zhu, Zhi; Zhang, Junyan; Xu, Huimian] China Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Shenyang, Liaoning Provin, Peoples R China; [Guan, Haixia] China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Yining; Sun, Mingjun] China Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Endoscopy, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Sun, MJ (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China.	smjmw@sina.com		Pan, Chen-Wei/0000-0003-3362-4613	Liaoning Province Science and Technology Department [2007225017, 2009225011-2, 2011415052]; Science and Technology projects in Shenyang City [F11-264-1-19]	Liaoning Province Science and Technology Department; Science and Technology projects in Shenyang City	This study was supported by grants from the research projects in Liaoning Province Science and Technology Department (No. 2007225017, No. 2009225011-2 and No. 2011415052) and Science and Technology projects in Shenyang City (No. F11-264-1-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Cai Z, 2010, MOL CELL PROTEOMICS, V9, P2617, DOI 10.1074/mcp.M110.000661; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; Rong YF, 2013, TUMOR BIOL, V34, P1523, DOI 10.1007/s13277-013-0679-1; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yao F, 2013, TUMOR BIOL, V34, P25, DOI 10.1007/s13277-012-0506-0; Zhang YJ, 2012, CANCER LETT, V321, P45, DOI 10.1016/j.canlet.2012.03.013	18	66	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91068	10.1371/journal.pone.0091068	http://dx.doi.org/10.1371/journal.pone.0091068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24788769	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800094
J	Wang, Y; Jin, S; Sonobe, Y; Cheng, Y; Horiuchi, H; Parajuli, B; Kawanokuchi, J; Mizuno, T; Takeuchi, H; Suzumura, A				Wang, Yue; Jin, Shijie; Sonobe, Yoshifumi; Cheng, Yi; Horiuchi, Hiroshi; Parajuli, Bijay; Kawanokuchi, Jun; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio			Interleukin-1 beta Induces Blood-Brain Barrier Disruption by Downregulating Sonic Hedgehog in Astrocytes	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; NEUROLOGICAL DISEASES; MOLECULAR-MECHANISMS; MAGNETIC-RESONANCE; ALZHEIMERS-DISEASE; CNS	The blood-brain barrier (BBB) is composed of capillary endothelial cells, pericytes, and perivascular astrocytes, which regulate central nervous system homeostasis. Sonic hedgehog (SHH) released from astrocytes plays an important role in the maintenance of BBB integrity. BBB disruption and microglial activation are common pathological features of various neurologic diseases such as multiple sclerosis, Parkinson's disease, amyotrophic lateral sclerosis, and Alzheimer's disease. Interleukin-1 beta (IL-1 beta), a major pro-inflammatory cytokine released from activated microglia, increases BBB permeability. Here we show that IL-1 beta abolishes the protective effect of astrocytes on BBB integrity by suppressing astrocytic SHH production. Astrocyte conditioned media, SHH, or SHH signal agonist strengthened BBB integrity by upregulating tight junction proteins, whereas SHH signal inhibitor abrogated these effects. Moreover, IL-1 beta increased astrocytic production of pro-inflammatory chemokines such as CCL2, CCL20, and CXCL2, which induce immune cell migration and exacerbate BBB disruption and neuroinflammation. Our findings suggest that astrocytic SHH is a potential therapeutic target that could be used to restore disrupted BBB in patients with neurologic diseases.	[Wang, Yue; Jin, Shijie; Sonobe, Yoshifumi; Cheng, Yi; Horiuchi, Hiroshi; Parajuli, Bijay; Kawanokuchi, Jun; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Nagoya, Aichi 464, Japan	Nagoya University	Takeuchi, H (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Nagoya, Aichi 464, Japan.	htake@riem.nagoya-u.ac.jp	Antaki, James/S-3051-2016; Vandenberghe, Stijn/T-9364-2019; Antaki, James Francis/AAC-5331-2020; Vandenberghe, Stijn/G-9038-2016; Bijay, Parajuli/AAT-5590-2021; Parajuli, Bijay/G-2961-2015	Antaki, James/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Antaki, James Francis/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Parajuli, Bijay/0000-0003-3813-113X; Horiuchi, Hiroshi/0000-0001-9008-2027; Takeuchi, Hideyuki/0000-0001-5912-7581	Ministry of Education, Culture, Sports, Science and Technology of Japan; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant from the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; and grants from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Araujo GLL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00077; Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; Blamire AM, 2000, J NEUROSCI, V20, P8153; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Carvey PM, 2009, J NEUROCHEM, V111, P291, DOI 10.1111/j.1471-4159.2009.06319.x; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Cheng Y, 2014, J NEUROIMMUNOL, V269, P38, DOI 10.1016/j.jneuroim.2014.02.001; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; FREQUIN STFM, 1992, J NEUROIMMUNOL, V40, P265, DOI 10.1016/0165-5728(92)90142-8; Friedman WJ, 1996, J BIOL CHEM, V271, P31115, DOI 10.1074/jbc.271.49.31115; Glazner GW, 2000, J NEUROCHEM, V75, P101, DOI 10.1046/j.1471-4159.2000.0750101.x; Grammas P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001918; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Herx LM, 2001, J NEUROPATH EXP NEUR, V60, P961, DOI 10.1093/jnen/60.10.961; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kraus J, 2006, DRUG DISCOV TODAY, V11, P755, DOI 10.1016/j.drudis.2006.06.008; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; Liang JF, 2008, BRAIN RES, V1210, P11, DOI 10.1016/j.brainres.2008.03.012; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; MARTINEY JA, 1990, AM J PATHOL, V137, P1411; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Mastronardi FG, 2004, J IMMUNOL, V172, P6418, DOI 10.4049/jimmunol.172.10.6418; Mastronardi FG, 2003, MULT SCLER, V9, P362, DOI 10.1191/1352458503ms924oa; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Parajuli B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.503; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Sonobe Y, 2009, J BIOL CHEM, V284, P31834, DOI 10.1074/jbc.M109.025940; SUZUMURA A, 1986, SCIENCE, V232, P991, DOI 10.1126/science.3010460; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Traiffort E, 2010, J NEUROCHEM, V113, P576, DOI 10.1111/j.1471-4159.2010.06642.x; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wang JY, 2008, P NATL ACAD SCI USA, V105, P3915, DOI 10.1073/pnas.0709592105; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	47	247	256	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110024	10.1371/journal.pone.0110024	http://dx.doi.org/10.1371/journal.pone.0110024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313834	Green Submitted, Green Published, gold			2022-12-25	WOS:000343662500094
J	Wang, YJ; Loghmanpour, N; Vandenberghe, S; Ferreira, A; Keller, B; Gorcsan, J; Antaki, J				Wang, Yajuan; Loghmanpour, Natasha; Vandenberghe, Stijn; Ferreira, Antonio; Keller, Bradley; Gorcsan, John; Antaki, James			Simulation of Dilated Heart Failure with Continuous Flow Circulatory Support	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICE; PRESSURE-VOLUME RELATIONS; TURBODYNAMIC BLOOD PUMPS; MYOCARDIAL RECOVERY; FILLING PRESSURES; RISK SCORE; IN-VIVO; EXERCISE; MODEL; REST	Lumped parameter models have been employed for decades to simulate important hemodynamic couplings between a left ventricular assist device (LVAD) and the native circulation. However, these studies seldom consider the pathological descending limb of the Frank-Starling response of the overloaded ventricle. This study introduces a dilated heart failure model featuring a unimodal end systolic pressure-volume relationship (ESPVR) to address this critical shortcoming. The resulting hemodynamic response to mechanical circulatory support are illustrated through numerical simulations of a rotodynamic, continuous flow ventricular assist device (cfVAD) coupled to systemic and pulmonary circulations with baroreflex control. The model further incorporated septal interaction to capture the influence of left ventricular (LV) unloading on right ventricular function. Four heart failure conditions were simulated (LV and bi-ventricular failure with/without pulmonary hypertension) in addition to normal baseline. Several metrics of LV function, including cardiac output and stroke work, exhibited a unimodal response whereby initial unloading improved function, and further unloading depleted preload reserve thereby reducing ventricular output. The concept of extremal loading was introduced to reflect the loading condition in which the intrinsic LV stroke work is maximized. Simulation of bi-ventricular failure with pulmonary hypertension revealed inadequacy of LV support alone. These simulations	[Wang, Yajuan; Loghmanpour, Natasha; Ferreira, Antonio; Antaki, James] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Vandenberghe, Stijn] Univ Bern, Bern, Switzerland; [Ferreira, Antonio] Univ Fed Maranhao, Maranhao, Brazil; [Keller, Bradley] Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA; [Gorcsan, John] Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA USA	Carnegie Mellon University; University of Bern; Universidade Federal do Maranhao; University of Louisville; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Antaki, J (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	antaki@cmu.edu	Antaki, James/S-3051-2016; Vandenberghe, Stijn/T-9364-2019; Antaki, James Francis/AAC-5331-2020; Vandenberghe, Stijn/G-9038-2016; Bijay, Parajuli/AAT-5590-2021; Parajuli, Bijay/G-2961-2015	Antaki, James/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Antaki, James Francis/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Parajuli, Bijay/0000-0003-3813-113X; Horiuchi, Hiroshi/0000-0001-9008-2027; Takeuchi, Hideyuki/0000-0001-5912-7581	NIH [1R01HL086918]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research was supported by NIH grant 1R01HL086918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKHOFF D, 1987, AM J PHYSIOL, V252, pH1218, DOI 10.1152/ajpheart.1987.252.6.H1218; CAREY CF, 1998, WASHINGTON MANUAL ME; Choi S., 1998, THESIS U PITTSBURGH; Chung DC, 1997, AM J PHYSIOL-HEART C, V272, pH2942, DOI 10.1152/ajpheart.1997.272.6.H2942; Dang NC, 2006, J HEART LUNG TRANSPL, V25, P1, DOI 10.1016/j.healun.2005.07.008; EHRSAM RE, 1983, CLIN SCI, V65, P653, DOI 10.1042/cs0650653; FARRAR DJ, 1985, WORLD J SURG, V9, P89, DOI 10.1007/BF01656260; Ferreira A, 2007, P ANN INT IEEE EMBS, P3978, DOI 10.1109/IEMBS.2007.4353205; Ferreira A, 2009, IEEE T BIO-MED ENG, V56, P656, DOI 10.1109/TBME.2008.2005960; Fitzpatrick JR, 2009, J THORAC CARDIOV SUR, V137, P971, DOI 10.1016/j.jtcvs.2008.09.021; Fitzpatrick JR, 2008, J HEART LUNG TRANSPL, V27, P1286, DOI 10.1016/j.healun.2008.09.006; Gorcsan J, 2003, J HEART LUNG TRANSPL, V22, P1304, DOI 10.1016/S1053-2498(03)00056-1; Gwak KW, 2004, IEEE DECIS CONTR P, P1069, DOI 10.1109/CDC.2004.1428833; Gwak KW, 2007, ASAIO J, V53, P403, DOI 10.1097/MAT.0b013e31806ada0a; Gwak KW, 2011, ARTIF ORGANS, V35, P725, DOI 10.1111/j.1525-1594.2011.01230.x; Hall JE, 2010, GUYTON HALL TXB MED, P110; KASS DA, 1989, CIRCULATION, V79, P167, DOI 10.1161/01.CIR.79.1.167; Katz AM, 2008, CIRC-HEART FAIL, V1, P63, DOI 10.1161/CIRCHEARTFAILURE.108.772756; Kinoshita M, 1988, ASAIO Trans, V34, P208; KORMOS RL, 1990, ANN THORAC SURG, V49, P261, DOI 10.1016/0003-4975(90)90148-Y; Kormos RL, 2010, J THORAC CARDIOV SUR, V139, P1316, DOI 10.1016/j.jtcvs.2009.11.020; Kovacs G, 2009, EUR RESPIR J, V34, P888, DOI 10.1183/09031936.00145608; Lisy O, 2000, CIRCULATION, V102, P338; LITTLE WC, 1988, CIRCULATION, V78, P736, DOI 10.1161/01.CIR.78.3.736; Matthews JC, 2008, J AM COLL CARDIOL, V51, P2163, DOI 10.1016/j.jacc.2008.03.009; Maybaum S, 2011, CIRCULATION, V123, P355, DOI 10.1161/CIRCULATIONAHA.110.005199; Morley D, 2007, J THORAC CARDIOV SUR, V133, P21, DOI 10.1016/j.jtcvs.2006.07.037; Moscato F, 2010, ARTIF ORGANS, V34, P736, DOI 10.1111/j.1525-1594.2010.01066.x; Nair PK, 2010, J HEART LUNG TRANSPL, V29, P201, DOI 10.1016/j.healun.2009.09.013; Nakatani S, 1996, J AM COLL CARDIOL, V27, P894, DOI 10.1016/0735-1097(95)00555-2; NORDENFELT I, 1985, CLIN PHYSIOL, V5, P161, DOI 10.1111/j.1475-097X.1985.tb00592.x; Palardy M, 2009, CIRC-HEART FAIL, V2, P181, DOI 10.1161/CIRCHEARTFAILURE.108.822999; Rose AG, 2000, ANN THORAC SURG, V70, P1270, DOI 10.1016/S0003-4975(00)01929-9; ROSS J, 1964, CIRCULATION, V29, P739, DOI 10.1161/01.CIR.29.5.739; SARNOFF SJ, 1954, CIRCULATION, V9, P706, DOI 10.1161/01.CIR.9.5.706; Schima H, 2004, J THORAC CARDIOV SUR, V127, P1743, DOI 10.1016/j.jtcvs.2003.09.029; Shi YB, 2006, ARTIF ORGANS, V30, P929, DOI 10.1111/j.1525-1594.2006.00326.x; SHROFF SG, 1985, AM J PHYSIOL, V249, pH358, DOI 10.1152/ajpheart.1985.249.2.H358; Simon MA, 2010, J CARD FAIL, V16, P99, DOI 10.1016/j.cardfail.2009.10.018; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Soloff LA, 1999, CIRCULATION, V100, P1012, DOI 10.1161/circ.100.9.1011/-b; Starling E. H., 1918, LINACRE LECT LAW HEA; STEVENSON LW, 1986, CIRCULATION, V74, P1303, DOI 10.1161/01.CIR.74.6.1303; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; THADANI U, 1978, AM J CARDIOL, V41, P52, DOI 10.1016/0002-9149(78)90131-5; Ursino M, 1998, AM J PHYSIOL-HEART C, V275, pH1733, DOI 10.1152/ajpheart.1998.275.5.H1733; Vandenberghe S, 2003, ARTIF ORGANS, V27, P1094, DOI 10.1111/j.1525-1594.2003.07198.x; Vollkron M, 2002, ARTIF ORGANS, V26, P349, DOI 10.1046/j.1525-1594.2002.06870.x; ZARET BL, 1984, EUR HEART J, V5, P850, DOI 10.1093/oxfordjournals.eurheartj.a061576	49	247	256	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85234	10.1371/journal.pone.0085234	http://dx.doi.org/10.1371/journal.pone.0085234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	25313834	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000027
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24941042	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon R. T., 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/NCLIMATE1958, 10.1038/nclimate1958]; R Core Team, 2021, R LANG ENV STAT COMP; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24941042	Green Published, gold, Green Accepted			2022-12-25	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000343943100017
